data_2mqe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mqe _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 15.6 mp0 . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.819 0.342 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.4 m -80.23 129.11 34.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.638 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -129.06 99.55 5.31 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.739 0.781 . . . . 0.0 111.741 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -83.71 127.7 33.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.054 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.645 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 55.4 m-85 -112.26 124.15 51.83 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.09 104.03 15.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.842 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.1 tp -105.7 123.59 48.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.04 130.47 35.55 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-O 122.1 0.952 . . . . 0.0 112.327 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.654 ' HG ' ' NH2' ' A' ' 256' ' ' ARG . 39.4 m -61.25 -31.44 71.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.2 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -57.96 -40.44 80.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.85 -43.55 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 84.6 mt -79.77 -77.93 0.17 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.526 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER -137.38 131.63 32.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.413 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -107.43 -64.93 1.15 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.28 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.69 -20.51 16.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.545 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.35 159.71 33.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.988 0.423 . . . . 0.0 110.209 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -53.65 -66.74 0.34 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.571 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.07 -2.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.087 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.8 p -53.17 135.99 36.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.034 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 54.2 mt -82.02 137.73 35.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.854 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.8 mtpm? -97.79 157.75 34.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.811 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 213' ' ' GLY . 84.6 Cg_exo -34.1 -76.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.597 2.198 . . . . 0.0 112.486 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.72 -19.17 0.58 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.043 0.449 . . . . 0.0 110.3 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.1 -51.73 9.83 Favored Glycine 0 N--CA 1.459 0.229 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -65.39 -40.57 93.61 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.204 0.526 . . . . 0.0 109.846 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.99 -54.75 41.06 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.018 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.25 86.68 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.615 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.34 -30.09 70.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.217 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.13 -46.56 56.07 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.848 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -62.33 -44.15 97.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.237 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.78 -38.07 89.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.544 ' CE1' ' OG ' ' A' ' 225' ' ' SER . 3.2 t80 -54.2 -50.84 66.16 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.066 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.8 t -55.78 -51.0 68.92 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.393 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.645 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 12.4 tt0 -52.64 -25.01 9.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.0 -18.78 17.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.656 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.544 ' OG ' ' CE1' ' A' ' 221' ' ' TYR . 1.3 m -77.42 -30.77 53.62 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.575 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -87.18 25.0 1.44 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 110.298 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.419 ' H ' HD22 ' A' ' 227' ' ' LEU . 0.8 OUTLIER -79.04 -179.14 6.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.811 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 1.6 t70 -100.93 133.47 21.04 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.75 -19.31 47.43 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.259 1.973 . . . . 0.0 112.744 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -37.15 -52.96 1.03 Allowed 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 110.511 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' GLY . 52.9 m-20 -98.3 -21.16 16.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 24.94 45.98 0.02 OUTLIER Glycine 0 C--N 1.343 0.96 0 O-C-N 123.744 0.653 . . . . 0.0 111.725 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 231' ' ' ASP . 5.2 m -119.44 114.29 22.09 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.032 0.444 . . . . 0.0 110.879 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.0 t -130.19 95.76 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.529 0.68 . . . . 0.0 109.977 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.76 122.77 49.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.345 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 83.0 t -95.63 125.41 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 41.7 mt -109.7 141.89 41.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.126 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -122.12 129.6 7.67 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -113.33 119.49 37.86 Favored 'General case' 0 C--N 1.349 0.574 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 31.1 p -109.97 168.96 9.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.84 0.352 . . . . 0.0 110.758 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.458 ' OD2' ' NH2' ' A' ' 307' ' ' ARG . 44.5 p-10 -90.69 -178.39 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -100.94 124.57 46.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.333 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.463 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 50.1 mm -117.7 12.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.414 0.626 . . . . 0.0 110.745 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.15 6.1 88.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -136.48 96.71 3.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.517 . . . . 0.0 109.729 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -52.22 -50.04 62.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.432 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.69 77.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.619 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -64.21 -43.84 93.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -61.19 -42.83 99.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.467 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.21 -40.11 95.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.377 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.35 -38.94 96.54 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 81.9 mt -73.56 -34.54 65.21 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.88 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 85.6 p -64.29 -40.25 95.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.129 0.49 . . . . 0.0 110.741 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.43 -39.84 62.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.314 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -61.25 -51.71 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.251 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.654 ' NH2' ' HG ' ' A' ' 198' ' ' SER . 8.5 ptm180 -64.05 -46.06 86.03 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.306 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.479 ' N ' ' CG ' ' A' ' 256' ' ' ARG . . . -56.74 -36.49 69.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.399 0.619 . . . . 0.0 109.703 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.75 -44.29 61.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.805 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.9 m -59.1 -39.81 83.38 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.254 0.55 . . . . 0.0 110.134 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.46 -51.73 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.922 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.4 -48.69 87.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.456 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -48.14 -41.46 26.78 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.95 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -78.74 -35.53 44.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.577 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -31.01 72.04 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.897 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.537 ' C ' ' H ' ' A' ' 267' ' ' LYS . 80.8 mt -65.49 -51.62 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 88.5 p -51.82 -8.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.789 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.537 ' H ' ' C ' ' A' ' 265' ' ' ILE . 67.8 mmtt -79.49 -4.45 51.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.541 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.34 41.75 2.92 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.86 127.64 23.92 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 117.031 0.416 . . . . 0.0 110.208 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.31 128.36 25.22 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.609 1.539 . . . . 0.0 111.84 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.07 -8.71 17.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -93.58 -22.9 18.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.191 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -79.86 -17.11 54.03 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.72 0.772 . . . . 0.0 111.032 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.0 pt -107.93 -170.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.463 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 3.2 m -166.86 131.76 2.09 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.224 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -103.1 111.67 24.14 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.768 0.318 . . . . 0.0 110.546 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 30.8 ttm105 -119.79 141.24 49.67 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.71 0.767 . . . . 0.0 111.566 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -92.46 95.27 2.0 Allowed Glycine 0 CA--C 1.519 0.342 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 238' ' ' GLY . 2.7 tpt -68.11 -10.64 55.55 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.223 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 40.58 -98.73 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -141.59 75.37 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 0.0 110.81 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 70.8 m -83.63 -5.62 59.23 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.61 79.2 0.91 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.313 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.71 104.29 0.26 Allowed 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.568 2.179 . . . . 0.0 112.959 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.2 m -75.31 -32.79 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.337 0.589 . . . . 0.0 110.344 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.689 ' C ' ' H ' ' A' ' 288' ' ' ASN . 44.4 p -56.94 -42.59 80.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.793 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.6 -0.3 0.02 OUTLIER Glycine 0 CA--C 1.532 1.124 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.689 ' H ' ' C ' ' A' ' 286' ' ' THR . 17.2 t-20 -122.74 -58.87 1.65 Allowed 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.9 -17.59 64.97 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.542 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 302' ' ' CYS . 72.1 m -116.78 25.6 10.43 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.384 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 293' ' ' VAL . 34.5 t70 -57.88 -49.92 75.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.0 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -76.19 32.41 0.12 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.316 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 291' ' ' ASP . 2.8 t -131.24 104.57 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.655 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -118.97 13.77 13.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . 0.401 ' OE1' ' CA ' ' A' ' 295' ' ' GLN . 0.0 OUTLIER -100.23 139.98 35.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.92 0.39 . . . . 0.0 110.101 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -50.48 -70.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.184 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.92 -39.05 68.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.545 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.36 80.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.261 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 303' ' ' LEU . 26.0 mt -72.65 -53.38 11.95 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.891 0.377 . . . . 0.0 110.815 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 69.4 mt -53.16 -35.14 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 0.0 109.905 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -76.18 -40.38 52.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.192 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.513 ' O ' ' SG ' ' A' ' 290' ' ' CYS . 5.5 t -82.48 -8.78 59.61 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.957 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 299' ' ' LEU . 34.8 mt -91.06 21.4 4.28 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.836 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.622 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.44 -40.3 1.22 Allowed Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.397 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 36.6 Cg_exo -59.14 7.96 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 123.707 2.938 . . . . 0.0 112.719 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 304' ' ' ALA . 5.3 m-20 -111.12 14.46 21.84 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.458 ' NH2' ' OD2' ' A' ' 241' ' ' ASP . 98.5 mtt180 -111.32 90.5 3.35 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.214 0.53 . . . . 0.0 109.75 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.0 ptp180 -162.81 132.63 4.4 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.47 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.15 142.3 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -118.83 106.71 12.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.208 0.527 . . . . 0.0 110.234 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.6 mm -80.05 118.2 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -102.74 102.28 12.43 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.62 0.248 . . . . 0.0 110.874 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 59.8 t -114.85 122.81 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.958 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -120.03 153.31 36.22 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.196 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 89.97 12.4 62.08 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 7.8 tt -95.17 135.64 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.155 0.502 . . . . 0.0 110.712 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp . . . . . 0 N--CA 1.463 0.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.298 -179.758 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 121.262 0.553 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.1 m -69.15 137.2 53.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.487 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 5.5 tptp -112.27 166.37 11.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.322 0.582 . . . . 0.0 110.605 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.412 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 96.6 m-70 -154.74 121.4 5.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.114 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.447 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 68.7 m-85 -108.48 121.05 44.16 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.9 104.08 15.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.497 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 33.8 tp -107.92 127.88 54.13 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -80.95 127.89 33.07 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.61 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.505 ' OG ' ' NH1' ' A' ' 256' ' ' ARG . 1.2 t -63.44 -31.79 73.05 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.024 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.456 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 9.7 t70 -57.16 -41.06 78.49 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.941 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.52 -43.73 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.69 -79.15 0.09 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.44 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -123.65 140.01 53.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.05 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.554 HD21 ' NZ ' ' A' ' 210' ' ' LYS . 52.8 m-80 -109.38 -76.65 0.61 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.383 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.596 ' CE1' ' ND2' ' A' ' 205' ' ' ASN . 53.3 p90 -96.54 -12.68 23.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.622 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 204' ' ' PHE . 30.1 m120 -75.96 160.7 29.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 110.204 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -55.46 -62.02 1.95 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.51 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.517 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.61 1.15 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.128 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.42 134.24 45.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.18 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.33 144.28 34.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.135 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.554 ' NZ ' HD21 ' A' ' 203' ' ' ASN . 21.9 mtmt -104.87 157.54 33.98 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.816 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -34.32 -76.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.5 2.133 . . . . 0.0 112.311 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.423 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 51.6 mp0 -49.75 -20.8 0.91 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.052 0.453 . . . . 0.0 110.316 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.6 -51.01 17.69 Favored Glycine 0 CA--C 1.518 0.232 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -65.34 -40.92 94.26 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.073 0.463 . . . . 0.0 109.763 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.1 -53.94 49.54 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.037 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.23 -38.45 91.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.798 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.76 -27.66 68.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.234 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -73.3 -46.27 50.57 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.381 0.61 . . . . 0.0 110.801 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -62.17 -42.15 98.99 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.096 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.9 -37.41 84.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.031 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.41 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.3 t80 -54.45 -49.49 69.92 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.822 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 225' ' ' SER . 45.9 t -59.84 -49.27 78.37 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.782 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 1.1 tm0? -50.08 -24.09 2.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.421 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 62.7 mt -97.34 -14.13 21.47 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 222' ' ' SER . 94.2 p -78.26 -22.32 48.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.766 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -94.62 18.08 12.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.996 0.427 . . . . 0.0 110.446 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.72 168.76 19.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.137 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.75 132.99 40.65 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 230' ' ' LYS . 56.4 Cg_endo -71.18 -17.56 31.23 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.777 2.318 . . . . 0.0 112.561 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 229' ' ' PRO . 79.9 tttt -32.59 -51.09 0.27 Allowed 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.797 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 232' ' ' GLY . 47.0 m-20 -108.41 -18.08 13.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.263 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.6 51.33 0.06 OUTLIER Glycine 0 N--CA 1.471 1.006 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.0 m -118.02 108.62 15.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 111.159 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.68 96.51 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.31 120.07 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.657 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 92.8 t -92.34 124.81 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.435 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 28.1 mt -109.11 143.64 38.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.016 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.33 130.47 7.54 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -115.32 116.8 28.89 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.439 ' HG1' HH21 ' A' ' 256' ' ' ARG . 69.8 m -104.08 160.58 14.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.643 0.259 . . . . 0.0 110.449 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -89.61 177.81 6.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.69 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.576 ' NE ' ' H ' ' A' ' 244' ' ' GLY . 1.0 OUTLIER -88.74 127.67 35.6 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.477 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 47.0 mm -118.34 9.71 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.248 0.547 . . . . 0.0 110.895 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.576 ' H ' ' NE ' ' A' ' 242' ' ' ARG . . . 102.43 -26.0 25.71 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -118.7 115.27 24.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.173 0.511 . . . . 0.0 110.26 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 246' ' ' ASP . 24.0 p-10 -60.15 -53.1 61.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.861 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.72 -38.93 70.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.299 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -63.0 -44.1 96.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.292 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -62.36 -40.23 95.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.348 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.79 -44.07 97.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.06 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.18 -36.33 93.29 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 36.5 mt -71.71 -37.14 70.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.336 . . . . 0.0 111.027 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.584 ' HG ' ' CA ' ' A' ' 278' ' ' GLY . 35.1 t -64.4 -41.29 96.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.942 0.401 . . . . 0.0 110.652 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.42 -47.76 72.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -59.07 -43.44 91.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.759 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.505 ' NH1' ' OG ' ' A' ' 198' ' ' SER . 0.0 OUTLIER -52.94 -64.17 0.91 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -56.6 -37.08 70.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.459 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.21 -46.83 87.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.655 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 75.7 m -60.66 -38.26 84.28 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.255 0.55 . . . . 0.0 110.439 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 96.0 t -63.98 -51.91 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.999 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 62.6 t -62.11 -49.03 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -45.39 -42.14 9.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.177 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.626 ' HH ' ' HZ1' ' A' ' 267' ' ' LYS . 54.8 t80 -82.04 -29.94 31.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.72 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.72 -8.59 56.11 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.726 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 267' ' ' LYS . 69.2 mt -87.23 -55.87 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.812 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 93.7 p -50.05 -5.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.07 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.626 ' HZ1' ' HH ' ' A' ' 263' ' ' TYR . 71.2 mmtt -77.23 -10.99 59.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.546 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.95 -7.93 23.51 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -80.94 129.84 65.96 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.338 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.44 131.17 39.34 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.75 1.634 . . . . 0.0 111.549 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.91 -8.21 34.83 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 111.251 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 25.9 p30 -94.89 -19.66 20.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.618 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 0.9 OUTLIER -80.87 -21.22 40.87 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.496 0.665 . . . . 0.0 110.636 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.3 pt -104.82 -170.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.589 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 14.9 t -170.94 132.96 0.88 Allowed 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.368 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.87 150.93 20.18 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.845 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 -160.99 150.25 16.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.202 0.525 . . . . 0.0 110.968 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.584 ' CA ' ' HG ' ' A' ' 253' ' ' SER . . . -104.44 145.65 16.06 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.506 ' N ' ' O ' ' A' ' 238' ' ' GLY . 85.6 mmm -120.64 2.71 10.67 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 121.967 0.107 . . . . 0.0 110.831 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 38.33 -97.89 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 279' ' ' MET . 6.9 pt-20 -142.03 68.89 1.32 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.656 0.265 . . . . 0.0 110.462 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 98.5 p -89.3 -2.67 58.54 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -154.14 65.52 5.1 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.515 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.7 107.61 2.51 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.56 2.173 . . . . 0.0 112.363 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 31.5 m -73.09 -29.08 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.521 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 288' ' ' ASN . 40.3 p -58.92 -46.15 88.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.569 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -49.6 -2.93 0.02 OUTLIER Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.626 ' H ' ' C ' ' A' ' 286' ' ' THR . 97.9 m-20 -119.98 -58.66 1.86 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.77 -3.61 51.57 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 286' ' ' THR . 0.5 OUTLIER -130.7 15.52 5.36 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.851 0.357 . . . . 0.0 110.155 179.395 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -65.9 -2.47 3.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.98 0.419 . . . . 0.0 110.304 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 290' ' ' CYS . 20.1 p-10 -109.9 31.71 5.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.86 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.416 ' CG2' ' SG ' ' A' ' 290' ' ' CYS . 20.8 t -130.25 121.33 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 110.33 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -119.32 12.19 12.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.702 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.96 130.59 45.33 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.088 0.47 . . . . 0.0 109.815 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -51.99 -64.85 0.68 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.937 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.21 -37.55 64.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.638 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.39 84.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.646 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 303' ' ' LEU . 17.4 mt -72.81 -47.86 42.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.004 0.43 . . . . 0.0 110.78 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.5 mt -60.47 -32.83 52.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.433 . . . . 0.0 110.262 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -82.92 -27.25 30.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.712 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 40.5 t -90.8 -20.37 22.42 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.761 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 299' ' ' LEU . 60.8 mt -85.71 24.96 1.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.528 0.517 . . . . 0.0 111.145 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.58 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -76.48 -44.09 3.32 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 22.4 Cg_exo -62.76 9.35 0.1 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.276 2.651 . . . . 0.0 112.084 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 304' ' ' ALA . 8.2 t70 -104.46 10.73 35.1 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.877 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.489 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 7.9 ptm180 -111.9 97.82 6.95 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.539 0.685 . . . . 0.0 109.965 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.543 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.6 ptm180 -159.0 132.3 7.24 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.333 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.63 141.11 16.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -121.35 106.2 11.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.072 0.463 . . . . 0.0 110.53 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.7 mm -78.55 117.48 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -97.49 132.0 43.59 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.23 118.43 32.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.255 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -115.89 134.55 54.87 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.83 -5.12 56.45 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 18.7 tt -79.91 147.17 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.953 0.406 . . . . 0.0 110.524 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.235 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.45 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 1.2 pm0 . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 120.606 0.241 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.3 m -75.11 137.88 41.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.696 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.494 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 13.5 tptt -111.26 166.86 10.74 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.487 0.661 . . . . 0.0 110.558 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.494 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 5.4 m80 -150.55 120.38 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.775 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -110.45 119.53 39.48 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 104.9 16.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.45 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 24.6 tp -107.96 122.82 47.6 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -78.62 130.4 35.86 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.909 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 202' ' ' PHE . 90.3 p -61.45 -29.36 69.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.105 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -60.27 -38.21 82.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.921 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.7 t -67.82 -42.97 86.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.0 mt -79.94 -78.15 0.17 Allowed 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.453 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER -135.39 127.03 28.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.501 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -102.33 -68.4 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.039 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -91.12 -22.69 20.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.552 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -69.22 161.22 29.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.912 0.387 . . . . 0.0 109.967 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -63.02 -57.28 11.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.44 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -165.92 -7.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.947 0.403 . . . . 0.0 110.206 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 69.4 p -52.46 131.22 33.39 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.262 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.8 mt -77.51 144.5 37.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.483 0.659 . . . . 0.0 111.211 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.9 mtpt -105.2 157.29 34.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.141 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 213' ' ' GLY . 89.3 Cg_exo -34.52 -76.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.762 2.308 . . . . 0.0 112.413 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -48.2 -20.37 0.37 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.099 0.476 . . . . 0.0 110.328 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.16 -48.51 19.42 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.389 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -65.62 -40.76 92.92 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.2 -52.34 65.73 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.076 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.88 85.45 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 121.56 0.695 . . . . 0.0 110.397 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 mt -65.62 -28.84 69.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.009 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -72.01 -47.85 48.94 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.371 0.605 . . . . 0.0 110.981 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.425 ' O ' ' OG ' ' A' ' 222' ' ' SER . 6.5 pt20 -62.51 -42.03 99.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.868 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.2 tp -64.91 -40.35 94.93 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -52.3 -47.27 66.02 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.813 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 219' ' ' GLN . 75.0 p -55.94 -51.27 68.25 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.796 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -52.28 -25.64 9.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 42.8 mt -99.15 -20.88 16.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.677 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 6.8 t -72.75 -24.34 60.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -102.79 23.73 11.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.66 147.62 39.34 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 315' ' ' GLY . 25.8 t0 -62.95 112.07 6.08 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 230' ' ' LYS . 50.7 Cg_exo -53.67 -20.89 17.92 Favored 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.517 2.145 . . . . 0.0 113.181 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 229' ' ' PRO . 11.2 mmmt -29.79 -52.54 0.14 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.952 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' GLY . 34.0 m-20 -105.98 -17.18 14.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.388 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 27.86 49.33 0.07 OUTLIER Glycine 0 N--CA 1.465 0.58 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.347 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.96 108.08 15.35 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.9 96.61 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.712 0.768 . . . . 0.0 110.018 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.8 t -96.19 117.78 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.291 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 88.2 t -95.26 121.4 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.033 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 24.6 mt -108.76 141.8 40.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.986 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.48 126.84 6.2 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.34 122.05 46.84 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.495 ' OG1' ' NH1' ' A' ' 256' ' ' ARG . 55.2 m -109.49 166.11 11.14 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.414 0.446 . . . . 0.0 110.613 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.524 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 40.1 p-10 -90.44 173.3 8.17 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.118 0.485 . . . . 0.0 111.17 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.41 ' NH2' ' OE2' ' A' ' 281' ' ' GLU . 64.0 ttm-85 -92.61 126.53 37.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.166 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.474 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 50.1 mm -118.32 15.15 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.231 0.538 . . . . 0.0 110.442 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 86.07 -1.86 87.69 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' SER . . . . . 0.659 ' HG ' ' H ' ' A' ' 248' ' ' TYR . 11.8 t -131.44 105.92 7.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.156 0.503 . . . . 0.0 110.179 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 247' ' ' ALA . 22.0 p-10 -55.54 -51.5 66.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.613 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 246' ' ' ASP . . . -55.54 -39.61 70.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.659 ' H ' ' HG ' ' A' ' 245' ' ' SER . 29.1 t80 -65.02 -43.46 92.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.204 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 17.6 t-20 -61.87 -43.15 99.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -65.74 -41.77 91.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.81 -39.52 98.09 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.404 ' CD1' ' CE2' ' A' ' 248' ' ' TYR . 27.4 mt -72.8 -35.93 67.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.501 -0.349 . . . . 0.0 110.594 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 39.5 t -62.96 -42.69 99.9 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.89 -46.88 79.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.895 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -55.92 -45.25 78.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.495 ' NH1' ' OG1' ' A' ' 240' ' ' THR . 28.8 ttm105 -55.29 -65.87 0.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.826 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.09 64.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.47 -48.4 64.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.612 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 77.6 p -57.7 -39.39 77.08 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.117 0.484 . . . . 0.0 110.404 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.32 -54.01 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.432 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.6 t -60.11 -49.12 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.954 -0.299 . . . . 0.0 110.492 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.09 -44.17 31.45 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.656 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.624 ' CE1' ' NZ ' ' A' ' 267' ' ' LYS . 90.3 t80 -78.39 -34.9 47.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.831 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.41 -25.97 68.23 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.094 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.473 ' C ' ' H ' ' A' ' 267' ' ' LYS . 86.6 mt -71.33 -52.46 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.777 0.322 . . . . 0.0 111.708 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 6.2 t -50.04 -10.92 0.06 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.48 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.624 ' NZ ' ' CE1' ' A' ' 263' ' ' TYR . 0.1 OUTLIER -77.81 -10.81 59.74 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.204 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 105.99 41.87 1.75 Allowed Glycine 0 CA--C 1.533 1.172 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.79 131.49 24.02 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-N 117.193 0.496 . . . . 0.0 110.79 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.46 125.26 17.18 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.553 1.502 . . . . 0.0 111.48 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.01 -8.39 29.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.135 0.493 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -91.2 -22.93 20.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.334 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -81.37 -20.22 41.01 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.465 0.65 . . . . 0.0 111.167 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.9 pt -103.71 -173.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.435 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 17.4 p -168.62 129.26 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.511 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.09 111.49 23.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.948 0.404 . . . . 0.0 110.583 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -120.72 146.46 46.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.464 0.65 . . . . 0.0 111.062 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.51 142.46 16.16 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.405 ' N ' ' O ' ' A' ' 238' ' ' GLY . 1.6 mmt -118.92 -5.87 10.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.92 -104.28 0.05 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.41 ' OE2' ' NH2' ' A' ' 242' ' ' ARG . 9.4 pt-20 -142.26 68.7 1.32 Allowed 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.859 -0.201 . . . . 0.0 110.789 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 74.3 m -67.09 -42.06 85.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.614 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.406 ' ND2' HH21 ' A' ' 308' ' ' ARG . 6.9 p-10 -125.66 80.54 66.3 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.105 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.87 106.67 0.66 Allowed 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.714 2.276 . . . . 0.0 112.543 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 12.5 m -75.81 -30.76 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.132 0.491 . . . . 0.0 110.414 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.677 ' C ' ' H ' ' A' ' 288' ' ' ASN . 60.4 p -56.69 -43.16 80.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.664 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.13 0.52 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.677 ' H ' ' C ' ' A' ' 286' ' ' THR . 24.1 t-20 -123.2 -58.53 1.63 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.22 -14.33 62.91 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.503 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 57.2 m -128.53 22.28 5.98 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.301 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -69.77 -2.49 12.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.697 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -110.24 32.09 5.41 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.535 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 23.3 t -130.93 124.02 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.99 0.424 . . . . 0.0 110.299 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -118.95 7.9 11.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.385 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -90.27 169.44 11.11 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -82.9 -71.18 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.683 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -57.88 -28.13 63.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.951 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.74 94.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.357 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 303' ' ' LEU . 47.6 mt -70.86 -49.11 49.61 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 110.534 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.4 mt -54.89 -31.67 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -80.25 -32.68 38.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.476 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -12.18 46.82 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.721 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 299' ' ' LEU . 48.5 mt -90.47 21.92 3.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.761 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.586 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -78.48 -43.26 2.01 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.98 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.5 Cg_exo -61.78 8.55 0.1 Allowed 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 123.409 2.739 . . . . 0.0 112.044 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.545 ' H ' ' C ' ' A' ' 304' ' ' ALA . 50.6 t0 -102.49 12.2 36.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.457 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -113.98 98.48 7.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.445 0.64 . . . . 0.0 109.838 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.552 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 33.5 ptt180 -157.73 130.9 7.62 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.306 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.5 140.06 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -120.84 105.83 11.08 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.362 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.0 mm -79.33 117.64 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.68 127.75 41.98 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.77 115.56 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.196 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -114.83 125.8 54.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 91.15 43.74 4.6 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.605 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.5 tt -114.83 168.61 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.605 ' O ' ' O ' ' A' ' 316' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 O-C-N 124.07 0.857 . . . . 0.0 110.868 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 1.6 pm0 . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.3 m -85.17 142.07 29.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.193 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -143.45 111.42 6.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.562 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.4 OUTLIER -97.96 148.28 23.63 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -112.07 130.36 55.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.913 0.387 . . . . 0.0 110.303 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.23 103.7 16.02 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.045 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 28.7 tp -108.47 128.37 54.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.178 0.513 . . . . 0.0 109.648 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -81.7 125.14 30.24 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.994 0.902 . . . . 0.0 112.16 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.669 ' HG ' ' NH2' ' A' ' 256' ' ' ARG . 18.5 m -61.05 -32.14 71.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.196 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -59.66 -36.72 76.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.34 -42.96 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 76.3 mt -78.9 -78.33 0.15 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.322 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.68 128.1 41.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.966 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.418 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 62.0 t-20 -111.93 -71.48 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.438 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -84.34 -32.32 24.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -73.73 165.89 24.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.196 0.522 . . . . 0.0 110.245 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.642 ' C ' HH22 ' A' ' 255' ' ' ARG . 32.6 mmtp -58.94 -82.41 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.457 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.484 ' N ' HH12 ' A' ' 255' ' ' ARG . . . -148.65 56.55 1.03 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 73.4 p -107.54 130.2 54.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.131 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 40.6 mt -78.04 134.97 37.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.732 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.4 mtmt -97.06 159.21 31.92 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.917 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 210' ' ' LYS . 88.8 Cg_exo -34.63 -76.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.235 1.957 . . . . 0.0 111.875 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.22 -22.13 0.96 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.101 0.477 . . . . 0.0 110.244 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.53 -52.0 14.35 Favored Glycine 0 N--CA 1.46 0.276 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -64.99 -39.56 93.66 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.323 0.583 . . . . 0.0 109.908 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.75 -54.66 43.76 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.153 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.6 -36.0 82.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.984 0.421 . . . . 0.0 110.678 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.3 mt -61.56 -31.66 71.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.152 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.67 -45.51 58.51 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.279 0.562 . . . . 0.0 110.616 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -61.52 -44.98 96.09 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.808 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 38.3 tp -63.65 -40.6 97.27 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.262 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.545 ' CZ ' ' OG ' ' A' ' 225' ' ' SER . 6.5 t80 -51.54 -48.35 63.06 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.985 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.7 t -54.25 -52.11 62.38 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.55 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -51.56 -26.66 9.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.4 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 21.7 mt -98.35 -19.0 18.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.545 ' OG ' ' CZ ' ' A' ' 221' ' ' TYR . 4.7 m -71.68 -32.91 68.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -96.96 21.68 9.37 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.07 151.49 38.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.794 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 315' ' ' GLY . 15.6 t0 -65.39 124.6 87.54 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.128 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 232' ' ' GLY . 48.0 Cg_endo -69.16 -19.73 38.59 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 122.894 2.396 . . . . 0.0 113.313 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 229' ' ' PRO . 39.0 ttmt -24.12 -50.06 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.576 0 O-C-N 123.62 0.575 . . . . 0.0 111.037 -177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.472 ' O ' ' C ' ' A' ' 232' ' ' GLY . 32.5 t70 -115.44 -12.9 11.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.212 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 25.66 49.93 0.04 OUTLIER Glycine 0 N--CA 1.472 1.095 0 O-C-N 123.861 0.725 . . . . 0.0 111.456 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.5 t -112.03 114.13 26.83 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 122.574 -0.368 . . . . 0.0 110.352 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.6 t -129.05 95.91 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.266 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 275' ' ' SER . 2.8 t -96.74 123.98 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.097 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.75 120.94 46.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.823 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 40.8 mt -103.74 145.38 30.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.167 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.68 129.04 7.34 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 1.0 OUTLIER -110.53 125.77 53.69 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.544 ' OG1' ' ND2' ' A' ' 249' ' ' ASN . 3.1 p -116.78 162.82 17.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.535 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 7.0 p30 -84.75 172.09 11.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -88.74 122.53 32.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.425 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 47.7 mm -118.06 7.94 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.293 0.568 . . . . 0.0 110.617 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 82.33 13.98 77.53 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -142.08 92.15 2.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.107 0.479 . . . . 0.0 109.943 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -49.25 -49.69 42.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.508 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.24 78.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.409 ' CE2' ' CD1' ' A' ' 252' ' ' LEU . 40.3 t80 -65.18 -43.2 92.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.062 0.458 . . . . 0.0 110.637 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.544 ' ND2' ' OG1' ' A' ' 240' ' ' THR . 27.4 t-20 -61.49 -43.4 98.94 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.634 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.52 -45.05 92.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.638 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.11 92.1 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.656 ' CD2' HH21 ' A' ' 255' ' ' ARG . 18.0 mt -64.69 -43.66 92.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.998 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 33.3 m -66.83 -43.69 83.09 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.885 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.58 -57.21 13.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.475 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.656 HH21 ' CD2' ' A' ' 252' ' ' LEU . 36.5 ptt85 -59.11 -45.16 91.58 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.156 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.669 ' NH2' ' HG ' ' A' ' 198' ' ' SER . 19.2 mtp-105 -58.16 -50.58 73.03 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.535 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.38 69.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.84 -40.39 72.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.137 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 256' ' ' ARG . 76.4 p -63.43 -37.86 88.93 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.192 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.48 -51.1 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.491 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.4 t -61.23 -49.56 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.2 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -45.94 -38.8 8.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.93 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.497 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 63.6 t80 -84.9 -31.68 23.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.49 -13.5 62.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.446 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 267' ' ' LYS . 66.5 mt -83.89 -52.15 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 111.148 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 9.0 t -50.49 -6.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.59 ' H ' ' C ' ' A' ' 265' ' ' ILE . 73.7 mmtt -79.63 -10.67 59.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.616 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 104.55 40.72 2.15 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.68 127.86 24.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.87 128.03 25.2 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.822 1.681 . . . . 0.0 111.811 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.07 -11.65 15.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.008 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.36 -26.07 21.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.774 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -74.51 -22.81 58.87 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.909 0.861 . . . . 0.0 110.659 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -104.14 -172.8 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.547 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 235' ' ' VAL . 13.3 t -170.24 124.8 0.74 Allowed 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.396 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.72 156.97 16.81 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.801 -0.562 . . . . 0.0 109.795 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -174.1 166.84 4.23 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 122.009 0.909 . . . . 0.0 110.855 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.22 146.03 16.02 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.341 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 4.3 tpt -116.0 -10.97 11.51 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.914 0.388 . . . . 0.0 110.291 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 53.7 -111.23 1.77 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -141.76 72.26 1.38 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.879 0.371 . . . . 0.0 110.403 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.1 t -62.23 -42.06 98.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.113 0.482 . . . . 0.0 111.369 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -129.07 79.16 75.03 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.43 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -54.66 107.97 0.26 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.452 2.101 . . . . 0.0 112.113 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.3 m -65.75 -44.99 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.632 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.662 ' C ' ' H ' ' A' ' 288' ' ' ASN . 67.5 p -60.6 -43.68 97.15 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.813 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.37 -6.88 0.01 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.662 ' H ' ' C ' ' A' ' 286' ' ' THR . 29.7 m-80 -130.47 -56.02 1.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.116 0.566 . . . . 0.0 109.675 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 m -64.47 -30.46 71.49 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.918 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 22.37 10.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.957 0.408 . . . . 0.0 110.453 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 45.7 t0 -63.46 -10.97 19.98 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.612 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -98.87 32.17 2.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.743 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 40.0 t -128.04 124.98 63.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.1 0.476 . . . . 0.0 110.196 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -119.13 11.01 12.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -100.07 130.26 46.21 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.411 0.624 . . . . 0.0 110.201 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 299' ' ' LEU . 7.9 ttm180 -52.61 -76.24 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.55 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -41.91 -38.35 1.54 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.11 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.85 94.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.104 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 296' ' ' ARG . 35.5 mt -72.2 -41.48 66.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.575 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.4 mm -57.65 -31.48 39.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.11 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -86.84 -43.9 12.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.51 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.75 -19.93 65.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.985 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.46 25.43 1.68 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.459 0.474 . . . . 0.0 111.255 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.57 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -77.2 -43.6 2.69 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.924 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 18.8 Cg_exo -64.73 7.96 0.23 Allowed 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.472 2.781 . . . . 0.0 111.511 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 304' ' ' ALA . 10.0 m-20 -103.29 7.74 38.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.02 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.418 ' NH1' ' OD1' ' A' ' 203' ' ' ASN . 64.7 mtm180 -112.61 94.75 5.06 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.236 0.541 . . . . 0.0 110.2 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 39.5 ptt180 -164.46 136.73 4.7 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.535 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.44 143.9 11.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.61 -0.681 . . . . 0.0 109.562 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -117.69 103.78 10.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 193' ' ' HIS . 0.3 OUTLIER -80.98 113.37 20.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.211 -178.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -92.84 119.32 32.05 Favored 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 123.374 0.421 . . . . 0.0 110.73 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.25 117.32 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.807 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -113.98 128.63 56.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 98.15 40.83 3.4 Favored Glycine 0 C--O 1.226 -0.366 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.664 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.1 tt -116.94 170.03 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.664 ' O ' ' O ' ' A' ' 316' ' ' ILE . 51.8 mtpt . . . . . 0 N--CA 1.464 0.254 0 O-C-N 124.074 0.859 . . . . 0.0 111.357 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.958 0.409 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 36.0 m -69.19 135.19 50.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.425 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 0.1 OUTLIER -115.38 169.44 9.15 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.411 0.624 . . . . 0.0 110.72 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 94.8 m-70 -155.68 125.44 6.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.081 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.534 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 66.3 m-85 -112.54 117.64 32.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.88 104.82 15.89 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.989 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 29.6 tp -108.47 130.82 55.25 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -79.39 128.44 33.34 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.948 0.88 . . . . 0.0 111.877 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 202' ' ' PHE . 18.0 t -64.06 -31.93 73.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.088 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -58.92 -37.28 76.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.979 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 91.6 t -66.81 -43.87 89.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.31 -77.73 0.16 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.947 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -126.0 129.55 49.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.716 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -101.35 -74.44 0.62 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.34 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.609 ' CE2' ' ND2' ' A' ' 205' ' ' ASN . 54.7 p90 -99.09 -21.67 16.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.932 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.609 ' ND2' ' CE2' ' A' ' 204' ' ' PHE . 32.9 m120 -72.77 164.67 26.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.272 0.558 . . . . 0.0 110.057 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.41 ' HG3' ' H ' ' A' ' 207' ' ' ALA . 5.3 pttm -49.56 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.198 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.41 ' H ' ' HG3' ' A' ' 206' ' ' LYS . . . -156.43 58.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.255 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.04 131.62 53.89 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.5 mt -75.21 139.35 42.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.747 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.2 mtpm? -98.44 158.72 32.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.708 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 213' ' ' GLY . 81.8 Cg_exo -34.01 -76.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.558 2.172 . . . . 0.0 112.013 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -50.9 -18.44 0.76 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.126 0.488 . . . . 0.0 110.162 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.72 -47.89 11.22 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -66.98 -40.27 87.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.34 70.19 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.24 83.41 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.411 0.624 . . . . 0.0 110.485 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.82 -30.92 71.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.063 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.49 -47.34 56.08 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.134 0.493 . . . . 0.0 110.867 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -63.9 -42.63 97.38 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.283 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 40.4 tp -64.87 -40.68 95.51 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.1 t80 -53.44 -49.11 68.05 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.968 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.5 m -55.76 -50.57 70.05 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.348 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.534 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 10.9 tt0 -53.17 -24.18 10.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.42 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 74.3 mt -95.96 -20.02 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.583 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.2 t -73.06 -21.57 60.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.92 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -99.75 20.42 14.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.714 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.27 161.4 28.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.18 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 315' ' ' GLY . 9.5 t0 -78.75 126.94 81.66 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' LYS . 45.9 Cg_endo -68.82 -17.27 41.99 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.718 2.279 . . . . 0.0 113.051 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 229' ' ' PRO . 14.4 mmtp -27.62 -46.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.74 0.65 . . . . 0.0 110.964 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.476 ' O ' ' C ' ' A' ' 232' ' ' GLY . 9.6 m-20 -117.89 -14.92 10.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.36 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.21 51.64 0.06 OUTLIER Glycine 0 N--CA 1.474 1.182 0 O-C-N 123.985 0.803 . . . . 0.0 111.346 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 73.6 m -116.63 111.97 20.61 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 122.788 -0.242 . . . . 0.0 110.791 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.3 t -126.71 96.47 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.019 0.438 . . . . 0.0 110.075 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.15 121.18 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.446 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.54 125.85 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.982 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 23.4 mt -109.08 143.96 37.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.933 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -120.13 138.95 13.42 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.622 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.2 OUTLIER -121.7 117.32 26.37 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.413 ' OG1' ' OD1' ' A' ' 249' ' ' ASN . 7.7 p -112.74 164.81 12.92 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.223 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.439 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 47.6 p-10 -85.22 177.53 7.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.32 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -104.0 127.2 51.55 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.103 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 51.1 mm -118.84 19.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.444 0.64 . . . . 0.0 110.706 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.44 7.51 86.31 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.8 t -136.3 99.06 4.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.996 0.427 . . . . 0.0 110.212 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -51.5 -50.04 60.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.577 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.94 -39.54 71.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.575 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -62.14 -47.16 85.78 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.97 0.414 . . . . 0.0 110.502 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 11.1 t-20 -62.2 -41.37 98.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.636 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -64.55 -44.27 91.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 110.751 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.09 -36.03 92.34 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.36 -34.76 63.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.687 0.279 . . . . 0.0 111.365 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.473 ' OG ' ' CA ' ' A' ' 278' ' ' GLY . 12.0 t -65.01 -43.76 91.42 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.016 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -71.09 -40.13 71.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.417 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -60.11 -50.02 75.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.592 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -61.19 -53.99 49.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.747 0.308 . . . . 0.0 110.351 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -54.58 -35.49 63.39 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.164 0.507 . . . . 0.0 109.919 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -71.3 -44.33 65.37 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.258 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 17.1 m -62.02 -37.49 85.12 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.528 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.12 -51.41 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.543 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.92 -48.64 87.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.054 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -45.48 -41.08 9.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.942 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.532 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 57.4 t80 -81.42 -30.69 33.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.653 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.5 -8.53 56.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.633 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.5 mt -87.33 -55.77 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.807 0.337 . . . . 0.0 111.264 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.9 m -50.72 -4.79 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.588 ' H ' ' C ' ' A' ' 265' ' ' ILE . 30.1 mmtp -79.39 -11.0 59.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.774 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.27 39.92 2.03 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 128.57 24.09 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.5 128.46 25.96 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.595 1.53 . . . . 0.0 112.037 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.8 -6.93 13.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.787 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 6.4 p30 -94.54 -21.75 18.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.905 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 1.2 ttpm? -80.4 -21.2 42.5 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.505 0.669 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . 0.41 ' O ' ' OG ' ' A' ' 275' ' ' SER . 1.6 pt -103.89 -171.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.626 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 274' ' ' ILE . 22.0 m -171.17 129.56 0.73 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.145 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.86 152.25 18.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -161.38 148.79 14.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.361 0.601 . . . . 0.0 110.6 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.473 ' CA ' ' OG ' ' A' ' 253' ' ' SER . . . -126.12 100.46 0.58 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.622 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 8.1 ptp -88.0 24.03 1.92 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.649 0.261 . . . . 0.0 110.931 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . 0.448 ' H ' ' HG ' ' A' ' 253' ' ' SER . . . 39.12 -93.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 279' ' ' MET . 4.5 pt-20 -140.68 74.91 1.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.826 0.346 . . . . 0.0 110.447 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.4 m -90.38 -0.73 57.77 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.466 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -153.86 56.28 1.54 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.354 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.61 109.49 1.86 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.558 2.172 . . . . 0.0 112.28 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 22.5 m -78.87 -23.94 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.436 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.7 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.6 OUTLIER -59.71 -45.06 93.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.702 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -49.95 -0.1 0.01 OUTLIER Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.7 ' H ' ' C ' ' A' ' 286' ' ' THR . 25.7 t-20 -124.72 -57.19 1.55 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.6 m -54.82 -42.52 72.0 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 8.2 m -94.22 34.78 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.287 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 41.4 t0 -74.77 -7.99 55.05 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.821 0.343 . . . . 0.0 110.792 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -106.47 30.04 6.35 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.435 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.41 126.56 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.236 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -119.88 13.73 12.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -87.6 171.54 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.073 0.463 . . . . 0.0 110.144 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -86.26 -71.1 0.56 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.605 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.57 -32.39 68.88 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.334 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.11 87.23 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.514 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 303' ' ' LEU . 7.5 mp -72.29 -48.34 43.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.917 0.389 . . . . 0.0 110.843 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 81.3 mt -45.49 -38.52 2.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -79.55 -40.78 28.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.406 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.5 t -72.7 -8.92 57.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.528 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.7 mm? -92.03 20.95 5.35 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.496 0.498 . . . . 0.0 110.305 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.648 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.02 -38.06 1.14 Allowed Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.029 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.5 Cg_exo -59.13 9.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 123.35 2.7 . . . . 0.0 112.593 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.564 ' H ' ' C ' ' A' ' 304' ' ' ALA . 33.6 p30 -114.77 15.44 17.49 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.69 0.281 . . . . 0.0 110.764 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -106.83 97.33 7.13 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.756 0.789 . . . . 0.0 110.285 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 16.6 ptm180 -171.12 157.84 5.3 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.881 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.91 148.0 21.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 87.9 mt-10 -121.06 105.91 11.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 110.753 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.44 117.28 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.201 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -97.69 122.74 41.13 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.038 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 28.6 t -124.65 117.07 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.1 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -115.39 121.63 43.36 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 103.91 40.17 2.36 Favored Glycine 0 N--CA 1.462 0.398 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.506 ' CG1' ' N ' ' A' ' 317' ' ' LYS . 12.4 tt -115.95 168.07 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 109.983 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.506 ' N ' ' CG1' ' A' ' 316' ' ' ILE . 5.0 tmtp? . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.495 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 1.1 pm0 . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m -87.59 145.21 26.3 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -118.59 170.26 9.11 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.22 0.533 . . . . 0.0 110.002 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -153.55 124.66 7.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.947 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -112.07 122.31 47.4 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.666 ' HG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -87.87 105.9 17.74 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.451 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 37.5 tp -108.21 123.58 48.97 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -81.13 128.25 33.54 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 122.615 1.198 . . . . 0.0 113.2 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 202' ' ' PHE . 20.4 t -59.31 -19.6 47.63 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.159 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.69 -47.85 84.0 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.407 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.64 -25.98 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.326 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 65.6 mt -90.56 -81.28 0.31 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.954 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.503 ' O ' ' OG ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -128.13 99.27 5.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.9 -178.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.639 ' ND2' ' HZ1' ' A' ' 210' ' ' LYS . 3.3 p30 -71.99 -71.78 0.26 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.406 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -105.73 -27.16 11.46 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.554 0.216 . . . . 0.0 110.9 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -61.98 167.83 3.59 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.992 0.425 . . . . 0.0 110.271 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -53.21 -81.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.515 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.449 ' O ' ' OG ' ' A' ' 259' ' ' SER . . . -161.86 54.2 0.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 60.0 p -107.28 136.97 46.2 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.9 mt -79.8 123.44 27.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.827 0.346 . . . . 0.0 111.633 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.639 ' HZ1' ' ND2' ' A' ' 203' ' ' ASN . 22.1 mtmt -84.14 158.51 61.17 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.26 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 213' ' ' GLY . 96.1 Cg_exo -32.75 -75.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.702 2.268 . . . . 0.0 112.824 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -49.12 -19.27 0.42 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.386 0.612 . . . . 0.0 110.191 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.33 -50.42 8.35 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.92 -40.62 95.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.224 0.535 . . . . 0.0 109.568 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -51.51 68.99 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.144 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.21 85.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.246 0.546 . . . . 0.0 110.036 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.3 mt -61.64 -37.8 85.35 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.183 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 32.1 m-20 -63.66 -45.57 89.54 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.112 0.482 . . . . 0.0 111.009 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -62.2 -44.22 97.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.299 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 37.6 tp -63.24 -39.94 96.02 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 225' ' ' SER . 16.1 t80 -53.9 -45.39 71.1 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 87.7 p -51.25 -53.53 34.53 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.038 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -53.83 -29.09 39.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.825 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 17.5 mt -93.64 -22.97 18.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.519 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 221' ' ' TYR . 7.2 p -77.86 -30.04 50.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -96.17 22.78 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.167 0.508 . . . . 0.0 110.437 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.401 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.6 OUTLIER -79.71 168.61 19.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.83 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.37 127.85 64.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 230' ' ' LYS . 68.6 Cg_endo -72.22 -16.53 28.24 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.072 1.848 . . . . 0.0 113.071 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.475 ' CG ' ' N ' ' A' ' 231' ' ' ASP . 19.5 ptmt -31.67 -45.77 0.1 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 123.583 0.552 . . . . 0.0 111.232 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' A' ' 230' ' ' LYS . 84.5 m-20 -111.92 -19.39 12.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.998 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 28.31 54.75 0.13 Allowed Glycine 0 N--CA 1.473 1.151 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.754 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.8 p -119.06 109.89 16.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.409 0.147 . . . . 0.0 111.151 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.4 t -125.47 94.74 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.699 0.761 . . . . 0.0 110.205 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.57 120.31 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.549 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 69.3 t -96.93 123.96 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.297 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.8 mt -107.2 137.83 44.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.185 0.517 . . . . 0.0 110.592 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -90.91 139.54 14.87 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.493 ' CZ ' ' CD ' ' A' ' 310' ' ' GLU . 11.6 m-85 -131.56 118.95 20.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.051 0.925 . . . . 0.0 108.794 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.0 t -129.49 171.05 12.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.843 0.354 . . . . 0.0 111.124 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -76.96 -176.12 3.82 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.321 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -105.82 121.83 44.85 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.781 0.324 . . . . 0.0 110.239 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.479 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 8.5 mm -118.82 11.15 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.552 0.691 . . . . 0.0 110.453 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.8 -47.36 3.06 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.5 m -68.3 101.04 1.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.314 0.578 . . . . 0.0 109.636 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -54.41 -52.3 62.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.548 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.41 -44.99 80.86 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.194 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -62.17 -45.02 95.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.91 0.385 . . . . 0.0 110.733 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.424 HD22 ' N ' ' A' ' 243' ' ' ILE . 28.0 m120 -62.3 -41.67 98.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -64.79 -41.8 95.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.673 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.27 96.2 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 27.7 mt -67.79 -40.76 83.88 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.679 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.5 t -62.2 -43.86 97.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.554 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -65.68 -41.4 92.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.004 0.431 . . . . 0.0 110.687 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.12 -48.84 77.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.665 ' NH2' HH21 ' A' ' 307' ' ' ARG . 66.7 mtt85 -61.36 -53.62 54.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.694 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.87 -30.22 65.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.463 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 5.5 tp-100 -75.45 -46.39 32.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.704 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.641 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 20.4 m -56.77 -37.19 70.75 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.996 0.903 . . . . 0.0 109.872 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 264' ' ' LEU . 44.8 t -71.07 -63.02 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.771 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.0 t -46.36 -63.84 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.731 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.641 ' OD1' ' O ' ' A' ' 259' ' ' SER . 28.6 p-10 -45.22 -38.72 5.64 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.079 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.524 ' N ' ' OD1' ' A' ' 262' ' ' ASP . 84.1 t80 -80.74 -31.94 35.84 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.981 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 260' ' ' VAL . 0.5 OUTLIER -70.27 -9.15 55.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.561 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.515 ' C ' ' H ' ' A' ' 267' ' ' LYS . 68.9 mt -86.83 -54.79 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.816 0.341 . . . . 0.0 111.744 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 39.0 m -51.59 -7.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.19 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 218' ' ' ASP . 0.0 OUTLIER -78.82 -11.34 59.99 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 109.52 39.49 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.98 130.19 23.84 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 117.173 0.487 . . . . 0.0 109.751 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.94 132.55 50.37 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.253 1.302 . . . . 0.0 112.4 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.33 -13.27 60.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.682 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -90.46 -17.45 27.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.484 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.51 -25.62 35.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.728 0.775 . . . . 0.0 110.413 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.3 pt -100.3 -178.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.548 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 7.7 t -162.17 126.48 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.58 113.97 25.79 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.887 0.375 . . . . 0.0 110.803 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -129.14 156.33 44.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.797 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.48 152.09 16.98 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 238' ' ' GLY . 6.5 tpt -118.11 -10.36 10.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.961 0.41 . . . . 0.0 110.242 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 60.28 -107.79 1.5 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.485 ' N ' ' CD ' ' A' ' 281' ' ' GLU . 1.0 OUTLIER -141.02 71.31 1.36 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.897 0.379 . . . . 0.0 110.235 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 72.8 m -93.44 7.42 44.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -160.98 70.72 2.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.94 105.74 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.35 2.033 . . . . 0.0 112.645 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.418 ' CG2' ' N ' ' A' ' 286' ' ' THR . 15.1 m -64.28 -42.06 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.572 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 288' ' ' ASN . 40.8 p -58.27 -45.67 87.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.102 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -43.95 -10.37 0.01 OUTLIER Glycine 0 CA--C 1.533 1.179 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 286' ' ' THR . 87.7 m-20 -129.77 -54.23 1.14 Allowed 'General case' 0 C--O 1.231 0.098 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 m -58.33 -44.22 88.57 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.13 33.09 4.16 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 109.903 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 293' ' ' VAL . 28.9 t0 -56.94 -42.65 80.46 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.447 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -75.08 33.18 0.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.49 ' H ' ' C ' ' A' ' 291' ' ' ASP . 15.5 t -131.91 113.51 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.943 0.401 . . . . 0.0 110.343 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -118.51 14.65 13.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.926 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -99.62 130.82 45.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.011 0.434 . . . . 0.0 110.166 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -50.47 -67.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.273 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.89 -38.31 61.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.72 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.96 89.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.332 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 60.3 mt -75.19 -50.25 16.85 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.878 0.37 . . . . 0.0 110.652 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 78.1 mt -52.72 -32.74 17.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.227 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -78.07 -46.22 21.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.924 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 11.9 t -70.64 -13.1 61.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.637 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 35.9 mt -92.58 24.47 3.5 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.398 0.437 . . . . 0.0 111.453 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.541 ' N ' ' HD2' ' A' ' 305' ' ' PRO . . . -78.45 -45.45 2.05 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.397 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 35.7 Cg_endo -69.28 8.7 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.203 1.935 . . . . 0.0 111.586 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 304' ' ' ALA . 9.4 t70 -104.76 9.76 34.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.228 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.665 HH21 ' NH2' ' A' ' 256' ' ' ARG . 38.6 mtp180 -107.76 116.39 31.86 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.212 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.666 ' NH2' ' HG1' ' A' ' 195' ' ' THR . 15.7 ptm180 -175.67 -171.31 0.46 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.5 m -144.77 154.16 14.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.493 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 95.2 mt-10 -121.7 105.25 10.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.044 0.45 . . . . 0.0 110.925 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.9 mm -80.54 116.71 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.488 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -99.63 119.6 38.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.774 0.321 . . . . 0.0 110.369 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.94 120.53 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.653 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -118.93 141.13 48.93 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.22 -22.55 40.17 Favored Glycine 0 N--CA 1.469 0.88 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.58 ' CG1' ' H ' ' A' ' 317' ' ' LYS . 14.6 tt -56.47 176.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.58 ' H ' ' CG1' ' A' ' 316' ' ' ILE . 49.5 tttt . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.522 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 121.165 0.507 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 m -77.16 140.01 40.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.53 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -147.36 117.83 7.45 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.029 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.2 OUTLIER -103.29 150.52 23.67 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.611 ' CE2' ' NE2' ' A' ' 223' ' ' GLN . 41.1 m-85 -111.76 121.92 46.39 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.798 0.332 . . . . 0.0 110.184 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.59 101.72 12.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 34.4 tp -104.28 132.52 50.44 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.996 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -78.2 127.04 31.67 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.897 0.856 . . . . 0.0 111.893 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 202' ' ' PHE . 39.2 t -63.75 -33.22 75.17 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.035 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.56 -38.75 81.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.259 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.21 -46.17 96.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.56 -76.34 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.484 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -130.7 143.5 50.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.363 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.468 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 46.5 t30 -129.77 -72.87 0.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.272 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.34 -37.94 56.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -71.92 165.12 24.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.445 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -57.67 -68.03 0.28 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.589 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.12 57.18 0.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.457 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 18.8 p -106.43 130.06 54.3 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.84 139.22 44.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.78 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 213' ' ' GLY . 30.7 mtmt -101.17 159.66 28.85 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 210' ' ' LYS . 86.3 Cg_exo -34.25 -77.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.387 2.058 . . . . 0.0 112.104 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.72 -20.29 1.2 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.173 0.511 . . . . 0.0 110.424 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.83 -49.69 16.61 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -67.9 -39.19 83.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.19 0.519 . . . . 0.0 109.807 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.29 -53.17 60.44 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.537 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.51 91.34 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.43 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 mt -62.45 -26.34 68.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.502 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -73.01 -46.08 54.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -63.65 -40.25 96.38 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.462 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.08 -40.09 92.39 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 223' ' ' GLN . 49.4 t80 -54.87 -58.33 8.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.535 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 15.4 m -58.94 -6.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.361 0.601 . . . . 0.0 110.788 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.611 ' NE2' ' CE2' ' A' ' 194' ' ' PHE . 4.0 tt0 -94.38 -34.23 12.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.684 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 42.7 mt -96.92 -13.03 22.7 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.809 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.3 t -83.24 -14.93 52.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.724 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -96.71 17.55 16.29 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.446 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.426 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.8 OUTLIER -78.18 178.92 7.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.653 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 315' ' ' GLY . 9.4 t70 -94.2 132.03 30.14 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.734 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 230' ' ' LYS . 42.3 Cg_endo -67.92 -20.47 45.07 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.817 2.344 . . . . 0.0 112.837 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 229' ' ' PRO . 40.6 mmtt -33.43 -53.07 0.4 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.055 0.455 . . . . 0.0 110.582 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 99.3 m-20 -102.76 -19.01 14.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.471 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.03 45.23 0.01 OUTLIER Glycine 0 N--CA 1.469 0.879 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 231' ' ' ASP . 28.0 m -112.22 111.38 22.23 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 71.6 t -126.31 94.06 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.761 0.791 . . . . 0.0 110.285 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.4 t -97.22 121.03 47.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.09 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.13 124.58 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.58 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.7 mt -109.49 141.34 42.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.974 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -125.16 126.08 5.85 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.31 120.39 42.08 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.4 m -108.98 168.53 9.29 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.403 ' O ' ' OE2' ' A' ' 281' ' ' GLU . 52.8 p-10 -95.14 -179.55 4.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.628 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -98.65 127.36 44.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.318 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.48 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 48.9 mm -118.31 14.2 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.313 0.578 . . . . 0.0 110.667 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 91.87 -3.05 77.19 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 4.2 m -134.01 104.36 6.21 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.998 0.428 . . . . 0.0 110.072 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -55.35 -50.81 68.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.476 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.72 -40.75 76.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.545 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.418 ' CE2' ' CD1' ' A' ' 252' ' ' LEU . 48.7 t80 -63.07 -44.56 95.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.293 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -62.67 -40.4 96.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.279 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -63.93 -43.1 96.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.497 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.468 ' C ' ' NH2' ' A' ' 255' ' ' ARG . . . -62.33 -35.86 92.24 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.418 ' CD1' ' CE2' ' A' ' 248' ' ' TYR . 14.4 mt -74.66 -35.91 62.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.499 -0.35 . . . . 0.0 111.084 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.4 p -64.64 -41.06 96.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.979 0.418 . . . . 0.0 110.512 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -70.36 -44.48 68.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.178 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.468 ' NH2' ' C ' ' A' ' 251' ' ' GLY . 63.5 mtm-85 -56.55 -46.78 80.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.803 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -60.46 -62.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.611 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.72 -34.78 19.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.104 0.478 . . . . 0.0 109.881 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -72.86 -46.07 54.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.406 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 61.5 m -60.11 -38.07 81.9 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.073 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.1 t -64.06 -50.8 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.331 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.5 t -62.31 -48.36 88.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.434 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.44 -41.86 21.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.061 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.637 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 85.5 t80 -79.39 -34.62 41.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.628 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -29.48 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.966 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' A' ' 267' ' ' LYS . 82.4 mt -68.73 -50.16 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 111.88 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 44.6 m -50.76 -8.51 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.906 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.637 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 11.4 mmtp -84.6 2.28 42.18 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.006 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.08 40.81 4.48 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.41 129.0 25.05 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.332 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.06 127.31 25.18 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.862 1.708 . . . . 0.0 111.725 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.22 -8.78 34.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.896 0.379 . . . . 0.0 111.341 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 64.7 t0 -91.86 -22.73 19.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.782 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -80.83 -19.16 45.21 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.486 0.66 . . . . 0.0 110.78 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 234' ' ' VAL . 1.7 pt -105.34 -171.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.745 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 1.6 t -168.5 136.27 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.206 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -106.91 110.72 22.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.819 0.342 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -117.1 142.73 46.63 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.447 0.642 . . . . 0.0 110.532 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.84 99.62 2.33 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.626 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.6 OUTLIER -79.29 9.94 4.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.823 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . 0.548 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 10.26 -95.89 0.01 OUTLIER Glycine 0 N--CA 1.476 1.314 0 O-C-N 123.534 0.521 . . . . 0.0 112.068 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 281' ' ' GLU . 56.1 mp0 -135.68 75.05 1.54 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.835 0.35 . . . . 0.0 110.591 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.495 ' OG ' ' SD ' ' A' ' 279' ' ' MET . 53.8 m -83.65 -3.63 57.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 283' ' ' ASN . 11.4 p-10 -176.42 80.21 0.27 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.593 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.14 107.64 0.27 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.65 2.233 . . . . 0.0 112.214 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 9.6 m -88.77 -36.63 9.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.524 0.678 . . . . 0.0 110.757 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -43.67 98.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.954 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 290' ' ' CYS . . . -45.57 -88.96 0.01 OUTLIER Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 287' ' ' GLY . 86.6 m-20 -27.61 -53.92 0.09 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.655 0.264 . . . . 0.0 110.35 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.4 m -56.06 -47.04 78.7 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.478 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . 0.621 ' N ' ' O ' ' A' ' 287' ' ' GLY . 0.3 OUTLIER -98.37 34.19 2.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 109.928 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 293' ' ' VAL . 51.5 t0 -57.98 -42.61 85.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.447 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -75.43 32.32 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 291' ' ' ASP . 21.2 t -131.18 113.14 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.92 0.391 . . . . 0.0 110.665 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -118.97 14.22 13.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.605 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -86.65 166.9 14.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.111 0.481 . . . . 0.0 110.308 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -78.78 -67.36 0.75 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.532 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 301' ' ' ASP . . . -61.77 -27.33 68.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.223 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.588 ' O ' ' OD1' ' A' ' 301' ' ' ASP . . . -71.99 -24.26 61.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.156 0.503 . . . . 0.0 110.933 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 71.2 mt -86.69 -48.11 8.57 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.66 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.74 -31.8 48.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.054 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.588 ' OD1' ' O ' ' A' ' 298' ' ' ALA . 43.3 p-10 -82.95 -43.77 16.08 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.602 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.574 ' N ' ' OD1' ' A' ' 301' ' ' ASP . 13.1 t -74.86 -13.77 60.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.156 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 35.4 mt -87.39 21.07 2.58 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.514 0.509 . . . . 0.0 110.466 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.626 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -72.73 -41.01 6.91 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.0 Cg_exo -58.94 7.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.464 2.776 . . . . 0.0 112.47 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' A' ' 304' ' ' ALA . 45.8 t0 -108.18 7.51 27.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.871 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.468 ' NH1' ' OD1' ' A' ' 203' ' ' ASN . 62.4 mtm180 -112.66 86.4 2.36 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.454 0.645 . . . . 0.0 109.376 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.546 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 11.0 ptp180 -156.7 130.48 8.3 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.174 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.64 139.69 18.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -122.5 103.41 8.69 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.317 0.58 . . . . 0.0 110.42 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.46 117.89 25.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -94.9 121.51 36.57 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.642 0.258 . . . . 0.0 110.891 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 54.6 t -122.95 117.89 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -114.27 133.87 55.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 102.25 18.84 15.79 Favored Glycine 0 C--O 1.22 -0.759 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 20.2 tt -105.29 146.81 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 110.644 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 64.9 pttt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.848 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.933 0.397 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.8 m -77.91 142.03 38.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.131 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 193' ' ' HIS . 21.5 tptt -114.42 166.83 11.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.123 0.487 . . . . 0.0 110.553 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 192' ' ' LYS . 53.2 m80 -155.74 124.21 5.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.836 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.617 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 60.2 m-85 -113.66 120.13 39.82 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.714 ' HG1' HH12 ' A' ' 308' ' ' ARG . 0.0 OUTLIER -85.15 103.66 14.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.08 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 28.8 tp -105.11 124.24 49.2 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -78.67 129.33 34.6 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 121.897 0.856 . . . . 0.0 112.206 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.0 t -62.3 -32.99 73.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.026 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -54.88 -35.94 64.6 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.085 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 71.0 t -71.48 -38.77 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.878 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.8 mt -84.41 -80.59 0.2 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.808 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -124.55 133.16 53.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.076 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.447 ' N ' ' OD1' ' A' ' 203' ' ' ASN . 1.6 m-20 -104.27 -71.11 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.567 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -107.49 -16.48 14.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.808 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 26.6 t30 -71.9 170.13 14.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.062 0.458 . . . . 0.0 110.241 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -52.49 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.491 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.475 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -162.19 4.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.503 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.528 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 76.8 p -55.02 144.89 21.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.014 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 28.0 mt -88.96 133.2 34.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 213' ' ' GLY . 1.5 mptm? -90.74 157.77 43.35 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.975 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -34.1 -74.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.636 2.224 . . . . 0.0 111.828 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -50.41 -21.63 1.53 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.076 0.465 . . . . 0.0 110.048 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.95 -50.27 13.83 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -66.36 -39.2 89.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.305 0.574 . . . . 0.0 110.151 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.3 -54.31 48.24 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.555 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.29 -38.42 91.07 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.703 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.9 mt -61.59 -27.36 68.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.503 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -74.21 -46.67 40.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.202 0.525 . . . . 0.0 110.443 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -61.77 -43.12 99.48 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.209 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 48.2 tp -66.8 -39.11 87.64 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.442 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' A' ' 267' ' ' LYS . 3.7 t80 -53.57 -49.37 67.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.849 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.7 t -58.11 -51.04 71.38 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.45 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.617 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 9.2 tt0 -52.18 -26.02 10.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.258 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 72.0 mt -96.13 -17.96 20.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.507 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.1 t -78.47 -17.6 56.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.758 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -97.36 20.67 11.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.785 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.495 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.8 OUTLIER -80.16 178.12 8.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.861 179.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -96.04 133.79 24.72 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.495 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.0 Cg_endo -69.75 -18.6 36.95 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.813 2.342 . . . . 0.0 112.356 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 229' ' ' PRO . 56.4 tttp -36.22 -53.66 0.81 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.457 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 232' ' ' GLY . 36.2 m-20 -100.79 -21.59 15.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.65 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.95 50.45 0.05 OUTLIER Glycine 0 N--CA 1.471 1.003 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.5 m -117.65 111.28 18.95 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 122.671 -0.311 . . . . 0.0 110.398 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 99.0 t -129.0 93.9 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.214 0.531 . . . . 0.0 110.145 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.6 t -98.27 123.4 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.621 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 95.3 t -95.36 127.85 47.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.641 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 39.1 mt -111.58 142.44 43.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 279' ' ' MET . . . -118.94 139.42 14.36 Favored Glycine 0 N--CA 1.48 1.587 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.4 OUTLIER -121.14 121.58 38.15 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.6 p -112.09 165.3 12.25 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.987 0.422 . . . . 0.0 110.236 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 241' ' ' ASP . 11.3 p30 -87.82 -177.79 5.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.443 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -105.18 120.23 41.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.052 0.453 . . . . 0.0 110.288 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.495 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 48.3 mm -119.09 15.02 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.399 0.619 . . . . 0.0 110.83 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.5 9.03 87.32 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.7 p -134.45 97.19 3.75 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.894 0.378 . . . . 0.0 110.334 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -52.57 -52.48 54.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.647 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.9 72.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -60.19 -46.75 88.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.524 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.4 HD22 ' H ' ' A' ' 243' ' ' ILE . 91.0 m-20 -61.9 -42.63 99.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.569 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -63.36 -42.54 98.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.553 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.68 -36.08 92.15 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.28 -32.98 63.12 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.704 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 12.0 m -65.36 -43.69 90.03 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.177 0.513 . . . . 0.0 110.598 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -70.42 -35.23 73.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.928 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -59.86 -50.04 75.34 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.549 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.511 ' NH1' ' O ' ' A' ' 239' ' ' TYR . 16.4 ptp180 -67.16 -47.52 70.77 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.406 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.47 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.83 -39.74 92.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.194 0.521 . . . . 0.0 110.189 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -74.6 -45.51 44.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.16 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 46.5 t -60.65 -38.54 85.2 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.084 0.469 . . . . 0.0 110.238 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 256' ' ' ARG . 91.6 t -64.92 -52.06 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.557 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.2 t -61.37 -49.11 85.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.326 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -44.96 -41.83 7.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.961 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -82.53 -30.31 29.83 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.34 -7.56 50.23 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.371 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 267' ' ' LYS . 61.2 mt -88.05 -54.7 7.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 72.8 m -51.22 -5.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.583 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.6 OUTLIER -79.7 -11.4 59.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.894 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.46 39.11 1.97 Allowed Glycine 0 C--N 1.323 -0.174 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.99 127.89 24.29 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.43 128.01 24.29 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.145 1.897 . . . . 0.0 112.273 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.09 -7.9 20.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.716 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -93.03 -24.41 18.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -78.53 -21.76 48.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.563 0.697 . . . . 0.0 110.587 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.4 pt -102.23 -173.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.865 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 26.3 t -171.61 132.49 0.75 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.484 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.89 153.08 19.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -158.49 144.72 17.1 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.091 0.472 . . . . 0.0 110.804 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.98 97.35 2.06 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.462 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.5 tpt -68.46 -10.68 56.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.907 0.384 . . . . 0.0 110.462 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 45.07 -104.62 0.07 OUTLIER Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.07 70.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.389 . . . . 0.0 110.548 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 14.1 m -88.82 -0.16 57.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.585 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' A' ' 283' ' ' ASN . 0.1 OUTLIER -169.5 76.66 0.69 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.675 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.76 111.32 3.26 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.536 2.158 . . . . 0.0 111.798 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 15.5 m -71.52 -39.46 70.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.86 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.66 ' C ' ' H ' ' A' ' 288' ' ' ASN . 21.1 p -63.68 -48.2 78.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.479 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.478 ' N ' ' HG1' ' A' ' 286' ' ' THR . . . -51.71 -0.53 0.03 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.66 ' H ' ' C ' ' A' ' 286' ' ' THR . 65.8 t30 -114.0 -60.17 1.92 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.8 t -79.04 -3.86 47.25 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.569 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 286' ' ' THR . 0.4 OUTLIER -127.32 18.22 7.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.531 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 30.1 p-10 -67.57 -3.08 7.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.378 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -99.89 33.41 2.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.451 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 26.6 t -127.95 122.87 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.889 0.376 . . . . 0.0 110.231 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -119.59 6.5 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.824 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.9 168.39 12.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.057 0.456 . . . . 0.0 110.168 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -80.02 -74.89 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.758 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -55.92 -26.46 47.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.818 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.89 -34.69 78.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.146 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.2 mt -75.46 -64.71 1.01 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 pt -48.41 -30.24 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.396 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -76.62 -42.66 41.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.567 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 15.3 t -80.45 -10.54 59.74 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.73 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 299' ' ' LEU . 54.2 mt -91.95 21.81 4.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.69 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -76.61 -45.12 3.25 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 121.156 0.503 . . . . 0.0 110.375 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 25.2 Cg_exo -61.81 9.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.233 2.622 . . . . 0.0 111.654 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 304' ' ' ALA . 51.0 t0 -106.49 11.08 31.1 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.623 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -111.25 103.26 11.65 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.349 0.595 . . . . 0.0 110.402 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.714 HH12 ' HG1' ' A' ' 195' ' ' THR . 0.0 OUTLIER -172.17 153.48 3.09 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.222 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.16 149.69 18.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -120.22 107.77 13.39 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.089 0.471 . . . . 0.0 110.839 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.5 mm -78.37 117.95 24.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -100.74 111.59 23.84 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.301 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 192' ' ' LYS . 86.6 t -119.63 123.65 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 O-C-N 123.66 0.6 . . . . 0.0 110.644 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -119.63 140.54 50.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.777 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 101.39 -0.35 53.63 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.8 tt -85.46 144.29 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.064 0.459 . . . . 0.0 110.485 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 52.0 tptt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.435 179.681 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.712 0.291 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.6 m -69.52 169.35 12.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.46 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.502 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 3.4 tptm -148.83 166.23 29.13 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.083 0.468 . . . . 0.0 110.083 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.502 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 12.8 m80 -153.5 123.93 7.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.756 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -112.09 115.6 29.15 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.592 ' HG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -86.07 103.14 14.46 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.775 -179.239 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.2 tp -108.72 132.93 53.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.451 ' CB ' ' HZ1' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -83.76 126.58 33.05 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.244 -178.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.4 m -62.02 -32.35 72.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.332 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.491 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 11.8 m-20 -59.31 -36.52 75.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.81 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.19 -42.91 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 92.7 mt -78.35 -79.48 0.12 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.244 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.427 ' CD1' ' NH1' ' A' ' 256' ' ' ARG . 0.1 OUTLIER -118.04 122.84 44.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.764 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.534 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 8.9 p-10 -91.32 -78.09 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.628 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.534 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 82.5 m-85 -98.0 -14.94 20.29 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.809 0.337 . . . . 0.0 110.659 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -72.61 154.54 40.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.235 0.54 . . . . 0.0 109.718 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.58 ' CG ' ' H ' ' A' ' 207' ' ' ALA . 42.2 pttt -49.8 -59.98 3.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.987 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.58 ' H ' ' CG ' ' A' ' 206' ' ' LYS . . . -168.71 57.18 0.05 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.603 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 64.4 p -107.23 129.92 54.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.7 mt -74.48 146.22 42.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.719 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 213' ' ' GLY . 22.7 mttp -105.87 158.5 32.28 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.946 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -33.85 -76.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.495 2.13 . . . . 0.0 112.231 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -52.62 -18.98 2.03 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.251 0.548 . . . . 0.0 110.16 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.38 -49.37 9.39 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -67.27 -40.8 86.23 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.186 0.517 . . . . 0.0 109.77 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.68 -50.89 71.7 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.589 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.26 86.58 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.635 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.1 mt -62.25 -31.37 71.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -70.17 -45.3 67.0 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.291 0.567 . . . . 0.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -63.06 -42.78 99.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.927 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 38.8 tp -63.87 -40.28 96.17 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.521 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.508 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.3 t80 -52.65 -47.3 67.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.534 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.7 m -52.27 -51.94 55.64 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.67 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -55.43 -26.4 41.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.469 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 67.4 mt -94.01 -23.85 17.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.675 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.1 t -75.79 -32.36 59.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.279 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -91.94 21.37 4.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.405 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.7 OUTLIER -77.34 173.46 11.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.199 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -88.35 133.7 36.1 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.457 ' O ' ' C ' ' A' ' 230' ' ' LYS . 55.0 Cg_endo -70.56 -18.22 33.38 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.569 2.179 . . . . 0.0 112.709 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 229' ' ' PRO . 11.1 mmtp -28.03 -49.22 0.06 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.594 0.559 . . . . 0.0 110.498 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 67.5 m-20 -118.51 -14.66 9.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.377 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.79 51.27 0.06 OUTLIER Glycine 0 N--CA 1.47 0.929 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.4 m -114.68 110.7 20.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.668 0.271 . . . . 0.0 110.99 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.32 95.67 3.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.811 0.815 . . . . 0.0 109.692 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.11 117.75 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.642 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 24.5 t -93.14 124.17 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.635 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.7 mt -108.6 137.79 45.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.065 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -120.52 132.42 9.26 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -116.64 126.52 53.35 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 8.0 t -125.14 162.25 25.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -77.35 -175.82 3.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.224 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.1 ptm85 -120.01 133.74 55.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.369 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 51.7 mm -118.42 24.14 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.582 0.706 . . . . 0.0 110.626 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 80.93 14.49 79.42 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.0 m -137.37 98.94 3.83 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.083 0.468 . . . . 0.0 110.005 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -52.23 -50.41 62.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.295 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.38 -45.65 80.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.939 0.4 . . . . 0.0 110.709 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -60.23 -41.67 93.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.349 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.495 HD22 ' CA ' ' A' ' 280' ' ' GLY . 0.6 OUTLIER -60.12 -50.73 72.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.623 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -57.0 -41.5 78.59 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.46 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.41 -41.32 98.49 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 35.6 mt -67.31 -41.03 86.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.913 0.387 . . . . 0.0 111.274 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.5 t -61.42 -40.23 93.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.999 0.428 . . . . 0.0 110.889 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.52 -42.18 78.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.232 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -58.6 -46.54 86.79 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.472 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.427 ' NH1' ' CD1' ' A' ' 202' ' ' PHE . 86.6 mtt-85 -63.92 -62.44 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.772 0.32 . . . . 0.0 110.774 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.39 -35.71 19.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 110.168 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.32 -45.49 59.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.585 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 13.3 t -59.62 -39.06 83.03 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.243 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.28 -52.83 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.414 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.54 -49.27 85.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.215 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -44.7 -42.78 7.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.14 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.638 ' CZ ' ' NZ ' ' A' ' 267' ' ' LYS . 62.2 t80 -80.41 -28.92 37.73 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.766 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.0 -4.53 38.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.102 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.3 mt -86.23 -52.94 11.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.7 p -54.47 -1.83 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.576 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.638 ' NZ ' ' CZ ' ' A' ' 263' ' ' TYR . 9.7 mptt -87.53 2.56 50.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.704 0.288 . . . . 0.0 110.703 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 89.81 38.31 6.56 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 269' ' ' ILE . 1.2 tp -119.16 120.29 31.23 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -49.09 128.03 18.65 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.173 1.249 . . . . 0.0 112.116 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.04 -16.23 50.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.114 0.483 . . . . 0.0 111.034 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 4.4 m-20 -85.25 -22.62 28.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.077 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -23.5 38.99 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.209 0.528 . . . . 0.0 110.545 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.5 pt -101.98 -174.84 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.985 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 34.8 m -168.96 127.33 1.02 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.224 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.17 110.52 23.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 110.413 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.546 ' NH1' ' SD ' ' A' ' 279' ' ' MET . 73.8 ttt-85 -115.29 139.74 49.71 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.433 0.635 . . . . 0.0 110.985 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.96 95.18 2.06 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.546 ' SD ' ' NH1' ' A' ' 277' ' ' ARG . 3.8 tpt -69.81 -10.63 59.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.665 0.269 . . . . 0.0 110.598 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . 0.495 ' CA ' HD22 ' A' ' 249' ' ' ASN . . . 41.75 -102.36 0.03 OUTLIER Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -141.65 75.58 1.5 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.784 0.326 . . . . 0.0 110.813 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 18.0 m -87.04 0.16 55.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.741 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.472 ' C ' HD21 ' A' ' 283' ' ' ASN . 0.4 OUTLIER -168.16 75.88 0.87 Allowed Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.47 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -60.82 104.14 0.26 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.554 2.17 . . . . 0.0 112.529 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 28.4 m -69.1 -44.44 81.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.306 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.653 ' C ' ' H ' ' A' ' 288' ' ' ASN . 7.6 p -62.49 -46.21 89.48 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.09 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.93 -1.83 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.653 ' H ' ' C ' ' A' ' 286' ' ' THR . 28.3 m120 -115.57 -59.36 2.01 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.1 t -80.88 -3.41 51.19 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.71 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . 0.503 ' N ' ' O ' ' A' ' 286' ' ' THR . 0.6 OUTLIER -127.61 16.89 6.97 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.343 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 31.6 p-10 -68.0 -3.06 8.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.986 0.422 . . . . 0.0 110.592 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -100.23 32.45 2.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.706 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 15.6 t -130.78 125.65 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.027 0.442 . . . . 0.0 110.304 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.92 10.64 12.31 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.12 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -104.06 136.28 43.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.099 0.475 . . . . 0.0 110.242 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.426 ' HG3' ' H ' ' A' ' 297' ' ' ALA . 0.1 OUTLIER -61.53 -46.37 90.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.941 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . 0.426 ' H ' ' HG3' ' A' ' 296' ' ' ARG . . . -62.68 -46.06 89.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.107 0.48 . . . . 0.0 111.183 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.98 -29.83 70.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.789 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 39.5 mt -78.17 -53.42 7.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.961 0.41 . . . . 0.0 110.535 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 40.0 mt -51.08 -34.81 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.922 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.9 -43.1 22.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.07 0.462 . . . . 0.0 110.315 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 38.9 t -73.93 -13.56 60.91 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.775 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 299' ' ' LEU . 53.5 mt -90.45 23.16 3.08 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.291 0.369 . . . . 0.0 111.07 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -77.39 -44.35 2.62 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.457 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.8 Cg_exo -62.47 9.35 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.416 2.744 . . . . 0.0 111.807 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 304' ' ' ALA . 0.4 OUTLIER -104.28 10.32 35.61 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.71 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.491 ' NH1' ' OD1' ' A' ' 199' ' ' ASP . 39.2 mtm105 -113.96 94.81 5.0 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.494 0.664 . . . . 0.0 110.195 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.592 ' NH2' ' HG1' ' A' ' 195' ' ' THR . 16.3 ptm180 -164.08 139.15 5.95 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.136 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 22.6 m -104.69 144.57 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 121.831 -0.543 . . . . 0.0 109.666 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -121.45 106.26 11.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.342 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.38 118.21 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.796 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 312' ' ' GLU . 0.1 OUTLIER -96.43 135.62 38.05 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.38 120.22 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.236 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -117.29 132.34 56.63 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.6 -13.85 50.44 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 20.1 tt -75.38 154.12 6.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.827 0.346 . . . . 0.0 110.487 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.2 pttt . . . . . 0 N--CA 1.464 0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.474 179.715 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.131 0.491 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.1 m -73.18 141.24 47.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.274 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -143.46 111.21 5.98 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.4 m-70 -101.39 150.45 23.0 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.577 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 59.6 m-85 -111.28 118.67 36.52 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 195' ' ' THR . 6.9 t -85.26 102.46 13.37 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.837 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.0 tp -105.34 137.26 43.42 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.437 0.637 . . . . 0.0 109.955 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 130.38 36.24 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-O 122.564 1.174 . . . . 0.0 112.021 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 202' ' ' PHE . 7.3 t -60.24 -24.74 65.11 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.255 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -58.31 -43.71 88.28 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.955 0.407 . . . . 0.0 110.423 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.85 -42.7 92.67 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.637 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.78 -78.36 0.18 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.391 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.47 ' O ' ' OG ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -128.43 102.73 6.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.98 -178.618 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.494 ' OD1' ' CD2' ' A' ' 204' ' ' PHE . 14.3 t-20 -67.4 -70.38 0.26 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.205 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.494 ' CD2' ' OD1' ' A' ' 203' ' ' ASN . 59.7 m-85 -108.51 -10.96 15.2 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.733 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -69.84 161.56 29.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.038 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -55.9 -75.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.415 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.59 49.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 41.6 p -107.33 128.02 54.08 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.819 0.342 . . . . 0.0 110.193 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.32 129.57 38.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.147 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 213' ' ' GLY . 58.5 mttt -91.6 159.92 37.65 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.696 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 210' ' ' LYS . 71.0 Cg_exo -33.12 -76.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.463 2.109 . . . . 0.0 111.549 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -49.57 -21.97 1.14 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.185 0.517 . . . . 0.0 110.31 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.27 -48.88 22.99 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.23 -38.91 91.89 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.91 63.23 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.225 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.33 -30.42 71.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.533 0.682 . . . . 0.0 110.237 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.24 -28.37 65.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.301 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -76.4 -48.54 19.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.32 0.581 . . . . 0.0 111.319 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.432 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 4.9 pt20 -64.02 -42.43 97.12 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.498 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.46 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 45.0 tp -63.96 -42.16 97.36 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.452 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.4 t80 -51.4 -50.57 59.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.46 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.643 ' HG ' ' H ' ' A' ' 223' ' ' GLN . 73.6 p -56.96 -50.31 73.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.456 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.643 ' H ' ' HG ' ' A' ' 222' ' ' SER . 10.5 tt0 -50.65 -25.82 4.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.506 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 39.0 mt -97.42 -15.27 20.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 53.4 p -79.76 -10.31 59.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.49 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -107.82 18.77 20.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.23 173.14 12.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.15 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 6.5 t70 -88.66 132.1 39.71 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 230' ' ' LYS . 57.1 Cg_endo -72.05 -18.8 27.18 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.718 2.279 . . . . 0.0 112.643 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 229' ' ' PRO . 61.9 tttm -32.63 -52.07 0.3 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.635 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 232' ' ' GLY . 85.8 m-20 -104.69 -17.94 14.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.579 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 27.41 50.19 0.07 OUTLIER Glycine 0 N--CA 1.474 1.215 0 O-C-N 123.917 0.761 . . . . 0.0 111.333 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 16.7 m -115.97 108.07 15.78 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 122.586 -0.361 . . . . 0.0 110.927 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -124.82 93.61 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.939 0.876 . . . . 0.0 109.926 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 66.5 t -97.7 120.89 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.456 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 48.6 t -93.36 124.48 45.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.493 ' CD2' ' HE ' ' A' ' 277' ' ' ARG . 28.8 mt -108.05 139.72 42.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.861 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -121.57 130.01 7.94 Favored Glycine 0 N--CA 1.477 1.38 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.634 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.12 119.47 36.51 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 241' ' ' ASP . 98.4 m -109.6 170.45 8.06 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.37 0.419 . . . . 0.0 110.462 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.495 ' N ' ' CG2' ' A' ' 240' ' ' THR . 26.1 p-10 -83.07 -176.08 6.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.448 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 281' ' ' GLU . 62.4 ttm-85 -105.23 121.96 44.94 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.813 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.46 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 46.3 mm -119.43 7.44 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.565 0.698 . . . . 0.0 110.813 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 85.62 -47.21 3.77 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.66 91.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 0.0 109.685 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -45.91 -48.23 16.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.41 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.4 82.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.878 0.37 . . . . 0.0 110.61 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -62.06 -45.24 94.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.525 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 241' ' ' ASP . 33.2 t30 -61.49 -43.87 98.09 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.652 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -64.76 -41.25 96.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.634 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.49 -36.78 93.65 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 30.5 mt -70.06 -41.17 74.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.915 0.388 . . . . 0.0 111.013 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 78.1 p -65.13 -39.61 93.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.818 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.3 -47.1 71.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.92 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -59.43 -43.84 93.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.799 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 239' ' ' TYR . 39.1 ttm180 -54.1 -61.41 2.32 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.329 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -58.7 -27.57 64.98 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.638 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -69.78 -47.31 63.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.374 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 38.5 m -62.17 -37.93 87.12 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.069 0.461 . . . . 0.0 110.393 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 77.4 t -63.65 -53.21 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.723 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.02 -48.77 86.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.669 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -45.16 -41.71 8.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.228 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.638 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 57.7 t80 -82.86 -28.9 29.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.764 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.01 -8.05 54.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.437 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.9 mt -88.44 -55.75 6.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.789 0.328 . . . . 0.0 111.619 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 41.6 m -50.61 -4.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.974 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.638 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 33.4 mmtm -77.48 -10.55 59.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.743 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.74 -7.44 22.09 Favored Glycine 0 C--O 1.227 -0.283 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.06 141.72 47.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.404 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.48 132.28 30.68 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.268 1.979 . . . . 0.0 111.826 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.04 -4.1 19.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.517 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -94.15 -26.24 16.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.451 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -79.55 -17.38 54.13 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.237 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.8 pt -104.24 -171.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.695 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 39.4 m -168.68 130.51 1.29 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.311 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.88 111.16 23.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.882 0.372 . . . . 0.0 110.627 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.493 ' HE ' ' CD2' ' A' ' 237' ' ' LEU . 41.4 ttp180 -123.13 148.74 45.38 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.152 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.63 148.83 16.49 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.545 ' N ' ' O ' ' A' ' 238' ' ' GLY . 83.9 mmm -121.99 15.98 10.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 119.335 -0.365 . . . . 0.0 111.554 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 23.32 -88.46 0.01 OUTLIER Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 279' ' ' MET . 0.6 OUTLIER -142.72 74.25 1.44 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.096 0.474 . . . . 0.0 110.738 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.4 t -72.22 -54.05 10.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.836 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -137.77 74.06 45.92 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.779 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.02 120.39 8.22 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.652 2.235 . . . . 0.0 112.26 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.4 m -75.91 -23.91 16.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.279 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.663 ' C ' ' H ' ' A' ' 288' ' ' ASN . 31.2 p -58.41 -44.9 89.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.612 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.21 -4.29 0.02 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.663 ' H ' ' C ' ' A' ' 286' ' ' THR . 22.0 m120 -126.13 -58.25 1.37 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.0 m -60.52 -22.86 64.06 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.55 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 63.5 m -121.07 27.79 8.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.47 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 29.4 p-10 -68.42 -2.85 9.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.664 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -111.49 31.98 5.73 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.494 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 15.5 t -137.86 117.67 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.865 0.364 . . . . 0.0 110.755 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -120.72 14.0 11.66 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.698 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.6 174.52 7.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.122 0.487 . . . . 0.0 109.849 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -81.01 -75.7 0.27 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -59.1 -27.52 65.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.984 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.87 95.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.481 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 303' ' ' LEU . 60.1 mt -69.36 -50.41 46.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.05 0.452 . . . . 0.0 110.646 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 62.7 mt -53.53 -34.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.006 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -78.34 -35.19 47.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.443 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.57 -10.59 55.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.539 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 299' ' ' LEU . 47.8 mt -91.55 23.77 3.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.515 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.583 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -85.12 -44.64 0.66 Allowed Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.5 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 33.1 Cg_exo -59.12 7.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.56 2.84 . . . . 0.0 112.232 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 304' ' ' ALA . 35.9 p30 -107.04 18.15 22.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.708 0.289 . . . . 0.0 110.796 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -113.21 98.58 7.22 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.514 0.673 . . . . 0.0 109.881 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 38.0 ptt180 -159.85 133.58 7.2 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.147 -0.621 . . . . 0.0 112.016 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.14 141.37 15.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -122.81 104.28 9.18 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.257 0.551 . . . . 0.0 110.313 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.87 117.47 25.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -93.35 123.05 36.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 123.12 0.263 . . . . 0.0 110.624 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 14.6 t -123.12 115.79 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.318 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -115.53 129.11 56.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 105.9 12.04 26.88 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 15.4 tt -93.71 137.34 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.226 0.536 . . . . 0.0 110.672 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.709 179.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.99 0.424 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 24.1 m -67.38 125.24 25.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.411 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 313' ' ' VAL . 41.6 tptt -117.1 162.14 18.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.205 0.526 . . . . 0.0 111.04 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -149.27 123.16 9.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.112 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -114.82 118.92 34.89 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.675 ' HG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -86.36 108.03 18.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.639 -179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 27.0 tp -109.4 125.35 52.3 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -83.17 129.9 35.06 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 122.192 0.996 . . . . 0.0 112.602 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 202' ' ' PHE . 93.6 p -60.35 -27.87 67.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.834 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 203' ' ' ASN . 14.1 t70 -54.28 -40.56 67.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.03 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.5 t -72.74 -33.44 44.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 79.2 mt -89.43 -79.54 0.33 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.51 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -127.86 116.27 19.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.745 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.43 ' OD1' ' OD1' ' A' ' 199' ' ' ASP . 3.1 m-80 -82.26 -64.59 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.772 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -116.73 -17.52 10.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.77 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.531 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 54.4 t30 -66.16 164.92 14.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.058 0.456 . . . . 0.0 110.194 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -50.85 -80.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.507 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.49 53.0 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.214 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.531 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 42.5 p -107.24 134.38 50.41 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.168 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.1 mt -78.17 127.3 32.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.284 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' GLY . 8.0 ptmt -85.01 161.87 51.31 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.717 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -36.89 -75.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.075 1.85 . . . . 0.0 111.553 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -50.54 -19.89 1.02 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.017 0.437 . . . . 0.0 109.963 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.84 -52.08 13.09 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.6 -38.89 90.75 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.158 0.504 . . . . 0.0 109.903 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.53 57.13 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.85 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.81 88.76 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.763 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.2 mt -62.27 -29.08 70.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.519 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -72.34 -45.94 57.69 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.379 0.609 . . . . 0.0 110.486 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.528 ' O ' ' NE2' ' A' ' 223' ' ' GLN . 6.7 mt-30 -62.14 -42.95 99.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.081 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.45 -39.63 92.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.586 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 225' ' ' SER . 7.1 t80 -52.87 -46.73 68.03 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.46 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.4 m -55.1 -51.32 66.79 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.684 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.872 ' H ' HE21 ' A' ' 223' ' ' GLN . 0.0 OUTLIER -55.86 -27.02 49.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.582 -179.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 78.0 mt -95.95 -21.18 18.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.769 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 221' ' ' TYR . 9.2 p -84.7 -13.43 51.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.476 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -106.4 23.6 13.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.157 0.503 . . . . 0.0 110.654 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 227' ' ' LEU . 0.9 OUTLIER -77.58 -179.31 5.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.687 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -101.41 109.11 58.05 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 232' ' ' GLY . 73.9 Cg_exo -44.45 -19.22 0.23 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.829 2.353 . . . . 0.0 112.964 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 229' ' ' PRO . 3.4 ttmp? -24.51 -47.57 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.691 0.619 . . . . 0.0 110.775 -178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 97.6 m-20 -116.49 -11.95 11.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.648 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 24.9 47.76 0.02 OUTLIER Glycine 0 N--CA 1.47 0.963 0 O-C-N 123.587 0.554 . . . . 0.0 111.841 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 231' ' ' ASP . 2.3 m -118.36 117.48 29.19 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 122.588 -0.36 . . . . 0.0 110.171 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.21 95.71 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.57 0.7 . . . . 0.0 110.675 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.3 125.18 51.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.283 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.86 129.83 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.428 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.0 mt -114.02 140.0 48.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 279' ' ' MET . . . -115.42 141.04 16.72 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.5 OUTLIER -121.55 123.93 43.16 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 249' ' ' ASN . 2.1 p -118.5 161.77 19.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.106 0.479 . . . . 0.0 110.076 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.526 ' OD2' ' NE ' ' A' ' 307' ' ' ARG . 8.5 p30 -84.05 174.91 9.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.337 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -97.31 122.28 40.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.226 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 48.0 mm -117.15 14.97 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.363 0.601 . . . . 0.0 110.65 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.2 4.51 88.95 Favored Glycine 0 C--N 1.314 -0.688 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 24.8 m -130.07 102.19 6.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 110.235 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -52.31 -51.96 55.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.679 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.9 -42.52 76.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.726 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.405 ' CE2' ' CD1' ' A' ' 252' ' ' LEU . 33.9 t80 -60.4 -46.08 91.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.552 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.444 ' O ' ' OG ' ' A' ' 253' ' ' SER . 14.5 t-20 -62.92 -46.09 89.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.829 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -63.01 -42.48 99.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.719 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.54 -38.16 95.91 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.405 ' CD1' ' CE2' ' A' ' 248' ' ' TYR . 28.1 mt -73.71 -34.37 64.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.676 0.274 . . . . 0.0 111.084 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 249' ' ' ASN . 4.4 m -65.26 -44.37 88.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.025 0.44 . . . . 0.0 110.629 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -68.26 -43.67 77.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.084 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -58.59 -47.14 85.3 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.914 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.68 -55.0 30.88 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.392 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.49 -33.76 68.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.193 0.521 . . . . 0.0 109.942 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -45.89 41.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.283 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 43.0 t -60.06 -39.85 87.45 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.23 -52.5 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.461 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.6 t -61.15 -49.48 84.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.172 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -44.9 -41.45 7.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.895 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.25 -29.7 31.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.568 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -7.73 52.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.268 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.58 ' C ' ' H ' ' A' ' 267' ' ' LYS . 59.7 mt -87.81 -57.15 4.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.845 0.355 . . . . 0.0 111.472 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 p -49.95 -6.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.974 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.58 ' H ' ' C ' ' A' ' 265' ' ' ILE . 4.8 mmtm -78.84 -10.6 59.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.092 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 108.8 37.42 2.04 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.04 128.21 24.21 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.75 130.43 37.12 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.892 1.728 . . . . 0.0 112.062 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.85 -9.27 35.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.001 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 52.0 t0 -92.79 -22.93 19.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.779 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.49 -21.17 45.7 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.714 0.769 . . . . 0.0 110.548 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -103.18 -171.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.051 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 1.3 m -166.8 130.23 1.9 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.153 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -105.02 112.79 26.05 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.633 0.254 . . . . 0.0 110.642 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -122.54 147.21 46.65 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.509 0.671 . . . . 0.0 110.517 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.77 99.09 2.25 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.4 tpt -67.99 -11.44 58.88 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.445 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.54 -95.53 0.01 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 279' ' ' MET . 97.8 mt-10 -141.41 75.68 1.51 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 110.8 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.1 p -87.76 -4.9 58.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -172.96 78.93 0.42 Allowed Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.756 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.29 104.62 0.43 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.539 2.159 . . . . 0.0 112.305 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 17.5 m -70.59 -40.39 77.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.268 0.556 . . . . 0.0 110.193 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.642 ' C ' ' H ' ' A' ' 288' ' ' ASN . 17.7 p -64.81 -47.44 78.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.099 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.418 ' H ' ' HG1' ' A' ' 286' ' ' THR . . . -51.65 -1.68 0.04 OUTLIER Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.642 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.5 t-20 -112.31 -59.83 1.95 Allowed 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.91 -4.18 55.97 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.382 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 286' ' ' THR . 0.7 OUTLIER -126.59 16.64 7.56 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.38 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.62 -3.1 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.382 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -101.95 32.37 3.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.36 121.43 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.02 0.438 . . . . 0.0 110.143 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -118.88 8.51 11.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.67 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -90.71 169.45 10.96 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 110.04 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -82.65 -78.24 0.21 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.636 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -50.7 -29.97 12.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.97 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.99 99.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.244 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.7 mt -68.93 -42.46 76.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.542 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.4 mm -59.48 -34.13 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.015 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.18 -25.41 31.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.412 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 11.3 t -94.34 -15.19 24.62 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.962 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 299' ' ' LEU . 54.1 mt -91.88 22.72 4.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.717 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.567 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -75.81 -44.86 4.04 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.316 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 22.2 Cg_exo -64.15 8.7 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.434 2.756 . . . . 0.0 111.817 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 304' ' ' ALA . 7.4 t70 -108.41 7.31 26.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.696 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.526 ' NE ' ' OD2' ' A' ' 241' ' ' ASP . 93.1 mtt180 -109.62 100.54 9.56 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.151 0.5 . . . . 0.0 110.086 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.675 ' NH2' ' HG1' ' A' ' 195' ' ' THR . 16.9 ptm180 -173.43 166.62 4.72 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.888 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.8 151.06 33.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -120.92 108.37 13.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.178 0.513 . . . . 0.0 110.251 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.4 mm -80.02 119.49 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.767 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -104.33 114.88 29.42 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.02 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 192' ' ' LYS . 70.4 t -127.81 123.18 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.658 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -118.98 148.14 43.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.009 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.43 25.03 31.85 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.645 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.2 tt -103.17 177.3 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.645 ' O ' ' O ' ' A' ' 316' ' ' ILE . 14.2 mptt . . . . . 0 CA--C 1.533 0.322 0 O-C-N 124.124 0.89 . . . . 0.0 110.763 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 120.949 0.404 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m -70.64 145.99 50.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.209 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.435 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 10.6 tptp -146.33 165.03 30.52 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.225 0.536 . . . . 0.0 110.326 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.435 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 89.2 m-70 -152.83 126.47 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.216 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 70.1 m-85 -114.84 124.67 52.33 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.538 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.52 108.97 19.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.859 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 27.5 tp -110.96 126.99 55.34 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -78.59 129.5 34.85 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.735 0.778 . . . . 0.0 111.932 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.447 ' H ' ' HA ' ' A' ' 308' ' ' ARG . 58.2 m -69.11 -30.86 69.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.404 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.461 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 2.4 p-10 -62.39 -33.81 75.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.657 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.48 -34.97 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.6 mt -85.62 -81.82 0.2 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.804 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -112.54 132.44 55.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.047 -179.292 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 199' ' ' ASP . 66.5 m-80 -111.65 -81.06 0.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.805 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -83.6 -37.61 22.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -64.43 162.29 15.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.056 0.455 . . . . 0.0 110.504 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -52.24 -66.94 0.3 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.583 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.49 61.14 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.471 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 75.3 p -107.44 134.12 50.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.138 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.66 145.08 45.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 213' ' ' GLY . 13.4 mmmt -104.1 153.11 39.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.017 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 210' ' ' LYS . 86.4 Cg_exo -32.34 -77.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.545 2.163 . . . . 0.0 112.265 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -51.22 -18.81 1.0 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.353 0.597 . . . . 0.0 110.376 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.9 -49.83 8.39 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.052 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -65.98 -41.93 90.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.079 0.466 . . . . 0.0 110.142 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.6 -49.6 75.88 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.399 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.81 92.55 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.486 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.01 -31.31 71.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.311 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.47 -46.32 66.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 0.0 110.852 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -62.71 -41.73 99.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.065 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 50.9 tp -66.02 -39.43 90.22 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.475 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.5 t80 -54.82 -47.99 73.38 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.168 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.1 t -57.6 -51.18 70.54 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.41 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 11.4 tt0 -53.45 -25.0 14.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.689 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 68.2 mt -100.29 -22.1 15.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 221' ' ' TYR . 7.5 t -67.87 -17.65 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 58.1 t-20 -111.83 29.46 7.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -78.94 141.69 37.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 109.987 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 315' ' ' GLY . 38.6 t0 -50.66 107.38 0.8 Allowed Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 232' ' ' GLY . 47.9 Cg_exo -54.3 -19.22 16.28 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.219 1.946 . . . . 0.0 113.018 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.494 ' C ' ' O ' ' A' ' 229' ' ' PRO . 38.1 ttmt -21.42 -50.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.539 0.525 . . . . 0.0 111.376 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 232' ' ' GLY . 2.6 m-20 -115.87 -8.09 11.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.96 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.09 54.77 0.16 Allowed Glycine 0 N--CA 1.473 1.119 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.563 ' H ' ' CE ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -123.24 116.7 23.81 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 121.294 0.569 . . . . 0.0 110.847 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 79.1 t -131.28 101.33 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.652 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.41 123.04 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.018 0.437 . . . . 0.0 110.59 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.73 127.67 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.244 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 28.3 mt -110.23 145.95 36.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.014 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -111.14 136.47 13.62 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.488 ' CZ ' ' CD ' ' A' ' 310' ' ' GLU . 6.7 m-85 -122.12 115.95 23.36 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 17.5 p -112.72 165.8 11.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.933 0.397 . . . . 0.0 110.692 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -88.43 -177.36 5.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.323 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -97.44 122.18 40.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.33 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.613 ' H ' HD22 ' A' ' 249' ' ' ASN . 47.9 mm -118.6 13.42 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.187 0.518 . . . . 0.0 110.689 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.14 1.56 80.52 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.3 p -129.05 104.45 7.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.173 0.511 . . . . 0.0 109.964 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -55.23 -53.13 59.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.358 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.96 -46.29 78.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -60.23 -44.98 94.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.62 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.613 HD22 ' H ' ' A' ' 243' ' ' ILE . 77.2 m-20 -61.43 -45.3 94.87 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.35 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -66.29 -37.69 86.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.551 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.11 -40.45 98.55 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.95 -29.92 62.26 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.695 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 14.9 m -66.81 -47.53 71.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.937 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.84 -41.39 78.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.325 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.16 -49.44 77.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.026 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -60.85 -58.6 7.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.495 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.98 -35.69 25.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.068 0.461 . . . . 0.0 109.902 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -71.57 -45.06 63.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.325 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 57.3 m -60.53 -39.47 87.96 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.446 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.69 -51.04 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.406 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.8 t -60.28 -49.7 83.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.152 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -44.63 -41.99 7.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.18 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.558 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 76.8 t80 -81.3 -29.16 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.037 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.93 -5.84 48.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.654 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 267' ' ' LYS . 53.0 mt -88.73 -60.3 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.917 0.389 . . . . 0.0 111.953 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 29.5 t -49.81 -4.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.391 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.597 ' H ' ' C ' ' A' ' 265' ' ' ILE . 70.7 mmtt -75.76 -10.79 59.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.442 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 116.76 -8.47 16.9 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -83.35 129.34 60.87 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.425 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.28 134.36 56.51 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.641 1.56 . . . . 0.0 111.896 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.61 55.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -92.61 -21.15 20.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.055 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -77.86 -22.97 49.06 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.611 0.719 . . . . 0.0 110.593 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -101.51 -170.94 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.771 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 15.2 t -170.08 130.18 0.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.102 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.29 153.3 17.89 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.942 -0.473 . . . . 0.0 109.756 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -161.48 149.4 15.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.023 0.44 . . . . 0.0 110.72 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.51 96.78 1.1 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 15.6 tpp -69.86 -13.15 62.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.509 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 57.79 -101.42 0.18 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.66 71.04 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.822 0.344 . . . . 0.0 110.779 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 25.2 t -90.78 -1.55 57.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.662 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -157.73 68.66 4.0 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.317 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.27 105.41 2.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.188 1.925 . . . . 0.0 112.301 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 30.2 m -75.54 -25.7 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.597 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.683 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.0 OUTLIER -58.64 -44.47 90.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.912 -179.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.409 ' N ' ' HG1' ' A' ' 286' ' ' THR . . . -48.5 -3.08 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.683 ' H ' ' C ' ' A' ' 286' ' ' THR . 94.8 m-20 -122.62 -57.82 1.71 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 m -63.89 -21.31 66.4 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.698 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 55.9 m -122.18 26.0 8.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.281 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 47.5 t0 -70.71 -6.04 34.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.594 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -110.11 30.55 6.63 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.572 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 15.1 t -133.39 120.04 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.462 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -120.27 8.93 10.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -86.17 171.96 10.91 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 110.074 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -80.91 -73.85 0.35 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.755 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -59.25 -26.86 65.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.21 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.55 84.65 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.8 mt -72.21 -47.68 48.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.744 0.307 . . . . 0.0 110.744 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.21 -31.27 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.081 0.467 . . . . 0.0 109.876 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -80.58 -29.65 36.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.68 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.6 t -93.31 -10.72 34.44 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 299' ' ' LEU . 49.8 mt -92.23 19.95 6.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.727 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.608 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -74.07 -41.85 5.46 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.4 Cg_exo -62.71 9.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.408 2.739 . . . . 0.0 112.314 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 304' ' ' ALA . 38.8 t0 -112.54 7.37 18.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.884 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 64.6 mtp180 -104.43 100.43 10.13 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.021 0.439 . . . . 0.0 110.05 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.447 ' HA ' ' H ' ' A' ' 198' ' ' SER . 39.2 ptt180 -171.32 -171.14 0.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.287 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.47 155.85 14.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.488 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 96.2 mt-10 -122.8 102.74 8.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.25 0.547 . . . . 0.0 110.395 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.6 mm -79.18 120.81 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.711 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -101.93 121.31 41.89 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.568 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 70.4 t -130.04 123.4 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.928 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.647 ' HZ1' ' CA ' ' A' ' 315' ' ' GLY . 0.0 OUTLIER -95.25 -174.21 3.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.935 178.365 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.647 ' CA ' ' HZ1' ' A' ' 314' ' ' LYS . . . 16.69 69.21 0.01 OUTLIER Glycine 0 N--CA 1.472 1.047 0 O-C-N 123.677 0.611 . . . . 0.0 112.386 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 317' ' ' LYS . 4.1 tt -115.18 160.06 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.44 ' H ' HG13 ' A' ' 316' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 122.239 1.018 . . . . 0.0 111.226 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.478 ' NE2' ' H ' ' A' ' 190' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.562 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.41 ' CG2' ' CE1' ' A' ' 193' ' ' HIS . 29.0 m -87.79 141.17 28.81 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.045 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -133.86 97.4 3.89 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.392 0.615 . . . . 0.0 111.725 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.41 ' CE1' ' CG2' ' A' ' 191' ' ' THR . 8.7 m80 -84.71 135.75 34.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.106 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.615 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 62.0 m-85 -111.04 124.32 51.94 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.876 0.37 . . . . 0.0 110.103 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.6 102.44 14.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.166 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 32.0 tp -104.54 125.66 50.9 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.301 0.572 . . . . 0.0 109.727 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -79.15 128.66 33.57 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-O 122.349 1.071 . . . . 0.0 112.177 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 307' ' ' ARG . 94.5 p -61.25 -30.6 70.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.289 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.56 -37.79 76.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.05 -43.79 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 90.4 mt -78.63 -78.25 0.15 Allowed 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.921 -0.711 . . . . 0.0 110.583 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -128.48 130.38 47.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.147 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -96.3 -70.92 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.472 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -106.31 -13.86 15.27 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.932 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.662 ' ND2' ' HZ2' ' A' ' 210' ' ' LYS . 98.6 m-20 -71.59 168.09 18.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.059 0.457 . . . . 0.0 110.199 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.631 ' NZ ' ' NH1' ' A' ' 255' ' ' ARG . 19.7 tptm -57.64 -69.94 0.15 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.483 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -163.12 -0.11 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.411 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 14.4 t -52.92 134.83 37.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.995 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.9 139.59 34.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.072 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.662 ' HZ2' ' ND2' ' A' ' 205' ' ' ASN . 28.4 mttp -98.34 158.32 32.86 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.822 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -34.47 -75.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.43 2.087 . . . . 0.0 111.831 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -51.21 -21.05 1.82 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.177 0.513 . . . . 0.0 110.243 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.59 -51.41 12.11 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.305 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -67.1 -39.1 86.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.322 0.582 . . . . 0.0 110.072 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.61 -53.79 53.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.757 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.52 87.64 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.699 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 mt -61.36 -28.21 69.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.311 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -74.83 -45.45 43.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.456 0.646 . . . . 0.0 110.53 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -61.51 -42.68 99.17 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.849 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 57.3 tp -65.58 -39.15 91.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.536 ' CZ ' ' OG ' ' A' ' 225' ' ' SER . 5.9 t80 -52.6 -50.1 63.74 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.228 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.4 t -53.87 -51.68 62.88 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.414 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.615 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 8.7 tt0 -52.76 -25.93 12.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.149 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 22.5 mt -99.13 -18.95 17.44 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.419 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.536 ' OG ' ' CZ ' ' A' ' 221' ' ' TYR . 1.7 m -73.36 -31.67 64.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.065 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -91.54 23.15 3.61 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.949 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.24 158.55 27.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.28 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 315' ' ' GLY . 10.0 t0 -76.43 128.93 81.24 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.304 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 230' ' ' LYS . 42.8 Cg_endo -68.36 -18.66 44.21 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.919 2.412 . . . . 0.0 112.813 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 229' ' ' PRO . 65.3 tttm -32.63 -47.31 0.16 Allowed 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 123.508 0.505 . . . . 0.0 110.468 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 232' ' ' GLY . 21.8 m-20 -108.55 -18.84 13.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.886 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.15 47.99 0.03 OUTLIER Glycine 0 N--CA 1.474 1.23 0 O-C-N 123.902 0.751 . . . . 0.0 111.234 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 231' ' ' ASP . 18.0 m -115.36 110.84 19.95 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.7 t -127.03 94.25 2.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.664 0.745 . . . . 0.0 110.074 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 16.0 t -98.72 122.74 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.642 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.87 123.24 49.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.667 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.5 mt -106.35 143.62 34.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.027 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -118.33 135.94 11.92 Favored Glycine 0 N--CA 1.478 1.441 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.334 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.629 ' CE2' ' SD ' ' A' ' 279' ' ' MET . 0.1 OUTLIER -121.2 116.84 25.68 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.2 t -108.09 167.95 9.64 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -90.85 -179.27 5.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.271 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -95.88 123.15 39.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.375 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.444 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 49.9 mm -118.12 9.18 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.418 0.628 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 81.86 4.39 90.32 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' SER . . . . . 0.611 ' HG ' ' H ' ' A' ' 248' ' ' TYR . 2.7 t -134.04 98.75 4.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.078 0.466 . . . . 0.0 110.327 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -52.69 -51.66 59.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.488 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.2 69.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.909 0.385 . . . . 0.0 110.413 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.611 ' H ' ' HG ' ' A' ' 245' ' ' SER . 46.4 t80 -61.27 -41.2 96.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.377 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -60.9 -46.47 90.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.424 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -61.62 -38.71 88.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.388 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.84 -38.33 96.34 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 34.2 mt -71.93 -39.19 69.64 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.378 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.5 t -64.55 -41.19 96.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.227 0.537 . . . . 0.0 110.951 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.01 -38.39 66.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.631 ' NH1' ' NZ ' ' A' ' 206' ' ' LYS . 17.3 mmt85 -60.12 -51.25 70.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.965 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.418 ' HG3' ' N ' ' A' ' 257' ' ' ALA . 20.1 ptp180 -64.18 -44.66 91.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -60.1 -37.1 78.95 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.305 0.574 . . . . 0.0 110.158 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -44.2 59.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.41 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 49.9 m -59.4 -38.37 80.39 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.094 0.474 . . . . 0.0 110.306 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 96.4 t -65.71 -52.72 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.376 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.3 t -61.83 -49.21 85.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.441 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -46.53 -41.34 14.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.856 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.573 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 58.3 t80 -81.28 -32.78 33.06 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.56 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -9.01 39.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.624 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.599 ' C ' ' H ' ' A' ' 267' ' ' LYS . 61.8 mt -86.4 -50.1 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 111.556 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 88.8 p -49.82 -5.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.199 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.599 ' H ' ' C ' ' A' ' 265' ' ' ILE . 2.0 mptp? -86.89 7.67 26.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 110.35 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 87.24 41.4 6.59 Favored Glycine 0 CA--C 1.507 -0.456 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.79 128.11 25.5 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.37 126.38 21.51 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.755 1.636 . . . . 0.0 111.982 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.49 -8.78 21.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.971 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -91.53 -22.97 20.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -80.46 -18.66 48.06 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.463 0.649 . . . . 0.0 110.713 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.7 pt -106.18 -171.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.777 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 28.7 t -171.05 127.63 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.327 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.14 110.56 23.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.472 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -120.18 148.09 44.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.46 0.647 . . . . 0.0 110.86 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.42 97.84 0.5 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.629 ' SD ' ' CE2' ' A' ' 239' ' ' TYR . 2.8 ptp -81.59 31.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.461 0.172 . . . . 0.0 110.816 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 38.19 -97.43 0.01 OUTLIER Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -141.84 70.57 1.34 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.704 0.288 . . . . 0.0 110.415 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.8 m -91.16 0.59 57.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.518 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -155.95 60.67 2.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.51 110.93 3.17 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.505 2.137 . . . . 0.0 112.03 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.5 m -71.37 -36.4 61.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.42 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.678 ' C ' ' H ' ' A' ' 288' ' ' ASN . 70.6 p -62.18 -45.75 92.0 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.083 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.31 -3.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.678 ' H ' ' C ' ' A' ' 286' ' ' THR . 55.8 t-20 -123.83 -57.78 1.61 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 m -58.94 -25.61 63.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.615 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 68.3 m -105.12 32.07 4.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 0.0 110.59 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.48 -2.81 18.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.456 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -109.98 30.98 6.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 10.5 t -132.17 121.65 46.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 120.919 0.39 . . . . 0.0 110.42 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -121.23 6.18 10.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . 0.432 ' O ' ' CD1' ' A' ' 299' ' ' LEU . 5.1 mt-30 -88.5 172.12 9.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.039 0.447 . . . . 0.0 110.402 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -82.01 -72.62 0.43 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.91 -28.99 66.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.47 . . . . 0.0 110.867 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.27 82.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.381 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 303' ' ' LEU . 42.5 mt -71.81 -52.16 18.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 63.6 mt -51.42 -34.73 15.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.51 -35.22 58.45 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.352 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.97 -8.22 57.41 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.814 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 299' ' ' LEU . 65.8 mt -96.23 15.53 20.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.723 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.616 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -76.78 -45.93 3.05 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.141 0.496 . . . . 0.0 110.008 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 28.0 Cg_exo -59.47 10.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 123.042 2.495 . . . . 0.0 111.818 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 304' ' ' ALA . 54.6 t0 -104.56 13.52 31.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.873 0.368 . . . . 0.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.447 ' O ' ' OG ' ' A' ' 198' ' ' SER . 78.8 mtp85 -112.58 102.23 10.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.299 0.571 . . . . 0.0 110.557 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.6 ptp180 -165.8 142.51 5.34 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.22 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 15.2 m -107.4 145.54 14.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -118.04 108.63 15.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.118 0.485 . . . . 0.0 110.74 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.4 mm -79.5 114.28 20.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -96.72 111.15 23.43 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.769 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.0 118.4 57.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 O-C-N 123.556 0.535 . . . . 0.0 110.919 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -116.25 131.07 57.05 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.69 33.88 5.96 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.705 ' O ' ' O ' ' A' ' 317' ' ' LYS . 10.5 tt -108.46 168.53 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.705 ' O ' ' O ' ' A' ' 316' ' ' ILE . 42.1 tttt . . . . . 0 CA--C 1.537 0.468 0 O-C-N 124.205 0.941 . . . . 0.0 111.556 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 121.124 0.488 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 48.9 m -64.97 125.79 25.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.402 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 313' ' ' VAL . 39.2 tptt -117.97 163.33 16.74 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.278 0.561 . . . . 0.0 111.086 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -153.17 125.44 8.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.366 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.4 ' CG ' HD13 ' A' ' 220' ' ' LEU . 64.3 m-85 -114.26 116.98 29.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.56 103.45 15.08 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.333 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.2 tp -106.64 130.36 54.4 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.911 0.386 . . . . 0.0 110.218 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -84.65 129.04 34.89 Favored 'General case' 0 C--O 1.255 1.355 0 CA-C-O 122.565 1.174 . . . . 0.0 111.819 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 202' ' ' PHE . 37.4 m -61.54 -18.15 57.95 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.53 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.58 -41.31 94.39 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.194 0.521 . . . . 0.0 110.201 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.9 t -72.45 -34.14 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.344 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 62.4 mt -88.12 -80.0 0.28 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.126 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -127.84 114.36 17.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.244 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.588 ' ND2' ' CE2' ' A' ' 204' ' ' PHE . 62.6 t30 -90.84 -72.09 0.59 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.473 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.588 ' CE2' ' ND2' ' A' ' 203' ' ' ASN . 88.3 m-85 -102.76 -25.89 13.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.795 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -63.56 170.71 3.0 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.982 0.42 . . . . 0.0 110.154 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -53.54 -83.33 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.652 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.04 53.69 0.15 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.443 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.7 t -107.33 145.44 32.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.848 0.356 . . . . 0.0 110.303 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.23 127.61 33.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 213' ' ' GLY . 12.7 mtpp -89.55 158.85 45.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.813 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 210' ' ' LYS . 76.8 Cg_exo -33.34 -76.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.499 2.133 . . . . 0.0 112.01 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -48.47 -22.54 0.74 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.146 0.498 . . . . 0.0 110.321 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.36 -48.45 18.78 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -63.19 -39.63 95.2 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.83 -53.88 52.77 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.568 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.83 -28.65 69.7 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.596 0.712 . . . . 0.0 110.537 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -31.63 68.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.364 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.21 -48.18 30.63 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.173 0.511 . . . . 0.0 111.263 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 12.1 pt20 -64.03 -44.46 92.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.981 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.461 ' N ' ' CG ' ' A' ' 219' ' ' GLN . 36.0 tp -62.7 -41.71 99.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.336 -0.545 . . . . 0.0 109.892 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 4.2 t80 -52.26 -48.1 65.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.374 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.5 m -52.81 -52.34 57.31 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.485 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -54.3 -27.3 34.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.186 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 85.0 mt -95.3 -20.28 19.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.668 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 221' ' ' TYR . 23.5 p -79.64 -21.2 45.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.831 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -99.1 21.46 11.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.558 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.437 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.8 OUTLIER -76.34 -179.68 5.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.61 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.434 ' OD2' ' CG ' ' A' ' 230' ' ' LYS . 2.8 t70 -99.09 132.64 23.15 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.41 -17.02 34.89 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.501 2.134 . . . . 0.0 112.94 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.434 ' CG ' ' OD2' ' A' ' 228' ' ' ASP . 40.4 mmtt -37.02 -45.27 0.57 Allowed 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.55 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' GLY . 95.1 m-20 -107.73 -19.89 13.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.442 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.7 49.04 0.05 OUTLIER Glycine 0 N--CA 1.469 0.847 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.24 112.4 19.44 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 122.591 -0.358 . . . . 0.0 110.791 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 52.2 t -130.93 93.38 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.426 0.632 . . . . 0.0 110.497 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.14 123.93 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.334 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.4 127.1 53.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.598 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 25.5 mt -110.17 145.36 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.068 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -115.81 142.2 17.4 Favored Glycine 0 N--CA 1.478 1.479 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.559 ' CE2' ' SD ' ' A' ' 279' ' ' MET . 0.7 OUTLIER -122.39 120.64 34.58 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.1 p -112.74 164.59 13.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.833 0.349 . . . . 0.0 110.239 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 241' ' ' ASP . 14.5 p-10 -88.47 -176.77 5.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.373 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -100.6 121.72 42.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.277 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 51.5 mm -118.63 11.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.311 0.577 . . . . 0.0 110.664 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.23 3.72 88.63 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.7 t -133.62 99.81 4.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.068 0.461 . . . . 0.0 110.013 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 56.1 t0 -52.57 -50.78 62.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.466 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.4 67.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.822 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.412 ' CE2' ' CD1' ' A' ' 252' ' ' LEU . 45.8 t80 -62.25 -47.99 81.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.513 HD22 HE21 ' A' ' 250' ' ' GLN . 0.1 OUTLIER -62.29 -40.78 97.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.575 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.513 HE21 HD22 ' A' ' 249' ' ' ASN . 97.6 mm-40 -60.42 -48.02 83.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.899 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.14 -36.4 92.9 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.412 ' CD1' ' CE2' ' A' ' 248' ' ' TYR . 25.9 mt -72.95 -35.98 67.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.097 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.1 m -63.73 -41.71 98.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.87 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -73.21 -35.42 66.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.353 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -60.21 -53.5 56.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.434 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 239' ' ' TYR . 17.4 ptp180 -62.91 -43.96 97.39 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.277 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.92 -38.87 90.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.319 0.581 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -71.84 -42.18 67.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.277 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 10.6 t -63.24 -38.76 92.41 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.371 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 256' ' ' ARG . 84.5 t -63.36 -51.21 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.277 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.7 t -62.19 -48.75 86.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.234 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -45.08 -41.23 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.08 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.527 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 49.6 t80 -81.79 -29.51 32.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.518 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.94 -7.72 53.42 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.48 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 267' ' ' LYS . 59.6 mt -86.95 -54.67 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 111.483 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 33.9 t -50.83 -5.2 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' H ' ' C ' ' A' ' 265' ' ' ILE . 32.2 mmtp -80.18 0.46 32.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.523 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 93.11 40.75 4.78 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.44 139.33 34.36 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.209 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -63.4 129.06 24.16 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.187 1.925 . . . . 0.0 112.097 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.74 -7.28 14.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.999 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -91.1 -28.07 18.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.89 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -77.49 -20.52 54.2 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.954 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.12 -178.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 13.2 m -171.2 129.63 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.51 155.63 16.69 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.149 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -161.56 149.43 15.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.105 0.479 . . . . 0.0 110.63 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -118.13 98.46 0.76 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.559 ' SD ' ' CE2' ' A' ' 239' ' ' TYR . 0.7 OUTLIER -80.08 18.19 0.88 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.718 -0.241 . . . . 0.0 110.838 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 43.77 -102.1 0.03 OUTLIER Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.443 ' OE1' ' OD1' ' A' ' 306' ' ' ASP . 5.4 mm-40 -136.21 74.61 1.51 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.852 0.384 . . . . 0.0 110.57 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.529 ' H ' ' CE ' ' A' ' 279' ' ' MET . 0.6 OUTLIER -88.71 2.18 53.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.337 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.81 77.36 1.06 Allowed Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.859 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.62 106.82 2.33 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.015 1.81 . . . . 0.0 111.698 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 286' ' ' THR . 5.2 m -68.29 -43.83 84.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.75 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.658 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.1 p -58.85 -44.15 90.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.134 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.58 -3.55 0.02 OUTLIER Glycine 0 CA--C 1.531 1.049 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.658 ' H ' ' C ' ' A' ' 286' ' ' THR . 90.9 m-20 -119.33 -57.72 1.98 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.35 -13.42 62.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.732 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.91 23.04 6.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.305 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.79 -11.18 54.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.345 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -96.72 33.25 1.89 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.566 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 19.2 t -128.94 124.64 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.447 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -118.68 7.54 11.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -94.93 126.67 40.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 110.2 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -49.59 -57.43 7.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.73 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.12 85.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.997 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.29 -31.2 72.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.546 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 32.6 mt -76.65 -54.15 7.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.4 mt -52.54 -35.79 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.041 0.448 . . . . 0.0 109.954 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -71.25 -42.05 69.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 8.7 t -81.73 -0.73 44.24 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 110.91 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.55 18.11 13.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.359 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.581 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -79.46 -44.23 1.63 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.297 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.5 Cg_exo -63.17 8.85 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 123.257 2.638 . . . . 0.0 111.991 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 304' ' ' ALA . 6.5 t0 -107.45 12.21 28.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -109.55 106.13 15.72 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.204 0.525 . . . . 0.0 110.118 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -173.09 167.76 4.88 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.769 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.25 151.18 34.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.403 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 90.3 mt-10 -122.3 106.85 11.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.057 0.455 . . . . 0.0 110.198 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.49 117.81 25.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -102.15 120.16 39.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.069 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 192' ' ' LYS . 62.0 t -133.41 123.65 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.421 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -118.66 141.7 48.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.583 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.88 -9.19 47.06 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.829 ' O ' ' O ' ' A' ' 317' ' ' LYS . 17.1 tt -81.1 152.92 4.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.829 ' O ' ' O ' ' A' ' 316' ' ' ILE . 40.4 tttm . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 122.234 1.016 . . . . 0.0 112.069 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.691 ' NE2' ' H ' ' A' ' 190' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 121.001 0.429 . . . . 0.0 110.646 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.2 m -75.41 132.26 40.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.138 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -146.07 118.72 8.58 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.524 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.4 m-70 -106.69 148.51 28.29 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -107.45 124.01 49.23 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.044 0.449 . . . . 0.0 110.097 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.76 101.67 12.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.567 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 38.6 tp -108.56 145.45 34.81 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.665 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 199' ' ' ASP . 1.6 tmtm? -88.98 125.8 35.14 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.721 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.0 t -67.92 -33.83 75.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.24 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.469 ' H ' ' HD2' ' A' ' 197' ' ' LYS . 17.3 t0 -63.69 -39.6 94.71 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.04 -47.93 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 47.0 mt -67.29 -78.37 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.057 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.2 117.93 35.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.67 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 199' ' ' ASP . 69.1 m-80 -90.55 -82.56 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.193 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -93.23 -16.57 24.64 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.716 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.689 HD21 ' NZ ' ' A' ' 210' ' ' LYS . 67.7 m-20 -75.49 156.82 34.8 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.264 0.554 . . . . 0.0 109.801 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.422 ' CD ' ' H ' ' A' ' 206' ' ' LYS . 12.9 mptt -50.0 -68.19 0.2 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.77 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.17 60.12 0.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.167 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.3 p -110.31 141.92 42.66 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.472 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 35.7 mt -85.17 135.21 34.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.435 0.636 . . . . 0.0 111.339 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.689 ' NZ ' HD21 ' A' ' 205' ' ' ASN . 40.2 mmtm -100.55 153.86 37.51 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.444 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LYS . 91.7 Cg_exo -30.86 -73.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 C-N-CA 122.47 2.113 . . . . 0.0 112.618 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -49.14 -28.23 4.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.041 0.448 . . . . 0.0 110.767 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.61 -47.7 32.77 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -62.53 -39.69 94.39 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.71 -54.34 47.3 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.255 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.76 -29.49 70.7 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.442 0.639 . . . . 0.0 110.156 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.05 -27.83 62.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.074 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . 0.545 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 34.3 m-20 -75.18 -49.76 18.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.491 0.662 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 5.3 pt20 -63.16 -42.55 99.45 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.361 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 31.7 tp -63.19 -41.79 99.24 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.409 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -51.56 -47.07 63.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.511 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.9 m -56.87 -50.82 71.31 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 118.786 -1.165 . . . . 0.0 110.689 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -52.27 -26.97 13.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.96 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 17.5 mt -96.31 -20.27 18.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.658 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.0 t -77.97 -21.22 51.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.054 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -100.22 19.39 16.59 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.813 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.69 160.74 29.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.754 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 4.7 t0 -77.71 113.16 29.83 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 230' ' ' LYS . 48.6 Cg_exo -50.19 -23.08 9.11 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 122.329 2.019 . . . . 0.0 113.082 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 229' ' ' PRO . 21.2 tptm -29.37 -53.16 0.13 Allowed 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 123.532 0.52 . . . . 0.0 111.085 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 233' ' ' SER . 91.5 m-20 -106.09 -16.03 14.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.021 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 24.94 44.84 0.01 OUTLIER Glycine 0 N--CA 1.469 0.836 0 O-C-N 123.954 0.783 . . . . 0.0 111.701 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 231' ' ' ASP . 41.6 m -114.07 110.58 20.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.828 0.346 . . . . 0.0 110.855 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 84.3 t -126.04 95.83 3.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.354 0.597 . . . . 0.0 109.852 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 t -97.25 121.48 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.239 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.8 t -92.87 118.98 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.253 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.45 144.04 31.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.788 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.438 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -125.51 126.05 5.78 Favored Glycine 0 N--CA 1.476 1.345 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.673 ' N ' HH22 ' A' ' 256' ' ' ARG . 0.2 OUTLIER -111.08 126.21 54.58 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.555 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.9 t -117.53 168.09 10.71 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.825 0.345 . . . . 0.0 110.243 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -91.53 176.42 6.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.648 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -92.69 126.47 37.79 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 48.6 mm -117.98 10.21 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.157 0.503 . . . . 0.0 110.661 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.42 7.25 76.41 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -140.63 104.11 4.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.245 0.545 . . . . 0.0 110.163 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 99.2 m-20 -57.1 -51.15 70.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.71 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.26 -46.18 76.1 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.044 0.449 . . . . 0.0 110.791 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -61.29 -40.81 95.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 246' ' ' ASP . 0.1 OUTLIER -58.12 -47.93 81.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.149 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.95 -40.5 93.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.712 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.15 -39.15 96.74 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.9 mt -70.38 -39.44 74.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 5.8 t -62.83 -42.28 99.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 110.809 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.52 -44.14 75.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.935 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -59.59 -47.93 83.65 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.45 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.673 HH22 ' N ' ' A' ' 239' ' ' TYR . 42.7 mtm105 -63.39 -49.63 73.03 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.333 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.76 81.08 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -70.59 -43.43 69.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.207 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.0 t -60.35 -39.29 86.62 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.278 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 91.3 t -62.83 -51.61 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.521 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 12.9 t -61.22 -48.34 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.625 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -47.87 -42.86 27.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.948 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -78.24 -35.26 48.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.994 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.36 -32.26 73.63 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.369 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.462 ' C ' ' H ' ' A' ' 267' ' ' LYS . 89.8 mt -66.59 -46.23 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 85.2 p -56.04 -10.44 0.82 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.29 0.566 . . . . 0.0 110.485 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.545 ' NZ ' ' OD1' ' A' ' 218' ' ' ASP . 20.5 mmmt -79.46 -3.54 47.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.684 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.06 43.73 3.74 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.349 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.29 129.37 24.2 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.57 129.66 30.43 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.406 1.404 . . . . 0.0 111.479 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -64.84 -9.69 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.036 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -91.46 -23.8 19.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.016 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.62 -23.81 56.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.437 0.637 . . . . 0.0 110.708 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.3 pt -103.35 -178.52 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.871 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 8.5 t -168.03 129.26 1.4 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.161 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.08 151.93 19.0 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -154.64 136.95 14.89 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.397 0.618 . . . . 0.0 111.649 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -87.29 91.37 1.73 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 4.3 tpt -69.05 -10.4 57.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.741 0.305 . . . . 0.0 110.503 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.09 -101.5 0.02 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -141.63 74.96 1.48 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.79 0.329 . . . . 0.0 110.574 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 25.4 t -82.36 -3.53 55.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.341 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -167.49 79.25 0.92 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.574 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.32 105.26 0.47 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.484 2.123 . . . . 0.0 112.201 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.401 ' CG2' ' N ' ' A' ' 286' ' ' THR . 6.4 m -71.41 -39.87 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.705 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.655 ' C ' ' H ' ' A' ' 288' ' ' ASN . 63.3 p -58.8 -42.68 89.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.506 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.64 -2.66 0.01 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.655 ' H ' ' C ' ' A' ' 286' ' ' THR . 71.3 m-80 -127.98 -57.52 1.24 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.9 m -59.53 -44.19 93.25 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.8 28.8 8.42 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.627 0.251 . . . . 0.0 110.788 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 48.2 t0 -66.36 -7.18 17.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.518 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -98.64 31.76 2.79 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.3 t -131.91 124.17 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.552 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -118.82 11.82 12.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.842 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -99.2 130.79 45.53 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.081 0.467 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -50.44 -66.08 0.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.375 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -55.08 -38.08 67.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.429 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.18 -37.44 87.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.427 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 303' ' ' LEU . 34.3 mt -72.19 -57.15 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.461 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 67.0 mt -50.71 -33.7 12.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.028 0.442 . . . . 0.0 109.895 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.18 -37.74 53.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.679 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.12 -11.91 55.86 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 299' ' ' LEU . 70.8 mt -89.03 23.86 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.781 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.572 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -74.37 -41.42 4.88 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.243 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 16.3 Cg_exo -67.65 9.17 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.483 2.122 . . . . 0.0 111.065 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 304' ' ' ALA . 30.0 t0 -102.31 1.19 35.34 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.491 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 304' ' ' ALA . 5.4 ptp180 -114.77 93.35 4.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.5 0.667 . . . . 0.0 109.509 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.513 ' NH1' ' OE2' ' A' ' 310' ' ' GLU . 36.6 ptt85 -154.37 131.8 11.25 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 122.012 0.91 . . . . 0.0 112.456 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.09 134.03 33.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.342 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.513 ' OE2' ' NH1' ' A' ' 308' ' ' ARG . 64.5 mt-10 -117.86 103.66 10.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.133 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 193' ' ' HIS . 0.9 OUTLIER -79.63 115.96 22.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -178.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.443 ' O ' ' OE1' ' A' ' 312' ' ' GLU . 6.8 tm-20 -90.93 126.73 36.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 123.201 0.313 . . . . 0.0 110.385 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.67 114.98 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.936 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -115.04 134.09 55.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 98.44 10.3 51.13 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.538 ' O ' ' NE2' ' A' ' 190' ' ' GLN . 19.7 tt -93.95 137.98 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.876 0.37 . . . . 0.0 110.502 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.355 179.842 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.945 0.402 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.439 ' CG2' ' HE2' ' A' ' 193' ' ' HIS . 59.0 m -79.42 126.96 31.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.302 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -143.17 108.72 5.08 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.325 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.439 ' HE2' ' CG2' ' A' ' 191' ' ' THR . 30.9 m170 -95.25 142.5 27.6 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 63.3 m-85 -107.38 123.67 48.7 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 195' ' ' THR . 7.9 t -86.83 102.61 14.46 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.766 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.3 tp -107.75 129.34 55.05 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.497 0.665 . . . . 0.0 109.296 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -85.99 131.85 34.19 Favored 'General case' 0 C--O 1.252 1.237 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.972 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.538 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 14.6 m -62.11 -26.56 68.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.577 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 200' ' ' VAL . 15.0 p-10 -59.07 -36.05 74.42 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.145 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.614 ' N ' ' OD1' ' A' ' 199' ' ' ASP . 31.9 t -71.3 -45.6 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 85.8 mt -79.49 -77.61 0.18 Allowed 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.963 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.486 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -133.45 139.43 46.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.469 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.524 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 9.9 p-10 -119.65 -72.75 0.67 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.781 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.524 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 94.2 m-85 -87.01 -31.08 20.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.067 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -69.81 167.57 16.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.168 0.508 . . . . 0.0 110.296 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -58.37 -75.16 0.05 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.479 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -161.18 55.8 0.29 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.37 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.0 p -106.88 132.94 52.27 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.3 mt -75.51 140.24 42.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.684 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 213' ' ' GLY . 20.5 mtmt -101.03 157.94 32.73 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 210' ' ' LYS . 75.9 Cg_exo -34.02 -76.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.529 2.152 . . . . 0.0 112.338 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -49.7 -20.09 0.75 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.313 0.578 . . . . 0.0 110.306 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.96 -51.33 14.99 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.391 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -64.07 -40.26 95.87 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.85 -53.87 51.49 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.45 87.46 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.724 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.3 mt -61.07 -30.77 70.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.872 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.07 -45.87 62.97 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.158 0.504 . . . . 0.0 111.095 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.406 ' O ' ' OG ' ' A' ' 222' ' ' SER . 3.0 mt-30 -61.75 -44.82 96.14 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.102 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 52.7 tp -65.25 -38.93 91.85 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.368 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.421 ' CG ' ' HD3' ' A' ' 267' ' ' LYS . 7.6 t80 -55.45 -45.49 76.86 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.982 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 219' ' ' GLN . 41.3 p -55.82 -53.34 57.89 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.153 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 12.9 pt20 -60.43 -19.95 58.05 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.646 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 70.2 mt -89.69 -27.48 20.08 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.025 0.441 . . . . 0.0 110.351 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 3.9 t -72.64 -22.92 60.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.6 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -98.92 18.61 16.76 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.722 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.41 160.47 29.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.94 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -70.74 125.02 91.93 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 230' ' ' LYS . 50.9 Cg_endo -69.86 -17.14 37.3 Favored 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.505 2.137 . . . . 0.0 113.126 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 229' ' ' PRO . 88.2 tttt -31.47 -48.21 0.13 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.749 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 95.7 m-20 -110.74 -17.58 13.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.217 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.22 48.72 0.03 OUTLIER Glycine 0 N--CA 1.474 1.167 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.6 m -115.36 112.36 22.24 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.766 0.317 . . . . 0.0 110.872 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.95 97.54 4.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.604 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.6 t -97.92 122.4 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.407 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.9 t -96.05 118.66 42.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.41 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 26.1 mt -108.96 106.23 16.1 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.602 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.413 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -87.17 127.83 8.65 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.8 OUTLIER -107.17 123.93 48.98 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 117.683 0.742 . . . . 0.0 109.453 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 241' ' ' ASP . 52.9 m -114.67 166.24 11.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.969 0.414 . . . . 0.0 110.296 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.471 ' N ' ' CG2' ' A' ' 240' ' ' THR . 53.6 p30 -86.02 -176.0 5.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.965 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -116.58 124.84 50.81 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.376 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.475 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 49.4 mm -114.8 23.26 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.557 0.694 . . . . 0.0 110.605 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.4 13.59 73.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.8 t -144.11 94.07 2.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.357 0.598 . . . . 0.0 110.006 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -46.58 -47.33 19.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.66 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.38 -37.58 78.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.193 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -61.51 -47.63 84.74 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.445 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 250' ' ' GLN . 0.1 OUTLIER -62.84 -41.6 99.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.5 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.492 ' N ' ' ND2' ' A' ' 249' ' ' ASN . 94.2 mt-30 -60.7 -45.99 92.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.919 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.15 96.13 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 26.2 mt -72.81 -37.87 67.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.245 -0.478 . . . . 0.0 111.074 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 29.9 t -63.47 -40.87 98.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.967 0.413 . . . . 0.0 110.239 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.94 -45.81 76.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.045 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -54.33 -45.64 72.7 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.555 HH22 ' N ' ' A' ' 308' ' ' ARG . 42.7 mtp180 -61.38 -64.09 1.06 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.477 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -51.56 -34.28 36.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.129 0.49 . . . . 0.0 109.884 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -73.32 -44.74 58.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.087 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 46.2 m -64.37 -37.75 88.6 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.449 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.52 -51.27 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.6 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.2 t -62.36 -48.65 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.039 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -45.06 -39.42 5.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -84.12 -30.34 26.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.687 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.43 -11.22 60.59 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.489 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.566 ' C ' ' H ' ' A' ' 267' ' ' LYS . 72.5 mt -86.91 -53.65 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 122.107 -0.37 . . . . 0.0 111.729 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.3 p -50.41 -4.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.23 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 265' ' ' ILE . 68.9 mttm -83.96 -0.19 50.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.925 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 105.26 -2.78 40.28 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.09 126.02 78.19 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.871 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.78 130.32 39.84 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.344 1.363 . . . . 0.0 111.256 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.29 -10.0 38.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.968 0.413 . . . . 0.0 111.407 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -90.78 -22.93 20.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.133 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -19.5 52.5 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.819 0.819 . . . . 0.0 110.664 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -107.03 -171.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.542 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.69 129.78 1.55 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.827 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.72 151.3 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -158.88 148.75 19.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 110.5 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -123.76 96.89 0.55 Allowed Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 21.3 ptm -94.66 21.45 7.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.921 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 37.74 -97.17 0.01 OUTLIER Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -143.33 75.92 1.5 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 37.3 t -63.82 -32.99 74.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.114 0.483 . . . . 0.0 111.166 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.41 ' C ' HD21 ' A' ' 283' ' ' ASN . 0.4 OUTLIER -131.17 77.66 74.2 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.954 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -54.23 108.04 0.26 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.749 2.299 . . . . 0.0 112.848 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 286' ' ' THR . 5.1 m -71.59 -40.3 70.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.489 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.677 ' C ' ' H ' ' A' ' 288' ' ' ASN . 2.2 p -58.97 -42.47 90.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.514 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.5 0.89 0.02 OUTLIER Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.677 ' H ' ' C ' ' A' ' 286' ' ' THR . 28.2 t-20 -125.07 -58.37 1.46 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.3 m -56.2 -42.84 77.82 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 22.8 m -95.74 34.42 1.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.502 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 292' ' ' ASN . 28.4 p30 -59.04 -33.04 70.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.818 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 23.3 m120 -88.78 33.92 0.77 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.434 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.57 109.43 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.849 0.356 . . . . 0.0 110.522 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -118.59 13.89 13.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.611 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -98.0 135.33 39.86 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.108 0.48 . . . . 0.0 109.851 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 299' ' ' LEU . 5.9 ttt-85 -51.09 -76.36 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.568 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -45.74 -41.03 10.18 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.139 0.495 . . . . 0.0 111.071 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.34 81.36 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.043 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 296' ' ' ARG . 16.9 mt -71.01 -43.95 66.87 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.771 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 12.2 mm -52.75 -36.84 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.34 -42.78 35.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.221 0.534 . . . . 0.0 110.315 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -5.6 35.71 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.857 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.34 20.24 8.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.573 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.548 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -79.84 -45.09 1.53 Allowed Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.18 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 24.7 Cg_exo -61.75 8.29 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 123.184 2.589 . . . . 0.0 111.941 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 304' ' ' ALA . 39.4 t0 -102.52 10.91 38.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.609 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.442 ' NH1' ' O ' ' A' ' 203' ' ' ASN . 88.2 mtm180 -112.94 91.65 3.73 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.298 0.571 . . . . 0.0 110.142 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.555 ' N ' HH22 ' A' ' 256' ' ' ARG . 16.4 ptm180 -157.67 129.22 6.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.628 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.99 138.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.431 0.634 . . . . 0.0 109.709 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -118.64 102.17 8.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.713 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.0 113.14 19.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.67 118.44 31.05 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.401 0.438 . . . . 0.0 110.154 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.5 114.66 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 O-C-N 123.567 0.542 . . . . 0.0 110.183 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -113.39 132.09 55.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 93.15 41.85 4.47 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.693 ' O ' ' O ' ' A' ' 317' ' ' LYS . 9.8 tt -114.65 169.63 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.693 ' O ' ' O ' ' A' ' 316' ' ' ILE . 27.5 tttp . . . . . 0 C--O 1.218 -0.586 0 O-C-N 123.963 0.79 . . . . 0.0 111.614 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.501 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 17.6 mp0 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.907 0.384 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 39.2 m -72.0 126.21 29.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.639 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -116.45 167.85 10.68 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.457 0.646 . . . . 0.0 111.032 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -155.93 123.39 5.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.595 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.591 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 60.9 m-85 -110.57 113.35 25.9 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.06 103.86 15.13 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.897 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.5 tp -108.94 135.34 50.3 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.287 0.565 . . . . 0.0 110.196 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.458 ' CD ' ' H ' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -88.73 132.14 34.73 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.968 0.89 . . . . 0.0 112.315 -178.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 202' ' ' PHE . 1.3 p -61.84 -24.07 66.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.665 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.14 -43.67 92.04 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.275 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.11 -42.41 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 78.9 mt -80.08 -79.36 0.15 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.86 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.3 OUTLIER -133.27 131.88 40.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.002 -178.067 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.54 ' O ' ' NH2' ' A' ' 307' ' ' ARG . 59.9 t30 -111.04 -71.24 0.77 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.674 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -91.28 -23.57 20.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.844 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -73.14 164.16 27.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 110.423 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -53.78 -74.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.144 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -160.09 3.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.338 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.7 p -54.98 141.35 34.21 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 85.9 mt -86.14 132.62 33.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.875 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.6 mttp -93.27 157.27 39.12 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.582 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -33.11 -74.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.767 2.311 . . . . 0.0 112.428 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.77 -24.24 1.34 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.136 0.493 . . . . 0.0 110.947 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.68 -48.16 18.32 Favored Glycine 0 C--O 1.227 -0.312 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -62.66 -40.83 98.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.346 0.593 . . . . 0.0 109.57 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.42 -55.27 33.58 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.38 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.35 85.0 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.212 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.1 -31.09 70.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.169 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -71.91 -46.73 56.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.935 0.398 . . . . 0.0 110.948 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -64.21 -44.57 91.52 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.564 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.9 tp -65.02 -38.12 89.86 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.439 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 2.4 t80 -54.83 -50.3 68.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.146 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 225' ' ' SER . 11.8 t -59.58 -50.67 73.01 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.571 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.591 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 9.2 tt0 -49.01 -24.25 1.45 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.667 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 51.3 mt -100.38 -13.73 18.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.606 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 222' ' ' SER . 33.2 t -73.29 -19.82 60.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -103.61 20.84 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.475 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.05 161.54 29.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -84.3 126.18 70.18 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 230' ' ' LYS . 59.9 Cg_endo -69.86 -16.26 37.06 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.982 1.788 . . . . 0.0 113.073 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 229' ' ' PRO . 3.1 tmtm? -30.49 -52.43 0.16 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.604 0.565 . . . . 0.0 111.066 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 232' ' ' GLY . 10.5 m-20 -104.67 -15.33 15.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.133 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.99 51.52 0.07 OUTLIER Glycine 0 N--CA 1.468 0.788 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.638 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.0 m -118.53 109.07 15.76 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 122.88 -0.188 . . . . 0.0 111.041 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 92.4 t -125.3 93.81 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.62 0.724 . . . . 0.0 109.989 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.6 t -98.33 119.49 46.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.159 0.504 . . . . 0.0 110.754 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.1 t -93.62 127.68 45.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.398 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.0 mt -110.35 139.62 45.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.381 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -120.56 131.55 8.83 Favored Glycine 0 N--CA 1.479 1.544 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -117.7 121.94 42.19 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.002 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.646 ' HG1' ' H ' ' A' ' 241' ' ' ASP . 9.0 t -115.45 174.26 6.1 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.646 ' H ' ' HG1' ' A' ' 240' ' ' THR . 23.0 m-20 -84.4 -178.2 6.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.165 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -115.84 125.41 52.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.953 0.406 . . . . 0.0 109.971 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.491 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 48.9 mm -117.81 18.57 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.75 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 77.92 15.97 80.51 Favored Glycine 0 C--N 1.315 -0.604 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.3 p -136.58 100.78 4.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.341 0.591 . . . . 0.0 109.947 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -54.21 -50.9 66.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.809 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.96 83.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.714 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -63.95 -41.77 97.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.334 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.455 ' ND2' ' CG2' ' A' ' 240' ' ' THR . 12.7 t-20 -59.01 -52.09 67.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -57.85 -39.86 78.74 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.681 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.88 99.14 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 31.7 mt -69.99 -38.99 76.18 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.747 -0.267 . . . . 0.0 110.707 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.3 t -62.32 -41.57 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.194 0.521 . . . . 0.0 110.622 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -70.47 -38.88 74.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.344 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -58.69 -51.25 70.75 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.303 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.438 ' NH1' ' O ' ' A' ' 239' ' ' TYR . 17.2 ptp180 -65.63 -45.74 81.88 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.754 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.55 98.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.401 0.619 . . . . 0.0 109.951 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -71.2 -43.61 67.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.334 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.9 m -60.05 -38.14 81.93 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.693 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 256' ' ' ARG . 89.4 t -65.13 -52.66 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.15 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.1 t -62.12 -48.91 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.621 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -47.18 -43.13 21.04 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.182 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.586 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 53.7 t80 -77.07 -33.47 57.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.981 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.54 -34.93 79.42 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 267' ' ' LYS . 96.9 mt -63.15 -44.85 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 120.831 0.348 . . . . 0.0 111.527 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 39.3 t -55.07 -8.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.404 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.586 ' CE ' ' CE2' ' A' ' 263' ' ' TYR . 68.8 mmtt -90.98 14.24 14.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.462 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.45 42.59 10.16 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.312 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.29 127.61 26.24 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 117.134 0.467 . . . . 0.0 110.074 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -54.14 128.33 29.42 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.356 1.371 . . . . 0.0 111.984 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.97 -11.87 50.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 111.025 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 272' ' ' ASP . 5.6 p-10 -92.29 -18.13 23.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.418 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -82.76 -23.19 34.06 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.764 0.792 . . . . 0.0 110.652 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.0 pt -102.48 -173.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.045 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 4.9 t -167.63 125.48 1.22 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.77 113.24 25.6 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.705 0.288 . . . . 0.0 110.812 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -119.17 141.86 48.47 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.426 0.632 . . . . 0.0 111.773 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.34 95.84 2.14 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -69.26 -10.45 57.87 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -178.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.09 -113.26 0.53 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.441 ' OE2' ' OD2' ' A' ' 306' ' ' ASP . 51.7 tt0 -143.96 71.87 1.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.7 t -63.84 -37.8 88.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.119 0.485 . . . . 0.0 111.409 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -131.6 83.1 59.27 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.27 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.8 105.79 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.163 1.908 . . . . 0.0 112.364 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 31.6 m -70.1 -44.44 78.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.181 0.515 . . . . 0.0 110.708 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.667 ' C ' ' H ' ' A' ' 288' ' ' ASN . 10.8 p -60.65 -44.62 96.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.934 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.417 ' N ' ' HG1' ' A' ' 286' ' ' THR . . . -52.93 1.92 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 286' ' ' THR . 75.6 m-20 -119.84 -59.43 1.8 Allowed 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.87 -20.5 66.26 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.804 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.25 26.36 9.51 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.873 0.368 . . . . 0.0 110.28 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 37.3 p-10 -69.93 -6.85 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.043 0.449 . . . . 0.0 110.505 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -100.63 31.51 3.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.288 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.74 129.3 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.207 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -119.41 5.9 11.14 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -97.57 130.28 44.63 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.1 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -52.61 -74.07 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.52 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -43.63 -39.59 3.64 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.214 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.97 95.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.755 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 48.5 mt -68.48 -42.52 78.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.692 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 15.3 mm -54.95 -36.29 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -73.13 -46.83 48.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.35 0.595 . . . . 0.0 109.745 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.7 t -71.04 -2.78 16.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.243 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.29 16.72 12.56 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.431 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.604 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -82.4 -44.32 0.97 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 120.838 0.351 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 49.3 Cg_exo -55.1 8.74 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 123.373 2.715 . . . . 0.0 112.835 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.604 ' H ' ' C ' ' A' ' 304' ' ' ALA . 88.2 m-20 -110.58 16.4 21.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.497 0.189 . . . . 0.0 110.682 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 8.4 ptm180 -112.46 91.71 3.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.846 0.831 . . . . 0.0 110.302 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -164.58 141.27 6.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.827 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.76 145.96 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.406 ' OE2' ' CZ ' ' A' ' 239' ' ' TYR . 32.9 mt-10 -122.05 107.83 12.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.946 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.22 118.42 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.37 125.68 43.61 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.051 0.453 . . . . 0.0 110.546 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.03 116.56 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.632 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -114.68 131.89 56.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 106.82 -23.87 26.74 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.657 ' O ' ' O ' ' A' ' 317' ' ' LYS . 13.6 tt -53.24 171.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.657 ' O ' ' O ' ' A' ' 316' ' ' ILE . 24.8 tttp . . . . . 0 N--CA 1.468 0.432 0 O-C-N 123.68 0.613 . . . . 0.0 111.792 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 120.941 0.401 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.466 ' CG2' ' HE2' ' A' ' 193' ' ' HIS . 15.4 m -81.87 135.94 35.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.366 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -147.26 118.01 7.58 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 120.875 0.369 . . . . 0.0 110.427 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 2.4 m170 -98.9 144.52 27.99 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -105.0 119.38 38.89 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.92 101.19 12.66 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.846 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 35.3 tp -108.38 143.7 36.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.144 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -94.75 133.45 38.42 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 122.157 0.979 . . . . 0.0 112.34 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 202' ' ' PHE . 1.2 m -62.06 -25.58 67.77 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.2 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.53 ' OD1' ' NE ' ' A' ' 307' ' ' ARG . 85.2 m-20 -60.44 -39.42 87.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.108 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.65 -45.21 85.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 50.7 mt -78.68 -78.01 0.15 Allowed 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.909 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -128.33 123.43 33.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.824 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -93.61 -74.17 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.568 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -104.05 -11.78 17.16 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -75.58 170.0 17.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.029 0.443 . . . . 0.0 110.179 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -54.81 -82.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.554 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -156.15 3.76 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.188 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.1 p -57.16 144.72 33.87 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 57.7 mt -89.25 136.1 33.21 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.268 0.556 . . . . 0.0 111.169 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 213' ' ' GLY . 55.6 mttt -98.34 157.51 34.27 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.098 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -33.75 -74.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.549 2.166 . . . . 0.0 111.993 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 27.3 mp0 -48.16 -27.62 2.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.127 0.489 . . . . 0.0 110.529 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.15 -47.79 35.42 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -64.65 -40.6 95.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.316 0.579 . . . . 0.0 109.888 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.32 -55.71 25.73 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.351 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.91 81.36 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.478 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.81 -27.05 68.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.24 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -77.36 -47.45 19.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.462 0.649 . . . . 0.0 110.841 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -62.11 -45.2 94.54 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.614 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 40.6 tp -63.83 -40.68 97.18 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 225' ' ' SER . 5.0 t80 -51.07 -48.79 61.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.451 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 59.1 p -55.32 -51.52 66.45 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.596 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -51.23 -26.14 6.63 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.424 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 17.8 mt -100.69 -19.03 16.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.525 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 221' ' ' TYR . 6.3 t -71.93 -27.51 62.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.997 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.506 ' OD1' ' NZ ' ' A' ' 317' ' ' LYS . 24.9 t-20 -103.32 23.68 12.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.937 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.36 152.97 34.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.687 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.647 ' N ' ' O ' ' A' ' 315' ' ' GLY . 16.0 t0 -66.04 115.65 25.3 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 232' ' ' GLY . 49.0 Cg_endo -70.14 -17.25 35.94 Favored 'Trans proline' 0 N--CA 1.505 2.164 0 C-N-CA 122.518 2.145 . . . . 0.0 112.941 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 229' ' ' PRO . 22.2 tptm -29.21 -47.68 0.06 Allowed 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 123.525 0.516 . . . . 0.0 110.962 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 232' ' ' GLY . 5.6 p30 -106.32 -14.07 15.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.388 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.25 56.13 0.17 Allowed Glycine 0 N--CA 1.469 0.878 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.7 t -119.72 99.98 6.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.574 0.226 . . . . 0.0 110.589 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 73.5 t -125.02 94.18 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.549 0.69 . . . . 0.0 110.437 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 8.4 t -98.11 121.47 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.53 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 18.3 t -91.58 122.12 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.572 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 39.0 mt -104.55 141.05 37.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.034 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.78 130.27 7.13 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.19 119.96 38.13 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.412 ' HG1' ' CG ' ' A' ' 249' ' ' ASN . 2.1 p -113.28 162.97 15.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.838 0.352 . . . . 0.0 110.071 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -83.3 173.03 11.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.386 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -101.18 125.24 47.78 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.426 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.463 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 8.1 mm -114.59 18.18 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.685 0.755 . . . . 0.0 110.453 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.92 13.73 71.33 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.0 m -143.07 96.46 2.93 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.103 0.478 . . . . 0.0 110.284 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 246' ' ' ASP . 27.4 p-10 -49.19 -48.6 45.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.418 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.15 -35.83 67.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.859 0.362 . . . . 0.0 110.276 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -70.0 -42.23 73.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.889 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.412 ' CG ' ' HG1' ' A' ' 240' ' ' THR . 20.1 t-20 -61.83 -49.72 75.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.235 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.42 -36.89 83.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.374 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.57 -41.18 98.68 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.71 -34.16 64.69 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.947 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.556 ' HG ' ' N ' ' A' ' 254' ' ' GLU . 85.0 p -64.0 -40.78 97.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.778 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.556 ' N ' ' HG ' ' A' ' 253' ' ' SER . 98.5 mt-10 -70.69 -43.03 69.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.109 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -58.64 -46.66 86.63 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.117 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -64.55 -60.91 2.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.905 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -48.44 -39.09 21.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 110.008 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -70.04 -43.26 71.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.373 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 44.5 m -59.3 -39.0 81.6 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.36 -51.72 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.157 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.37 -48.89 86.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.687 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -46.99 -41.39 16.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.125 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -81.74 -32.95 31.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.66 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -24.28 67.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.254 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.562 ' C ' ' H ' ' A' ' 267' ' ' LYS . 87.1 mt -73.51 -51.18 26.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 111.718 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 5.1 m -50.34 -8.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.801 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 265' ' ' ILE . 27.9 mmtp -82.68 -1.94 52.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 95.08 41.62 3.98 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.42 HD13 ' HZ3' ' A' ' 273' ' ' LYS . 0.2 OUTLIER -123.32 129.43 24.91 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.75 125.81 19.18 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.754 1.636 . . . . 0.0 111.736 176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.55 -8.5 20.09 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -90.69 -24.08 20.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.719 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.42 ' HZ3' HD13 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -78.64 -21.94 47.63 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.315 0.578 . . . . 0.0 111.034 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -104.48 -174.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.562 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 38.5 t -170.94 131.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.442 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.96 150.2 20.72 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -154.0 138.01 16.38 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.32 0.581 . . . . 0.0 111.293 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -90.17 94.0 1.93 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.402 ' HG2' ' CZ ' ' A' ' 239' ' ' TYR . 2.6 tpt -71.23 -7.04 44.2 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.611 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.53 -98.31 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -142.63 75.61 1.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.757 0.313 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 85.9 p -83.69 -1.64 54.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.977 0.418 . . . . 0.0 110.905 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.537 ' C ' HD21 ' A' ' 283' ' ' ASN . 0.1 OUTLIER -162.89 74.71 2.01 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.94 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -60.06 103.23 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.401 2.068 . . . . 0.0 113.198 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 13.8 m -69.91 -35.57 65.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.182 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.653 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.0 OUTLIER -59.5 -46.44 88.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.401 -179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.05 -5.58 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.653 ' H ' ' C ' ' A' ' 286' ' ' THR . 45.5 t30 -127.22 -57.26 1.31 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.844 0.457 . . . . 0.0 109.781 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.413 ' O ' ' CG2' ' A' ' 289' ' ' THR . 3.5 m -68.56 -10.71 57.54 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.666 0.27 . . . . 0.0 110.614 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 286' ' ' THR . 72.4 m -132.78 19.06 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 110.396 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -67.35 -5.43 14.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.663 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -108.68 32.24 5.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 7.2 t -131.63 120.48 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.68 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -119.7 10.44 11.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.952 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -101.57 135.8 42.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.145 0.498 . . . . 0.0 110.142 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -52.0 -70.32 0.09 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.845 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.77 -39.23 58.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.94 -39.64 95.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.424 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 303' ' ' LEU . 20.5 mt -65.94 -52.41 50.0 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.43 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 64.5 mt -53.04 -33.03 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.938 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -79.42 -24.23 42.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.979 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -98.03 -12.68 21.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.384 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 299' ' ' LEU . 80.6 mt -91.69 18.77 7.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.883 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.646 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -77.81 -53.25 1.51 Allowed Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.519 177.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 13.0 Cg_endo -53.7 9.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.225 0 C-N-CA 122.852 2.368 . . . . 0.0 112.888 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.646 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.3 t0 -103.1 16.75 25.79 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.53 ' NE ' ' OD1' ' A' ' 199' ' ' ASP . 18.0 ptt-85 -114.35 93.3 4.28 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.78 0.8 . . . . 0.0 110.415 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.502 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 48.1 ptt85 -157.46 131.73 8.35 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.59 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 7.8 m -102.02 140.13 21.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -120.84 105.69 10.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.372 0.606 . . . . 0.0 110.519 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.17 115.94 22.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.465 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -90.68 117.37 29.28 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 123.091 0.245 . . . . 0.0 110.368 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.62 115.81 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.4 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -114.32 126.98 55.63 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.9 43.99 2.96 Favored Glycine 0 C--O 1.219 -0.807 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.692 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.5 tt -119.81 170.51 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.692 ' O ' ' O ' ' A' ' 316' ' ' ILE . 65.0 mttp . . . . . 0 N--CA 1.466 0.37 0 O-C-N 124.125 0.891 . . . . 0.0 111.293 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.8 0.333 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.1 m -74.99 130.5 39.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.191 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -147.32 117.54 7.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.167 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.518 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.5 OUTLIER -103.76 151.39 23.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -111.96 122.69 48.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.914 0.388 . . . . 0.0 110.062 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.08 102.44 13.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.541 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 26.8 tp -104.83 131.69 51.99 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.308 0.575 . . . . 0.0 109.728 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -82.51 129.8 34.99 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.196 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.6 t -62.74 -31.44 72.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.087 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.426 ' OD1' ' OD1' ' A' ' 203' ' ' ASN . 16.2 t70 -59.42 -37.98 79.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.231 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.88 -42.94 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.503 ' O ' ' CG ' ' A' ' 210' ' ' LYS . 84.6 mt -80.01 -77.98 0.18 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.437 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.37 125.31 44.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.744 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.535 HD22 ' HZ3' ' A' ' 210' ' ' LYS . 44.0 m-80 -88.3 -70.09 0.66 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.82 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -113.0 -10.58 13.48 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.749 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -74.63 164.83 26.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.139 0.495 . . . . 0.0 110.035 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -52.51 -77.82 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.292 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.67 56.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.489 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.2 p -107.69 132.97 52.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.179 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.74 132.29 35.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.809 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.535 ' HZ3' HD22 ' A' ' 203' ' ' ASN . 0.0 OUTLIER -95.62 165.74 16.01 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.672 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -36.14 -76.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.499 2.133 . . . . 0.0 111.973 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -49.96 -20.51 0.94 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.319 0.581 . . . . 0.0 110.277 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.37 -51.45 12.91 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -66.15 -38.25 87.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.023 0.439 . . . . 0.0 109.93 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.4 -53.3 59.85 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.06 -33.76 76.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.575 0.702 . . . . 0.0 110.336 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.2 mt -69.5 -26.2 64.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.394 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -76.23 -49.46 17.08 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.482 0.658 . . . . 0.0 111.113 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.427 ' O ' ' OG ' ' A' ' 222' ' ' SER . 13.3 pt20 -63.91 -41.11 97.76 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.364 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 36.8 tp -63.5 -41.81 98.53 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.662 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.8 t80 -51.59 -48.95 62.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.805 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 219' ' ' GLN . 80.7 p -55.55 -51.37 67.3 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.475 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -53.26 -27.35 22.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.365 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.4 mt -95.61 -19.48 19.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.759 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 221' ' ' TYR . 8.4 t -78.57 -30.38 46.75 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.357 0.41 . . . . 0.0 110.886 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 52.3 t-20 -86.11 20.2 2.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.708 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.412 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.8 OUTLIER -77.75 -178.79 5.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.933 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 315' ' ' GLY . 49.4 t0 -100.09 105.19 33.99 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 232' ' ' GLY . 32.5 Cg_exo -55.6 -20.64 28.06 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 123.077 2.518 . . . . 0.0 113.61 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 229' ' ' PRO . 62.6 pttt -27.22 -40.48 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.162 0.506 . . . . 0.0 111.318 -176.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 229' ' ' PRO . 13.3 p30 -115.23 -14.74 11.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.304 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.03 59.82 0.16 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.8 m -118.64 102.09 8.6 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.9 t -126.69 92.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.701 0.762 . . . . 0.0 110.273 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.1 t -98.37 121.88 49.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.35 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.23 125.22 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.0 mt -108.49 141.24 40.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.315 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.87 129.02 7.3 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -113.29 121.6 44.92 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.652 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 6.7 p -115.88 162.63 17.06 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.452 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 45.7 p30 -82.93 172.3 12.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.632 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.602 ' NH1' ' N ' ' A' ' 245' ' ' SER . 0.1 OUTLIER -94.62 126.21 39.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.932 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 50.4 mm -118.61 14.34 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.416 0.627 . . . . 0.0 110.708 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.425 ' C ' ' NH1' ' A' ' 242' ' ' ARG . . . 77.93 11.0 85.83 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' SER . . . . . 0.602 ' N ' ' NH1' ' A' ' 242' ' ' ARG . 11.2 m -135.97 94.61 3.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.114 0.483 . . . . 0.0 110.049 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.536 ' OD1' ' NH2' ' A' ' 242' ' ' ARG . 47.1 m-20 -46.81 -50.28 18.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.446 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.49 -42.38 74.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.635 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -66.0 -38.83 89.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.54 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 27.3 t-20 -61.78 -52.6 63.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.107 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.67 -32.78 74.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.545 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.92 -43.79 98.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.69 -35.48 67.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.763 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.8 t -64.76 -44.47 89.97 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.106 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.19 -42.4 75.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.176 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -49.9 75.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.357 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.52 -52.38 65.44 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.607 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.11 -31.89 65.77 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -73.71 -45.01 54.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.234 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.486 ' HG ' ' N ' ' A' ' 260' ' ' VAL . 77.4 p -61.38 -37.93 85.17 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.43 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.486 ' N ' ' HG ' ' A' ' 259' ' ' SER . 91.8 t -65.11 -53.1 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.299 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.97 -49.37 85.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.329 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -46.35 -40.77 12.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.93 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.726 ' HH ' ' HZ1' ' A' ' 267' ' ' LYS . 83.3 t80 -82.65 -31.96 28.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.606 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.37 -9.94 57.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.451 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.568 ' C ' ' H ' ' A' ' 267' ' ' LYS . 62.8 mt -87.14 -53.57 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.775 0.322 . . . . 0.0 111.39 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.2 m -49.79 -6.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.004 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.726 ' HZ1' ' HH ' ' A' ' 263' ' ' TYR . 30.0 mmtm -81.39 -3.94 54.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.81 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.42 39.77 3.37 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.69 127.52 25.16 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.748 0.274 . . . . 0.0 110.378 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.48 128.25 27.19 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.917 1.745 . . . . 0.0 111.79 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.79 -7.92 24.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.237 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -91.97 -23.09 19.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.827 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -80.38 -19.71 45.72 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.297 0.57 . . . . 0.0 110.977 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.8 pt -104.45 -171.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.525 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 3.1 t -169.45 130.16 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.314 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -101.72 110.7 22.75 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.917 0.389 . . . . 0.0 110.76 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.26 140.52 49.24 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.7 0.762 . . . . 0.0 111.345 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -91.38 93.89 1.89 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 2.2 tpt -69.19 -8.36 44.97 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.419 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.97 -107.94 0.09 OUTLIER Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.27 59.03 1.59 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.75 0.309 . . . . 0.0 110.558 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.0 t -83.04 -8.06 59.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.697 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -157.33 66.27 3.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.471 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.28 110.82 3.14 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.634 2.222 . . . . 0.0 112.042 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.0 m -73.23 -25.32 21.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.525 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.646 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.5 p -61.44 -46.34 90.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.911 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.81 -5.77 0.01 OUTLIER Glycine 0 CA--C 1.536 1.356 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.646 ' H ' ' C ' ' A' ' 286' ' ' THR . 35.7 m120 -125.49 -55.43 1.54 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.8 m -66.02 -16.32 63.8 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.947 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 302' ' ' CYS . 92.0 m -118.51 24.78 10.71 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.634 0.254 . . . . 0.0 110.424 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 293' ' ' VAL . 57.4 t0 -57.8 -46.57 84.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.75 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -74.48 33.86 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.596 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' A' ' 291' ' ' ASP . 3.1 t -133.32 104.12 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.387 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -119.41 14.43 12.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.916 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.46 142.1 33.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.06 0.457 . . . . 0.0 109.921 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -51.37 -72.07 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.164 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.09 -40.5 67.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.697 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.71 88.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 17.5 mt -66.61 -55.71 14.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.546 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.27 -37.01 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.991 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -72.56 -33.28 66.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.554 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.477 ' O ' ' SG ' ' A' ' 290' ' ' CYS . 1.8 t -92.12 -4.62 54.06 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.68 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.3 mm? -96.58 19.19 12.68 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.682 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -81.62 -44.42 1.1 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.343 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.2 Cg_exo -58.18 10.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 123.319 2.679 . . . . 0.0 112.376 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.609 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.5 t0 -109.91 17.0 21.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 307' ' ' ARG . 18.8 ptt85 -113.06 90.96 3.49 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.652 0.739 . . . . 0.0 110.246 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.53 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 38.3 ptt180 -158.93 130.23 6.29 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.206 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.86 140.53 16.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -120.85 104.3 9.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.451 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 193' ' ' HIS . 0.5 OUTLIER -78.46 118.38 25.55 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -95.99 119.84 35.2 Favored 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 123.171 0.294 . . . . 0.0 110.816 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 58.3 t -122.64 118.74 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 O-C-N 123.554 0.534 . . . . 0.0 111.088 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -114.8 131.1 56.92 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.05 36.36 4.48 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.669 ' O ' ' O ' ' A' ' 317' ' ' LYS . 11.4 tt -113.3 169.36 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 316' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.223 -0.339 0 O-C-N 124.079 0.862 . . . . 0.0 111.251 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.449 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.114 0.483 . . . . 0.0 110.474 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 35.5 m -70.76 138.41 50.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.447 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 1.3 mmtm -115.17 172.21 7.21 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.425 0.631 . . . . 0.0 110.667 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 59.3 m80 -157.63 126.4 5.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.326 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.66 116.31 29.95 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.65 103.31 13.65 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.947 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 29.5 tp -106.62 130.01 54.44 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.581 0.705 . . . . 0.0 110.02 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -79.14 127.31 31.86 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 122.572 1.177 . . . . 0.0 112.468 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.522 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 15.4 m -61.73 -35.03 76.89 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.508 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -57.2 -34.6 68.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.95 -44.12 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.7 mt -79.8 -77.36 0.19 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.574 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.03 124.7 42.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.936 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.578 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 5.0 p-10 -100.51 -76.45 0.56 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.465 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . 0.578 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 68.0 m-85 -96.85 -20.53 18.09 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 110.738 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -70.97 165.25 23.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.124 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -51.12 -81.8 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.63 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.0 56.05 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.453 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 28.5 p -109.17 143.5 38.5 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 110.211 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.0 mt -81.03 132.17 35.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.839 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 213' ' ' GLY . 30.8 mmtm -93.96 157.48 37.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.982 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 210' ' ' LYS . 75.6 Cg_exo -32.43 -76.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.309 2.006 . . . . 0.0 111.951 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 1.9 pm0 -48.36 -23.23 0.86 Allowed 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.512 0.672 . . . . 0.0 110.271 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.52 -44.14 27.86 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.198 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -68.03 -40.45 82.9 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.201 0.524 . . . . 0.0 109.742 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.31 -52.89 62.87 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.727 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.53 -35.8 80.58 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.143 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.35 -28.36 69.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.21 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -76.63 -47.49 22.07 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.314 0.578 . . . . 0.0 110.825 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -61.72 -44.39 97.02 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.336 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 39.4 tp -65.17 -40.24 94.02 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.403 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.504 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.3 t80 -51.89 -48.69 63.99 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.35 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.4 m -55.29 -52.31 63.84 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.048 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -49.83 -24.83 2.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.387 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 18.7 mt -98.35 -16.94 19.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.77 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 79.9 p -75.62 -21.95 57.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.896 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -104.05 20.07 18.91 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.992 0.425 . . . . 0.0 110.999 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.61 156.03 31.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.158 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 315' ' ' GLY . 23.6 t0 -70.54 119.47 72.77 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.881 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.504 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.3 Cg_endo -69.85 -19.27 35.93 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.758 2.305 . . . . 0.0 113.194 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 229' ' ' PRO . 50.4 tptt -23.98 -50.39 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 124.068 0.855 . . . . 0.0 110.88 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 232' ' ' GLY . 7.7 p30 -113.18 -12.67 13.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.282 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 27.8 59.65 0.12 Allowed Glycine 0 N--CA 1.475 1.258 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 64.1 m -117.83 107.14 13.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 122.736 -0.273 . . . . 0.0 110.726 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 84.0 t -127.3 95.09 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.555 0.693 . . . . 0.0 110.078 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.8 t -97.85 120.93 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.187 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.1 t -92.73 125.3 45.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.719 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 59.5 mt -108.4 142.59 38.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.391 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.479 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -125.62 130.04 7.09 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -116.39 122.48 44.97 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.415 ' HG1' ' HB2' ' A' ' 253' ' ' SER . 2.9 p -108.46 171.42 7.42 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.051 0.453 . . . . 0.0 109.846 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -92.68 -178.07 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -102.58 121.93 43.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.411 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.508 ' H ' HD22 ' A' ' 249' ' ' ASN . 49.8 mm -118.42 13.13 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.503 0.668 . . . . 0.0 110.864 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.32 9.82 83.16 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.6 m -140.28 91.72 2.47 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.239 0.542 . . . . 0.0 110.308 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -48.23 -49.9 31.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.675 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.74 77.51 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.7 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -59.71 -47.78 84.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 110.423 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.508 HD22 ' H ' ' A' ' 243' ' ' ILE . 87.2 m-20 -62.83 -41.38 99.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.458 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -57.08 -46.22 82.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.184 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.01 -34.66 90.52 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.63 -38.92 70.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.739 0.304 . . . . 0.0 111.121 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 6.5 t -64.97 -43.2 93.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.694 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.98 -46.03 75.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.145 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -55.64 -46.73 77.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.036 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.522 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 50.7 mtp180 -62.53 -61.92 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 110.174 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -50.48 -36.64 34.61 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.286 0.565 . . . . 0.0 109.893 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -73.05 -45.6 56.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.897 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 40.0 t -58.59 -37.97 76.93 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.829 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.3 -51.08 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.049 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 12.8 t -61.92 -48.59 87.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.59 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -47.29 -43.08 22.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.878 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.552 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 48.6 t80 -77.42 -34.65 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.449 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -34.36 78.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.961 0.41 . . . . 0.0 110.525 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.564 ' C ' ' H ' ' A' ' 267' ' ' LYS . 88.3 mt -62.73 -50.33 80.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.253 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.9 t -49.31 -8.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.88 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.564 ' H ' ' C ' ' A' ' 265' ' ' ILE . 32.2 mmtp -86.64 12.52 10.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.504 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 79.68 42.66 11.06 Favored Glycine 0 CA--C 1.509 -0.302 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.024 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.12 128.72 25.21 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.226 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.72 127.94 26.47 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.968 1.779 . . . . 0.0 112.274 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.52 -8.71 28.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.841 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -91.94 -23.46 19.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.919 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.03 -22.95 44.68 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.534 0.683 . . . . 0.0 110.61 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.5 pt -102.1 -175.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.822 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 6.7 t -170.48 127.09 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.591 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.46 151.3 19.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -156.73 144.06 18.95 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 111.036 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -97.22 97.21 1.95 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.415 ' HG3' ' CZ ' ' A' ' 239' ' ' TYR . 1.2 mmt -68.6 -7.64 34.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.252 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 45.6 -109.17 0.29 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 281' ' ' GLU . 51.9 mp0 -131.21 57.12 1.77 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.644 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 6.2 t -80.23 -4.59 53.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.627 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -155.87 67.93 4.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.934 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.77 105.8 2.15 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.304 2.003 . . . . 0.0 111.613 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 15.1 m -69.62 -36.71 71.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.636 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.9 OUTLIER -63.75 -46.94 83.04 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.194 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -46.79 -6.89 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.636 ' H ' ' C ' ' A' ' 286' ' ' THR . 21.5 t-20 -124.65 -58.44 1.5 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.749 0.309 . . . . 0.0 110.367 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.0 m -63.5 -24.87 68.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.654 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.34 27.02 9.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.192 0.307 . . . . 0.0 110.32 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 288' ' ' ASN . 2.4 p30 -69.96 -5.78 28.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.708 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -98.33 32.97 2.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.609 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.8 t -131.38 123.9 53.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.894 0.378 . . . . 0.0 110.293 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -118.89 8.16 11.66 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.874 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -88.03 169.33 12.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.135 0.493 . . . . 0.0 110.069 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? -85.2 -68.01 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.905 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -60.44 -30.98 69.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.094 0.473 . . . . 0.0 110.831 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.81 83.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.404 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 63.0 mt -74.38 -54.67 7.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 72.9 mt -46.91 -36.53 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.062 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.94 -44.36 48.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.143 0.497 . . . . 0.0 110.688 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.2 t -75.57 -3.3 33.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.788 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -96.19 16.66 17.59 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.383 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.578 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.04 -46.03 1.44 Allowed Pre-proline 0 C--O 1.241 0.632 0 CA-C-O 121.336 0.588 . . . . 0.0 110.052 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 24.5 Cg_exo -61.5 8.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.12 2.547 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.567 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.2 t0 -103.79 14.82 30.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.679 0.276 . . . . 0.0 110.687 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.507 ' C ' ' HG ' ' A' ' 198' ' ' SER . 90.0 mtm-85 -114.31 96.88 6.0 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 121.773 0.797 . . . . 0.0 109.788 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.544 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 15.8 ptm180 -156.71 130.13 8.09 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.988 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.9 140.69 16.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -123.25 105.25 9.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.316 0.579 . . . . 0.0 111.044 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.77 118.7 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.32 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -95.1 124.33 39.08 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.154 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 192' ' ' LYS . 21.9 t -123.66 117.79 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.175 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -116.67 130.59 56.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 95.04 37.93 5.02 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.589 ' O ' ' O ' ' A' ' 317' ' ' LYS . 13.4 tt -117.51 173.42 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.589 ' O ' ' O ' ' A' ' 316' ' ' ILE . 98.1 mttt . . . . . 0 CA--C 1.536 0.42 0 O-C-N 124.154 0.909 . . . . 0.0 110.51 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.402 ' OE1' ' C ' ' A' ' 317' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 121.104 0.478 . . . . 0.0 109.913 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.595 ' CG2' ' HE2' ' A' ' 193' ' ' HIS . 17.6 m -74.39 130.77 40.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.999 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -147.7 120.31 8.57 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.595 ' HE2' ' CG2' ' A' ' 191' ' ' THR . 3.4 m170 -108.07 151.45 25.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -112.1 121.47 45.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.317 0.579 . . . . 0.0 110.121 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.4 t -86.2 102.04 13.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.568 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 32.0 tp -104.48 131.95 51.28 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.15 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -81.37 126.37 31.52 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.188 -177.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.444 ' HG ' ' N ' ' A' ' 199' ' ' ASP . 96.1 p -61.5 -32.63 72.67 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.937 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.444 ' N ' ' HG ' ' A' ' 198' ' ' SER . 46.2 t0 -59.43 -41.73 90.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.377 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 82.6 t -61.92 -48.75 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.14 -77.81 0.09 Allowed 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.396 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -120.17 123.16 42.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.33 -179.154 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -86.74 -73.78 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.052 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -107.43 -11.9 15.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.772 0.32 . . . . 0.0 110.51 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -72.44 163.52 27.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.152 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -52.13 -78.25 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.255 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.33 57.01 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.27 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.8 t -108.8 137.79 46.17 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.304 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.433 HD12 ' CG ' ' A' ' 263' ' ' TYR . 10.7 mt -80.95 131.75 35.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.34 0.591 . . . . 0.0 111.394 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 213' ' ' GLY . 9.2 pttp -94.77 154.62 39.86 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.443 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 210' ' ' LYS . 93.5 Cg_exo -31.15 -73.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.269 1.979 . . . . 0.0 112.306 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -50.75 -25.11 3.98 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.954 0.407 . . . . 0.0 110.591 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.86 -46.58 16.83 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -62.42 -41.04 98.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.39 -52.84 62.22 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.373 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.64 70.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.585 0.707 . . . . 0.0 110.292 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.95 -29.69 66.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.169 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . 0.476 ' CB ' ' HZ1' ' A' ' 267' ' ' LYS . 23.8 t0 -75.73 -49.07 19.32 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.154 0.502 . . . . 0.0 111.236 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.538 ' O ' ' NE2' ' A' ' 223' ' ' GLN . 2.6 pt20 -61.93 -42.79 99.5 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.497 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 31.5 tp -65.41 -40.1 92.96 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.3 t80 -52.56 -45.49 66.44 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.907 178.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.3 t -55.5 -51.25 67.63 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.357 -178.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.805 ' H ' HE21 ' A' ' 223' ' ' GLN . 0.0 OUTLIER -54.14 -25.69 23.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.495 -179.263 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 18.3 mt -97.86 -21.95 16.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.758 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.2 t -75.26 -32.77 61.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.349 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -97.1 24.16 6.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 -179.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.25 157.7 32.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 315' ' ' GLY . 8.0 t70 -71.73 120.48 80.23 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 232' ' ' GLY . 56.7 Cg_endo -67.78 -20.08 46.38 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.801 1.667 . . . . 0.0 113.522 -177.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 229' ' ' PRO . 51.3 tptt -28.6 -44.86 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.388 0.43 . . . . 0.0 111.299 -178.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 232' ' ' GLY . 72.5 m-20 -109.77 -14.42 14.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.507 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 25.16 51.38 0.04 OUTLIER Glycine 0 N--CA 1.469 0.834 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.1 m -117.84 109.98 17.22 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.738 0.304 . . . . 0.0 111.101 -178.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.48 94.03 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 121.641 0.734 . . . . 0.0 110.116 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.86 121.82 47.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.271 -178.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.3 121.58 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.515 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.52 141.01 37.74 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.006 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.7 126.14 6.25 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.66 124.87 53.22 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.2 t -115.96 168.85 9.71 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.832 0.348 . . . . 0.0 110.505 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -92.36 -177.21 4.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.576 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.574 ' NE ' ' OE1' ' A' ' 281' ' ' GLU . 92.2 mtt180 -100.62 128.02 46.81 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.989 0.423 . . . . 0.0 110.482 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.493 ' H ' HD22 ' A' ' 249' ' ' ASN . 47.1 mm -118.28 11.67 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.91 3.48 89.22 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.5 t -135.23 102.85 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.286 0.565 . . . . 0.0 110.361 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -55.16 -51.71 65.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.548 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.36 70.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.548 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -62.91 -42.12 99.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.307 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.493 HD22 ' H ' ' A' ' 243' ' ' ILE . 98.4 m-20 -61.43 -46.31 90.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.587 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -61.25 -41.63 97.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.451 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.94 -36.07 92.94 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.9 mt -70.59 -41.26 72.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.81 178.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.693 ' HG ' ' H ' ' A' ' 280' ' ' GLY . 11.7 t -65.33 -42.65 92.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.57 -49.11 72.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.129 0.49 . . . . 0.0 109.816 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -58.46 -44.84 89.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.256 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 51.8 ttm-85 -51.27 -64.25 0.87 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.54 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -56.84 -31.38 64.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.244 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -66.09 -48.19 71.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.542 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.47 ' O ' ' OD2' ' A' ' 262' ' ' ASP . 13.6 t -60.06 -39.13 84.95 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.467 0.651 . . . . 0.0 110.826 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.24 -50.67 79.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.216 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.2 -48.92 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.794 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 259' ' ' SER . 0.0 OUTLIER -47.53 -41.73 21.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.144 0.497 . . . . 0.0 110.014 -177.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.433 ' CG ' HD12 ' A' ' 209' ' ' LEU . 15.6 t80 -79.85 -34.11 39.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.83 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -33.87 76.84 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.33 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 267' ' ' LYS . 84.6 mt -65.99 -49.36 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 79.0 p -54.07 -11.1 0.41 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.966 -178.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.476 ' HZ1' ' CB ' ' A' ' 218' ' ' ASP . 70.9 mmtt -78.41 -7.46 57.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.683 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 101.61 43.06 2.2 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.768 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.3 128.74 23.65 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 117.12 0.46 . . . . 0.0 110.029 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.22 129.2 27.85 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.694 1.596 . . . . 0.0 111.817 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.68 -10.53 47.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.954 0.406 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -90.66 -21.36 21.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.385 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -19.9 41.88 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.948 0.88 . . . . 0.0 110.975 -179.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.3 pt -104.96 -173.5 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.455 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 15.7 t -166.62 135.82 2.98 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.283 178.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -108.06 110.48 22.18 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.957 0.408 . . . . 0.0 110.838 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -115.46 137.24 52.26 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.386 0.612 . . . . 0.0 111.503 -178.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 280' ' ' GLY . . . -86.85 92.09 1.78 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 178.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 280' ' ' GLY . 5.1 tpt -66.19 3.9 0.8 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.502 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . 0.693 ' H ' ' HG ' ' A' ' 253' ' ' SER . . . 35.35 -104.64 0.02 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.12 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.574 ' OE1' ' NE ' ' A' ' 242' ' ' ARG . 30.9 tt0 -142.62 58.21 1.44 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.3 m -85.33 -4.02 59.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -149.59 65.61 7.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.233 -179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.31 148.31 90.96 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.21 1.94 . . . . 0.0 111.26 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.41 ' CG2' ' H ' ' A' ' 286' ' ' THR . 19.6 m -110.95 -55.36 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.247 0.546 . . . . 0.0 110.907 178.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.633 ' C ' ' H ' ' A' ' 288' ' ' ASN . 18.6 p -58.91 -40.78 85.55 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.075 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.61 -7.73 0.01 OUTLIER Glycine 0 CA--C 1.531 1.078 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.633 ' H ' ' C ' ' A' ' 286' ' ' THR . 3.2 m-20 -123.45 -54.99 1.76 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.8 m -66.89 -22.03 65.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.324 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.95 24.53 10.14 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.756 0.312 . . . . 0.0 110.481 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -66.58 -9.01 30.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.981 0.42 . . . . 0.0 110.358 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -93.77 33.72 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.173 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.32 120.59 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.8 0.333 . . . . 0.0 110.733 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 13.03 13.14 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . 0.424 ' N ' ' CD ' ' A' ' 295' ' ' GLN . 0.1 OUTLIER -99.59 136.93 38.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.974 0.416 . . . . 0.0 109.953 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -58.14 -46.12 86.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.2 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -67.11 -46.93 72.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.285 -178.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.19 -26.36 68.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.661 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 303' ' ' LEU . 31.8 mt -76.12 -57.04 4.11 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.549 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.36 -36.97 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.0 109.882 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -72.0 -40.34 68.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.099 178.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 9.1 t -83.68 -8.02 59.37 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.562 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 299' ' ' LEU . 49.4 mt -93.77 21.73 6.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.463 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -80.25 -43.35 1.4 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 121.055 0.455 . . . . 0.0 110.711 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.3 Cg_exo -60.77 10.27 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.398 2.732 . . . . 0.0 111.681 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.599 ' H ' ' C ' ' A' ' 304' ' ' ALA . 2.0 m-20 -103.88 14.26 31.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.743 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.427 ' O ' ' OG ' ' A' ' 198' ' ' SER . 85.9 mtm-85 -115.87 93.84 4.42 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.239 0.543 . . . . 0.0 110.165 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.505 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 8.4 ptm180 -154.44 128.4 8.85 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.512 0.673 . . . . 0.0 112.575 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.54 135.57 28.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.508 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.448 ' OE2' ' CZ ' ' A' ' 239' ' ' TYR . 28.5 mt-10 -118.66 104.37 10.56 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.26 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 193' ' ' HIS . 0.9 OUTLIER -79.48 117.86 25.93 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.543 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -96.0 121.61 37.93 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.141 0.495 . . . . 0.0 110.594 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.34 117.27 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.955 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -112.92 138.67 49.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 87.82 39.14 7.17 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -178.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.715 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.3 tt -116.68 169.31 7.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.715 ' O ' ' O ' ' A' ' 316' ' ' ILE . 68.2 mttm . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 121.7 0.762 . . . . 0.0 112.016 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.703 0.287 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.426 ' CG2' ' N ' ' A' ' 192' ' ' LYS . 43.3 m -76.59 167.03 22.57 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.008 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 191' ' ' THR . 3.8 tptm -152.37 98.5 2.4 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.561 0.696 . . . . 0.0 110.998 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -85.27 125.16 32.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.408 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.562 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 54.4 m-85 -112.73 119.27 37.49 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' A' ' 195' ' ' THR . 7.7 t -86.4 104.93 16.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.427 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 27.7 tp -107.38 129.47 54.92 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.068 0.461 . . . . 0.0 109.773 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -78.81 126.78 31.18 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.876 0.845 . . . . 0.0 112.113 -178.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 202' ' ' PHE . 94.6 p -62.74 -30.29 71.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.984 179.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.435 ' N ' ' HG ' ' A' ' 198' ' ' SER . 98.3 m-20 -58.86 -40.27 83.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.32 -46.27 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 90.3 mt -75.93 -76.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.359 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -126.48 128.29 46.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.946 -179.787 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -108.45 -76.18 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.27 -34.09 17.83 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.561 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.468 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 48.9 p30 -62.79 165.77 6.27 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.076 0.465 . . . . 0.0 110.223 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -54.93 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.54 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.3 52.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.63 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.468 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 60.9 p -107.14 137.76 44.59 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.279 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.2 mt -74.6 142.74 44.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.18 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 213' ' ' GLY . 34.4 mtpt -101.83 159.68 28.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.137 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 210' ' ' LYS . 82.2 Cg_exo -33.96 -77.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.418 2.079 . . . . 0.0 111.982 179.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -51.47 -17.01 0.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.262 0.553 . . . . 0.0 110.181 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.99 -48.22 10.24 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.343 178.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . 0.402 ' NE2' ' CE1' ' A' ' 263' ' ' TYR . 93.1 mt-30 -67.62 -40.11 84.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.139 0.495 . . . . 0.0 109.783 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.49 -50.34 74.11 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.07 -32.65 74.46 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.509 0.671 . . . . 0.0 110.311 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.9 mt -70.33 -26.89 63.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.421 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -74.94 -47.66 28.47 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.36 0.6 . . . . 0.0 111.178 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -64.63 -40.72 95.96 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.469 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.2 tp -63.78 -41.47 97.95 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.488 178.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 225' ' ' SER . 6.3 t80 -53.02 -51.02 63.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.998 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 6.1 t -53.19 -51.48 61.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.266 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.562 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 11.1 tt0 -55.12 -25.92 34.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 86.5 mt -94.89 -20.28 19.56 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.641 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 221' ' ' TYR . 24.6 p -83.36 -11.42 57.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.396 0.435 . . . . 0.0 110.444 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 13.7 t-20 -97.48 22.4 8.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.237 0.541 . . . . 0.0 110.263 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.495 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.6 OUTLIER -80.03 -177.69 6.14 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.975 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 315' ' ' GLY . 21.5 t0 -100.26 108.02 50.48 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.77 178.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 230' ' ' LYS . 75.6 Cg_exo -46.19 -21.01 1.0 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.667 2.245 . . . . 0.0 112.917 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 229' ' ' PRO . 65.0 tttm -35.91 -52.21 0.73 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.041 0.448 . . . . 0.0 110.546 -177.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.47 ' O ' ' C ' ' A' ' 232' ' ' GLY . 57.4 m-20 -98.71 -21.52 16.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.528 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.17 50.32 0.04 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 123.849 0.718 . . . . 0.0 111.646 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.68 111.81 19.0 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 122.574 -0.368 . . . . 0.0 110.69 -179.182 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.02 97.32 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.712 0.767 . . . . 0.0 110.311 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.4 t -99.67 121.17 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.554 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 85.7 t -95.41 126.86 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.428 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.2 mt -111.93 140.53 46.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.051 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.429 ' O ' ' SD ' ' A' ' 279' ' ' MET . . . -116.7 136.48 12.81 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -120.81 122.04 39.45 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.511 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.425 ' OG1' ' OG ' ' A' ' 253' ' ' SER . 3.3 p -113.3 165.8 12.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 0.0 110.218 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.98 -177.32 5.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.644 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -98.42 122.06 41.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.281 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.473 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 49.3 mm -118.55 13.6 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.274 0.559 . . . . 0.0 110.702 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 82.73 2.65 90.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.9 m -132.79 98.92 4.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.033 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -54.01 -51.61 63.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.461 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.74 -41.6 74.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.505 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -63.36 -43.24 98.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.67 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.06 -42.38 99.13 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.523 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -64.04 -41.57 97.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.785 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.23 -39.07 97.21 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 33.5 mt -69.08 -38.2 78.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.764 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.425 ' OG ' ' OG1' ' A' ' 240' ' ' THR . 15.4 m -63.66 -43.74 95.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.959 0.409 . . . . 0.0 111.011 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.11 -40.83 91.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.045 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER -60.09 -47.41 86.01 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.28 -179.718 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.762 HH22 ' HE ' ' A' ' 307' ' ' ARG . 99.6 mtt180 -61.36 -58.78 6.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.115 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -52.74 -32.67 44.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.109 0.48 . . . . 0.0 109.753 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.56 -51.28 15.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.352 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.476 ' O ' ' OD2' ' A' ' 262' ' ' ASP . 66.2 m -58.86 -38.79 79.56 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.667 0.746 . . . . 0.0 110.268 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.4 -50.1 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.365 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 12.8 t -62.08 -49.16 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.475 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 259' ' ' SER . 0.0 OUTLIER -45.06 -42.43 8.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.16 0.505 . . . . 0.0 110.272 -178.573 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.402 ' CE1' ' NE2' ' A' ' 214' ' ' GLN . 19.9 t80 -80.62 -31.38 36.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.637 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.9 -7.39 45.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.285 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 267' ' ' LYS . 69.6 mt -88.62 -58.35 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 111.612 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.1 p -49.17 -6.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.075 -178.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.0 OUTLIER -78.19 -11.69 59.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.847 0.356 . . . . 0.0 110.527 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 108.67 39.88 1.68 Allowed Glycine 0 C--N 1.329 0.161 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.0 129.98 23.88 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.0 128.85 30.6 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.67 1.58 . . . . 0.0 111.698 176.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.23 -10.17 47.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.849 0.357 . . . . 0.0 111.122 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 33.5 p30 -92.61 -18.21 23.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.479 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 1.4 ttpm? -83.98 -18.26 37.79 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.605 0.717 . . . . 0.0 110.71 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.7 pt -105.27 -171.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.717 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 7.6 t -168.53 133.19 1.62 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.202 179.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -105.2 112.04 25.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.784 0.326 . . . . 0.0 110.608 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 150.34 45.61 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.539 0.685 . . . . 0.0 110.982 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -115.37 97.63 0.81 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.603 ' HE2' ' H ' ' A' ' 282' ' ' SER . 3.3 ppp? -80.85 6.74 12.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.884 0.374 . . . . 0.0 111.001 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 47.38 -99.17 0.02 OUTLIER Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.983 179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 281' ' ' GLU . 1.8 pm0 -139.36 80.14 1.76 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.845 0.355 . . . . 0.0 111.032 -178.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.603 ' H ' ' HE2' ' A' ' 279' ' ' MET . 88.0 p -88.92 -2.0 58.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.071 -179.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -163.02 75.6 1.93 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.296 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.34 103.7 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.461 2.107 . . . . 0.0 112.805 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.74 -35.88 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.231 0.539 . . . . 0.0 110.095 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.684 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.9 OUTLIER -58.98 -43.51 91.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.507 -179.714 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.38 -0.8 0.02 OUTLIER Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.684 ' H ' ' C ' ' A' ' 286' ' ' THR . 11.0 t30 -122.16 -58.62 1.71 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.7 m -58.73 -23.0 59.07 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.737 0.303 . . . . 0.0 110.524 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 3.3 m -120.29 28.49 8.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.143 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -70.78 -17.88 62.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.86 0.362 . . . . 0.0 110.952 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -97.57 31.47 2.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.437 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 23.6 t -137.95 129.31 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.194 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -121.23 13.3 11.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -96.44 131.37 43.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.168 0.509 . . . . 0.0 110.249 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -52.76 -67.98 0.21 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.031 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.48 -41.2 60.76 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.891 -178.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.26 80.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.424 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 303' ' ' LEU . 4.9 mp -72.74 -52.03 16.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.714 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 81.6 mt -43.17 -38.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.906 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -76.51 -43.53 39.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.359 178.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.7 t -73.93 -5.43 41.14 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.505 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.4 mm? -94.55 13.35 24.37 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.57 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.598 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -73.73 -43.1 6.56 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.734 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.5 Cg_exo -60.81 9.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.438 2.759 . . . . 0.0 112.255 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 304' ' ' ALA . 53.1 t0 -108.81 9.5 26.82 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.662 0.268 . . . . 0.0 110.669 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.762 ' HE ' HH22 ' A' ' 256' ' ' ARG . 68.3 mtp180 -112.38 98.87 7.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.333 0.587 . . . . 0.0 110.148 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.466 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 36.5 ptt180 -167.75 144.54 4.23 Favored 'General case' 0 C--O 1.215 -0.763 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.784 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 22.4 m -107.2 147.67 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -121.02 110.62 16.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.146 0.498 . . . . 0.0 111.091 -178.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.4 mm -80.49 118.31 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -104.33 98.96 8.67 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.942 -179.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.0 t -106.06 123.48 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.444 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -115.53 146.89 41.3 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.999 179.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 91.96 15.84 52.99 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -179.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.42 143.71 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.211 0.529 . . . . 0.0 110.825 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 41.4 tptt . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.767 179.385 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 N--CA 1.463 0.197 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.7 m -86.92 146.01 26.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.271 179.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 313' ' ' VAL . 20.4 mmtt -112.92 149.78 32.73 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.335 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -128.01 114.16 16.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.191 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -114.03 116.47 29.24 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.678 177.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.1 102.18 13.63 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.584 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 29.4 tp -103.27 119.85 39.65 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.737 -179.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -77.59 127.69 32.91 Favored 'General case' 0 C--O 1.255 1.366 0 CA-C-O 123.052 1.406 . . . . 0.0 112.765 -178.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 202' ' ' PHE . 78.4 p -59.48 -20.13 53.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.874 178.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -55.97 -43.63 77.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.15 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 6.7 t -74.6 -28.07 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 51.9 mt -93.52 -81.75 0.36 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.776 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.0 OUTLIER -113.27 130.28 56.29 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.869 -179.161 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.539 ' O ' ' NH1' ' A' ' 307' ' ' ARG . 7.7 m120 -98.7 -72.7 0.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -117.27 -21.13 8.89 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.817 0.341 . . . . 0.0 110.283 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.31 172.12 6.34 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.052 0.453 . . . . 0.0 110.321 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -53.37 -92.26 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.657 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -151.29 59.38 0.9 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.506 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 68.1 p -106.9 129.54 54.71 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 37.3 mt -74.7 125.01 27.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.697 -178.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 213' ' ' GLY . 50.4 mttt -86.32 158.52 54.88 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.72 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' N ' ' A' ' 213' ' ' GLY . 73.4 Cg_exo -34.01 -75.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.585 2.19 . . . . 0.0 112.045 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -49.02 -20.06 0.49 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.162 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.79 -51.32 11.4 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 178.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -66.19 -38.95 89.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.355 0.597 . . . . 0.0 110.241 179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.83 -53.75 54.86 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.67 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.37 90.83 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.981 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.88 -29.58 70.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.574 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -71.76 -46.28 58.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.219 0.533 . . . . 0.0 110.239 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.543 ' O ' ' NE2' ' A' ' 223' ' ' GLN . 7.1 mt-30 -62.16 -44.02 97.53 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.218 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.16 -41.02 97.31 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' A' ' 225' ' ' SER . 3.7 t80 -52.93 -47.69 67.86 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.528 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 72.6 m -53.22 -52.69 58.1 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.424 -178.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.836 ' H ' HE21 ' A' ' 223' ' ' GLN . 0.0 OUTLIER -55.78 -27.64 52.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.608 -179.203 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 86.6 mt -92.43 -23.12 19.27 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.713 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 221' ' ' TYR . 8.1 t -77.56 -19.78 55.13 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.57 0.544 . . . . 0.0 110.738 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -96.05 22.17 7.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.068 0.461 . . . . 0.0 110.688 -179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 227' ' ' LEU . 0.7 OUTLIER -74.03 -177.68 3.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.219 179.903 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 230' ' ' LYS . 3.7 t0 -99.43 127.08 35.38 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 232' ' ' GLY . 55.4 Cg_endo -69.73 -22.52 32.12 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.959 2.44 . . . . 0.0 113.593 -178.209 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.556 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 34.6 ttmt -23.74 -51.97 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.688 0.617 . . . . 0.0 111.1 -177.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 232' ' ' GLY . 90.2 m-20 -109.54 -10.48 14.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.939 178.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 27.32 58.13 0.1 Allowed Glycine 0 N--CA 1.471 0.992 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.687 ' N ' ' HZ2' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -124.34 119.0 28.01 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-O 121.249 0.547 . . . . 0.0 110.454 -179.549 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -132.75 99.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.514 0.673 . . . . 0.0 109.805 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.19 127.09 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.152 0.501 . . . . 0.0 111.11 -178.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 89.4 t -102.12 128.39 54.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.399 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 18.2 mt -108.78 140.43 42.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.016 0.436 . . . . 0.0 110.459 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -98.95 138.26 13.75 Favored Glycine 0 N--CA 1.472 1.092 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.201 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 308' ' ' ARG . 9.7 m-85 -125.63 115.82 20.74 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 4.9 t -117.18 163.94 15.53 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.461 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 48.9 p-10 -87.74 -174.92 4.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.417 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -99.21 121.79 41.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 110.075 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.65 ' H ' HD22 ' A' ' 249' ' ' ASN . 47.8 mm -116.1 12.62 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.371 0.605 . . . . 0.0 110.728 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.05 -3.52 65.21 Favored Glycine 0 C--N 1.315 -0.584 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -125.39 105.26 8.95 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.93 -55.2 37.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.36 69.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.576 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -63.03 -44.88 94.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.775 -179.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.65 HD22 ' H ' ' A' ' 243' ' ' ILE . 57.8 m-80 -61.88 -42.16 98.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.398 -179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.43 ' O ' ' OG ' ' A' ' 253' ' ' SER . 70.7 tp60 -64.27 -41.81 96.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.644 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.74 -38.31 96.25 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.2 -38.58 78.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.849 0.357 . . . . 0.0 111.199 179.059 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.479 ' HG ' ' H ' ' A' ' 254' ' ' GLU . 78.1 p -63.56 -44.01 95.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.479 ' H ' ' HG ' ' A' ' 253' ' ' SER . 98.0 mt-10 -66.43 -45.11 80.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.437 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -56.8 -50.52 72.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.319 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.711 HH22 ' N ' ' A' ' 308' ' ' ARG . 70.3 mtp180 -59.13 -59.01 6.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.473 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.2 -35.68 17.79 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.172 0.511 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.408 ' NE2' ' OD1' ' A' ' 262' ' ' ASP . 68.0 tp60 -69.9 -43.75 71.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.154 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.7 t -60.86 -39.64 89.92 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.314 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.28 -54.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.773 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.21 -50.01 81.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.45 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.408 ' OD1' ' NE2' ' A' ' 258' ' ' GLN . 25.8 m-20 -44.6 -41.75 6.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -83.55 -29.67 27.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.745 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -7.0 45.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.474 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.613 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.0 mt -87.09 -55.74 6.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.832 0.349 . . . . 0.0 111.539 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.3 m -50.93 -5.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.887 -178.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 265' ' ' ILE . 5.7 mmtm -77.17 -9.87 59.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.94 38.17 2.22 Favored Glycine 0 N--CA 1.458 0.15 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.07 128.35 23.76 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.24 130.24 34.71 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.965 1.777 . . . . 0.0 112.081 177.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.01 -10.71 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.917 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -92.84 -22.71 19.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.898 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -78.34 -23.21 47.09 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.632 0.73 . . . . 0.0 110.472 -179.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.4 pt -101.19 -170.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.71 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 8.2 t -169.04 126.3 0.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.012 179.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.91 114.55 26.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.795 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -129.28 157.47 41.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.311 0.577 . . . . 0.0 110.18 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.54 155.11 16.25 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.541 ' N ' ' O ' ' A' ' 238' ' ' GLY . 5.5 tpt -118.62 -10.0 10.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.964 0.411 . . . . 0.0 110.293 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 53.58 -110.88 1.57 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -137.33 74.94 1.5 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.804 0.335 . . . . 0.0 110.732 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.408 ' C ' ' ND2' ' A' ' 283' ' ' ASN . 47.9 t -72.86 -48.42 37.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.12 0.486 . . . . 0.0 111.498 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 282' ' ' SER . 3.8 m-80 -144.63 76.77 14.06 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.12 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.55 123.26 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.627 2.218 . . . . 0.0 111.744 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.06 -35.87 42.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.115 0.483 . . . . 0.0 110.556 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.645 ' C ' ' H ' ' A' ' 288' ' ' ASN . 71.7 p -67.38 -50.03 61.41 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.643 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.623 ' H ' ' HG1' ' A' ' 286' ' ' THR . . . -55.12 1.73 0.05 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.645 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.7 t-20 -111.64 -61.12 1.75 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.3 t -76.91 -7.35 55.37 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.568 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.45 21.25 7.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.541 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -69.59 -4.2 18.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.575 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -96.6 33.02 1.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.661 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.8 t -125.65 129.96 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.944 0.402 . . . . 0.0 109.917 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.78 4.32 12.25 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -100.25 130.9 46.43 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.19 0.519 . . . . 0.0 110.432 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 299' ' ' LEU . 5.0 ttt180 -53.26 -75.62 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.604 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -42.36 -37.48 1.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.1 0.476 . . . . 0.0 110.747 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.48 84.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.793 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 296' ' ' ARG . 20.8 mt -73.12 -44.32 60.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.168 0.509 . . . . 0.0 110.575 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.3 mm -60.84 -31.39 49.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.989 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -81.38 -28.97 34.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.611 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.3 t -93.68 -11.23 32.03 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.85 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 299' ' ' LEU . 37.7 mt -93.28 20.36 7.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -78.44 -46.11 2.03 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.288 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.7 Cg_exo -59.76 8.83 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.214 2.609 . . . . 0.0 111.886 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.581 ' H ' ' C ' ' A' ' 304' ' ' ALA . 47.2 t0 -109.47 12.11 24.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.793 0.33 . . . . 0.0 110.852 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 203' ' ' ASN . 65.0 mtp180 -109.4 109.74 20.68 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.176 0.512 . . . . 0.0 110.36 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.711 ' N ' HH22 ' A' ' 256' ' ' ARG . 10.4 ptp180 -174.16 -172.38 0.7 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.998 -179.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.35 157.11 15.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 177.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -121.79 106.65 11.48 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.221 0.534 . . . . 0.0 111.282 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.68 122.48 35.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.305 -178.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -108.06 116.65 32.34 Favored 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 123.775 0.672 . . . . 0.0 110.27 -178.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 192' ' ' LYS . 80.2 t -130.77 125.71 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.154 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.687 ' HZ2' ' N ' ' A' ' 233' ' ' SER . 0.0 OUTLIER -99.41 179.53 4.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.335 179.043 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.52 -49.71 1.03 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 177.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 14.2 tt -47.07 150.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.098 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.058 179.649 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.7 m -69.12 139.03 54.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.291 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -142.33 114.0 7.95 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.9 m-70 -102.95 144.53 31.12 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.546 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 78.1 m-85 -107.22 130.68 54.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' A' ' 195' ' ' THR . 8.0 t -86.32 104.35 15.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.825 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mt -108.83 131.55 54.88 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.38 137.92 32.22 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 122.727 1.251 . . . . 0.0 110.991 -178.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 202' ' ' PHE . 0.9 OUTLIER -61.01 -18.21 56.45 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.427 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -57.13 -49.99 74.21 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.863 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 4.7 m -68.26 -38.55 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.735 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 33.2 mt -82.79 -78.76 0.2 Allowed 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.449 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -138.06 137.86 38.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.841 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.733 HD21 HH11 ' A' ' 307' ' ' ARG . 0.8 OUTLIER -119.49 -75.99 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.552 179.808 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -81.69 -37.7 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.933 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -67.26 170.52 7.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.144 0.497 . . . . 0.0 110.494 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -59.32 -82.82 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.775 -179.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -153.67 54.23 0.73 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.166 0.507 . . . . 0.0 110.349 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.57 127.93 53.72 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.486 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.6 mt -70.21 140.89 52.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 -179.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 213' ' ' GLY . 4.1 mtmp? -103.51 157.36 34.01 Favored Pre-proline 0 N--CA 1.466 0.326 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -32.97 -76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.718 2.279 . . . . 0.0 112.352 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -49.84 -20.32 0.85 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.326 0.584 . . . . 0.0 110.548 -179.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.53 -50.08 12.85 Favored Glycine 0 N--CA 1.461 0.365 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.084 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -65.15 -40.88 95.0 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.232 0.539 . . . . 0.0 109.944 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.0 67.04 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.07 -38.69 91.97 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.607 -179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.31 -28.88 70.05 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.277 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -71.18 -47.24 58.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.374 0.607 . . . . 0.0 110.808 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -62.62 -43.5 98.66 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.974 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.54 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 60.9 tp -65.23 -39.36 92.63 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.235 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.431 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.7 t80 -53.42 -47.94 69.18 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.845 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.8 t -59.32 -50.07 75.39 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.537 -178.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 9.0 tt0 -51.95 -24.99 7.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.942 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 23.3 mt -96.68 -17.15 20.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.508 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 10.5 t -81.63 -16.12 52.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.795 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -103.32 17.72 23.43 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.581 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.38 -179.44 3.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.323 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -97.96 109.46 51.56 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 230' ' ' LYS . 78.5 Cg_exo -47.6 -19.57 1.33 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.349 2.033 . . . . 0.0 113.438 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 229' ' ' PRO . 1.5 tmtp? -27.13 -51.79 0.06 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.261 0.553 . . . . 0.0 111.11 -177.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 232' ' ' GLY . 67.9 m-20 -110.14 -13.73 14.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.478 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.51 46.61 0.02 OUTLIER Glycine 0 N--CA 1.474 1.228 0 O-C-N 124.101 0.876 . . . . 0.0 111.272 179.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 231' ' ' ASP . 74.6 m -114.96 109.93 18.85 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.568 0.223 . . . . 0.0 111.149 -178.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 77.4 t -125.64 95.05 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.37 0.605 . . . . 0.0 109.933 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.7 t -96.69 121.14 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.296 0.569 . . . . 0.0 110.7 -178.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 96.5 t -91.07 122.3 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 45.9 mt -105.79 140.86 38.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.427 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -125.03 129.72 7.11 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -113.91 117.01 30.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.824 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.411 ' OG1' ' NH2' ' A' ' 256' ' ' ARG . 9.7 t -104.88 178.54 4.53 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.133 0.492 . . . . 0.0 110.975 -178.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 307' ' ' ARG . 41.8 m-20 -83.79 -177.08 6.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.394 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -117.02 120.28 37.9 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.768 0.318 . . . . 0.0 110.501 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.491 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 45.4 mm -120.67 12.66 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.504 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.96 -43.5 3.26 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 6.9 m -71.1 94.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.362 0.601 . . . . 0.0 109.934 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -48.51 -48.34 38.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.203 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.14 84.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.749 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -62.14 -42.22 99.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.148 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.531 HD22 ' CA ' ' A' ' 280' ' ' GLY . 0.5 OUTLIER -60.38 -53.08 61.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 -179.775 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -61.67 -37.65 84.86 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.42 -41.83 99.63 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.24 -37.78 71.99 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.073 178.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.594 ' HG ' ' CA ' ' A' ' 278' ' ' GLY . 4.2 t -63.0 -39.68 95.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.115 0.483 . . . . 0.0 110.879 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -73.19 -39.65 65.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.46 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -58.83 -51.75 68.65 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.517 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.411 ' NH2' ' OG1' ' A' ' 240' ' ' THR . 18.1 ptp180 -64.39 -44.28 91.81 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.899 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.28 98.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.571 0.7 . . . . 0.0 110.421 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -70.72 -42.06 71.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.684 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.8 m -60.61 -39.14 87.09 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.383 0.611 . . . . 0.0 110.355 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.97 -50.65 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.95 179.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.8 t -61.32 -48.27 89.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 121.165 0.507 . . . . 0.0 110.315 179.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -47.93 -40.9 23.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.908 -178.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.405 ' OH ' ' NZ ' ' A' ' 267' ' ' LYS . 88.6 t80 -79.66 -35.59 39.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.026 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.14 -29.11 70.25 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.99 -179.023 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.512 ' C ' ' H ' ' A' ' 267' ' ' LYS . 89.0 mt -69.06 -49.54 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 120.797 0.332 . . . . 0.0 111.82 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 18.5 m -52.43 -8.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.512 ' H ' ' C ' ' A' ' 265' ' ' ILE . 12.3 mmtt -79.75 -6.21 56.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.683 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.06 42.21 2.87 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.19 129.41 24.22 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 117.101 0.451 . . . . 0.0 110.583 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.56 129.34 29.21 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.325 1.35 . . . . 0.0 112.002 178.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.4 -11.05 38.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.74 -22.9 21.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -179.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.47 -23.54 50.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.295 0.569 . . . . 0.0 110.529 -179.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.8 pt -104.18 -175.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.751 -179.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 25.7 m -169.28 132.53 1.29 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.326 178.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.93 148.99 22.05 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -153.1 138.09 17.22 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.394 0.616 . . . . 0.0 111.172 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.594 ' CA ' ' HG ' ' A' ' 253' ' ' SER . . . -89.06 94.95 2.05 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -70.36 -6.88 38.53 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.535 -179.551 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . 0.531 ' CA ' HD22 ' A' ' 249' ' ' ASN . . . 42.62 -112.56 0.48 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.88 73.75 1.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.688 0.28 . . . . 0.0 110.317 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 31.9 t -71.27 -37.5 71.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.043 0.449 . . . . 0.0 111.613 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -129.44 79.32 74.15 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.698 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.04 110.35 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.501 2.134 . . . . 0.0 112.112 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 9.1 m -73.14 -36.07 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.76 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.629 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.1 OUTLIER -62.21 -49.35 76.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.097 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -52.51 0.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 286' ' ' THR . 2.5 t-20 -116.21 -59.69 1.95 Allowed 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -78.18 -3.61 43.44 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.438 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.75 17.9 4.25 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 292' ' ' ASN . 37.9 p-10 -61.53 -36.9 81.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.986 0.422 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 26.4 t-20 -78.73 33.32 0.21 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.947 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.456 ' H ' ' C ' ' A' ' 291' ' ' ASP . 12.1 t -135.93 124.92 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.005 0.431 . . . . 0.0 110.358 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -120.18 16.41 12.35 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.087 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -100.35 133.44 44.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.12 0.486 . . . . 0.0 110.66 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -59.96 -60.46 3.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.607 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.68 -43.26 65.45 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.978 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.93 89.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.268 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 303' ' ' LEU . 4.8 mp -75.62 -61.35 1.95 Allowed 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.324 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' LEU . 72.4 mt -42.32 -34.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.057 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -77.9 -38.72 45.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.316 178.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 299' ' ' LEU . 40.7 t -84.7 -6.99 59.38 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.005 0.431 . . . . 0.0 110.858 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 299' ' ' LEU . 92.8 mt -90.5 15.11 11.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.843 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -77.11 -53.28 1.72 Allowed Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.437 177.683 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 11.2 Cg_endo -54.25 8.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.178 1.919 . . . . 0.0 113.186 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.597 ' H ' ' C ' ' A' ' 304' ' ' ALA . 59.4 t0 -101.4 12.88 36.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.733 HH11 HD21 ' A' ' 203' ' ' ASN . 15.1 ptp180 -113.61 95.2 5.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.189 0.995 . . . . 0.0 110.224 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.551 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.4 ptp180 -156.31 128.24 7.38 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.456 -178.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.01 135.6 30.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -118.51 104.91 11.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.333 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.7 mm -77.82 115.31 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -94.66 123.79 38.31 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 123.13 0.269 . . . . 0.0 110.672 -178.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 11.5 t -125.57 115.51 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.911 -178.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -114.72 134.46 55.08 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.14 17.1 25.9 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.6 tt -103.9 148.9 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.968 0.413 . . . . 0.0 110.38 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.612 -179.774 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.233 0 CA-C-O 120.916 0.389 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.1 m -67.8 139.12 56.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.146 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.461 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 7.5 mmtt -110.47 161.69 15.43 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.666 0.746 . . . . 0.0 110.611 179.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.461 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 7.0 m-70 -148.27 119.87 8.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.017 -179.514 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -110.89 120.48 42.53 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.17 103.81 15.15 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.245 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 32.2 tp -108.67 128.78 55.15 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -81.81 130.09 34.95 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-O 121.776 0.798 . . . . 0.0 112.291 -178.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -64.99 -27.57 68.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.697 179.723 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.62 -38.48 84.89 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.849 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.25 -42.86 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.12 -79.1 0.13 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.768 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.46 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -124.56 129.5 50.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.779 -179.228 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.56 HD21 ' NZ ' ' A' ' 210' ' ' LYS . 66.0 m-80 -94.44 -74.42 0.54 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.721 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.49 -10.09 14.56 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.7 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -74.3 165.37 25.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.188 0.518 . . . . 0.0 109.919 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.04 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.825 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.09 2.52 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.927 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 63.7 p -53.03 136.27 35.57 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.903 0.383 . . . . 0.0 110.282 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 83.6 mt -82.9 136.36 34.61 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.293 0.568 . . . . 0.0 111.364 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.56 ' NZ ' HD21 ' A' ' 203' ' ' ASN . 31.2 mtmt -98.6 157.59 34.0 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.956 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -34.44 -75.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.383 2.055 . . . . 0.0 112.419 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 57.0 mp0 -48.9 -24.5 1.5 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.361 0.6 . . . . 0.0 110.225 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -70.92 -51.16 20.29 Favored Glycine 0 CA--C 1.517 0.209 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.603 178.494 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.14 -41.02 99.22 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.318 0.58 . . . . 0.0 109.465 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . 0.465 ' O ' ' NE2' ' A' ' 219' ' ' GLN . . . -54.18 -56.1 21.48 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.973 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.61 72.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.56 0.695 . . . . 0.0 110.612 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.11 -25.97 63.75 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.57 179.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -75.59 -49.84 17.35 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.881 0.848 . . . . 0.0 111.054 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 215' ' ' ALA . 0.0 OUTLIER -62.46 -44.54 96.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.421 179.58 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 42.3 tp -62.36 -40.73 97.37 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.411 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.4 t80 -51.8 -49.51 62.58 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.896 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.0 m -54.88 -51.02 67.27 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.716 -178.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -51.55 -26.5 8.72 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.424 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 43.1 mt -100.4 -17.95 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.589 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.1 t -73.79 -28.28 61.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.191 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -95.79 23.91 5.85 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.85 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.61 167.42 21.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.201 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -82.01 129.19 65.4 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 230' ' ' LYS . 53.8 Cg_endo -70.36 -18.73 34.0 Favored 'Trans proline' 0 N--CA 1.506 2.248 0 C-N-CA 122.979 2.452 . . . . 0.0 112.832 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 229' ' ' PRO . 24.6 mmtm -32.32 -52.27 0.28 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.525 -177.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 232' ' ' GLY . 58.4 m-20 -104.45 -17.48 14.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.153 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.75 50.81 0.06 OUTLIER Glycine 0 N--CA 1.471 0.982 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.8 t -118.25 108.47 15.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.819 0.343 . . . . 0.0 110.935 -178.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 15.7 t -125.93 95.61 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.285 178.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.4 120.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.245 -178.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 73.6 t -91.45 126.66 44.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.223 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 23.8 mt -109.97 140.24 44.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.886 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -122.54 130.09 7.78 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.21 117.13 29.63 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.028 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.6 p -103.8 171.31 7.43 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 242' ' ' ARG . 43.6 t0 -85.45 -176.28 6.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.726 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.514 ' H ' ' CG ' ' A' ' 241' ' ' ASP . 88.9 mtm180 -109.34 120.65 43.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.957 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 50.0 mm -120.08 14.47 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.639 0.733 . . . . 0.0 110.645 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.09 -47.81 3.39 Favored Glycine 0 C--N 1.314 -0.653 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.9 p -76.2 91.16 3.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.287 0.565 . . . . 0.0 109.712 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -45.38 -46.5 13.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.372 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.97 80.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.76 -45.9 90.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.989 0.423 . . . . 0.0 110.347 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -62.08 -40.99 97.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.098 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.05 -40.87 95.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.874 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.27 -38.77 96.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 98.3 mt -74.95 -31.2 61.43 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.931 178.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.5 t -66.49 -45.39 79.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.856 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.39 -39.54 71.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.226 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -61.59 -49.84 75.02 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.508 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.28 -51.45 67.66 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.426 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -53.95 -34.34 59.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.162 0.506 . . . . 0.0 109.922 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -71.88 -42.99 66.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.0 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.782 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 16.7 t -62.02 -35.83 79.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.179 0.99 . . . . 0.0 109.92 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.65 -54.5 22.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.341 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.44 -50.2 79.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.782 ' OD1' ' O ' ' A' ' 259' ' ' SER . 40.7 p-10 -49.57 -37.64 28.12 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.577 -177.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.656 ' N ' ' OD1' ' A' ' 262' ' ' ASP . 35.0 t80 -81.34 -33.87 32.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.377 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -22.15 66.86 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.893 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.517 ' C ' ' H ' ' A' ' 267' ' ' LYS . 87.7 mt -78.24 -52.29 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.49 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 62.0 m -49.33 -10.18 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.899 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.0 OUTLIER -77.51 -11.2 59.83 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.302 -179.398 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.8 42.32 1.58 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.67 137.66 30.91 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 117.188 0.494 . . . . 0.0 110.575 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.81 124.23 15.55 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.698 1.599 . . . . 0.0 111.755 177.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.94 -9.83 42.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.874 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -91.22 -23.95 20.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.706 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -79.81 -19.34 48.72 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.585 0.707 . . . . 0.0 110.994 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.5 pt -104.91 -171.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.532 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 47.4 t -170.82 137.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.105 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.43 150.56 22.05 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -155.68 139.79 16.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.538 0.685 . . . . 0.0 111.455 178.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -93.97 96.96 2.13 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -69.96 -4.49 20.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.875 0.369 . . . . 0.0 110.345 -179.028 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.87 -116.28 1.2 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.426 ' O ' ' OE1' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -138.21 71.0 1.39 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.764 0.316 . . . . 0.0 110.462 -179.658 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.14 5.61 49.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.276 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 283' ' ' ASN . 13.7 p-10 -159.82 74.82 3.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.75 108.32 2.25 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.424 2.083 . . . . 0.0 112.073 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.461 ' CG2' ' N ' ' A' ' 286' ' ' THR . 6.2 m -70.45 -43.03 78.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.661 ' C ' ' H ' ' A' ' 288' ' ' ASN . 65.7 p -58.83 -43.6 90.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.078 -179.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.62 -0.55 0.03 OUTLIER Glycine 0 CA--C 1.533 1.159 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.661 ' H ' ' C ' ' A' ' 286' ' ' THR . 18.9 m120 -119.86 -59.09 1.83 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -18.75 65.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.572 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.46 25.79 9.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.291 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 51.5 t0 -69.19 -10.95 60.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 110.393 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -94.89 32.58 1.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.528 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.1 t -129.92 127.26 63.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 110.237 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -117.77 8.13 12.64 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.969 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -95.36 127.81 41.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.044 0.449 . . . . 0.0 109.95 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -55.94 -50.47 70.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.516 -179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.78 96.91 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.982 -179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.25 -30.09 70.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.62 179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 303' ' ' LEU . 39.6 mt -79.18 -57.04 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.398 -179.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.7 mt -45.89 -36.52 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.948 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -74.39 -47.21 35.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.509 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 6.7 t -75.8 -4.95 43.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.278 -179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 299' ' ' LEU . 50.5 mt -96.06 13.06 28.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.529 -179.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.638 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -75.13 -46.13 4.69 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.828 0.347 . . . . 0.0 110.083 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 32.1 Cg_exo -56.41 10.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.971 2.448 . . . . 0.0 112.258 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.638 ' H ' ' C ' ' A' ' 304' ' ' ALA . 46.9 t0 -101.06 13.49 35.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.741 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.425 HH11 ' C ' ' A' ' 304' ' ' ALA . 28.9 ptt-85 -113.04 101.72 9.73 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.991 0.9 . . . . 0.0 110.86 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.565 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 20.4 ptp180 -162.02 132.31 4.83 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.24 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.6 142.25 14.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -121.58 108.11 13.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.985 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.8 mm -78.97 119.75 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . 0.442 ' OE2' ' CE1' ' A' ' 193' ' ' HIS . 28.2 tp10 -99.06 120.58 39.72 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.04 -178.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 66.8 t -126.88 119.47 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 123.578 0.549 . . . . 0.0 111.318 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -117.34 125.2 50.64 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 118.15 -18.6 11.23 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.25 144.1 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.377 179.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 18.1 tptm . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.458 -179.963 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.462 ' H ' HE21 ' A' ' 190' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.809 0.337 . . . . 0.0 110.245 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 36.5 m -70.92 142.78 51.09 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.667 179.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.453 ' CD ' ' H ' ' A' ' 193' ' ' HIS . 5.3 tmtt? -111.49 162.36 15.18 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.381 0.61 . . . . 0.0 110.715 179.668 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.453 ' H ' ' CD ' ' A' ' 192' ' ' LYS . 53.9 m80 -152.82 121.18 6.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.674 179.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.634 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 59.6 m-85 -113.07 123.29 49.93 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.53 103.59 14.53 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.597 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mt -104.69 122.34 45.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.039 0.447 . . . . 0.0 109.983 -179.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.449 ' O ' HG21 ' A' ' 200' ' ' VAL . 8.9 ptpp? -85.73 135.0 33.93 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 122.52 1.153 . . . . 0.0 111.542 -179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 202' ' ' PHE . 4.0 p -59.74 -19.59 51.11 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.679 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -51.86 -50.02 61.75 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.927 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 197' ' ' LYS . 27.2 m -70.92 -33.68 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.675 178.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 20.5 mt -86.45 -80.36 0.24 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.356 179.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -135.18 145.41 47.7 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.607 -179.146 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -112.58 -67.74 0.98 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.504 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -112.45 -16.57 12.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.574 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -68.28 167.02 15.25 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.01 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.629 ' CG ' ' H ' ' A' ' 207' ' ' ALA . 18.2 pttt -51.29 -70.29 0.09 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.628 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.629 ' H ' ' CG ' ' A' ' 206' ' ' LYS . . . -166.62 -1.18 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.331 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.9 t -52.81 137.16 32.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.897 0.38 . . . . 0.0 110.494 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 96.7 mt -80.17 144.28 33.13 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.566 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 213' ' ' GLY . 38.5 mttm -106.46 156.28 37.29 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.009 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -34.47 -76.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.713 2.275 . . . . 0.0 112.091 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -48.73 -22.16 0.74 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.052 0.453 . . . . 0.0 110.413 -179.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.15 -49.64 15.35 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 178.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.82 -39.94 91.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.26 0.552 . . . . 0.0 110.118 179.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.74 54.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.836 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.95 -37.2 86.53 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.03 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.9 mt -62.72 -30.64 71.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.867 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -71.24 -46.49 60.97 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.087 0.47 . . . . 0.0 110.379 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -63.33 -44.09 95.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.306 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 47.5 tp -63.94 -39.89 95.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.537 ' CE1' ' OG ' ' A' ' 225' ' ' SER . 3.8 t80 -54.02 -49.56 68.63 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.652 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 69.6 m -57.35 -50.56 72.58 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.366 -178.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.634 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 11.3 tt0 -52.85 -26.22 13.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.254 -179.56 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 82.6 mt -97.53 -17.83 19.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.509 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.537 ' OG ' ' CE1' ' A' ' 221' ' ' TYR . 4.8 m -78.81 -12.16 60.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.742 -179.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -104.75 22.34 15.29 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 110.325 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.42 ' H ' HD23 ' A' ' 227' ' ' LEU . 0.9 OUTLIER -76.15 177.69 6.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.242 179.614 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 315' ' ' GLY . 31.2 t0 -98.97 108.8 51.24 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 230' ' ' LYS . 75.7 Cg_exo -46.9 -19.44 0.79 Allowed 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.605 2.204 . . . . 0.0 113.023 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 229' ' ' PRO . 52.8 tptt -27.11 -52.07 0.06 Allowed 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 123.559 0.537 . . . . 0.0 111.016 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' GLY . 79.1 m-20 -109.4 -15.41 14.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.322 179.019 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.83 50.83 0.06 OUTLIER Glycine 0 C--N 1.338 0.68 0 O-C-N 123.892 0.745 . . . . 0.0 111.666 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 t -117.92 111.08 18.52 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.271 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.83 96.15 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.317 178.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.0 t -99.03 123.12 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.816 -178.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 94.8 t -97.88 126.73 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.397 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.9 mt -110.45 143.88 40.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.513 -179.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 279' ' ' MET . . . -119.41 139.55 14.23 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.3 OUTLIER -120.34 119.66 33.76 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -178.748 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.41 167.09 12.26 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.827 0.346 . . . . 0.0 110.414 -179.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.499 ' OD2' ' NE ' ' A' ' 307' ' ' ARG . 38.0 m-20 -81.21 -177.03 6.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.458 -179.023 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -105.52 125.71 51.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.33 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 50.0 mm -116.9 9.17 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.461 0.648 . . . . 0.0 110.829 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.48 10.33 85.72 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.4 m -129.59 106.38 8.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.128 0.489 . . . . 0.0 109.883 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.446 ' CG ' ' N ' ' A' ' 247' ' ' ALA . 22.1 p-10 -57.43 -53.68 55.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.912 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' A' ' 246' ' ' ASP . . . -54.63 -44.1 72.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.498 . . . . 0.0 110.458 -179.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -69.63 -41.3 75.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.994 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.529 ' ND2' ' OE2' ' A' ' 281' ' ' GLU . 18.0 t-20 -61.35 -52.49 64.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.713 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -63.88 -38.17 90.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.555 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.53 -37.36 93.21 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.4 mt -71.6 -39.06 70.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.641 0.258 . . . . 0.0 110.692 178.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 52.4 p -61.71 -40.66 95.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.984 0.421 . . . . 0.0 110.599 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -69.52 -43.59 72.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.564 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -57.32 -47.46 81.49 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.414 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.423 ' NH2' HH12 ' A' ' 307' ' ' ARG . 79.4 mtt-85 -62.99 -51.32 67.31 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.445 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.5 81.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.254 0.55 . . . . 0.0 109.874 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -72.11 -44.08 63.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.432 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 13.5 t -61.44 -38.36 86.9 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.43 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.54 -52.59 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.723 179.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 41.9 t -60.52 -48.61 87.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.964 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -46.01 -41.86 12.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.077 -179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -82.89 -30.83 28.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.08 -9.42 58.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.304 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.6 mt -86.01 -53.89 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.353 179.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 84.6 p -51.37 -6.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.689 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 265' ' ' ILE . 10.0 mmpt? -76.18 -12.52 60.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 104.43 42.17 1.92 Allowed Glycine 0 N--CA 1.459 0.21 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.1 tt -127.3 131.46 23.85 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 117.045 0.422 . . . . 0.0 110.852 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.87 125.41 17.02 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.187 1.258 . . . . 0.0 111.923 177.36 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.39 -6.32 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 179.196 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -92.88 -23.67 18.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.944 -179.3 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -80.37 -18.7 48.25 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.443 0.64 . . . . 0.0 110.957 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.7 pt -106.58 -174.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.516 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 25.8 t -171.53 134.14 0.83 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.54 152.85 18.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -159.62 147.1 16.94 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.547 0.689 . . . . 0.0 111.037 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.1 143.89 16.88 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.449 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.1 tpt -114.92 -3.65 12.67 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.616 0.246 . . . . 0.0 110.385 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.07 -100.26 0.02 OUTLIER Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.529 ' OE2' ' ND2' ' A' ' 249' ' ' ASN . 28.4 mp0 -142.11 54.25 1.46 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.705 -0.248 . . . . 0.0 110.573 179.314 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.6 m -65.59 -0.05 1.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 0.0 110.697 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 281' ' ' GLU . 48.1 t-20 -167.19 85.43 0.82 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.32 106.25 2.01 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.212 1.941 . . . . 0.0 112.599 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.6 m -94.65 -17.83 7.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 121.314 0.578 . . . . 0.0 110.645 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.574 ' HG1' ' CD2' ' A' ' 303' ' ' LEU . 19.7 p -58.02 -42.78 86.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.595 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 290' ' ' CYS . . . -48.09 -93.04 0.01 OUTLIER Glycine 0 C--O 1.225 -0.406 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 287' ' ' GLY . 57.6 t30 -28.53 -56.91 0.12 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.803 0.355 . . . . 0.0 110.432 -178.552 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 m -56.73 -45.28 82.06 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.693 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 287' ' ' GLY . 24.1 m -101.77 32.76 3.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.188 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 293' ' ' VAL . 47.5 t0 -56.21 -47.91 77.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.825 0.345 . . . . 0.0 110.605 -179.074 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 292' ' ' ASN . 58.5 t-20 -76.59 31.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.814 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 291' ' ' ASP . 10.6 t -129.48 107.34 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -119.38 14.02 12.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.738 179.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -100.23 134.09 43.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.129 0.49 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -49.81 -69.19 0.12 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.438 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.61 -38.84 60.92 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.448 0.642 . . . . 0.0 110.746 -178.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.04 -34.96 79.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 303' ' ' LEU . 16.6 mt -73.87 -56.98 4.29 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.2 mt -46.16 -29.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.425 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -83.59 -44.04 15.02 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.336 178.3 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 1.9 t -74.51 -16.71 60.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.989 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.574 ' CD2' ' HG1' ' A' ' 286' ' ' THR . 76.6 mt -82.58 25.15 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.817 0.698 . . . . 0.0 110.448 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.619 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -81.11 -38.0 0.96 Allowed Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 32.3 Cg_exo -58.54 6.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.442 2.761 . . . . 0.0 112.748 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 304' ' ' ALA . 2.8 m-20 -111.6 15.64 21.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.744 0.307 . . . . 0.0 110.513 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.499 ' NE ' ' OD2' ' A' ' 241' ' ' ASP . 96.0 mtt-85 -108.54 94.27 4.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.275 0.56 . . . . 0.0 110.16 179.098 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 8.2 ptm180 -168.56 158.35 9.38 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.001 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.64 150.87 26.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.457 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 92.4 mt-10 -121.1 106.85 11.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.405 0.622 . . . . 0.0 110.855 -178.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.5 mm -79.31 117.93 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.964 -178.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -102.87 127.36 50.09 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.6 t -132.2 122.21 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 O-C-N 124.077 0.861 . . . . 0.0 111.753 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -116.8 132.31 56.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.88 37.26 4.74 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 317' ' ' LYS . 7.2 tt -109.03 168.06 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.672 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.619 ' O ' ' O ' ' A' ' 316' ' ' ILE . 21.4 pttm . . . . . 0 CA--C 1.534 0.329 0 O-C-N 124.303 1.002 . . . . 0.0 111.987 -179.322 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 121.081 0.467 . . . . 0.0 109.925 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.423 ' CG2' ' CE1' ' A' ' 193' ' ' HIS . 6.9 m -68.47 136.34 53.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.336 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -140.06 105.59 5.1 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.58 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.423 ' CE1' ' CG2' ' A' ' 191' ' ' THR . 2.7 m80 -94.85 145.3 24.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.625 ' CE2' ' NE2' ' A' ' 223' ' ' GLN . 33.1 m-85 -111.81 123.9 51.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.43 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.547 ' HG1' HH21 ' A' ' 308' ' ' ARG . 5.6 t -84.24 103.76 13.7 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.556 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.0 tp -108.34 128.98 55.23 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.066 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -83.82 129.13 34.94 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 122.297 1.046 . . . . 0.0 112.218 -178.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 202' ' ' PHE . 15.3 m -63.91 -30.36 71.45 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.396 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.03 -41.08 74.42 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.14 -42.5 88.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.164 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 61.1 mt -79.18 -79.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.911 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -120.09 122.46 41.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.747 -179.123 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.515 ' H ' HD22 ' A' ' 205' ' ' ASN . 22.5 t-20 -87.24 -75.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -113.08 -10.71 13.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.725 HD21 ' H ' ' A' ' 205' ' ' ASN . 0.1 OUTLIER -76.25 171.29 14.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.182 179.955 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -50.0 -87.49 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.408 -178.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -154.78 5.97 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.278 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 8.7 t -54.35 141.94 28.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.254 -179.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 36.8 mt -83.1 133.98 35.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.244 0.545 . . . . 0.0 111.166 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.457 ' NZ ' ' CB ' ' A' ' 210' ' ' LYS . 6.4 mtpm? -99.14 156.73 35.14 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.064 179.001 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -34.94 -75.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.557 2.171 . . . . 0.0 112.0 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -46.32 -26.66 0.86 Allowed 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.28 0.562 . . . . 0.0 110.307 -179.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -69.03 -51.99 25.79 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -58.65 -39.73 81.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.78 -60.15 3.61 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.419 179.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.91 -25.98 68.39 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.695 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -30.4 65.09 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.513 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.93 -47.58 28.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.819 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 13.3 pt20 -63.97 -42.79 97.15 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.91 -179.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.442 ' N ' ' CG ' ' A' ' 219' ' ' GLN . 48.1 tp -59.61 -41.51 90.54 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.577 ' C ' ' H ' ' A' ' 223' ' ' GLN . 10.1 t80 -54.94 -60.61 3.13 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.154 177.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.4 m -54.44 -8.21 0.2 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.076 0.465 . . . . 0.0 110.642 -179.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.625 ' NE2' ' CE2' ' A' ' 194' ' ' PHE . 3.3 tt0 -93.51 -33.82 13.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.339 178.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 73.5 mt -97.69 -11.42 23.51 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.623 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 25.8 p -79.21 -26.23 42.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.973 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -88.03 18.88 3.92 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.024 0.44 . . . . 0.0 110.496 -179.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.12 156.84 33.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -78.77 116.71 61.81 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 232' ' ' GLY . 59.6 Cg_exo -48.92 -21.99 4.36 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.893 2.395 . . . . 0.0 113.059 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 229' ' ' PRO . 27.2 tptp -24.76 -52.35 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 123.75 0.656 . . . . 0.0 110.802 -177.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 233' ' ' SER . 72.7 m-20 -109.79 -11.49 14.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.8 179.039 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 24.73 42.86 0.01 OUTLIER Glycine 0 N--CA 1.47 0.935 0 O-C-N 123.953 0.783 . . . . 0.0 111.679 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -112.77 114.55 27.17 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 122.516 -0.402 . . . . 0.0 110.449 -178.61 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 75.4 t -129.22 93.88 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.807 0.813 . . . . 0.0 110.325 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.5 t -97.08 123.29 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.001 -179.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.2 t -95.65 122.46 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.648 179.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 75.3 mt -105.58 141.95 36.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.032 -179.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.34 127.3 6.39 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -110.25 122.77 48.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.302 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 241' ' ' ASP . 51.0 m -117.3 164.75 14.35 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.322 0.389 . . . . 0.0 110.238 -179.265 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 240' ' ' THR . 42.3 p-10 -80.95 -175.87 5.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.605 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -116.88 122.89 45.64 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 -179.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 51.8 mm -118.11 17.22 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.725 0.774 . . . . 0.0 110.808 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.28 -49.04 2.4 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 245' ' ' SER . . . . . 0.485 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 5.6 t -76.14 88.72 3.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.918 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -40.4 -43.55 1.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.729 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.4 -38.69 91.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.352 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 245' ' ' SER . 67.1 t80 -59.23 -50.28 74.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.936 -179.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 245' ' ' SER . 2.7 p-10 -64.13 -40.74 96.83 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.185 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -61.38 -45.71 93.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.59 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.18 -35.71 92.45 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.41 -40.37 73.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.006 0.431 . . . . 0.0 111.106 178.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.0 t -62.84 -39.24 93.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.515 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -68.69 -45.08 72.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.247 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.18 -44.9 88.23 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.067 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.34 -61.41 2.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.678 178.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.88 -34.04 18.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.105 0.479 . . . . 0.0 110.026 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -72.25 -44.82 62.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.449 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.4 t -58.48 -39.53 80.22 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.301 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.91 -53.44 41.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.392 178.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 4.7 t -60.96 -50.19 81.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.436 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -46.28 -41.38 13.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.206 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.51 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 60.8 t80 -80.77 -32.78 35.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.809 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.17 -32.81 74.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.21 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.568 ' C ' ' H ' ' A' ' 267' ' ' LYS . 83.8 mt -63.85 -48.27 87.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.322 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 28.2 m -51.45 -6.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.755 -179.276 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.568 ' H ' ' C ' ' A' ' 265' ' ' ILE . 33.1 mmtp -87.19 9.15 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.505 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 84.4 40.83 8.2 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.74 126.35 25.75 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.9 130.28 36.92 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.98 1.787 . . . . 0.0 112.094 177.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.17 -9.45 31.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 65.6 t0 -90.88 -23.42 20.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.529 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -79.24 -21.14 46.62 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.608 0.718 . . . . 0.0 110.526 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.5 pt -105.35 -171.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 11.9 t -169.55 130.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.176 178.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -104.45 110.17 22.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.873 0.368 . . . . 0.0 110.535 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -115.47 140.96 48.67 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.574 0.702 . . . . 0.0 111.097 -179.646 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.578 ' O ' ' NH1' ' A' ' 277' ' ' ARG . . . -90.18 93.35 1.86 Allowed Glycine 0 CA--C 1.519 0.329 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.49 ' N ' ' O ' ' A' ' 238' ' ' GLY . 3.6 tpt -71.62 0.69 8.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.085 -178.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 31.87 -100.07 0.01 OUTLIER Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -144.1 70.18 1.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.714 0.292 . . . . 0.0 110.891 179.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.6 p -64.35 -44.24 92.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.192 0.52 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -125.4 80.47 65.43 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.961 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.18 105.76 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.686 2.257 . . . . 0.0 112.669 -179.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 10.4 m -71.02 -32.83 49.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.193 0.52 . . . . 0.0 110.687 179.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.648 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.2 OUTLIER -57.23 -44.55 83.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.357 -179.218 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.84 -5.82 0.02 OUTLIER Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.648 ' H ' ' C ' ' A' ' 286' ' ' THR . 13.2 m120 -125.46 -58.51 1.42 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.9 m -58.89 -24.64 62.52 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.553 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 84.8 m -116.11 29.6 7.87 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.451 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.93 -4.28 19.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.612 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -109.87 31.48 5.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.661 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.52 121.3 45.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.969 0.414 . . . . 0.0 110.41 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -120.79 7.34 10.46 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.8 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . 0.419 ' O ' ' CD1' ' A' ' 299' ' ' LEU . 7.6 mt-30 -89.14 172.67 8.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.98 0.419 . . . . 0.0 110.014 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -84.99 -70.47 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.584 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.84 -31.62 68.67 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.89 -178.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.89 -39.93 87.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.5 mt -69.78 -48.89 57.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.015 0.436 . . . . 0.0 110.644 179.751 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 60.8 mt -49.15 -36.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.899 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.6 -40.27 29.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.117 0.484 . . . . 0.0 110.646 178.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.1 t -74.36 -10.64 59.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.988 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 299' ' ' LEU . 61.4 mt -91.89 22.59 4.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.643 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -83.21 -41.56 0.83 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.995 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 31.9 Cg_exo -55.8 10.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 123.293 2.662 . . . . 0.0 112.403 -179.07 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.63 ' H ' ' C ' ' A' ' 304' ' ' ALA . 27.5 m-20 -109.55 21.72 16.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.639 0.257 . . . . 0.0 110.849 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -114.04 84.99 2.13 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.14 0.972 . . . . 0.0 110.259 178.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.547 HH21 ' HG1' ' A' ' 195' ' ' THR . 16.4 ptm180 -156.49 128.06 7.16 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.062 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.77 139.14 19.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.466 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -119.69 104.51 10.32 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.303 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.36 116.71 23.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.312 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -96.14 122.14 38.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.819 0.342 . . . . 0.0 111.033 -178.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.0 t -129.5 122.46 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.869 179.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -118.57 144.86 45.8 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.308 178.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 92.26 22.42 29.72 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -178.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.661 ' O ' ' O ' ' A' ' 317' ' ' LYS . 10.8 tt -99.16 170.86 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.661 ' O ' ' O ' ' A' ' 316' ' ' ILE . 29.5 tttp . . . . . 0 CA--C 1.539 0.529 0 O-C-N 123.943 0.777 . . . . 0.0 110.958 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.512 ' NE2' ' H ' ' A' ' 190' ' ' GLN . 1.5 pm0 . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 120.825 0.345 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 192' ' ' LYS . 44.6 m -76.45 170.49 16.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.43 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 191' ' ' THR . 13.0 tptp -141.88 160.64 39.78 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 109.978 178.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -152.02 124.27 8.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.108 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 223' ' ' GLN . 52.1 m-85 -114.37 119.11 35.81 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.438 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.406 ' O ' ' CG2' ' A' ' 195' ' ' THR . 5.5 t -86.49 105.23 16.65 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.555 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 27.0 tp -106.74 123.4 48.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.031 0.443 . . . . 0.0 109.933 -179.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -74.53 129.34 37.56 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 122.587 1.184 . . . . 0.0 112.277 -178.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 202' ' ' PHE . 41.6 t -62.97 -40.31 97.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.173 178.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -45.75 -34.88 3.91 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.719 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.75 -56.82 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.87 -77.8 0.07 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.815 -179.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -106.03 135.7 47.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.858 -178.188 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -98.3 -78.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -117.74 -19.04 9.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.963 179.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -65.99 171.75 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.127 0.489 . . . . 0.0 110.199 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -53.79 -81.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.844 -179.231 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -157.9 58.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.51 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.0 p -106.95 131.18 54.32 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 110.056 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.4 mt -71.92 145.11 48.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.256 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.9 mtpm? -107.91 158.03 34.54 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.304 179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 213' ' ' GLY . 74.8 Cg_exo -34.91 -77.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.3 2.0 . . . . 0.0 112.01 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -48.41 -19.19 0.29 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 -179.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.88 -50.23 19.6 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 178.794 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -65.13 -38.39 90.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.145 0.498 . . . . 0.0 109.77 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.91 -53.87 53.3 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.011 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.91 -33.82 76.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.615 0.721 . . . . 0.0 110.383 -179.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.67 -25.9 65.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.603 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . 0.551 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 72.2 m-20 -72.79 -47.11 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.569 0.7 . . . . 0.0 109.9 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.35 -40.29 96.86 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.99 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.8 tp -60.37 -40.98 92.76 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.532 ' C ' ' H ' ' A' ' 223' ' ' GLN . 69.4 t80 -55.34 -58.95 5.62 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.922 178.259 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 58.8 m -57.14 -7.49 0.53 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.289 0.566 . . . . 0.0 110.216 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.639 ' NE2' ' CE1' ' A' ' 194' ' ' PHE . 5.4 tt0 -95.06 -35.54 11.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.384 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.51 -11.38 25.56 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.658 -179.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 75.8 p -85.89 -7.31 58.78 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.542 0.526 . . . . 0.0 110.579 -179.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 223' ' ' GLN . 51.2 p30 -101.35 19.23 18.15 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.311 0.577 . . . . 0.0 110.529 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 227' ' ' LEU . 0.7 OUTLIER -78.31 -177.3 5.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.136 -179.973 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -100.69 108.47 53.78 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 230' ' ' LYS . 72.5 Cg_exo -45.62 -21.39 0.84 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.673 2.249 . . . . 0.0 112.897 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 229' ' ' PRO . 88.0 tttt -34.47 -52.07 0.48 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 110.546 -178.15 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 232' ' ' GLY . 25.6 m-20 -98.54 -20.01 17.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.762 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 28.32 52.4 0.11 Allowed Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 59.7 m -118.93 115.17 23.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.557 0.217 . . . . 0.0 111.107 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 72.8 t -133.48 92.26 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.794 0.807 . . . . 0.0 110.195 178.43 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.11 127.62 51.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.279 0.561 . . . . 0.0 110.61 -178.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 91.3 t -100.63 126.42 54.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.399 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.8 mt -111.94 131.64 55.26 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.469 -178.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -86.08 138.37 15.96 Favored Glycine 0 N--CA 1.467 0.766 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.555 ' O ' ' NH2' ' A' ' 256' ' ' ARG . 11.4 m-85 -131.04 115.89 17.05 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 117.799 0.799 . . . . 0.0 109.431 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.402 ' HA ' HH12 ' A' ' 256' ' ' ARG . 14.8 t -126.71 172.8 10.01 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.465 -179.154 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -86.19 -175.23 5.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.432 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.404 ' H ' HD13 ' A' ' 303' ' ' LEU . 60.6 ttp180 -102.3 124.48 47.95 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.245 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.495 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 47.7 mm -117.64 14.42 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.456 0.646 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 71.8 5.06 60.18 Favored Glycine 0 C--N 1.317 -0.493 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 5.3 t -124.68 105.29 9.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.862 0.363 . . . . 0.0 110.199 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -57.11 -55.22 37.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.195 -179.075 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.77 -46.02 78.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.38 -42.0 98.8 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.886 -179.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.79 -44.87 96.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.642 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -65.28 -39.64 92.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.19 -42.49 99.8 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.92 -41.81 86.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.006 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.533 ' HG ' ' H ' ' A' ' 280' ' ' GLY . 6.5 t -66.2 -48.36 70.88 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.118 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.25 -52.21 66.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.589 -179.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -55.5 -47.31 76.38 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.273 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.668 HH22 ' N ' ' A' ' 308' ' ' ARG . 66.3 mtp180 -58.29 -59.31 5.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.162 179.158 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -50.59 -32.62 19.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.121 0.486 . . . . 0.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -73.12 -49.7 26.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.986 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 44.6 t -53.42 -41.29 65.88 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.153 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.65 -54.88 23.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.603 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.4 t -57.64 -50.42 77.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.212 -179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -46.33 -42.84 15.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.914 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -81.55 -31.14 32.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.592 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.05 -7.96 50.09 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.274 -179.195 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.603 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.2 mt -86.51 -55.69 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 120.84 0.352 . . . . 0.0 111.408 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.7 t -49.78 -6.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.909 -178.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.603 ' H ' ' C ' ' A' ' 265' ' ' ILE . 22.9 mmmt -76.98 -11.38 59.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.08 39.71 1.93 Allowed Glycine 0 CA--C 1.509 -0.291 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.86 133.02 24.66 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.241 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.64 128.88 32.13 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.833 1.689 . . . . 0.0 112.174 176.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.73 -9.31 42.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.986 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.23 -21.32 21.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.774 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -82.54 -20.12 37.27 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.426 0.631 . . . . 0.0 110.893 -179.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 234' ' ' VAL . 1.6 pt -103.76 -172.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.118 -178.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 27.9 t -168.81 143.09 3.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.297 178.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -115.72 113.78 23.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.806 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -127.22 150.93 49.31 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.929 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -105.37 100.58 1.74 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 3.4 tpp -70.03 -13.04 62.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.066 0.46 . . . . 0.0 110.155 -179.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . 0.533 ' H ' ' HG ' ' A' ' 253' ' ' SER . . . 63.46 -103.23 0.64 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -141.89 74.12 1.44 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.84 0.353 . . . . 0.0 110.587 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 84.8 p -95.58 2.23 54.13 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.7 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.6 70.52 3.73 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.553 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.94 105.6 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.406 2.071 . . . . 0.0 112.291 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 14.7 m -69.58 -31.94 50.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.46 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.611 ' C ' ' H ' ' A' ' 288' ' ' ASN . 41.7 p -57.35 -43.96 83.9 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.736 -179.243 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . 0.593 ' N ' ' HG1' ' A' ' 286' ' ' THR . . . -45.62 -7.93 0.01 OUTLIER Glycine 0 CA--C 1.534 1.222 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.298 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.9 t30 -126.84 -56.57 1.36 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.918 0.389 . . . . 0.0 110.137 178.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.3 m -55.23 -40.4 70.83 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.281 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 72.1 m -98.6 36.44 1.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.421 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -74.56 -2.48 26.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.498 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.06 31.67 5.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.497 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.1 t -132.05 123.76 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.526 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -119.39 4.43 11.21 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.208 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -99.64 136.21 39.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.157 0.503 . . . . 0.0 110.095 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -51.43 -76.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.774 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -46.0 -39.17 8.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 -178.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.29 88.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.959 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.69 -43.54 79.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.566 179.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.4 mm -58.08 -37.21 60.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.783 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -74.01 -35.65 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.082 179.126 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.1 t -81.77 -3.2 53.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.416 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.404 HD13 ' H ' ' A' ' 242' ' ' ARG . 0.5 OUTLIER -94.18 22.33 6.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.235 -179.485 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.61 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -82.65 -41.82 0.91 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.602 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.8 Cg_exo -60.03 10.09 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.294 2.662 . . . . 0.0 112.099 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 304' ' ' ALA . 57.9 t0 -115.12 18.89 16.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.958 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -109.01 107.18 17.44 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.377 0.608 . . . . 0.0 110.345 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.668 ' N ' HH22 ' A' ' 256' ' ' ARG . 18.0 ptp180 -171.86 -173.74 1.21 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.984 -179.186 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.35 153.65 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.496 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 95.7 mt-10 -124.64 102.53 7.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.317 0.579 . . . . 0.0 110.801 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.4 mm -81.58 120.34 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.14 -179.162 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -104.92 119.87 40.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.798 0.332 . . . . 0.0 110.426 -178.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.6 t -130.43 124.76 58.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.59 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -118.83 148.19 43.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.56 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.88 4.4 57.83 Favored Glycine 0 N--CA 1.462 0.43 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 16.0 tt -91.55 141.79 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.206 0.527 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 19.0 tptp . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.794 -179.396 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.919 0.39 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 24.3 m -78.11 127.12 31.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.2 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -146.71 116.45 7.19 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.467 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . 0.5 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 2.2 m-70 -101.18 147.72 25.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -109.77 128.53 55.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.911 0.386 . . . . 0.0 110.302 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.94 103.24 15.13 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.98 -179.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 24.8 tp -107.96 129.04 55.14 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 109.955 -179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -80.9 126.57 31.52 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 121.905 0.86 . . . . 0.0 112.033 -178.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.5 t -65.27 -28.08 69.09 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.066 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -62.92 -37.94 88.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.034 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.96 -44.36 92.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.56 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.75 -78.75 0.11 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.289 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.28 118.67 30.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.031 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -94.62 -78.3 0.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.702 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -88.47 -26.94 21.81 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.765 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -69.79 158.43 35.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.153 0.501 . . . . 0.0 110.381 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -51.42 -71.47 0.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.221 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -159.77 56.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.428 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 38.5 p -108.08 133.04 52.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.821 0.343 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.06 138.61 39.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 -179.133 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.8 mtpm? -101.49 157.47 33.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.302 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 210' ' ' LYS . 76.0 Cg_exo -33.22 -75.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.598 2.199 . . . . 0.0 111.969 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -49.61 -23.4 1.67 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.18 0.514 . . . . 0.0 110.328 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.94 -48.73 19.6 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -66.61 -38.74 87.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.14 0.495 . . . . 0.0 110.012 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.84 -53.06 62.46 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.444 -179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.75 88.53 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.635 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.0 mt -62.53 -27.6 69.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.487 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . 0.524 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 51.3 m-20 -73.81 -46.45 45.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.219 0.533 . . . . 0.0 110.535 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.62 -42.89 99.85 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.174 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 42.9 tp -66.37 -38.96 88.74 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.436 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.2 t80 -53.78 -50.72 65.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.123 179.379 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 225' ' ' SER . 75.9 p -60.15 -49.75 76.41 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.378 -178.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -49.57 -25.89 3.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.184 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 64.7 mt -97.19 -13.45 22.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.364 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' SER . 36.9 t -72.86 -21.57 60.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.698 179.511 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -99.91 16.79 22.68 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.74 150.69 36.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.138 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 315' ' ' GLY . 6.7 t0 -67.12 124.13 88.1 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.468 178.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 230' ' ' LYS . 44.5 Cg_endo -69.15 -19.67 38.75 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.79 2.327 . . . . 0.0 112.846 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 229' ' ' PRO . 63.4 tttp -30.09 -52.42 0.15 Allowed 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.682 0.614 . . . . 0.0 110.457 -178.386 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.485 ' O ' ' OG ' ' A' ' 233' ' ' SER . 20.6 m-20 -103.28 -18.25 14.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.485 178.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.478 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.75 47.33 0.03 OUTLIER Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 231' ' ' ASP . 0.4 OUTLIER -112.59 111.25 21.93 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.146 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.56 94.42 2.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.311 0.577 . . . . 0.0 109.895 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.2 t -96.47 122.65 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.237 -178.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 t -95.68 119.7 44.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.642 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 47.4 mt -103.76 147.38 27.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.049 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.85 133.13 8.15 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.636 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.4 OUTLIER -116.54 119.84 36.84 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.504 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.441 ' O ' ' OD1' ' A' ' 306' ' ' ASP . 3.3 p -106.92 168.15 9.39 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 120.772 0.32 . . . . 0.0 110.344 -179.445 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -81.85 179.93 7.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.525 -179.666 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -99.6 119.44 38.08 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.862 0.363 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 49.4 mm -121.4 6.18 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.404 0.621 . . . . 0.0 111.058 179.358 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.41 -47.65 3.66 Favored Glycine 0 C--N 1.314 -0.666 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.2 p -73.7 90.08 1.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 109.887 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 91.7 m-20 -43.0 -46.55 5.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.676 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.6 83.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -61.08 -49.31 77.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 246' ' ' ASP . 0.2 OUTLIER -63.22 -42.75 99.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.584 -179.741 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -63.71 -46.13 86.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.723 -179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.39 -35.03 90.39 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.5 -37.53 65.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.887 0.375 . . . . 0.0 111.129 178.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 253' ' ' SER . . . . . 0.412 ' OG ' ' OG1' ' A' ' 240' ' ' THR . 20.8 m -64.12 -40.95 97.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.747 -179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 258' ' ' GLN . 96.9 mt-10 -71.7 -41.39 68.66 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.189 179.595 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -59.52 -48.3 82.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.524 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -63.26 -60.38 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.961 179.254 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -52.1 -36.62 51.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.551 HE21 ' C ' ' A' ' 258' ' ' GLN . 0.6 OUTLIER -70.84 -42.72 69.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.218 179.665 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.3 t -63.02 -36.77 84.67 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.357 0.599 . . . . 0.0 110.272 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.27 -50.19 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.552 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.6 t -60.88 -49.43 84.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.29 179.27 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . 0.549 ' OD2' ' NE2' ' A' ' 258' ' ' GLN . 7.9 m-20 -45.7 -39.81 8.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.9 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -83.2 -32.31 26.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.1 -11.11 60.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.488 -179.287 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.585 ' C ' ' H ' ' A' ' 267' ' ' LYS . 64.6 mt -86.11 -53.14 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-O 120.723 0.297 . . . . 0.0 110.925 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.4 m -50.34 -6.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.585 ' H ' ' C ' ' A' ' 265' ' ' ILE . 22.9 mmmt -80.58 -12.06 59.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.862 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.75 40.41 1.87 Allowed Glycine 0 CA--C 1.51 -0.221 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.446 HG23 HD13 ' A' ' 269' ' ' ILE . 0.4 OUTLIER -126.25 129.16 24.27 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.854 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.86 128.17 27.62 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.958 1.772 . . . . 0.0 112.04 176.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.02 -8.97 18.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.799 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.32 -23.23 21.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.772 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -80.31 -20.08 45.12 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.38 0.609 . . . . 0.0 110.487 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -105.62 -173.36 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.795 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 27.3 t -172.4 129.76 0.57 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 179.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.39 153.72 17.66 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.019 -0.425 . . . . 0.0 109.859 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -162.31 151.56 15.62 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 178.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -127.56 97.65 0.47 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.636 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 10.5 ptm -85.99 26.8 0.96 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.847 0.356 . . . . 0.0 110.984 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.3 -107.37 0.1 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.82 73.44 1.4 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.683 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.1 t -76.28 -33.72 59.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.108 0.48 . . . . 0.0 111.216 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -124.39 66.37 44.06 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 -179.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.14 117.71 5.12 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.626 2.218 . . . . 0.0 111.506 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 15.0 m -70.8 -38.5 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.701 179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 288' ' ' ASN . 2.8 p -61.43 -47.15 87.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.559 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.07 -3.4 0.05 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.619 ' H ' ' C ' ' A' ' 286' ' ' THR . 89.3 m-20 -114.29 -60.97 1.81 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.018 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.8 t -77.69 -3.07 39.23 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.558 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 286' ' ' THR . 0.5 OUTLIER -126.97 18.51 7.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.607 -179.911 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 36.7 p-10 -68.55 -2.98 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.503 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 292' ' ' ASN . 19.7 p30 -101.06 32.6 3.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.514 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.2 t -130.77 124.33 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.764 0.316 . . . . 0.0 110.437 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -120.21 9.62 11.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.879 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.39 131.24 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.134 0.492 . . . . 0.0 110.064 -179.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -50.55 -68.61 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.076 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.97 -38.7 57.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.53 -36.55 82.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.445 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 303' ' ' LEU . 28.0 mt -72.54 -55.01 7.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.474 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 68.5 mt -50.96 -35.4 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.005 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.11 -31.98 58.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.593 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.49 -5.06 56.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.4 mm? -94.23 19.66 9.1 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.289 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.576 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.43 -45.78 1.34 Allowed Pre-proline 0 CA--C 1.536 0.424 0 CA-C-O 121.051 0.453 . . . . 0.0 110.184 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 25.7 Cg_exo -60.97 9.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.134 2.556 . . . . 0.0 111.969 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 304' ' ' ALA . 8.1 t70 -106.0 14.12 28.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.874 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 307' ' ' ARG . 15.6 ptt180 -110.28 99.01 8.12 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.921 0.867 . . . . 0.0 110.346 179.214 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.537 ' NH1' ' OE2' ' A' ' 310' ' ' GLU . 43.7 ptt85 -166.03 139.09 4.13 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.398 -179.219 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.02 145.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.537 ' OE2' ' NH1' ' A' ' 308' ' ' ARG . 78.6 mt-10 -118.71 104.03 10.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.31 0.576 . . . . 0.0 110.865 178.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 193' ' ' HIS . 0.4 OUTLIER -80.12 113.4 19.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.11 -178.953 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -92.11 123.27 35.34 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 123.525 0.516 . . . . 0.0 110.738 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.14 115.32 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 O-C-N 123.528 0.518 . . . . 0.0 110.875 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -114.7 126.58 55.02 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.52 39.61 3.39 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.719 ' O ' ' O ' ' A' ' 317' ' ' LYS . 6.3 tt -110.97 164.74 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.719 ' O ' ' O ' ' A' ' 316' ' ' ILE . 20.5 pttp . . . . . 0 C--O 1.219 -0.501 0 O-C-N 124.273 0.983 . . . . 0.0 111.319 -178.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 24.3 m -79.06 125.6 29.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.829 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -144.45 112.73 6.47 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.71 0.291 . . . . 0.0 110.555 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -99.4 144.41 28.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -106.89 129.79 54.66 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.87 0.367 . . . . 0.0 110.204 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.14 105.38 17.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.931 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 34.3 tp -110.16 129.63 55.68 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -80.74 127.92 33.05 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 122.036 0.922 . . . . 0.0 112.437 -178.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 202' ' ' PHE . 68.6 p -63.31 -31.79 73.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.091 179.489 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.456 ' OD1' ' ND2' ' A' ' 203' ' ' ASN . 22.0 t70 -59.75 -37.46 79.06 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.181 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.23 -44.41 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 84.3 mt -77.6 -77.53 0.15 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.461 179.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -118.51 125.42 49.83 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.637 -179.754 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.456 ' ND2' ' OD1' ' A' ' 199' ' ' ASP . 7.2 m120 -94.37 -80.25 0.4 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.767 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -103.31 -17.71 15.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.695 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -70.54 169.66 13.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.998 0.427 . . . . 0.0 110.086 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -53.15 -78.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.267 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.36 59.11 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.552 179.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.7 p -108.79 135.3 50.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.048 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.1 135.57 39.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.874 -178.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 213' ' ' GLY . 4.4 mtmp? -96.57 159.97 30.56 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.815 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -34.05 -76.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.417 2.078 . . . . 0.0 111.78 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 31.6 mp0 -50.02 -20.18 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.242 0.544 . . . . 0.0 110.214 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.59 -47.87 14.65 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.368 178.669 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -67.86 -40.04 83.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.255 0.55 . . . . 0.0 110.066 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.54 65.24 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.696 -179.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.03 -35.68 81.05 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.62 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.0 -32.99 73.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.548 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . 0.535 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 4.4 m-20 -70.97 -44.83 65.19 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.501 0.667 . . . . 0.0 110.405 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.443 ' O ' ' OG ' ' A' ' 222' ' ' SER . 12.6 mt-30 -61.19 -44.0 97.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.085 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 41.4 tp -64.43 -40.37 95.63 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.379 178.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.409 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.9 t80 -51.79 -48.83 63.65 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.31 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 219' ' ' GLN . 59.5 p -55.04 -51.67 65.59 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.58 -178.239 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -51.99 -26.76 11.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.423 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 15.6 mt -97.11 -20.31 18.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.717 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.7 p -74.5 -22.59 58.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.759 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -102.72 19.72 18.66 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.893 -179.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.9 143.15 41.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.929 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 315' ' ' GLY . 47.2 t0 -52.4 108.19 1.02 Allowed Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 123.37 0.419 . . . . 0.0 110.434 178.056 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.3 Cg_exo -51.8 -24.5 18.53 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.737 2.291 . . . . 0.0 113.043 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 230' ' ' LYS . . . . . 0.513 ' CB ' ' HZ3' ' A' ' 230' ' ' LYS . 7.5 ttpm? -30.25 -53.16 0.16 Allowed 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 123.568 0.543 . . . . 0.0 110.951 -177.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 232' ' ' GLY . 38.9 m-20 -102.43 -17.65 15.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.751 179.009 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.17 46.35 0.02 OUTLIER Glycine 0 N--CA 1.475 1.259 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 231' ' ' ASP . 38.1 m -112.72 110.39 20.48 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.672 0.272 . . . . 0.0 110.928 -178.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 76.6 t -127.56 94.09 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.481 0.658 . . . . 0.0 109.959 178.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.0 t -96.4 123.07 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.107 -178.117 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 87.4 t -92.54 120.21 41.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.442 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 57.1 mt -104.35 144.35 31.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.961 -179.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.16 130.27 7.28 Favored Glycine 0 N--CA 1.482 1.723 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.871 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.4 OUTLIER -114.91 125.43 53.63 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.83 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 43.0 p -120.92 166.93 13.12 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 109.933 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -80.84 -175.12 5.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.417 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -113.72 122.88 48.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.198 0.523 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 47.6 mm -120.06 14.73 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.719 0.771 . . . . 0.0 110.633 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.29 -47.46 3.31 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 20.7 m -73.19 89.66 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.114 0.483 . . . . 0.0 110.006 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 246' ' ' ASP . . . . . 0.547 ' O ' ' NE2' ' A' ' 250' ' ' GLN . 98.9 m-20 -44.36 -46.17 9.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.365 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.81 86.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.629 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -60.33 -44.59 95.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.54 -179.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -62.46 -43.47 98.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.562 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 246' ' ' ASP . 0.9 OUTLIER -65.69 -41.95 91.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.513 -179.991 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.86 95.91 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 39.1 mt -70.25 -39.41 75.01 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.065 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 3.7 t -63.21 -42.78 99.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 0.0 110.605 -178.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -69.33 -35.43 75.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.36 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.4 tpp85 -60.66 -54.3 47.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.672 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.477 ' O ' ' CG2' ' A' ' 260' ' ' VAL . 16.4 ptp180 -64.42 -44.6 90.68 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 120.95 0.405 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.7 -39.2 90.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.46 0.647 . . . . 0.0 110.303 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -74.99 -43.87 51.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.266 179.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 6.9 t -61.98 -38.43 88.57 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.29 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 256' ' ' ARG . 94.4 t -64.75 -50.98 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.622 178.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 14.4 t -61.29 -49.1 85.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.298 179.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -46.48 -40.8 13.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.079 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 263' ' ' TYR . . . . . 0.622 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 67.0 t80 -81.71 -33.9 30.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -28.95 69.81 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.208 -179.521 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 267' ' ' LYS . 81.6 mt -67.18 -52.22 45.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.273 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.4 p -49.65 -7.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 -179.108 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.622 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 66.3 mmtt -79.97 -5.63 56.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.711 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 97.09 42.3 3.3 Favored Glycine 0 CA--C 1.508 -0.373 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 130.83 23.89 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.321 179.075 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.35 128.34 28.83 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.781 1.654 . . . . 0.0 112.104 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -63.12 -11.0 16.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -88.68 -26.3 21.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.679 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -24.59 58.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.386 0.612 . . . . 0.0 110.457 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -101.83 -176.79 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.857 -179.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 16.3 m -169.21 126.67 0.95 Allowed 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.653 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -94.93 151.11 19.48 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -155.89 142.17 18.41 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.377 0.608 . . . . 0.0 111.179 179.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -93.08 93.16 1.72 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 239' ' ' TYR . 5.0 tpt -70.49 -3.89 20.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.674 0.273 . . . . 0.0 110.65 -179.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.06 -116.32 0.85 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -135.87 70.47 1.42 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.604 -0.351 . . . . 0.0 110.526 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.7 m -77.58 -40.08 43.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.306 0.574 . . . . 0.0 111.477 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -124.58 62.37 32.7 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.659 -178.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.59 112.75 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.801 2.334 . . . . 0.0 111.364 179.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 32.1 m -71.37 -39.51 71.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.891 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 288' ' ' ASN . 51.4 p -63.61 -48.27 78.02 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.779 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.77 -2.01 0.05 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 288' ' ' ASN . . . . . 0.619 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.1 t30 -113.55 -60.41 1.89 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.704 0.288 . . . . 0.0 110.308 179.005 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -80.43 -2.76 47.09 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.73 -179.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 290' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 286' ' ' THR . 0.5 OUTLIER -126.88 17.53 7.33 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.889 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 32.8 p-10 -69.82 -3.28 14.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.977 0.418 . . . . 0.0 110.506 -179.594 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -99.75 32.06 3.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.429 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.87 127.36 52.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.954 0.407 . . . . 0.0 110.357 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -118.75 13.42 13.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.063 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 295' ' ' GLN . . . . . 0.602 HE22 ' CZ ' ' A' ' 296' ' ' ARG . 8.8 mm-40 -105.92 137.64 43.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.587 0.708 . . . . 0.0 110.248 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 296' ' ' ARG . . . . . 0.602 ' CZ ' HE22 ' A' ' 295' ' ' GLN . 0.0 OUTLIER -61.15 -54.59 42.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.468 179.954 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.62 85.83 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.016 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.18 -33.31 75.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.557 179.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 303' ' ' LEU . 33.4 mt -82.48 -61.67 1.83 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.496 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 296' ' ' ARG . 45.0 mt -42.83 -34.47 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.63 -44.26 19.15 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.124 0.488 . . . . 0.0 110.318 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 44.2 t -74.88 -8.18 55.71 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.978 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 299' ' ' LEU . 73.9 mt -92.98 17.86 10.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.732 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.573 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -79.24 -45.56 1.68 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.336 179.711 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 305' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.5 Cg_exo -59.63 8.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.085 2.523 . . . . 0.0 111.821 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 304' ' ' ALA . 49.6 m-20 -103.87 12.04 34.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 307' ' ' ARG . . . . . 0.42 ' O ' ' OG ' ' A' ' 198' ' ' SER . 98.9 mtt180 -114.45 94.63 4.88 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.606 0.717 . . . . 0.0 110.176 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . 0.417 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 39.4 ptt180 -154.38 131.46 11.0 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.694 0.759 . . . . 0.0 112.295 -179.018 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.49 134.49 32.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.046 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -116.74 104.63 11.54 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.305 0.574 . . . . 0.0 110.295 -179.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.5 mm -78.96 114.04 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -92.17 122.21 34.44 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 123.532 0.52 . . . . 0.0 110.488 -179.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.23 114.83 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.549 -179.309 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -113.9 127.07 55.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.0 39.88 3.44 Favored Glycine 0 N--CA 1.461 0.347 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . 0.696 ' O ' ' O ' ' A' ' 317' ' ' LYS . 11.1 tt -117.09 172.67 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 317' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 316' ' ' ILE . 8.9 mtmp? . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 122.121 0.962 . . . . 0.0 111.376 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.24 152.44 66.84 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.547 2.165 . . . . 0.0 112.107 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.476 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -171.14 51.38 0.16 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.488 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 41.0 Cg_endo -66.6 -58.2 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.767 2.311 . . . . 0.0 111.967 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 178.97 74.62 0.15 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.337 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -54.04 120.94 8.75 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.372 2.048 . . . . 0.0 112.185 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.503 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -96.55 -47.25 0.24 Allowed Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.266 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 72.4 Cg_endo -80.46 153.93 21.0 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.209 1.939 . . . . 0.0 112.361 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 190' ' ' GLN . 96.8 mt-10 -69.71 131.38 44.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.321 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 t -67.1 146.68 13.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.334 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 188' ' ' GLU . 15.6 mp0 -102.03 82.66 2.26 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.819 0.342 . . . . 0.0 110.688 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.4 m -80.23 129.11 34.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.638 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -129.06 99.55 5.31 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.739 0.781 . . . . 0.0 111.741 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -83.71 127.7 33.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.054 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.645 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 55.4 m-85 -112.26 124.15 51.83 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.09 104.03 15.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.842 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.1 tp -105.7 123.59 48.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.04 130.47 35.55 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-O 122.1 0.952 . . . . 0.0 112.327 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.654 ' HG ' ' NH2' ' A' ' 256' ' ' ARG . 39.4 m -61.25 -31.44 71.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.2 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -57.96 -40.44 80.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.85 -43.55 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 84.6 mt -79.77 -77.93 0.17 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.526 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER -137.38 131.63 32.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.413 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -107.43 -64.93 1.15 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.28 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.69 -20.51 16.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.545 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.35 159.71 33.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.988 0.423 . . . . 0.0 110.209 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -53.65 -66.74 0.34 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.571 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.07 -2.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.087 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 40.8 p -53.17 135.99 36.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.034 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 54.2 mt -82.02 137.73 35.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.854 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.8 mtpm? -97.79 157.75 34.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.811 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 213' ' ' GLY . 84.6 Cg_exo -34.1 -76.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.597 2.198 . . . . 0.0 112.486 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.72 -19.17 0.58 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.043 0.449 . . . . 0.0 110.3 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.1 -51.73 9.83 Favored Glycine 0 N--CA 1.459 0.229 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -65.39 -40.57 93.61 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.204 0.526 . . . . 0.0 109.846 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.99 -54.75 41.06 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.018 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.25 86.68 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.615 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.34 -30.09 70.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.217 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.13 -46.56 56.07 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.848 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -62.33 -44.15 97.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.237 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.78 -38.07 89.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.544 ' CE1' ' OG ' ' A' ' 225' ' ' SER . 3.2 t80 -54.2 -50.84 66.16 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.066 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.8 t -55.78 -51.0 68.92 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.393 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.645 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 12.4 tt0 -52.64 -25.01 9.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.0 -18.78 17.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.656 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.544 ' OG ' ' CE1' ' A' ' 221' ' ' TYR . 1.3 m -77.42 -30.77 53.62 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.575 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -87.18 25.0 1.44 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 110.298 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.419 ' H ' HD22 ' A' ' 227' ' ' LEU . 0.8 OUTLIER -79.04 -179.14 6.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.811 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 1.6 t70 -100.93 133.47 21.04 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.75 -19.31 47.43 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.259 1.973 . . . . 0.0 112.744 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -37.15 -52.96 1.03 Allowed 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 110.511 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' GLY . 52.9 m-20 -98.3 -21.16 16.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 24.94 45.98 0.02 OUTLIER Glycine 0 C--N 1.343 0.96 0 O-C-N 123.744 0.653 . . . . 0.0 111.725 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 231' ' ' ASP . 5.2 m -119.44 114.29 22.09 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.032 0.444 . . . . 0.0 110.879 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 43.0 t -130.19 95.76 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.529 0.68 . . . . 0.0 109.977 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.76 122.77 49.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.345 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 83.0 t -95.63 125.41 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 41.7 mt -109.7 141.89 41.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.126 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -122.12 129.6 7.67 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -113.33 119.49 37.86 Favored 'General case' 0 C--N 1.349 0.574 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 31.1 p -109.97 168.96 9.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.84 0.352 . . . . 0.0 110.758 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.458 ' OD2' ' NH2' ' A' ' 307' ' ' ARG . 44.5 p-10 -90.69 -178.39 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -100.94 124.57 46.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.333 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.463 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 50.1 mm -117.7 12.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.414 0.626 . . . . 0.0 110.745 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.15 6.1 88.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -136.48 96.71 3.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.517 . . . . 0.0 109.729 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -52.22 -50.04 62.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.432 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.69 77.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.619 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -64.21 -43.84 93.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -61.19 -42.83 99.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.467 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.21 -40.11 95.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.377 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.35 -38.94 96.54 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 81.9 mt -73.56 -34.54 65.21 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.88 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 85.6 p -64.29 -40.25 95.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.129 0.49 . . . . 0.0 110.741 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.43 -39.84 62.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.314 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -61.25 -51.71 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.251 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.654 ' NH2' ' HG ' ' A' ' 198' ' ' SER . 8.5 ptm180 -64.05 -46.06 86.03 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.306 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.479 ' N ' ' CG ' ' A' ' 256' ' ' ARG . . . -56.74 -36.49 69.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.399 0.619 . . . . 0.0 109.703 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.75 -44.29 61.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.805 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.9 m -59.1 -39.81 83.38 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.254 0.55 . . . . 0.0 110.134 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.46 -51.73 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.922 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.4 -48.69 87.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.456 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -48.14 -41.46 26.78 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.95 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -78.74 -35.53 44.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.577 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -31.01 72.04 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.897 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.537 ' C ' ' H ' ' A' ' 267' ' ' LYS . 80.8 mt -65.49 -51.62 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 88.5 p -51.82 -8.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.789 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.537 ' H ' ' C ' ' A' ' 265' ' ' ILE . 67.8 mmtt -79.49 -4.45 51.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.541 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.34 41.75 2.92 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.86 127.64 23.92 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 117.031 0.416 . . . . 0.0 110.208 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.31 128.36 25.22 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.609 1.539 . . . . 0.0 111.84 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.07 -8.71 17.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -93.58 -22.9 18.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.191 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -79.86 -17.11 54.03 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.72 0.772 . . . . 0.0 111.032 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.0 pt -107.93 -170.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.463 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 3.2 m -166.86 131.76 2.09 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.224 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -103.1 111.67 24.14 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.768 0.318 . . . . 0.0 110.546 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 30.8 ttm105 -119.79 141.24 49.67 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.71 0.767 . . . . 0.0 111.566 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -92.46 95.27 2.0 Allowed Glycine 0 CA--C 1.519 0.342 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 238' ' ' GLY . 2.7 tpt -68.11 -10.64 55.55 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.223 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 40.58 -98.73 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -141.59 75.37 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 0.0 110.81 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 70.8 m -83.63 -5.62 59.23 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.61 79.2 0.91 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.313 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.71 104.29 0.26 Allowed 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.568 2.179 . . . . 0.0 112.959 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.2 m -75.31 -32.79 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.337 0.589 . . . . 0.0 110.344 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.689 ' C ' ' H ' ' A' ' 288' ' ' ASN . 44.4 p -56.94 -42.59 80.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.793 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.6 -0.3 0.02 OUTLIER Glycine 0 CA--C 1.532 1.124 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.689 ' H ' ' C ' ' A' ' 286' ' ' THR . 17.2 t-20 -122.74 -58.87 1.65 Allowed 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.9 -17.59 64.97 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.542 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 302' ' ' CYS . 72.1 m -116.78 25.6 10.43 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.384 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 293' ' ' VAL . 34.5 t70 -57.88 -49.92 75.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.0 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -76.19 32.41 0.12 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.316 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 291' ' ' ASP . 2.8 t -131.24 104.57 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.655 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -118.97 13.77 13.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . 0.401 ' OE1' ' CA ' ' A' ' 295' ' ' GLN . 0.0 OUTLIER -100.23 139.98 35.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.92 0.39 . . . . 0.0 110.101 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -50.48 -70.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.184 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.92 -39.05 68.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.545 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.36 80.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.261 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 303' ' ' LEU . 26.0 mt -72.65 -53.38 11.95 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.891 0.377 . . . . 0.0 110.815 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 69.4 mt -53.16 -35.14 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 0.0 109.905 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -76.18 -40.38 52.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.192 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.513 ' O ' ' SG ' ' A' ' 290' ' ' CYS . 5.5 t -82.48 -8.78 59.61 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.957 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 299' ' ' LEU . 34.8 mt -91.06 21.4 4.28 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.836 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.622 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.44 -40.3 1.22 Allowed Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.397 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 36.6 Cg_exo -59.14 7.96 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 123.707 2.938 . . . . 0.0 112.719 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 304' ' ' ALA . 5.3 m-20 -111.12 14.46 21.84 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.458 ' NH2' ' OD2' ' A' ' 241' ' ' ASP . 98.5 mtt180 -111.32 90.5 3.35 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.214 0.53 . . . . 0.0 109.75 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.0 ptp180 -162.81 132.63 4.4 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.47 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.15 142.3 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -118.83 106.71 12.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.208 0.527 . . . . 0.0 110.234 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.6 mm -80.05 118.2 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -102.74 102.28 12.43 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.62 0.248 . . . . 0.0 110.874 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 59.8 t -114.85 122.81 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.958 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -120.03 153.31 36.22 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.196 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 89.97 12.4 62.08 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 7.8 tt -95.17 135.64 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.155 0.502 . . . . 0.0 110.712 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -107.81 153.69 22.63 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.298 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -153.37 166.54 32.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.354 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 320' ' ' VAL . 13.2 p -73.35 164.64 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.364 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.413 ' N ' ' CG2' ' A' ' 319' ' ' VAL . 25.0 t -62.77 129.53 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.946 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 5.3 p -84.89 138.0 32.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.962 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -91.16 131.08 37.83 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.862 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 324' ' ' GLN . 50.4 Cg_exo -49.01 136.18 29.34 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.608 1.539 . . . . 0.0 112.328 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 323' ' ' PRO . 7.3 tt0 43.48 99.25 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.729 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.49 179.945 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.449 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 36.2 Cg_endo -63.92 -31.3 67.24 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.73 2.287 . . . . 0.0 112.02 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 176.32 55.84 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.503 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.19 -65.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.792 2.328 . . . . 0.0 112.11 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.428 ' CB ' ' CD ' ' A' ' 185' ' ' PRO . . . -79.4 -62.05 0.45 Allowed Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.451 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 184' ' ' ALA . 28.9 Cg_endo -60.25 144.64 99.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.158 1.905 . . . . 0.0 111.514 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 188' ' ' GLU . . . -121.37 95.9 48.16 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.002 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -47.78 76.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 122.605 2.204 . . . . 0.0 112.383 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.594 ' N ' ' O ' ' A' ' 186' ' ' ALA . 90.0 mt-10 -153.1 120.78 6.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.3 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 98.3 t -130.19 131.95 65.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.234 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.58 112.15 16.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.262 0.553 . . . . 0.0 110.385 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.1 m -69.15 137.2 53.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.487 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 5.5 tptp -112.27 166.37 11.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.322 0.582 . . . . 0.0 110.605 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.412 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 96.6 m-70 -154.74 121.4 5.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.114 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.447 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 68.7 m-85 -108.48 121.05 44.16 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.9 104.08 15.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.497 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 33.8 tp -107.92 127.88 54.13 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -80.95 127.89 33.07 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.61 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.505 ' OG ' ' NH1' ' A' ' 256' ' ' ARG . 1.2 t -63.44 -31.79 73.05 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.024 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.456 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 9.7 t70 -57.16 -41.06 78.49 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.941 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.52 -43.73 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.69 -79.15 0.09 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.44 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -123.65 140.01 53.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.05 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.554 HD21 ' NZ ' ' A' ' 210' ' ' LYS . 52.8 m-80 -109.38 -76.65 0.61 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.383 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.596 ' CE1' ' ND2' ' A' ' 205' ' ' ASN . 53.3 p90 -96.54 -12.68 23.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.622 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 204' ' ' PHE . 30.1 m120 -75.96 160.7 29.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 110.204 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -55.46 -62.02 1.95 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.51 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.517 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.61 1.15 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.128 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.42 134.24 45.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.18 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.33 144.28 34.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.135 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.554 ' NZ ' HD21 ' A' ' 203' ' ' ASN . 21.9 mtmt -104.87 157.54 33.98 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.816 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -34.32 -76.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.5 2.133 . . . . 0.0 112.311 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.423 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 51.6 mp0 -49.75 -20.8 0.91 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.052 0.453 . . . . 0.0 110.316 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.6 -51.01 17.69 Favored Glycine 0 CA--C 1.518 0.232 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -65.34 -40.92 94.26 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.073 0.463 . . . . 0.0 109.763 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.1 -53.94 49.54 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.037 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.23 -38.45 91.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.798 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.76 -27.66 68.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.234 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -73.3 -46.27 50.57 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.381 0.61 . . . . 0.0 110.801 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -62.17 -42.15 98.99 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.096 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.9 -37.41 84.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.031 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.41 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.3 t80 -54.45 -49.49 69.92 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.822 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 225' ' ' SER . 45.9 t -59.84 -49.27 78.37 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.782 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 1.1 tm0? -50.08 -24.09 2.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.421 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 62.7 mt -97.34 -14.13 21.47 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 222' ' ' SER . 94.2 p -78.26 -22.32 48.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.766 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -94.62 18.08 12.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.996 0.427 . . . . 0.0 110.446 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.72 168.76 19.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.137 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.75 132.99 40.65 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 230' ' ' LYS . 56.4 Cg_endo -71.18 -17.56 31.23 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.777 2.318 . . . . 0.0 112.561 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 229' ' ' PRO . 79.9 tttt -32.59 -51.09 0.27 Allowed 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.797 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 232' ' ' GLY . 47.0 m-20 -108.41 -18.08 13.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.263 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.6 51.33 0.06 OUTLIER Glycine 0 N--CA 1.471 1.006 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.0 m -118.02 108.62 15.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 111.159 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.68 96.51 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.31 120.07 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.657 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 92.8 t -92.34 124.81 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.435 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 28.1 mt -109.11 143.64 38.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.016 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.33 130.47 7.54 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -115.32 116.8 28.89 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.439 ' HG1' HH21 ' A' ' 256' ' ' ARG . 69.8 m -104.08 160.58 14.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.643 0.259 . . . . 0.0 110.449 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -89.61 177.81 6.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.69 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.576 ' NE ' ' H ' ' A' ' 244' ' ' GLY . 1.0 OUTLIER -88.74 127.67 35.6 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.477 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 47.0 mm -118.34 9.71 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.248 0.547 . . . . 0.0 110.895 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.576 ' H ' ' NE ' ' A' ' 242' ' ' ARG . . . 102.43 -26.0 25.71 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -118.7 115.27 24.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.173 0.511 . . . . 0.0 110.26 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 246' ' ' ASP . 24.0 p-10 -60.15 -53.1 61.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.861 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.72 -38.93 70.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.299 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -63.0 -44.1 96.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.292 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -62.36 -40.23 95.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.348 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.79 -44.07 97.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.06 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.18 -36.33 93.29 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 36.5 mt -71.71 -37.14 70.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.336 . . . . 0.0 111.027 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.584 ' HG ' ' CA ' ' A' ' 278' ' ' GLY . 35.1 t -64.4 -41.29 96.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.942 0.401 . . . . 0.0 110.652 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.42 -47.76 72.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -59.07 -43.44 91.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.759 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.505 ' NH1' ' OG ' ' A' ' 198' ' ' SER . 0.0 OUTLIER -52.94 -64.17 0.91 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -56.6 -37.08 70.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.459 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.21 -46.83 87.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.655 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 75.7 m -60.66 -38.26 84.28 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.255 0.55 . . . . 0.0 110.439 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 96.0 t -63.98 -51.91 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.999 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 62.6 t -62.11 -49.03 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -45.39 -42.14 9.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.177 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.626 ' HH ' ' HZ1' ' A' ' 267' ' ' LYS . 54.8 t80 -82.04 -29.94 31.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.72 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.72 -8.59 56.11 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.726 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 267' ' ' LYS . 69.2 mt -87.23 -55.87 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.812 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 93.7 p -50.05 -5.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.07 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.626 ' HZ1' ' HH ' ' A' ' 263' ' ' TYR . 71.2 mmtt -77.23 -10.99 59.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.546 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.95 -7.93 23.51 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -80.94 129.84 65.96 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.338 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.44 131.17 39.34 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.75 1.634 . . . . 0.0 111.549 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.91 -8.21 34.83 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 111.251 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 25.9 p30 -94.89 -19.66 20.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.618 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 0.9 OUTLIER -80.87 -21.22 40.87 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.496 0.665 . . . . 0.0 110.636 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.3 pt -104.82 -170.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.589 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 14.9 t -170.94 132.96 0.88 Allowed 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.368 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.87 150.93 20.18 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.845 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 -160.99 150.25 16.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.202 0.525 . . . . 0.0 110.968 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.584 ' CA ' ' HG ' ' A' ' 253' ' ' SER . . . -104.44 145.65 16.06 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.506 ' N ' ' O ' ' A' ' 238' ' ' GLY . 85.6 mmm -120.64 2.71 10.67 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 121.967 0.107 . . . . 0.0 110.831 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 38.33 -97.89 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 279' ' ' MET . 6.9 pt-20 -142.03 68.89 1.32 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.656 0.265 . . . . 0.0 110.462 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 98.5 p -89.3 -2.67 58.54 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -154.14 65.52 5.1 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.515 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.7 107.61 2.51 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.56 2.173 . . . . 0.0 112.363 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 31.5 m -73.09 -29.08 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.521 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 288' ' ' ASN . 40.3 p -58.92 -46.15 88.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.569 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -49.6 -2.93 0.02 OUTLIER Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.626 ' H ' ' C ' ' A' ' 286' ' ' THR . 97.9 m-20 -119.98 -58.66 1.86 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.77 -3.61 51.57 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . 0.473 ' N ' ' O ' ' A' ' 286' ' ' THR . 0.5 OUTLIER -130.7 15.52 5.36 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.851 0.357 . . . . 0.0 110.155 179.395 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -65.9 -2.47 3.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.98 0.419 . . . . 0.0 110.304 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 290' ' ' CYS . 20.1 p-10 -109.9 31.71 5.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.86 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.416 ' CG2' ' SG ' ' A' ' 290' ' ' CYS . 20.8 t -130.25 121.33 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 110.33 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -119.32 12.19 12.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.702 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.96 130.59 45.33 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.088 0.47 . . . . 0.0 109.815 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -51.99 -64.85 0.68 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.937 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.21 -37.55 64.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.638 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.39 84.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.646 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 303' ' ' LEU . 17.4 mt -72.81 -47.86 42.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.004 0.43 . . . . 0.0 110.78 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.5 mt -60.47 -32.83 52.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.433 . . . . 0.0 110.262 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -82.92 -27.25 30.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.712 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 40.5 t -90.8 -20.37 22.42 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.761 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 299' ' ' LEU . 60.8 mt -85.71 24.96 1.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.528 0.517 . . . . 0.0 111.145 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.58 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -76.48 -44.09 3.32 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 22.4 Cg_exo -62.76 9.35 0.1 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.276 2.651 . . . . 0.0 112.084 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 304' ' ' ALA . 8.2 t70 -104.46 10.73 35.1 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.877 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.489 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 7.9 ptm180 -111.9 97.82 6.95 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.539 0.685 . . . . 0.0 109.965 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.543 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.6 ptm180 -159.0 132.3 7.24 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.333 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.63 141.11 16.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -121.35 106.2 11.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.072 0.463 . . . . 0.0 110.53 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.7 mm -78.55 117.48 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -97.49 132.0 43.59 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.23 118.43 32.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.255 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -115.89 134.55 54.87 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.83 -5.12 56.45 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 18.7 tt -79.91 147.17 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.953 0.406 . . . . 0.0 110.524 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -110.78 150.14 29.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.235 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -111.3 120.54 42.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.707 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.74 136.83 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.296 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.55 129.08 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.198 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 57.1 p -144.85 160.01 41.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.276 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -120.98 83.21 37.27 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.154 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.7 149.82 18.55 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.655 2.237 . . . . 0.0 112.15 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -83.37 -13.62 54.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.318 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.564 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.17 -37.66 59.2 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.526 2.151 . . . . 0.0 112.054 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 62.83 71.09 0.7 Allowed Pre-proline 0 C--O 1.232 0.153 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.82 152.25 46.86 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.312 2.008 . . . . 0.0 112.146 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.12 70.13 2.6 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.924 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.54 -16.92 30.44 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.345 2.03 . . . . 0.0 111.965 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -133.45 152.04 78.5 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.864 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -47.43 -48.97 14.04 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.239 1.959 . . . . 0.0 112.487 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -171.89 -114.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.963 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 69.8 t -126.29 135.45 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.25 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.45 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 1.2 pm0 -118.73 121.2 39.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.627 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.3 m -75.11 137.88 41.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.696 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.494 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 13.5 tptt -111.26 166.86 10.74 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.487 0.661 . . . . 0.0 110.558 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.494 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 5.4 m80 -150.55 120.38 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.775 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -110.45 119.53 39.48 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 104.9 16.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.45 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 24.6 tp -107.96 122.82 47.6 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -78.62 130.4 35.86 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.909 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 202' ' ' PHE . 90.3 p -61.45 -29.36 69.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.105 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -60.27 -38.21 82.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.921 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.7 t -67.82 -42.97 86.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.0 mt -79.94 -78.15 0.17 Allowed 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.453 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER -135.39 127.03 28.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.501 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -102.33 -68.4 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.039 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -91.12 -22.69 20.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.552 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -69.22 161.22 29.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.912 0.387 . . . . 0.0 109.967 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -63.02 -57.28 11.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.44 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -165.92 -7.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.947 0.403 . . . . 0.0 110.206 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 69.4 p -52.46 131.22 33.39 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.262 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.8 mt -77.51 144.5 37.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.483 0.659 . . . . 0.0 111.211 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.9 mtpt -105.2 157.29 34.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.141 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 213' ' ' GLY . 89.3 Cg_exo -34.52 -76.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.762 2.308 . . . . 0.0 112.413 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -48.2 -20.37 0.37 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.099 0.476 . . . . 0.0 110.328 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.16 -48.51 19.42 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.389 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -65.62 -40.76 92.92 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.2 -52.34 65.73 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.076 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.88 85.45 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 121.56 0.695 . . . . 0.0 110.397 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 mt -65.62 -28.84 69.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.009 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -72.01 -47.85 48.94 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.371 0.605 . . . . 0.0 110.981 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.425 ' O ' ' OG ' ' A' ' 222' ' ' SER . 6.5 pt20 -62.51 -42.03 99.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.868 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.2 tp -64.91 -40.35 94.93 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -52.3 -47.27 66.02 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.813 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 219' ' ' GLN . 75.0 p -55.94 -51.27 68.25 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.796 -178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -52.28 -25.64 9.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 42.8 mt -99.15 -20.88 16.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.677 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 6.8 t -72.75 -24.34 60.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -102.79 23.73 11.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.66 147.62 39.34 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 315' ' ' GLY . 25.8 t0 -62.95 112.07 6.08 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 230' ' ' LYS . 50.7 Cg_exo -53.67 -20.89 17.92 Favored 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.517 2.145 . . . . 0.0 113.181 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 229' ' ' PRO . 11.2 mmmt -29.79 -52.54 0.14 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.952 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' GLY . 34.0 m-20 -105.98 -17.18 14.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.388 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 27.86 49.33 0.07 OUTLIER Glycine 0 N--CA 1.465 0.58 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.347 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.96 108.08 15.35 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.9 96.61 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.712 0.768 . . . . 0.0 110.018 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.8 t -96.19 117.78 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.291 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 88.2 t -95.26 121.4 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.033 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 24.6 mt -108.76 141.8 40.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.986 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.48 126.84 6.2 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.34 122.05 46.84 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.495 ' OG1' ' NH1' ' A' ' 256' ' ' ARG . 55.2 m -109.49 166.11 11.14 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.414 0.446 . . . . 0.0 110.613 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.524 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 40.1 p-10 -90.44 173.3 8.17 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.118 0.485 . . . . 0.0 111.17 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.41 ' NH2' ' OE2' ' A' ' 281' ' ' GLU . 64.0 ttm-85 -92.61 126.53 37.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.166 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.474 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 50.1 mm -118.32 15.15 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.231 0.538 . . . . 0.0 110.442 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 86.07 -1.86 87.69 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.659 ' HG ' ' H ' ' A' ' 248' ' ' TYR . 11.8 t -131.44 105.92 7.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.156 0.503 . . . . 0.0 110.179 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 247' ' ' ALA . 22.0 p-10 -55.54 -51.5 66.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.613 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 246' ' ' ASP . . . -55.54 -39.61 70.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.659 ' H ' ' HG ' ' A' ' 245' ' ' SER . 29.1 t80 -65.02 -43.46 92.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.204 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 17.6 t-20 -61.87 -43.15 99.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -65.74 -41.77 91.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.81 -39.52 98.09 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.404 ' CD1' ' CE2' ' A' ' 248' ' ' TYR . 27.4 mt -72.8 -35.93 67.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.501 -0.349 . . . . 0.0 110.594 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 39.5 t -62.96 -42.69 99.9 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.89 -46.88 79.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.895 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -55.92 -45.25 78.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.495 ' NH1' ' OG1' ' A' ' 240' ' ' THR . 28.8 ttm105 -55.29 -65.87 0.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.826 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.09 64.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.47 -48.4 64.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.612 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 77.6 p -57.7 -39.39 77.08 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.117 0.484 . . . . 0.0 110.404 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.32 -54.01 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.432 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.6 t -60.11 -49.12 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.954 -0.299 . . . . 0.0 110.492 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.09 -44.17 31.45 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.656 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.624 ' CE1' ' NZ ' ' A' ' 267' ' ' LYS . 90.3 t80 -78.39 -34.9 47.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.831 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.41 -25.97 68.23 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.094 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.473 ' C ' ' H ' ' A' ' 267' ' ' LYS . 86.6 mt -71.33 -52.46 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.777 0.322 . . . . 0.0 111.708 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 6.2 t -50.04 -10.92 0.06 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.48 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.624 ' NZ ' ' CE1' ' A' ' 263' ' ' TYR . 0.1 OUTLIER -77.81 -10.81 59.74 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.204 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 105.99 41.87 1.75 Allowed Glycine 0 CA--C 1.533 1.172 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.79 131.49 24.02 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-N 117.193 0.496 . . . . 0.0 110.79 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.46 125.26 17.18 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.553 1.502 . . . . 0.0 111.48 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.01 -8.39 29.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.135 0.493 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -91.2 -22.93 20.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.334 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -81.37 -20.22 41.01 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.465 0.65 . . . . 0.0 111.167 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.9 pt -103.71 -173.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.435 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 17.4 p -168.62 129.26 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.511 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.09 111.49 23.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.948 0.404 . . . . 0.0 110.583 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -120.72 146.46 46.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.464 0.65 . . . . 0.0 111.062 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.51 142.46 16.16 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.405 ' N ' ' O ' ' A' ' 238' ' ' GLY . 1.6 mmt -118.92 -5.87 10.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.92 -104.28 0.05 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.41 ' OE2' ' NH2' ' A' ' 242' ' ' ARG . 9.4 pt-20 -142.26 68.7 1.32 Allowed 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.859 -0.201 . . . . 0.0 110.789 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 74.3 m -67.09 -42.06 85.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.614 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.406 ' ND2' HH21 ' A' ' 308' ' ' ARG . 6.9 p-10 -125.66 80.54 66.3 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.105 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.87 106.67 0.66 Allowed 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.714 2.276 . . . . 0.0 112.543 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 12.5 m -75.81 -30.76 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.132 0.491 . . . . 0.0 110.414 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.677 ' C ' ' H ' ' A' ' 288' ' ' ASN . 60.4 p -56.69 -43.16 80.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.664 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.13 0.52 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.677 ' H ' ' C ' ' A' ' 286' ' ' THR . 24.1 t-20 -123.2 -58.53 1.63 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.22 -14.33 62.91 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.503 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 57.2 m -128.53 22.28 5.98 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.301 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -69.77 -2.49 12.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.697 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -110.24 32.09 5.41 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.535 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 23.3 t -130.93 124.02 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.99 0.424 . . . . 0.0 110.299 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -118.95 7.9 11.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.385 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -90.27 169.44 11.11 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -82.9 -71.18 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.683 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -57.88 -28.13 63.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.951 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.74 94.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.357 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 303' ' ' LEU . 47.6 mt -70.86 -49.11 49.61 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 110.534 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.4 mt -54.89 -31.67 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -80.25 -32.68 38.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.476 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -12.18 46.82 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.721 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 299' ' ' LEU . 48.5 mt -90.47 21.92 3.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.761 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.586 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -78.48 -43.26 2.01 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.98 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.5 Cg_exo -61.78 8.55 0.1 Allowed 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 123.409 2.739 . . . . 0.0 112.044 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.545 ' H ' ' C ' ' A' ' 304' ' ' ALA . 50.6 t0 -102.49 12.2 36.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.457 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -113.98 98.48 7.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.445 0.64 . . . . 0.0 109.838 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.552 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 33.5 ptt180 -157.73 130.9 7.62 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.306 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.5 140.06 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -120.84 105.83 11.08 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.362 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.0 mm -79.33 117.64 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.68 127.75 41.98 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.77 115.56 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.196 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -114.83 125.8 54.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 91.15 43.74 4.6 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.605 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.5 tt -114.83 168.61 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.605 ' O ' ' O ' ' A' ' 316' ' ' ILE . 0.1 OUTLIER -48.52 -147.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 O-C-N 124.07 0.857 . . . . 0.0 110.868 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.415 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 6.9 m-20 -154.55 101.3 2.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.219 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 62.9 t -116.23 131.46 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 92.7 t -80.09 130.1 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.13 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.543 ' HG1' ' N ' ' A' ' 322' ' ' GLN . 1.0 OUTLIER -86.68 161.09 18.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.285 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . 0.543 ' N ' ' HG1' ' A' ' 321' ' ' THR . 1.8 pt20 -142.21 84.26 11.67 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.176 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.73 -33.74 71.41 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.668 2.245 . . . . 0.0 112.06 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -49.57 -21.22 0.93 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.71 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.514 179.693 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.562 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 23.0 Cg_endo -59.03 -41.3 62.75 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.959 2.439 . . . . 0.0 112.127 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 178.45 61.68 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.333 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.86 90.09 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.619 2.213 . . . . 0.0 111.868 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 185' ' ' PRO . . . -172.59 75.35 0.44 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 184' ' ' ALA . 50.0 Cg_exo -51.17 -171.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.65 2.234 . . . . 0.0 111.773 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -133.03 72.56 76.47 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.275 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 188' ' ' GLU . 61.6 Cg_endo -77.13 174.65 12.47 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.717 2.278 . . . . 0.0 111.846 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 187' ' ' PRO . 79.7 mm-40 56.03 160.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.348 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 60.5 t -128.45 135.29 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.439 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 1.6 pm0 -122.4 128.36 50.84 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.384 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.3 m -85.17 142.07 29.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.193 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -143.45 111.42 6.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.562 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.4 OUTLIER -97.96 148.28 23.63 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -112.07 130.36 55.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.913 0.387 . . . . 0.0 110.303 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.23 103.7 16.02 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.045 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 28.7 tp -108.47 128.37 54.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.178 0.513 . . . . 0.0 109.648 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -81.7 125.14 30.24 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.994 0.902 . . . . 0.0 112.16 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.669 ' HG ' ' NH2' ' A' ' 256' ' ' ARG . 18.5 m -61.05 -32.14 71.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.196 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -59.66 -36.72 76.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.34 -42.96 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 76.3 mt -78.9 -78.33 0.15 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.322 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.68 128.1 41.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.966 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.418 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 62.0 t-20 -111.93 -71.48 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.438 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -84.34 -32.32 24.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -73.73 165.89 24.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.196 0.522 . . . . 0.0 110.245 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.642 ' C ' HH22 ' A' ' 255' ' ' ARG . 32.6 mmtp -58.94 -82.41 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.457 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.484 ' N ' HH12 ' A' ' 255' ' ' ARG . . . -148.65 56.55 1.03 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 73.4 p -107.54 130.2 54.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.131 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 40.6 mt -78.04 134.97 37.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.732 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.4 mtmt -97.06 159.21 31.92 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.917 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 210' ' ' LYS . 88.8 Cg_exo -34.63 -76.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.235 1.957 . . . . 0.0 111.875 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.22 -22.13 0.96 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.101 0.477 . . . . 0.0 110.244 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.53 -52.0 14.35 Favored Glycine 0 N--CA 1.46 0.276 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -64.99 -39.56 93.66 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.323 0.583 . . . . 0.0 109.908 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.75 -54.66 43.76 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.153 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.6 -36.0 82.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.984 0.421 . . . . 0.0 110.678 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.3 mt -61.56 -31.66 71.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.152 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.67 -45.51 58.51 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.279 0.562 . . . . 0.0 110.616 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -61.52 -44.98 96.09 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.808 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 38.3 tp -63.65 -40.6 97.27 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.262 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.545 ' CZ ' ' OG ' ' A' ' 225' ' ' SER . 6.5 t80 -51.54 -48.35 63.06 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.985 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.7 t -54.25 -52.11 62.38 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.55 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -51.56 -26.66 9.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.4 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 21.7 mt -98.35 -19.0 18.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.545 ' OG ' ' CZ ' ' A' ' 221' ' ' TYR . 4.7 m -71.68 -32.91 68.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -96.96 21.68 9.37 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.07 151.49 38.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.794 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 315' ' ' GLY . 15.6 t0 -65.39 124.6 87.54 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.128 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 232' ' ' GLY . 48.0 Cg_endo -69.16 -19.73 38.59 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 122.894 2.396 . . . . 0.0 113.313 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 229' ' ' PRO . 39.0 ttmt -24.12 -50.06 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.576 0 O-C-N 123.62 0.575 . . . . 0.0 111.037 -177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.472 ' O ' ' C ' ' A' ' 232' ' ' GLY . 32.5 t70 -115.44 -12.9 11.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.212 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 25.66 49.93 0.04 OUTLIER Glycine 0 N--CA 1.472 1.095 0 O-C-N 123.861 0.725 . . . . 0.0 111.456 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.5 t -112.03 114.13 26.83 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 122.574 -0.368 . . . . 0.0 110.352 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.6 t -129.05 95.91 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.266 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 275' ' ' SER . 2.8 t -96.74 123.98 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.097 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.75 120.94 46.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.823 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 40.8 mt -103.74 145.38 30.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.167 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.68 129.04 7.34 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 1.0 OUTLIER -110.53 125.77 53.69 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.544 ' OG1' ' ND2' ' A' ' 249' ' ' ASN . 3.1 p -116.78 162.82 17.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.535 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 7.0 p30 -84.75 172.09 11.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -88.74 122.53 32.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.425 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 47.7 mm -118.06 7.94 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.293 0.568 . . . . 0.0 110.617 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 82.33 13.98 77.53 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -142.08 92.15 2.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.107 0.479 . . . . 0.0 109.943 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -49.25 -49.69 42.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.508 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.24 78.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.409 ' CE2' ' CD1' ' A' ' 252' ' ' LEU . 40.3 t80 -65.18 -43.2 92.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.062 0.458 . . . . 0.0 110.637 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.544 ' ND2' ' OG1' ' A' ' 240' ' ' THR . 27.4 t-20 -61.49 -43.4 98.94 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.634 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.52 -45.05 92.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.638 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.11 92.1 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.656 ' CD2' HH21 ' A' ' 255' ' ' ARG . 18.0 mt -64.69 -43.66 92.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.998 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 33.3 m -66.83 -43.69 83.09 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.885 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.58 -57.21 13.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.475 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.656 HH21 ' CD2' ' A' ' 252' ' ' LEU . 36.5 ptt85 -59.11 -45.16 91.58 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.156 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.669 ' NH2' ' HG ' ' A' ' 198' ' ' SER . 19.2 mtp-105 -58.16 -50.58 73.03 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.535 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.38 69.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.84 -40.39 72.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.137 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 256' ' ' ARG . 76.4 p -63.43 -37.86 88.93 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.192 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.48 -51.1 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.491 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.4 t -61.23 -49.56 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.2 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -45.94 -38.8 8.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.93 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.497 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 63.6 t80 -84.9 -31.68 23.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.49 -13.5 62.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.446 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 267' ' ' LYS . 66.5 mt -83.89 -52.15 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 111.148 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 9.0 t -50.49 -6.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.59 ' H ' ' C ' ' A' ' 265' ' ' ILE . 73.7 mmtt -79.63 -10.67 59.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.616 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 104.55 40.72 2.15 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.68 127.86 24.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.87 128.03 25.2 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.822 1.681 . . . . 0.0 111.811 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.07 -11.65 15.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.008 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.36 -26.07 21.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.774 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -74.51 -22.81 58.87 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.909 0.861 . . . . 0.0 110.659 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -104.14 -172.8 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.547 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 235' ' ' VAL . 13.3 t -170.24 124.8 0.74 Allowed 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.396 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.72 156.97 16.81 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.801 -0.562 . . . . 0.0 109.795 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -174.1 166.84 4.23 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 122.009 0.909 . . . . 0.0 110.855 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.22 146.03 16.02 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.341 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 4.3 tpt -116.0 -10.97 11.51 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.914 0.388 . . . . 0.0 110.291 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 53.7 -111.23 1.77 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -141.76 72.26 1.38 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.879 0.371 . . . . 0.0 110.403 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.1 t -62.23 -42.06 98.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.113 0.482 . . . . 0.0 111.369 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -129.07 79.16 75.03 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.43 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -54.66 107.97 0.26 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.452 2.101 . . . . 0.0 112.113 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.3 m -65.75 -44.99 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.632 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.662 ' C ' ' H ' ' A' ' 288' ' ' ASN . 67.5 p -60.6 -43.68 97.15 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.813 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.37 -6.88 0.01 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.662 ' H ' ' C ' ' A' ' 286' ' ' THR . 29.7 m-80 -130.47 -56.02 1.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.116 0.566 . . . . 0.0 109.675 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 m -64.47 -30.46 71.49 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.918 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 22.37 10.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.957 0.408 . . . . 0.0 110.453 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 45.7 t0 -63.46 -10.97 19.98 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.612 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -98.87 32.17 2.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.743 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 40.0 t -128.04 124.98 63.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.1 0.476 . . . . 0.0 110.196 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -119.13 11.01 12.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -100.07 130.26 46.21 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.411 0.624 . . . . 0.0 110.201 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 299' ' ' LEU . 7.9 ttm180 -52.61 -76.24 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.55 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -41.91 -38.35 1.54 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.11 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.85 94.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.104 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 296' ' ' ARG . 35.5 mt -72.2 -41.48 66.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.575 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.4 mm -57.65 -31.48 39.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.11 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -86.84 -43.9 12.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.51 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.75 -19.93 65.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.985 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.46 25.43 1.68 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.459 0.474 . . . . 0.0 111.255 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.57 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -77.2 -43.6 2.69 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.924 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 18.8 Cg_exo -64.73 7.96 0.23 Allowed 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.472 2.781 . . . . 0.0 111.511 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 304' ' ' ALA . 10.0 m-20 -103.29 7.74 38.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.02 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.418 ' NH1' ' OD1' ' A' ' 203' ' ' ASN . 64.7 mtm180 -112.61 94.75 5.06 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.236 0.541 . . . . 0.0 110.2 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 39.5 ptt180 -164.46 136.73 4.7 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.535 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.44 143.9 11.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.61 -0.681 . . . . 0.0 109.562 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -117.69 103.78 10.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 193' ' ' HIS . 0.3 OUTLIER -80.98 113.37 20.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.211 -178.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -92.84 119.32 32.05 Favored 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 123.374 0.421 . . . . 0.0 110.73 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.25 117.32 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.807 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -113.98 128.63 56.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 98.15 40.83 3.4 Favored Glycine 0 C--O 1.226 -0.366 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.664 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.1 tt -116.94 170.03 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.664 ' O ' ' O ' ' A' ' 316' ' ' ILE . 51.8 mtpt -43.44 -156.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.074 0.859 . . . . 0.0 111.357 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -75.65 173.26 11.29 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.554 -0.716 . . . . 0.0 110.713 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.49 133.38 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.089 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.58 134.91 27.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.428 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.4 m -52.8 139.89 25.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.951 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -134.39 132.4 20.94 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -48.92 139.51 25.3 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.123 1.882 . . . . 0.0 112.352 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.442 ' CD ' ' N ' ' A' ' 324' ' ' GLN . 22.6 mp0 -83.73 -16.73 43.76 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.507 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.555 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.502 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 36.5 Cg_endo -63.81 -28.89 67.96 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.923 2.415 . . . . 0.0 111.955 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.25 72.25 0.45 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.477 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -53.57 93.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.753 2.302 . . . . 0.0 111.964 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.438 ' N ' ' CD ' ' A' ' 185' ' ' PRO . . . -170.5 53.93 0.22 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.348 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 184' ' ' ALA . 56.8 Cg_endo -69.73 155.78 65.14 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.662 2.242 . . . . 0.0 111.487 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -135.5 126.43 17.15 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.359 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -47.02 -47.31 16.96 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.137 1.891 . . . . 0.0 112.532 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 39.83 59.56 1.87 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 94.4 t -88.03 105.7 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.469 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -108.54 126.69 53.21 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.9 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 36.0 m -69.19 135.19 50.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.425 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 0.1 OUTLIER -115.38 169.44 9.15 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.411 0.624 . . . . 0.0 110.72 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 94.8 m-70 -155.68 125.44 6.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.081 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.534 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 66.3 m-85 -112.54 117.64 32.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.88 104.82 15.89 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.989 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 29.6 tp -108.47 130.82 55.25 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -79.39 128.44 33.34 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.948 0.88 . . . . 0.0 111.877 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 202' ' ' PHE . 18.0 t -64.06 -31.93 73.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.088 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -58.92 -37.28 76.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.979 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 91.6 t -66.81 -43.87 89.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.31 -77.73 0.16 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.947 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -126.0 129.55 49.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.716 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -101.35 -74.44 0.62 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.34 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.609 ' CE2' ' ND2' ' A' ' 205' ' ' ASN . 54.7 p90 -99.09 -21.67 16.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.932 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.609 ' ND2' ' CE2' ' A' ' 204' ' ' PHE . 32.9 m120 -72.77 164.67 26.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.272 0.558 . . . . 0.0 110.057 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.41 ' HG3' ' H ' ' A' ' 207' ' ' ALA . 5.3 pttm -49.56 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.198 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.41 ' H ' ' HG3' ' A' ' 206' ' ' LYS . . . -156.43 58.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.255 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.04 131.62 53.89 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.5 mt -75.21 139.35 42.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.747 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.2 mtpm? -98.44 158.72 32.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.708 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 213' ' ' GLY . 81.8 Cg_exo -34.01 -76.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.558 2.172 . . . . 0.0 112.013 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -50.9 -18.44 0.76 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.126 0.488 . . . . 0.0 110.162 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.72 -47.89 11.22 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -66.98 -40.27 87.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.34 70.19 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.24 83.41 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.411 0.624 . . . . 0.0 110.485 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.82 -30.92 71.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.063 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.49 -47.34 56.08 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.134 0.493 . . . . 0.0 110.867 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -63.9 -42.63 97.38 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.283 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 40.4 tp -64.87 -40.68 95.51 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.1 t80 -53.44 -49.11 68.05 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.968 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.5 m -55.76 -50.57 70.05 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.348 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.534 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 10.9 tt0 -53.17 -24.18 10.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.42 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 74.3 mt -95.96 -20.02 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.583 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.2 t -73.06 -21.57 60.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.92 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -99.75 20.42 14.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.714 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.27 161.4 28.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.18 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 315' ' ' GLY . 9.5 t0 -78.75 126.94 81.66 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' LYS . 45.9 Cg_endo -68.82 -17.27 41.99 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.718 2.279 . . . . 0.0 113.051 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 229' ' ' PRO . 14.4 mmtp -27.62 -46.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.74 0.65 . . . . 0.0 110.964 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.476 ' O ' ' C ' ' A' ' 232' ' ' GLY . 9.6 m-20 -117.89 -14.92 10.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.36 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.21 51.64 0.06 OUTLIER Glycine 0 N--CA 1.474 1.182 0 O-C-N 123.985 0.803 . . . . 0.0 111.346 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 73.6 m -116.63 111.97 20.61 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 122.788 -0.242 . . . . 0.0 110.791 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.3 t -126.71 96.47 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.019 0.438 . . . . 0.0 110.075 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.15 121.18 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.446 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.54 125.85 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.982 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 23.4 mt -109.08 143.96 37.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.933 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -120.13 138.95 13.42 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.622 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.2 OUTLIER -121.7 117.32 26.37 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.413 ' OG1' ' OD1' ' A' ' 249' ' ' ASN . 7.7 p -112.74 164.81 12.92 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.223 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.439 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 47.6 p-10 -85.22 177.53 7.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.32 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -104.0 127.2 51.55 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.103 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 51.1 mm -118.84 19.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.444 0.64 . . . . 0.0 110.706 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.44 7.51 86.31 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.8 t -136.3 99.06 4.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.996 0.427 . . . . 0.0 110.212 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -51.5 -50.04 60.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.577 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.94 -39.54 71.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.575 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -62.14 -47.16 85.78 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.97 0.414 . . . . 0.0 110.502 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 11.1 t-20 -62.2 -41.37 98.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.636 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -64.55 -44.27 91.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 110.751 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.09 -36.03 92.34 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.36 -34.76 63.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.687 0.279 . . . . 0.0 111.365 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.473 ' OG ' ' CA ' ' A' ' 278' ' ' GLY . 12.0 t -65.01 -43.76 91.42 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.016 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -71.09 -40.13 71.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.417 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -60.11 -50.02 75.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.592 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -61.19 -53.99 49.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.747 0.308 . . . . 0.0 110.351 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -54.58 -35.49 63.39 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.164 0.507 . . . . 0.0 109.919 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -71.3 -44.33 65.37 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.258 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 17.1 m -62.02 -37.49 85.12 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.528 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.12 -51.41 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.543 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.92 -48.64 87.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.054 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -45.48 -41.08 9.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.942 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.532 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 57.4 t80 -81.42 -30.69 33.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.653 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.5 -8.53 56.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.633 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.5 mt -87.33 -55.77 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.807 0.337 . . . . 0.0 111.264 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.9 m -50.72 -4.79 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.588 ' H ' ' C ' ' A' ' 265' ' ' ILE . 30.1 mmtp -79.39 -11.0 59.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.774 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.27 39.92 2.03 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 128.57 24.09 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.5 128.46 25.96 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.595 1.53 . . . . 0.0 112.037 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.8 -6.93 13.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.787 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 6.4 p30 -94.54 -21.75 18.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.905 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 1.2 ttpm? -80.4 -21.2 42.5 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.505 0.669 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . 0.41 ' O ' ' OG ' ' A' ' 275' ' ' SER . 1.6 pt -103.89 -171.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.626 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 274' ' ' ILE . 22.0 m -171.17 129.56 0.73 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.145 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.86 152.25 18.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -161.38 148.79 14.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.361 0.601 . . . . 0.0 110.6 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.473 ' CA ' ' OG ' ' A' ' 253' ' ' SER . . . -126.12 100.46 0.58 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.622 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 8.1 ptp -88.0 24.03 1.92 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.649 0.261 . . . . 0.0 110.931 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.448 ' H ' ' HG ' ' A' ' 253' ' ' SER . . . 39.12 -93.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 279' ' ' MET . 4.5 pt-20 -140.68 74.91 1.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.826 0.346 . . . . 0.0 110.447 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.4 m -90.38 -0.73 57.77 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.466 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -153.86 56.28 1.54 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.354 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.61 109.49 1.86 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.558 2.172 . . . . 0.0 112.28 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 22.5 m -78.87 -23.94 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.436 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.7 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.6 OUTLIER -59.71 -45.06 93.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.702 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -49.95 -0.1 0.01 OUTLIER Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.7 ' H ' ' C ' ' A' ' 286' ' ' THR . 25.7 t-20 -124.72 -57.19 1.55 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.6 m -54.82 -42.52 72.0 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 8.2 m -94.22 34.78 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.287 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 41.4 t0 -74.77 -7.99 55.05 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.821 0.343 . . . . 0.0 110.792 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -106.47 30.04 6.35 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.435 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.41 126.56 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.236 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -119.88 13.73 12.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -87.6 171.54 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.073 0.463 . . . . 0.0 110.144 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -86.26 -71.1 0.56 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.605 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.57 -32.39 68.88 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.334 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.11 87.23 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.514 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 303' ' ' LEU . 7.5 mp -72.29 -48.34 43.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.917 0.389 . . . . 0.0 110.843 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 81.3 mt -45.49 -38.52 2.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -79.55 -40.78 28.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.406 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.5 t -72.7 -8.92 57.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.528 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.7 mm? -92.03 20.95 5.35 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.496 0.498 . . . . 0.0 110.305 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.648 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.02 -38.06 1.14 Allowed Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.029 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.5 Cg_exo -59.13 9.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 123.35 2.7 . . . . 0.0 112.593 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.564 ' H ' ' C ' ' A' ' 304' ' ' ALA . 33.6 p30 -114.77 15.44 17.49 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.69 0.281 . . . . 0.0 110.764 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -106.83 97.33 7.13 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.756 0.789 . . . . 0.0 110.285 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 16.6 ptm180 -171.12 157.84 5.3 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.881 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.91 148.0 21.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 87.9 mt-10 -121.06 105.91 11.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 110.753 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.44 117.28 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.201 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -97.69 122.74 41.13 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.038 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 28.6 t -124.65 117.07 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.1 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -115.39 121.63 43.36 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 103.91 40.17 2.36 Favored Glycine 0 N--CA 1.462 0.398 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.506 ' CG1' ' N ' ' A' ' 317' ' ' LYS . 12.4 tt -115.95 168.07 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 109.983 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.506 ' N ' ' CG1' ' A' ' 316' ' ' ILE . 5.0 tmtp? -126.43 138.18 53.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.495 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -158.01 170.48 22.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.511 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.27 124.68 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 8.1 p -156.86 150.24 9.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.749 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.4 p -66.91 137.0 56.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -83.79 141.72 41.54 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.884 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.03 158.48 49.5 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.448 2.098 . . . . 0.0 112.081 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -84.13 96.43 8.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.304 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.434 -179.842 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.43 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 180' ' ' ALA . 25.0 Cg_exo -61.59 145.68 97.51 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.332 2.021 . . . . 0.0 111.709 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.63 147.81 11.01 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.382 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -71.1 146.37 51.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.17 1.913 . . . . 0.0 111.597 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -98.61 149.4 35.7 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.295 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -41.44 116.42 0.49 Allowed 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.75 1.633 . . . . 0.0 111.889 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.548 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . 174.82 -44.82 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 34.9 Cg_exo -60.21 145.46 98.47 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.48 2.12 . . . . 0.0 111.88 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -58.55 137.25 57.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.164 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 9.7 t -84.59 158.37 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.3 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 1.1 pm0 -126.11 109.6 12.56 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m -87.59 145.21 26.3 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -118.59 170.26 9.11 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.22 0.533 . . . . 0.0 110.002 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -153.55 124.66 7.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.947 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -112.07 122.31 47.4 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.666 ' HG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -87.87 105.9 17.74 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.451 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 37.5 tp -108.21 123.58 48.97 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -81.13 128.25 33.54 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 122.615 1.198 . . . . 0.0 113.2 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 202' ' ' PHE . 20.4 t -59.31 -19.6 47.63 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.159 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.69 -47.85 84.0 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.407 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.5 m -71.64 -25.98 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.326 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 65.6 mt -90.56 -81.28 0.31 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.954 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.503 ' O ' ' OG ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -128.13 99.27 5.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.9 -178.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.639 ' ND2' ' HZ1' ' A' ' 210' ' ' LYS . 3.3 p30 -71.99 -71.78 0.26 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.406 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -105.73 -27.16 11.46 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.554 0.216 . . . . 0.0 110.9 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -61.98 167.83 3.59 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.992 0.425 . . . . 0.0 110.271 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -53.21 -81.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.515 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.449 ' O ' ' OG ' ' A' ' 259' ' ' SER . . . -161.86 54.2 0.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 60.0 p -107.28 136.97 46.2 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.9 mt -79.8 123.44 27.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.827 0.346 . . . . 0.0 111.633 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.639 ' HZ1' ' ND2' ' A' ' 203' ' ' ASN . 22.1 mtmt -84.14 158.51 61.17 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.26 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 213' ' ' GLY . 96.1 Cg_exo -32.75 -75.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.702 2.268 . . . . 0.0 112.824 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -49.12 -19.27 0.42 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.386 0.612 . . . . 0.0 110.191 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.33 -50.42 8.35 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.92 -40.62 95.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.224 0.535 . . . . 0.0 109.568 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -51.51 68.99 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.144 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.21 85.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.246 0.546 . . . . 0.0 110.036 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.3 mt -61.64 -37.8 85.35 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.183 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 32.1 m-20 -63.66 -45.57 89.54 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.112 0.482 . . . . 0.0 111.009 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -62.2 -44.22 97.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.299 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 37.6 tp -63.24 -39.94 96.02 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 225' ' ' SER . 16.1 t80 -53.9 -45.39 71.1 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 87.7 p -51.25 -53.53 34.53 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.038 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -53.83 -29.09 39.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.825 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 17.5 mt -93.64 -22.97 18.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.519 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 221' ' ' TYR . 7.2 p -77.86 -30.04 50.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -96.17 22.78 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.167 0.508 . . . . 0.0 110.437 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.401 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.6 OUTLIER -79.71 168.61 19.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.83 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.37 127.85 64.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 230' ' ' LYS . 68.6 Cg_endo -72.22 -16.53 28.24 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.072 1.848 . . . . 0.0 113.071 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.475 ' CG ' ' N ' ' A' ' 231' ' ' ASP . 19.5 ptmt -31.67 -45.77 0.1 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 123.583 0.552 . . . . 0.0 111.232 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' A' ' 230' ' ' LYS . 84.5 m-20 -111.92 -19.39 12.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.998 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 28.31 54.75 0.13 Allowed Glycine 0 N--CA 1.473 1.151 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.754 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.8 p -119.06 109.89 16.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.409 0.147 . . . . 0.0 111.151 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.4 t -125.47 94.74 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.699 0.761 . . . . 0.0 110.205 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.57 120.31 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.549 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 69.3 t -96.93 123.96 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.297 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.8 mt -107.2 137.83 44.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.185 0.517 . . . . 0.0 110.592 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -90.91 139.54 14.87 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.493 ' CZ ' ' CD ' ' A' ' 310' ' ' GLU . 11.6 m-85 -131.56 118.95 20.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.051 0.925 . . . . 0.0 108.794 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.0 t -129.49 171.05 12.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.843 0.354 . . . . 0.0 111.124 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -76.96 -176.12 3.82 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.321 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -105.82 121.83 44.85 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.781 0.324 . . . . 0.0 110.239 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.479 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 8.5 mm -118.82 11.15 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.552 0.691 . . . . 0.0 110.453 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.8 -47.36 3.06 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.5 m -68.3 101.04 1.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.314 0.578 . . . . 0.0 109.636 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -54.41 -52.3 62.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.548 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.41 -44.99 80.86 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.194 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -62.17 -45.02 95.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.91 0.385 . . . . 0.0 110.733 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.424 HD22 ' N ' ' A' ' 243' ' ' ILE . 28.0 m120 -62.3 -41.67 98.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -64.79 -41.8 95.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.673 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.27 96.2 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 27.7 mt -67.79 -40.76 83.88 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.679 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.5 t -62.2 -43.86 97.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.554 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -65.68 -41.4 92.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.004 0.431 . . . . 0.0 110.687 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.12 -48.84 77.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.665 ' NH2' HH21 ' A' ' 307' ' ' ARG . 66.7 mtt85 -61.36 -53.62 54.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.694 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.87 -30.22 65.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.463 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 5.5 tp-100 -75.45 -46.39 32.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.704 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.641 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 20.4 m -56.77 -37.19 70.75 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.996 0.903 . . . . 0.0 109.872 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 264' ' ' LEU . 44.8 t -71.07 -63.02 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.771 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 17.0 t -46.36 -63.84 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.731 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.641 ' OD1' ' O ' ' A' ' 259' ' ' SER . 28.6 p-10 -45.22 -38.72 5.64 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.079 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.524 ' N ' ' OD1' ' A' ' 262' ' ' ASP . 84.1 t80 -80.74 -31.94 35.84 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.981 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 260' ' ' VAL . 0.5 OUTLIER -70.27 -9.15 55.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.561 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.515 ' C ' ' H ' ' A' ' 267' ' ' LYS . 68.9 mt -86.83 -54.79 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.816 0.341 . . . . 0.0 111.744 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 39.0 m -51.59 -7.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.19 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 218' ' ' ASP . 0.0 OUTLIER -78.82 -11.34 59.99 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 109.52 39.49 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.98 130.19 23.84 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 117.173 0.487 . . . . 0.0 109.751 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.94 132.55 50.37 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.253 1.302 . . . . 0.0 112.4 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.33 -13.27 60.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.682 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -90.46 -17.45 27.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.484 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.51 -25.62 35.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.728 0.775 . . . . 0.0 110.413 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.3 pt -100.3 -178.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.548 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 7.7 t -162.17 126.48 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.58 113.97 25.79 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.887 0.375 . . . . 0.0 110.803 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -129.14 156.33 44.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.797 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.48 152.09 16.98 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 238' ' ' GLY . 6.5 tpt -118.11 -10.36 10.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.961 0.41 . . . . 0.0 110.242 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 60.28 -107.79 1.5 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.485 ' N ' ' CD ' ' A' ' 281' ' ' GLU . 1.0 OUTLIER -141.02 71.31 1.36 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.897 0.379 . . . . 0.0 110.235 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 72.8 m -93.44 7.42 44.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -160.98 70.72 2.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.94 105.74 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.35 2.033 . . . . 0.0 112.645 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.418 ' CG2' ' N ' ' A' ' 286' ' ' THR . 15.1 m -64.28 -42.06 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.572 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 288' ' ' ASN . 40.8 p -58.27 -45.67 87.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.102 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -43.95 -10.37 0.01 OUTLIER Glycine 0 CA--C 1.533 1.179 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 286' ' ' THR . 87.7 m-20 -129.77 -54.23 1.14 Allowed 'General case' 0 C--O 1.231 0.098 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 m -58.33 -44.22 88.57 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.13 33.09 4.16 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 109.903 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 293' ' ' VAL . 28.9 t0 -56.94 -42.65 80.46 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.447 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -75.08 33.18 0.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.49 ' H ' ' C ' ' A' ' 291' ' ' ASP . 15.5 t -131.91 113.51 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.943 0.401 . . . . 0.0 110.343 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -118.51 14.65 13.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.926 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -99.62 130.82 45.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.011 0.434 . . . . 0.0 110.166 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -50.47 -67.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.273 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.89 -38.31 61.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.72 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.96 89.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.332 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 60.3 mt -75.19 -50.25 16.85 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.878 0.37 . . . . 0.0 110.652 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 78.1 mt -52.72 -32.74 17.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.227 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -78.07 -46.22 21.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.924 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 11.9 t -70.64 -13.1 61.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.637 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 35.9 mt -92.58 24.47 3.5 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.398 0.437 . . . . 0.0 111.453 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.541 ' N ' ' HD2' ' A' ' 305' ' ' PRO . . . -78.45 -45.45 2.05 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.397 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 35.7 Cg_endo -69.28 8.7 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.203 1.935 . . . . 0.0 111.586 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 304' ' ' ALA . 9.4 t70 -104.76 9.76 34.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.228 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.665 HH21 ' NH2' ' A' ' 256' ' ' ARG . 38.6 mtp180 -107.76 116.39 31.86 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.212 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.666 ' NH2' ' HG1' ' A' ' 195' ' ' THR . 15.7 ptm180 -175.67 -171.31 0.46 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.5 m -144.77 154.16 14.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.493 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 95.2 mt-10 -121.7 105.25 10.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.044 0.45 . . . . 0.0 110.925 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.9 mm -80.54 116.71 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.488 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -99.63 119.6 38.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.774 0.321 . . . . 0.0 110.369 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.94 120.53 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.653 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -118.93 141.13 48.93 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.22 -22.55 40.17 Favored Glycine 0 N--CA 1.469 0.88 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.58 ' CG1' ' H ' ' A' ' 317' ' ' LYS . 14.6 tt -56.47 176.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.58 ' H ' ' CG1' ' A' ' 316' ' ' ILE . 49.5 tttt -54.81 -147.65 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.522 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -162.15 151.73 16.11 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 4.0 p -138.81 139.45 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 56.5 t -122.03 129.75 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 53.0 m -99.64 162.64 12.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.903 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -118.39 85.36 25.49 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.013 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.98 -39.19 79.95 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.32 2.013 . . . . 0.0 112.261 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.421 ' O ' ' OXT' ' A' ' 325' ' ' ALA . 59.6 tt0 -156.54 -64.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.62 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' A' ' 324' ' ' GLN . . . . . . . . 0 C--O 1.218 -0.553 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.567 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.448 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 44.9 Cg_endo -67.01 153.7 77.02 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.733 2.288 . . . . 0.0 111.963 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -173.85 61.41 0.25 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.613 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.89 43.22 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.722 2.281 . . . . 0.0 111.868 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 60.44 72.87 0.68 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.471 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.52 145.71 98.27 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.813 2.342 . . . . 0.0 111.955 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.463 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -162.29 52.64 0.38 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.614 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 41.9 Cg_endo -67.17 -19.76 50.45 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.752 2.302 . . . . 0.0 111.927 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -60.42 159.38 10.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.47 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 85.7 t -107.22 134.22 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.913 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -118.26 100.21 7.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.165 0.507 . . . . 0.0 110.463 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 m -77.16 140.01 40.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.53 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -147.36 117.83 7.45 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.029 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.2 OUTLIER -103.29 150.52 23.67 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.611 ' CE2' ' NE2' ' A' ' 223' ' ' GLN . 41.1 m-85 -111.76 121.92 46.39 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.798 0.332 . . . . 0.0 110.184 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.59 101.72 12.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 34.4 tp -104.28 132.52 50.44 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.996 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -78.2 127.04 31.67 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.897 0.856 . . . . 0.0 111.893 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 202' ' ' PHE . 39.2 t -63.75 -33.22 75.17 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.035 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.56 -38.75 81.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.259 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.21 -46.17 96.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.3 mt -75.56 -76.34 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.659 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.484 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -130.7 143.5 50.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.363 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.468 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 46.5 t30 -129.77 -72.87 0.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.272 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.34 -37.94 56.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -71.92 165.12 24.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.445 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -57.67 -68.03 0.28 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.589 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.12 57.18 0.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.457 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 18.8 p -106.43 130.06 54.3 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.84 139.22 44.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.78 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 213' ' ' GLY . 30.7 mtmt -101.17 159.66 28.85 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 210' ' ' LYS . 86.3 Cg_exo -34.25 -77.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.387 2.058 . . . . 0.0 112.104 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.72 -20.29 1.2 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.173 0.511 . . . . 0.0 110.424 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.83 -49.69 16.61 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -67.9 -39.19 83.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.19 0.519 . . . . 0.0 109.807 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.29 -53.17 60.44 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.537 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.51 91.34 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.43 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 mt -62.45 -26.34 68.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.502 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -73.01 -46.08 54.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -63.65 -40.25 96.38 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.462 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.08 -40.09 92.39 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 223' ' ' GLN . 49.4 t80 -54.87 -58.33 8.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.535 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 15.4 m -58.94 -6.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.361 0.601 . . . . 0.0 110.788 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.611 ' NE2' ' CE2' ' A' ' 194' ' ' PHE . 4.0 tt0 -94.38 -34.23 12.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.684 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 42.7 mt -96.92 -13.03 22.7 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.809 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.3 t -83.24 -14.93 52.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.724 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -96.71 17.55 16.29 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.446 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.426 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.8 OUTLIER -78.18 178.92 7.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.653 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 315' ' ' GLY . 9.4 t70 -94.2 132.03 30.14 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.734 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 230' ' ' LYS . 42.3 Cg_endo -67.92 -20.47 45.07 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.817 2.344 . . . . 0.0 112.837 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 229' ' ' PRO . 40.6 mmtt -33.43 -53.07 0.4 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.055 0.455 . . . . 0.0 110.582 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 99.3 m-20 -102.76 -19.01 14.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.471 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.03 45.23 0.01 OUTLIER Glycine 0 N--CA 1.469 0.879 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 231' ' ' ASP . 28.0 m -112.22 111.38 22.23 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 71.6 t -126.31 94.06 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.761 0.791 . . . . 0.0 110.285 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.4 t -97.22 121.03 47.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.09 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.13 124.58 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.58 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.7 mt -109.49 141.34 42.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.974 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -125.16 126.08 5.85 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.31 120.39 42.08 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.4 m -108.98 168.53 9.29 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.403 ' O ' ' OE2' ' A' ' 281' ' ' GLU . 52.8 p-10 -95.14 -179.55 4.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.628 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -98.65 127.36 44.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.318 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.48 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 48.9 mm -118.31 14.2 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.313 0.578 . . . . 0.0 110.667 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 91.87 -3.05 77.19 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 4.2 m -134.01 104.36 6.21 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.998 0.428 . . . . 0.0 110.072 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -55.35 -50.81 68.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.476 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.72 -40.75 76.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.545 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.418 ' CE2' ' CD1' ' A' ' 252' ' ' LEU . 48.7 t80 -63.07 -44.56 95.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.293 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -62.67 -40.4 96.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.279 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -63.93 -43.1 96.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.497 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.468 ' C ' ' NH2' ' A' ' 255' ' ' ARG . . . -62.33 -35.86 92.24 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.418 ' CD1' ' CE2' ' A' ' 248' ' ' TYR . 14.4 mt -74.66 -35.91 62.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.499 -0.35 . . . . 0.0 111.084 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.4 p -64.64 -41.06 96.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.979 0.418 . . . . 0.0 110.512 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -70.36 -44.48 68.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.178 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.468 ' NH2' ' C ' ' A' ' 251' ' ' GLY . 63.5 mtm-85 -56.55 -46.78 80.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.803 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -60.46 -62.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.611 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.72 -34.78 19.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.104 0.478 . . . . 0.0 109.881 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -72.86 -46.07 54.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.406 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 61.5 m -60.11 -38.07 81.9 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.073 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.1 t -64.06 -50.8 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.331 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.5 t -62.31 -48.36 88.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.434 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.44 -41.86 21.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.061 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.637 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 85.5 t80 -79.39 -34.62 41.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.628 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -29.48 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.966 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' A' ' 267' ' ' LYS . 82.4 mt -68.73 -50.16 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 111.88 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 44.6 m -50.76 -8.51 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.906 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.637 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 11.4 mmtp -84.6 2.28 42.18 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.006 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.08 40.81 4.48 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.41 129.0 25.05 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.332 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.06 127.31 25.18 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.862 1.708 . . . . 0.0 111.725 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.22 -8.78 34.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.896 0.379 . . . . 0.0 111.341 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 64.7 t0 -91.86 -22.73 19.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.782 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -80.83 -19.16 45.21 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.486 0.66 . . . . 0.0 110.78 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 234' ' ' VAL . 1.7 pt -105.34 -171.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.745 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 1.6 t -168.5 136.27 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.206 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -106.91 110.72 22.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.819 0.342 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -117.1 142.73 46.63 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.447 0.642 . . . . 0.0 110.532 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.84 99.62 2.33 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.626 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.6 OUTLIER -79.29 9.94 4.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.823 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.548 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 10.26 -95.89 0.01 OUTLIER Glycine 0 N--CA 1.476 1.314 0 O-C-N 123.534 0.521 . . . . 0.0 112.068 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 281' ' ' GLU . 56.1 mp0 -135.68 75.05 1.54 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.835 0.35 . . . . 0.0 110.591 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.495 ' OG ' ' SD ' ' A' ' 279' ' ' MET . 53.8 m -83.65 -3.63 57.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 283' ' ' ASN . 11.4 p-10 -176.42 80.21 0.27 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.593 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.14 107.64 0.27 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.65 2.233 . . . . 0.0 112.214 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 9.6 m -88.77 -36.63 9.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.524 0.678 . . . . 0.0 110.757 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -43.67 98.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.954 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 290' ' ' CYS . . . -45.57 -88.96 0.01 OUTLIER Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 287' ' ' GLY . 86.6 m-20 -27.61 -53.92 0.09 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.655 0.264 . . . . 0.0 110.35 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.4 m -56.06 -47.04 78.7 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.478 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . 0.621 ' N ' ' O ' ' A' ' 287' ' ' GLY . 0.3 OUTLIER -98.37 34.19 2.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 109.928 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 293' ' ' VAL . 51.5 t0 -57.98 -42.61 85.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.447 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -75.43 32.32 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 291' ' ' ASP . 21.2 t -131.18 113.14 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.92 0.391 . . . . 0.0 110.665 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -118.97 14.22 13.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.605 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -86.65 166.9 14.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.111 0.481 . . . . 0.0 110.308 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -78.78 -67.36 0.75 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.532 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 301' ' ' ASP . . . -61.77 -27.33 68.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.223 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.588 ' O ' ' OD1' ' A' ' 301' ' ' ASP . . . -71.99 -24.26 61.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.156 0.503 . . . . 0.0 110.933 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 71.2 mt -86.69 -48.11 8.57 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.66 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.74 -31.8 48.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.054 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.588 ' OD1' ' O ' ' A' ' 298' ' ' ALA . 43.3 p-10 -82.95 -43.77 16.08 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.602 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.574 ' N ' ' OD1' ' A' ' 301' ' ' ASP . 13.1 t -74.86 -13.77 60.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.156 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 35.4 mt -87.39 21.07 2.58 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.514 0.509 . . . . 0.0 110.466 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.626 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -72.73 -41.01 6.91 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.0 Cg_exo -58.94 7.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.464 2.776 . . . . 0.0 112.47 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' A' ' 304' ' ' ALA . 45.8 t0 -108.18 7.51 27.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.871 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.468 ' NH1' ' OD1' ' A' ' 203' ' ' ASN . 62.4 mtm180 -112.66 86.4 2.36 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.454 0.645 . . . . 0.0 109.376 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.546 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 11.0 ptp180 -156.7 130.48 8.3 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.174 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.64 139.69 18.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -122.5 103.41 8.69 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.317 0.58 . . . . 0.0 110.42 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.46 117.89 25.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -94.9 121.51 36.57 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.642 0.258 . . . . 0.0 110.891 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 54.6 t -122.95 117.89 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -114.27 133.87 55.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 102.25 18.84 15.79 Favored Glycine 0 C--O 1.22 -0.759 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 20.2 tt -105.29 146.81 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 110.644 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -123.23 163.29 20.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.848 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -162.95 175.01 11.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.973 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . 0.45 ' CG2' ' N ' ' A' ' 320' ' ' VAL . 5.4 p -77.48 160.7 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.51 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.45 ' N ' ' CG2' ' A' ' 319' ' ' VAL . 34.6 m -63.82 137.03 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.271 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.468 ' CG2' ' N ' ' A' ' 322' ' ' GLN . 99.0 m -124.1 164.65 19.0 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.463 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . 0.468 ' N ' ' CG2' ' A' ' 321' ' ' THR . 23.3 mp0 -65.47 148.17 98.22 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.09 -11.82 31.11 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.564 2.176 . . . . 0.0 112.035 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -67.66 61.93 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.692 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.547 179.941 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 25.6 Cg_endo -60.36 -29.47 88.9 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.525 2.15 . . . . 0.0 111.855 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -52.28 175.1 0.1 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -55.56 138.12 79.78 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.417 2.078 . . . . 0.0 112.014 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -72.97 151.49 90.65 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.512 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.05 152.02 73.06 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.876 2.384 . . . . 0.0 111.92 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.569 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . 176.28 -46.4 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.272 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 47.9 Cg_exo -54.7 -38.81 91.28 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.567 2.178 . . . . 0.0 112.183 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 188' ' ' GLU . 56.0 mp0 -84.12 147.66 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.316 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.07 137.99 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.179 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -122.93 127.01 48.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.8 m -77.91 142.03 38.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.131 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 193' ' ' HIS . 21.5 tptt -114.42 166.83 11.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.123 0.487 . . . . 0.0 110.553 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 192' ' ' LYS . 53.2 m80 -155.74 124.21 5.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.836 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.617 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 60.2 m-85 -113.66 120.13 39.82 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.714 ' HG1' HH12 ' A' ' 308' ' ' ARG . 0.0 OUTLIER -85.15 103.66 14.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.08 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 28.8 tp -105.11 124.24 49.2 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -78.67 129.33 34.6 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 121.897 0.856 . . . . 0.0 112.206 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.0 t -62.3 -32.99 73.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.026 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -54.88 -35.94 64.6 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.085 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 71.0 t -71.48 -38.77 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.878 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.8 mt -84.41 -80.59 0.2 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.808 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -124.55 133.16 53.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.076 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.447 ' N ' ' OD1' ' A' ' 203' ' ' ASN . 1.6 m-20 -104.27 -71.11 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.567 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -107.49 -16.48 14.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.808 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 26.6 t30 -71.9 170.13 14.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.062 0.458 . . . . 0.0 110.241 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -52.49 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.491 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.475 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -162.19 4.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.503 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.528 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 76.8 p -55.02 144.89 21.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.014 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 28.0 mt -88.96 133.2 34.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 213' ' ' GLY . 1.5 mptm? -90.74 157.77 43.35 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.975 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -34.1 -74.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.636 2.224 . . . . 0.0 111.828 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -50.41 -21.63 1.53 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.076 0.465 . . . . 0.0 110.048 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.95 -50.27 13.83 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -66.36 -39.2 89.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.305 0.574 . . . . 0.0 110.151 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.3 -54.31 48.24 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.555 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.29 -38.42 91.07 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.703 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.9 mt -61.59 -27.36 68.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.503 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -74.21 -46.67 40.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.202 0.525 . . . . 0.0 110.443 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -61.77 -43.12 99.48 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.209 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 48.2 tp -66.8 -39.11 87.64 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.442 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' A' ' 267' ' ' LYS . 3.7 t80 -53.57 -49.37 67.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.849 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.7 t -58.11 -51.04 71.38 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.45 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.617 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 9.2 tt0 -52.18 -26.02 10.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.258 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 72.0 mt -96.13 -17.96 20.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.507 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.1 t -78.47 -17.6 56.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.758 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -97.36 20.67 11.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.785 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.495 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.8 OUTLIER -80.16 178.12 8.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.861 179.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -96.04 133.79 24.72 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.495 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.0 Cg_endo -69.75 -18.6 36.95 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.813 2.342 . . . . 0.0 112.356 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 229' ' ' PRO . 56.4 tttp -36.22 -53.66 0.81 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.457 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 232' ' ' GLY . 36.2 m-20 -100.79 -21.59 15.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.65 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.95 50.45 0.05 OUTLIER Glycine 0 N--CA 1.471 1.003 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.5 m -117.65 111.28 18.95 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 122.671 -0.311 . . . . 0.0 110.398 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 99.0 t -129.0 93.9 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.214 0.531 . . . . 0.0 110.145 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.6 t -98.27 123.4 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.621 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 95.3 t -95.36 127.85 47.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.641 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 39.1 mt -111.58 142.44 43.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 279' ' ' MET . . . -118.94 139.42 14.36 Favored Glycine 0 N--CA 1.48 1.587 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.4 OUTLIER -121.14 121.58 38.15 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.6 p -112.09 165.3 12.25 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.987 0.422 . . . . 0.0 110.236 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 241' ' ' ASP . 11.3 p30 -87.82 -177.79 5.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.443 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -105.18 120.23 41.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.052 0.453 . . . . 0.0 110.288 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.495 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 48.3 mm -119.09 15.02 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.399 0.619 . . . . 0.0 110.83 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.5 9.03 87.32 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.7 p -134.45 97.19 3.75 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.894 0.378 . . . . 0.0 110.334 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -52.57 -52.48 54.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.647 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.9 72.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -60.19 -46.75 88.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.524 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.4 HD22 ' H ' ' A' ' 243' ' ' ILE . 91.0 m-20 -61.9 -42.63 99.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.569 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -63.36 -42.54 98.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.553 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.68 -36.08 92.15 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.28 -32.98 63.12 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.704 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 12.0 m -65.36 -43.69 90.03 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.177 0.513 . . . . 0.0 110.598 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -70.42 -35.23 73.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.928 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -59.86 -50.04 75.34 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.549 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.511 ' NH1' ' O ' ' A' ' 239' ' ' TYR . 16.4 ptp180 -67.16 -47.52 70.77 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.406 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.47 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.83 -39.74 92.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.194 0.521 . . . . 0.0 110.189 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -74.6 -45.51 44.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.16 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 46.5 t -60.65 -38.54 85.2 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.084 0.469 . . . . 0.0 110.238 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 256' ' ' ARG . 91.6 t -64.92 -52.06 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.557 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.2 t -61.37 -49.11 85.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.326 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -44.96 -41.83 7.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.961 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -82.53 -30.31 29.83 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.34 -7.56 50.23 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.371 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 267' ' ' LYS . 61.2 mt -88.05 -54.7 7.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 72.8 m -51.22 -5.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.583 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.6 OUTLIER -79.7 -11.4 59.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.894 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.46 39.11 1.97 Allowed Glycine 0 C--N 1.323 -0.174 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.99 127.89 24.29 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.43 128.01 24.29 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.145 1.897 . . . . 0.0 112.273 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.09 -7.9 20.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.716 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -93.03 -24.41 18.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -78.53 -21.76 48.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.563 0.697 . . . . 0.0 110.587 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.4 pt -102.23 -173.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.865 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 26.3 t -171.61 132.49 0.75 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.484 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.89 153.08 19.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -158.49 144.72 17.1 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.091 0.472 . . . . 0.0 110.804 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.98 97.35 2.06 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.462 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.5 tpt -68.46 -10.68 56.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.907 0.384 . . . . 0.0 110.462 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 45.07 -104.62 0.07 OUTLIER Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.07 70.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.389 . . . . 0.0 110.548 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 14.1 m -88.82 -0.16 57.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.585 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' A' ' 283' ' ' ASN . 0.1 OUTLIER -169.5 76.66 0.69 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.675 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.76 111.32 3.26 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.536 2.158 . . . . 0.0 111.798 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 15.5 m -71.52 -39.46 70.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.86 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.66 ' C ' ' H ' ' A' ' 288' ' ' ASN . 21.1 p -63.68 -48.2 78.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.479 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.478 ' N ' ' HG1' ' A' ' 286' ' ' THR . . . -51.71 -0.53 0.03 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.66 ' H ' ' C ' ' A' ' 286' ' ' THR . 65.8 t30 -114.0 -60.17 1.92 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.8 t -79.04 -3.86 47.25 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.569 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 286' ' ' THR . 0.4 OUTLIER -127.32 18.22 7.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.531 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 30.1 p-10 -67.57 -3.08 7.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.378 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -99.89 33.41 2.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.451 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 26.6 t -127.95 122.87 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.889 0.376 . . . . 0.0 110.231 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -119.59 6.5 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.824 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.9 168.39 12.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.057 0.456 . . . . 0.0 110.168 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -80.02 -74.89 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.758 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -55.92 -26.46 47.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.818 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.89 -34.69 78.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.146 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.2 mt -75.46 -64.71 1.01 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 pt -48.41 -30.24 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.396 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -76.62 -42.66 41.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.567 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 15.3 t -80.45 -10.54 59.74 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.73 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 299' ' ' LEU . 54.2 mt -91.95 21.81 4.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.69 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -76.61 -45.12 3.25 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 121.156 0.503 . . . . 0.0 110.375 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 25.2 Cg_exo -61.81 9.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.233 2.622 . . . . 0.0 111.654 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 304' ' ' ALA . 51.0 t0 -106.49 11.08 31.1 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.623 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -111.25 103.26 11.65 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.349 0.595 . . . . 0.0 110.402 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.714 HH12 ' HG1' ' A' ' 195' ' ' THR . 0.0 OUTLIER -172.17 153.48 3.09 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.222 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.16 149.69 18.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -120.22 107.77 13.39 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.089 0.471 . . . . 0.0 110.839 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.5 mm -78.37 117.95 24.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -100.74 111.59 23.84 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.301 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 192' ' ' LYS . 86.6 t -119.63 123.65 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 O-C-N 123.66 0.6 . . . . 0.0 110.644 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -119.63 140.54 50.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.777 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 101.39 -0.35 53.63 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.8 tt -85.46 144.29 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.064 0.459 . . . . 0.0 110.485 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -85.6 130.33 34.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.435 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -92.12 109.49 20.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.601 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 4.3 m -107.02 174.58 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.058 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 2.5 m -95.27 90.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.059 0.457 . . . . 0.0 110.378 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 6.8 t -152.36 112.82 4.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.137 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -93.33 117.38 67.4 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.789 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.57 -17.05 23.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.492 2.128 . . . . 0.0 112.219 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -97.61 124.58 41.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.408 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.596 179.929 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.23 113.8 3.65 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.502 2.135 . . . . 0.0 112.21 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.553 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -86.41 -45.96 0.56 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.171 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 73.6 Cg_endo -81.98 12.5 2.78 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.636 2.224 . . . . 0.0 112.333 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.438 ' N ' ' HD2' ' A' ' 185' ' ' PRO . . . -39.11 -61.34 0.97 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.367 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 184' ' ' ALA . 27.2 Cg_endo -60.33 145.41 98.68 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.374 2.049 . . . . 0.0 111.862 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -173.55 89.68 0.37 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.335 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.0 139.1 61.79 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.411 2.074 . . . . 0.0 112.06 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -93.7 159.82 15.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.545 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 12.3 t -75.08 141.79 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.239 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -114.72 89.53 3.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.34 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.6 m -69.52 169.35 12.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.46 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.502 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 3.4 tptm -148.83 166.23 29.13 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.083 0.468 . . . . 0.0 110.083 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.502 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 12.8 m80 -153.5 123.93 7.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.756 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -112.09 115.6 29.15 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.592 ' HG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -86.07 103.14 14.46 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.775 -179.239 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.2 tp -108.72 132.93 53.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.451 ' CB ' ' HZ1' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -83.76 126.58 33.05 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.244 -178.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.4 m -62.02 -32.35 72.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.332 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.491 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 11.8 m-20 -59.31 -36.52 75.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.81 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 94.9 t -68.19 -42.91 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 92.7 mt -78.35 -79.48 0.12 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.244 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.427 ' CD1' ' NH1' ' A' ' 256' ' ' ARG . 0.1 OUTLIER -118.04 122.84 44.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.764 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.534 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 8.9 p-10 -91.32 -78.09 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.628 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.534 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 82.5 m-85 -98.0 -14.94 20.29 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.809 0.337 . . . . 0.0 110.659 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -72.61 154.54 40.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.235 0.54 . . . . 0.0 109.718 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.58 ' CG ' ' H ' ' A' ' 207' ' ' ALA . 42.2 pttt -49.8 -59.98 3.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.987 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.58 ' H ' ' CG ' ' A' ' 206' ' ' LYS . . . -168.71 57.18 0.05 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.603 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 64.4 p -107.23 129.92 54.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.7 mt -74.48 146.22 42.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.719 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 213' ' ' GLY . 22.7 mttp -105.87 158.5 32.28 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.946 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -33.85 -76.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.495 2.13 . . . . 0.0 112.231 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -52.62 -18.98 2.03 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.251 0.548 . . . . 0.0 110.16 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.38 -49.37 9.39 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -67.27 -40.8 86.23 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.186 0.517 . . . . 0.0 109.77 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.68 -50.89 71.7 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.589 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.26 86.58 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.635 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.1 mt -62.25 -31.37 71.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -70.17 -45.3 67.0 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.291 0.567 . . . . 0.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -63.06 -42.78 99.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.927 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 38.8 tp -63.87 -40.28 96.17 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.521 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.508 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.3 t80 -52.65 -47.3 67.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.534 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.7 m -52.27 -51.94 55.64 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.67 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -55.43 -26.4 41.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.469 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 67.4 mt -94.01 -23.85 17.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.675 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.1 t -75.79 -32.36 59.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.279 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -91.94 21.37 4.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.405 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.7 OUTLIER -77.34 173.46 11.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.199 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -88.35 133.7 36.1 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.457 ' O ' ' C ' ' A' ' 230' ' ' LYS . 55.0 Cg_endo -70.56 -18.22 33.38 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.569 2.179 . . . . 0.0 112.709 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 229' ' ' PRO . 11.1 mmtp -28.03 -49.22 0.06 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.594 0.559 . . . . 0.0 110.498 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 67.5 m-20 -118.51 -14.66 9.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.377 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.79 51.27 0.06 OUTLIER Glycine 0 N--CA 1.47 0.929 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.4 m -114.68 110.7 20.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.668 0.271 . . . . 0.0 110.99 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.32 95.67 3.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.811 0.815 . . . . 0.0 109.692 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.11 117.75 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.642 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 24.5 t -93.14 124.17 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.635 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.7 mt -108.6 137.79 45.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.065 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -120.52 132.42 9.26 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -116.64 126.52 53.35 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 8.0 t -125.14 162.25 25.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -77.35 -175.82 3.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.224 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.1 ptm85 -120.01 133.74 55.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.369 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 51.7 mm -118.42 24.14 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.582 0.706 . . . . 0.0 110.626 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 80.93 14.49 79.42 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.0 m -137.37 98.94 3.83 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.083 0.468 . . . . 0.0 110.005 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -52.23 -50.41 62.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.295 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.38 -45.65 80.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.939 0.4 . . . . 0.0 110.709 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -60.23 -41.67 93.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.349 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.495 HD22 ' CA ' ' A' ' 280' ' ' GLY . 0.6 OUTLIER -60.12 -50.73 72.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.623 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -57.0 -41.5 78.59 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.46 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.41 -41.32 98.49 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 35.6 mt -67.31 -41.03 86.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.913 0.387 . . . . 0.0 111.274 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.5 t -61.42 -40.23 93.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.999 0.428 . . . . 0.0 110.889 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.52 -42.18 78.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.232 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -58.6 -46.54 86.79 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.472 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.427 ' NH1' ' CD1' ' A' ' 202' ' ' PHE . 86.6 mtt-85 -63.92 -62.44 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.772 0.32 . . . . 0.0 110.774 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.39 -35.71 19.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 110.168 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.32 -45.49 59.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.585 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 13.3 t -59.62 -39.06 83.03 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.243 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.28 -52.83 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.414 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.54 -49.27 85.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.215 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -44.7 -42.78 7.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.14 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.638 ' CZ ' ' NZ ' ' A' ' 267' ' ' LYS . 62.2 t80 -80.41 -28.92 37.73 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.766 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.0 -4.53 38.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.102 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.3 mt -86.23 -52.94 11.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.7 p -54.47 -1.83 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.576 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.638 ' NZ ' ' CZ ' ' A' ' 263' ' ' TYR . 9.7 mptt -87.53 2.56 50.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.704 0.288 . . . . 0.0 110.703 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 89.81 38.31 6.56 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 269' ' ' ILE . 1.2 tp -119.16 120.29 31.23 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -49.09 128.03 18.65 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.173 1.249 . . . . 0.0 112.116 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.04 -16.23 50.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.114 0.483 . . . . 0.0 111.034 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 4.4 m-20 -85.25 -22.62 28.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.077 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -23.5 38.99 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.209 0.528 . . . . 0.0 110.545 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.5 pt -101.98 -174.84 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.985 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 34.8 m -168.96 127.33 1.02 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.224 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.17 110.52 23.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 110.413 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.546 ' NH1' ' SD ' ' A' ' 279' ' ' MET . 73.8 ttt-85 -115.29 139.74 49.71 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.433 0.635 . . . . 0.0 110.985 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.96 95.18 2.06 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.546 ' SD ' ' NH1' ' A' ' 277' ' ' ARG . 3.8 tpt -69.81 -10.63 59.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.665 0.269 . . . . 0.0 110.598 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.495 ' CA ' HD22 ' A' ' 249' ' ' ASN . . . 41.75 -102.36 0.03 OUTLIER Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -141.65 75.58 1.5 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.784 0.326 . . . . 0.0 110.813 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 18.0 m -87.04 0.16 55.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.741 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.472 ' C ' HD21 ' A' ' 283' ' ' ASN . 0.4 OUTLIER -168.16 75.88 0.87 Allowed Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.47 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -60.82 104.14 0.26 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.554 2.17 . . . . 0.0 112.529 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 28.4 m -69.1 -44.44 81.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.306 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.653 ' C ' ' H ' ' A' ' 288' ' ' ASN . 7.6 p -62.49 -46.21 89.48 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.09 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.93 -1.83 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.653 ' H ' ' C ' ' A' ' 286' ' ' THR . 28.3 m120 -115.57 -59.36 2.01 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.1 t -80.88 -3.41 51.19 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.71 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . 0.503 ' N ' ' O ' ' A' ' 286' ' ' THR . 0.6 OUTLIER -127.61 16.89 6.97 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.343 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 31.6 p-10 -68.0 -3.06 8.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.986 0.422 . . . . 0.0 110.592 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -100.23 32.45 2.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.706 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 15.6 t -130.78 125.65 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.027 0.442 . . . . 0.0 110.304 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.92 10.64 12.31 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.12 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -104.06 136.28 43.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.099 0.475 . . . . 0.0 110.242 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.426 ' HG3' ' H ' ' A' ' 297' ' ' ALA . 0.1 OUTLIER -61.53 -46.37 90.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.941 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . 0.426 ' H ' ' HG3' ' A' ' 296' ' ' ARG . . . -62.68 -46.06 89.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.107 0.48 . . . . 0.0 111.183 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.98 -29.83 70.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.789 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 39.5 mt -78.17 -53.42 7.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.961 0.41 . . . . 0.0 110.535 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 40.0 mt -51.08 -34.81 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.922 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.9 -43.1 22.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.07 0.462 . . . . 0.0 110.315 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 38.9 t -73.93 -13.56 60.91 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.775 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 299' ' ' LEU . 53.5 mt -90.45 23.16 3.08 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.291 0.369 . . . . 0.0 111.07 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -77.39 -44.35 2.62 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.457 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.8 Cg_exo -62.47 9.35 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.416 2.744 . . . . 0.0 111.807 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 304' ' ' ALA . 0.4 OUTLIER -104.28 10.32 35.61 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.71 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.491 ' NH1' ' OD1' ' A' ' 199' ' ' ASP . 39.2 mtm105 -113.96 94.81 5.0 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.494 0.664 . . . . 0.0 110.195 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.592 ' NH2' ' HG1' ' A' ' 195' ' ' THR . 16.3 ptm180 -164.08 139.15 5.95 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.136 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 22.6 m -104.69 144.57 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 121.831 -0.543 . . . . 0.0 109.666 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -121.45 106.26 11.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.342 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.38 118.21 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.796 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 312' ' ' GLU . 0.1 OUTLIER -96.43 135.62 38.05 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.2 t -133.38 120.22 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.236 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -117.29 132.34 56.63 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.6 -13.85 50.44 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 20.1 tt -75.38 154.12 6.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.827 0.346 . . . . 0.0 110.487 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -128.02 167.91 16.05 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.474 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.453 ' OD2' ' NZ ' ' A' ' 192' ' ' LYS . 33.0 m-20 -160.61 172.83 16.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.502 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.94 151.21 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.301 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 14.2 p -109.83 135.23 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.17 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 43.6 p -129.65 164.54 23.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.306 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . 0.448 ' N ' ' CD ' ' A' ' 322' ' ' GLN . 6.0 mp0 -80.84 149.2 66.79 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.827 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.93 150.51 73.26 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.421 2.081 . . . . 0.0 112.106 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -156.32 116.51 3.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.398 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.491 179.866 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.98 -22.77 47.64 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.927 2.418 . . . . 0.0 111.883 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 184' ' ' ALA . . . -155.82 75.18 5.03 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.544 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.8 85.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.554 2.169 . . . . 0.0 112.163 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.605 ' N ' ' CD ' ' A' ' 185' ' ' PRO . . . -95.75 -43.35 0.27 Allowed Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.138 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 184' ' ' ALA . 38.2 Cg_exo -59.31 142.44 99.11 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.524 2.149 . . . . 0.0 112.06 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.3 116.05 65.95 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.333 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.23 -77.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.079 1.852 . . . . 0.0 112.194 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -168.95 154.12 6.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.099 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 66.1 t -121.06 140.63 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.032 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.41 ' OE1' ' N ' ' A' ' 318' ' ' ASP . 2.0 pt20 -122.87 117.22 25.09 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.477 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.1 m -73.18 141.24 47.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.274 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -143.46 111.21 5.98 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.4 m-70 -101.39 150.45 23.0 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.577 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 59.6 m-85 -111.28 118.67 36.52 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 195' ' ' THR . 6.9 t -85.26 102.46 13.37 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.837 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.0 tp -105.34 137.26 43.42 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.437 0.637 . . . . 0.0 109.955 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 130.38 36.24 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-O 122.564 1.174 . . . . 0.0 112.021 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 202' ' ' PHE . 7.3 t -60.24 -24.74 65.11 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.255 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -58.31 -43.71 88.28 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.955 0.407 . . . . 0.0 110.423 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.85 -42.7 92.67 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.637 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.78 -78.36 0.18 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.391 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.47 ' O ' ' OG ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -128.43 102.73 6.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.98 -178.618 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.494 ' OD1' ' CD2' ' A' ' 204' ' ' PHE . 14.3 t-20 -67.4 -70.38 0.26 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.205 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.494 ' CD2' ' OD1' ' A' ' 203' ' ' ASN . 59.7 m-85 -108.51 -10.96 15.2 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.733 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -69.84 161.56 29.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.038 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -55.9 -75.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.415 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.59 49.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 41.6 p -107.33 128.02 54.08 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.819 0.342 . . . . 0.0 110.193 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 30.5 mt -73.32 129.57 38.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.147 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 213' ' ' GLY . 58.5 mttt -91.6 159.92 37.65 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.696 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 210' ' ' LYS . 71.0 Cg_exo -33.12 -76.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.463 2.109 . . . . 0.0 111.549 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -49.57 -21.97 1.14 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.185 0.517 . . . . 0.0 110.31 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.27 -48.88 22.99 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.23 -38.91 91.89 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.91 63.23 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.225 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.33 -30.42 71.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.533 0.682 . . . . 0.0 110.237 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.24 -28.37 65.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.301 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -76.4 -48.54 19.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.32 0.581 . . . . 0.0 111.319 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.432 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 4.9 pt20 -64.02 -42.43 97.12 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.498 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.46 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 45.0 tp -63.96 -42.16 97.36 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.452 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.4 t80 -51.4 -50.57 59.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.46 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.643 ' HG ' ' H ' ' A' ' 223' ' ' GLN . 73.6 p -56.96 -50.31 73.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.456 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.643 ' H ' ' HG ' ' A' ' 222' ' ' SER . 10.5 tt0 -50.65 -25.82 4.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.506 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 39.0 mt -97.42 -15.27 20.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 53.4 p -79.76 -10.31 59.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.49 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -107.82 18.77 20.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.23 173.14 12.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.15 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 6.5 t70 -88.66 132.1 39.71 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 230' ' ' LYS . 57.1 Cg_endo -72.05 -18.8 27.18 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.718 2.279 . . . . 0.0 112.643 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 229' ' ' PRO . 61.9 tttm -32.63 -52.07 0.3 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.635 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 232' ' ' GLY . 85.8 m-20 -104.69 -17.94 14.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.579 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 27.41 50.19 0.07 OUTLIER Glycine 0 N--CA 1.474 1.215 0 O-C-N 123.917 0.761 . . . . 0.0 111.333 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 16.7 m -115.97 108.07 15.78 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 122.586 -0.361 . . . . 0.0 110.927 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -124.82 93.61 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.939 0.876 . . . . 0.0 109.926 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 66.5 t -97.7 120.89 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.456 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 48.6 t -93.36 124.48 45.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.493 ' CD2' ' HE ' ' A' ' 277' ' ' ARG . 28.8 mt -108.05 139.72 42.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.861 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -121.57 130.01 7.94 Favored Glycine 0 N--CA 1.477 1.38 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.634 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.12 119.47 36.51 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 241' ' ' ASP . 98.4 m -109.6 170.45 8.06 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.37 0.419 . . . . 0.0 110.462 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.495 ' N ' ' CG2' ' A' ' 240' ' ' THR . 26.1 p-10 -83.07 -176.08 6.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.448 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 281' ' ' GLU . 62.4 ttm-85 -105.23 121.96 44.94 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.813 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.46 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 46.3 mm -119.43 7.44 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.565 0.698 . . . . 0.0 110.813 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 85.62 -47.21 3.77 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.66 91.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 0.0 109.685 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -45.91 -48.23 16.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.41 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.4 82.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.878 0.37 . . . . 0.0 110.61 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -62.06 -45.24 94.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.525 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 241' ' ' ASP . 33.2 t30 -61.49 -43.87 98.09 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.652 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -64.76 -41.25 96.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.634 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.49 -36.78 93.65 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 30.5 mt -70.06 -41.17 74.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.915 0.388 . . . . 0.0 111.013 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 78.1 p -65.13 -39.61 93.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.818 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.3 -47.1 71.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.92 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -59.43 -43.84 93.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.799 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 239' ' ' TYR . 39.1 ttm180 -54.1 -61.41 2.32 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.329 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -58.7 -27.57 64.98 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.638 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -69.78 -47.31 63.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.374 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 38.5 m -62.17 -37.93 87.12 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.069 0.461 . . . . 0.0 110.393 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 77.4 t -63.65 -53.21 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.723 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.02 -48.77 86.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.669 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -45.16 -41.71 8.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.228 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.638 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 57.7 t80 -82.86 -28.9 29.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.764 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.01 -8.05 54.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.437 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.9 mt -88.44 -55.75 6.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.789 0.328 . . . . 0.0 111.619 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 41.6 m -50.61 -4.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.974 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.638 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 33.4 mmtm -77.48 -10.55 59.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.743 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.74 -7.44 22.09 Favored Glycine 0 C--O 1.227 -0.283 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.06 141.72 47.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.404 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.48 132.28 30.68 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.268 1.979 . . . . 0.0 111.826 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.04 -4.1 19.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.517 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -94.15 -26.24 16.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.451 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -79.55 -17.38 54.13 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.237 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.8 pt -104.24 -171.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.695 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 39.4 m -168.68 130.51 1.29 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.311 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.88 111.16 23.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.882 0.372 . . . . 0.0 110.627 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.493 ' HE ' ' CD2' ' A' ' 237' ' ' LEU . 41.4 ttp180 -123.13 148.74 45.38 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.152 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.63 148.83 16.49 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.545 ' N ' ' O ' ' A' ' 238' ' ' GLY . 83.9 mmm -121.99 15.98 10.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 119.335 -0.365 . . . . 0.0 111.554 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 23.32 -88.46 0.01 OUTLIER Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 279' ' ' MET . 0.6 OUTLIER -142.72 74.25 1.44 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.096 0.474 . . . . 0.0 110.738 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.4 t -72.22 -54.05 10.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.836 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -137.77 74.06 45.92 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.779 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.02 120.39 8.22 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.652 2.235 . . . . 0.0 112.26 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.4 m -75.91 -23.91 16.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.279 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.663 ' C ' ' H ' ' A' ' 288' ' ' ASN . 31.2 p -58.41 -44.9 89.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.612 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.21 -4.29 0.02 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.663 ' H ' ' C ' ' A' ' 286' ' ' THR . 22.0 m120 -126.13 -58.25 1.37 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.0 m -60.52 -22.86 64.06 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.55 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 63.5 m -121.07 27.79 8.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.47 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 29.4 p-10 -68.42 -2.85 9.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.664 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -111.49 31.98 5.73 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.494 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 15.5 t -137.86 117.67 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.865 0.364 . . . . 0.0 110.755 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -120.72 14.0 11.66 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.698 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.6 174.52 7.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.122 0.487 . . . . 0.0 109.849 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -81.01 -75.7 0.27 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -59.1 -27.52 65.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.984 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.87 95.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.481 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 303' ' ' LEU . 60.1 mt -69.36 -50.41 46.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.05 0.452 . . . . 0.0 110.646 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 62.7 mt -53.53 -34.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.006 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -78.34 -35.19 47.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.443 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.57 -10.59 55.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.539 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 299' ' ' LEU . 47.8 mt -91.55 23.77 3.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.515 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.583 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -85.12 -44.64 0.66 Allowed Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.5 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 33.1 Cg_exo -59.12 7.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.56 2.84 . . . . 0.0 112.232 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 304' ' ' ALA . 35.9 p30 -107.04 18.15 22.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.708 0.289 . . . . 0.0 110.796 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -113.21 98.58 7.22 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.514 0.673 . . . . 0.0 109.881 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 38.0 ptt180 -159.85 133.58 7.2 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.147 -0.621 . . . . 0.0 112.016 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.14 141.37 15.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -122.81 104.28 9.18 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.257 0.551 . . . . 0.0 110.313 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.87 117.47 25.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -93.35 123.05 36.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 123.12 0.263 . . . . 0.0 110.624 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 14.6 t -123.12 115.79 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.318 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -115.53 129.11 56.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 105.9 12.04 26.88 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 15.4 tt -93.71 137.34 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.226 0.536 . . . . 0.0 110.672 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -85.18 129.61 34.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.709 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.41 ' N ' ' OE1' ' A' ' 190' ' ' GLN . 4.3 p-10 -157.3 169.11 25.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.618 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.67 131.08 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.488 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 41.7 t -52.27 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.389 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 57.1 p -82.37 132.78 35.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.126 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -117.2 149.28 44.15 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.655 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.93 -82.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.447 2.098 . . . . 0.0 112.013 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 43.91 91.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.662 -179.904 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.24 142.52 73.71 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.583 2.189 . . . . 0.0 111.752 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.616 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -103.85 -42.55 0.18 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.275 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 48.0 Cg_exo -55.16 -36.4 93.02 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.615 2.21 . . . . 0.0 111.968 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -155.49 149.8 19.76 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.688 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.08 -31.86 44.89 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.552 2.168 . . . . 0.0 112.036 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 41.22 63.65 5.86 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.765 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.57 149.16 38.47 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.711 2.274 . . . . 0.0 112.011 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -105.72 9.76 32.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.626 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 58.6 t -121.26 127.48 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.512 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -100.22 83.68 2.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.349 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 24.1 m -67.38 125.24 25.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.411 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 313' ' ' VAL . 41.6 tptt -117.1 162.14 18.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.205 0.526 . . . . 0.0 111.04 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -149.27 123.16 9.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.112 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -114.82 118.92 34.89 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.675 ' HG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -86.36 108.03 18.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.639 -179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 27.0 tp -109.4 125.35 52.3 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -83.17 129.9 35.06 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 122.192 0.996 . . . . 0.0 112.602 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 202' ' ' PHE . 93.6 p -60.35 -27.87 67.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.834 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 203' ' ' ASN . 14.1 t70 -54.28 -40.56 67.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.03 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.5 t -72.74 -33.44 44.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 79.2 mt -89.43 -79.54 0.33 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.51 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -127.86 116.27 19.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.745 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.43 ' OD1' ' OD1' ' A' ' 199' ' ' ASP . 3.1 m-80 -82.26 -64.59 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.772 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -116.73 -17.52 10.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.77 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.531 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 54.4 t30 -66.16 164.92 14.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.058 0.456 . . . . 0.0 110.194 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -50.85 -80.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.507 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.49 53.0 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.214 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.531 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 42.5 p -107.24 134.38 50.41 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.168 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.1 mt -78.17 127.3 32.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.284 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' GLY . 8.0 ptmt -85.01 161.87 51.31 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.717 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -36.89 -75.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.075 1.85 . . . . 0.0 111.553 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -50.54 -19.89 1.02 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.017 0.437 . . . . 0.0 109.963 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.84 -52.08 13.09 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.6 -38.89 90.75 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.158 0.504 . . . . 0.0 109.903 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.53 57.13 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.85 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.81 88.76 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.763 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.2 mt -62.27 -29.08 70.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.519 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -72.34 -45.94 57.69 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.379 0.609 . . . . 0.0 110.486 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.528 ' O ' ' NE2' ' A' ' 223' ' ' GLN . 6.7 mt-30 -62.14 -42.95 99.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.081 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.45 -39.63 92.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.586 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 225' ' ' SER . 7.1 t80 -52.87 -46.73 68.03 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.46 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.4 m -55.1 -51.32 66.79 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.684 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.872 ' H ' HE21 ' A' ' 223' ' ' GLN . 0.0 OUTLIER -55.86 -27.02 49.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.582 -179.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 78.0 mt -95.95 -21.18 18.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.769 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 221' ' ' TYR . 9.2 p -84.7 -13.43 51.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.476 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -106.4 23.6 13.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.157 0.503 . . . . 0.0 110.654 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 227' ' ' LEU . 0.9 OUTLIER -77.58 -179.31 5.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.687 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -101.41 109.11 58.05 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 232' ' ' GLY . 73.9 Cg_exo -44.45 -19.22 0.23 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.829 2.353 . . . . 0.0 112.964 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 229' ' ' PRO . 3.4 ttmp? -24.51 -47.57 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.691 0.619 . . . . 0.0 110.775 -178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 97.6 m-20 -116.49 -11.95 11.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.648 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 24.9 47.76 0.02 OUTLIER Glycine 0 N--CA 1.47 0.963 0 O-C-N 123.587 0.554 . . . . 0.0 111.841 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 231' ' ' ASP . 2.3 m -118.36 117.48 29.19 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 122.588 -0.36 . . . . 0.0 110.171 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.21 95.71 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.57 0.7 . . . . 0.0 110.675 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.3 125.18 51.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.283 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.86 129.83 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.428 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.0 mt -114.02 140.0 48.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 279' ' ' MET . . . -115.42 141.04 16.72 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.5 OUTLIER -121.55 123.93 43.16 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 249' ' ' ASN . 2.1 p -118.5 161.77 19.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.106 0.479 . . . . 0.0 110.076 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.526 ' OD2' ' NE ' ' A' ' 307' ' ' ARG . 8.5 p30 -84.05 174.91 9.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.337 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -97.31 122.28 40.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.226 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 48.0 mm -117.15 14.97 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.363 0.601 . . . . 0.0 110.65 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.2 4.51 88.95 Favored Glycine 0 C--N 1.314 -0.688 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 24.8 m -130.07 102.19 6.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 110.235 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -52.31 -51.96 55.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.679 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.9 -42.52 76.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.726 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.405 ' CE2' ' CD1' ' A' ' 252' ' ' LEU . 33.9 t80 -60.4 -46.08 91.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.552 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.444 ' O ' ' OG ' ' A' ' 253' ' ' SER . 14.5 t-20 -62.92 -46.09 89.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.829 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -63.01 -42.48 99.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.719 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.54 -38.16 95.91 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.405 ' CD1' ' CE2' ' A' ' 248' ' ' TYR . 28.1 mt -73.71 -34.37 64.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.676 0.274 . . . . 0.0 111.084 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 249' ' ' ASN . 4.4 m -65.26 -44.37 88.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.025 0.44 . . . . 0.0 110.629 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -68.26 -43.67 77.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.084 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -58.59 -47.14 85.3 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.914 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.68 -55.0 30.88 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.392 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.49 -33.76 68.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.193 0.521 . . . . 0.0 109.942 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -45.89 41.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.283 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 43.0 t -60.06 -39.85 87.45 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.23 -52.5 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.461 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.6 t -61.15 -49.48 84.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.172 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -44.9 -41.45 7.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.895 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.25 -29.7 31.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.568 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -7.73 52.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.268 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.58 ' C ' ' H ' ' A' ' 267' ' ' LYS . 59.7 mt -87.81 -57.15 4.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.845 0.355 . . . . 0.0 111.472 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 p -49.95 -6.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.974 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.58 ' H ' ' C ' ' A' ' 265' ' ' ILE . 4.8 mmtm -78.84 -10.6 59.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.092 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 108.8 37.42 2.04 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.04 128.21 24.21 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.75 130.43 37.12 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.892 1.728 . . . . 0.0 112.062 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.85 -9.27 35.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.001 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 52.0 t0 -92.79 -22.93 19.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.779 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.49 -21.17 45.7 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.714 0.769 . . . . 0.0 110.548 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -103.18 -171.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.051 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 1.3 m -166.8 130.23 1.9 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.153 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -105.02 112.79 26.05 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.633 0.254 . . . . 0.0 110.642 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -122.54 147.21 46.65 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.509 0.671 . . . . 0.0 110.517 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.77 99.09 2.25 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.4 tpt -67.99 -11.44 58.88 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.445 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.54 -95.53 0.01 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 279' ' ' MET . 97.8 mt-10 -141.41 75.68 1.51 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 110.8 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.1 p -87.76 -4.9 58.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -172.96 78.93 0.42 Allowed Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.756 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.29 104.62 0.43 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.539 2.159 . . . . 0.0 112.305 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 17.5 m -70.59 -40.39 77.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.268 0.556 . . . . 0.0 110.193 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.642 ' C ' ' H ' ' A' ' 288' ' ' ASN . 17.7 p -64.81 -47.44 78.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.099 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.418 ' H ' ' HG1' ' A' ' 286' ' ' THR . . . -51.65 -1.68 0.04 OUTLIER Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.642 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.5 t-20 -112.31 -59.83 1.95 Allowed 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.91 -4.18 55.97 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.382 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 286' ' ' THR . 0.7 OUTLIER -126.59 16.64 7.56 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.38 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.62 -3.1 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.382 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -101.95 32.37 3.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.8 t -129.36 121.43 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.02 0.438 . . . . 0.0 110.143 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -118.88 8.51 11.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.67 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -90.71 169.45 10.96 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 110.04 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -82.65 -78.24 0.21 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.636 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -50.7 -29.97 12.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.97 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.99 99.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.244 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.7 mt -68.93 -42.46 76.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.542 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.4 mm -59.48 -34.13 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.015 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.18 -25.41 31.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.412 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 11.3 t -94.34 -15.19 24.62 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.962 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 299' ' ' LEU . 54.1 mt -91.88 22.72 4.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.717 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.567 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -75.81 -44.86 4.04 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.316 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 22.2 Cg_exo -64.15 8.7 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.434 2.756 . . . . 0.0 111.817 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 304' ' ' ALA . 7.4 t70 -108.41 7.31 26.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.696 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.526 ' NE ' ' OD2' ' A' ' 241' ' ' ASP . 93.1 mtt180 -109.62 100.54 9.56 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.151 0.5 . . . . 0.0 110.086 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.675 ' NH2' ' HG1' ' A' ' 195' ' ' THR . 16.9 ptm180 -173.43 166.62 4.72 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.888 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.8 151.06 33.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -120.92 108.37 13.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.178 0.513 . . . . 0.0 110.251 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.4 mm -80.02 119.49 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.767 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -104.33 114.88 29.42 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.02 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 192' ' ' LYS . 70.4 t -127.81 123.18 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.658 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -118.98 148.14 43.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.009 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.43 25.03 31.85 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.645 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.2 tt -103.17 177.3 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.645 ' O ' ' O ' ' A' ' 316' ' ' ILE . 14.2 mptt -44.01 -160.74 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 O-C-N 124.124 0.89 . . . . 0.0 110.763 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 319' ' ' VAL . 49.5 t0 -67.81 154.31 41.82 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.762 -0.586 . . . . 0.0 110.905 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . 0.43 ' N ' ' OD1' ' A' ' 318' ' ' ASP . 6.2 p -126.22 131.56 71.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.074 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.05 119.05 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.128 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.1 t -151.76 116.26 5.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.231 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -96.2 146.96 32.21 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.652 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.77 -47.54 9.7 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.226 1.951 . . . . 0.0 112.626 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -142.36 121.87 13.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.516 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.466 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.12 43.43 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.763 2.309 . . . . 0.0 111.865 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -152.38 59.09 2.81 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.718 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.16 160.87 46.19 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.682 2.254 . . . . 0.0 111.921 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.424 ' N ' ' HD2' ' A' ' 185' ' ' PRO . . . -167.98 -61.79 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.279 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 184' ' ' ALA . 30.7 Cg_endo -61.19 150.01 86.57 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.412 2.075 . . . . 0.0 111.902 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' A' ' 188' ' ' GLU . . . -140.0 71.72 34.64 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.239 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -75.7 25.48 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.62 2.213 . . . . 0.0 112.055 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 186' ' ' ALA . 96.0 mt-10 57.43 -140.78 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.075 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.67 133.23 40.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.537 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -95.91 99.52 11.3 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.949 0.404 . . . . 0.0 110.776 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m -70.64 145.99 50.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.209 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.435 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 10.6 tptp -146.33 165.03 30.52 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.225 0.536 . . . . 0.0 110.326 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.435 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 89.2 m-70 -152.83 126.47 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.216 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 70.1 m-85 -114.84 124.67 52.33 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.538 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.52 108.97 19.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.859 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 27.5 tp -110.96 126.99 55.34 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -78.59 129.5 34.85 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.735 0.778 . . . . 0.0 111.932 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.447 ' H ' ' HA ' ' A' ' 308' ' ' ARG . 58.2 m -69.11 -30.86 69.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.404 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.461 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 2.4 p-10 -62.39 -33.81 75.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.657 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.48 -34.97 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.6 mt -85.62 -81.82 0.2 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.804 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -112.54 132.44 55.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.047 -179.292 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 199' ' ' ASP . 66.5 m-80 -111.65 -81.06 0.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.805 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -83.6 -37.61 22.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -64.43 162.29 15.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.056 0.455 . . . . 0.0 110.504 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -52.24 -66.94 0.3 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.583 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.49 61.14 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.471 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 75.3 p -107.44 134.12 50.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.138 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.66 145.08 45.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 213' ' ' GLY . 13.4 mmmt -104.1 153.11 39.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.017 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 210' ' ' LYS . 86.4 Cg_exo -32.34 -77.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.545 2.163 . . . . 0.0 112.265 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -51.22 -18.81 1.0 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.353 0.597 . . . . 0.0 110.376 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.9 -49.83 8.39 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.052 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -65.98 -41.93 90.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.079 0.466 . . . . 0.0 110.142 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.6 -49.6 75.88 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.399 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.81 92.55 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.486 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.01 -31.31 71.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.311 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.47 -46.32 66.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 0.0 110.852 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -62.71 -41.73 99.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.065 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 50.9 tp -66.02 -39.43 90.22 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.475 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.5 t80 -54.82 -47.99 73.38 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.168 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.1 t -57.6 -51.18 70.54 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.41 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 11.4 tt0 -53.45 -25.0 14.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.689 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 68.2 mt -100.29 -22.1 15.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 221' ' ' TYR . 7.5 t -67.87 -17.65 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 58.1 t-20 -111.83 29.46 7.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -78.94 141.69 37.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 109.987 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 315' ' ' GLY . 38.6 t0 -50.66 107.38 0.8 Allowed Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 232' ' ' GLY . 47.9 Cg_exo -54.3 -19.22 16.28 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.219 1.946 . . . . 0.0 113.018 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.494 ' C ' ' O ' ' A' ' 229' ' ' PRO . 38.1 ttmt -21.42 -50.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.539 0.525 . . . . 0.0 111.376 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 232' ' ' GLY . 2.6 m-20 -115.87 -8.09 11.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.96 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.09 54.77 0.16 Allowed Glycine 0 N--CA 1.473 1.119 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.563 ' H ' ' CE ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -123.24 116.7 23.81 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 121.294 0.569 . . . . 0.0 110.847 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 79.1 t -131.28 101.33 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.652 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.41 123.04 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.018 0.437 . . . . 0.0 110.59 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.73 127.67 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.244 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 28.3 mt -110.23 145.95 36.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.014 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -111.14 136.47 13.62 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.488 ' CZ ' ' CD ' ' A' ' 310' ' ' GLU . 6.7 m-85 -122.12 115.95 23.36 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 17.5 p -112.72 165.8 11.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.933 0.397 . . . . 0.0 110.692 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -88.43 -177.36 5.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.323 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -97.44 122.18 40.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.33 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.613 ' H ' HD22 ' A' ' 249' ' ' ASN . 47.9 mm -118.6 13.42 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.187 0.518 . . . . 0.0 110.689 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.14 1.56 80.52 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.3 p -129.05 104.45 7.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.173 0.511 . . . . 0.0 109.964 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -55.23 -53.13 59.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.358 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.96 -46.29 78.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -60.23 -44.98 94.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.62 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.613 HD22 ' H ' ' A' ' 243' ' ' ILE . 77.2 m-20 -61.43 -45.3 94.87 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.35 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -66.29 -37.69 86.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.551 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.11 -40.45 98.55 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.95 -29.92 62.26 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.695 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 14.9 m -66.81 -47.53 71.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.937 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.84 -41.39 78.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.325 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.16 -49.44 77.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.026 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -60.85 -58.6 7.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.495 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.98 -35.69 25.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.068 0.461 . . . . 0.0 109.902 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -71.57 -45.06 63.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.325 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 57.3 m -60.53 -39.47 87.96 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.446 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.69 -51.04 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.406 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.8 t -60.28 -49.7 83.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.152 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -44.63 -41.99 7.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.18 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.558 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 76.8 t80 -81.3 -29.16 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.037 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.93 -5.84 48.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.654 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.597 ' C ' ' H ' ' A' ' 267' ' ' LYS . 53.0 mt -88.73 -60.3 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.917 0.389 . . . . 0.0 111.953 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 29.5 t -49.81 -4.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.391 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.597 ' H ' ' C ' ' A' ' 265' ' ' ILE . 70.7 mmtt -75.76 -10.79 59.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.442 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 116.76 -8.47 16.9 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -83.35 129.34 60.87 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.425 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.28 134.36 56.51 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.641 1.56 . . . . 0.0 111.896 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.61 55.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -92.61 -21.15 20.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.055 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -77.86 -22.97 49.06 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.611 0.719 . . . . 0.0 110.593 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -101.51 -170.94 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.771 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 15.2 t -170.08 130.18 0.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.102 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.29 153.3 17.89 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.942 -0.473 . . . . 0.0 109.756 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -161.48 149.4 15.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.023 0.44 . . . . 0.0 110.72 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.51 96.78 1.1 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 15.6 tpp -69.86 -13.15 62.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.509 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 57.79 -101.42 0.18 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.66 71.04 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.822 0.344 . . . . 0.0 110.779 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 25.2 t -90.78 -1.55 57.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.662 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -157.73 68.66 4.0 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.317 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.27 105.41 2.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.188 1.925 . . . . 0.0 112.301 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 30.2 m -75.54 -25.7 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.597 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.683 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.0 OUTLIER -58.64 -44.47 90.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.912 -179.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.409 ' N ' ' HG1' ' A' ' 286' ' ' THR . . . -48.5 -3.08 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.683 ' H ' ' C ' ' A' ' 286' ' ' THR . 94.8 m-20 -122.62 -57.82 1.71 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 m -63.89 -21.31 66.4 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.698 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 55.9 m -122.18 26.0 8.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.281 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 47.5 t0 -70.71 -6.04 34.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.594 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -110.11 30.55 6.63 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.572 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 15.1 t -133.39 120.04 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.462 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -120.27 8.93 10.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -86.17 171.96 10.91 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 110.074 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -80.91 -73.85 0.35 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.755 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -59.25 -26.86 65.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.21 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.55 84.65 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.8 mt -72.21 -47.68 48.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.744 0.307 . . . . 0.0 110.744 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.21 -31.27 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.081 0.467 . . . . 0.0 109.876 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -80.58 -29.65 36.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.68 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.6 t -93.31 -10.72 34.44 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 299' ' ' LEU . 49.8 mt -92.23 19.95 6.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.727 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.608 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -74.07 -41.85 5.46 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.4 Cg_exo -62.71 9.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.408 2.739 . . . . 0.0 112.314 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 304' ' ' ALA . 38.8 t0 -112.54 7.37 18.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.884 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 64.6 mtp180 -104.43 100.43 10.13 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.021 0.439 . . . . 0.0 110.05 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.447 ' HA ' ' H ' ' A' ' 198' ' ' SER . 39.2 ptt180 -171.32 -171.14 0.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.287 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.47 155.85 14.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.488 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 96.2 mt-10 -122.8 102.74 8.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.25 0.547 . . . . 0.0 110.395 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.6 mm -79.18 120.81 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.711 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -101.93 121.31 41.89 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.568 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 70.4 t -130.04 123.4 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.928 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.647 ' HZ1' ' CA ' ' A' ' 315' ' ' GLY . 0.0 OUTLIER -95.25 -174.21 3.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.935 178.365 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.647 ' CA ' ' HZ1' ' A' ' 314' ' ' LYS . . . 16.69 69.21 0.01 OUTLIER Glycine 0 N--CA 1.472 1.047 0 O-C-N 123.677 0.611 . . . . 0.0 112.386 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.644 ' O ' ' N ' ' A' ' 318' ' ' ASP . 4.1 tt -115.18 160.06 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.44 ' H ' HG13 ' A' ' 316' ' ' ILE . 0.1 OUTLIER -46.36 79.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 122.239 1.018 . . . . 0.0 111.226 -178.226 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.644 ' N ' ' O ' ' A' ' 316' ' ' ILE . 3.1 p30 -56.81 175.81 0.11 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.44 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.47 122.84 49.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 14.5 m -51.93 173.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.425 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.1 p -55.91 128.05 33.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.953 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 323' ' ' PRO . 1.6 pp0? -85.34 148.77 50.64 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.754 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.515 ' O ' ' NE2' ' A' ' 322' ' ' GLN . 51.7 Cg_exo -48.37 136.28 25.57 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.85 1.7 . . . . 0.0 112.36 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -83.86 -13.64 53.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.586 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.401 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.66 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.502 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 29.6 Cg_endo -62.04 -47.23 10.89 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.931 2.421 . . . . 0.0 111.86 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 169.83 152.14 0.16 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.472 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.34 142.71 55.68 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.515 2.144 . . . . 0.0 111.726 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 170.86 131.93 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.617 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.76 -18.44 24.99 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.508 2.139 . . . . 0.0 112.226 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -162.15 72.3 2.3 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.474 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.45 155.33 55.4 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.499 2.133 . . . . 0.0 111.832 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -132.51 179.75 5.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.165 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.3 140.88 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.126 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.478 ' NE2' ' H ' ' A' ' 190' ' ' GLN . 1.0 OUTLIER -123.2 132.25 53.98 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.562 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.41 ' CG2' ' CE1' ' A' ' 193' ' ' HIS . 29.0 m -87.79 141.17 28.81 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.045 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.639 ' HZ2' ' HG1' ' A' ' 321' ' ' THR . 41.2 tptt -133.86 97.4 3.89 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.392 0.615 . . . . 0.0 111.725 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.41 ' CE1' ' CG2' ' A' ' 191' ' ' THR . 8.7 m80 -84.71 135.75 34.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.106 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.615 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 62.0 m-85 -111.04 124.32 51.94 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.876 0.37 . . . . 0.0 110.103 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.6 102.44 14.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.166 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 32.0 tp -104.54 125.66 50.9 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.301 0.572 . . . . 0.0 109.727 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -79.15 128.66 33.57 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-O 122.349 1.071 . . . . 0.0 112.177 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 307' ' ' ARG . 94.5 p -61.25 -30.6 70.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.289 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.56 -37.79 76.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.05 -43.79 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 90.4 mt -78.63 -78.25 0.15 Allowed 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.921 -0.711 . . . . 0.0 110.583 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -128.48 130.38 47.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.147 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -96.3 -70.92 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.472 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -106.31 -13.86 15.27 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.932 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.662 ' ND2' ' HZ2' ' A' ' 210' ' ' LYS . 98.6 m-20 -71.59 168.09 18.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.059 0.457 . . . . 0.0 110.199 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.631 ' NZ ' ' NH1' ' A' ' 255' ' ' ARG . 19.7 tptm -57.64 -69.94 0.15 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.483 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -163.12 -0.11 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.411 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 14.4 t -52.92 134.83 37.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.995 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.9 139.59 34.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.072 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.662 ' HZ2' ' ND2' ' A' ' 205' ' ' ASN . 28.4 mttp -98.34 158.32 32.86 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.822 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -34.47 -75.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.43 2.087 . . . . 0.0 111.831 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -51.21 -21.05 1.82 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.177 0.513 . . . . 0.0 110.243 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.59 -51.41 12.11 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.305 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -67.1 -39.1 86.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.322 0.582 . . . . 0.0 110.072 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.61 -53.79 53.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.757 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.52 87.64 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.699 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 mt -61.36 -28.21 69.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.311 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -74.83 -45.45 43.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.456 0.646 . . . . 0.0 110.53 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -61.51 -42.68 99.17 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.849 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 57.3 tp -65.58 -39.15 91.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.536 ' CZ ' ' OG ' ' A' ' 225' ' ' SER . 5.9 t80 -52.6 -50.1 63.74 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.228 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.4 t -53.87 -51.68 62.88 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.414 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.615 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 8.7 tt0 -52.76 -25.93 12.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.149 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 22.5 mt -99.13 -18.95 17.44 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.419 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.536 ' OG ' ' CZ ' ' A' ' 221' ' ' TYR . 1.7 m -73.36 -31.67 64.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.065 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -91.54 23.15 3.61 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.949 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.24 158.55 27.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.28 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 315' ' ' GLY . 10.0 t0 -76.43 128.93 81.24 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.304 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 230' ' ' LYS . 42.8 Cg_endo -68.36 -18.66 44.21 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.919 2.412 . . . . 0.0 112.813 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 229' ' ' PRO . 65.3 tttm -32.63 -47.31 0.16 Allowed 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 123.508 0.505 . . . . 0.0 110.468 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 232' ' ' GLY . 21.8 m-20 -108.55 -18.84 13.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.886 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.15 47.99 0.03 OUTLIER Glycine 0 N--CA 1.474 1.23 0 O-C-N 123.902 0.751 . . . . 0.0 111.234 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 231' ' ' ASP . 18.0 m -115.36 110.84 19.95 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.7 t -127.03 94.25 2.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.664 0.745 . . . . 0.0 110.074 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 16.0 t -98.72 122.74 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.642 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.87 123.24 49.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.667 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.5 mt -106.35 143.62 34.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.027 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -118.33 135.94 11.92 Favored Glycine 0 N--CA 1.478 1.441 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.334 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.629 ' CE2' ' SD ' ' A' ' 279' ' ' MET . 0.1 OUTLIER -121.2 116.84 25.68 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.2 t -108.09 167.95 9.64 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -90.85 -179.27 5.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.271 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -95.88 123.15 39.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.375 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.444 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 49.9 mm -118.12 9.18 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.418 0.628 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 81.86 4.39 90.32 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.611 ' HG ' ' H ' ' A' ' 248' ' ' TYR . 2.7 t -134.04 98.75 4.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.078 0.466 . . . . 0.0 110.327 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -52.69 -51.66 59.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.488 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.2 69.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.909 0.385 . . . . 0.0 110.413 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.611 ' H ' ' HG ' ' A' ' 245' ' ' SER . 46.4 t80 -61.27 -41.2 96.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.377 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -60.9 -46.47 90.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.424 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -61.62 -38.71 88.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.388 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.84 -38.33 96.34 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 34.2 mt -71.93 -39.19 69.64 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.378 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.5 t -64.55 -41.19 96.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.227 0.537 . . . . 0.0 110.951 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.01 -38.39 66.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.631 ' NH1' ' NZ ' ' A' ' 206' ' ' LYS . 17.3 mmt85 -60.12 -51.25 70.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.965 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.418 ' HG3' ' N ' ' A' ' 257' ' ' ALA . 20.1 ptp180 -64.18 -44.66 91.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -60.1 -37.1 78.95 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.305 0.574 . . . . 0.0 110.158 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -44.2 59.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.41 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 49.9 m -59.4 -38.37 80.39 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.094 0.474 . . . . 0.0 110.306 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 96.4 t -65.71 -52.72 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.376 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.3 t -61.83 -49.21 85.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.441 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -46.53 -41.34 14.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.856 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.573 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 58.3 t80 -81.28 -32.78 33.06 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.56 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -9.01 39.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.624 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.599 ' C ' ' H ' ' A' ' 267' ' ' LYS . 61.8 mt -86.4 -50.1 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 111.556 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 88.8 p -49.82 -5.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.199 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.599 ' H ' ' C ' ' A' ' 265' ' ' ILE . 2.0 mptp? -86.89 7.67 26.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 110.35 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 87.24 41.4 6.59 Favored Glycine 0 CA--C 1.507 -0.456 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.79 128.11 25.5 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.37 126.38 21.51 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.755 1.636 . . . . 0.0 111.982 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.49 -8.78 21.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.971 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -91.53 -22.97 20.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -80.46 -18.66 48.06 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.463 0.649 . . . . 0.0 110.713 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.7 pt -106.18 -171.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.777 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 28.7 t -171.05 127.63 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.327 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.14 110.56 23.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.472 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -120.18 148.09 44.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.46 0.647 . . . . 0.0 110.86 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.42 97.84 0.5 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.629 ' SD ' ' CE2' ' A' ' 239' ' ' TYR . 2.8 ptp -81.59 31.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.461 0.172 . . . . 0.0 110.816 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 38.19 -97.43 0.01 OUTLIER Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -141.84 70.57 1.34 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.704 0.288 . . . . 0.0 110.415 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.8 m -91.16 0.59 57.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.518 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -155.95 60.67 2.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.51 110.93 3.17 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.505 2.137 . . . . 0.0 112.03 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.5 m -71.37 -36.4 61.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.42 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.678 ' C ' ' H ' ' A' ' 288' ' ' ASN . 70.6 p -62.18 -45.75 92.0 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.083 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.31 -3.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.678 ' H ' ' C ' ' A' ' 286' ' ' THR . 55.8 t-20 -123.83 -57.78 1.61 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 m -58.94 -25.61 63.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.615 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 68.3 m -105.12 32.07 4.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 0.0 110.59 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.48 -2.81 18.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.456 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -109.98 30.98 6.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 10.5 t -132.17 121.65 46.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 120.919 0.39 . . . . 0.0 110.42 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -121.23 6.18 10.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . 0.432 ' O ' ' CD1' ' A' ' 299' ' ' LEU . 5.1 mt-30 -88.5 172.12 9.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.039 0.447 . . . . 0.0 110.402 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -82.01 -72.62 0.43 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.91 -28.99 66.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.47 . . . . 0.0 110.867 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.27 82.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.381 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 303' ' ' LEU . 42.5 mt -71.81 -52.16 18.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 63.6 mt -51.42 -34.73 15.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.51 -35.22 58.45 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.352 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.97 -8.22 57.41 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.814 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 299' ' ' LEU . 65.8 mt -96.23 15.53 20.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.723 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.616 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -76.78 -45.93 3.05 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.141 0.496 . . . . 0.0 110.008 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 28.0 Cg_exo -59.47 10.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 123.042 2.495 . . . . 0.0 111.818 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.616 ' H ' ' C ' ' A' ' 304' ' ' ALA . 54.6 t0 -104.56 13.52 31.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.873 0.368 . . . . 0.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.447 ' O ' ' OG ' ' A' ' 198' ' ' SER . 78.8 mtp85 -112.58 102.23 10.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.299 0.571 . . . . 0.0 110.557 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.6 ptp180 -165.8 142.51 5.34 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.22 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 15.2 m -107.4 145.54 14.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -118.04 108.63 15.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.118 0.485 . . . . 0.0 110.74 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.4 mm -79.5 114.28 20.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -96.72 111.15 23.43 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.769 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.0 118.4 57.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 O-C-N 123.556 0.535 . . . . 0.0 110.919 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -116.25 131.07 57.05 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.69 33.88 5.96 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.705 ' O ' ' O ' ' A' ' 317' ' ' LYS . 10.5 tt -108.46 168.53 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.705 ' O ' ' O ' ' A' ' 316' ' ' ILE . 42.1 tttt -43.04 -150.98 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 O-C-N 124.205 0.941 . . . . 0.0 111.556 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.427 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 88.2 m-20 -73.93 171.09 14.07 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 121.441 -0.787 . . . . 0.0 110.45 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.26 122.97 69.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.247 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.592 ' H ' ' HZ3' ' A' ' 192' ' ' LYS . 3.8 m -142.88 126.05 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.399 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.639 ' HG1' ' HZ2' ' A' ' 192' ' ' LYS . 64.0 m -151.49 96.74 2.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.245 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -87.76 115.5 63.19 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.832 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.92 -12.25 21.67 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.389 2.059 . . . . 0.0 112.164 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -68.56 -137.1 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.628 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.487 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.546 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 68.5 Cg_endo -83.67 125.58 3.82 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.294 1.996 . . . . 0.0 112.085 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.526 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -161.23 47.35 0.22 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.784 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 58.1 Cg_endo -69.52 160.98 47.68 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.77 2.313 . . . . 0.0 111.78 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 70.89 74.59 0.25 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.651 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.34 163.4 37.93 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.47 2.114 . . . . 0.0 112.0 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.566 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -178.48 -44.06 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.469 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 44.8 Cg_exo -55.85 -29.57 73.03 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.578 2.185 . . . . 0.0 112.084 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -45.21 144.33 1.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.643 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 88.3 t -123.24 128.95 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.524 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -103.08 85.7 2.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 48.9 m -64.97 125.79 25.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.402 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 313' ' ' VAL . 39.2 tptt -117.97 163.33 16.74 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.278 0.561 . . . . 0.0 111.086 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -153.17 125.44 8.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.366 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.4 ' CG ' HD13 ' A' ' 220' ' ' LEU . 64.3 m-85 -114.26 116.98 29.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.56 103.45 15.08 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.333 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 31.2 tp -106.64 130.36 54.4 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.911 0.386 . . . . 0.0 110.218 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -84.65 129.04 34.89 Favored 'General case' 0 C--O 1.255 1.355 0 CA-C-O 122.565 1.174 . . . . 0.0 111.819 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 202' ' ' PHE . 37.4 m -61.54 -18.15 57.95 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.53 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.58 -41.31 94.39 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.194 0.521 . . . . 0.0 110.201 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.9 t -72.45 -34.14 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.344 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 62.4 mt -88.12 -80.0 0.28 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.126 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -127.84 114.36 17.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.244 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.588 ' ND2' ' CE2' ' A' ' 204' ' ' PHE . 62.6 t30 -90.84 -72.09 0.59 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.473 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.588 ' CE2' ' ND2' ' A' ' 203' ' ' ASN . 88.3 m-85 -102.76 -25.89 13.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.795 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -63.56 170.71 3.0 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.982 0.42 . . . . 0.0 110.154 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -53.54 -83.33 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.652 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.04 53.69 0.15 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.443 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.7 t -107.33 145.44 32.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.848 0.356 . . . . 0.0 110.303 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.23 127.61 33.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 213' ' ' GLY . 12.7 mtpp -89.55 158.85 45.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.813 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 210' ' ' LYS . 76.8 Cg_exo -33.34 -76.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.499 2.133 . . . . 0.0 112.01 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -48.47 -22.54 0.74 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.146 0.498 . . . . 0.0 110.321 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.36 -48.45 18.78 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -63.19 -39.63 95.2 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.83 -53.88 52.77 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.568 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.83 -28.65 69.7 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.596 0.712 . . . . 0.0 110.537 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -31.63 68.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.364 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.21 -48.18 30.63 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.173 0.511 . . . . 0.0 111.263 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 12.1 pt20 -64.03 -44.46 92.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.981 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.461 ' N ' ' CG ' ' A' ' 219' ' ' GLN . 36.0 tp -62.7 -41.71 99.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.336 -0.545 . . . . 0.0 109.892 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 4.2 t80 -52.26 -48.1 65.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.374 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.5 m -52.81 -52.34 57.31 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.485 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -54.3 -27.3 34.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.186 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 85.0 mt -95.3 -20.28 19.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.668 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 221' ' ' TYR . 23.5 p -79.64 -21.2 45.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.831 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -99.1 21.46 11.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.558 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.437 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.8 OUTLIER -76.34 -179.68 5.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.61 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.434 ' OD2' ' CG ' ' A' ' 230' ' ' LYS . 2.8 t70 -99.09 132.64 23.15 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.41 -17.02 34.89 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.501 2.134 . . . . 0.0 112.94 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.434 ' CG ' ' OD2' ' A' ' 228' ' ' ASP . 40.4 mmtt -37.02 -45.27 0.57 Allowed 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.55 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' GLY . 95.1 m-20 -107.73 -19.89 13.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.442 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.7 49.04 0.05 OUTLIER Glycine 0 N--CA 1.469 0.847 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.24 112.4 19.44 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 122.591 -0.358 . . . . 0.0 110.791 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 52.2 t -130.93 93.38 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.426 0.632 . . . . 0.0 110.497 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.14 123.93 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.334 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.4 127.1 53.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.598 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 25.5 mt -110.17 145.36 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.068 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -115.81 142.2 17.4 Favored Glycine 0 N--CA 1.478 1.479 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.559 ' CE2' ' SD ' ' A' ' 279' ' ' MET . 0.7 OUTLIER -122.39 120.64 34.58 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.1 p -112.74 164.59 13.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.833 0.349 . . . . 0.0 110.239 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 241' ' ' ASP . 14.5 p-10 -88.47 -176.77 5.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.373 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -100.6 121.72 42.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.277 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 51.5 mm -118.63 11.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.311 0.577 . . . . 0.0 110.664 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.23 3.72 88.63 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.7 t -133.62 99.81 4.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.068 0.461 . . . . 0.0 110.013 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 56.1 t0 -52.57 -50.78 62.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.466 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.4 67.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.822 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.412 ' CE2' ' CD1' ' A' ' 252' ' ' LEU . 45.8 t80 -62.25 -47.99 81.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.513 HD22 HE21 ' A' ' 250' ' ' GLN . 0.1 OUTLIER -62.29 -40.78 97.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.575 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.513 HE21 HD22 ' A' ' 249' ' ' ASN . 97.6 mm-40 -60.42 -48.02 83.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.899 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.14 -36.4 92.9 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.412 ' CD1' ' CE2' ' A' ' 248' ' ' TYR . 25.9 mt -72.95 -35.98 67.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.097 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.1 m -63.73 -41.71 98.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.87 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -73.21 -35.42 66.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.353 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -60.21 -53.5 56.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.434 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 239' ' ' TYR . 17.4 ptp180 -62.91 -43.96 97.39 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.277 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.92 -38.87 90.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.319 0.581 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -71.84 -42.18 67.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.277 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 10.6 t -63.24 -38.76 92.41 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.371 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 256' ' ' ARG . 84.5 t -63.36 -51.21 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.277 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.7 t -62.19 -48.75 86.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.234 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -45.08 -41.23 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.08 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.527 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 49.6 t80 -81.79 -29.51 32.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.518 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.94 -7.72 53.42 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.48 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 267' ' ' LYS . 59.6 mt -86.95 -54.67 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 111.483 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 33.9 t -50.83 -5.2 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' H ' ' C ' ' A' ' 265' ' ' ILE . 32.2 mmtp -80.18 0.46 32.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.523 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 93.11 40.75 4.78 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.44 139.33 34.36 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.209 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -63.4 129.06 24.16 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.187 1.925 . . . . 0.0 112.097 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.74 -7.28 14.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.999 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -91.1 -28.07 18.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.89 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -77.49 -20.52 54.2 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.954 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.12 -178.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 13.2 m -171.2 129.63 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.51 155.63 16.69 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.149 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -161.56 149.43 15.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.105 0.479 . . . . 0.0 110.63 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -118.13 98.46 0.76 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.559 ' SD ' ' CE2' ' A' ' 239' ' ' TYR . 0.7 OUTLIER -80.08 18.19 0.88 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.718 -0.241 . . . . 0.0 110.838 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 43.77 -102.1 0.03 OUTLIER Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.443 ' OE1' ' OD1' ' A' ' 306' ' ' ASP . 5.4 mm-40 -136.21 74.61 1.51 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.852 0.384 . . . . 0.0 110.57 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.529 ' H ' ' CE ' ' A' ' 279' ' ' MET . 0.6 OUTLIER -88.71 2.18 53.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.337 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.81 77.36 1.06 Allowed Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.859 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.62 106.82 2.33 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.015 1.81 . . . . 0.0 111.698 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 286' ' ' THR . 5.2 m -68.29 -43.83 84.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.75 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.658 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.1 p -58.85 -44.15 90.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.134 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.58 -3.55 0.02 OUTLIER Glycine 0 CA--C 1.531 1.049 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.658 ' H ' ' C ' ' A' ' 286' ' ' THR . 90.9 m-20 -119.33 -57.72 1.98 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.35 -13.42 62.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.732 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.91 23.04 6.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.305 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.79 -11.18 54.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.345 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -96.72 33.25 1.89 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.566 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 19.2 t -128.94 124.64 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.447 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -118.68 7.54 11.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -94.93 126.67 40.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 110.2 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -49.59 -57.43 7.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.73 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.12 85.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.997 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.29 -31.2 72.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.546 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 32.6 mt -76.65 -54.15 7.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.4 mt -52.54 -35.79 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.041 0.448 . . . . 0.0 109.954 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -71.25 -42.05 69.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 8.7 t -81.73 -0.73 44.24 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 110.91 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.55 18.11 13.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.359 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.581 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -79.46 -44.23 1.63 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.297 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.5 Cg_exo -63.17 8.85 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 123.257 2.638 . . . . 0.0 111.991 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 304' ' ' ALA . 6.5 t0 -107.45 12.21 28.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -109.55 106.13 15.72 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.204 0.525 . . . . 0.0 110.118 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -173.09 167.76 4.88 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.769 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.25 151.18 34.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.403 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 90.3 mt-10 -122.3 106.85 11.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.057 0.455 . . . . 0.0 110.198 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.49 117.81 25.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -102.15 120.16 39.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.069 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 192' ' ' LYS . 62.0 t -133.41 123.65 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.421 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -118.66 141.7 48.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.583 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.88 -9.19 47.06 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.829 ' O ' ' O ' ' A' ' 317' ' ' LYS . 17.1 tt -81.1 152.92 4.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.829 ' O ' ' O ' ' A' ' 316' ' ' ILE . 40.4 tttm -33.24 -141.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.234 1.016 . . . . 0.0 112.069 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.427 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 35.7 t70 -165.31 111.21 0.92 Allowed 'General case' 0 C--N 1.317 -0.841 0 O-C-N 120.771 -1.206 . . . . 0.0 110.245 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.6 m -108.2 156.47 8.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.146 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 19.4 m -91.79 154.42 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.663 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 20.5 m -65.47 144.05 57.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.364 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -128.3 84.8 62.17 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.283 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.11 147.17 84.69 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.699 2.266 . . . . 0.0 111.977 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.7 125.26 23.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.353 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.484 -179.878 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.512 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 72.4 Cg_endo -84.25 77.38 3.21 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.255 1.97 . . . . 0.0 112.254 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.446 ' CB ' ' CD ' ' A' ' 183' ' ' PRO . . . -76.46 -64.38 0.5 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.986 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 184' ' ' ALA . 28.2 Cg_endo -59.49 -38.88 80.5 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.283 1.988 . . . . 0.0 112.035 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 183' ' ' PRO . . . 58.54 145.2 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.62 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.21 160.15 45.81 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.498 2.132 . . . . 0.0 112.061 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' A' ' 187' ' ' PRO . . . 169.87 -62.4 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.136 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 186' ' ' ALA . 37.4 Cg_endo -63.22 -166.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.266 1.977 . . . . 0.0 111.95 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 65.86 44.81 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.117 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.93 130.87 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.199 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.691 ' NE2' ' H ' ' A' ' 190' ' ' GLN . 0.0 OUTLIER -112.52 96.39 5.97 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.001 0.429 . . . . 0.0 110.646 -179.279 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.2 m -75.41 132.26 40.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.138 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -146.07 118.72 8.58 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.524 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.4 m-70 -106.69 148.51 28.29 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -107.45 124.01 49.23 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.044 0.449 . . . . 0.0 110.097 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.76 101.67 12.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.567 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 38.6 tp -108.56 145.45 34.81 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.665 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 199' ' ' ASP . 1.6 tmtm? -88.98 125.8 35.14 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.721 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.0 t -67.92 -33.83 75.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.24 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.469 ' H ' ' HD2' ' A' ' 197' ' ' LYS . 17.3 t0 -63.69 -39.6 94.71 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.04 -47.93 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 47.0 mt -67.29 -78.37 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.057 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.2 117.93 35.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.67 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 199' ' ' ASP . 69.1 m-80 -90.55 -82.56 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.193 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -93.23 -16.57 24.64 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.716 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.689 HD21 ' NZ ' ' A' ' 210' ' ' LYS . 67.7 m-20 -75.49 156.82 34.8 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.264 0.554 . . . . 0.0 109.801 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.422 ' CD ' ' H ' ' A' ' 206' ' ' LYS . 12.9 mptt -50.0 -68.19 0.2 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.77 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.17 60.12 0.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.167 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.3 p -110.31 141.92 42.66 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.472 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 35.7 mt -85.17 135.21 34.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.435 0.636 . . . . 0.0 111.339 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.689 ' NZ ' HD21 ' A' ' 205' ' ' ASN . 40.2 mmtm -100.55 153.86 37.51 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.444 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LYS . 91.7 Cg_exo -30.86 -73.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 C-N-CA 122.47 2.113 . . . . 0.0 112.618 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -49.14 -28.23 4.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.041 0.448 . . . . 0.0 110.767 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.61 -47.7 32.77 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -62.53 -39.69 94.39 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.71 -54.34 47.3 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.255 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.76 -29.49 70.7 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.442 0.639 . . . . 0.0 110.156 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.05 -27.83 62.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.074 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . 0.545 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 34.3 m-20 -75.18 -49.76 18.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.491 0.662 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 5.3 pt20 -63.16 -42.55 99.45 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.361 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 31.7 tp -63.19 -41.79 99.24 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.409 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -51.56 -47.07 63.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.511 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.9 m -56.87 -50.82 71.31 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 118.786 -1.165 . . . . 0.0 110.689 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -52.27 -26.97 13.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.96 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 17.5 mt -96.31 -20.27 18.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.658 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.0 t -77.97 -21.22 51.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.054 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -100.22 19.39 16.59 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.813 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.69 160.74 29.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.754 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 4.7 t0 -77.71 113.16 29.83 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 230' ' ' LYS . 48.6 Cg_exo -50.19 -23.08 9.11 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 122.329 2.019 . . . . 0.0 113.082 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 229' ' ' PRO . 21.2 tptm -29.37 -53.16 0.13 Allowed 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 123.532 0.52 . . . . 0.0 111.085 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 233' ' ' SER . 91.5 m-20 -106.09 -16.03 14.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.021 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 24.94 44.84 0.01 OUTLIER Glycine 0 N--CA 1.469 0.836 0 O-C-N 123.954 0.783 . . . . 0.0 111.701 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 231' ' ' ASP . 41.6 m -114.07 110.58 20.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.828 0.346 . . . . 0.0 110.855 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 84.3 t -126.04 95.83 3.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.354 0.597 . . . . 0.0 109.852 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 t -97.25 121.48 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.239 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.8 t -92.87 118.98 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.253 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.45 144.04 31.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.788 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.438 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -125.51 126.05 5.78 Favored Glycine 0 N--CA 1.476 1.345 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.673 ' N ' HH22 ' A' ' 256' ' ' ARG . 0.2 OUTLIER -111.08 126.21 54.58 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.555 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.9 t -117.53 168.09 10.71 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.825 0.345 . . . . 0.0 110.243 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -91.53 176.42 6.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.648 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -92.69 126.47 37.79 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 48.6 mm -117.98 10.21 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.157 0.503 . . . . 0.0 110.661 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.42 7.25 76.41 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -140.63 104.11 4.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.245 0.545 . . . . 0.0 110.163 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 99.2 m-20 -57.1 -51.15 70.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.71 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.26 -46.18 76.1 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.044 0.449 . . . . 0.0 110.791 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -61.29 -40.81 95.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 246' ' ' ASP . 0.1 OUTLIER -58.12 -47.93 81.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.149 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.95 -40.5 93.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.712 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.15 -39.15 96.74 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.9 mt -70.38 -39.44 74.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 5.8 t -62.83 -42.28 99.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 110.809 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.52 -44.14 75.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.935 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -59.59 -47.93 83.65 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.45 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.673 HH22 ' N ' ' A' ' 239' ' ' TYR . 42.7 mtm105 -63.39 -49.63 73.03 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.333 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.76 81.08 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -70.59 -43.43 69.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.207 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.0 t -60.35 -39.29 86.62 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.278 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 91.3 t -62.83 -51.61 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.521 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 12.9 t -61.22 -48.34 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.625 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -47.87 -42.86 27.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.948 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -78.24 -35.26 48.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.994 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.36 -32.26 73.63 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.369 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.462 ' C ' ' H ' ' A' ' 267' ' ' LYS . 89.8 mt -66.59 -46.23 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 85.2 p -56.04 -10.44 0.82 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.29 0.566 . . . . 0.0 110.485 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.545 ' NZ ' ' OD1' ' A' ' 218' ' ' ASP . 20.5 mmmt -79.46 -3.54 47.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.684 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.06 43.73 3.74 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.349 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.29 129.37 24.2 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.57 129.66 30.43 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.406 1.404 . . . . 0.0 111.479 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -64.84 -9.69 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.036 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -91.46 -23.8 19.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.016 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.62 -23.81 56.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.437 0.637 . . . . 0.0 110.708 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.3 pt -103.35 -178.52 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.871 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 8.5 t -168.03 129.26 1.4 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.161 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.08 151.93 19.0 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -154.64 136.95 14.89 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.397 0.618 . . . . 0.0 111.649 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -87.29 91.37 1.73 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 4.3 tpt -69.05 -10.4 57.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.741 0.305 . . . . 0.0 110.503 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.09 -101.5 0.02 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -141.63 74.96 1.48 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.79 0.329 . . . . 0.0 110.574 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 25.4 t -82.36 -3.53 55.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.341 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -167.49 79.25 0.92 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.574 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.32 105.26 0.47 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.484 2.123 . . . . 0.0 112.201 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.401 ' CG2' ' N ' ' A' ' 286' ' ' THR . 6.4 m -71.41 -39.87 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.705 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.655 ' C ' ' H ' ' A' ' 288' ' ' ASN . 63.3 p -58.8 -42.68 89.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.506 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.64 -2.66 0.01 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.655 ' H ' ' C ' ' A' ' 286' ' ' THR . 71.3 m-80 -127.98 -57.52 1.24 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.9 m -59.53 -44.19 93.25 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.8 28.8 8.42 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.627 0.251 . . . . 0.0 110.788 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 48.2 t0 -66.36 -7.18 17.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.518 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -98.64 31.76 2.79 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.3 t -131.91 124.17 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.552 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -118.82 11.82 12.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.842 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -99.2 130.79 45.53 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.081 0.467 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -50.44 -66.08 0.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.375 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -55.08 -38.08 67.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.429 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.18 -37.44 87.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.427 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 303' ' ' LEU . 34.3 mt -72.19 -57.15 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.461 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 67.0 mt -50.71 -33.7 12.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.028 0.442 . . . . 0.0 109.895 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.18 -37.74 53.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.679 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.12 -11.91 55.86 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 299' ' ' LEU . 70.8 mt -89.03 23.86 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.781 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.572 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -74.37 -41.42 4.88 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.243 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 16.3 Cg_exo -67.65 9.17 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.483 2.122 . . . . 0.0 111.065 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 304' ' ' ALA . 30.0 t0 -102.31 1.19 35.34 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.491 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 304' ' ' ALA . 5.4 ptp180 -114.77 93.35 4.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.5 0.667 . . . . 0.0 109.509 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.513 ' NH1' ' OE2' ' A' ' 310' ' ' GLU . 36.6 ptt85 -154.37 131.8 11.25 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 122.012 0.91 . . . . 0.0 112.456 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.09 134.03 33.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.342 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.513 ' OE2' ' NH1' ' A' ' 308' ' ' ARG . 64.5 mt-10 -117.86 103.66 10.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.133 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 193' ' ' HIS . 0.9 OUTLIER -79.63 115.96 22.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -178.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.443 ' O ' ' OE1' ' A' ' 312' ' ' GLU . 6.8 tm-20 -90.93 126.73 36.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 123.201 0.313 . . . . 0.0 110.385 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.67 114.98 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.936 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -115.04 134.09 55.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 98.44 10.3 51.13 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.538 ' O ' ' NE2' ' A' ' 190' ' ' GLN . 19.7 tt -93.95 137.98 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.876 0.37 . . . . 0.0 110.502 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -83.96 127.12 33.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.355 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -83.57 105.62 14.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.752 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 4.6 p -68.57 156.52 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.316 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 6.2 p -41.87 126.05 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.697 0.284 . . . . 0.0 110.793 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 8.4 t -75.77 138.15 41.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.586 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -65.64 149.78 96.91 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.381 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.86 135.9 10.01 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.782 1.654 . . . . 0.0 112.158 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -130.68 121.14 24.97 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.412 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.391 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -41.3 -61.75 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.249 1.966 . . . . 0.0 112.943 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 176.8 58.23 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.039 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.88 -22.2 56.43 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.756 2.304 . . . . 0.0 111.69 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -164.06 132.89 2.83 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.865 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.22 -15.46 25.48 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.002 1.801 . . . . 0.0 112.303 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -148.58 78.68 9.08 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.677 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.7 -37.45 64.48 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.645 2.23 . . . . 0.0 111.814 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 60.29 -109.39 0.41 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.291 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 47.3 t -148.84 140.07 17.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.616 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -102.84 82.86 2.16 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.945 0.402 . . . . 0.0 110.579 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.439 ' CG2' ' HE2' ' A' ' 193' ' ' HIS . 59.0 m -79.42 126.96 31.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.302 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -143.17 108.72 5.08 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.325 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.439 ' HE2' ' CG2' ' A' ' 191' ' ' THR . 30.9 m170 -95.25 142.5 27.6 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 63.3 m-85 -107.38 123.67 48.7 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 195' ' ' THR . 7.9 t -86.83 102.61 14.46 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.766 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.3 tp -107.75 129.34 55.05 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.497 0.665 . . . . 0.0 109.296 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -85.99 131.85 34.19 Favored 'General case' 0 C--O 1.252 1.237 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.972 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.538 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 14.6 m -62.11 -26.56 68.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.577 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 200' ' ' VAL . 15.0 p-10 -59.07 -36.05 74.42 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.145 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.614 ' N ' ' OD1' ' A' ' 199' ' ' ASP . 31.9 t -71.3 -45.6 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 85.8 mt -79.49 -77.61 0.18 Allowed 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.963 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.486 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -133.45 139.43 46.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.469 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.524 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 9.9 p-10 -119.65 -72.75 0.67 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.781 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.524 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 94.2 m-85 -87.01 -31.08 20.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.067 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -69.81 167.57 16.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.168 0.508 . . . . 0.0 110.296 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -58.37 -75.16 0.05 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.479 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -161.18 55.8 0.29 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.37 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.0 p -106.88 132.94 52.27 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.3 mt -75.51 140.24 42.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.684 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 213' ' ' GLY . 20.5 mtmt -101.03 157.94 32.73 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 210' ' ' LYS . 75.9 Cg_exo -34.02 -76.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.529 2.152 . . . . 0.0 112.338 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -49.7 -20.09 0.75 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.313 0.578 . . . . 0.0 110.306 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.96 -51.33 14.99 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.391 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -64.07 -40.26 95.87 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.85 -53.87 51.49 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.45 87.46 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.724 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.3 mt -61.07 -30.77 70.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.872 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.07 -45.87 62.97 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.158 0.504 . . . . 0.0 111.095 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.406 ' O ' ' OG ' ' A' ' 222' ' ' SER . 3.0 mt-30 -61.75 -44.82 96.14 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.102 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 52.7 tp -65.25 -38.93 91.85 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.368 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.421 ' CG ' ' HD3' ' A' ' 267' ' ' LYS . 7.6 t80 -55.45 -45.49 76.86 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.982 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 219' ' ' GLN . 41.3 p -55.82 -53.34 57.89 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.153 -176.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 12.9 pt20 -60.43 -19.95 58.05 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.646 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 70.2 mt -89.69 -27.48 20.08 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.025 0.441 . . . . 0.0 110.351 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 3.9 t -72.64 -22.92 60.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.6 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -98.92 18.61 16.76 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.722 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.41 160.47 29.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.94 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -70.74 125.02 91.93 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 230' ' ' LYS . 50.9 Cg_endo -69.86 -17.14 37.3 Favored 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.505 2.137 . . . . 0.0 113.126 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 229' ' ' PRO . 88.2 tttt -31.47 -48.21 0.13 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.749 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 95.7 m-20 -110.74 -17.58 13.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.217 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.22 48.72 0.03 OUTLIER Glycine 0 N--CA 1.474 1.167 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.6 m -115.36 112.36 22.24 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.766 0.317 . . . . 0.0 110.872 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.95 97.54 4.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.604 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.6 t -97.92 122.4 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.407 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.9 t -96.05 118.66 42.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.41 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 26.1 mt -108.96 106.23 16.1 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.602 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.413 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -87.17 127.83 8.65 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.8 OUTLIER -107.17 123.93 48.98 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 117.683 0.742 . . . . 0.0 109.453 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 241' ' ' ASP . 52.9 m -114.67 166.24 11.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.969 0.414 . . . . 0.0 110.296 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.471 ' N ' ' CG2' ' A' ' 240' ' ' THR . 53.6 p30 -86.02 -176.0 5.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.965 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -116.58 124.84 50.81 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.376 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.475 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 49.4 mm -114.8 23.26 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.557 0.694 . . . . 0.0 110.605 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.4 13.59 73.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.8 t -144.11 94.07 2.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.357 0.598 . . . . 0.0 110.006 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -46.58 -47.33 19.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.66 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.38 -37.58 78.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.193 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -61.51 -47.63 84.74 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.445 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 250' ' ' GLN . 0.1 OUTLIER -62.84 -41.6 99.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.5 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.492 ' N ' ' ND2' ' A' ' 249' ' ' ASN . 94.2 mt-30 -60.7 -45.99 92.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.919 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.15 96.13 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 26.2 mt -72.81 -37.87 67.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.245 -0.478 . . . . 0.0 111.074 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 29.9 t -63.47 -40.87 98.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.967 0.413 . . . . 0.0 110.239 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.94 -45.81 76.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.045 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -54.33 -45.64 72.7 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.555 HH22 ' N ' ' A' ' 308' ' ' ARG . 42.7 mtp180 -61.38 -64.09 1.06 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.477 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -51.56 -34.28 36.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.129 0.49 . . . . 0.0 109.884 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -73.32 -44.74 58.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.087 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 46.2 m -64.37 -37.75 88.6 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.449 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.52 -51.27 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.6 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.2 t -62.36 -48.65 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.039 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -45.06 -39.42 5.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -84.12 -30.34 26.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.687 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.43 -11.22 60.59 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.489 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.566 ' C ' ' H ' ' A' ' 267' ' ' LYS . 72.5 mt -86.91 -53.65 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 122.107 -0.37 . . . . 0.0 111.729 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.3 p -50.41 -4.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.23 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 265' ' ' ILE . 68.9 mttm -83.96 -0.19 50.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.925 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 105.26 -2.78 40.28 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.09 126.02 78.19 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.871 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.78 130.32 39.84 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.344 1.363 . . . . 0.0 111.256 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.29 -10.0 38.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.968 0.413 . . . . 0.0 111.407 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -90.78 -22.93 20.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.133 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -19.5 52.5 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.819 0.819 . . . . 0.0 110.664 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -107.03 -171.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.542 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.69 129.78 1.55 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.827 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.72 151.3 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -158.88 148.75 19.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 110.5 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -123.76 96.89 0.55 Allowed Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 21.3 ptm -94.66 21.45 7.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.921 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 37.74 -97.17 0.01 OUTLIER Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -143.33 75.92 1.5 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 37.3 t -63.82 -32.99 74.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.114 0.483 . . . . 0.0 111.166 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.41 ' C ' HD21 ' A' ' 283' ' ' ASN . 0.4 OUTLIER -131.17 77.66 74.2 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.954 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -54.23 108.04 0.26 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.749 2.299 . . . . 0.0 112.848 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 286' ' ' THR . 5.1 m -71.59 -40.3 70.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.489 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.677 ' C ' ' H ' ' A' ' 288' ' ' ASN . 2.2 p -58.97 -42.47 90.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.514 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.5 0.89 0.02 OUTLIER Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.677 ' H ' ' C ' ' A' ' 286' ' ' THR . 28.2 t-20 -125.07 -58.37 1.46 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.3 m -56.2 -42.84 77.82 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 22.8 m -95.74 34.42 1.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.502 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 292' ' ' ASN . 28.4 p30 -59.04 -33.04 70.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.818 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 23.3 m120 -88.78 33.92 0.77 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.434 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.57 109.43 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.849 0.356 . . . . 0.0 110.522 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -118.59 13.89 13.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.611 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -98.0 135.33 39.86 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.108 0.48 . . . . 0.0 109.851 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 299' ' ' LEU . 5.9 ttt-85 -51.09 -76.36 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.568 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -45.74 -41.03 10.18 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.139 0.495 . . . . 0.0 111.071 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.34 81.36 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.043 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 296' ' ' ARG . 16.9 mt -71.01 -43.95 66.87 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.771 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 12.2 mm -52.75 -36.84 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.34 -42.78 35.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.221 0.534 . . . . 0.0 110.315 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -5.6 35.71 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.857 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.34 20.24 8.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.573 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.548 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -79.84 -45.09 1.53 Allowed Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.18 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 24.7 Cg_exo -61.75 8.29 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 123.184 2.589 . . . . 0.0 111.941 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 304' ' ' ALA . 39.4 t0 -102.52 10.91 38.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.609 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.442 ' NH1' ' O ' ' A' ' 203' ' ' ASN . 88.2 mtm180 -112.94 91.65 3.73 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.298 0.571 . . . . 0.0 110.142 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.555 ' N ' HH22 ' A' ' 256' ' ' ARG . 16.4 ptm180 -157.67 129.22 6.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.628 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.99 138.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.431 0.634 . . . . 0.0 109.709 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -118.64 102.17 8.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.713 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.0 113.14 19.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.67 118.44 31.05 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.401 0.438 . . . . 0.0 110.154 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.5 114.66 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 O-C-N 123.567 0.542 . . . . 0.0 110.183 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -113.39 132.09 55.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 93.15 41.85 4.47 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.693 ' O ' ' O ' ' A' ' 317' ' ' LYS . 9.8 tt -114.65 169.63 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.693 ' O ' ' O ' ' A' ' 316' ' ' ILE . 27.5 tttp -42.65 -150.78 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.586 0 O-C-N 123.963 0.79 . . . . 0.0 111.614 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.4 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 98.8 m-20 -79.26 156.68 27.99 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.612 -0.68 . . . . 0.0 110.556 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 78.1 t -132.95 135.32 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.268 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 66.1 t -72.19 133.21 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.59 132.59 54.76 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.31 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 324' ' ' GLN . 4.1 pt20 -88.81 152.07 48.32 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.579 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.25 -41.09 13.34 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.561 2.174 . . . . 0.0 111.971 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.426 ' O ' ' OE1' ' A' ' 322' ' ' GLN . 0.4 OUTLIER -93.68 105.88 17.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.047 0.451 . . . . 0.0 110.702 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.452 179.859 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.33 143.15 94.6 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.598 2.199 . . . . 0.0 111.825 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.99 69.65 1.19 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.573 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.93 105.75 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.083 1.855 . . . . 0.0 111.683 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -169.56 89.41 0.57 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.201 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.28 -36.67 57.81 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.178 1.919 . . . . 0.0 112.031 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 187' ' ' PRO . . . 51.33 85.44 0.18 Allowed Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.366 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 186' ' ' ALA . 51.2 Cg_exo -53.01 -139.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.917 2.411 . . . . 0.0 112.578 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -43.83 125.73 4.35 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.182 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.09 173.05 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.303 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.501 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 17.6 mp0 -102.68 83.34 2.25 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.907 0.384 . . . . 0.0 111.16 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 39.2 m -72.0 126.21 29.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.639 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -116.45 167.85 10.68 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.457 0.646 . . . . 0.0 111.032 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -155.93 123.39 5.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.595 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.591 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 60.9 m-85 -110.57 113.35 25.9 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.06 103.86 15.13 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.897 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.5 tp -108.94 135.34 50.3 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.287 0.565 . . . . 0.0 110.196 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.458 ' CD ' ' H ' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -88.73 132.14 34.73 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.968 0.89 . . . . 0.0 112.315 -178.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 202' ' ' PHE . 1.3 p -61.84 -24.07 66.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.665 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.14 -43.67 92.04 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.275 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.11 -42.41 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 78.9 mt -80.08 -79.36 0.15 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.86 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.3 OUTLIER -133.27 131.88 40.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.002 -178.067 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.54 ' O ' ' NH2' ' A' ' 307' ' ' ARG . 59.9 t30 -111.04 -71.24 0.77 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.674 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -91.28 -23.57 20.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.844 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -73.14 164.16 27.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 110.423 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -53.78 -74.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.144 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -160.09 3.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.338 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.7 p -54.98 141.35 34.21 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 85.9 mt -86.14 132.62 33.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.875 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.6 mttp -93.27 157.27 39.12 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.582 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -33.11 -74.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.767 2.311 . . . . 0.0 112.428 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.77 -24.24 1.34 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.136 0.493 . . . . 0.0 110.947 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.68 -48.16 18.32 Favored Glycine 0 C--O 1.227 -0.312 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -62.66 -40.83 98.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.346 0.593 . . . . 0.0 109.57 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.42 -55.27 33.58 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.38 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.35 85.0 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.212 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.1 -31.09 70.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.169 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -71.91 -46.73 56.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.935 0.398 . . . . 0.0 110.948 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -64.21 -44.57 91.52 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.564 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.9 tp -65.02 -38.12 89.86 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.439 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 2.4 t80 -54.83 -50.3 68.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.146 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 225' ' ' SER . 11.8 t -59.58 -50.67 73.01 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.571 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.591 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 9.2 tt0 -49.01 -24.25 1.45 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.667 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 51.3 mt -100.38 -13.73 18.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.606 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 222' ' ' SER . 33.2 t -73.29 -19.82 60.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -103.61 20.84 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.475 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.05 161.54 29.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -84.3 126.18 70.18 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 230' ' ' LYS . 59.9 Cg_endo -69.86 -16.26 37.06 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.982 1.788 . . . . 0.0 113.073 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 229' ' ' PRO . 3.1 tmtm? -30.49 -52.43 0.16 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.604 0.565 . . . . 0.0 111.066 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 232' ' ' GLY . 10.5 m-20 -104.67 -15.33 15.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.133 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.99 51.52 0.07 OUTLIER Glycine 0 N--CA 1.468 0.788 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.638 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.0 m -118.53 109.07 15.76 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 122.88 -0.188 . . . . 0.0 111.041 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 92.4 t -125.3 93.81 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.62 0.724 . . . . 0.0 109.989 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.6 t -98.33 119.49 46.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.159 0.504 . . . . 0.0 110.754 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 22.1 t -93.62 127.68 45.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.398 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.0 mt -110.35 139.62 45.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.381 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -120.56 131.55 8.83 Favored Glycine 0 N--CA 1.479 1.544 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -117.7 121.94 42.19 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.002 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.646 ' HG1' ' H ' ' A' ' 241' ' ' ASP . 9.0 t -115.45 174.26 6.1 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.646 ' H ' ' HG1' ' A' ' 240' ' ' THR . 23.0 m-20 -84.4 -178.2 6.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.165 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -115.84 125.41 52.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.953 0.406 . . . . 0.0 109.971 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.491 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 48.9 mm -117.81 18.57 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.75 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 77.92 15.97 80.51 Favored Glycine 0 C--N 1.315 -0.604 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.3 p -136.58 100.78 4.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.341 0.591 . . . . 0.0 109.947 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -54.21 -50.9 66.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.809 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.96 83.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.714 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -63.95 -41.77 97.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.334 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.455 ' ND2' ' CG2' ' A' ' 240' ' ' THR . 12.7 t-20 -59.01 -52.09 67.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -57.85 -39.86 78.74 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.681 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.88 99.14 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 31.7 mt -69.99 -38.99 76.18 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.747 -0.267 . . . . 0.0 110.707 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.3 t -62.32 -41.57 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.194 0.521 . . . . 0.0 110.622 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -70.47 -38.88 74.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.344 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -58.69 -51.25 70.75 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.303 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.438 ' NH1' ' O ' ' A' ' 239' ' ' TYR . 17.2 ptp180 -65.63 -45.74 81.88 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.754 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.55 98.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.401 0.619 . . . . 0.0 109.951 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -71.2 -43.61 67.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.334 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.9 m -60.05 -38.14 81.93 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.693 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 256' ' ' ARG . 89.4 t -65.13 -52.66 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.15 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.1 t -62.12 -48.91 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.621 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -47.18 -43.13 21.04 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.182 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.586 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 53.7 t80 -77.07 -33.47 57.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.981 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.54 -34.93 79.42 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 267' ' ' LYS . 96.9 mt -63.15 -44.85 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 120.831 0.348 . . . . 0.0 111.527 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 39.3 t -55.07 -8.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.404 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.586 ' CE ' ' CE2' ' A' ' 263' ' ' TYR . 68.8 mmtt -90.98 14.24 14.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.462 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.45 42.59 10.16 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.312 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.29 127.61 26.24 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 117.134 0.467 . . . . 0.0 110.074 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -54.14 128.33 29.42 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.356 1.371 . . . . 0.0 111.984 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.97 -11.87 50.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 111.025 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 272' ' ' ASP . 5.6 p-10 -92.29 -18.13 23.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.418 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -82.76 -23.19 34.06 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.764 0.792 . . . . 0.0 110.652 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.0 pt -102.48 -173.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.045 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 4.9 t -167.63 125.48 1.22 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.77 113.24 25.6 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.705 0.288 . . . . 0.0 110.812 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -119.17 141.86 48.47 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.426 0.632 . . . . 0.0 111.773 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.34 95.84 2.14 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -69.26 -10.45 57.87 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -178.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.09 -113.26 0.53 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.441 ' OE2' ' OD2' ' A' ' 306' ' ' ASP . 51.7 tt0 -143.96 71.87 1.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.7 t -63.84 -37.8 88.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.119 0.485 . . . . 0.0 111.409 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -131.6 83.1 59.27 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.27 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.8 105.79 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.163 1.908 . . . . 0.0 112.364 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 31.6 m -70.1 -44.44 78.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.181 0.515 . . . . 0.0 110.708 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.667 ' C ' ' H ' ' A' ' 288' ' ' ASN . 10.8 p -60.65 -44.62 96.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.934 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.417 ' N ' ' HG1' ' A' ' 286' ' ' THR . . . -52.93 1.92 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 286' ' ' THR . 75.6 m-20 -119.84 -59.43 1.8 Allowed 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.87 -20.5 66.26 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.804 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.25 26.36 9.51 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.873 0.368 . . . . 0.0 110.28 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 37.3 p-10 -69.93 -6.85 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.043 0.449 . . . . 0.0 110.505 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -100.63 31.51 3.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.288 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.74 129.3 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.207 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -119.41 5.9 11.14 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -97.57 130.28 44.63 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.1 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -52.61 -74.07 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.52 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -43.63 -39.59 3.64 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.214 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.97 95.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.755 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 48.5 mt -68.48 -42.52 78.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.692 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 15.3 mm -54.95 -36.29 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -73.13 -46.83 48.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.35 0.595 . . . . 0.0 109.745 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.7 t -71.04 -2.78 16.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.243 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.29 16.72 12.56 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.431 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.604 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -82.4 -44.32 0.97 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 120.838 0.351 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 49.3 Cg_exo -55.1 8.74 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 123.373 2.715 . . . . 0.0 112.835 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.604 ' H ' ' C ' ' A' ' 304' ' ' ALA . 88.2 m-20 -110.58 16.4 21.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.497 0.189 . . . . 0.0 110.682 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 8.4 ptm180 -112.46 91.71 3.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.846 0.831 . . . . 0.0 110.302 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -164.58 141.27 6.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.827 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.76 145.96 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.406 ' OE2' ' CZ ' ' A' ' 239' ' ' TYR . 32.9 mt-10 -122.05 107.83 12.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.946 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.22 118.42 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.37 125.68 43.61 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.051 0.453 . . . . 0.0 110.546 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.03 116.56 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.632 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -114.68 131.89 56.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 106.82 -23.87 26.74 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.657 ' O ' ' O ' ' A' ' 317' ' ' LYS . 13.6 tt -53.24 171.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.657 ' O ' ' O ' ' A' ' 316' ' ' ILE . 24.8 tttp -45.34 -149.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.68 0.613 . . . . 0.0 111.792 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.412 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 54.6 p-10 -63.78 169.51 4.04 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.599 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.94 147.64 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.008 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 19.2 m -68.05 133.68 31.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.47 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 23.3 m -81.49 130.55 35.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.242 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -126.3 85.11 60.57 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.4 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.07 146.56 93.88 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.648 2.232 . . . . 0.0 112.083 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -73.3 47.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.356 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.518 -179.969 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.434 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 180' ' ' ALA . 27.6 Cg_exo -61.61 149.83 88.1 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.048 2.499 . . . . 0.0 111.736 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.431 ' CB ' ' CD ' ' A' ' 183' ' ' PRO . . . -171.6 -62.62 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.786 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 182' ' ' ALA . 30.7 Cg_endo -60.36 142.92 99.27 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.433 2.089 . . . . 0.0 112.017 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 172.07 74.73 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.109 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' A' ' 186' ' ' ALA . 46.7 Cg_exo -55.09 135.34 68.37 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.512 2.141 . . . . 0.0 111.686 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 185' ' ' PRO . . . 163.76 155.17 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.363 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 188' ' ' GLU . 36.8 Cg_endo -65.71 -81.61 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.634 2.223 . . . . 0.0 111.676 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 187' ' ' PRO . 18.7 tp10 55.34 162.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.952 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 60.5 t -106.87 136.91 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -113.95 105.36 13.15 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.545 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.466 ' CG2' ' HE2' ' A' ' 193' ' ' HIS . 15.4 m -81.87 135.94 35.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.366 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -147.26 118.01 7.58 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 120.875 0.369 . . . . 0.0 110.427 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 2.4 m170 -98.9 144.52 27.99 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -105.0 119.38 38.89 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.92 101.19 12.66 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.846 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 35.3 tp -108.38 143.7 36.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.144 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -94.75 133.45 38.42 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 122.157 0.979 . . . . 0.0 112.34 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 202' ' ' PHE . 1.2 m -62.06 -25.58 67.77 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.2 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.53 ' OD1' ' NE ' ' A' ' 307' ' ' ARG . 85.2 m-20 -60.44 -39.42 87.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.108 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.65 -45.21 85.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 50.7 mt -78.68 -78.01 0.15 Allowed 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.909 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -128.33 123.43 33.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.824 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -93.61 -74.17 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.568 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -104.05 -11.78 17.16 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -75.58 170.0 17.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.029 0.443 . . . . 0.0 110.179 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -54.81 -82.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.554 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -156.15 3.76 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.188 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.1 p -57.16 144.72 33.87 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 57.7 mt -89.25 136.1 33.21 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.268 0.556 . . . . 0.0 111.169 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 213' ' ' GLY . 55.6 mttt -98.34 157.51 34.27 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.098 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -33.75 -74.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.549 2.166 . . . . 0.0 111.993 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 27.3 mp0 -48.16 -27.62 2.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.127 0.489 . . . . 0.0 110.529 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.15 -47.79 35.42 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -64.65 -40.6 95.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.316 0.579 . . . . 0.0 109.888 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.32 -55.71 25.73 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.351 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.91 81.36 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.478 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.81 -27.05 68.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.24 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -77.36 -47.45 19.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.462 0.649 . . . . 0.0 110.841 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -62.11 -45.2 94.54 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.614 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 40.6 tp -63.83 -40.68 97.18 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 225' ' ' SER . 5.0 t80 -51.07 -48.79 61.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.451 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 59.1 p -55.32 -51.52 66.45 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.596 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -51.23 -26.14 6.63 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.424 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 17.8 mt -100.69 -19.03 16.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.525 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 221' ' ' TYR . 6.3 t -71.93 -27.51 62.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.997 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.506 ' OD1' ' NZ ' ' A' ' 317' ' ' LYS . 24.9 t-20 -103.32 23.68 12.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.937 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.36 152.97 34.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.687 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.647 ' N ' ' O ' ' A' ' 315' ' ' GLY . 16.0 t0 -66.04 115.65 25.3 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 232' ' ' GLY . 49.0 Cg_endo -70.14 -17.25 35.94 Favored 'Trans proline' 0 N--CA 1.505 2.164 0 C-N-CA 122.518 2.145 . . . . 0.0 112.941 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 229' ' ' PRO . 22.2 tptm -29.21 -47.68 0.06 Allowed 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 123.525 0.516 . . . . 0.0 110.962 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 232' ' ' GLY . 5.6 p30 -106.32 -14.07 15.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.388 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.25 56.13 0.17 Allowed Glycine 0 N--CA 1.469 0.878 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.7 t -119.72 99.98 6.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.574 0.226 . . . . 0.0 110.589 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 73.5 t -125.02 94.18 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.549 0.69 . . . . 0.0 110.437 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 8.4 t -98.11 121.47 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.53 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 18.3 t -91.58 122.12 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.572 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 39.0 mt -104.55 141.05 37.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.034 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.78 130.27 7.13 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.19 119.96 38.13 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.412 ' HG1' ' CG ' ' A' ' 249' ' ' ASN . 2.1 p -113.28 162.97 15.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.838 0.352 . . . . 0.0 110.071 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -83.3 173.03 11.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.386 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -101.18 125.24 47.78 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.426 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.463 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 8.1 mm -114.59 18.18 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.685 0.755 . . . . 0.0 110.453 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.92 13.73 71.33 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.0 m -143.07 96.46 2.93 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.103 0.478 . . . . 0.0 110.284 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 246' ' ' ASP . 27.4 p-10 -49.19 -48.6 45.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.418 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.15 -35.83 67.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.859 0.362 . . . . 0.0 110.276 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -70.0 -42.23 73.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.889 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.412 ' CG ' ' HG1' ' A' ' 240' ' ' THR . 20.1 t-20 -61.83 -49.72 75.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.235 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.42 -36.89 83.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.374 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.57 -41.18 98.68 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.71 -34.16 64.69 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.947 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.556 ' HG ' ' N ' ' A' ' 254' ' ' GLU . 85.0 p -64.0 -40.78 97.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.778 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.556 ' N ' ' HG ' ' A' ' 253' ' ' SER . 98.5 mt-10 -70.69 -43.03 69.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.109 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -58.64 -46.66 86.63 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.117 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -64.55 -60.91 2.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.905 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -48.44 -39.09 21.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 110.008 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -70.04 -43.26 71.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.373 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 44.5 m -59.3 -39.0 81.6 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.36 -51.72 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.157 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.37 -48.89 86.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.687 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -46.99 -41.39 16.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.125 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -81.74 -32.95 31.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.66 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -24.28 67.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.254 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.562 ' C ' ' H ' ' A' ' 267' ' ' LYS . 87.1 mt -73.51 -51.18 26.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 111.718 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 5.1 m -50.34 -8.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.801 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 265' ' ' ILE . 27.9 mmtp -82.68 -1.94 52.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 95.08 41.62 3.98 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.42 HD13 ' HZ3' ' A' ' 273' ' ' LYS . 0.2 OUTLIER -123.32 129.43 24.91 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.75 125.81 19.18 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.754 1.636 . . . . 0.0 111.736 176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.55 -8.5 20.09 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -90.69 -24.08 20.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.719 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.42 ' HZ3' HD13 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -78.64 -21.94 47.63 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.315 0.578 . . . . 0.0 111.034 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -104.48 -174.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.562 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 38.5 t -170.94 131.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.442 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.96 150.2 20.72 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -154.0 138.01 16.38 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.32 0.581 . . . . 0.0 111.293 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -90.17 94.0 1.93 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.402 ' HG2' ' CZ ' ' A' ' 239' ' ' TYR . 2.6 tpt -71.23 -7.04 44.2 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.611 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.53 -98.31 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -142.63 75.61 1.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.757 0.313 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 85.9 p -83.69 -1.64 54.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.977 0.418 . . . . 0.0 110.905 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.537 ' C ' HD21 ' A' ' 283' ' ' ASN . 0.1 OUTLIER -162.89 74.71 2.01 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.94 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -60.06 103.23 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.401 2.068 . . . . 0.0 113.198 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 13.8 m -69.91 -35.57 65.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.182 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.653 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.0 OUTLIER -59.5 -46.44 88.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.401 -179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.05 -5.58 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.653 ' H ' ' C ' ' A' ' 286' ' ' THR . 45.5 t30 -127.22 -57.26 1.31 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.844 0.457 . . . . 0.0 109.781 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.413 ' O ' ' CG2' ' A' ' 289' ' ' THR . 3.5 m -68.56 -10.71 57.54 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.666 0.27 . . . . 0.0 110.614 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 286' ' ' THR . 72.4 m -132.78 19.06 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 110.396 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -67.35 -5.43 14.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.663 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -108.68 32.24 5.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 7.2 t -131.63 120.48 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.68 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -119.7 10.44 11.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.952 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -101.57 135.8 42.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.145 0.498 . . . . 0.0 110.142 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -52.0 -70.32 0.09 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.845 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.77 -39.23 58.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.94 -39.64 95.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.424 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 303' ' ' LEU . 20.5 mt -65.94 -52.41 50.0 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.43 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 64.5 mt -53.04 -33.03 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.938 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -79.42 -24.23 42.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.979 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -98.03 -12.68 21.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.384 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 299' ' ' LEU . 80.6 mt -91.69 18.77 7.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.883 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.646 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -77.81 -53.25 1.51 Allowed Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.519 177.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 13.0 Cg_endo -53.7 9.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.225 0 C-N-CA 122.852 2.368 . . . . 0.0 112.888 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.646 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.3 t0 -103.1 16.75 25.79 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.53 ' NE ' ' OD1' ' A' ' 199' ' ' ASP . 18.0 ptt-85 -114.35 93.3 4.28 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.78 0.8 . . . . 0.0 110.415 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.502 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 48.1 ptt85 -157.46 131.73 8.35 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.59 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 7.8 m -102.02 140.13 21.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -120.84 105.69 10.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.372 0.606 . . . . 0.0 110.519 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.17 115.94 22.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.465 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -90.68 117.37 29.28 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 123.091 0.245 . . . . 0.0 110.368 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.62 115.81 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.4 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -114.32 126.98 55.63 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.9 43.99 2.96 Favored Glycine 0 C--O 1.219 -0.807 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.692 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.5 tt -119.81 170.51 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.692 ' O ' ' O ' ' A' ' 316' ' ' ILE . 65.0 mttp -40.68 -160.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.125 0.891 . . . . 0.0 111.293 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 319' ' ' VAL . 35.3 t0 -84.72 175.31 9.27 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.481 -0.762 . . . . 0.0 110.909 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . 0.457 ' H ' ' CG ' ' A' ' 318' ' ' ASP . 80.0 t -127.26 128.65 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.256 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.65 118.06 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.101 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.6 p -151.08 125.31 9.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.305 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -59.27 148.46 72.25 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.778 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.52 152.44 74.92 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.409 2.073 . . . . 0.0 111.985 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 62.27 53.69 2.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.62 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.636 179.848 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.521 ' C ' ' H ' ' A' ' 182' ' ' ALA . . . . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 44.6 Cg_endo -68.65 22.67 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.708 2.272 . . . . 0.0 112.038 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 180' ' ' ALA . . . 66.45 76.86 0.28 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.31 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.0 -35.97 63.06 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.765 2.31 . . . . 0.0 111.94 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 60.22 78.39 0.33 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.215 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.66 144.19 86.84 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.559 2.173 . . . . 0.0 111.897 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -138.71 67.26 43.08 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.319 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.444 ' O ' ' NZ ' ' A' ' 230' ' ' LYS . 46.7 Cg_endo -68.77 148.85 72.27 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.487 2.125 . . . . 0.0 112.05 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.52 174.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.278 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.1 t -78.03 107.22 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.256 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -107.01 103.25 12.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.332 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.1 m -74.99 130.5 39.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.191 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -147.32 117.54 7.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.167 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.518 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.5 OUTLIER -103.76 151.39 23.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -111.96 122.69 48.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.914 0.388 . . . . 0.0 110.062 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.08 102.44 13.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.541 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 26.8 tp -104.83 131.69 51.99 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.308 0.575 . . . . 0.0 109.728 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -82.51 129.8 34.99 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.196 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.6 t -62.74 -31.44 72.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.087 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.426 ' OD1' ' OD1' ' A' ' 203' ' ' ASN . 16.2 t70 -59.42 -37.98 79.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.231 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.88 -42.94 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.503 ' O ' ' CG ' ' A' ' 210' ' ' LYS . 84.6 mt -80.01 -77.98 0.18 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.437 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.37 125.31 44.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.744 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.535 HD22 ' HZ3' ' A' ' 210' ' ' LYS . 44.0 m-80 -88.3 -70.09 0.66 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.82 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -113.0 -10.58 13.48 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.749 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -74.63 164.83 26.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.139 0.495 . . . . 0.0 110.035 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -52.51 -77.82 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.292 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.67 56.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.489 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.2 p -107.69 132.97 52.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.179 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.74 132.29 35.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.809 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.535 ' HZ3' HD22 ' A' ' 203' ' ' ASN . 0.0 OUTLIER -95.62 165.74 16.01 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.672 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -36.14 -76.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.499 2.133 . . . . 0.0 111.973 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -49.96 -20.51 0.94 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.319 0.581 . . . . 0.0 110.277 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.37 -51.45 12.91 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -66.15 -38.25 87.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.023 0.439 . . . . 0.0 109.93 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.4 -53.3 59.85 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.06 -33.76 76.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.575 0.702 . . . . 0.0 110.336 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.2 mt -69.5 -26.2 64.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.394 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -76.23 -49.46 17.08 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.482 0.658 . . . . 0.0 111.113 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.427 ' O ' ' OG ' ' A' ' 222' ' ' SER . 13.3 pt20 -63.91 -41.11 97.76 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.364 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 36.8 tp -63.5 -41.81 98.53 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.662 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.8 t80 -51.59 -48.95 62.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.805 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 219' ' ' GLN . 80.7 p -55.55 -51.37 67.3 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.475 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -53.26 -27.35 22.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.365 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 47.4 mt -95.61 -19.48 19.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.759 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 221' ' ' TYR . 8.4 t -78.57 -30.38 46.75 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.357 0.41 . . . . 0.0 110.886 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 52.3 t-20 -86.11 20.2 2.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.708 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.412 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.8 OUTLIER -77.75 -178.79 5.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.933 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 315' ' ' GLY . 49.4 t0 -100.09 105.19 33.99 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 232' ' ' GLY . 32.5 Cg_exo -55.6 -20.64 28.06 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 123.077 2.518 . . . . 0.0 113.61 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 229' ' ' PRO . 62.6 pttt -27.22 -40.48 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.162 0.506 . . . . 0.0 111.318 -176.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 229' ' ' PRO . 13.3 p30 -115.23 -14.74 11.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.304 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.03 59.82 0.16 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.8 m -118.64 102.09 8.6 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 58.9 t -126.69 92.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.701 0.762 . . . . 0.0 110.273 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.1 t -98.37 121.88 49.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.35 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.23 125.22 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.0 mt -108.49 141.24 40.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.315 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.87 129.02 7.3 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -113.29 121.6 44.92 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.652 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 6.7 p -115.88 162.63 17.06 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.452 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 45.7 p30 -82.93 172.3 12.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.632 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.602 ' NH1' ' N ' ' A' ' 245' ' ' SER . 0.1 OUTLIER -94.62 126.21 39.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.932 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 50.4 mm -118.61 14.34 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.416 0.627 . . . . 0.0 110.708 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.425 ' C ' ' NH1' ' A' ' 242' ' ' ARG . . . 77.93 11.0 85.83 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.602 ' N ' ' NH1' ' A' ' 242' ' ' ARG . 11.2 m -135.97 94.61 3.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.114 0.483 . . . . 0.0 110.049 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.536 ' OD1' ' NH2' ' A' ' 242' ' ' ARG . 47.1 m-20 -46.81 -50.28 18.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.446 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.49 -42.38 74.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.635 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -66.0 -38.83 89.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.54 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 27.3 t-20 -61.78 -52.6 63.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.107 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.67 -32.78 74.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.545 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.92 -43.79 98.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 33.0 mt -72.69 -35.48 67.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.763 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.8 t -64.76 -44.47 89.97 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.106 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.19 -42.4 75.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.176 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -49.9 75.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.357 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.52 -52.38 65.44 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.607 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.11 -31.89 65.77 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -73.71 -45.01 54.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.234 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.486 ' HG ' ' N ' ' A' ' 260' ' ' VAL . 77.4 p -61.38 -37.93 85.17 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.43 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.486 ' N ' ' HG ' ' A' ' 259' ' ' SER . 91.8 t -65.11 -53.1 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.299 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.8 t -60.97 -49.37 85.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.329 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -46.35 -40.77 12.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.93 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.726 ' HH ' ' HZ1' ' A' ' 267' ' ' LYS . 83.3 t80 -82.65 -31.96 28.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.606 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.37 -9.94 57.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.451 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.568 ' C ' ' H ' ' A' ' 267' ' ' LYS . 62.8 mt -87.14 -53.57 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.775 0.322 . . . . 0.0 111.39 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.2 m -49.79 -6.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.004 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.726 ' HZ1' ' HH ' ' A' ' 263' ' ' TYR . 30.0 mmtm -81.39 -3.94 54.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.81 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.42 39.77 3.37 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.69 127.52 25.16 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.748 0.274 . . . . 0.0 110.378 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.48 128.25 27.19 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.917 1.745 . . . . 0.0 111.79 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.79 -7.92 24.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.237 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -91.97 -23.09 19.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.827 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -80.38 -19.71 45.72 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.297 0.57 . . . . 0.0 110.977 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.8 pt -104.45 -171.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.525 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 3.1 t -169.45 130.16 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.314 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -101.72 110.7 22.75 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.917 0.389 . . . . 0.0 110.76 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.26 140.52 49.24 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.7 0.762 . . . . 0.0 111.345 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -91.38 93.89 1.89 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 2.2 tpt -69.19 -8.36 44.97 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.419 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.97 -107.94 0.09 OUTLIER Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.27 59.03 1.59 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.75 0.309 . . . . 0.0 110.558 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.0 t -83.04 -8.06 59.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.697 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -157.33 66.27 3.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.471 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.28 110.82 3.14 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.634 2.222 . . . . 0.0 112.042 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.0 m -73.23 -25.32 21.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.525 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.646 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.5 p -61.44 -46.34 90.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.911 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.81 -5.77 0.01 OUTLIER Glycine 0 CA--C 1.536 1.356 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.646 ' H ' ' C ' ' A' ' 286' ' ' THR . 35.7 m120 -125.49 -55.43 1.54 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.8 m -66.02 -16.32 63.8 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.947 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 302' ' ' CYS . 92.0 m -118.51 24.78 10.71 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.634 0.254 . . . . 0.0 110.424 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 293' ' ' VAL . 57.4 t0 -57.8 -46.57 84.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.75 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -74.48 33.86 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.596 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' A' ' 291' ' ' ASP . 3.1 t -133.32 104.12 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.387 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -119.41 14.43 12.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.916 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.46 142.1 33.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.06 0.457 . . . . 0.0 109.921 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -51.37 -72.07 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.164 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.09 -40.5 67.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.697 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.71 88.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 17.5 mt -66.61 -55.71 14.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.546 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.27 -37.01 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.991 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -72.56 -33.28 66.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.554 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.477 ' O ' ' SG ' ' A' ' 290' ' ' CYS . 1.8 t -92.12 -4.62 54.06 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.68 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.3 mm? -96.58 19.19 12.68 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.682 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -81.62 -44.42 1.1 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.343 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.2 Cg_exo -58.18 10.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 123.319 2.679 . . . . 0.0 112.376 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.609 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.5 t0 -109.91 17.0 21.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 307' ' ' ARG . 18.8 ptt85 -113.06 90.96 3.49 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.652 0.739 . . . . 0.0 110.246 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.53 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 38.3 ptt180 -158.93 130.23 6.29 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.206 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.86 140.53 16.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -120.85 104.3 9.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.451 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 193' ' ' HIS . 0.5 OUTLIER -78.46 118.38 25.55 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -95.99 119.84 35.2 Favored 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 123.171 0.294 . . . . 0.0 110.816 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 58.3 t -122.64 118.74 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 O-C-N 123.554 0.534 . . . . 0.0 111.088 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -114.8 131.1 56.92 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.05 36.36 4.48 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.669 ' O ' ' O ' ' A' ' 317' ' ' LYS . 11.4 tt -113.3 169.36 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 316' ' ' ILE . 0.8 OUTLIER -43.18 -156.16 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 O-C-N 124.079 0.862 . . . . 0.0 111.251 -178.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -74.34 172.66 11.47 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.802 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.8 p -114.83 126.49 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.083 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.3 t -80.37 134.31 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.906 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.2 t -126.86 158.34 36.95 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.045 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -141.36 132.11 13.25 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.783 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 324' ' ' GLN . 51.3 Cg_exo -50.21 144.69 22.39 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.003 1.802 . . . . 0.0 112.212 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 323' ' ' PRO . 56.8 tt0 59.11 149.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.596 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.52 -179.801 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.555 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 62.1 Cg_endo -83.56 117.11 2.35 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 122.474 2.116 . . . . 0.0 112.016 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 50.92 61.27 13.53 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.405 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.44 96.34 0.97 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.468 2.112 . . . . 0.0 111.982 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -169.16 159.6 7.69 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.44 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.53 151.28 70.35 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.597 2.198 . . . . 0.0 111.436 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -133.06 149.91 74.08 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.756 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.12 137.04 37.82 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.283 1.989 . . . . 0.0 112.052 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -103.98 4.67 34.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.625 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.31 132.78 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.408 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.449 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 0.3 OUTLIER -122.74 114.76 20.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.114 0.483 . . . . 0.0 110.474 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 35.5 m -70.76 138.41 50.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.447 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 1.3 mmtm -115.17 172.21 7.21 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.425 0.631 . . . . 0.0 110.667 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 59.3 m80 -157.63 126.4 5.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.326 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.66 116.31 29.95 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.65 103.31 13.65 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.947 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 29.5 tp -106.62 130.01 54.44 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.581 0.705 . . . . 0.0 110.02 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -79.14 127.31 31.86 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 122.572 1.177 . . . . 0.0 112.468 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.522 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 15.4 m -61.73 -35.03 76.89 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.508 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -57.2 -34.6 68.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.95 -44.12 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.7 mt -79.8 -77.36 0.19 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.574 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.03 124.7 42.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.936 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.578 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 5.0 p-10 -100.51 -76.45 0.56 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.465 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . 0.578 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 68.0 m-85 -96.85 -20.53 18.09 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 110.738 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -70.97 165.25 23.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.124 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -51.12 -81.8 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.63 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.0 56.05 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.453 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 28.5 p -109.17 143.5 38.5 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 110.211 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.0 mt -81.03 132.17 35.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.839 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 213' ' ' GLY . 30.8 mmtm -93.96 157.48 37.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.982 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 210' ' ' LYS . 75.6 Cg_exo -32.43 -76.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.309 2.006 . . . . 0.0 111.951 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 1.9 pm0 -48.36 -23.23 0.86 Allowed 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.512 0.672 . . . . 0.0 110.271 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.52 -44.14 27.86 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.198 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -68.03 -40.45 82.9 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.201 0.524 . . . . 0.0 109.742 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.31 -52.89 62.87 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.727 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.53 -35.8 80.58 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.143 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.35 -28.36 69.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.21 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -76.63 -47.49 22.07 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.314 0.578 . . . . 0.0 110.825 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -61.72 -44.39 97.02 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.336 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 39.4 tp -65.17 -40.24 94.02 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.403 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.504 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.3 t80 -51.89 -48.69 63.99 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.35 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.4 m -55.29 -52.31 63.84 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.048 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -49.83 -24.83 2.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.387 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 18.7 mt -98.35 -16.94 19.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.77 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 79.9 p -75.62 -21.95 57.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.896 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -104.05 20.07 18.91 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.992 0.425 . . . . 0.0 110.999 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.61 156.03 31.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.158 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 315' ' ' GLY . 23.6 t0 -70.54 119.47 72.77 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.881 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.504 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.3 Cg_endo -69.85 -19.27 35.93 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.758 2.305 . . . . 0.0 113.194 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 229' ' ' PRO . 50.4 tptt -23.98 -50.39 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 124.068 0.855 . . . . 0.0 110.88 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 232' ' ' GLY . 7.7 p30 -113.18 -12.67 13.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.282 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 27.8 59.65 0.12 Allowed Glycine 0 N--CA 1.475 1.258 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 64.1 m -117.83 107.14 13.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 122.736 -0.273 . . . . 0.0 110.726 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 84.0 t -127.3 95.09 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.555 0.693 . . . . 0.0 110.078 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.8 t -97.85 120.93 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.187 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.1 t -92.73 125.3 45.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.719 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 59.5 mt -108.4 142.59 38.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.391 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.479 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -125.62 130.04 7.09 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -116.39 122.48 44.97 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.415 ' HG1' ' HB2' ' A' ' 253' ' ' SER . 2.9 p -108.46 171.42 7.42 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.051 0.453 . . . . 0.0 109.846 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -92.68 -178.07 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -102.58 121.93 43.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.411 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.508 ' H ' HD22 ' A' ' 249' ' ' ASN . 49.8 mm -118.42 13.13 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.503 0.668 . . . . 0.0 110.864 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.32 9.82 83.16 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.6 m -140.28 91.72 2.47 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.239 0.542 . . . . 0.0 110.308 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -48.23 -49.9 31.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.675 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.74 77.51 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.7 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -59.71 -47.78 84.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 110.423 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.508 HD22 ' H ' ' A' ' 243' ' ' ILE . 87.2 m-20 -62.83 -41.38 99.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.458 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -57.08 -46.22 82.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.184 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.01 -34.66 90.52 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.63 -38.92 70.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.739 0.304 . . . . 0.0 111.121 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 6.5 t -64.97 -43.2 93.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.694 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.98 -46.03 75.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.145 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -55.64 -46.73 77.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.036 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.522 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 50.7 mtp180 -62.53 -61.92 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 110.174 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -50.48 -36.64 34.61 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.286 0.565 . . . . 0.0 109.893 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -73.05 -45.6 56.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.897 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 40.0 t -58.59 -37.97 76.93 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.829 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.3 -51.08 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.049 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 12.8 t -61.92 -48.59 87.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.59 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -47.29 -43.08 22.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.878 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.552 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 48.6 t80 -77.42 -34.65 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.449 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -34.36 78.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.961 0.41 . . . . 0.0 110.525 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.564 ' C ' ' H ' ' A' ' 267' ' ' LYS . 88.3 mt -62.73 -50.33 80.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.253 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.9 t -49.31 -8.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.88 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.564 ' H ' ' C ' ' A' ' 265' ' ' ILE . 32.2 mmtp -86.64 12.52 10.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.504 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 79.68 42.66 11.06 Favored Glycine 0 CA--C 1.509 -0.302 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.024 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.12 128.72 25.21 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.226 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.72 127.94 26.47 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.968 1.779 . . . . 0.0 112.274 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.52 -8.71 28.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.841 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -91.94 -23.46 19.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.919 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.03 -22.95 44.68 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.534 0.683 . . . . 0.0 110.61 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.5 pt -102.1 -175.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.822 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 6.7 t -170.48 127.09 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.591 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.46 151.3 19.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -156.73 144.06 18.95 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 111.036 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -97.22 97.21 1.95 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.415 ' HG3' ' CZ ' ' A' ' 239' ' ' TYR . 1.2 mmt -68.6 -7.64 34.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.252 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 45.6 -109.17 0.29 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 281' ' ' GLU . 51.9 mp0 -131.21 57.12 1.77 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.644 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 6.2 t -80.23 -4.59 53.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.627 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -155.87 67.93 4.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.934 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.77 105.8 2.15 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.304 2.003 . . . . 0.0 111.613 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 15.1 m -69.62 -36.71 71.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.636 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.9 OUTLIER -63.75 -46.94 83.04 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.194 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -46.79 -6.89 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.636 ' H ' ' C ' ' A' ' 286' ' ' THR . 21.5 t-20 -124.65 -58.44 1.5 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.749 0.309 . . . . 0.0 110.367 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.0 m -63.5 -24.87 68.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.654 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.34 27.02 9.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.192 0.307 . . . . 0.0 110.32 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 288' ' ' ASN . 2.4 p30 -69.96 -5.78 28.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.708 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -98.33 32.97 2.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.609 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.8 t -131.38 123.9 53.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.894 0.378 . . . . 0.0 110.293 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -118.89 8.16 11.66 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.874 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -88.03 169.33 12.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.135 0.493 . . . . 0.0 110.069 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? -85.2 -68.01 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.905 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -60.44 -30.98 69.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.094 0.473 . . . . 0.0 110.831 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.81 83.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.404 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 63.0 mt -74.38 -54.67 7.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 72.9 mt -46.91 -36.53 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.062 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.94 -44.36 48.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.143 0.497 . . . . 0.0 110.688 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.2 t -75.57 -3.3 33.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.788 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -96.19 16.66 17.59 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.383 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.578 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.04 -46.03 1.44 Allowed Pre-proline 0 C--O 1.241 0.632 0 CA-C-O 121.336 0.588 . . . . 0.0 110.052 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 24.5 Cg_exo -61.5 8.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.12 2.547 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.567 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.2 t0 -103.79 14.82 30.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.679 0.276 . . . . 0.0 110.687 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.507 ' C ' ' HG ' ' A' ' 198' ' ' SER . 90.0 mtm-85 -114.31 96.88 6.0 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 121.773 0.797 . . . . 0.0 109.788 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.544 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 15.8 ptm180 -156.71 130.13 8.09 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.988 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.9 140.69 16.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -123.25 105.25 9.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.316 0.579 . . . . 0.0 111.044 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.77 118.7 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.32 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -95.1 124.33 39.08 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.154 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 192' ' ' LYS . 21.9 t -123.66 117.79 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.175 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -116.67 130.59 56.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 95.04 37.93 5.02 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.589 ' O ' ' O ' ' A' ' 317' ' ' LYS . 13.4 tt -117.51 173.42 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.589 ' O ' ' O ' ' A' ' 316' ' ' ILE . 98.1 mttt -49.77 -150.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 O-C-N 124.154 0.909 . . . . 0.0 110.51 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 318' ' ' ASP . 40.8 p-10 -156.24 117.54 3.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.454 -0.779 . . . . 0.0 110.424 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.71 132.13 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 47.9 t -131.64 91.94 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.14 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 22.2 p -88.22 165.13 15.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.311 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -117.64 84.27 19.14 Favored Pre-proline 0 N--CA 1.468 0.433 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.444 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.28 -10.72 17.64 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.762 2.308 . . . . 0.0 111.935 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -168.33 -87.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.452 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.505 -179.846 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.6 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 27.7 Cg_exo -60.75 144.58 99.57 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.632 2.221 . . . . 0.0 112.307 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.612 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -82.82 -41.8 0.88 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.537 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 23.8 Cg_exo -62.94 16.06 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.795 2.33 . . . . 0.0 112.024 179.268 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.564 ' H ' ' C ' ' A' ' 182' ' ' ALA . . . -40.67 149.09 0.34 Allowed Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.828 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.93 -176.17 1.98 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.311 2.007 . . . . 0.0 112.165 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.419 ' CB ' ' CD ' ' A' ' 187' ' ' PRO . . . -165.85 -62.47 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.231 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 186' ' ' ALA . 36.5 Cg_endo -63.47 152.26 81.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.342 2.028 . . . . 0.0 111.624 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -52.34 125.83 17.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.725 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.43 130.82 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.108 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.402 ' OE1' ' C ' ' A' ' 317' ' ' LYS . 0.3 OUTLIER -105.41 85.33 2.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.104 0.478 . . . . 0.0 109.913 -179.823 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.595 ' CG2' ' HE2' ' A' ' 193' ' ' HIS . 17.6 m -74.39 130.77 40.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.999 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -147.7 120.31 8.57 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.595 ' HE2' ' CG2' ' A' ' 191' ' ' THR . 3.4 m170 -108.07 151.45 25.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -112.1 121.47 45.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.317 0.579 . . . . 0.0 110.121 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.4 t -86.2 102.04 13.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.568 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 32.0 tp -104.48 131.95 51.28 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.15 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -81.37 126.37 31.52 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.188 -177.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.444 ' HG ' ' N ' ' A' ' 199' ' ' ASP . 96.1 p -61.5 -32.63 72.67 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.937 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.444 ' N ' ' HG ' ' A' ' 198' ' ' SER . 46.2 t0 -59.43 -41.73 90.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.377 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 82.6 t -61.92 -48.75 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.14 -77.81 0.09 Allowed 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.396 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -120.17 123.16 42.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.33 -179.154 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -86.74 -73.78 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.052 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -107.43 -11.9 15.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.772 0.32 . . . . 0.0 110.51 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -72.44 163.52 27.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.152 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -52.13 -78.25 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.255 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.33 57.01 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.27 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.8 t -108.8 137.79 46.17 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.304 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.433 HD12 ' CG ' ' A' ' 263' ' ' TYR . 10.7 mt -80.95 131.75 35.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.34 0.591 . . . . 0.0 111.394 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 213' ' ' GLY . 9.2 pttp -94.77 154.62 39.86 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.443 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 210' ' ' LYS . 93.5 Cg_exo -31.15 -73.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.269 1.979 . . . . 0.0 112.306 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -50.75 -25.11 3.98 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.954 0.407 . . . . 0.0 110.591 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.86 -46.58 16.83 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -62.42 -41.04 98.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.39 -52.84 62.22 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.373 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.64 70.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.585 0.707 . . . . 0.0 110.292 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.95 -29.69 66.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.169 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . 0.476 ' CB ' ' HZ1' ' A' ' 267' ' ' LYS . 23.8 t0 -75.73 -49.07 19.32 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.154 0.502 . . . . 0.0 111.236 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.538 ' O ' ' NE2' ' A' ' 223' ' ' GLN . 2.6 pt20 -61.93 -42.79 99.5 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.497 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 31.5 tp -65.41 -40.1 92.96 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.3 t80 -52.56 -45.49 66.44 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.907 178.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.3 t -55.5 -51.25 67.63 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.357 -178.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.805 ' H ' HE21 ' A' ' 223' ' ' GLN . 0.0 OUTLIER -54.14 -25.69 23.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.495 -179.263 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 18.3 mt -97.86 -21.95 16.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.758 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.2 t -75.26 -32.77 61.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.349 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -97.1 24.16 6.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 -179.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.25 157.7 32.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 315' ' ' GLY . 8.0 t70 -71.73 120.48 80.23 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 232' ' ' GLY . 56.7 Cg_endo -67.78 -20.08 46.38 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.801 1.667 . . . . 0.0 113.522 -177.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 229' ' ' PRO . 51.3 tptt -28.6 -44.86 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.388 0.43 . . . . 0.0 111.299 -178.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 232' ' ' GLY . 72.5 m-20 -109.77 -14.42 14.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.507 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 25.16 51.38 0.04 OUTLIER Glycine 0 N--CA 1.469 0.834 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.1 m -117.84 109.98 17.22 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.738 0.304 . . . . 0.0 111.101 -178.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.48 94.03 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 121.641 0.734 . . . . 0.0 110.116 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.86 121.82 47.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.271 -178.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.3 121.58 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.515 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.52 141.01 37.74 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.006 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.7 126.14 6.25 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.66 124.87 53.22 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.2 t -115.96 168.85 9.71 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.832 0.348 . . . . 0.0 110.505 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -92.36 -177.21 4.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.576 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.574 ' NE ' ' OE1' ' A' ' 281' ' ' GLU . 92.2 mtt180 -100.62 128.02 46.81 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.989 0.423 . . . . 0.0 110.482 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.493 ' H ' HD22 ' A' ' 249' ' ' ASN . 47.1 mm -118.28 11.67 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.91 3.48 89.22 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.5 t -135.23 102.85 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.286 0.565 . . . . 0.0 110.361 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -55.16 -51.71 65.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.548 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.36 70.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.548 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -62.91 -42.12 99.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.307 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.493 HD22 ' H ' ' A' ' 243' ' ' ILE . 98.4 m-20 -61.43 -46.31 90.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.587 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -61.25 -41.63 97.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.451 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.94 -36.07 92.94 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.9 mt -70.59 -41.26 72.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.81 178.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.693 ' HG ' ' H ' ' A' ' 280' ' ' GLY . 11.7 t -65.33 -42.65 92.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.57 -49.11 72.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.129 0.49 . . . . 0.0 109.816 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -58.46 -44.84 89.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.256 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 51.8 ttm-85 -51.27 -64.25 0.87 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.54 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -56.84 -31.38 64.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.244 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -66.09 -48.19 71.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.542 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.47 ' O ' ' OD2' ' A' ' 262' ' ' ASP . 13.6 t -60.06 -39.13 84.95 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.467 0.651 . . . . 0.0 110.826 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.24 -50.67 79.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.216 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.2 -48.92 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.794 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 259' ' ' SER . 0.0 OUTLIER -47.53 -41.73 21.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.144 0.497 . . . . 0.0 110.014 -177.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.433 ' CG ' HD12 ' A' ' 209' ' ' LEU . 15.6 t80 -79.85 -34.11 39.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.83 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -33.87 76.84 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.33 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 267' ' ' LYS . 84.6 mt -65.99 -49.36 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 79.0 p -54.07 -11.1 0.41 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.966 -178.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.476 ' HZ1' ' CB ' ' A' ' 218' ' ' ASP . 70.9 mmtt -78.41 -7.46 57.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.683 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 101.61 43.06 2.2 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.768 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.3 128.74 23.65 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 117.12 0.46 . . . . 0.0 110.029 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.22 129.2 27.85 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.694 1.596 . . . . 0.0 111.817 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.68 -10.53 47.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.954 0.406 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -90.66 -21.36 21.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.385 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -19.9 41.88 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.948 0.88 . . . . 0.0 110.975 -179.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.3 pt -104.96 -173.5 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.455 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 15.7 t -166.62 135.82 2.98 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.283 178.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -108.06 110.48 22.18 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.957 0.408 . . . . 0.0 110.838 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -115.46 137.24 52.26 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.386 0.612 . . . . 0.0 111.503 -178.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 280' ' ' GLY . . . -86.85 92.09 1.78 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 178.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 280' ' ' GLY . 5.1 tpt -66.19 3.9 0.8 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.502 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.693 ' H ' ' HG ' ' A' ' 253' ' ' SER . . . 35.35 -104.64 0.02 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.12 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.574 ' OE1' ' NE ' ' A' ' 242' ' ' ARG . 30.9 tt0 -142.62 58.21 1.44 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.3 m -85.33 -4.02 59.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -149.59 65.61 7.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.233 -179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.31 148.31 90.96 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.21 1.94 . . . . 0.0 111.26 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.41 ' CG2' ' H ' ' A' ' 286' ' ' THR . 19.6 m -110.95 -55.36 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.247 0.546 . . . . 0.0 110.907 178.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.633 ' C ' ' H ' ' A' ' 288' ' ' ASN . 18.6 p -58.91 -40.78 85.55 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.075 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.61 -7.73 0.01 OUTLIER Glycine 0 CA--C 1.531 1.078 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.633 ' H ' ' C ' ' A' ' 286' ' ' THR . 3.2 m-20 -123.45 -54.99 1.76 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.8 m -66.89 -22.03 65.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.324 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.95 24.53 10.14 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.756 0.312 . . . . 0.0 110.481 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -66.58 -9.01 30.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.981 0.42 . . . . 0.0 110.358 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -93.77 33.72 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.173 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.32 120.59 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.8 0.333 . . . . 0.0 110.733 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 13.03 13.14 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . 0.424 ' N ' ' CD ' ' A' ' 295' ' ' GLN . 0.1 OUTLIER -99.59 136.93 38.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.974 0.416 . . . . 0.0 109.953 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -58.14 -46.12 86.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.2 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -67.11 -46.93 72.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.285 -178.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.19 -26.36 68.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.661 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 303' ' ' LEU . 31.8 mt -76.12 -57.04 4.11 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.549 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.36 -36.97 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.0 109.882 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -72.0 -40.34 68.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.099 178.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 9.1 t -83.68 -8.02 59.37 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.562 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 299' ' ' LEU . 49.4 mt -93.77 21.73 6.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.463 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -80.25 -43.35 1.4 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 121.055 0.455 . . . . 0.0 110.711 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.3 Cg_exo -60.77 10.27 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.398 2.732 . . . . 0.0 111.681 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.599 ' H ' ' C ' ' A' ' 304' ' ' ALA . 2.0 m-20 -103.88 14.26 31.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.743 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.427 ' O ' ' OG ' ' A' ' 198' ' ' SER . 85.9 mtm-85 -115.87 93.84 4.42 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.239 0.543 . . . . 0.0 110.165 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.505 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 8.4 ptm180 -154.44 128.4 8.85 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.512 0.673 . . . . 0.0 112.575 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.54 135.57 28.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.508 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.448 ' OE2' ' CZ ' ' A' ' 239' ' ' TYR . 28.5 mt-10 -118.66 104.37 10.56 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.26 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 193' ' ' HIS . 0.9 OUTLIER -79.48 117.86 25.93 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.543 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -96.0 121.61 37.93 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.141 0.495 . . . . 0.0 110.594 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.34 117.27 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.955 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -112.92 138.67 49.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 87.82 39.14 7.17 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -178.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.715 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.3 tt -116.68 169.31 7.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.715 ' O ' ' O ' ' A' ' 316' ' ' ILE . 68.2 mttm -38.78 -163.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.7 0.762 . . . . 0.0 112.016 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -87.9 172.71 9.4 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.657 -0.652 . . . . 0.0 110.729 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 16.1 t -98.08 97.87 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.804 179.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.67 130.29 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.472 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.3 p -117.57 96.77 5.54 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.318 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -116.69 89.32 27.94 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.001 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.89 135.97 59.01 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.102 1.868 . . . . 0.0 111.858 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.431 ' O ' ' OXT' ' A' ' 325' ' ' ALA . 29.4 pt20 -157.08 151.76 25.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.573 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.431 ' OXT' ' O ' ' A' ' 324' ' ' GLN . . . . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.661 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.05 -19.91 44.93 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.768 2.312 . . . . 0.0 112.018 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 59.56 73.51 0.66 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.334 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.79 148.05 93.22 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.895 2.397 . . . . 0.0 111.918 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.44 69.94 46.32 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.37 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.26 -39.77 79.79 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.623 2.215 . . . . 0.0 112.005 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -174.48 78.69 0.34 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.444 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 188' ' ' GLU . 50.5 Cg_exo -51.8 -35.25 58.12 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.67 2.247 . . . . 0.0 112.016 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 187' ' ' PRO . 84.7 tt0 57.04 114.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.476 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.0 t -135.26 131.25 51.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.133 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -112.87 85.85 2.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.711 -179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.426 ' CG2' ' N ' ' A' ' 192' ' ' LYS . 43.3 m -76.59 167.03 22.57 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.008 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 191' ' ' THR . 3.8 tptm -152.37 98.5 2.4 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.561 0.696 . . . . 0.0 110.998 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -85.27 125.16 32.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.408 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.562 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 54.4 m-85 -112.73 119.27 37.49 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' A' ' 195' ' ' THR . 7.7 t -86.4 104.93 16.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.427 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 27.7 tp -107.38 129.47 54.92 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.068 0.461 . . . . 0.0 109.773 -179.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -78.81 126.78 31.18 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.876 0.845 . . . . 0.0 112.113 -178.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 202' ' ' PHE . 94.6 p -62.74 -30.29 71.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.984 179.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.435 ' N ' ' HG ' ' A' ' 198' ' ' SER . 98.3 m-20 -58.86 -40.27 83.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.32 -46.27 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 90.3 mt -75.93 -76.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.359 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -126.48 128.29 46.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.946 -179.787 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -108.45 -76.18 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.27 -34.09 17.83 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.561 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.468 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 48.9 p30 -62.79 165.77 6.27 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.076 0.465 . . . . 0.0 110.223 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -54.93 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.54 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.3 52.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.63 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.468 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 60.9 p -107.14 137.76 44.59 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.279 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.2 mt -74.6 142.74 44.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.18 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 213' ' ' GLY . 34.4 mtpt -101.83 159.68 28.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.137 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 210' ' ' LYS . 82.2 Cg_exo -33.96 -77.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.418 2.079 . . . . 0.0 111.982 179.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -51.47 -17.01 0.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.262 0.553 . . . . 0.0 110.181 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.99 -48.22 10.24 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.343 178.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . 0.402 ' NE2' ' CE1' ' A' ' 263' ' ' TYR . 93.1 mt-30 -67.62 -40.11 84.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.139 0.495 . . . . 0.0 109.783 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.49 -50.34 74.11 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.07 -32.65 74.46 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.509 0.671 . . . . 0.0 110.311 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.9 mt -70.33 -26.89 63.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.421 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -74.94 -47.66 28.47 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.36 0.6 . . . . 0.0 111.178 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -64.63 -40.72 95.96 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.469 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.2 tp -63.78 -41.47 97.95 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.488 178.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 225' ' ' SER . 6.3 t80 -53.02 -51.02 63.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.998 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 6.1 t -53.19 -51.48 61.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.266 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.562 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 11.1 tt0 -55.12 -25.92 34.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 86.5 mt -94.89 -20.28 19.56 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.641 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 221' ' ' TYR . 24.6 p -83.36 -11.42 57.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.396 0.435 . . . . 0.0 110.444 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 13.7 t-20 -97.48 22.4 8.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.237 0.541 . . . . 0.0 110.263 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.495 HD21 ' H ' ' A' ' 227' ' ' LEU . 0.6 OUTLIER -80.03 -177.69 6.14 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.975 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 315' ' ' GLY . 21.5 t0 -100.26 108.02 50.48 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.77 178.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 230' ' ' LYS . 75.6 Cg_exo -46.19 -21.01 1.0 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.667 2.245 . . . . 0.0 112.917 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 229' ' ' PRO . 65.0 tttm -35.91 -52.21 0.73 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.041 0.448 . . . . 0.0 110.546 -177.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.47 ' O ' ' C ' ' A' ' 232' ' ' GLY . 57.4 m-20 -98.71 -21.52 16.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.528 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.17 50.32 0.04 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 123.849 0.718 . . . . 0.0 111.646 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.68 111.81 19.0 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 122.574 -0.368 . . . . 0.0 110.69 -179.182 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.02 97.32 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.712 0.767 . . . . 0.0 110.311 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.4 t -99.67 121.17 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.554 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 85.7 t -95.41 126.86 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.428 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.2 mt -111.93 140.53 46.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.051 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.429 ' O ' ' SD ' ' A' ' 279' ' ' MET . . . -116.7 136.48 12.81 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -120.81 122.04 39.45 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.511 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.425 ' OG1' ' OG ' ' A' ' 253' ' ' SER . 3.3 p -113.3 165.8 12.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 0.0 110.218 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.98 -177.32 5.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.644 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -98.42 122.06 41.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.281 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.473 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 49.3 mm -118.55 13.6 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.274 0.559 . . . . 0.0 110.702 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 82.73 2.65 90.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.9 m -132.79 98.92 4.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.033 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -54.01 -51.61 63.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.461 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.74 -41.6 74.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.505 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -63.36 -43.24 98.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.67 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.06 -42.38 99.13 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.523 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -64.04 -41.57 97.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.785 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.23 -39.07 97.21 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 33.5 mt -69.08 -38.2 78.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.764 179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.425 ' OG ' ' OG1' ' A' ' 240' ' ' THR . 15.4 m -63.66 -43.74 95.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.959 0.409 . . . . 0.0 111.011 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.11 -40.83 91.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.045 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER -60.09 -47.41 86.01 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.28 -179.718 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.762 HH22 ' HE ' ' A' ' 307' ' ' ARG . 99.6 mtt180 -61.36 -58.78 6.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.115 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -52.74 -32.67 44.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.109 0.48 . . . . 0.0 109.753 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.56 -51.28 15.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.352 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.476 ' O ' ' OD2' ' A' ' 262' ' ' ASP . 66.2 m -58.86 -38.79 79.56 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.667 0.746 . . . . 0.0 110.268 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.4 -50.1 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.365 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 12.8 t -62.08 -49.16 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.475 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 259' ' ' SER . 0.0 OUTLIER -45.06 -42.43 8.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.16 0.505 . . . . 0.0 110.272 -178.573 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.402 ' CE1' ' NE2' ' A' ' 214' ' ' GLN . 19.9 t80 -80.62 -31.38 36.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.637 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.9 -7.39 45.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.285 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 267' ' ' LYS . 69.6 mt -88.62 -58.35 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 111.612 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.1 p -49.17 -6.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.075 -178.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.0 OUTLIER -78.19 -11.69 59.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.847 0.356 . . . . 0.0 110.527 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 108.67 39.88 1.68 Allowed Glycine 0 C--N 1.329 0.161 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.0 129.98 23.88 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.0 128.85 30.6 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.67 1.58 . . . . 0.0 111.698 176.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.23 -10.17 47.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.849 0.357 . . . . 0.0 111.122 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 33.5 p30 -92.61 -18.21 23.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.479 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 1.4 ttpm? -83.98 -18.26 37.79 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.605 0.717 . . . . 0.0 110.71 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.7 pt -105.27 -171.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.717 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 7.6 t -168.53 133.19 1.62 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.202 179.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -105.2 112.04 25.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.784 0.326 . . . . 0.0 110.608 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 150.34 45.61 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.539 0.685 . . . . 0.0 110.982 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -115.37 97.63 0.81 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.603 ' HE2' ' H ' ' A' ' 282' ' ' SER . 3.3 ppp? -80.85 6.74 12.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.884 0.374 . . . . 0.0 111.001 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 47.38 -99.17 0.02 OUTLIER Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.983 179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 281' ' ' GLU . 1.8 pm0 -139.36 80.14 1.76 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.845 0.355 . . . . 0.0 111.032 -178.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.603 ' H ' ' HE2' ' A' ' 279' ' ' MET . 88.0 p -88.92 -2.0 58.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.071 -179.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -163.02 75.6 1.93 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.296 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.34 103.7 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.461 2.107 . . . . 0.0 112.805 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.74 -35.88 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.231 0.539 . . . . 0.0 110.095 179.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.684 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.9 OUTLIER -58.98 -43.51 91.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.507 -179.714 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.38 -0.8 0.02 OUTLIER Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.684 ' H ' ' C ' ' A' ' 286' ' ' THR . 11.0 t30 -122.16 -58.62 1.71 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.7 m -58.73 -23.0 59.07 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.737 0.303 . . . . 0.0 110.524 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 3.3 m -120.29 28.49 8.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.143 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -70.78 -17.88 62.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.86 0.362 . . . . 0.0 110.952 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -97.57 31.47 2.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.437 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 23.6 t -137.95 129.31 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.194 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -121.23 13.3 11.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -96.44 131.37 43.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.168 0.509 . . . . 0.0 110.249 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -52.76 -67.98 0.21 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.031 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.48 -41.2 60.76 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.891 -178.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.26 80.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.424 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 303' ' ' LEU . 4.9 mp -72.74 -52.03 16.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.714 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 81.6 mt -43.17 -38.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.906 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -76.51 -43.53 39.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.359 178.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.7 t -73.93 -5.43 41.14 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.505 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.4 mm? -94.55 13.35 24.37 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.57 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.598 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -73.73 -43.1 6.56 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.734 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.5 Cg_exo -60.81 9.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.438 2.759 . . . . 0.0 112.255 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 304' ' ' ALA . 53.1 t0 -108.81 9.5 26.82 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.662 0.268 . . . . 0.0 110.669 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.762 ' HE ' HH22 ' A' ' 256' ' ' ARG . 68.3 mtp180 -112.38 98.87 7.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.333 0.587 . . . . 0.0 110.148 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.466 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 36.5 ptt180 -167.75 144.54 4.23 Favored 'General case' 0 C--O 1.215 -0.763 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.784 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 22.4 m -107.2 147.67 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -121.02 110.62 16.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.146 0.498 . . . . 0.0 111.091 -178.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.4 mm -80.49 118.31 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -104.33 98.96 8.67 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.942 -179.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.0 t -106.06 123.48 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.444 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -115.53 146.89 41.3 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.999 179.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 91.96 15.84 52.99 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -179.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.42 143.71 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.211 0.529 . . . . 0.0 110.825 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -87.28 129.68 34.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.767 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -50.9 94.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.482 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 19.2 t -74.61 133.92 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.446 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 12.4 t -88.49 120.83 37.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.414 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 4.8 t -150.92 167.37 27.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.439 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . 0.547 ' CD ' ' H ' ' A' ' 322' ' ' GLN . 7.8 mp0 -80.09 146.69 63.66 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.684 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.86 -26.52 51.99 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.388 2.059 . . . . 0.0 112.079 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -87.95 -42.63 12.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.721 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.603 -179.948 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.545 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 73.4 Cg_endo -79.62 153.93 23.56 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.499 2.133 . . . . 0.0 112.157 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 59.44 78.73 0.33 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.475 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.03 145.3 98.1 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.861 2.374 . . . . 0.0 112.058 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.46 ' N ' ' HD2' ' A' ' 185' ' ' PRO . . . -179.47 -61.45 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.127 -179.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 184' ' ' ALA . 25.4 Cg_endo -60.14 146.05 97.1 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.568 2.179 . . . . 0.0 111.962 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.458 ' CB ' ' CD ' ' A' ' 187' ' ' PRO . . . -47.64 179.54 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.333 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 186' ' ' ALA . 33.3 Cg_exo -60.83 151.21 78.82 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.809 2.339 . . . . 0.0 112.111 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -44.65 157.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.34 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.1 p -80.66 172.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.185 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -123.35 111.78 16.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.827 179.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.7 m -86.92 146.01 26.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.271 179.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 313' ' ' VAL . 20.4 mmtt -112.92 149.78 32.73 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.335 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -128.01 114.16 16.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.191 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -114.03 116.47 29.24 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.678 177.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.1 102.18 13.63 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.584 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 29.4 tp -103.27 119.85 39.65 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.737 -179.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -77.59 127.69 32.91 Favored 'General case' 0 C--O 1.255 1.366 0 CA-C-O 123.052 1.406 . . . . 0.0 112.765 -178.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 202' ' ' PHE . 78.4 p -59.48 -20.13 53.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.874 178.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -55.97 -43.63 77.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.15 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 6.7 t -74.6 -28.07 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 51.9 mt -93.52 -81.75 0.36 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.776 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.0 OUTLIER -113.27 130.28 56.29 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.869 -179.161 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.539 ' O ' ' NH1' ' A' ' 307' ' ' ARG . 7.7 m120 -98.7 -72.7 0.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -117.27 -21.13 8.89 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.817 0.341 . . . . 0.0 110.283 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.31 172.12 6.34 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.052 0.453 . . . . 0.0 110.321 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -53.37 -92.26 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.657 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -151.29 59.38 0.9 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.506 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 68.1 p -106.9 129.54 54.71 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 37.3 mt -74.7 125.01 27.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.697 -178.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 213' ' ' GLY . 50.4 mttt -86.32 158.52 54.88 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.72 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' N ' ' A' ' 213' ' ' GLY . 73.4 Cg_exo -34.01 -75.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.585 2.19 . . . . 0.0 112.045 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -49.02 -20.06 0.49 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.162 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.79 -51.32 11.4 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 178.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -66.19 -38.95 89.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.355 0.597 . . . . 0.0 110.241 179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.83 -53.75 54.86 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.67 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.37 90.83 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.981 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.88 -29.58 70.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.574 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -71.76 -46.28 58.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.219 0.533 . . . . 0.0 110.239 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.543 ' O ' ' NE2' ' A' ' 223' ' ' GLN . 7.1 mt-30 -62.16 -44.02 97.53 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.218 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.16 -41.02 97.31 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' A' ' 225' ' ' SER . 3.7 t80 -52.93 -47.69 67.86 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.528 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 72.6 m -53.22 -52.69 58.1 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.424 -178.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.836 ' H ' HE21 ' A' ' 223' ' ' GLN . 0.0 OUTLIER -55.78 -27.64 52.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.608 -179.203 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 86.6 mt -92.43 -23.12 19.27 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.713 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 221' ' ' TYR . 8.1 t -77.56 -19.78 55.13 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.57 0.544 . . . . 0.0 110.738 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -96.05 22.17 7.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.068 0.461 . . . . 0.0 110.688 -179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 227' ' ' LEU . 0.7 OUTLIER -74.03 -177.68 3.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.219 179.903 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 230' ' ' LYS . 3.7 t0 -99.43 127.08 35.38 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 232' ' ' GLY . 55.4 Cg_endo -69.73 -22.52 32.12 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.959 2.44 . . . . 0.0 113.593 -178.209 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.556 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 34.6 ttmt -23.74 -51.97 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.688 0.617 . . . . 0.0 111.1 -177.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 232' ' ' GLY . 90.2 m-20 -109.54 -10.48 14.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.939 178.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 27.32 58.13 0.1 Allowed Glycine 0 N--CA 1.471 0.992 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.687 ' N ' ' HZ2' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -124.34 119.0 28.01 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-O 121.249 0.547 . . . . 0.0 110.454 -179.549 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -132.75 99.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.514 0.673 . . . . 0.0 109.805 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.19 127.09 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.152 0.501 . . . . 0.0 111.11 -178.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 89.4 t -102.12 128.39 54.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.399 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 18.2 mt -108.78 140.43 42.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.016 0.436 . . . . 0.0 110.459 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -98.95 138.26 13.75 Favored Glycine 0 N--CA 1.472 1.092 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.201 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 308' ' ' ARG . 9.7 m-85 -125.63 115.82 20.74 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 4.9 t -117.18 163.94 15.53 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.461 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 48.9 p-10 -87.74 -174.92 4.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.417 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -99.21 121.79 41.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 110.075 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.65 ' H ' HD22 ' A' ' 249' ' ' ASN . 47.8 mm -116.1 12.62 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.371 0.605 . . . . 0.0 110.728 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.05 -3.52 65.21 Favored Glycine 0 C--N 1.315 -0.584 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -125.39 105.26 8.95 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.93 -55.2 37.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.36 69.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.576 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -63.03 -44.88 94.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.775 -179.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.65 HD22 ' H ' ' A' ' 243' ' ' ILE . 57.8 m-80 -61.88 -42.16 98.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.398 -179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.43 ' O ' ' OG ' ' A' ' 253' ' ' SER . 70.7 tp60 -64.27 -41.81 96.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.644 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.74 -38.31 96.25 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.2 -38.58 78.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.849 0.357 . . . . 0.0 111.199 179.059 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.479 ' HG ' ' H ' ' A' ' 254' ' ' GLU . 78.1 p -63.56 -44.01 95.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.479 ' H ' ' HG ' ' A' ' 253' ' ' SER . 98.0 mt-10 -66.43 -45.11 80.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.437 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -56.8 -50.52 72.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.319 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.711 HH22 ' N ' ' A' ' 308' ' ' ARG . 70.3 mtp180 -59.13 -59.01 6.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.473 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.2 -35.68 17.79 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.172 0.511 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.408 ' NE2' ' OD1' ' A' ' 262' ' ' ASP . 68.0 tp60 -69.9 -43.75 71.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.154 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.7 t -60.86 -39.64 89.92 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.314 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.28 -54.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.773 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.21 -50.01 81.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.45 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.408 ' OD1' ' NE2' ' A' ' 258' ' ' GLN . 25.8 m-20 -44.6 -41.75 6.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -83.55 -29.67 27.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.745 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -7.0 45.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.474 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.613 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.0 mt -87.09 -55.74 6.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.832 0.349 . . . . 0.0 111.539 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.3 m -50.93 -5.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.887 -178.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 265' ' ' ILE . 5.7 mmtm -77.17 -9.87 59.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.94 38.17 2.22 Favored Glycine 0 N--CA 1.458 0.15 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.07 128.35 23.76 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.24 130.24 34.71 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.965 1.777 . . . . 0.0 112.081 177.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.01 -10.71 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.917 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -92.84 -22.71 19.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.898 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -78.34 -23.21 47.09 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.632 0.73 . . . . 0.0 110.472 -179.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.4 pt -101.19 -170.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.71 -178.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 8.2 t -169.04 126.3 0.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.012 179.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.91 114.55 26.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.795 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -129.28 157.47 41.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.311 0.577 . . . . 0.0 110.18 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.54 155.11 16.25 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.541 ' N ' ' O ' ' A' ' 238' ' ' GLY . 5.5 tpt -118.62 -10.0 10.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.964 0.411 . . . . 0.0 110.293 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 53.58 -110.88 1.57 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -137.33 74.94 1.5 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.804 0.335 . . . . 0.0 110.732 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.408 ' C ' ' ND2' ' A' ' 283' ' ' ASN . 47.9 t -72.86 -48.42 37.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.12 0.486 . . . . 0.0 111.498 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 282' ' ' SER . 3.8 m-80 -144.63 76.77 14.06 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.12 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.55 123.26 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.627 2.218 . . . . 0.0 111.744 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.06 -35.87 42.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.115 0.483 . . . . 0.0 110.556 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.645 ' C ' ' H ' ' A' ' 288' ' ' ASN . 71.7 p -67.38 -50.03 61.41 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.643 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.623 ' H ' ' HG1' ' A' ' 286' ' ' THR . . . -55.12 1.73 0.05 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.645 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.7 t-20 -111.64 -61.12 1.75 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.3 t -76.91 -7.35 55.37 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.568 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.45 21.25 7.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.541 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -69.59 -4.2 18.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.575 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -96.6 33.02 1.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.661 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.8 t -125.65 129.96 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.944 0.402 . . . . 0.0 109.917 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.78 4.32 12.25 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -100.25 130.9 46.43 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.19 0.519 . . . . 0.0 110.432 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 299' ' ' LEU . 5.0 ttt180 -53.26 -75.62 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.604 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -42.36 -37.48 1.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.1 0.476 . . . . 0.0 110.747 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.48 84.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.793 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 296' ' ' ARG . 20.8 mt -73.12 -44.32 60.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.168 0.509 . . . . 0.0 110.575 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 6.3 mm -60.84 -31.39 49.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.989 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -81.38 -28.97 34.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.611 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.3 t -93.68 -11.23 32.03 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.85 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 299' ' ' LEU . 37.7 mt -93.28 20.36 7.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -78.44 -46.11 2.03 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.288 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.7 Cg_exo -59.76 8.83 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.214 2.609 . . . . 0.0 111.886 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.581 ' H ' ' C ' ' A' ' 304' ' ' ALA . 47.2 t0 -109.47 12.11 24.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.793 0.33 . . . . 0.0 110.852 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 203' ' ' ASN . 65.0 mtp180 -109.4 109.74 20.68 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.176 0.512 . . . . 0.0 110.36 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.711 ' N ' HH22 ' A' ' 256' ' ' ARG . 10.4 ptp180 -174.16 -172.38 0.7 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.998 -179.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.35 157.11 15.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 177.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -121.79 106.65 11.48 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.221 0.534 . . . . 0.0 111.282 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.68 122.48 35.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.305 -178.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -108.06 116.65 32.34 Favored 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 123.775 0.672 . . . . 0.0 110.27 -178.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 192' ' ' LYS . 80.2 t -130.77 125.71 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.154 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.687 ' HZ2' ' N ' ' A' ' 233' ' ' SER . 0.0 OUTLIER -99.41 179.53 4.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.335 179.043 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.52 -49.71 1.03 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 177.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 14.2 tt -47.07 150.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.098 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -113.12 161.94 16.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.058 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -65.16 92.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.703 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 28.6 m -59.25 176.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.247 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.55 133.13 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.0 m -118.87 135.48 54.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.615 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -48.86 151.89 2.0 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.415 -179.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.64 149.47 87.27 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.658 2.239 . . . . 0.0 112.229 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 54.03 89.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.457 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.605 179.952 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.66 -39.46 76.02 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.486 2.124 . . . . 0.0 112.332 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -82.88 139.67 43.21 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.563 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.24 158.85 48.21 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.299 2.0 . . . . 0.0 111.809 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -157.01 144.89 14.12 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.56 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.86 -17.91 36.85 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.228 1.952 . . . . 0.0 112.278 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 70.86 73.48 0.27 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.15 -179.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 188' ' ' GLU . 35.0 Cg_exo -55.77 178.3 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.718 2.279 . . . . 0.0 112.128 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 188' ' ' GLU . 1.1 tm-20 77.63 40.07 0.17 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.504 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.4 t -135.23 132.72 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 0.1 OUTLIER -122.92 101.92 7.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.013 179.493 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.7 m -69.12 139.03 54.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.291 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -142.33 114.0 7.95 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.9 m-70 -102.95 144.53 31.12 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.546 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 78.1 m-85 -107.22 130.68 54.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' A' ' 195' ' ' THR . 8.0 t -86.32 104.35 15.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.825 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mt -108.83 131.55 54.88 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.38 137.92 32.22 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 122.727 1.251 . . . . 0.0 110.991 -178.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 202' ' ' PHE . 0.9 OUTLIER -61.01 -18.21 56.45 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.427 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -57.13 -49.99 74.21 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.863 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 4.7 m -68.26 -38.55 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.735 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 33.2 mt -82.79 -78.76 0.2 Allowed 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.449 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -138.06 137.86 38.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.841 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.733 HD21 HH11 ' A' ' 307' ' ' ARG . 0.8 OUTLIER -119.49 -75.99 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.552 179.808 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -81.69 -37.7 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.933 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -67.26 170.52 7.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.144 0.497 . . . . 0.0 110.494 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -59.32 -82.82 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.775 -179.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -153.67 54.23 0.73 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.166 0.507 . . . . 0.0 110.349 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.57 127.93 53.72 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.486 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.6 mt -70.21 140.89 52.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 -179.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 213' ' ' GLY . 4.1 mtmp? -103.51 157.36 34.01 Favored Pre-proline 0 N--CA 1.466 0.326 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -32.97 -76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.718 2.279 . . . . 0.0 112.352 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -49.84 -20.32 0.85 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.326 0.584 . . . . 0.0 110.548 -179.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.53 -50.08 12.85 Favored Glycine 0 N--CA 1.461 0.365 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.084 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -65.15 -40.88 95.0 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.232 0.539 . . . . 0.0 109.944 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.0 67.04 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.07 -38.69 91.97 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.607 -179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.31 -28.88 70.05 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.277 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -71.18 -47.24 58.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.374 0.607 . . . . 0.0 110.808 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -62.62 -43.5 98.66 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.974 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.54 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 60.9 tp -65.23 -39.36 92.63 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.235 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.431 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.7 t80 -53.42 -47.94 69.18 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.845 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.8 t -59.32 -50.07 75.39 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.537 -178.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 9.0 tt0 -51.95 -24.99 7.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.942 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 23.3 mt -96.68 -17.15 20.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.508 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 10.5 t -81.63 -16.12 52.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.795 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -103.32 17.72 23.43 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.581 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.38 -179.44 3.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.323 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -97.96 109.46 51.56 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 230' ' ' LYS . 78.5 Cg_exo -47.6 -19.57 1.33 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.349 2.033 . . . . 0.0 113.438 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 229' ' ' PRO . 1.5 tmtp? -27.13 -51.79 0.06 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.261 0.553 . . . . 0.0 111.11 -177.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 232' ' ' GLY . 67.9 m-20 -110.14 -13.73 14.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.478 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.51 46.61 0.02 OUTLIER Glycine 0 N--CA 1.474 1.228 0 O-C-N 124.101 0.876 . . . . 0.0 111.272 179.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 231' ' ' ASP . 74.6 m -114.96 109.93 18.85 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.568 0.223 . . . . 0.0 111.149 -178.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 77.4 t -125.64 95.05 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.37 0.605 . . . . 0.0 109.933 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.7 t -96.69 121.14 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.296 0.569 . . . . 0.0 110.7 -178.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 96.5 t -91.07 122.3 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 45.9 mt -105.79 140.86 38.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.427 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -125.03 129.72 7.11 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -113.91 117.01 30.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.824 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.411 ' OG1' ' NH2' ' A' ' 256' ' ' ARG . 9.7 t -104.88 178.54 4.53 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.133 0.492 . . . . 0.0 110.975 -178.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 307' ' ' ARG . 41.8 m-20 -83.79 -177.08 6.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.394 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -117.02 120.28 37.9 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.768 0.318 . . . . 0.0 110.501 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.491 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 45.4 mm -120.67 12.66 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.504 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.96 -43.5 3.26 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 6.9 m -71.1 94.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.362 0.601 . . . . 0.0 109.934 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -48.51 -48.34 38.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.203 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.14 84.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.749 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -62.14 -42.22 99.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.148 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.531 HD22 ' CA ' ' A' ' 280' ' ' GLY . 0.5 OUTLIER -60.38 -53.08 61.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 -179.775 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -61.67 -37.65 84.86 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.42 -41.83 99.63 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.24 -37.78 71.99 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.073 178.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.594 ' HG ' ' CA ' ' A' ' 278' ' ' GLY . 4.2 t -63.0 -39.68 95.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.115 0.483 . . . . 0.0 110.879 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -73.19 -39.65 65.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.46 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -58.83 -51.75 68.65 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.517 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.411 ' NH2' ' OG1' ' A' ' 240' ' ' THR . 18.1 ptp180 -64.39 -44.28 91.81 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.899 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.28 98.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.571 0.7 . . . . 0.0 110.421 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -70.72 -42.06 71.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.684 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.8 m -60.61 -39.14 87.09 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.383 0.611 . . . . 0.0 110.355 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 88.8 t -63.97 -50.65 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.95 179.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.8 t -61.32 -48.27 89.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 121.165 0.507 . . . . 0.0 110.315 179.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -47.93 -40.9 23.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.908 -178.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.405 ' OH ' ' NZ ' ' A' ' 267' ' ' LYS . 88.6 t80 -79.66 -35.59 39.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.026 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.14 -29.11 70.25 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.99 -179.023 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.512 ' C ' ' H ' ' A' ' 267' ' ' LYS . 89.0 mt -69.06 -49.54 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 120.797 0.332 . . . . 0.0 111.82 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 18.5 m -52.43 -8.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.512 ' H ' ' C ' ' A' ' 265' ' ' ILE . 12.3 mmtt -79.75 -6.21 56.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.683 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.06 42.21 2.87 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.19 129.41 24.22 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 117.101 0.451 . . . . 0.0 110.583 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.56 129.34 29.21 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.325 1.35 . . . . 0.0 112.002 178.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.4 -11.05 38.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.74 -22.9 21.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -179.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.47 -23.54 50.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.295 0.569 . . . . 0.0 110.529 -179.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.8 pt -104.18 -175.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.751 -179.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 25.7 m -169.28 132.53 1.29 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.326 178.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.93 148.99 22.05 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -153.1 138.09 17.22 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.394 0.616 . . . . 0.0 111.172 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.594 ' CA ' ' HG ' ' A' ' 253' ' ' SER . . . -89.06 94.95 2.05 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -70.36 -6.88 38.53 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.535 -179.551 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.531 ' CA ' HD22 ' A' ' 249' ' ' ASN . . . 42.62 -112.56 0.48 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.88 73.75 1.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.688 0.28 . . . . 0.0 110.317 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 31.9 t -71.27 -37.5 71.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.043 0.449 . . . . 0.0 111.613 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -129.44 79.32 74.15 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.698 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.04 110.35 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.501 2.134 . . . . 0.0 112.112 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 9.1 m -73.14 -36.07 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.76 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.629 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.1 OUTLIER -62.21 -49.35 76.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.097 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -52.51 0.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.629 ' H ' ' C ' ' A' ' 286' ' ' THR . 2.5 t-20 -116.21 -59.69 1.95 Allowed 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -78.18 -3.61 43.44 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.438 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.75 17.9 4.25 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 292' ' ' ASN . 37.9 p-10 -61.53 -36.9 81.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.986 0.422 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 26.4 t-20 -78.73 33.32 0.21 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.947 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.456 ' H ' ' C ' ' A' ' 291' ' ' ASP . 12.1 t -135.93 124.92 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.005 0.431 . . . . 0.0 110.358 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -120.18 16.41 12.35 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.087 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -100.35 133.44 44.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.12 0.486 . . . . 0.0 110.66 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -59.96 -60.46 3.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.607 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.68 -43.26 65.45 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.978 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.93 89.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.268 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 303' ' ' LEU . 4.8 mp -75.62 -61.35 1.95 Allowed 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.324 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' LEU . 72.4 mt -42.32 -34.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.057 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -77.9 -38.72 45.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.316 178.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 299' ' ' LEU . 40.7 t -84.7 -6.99 59.38 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.005 0.431 . . . . 0.0 110.858 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 299' ' ' LEU . 92.8 mt -90.5 15.11 11.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.843 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.597 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -77.11 -53.28 1.72 Allowed Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.437 177.683 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 11.2 Cg_endo -54.25 8.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.178 1.919 . . . . 0.0 113.186 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.597 ' H ' ' C ' ' A' ' 304' ' ' ALA . 59.4 t0 -101.4 12.88 36.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.733 HH11 HD21 ' A' ' 203' ' ' ASN . 15.1 ptp180 -113.61 95.2 5.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.189 0.995 . . . . 0.0 110.224 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.551 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.4 ptp180 -156.31 128.24 7.38 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.456 -178.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.01 135.6 30.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -118.51 104.91 11.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.333 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.7 mm -77.82 115.31 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -94.66 123.79 38.31 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 123.13 0.269 . . . . 0.0 110.672 -178.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 11.5 t -125.57 115.51 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.911 -178.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -114.72 134.46 55.08 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.14 17.1 25.9 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.6 tt -103.9 148.9 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.968 0.413 . . . . 0.0 110.38 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -137.24 124.54 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.612 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 319' ' ' VAL . 52.8 t0 -169.14 153.14 5.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.403 179.889 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . 0.472 ' N ' ' OD1' ' A' ' 318' ' ' ASP . 14.9 p -67.4 148.05 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.321 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.66 141.31 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.446 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 62.0 p -80.54 163.0 24.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.25 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' A' ' 322' ' ' GLN . 22.5 mp0 -112.94 85.61 8.05 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.169 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.67 -178.9 4.86 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.057 1.838 . . . . 0.0 111.983 -179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 68.27 -66.0 0.24 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.326 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.584 179.967 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.41 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 48.2 Cg_endo -67.64 148.89 78.87 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.597 2.198 . . . . 0.0 111.835 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.86 149.52 1.87 Allowed Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.621 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.31 -32.47 50.85 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.558 2.172 . . . . 0.0 112.411 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 168.26 81.13 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.1 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.84 68.04 8.09 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.461 2.107 . . . . 0.0 112.333 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.453 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -79.37 -51.01 1.27 Allowed Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.056 178.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 73.4 Cg_endo -75.47 152.82 39.07 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.154 1.903 . . . . 0.0 112.54 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.59 -164.15 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.701 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.7 p -94.01 170.59 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.304 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 0.8 OUTLIER -125.15 103.92 8.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.171 179.545 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.1 m -67.8 139.12 56.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.146 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.461 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 7.5 mmtt -110.47 161.69 15.43 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.666 0.746 . . . . 0.0 110.611 179.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.461 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 7.0 m-70 -148.27 119.87 8.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.017 -179.514 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -110.89 120.48 42.53 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.17 103.81 15.15 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.245 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 32.2 tp -108.67 128.78 55.15 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -81.81 130.09 34.95 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-O 121.776 0.798 . . . . 0.0 112.291 -178.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -64.99 -27.57 68.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.697 179.723 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.62 -38.48 84.89 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.849 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.25 -42.86 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.12 -79.1 0.13 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.768 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.46 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -124.56 129.5 50.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.779 -179.228 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.56 HD21 ' NZ ' ' A' ' 210' ' ' LYS . 66.0 m-80 -94.44 -74.42 0.54 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.721 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.49 -10.09 14.56 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.7 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -74.3 165.37 25.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.188 0.518 . . . . 0.0 109.919 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.04 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.825 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.09 2.52 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.927 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 63.7 p -53.03 136.27 35.57 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.903 0.383 . . . . 0.0 110.282 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 83.6 mt -82.9 136.36 34.61 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.293 0.568 . . . . 0.0 111.364 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.56 ' NZ ' HD21 ' A' ' 203' ' ' ASN . 31.2 mtmt -98.6 157.59 34.0 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.956 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -34.44 -75.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.383 2.055 . . . . 0.0 112.419 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 57.0 mp0 -48.9 -24.5 1.5 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.361 0.6 . . . . 0.0 110.225 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -70.92 -51.16 20.29 Favored Glycine 0 CA--C 1.517 0.209 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.603 178.494 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.14 -41.02 99.22 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.318 0.58 . . . . 0.0 109.465 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.465 ' O ' ' NE2' ' A' ' 219' ' ' GLN . . . -54.18 -56.1 21.48 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.973 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.61 72.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.56 0.695 . . . . 0.0 110.612 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.11 -25.97 63.75 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.57 179.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -75.59 -49.84 17.35 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.881 0.848 . . . . 0.0 111.054 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 215' ' ' ALA . 0.0 OUTLIER -62.46 -44.54 96.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.421 179.58 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 42.3 tp -62.36 -40.73 97.37 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.411 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.4 t80 -51.8 -49.51 62.58 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.896 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.0 m -54.88 -51.02 67.27 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.716 -178.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -51.55 -26.5 8.72 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.424 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 43.1 mt -100.4 -17.95 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.589 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.1 t -73.79 -28.28 61.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.191 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -95.79 23.91 5.85 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.85 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.61 167.42 21.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.201 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -82.01 129.19 65.4 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 230' ' ' LYS . 53.8 Cg_endo -70.36 -18.73 34.0 Favored 'Trans proline' 0 N--CA 1.506 2.248 0 C-N-CA 122.979 2.452 . . . . 0.0 112.832 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 229' ' ' PRO . 24.6 mmtm -32.32 -52.27 0.28 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.525 -177.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 232' ' ' GLY . 58.4 m-20 -104.45 -17.48 14.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.153 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.75 50.81 0.06 OUTLIER Glycine 0 N--CA 1.471 0.982 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.8 t -118.25 108.47 15.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.819 0.343 . . . . 0.0 110.935 -178.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 15.7 t -125.93 95.61 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.285 178.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.4 120.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.245 -178.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 73.6 t -91.45 126.66 44.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.223 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 23.8 mt -109.97 140.24 44.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.886 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -122.54 130.09 7.78 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.21 117.13 29.63 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.028 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.6 p -103.8 171.31 7.43 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 242' ' ' ARG . 43.6 t0 -85.45 -176.28 6.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.726 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.514 ' H ' ' CG ' ' A' ' 241' ' ' ASP . 88.9 mtm180 -109.34 120.65 43.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.957 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 50.0 mm -120.08 14.47 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.639 0.733 . . . . 0.0 110.645 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.09 -47.81 3.39 Favored Glycine 0 C--N 1.314 -0.653 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.9 p -76.2 91.16 3.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.287 0.565 . . . . 0.0 109.712 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -45.38 -46.5 13.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.372 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.97 80.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.76 -45.9 90.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.989 0.423 . . . . 0.0 110.347 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -62.08 -40.99 97.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.098 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.05 -40.87 95.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.874 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.27 -38.77 96.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 98.3 mt -74.95 -31.2 61.43 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.931 178.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.5 t -66.49 -45.39 79.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.856 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.39 -39.54 71.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.226 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -61.59 -49.84 75.02 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.508 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.28 -51.45 67.66 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.426 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -53.95 -34.34 59.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.162 0.506 . . . . 0.0 109.922 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -71.88 -42.99 66.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.0 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.782 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 16.7 t -62.02 -35.83 79.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.179 0.99 . . . . 0.0 109.92 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.65 -54.5 22.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.341 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.44 -50.2 79.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.782 ' OD1' ' O ' ' A' ' 259' ' ' SER . 40.7 p-10 -49.57 -37.64 28.12 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.577 -177.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.656 ' N ' ' OD1' ' A' ' 262' ' ' ASP . 35.0 t80 -81.34 -33.87 32.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.377 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -22.15 66.86 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.893 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.517 ' C ' ' H ' ' A' ' 267' ' ' LYS . 87.7 mt -78.24 -52.29 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.49 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 62.0 m -49.33 -10.18 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.899 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.0 OUTLIER -77.51 -11.2 59.83 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.302 -179.398 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.8 42.32 1.58 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.67 137.66 30.91 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 117.188 0.494 . . . . 0.0 110.575 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.81 124.23 15.55 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.698 1.599 . . . . 0.0 111.755 177.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.94 -9.83 42.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.874 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -91.22 -23.95 20.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.706 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -79.81 -19.34 48.72 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.585 0.707 . . . . 0.0 110.994 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.5 pt -104.91 -171.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.532 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 47.4 t -170.82 137.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.105 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.43 150.56 22.05 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -155.68 139.79 16.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.538 0.685 . . . . 0.0 111.455 178.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -93.97 96.96 2.13 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -69.96 -4.49 20.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.875 0.369 . . . . 0.0 110.345 -179.028 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.87 -116.28 1.2 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.426 ' O ' ' OE1' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -138.21 71.0 1.39 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.764 0.316 . . . . 0.0 110.462 -179.658 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.14 5.61 49.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.276 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 283' ' ' ASN . 13.7 p-10 -159.82 74.82 3.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.75 108.32 2.25 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.424 2.083 . . . . 0.0 112.073 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.461 ' CG2' ' N ' ' A' ' 286' ' ' THR . 6.2 m -70.45 -43.03 78.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.661 ' C ' ' H ' ' A' ' 288' ' ' ASN . 65.7 p -58.83 -43.6 90.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.078 -179.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.62 -0.55 0.03 OUTLIER Glycine 0 CA--C 1.533 1.159 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.661 ' H ' ' C ' ' A' ' 286' ' ' THR . 18.9 m120 -119.86 -59.09 1.83 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -18.75 65.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.572 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.46 25.79 9.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.291 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 51.5 t0 -69.19 -10.95 60.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 110.393 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -94.89 32.58 1.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.528 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.1 t -129.92 127.26 63.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 110.237 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -117.77 8.13 12.64 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.969 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -95.36 127.81 41.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.044 0.449 . . . . 0.0 109.95 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -55.94 -50.47 70.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.516 -179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.78 96.91 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.982 -179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.25 -30.09 70.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.62 179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 303' ' ' LEU . 39.6 mt -79.18 -57.04 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.398 -179.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.7 mt -45.89 -36.52 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.948 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -74.39 -47.21 35.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.509 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 6.7 t -75.8 -4.95 43.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.278 -179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 299' ' ' LEU . 50.5 mt -96.06 13.06 28.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.529 -179.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.638 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -75.13 -46.13 4.69 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.828 0.347 . . . . 0.0 110.083 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 32.1 Cg_exo -56.41 10.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.971 2.448 . . . . 0.0 112.258 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.638 ' H ' ' C ' ' A' ' 304' ' ' ALA . 46.9 t0 -101.06 13.49 35.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.741 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.425 HH11 ' C ' ' A' ' 304' ' ' ALA . 28.9 ptt-85 -113.04 101.72 9.73 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.991 0.9 . . . . 0.0 110.86 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.565 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 20.4 ptp180 -162.02 132.31 4.83 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.24 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.6 142.25 14.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -121.58 108.11 13.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.985 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.8 mm -78.97 119.75 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.442 ' OE2' ' CE1' ' A' ' 193' ' ' HIS . 28.2 tp10 -99.06 120.58 39.72 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.04 -178.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 66.8 t -126.88 119.47 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 123.578 0.549 . . . . 0.0 111.318 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -117.34 125.2 50.64 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 118.15 -18.6 11.23 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.25 144.1 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.377 179.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -111.47 87.34 2.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.458 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -115.31 109.69 18.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.224 179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.9 t -84.84 102.03 10.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.188 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 16.4 m -143.22 126.74 13.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.438 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.88 124.66 8.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.365 179.464 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -134.28 84.33 41.77 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.055 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 324' ' ' GLN . 37.6 Cg_exo -59.06 148.63 84.47 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.732 2.288 . . . . 0.0 111.628 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 323' ' ' PRO . 87.0 mt-30 58.03 142.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.797 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.608 -179.888 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.435 ' CB ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 180' ' ' ALA . 32.3 Cg_exo -61.14 144.67 99.19 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.484 2.123 . . . . 0.0 112.034 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.425 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . 55.99 54.29 8.67 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.743 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 38.3 Cg_endo -66.19 -21.52 55.13 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 122.789 2.326 . . . . 0.0 111.685 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.424 ' CB ' ' CD ' ' A' ' 185' ' ' PRO . . . 64.21 179.24 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.569 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 184' ' ' ALA . 27.7 Cg_exo -61.95 149.33 90.66 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.631 2.221 . . . . 0.0 111.958 179.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -38.04 103.3 0.26 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.793 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -49.99 -40.3 49.7 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.952 1.768 . . . . 0.0 112.461 -179.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -51.77 156.15 1.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.244 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.9 t -90.64 156.02 3.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.306 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.462 ' H ' HE21 ' A' ' 190' ' ' GLN . 0.0 OUTLIER -126.66 100.54 6.25 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.245 179.694 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 36.5 m -70.92 142.78 51.09 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.667 179.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.453 ' CD ' ' H ' ' A' ' 193' ' ' HIS . 5.3 tmtt? -111.49 162.36 15.18 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.381 0.61 . . . . 0.0 110.715 179.668 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.453 ' H ' ' CD ' ' A' ' 192' ' ' LYS . 53.9 m80 -152.82 121.18 6.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.674 179.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.634 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 59.6 m-85 -113.07 123.29 49.93 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.53 103.59 14.53 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.597 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mt -104.69 122.34 45.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.039 0.447 . . . . 0.0 109.983 -179.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.449 ' O ' HG21 ' A' ' 200' ' ' VAL . 8.9 ptpp? -85.73 135.0 33.93 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 122.52 1.153 . . . . 0.0 111.542 -179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 202' ' ' PHE . 4.0 p -59.74 -19.59 51.11 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.679 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -51.86 -50.02 61.75 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.927 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 197' ' ' LYS . 27.2 m -70.92 -33.68 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.675 178.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 20.5 mt -86.45 -80.36 0.24 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.356 179.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -135.18 145.41 47.7 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.607 -179.146 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -112.58 -67.74 0.98 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.504 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -112.45 -16.57 12.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.574 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -68.28 167.02 15.25 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.01 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.629 ' CG ' ' H ' ' A' ' 207' ' ' ALA . 18.2 pttt -51.29 -70.29 0.09 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.628 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.629 ' H ' ' CG ' ' A' ' 206' ' ' LYS . . . -166.62 -1.18 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.331 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.9 t -52.81 137.16 32.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.897 0.38 . . . . 0.0 110.494 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 96.7 mt -80.17 144.28 33.13 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.566 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 213' ' ' GLY . 38.5 mttm -106.46 156.28 37.29 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.009 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -34.47 -76.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.713 2.275 . . . . 0.0 112.091 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -48.73 -22.16 0.74 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.052 0.453 . . . . 0.0 110.413 -179.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.15 -49.64 15.35 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 178.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.82 -39.94 91.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.26 0.552 . . . . 0.0 110.118 179.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.74 54.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.836 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.95 -37.2 86.53 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.03 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.9 mt -62.72 -30.64 71.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.867 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -71.24 -46.49 60.97 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.087 0.47 . . . . 0.0 110.379 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -63.33 -44.09 95.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.306 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 47.5 tp -63.94 -39.89 95.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.537 ' CE1' ' OG ' ' A' ' 225' ' ' SER . 3.8 t80 -54.02 -49.56 68.63 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.652 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 69.6 m -57.35 -50.56 72.58 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.366 -178.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.634 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 11.3 tt0 -52.85 -26.22 13.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.254 -179.56 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 82.6 mt -97.53 -17.83 19.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.509 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.537 ' OG ' ' CE1' ' A' ' 221' ' ' TYR . 4.8 m -78.81 -12.16 60.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.742 -179.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -104.75 22.34 15.29 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 110.325 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.42 ' H ' HD23 ' A' ' 227' ' ' LEU . 0.9 OUTLIER -76.15 177.69 6.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.242 179.614 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 315' ' ' GLY . 31.2 t0 -98.97 108.8 51.24 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 230' ' ' LYS . 75.7 Cg_exo -46.9 -19.44 0.79 Allowed 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.605 2.204 . . . . 0.0 113.023 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 229' ' ' PRO . 52.8 tptt -27.11 -52.07 0.06 Allowed 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 123.559 0.537 . . . . 0.0 111.016 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' GLY . 79.1 m-20 -109.4 -15.41 14.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.322 179.019 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.83 50.83 0.06 OUTLIER Glycine 0 C--N 1.338 0.68 0 O-C-N 123.892 0.745 . . . . 0.0 111.666 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 t -117.92 111.08 18.52 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.271 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.83 96.15 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.317 178.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.0 t -99.03 123.12 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.816 -178.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 94.8 t -97.88 126.73 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.397 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.9 mt -110.45 143.88 40.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.513 -179.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 279' ' ' MET . . . -119.41 139.55 14.23 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.3 OUTLIER -120.34 119.66 33.76 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -178.748 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.41 167.09 12.26 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.827 0.346 . . . . 0.0 110.414 -179.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.499 ' OD2' ' NE ' ' A' ' 307' ' ' ARG . 38.0 m-20 -81.21 -177.03 6.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.458 -179.023 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -105.52 125.71 51.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.33 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 50.0 mm -116.9 9.17 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.461 0.648 . . . . 0.0 110.829 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.48 10.33 85.72 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.4 m -129.59 106.38 8.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.128 0.489 . . . . 0.0 109.883 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.446 ' CG ' ' N ' ' A' ' 247' ' ' ALA . 22.1 p-10 -57.43 -53.68 55.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.912 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' A' ' 246' ' ' ASP . . . -54.63 -44.1 72.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.498 . . . . 0.0 110.458 -179.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -69.63 -41.3 75.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.994 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.529 ' ND2' ' OE2' ' A' ' 281' ' ' GLU . 18.0 t-20 -61.35 -52.49 64.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.713 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -63.88 -38.17 90.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.555 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.53 -37.36 93.21 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 32.4 mt -71.6 -39.06 70.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.641 0.258 . . . . 0.0 110.692 178.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 52.4 p -61.71 -40.66 95.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.984 0.421 . . . . 0.0 110.599 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -69.52 -43.59 72.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.564 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -57.32 -47.46 81.49 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.414 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.423 ' NH2' HH12 ' A' ' 307' ' ' ARG . 79.4 mtt-85 -62.99 -51.32 67.31 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.445 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.5 81.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.254 0.55 . . . . 0.0 109.874 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -72.11 -44.08 63.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.432 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 13.5 t -61.44 -38.36 86.9 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.43 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 95.8 t -64.54 -52.59 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.723 179.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 41.9 t -60.52 -48.61 87.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.964 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -46.01 -41.86 12.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.077 -179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -82.89 -30.83 28.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.08 -9.42 58.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.304 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.6 mt -86.01 -53.89 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.353 179.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 84.6 p -51.37 -6.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.689 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 265' ' ' ILE . 10.0 mmpt? -76.18 -12.52 60.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 104.43 42.17 1.92 Allowed Glycine 0 N--CA 1.459 0.21 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.1 tt -127.3 131.46 23.85 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 117.045 0.422 . . . . 0.0 110.852 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.87 125.41 17.02 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.187 1.258 . . . . 0.0 111.923 177.36 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.39 -6.32 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 179.196 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -92.88 -23.67 18.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.944 -179.3 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -80.37 -18.7 48.25 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.443 0.64 . . . . 0.0 110.957 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.7 pt -106.58 -174.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.516 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 25.8 t -171.53 134.14 0.83 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.54 152.85 18.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -159.62 147.1 16.94 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.547 0.689 . . . . 0.0 111.037 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.1 143.89 16.88 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.449 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.1 tpt -114.92 -3.65 12.67 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.616 0.246 . . . . 0.0 110.385 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.07 -100.26 0.02 OUTLIER Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.529 ' OE2' ' ND2' ' A' ' 249' ' ' ASN . 28.4 mp0 -142.11 54.25 1.46 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.705 -0.248 . . . . 0.0 110.573 179.314 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.6 m -65.59 -0.05 1.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 0.0 110.697 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 281' ' ' GLU . 48.1 t-20 -167.19 85.43 0.82 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.32 106.25 2.01 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.212 1.941 . . . . 0.0 112.599 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.6 m -94.65 -17.83 7.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 121.314 0.578 . . . . 0.0 110.645 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.574 ' HG1' ' CD2' ' A' ' 303' ' ' LEU . 19.7 p -58.02 -42.78 86.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.595 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 290' ' ' CYS . . . -48.09 -93.04 0.01 OUTLIER Glycine 0 C--O 1.225 -0.406 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 287' ' ' GLY . 57.6 t30 -28.53 -56.91 0.12 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.803 0.355 . . . . 0.0 110.432 -178.552 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 m -56.73 -45.28 82.06 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.693 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 287' ' ' GLY . 24.1 m -101.77 32.76 3.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.188 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 293' ' ' VAL . 47.5 t0 -56.21 -47.91 77.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.825 0.345 . . . . 0.0 110.605 -179.074 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 292' ' ' ASN . 58.5 t-20 -76.59 31.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.814 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 291' ' ' ASP . 10.6 t -129.48 107.34 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -119.38 14.02 12.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.738 179.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -100.23 134.09 43.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.129 0.49 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -49.81 -69.19 0.12 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.438 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.61 -38.84 60.92 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.448 0.642 . . . . 0.0 110.746 -178.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.04 -34.96 79.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 303' ' ' LEU . 16.6 mt -73.87 -56.98 4.29 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.2 mt -46.16 -29.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.425 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -83.59 -44.04 15.02 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.336 178.3 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 1.9 t -74.51 -16.71 60.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.989 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.574 ' CD2' ' HG1' ' A' ' 286' ' ' THR . 76.6 mt -82.58 25.15 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.817 0.698 . . . . 0.0 110.448 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.619 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -81.11 -38.0 0.96 Allowed Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 32.3 Cg_exo -58.54 6.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.442 2.761 . . . . 0.0 112.748 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 304' ' ' ALA . 2.8 m-20 -111.6 15.64 21.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.744 0.307 . . . . 0.0 110.513 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.499 ' NE ' ' OD2' ' A' ' 241' ' ' ASP . 96.0 mtt-85 -108.54 94.27 4.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.275 0.56 . . . . 0.0 110.16 179.098 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 8.2 ptm180 -168.56 158.35 9.38 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.001 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.64 150.87 26.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.457 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 92.4 mt-10 -121.1 106.85 11.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.405 0.622 . . . . 0.0 110.855 -178.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.5 mm -79.31 117.93 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.964 -178.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -102.87 127.36 50.09 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.6 t -132.2 122.21 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 O-C-N 124.077 0.861 . . . . 0.0 111.753 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -116.8 132.31 56.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.88 37.26 4.74 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 317' ' ' LYS . 7.2 tt -109.03 168.06 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.672 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.619 ' O ' ' O ' ' A' ' 316' ' ' ILE . 21.4 pttm -45.97 -147.62 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 O-C-N 124.303 1.002 . . . . 0.0 111.987 -179.322 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -73.28 168.86 18.3 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.549 -0.72 . . . . 0.0 110.818 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.4 p -99.64 125.1 53.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.104 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 19.9 t -87.1 131.83 34.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.181 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.5 p -116.09 157.67 24.36 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.169 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -74.68 150.91 86.82 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.664 -179.508 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.56 -64.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.533 2.155 . . . . 0.0 112.072 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -86.84 -98.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.597 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.38 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.474 179.995 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.491 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 40.5 Cg_endo -65.47 143.98 77.84 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.874 2.383 . . . . 0.0 111.72 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.577 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . 177.68 -44.71 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.051 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 22.9 Cg_exo -63.74 160.92 34.44 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.951 2.434 . . . . 0.0 111.685 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -117.64 83.11 16.98 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.913 179.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -49.4 116.94 2.56 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.423 2.082 . . . . 0.0 112.02 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.546 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -173.4 47.0 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.373 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 37.6 Cg_endo -64.0 145.97 90.52 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.83 2.353 . . . . 0.0 112.049 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -76.76 -4.92 45.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.619 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 18.4 t -138.69 133.77 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.519 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 190' ' ' GLN . 0.1 OUTLIER -118.47 92.39 3.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.925 179.694 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.423 ' CG2' ' CE1' ' A' ' 193' ' ' HIS . 6.9 m -68.47 136.34 53.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.336 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -140.06 105.59 5.1 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.58 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.423 ' CE1' ' CG2' ' A' ' 191' ' ' THR . 2.7 m80 -94.85 145.3 24.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.625 ' CE2' ' NE2' ' A' ' 223' ' ' GLN . 33.1 m-85 -111.81 123.9 51.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.43 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.547 ' HG1' HH21 ' A' ' 308' ' ' ARG . 5.6 t -84.24 103.76 13.7 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.556 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.0 tp -108.34 128.98 55.23 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.066 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -83.82 129.13 34.94 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 122.297 1.046 . . . . 0.0 112.218 -178.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 202' ' ' PHE . 15.3 m -63.91 -30.36 71.45 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.396 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.03 -41.08 74.42 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.14 -42.5 88.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.164 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 61.1 mt -79.18 -79.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.911 179.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -120.09 122.46 41.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.747 -179.123 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.515 ' H ' HD22 ' A' ' 205' ' ' ASN . 22.5 t-20 -87.24 -75.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -113.08 -10.71 13.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.725 HD21 ' H ' ' A' ' 205' ' ' ASN . 0.1 OUTLIER -76.25 171.29 14.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.182 179.955 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -50.0 -87.49 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.408 -178.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -154.78 5.97 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.278 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 8.7 t -54.35 141.94 28.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.254 -179.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 36.8 mt -83.1 133.98 35.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.244 0.545 . . . . 0.0 111.166 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.457 ' NZ ' ' CB ' ' A' ' 210' ' ' LYS . 6.4 mtpm? -99.14 156.73 35.14 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.064 179.001 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -34.94 -75.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.557 2.171 . . . . 0.0 112.0 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -46.32 -26.66 0.86 Allowed 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.28 0.562 . . . . 0.0 110.307 -179.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -69.03 -51.99 25.79 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -58.65 -39.73 81.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.78 -60.15 3.61 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.419 179.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.91 -25.98 68.39 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.695 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -30.4 65.09 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.513 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.93 -47.58 28.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.819 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 13.3 pt20 -63.97 -42.79 97.15 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.91 -179.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.442 ' N ' ' CG ' ' A' ' 219' ' ' GLN . 48.1 tp -59.61 -41.51 90.54 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.577 ' C ' ' H ' ' A' ' 223' ' ' GLN . 10.1 t80 -54.94 -60.61 3.13 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.154 177.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.4 m -54.44 -8.21 0.2 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.076 0.465 . . . . 0.0 110.642 -179.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.625 ' NE2' ' CE2' ' A' ' 194' ' ' PHE . 3.3 tt0 -93.51 -33.82 13.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.339 178.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 73.5 mt -97.69 -11.42 23.51 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.623 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 25.8 p -79.21 -26.23 42.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.973 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -88.03 18.88 3.92 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.024 0.44 . . . . 0.0 110.496 -179.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.12 156.84 33.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -78.77 116.71 61.81 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 232' ' ' GLY . 59.6 Cg_exo -48.92 -21.99 4.36 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.893 2.395 . . . . 0.0 113.059 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 229' ' ' PRO . 27.2 tptp -24.76 -52.35 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 123.75 0.656 . . . . 0.0 110.802 -177.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 233' ' ' SER . 72.7 m-20 -109.79 -11.49 14.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.8 179.039 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 24.73 42.86 0.01 OUTLIER Glycine 0 N--CA 1.47 0.935 0 O-C-N 123.953 0.783 . . . . 0.0 111.679 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -112.77 114.55 27.17 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 122.516 -0.402 . . . . 0.0 110.449 -178.61 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 75.4 t -129.22 93.88 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.807 0.813 . . . . 0.0 110.325 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.5 t -97.08 123.29 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.001 -179.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.2 t -95.65 122.46 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.648 179.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 75.3 mt -105.58 141.95 36.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.032 -179.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.34 127.3 6.39 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -110.25 122.77 48.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.302 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 241' ' ' ASP . 51.0 m -117.3 164.75 14.35 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.322 0.389 . . . . 0.0 110.238 -179.265 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.466 ' N ' ' CG2' ' A' ' 240' ' ' THR . 42.3 p-10 -80.95 -175.87 5.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.605 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -116.88 122.89 45.64 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 -179.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 51.8 mm -118.11 17.22 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.725 0.774 . . . . 0.0 110.808 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.28 -49.04 2.4 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.485 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 5.6 t -76.14 88.72 3.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.918 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -40.4 -43.55 1.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.729 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.4 -38.69 91.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.352 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 245' ' ' SER . 67.1 t80 -59.23 -50.28 74.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.936 -179.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 245' ' ' SER . 2.7 p-10 -64.13 -40.74 96.83 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.185 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -61.38 -45.71 93.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.59 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.18 -35.71 92.45 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.41 -40.37 73.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.006 0.431 . . . . 0.0 111.106 178.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.0 t -62.84 -39.24 93.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.515 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -68.69 -45.08 72.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.247 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.18 -44.9 88.23 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.067 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.34 -61.41 2.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.678 178.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.88 -34.04 18.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.105 0.479 . . . . 0.0 110.026 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -72.25 -44.82 62.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.449 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.4 t -58.48 -39.53 80.22 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.301 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.91 -53.44 41.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.392 178.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 4.7 t -60.96 -50.19 81.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.436 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -46.28 -41.38 13.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.206 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.51 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 60.8 t80 -80.77 -32.78 35.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.809 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.17 -32.81 74.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.21 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.568 ' C ' ' H ' ' A' ' 267' ' ' LYS . 83.8 mt -63.85 -48.27 87.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.322 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 28.2 m -51.45 -6.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.755 -179.276 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.568 ' H ' ' C ' ' A' ' 265' ' ' ILE . 33.1 mmtp -87.19 9.15 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.505 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 84.4 40.83 8.2 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.74 126.35 25.75 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.9 130.28 36.92 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.98 1.787 . . . . 0.0 112.094 177.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.17 -9.45 31.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 65.6 t0 -90.88 -23.42 20.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.529 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -79.24 -21.14 46.62 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.608 0.718 . . . . 0.0 110.526 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.5 pt -105.35 -171.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 11.9 t -169.55 130.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.176 178.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -104.45 110.17 22.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.873 0.368 . . . . 0.0 110.535 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -115.47 140.96 48.67 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.574 0.702 . . . . 0.0 111.097 -179.646 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.578 ' O ' ' NH1' ' A' ' 277' ' ' ARG . . . -90.18 93.35 1.86 Allowed Glycine 0 CA--C 1.519 0.329 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.49 ' N ' ' O ' ' A' ' 238' ' ' GLY . 3.6 tpt -71.62 0.69 8.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.085 -178.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 31.87 -100.07 0.01 OUTLIER Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -144.1 70.18 1.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.714 0.292 . . . . 0.0 110.891 179.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.6 p -64.35 -44.24 92.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.192 0.52 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -125.4 80.47 65.43 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.961 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.18 105.76 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.686 2.257 . . . . 0.0 112.669 -179.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 10.4 m -71.02 -32.83 49.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.193 0.52 . . . . 0.0 110.687 179.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.648 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.2 OUTLIER -57.23 -44.55 83.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.357 -179.218 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.84 -5.82 0.02 OUTLIER Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.648 ' H ' ' C ' ' A' ' 286' ' ' THR . 13.2 m120 -125.46 -58.51 1.42 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.9 m -58.89 -24.64 62.52 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.553 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 84.8 m -116.11 29.6 7.87 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.451 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.93 -4.28 19.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.612 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -109.87 31.48 5.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.661 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.52 121.3 45.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.969 0.414 . . . . 0.0 110.41 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -120.79 7.34 10.46 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.8 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . 0.419 ' O ' ' CD1' ' A' ' 299' ' ' LEU . 7.6 mt-30 -89.14 172.67 8.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.98 0.419 . . . . 0.0 110.014 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -84.99 -70.47 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.584 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.84 -31.62 68.67 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.89 -178.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.89 -39.93 87.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.5 mt -69.78 -48.89 57.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.015 0.436 . . . . 0.0 110.644 179.751 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 60.8 mt -49.15 -36.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.899 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.6 -40.27 29.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.117 0.484 . . . . 0.0 110.646 178.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.1 t -74.36 -10.64 59.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.988 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 299' ' ' LEU . 61.4 mt -91.89 22.59 4.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.643 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -83.21 -41.56 0.83 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.995 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 31.9 Cg_exo -55.8 10.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 123.293 2.662 . . . . 0.0 112.403 -179.07 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.63 ' H ' ' C ' ' A' ' 304' ' ' ALA . 27.5 m-20 -109.55 21.72 16.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.639 0.257 . . . . 0.0 110.849 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -114.04 84.99 2.13 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.14 0.972 . . . . 0.0 110.259 178.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.547 HH21 ' HG1' ' A' ' 195' ' ' THR . 16.4 ptm180 -156.49 128.06 7.16 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.062 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.77 139.14 19.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.466 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -119.69 104.51 10.32 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.303 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.36 116.71 23.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.312 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -96.14 122.14 38.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.819 0.342 . . . . 0.0 111.033 -178.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.0 t -129.5 122.46 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.869 179.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -118.57 144.86 45.8 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.308 178.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 92.26 22.42 29.72 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -178.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.661 ' O ' ' O ' ' A' ' 317' ' ' LYS . 10.8 tt -99.16 170.86 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.661 ' O ' ' O ' ' A' ' 316' ' ' ILE . 29.5 tttp -44.5 -153.73 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.943 0.777 . . . . 0.0 110.958 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . 0.503 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 32.3 t70 -68.79 160.01 31.3 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.543 -0.723 . . . . 0.0 110.891 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 4.0 p -127.3 129.8 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.177 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 11.4 p -153.32 135.55 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.395 179.546 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.6 p -143.56 154.39 43.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.644 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.53 150.56 6.58 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.537 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.57 151.81 79.11 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.573 2.182 . . . . 0.0 112.055 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 49.05 93.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.518 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.524 -179.954 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.534 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 73.4 Cg_endo -79.25 166.31 22.71 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.55 2.166 . . . . 0.0 112.047 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.569 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -176.27 -45.35 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.963 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 35.7 Cg_exo -59.5 72.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.657 2.238 . . . . 0.0 111.978 -179.264 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 182' ' ' ALA . . . 62.23 146.76 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.472 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -40.33 117.27 0.44 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.333 2.022 . . . . 0.0 112.323 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.512 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -81.7 -48.32 0.99 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.963 178.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 73.7 Cg_endo -79.55 158.48 25.38 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.589 2.193 . . . . 0.0 112.38 -179.196 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -160.07 2.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.18 0.514 . . . . 0.0 110.292 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 79.8 t -135.4 134.47 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.332 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.512 ' NE2' ' H ' ' A' ' 190' ' ' GLN . 1.5 pm0 -120.1 135.41 54.96 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.238 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.451 ' CG2' ' N ' ' A' ' 192' ' ' LYS . 44.6 m -76.45 170.49 16.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.43 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 191' ' ' THR . 13.0 tptp -141.88 160.64 39.78 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 109.978 178.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -152.02 124.27 8.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.108 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 223' ' ' GLN . 52.1 m-85 -114.37 119.11 35.81 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.438 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.406 ' O ' ' CG2' ' A' ' 195' ' ' THR . 5.5 t -86.49 105.23 16.65 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.555 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 27.0 tp -106.74 123.4 48.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.031 0.443 . . . . 0.0 109.933 -179.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -74.53 129.34 37.56 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 122.587 1.184 . . . . 0.0 112.277 -178.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 202' ' ' PHE . 41.6 t -62.97 -40.31 97.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.173 178.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -45.75 -34.88 3.91 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.719 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.75 -56.82 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.87 -77.8 0.07 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.815 -179.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -106.03 135.7 47.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.858 -178.188 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -98.3 -78.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -117.74 -19.04 9.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.963 179.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -65.99 171.75 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.127 0.489 . . . . 0.0 110.199 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -53.79 -81.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.844 -179.231 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -157.9 58.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.51 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.0 p -106.95 131.18 54.32 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 110.056 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.4 mt -71.92 145.11 48.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.256 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.9 mtpm? -107.91 158.03 34.54 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.304 179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 213' ' ' GLY . 74.8 Cg_exo -34.91 -77.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.3 2.0 . . . . 0.0 112.01 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -48.41 -19.19 0.29 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 -179.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.88 -50.23 19.6 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 178.794 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -65.13 -38.39 90.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.145 0.498 . . . . 0.0 109.77 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.91 -53.87 53.3 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.011 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.91 -33.82 76.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.615 0.721 . . . . 0.0 110.383 -179.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.67 -25.9 65.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.603 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . 0.551 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 72.2 m-20 -72.79 -47.11 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.569 0.7 . . . . 0.0 109.9 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.35 -40.29 96.86 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.99 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.8 tp -60.37 -40.98 92.76 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.532 ' C ' ' H ' ' A' ' 223' ' ' GLN . 69.4 t80 -55.34 -58.95 5.62 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.922 178.259 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 58.8 m -57.14 -7.49 0.53 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.289 0.566 . . . . 0.0 110.216 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.639 ' NE2' ' CE1' ' A' ' 194' ' ' PHE . 5.4 tt0 -95.06 -35.54 11.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.384 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.51 -11.38 25.56 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.658 -179.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 75.8 p -85.89 -7.31 58.78 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.542 0.526 . . . . 0.0 110.579 -179.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 223' ' ' GLN . 51.2 p30 -101.35 19.23 18.15 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.311 0.577 . . . . 0.0 110.529 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.479 ' H ' HD23 ' A' ' 227' ' ' LEU . 0.7 OUTLIER -78.31 -177.3 5.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.136 -179.973 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -100.69 108.47 53.78 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 230' ' ' LYS . 72.5 Cg_exo -45.62 -21.39 0.84 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.673 2.249 . . . . 0.0 112.897 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 229' ' ' PRO . 88.0 tttt -34.47 -52.07 0.48 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 110.546 -178.15 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 232' ' ' GLY . 25.6 m-20 -98.54 -20.01 17.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.762 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 28.32 52.4 0.11 Allowed Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 59.7 m -118.93 115.17 23.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.557 0.217 . . . . 0.0 111.107 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 72.8 t -133.48 92.26 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.794 0.807 . . . . 0.0 110.195 178.43 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.11 127.62 51.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.279 0.561 . . . . 0.0 110.61 -178.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 91.3 t -100.63 126.42 54.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.399 179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.8 mt -111.94 131.64 55.26 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.469 -178.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -86.08 138.37 15.96 Favored Glycine 0 N--CA 1.467 0.766 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.555 ' O ' ' NH2' ' A' ' 256' ' ' ARG . 11.4 m-85 -131.04 115.89 17.05 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 117.799 0.799 . . . . 0.0 109.431 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.402 ' HA ' HH12 ' A' ' 256' ' ' ARG . 14.8 t -126.71 172.8 10.01 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.465 -179.154 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -86.19 -175.23 5.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.432 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.404 ' H ' HD13 ' A' ' 303' ' ' LEU . 60.6 ttp180 -102.3 124.48 47.95 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.245 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.495 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 47.7 mm -117.64 14.42 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.456 0.646 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 71.8 5.06 60.18 Favored Glycine 0 C--N 1.317 -0.493 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 5.3 t -124.68 105.29 9.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.862 0.363 . . . . 0.0 110.199 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -57.11 -55.22 37.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.195 -179.075 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.77 -46.02 78.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -63.38 -42.0 98.8 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.886 -179.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.79 -44.87 96.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.642 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -65.28 -39.64 92.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.19 -42.49 99.8 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.92 -41.81 86.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.006 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.533 ' HG ' ' H ' ' A' ' 280' ' ' GLY . 6.5 t -66.2 -48.36 70.88 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.118 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.25 -52.21 66.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.589 -179.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -55.5 -47.31 76.38 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.273 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.668 HH22 ' N ' ' A' ' 308' ' ' ARG . 66.3 mtp180 -58.29 -59.31 5.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.162 179.158 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -50.59 -32.62 19.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.121 0.486 . . . . 0.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -73.12 -49.7 26.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.986 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 44.6 t -53.42 -41.29 65.88 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.153 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.65 -54.88 23.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.603 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.4 t -57.64 -50.42 77.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.212 -179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -46.33 -42.84 15.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.914 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -81.55 -31.14 32.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.592 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.05 -7.96 50.09 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.274 -179.195 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.603 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.2 mt -86.51 -55.69 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 120.84 0.352 . . . . 0.0 111.408 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.7 t -49.78 -6.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.909 -178.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.603 ' H ' ' C ' ' A' ' 265' ' ' ILE . 22.9 mmmt -76.98 -11.38 59.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.08 39.71 1.93 Allowed Glycine 0 CA--C 1.509 -0.291 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.86 133.02 24.66 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.241 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.64 128.88 32.13 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.833 1.689 . . . . 0.0 112.174 176.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.73 -9.31 42.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.986 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.23 -21.32 21.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.774 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -82.54 -20.12 37.27 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.426 0.631 . . . . 0.0 110.893 -179.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 234' ' ' VAL . 1.6 pt -103.76 -172.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.118 -178.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 27.9 t -168.81 143.09 3.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.297 178.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -115.72 113.78 23.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.806 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -127.22 150.93 49.31 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.929 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -105.37 100.58 1.74 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 3.4 tpp -70.03 -13.04 62.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.066 0.46 . . . . 0.0 110.155 -179.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.533 ' H ' ' HG ' ' A' ' 253' ' ' SER . . . 63.46 -103.23 0.64 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -141.89 74.12 1.44 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.84 0.353 . . . . 0.0 110.587 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 84.8 p -95.58 2.23 54.13 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.7 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.6 70.52 3.73 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.553 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.94 105.6 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.406 2.071 . . . . 0.0 112.291 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 14.7 m -69.58 -31.94 50.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.46 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.611 ' C ' ' H ' ' A' ' 288' ' ' ASN . 41.7 p -57.35 -43.96 83.9 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.736 -179.243 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . 0.593 ' N ' ' HG1' ' A' ' 286' ' ' THR . . . -45.62 -7.93 0.01 OUTLIER Glycine 0 CA--C 1.534 1.222 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.298 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.9 t30 -126.84 -56.57 1.36 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.918 0.389 . . . . 0.0 110.137 178.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.3 m -55.23 -40.4 70.83 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.281 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 72.1 m -98.6 36.44 1.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.421 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -74.56 -2.48 26.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.498 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.06 31.67 5.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.497 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.1 t -132.05 123.76 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.526 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -119.39 4.43 11.21 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.208 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -99.64 136.21 39.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.157 0.503 . . . . 0.0 110.095 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -51.43 -76.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.774 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -46.0 -39.17 8.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 -178.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.29 88.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.959 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.69 -43.54 79.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.566 179.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.4 mm -58.08 -37.21 60.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.783 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -74.01 -35.65 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.082 179.126 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.1 t -81.77 -3.2 53.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.416 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.404 HD13 ' H ' ' A' ' 242' ' ' ARG . 0.5 OUTLIER -94.18 22.33 6.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.235 -179.485 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.61 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -82.65 -41.82 0.91 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.602 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.8 Cg_exo -60.03 10.09 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.294 2.662 . . . . 0.0 112.099 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 304' ' ' ALA . 57.9 t0 -115.12 18.89 16.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.958 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -109.01 107.18 17.44 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.377 0.608 . . . . 0.0 110.345 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.668 ' N ' HH22 ' A' ' 256' ' ' ARG . 18.0 ptp180 -171.86 -173.74 1.21 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.984 -179.186 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.35 153.65 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.496 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 95.7 mt-10 -124.64 102.53 7.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.317 0.579 . . . . 0.0 110.801 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.4 mm -81.58 120.34 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.14 -179.162 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -104.92 119.87 40.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.798 0.332 . . . . 0.0 110.426 -178.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.6 t -130.43 124.76 58.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.59 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -118.83 148.19 43.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.56 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.88 4.4 57.83 Favored Glycine 0 N--CA 1.462 0.43 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 16.0 tt -91.55 141.79 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.206 0.527 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -75.93 120.37 21.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.794 -179.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -159.73 169.95 22.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.772 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.77 133.86 30.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.277 179.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.17 136.18 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.174 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.5 t -146.76 170.19 17.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.699 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . 0.518 ' N ' ' OE1' ' A' ' 322' ' ' GLN . 1.5 mp0 -81.63 118.29 71.62 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.673 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -49.15 -38.27 40.44 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.181 1.921 . . . . 0.0 112.403 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 47.17 72.68 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 110.389 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.33 -179.908 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.624 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 26.1 Cg_exo -61.55 147.19 96.02 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.833 2.355 . . . . 0.0 111.948 -179.429 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -157.89 153.3 22.14 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.361 179.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.08 -21.76 48.56 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.713 2.275 . . . . 0.0 111.759 179.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -58.81 159.96 11.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.473 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.66 154.4 64.21 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.786 2.324 . . . . 0.0 112.058 179.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.9 151.06 16.69 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.326 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.11 -56.01 0.42 Allowed 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.8 2.334 . . . . 0.0 112.227 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 46.79 -130.94 1.33 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.366 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 11.9 t -79.21 106.51 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.232 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -106.34 105.42 15.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.446 -179.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 24.3 m -78.11 127.12 31.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.2 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -146.71 116.45 7.19 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.467 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . 0.5 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 2.2 m-70 -101.18 147.72 25.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -109.77 128.53 55.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.911 0.386 . . . . 0.0 110.302 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.94 103.24 15.13 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.98 -179.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 24.8 tp -107.96 129.04 55.14 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 109.955 -179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -80.9 126.57 31.52 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 121.905 0.86 . . . . 0.0 112.033 -178.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.5 t -65.27 -28.08 69.09 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.066 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -62.92 -37.94 88.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.034 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.96 -44.36 92.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.56 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.75 -78.75 0.11 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.289 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.28 118.67 30.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.031 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -94.62 -78.3 0.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.702 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -88.47 -26.94 21.81 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.765 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -69.79 158.43 35.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.153 0.501 . . . . 0.0 110.381 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -51.42 -71.47 0.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.221 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -159.77 56.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.428 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 38.5 p -108.08 133.04 52.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.821 0.343 . . . . 0.0 110.172 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.06 138.61 39.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 -179.133 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.8 mtpm? -101.49 157.47 33.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.302 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 210' ' ' LYS . 76.0 Cg_exo -33.22 -75.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.598 2.199 . . . . 0.0 111.969 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -49.61 -23.4 1.67 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.18 0.514 . . . . 0.0 110.328 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.94 -48.73 19.6 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -66.61 -38.74 87.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.14 0.495 . . . . 0.0 110.012 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.84 -53.06 62.46 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.444 -179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.75 88.53 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.635 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.0 mt -62.53 -27.6 69.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.487 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . 0.524 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 51.3 m-20 -73.81 -46.45 45.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.219 0.533 . . . . 0.0 110.535 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.62 -42.89 99.85 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.174 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 42.9 tp -66.37 -38.96 88.74 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.436 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.2 t80 -53.78 -50.72 65.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.123 179.379 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 225' ' ' SER . 75.9 p -60.15 -49.75 76.41 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.378 -178.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -49.57 -25.89 3.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.184 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 64.7 mt -97.19 -13.45 22.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.364 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' SER . 36.9 t -72.86 -21.57 60.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.698 179.511 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -99.91 16.79 22.68 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.74 150.69 36.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.138 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 315' ' ' GLY . 6.7 t0 -67.12 124.13 88.1 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.468 178.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 230' ' ' LYS . 44.5 Cg_endo -69.15 -19.67 38.75 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.79 2.327 . . . . 0.0 112.846 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 229' ' ' PRO . 63.4 tttp -30.09 -52.42 0.15 Allowed 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.682 0.614 . . . . 0.0 110.457 -178.386 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.485 ' O ' ' OG ' ' A' ' 233' ' ' SER . 20.6 m-20 -103.28 -18.25 14.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.485 178.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.478 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.75 47.33 0.03 OUTLIER Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 231' ' ' ASP . 0.4 OUTLIER -112.59 111.25 21.93 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.146 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.56 94.42 2.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.311 0.577 . . . . 0.0 109.895 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.2 t -96.47 122.65 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.237 -178.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 t -95.68 119.7 44.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.642 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 47.4 mt -103.76 147.38 27.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.049 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.85 133.13 8.15 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.636 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.4 OUTLIER -116.54 119.84 36.84 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.504 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.441 ' O ' ' OD1' ' A' ' 306' ' ' ASP . 3.3 p -106.92 168.15 9.39 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 120.772 0.32 . . . . 0.0 110.344 -179.445 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -81.85 179.93 7.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.525 -179.666 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -99.6 119.44 38.08 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.862 0.363 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 49.4 mm -121.4 6.18 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.404 0.621 . . . . 0.0 111.058 179.358 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.41 -47.65 3.66 Favored Glycine 0 C--N 1.314 -0.666 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.2 p -73.7 90.08 1.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 109.887 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 91.7 m-20 -43.0 -46.55 5.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.676 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.6 83.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -61.08 -49.31 77.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 246' ' ' ASP . 0.2 OUTLIER -63.22 -42.75 99.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.584 -179.741 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -63.71 -46.13 86.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.723 -179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.39 -35.03 90.39 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.5 -37.53 65.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.887 0.375 . . . . 0.0 111.129 178.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.412 ' OG ' ' OG1' ' A' ' 240' ' ' THR . 20.8 m -64.12 -40.95 97.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.747 -179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 258' ' ' GLN . 96.9 mt-10 -71.7 -41.39 68.66 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.189 179.595 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -59.52 -48.3 82.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.524 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -63.26 -60.38 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.961 179.254 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -52.1 -36.62 51.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.551 HE21 ' C ' ' A' ' 258' ' ' GLN . 0.6 OUTLIER -70.84 -42.72 69.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.218 179.665 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.3 t -63.02 -36.77 84.67 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.357 0.599 . . . . 0.0 110.272 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.27 -50.19 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.552 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.6 t -60.88 -49.43 84.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.29 179.27 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . 0.549 ' OD2' ' NE2' ' A' ' 258' ' ' GLN . 7.9 m-20 -45.7 -39.81 8.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.9 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -83.2 -32.31 26.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.1 -11.11 60.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.488 -179.287 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.585 ' C ' ' H ' ' A' ' 267' ' ' LYS . 64.6 mt -86.11 -53.14 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-O 120.723 0.297 . . . . 0.0 110.925 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.4 m -50.34 -6.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.585 ' H ' ' C ' ' A' ' 265' ' ' ILE . 22.9 mmmt -80.58 -12.06 59.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.862 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.75 40.41 1.87 Allowed Glycine 0 CA--C 1.51 -0.221 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.446 HG23 HD13 ' A' ' 269' ' ' ILE . 0.4 OUTLIER -126.25 129.16 24.27 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.854 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.86 128.17 27.62 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.958 1.772 . . . . 0.0 112.04 176.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.02 -8.97 18.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.799 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.32 -23.23 21.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.772 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -80.31 -20.08 45.12 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.38 0.609 . . . . 0.0 110.487 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -105.62 -173.36 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.795 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 27.3 t -172.4 129.76 0.57 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 179.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.39 153.72 17.66 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.019 -0.425 . . . . 0.0 109.859 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -162.31 151.56 15.62 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 178.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -127.56 97.65 0.47 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.636 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 10.5 ptm -85.99 26.8 0.96 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.847 0.356 . . . . 0.0 110.984 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.3 -107.37 0.1 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.82 73.44 1.4 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.683 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.1 t -76.28 -33.72 59.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.108 0.48 . . . . 0.0 111.216 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -124.39 66.37 44.06 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 -179.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.14 117.71 5.12 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.626 2.218 . . . . 0.0 111.506 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 15.0 m -70.8 -38.5 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.701 179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 288' ' ' ASN . 2.8 p -61.43 -47.15 87.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.559 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.07 -3.4 0.05 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.619 ' H ' ' C ' ' A' ' 286' ' ' THR . 89.3 m-20 -114.29 -60.97 1.81 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.018 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.8 t -77.69 -3.07 39.23 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.558 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 286' ' ' THR . 0.5 OUTLIER -126.97 18.51 7.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.607 -179.911 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 36.7 p-10 -68.55 -2.98 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.503 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 292' ' ' ASN . 19.7 p30 -101.06 32.6 3.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.514 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.2 t -130.77 124.33 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.764 0.316 . . . . 0.0 110.437 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -120.21 9.62 11.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.879 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.39 131.24 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.134 0.492 . . . . 0.0 110.064 -179.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -50.55 -68.61 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.076 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.97 -38.7 57.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.53 -36.55 82.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.445 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 303' ' ' LEU . 28.0 mt -72.54 -55.01 7.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.474 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 68.5 mt -50.96 -35.4 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.005 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.11 -31.98 58.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.593 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.49 -5.06 56.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.4 mm? -94.23 19.66 9.1 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.289 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.576 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.43 -45.78 1.34 Allowed Pre-proline 0 CA--C 1.536 0.424 0 CA-C-O 121.051 0.453 . . . . 0.0 110.184 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 25.7 Cg_exo -60.97 9.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.134 2.556 . . . . 0.0 111.969 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 304' ' ' ALA . 8.1 t70 -106.0 14.12 28.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.874 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 307' ' ' ARG . 15.6 ptt180 -110.28 99.01 8.12 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.921 0.867 . . . . 0.0 110.346 179.214 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.537 ' NH1' ' OE2' ' A' ' 310' ' ' GLU . 43.7 ptt85 -166.03 139.09 4.13 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.398 -179.219 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.02 145.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.537 ' OE2' ' NH1' ' A' ' 308' ' ' ARG . 78.6 mt-10 -118.71 104.03 10.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.31 0.576 . . . . 0.0 110.865 178.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 193' ' ' HIS . 0.4 OUTLIER -80.12 113.4 19.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.11 -178.953 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -92.11 123.27 35.34 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 123.525 0.516 . . . . 0.0 110.738 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.14 115.32 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 O-C-N 123.528 0.518 . . . . 0.0 110.875 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -114.7 126.58 55.02 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.52 39.61 3.39 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.719 ' O ' ' O ' ' A' ' 317' ' ' LYS . 6.3 tt -110.97 164.74 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.719 ' O ' ' O ' ' A' ' 316' ' ' ILE . 20.5 pttp -42.45 -149.01 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.501 0 O-C-N 124.273 0.983 . . . . 0.0 111.319 -178.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -84.83 175.84 8.88 Favored 'General case' 0 C--N 1.318 -0.773 0 O-C-N 121.372 -0.83 . . . . 0.0 111.103 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.0 p -140.92 138.47 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.546 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 62.1 t -71.35 129.1 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.018 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 74.8 p -113.91 134.48 54.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.997 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -140.99 113.51 6.94 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.118 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -48.06 -38.35 31.88 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.307 2.004 . . . . 0.0 112.267 179.5 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -75.95 139.32 41.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.34 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.587 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.507 -179.972 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -46.96 131.31 16.81 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.271 1.981 . . . . 0.0 111.711 178.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.618 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -102.81 -42.35 0.2 Allowed Pre-proline 0 N--CA 1.466 0.351 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.248 179.65 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 36.9 Cg_exo -59.45 143.29 99.74 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.565 2.177 . . . . 0.0 111.847 -178.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -95.76 120.68 62.88 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.224 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.53 137.08 26.18 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.967 1.778 . . . . 0.0 112.395 179.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.526 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -69.41 -47.86 26.15 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.094 178.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 71.0 Cg_endo -78.29 150.54 25.71 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.665 2.243 . . . . 0.0 112.115 -178.861 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.562 ' CG ' HE21 ' A' ' 190' ' ' GLN . 16.9 pt-20 -171.02 -147.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.433 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 10.6 t -88.77 100.84 11.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.202 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.562 HE21 ' CG ' ' A' ' 188' ' ' GLU . 81.8 mm-40 -106.3 107.7 18.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.338 -179.446 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 24.3 m -79.06 125.6 29.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.829 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -144.45 112.73 6.47 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.71 0.291 . . . . 0.0 110.555 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -99.4 144.41 28.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -106.89 129.79 54.66 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.87 0.367 . . . . 0.0 110.204 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.14 105.38 17.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.931 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 34.3 tp -110.16 129.63 55.68 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -80.74 127.92 33.05 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 122.036 0.922 . . . . 0.0 112.437 -178.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 202' ' ' PHE . 68.6 p -63.31 -31.79 73.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.091 179.489 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.456 ' OD1' ' ND2' ' A' ' 203' ' ' ASN . 22.0 t70 -59.75 -37.46 79.06 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.181 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.23 -44.41 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 84.3 mt -77.6 -77.53 0.15 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.461 179.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -118.51 125.42 49.83 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.637 -179.754 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.456 ' ND2' ' OD1' ' A' ' 199' ' ' ASP . 7.2 m120 -94.37 -80.25 0.4 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.767 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -103.31 -17.71 15.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.695 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -70.54 169.66 13.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.998 0.427 . . . . 0.0 110.086 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -53.15 -78.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.267 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.36 59.11 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.552 179.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.7 p -108.79 135.3 50.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.048 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.1 135.57 39.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.874 -178.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 213' ' ' GLY . 4.4 mtmp? -96.57 159.97 30.56 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.815 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -34.05 -76.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.417 2.078 . . . . 0.0 111.78 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 31.6 mp0 -50.02 -20.18 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.242 0.544 . . . . 0.0 110.214 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.59 -47.87 14.65 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.368 178.669 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -67.86 -40.04 83.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.255 0.55 . . . . 0.0 110.066 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.54 65.24 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.696 -179.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.03 -35.68 81.05 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.62 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.0 -32.99 73.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.548 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . 0.535 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 4.4 m-20 -70.97 -44.83 65.19 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.501 0.667 . . . . 0.0 110.405 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.443 ' O ' ' OG ' ' A' ' 222' ' ' SER . 12.6 mt-30 -61.19 -44.0 97.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.085 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 41.4 tp -64.43 -40.37 95.63 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.379 178.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.409 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.9 t80 -51.79 -48.83 63.65 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.31 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 219' ' ' GLN . 59.5 p -55.04 -51.67 65.59 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.58 -178.239 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -51.99 -26.76 11.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.423 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 220' ' ' LEU . 15.6 mt -97.11 -20.31 18.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.717 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.7 p -74.5 -22.59 58.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.759 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -102.72 19.72 18.66 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.893 -179.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.9 143.15 41.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.929 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 315' ' ' GLY . 47.2 t0 -52.4 108.19 1.02 Allowed Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 123.37 0.419 . . . . 0.0 110.434 178.056 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.3 Cg_exo -51.8 -24.5 18.53 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.737 2.291 . . . . 0.0 113.043 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . 0.513 ' CB ' ' HZ3' ' A' ' 230' ' ' LYS . 7.5 ttpm? -30.25 -53.16 0.16 Allowed 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 123.568 0.543 . . . . 0.0 110.951 -177.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 232' ' ' GLY . 38.9 m-20 -102.43 -17.65 15.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.751 179.009 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.17 46.35 0.02 OUTLIER Glycine 0 N--CA 1.475 1.259 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 231' ' ' ASP . 38.1 m -112.72 110.39 20.48 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.672 0.272 . . . . 0.0 110.928 -178.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 76.6 t -127.56 94.09 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.481 0.658 . . . . 0.0 109.959 178.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.0 t -96.4 123.07 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.107 -178.117 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 87.4 t -92.54 120.21 41.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.442 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 57.1 mt -104.35 144.35 31.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.961 -179.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.16 130.27 7.28 Favored Glycine 0 N--CA 1.482 1.723 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.871 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.4 OUTLIER -114.91 125.43 53.63 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.83 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 43.0 p -120.92 166.93 13.12 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 109.933 -179.374 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -80.84 -175.12 5.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.417 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -113.72 122.88 48.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.198 0.523 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 243' ' ' ILE . 47.6 mm -120.06 14.73 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.719 0.771 . . . . 0.0 110.633 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.29 -47.46 3.31 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 20.7 m -73.19 89.66 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.114 0.483 . . . . 0.0 110.006 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.547 ' O ' ' NE2' ' A' ' 250' ' ' GLN . 98.9 m-20 -44.36 -46.17 9.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.365 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.81 86.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.629 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -60.33 -44.59 95.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.54 -179.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -62.46 -43.47 98.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.562 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 246' ' ' ASP . 0.9 OUTLIER -65.69 -41.95 91.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.513 -179.991 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.86 95.91 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 39.1 mt -70.25 -39.41 75.01 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.065 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 3.7 t -63.21 -42.78 99.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 0.0 110.605 -178.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -69.33 -35.43 75.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.36 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.4 tpp85 -60.66 -54.3 47.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.672 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.477 ' O ' ' CG2' ' A' ' 260' ' ' VAL . 16.4 ptp180 -64.42 -44.6 90.68 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 120.95 0.405 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.7 -39.2 90.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.46 0.647 . . . . 0.0 110.303 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -74.99 -43.87 51.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.266 179.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 6.9 t -61.98 -38.43 88.57 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.29 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 256' ' ' ARG . 94.4 t -64.75 -50.98 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.622 178.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 14.4 t -61.29 -49.1 85.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.298 179.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -46.48 -40.8 13.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.079 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 263' ' ' TYR . . . . . 0.622 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 67.0 t80 -81.71 -33.9 30.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -28.95 69.81 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.208 -179.521 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 267' ' ' LYS . 81.6 mt -67.18 -52.22 45.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.273 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.4 p -49.65 -7.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 -179.108 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.622 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 66.3 mmtt -79.97 -5.63 56.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.711 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 97.09 42.3 3.3 Favored Glycine 0 CA--C 1.508 -0.373 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 130.83 23.89 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.321 179.075 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.35 128.34 28.83 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.781 1.654 . . . . 0.0 112.104 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -63.12 -11.0 16.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -88.68 -26.3 21.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.679 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -24.59 58.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.386 0.612 . . . . 0.0 110.457 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.6 pt -101.83 -176.79 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.857 -179.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 16.3 m -169.21 126.67 0.95 Allowed 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.653 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -94.93 151.11 19.48 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -155.89 142.17 18.41 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.377 0.608 . . . . 0.0 111.179 179.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -93.08 93.16 1.72 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 239' ' ' TYR . 5.0 tpt -70.49 -3.89 20.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.674 0.273 . . . . 0.0 110.65 -179.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.06 -116.32 0.85 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -135.87 70.47 1.42 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.604 -0.351 . . . . 0.0 110.526 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.7 m -77.58 -40.08 43.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.306 0.574 . . . . 0.0 111.477 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -124.58 62.37 32.7 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.659 -178.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.59 112.75 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.801 2.334 . . . . 0.0 111.364 179.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 32.1 m -71.37 -39.51 71.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.891 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 288' ' ' ASN . 51.4 p -63.61 -48.27 78.02 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.779 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.77 -2.01 0.05 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 288' ' ' ASN . . . . . 0.619 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.1 t30 -113.55 -60.41 1.89 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.704 0.288 . . . . 0.0 110.308 179.005 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -80.43 -2.76 47.09 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.73 -179.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 290' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 286' ' ' THR . 0.5 OUTLIER -126.88 17.53 7.33 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.889 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 32.8 p-10 -69.82 -3.28 14.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.977 0.418 . . . . 0.0 110.506 -179.594 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -99.75 32.06 3.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.429 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.87 127.36 52.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.954 0.407 . . . . 0.0 110.357 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -118.75 13.42 13.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.063 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 295' ' ' GLN . . . . . 0.602 HE22 ' CZ ' ' A' ' 296' ' ' ARG . 8.8 mm-40 -105.92 137.64 43.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.587 0.708 . . . . 0.0 110.248 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 296' ' ' ARG . . . . . 0.602 ' CZ ' HE22 ' A' ' 295' ' ' GLN . 0.0 OUTLIER -61.15 -54.59 42.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.468 179.954 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.62 85.83 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.016 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.18 -33.31 75.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.557 179.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 303' ' ' LEU . 33.4 mt -82.48 -61.67 1.83 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.496 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 296' ' ' ARG . 45.0 mt -42.83 -34.47 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.63 -44.26 19.15 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.124 0.488 . . . . 0.0 110.318 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 44.2 t -74.88 -8.18 55.71 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.978 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 299' ' ' LEU . 73.9 mt -92.98 17.86 10.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.732 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.573 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -79.24 -45.56 1.68 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.336 179.711 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 305' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.5 Cg_exo -59.63 8.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.085 2.523 . . . . 0.0 111.821 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 304' ' ' ALA . 49.6 m-20 -103.87 12.04 34.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 307' ' ' ARG . . . . . 0.42 ' O ' ' OG ' ' A' ' 198' ' ' SER . 98.9 mtt180 -114.45 94.63 4.88 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.606 0.717 . . . . 0.0 110.176 179.244 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . 0.417 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 39.4 ptt180 -154.38 131.46 11.0 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.694 0.759 . . . . 0.0 112.295 -179.018 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.49 134.49 32.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.046 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -116.74 104.63 11.54 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.305 0.574 . . . . 0.0 110.295 -179.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.5 mm -78.96 114.04 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -92.17 122.21 34.44 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 123.532 0.52 . . . . 0.0 110.488 -179.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 25.2 t -122.23 114.83 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.549 -179.309 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -113.9 127.07 55.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.0 39.88 3.44 Favored Glycine 0 N--CA 1.461 0.347 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . 0.696 ' O ' ' O ' ' A' ' 317' ' ' LYS . 11.1 tt -117.09 172.67 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 317' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 316' ' ' ILE . 8.9 mtmp? -39.87 -162.8 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.121 0.962 . . . . 0.0 111.376 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -85.14 175.23 9.11 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 120.968 -1.083 . . . . 0.0 111.368 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.19 156.23 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.152 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 12.0 p -110.95 126.77 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.127 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 72.3 p -97.64 133.51 42.09 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.091 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -143.53 153.23 58.4 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.731 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -48.48 143.36 15.86 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.296 1.997 . . . . 0.0 112.24 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -75.2 121.8 22.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.437 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.576 179.839 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 15.6 mp0 . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.819 0.342 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.4 m -80.23 129.11 34.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.638 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -129.06 99.55 5.31 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.739 0.781 . . . . 0.0 111.741 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -83.71 127.7 33.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.054 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.495 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 55.4 m-85 -112.26 124.15 51.83 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.09 104.03 15.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.842 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.692 ' CD2' HD11 ' A' ' 201' ' ' LEU . 31.1 tp -105.7 123.59 48.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.04 130.47 35.55 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-O 122.1 0.952 . . . . 0.0 112.327 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.57 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 39.4 m -61.25 -31.44 71.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.2 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -57.96 -40.44 80.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.85 -43.55 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 196' ' ' LEU . 84.6 mt -79.77 -77.93 0.17 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.526 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER -137.38 131.63 32.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.413 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -107.43 -64.93 1.15 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.28 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.69 -20.51 16.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.545 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.35 159.71 33.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.988 0.423 . . . . 0.0 110.209 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -53.65 -66.74 0.34 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.571 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.07 -2.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.087 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.409 ' H ' ' H ' ' A' ' 207' ' ' ALA . 40.8 p -53.17 135.99 36.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.034 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 54.2 mt -82.02 137.73 35.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.854 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.8 mtpm? -97.79 157.75 34.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.811 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 213' ' ' GLY . 84.6 Cg_exo -34.1 -76.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.597 2.198 . . . . 0.0 112.486 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.72 -19.17 0.58 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.043 0.449 . . . . 0.0 110.3 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.1 -51.73 9.83 Favored Glycine 0 N--CA 1.459 0.229 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -65.39 -40.57 93.61 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.204 0.526 . . . . 0.0 109.846 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.99 -54.75 41.06 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.018 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.25 86.68 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.615 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.34 -30.09 70.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.217 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.13 -46.56 56.07 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.848 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -62.33 -44.15 97.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.237 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.78 -38.07 89.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.476 ' O ' ' OG ' ' A' ' 225' ' ' SER . 3.2 t80 -54.2 -50.84 66.16 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.066 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.8 t -55.78 -51.0 68.92 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.393 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.495 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 56.7 tt0 -52.64 -25.01 9.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.874 HD22 HG21 ' A' ' 313' ' ' VAL . 85.2 mt -99.0 -18.78 17.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.656 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 221' ' ' TYR . 1.3 m -77.42 -30.77 53.62 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.575 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -87.18 25.0 1.44 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 110.298 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.04 -179.14 6.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.811 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 1.6 t70 -100.93 133.47 21.04 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.75 -19.31 47.43 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.259 1.973 . . . . 0.0 112.744 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -37.15 -52.96 1.03 Allowed 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 110.511 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' GLY . 52.9 m-20 -98.3 -21.16 16.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 24.94 45.98 0.02 OUTLIER Glycine 0 C--N 1.343 0.96 0 O-C-N 123.744 0.653 . . . . 0.0 111.725 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 231' ' ' ASP . 5.2 m -119.44 114.29 22.09 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.032 0.444 . . . . 0.0 110.879 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.477 HG22 HG13 ' A' ' 313' ' ' VAL . 43.0 t -130.19 95.76 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.529 0.68 . . . . 0.0 109.977 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.4 HG11 HH12 ' A' ' 277' ' ' ARG . 10.6 t -97.76 122.77 49.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.345 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.459 HG21 HG22 ' A' ' 261' ' ' VAL . 83.0 t -95.63 125.41 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 41.7 mt -109.7 141.89 41.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.126 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -122.12 129.6 7.67 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.57 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -113.33 119.49 37.86 Favored 'General case' 0 C--N 1.349 0.574 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 31.1 p -109.97 168.96 9.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.84 0.352 . . . . 0.0 110.758 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.458 ' OD2' ' NH2' ' A' ' 307' ' ' ARG . 44.5 p-10 -90.69 -178.39 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -100.94 124.57 46.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.333 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.1 mm -117.7 12.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.414 0.626 . . . . 0.0 110.745 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.15 6.1 88.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -136.48 96.71 3.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.517 . . . . 0.0 109.729 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -52.22 -50.04 62.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.432 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.69 77.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.619 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.62 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 58.6 t80 -64.21 -43.84 93.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.475 HD22 ' H ' ' A' ' 243' ' ' ILE . 89.4 m-20 -61.19 -42.83 99.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.467 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.21 -40.11 95.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.377 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.35 -38.94 96.54 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.62 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 81.9 mt -73.56 -34.54 65.21 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.88 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 85.6 p -64.29 -40.25 95.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.129 0.49 . . . . 0.0 110.741 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.43 -39.84 62.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.314 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -61.25 -51.71 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.251 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.57 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 8.5 ptm180 -64.05 -46.06 86.03 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.306 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.479 ' N ' ' CG ' ' A' ' 256' ' ' ARG . . . -56.74 -36.49 69.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.399 0.619 . . . . 0.0 109.703 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -72.75 -44.29 61.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.805 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.9 m -59.1 -39.81 83.38 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.254 0.55 . . . . 0.0 110.134 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 256' ' ' ARG . 97.6 t -64.46 -51.73 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.922 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.559 HG13 HD12 ' A' ' 274' ' ' ILE . 21.3 t -62.4 -48.69 87.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.456 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -48.14 -41.46 26.78 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.95 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -78.74 -35.53 44.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.577 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -31.01 72.04 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.897 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.51 ' C ' ' H ' ' A' ' 267' ' ' LYS . 80.8 mt -65.49 -51.62 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 88.5 p -51.82 -8.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.789 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 265' ' ' ILE . 67.8 mmtt -79.49 -4.45 51.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.541 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.34 41.75 2.92 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.86 127.64 23.92 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 117.031 0.416 . . . . 0.0 110.208 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.31 128.36 25.22 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.609 1.539 . . . . 0.0 111.84 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.07 -8.71 17.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -93.58 -22.9 18.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.191 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -79.86 -17.11 54.03 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.72 0.772 . . . . 0.0 111.032 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.559 HD12 HG13 ' A' ' 261' ' ' VAL . 2.0 pt -107.93 -170.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.463 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 3.2 m -166.86 131.76 2.09 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.224 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -103.1 111.67 24.14 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.768 0.318 . . . . 0.0 110.546 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.4 HH12 HG11 ' A' ' 235' ' ' VAL . 30.8 ttm105 -119.79 141.24 49.67 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.71 0.767 . . . . 0.0 111.566 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -92.46 95.27 2.0 Allowed Glycine 0 CA--C 1.519 0.342 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 238' ' ' GLY . 2.7 tpt -68.11 -10.64 55.55 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.223 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 40.58 -98.73 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -141.59 75.37 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 0.0 110.81 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 70.8 m -83.63 -5.62 59.23 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -167.61 79.2 0.91 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.313 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.71 104.29 0.26 Allowed 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.568 2.179 . . . . 0.0 112.959 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 289' ' ' THR . 27.2 m -75.31 -32.79 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.337 0.589 . . . . 0.0 110.344 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.628 ' C ' ' H ' ' A' ' 288' ' ' ASN . 44.4 p -56.94 -42.59 80.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.793 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.6 -0.3 0.02 OUTLIER Glycine 0 CA--C 1.532 1.124 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.628 ' H ' ' C ' ' A' ' 286' ' ' THR . 17.2 t-20 -122.74 -58.87 1.65 Allowed 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.5 OUTLIER -66.9 -17.59 64.97 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.542 -178.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 302' ' ' CYS . 72.1 m -116.78 25.6 10.43 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.384 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 293' ' ' VAL . 34.5 t70 -57.88 -49.92 75.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.0 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -76.19 32.41 0.12 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.316 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' A' ' 291' ' ' ASP . 2.8 t -131.24 104.57 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.655 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -118.97 13.77 13.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.401 ' OE1' ' CA ' ' A' ' 295' ' ' GLN . 0.0 OUTLIER -100.23 139.98 35.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.92 0.39 . . . . 0.0 110.101 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -50.48 -70.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.184 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.92 -39.05 68.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.545 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.36 80.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.261 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 303' ' ' LEU . 26.0 mt -72.65 -53.38 11.95 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.891 0.377 . . . . 0.0 110.815 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 69.4 mt -53.16 -35.14 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 0.0 109.905 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -76.18 -40.38 52.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.192 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.513 ' O ' ' SG ' ' A' ' 290' ' ' CYS . 5.5 t -82.48 -8.78 59.61 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.957 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 299' ' ' LEU . 34.8 mt -91.06 21.4 4.28 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.836 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.622 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.44 -40.3 1.22 Allowed Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.397 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 36.6 Cg_exo -59.14 7.96 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 123.707 2.938 . . . . 0.0 112.719 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 304' ' ' ALA . 5.3 m-20 -111.12 14.46 21.84 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.458 ' NH2' ' OD2' ' A' ' 241' ' ' ASP . 98.5 mtt180 -111.32 90.5 3.35 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.214 0.53 . . . . 0.0 109.75 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.0 ptp180 -162.81 132.63 4.4 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.47 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.464 HG12 HH22 ' A' ' 256' ' ' ARG . 0.2 OUTLIER -96.15 142.3 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -118.83 106.71 12.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.208 0.527 . . . . 0.0 110.234 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.409 HD13 HG13 ' A' ' 236' ' ' VAL . 3.6 mm -80.05 118.2 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -102.74 102.28 12.43 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.62 0.248 . . . . 0.0 110.874 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.874 HG21 HD22 ' A' ' 224' ' ' LEU . 59.8 t -114.85 122.81 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.958 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -120.03 153.31 36.22 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.196 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 89.97 12.4 62.08 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 7.8 tt -95.17 135.64 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.155 0.502 . . . . 0.0 110.712 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp . . . . . 0 N--CA 1.463 0.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.298 -179.758 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 121.262 0.553 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.1 m -69.15 137.2 53.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.487 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 5.5 tptp -112.27 166.37 11.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.322 0.582 . . . . 0.0 110.605 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.412 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 96.6 m-70 -154.74 121.4 5.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.114 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.447 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 68.7 m-85 -108.48 121.05 44.16 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.9 104.08 15.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.497 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.685 ' CD2' HD11 ' A' ' 201' ' ' LEU . 33.8 tp -107.92 127.88 54.13 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.451 ' HG2' ' H ' ' A' ' 199' ' ' ASP . 36.3 ttmt -80.95 127.89 33.07 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.61 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.505 ' OG ' ' NH1' ' A' ' 256' ' ' ARG . 1.2 t -63.44 -31.79 73.05 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.024 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.86 ' CG ' HD22 ' A' ' 203' ' ' ASN . 9.7 t70 -57.16 -41.06 78.49 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.941 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.52 -43.73 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.685 HD11 ' CD2' ' A' ' 196' ' ' LEU . 95.8 mt -74.69 -79.15 0.09 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.44 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -123.65 140.01 53.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.05 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.86 HD22 ' CG ' ' A' ' 199' ' ' ASP . 17.6 m120 -109.38 -76.65 0.61 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.383 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.445 ' CE1' ' OD1' ' A' ' 205' ' ' ASN . 53.3 p90 -96.54 -12.68 23.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.622 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.445 ' OD1' ' CE1' ' A' ' 204' ' ' PHE . 81.9 m-20 -75.96 160.7 29.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 110.204 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -55.46 -62.02 1.95 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.51 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.517 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.61 1.15 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.128 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.42 134.24 45.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.18 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.33 144.28 34.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.135 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 213' ' ' GLY . 21.9 mtmt -104.87 157.54 33.98 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.816 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -34.32 -76.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.5 2.133 . . . . 0.0 112.311 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 51.6 mp0 -49.75 -20.8 0.91 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.052 0.453 . . . . 0.0 110.316 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.6 -51.01 17.69 Favored Glycine 0 CA--C 1.518 0.232 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -65.34 -40.92 94.26 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.073 0.463 . . . . 0.0 109.763 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.1 -53.94 49.54 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.037 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.23 -38.45 91.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.798 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.76 -27.66 68.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.234 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -73.3 -46.27 50.57 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.381 0.61 . . . . 0.0 110.801 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -62.17 -42.15 98.99 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.096 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.9 -37.41 84.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.031 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.41 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.3 t80 -54.45 -49.49 69.92 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.822 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 225' ' ' SER . 45.9 t -59.84 -49.27 78.37 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.782 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 1.1 tm0? -50.08 -24.09 2.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.421 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.601 ' O ' HD22 ' A' ' 227' ' ' LEU . 62.7 mt -97.34 -14.13 21.47 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 222' ' ' SER . 94.2 p -78.26 -22.32 48.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.766 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -94.62 18.08 12.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.996 0.427 . . . . 0.0 110.446 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -78.72 168.76 19.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.137 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.75 132.99 40.65 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 230' ' ' LYS . 56.4 Cg_endo -71.18 -17.56 31.23 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.777 2.318 . . . . 0.0 112.561 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 229' ' ' PRO . 79.9 tttt -32.59 -51.09 0.27 Allowed 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.797 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 232' ' ' GLY . 47.0 m-20 -108.41 -18.08 13.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.263 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.6 51.33 0.06 OUTLIER Glycine 0 N--CA 1.471 1.006 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.0 m -118.02 108.62 15.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 111.159 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.68 96.51 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.31 120.07 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.657 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.562 HG13 HD13 ' A' ' 311' ' ' ILE . 92.8 t -92.34 124.81 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.435 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 277' ' ' ARG . 28.1 mt -109.11 143.64 38.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.016 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.33 130.47 7.54 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.622 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -115.32 116.8 28.89 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 241' ' ' ASP . 69.8 m -104.08 160.58 14.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.643 0.259 . . . . 0.0 110.449 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.461 ' N ' HG22 ' A' ' 240' ' ' THR . 39.7 p-10 -89.61 177.81 6.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.69 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.629 ' NE ' ' H ' ' A' ' 244' ' ' GLY . 1.0 OUTLIER -88.74 127.67 35.6 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.0 mm -118.34 9.71 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.248 0.547 . . . . 0.0 110.895 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.629 ' H ' ' NE ' ' A' ' 242' ' ' ARG . . . 102.43 -26.0 25.71 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -118.7 115.27 24.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.173 0.511 . . . . 0.0 110.26 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 246' ' ' ASP . 24.0 p-10 -60.15 -53.1 61.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.861 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.72 -38.93 70.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.299 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.585 ' CE2' HD11 ' A' ' 252' ' ' LEU . 47.8 t80 -63.0 -44.1 96.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.292 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -62.36 -40.23 95.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.348 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.79 -44.07 97.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.06 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.18 -36.33 93.29 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.585 HD11 ' CE2' ' A' ' 248' ' ' TYR . 36.5 mt -71.71 -37.14 70.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.336 . . . . 0.0 111.027 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 35.1 t -64.4 -41.29 96.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.942 0.401 . . . . 0.0 110.652 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.42 -47.76 72.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -59.07 -43.44 91.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.759 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.505 ' NH1' ' OG ' ' A' ' 198' ' ' SER . 0.0 OUTLIER -52.94 -64.17 0.91 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.378 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -56.6 -37.08 70.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.459 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.21 -46.83 87.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.655 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 75.7 m -60.66 -38.26 84.28 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.255 0.55 . . . . 0.0 110.439 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 256' ' ' ARG . 96.0 t -63.98 -51.91 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.999 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.702 HG21 ' HB2' ' A' ' 276' ' ' ALA . 62.6 t -62.11 -49.03 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -45.39 -42.14 9.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.177 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.508 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 54.8 t80 -82.04 -29.94 31.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.72 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.4 ' O ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -72.72 -8.59 56.11 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.726 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.566 ' C ' ' H ' ' A' ' 267' ' ' LYS . 69.2 mt -87.23 -55.87 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.812 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 93.7 p -50.05 -5.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.07 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 265' ' ' ILE . 71.2 mmtt -77.23 -10.99 59.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.546 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.95 -7.93 23.51 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -80.94 129.84 65.96 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.338 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.44 131.17 39.34 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.75 1.634 . . . . 0.0 111.549 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.91 -8.21 34.83 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 111.251 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 25.9 p30 -94.89 -19.66 20.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.618 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 0.9 OUTLIER -80.87 -21.22 40.87 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.496 0.665 . . . . 0.0 110.636 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.47 HD12 HG13 ' A' ' 261' ' ' VAL . 1.3 pt -104.82 -170.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.589 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 14.9 t -170.94 132.96 0.88 Allowed 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.368 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.702 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -96.87 150.93 20.18 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.845 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.477 ' HB3' HD23 ' A' ' 237' ' ' LEU . 63.5 ttt-85 -160.99 150.25 16.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.202 0.525 . . . . 0.0 110.968 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.44 145.65 16.06 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.475 ' SD ' HD22 ' A' ' 237' ' ' LEU . 85.6 mmm -120.64 2.71 10.67 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 121.967 0.107 . . . . 0.0 110.831 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 38.33 -97.89 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 279' ' ' MET . 6.9 pt-20 -142.03 68.89 1.32 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.656 0.265 . . . . 0.0 110.462 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 98.5 p -89.3 -2.67 58.54 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -154.14 65.52 5.1 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.515 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.7 107.61 2.51 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.56 2.173 . . . . 0.0 112.363 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 31.5 m -73.09 -29.08 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.521 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.634 HG21 ' HA ' ' A' ' 303' ' ' LEU . 40.3 p -58.92 -46.15 88.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.569 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -49.6 -2.93 0.02 OUTLIER Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 286' ' ' THR . 97.9 m-20 -119.98 -58.66 1.86 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.77 -3.61 51.57 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.683 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -130.7 15.52 5.36 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.851 0.357 . . . . 0.0 110.155 179.395 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -65.9 -2.47 3.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.98 0.419 . . . . 0.0 110.304 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -109.9 31.71 5.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.86 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.683 HG21 ' SG ' ' A' ' 290' ' ' CYS . 20.8 t -130.25 121.33 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 110.33 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -119.32 12.19 12.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.702 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.96 130.59 45.33 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.088 0.47 . . . . 0.0 109.815 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -51.99 -64.85 0.68 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.937 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.21 -37.55 64.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.638 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.39 84.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.646 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 303' ' ' LEU . 17.4 mt -72.81 -47.86 42.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.004 0.43 . . . . 0.0 110.78 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.5 mt -60.47 -32.83 52.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.433 . . . . 0.0 110.262 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -82.92 -27.25 30.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.712 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 40.5 t -90.8 -20.37 22.42 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.761 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.634 ' HA ' HG21 ' A' ' 286' ' ' THR . 60.8 mt -85.71 24.96 1.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.528 0.517 . . . . 0.0 111.145 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.58 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -76.48 -44.09 3.32 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 22.4 Cg_exo -62.76 9.35 0.1 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.276 2.651 . . . . 0.0 112.084 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 304' ' ' ALA . 8.2 t70 -104.46 10.73 35.1 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.877 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.489 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 7.9 ptm180 -111.9 97.82 6.95 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.539 0.685 . . . . 0.0 109.965 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.543 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.6 ptm180 -159.0 132.3 7.24 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.333 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.63 141.11 16.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -121.35 106.2 11.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.072 0.463 . . . . 0.0 110.53 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.562 HD13 HG13 ' A' ' 236' ' ' VAL . 3.7 mm -78.55 117.48 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -97.49 132.0 43.59 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.434 HG21 HD22 ' A' ' 224' ' ' LEU . 2.2 t -133.23 118.43 32.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.255 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -115.89 134.55 54.87 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.83 -5.12 56.45 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 18.7 tt -79.91 147.17 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.953 0.406 . . . . 0.0 110.524 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.235 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.45 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 1.2 pm0 . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 120.606 0.241 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.3 m -75.11 137.88 41.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.696 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.494 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 13.5 tptt -111.26 166.86 10.74 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.487 0.661 . . . . 0.0 110.558 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.494 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 5.4 m80 -150.55 120.38 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.775 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -110.45 119.53 39.48 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 104.9 16.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.45 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.673 ' CD2' HD11 ' A' ' 201' ' ' LEU . 24.6 tp -107.96 122.82 47.6 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -78.62 130.4 35.86 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.909 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 202' ' ' PHE . 90.3 p -61.45 -29.36 69.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.105 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -60.27 -38.21 82.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.921 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.7 t -67.82 -42.97 86.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.673 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.0 mt -79.94 -78.15 0.17 Allowed 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.453 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER -135.39 127.03 28.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.501 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -102.33 -68.4 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.039 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -91.12 -22.69 20.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.552 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -69.22 161.22 29.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.912 0.387 . . . . 0.0 109.967 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -63.02 -57.28 11.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.44 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -165.92 -7.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.947 0.403 . . . . 0.0 110.206 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 69.4 p -52.46 131.22 33.39 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.262 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.8 mt -77.51 144.5 37.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.483 0.659 . . . . 0.0 111.211 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.9 mtpt -105.2 157.29 34.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.141 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 213' ' ' GLY . 89.3 Cg_exo -34.52 -76.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.762 2.308 . . . . 0.0 112.413 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -48.2 -20.37 0.37 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.099 0.476 . . . . 0.0 110.328 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.16 -48.51 19.42 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.389 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -65.62 -40.76 92.92 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.2 -52.34 65.73 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.076 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.88 85.45 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 121.56 0.695 . . . . 0.0 110.397 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 mt -65.62 -28.84 69.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.009 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -72.01 -47.85 48.94 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.371 0.605 . . . . 0.0 110.981 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -62.51 -42.03 99.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.868 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.2 tp -64.91 -40.35 94.93 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.403 ' CG ' ' HB3' ' A' ' 267' ' ' LYS . 5.9 t80 -52.3 -47.27 66.02 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 75.0 p -55.94 -51.27 68.25 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.796 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -52.28 -25.64 9.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.56 ' O ' HD22 ' A' ' 227' ' ' LEU . 42.8 mt -99.15 -20.88 16.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.677 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 6.8 t -72.75 -24.34 60.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -102.79 23.73 11.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.56 HD22 ' O ' ' A' ' 224' ' ' LEU . 1.0 OUTLIER -75.66 147.62 39.34 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 315' ' ' GLY . 25.8 t0 -62.95 112.07 6.08 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 230' ' ' LYS . 50.7 Cg_exo -53.67 -20.89 17.92 Favored 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.517 2.145 . . . . 0.0 113.181 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 229' ' ' PRO . 11.2 mmmt -29.79 -52.54 0.14 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.952 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' GLY . 34.0 m-20 -105.98 -17.18 14.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.388 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 27.86 49.33 0.07 OUTLIER Glycine 0 N--CA 1.465 0.58 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.347 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.96 108.08 15.35 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.9 96.61 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.712 0.768 . . . . 0.0 110.018 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.8 t -96.19 117.78 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.291 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 261' ' ' VAL . 88.2 t -95.26 121.4 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.033 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 277' ' ' ARG . 24.6 mt -108.76 141.8 40.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.986 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -124.48 126.84 6.2 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.34 122.05 46.84 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 241' ' ' ASP . 55.2 m -109.49 166.11 11.14 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.414 0.446 . . . . 0.0 110.613 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.593 ' N ' HG22 ' A' ' 240' ' ' THR . 40.1 p-10 -90.44 173.3 8.17 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.118 0.485 . . . . 0.0 111.17 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.41 ' NH2' ' OE2' ' A' ' 281' ' ' GLU . 64.0 ttm-85 -92.61 126.53 37.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.166 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.1 mm -118.32 15.15 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.231 0.538 . . . . 0.0 110.442 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 86.07 -1.86 87.69 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 11.8 t -131.44 105.92 7.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.156 0.503 . . . . 0.0 110.179 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 247' ' ' ALA . 22.0 p-10 -55.54 -51.5 66.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.613 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 246' ' ' ASP . . . -55.54 -39.61 70.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.551 ' CE2' HD11 ' A' ' 252' ' ' LEU . 29.1 t80 -65.02 -43.46 92.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.204 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 17.6 t-20 -61.87 -43.15 99.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -65.74 -41.77 91.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.81 -39.52 98.09 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' A' ' 248' ' ' TYR . 27.4 mt -72.8 -35.93 67.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.501 -0.349 . . . . 0.0 110.594 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 39.5 t -62.96 -42.69 99.9 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.89 -46.88 79.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.895 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -55.92 -45.25 78.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 260' ' ' VAL . 28.8 ttm105 -55.29 -65.87 0.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.826 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.09 64.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -68.47 -48.4 64.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.612 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 77.6 p -57.7 -39.39 77.08 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.117 0.484 . . . . 0.0 110.404 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 256' ' ' ARG . 58.8 t -65.32 -54.01 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.432 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.483 HG13 HD12 ' A' ' 274' ' ' ILE . 17.6 t -60.11 -49.12 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.954 -0.299 . . . . 0.0 110.492 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.09 -44.17 31.45 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.656 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.585 ' CE1' ' NZ ' ' A' ' 267' ' ' LYS . 90.3 t80 -78.39 -34.9 47.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.831 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -62.41 -25.97 68.23 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.094 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 267' ' ' LYS . 86.6 mt -71.33 -52.46 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.777 0.322 . . . . 0.0 111.708 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 6.2 t -50.04 -10.92 0.06 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.48 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.585 ' NZ ' ' CE1' ' A' ' 263' ' ' TYR . 0.1 OUTLIER -77.81 -10.81 59.74 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.204 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 105.99 41.87 1.75 Allowed Glycine 0 CA--C 1.533 1.172 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.79 131.49 24.02 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-N 117.193 0.496 . . . . 0.0 110.79 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.46 125.26 17.18 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.553 1.502 . . . . 0.0 111.48 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.01 -8.39 29.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.135 0.493 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -91.2 -22.93 20.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.334 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -81.37 -20.22 41.01 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.465 0.65 . . . . 0.0 111.167 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.483 HD12 HG13 ' A' ' 261' ' ' VAL . 1.9 pt -103.71 -173.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.435 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 17.4 p -168.62 129.26 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.511 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.09 111.49 23.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.948 0.404 . . . . 0.0 110.583 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.486 ' HB3' HD23 ' A' ' 237' ' ' LEU . 64.9 ttt180 -120.72 146.46 46.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.464 0.65 . . . . 0.0 111.062 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.51 142.46 16.16 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 1.6 mmt -118.92 -5.87 10.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.92 -104.28 0.05 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.41 ' OE2' ' NH2' ' A' ' 242' ' ' ARG . 9.4 pt-20 -142.26 68.7 1.32 Allowed 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.859 -0.201 . . . . 0.0 110.789 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 74.3 m -67.09 -42.06 85.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.614 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.419 ' ND2' HH21 ' A' ' 308' ' ' ARG . 6.9 p-10 -125.66 80.54 66.3 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.105 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.87 106.67 0.66 Allowed 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.714 2.276 . . . . 0.0 112.543 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 289' ' ' THR . 12.5 m -75.81 -30.76 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.132 0.491 . . . . 0.0 110.414 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.63 ' C ' ' H ' ' A' ' 288' ' ' ASN . 60.4 p -56.69 -43.16 80.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.664 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.13 0.52 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.63 ' H ' ' C ' ' A' ' 286' ' ' THR . 24.1 t-20 -123.2 -58.53 1.63 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER -68.22 -14.33 62.91 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.503 -178.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 57.2 m -128.53 22.28 5.98 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.301 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -69.77 -2.49 12.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.697 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -110.24 32.09 5.41 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.535 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 23.3 t -130.93 124.02 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.99 0.424 . . . . 0.0 110.299 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -118.95 7.9 11.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.385 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.437 ' O ' HD12 ' A' ' 299' ' ' LEU . 4.6 mt-30 -90.27 169.44 11.11 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -82.9 -71.18 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.683 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -57.88 -28.13 63.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.951 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.74 94.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.357 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 303' ' ' LEU . 47.6 mt -70.86 -49.11 49.61 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 110.534 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.4 mt -54.89 -31.67 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -80.25 -32.68 38.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.476 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -12.18 46.82 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.721 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.574 ' HA ' HG21 ' A' ' 286' ' ' THR . 48.5 mt -90.47 21.92 3.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.761 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.586 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -78.48 -43.26 2.01 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.98 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.5 Cg_exo -61.78 8.55 0.1 Allowed 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 123.409 2.739 . . . . 0.0 112.044 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 304' ' ' ALA . 50.6 t0 -102.49 12.2 36.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.457 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -113.98 98.48 7.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.445 0.64 . . . . 0.0 109.838 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.552 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 33.5 ptt180 -157.73 130.9 7.62 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.306 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.5 140.06 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -120.84 105.83 11.08 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.362 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.414 HD13 HG13 ' A' ' 236' ' ' VAL . 4.0 mm -79.33 117.64 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.68 127.75 41.98 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.428 HG21 ' CD2' ' A' ' 224' ' ' LEU . 2.4 t -126.77 115.56 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.196 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -114.83 125.8 54.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 91.15 43.74 4.6 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.605 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.5 tt -114.83 168.61 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.605 ' O ' ' O ' ' A' ' 316' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 O-C-N 124.07 0.857 . . . . 0.0 110.868 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.48 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 1.6 pm0 . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.543 HG22 ' CE1' ' A' ' 193' ' ' HIS . 13.3 m -85.17 142.07 29.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.193 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -143.45 111.42 6.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.562 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.4 OUTLIER -97.96 148.28 23.63 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -112.07 130.36 55.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.913 0.387 . . . . 0.0 110.303 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -88.23 103.7 16.02 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.045 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.717 ' CD2' HD11 ' A' ' 201' ' ' LEU . 28.7 tp -108.47 128.37 54.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.178 0.513 . . . . 0.0 109.648 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.437 ' HB3' HG23 ' A' ' 200' ' ' VAL . 34.0 ttmt -81.7 125.14 30.24 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.994 0.902 . . . . 0.0 112.16 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.481 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 18.5 m -61.05 -32.14 71.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.196 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.419 ' H ' ' HG2' ' A' ' 197' ' ' LYS . 9.9 t0 -59.66 -36.72 76.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 197' ' ' LYS . 87.3 t -67.34 -42.96 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.717 HD11 ' CD2' ' A' ' 196' ' ' LEU . 76.3 mt -78.9 -78.33 0.15 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.322 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.68 128.1 41.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.966 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.418 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 62.0 t-20 -111.93 -71.48 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.438 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -84.34 -32.32 24.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -73.73 165.89 24.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.196 0.522 . . . . 0.0 110.245 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.675 ' C ' HH22 ' A' ' 255' ' ' ARG . 32.6 mmtp -58.94 -82.41 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.457 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.57 ' HB2' ' NH1' ' A' ' 255' ' ' ARG . . . -148.65 56.55 1.03 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 73.4 p -107.54 130.2 54.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.131 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 40.6 mt -78.04 134.97 37.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.732 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.4 mtmt -97.06 159.21 31.92 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.917 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 210' ' ' LYS . 88.8 Cg_exo -34.63 -76.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.235 1.957 . . . . 0.0 111.875 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.22 -22.13 0.96 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.101 0.477 . . . . 0.0 110.244 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.53 -52.0 14.35 Favored Glycine 0 N--CA 1.46 0.276 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -64.99 -39.56 93.66 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.323 0.583 . . . . 0.0 109.908 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.75 -54.66 43.76 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.153 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.6 -36.0 82.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.984 0.421 . . . . 0.0 110.678 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.3 mt -61.56 -31.66 71.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.152 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.67 -45.51 58.51 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.279 0.562 . . . . 0.0 110.616 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -61.52 -44.98 96.09 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.808 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.478 HD21 HD12 ' A' ' 311' ' ' ILE . 38.3 tp -63.65 -40.6 97.27 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.262 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.433 ' CE1' ' OG ' ' A' ' 225' ' ' SER . 6.5 t80 -51.54 -48.35 63.06 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.985 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.7 t -54.25 -52.11 62.38 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.55 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -51.56 -26.66 9.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.4 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.797 HD22 HG21 ' A' ' 313' ' ' VAL . 21.7 mt -98.35 -19.0 18.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.433 ' OG ' ' CE1' ' A' ' 221' ' ' TYR . 4.7 m -71.68 -32.91 68.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -96.96 21.68 9.37 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.677 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -75.07 151.49 38.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.794 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 315' ' ' GLY . 15.6 t0 -65.39 124.6 87.54 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.128 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 232' ' ' GLY . 48.0 Cg_endo -69.16 -19.73 38.59 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 122.894 2.396 . . . . 0.0 113.313 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 229' ' ' PRO . 39.0 ttmt -24.12 -50.06 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.576 0 O-C-N 123.62 0.575 . . . . 0.0 111.037 -177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.472 ' O ' ' C ' ' A' ' 232' ' ' GLY . 32.5 t70 -115.44 -12.9 11.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.212 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 25.66 49.93 0.04 OUTLIER Glycine 0 N--CA 1.472 1.095 0 O-C-N 123.861 0.725 . . . . 0.0 111.456 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.5 t -112.03 114.13 26.83 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 122.574 -0.368 . . . . 0.0 110.352 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.6 t -129.05 95.91 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.266 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 275' ' ' SER . 2.8 t -96.74 123.98 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.097 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.484 HG22 HG23 ' A' ' 311' ' ' ILE . 21.2 t -96.75 120.94 46.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.823 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 40.8 mt -103.74 145.38 30.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.167 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.68 129.04 7.34 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 308' ' ' ARG . 1.0 OUTLIER -110.53 125.77 53.69 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.544 ' OG1' ' ND2' ' A' ' 249' ' ' ASN . 3.1 p -116.78 162.82 17.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.535 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 7.0 p30 -84.75 172.09 11.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -88.74 122.53 32.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.425 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.7 mm -118.06 7.94 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.293 0.568 . . . . 0.0 110.617 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 82.33 13.98 77.53 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -142.08 92.15 2.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.107 0.479 . . . . 0.0 109.943 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -49.25 -49.69 42.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.508 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.24 78.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.797 ' CE2' HD11 ' A' ' 252' ' ' LEU . 40.3 t80 -65.18 -43.2 92.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.062 0.458 . . . . 0.0 110.637 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.544 ' ND2' ' OG1' ' A' ' 240' ' ' THR . 27.4 t-20 -61.49 -43.4 98.94 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.634 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.52 -45.05 92.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.638 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.11 92.1 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 1.108 HD23 ' HE ' ' A' ' 255' ' ' ARG . 18.0 mt -64.69 -43.66 92.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.998 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 33.3 m -66.83 -43.69 83.09 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.885 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.58 -57.21 13.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.475 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 1.108 ' HE ' HD23 ' A' ' 252' ' ' LEU . 36.5 ptt85 -59.11 -45.16 91.58 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.156 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.481 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 19.2 mtp-105 -58.16 -50.58 73.03 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.535 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.38 69.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.84 -40.39 72.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.137 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 76.4 p -63.43 -37.86 88.93 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.192 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.48 -51.1 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.491 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' A' ' 276' ' ' ALA . 23.4 t -61.23 -49.56 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.2 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -45.94 -38.8 8.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.93 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.497 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 63.6 t80 -84.9 -31.68 23.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.49 -13.5 62.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.446 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.561 ' C ' ' H ' ' A' ' 267' ' ' LYS . 66.5 mt -83.89 -52.15 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 111.148 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 9.0 t -50.49 -6.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.561 ' H ' ' C ' ' A' ' 265' ' ' ILE . 73.7 mmtt -79.63 -10.67 59.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.616 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 104.55 40.72 2.15 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.68 127.86 24.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.87 128.03 25.2 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.822 1.681 . . . . 0.0 111.811 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.07 -11.65 15.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.008 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.36 -26.07 21.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.774 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.436 ' CE ' HD21 ' A' ' 227' ' ' LEU . 7.0 tttm -74.51 -22.81 58.87 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.909 0.861 . . . . 0.0 110.659 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -104.14 -172.8 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.547 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 235' ' ' VAL . 13.3 t -170.24 124.8 0.74 Allowed 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.396 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.678 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -99.72 156.97 16.81 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.801 -0.562 . . . . 0.0 109.795 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -174.1 166.84 4.23 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 122.009 0.909 . . . . 0.0 110.855 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.22 146.03 16.02 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.341 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 4.3 tpt -116.0 -10.97 11.51 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.914 0.388 . . . . 0.0 110.291 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 53.7 -111.23 1.77 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -141.76 72.26 1.38 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.879 0.371 . . . . 0.0 110.403 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.1 t -62.23 -42.06 98.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.113 0.482 . . . . 0.0 111.369 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -129.07 79.16 75.03 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.43 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -54.66 107.97 0.26 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.452 2.101 . . . . 0.0 112.113 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 286' ' ' THR . 27.3 m -65.75 -44.99 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.632 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.637 ' O ' ' N ' ' A' ' 288' ' ' ASN . 67.5 p -60.6 -43.68 97.15 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.813 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.37 -6.88 0.01 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.637 ' N ' ' O ' ' A' ' 286' ' ' THR . 29.7 m-80 -130.47 -56.02 1.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.116 0.566 . . . . 0.0 109.675 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 m -64.47 -30.46 71.49 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.918 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.59 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -121.3 22.37 10.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.957 0.408 . . . . 0.0 110.453 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 45.7 t0 -63.46 -10.97 19.98 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.612 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -98.87 32.17 2.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.743 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.59 HG21 ' SG ' ' A' ' 290' ' ' CYS . 40.0 t -128.04 124.98 63.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.1 0.476 . . . . 0.0 110.196 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -119.13 11.01 12.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -100.07 130.26 46.21 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.411 0.624 . . . . 0.0 110.201 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 299' ' ' LEU . 7.9 ttm180 -52.61 -76.24 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.55 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -41.91 -38.35 1.54 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.11 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.85 94.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.104 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 296' ' ' ARG . 35.5 mt -72.2 -41.48 66.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.575 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.4 mm -57.65 -31.48 39.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.11 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -86.84 -43.9 12.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.51 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.75 -19.93 65.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.985 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.46 25.43 1.68 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.459 0.474 . . . . 0.0 111.255 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.57 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -77.2 -43.6 2.69 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.924 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 18.8 Cg_exo -64.73 7.96 0.23 Allowed 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.472 2.781 . . . . 0.0 111.511 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 304' ' ' ALA . 10.0 m-20 -103.29 7.74 38.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.02 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.418 ' NH1' ' OD1' ' A' ' 203' ' ' ASN . 64.7 mtm180 -112.61 94.75 5.06 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.236 0.541 . . . . 0.0 110.2 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 39.5 ptt180 -164.46 136.73 4.7 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.535 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.44 143.9 11.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.61 -0.681 . . . . 0.0 109.562 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -117.69 103.78 10.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.484 HG23 HG22 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -80.98 113.37 20.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.211 -178.371 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -92.84 119.32 32.05 Favored 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 123.374 0.421 . . . . 0.0 110.73 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.797 HG21 HD22 ' A' ' 224' ' ' LEU . 60.9 t -119.25 117.32 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.807 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -113.98 128.63 56.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 98.15 40.83 3.4 Favored Glycine 0 C--O 1.226 -0.366 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.664 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.1 tt -116.94 170.03 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.664 ' O ' ' O ' ' A' ' 316' ' ' ILE . 51.8 mtpt . . . . . 0 N--CA 1.464 0.254 0 O-C-N 124.074 0.859 . . . . 0.0 111.357 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.958 0.409 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 36.0 m -69.19 135.19 50.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.425 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 0.1 OUTLIER -115.38 169.44 9.15 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.411 0.624 . . . . 0.0 110.72 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 94.8 m-70 -155.68 125.44 6.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.081 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -112.54 117.64 32.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.409 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.88 104.82 15.89 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.989 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.684 ' CD2' HD11 ' A' ' 201' ' ' LEU . 29.6 tp -108.47 130.82 55.25 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.423 ' HG3' ' H ' ' A' ' 199' ' ' ASP . 20.8 tptp -79.39 128.44 33.34 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.948 0.88 . . . . 0.0 111.877 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 202' ' ' PHE . 18.0 t -64.06 -31.93 73.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.088 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.423 ' H ' ' HG3' ' A' ' 197' ' ' LYS . 46.7 t0 -58.92 -37.28 76.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.979 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 197' ' ' LYS . 91.6 t -66.81 -43.87 89.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.684 HD11 ' CD2' ' A' ' 196' ' ' LEU . 90.7 mt -78.31 -77.73 0.16 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.947 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -126.0 129.55 49.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.716 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -101.35 -74.44 0.62 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.34 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.453 ' CE2' ' OD1' ' A' ' 205' ' ' ASN . 54.7 p90 -99.09 -21.67 16.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.932 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.453 ' OD1' ' CE2' ' A' ' 204' ' ' PHE . 62.2 m-80 -72.77 164.67 26.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.272 0.558 . . . . 0.0 110.057 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.3 pttm -49.56 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.198 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -156.43 58.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.255 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.04 131.62 53.89 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.5 mt -75.21 139.35 42.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.747 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.2 mtpm? -98.44 158.72 32.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.708 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 213' ' ' GLY . 81.8 Cg_exo -34.01 -76.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.558 2.172 . . . . 0.0 112.013 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -50.9 -18.44 0.76 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.126 0.488 . . . . 0.0 110.162 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.72 -47.89 11.22 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -66.98 -40.27 87.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.34 70.19 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.24 83.41 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.411 0.624 . . . . 0.0 110.485 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.82 -30.92 71.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.063 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.49 -47.34 56.08 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.134 0.493 . . . . 0.0 110.867 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -63.9 -42.63 97.38 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.283 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.505 HD21 HD12 ' A' ' 311' ' ' ILE . 40.4 tp -64.87 -40.68 95.51 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.1 t80 -53.44 -49.11 68.05 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.968 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.5 m -55.76 -50.57 70.05 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.348 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -53.17 -24.18 10.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.42 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.739 HD22 HG21 ' A' ' 313' ' ' VAL . 74.3 mt -95.96 -20.02 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.583 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.2 t -73.06 -21.57 60.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.92 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -99.75 20.42 14.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.714 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -76.27 161.4 28.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.18 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 315' ' ' GLY . 9.5 t0 -78.75 126.94 81.66 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' LYS . 45.9 Cg_endo -68.82 -17.27 41.99 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.718 2.279 . . . . 0.0 113.051 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 229' ' ' PRO . 14.4 mmtp -27.62 -46.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.74 0.65 . . . . 0.0 110.964 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.476 ' O ' ' C ' ' A' ' 232' ' ' GLY . 9.6 m-20 -117.89 -14.92 10.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.36 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.21 51.64 0.06 OUTLIER Glycine 0 N--CA 1.474 1.182 0 O-C-N 123.985 0.803 . . . . 0.0 111.346 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 73.6 m -116.63 111.97 20.61 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 122.788 -0.242 . . . . 0.0 110.791 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.3 t -126.71 96.47 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.019 0.438 . . . . 0.0 110.075 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.15 121.18 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.446 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 311' ' ' ILE . 24.2 t -95.54 125.85 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.982 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.641 HD23 ' HB3' ' A' ' 277' ' ' ARG . 23.4 mt -109.08 143.96 37.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.933 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.695 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -120.13 138.95 13.42 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.622 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.2 OUTLIER -121.7 117.32 26.37 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.23 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.413 ' OG1' ' OD1' ' A' ' 249' ' ' ASN . 7.7 p -112.74 164.81 12.92 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.223 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.439 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 47.6 p-10 -85.22 177.53 7.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.32 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -104.0 127.2 51.55 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.103 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.1 mm -118.84 19.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.444 0.64 . . . . 0.0 110.706 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.44 7.51 86.31 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.8 t -136.3 99.06 4.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.996 0.427 . . . . 0.0 110.212 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -51.5 -50.04 60.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.577 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.94 -39.54 71.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.575 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.628 ' CE2' HD11 ' A' ' 252' ' ' LEU . 48.1 t80 -62.14 -47.16 85.78 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.97 0.414 . . . . 0.0 110.502 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 11.1 t-20 -62.2 -41.37 98.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.636 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -64.55 -44.27 91.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 110.751 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.09 -36.03 92.34 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.628 HD11 ' CE2' ' A' ' 248' ' ' TYR . 78.5 mt -74.36 -34.76 63.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.687 0.279 . . . . 0.0 111.365 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.473 ' OG ' ' CA ' ' A' ' 278' ' ' GLY . 12.0 t -65.01 -43.76 91.42 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.016 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -71.09 -40.13 71.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.417 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -60.11 -50.02 75.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.592 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.524 ' O ' HG23 ' A' ' 260' ' ' VAL . 86.2 mtt-85 -61.19 -53.99 49.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.747 0.308 . . . . 0.0 110.351 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -54.58 -35.49 63.39 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.164 0.507 . . . . 0.0 109.919 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -71.3 -44.33 65.37 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.258 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 17.1 m -62.02 -37.49 85.12 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.528 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 256' ' ' ARG . 96.7 t -65.12 -51.41 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.543 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.559 HG13 HD12 ' A' ' 274' ' ' ILE . 25.3 t -61.92 -48.64 87.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.054 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -45.48 -41.08 9.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.942 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.532 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 57.4 t80 -81.42 -30.69 33.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.653 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -73.5 -8.53 56.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.633 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.5 mt -87.33 -55.77 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.807 0.337 . . . . 0.0 111.264 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.9 m -50.72 -4.79 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.573 ' H ' ' C ' ' A' ' 265' ' ' ILE . 30.1 mmtp -79.39 -11.0 59.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.774 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.27 39.92 2.03 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 128.57 24.09 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.5 128.46 25.96 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.595 1.53 . . . . 0.0 112.037 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.8 -6.93 13.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.787 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 6.4 p30 -94.54 -21.75 18.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.905 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 1.2 ttpm? -80.4 -21.2 42.5 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.505 0.669 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.559 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -103.89 -171.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.626 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 22.0 m -171.17 129.56 0.73 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.145 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.86 152.25 18.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.641 ' HB3' HD23 ' A' ' 237' ' ' LEU . 69.2 ttt-85 -161.38 148.79 14.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.361 0.601 . . . . 0.0 110.6 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.473 ' CA ' ' OG ' ' A' ' 253' ' ' SER . . . -126.12 100.46 0.58 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.622 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 8.1 ptp -88.0 24.03 1.92 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.649 0.261 . . . . 0.0 110.931 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.12 -93.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 279' ' ' MET . 4.5 pt-20 -140.68 74.91 1.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.826 0.346 . . . . 0.0 110.447 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.4 m -90.38 -0.73 57.77 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.466 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -153.86 56.28 1.54 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.354 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.61 109.49 1.86 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.558 2.172 . . . . 0.0 112.28 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 22.5 m -78.87 -23.94 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.436 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.648 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.6 OUTLIER -59.71 -45.06 93.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.702 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -49.95 -0.1 0.01 OUTLIER Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.648 ' H ' ' C ' ' A' ' 286' ' ' THR . 25.7 t-20 -124.72 -57.19 1.55 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.6 m -54.82 -42.52 72.0 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 8.2 m -94.22 34.78 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.287 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 41.4 t0 -74.77 -7.99 55.05 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.821 0.343 . . . . 0.0 110.792 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -106.47 30.04 6.35 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.435 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.41 126.56 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.236 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -119.88 13.73 12.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.524 ' O ' HD13 ' A' ' 299' ' ' LEU . 2.1 mp0 -87.6 171.54 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.073 0.463 . . . . 0.0 110.144 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -86.26 -71.1 0.56 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.605 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.57 -32.39 68.88 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.334 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.11 87.23 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.514 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 295' ' ' GLN . 7.5 mp -72.29 -48.34 43.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.917 0.389 . . . . 0.0 110.843 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 81.3 mt -45.49 -38.52 2.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -79.55 -40.78 28.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.406 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 3.5 t -72.7 -8.92 57.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.528 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.7 mm? -92.03 20.95 5.35 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.496 0.498 . . . . 0.0 110.305 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.648 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.02 -38.06 1.14 Allowed Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.029 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.5 Cg_exo -59.13 9.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 123.35 2.7 . . . . 0.0 112.593 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 304' ' ' ALA . 33.6 p30 -114.77 15.44 17.49 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.69 0.281 . . . . 0.0 110.764 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -106.83 97.33 7.13 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.756 0.789 . . . . 0.0 110.285 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 16.6 ptm180 -171.12 157.84 5.3 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.881 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.695 HG12 ' HA2' ' A' ' 238' ' ' GLY . 34.5 m -117.91 148.0 21.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 87.9 mt-10 -121.06 105.91 11.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 110.753 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.506 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -78.44 117.28 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.201 -178.44 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -97.69 122.74 41.13 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.038 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.739 HG21 HD22 ' A' ' 224' ' ' LEU . 28.6 t -124.65 117.07 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.1 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -115.39 121.63 43.36 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 103.91 40.17 2.36 Favored Glycine 0 N--CA 1.462 0.398 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.506 ' CG1' ' N ' ' A' ' 317' ' ' LYS . 12.4 tt -115.95 168.07 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 109.983 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.506 ' N ' ' CG1' ' A' ' 316' ' ' ILE . 5.0 tmtp? . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.495 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.471 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 1.1 pm0 . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m -87.59 145.21 26.3 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -118.59 170.26 9.11 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.22 0.533 . . . . 0.0 110.002 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -153.55 124.66 7.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.947 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -112.07 122.31 47.4 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.485 ' OG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -87.87 105.9 17.74 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.451 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.694 ' CD2' HD11 ' A' ' 201' ' ' LEU . 37.5 tp -108.21 123.58 48.97 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.425 ' NZ ' ' OD2' ' A' ' 199' ' ' ASP . 5.3 ttpp -81.13 128.25 33.54 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 122.615 1.198 . . . . 0.0 113.2 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 202' ' ' PHE . 20.4 t -59.31 -19.6 47.63 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.159 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.425 ' OD2' ' NZ ' ' A' ' 197' ' ' LYS . 21.0 m-20 -59.69 -47.85 84.0 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.407 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 200' ' ' VAL . 2.5 m -71.64 -25.98 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.326 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.694 HD11 ' CD2' ' A' ' 196' ' ' LEU . 65.6 mt -90.56 -81.28 0.31 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.954 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.503 ' O ' ' OG ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -128.13 99.27 5.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.9 -178.066 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.53 HD21 ' HZ3' ' A' ' 210' ' ' LYS . 3.3 p30 -71.99 -71.78 0.26 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.406 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -105.73 -27.16 11.46 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.554 0.216 . . . . 0.0 110.9 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -61.98 167.83 3.59 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.992 0.425 . . . . 0.0 110.271 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -53.21 -81.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.515 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.47 ' HB1' ' OG ' ' A' ' 259' ' ' SER . . . -161.86 54.2 0.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 60.0 p -107.28 136.97 46.2 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.406 HD22 HD22 ' A' ' 201' ' ' LEU . 18.9 mt -79.8 123.44 27.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.827 0.346 . . . . 0.0 111.633 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.53 ' HZ3' HD21 ' A' ' 203' ' ' ASN . 22.1 mtmt -84.14 158.51 61.17 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.26 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 213' ' ' GLY . 96.1 Cg_exo -32.75 -75.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.702 2.268 . . . . 0.0 112.824 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -49.12 -19.27 0.42 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.386 0.612 . . . . 0.0 110.191 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.33 -50.42 8.35 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.92 -40.62 95.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.224 0.535 . . . . 0.0 109.568 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -51.51 68.99 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.144 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.21 85.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.246 0.546 . . . . 0.0 110.036 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.3 mt -61.64 -37.8 85.35 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.183 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASP . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 32.1 m-20 -63.66 -45.57 89.54 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.112 0.482 . . . . 0.0 111.009 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -62.2 -44.22 97.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.299 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 37.6 tp -63.24 -39.94 96.02 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 225' ' ' SER . 16.1 t80 -53.9 -45.39 71.1 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 87.7 p -51.25 -53.53 34.53 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.038 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -53.83 -29.09 39.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.825 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.579 ' O ' HD22 ' A' ' 227' ' ' LEU . 17.5 mt -93.64 -22.97 18.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.519 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 221' ' ' TYR . 7.2 p -77.86 -30.04 50.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -96.17 22.78 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.167 0.508 . . . . 0.0 110.437 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.579 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.6 OUTLIER -79.71 168.61 19.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.83 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.37 127.85 64.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 230' ' ' LYS . 68.6 Cg_endo -72.22 -16.53 28.24 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.072 1.848 . . . . 0.0 113.071 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.475 ' CG ' ' N ' ' A' ' 231' ' ' ASP . 19.5 ptmt -31.67 -45.77 0.1 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 123.583 0.552 . . . . 0.0 111.232 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' A' ' 230' ' ' LYS . 84.5 m-20 -111.92 -19.39 12.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.998 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 28.31 54.75 0.13 Allowed Glycine 0 N--CA 1.473 1.151 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.754 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.8 p -119.06 109.89 16.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.409 0.147 . . . . 0.0 111.151 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.4 t -125.47 94.74 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.699 0.761 . . . . 0.0 110.205 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.57 120.31 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.549 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.44 HG13 HD13 ' A' ' 311' ' ' ILE . 69.3 t -96.93 123.96 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.297 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.8 mt -107.2 137.83 44.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.185 0.517 . . . . 0.0 110.592 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -90.91 139.54 14.87 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.493 ' CZ ' ' CD ' ' A' ' 310' ' ' GLU . 11.6 m-85 -131.56 118.95 20.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.051 0.925 . . . . 0.0 108.794 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.0 t -129.49 171.05 12.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.843 0.354 . . . . 0.0 111.124 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -76.96 -176.12 3.82 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.321 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -105.82 121.83 44.85 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.781 0.324 . . . . 0.0 110.239 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 243' ' ' ILE . 8.5 mm -118.82 11.15 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.552 0.691 . . . . 0.0 110.453 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.8 -47.36 3.06 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.5 m -68.3 101.04 1.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.314 0.578 . . . . 0.0 109.636 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -54.41 -52.3 62.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.548 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.41 -44.99 80.86 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.194 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.599 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 56.1 t80 -62.17 -45.02 95.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.91 0.385 . . . . 0.0 110.733 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.418 HD22 ' H ' ' A' ' 243' ' ' ILE . 72.9 m-20 -62.3 -41.67 98.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -64.79 -41.8 95.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.673 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.27 96.2 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.599 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 27.7 mt -67.79 -40.76 83.88 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.679 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.5 t -62.2 -43.86 97.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.554 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -65.68 -41.4 92.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.004 0.431 . . . . 0.0 110.687 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.12 -48.84 77.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.684 ' NH2' HH21 ' A' ' 307' ' ' ARG . 66.7 mtt85 -61.36 -53.62 54.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.694 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.87 -30.22 65.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.463 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 5.5 tp-100 -75.45 -46.39 32.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.704 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.641 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 20.4 m -56.77 -37.19 70.75 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.996 0.903 . . . . 0.0 109.872 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 256' ' ' ARG . 44.8 t -71.07 -63.02 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.771 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 276' ' ' ALA . 17.0 t -46.36 -63.84 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.731 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.641 ' OD1' ' O ' ' A' ' 259' ' ' SER . 28.6 p-10 -45.22 -38.72 5.64 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.079 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.524 ' N ' ' OD1' ' A' ' 262' ' ' ASP . 84.1 t80 -80.74 -31.94 35.84 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.981 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 260' ' ' VAL . 0.5 OUTLIER -70.27 -9.15 55.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.561 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.487 ' C ' ' H ' ' A' ' 267' ' ' LYS . 68.9 mt -86.83 -54.79 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.816 0.341 . . . . 0.0 111.744 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 39.0 m -51.59 -7.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.19 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 218' ' ' ASP . 0.0 OUTLIER -78.82 -11.34 59.99 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 109.52 39.49 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.98 130.19 23.84 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 117.173 0.487 . . . . 0.0 109.751 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.94 132.55 50.37 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.253 1.302 . . . . 0.0 112.4 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.33 -13.27 60.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.682 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -90.46 -17.45 27.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.484 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.51 -25.62 35.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.728 0.775 . . . . 0.0 110.413 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.3 pt -100.3 -178.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.548 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 7.7 t -162.17 126.48 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.613 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -97.58 113.97 25.79 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.887 0.375 . . . . 0.0 110.803 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -129.14 156.33 44.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.797 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.48 152.09 16.98 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 238' ' ' GLY . 6.5 tpt -118.11 -10.36 10.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.961 0.41 . . . . 0.0 110.242 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 60.28 -107.79 1.5 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.485 ' CD ' ' N ' ' A' ' 281' ' ' GLU . 1.0 OUTLIER -141.02 71.31 1.36 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.897 0.379 . . . . 0.0 110.235 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 72.8 m -93.44 7.42 44.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -160.98 70.72 2.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.94 105.74 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.35 2.033 . . . . 0.0 112.645 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 286' ' ' THR . 15.1 m -64.28 -42.06 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.572 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.589 ' O ' ' N ' ' A' ' 288' ' ' ASN . 40.8 p -58.27 -45.67 87.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.102 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -43.95 -10.37 0.01 OUTLIER Glycine 0 CA--C 1.533 1.179 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 286' ' ' THR . 87.7 m-20 -129.77 -54.23 1.14 Allowed 'General case' 0 C--O 1.231 0.098 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 m -58.33 -44.22 88.57 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -107.13 33.09 4.16 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 109.903 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 293' ' ' VAL . 28.9 t0 -56.94 -42.65 80.46 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.447 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -75.08 33.18 0.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.502 HG21 ' SG ' ' A' ' 290' ' ' CYS . 15.5 t -131.91 113.51 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.943 0.401 . . . . 0.0 110.343 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -118.51 14.65 13.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.926 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -99.62 130.82 45.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.011 0.434 . . . . 0.0 110.166 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -50.47 -67.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.273 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.89 -38.31 61.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.72 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.96 89.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.332 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 60.3 mt -75.19 -50.25 16.85 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.878 0.37 . . . . 0.0 110.652 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 78.1 mt -52.72 -32.74 17.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.227 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -78.07 -46.22 21.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.924 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 11.9 t -70.64 -13.1 61.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.637 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 35.9 mt -92.58 24.47 3.5 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.398 0.437 . . . . 0.0 111.453 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 305' ' ' PRO . . . -78.45 -45.45 2.05 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.397 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 35.7 Cg_endo -69.28 8.7 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.203 1.935 . . . . 0.0 111.586 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 306' ' ' ASP . 9.4 t70 -104.76 9.76 34.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.228 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.684 HH21 ' NH2' ' A' ' 256' ' ' ARG . 38.6 mtp180 -107.76 116.39 31.86 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.212 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.485 ' NH2' ' OG1' ' A' ' 195' ' ' THR . 15.7 ptm180 -175.67 -171.31 0.46 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.5 m -144.77 154.16 14.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.493 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 95.2 mt-10 -121.7 105.25 10.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.044 0.45 . . . . 0.0 110.925 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.44 HD13 HG13 ' A' ' 236' ' ' VAL . 3.9 mm -80.54 116.71 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.488 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -99.63 119.6 38.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.774 0.321 . . . . 0.0 110.369 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 224' ' ' LEU . 2.5 t -118.94 120.53 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.653 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -118.93 141.13 48.93 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.22 -22.55 40.17 Favored Glycine 0 N--CA 1.469 0.88 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.551 ' CG1' ' H ' ' A' ' 317' ' ' LYS . 14.6 tt -56.47 176.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.551 ' H ' ' CG1' ' A' ' 316' ' ' ILE . 49.5 tttt . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.522 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 121.165 0.507 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.564 HG22 ' CE1' ' A' ' 193' ' ' HIS . 12.2 m -77.16 140.01 40.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.53 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -147.36 117.83 7.45 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.029 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.2 OUTLIER -103.29 150.52 23.67 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.552 ' CE1' HD21 ' A' ' 224' ' ' LEU . 41.1 m-85 -111.76 121.92 46.39 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.798 0.332 . . . . 0.0 110.184 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.59 101.72 12.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.709 ' CD2' HD11 ' A' ' 201' ' ' LEU . 34.4 tp -104.28 132.52 50.44 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.996 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.408 ' HB3' HG23 ' A' ' 200' ' ' VAL . 2.1 ttmp? -78.2 127.04 31.67 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.897 0.856 . . . . 0.0 111.893 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 202' ' ' PHE . 39.2 t -63.75 -33.22 75.17 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.035 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.56 -38.75 81.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.259 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 197' ' ' LYS . 62.0 t -63.21 -46.17 96.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.709 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.3 mt -75.56 -76.34 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.659 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.484 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -130.7 143.5 50.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.363 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.468 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 46.5 t30 -129.77 -72.87 0.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.272 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.34 -37.94 56.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -71.92 165.12 24.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.445 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -57.67 -68.03 0.28 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.589 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.12 57.18 0.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.457 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 18.8 p -106.43 130.06 54.3 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.84 139.22 44.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.78 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 213' ' ' GLY . 30.7 mtmt -101.17 159.66 28.85 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 210' ' ' LYS . 86.3 Cg_exo -34.25 -77.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.387 2.058 . . . . 0.0 112.104 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.72 -20.29 1.2 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.173 0.511 . . . . 0.0 110.424 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.83 -49.69 16.61 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -67.9 -39.19 83.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.19 0.519 . . . . 0.0 109.807 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.29 -53.17 60.44 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.537 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.51 91.34 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.43 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 mt -62.45 -26.34 68.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.502 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -73.01 -46.08 54.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -63.65 -40.25 96.38 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.462 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 311' ' ' ILE . 55.7 tp -61.08 -40.09 92.39 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.512 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 49.4 t80 -54.87 -58.33 8.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.535 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 15.4 m -58.94 -6.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.361 0.601 . . . . 0.0 110.788 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.461 ' OE1' ' CE2' ' A' ' 194' ' ' PHE . 19.0 tt0 -94.38 -34.23 12.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.684 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 1.085 HD22 HG21 ' A' ' 313' ' ' VAL . 42.7 mt -96.92 -13.03 22.7 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.809 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.3 t -83.24 -14.93 52.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.724 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -96.71 17.55 16.29 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.446 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -78.18 178.92 7.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.653 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 315' ' ' GLY . 9.4 t70 -94.2 132.03 30.14 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.734 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 230' ' ' LYS . 42.3 Cg_endo -67.92 -20.47 45.07 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.817 2.344 . . . . 0.0 112.837 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 229' ' ' PRO . 40.6 mmtt -33.43 -53.07 0.4 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.055 0.455 . . . . 0.0 110.582 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 99.3 m-20 -102.76 -19.01 14.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.471 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.03 45.23 0.01 OUTLIER Glycine 0 N--CA 1.469 0.879 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 231' ' ' ASP . 28.0 m -112.22 111.38 22.23 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 71.6 t -126.31 94.06 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.761 0.791 . . . . 0.0 110.285 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.4 t -97.22 121.03 47.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.09 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 311' ' ' ILE . 22.0 t -93.13 124.58 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.58 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 277' ' ' ARG . 19.7 mt -109.49 141.34 42.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.974 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -125.16 126.08 5.85 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.31 120.39 42.08 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 241' ' ' ASP . 2.4 m -108.98 168.53 9.29 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 240' ' ' THR . 52.8 p-10 -95.14 -179.55 4.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.628 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 244' ' ' GLY . 38.6 ttm180 -98.65 127.36 44.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.318 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.711 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.9 mm -118.31 14.2 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.313 0.578 . . . . 0.0 110.667 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.408 ' H ' ' HG2' ' A' ' 242' ' ' ARG . . . 91.87 -3.05 77.19 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 4.2 m -134.01 104.36 6.21 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.998 0.428 . . . . 0.0 110.072 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -55.35 -50.81 68.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.476 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.72 -40.75 76.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.545 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.565 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 48.7 t80 -63.07 -44.56 95.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.293 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -62.67 -40.4 96.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.279 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -63.93 -43.1 96.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.497 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.468 ' C ' ' NH2' ' A' ' 255' ' ' ARG . . . -62.33 -35.86 92.24 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.789 HD22 HH12 ' A' ' 256' ' ' ARG . 14.4 mt -74.66 -35.91 62.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.499 -0.35 . . . . 0.0 111.084 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.4 p -64.64 -41.06 96.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.979 0.418 . . . . 0.0 110.512 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -70.36 -44.48 68.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.178 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.468 ' NH2' ' C ' ' A' ' 251' ' ' GLY . 63.5 mtm-85 -56.55 -46.78 80.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.803 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.789 HH12 HD22 ' A' ' 252' ' ' LEU . 67.2 mtt85 -60.46 -62.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.611 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.72 -34.78 19.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.104 0.478 . . . . 0.0 109.881 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -72.86 -46.07 54.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.406 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 61.5 m -60.11 -38.07 81.9 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.073 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.1 t -64.06 -50.8 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.331 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.58 HG13 HD12 ' A' ' 274' ' ' ILE . 9.5 t -62.31 -48.36 88.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.434 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.44 -41.86 21.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.061 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.637 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 85.5 t80 -79.39 -34.62 41.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.628 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -64.76 -29.48 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.966 -179.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 267' ' ' LYS . 82.4 mt -68.73 -50.16 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 111.88 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 44.6 m -50.76 -8.51 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.906 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.637 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 11.4 mmtp -84.6 2.28 42.18 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.006 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.08 40.81 4.48 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.41 129.0 25.05 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.332 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.06 127.31 25.18 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.862 1.708 . . . . 0.0 111.725 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.22 -8.78 34.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.896 0.379 . . . . 0.0 111.341 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 64.7 t0 -91.86 -22.73 19.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.782 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -80.83 -19.16 45.21 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.486 0.66 . . . . 0.0 110.78 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.58 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -105.34 -171.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.745 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 1.6 t -168.5 136.27 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.206 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -106.91 110.72 22.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.819 0.342 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.486 ' HB3' HD23 ' A' ' 237' ' ' LEU . 58.9 ttm-85 -117.1 142.73 46.63 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.447 0.642 . . . . 0.0 110.532 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.84 99.62 2.33 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.626 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.6 OUTLIER -79.29 9.94 4.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.823 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLY . . . . . 0.548 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 10.26 -95.89 0.01 OUTLIER Glycine 0 N--CA 1.476 1.314 0 O-C-N 123.534 0.521 . . . . 0.0 112.068 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 281' ' ' GLU . 56.1 mp0 -135.68 75.05 1.54 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.835 0.35 . . . . 0.0 110.591 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.429 ' OG ' ' SD ' ' A' ' 279' ' ' MET . 53.8 m -83.65 -3.63 57.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 283' ' ' ASN . 11.4 p-10 -176.42 80.21 0.27 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.593 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.14 107.64 0.27 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.65 2.233 . . . . 0.0 112.214 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 286' ' ' THR . 9.6 m -88.77 -36.63 9.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.524 0.678 . . . . 0.0 110.757 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 286' ' ' THR . 0.2 OUTLIER -60.92 -43.67 98.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.954 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 290' ' ' CYS . . . -45.57 -88.96 0.01 OUTLIER Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 287' ' ' GLY . 86.6 m-20 -27.61 -53.92 0.09 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.655 0.264 . . . . 0.0 110.35 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.4 m -56.06 -47.04 78.7 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.478 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.621 ' N ' ' O ' ' A' ' 287' ' ' GLY . 0.3 OUTLIER -98.37 34.19 2.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 109.928 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 293' ' ' VAL . 51.5 t0 -57.98 -42.61 85.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.447 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -75.43 32.32 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.569 HG21 ' SG ' ' A' ' 290' ' ' CYS . 21.2 t -131.18 113.14 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.92 0.391 . . . . 0.0 110.665 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -118.97 14.22 13.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.605 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.446 ' O ' HD12 ' A' ' 299' ' ' LEU . 1.6 mt-30 -86.65 166.9 14.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.111 0.481 . . . . 0.0 110.308 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -78.78 -67.36 0.75 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.532 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 301' ' ' ASP . . . -61.77 -27.33 68.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.223 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.588 ' O ' ' OD1' ' A' ' 301' ' ' ASP . . . -71.99 -24.26 61.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.156 0.503 . . . . 0.0 110.933 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 295' ' ' GLN . 71.2 mt -86.69 -48.11 8.57 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.66 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.74 -31.8 48.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.054 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.588 ' OD1' ' O ' ' A' ' 298' ' ' ALA . 43.3 p-10 -82.95 -43.77 16.08 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.602 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.574 ' N ' ' OD1' ' A' ' 301' ' ' ASP . 13.1 t -74.86 -13.77 60.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.156 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 35.4 mt -87.39 21.07 2.58 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.514 0.509 . . . . 0.0 110.466 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.626 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -72.73 -41.01 6.91 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.0 Cg_exo -58.94 7.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.464 2.776 . . . . 0.0 112.47 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 304' ' ' ALA . 45.8 t0 -108.18 7.51 27.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.871 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.468 ' NH1' ' OD1' ' A' ' 203' ' ' ASN . 62.4 mtm180 -112.66 86.4 2.36 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.454 0.645 . . . . 0.0 109.376 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.546 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 11.0 ptp180 -156.7 130.48 8.3 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.174 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.64 139.69 18.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -122.5 103.41 8.69 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.317 0.58 . . . . 0.0 110.42 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.505 HG23 HG22 ' A' ' 236' ' ' VAL . 0.8 OUTLIER -79.46 117.89 25.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.509 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -94.9 121.51 36.57 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.642 0.258 . . . . 0.0 110.891 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 1.085 HG21 HD22 ' A' ' 224' ' ' LEU . 54.6 t -122.95 117.89 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -114.27 133.87 55.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 102.25 18.84 15.79 Favored Glycine 0 C--O 1.22 -0.759 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 20.2 tt -105.29 146.81 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 110.644 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 64.9 pttt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.848 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.933 0.397 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.8 m -77.91 142.03 38.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.131 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 193' ' ' HIS . 21.5 tptt -114.42 166.83 11.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.123 0.487 . . . . 0.0 110.553 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 192' ' ' LYS . 53.2 m80 -155.74 124.21 5.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.836 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.479 ' CE2' HD21 ' A' ' 224' ' ' LEU . 60.2 m-85 -113.66 120.13 39.82 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.15 103.66 14.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.08 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.708 ' CD2' HD11 ' A' ' 201' ' ' LEU . 28.8 tp -105.11 124.24 49.2 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -78.67 129.33 34.6 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 121.897 0.856 . . . . 0.0 112.206 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.0 t -62.3 -32.99 73.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.026 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -54.88 -35.94 64.6 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.085 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 71.0 t -71.48 -38.77 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.878 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.708 HD11 ' CD2' ' A' ' 196' ' ' LEU . 91.8 mt -84.41 -80.59 0.2 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.808 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -124.55 133.16 53.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.076 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.447 ' N ' ' OD1' ' A' ' 203' ' ' ASN . 1.6 m-20 -104.27 -71.11 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.567 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -107.49 -16.48 14.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.808 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -71.9 170.13 14.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.062 0.458 . . . . 0.0 110.241 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -52.49 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.491 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.475 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -162.19 4.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.503 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 76.8 p -55.02 144.89 21.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.014 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 28.0 mt -88.96 133.2 34.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 213' ' ' GLY . 1.5 mptm? -90.74 157.77 43.35 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.975 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -34.1 -74.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.636 2.224 . . . . 0.0 111.828 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -50.41 -21.63 1.53 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.076 0.465 . . . . 0.0 110.048 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.95 -50.27 13.83 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -66.36 -39.2 89.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.305 0.574 . . . . 0.0 110.151 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.3 -54.31 48.24 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.555 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.29 -38.42 91.07 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.703 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.9 mt -61.59 -27.36 68.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.503 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -74.21 -46.67 40.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.202 0.525 . . . . 0.0 110.443 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -61.77 -43.12 99.48 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.209 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 48.2 tp -66.8 -39.11 87.64 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.442 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.435 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.7 t80 -53.57 -49.37 67.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.849 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.7 t -58.11 -51.04 71.38 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.45 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.467 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 58.5 tt0 -52.18 -26.02 10.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.258 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.982 HD22 HG21 ' A' ' 313' ' ' VAL . 72.0 mt -96.13 -17.96 20.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.507 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.1 t -78.47 -17.6 56.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.758 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -97.36 20.67 11.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.785 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.522 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -80.16 178.12 8.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.861 179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -96.04 133.79 24.72 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.495 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.0 Cg_endo -69.75 -18.6 36.95 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.813 2.342 . . . . 0.0 112.356 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 229' ' ' PRO . 56.4 tttp -36.22 -53.66 0.81 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.457 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 232' ' ' GLY . 36.2 m-20 -100.79 -21.59 15.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.65 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.95 50.45 0.05 OUTLIER Glycine 0 N--CA 1.471 1.003 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.5 m -117.65 111.28 18.95 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 122.671 -0.311 . . . . 0.0 110.398 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 99.0 t -129.0 93.9 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.214 0.531 . . . . 0.0 110.145 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.6 t -98.27 123.4 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.621 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 311' ' ' ILE . 95.3 t -95.36 127.85 47.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.641 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 39.1 mt -111.58 142.44 43.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.662 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -118.94 139.42 14.36 Favored Glycine 0 N--CA 1.48 1.587 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.4 OUTLIER -121.14 121.58 38.15 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.453 HG22 ' NH2' ' A' ' 256' ' ' ARG . 2.6 p -112.09 165.3 12.25 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.987 0.422 . . . . 0.0 110.236 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 241' ' ' ASP . 11.3 p30 -87.82 -177.79 5.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.443 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -105.18 120.23 41.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.052 0.453 . . . . 0.0 110.288 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.3 mm -119.09 15.02 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.399 0.619 . . . . 0.0 110.83 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.5 9.03 87.32 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.7 p -134.45 97.19 3.75 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.894 0.378 . . . . 0.0 110.334 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -52.57 -52.48 54.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.647 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.9 72.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.58 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 56.3 t80 -60.19 -46.75 88.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.524 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 12.5 m120 -61.9 -42.63 99.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.569 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -63.36 -42.54 98.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.553 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.68 -36.08 92.15 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.58 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 32.5 mt -74.28 -32.98 63.12 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.704 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 12.0 m -65.36 -43.69 90.03 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.177 0.513 . . . . 0.0 110.598 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -70.42 -35.23 73.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.928 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -59.86 -50.04 75.34 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.549 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.858 ' O ' HG23 ' A' ' 260' ' ' VAL . 16.4 ptp180 -67.16 -47.52 70.77 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.406 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.83 -39.74 92.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.194 0.521 . . . . 0.0 110.189 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -74.6 -45.51 44.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.16 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 46.5 t -60.65 -38.54 85.2 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.084 0.469 . . . . 0.0 110.238 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.6 t -64.92 -52.06 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.557 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.6 HG13 HD12 ' A' ' 274' ' ' ILE . 18.2 t -61.37 -49.11 85.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.326 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -44.96 -41.83 7.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.961 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -82.53 -30.31 29.83 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -72.34 -7.56 50.23 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.371 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 267' ' ' LYS . 61.2 mt -88.05 -54.7 7.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 72.8 m -51.22 -5.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.6 OUTLIER -79.7 -11.4 59.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.894 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.46 39.11 1.97 Allowed Glycine 0 C--N 1.323 -0.174 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.99 127.89 24.29 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.43 128.01 24.29 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.145 1.897 . . . . 0.0 112.273 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.09 -7.9 20.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.716 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -93.03 -24.41 18.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -78.53 -21.76 48.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.563 0.697 . . . . 0.0 110.587 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.6 HD12 HG13 ' A' ' 261' ' ' VAL . 1.4 pt -102.23 -173.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.865 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 26.3 t -171.61 132.49 0.75 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.484 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.89 153.08 19.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -158.49 144.72 17.1 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.091 0.472 . . . . 0.0 110.804 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.98 97.35 2.06 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.462 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.5 tpt -68.46 -10.68 56.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.907 0.384 . . . . 0.0 110.462 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 45.07 -104.62 0.07 OUTLIER Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.07 70.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.389 . . . . 0.0 110.548 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 14.1 m -88.82 -0.16 57.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.585 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.441 HD22 ' HE2' ' A' ' 239' ' ' TYR . 5.9 p30 -169.5 76.66 0.69 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.675 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.76 111.32 3.26 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.536 2.158 . . . . 0.0 111.798 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 286' ' ' THR . 15.5 m -71.52 -39.46 70.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.86 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.625 ' C ' ' H ' ' A' ' 288' ' ' ASN . 21.1 p -63.68 -48.2 78.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.479 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.71 -0.53 0.03 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.625 ' H ' ' C ' ' A' ' 286' ' ' THR . 65.8 t30 -114.0 -60.17 1.92 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.8 t -79.04 -3.86 47.25 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.569 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.4 OUTLIER -127.32 18.22 7.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.531 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 30.1 p-10 -67.57 -3.08 7.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.378 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -99.89 33.41 2.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.451 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.488 HG21 ' SG ' ' A' ' 290' ' ' CYS . 26.6 t -127.95 122.87 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.889 0.376 . . . . 0.0 110.231 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -119.59 6.5 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.824 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.9 168.39 12.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.057 0.456 . . . . 0.0 110.168 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -80.02 -74.89 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.758 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 300' ' ' ILE . . . -55.92 -26.46 47.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.818 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.89 -34.69 78.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.146 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.2 mt -75.46 -64.71 1.01 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 297' ' ' ALA . 10.9 pt -48.41 -30.24 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.396 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -76.62 -42.66 41.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.567 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 15.3 t -80.45 -10.54 59.74 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.73 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.52 HD23 ' OG1' ' A' ' 286' ' ' THR . 54.2 mt -91.95 21.81 4.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.69 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -76.61 -45.12 3.25 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 121.156 0.503 . . . . 0.0 110.375 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 25.2 Cg_exo -61.81 9.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.233 2.622 . . . . 0.0 111.654 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 304' ' ' ALA . 51.0 t0 -106.49 11.08 31.1 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.623 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -111.25 103.26 11.65 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.349 0.595 . . . . 0.0 110.402 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -172.17 153.48 3.09 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.222 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.662 HG12 ' HA2' ' A' ' 238' ' ' GLY . 34.7 m -116.16 149.69 18.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -120.22 107.77 13.39 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.089 0.471 . . . . 0.0 110.839 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 236' ' ' VAL . 3.5 mm -78.37 117.95 24.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -100.74 111.59 23.84 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.301 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.982 HG21 HD22 ' A' ' 224' ' ' LEU . 86.6 t -119.63 123.65 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 O-C-N 123.66 0.6 . . . . 0.0 110.644 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -119.63 140.54 50.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.777 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 101.39 -0.35 53.63 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.8 tt -85.46 144.29 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.064 0.459 . . . . 0.0 110.485 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 52.0 tptt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.435 179.681 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.712 0.291 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.589 HG22 ' N ' ' A' ' 192' ' ' LYS . 23.6 m -69.52 169.35 12.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.46 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.589 ' N ' HG22 ' A' ' 191' ' ' THR . 3.4 tptm -148.83 166.23 29.13 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.083 0.468 . . . . 0.0 110.083 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.502 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 12.8 m80 -153.5 123.93 7.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.756 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -112.09 115.6 29.15 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.434 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.07 103.14 14.46 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.775 -179.239 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.695 ' CD2' HD11 ' A' ' 201' ' ' LEU . 30.2 tp -108.72 132.93 53.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.413 ' HB3' HG23 ' A' ' 200' ' ' VAL . 0.0 OUTLIER -83.76 126.58 33.05 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.244 -178.232 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.4 m -62.02 -32.35 72.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.332 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.491 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 11.8 m-20 -59.31 -36.52 75.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.81 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 197' ' ' LYS . 94.9 t -68.19 -42.91 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.695 HD11 ' CD2' ' A' ' 196' ' ' LEU . 92.7 mt -78.35 -79.48 0.12 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.244 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.427 ' CD1' ' NH1' ' A' ' 256' ' ' ARG . 0.1 OUTLIER -118.04 122.84 44.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.764 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 8.9 p-10 -91.32 -78.09 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.628 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.503 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 82.5 m-85 -98.0 -14.94 20.29 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.809 0.337 . . . . 0.0 110.659 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -72.61 154.54 40.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.235 0.54 . . . . 0.0 109.718 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.56 ' CG ' ' H ' ' A' ' 207' ' ' ALA . 42.2 pttt -49.8 -59.98 3.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.987 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.56 ' H ' ' CG ' ' A' ' 206' ' ' LYS . . . -168.71 57.18 0.05 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.603 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 64.4 p -107.23 129.92 54.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.7 mt -74.48 146.22 42.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.719 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 213' ' ' GLY . 22.7 mttp -105.87 158.5 32.28 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.946 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -33.85 -76.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.495 2.13 . . . . 0.0 112.231 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -52.62 -18.98 2.03 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.251 0.548 . . . . 0.0 110.16 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.38 -49.37 9.39 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -67.27 -40.8 86.23 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.186 0.517 . . . . 0.0 109.77 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.68 -50.89 71.7 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.589 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.26 86.58 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.635 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.1 mt -62.25 -31.37 71.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -70.17 -45.3 67.0 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.291 0.567 . . . . 0.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -63.06 -42.78 99.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.927 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.432 HD21 HD12 ' A' ' 311' ' ' ILE . 38.8 tp -63.87 -40.28 96.17 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.521 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.508 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.3 t80 -52.65 -47.3 67.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.534 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.7 m -52.27 -51.94 55.64 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.67 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -55.43 -26.4 41.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.469 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.559 ' O ' HD22 ' A' ' 227' ' ' LEU . 67.4 mt -94.01 -23.85 17.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.675 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.1 t -75.79 -32.36 59.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.279 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -91.94 21.37 4.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.7 OUTLIER -77.34 173.46 11.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.199 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -88.35 133.7 36.1 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.457 ' O ' ' C ' ' A' ' 230' ' ' LYS . 55.0 Cg_endo -70.56 -18.22 33.38 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.569 2.179 . . . . 0.0 112.709 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 229' ' ' PRO . 11.1 mmtp -28.03 -49.22 0.06 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.594 0.559 . . . . 0.0 110.498 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 67.5 m-20 -118.51 -14.66 9.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.377 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.79 51.27 0.06 OUTLIER Glycine 0 N--CA 1.47 0.929 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.4 m -114.68 110.7 20.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.668 0.271 . . . . 0.0 110.99 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.32 95.67 3.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.811 0.815 . . . . 0.0 109.692 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.11 117.75 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.642 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.495 HG21 ' CG2' ' A' ' 261' ' ' VAL . 24.5 t -93.14 124.17 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.635 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.7 mt -108.6 137.79 45.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.065 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.613 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -120.52 132.42 9.26 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -116.64 126.52 53.35 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.614 HG23 ' ND2' ' A' ' 249' ' ' ASN . 8.0 t -125.14 162.25 25.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.501 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 55.7 p-10 -77.35 -175.82 3.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.224 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.1 ptm85 -120.01 133.74 55.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.369 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.7 mm -118.42 24.14 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.582 0.706 . . . . 0.0 110.626 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 80.93 14.49 79.42 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.0 m -137.37 98.94 3.83 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.083 0.468 . . . . 0.0 110.005 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -52.23 -50.41 62.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.295 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.38 -45.65 80.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.939 0.4 . . . . 0.0 110.709 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.629 ' CE2' HD11 ' A' ' 252' ' ' LEU . 52.1 t80 -60.23 -41.67 93.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.349 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.614 ' ND2' HG23 ' A' ' 240' ' ' THR . 15.1 t-20 -60.12 -50.73 72.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.623 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -57.0 -41.5 78.59 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.46 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.41 -41.32 98.49 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.629 HD11 ' CE2' ' A' ' 248' ' ' TYR . 35.6 mt -67.31 -41.03 86.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.913 0.387 . . . . 0.0 111.274 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.5 t -61.42 -40.23 93.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.999 0.428 . . . . 0.0 110.889 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.52 -42.18 78.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.232 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -58.6 -46.54 86.79 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.472 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.427 ' NH1' ' CD1' ' A' ' 202' ' ' PHE . 86.6 mtt-85 -63.92 -62.44 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.772 0.32 . . . . 0.0 110.774 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.39 -35.71 19.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 110.168 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -72.32 -45.49 59.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.585 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 13.3 t -59.62 -39.06 83.03 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.243 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.28 -52.83 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.414 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.592 HG13 HD12 ' A' ' 274' ' ' ILE . 5.1 t -61.54 -49.27 85.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.215 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -44.7 -42.78 7.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.14 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.638 ' CZ ' ' NZ ' ' A' ' 267' ' ' LYS . 62.2 t80 -80.41 -28.92 37.73 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.766 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -75.0 -4.53 38.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.102 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.576 ' HA ' HG22 ' A' ' 269' ' ' ILE . 55.3 mt -86.23 -52.94 11.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.7 p -54.47 -1.83 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.576 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.638 ' NZ ' ' CZ ' ' A' ' 263' ' ' TYR . 9.7 mptt -87.53 2.56 50.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.704 0.288 . . . . 0.0 110.703 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 89.81 38.31 6.56 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 265' ' ' ILE . 1.2 tp -119.16 120.29 31.23 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -49.09 128.03 18.65 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.173 1.249 . . . . 0.0 112.116 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.04 -16.23 50.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.114 0.483 . . . . 0.0 111.034 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 4.4 m-20 -85.25 -22.62 28.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.077 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -23.5 38.99 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.209 0.528 . . . . 0.0 110.545 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.592 HD12 HG13 ' A' ' 261' ' ' VAL . 1.5 pt -101.98 -174.84 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.985 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 34.8 m -168.96 127.33 1.02 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.224 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.17 110.52 23.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 110.413 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.546 ' NH1' ' SD ' ' A' ' 279' ' ' MET . 73.8 ttt-85 -115.29 139.74 49.71 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.433 0.635 . . . . 0.0 110.985 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.96 95.18 2.06 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.546 ' SD ' ' NH1' ' A' ' 277' ' ' ARG . 3.8 tpt -69.81 -10.63 59.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.665 0.269 . . . . 0.0 110.598 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLY . . . . . 0.408 ' HA2' HG22 ' A' ' 240' ' ' THR . . . 41.75 -102.36 0.03 OUTLIER Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -141.65 75.58 1.5 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.784 0.326 . . . . 0.0 110.813 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 18.0 m -87.04 0.16 55.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.741 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -168.16 75.88 0.87 Allowed Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.47 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -60.82 104.14 0.26 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.554 2.17 . . . . 0.0 112.529 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 286' ' ' THR . 28.4 m -69.1 -44.44 81.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.306 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 302' ' ' CYS . 7.6 p -62.49 -46.21 89.48 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.09 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.93 -1.83 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 286' ' ' THR . 28.3 m120 -115.57 -59.36 2.01 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.1 t -80.88 -3.41 51.19 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.71 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.59 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.6 OUTLIER -127.61 16.89 6.97 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.343 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 31.6 p-10 -68.0 -3.06 8.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.986 0.422 . . . . 0.0 110.592 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -100.23 32.45 2.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.706 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.59 HG21 ' SG ' ' A' ' 290' ' ' CYS . 15.6 t -130.78 125.65 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.027 0.442 . . . . 0.0 110.304 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.92 10.64 12.31 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.12 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -104.06 136.28 43.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.099 0.475 . . . . 0.0 110.242 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 297' ' ' ALA . 0.1 OUTLIER -61.53 -46.37 90.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.941 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 296' ' ' ARG . . . -62.68 -46.06 89.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.107 0.48 . . . . 0.0 111.183 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.98 -29.83 70.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.789 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 39.5 mt -78.17 -53.42 7.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.961 0.41 . . . . 0.0 110.535 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 40.0 mt -51.08 -34.81 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.922 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.9 -43.1 22.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.07 0.462 . . . . 0.0 110.315 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.608 ' O ' HG21 ' A' ' 286' ' ' THR . 38.9 t -73.93 -13.56 60.91 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.775 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 299' ' ' LEU . 53.5 mt -90.45 23.16 3.08 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.291 0.369 . . . . 0.0 111.07 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -77.39 -44.35 2.62 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.457 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.8 Cg_exo -62.47 9.35 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.416 2.744 . . . . 0.0 111.807 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 304' ' ' ALA . 0.4 OUTLIER -104.28 10.32 35.61 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.71 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.491 ' NH1' ' OD1' ' A' ' 199' ' ' ASP . 39.2 mtm105 -113.96 94.81 5.0 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.494 0.664 . . . . 0.0 110.195 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.452 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.3 ptm180 -164.08 139.15 5.95 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.136 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.613 HG12 ' HA2' ' A' ' 238' ' ' GLY . 22.6 m -104.69 144.57 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 121.831 -0.543 . . . . 0.0 109.666 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -121.45 106.26 11.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.342 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.452 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.38 118.21 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.796 -177.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 312' ' ' GLU . 0.1 OUTLIER -96.43 135.62 38.05 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.403 HG21 ' CD2' ' A' ' 224' ' ' LEU . 2.2 t -133.38 120.22 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.236 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -117.29 132.34 56.63 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.6 -13.85 50.44 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 20.1 tt -75.38 154.12 6.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.827 0.346 . . . . 0.0 110.487 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.2 pttt . . . . . 0 N--CA 1.464 0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.474 179.715 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.131 0.491 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.424 HG22 ' NE2' ' A' ' 193' ' ' HIS . 12.1 m -73.18 141.24 47.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.274 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -143.46 111.21 5.98 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.4 m-70 -101.39 150.45 23.0 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.434 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 59.6 m-85 -111.28 118.67 36.52 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 195' ' ' THR . 6.9 t -85.26 102.46 13.37 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.837 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.769 HD23 HD11 ' A' ' 201' ' ' LEU . 31.0 tp -105.34 137.26 43.42 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.437 0.637 . . . . 0.0 109.955 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.444 ' H ' ' HG2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -90.06 130.38 36.24 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-O 122.564 1.174 . . . . 0.0 112.021 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 202' ' ' PHE . 7.3 t -60.24 -24.74 65.11 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.255 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -58.31 -43.71 88.28 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.955 0.407 . . . . 0.0 110.423 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.85 -42.7 92.67 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.637 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.769 HD11 HD23 ' A' ' 196' ' ' LEU . 84.9 mt -80.78 -78.36 0.18 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.391 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.47 ' O ' ' OG ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -128.43 102.73 6.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.98 -178.618 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.494 ' OD1' ' CD2' ' A' ' 204' ' ' PHE . 14.3 t-20 -67.4 -70.38 0.26 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.205 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.494 ' CD2' ' OD1' ' A' ' 203' ' ' ASN . 59.7 m-85 -108.51 -10.96 15.2 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.733 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -69.84 161.56 29.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.038 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -55.9 -75.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.415 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.59 49.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 41.6 p -107.33 128.02 54.08 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.819 0.342 . . . . 0.0 110.193 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.47 HD22 HD22 ' A' ' 201' ' ' LEU . 30.5 mt -73.32 129.57 38.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.147 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 213' ' ' GLY . 58.5 mttt -91.6 159.92 37.65 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.696 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 210' ' ' LYS . 71.0 Cg_exo -33.12 -76.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.463 2.109 . . . . 0.0 111.549 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -49.57 -21.97 1.14 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.185 0.517 . . . . 0.0 110.31 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.27 -48.88 22.99 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.23 -38.91 91.89 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.91 63.23 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.225 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.33 -30.42 71.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.533 0.682 . . . . 0.0 110.237 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.24 -28.37 65.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.301 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -76.4 -48.54 19.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.32 0.581 . . . . 0.0 111.319 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.432 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 17.6 pt20 -64.02 -42.43 97.12 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.498 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.484 HD21 HD12 ' A' ' 311' ' ' ILE . 45.0 tp -63.96 -42.16 97.36 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.452 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.4 t80 -51.4 -50.57 59.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.46 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.6 p -56.96 -50.31 73.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.456 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.434 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 59.3 tt0 -50.65 -25.82 4.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.506 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.686 HD22 HG21 ' A' ' 313' ' ' VAL . 39.0 mt -97.42 -15.27 20.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 53.4 p -79.76 -10.31 59.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.49 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -107.82 18.77 20.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.499 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.23 173.14 12.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.15 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 6.5 t70 -88.66 132.1 39.71 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 230' ' ' LYS . 57.1 Cg_endo -72.05 -18.8 27.18 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.718 2.279 . . . . 0.0 112.643 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 229' ' ' PRO . 61.9 tttm -32.63 -52.07 0.3 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.635 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 232' ' ' GLY . 85.8 m-20 -104.69 -17.94 14.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.579 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 27.41 50.19 0.07 OUTLIER Glycine 0 N--CA 1.474 1.215 0 O-C-N 123.917 0.761 . . . . 0.0 111.333 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 16.7 m -115.97 108.07 15.78 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 122.586 -0.361 . . . . 0.0 110.927 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 74.2 t -124.82 93.61 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.939 0.876 . . . . 0.0 109.926 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.405 HG11 ' NH2' ' A' ' 277' ' ' ARG . 66.5 t -97.7 120.89 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.456 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.572 HG22 HG23 ' A' ' 311' ' ' ILE . 48.6 t -93.36 124.48 45.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.522 HD21 ' NE ' ' A' ' 277' ' ' ARG . 28.8 mt -108.05 139.72 42.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.861 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -121.57 130.01 7.94 Favored Glycine 0 N--CA 1.477 1.38 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.12 119.47 36.51 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.637 HG22 ' N ' ' A' ' 241' ' ' ASP . 98.4 m -109.6 170.45 8.06 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.37 0.419 . . . . 0.0 110.462 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.637 ' N ' HG22 ' A' ' 240' ' ' THR . 26.1 p-10 -83.07 -176.08 6.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.448 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 281' ' ' GLU . 62.4 ttm-85 -105.23 121.96 44.94 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.813 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 243' ' ' ILE . 46.3 mm -119.43 7.44 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.565 0.698 . . . . 0.0 110.813 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 85.62 -47.21 3.77 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.66 91.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 0.0 109.685 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -45.91 -48.23 16.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.41 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.4 82.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.878 0.37 . . . . 0.0 110.61 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.615 ' CE2' HD11 ' A' ' 252' ' ' LEU . 51.7 t80 -62.06 -45.24 94.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.525 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 241' ' ' ASP . 33.2 t30 -61.49 -43.87 98.09 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.652 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -64.76 -41.25 96.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.634 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.49 -36.78 93.65 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.615 HD11 ' CE2' ' A' ' 248' ' ' TYR . 30.5 mt -70.06 -41.17 74.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.915 0.388 . . . . 0.0 111.013 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 78.1 p -65.13 -39.61 93.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.818 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.3 -47.1 71.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.92 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -59.43 -43.84 93.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.799 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 239' ' ' TYR . 39.1 ttm180 -54.1 -61.41 2.32 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.329 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -58.7 -27.57 64.98 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.638 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -69.78 -47.31 63.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.374 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 38.5 m -62.17 -37.93 87.12 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.069 0.461 . . . . 0.0 110.393 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 256' ' ' ARG . 77.4 t -63.65 -53.21 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.723 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.533 HG13 HD12 ' A' ' 274' ' ' ILE . 18.0 t -62.02 -48.77 86.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.669 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -45.16 -41.71 8.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.228 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.638 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 57.7 t80 -82.86 -28.9 29.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.764 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.01 -8.05 54.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.437 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.9 mt -88.44 -55.75 6.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.789 0.328 . . . . 0.0 111.619 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 41.6 m -50.61 -4.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.974 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.638 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 33.4 mmtm -77.48 -10.55 59.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.743 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.74 -7.44 22.09 Favored Glycine 0 C--O 1.227 -0.283 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.06 141.72 47.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.404 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.48 132.28 30.68 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.268 1.979 . . . . 0.0 111.826 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.04 -4.1 19.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.517 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -94.15 -26.24 16.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.451 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -79.55 -17.38 54.13 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.237 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.533 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -104.24 -171.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.695 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 39.4 m -168.68 130.51 1.29 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.311 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.88 111.16 23.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.882 0.372 . . . . 0.0 110.627 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.522 ' NE ' HD21 ' A' ' 237' ' ' LEU . 41.4 ttp180 -123.13 148.74 45.38 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.152 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.63 148.83 16.49 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.545 ' N ' ' O ' ' A' ' 238' ' ' GLY . 83.9 mmm -121.99 15.98 10.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 119.335 -0.365 . . . . 0.0 111.554 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 23.32 -88.46 0.01 OUTLIER Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 279' ' ' MET . 0.6 OUTLIER -142.72 74.25 1.44 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.096 0.474 . . . . 0.0 110.738 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.4 t -72.22 -54.05 10.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.836 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -137.77 74.06 45.92 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.779 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.02 120.39 8.22 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.652 2.235 . . . . 0.0 112.26 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.4 m -75.91 -23.91 16.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.279 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.615 ' C ' ' H ' ' A' ' 288' ' ' ASN . 31.2 p -58.41 -44.9 89.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.612 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.21 -4.29 0.02 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.615 ' H ' ' C ' ' A' ' 286' ' ' THR . 82.1 m-20 -126.13 -58.25 1.37 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.0 m -60.52 -22.86 64.06 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.55 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 63.5 m -121.07 27.79 8.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.47 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 29.4 p-10 -68.42 -2.85 9.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.664 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -111.49 31.98 5.73 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.494 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.405 ' O ' HD21 ' A' ' 299' ' ' LEU . 15.5 t -137.86 117.67 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.865 0.364 . . . . 0.0 110.755 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -120.72 14.0 11.66 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.698 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.442 ' O ' HD12 ' A' ' 299' ' ' LEU . 1.5 mp0 -89.6 174.52 7.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.122 0.487 . . . . 0.0 109.849 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -81.01 -75.7 0.27 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -59.1 -27.52 65.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.984 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.87 95.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.481 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 303' ' ' LEU . 60.1 mt -69.36 -50.41 46.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.05 0.452 . . . . 0.0 110.646 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 62.7 mt -53.53 -34.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.006 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -78.34 -35.19 47.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.443 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 0.8 OUTLIER -85.57 -10.59 55.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.539 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.571 ' HA ' HG21 ' A' ' 286' ' ' THR . 47.8 mt -91.55 23.77 3.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.515 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.583 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -85.12 -44.64 0.66 Allowed Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.5 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 33.1 Cg_exo -59.12 7.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.56 2.84 . . . . 0.0 112.232 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 304' ' ' ALA . 35.9 p30 -107.04 18.15 22.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.708 0.289 . . . . 0.0 110.796 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -113.21 98.58 7.22 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.514 0.673 . . . . 0.0 109.881 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 38.0 ptt180 -159.85 133.58 7.2 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.147 -0.621 . . . . 0.0 112.016 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.14 141.37 15.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -122.81 104.28 9.18 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.257 0.551 . . . . 0.0 110.313 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.572 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.87 117.47 25.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -93.35 123.05 36.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 123.12 0.263 . . . . 0.0 110.624 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.686 HG21 HD22 ' A' ' 224' ' ' LEU . 14.6 t -123.12 115.79 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.318 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -115.53 129.11 56.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 105.9 12.04 26.88 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 15.4 tt -93.71 137.34 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.226 0.536 . . . . 0.0 110.672 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.709 179.939 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.99 0.424 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.456 HG22 ' NE2' ' A' ' 193' ' ' HIS . 24.1 m -67.38 125.24 25.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.411 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 313' ' ' VAL . 41.6 tptt -117.1 162.14 18.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.205 0.526 . . . . 0.0 111.04 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.456 ' NE2' HG22 ' A' ' 191' ' ' THR . 87.2 m-70 -149.27 123.16 9.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.112 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.487 ' CE2' HD21 ' A' ' 224' ' ' LEU . 65.2 m-85 -114.82 118.92 34.89 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.469 ' OG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -86.36 108.03 18.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.639 -179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.713 ' CD2' HD11 ' A' ' 201' ' ' LEU . 27.0 tp -109.4 125.35 52.3 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -83.17 129.9 35.06 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 122.192 0.996 . . . . 0.0 112.602 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 202' ' ' PHE . 93.6 p -60.35 -27.87 67.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.834 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 203' ' ' ASN . 14.1 t70 -54.28 -40.56 67.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.03 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.5 t -72.74 -33.44 44.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.713 HD11 ' CD2' ' A' ' 196' ' ' LEU . 79.2 mt -89.43 -79.54 0.33 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.51 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -127.86 116.27 19.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.745 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.43 ' OD1' ' OD1' ' A' ' 199' ' ' ASP . 3.1 m-80 -82.26 -64.59 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.772 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -116.73 -17.52 10.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.77 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -66.16 164.92 14.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.058 0.456 . . . . 0.0 110.194 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -50.85 -80.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.507 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.49 53.0 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.214 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 42.5 p -107.24 134.38 50.41 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.168 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.403 HD22 HD22 ' A' ' 201' ' ' LEU . 18.1 mt -78.17 127.3 32.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.284 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' GLY . 8.0 ptmt -85.01 161.87 51.31 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.717 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -36.89 -75.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.075 1.85 . . . . 0.0 111.553 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -50.54 -19.89 1.02 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.017 0.437 . . . . 0.0 109.963 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.84 -52.08 13.09 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.6 -38.89 90.75 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.158 0.504 . . . . 0.0 109.903 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.53 57.13 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.85 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.81 88.76 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.763 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.2 mt -62.27 -29.08 70.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.519 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -72.34 -45.94 57.69 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.379 0.609 . . . . 0.0 110.486 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -62.14 -42.95 99.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.081 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.45 -39.63 92.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.586 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 225' ' ' SER . 7.1 t80 -52.87 -46.73 68.03 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.46 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.4 m -55.1 -51.32 66.79 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.684 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 223' ' ' GLN . 4.2 mp0 -55.86 -27.02 49.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.582 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.995 HD22 HG21 ' A' ' 313' ' ' VAL . 78.0 mt -95.95 -21.18 18.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.769 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 221' ' ' TYR . 9.2 p -84.7 -13.43 51.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.476 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -106.4 23.6 13.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.157 0.503 . . . . 0.0 110.654 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.58 -179.31 5.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.687 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -101.41 109.11 58.05 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 232' ' ' GLY . 73.9 Cg_exo -44.45 -19.22 0.23 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.829 2.353 . . . . 0.0 112.964 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 229' ' ' PRO . 3.4 ttmp? -24.51 -47.57 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.691 0.619 . . . . 0.0 110.775 -178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 97.6 m-20 -116.49 -11.95 11.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.648 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 24.9 47.76 0.02 OUTLIER Glycine 0 N--CA 1.47 0.963 0 O-C-N 123.587 0.554 . . . . 0.0 111.841 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 231' ' ' ASP . 2.3 m -118.36 117.48 29.19 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 122.588 -0.36 . . . . 0.0 110.171 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.618 HG22 HG22 ' A' ' 313' ' ' VAL . 59.6 t -132.21 95.71 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.57 0.7 . . . . 0.0 110.675 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.3 125.18 51.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.283 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.86 129.83 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.428 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.0 mt -114.02 140.0 48.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.684 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -115.42 141.04 16.72 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.5 OUTLIER -121.55 123.93 43.16 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 249' ' ' ASN . 2.1 p -118.5 161.77 19.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.106 0.479 . . . . 0.0 110.076 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.526 ' OD2' ' NE ' ' A' ' 307' ' ' ARG . 8.5 p30 -84.05 174.91 9.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.337 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -97.31 122.28 40.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.226 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.0 mm -117.15 14.97 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.363 0.601 . . . . 0.0 110.65 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.2 4.51 88.95 Favored Glycine 0 C--N 1.314 -0.688 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 24.8 m -130.07 102.19 6.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 110.235 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -52.31 -51.96 55.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.679 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.9 -42.52 76.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.726 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.569 ' CE2' HD11 ' A' ' 252' ' ' LEU . 33.9 t80 -60.4 -46.08 91.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.552 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.439 ' O ' ' OG ' ' A' ' 253' ' ' SER . 14.5 t-20 -62.92 -46.09 89.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.829 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -63.01 -42.48 99.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.719 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.54 -38.16 95.91 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.569 HD11 ' CE2' ' A' ' 248' ' ' TYR . 28.1 mt -73.71 -34.37 64.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.676 0.274 . . . . 0.0 111.084 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 249' ' ' ASN . 4.4 m -65.26 -44.37 88.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.025 0.44 . . . . 0.0 110.629 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -68.26 -43.67 77.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.084 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -58.59 -47.14 85.3 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.914 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.611 ' O ' HG23 ' A' ' 260' ' ' VAL . 99.5 mtt180 -62.68 -55.0 30.88 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.392 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.49 -33.76 68.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.193 0.521 . . . . 0.0 109.942 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -74.71 -45.89 41.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.283 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 43.0 t -60.06 -39.85 87.45 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 256' ' ' ARG . 86.2 t -64.23 -52.5 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.461 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.619 HG13 HD12 ' A' ' 274' ' ' ILE . 10.6 t -61.15 -49.48 84.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.172 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -44.9 -41.45 7.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.895 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.25 -29.7 31.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.568 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.405 ' O ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -72.8 -7.73 52.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.268 -179.447 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.559 ' C ' ' H ' ' A' ' 267' ' ' LYS . 59.7 mt -87.81 -57.15 4.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.845 0.355 . . . . 0.0 111.472 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 p -49.95 -6.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.974 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 265' ' ' ILE . 4.8 mmtm -78.84 -10.6 59.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.092 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 108.8 37.42 2.04 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.04 128.21 24.21 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.75 130.43 37.12 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.892 1.728 . . . . 0.0 112.062 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.85 -9.27 35.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.001 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 52.0 t0 -92.79 -22.93 19.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.779 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.404 ' HZ2' ' HB3' ' A' ' 273' ' ' LYS . 1.0 OUTLIER -79.49 -21.17 45.7 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.714 0.769 . . . . 0.0 110.548 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.619 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -103.18 -171.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.051 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 1.3 m -166.8 130.23 1.9 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.153 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -105.02 112.79 26.05 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.633 0.254 . . . . 0.0 110.642 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -122.54 147.21 46.65 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.509 0.671 . . . . 0.0 110.517 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.77 99.09 2.25 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.4 tpt -67.99 -11.44 58.88 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.445 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.54 -95.53 0.01 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 279' ' ' MET . 97.8 mt-10 -141.41 75.68 1.51 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 110.8 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.1 p -87.76 -4.9 58.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -172.96 78.93 0.42 Allowed Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.756 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.29 104.62 0.43 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.539 2.159 . . . . 0.0 112.305 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 286' ' ' THR . 17.5 m -70.59 -40.39 77.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.268 0.556 . . . . 0.0 110.193 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.603 ' C ' ' H ' ' A' ' 288' ' ' ASN . 17.7 p -64.81 -47.44 78.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.099 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.65 -1.68 0.04 OUTLIER Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.5 t-20 -112.31 -59.83 1.95 Allowed 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.91 -4.18 55.97 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.382 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.636 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.7 OUTLIER -126.59 16.64 7.56 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.38 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.62 -3.1 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.382 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -101.95 32.37 3.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.636 HG21 ' SG ' ' A' ' 290' ' ' CYS . 21.8 t -129.36 121.43 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.02 0.438 . . . . 0.0 110.143 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -118.88 8.51 11.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.67 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.431 ' O ' HD12 ' A' ' 299' ' ' LEU . 3.2 mp0 -90.71 169.45 10.96 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 110.04 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -82.65 -78.24 0.21 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.636 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -50.7 -29.97 12.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.97 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.99 99.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.244 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.7 mt -68.93 -42.46 76.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.542 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.4 mm -59.48 -34.13 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.015 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.18 -25.41 31.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.412 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.556 ' O ' HG21 ' A' ' 286' ' ' THR . 11.3 t -94.34 -15.19 24.62 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.962 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 299' ' ' LEU . 54.1 mt -91.88 22.72 4.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.717 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.567 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -75.81 -44.86 4.04 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.316 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 22.2 Cg_exo -64.15 8.7 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.434 2.756 . . . . 0.0 111.817 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 304' ' ' ALA . 7.4 t70 -108.41 7.31 26.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.696 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.526 ' NE ' ' OD2' ' A' ' 241' ' ' ASP . 93.1 mtt180 -109.62 100.54 9.56 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.151 0.5 . . . . 0.0 110.086 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.469 ' NH2' ' OG1' ' A' ' 195' ' ' THR . 16.9 ptm180 -173.43 166.62 4.72 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.888 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.684 HG12 ' HA2' ' A' ' 238' ' ' GLY . 34.2 m -126.8 151.06 33.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -120.92 108.37 13.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.178 0.513 . . . . 0.0 110.251 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.4 mm -80.02 119.49 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.767 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -104.33 114.88 29.42 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.02 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.995 HG21 HD22 ' A' ' 224' ' ' LEU . 70.4 t -127.81 123.18 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.658 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -118.98 148.14 43.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.009 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.43 25.03 31.85 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.645 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.2 tt -103.17 177.3 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.645 ' O ' ' O ' ' A' ' 316' ' ' ILE . 14.2 mptt . . . . . 0 CA--C 1.533 0.322 0 O-C-N 124.124 0.89 . . . . 0.0 110.763 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 120.949 0.404 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m -70.64 145.99 50.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.209 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.435 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 10.6 tptp -146.33 165.03 30.52 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.225 0.536 . . . . 0.0 110.326 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.435 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 89.2 m-70 -152.83 126.47 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.216 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.461 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 70.1 m-85 -114.84 124.67 52.33 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.538 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -87.52 108.97 19.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.859 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.708 ' CD2' HD11 ' A' ' 201' ' ' LEU . 27.5 tp -110.96 126.99 55.34 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -78.59 129.5 34.85 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.735 0.778 . . . . 0.0 111.932 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.486 ' H ' ' HA ' ' A' ' 308' ' ' ARG . 58.2 m -69.11 -30.86 69.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.404 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.461 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 2.4 p-10 -62.39 -33.81 75.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.657 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.48 -34.97 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.708 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.6 mt -85.62 -81.82 0.2 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.804 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -112.54 132.44 55.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.047 -179.292 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 199' ' ' ASP . 66.5 m-80 -111.65 -81.06 0.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.805 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -83.6 -37.61 22.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -64.43 162.29 15.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.056 0.455 . . . . 0.0 110.504 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -52.24 -66.94 0.3 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.583 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.49 61.14 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.471 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 75.3 p -107.44 134.12 50.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.138 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.66 145.08 45.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 213' ' ' GLY . 13.4 mmmt -104.1 153.11 39.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.017 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 210' ' ' LYS . 86.4 Cg_exo -32.34 -77.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.545 2.163 . . . . 0.0 112.265 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -51.22 -18.81 1.0 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.353 0.597 . . . . 0.0 110.376 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.9 -49.83 8.39 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.052 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -65.98 -41.93 90.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.079 0.466 . . . . 0.0 110.142 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.6 -49.6 75.88 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.399 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.81 92.55 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.486 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.01 -31.31 71.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.311 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.47 -46.32 66.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 0.0 110.852 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -62.71 -41.73 99.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.065 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 50.9 tp -66.02 -39.43 90.22 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.475 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.5 t80 -54.82 -47.99 73.38 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.168 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.1 t -57.6 -51.18 70.54 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.41 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.461 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 58.5 tt0 -53.45 -25.0 14.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.689 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.902 HD22 HG21 ' A' ' 313' ' ' VAL . 68.2 mt -100.29 -22.1 15.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 221' ' ' TYR . 7.5 t -67.87 -17.65 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 58.1 t-20 -111.83 29.46 7.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 227' ' ' LEU . 1.1 pt? -78.94 141.69 37.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 109.987 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 315' ' ' GLY . 38.6 t0 -50.66 107.38 0.8 Allowed Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 232' ' ' GLY . 47.9 Cg_exo -54.3 -19.22 16.28 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.219 1.946 . . . . 0.0 113.018 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.494 ' C ' ' O ' ' A' ' 229' ' ' PRO . 38.1 ttmt -21.42 -50.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.539 0.525 . . . . 0.0 111.376 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 232' ' ' GLY . 2.6 m-20 -115.87 -8.09 11.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.96 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.09 54.77 0.16 Allowed Glycine 0 N--CA 1.473 1.119 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.648 ' H ' ' HD2' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -123.24 116.7 23.81 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 121.294 0.569 . . . . 0.0 110.847 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 79.1 t -131.28 101.33 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.652 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.41 123.04 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.018 0.437 . . . . 0.0 110.59 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.541 HG13 HD13 ' A' ' 311' ' ' ILE . 87.2 t -94.73 127.67 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.244 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 28.3 mt -110.23 145.95 36.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.014 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -111.14 136.47 13.62 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.488 ' CZ ' ' CD ' ' A' ' 310' ' ' GLU . 6.7 m-85 -122.12 115.95 23.36 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 17.5 p -112.72 165.8 11.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.933 0.397 . . . . 0.0 110.692 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -88.43 -177.36 5.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.323 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -97.44 122.18 40.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.33 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.9 mm -118.6 13.42 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.187 0.518 . . . . 0.0 110.689 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.14 1.56 80.52 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.3 p -129.05 104.45 7.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.173 0.511 . . . . 0.0 109.964 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -55.23 -53.13 59.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.358 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.96 -46.29 78.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.59 ' CE2' HD11 ' A' ' 252' ' ' LEU . 62.8 t80 -60.23 -44.98 94.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.62 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.682 HD21 ' H ' ' A' ' 243' ' ' ILE . 77.2 m-20 -61.43 -45.3 94.87 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.35 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -66.29 -37.69 86.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.551 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.11 -40.45 98.55 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.59 HD11 ' CE2' ' A' ' 248' ' ' TYR . 85.4 mt -73.95 -29.92 62.26 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.695 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 14.9 m -66.81 -47.53 71.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.937 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.84 -41.39 78.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.325 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.16 -49.44 77.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.026 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -60.85 -58.6 7.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.495 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.98 -35.69 25.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.068 0.461 . . . . 0.0 109.902 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -71.57 -45.06 63.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.325 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 57.3 m -60.53 -39.47 87.96 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.446 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.69 -51.04 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.406 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.595 HG13 HD12 ' A' ' 274' ' ' ILE . 28.8 t -60.28 -49.7 83.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.152 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -44.63 -41.99 7.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.18 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.558 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 76.8 t80 -81.3 -29.16 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.037 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.93 -5.84 48.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.654 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 267' ' ' LYS . 53.0 mt -88.73 -60.3 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.917 0.389 . . . . 0.0 111.953 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 29.5 t -49.81 -4.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.391 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' A' ' 265' ' ' ILE . 70.7 mmtt -75.76 -10.79 59.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.442 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 116.76 -8.47 16.9 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -83.35 129.34 60.87 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.425 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.28 134.36 56.51 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.641 1.56 . . . . 0.0 111.896 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.61 55.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -92.61 -21.15 20.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.055 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -77.86 -22.97 49.06 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.611 0.719 . . . . 0.0 110.593 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.595 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -101.51 -170.94 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.771 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 15.2 t -170.08 130.18 0.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.102 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.41 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -96.29 153.3 17.89 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.942 -0.473 . . . . 0.0 109.756 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -161.48 149.4 15.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.023 0.44 . . . . 0.0 110.72 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.51 96.78 1.1 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 15.6 tpp -69.86 -13.15 62.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.509 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 57.79 -101.42 0.18 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.66 71.04 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.822 0.344 . . . . 0.0 110.779 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 25.2 t -90.78 -1.55 57.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.662 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -157.73 68.66 4.0 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.317 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.27 105.41 2.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.188 1.925 . . . . 0.0 112.301 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 30.2 m -75.54 -25.7 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.597 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.617 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.0 OUTLIER -58.64 -44.47 90.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.912 -179.31 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.5 -3.08 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.617 ' H ' ' C ' ' A' ' 286' ' ' THR . 94.8 m-20 -122.62 -57.82 1.71 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 m -63.89 -21.31 66.4 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.698 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 55.9 m -122.18 26.0 8.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.281 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 47.5 t0 -70.71 -6.04 34.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.594 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -110.11 30.55 6.63 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.572 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 15.1 t -133.39 120.04 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.462 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -120.27 8.93 10.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.473 ' O ' HD12 ' A' ' 299' ' ' LEU . 3.0 mt-30 -86.17 171.96 10.91 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -80.91 -73.85 0.35 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.755 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -59.25 -26.86 65.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.21 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.55 84.65 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.8 mt -72.21 -47.68 48.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.744 0.307 . . . . 0.0 110.744 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.21 -31.27 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.081 0.467 . . . . 0.0 109.876 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -80.58 -29.65 36.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.68 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.6 t -93.31 -10.72 34.44 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 299' ' ' LEU . 49.8 mt -92.23 19.95 6.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.727 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.608 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -74.07 -41.85 5.46 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.4 Cg_exo -62.71 9.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.408 2.739 . . . . 0.0 112.314 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 304' ' ' ALA . 38.8 t0 -112.54 7.37 18.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.884 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 64.6 mtp180 -104.43 100.43 10.13 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.021 0.439 . . . . 0.0 110.05 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.486 ' HA ' ' H ' ' A' ' 198' ' ' SER . 39.2 ptt180 -171.32 -171.14 0.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.287 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.47 155.85 14.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.488 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 96.2 mt-10 -122.8 102.74 8.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.25 0.547 . . . . 0.0 110.395 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.541 HD13 HG13 ' A' ' 236' ' ' VAL . 3.6 mm -79.18 120.81 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.711 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -101.93 121.31 41.89 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.568 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.902 HG21 HD22 ' A' ' 224' ' ' LEU . 70.4 t -130.04 123.4 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.928 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.648 ' HD2' ' H ' ' A' ' 233' ' ' SER . 0.0 OUTLIER -95.25 -174.21 3.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.935 178.365 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.565 ' CA ' ' HZ3' ' A' ' 314' ' ' LYS . . . 16.69 69.21 0.01 OUTLIER Glycine 0 N--CA 1.472 1.047 0 O-C-N 123.677 0.611 . . . . 0.0 112.386 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 317' ' ' LYS . 4.1 tt -115.18 160.06 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.46 ' H ' HG13 ' A' ' 316' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 122.239 1.018 . . . . 0.0 111.226 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.41 ' CG2' ' CE1' ' A' ' 193' ' ' HIS . 29.0 m -87.79 141.17 28.81 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.045 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -133.86 97.4 3.89 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.392 0.615 . . . . 0.0 111.725 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.41 ' CE1' ' CG2' ' A' ' 191' ' ' THR . 8.7 m80 -84.71 135.75 34.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.106 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.472 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 62.0 m-85 -111.04 124.32 51.94 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.876 0.37 . . . . 0.0 110.103 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.6 102.44 14.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.166 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.692 ' CD2' HD11 ' A' ' 201' ' ' LEU . 32.0 tp -104.54 125.66 50.9 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.301 0.572 . . . . 0.0 109.727 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.406 ' HG3' ' H ' ' A' ' 199' ' ' ASP . 39.8 tptt -79.15 128.66 33.57 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-O 122.349 1.071 . . . . 0.0 112.177 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 202' ' ' PHE . 94.5 p -61.25 -30.6 70.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.289 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.406 ' H ' ' HG3' ' A' ' 197' ' ' LYS . 95.8 m-20 -58.56 -37.79 76.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.05 -43.79 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 196' ' ' LEU . 90.4 mt -78.63 -78.25 0.15 Allowed 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.921 -0.711 . . . . 0.0 110.583 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -128.48 130.38 47.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.147 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -96.3 -70.92 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.472 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.493 ' CE1' ' ND2' ' A' ' 205' ' ' ASN . 24.4 p90 -106.31 -13.86 15.27 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.932 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.493 ' ND2' ' CE1' ' A' ' 204' ' ' PHE . 8.8 m120 -71.59 168.09 18.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.059 0.457 . . . . 0.0 110.199 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.631 ' NZ ' ' NH1' ' A' ' 255' ' ' ARG . 19.7 tptm -57.64 -69.94 0.15 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.483 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -163.12 -0.11 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.411 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 14.4 t -52.92 134.83 37.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.995 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.9 139.59 34.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.072 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 213' ' ' GLY . 28.4 mttp -98.34 158.32 32.86 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.822 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -34.47 -75.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.43 2.087 . . . . 0.0 111.831 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -51.21 -21.05 1.82 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.177 0.513 . . . . 0.0 110.243 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.59 -51.41 12.11 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.305 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -67.1 -39.1 86.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.322 0.582 . . . . 0.0 110.072 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.61 -53.79 53.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.757 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.52 87.64 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.699 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 mt -61.36 -28.21 69.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.311 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -74.83 -45.45 43.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.456 0.646 . . . . 0.0 110.53 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -61.51 -42.68 99.17 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.849 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 57.3 tp -65.58 -39.15 91.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.523 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.9 t80 -52.6 -50.1 63.74 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.228 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.4 t -53.87 -51.68 62.88 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.414 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.472 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 55.2 tt0 -52.76 -25.93 12.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.149 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.982 HD22 HG21 ' A' ' 313' ' ' VAL . 22.5 mt -99.13 -18.95 17.44 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.419 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 221' ' ' TYR . 1.7 m -73.36 -31.67 64.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.065 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -91.54 23.15 3.61 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.949 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.566 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -79.24 158.55 27.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.28 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 315' ' ' GLY . 10.0 t0 -76.43 128.93 81.24 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.304 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 230' ' ' LYS . 42.8 Cg_endo -68.36 -18.66 44.21 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.919 2.412 . . . . 0.0 112.813 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 229' ' ' PRO . 65.3 tttm -32.63 -47.31 0.16 Allowed 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 123.508 0.505 . . . . 0.0 110.468 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 232' ' ' GLY . 21.8 m-20 -108.55 -18.84 13.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.886 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.15 47.99 0.03 OUTLIER Glycine 0 N--CA 1.474 1.23 0 O-C-N 123.902 0.751 . . . . 0.0 111.234 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 231' ' ' ASP . 18.0 m -115.36 110.84 19.95 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.7 t -127.03 94.25 2.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.664 0.745 . . . . 0.0 110.074 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 16.0 t -98.72 122.74 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.642 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.505 HG13 HD13 ' A' ' 311' ' ' ILE . 89.2 t -96.87 123.24 49.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.667 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.5 mt -106.35 143.62 34.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.027 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -118.33 135.94 11.92 Favored Glycine 0 N--CA 1.478 1.441 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.334 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.629 ' CE2' ' SD ' ' A' ' 279' ' ' MET . 0.1 OUTLIER -121.2 116.84 25.68 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.531 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.2 t -108.09 167.95 9.64 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -90.85 -179.27 5.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.271 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -95.88 123.15 39.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.375 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.9 mm -118.12 9.18 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.418 0.628 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 81.86 4.39 90.32 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.7 t -134.04 98.75 4.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.078 0.466 . . . . 0.0 110.327 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -52.69 -51.66 59.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.488 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.2 69.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.909 0.385 . . . . 0.0 110.413 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.601 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 46.4 t80 -61.27 -41.2 96.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.377 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -60.9 -46.47 90.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.424 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -61.62 -38.71 88.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.388 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.84 -38.33 96.34 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 34.2 mt -71.93 -39.19 69.64 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.378 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.5 t -64.55 -41.19 96.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.227 0.537 . . . . 0.0 110.951 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.01 -38.39 66.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.631 ' NH1' ' NZ ' ' A' ' 206' ' ' LYS . 17.3 mmt85 -60.12 -51.25 70.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.965 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.7 ' O ' HG23 ' A' ' 260' ' ' VAL . 20.1 ptp180 -64.18 -44.66 91.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -60.1 -37.1 78.95 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.305 0.574 . . . . 0.0 110.158 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -73.35 -44.2 59.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.41 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 49.9 m -59.4 -38.37 80.39 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.094 0.474 . . . . 0.0 110.306 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 256' ' ' ARG . 96.4 t -65.71 -52.72 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.376 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.613 HG13 HD12 ' A' ' 274' ' ' ILE . 9.3 t -61.83 -49.21 85.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.441 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -46.53 -41.34 14.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.856 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.573 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 58.3 t80 -81.28 -32.78 33.06 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.56 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -67.7 -9.01 39.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.624 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 267' ' ' LYS . 61.8 mt -86.4 -50.1 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 111.556 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 88.8 p -49.82 -5.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.199 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.586 ' CD ' ' N ' ' A' ' 267' ' ' LYS . 2.0 mptp? -86.89 7.67 26.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 110.35 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 87.24 41.4 6.59 Favored Glycine 0 CA--C 1.507 -0.456 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.79 128.11 25.5 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.37 126.38 21.51 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.755 1.636 . . . . 0.0 111.982 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.49 -8.78 21.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.971 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -91.53 -22.97 20.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -80.46 -18.66 48.06 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.463 0.649 . . . . 0.0 110.713 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.613 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -106.18 -171.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.777 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 28.7 t -171.05 127.63 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.327 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.14 110.56 23.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.472 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -120.18 148.09 44.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.46 0.647 . . . . 0.0 110.86 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.42 97.84 0.5 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.629 ' SD ' ' CE2' ' A' ' 239' ' ' TYR . 2.8 ptp -81.59 31.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.461 0.172 . . . . 0.0 110.816 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 38.19 -97.43 0.01 OUTLIER Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -141.84 70.57 1.34 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.704 0.288 . . . . 0.0 110.415 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.8 m -91.16 0.59 57.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.518 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -155.95 60.67 2.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.51 110.93 3.17 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.505 2.137 . . . . 0.0 112.03 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 286' ' ' THR . 11.5 m -71.37 -36.4 61.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.42 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 288' ' ' ASN . 70.6 p -62.18 -45.75 92.0 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.083 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.31 -3.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.619 ' H ' ' C ' ' A' ' 286' ' ' THR . 55.8 t-20 -123.83 -57.78 1.61 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 m -58.94 -25.61 63.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.615 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 68.3 m -105.12 32.07 4.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 0.0 110.59 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.48 -2.81 18.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.456 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -109.98 30.98 6.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 10.5 t -132.17 121.65 46.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 120.919 0.39 . . . . 0.0 110.42 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -121.23 6.18 10.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.513 ' O ' HD12 ' A' ' 299' ' ' LEU . 5.1 mt-30 -88.5 172.12 9.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.039 0.447 . . . . 0.0 110.402 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -82.01 -72.62 0.43 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.91 -28.99 66.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.47 . . . . 0.0 110.867 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.27 82.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.381 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 303' ' ' LEU . 42.5 mt -71.81 -52.16 18.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 63.6 mt -51.42 -34.73 15.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.51 -35.22 58.45 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.352 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.97 -8.22 57.41 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.814 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 299' ' ' LEU . 65.8 mt -96.23 15.53 20.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.723 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -76.78 -45.93 3.05 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.141 0.496 . . . . 0.0 110.008 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 28.0 Cg_exo -59.47 10.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 123.042 2.495 . . . . 0.0 111.818 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 304' ' ' ALA . 54.6 t0 -104.56 13.52 31.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.873 0.368 . . . . 0.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.429 ' NH1' HH22 ' A' ' 256' ' ' ARG . 78.8 mtp85 -112.58 102.23 10.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.299 0.571 . . . . 0.0 110.557 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.6 ptp180 -165.8 142.51 5.34 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.22 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 15.2 m -107.4 145.54 14.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -118.04 108.63 15.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.118 0.485 . . . . 0.0 110.74 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.505 HD13 HG13 ' A' ' 236' ' ' VAL . 3.4 mm -79.5 114.28 20.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -96.72 111.15 23.43 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.769 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.982 HG21 HD22 ' A' ' 224' ' ' LEU . 59.0 t -113.0 118.4 57.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 O-C-N 123.556 0.535 . . . . 0.0 110.919 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -116.25 131.07 57.05 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.69 33.88 5.96 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.705 ' O ' ' O ' ' A' ' 317' ' ' LYS . 10.5 tt -108.46 168.53 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.705 ' O ' ' O ' ' A' ' 316' ' ' ILE . 42.1 tttt . . . . . 0 CA--C 1.537 0.468 0 O-C-N 124.205 0.941 . . . . 0.0 111.556 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 121.124 0.488 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 48.9 m -64.97 125.79 25.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.402 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 313' ' ' VAL . 39.2 tptt -117.97 163.33 16.74 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.278 0.561 . . . . 0.0 111.086 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -153.17 125.44 8.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.366 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -114.26 116.98 29.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.56 103.45 15.08 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.333 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.671 ' CD2' HD11 ' A' ' 201' ' ' LEU . 31.2 tp -106.64 130.36 54.4 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.911 0.386 . . . . 0.0 110.218 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -84.65 129.04 34.89 Favored 'General case' 0 C--O 1.255 1.355 0 CA-C-O 122.565 1.174 . . . . 0.0 111.819 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 202' ' ' PHE . 37.4 m -61.54 -18.15 57.95 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.53 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.58 -41.31 94.39 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.194 0.521 . . . . 0.0 110.201 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.9 t -72.45 -34.14 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.344 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.671 HD11 ' CD2' ' A' ' 196' ' ' LEU . 62.4 mt -88.12 -80.0 0.28 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.126 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -127.84 114.36 17.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.244 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.438 ' OD1' ' CE2' ' A' ' 204' ' ' PHE . 2.7 t-20 -90.84 -72.09 0.59 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.473 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.438 ' CE2' ' OD1' ' A' ' 203' ' ' ASN . 88.3 m-85 -102.76 -25.89 13.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.795 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -63.56 170.71 3.0 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.982 0.42 . . . . 0.0 110.154 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -53.54 -83.33 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.652 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.04 53.69 0.15 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.443 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.7 t -107.33 145.44 32.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.848 0.356 . . . . 0.0 110.303 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.23 127.61 33.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 213' ' ' GLY . 12.7 mtpp -89.55 158.85 45.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.813 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 210' ' ' LYS . 76.8 Cg_exo -33.34 -76.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.499 2.133 . . . . 0.0 112.01 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -48.47 -22.54 0.74 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.146 0.498 . . . . 0.0 110.321 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.36 -48.45 18.78 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -63.19 -39.63 95.2 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.83 -53.88 52.77 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.568 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.83 -28.65 69.7 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.596 0.712 . . . . 0.0 110.537 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -31.63 68.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.364 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.21 -48.18 30.63 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.173 0.511 . . . . 0.0 111.263 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 12.1 pt20 -64.03 -44.46 92.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.981 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 311' ' ' ILE . 36.0 tp -62.7 -41.71 99.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.336 -0.545 . . . . 0.0 109.892 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 4.2 t80 -52.26 -48.1 65.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.374 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.5 m -52.81 -52.34 57.31 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.485 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -54.3 -27.3 34.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.186 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.718 HD22 HG21 ' A' ' 313' ' ' VAL . 85.0 mt -95.3 -20.28 19.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.668 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 221' ' ' TYR . 23.5 p -79.64 -21.2 45.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.831 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -99.1 21.46 11.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.558 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.34 -179.68 5.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.61 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.434 ' OD2' ' CG ' ' A' ' 230' ' ' LYS . 2.8 t70 -99.09 132.64 23.15 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.41 -17.02 34.89 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.501 2.134 . . . . 0.0 112.94 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.434 ' CG ' ' OD2' ' A' ' 228' ' ' ASP . 40.4 mmtt -37.02 -45.27 0.57 Allowed 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.55 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' GLY . 95.1 m-20 -107.73 -19.89 13.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.442 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.7 49.04 0.05 OUTLIER Glycine 0 N--CA 1.469 0.847 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.24 112.4 19.44 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 122.591 -0.358 . . . . 0.0 110.791 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 313' ' ' VAL . 52.2 t -130.93 93.38 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.426 0.632 . . . . 0.0 110.497 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.14 123.93 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.334 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 311' ' ' ILE . 22.0 t -100.4 127.1 53.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.598 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.549 HD23 ' HB3' ' A' ' 277' ' ' ARG . 25.5 mt -110.17 145.36 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.068 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.653 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -115.81 142.2 17.4 Favored Glycine 0 N--CA 1.478 1.479 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.559 ' CE2' ' SD ' ' A' ' 279' ' ' MET . 0.7 OUTLIER -122.39 120.64 34.58 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.484 HG22 ' NH2' ' A' ' 256' ' ' ARG . 3.1 p -112.74 164.59 13.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.833 0.349 . . . . 0.0 110.239 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 241' ' ' ASP . 14.5 p-10 -88.47 -176.77 5.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.373 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -100.6 121.72 42.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.277 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.5 mm -118.63 11.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.311 0.577 . . . . 0.0 110.664 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.23 3.72 88.63 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.7 t -133.62 99.81 4.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.068 0.461 . . . . 0.0 110.013 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 56.1 t0 -52.57 -50.78 62.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.466 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.4 67.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.822 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.543 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 45.8 t80 -62.25 -47.99 81.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.454 ' C ' ' ND2' ' A' ' 249' ' ' ASN . 0.1 OUTLIER -62.29 -40.78 97.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.575 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.401 ' N ' ' ND2' ' A' ' 249' ' ' ASN . 27.2 mm100 -60.42 -48.02 83.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.899 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.14 -36.4 92.9 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.543 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 25.9 mt -72.95 -35.98 67.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.097 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.1 m -63.73 -41.71 98.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.87 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -73.21 -35.42 66.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.353 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -60.21 -53.5 56.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.434 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.868 ' O ' HG23 ' A' ' 260' ' ' VAL . 17.4 ptp180 -62.91 -43.96 97.39 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.277 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.451 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.92 -38.87 90.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.319 0.581 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -71.84 -42.18 67.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.277 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 10.6 t -63.24 -38.76 92.41 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.371 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 256' ' ' ARG . 84.5 t -63.36 -51.21 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.277 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.602 HG13 HD12 ' A' ' 274' ' ' ILE . 18.7 t -62.19 -48.75 86.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.234 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -45.08 -41.23 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.08 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.527 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 49.6 t80 -81.79 -29.51 32.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.518 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.94 -7.72 53.42 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.48 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' A' ' 267' ' ' LYS . 59.6 mt -86.95 -54.67 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 111.483 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 33.9 t -50.83 -5.2 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 265' ' ' ILE . 32.2 mmtp -80.18 0.46 32.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.523 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 93.11 40.75 4.78 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.44 139.33 34.36 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.209 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -63.4 129.06 24.16 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.187 1.925 . . . . 0.0 112.097 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.74 -7.28 14.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.999 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -91.1 -28.07 18.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.89 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -77.49 -20.52 54.2 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.954 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.602 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -103.12 -178.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.877 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 13.2 m -171.2 129.63 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.51 155.63 16.69 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.149 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.549 ' HB3' HD23 ' A' ' 237' ' ' LEU . 55.1 ttt85 -161.56 149.43 15.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.105 0.479 . . . . 0.0 110.63 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -118.13 98.46 0.76 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.687 ' HE3' ' H ' ' A' ' 282' ' ' SER . 0.7 OUTLIER -80.08 18.19 0.88 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.718 -0.241 . . . . 0.0 110.838 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 43.77 -102.1 0.03 OUTLIER Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.443 ' OE1' ' OD1' ' A' ' 306' ' ' ASP . 5.4 mm-40 -136.21 74.61 1.51 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.852 0.384 . . . . 0.0 110.57 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.687 ' H ' ' HE3' ' A' ' 279' ' ' MET . 0.6 OUTLIER -88.71 2.18 53.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.337 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -166.81 77.36 1.06 Allowed Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.859 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.62 106.82 2.33 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.015 1.81 . . . . 0.0 111.698 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 286' ' ' THR . 5.2 m -68.29 -43.83 84.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.75 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.1 p -58.85 -44.15 90.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.134 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.58 -3.55 0.02 OUTLIER Glycine 0 CA--C 1.531 1.049 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 286' ' ' THR . 90.9 m-20 -119.33 -57.72 1.98 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.8 OUTLIER -70.35 -13.42 62.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.732 -178.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.91 23.04 6.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.305 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.79 -11.18 54.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.345 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -96.72 33.25 1.89 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.566 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 19.2 t -128.94 124.64 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.447 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -118.68 7.54 11.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -94.93 126.67 40.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 110.2 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -49.59 -57.43 7.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.73 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.12 85.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.997 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.29 -31.2 72.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.546 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 32.6 mt -76.65 -54.15 7.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.4 mt -52.54 -35.79 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.041 0.448 . . . . 0.0 109.954 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -71.25 -42.05 69.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 8.7 t -81.73 -0.73 44.24 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 110.91 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.418 HD12 ' CB ' ' A' ' 241' ' ' ASP . 0.4 OUTLIER -95.55 18.11 13.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.359 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.581 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -79.46 -44.23 1.63 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.297 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.5 Cg_exo -63.17 8.85 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 123.257 2.638 . . . . 0.0 111.991 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 304' ' ' ALA . 6.5 t0 -107.45 12.21 28.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -109.55 106.13 15.72 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.204 0.525 . . . . 0.0 110.118 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -173.09 167.76 4.88 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.769 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.653 HG12 ' HA2' ' A' ' 238' ' ' GLY . 26.8 m -128.25 151.18 34.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.435 ' CD ' ' HH ' ' A' ' 239' ' ' TYR . 90.3 mt-10 -122.3 106.85 11.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.057 0.455 . . . . 0.0 110.198 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.49 117.81 25.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -102.15 120.16 39.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.069 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.718 HG21 HD22 ' A' ' 224' ' ' LEU . 62.0 t -133.41 123.65 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.421 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -118.66 141.7 48.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.583 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.88 -9.19 47.06 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.829 ' O ' ' O ' ' A' ' 317' ' ' LYS . 17.1 tt -81.1 152.92 4.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.829 ' O ' ' O ' ' A' ' 316' ' ' ILE . 40.4 tttm . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 122.234 1.016 . . . . 0.0 112.069 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 121.001 0.429 . . . . 0.0 110.646 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.535 HG22 ' NE2' ' A' ' 193' ' ' HIS . 16.2 m -75.41 132.26 40.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.138 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -146.07 118.72 8.58 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.535 ' NE2' HG22 ' A' ' 191' ' ' THR . 1.4 m-70 -106.69 148.51 28.29 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -107.45 124.01 49.23 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.044 0.449 . . . . 0.0 110.097 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.76 101.67 12.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.567 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.767 ' CD2' HD11 ' A' ' 201' ' ' LEU . 38.6 tp -108.56 145.45 34.81 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.665 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.552 ' HD2' ' H ' ' A' ' 199' ' ' ASP . 1.6 tmtm? -88.98 125.8 35.14 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.721 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.0 t -67.92 -33.83 75.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.24 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.552 ' H ' ' HD2' ' A' ' 197' ' ' LYS . 17.3 t0 -63.69 -39.6 94.71 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 197' ' ' LYS . 51.0 t -61.04 -47.93 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.767 HD11 ' CD2' ' A' ' 196' ' ' LEU . 47.0 mt -67.29 -78.37 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.057 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.2 117.93 35.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.67 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 199' ' ' ASP . 69.1 m-80 -90.55 -82.56 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.193 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -93.23 -16.57 24.64 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.716 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -75.49 156.82 34.8 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.264 0.554 . . . . 0.0 109.801 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.491 ' H ' ' CD ' ' A' ' 206' ' ' LYS . 12.9 mptt -50.0 -68.19 0.2 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.77 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.17 60.12 0.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.167 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.3 p -110.31 141.92 42.66 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.472 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.738 HD22 HD22 ' A' ' 201' ' ' LEU . 35.7 mt -85.17 135.21 34.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.435 0.636 . . . . 0.0 111.339 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 213' ' ' GLY . 40.2 mmtm -100.55 153.86 37.51 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.444 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LYS . 91.7 Cg_exo -30.86 -73.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 C-N-CA 122.47 2.113 . . . . 0.0 112.618 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -49.14 -28.23 4.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.041 0.448 . . . . 0.0 110.767 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.61 -47.7 32.77 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -62.53 -39.69 94.39 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.71 -54.34 47.3 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.255 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.76 -29.49 70.7 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.442 0.639 . . . . 0.0 110.156 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.539 HD23 HD21 ' A' ' 201' ' ' LEU . 0.6 OUTLIER -72.05 -27.83 62.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.074 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ASP . . . . . 0.514 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 34.3 m-20 -75.18 -49.76 18.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.491 0.662 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 18.3 pt20 -63.16 -42.55 99.45 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.361 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 31.7 tp -63.19 -41.79 99.24 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.409 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -51.56 -47.07 63.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.511 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.9 m -56.87 -50.82 71.31 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 118.786 -1.165 . . . . 0.0 110.689 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -52.27 -26.97 13.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.96 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.635 HD22 HG21 ' A' ' 313' ' ' VAL . 17.5 mt -96.31 -20.27 18.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.658 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.0 t -77.97 -21.22 51.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.054 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -100.22 19.39 16.59 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.813 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.563 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -75.69 160.74 29.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.754 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 4.7 t0 -77.71 113.16 29.83 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 230' ' ' LYS . 48.6 Cg_exo -50.19 -23.08 9.11 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 122.329 2.019 . . . . 0.0 113.082 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 229' ' ' PRO . 21.2 tptm -29.37 -53.16 0.13 Allowed 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 123.532 0.52 . . . . 0.0 111.085 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 233' ' ' SER . 91.5 m-20 -106.09 -16.03 14.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.021 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 24.94 44.84 0.01 OUTLIER Glycine 0 N--CA 1.469 0.836 0 O-C-N 123.954 0.783 . . . . 0.0 111.701 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 231' ' ' ASP . 41.6 m -114.07 110.58 20.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.828 0.346 . . . . 0.0 110.855 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 84.3 t -126.04 95.83 3.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.354 0.597 . . . . 0.0 109.852 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 t -97.25 121.48 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.239 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.442 HG21 ' CG2' ' A' ' 261' ' ' VAL . 10.8 t -92.87 118.98 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.253 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.45 144.04 31.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.788 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.438 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -125.51 126.05 5.78 Favored Glycine 0 N--CA 1.476 1.345 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.694 ' N ' HH22 ' A' ' 256' ' ' ARG . 0.2 OUTLIER -111.08 126.21 54.58 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.555 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.9 t -117.53 168.09 10.71 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.825 0.345 . . . . 0.0 110.243 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -91.53 176.42 6.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.648 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -92.69 126.47 37.79 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.6 mm -117.98 10.21 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.157 0.503 . . . . 0.0 110.661 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.42 7.25 76.41 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -140.63 104.11 4.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.245 0.545 . . . . 0.0 110.163 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 99.2 m-20 -57.1 -51.15 70.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.71 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.26 -46.18 76.1 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.044 0.449 . . . . 0.0 110.791 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.588 ' CE2' HD11 ' A' ' 252' ' ' LEU . 48.0 t80 -61.29 -40.81 95.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 246' ' ' ASP . 0.1 OUTLIER -58.12 -47.93 81.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.149 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.95 -40.5 93.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.712 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.15 -39.15 96.74 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.588 HD11 ' CE2' ' A' ' 248' ' ' TYR . 32.9 mt -70.38 -39.44 74.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 5.8 t -62.83 -42.28 99.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 110.809 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.52 -44.14 75.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.935 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -59.59 -47.93 83.65 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.45 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.694 HH22 ' N ' ' A' ' 239' ' ' TYR . 42.7 mtm105 -63.39 -49.63 73.03 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.333 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.76 81.08 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -70.59 -43.43 69.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.207 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.0 t -60.35 -39.29 86.62 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.278 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.3 t -62.83 -51.61 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.521 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.56 HG13 HD12 ' A' ' 274' ' ' ILE . 12.9 t -61.22 -48.34 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.625 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -47.87 -42.86 27.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.948 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.421 ' CG ' HD12 ' A' ' 209' ' ' LEU . 66.5 t80 -78.24 -35.26 48.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.994 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.36 -32.26 73.63 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.369 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 267' ' ' LYS . 89.8 mt -66.59 -46.23 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 85.2 p -56.04 -10.44 0.82 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.29 0.566 . . . . 0.0 110.485 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.514 ' NZ ' ' OD1' ' A' ' 218' ' ' ASP . 20.5 mmmt -79.46 -3.54 47.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.684 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.06 43.73 3.74 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.349 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.29 129.37 24.2 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.57 129.66 30.43 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.406 1.404 . . . . 0.0 111.479 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -64.84 -9.69 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.036 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -91.46 -23.8 19.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.016 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.62 -23.81 56.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.437 0.637 . . . . 0.0 110.708 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.56 HD12 HG13 ' A' ' 261' ' ' VAL . 2.3 pt -103.35 -178.52 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.871 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 8.5 t -168.03 129.26 1.4 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.161 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.08 151.93 19.0 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -154.64 136.95 14.89 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.397 0.618 . . . . 0.0 111.649 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -87.29 91.37 1.73 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 4.3 tpt -69.05 -10.4 57.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.741 0.305 . . . . 0.0 110.503 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.09 -101.5 0.02 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -141.63 74.96 1.48 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.79 0.329 . . . . 0.0 110.574 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 25.4 t -82.36 -3.53 55.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.341 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -167.49 79.25 0.92 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.574 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.32 105.26 0.47 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.484 2.123 . . . . 0.0 112.201 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.468 HG23 ' N ' ' A' ' 286' ' ' THR . 6.4 m -71.41 -39.87 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.705 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.588 ' C ' ' H ' ' A' ' 288' ' ' ASN . 63.3 p -58.8 -42.68 89.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.506 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.64 -2.66 0.01 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.588 ' H ' ' C ' ' A' ' 286' ' ' THR . 71.3 m-80 -127.98 -57.52 1.24 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.9 m -59.53 -44.19 93.25 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.566 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -111.8 28.8 8.42 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.627 0.251 . . . . 0.0 110.788 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 48.2 t0 -66.36 -7.18 17.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.518 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.64 31.76 2.79 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.566 HG21 ' SG ' ' A' ' 290' ' ' CYS . 22.3 t -131.91 124.17 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.552 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -118.82 11.82 12.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.842 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -99.2 130.79 45.53 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.081 0.467 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -50.44 -66.08 0.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.375 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -55.08 -38.08 67.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.429 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.18 -37.44 87.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.427 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 303' ' ' LEU . 34.3 mt -72.19 -57.15 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.461 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 67.0 mt -50.71 -33.7 12.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.028 0.442 . . . . 0.0 109.895 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.18 -37.74 53.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.679 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.12 -11.91 55.86 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.538 HD23 HG21 ' A' ' 286' ' ' THR . 70.8 mt -89.03 23.86 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.781 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.572 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -74.37 -41.42 4.88 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.243 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 16.3 Cg_exo -67.65 9.17 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.483 2.122 . . . . 0.0 111.065 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 304' ' ' ALA . 30.0 t0 -102.31 1.19 35.34 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.491 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 304' ' ' ALA . 5.4 ptp180 -114.77 93.35 4.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.5 0.667 . . . . 0.0 109.509 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.513 ' NH1' ' OE2' ' A' ' 310' ' ' GLU . 36.6 ptt85 -154.37 131.8 11.25 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 122.012 0.91 . . . . 0.0 112.456 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.09 134.03 33.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.342 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.513 ' OE2' ' NH1' ' A' ' 308' ' ' ARG . 64.5 mt-10 -117.86 103.66 10.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.133 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.465 HD12 HD21 ' A' ' 220' ' ' LEU . 0.9 OUTLIER -79.63 115.96 22.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -178.153 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 312' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 312' ' ' GLU . 6.8 tm-20 -90.93 126.73 36.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 123.201 0.313 . . . . 0.0 110.385 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.635 HG21 HD22 ' A' ' 224' ' ' LEU . 2.8 t -125.67 114.98 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.936 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -115.04 134.09 55.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 98.44 10.3 51.13 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.7 tt -93.95 137.98 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.876 0.37 . . . . 0.0 110.502 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.355 179.842 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.945 0.402 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.424 ' CG2' ' NE2' ' A' ' 193' ' ' HIS . 59.0 m -79.42 126.96 31.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.302 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -143.17 108.72 5.08 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.325 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.424 ' NE2' ' CG2' ' A' ' 191' ' ' THR . 30.9 m170 -95.25 142.5 27.6 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 63.3 m-85 -107.38 123.67 48.7 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 195' ' ' THR . 7.9 t -86.83 102.61 14.46 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.766 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.686 ' CD2' HD11 ' A' ' 201' ' ' LEU . 30.3 tp -107.75 129.34 55.05 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.497 0.665 . . . . 0.0 109.296 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 197' ' ' LYS . 14.5 ptpt -85.99 131.85 34.19 Favored 'General case' 0 C--O 1.252 1.237 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.972 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.538 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 14.6 m -62.11 -26.56 68.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.577 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 200' ' ' VAL . 15.0 p-10 -59.07 -36.05 74.42 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.145 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.614 ' N ' ' OD1' ' A' ' 199' ' ' ASP . 31.9 t -71.3 -45.6 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' A' ' 196' ' ' LEU . 85.8 mt -79.49 -77.61 0.18 Allowed 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.963 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.486 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -133.45 139.43 46.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.469 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.496 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 9.9 p-10 -119.65 -72.75 0.67 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.781 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.496 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 94.2 m-85 -87.01 -31.08 20.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.067 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -69.81 167.57 16.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.168 0.508 . . . . 0.0 110.296 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -58.37 -75.16 0.05 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.479 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -161.18 55.8 0.29 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.37 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.0 p -106.88 132.94 52.27 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.3 mt -75.51 140.24 42.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.684 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 213' ' ' GLY . 20.5 mtmt -101.03 157.94 32.73 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 210' ' ' LYS . 75.9 Cg_exo -34.02 -76.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.529 2.152 . . . . 0.0 112.338 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -49.7 -20.09 0.75 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.313 0.578 . . . . 0.0 110.306 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.96 -51.33 14.99 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.391 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -64.07 -40.26 95.87 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.85 -53.87 51.49 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.45 87.46 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.724 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.3 mt -61.07 -30.77 70.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.872 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.07 -45.87 62.97 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.158 0.504 . . . . 0.0 111.095 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -61.75 -44.82 96.14 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.102 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 52.7 tp -65.25 -38.93 91.85 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.368 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.466 ' CG ' ' HD3' ' A' ' 267' ' ' LYS . 7.6 t80 -55.45 -45.49 76.86 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.982 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.3 p -55.82 -53.34 57.89 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.153 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 12.9 pt20 -60.43 -19.95 58.05 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.646 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.696 HD22 HG21 ' A' ' 313' ' ' VAL . 70.2 mt -89.69 -27.48 20.08 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.025 0.441 . . . . 0.0 110.351 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 3.9 t -72.64 -22.92 60.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.6 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -98.92 18.61 16.76 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.722 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.652 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.41 160.47 29.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.94 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -70.74 125.02 91.93 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 230' ' ' LYS . 50.9 Cg_endo -69.86 -17.14 37.3 Favored 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.505 2.137 . . . . 0.0 113.126 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 229' ' ' PRO . 88.2 tttt -31.47 -48.21 0.13 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.749 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 95.7 m-20 -110.74 -17.58 13.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.217 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.22 48.72 0.03 OUTLIER Glycine 0 N--CA 1.474 1.167 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.6 m -115.36 112.36 22.24 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.766 0.317 . . . . 0.0 110.872 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.95 97.54 4.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.604 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.6 t -97.92 122.4 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.407 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 311' ' ' ILE . 16.9 t -96.05 118.66 42.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.41 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 277' ' ' ARG . 26.1 mt -108.96 106.23 16.1 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.602 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.413 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -87.17 127.83 8.65 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.8 OUTLIER -107.17 123.93 48.98 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 117.683 0.742 . . . . 0.0 109.453 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.596 HG22 ' N ' ' A' ' 241' ' ' ASP . 52.9 m -114.67 166.24 11.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.969 0.414 . . . . 0.0 110.296 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.596 ' N ' HG22 ' A' ' 240' ' ' THR . 53.6 p30 -86.02 -176.0 5.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.965 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 244' ' ' GLY . 59.2 ttp180 -116.58 124.84 50.81 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.376 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.4 mm -114.8 23.26 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.557 0.694 . . . . 0.0 110.605 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.4 ' H ' ' HG2' ' A' ' 242' ' ' ARG . . . 84.4 13.59 73.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.8 t -144.11 94.07 2.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.357 0.598 . . . . 0.0 110.006 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -46.58 -47.33 19.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.66 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.38 -37.58 78.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.193 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.492 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 52.6 t80 -61.51 -47.63 84.74 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.445 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 250' ' ' GLN . 0.1 OUTLIER -62.84 -41.6 99.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.5 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.492 ' N ' ' ND2' ' A' ' 249' ' ' ASN . 94.2 mt-30 -60.7 -45.99 92.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.919 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.15 96.13 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.492 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 26.2 mt -72.81 -37.87 67.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.245 -0.478 . . . . 0.0 111.074 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 29.9 t -63.47 -40.87 98.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.967 0.413 . . . . 0.0 110.239 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.94 -45.81 76.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.045 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -54.33 -45.64 72.7 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.573 HH22 ' N ' ' A' ' 308' ' ' ARG . 42.7 mtp180 -61.38 -64.09 1.06 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.477 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -51.56 -34.28 36.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.129 0.49 . . . . 0.0 109.884 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -73.32 -44.74 58.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.087 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 46.2 m -64.37 -37.75 88.6 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.449 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.7 t -64.52 -51.27 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.6 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.536 HG13 HD12 ' A' ' 274' ' ' ILE . 18.2 t -62.36 -48.65 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.039 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -45.06 -39.42 5.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -84.12 -30.34 26.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.687 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.43 -11.22 60.59 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.489 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.533 ' C ' ' H ' ' A' ' 267' ' ' LYS . 72.5 mt -86.91 -53.65 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 122.107 -0.37 . . . . 0.0 111.729 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.3 p -50.41 -4.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.23 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 265' ' ' ILE . 68.9 mttm -83.96 -0.19 50.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.925 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 105.26 -2.78 40.28 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.09 126.02 78.19 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.871 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.78 130.32 39.84 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.344 1.363 . . . . 0.0 111.256 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.29 -10.0 38.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.968 0.413 . . . . 0.0 111.407 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -90.78 -22.93 20.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.133 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -19.5 52.5 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.819 0.819 . . . . 0.0 110.664 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.536 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -107.03 -171.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.542 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.69 129.78 1.55 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.827 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.72 151.3 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.59 ' HB3' HD23 ' A' ' 237' ' ' LEU . 60.8 ttt180 -158.88 148.75 19.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 110.5 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -123.76 96.89 0.55 Allowed Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 21.3 ptm -94.66 21.45 7.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.921 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 37.74 -97.17 0.01 OUTLIER Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -143.33 75.92 1.5 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 37.3 t -63.82 -32.99 74.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.114 0.483 . . . . 0.0 111.166 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -131.17 77.66 74.2 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.954 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -54.23 108.04 0.26 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.749 2.299 . . . . 0.0 112.848 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 286' ' ' THR . 5.1 m -71.59 -40.3 70.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.489 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.631 ' C ' ' H ' ' A' ' 288' ' ' ASN . 2.2 p -58.97 -42.47 90.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.514 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.5 0.89 0.02 OUTLIER Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.631 ' H ' ' C ' ' A' ' 286' ' ' THR . 28.2 t-20 -125.07 -58.37 1.46 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.3 m -56.2 -42.84 77.82 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 22.8 m -95.74 34.42 1.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.502 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 292' ' ' ASN . 28.4 p30 -59.04 -33.04 70.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.818 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 23.3 m120 -88.78 33.92 0.77 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.434 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.57 109.43 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.849 0.356 . . . . 0.0 110.522 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -118.59 13.89 13.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.611 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -98.0 135.33 39.86 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.108 0.48 . . . . 0.0 109.851 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 299' ' ' LEU . 5.9 ttt-85 -51.09 -76.36 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.568 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -45.74 -41.03 10.18 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.139 0.495 . . . . 0.0 111.071 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.34 81.36 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.043 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 296' ' ' ARG . 16.9 mt -71.01 -43.95 66.87 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.771 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 12.2 mm -52.75 -36.84 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.34 -42.78 35.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.221 0.534 . . . . 0.0 110.315 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -5.6 35.71 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.857 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.34 20.24 8.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.573 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.548 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -79.84 -45.09 1.53 Allowed Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.18 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 24.7 Cg_exo -61.75 8.29 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 123.184 2.589 . . . . 0.0 111.941 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 304' ' ' ALA . 39.4 t0 -102.52 10.91 38.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.609 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.442 ' NH1' ' O ' ' A' ' 203' ' ' ASN . 88.2 mtm180 -112.94 91.65 3.73 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.298 0.571 . . . . 0.0 110.142 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.573 ' N ' HH22 ' A' ' 256' ' ' ARG . 16.4 ptm180 -157.67 129.22 6.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.628 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.99 138.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.431 0.634 . . . . 0.0 109.709 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -118.64 102.17 8.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.713 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.536 HG23 HG22 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -81.0 113.14 19.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.67 118.44 31.05 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.401 0.438 . . . . 0.0 110.154 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.696 HG21 HD22 ' A' ' 224' ' ' LEU . 47.8 t -116.5 114.66 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 O-C-N 123.567 0.542 . . . . 0.0 110.183 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -113.39 132.09 55.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 93.15 41.85 4.47 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.693 ' O ' ' O ' ' A' ' 317' ' ' LYS . 9.8 tt -114.65 169.63 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.693 ' O ' ' O ' ' A' ' 316' ' ' ILE . 27.5 tttp . . . . . 0 C--O 1.218 -0.586 0 O-C-N 123.963 0.79 . . . . 0.0 111.614 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.501 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 17.6 mp0 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.907 0.384 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 39.2 m -72.0 126.21 29.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.639 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -116.45 167.85 10.68 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.457 0.646 . . . . 0.0 111.032 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -155.93 123.39 5.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.595 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.452 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 60.9 m-85 -110.57 113.35 25.9 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.06 103.86 15.13 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.897 -179.442 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.68 HD23 HD11 ' A' ' 201' ' ' LEU . 30.5 tp -108.94 135.34 50.3 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.287 0.565 . . . . 0.0 110.196 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.517 ' H ' ' CD ' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -88.73 132.14 34.73 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.968 0.89 . . . . 0.0 112.315 -178.006 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 202' ' ' PHE . 1.3 p -61.84 -24.07 66.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.665 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.14 -43.67 92.04 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.275 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.11 -42.41 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.68 HD11 HD23 ' A' ' 196' ' ' LEU . 78.9 mt -80.08 -79.36 0.15 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.86 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.3 OUTLIER -133.27 131.88 40.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.002 -178.067 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.54 ' O ' ' NH2' ' A' ' 307' ' ' ARG . 59.9 t30 -111.04 -71.24 0.77 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.674 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -91.28 -23.57 20.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.844 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -73.14 164.16 27.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 110.423 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -53.78 -74.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.144 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -160.09 3.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.338 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.7 p -54.98 141.35 34.21 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 85.9 mt -86.14 132.62 33.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.875 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.6 mttp -93.27 157.27 39.12 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.582 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -33.11 -74.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.767 2.311 . . . . 0.0 112.428 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.77 -24.24 1.34 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.136 0.493 . . . . 0.0 110.947 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.68 -48.16 18.32 Favored Glycine 0 C--O 1.227 -0.312 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -62.66 -40.83 98.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.346 0.593 . . . . 0.0 109.57 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.42 -55.27 33.58 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.38 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.35 85.0 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.212 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.1 -31.09 70.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.169 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -71.91 -46.73 56.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.935 0.398 . . . . 0.0 110.948 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -64.21 -44.57 91.52 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.564 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.9 tp -65.02 -38.12 89.86 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.539 ' HE1' HD13 ' A' ' 269' ' ' ILE . 2.4 t80 -54.83 -50.3 68.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.146 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 225' ' ' SER . 11.8 t -59.58 -50.67 73.01 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.571 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.452 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 58.7 tt0 -49.01 -24.25 1.45 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.667 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.507 ' O ' HD22 ' A' ' 227' ' ' LEU . 51.3 mt -100.38 -13.73 18.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.606 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 222' ' ' SER . 33.2 t -73.29 -19.82 60.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -103.61 20.84 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.475 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -74.05 161.54 29.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.81 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -84.3 126.18 70.18 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 230' ' ' LYS . 59.9 Cg_endo -69.86 -16.26 37.06 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.982 1.788 . . . . 0.0 113.073 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 229' ' ' PRO . 3.1 tmtm? -30.49 -52.43 0.16 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.604 0.565 . . . . 0.0 111.066 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 232' ' ' GLY . 10.5 m-20 -104.67 -15.33 15.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.133 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.99 51.52 0.07 OUTLIER Glycine 0 N--CA 1.468 0.788 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.638 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.0 m -118.53 109.07 15.76 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 122.88 -0.188 . . . . 0.0 111.041 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 92.4 t -125.3 93.81 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.62 0.724 . . . . 0.0 109.989 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.6 t -98.33 119.49 46.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.159 0.504 . . . . 0.0 110.754 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.538 HG22 HG23 ' A' ' 311' ' ' ILE . 22.1 t -93.62 127.68 45.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.398 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.0 mt -110.35 139.62 45.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.381 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -120.56 131.55 8.83 Favored Glycine 0 N--CA 1.479 1.544 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -117.7 121.94 42.19 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.002 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.532 HG23 ' ND2' ' A' ' 249' ' ' ASN . 9.0 t -115.45 174.26 6.1 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -84.4 -178.2 6.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.165 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.568 ' H ' HD12 ' A' ' 303' ' ' LEU . 59.2 ttp180 -115.84 125.41 52.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.953 0.406 . . . . 0.0 109.971 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.9 mm -117.81 18.57 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.75 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 77.92 15.97 80.51 Favored Glycine 0 C--N 1.315 -0.604 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.3 p -136.58 100.78 4.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.341 0.591 . . . . 0.0 109.947 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -54.21 -50.9 66.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.809 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.96 83.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.714 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.538 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 55.6 t80 -63.95 -41.77 97.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.334 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.532 ' ND2' HG23 ' A' ' 240' ' ' THR . 12.7 t-20 -59.01 -52.09 67.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -57.85 -39.86 78.74 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.681 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.88 99.14 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 31.7 mt -69.99 -38.99 76.18 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.747 -0.267 . . . . 0.0 110.707 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.3 t -62.32 -41.57 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.194 0.521 . . . . 0.0 110.622 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -70.47 -38.88 74.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.344 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -58.69 -51.25 70.75 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.303 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.854 ' O ' HG23 ' A' ' 260' ' ' VAL . 17.2 ptp180 -65.63 -45.74 81.88 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.754 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.55 98.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.401 0.619 . . . . 0.0 109.951 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -71.2 -43.61 67.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.334 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.9 m -60.05 -38.14 81.93 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.693 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 256' ' ' ARG . 89.4 t -65.13 -52.66 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.15 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.662 HG13 HD12 ' A' ' 274' ' ' ILE . 9.1 t -62.12 -48.91 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.621 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -47.18 -43.13 21.04 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.182 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.586 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 53.7 t80 -77.07 -33.47 57.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.981 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.54 -34.93 79.42 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.48 ' C ' ' H ' ' A' ' 267' ' ' LYS . 96.9 mt -63.15 -44.85 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 120.831 0.348 . . . . 0.0 111.527 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 39.3 t -55.07 -8.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.404 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.586 ' CE ' ' CE2' ' A' ' 263' ' ' TYR . 68.8 mmtt -90.98 14.24 14.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.462 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.45 42.59 10.16 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.312 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.539 HD13 ' HE1' ' A' ' 221' ' ' TYR . 0.8 OUTLIER -120.29 127.61 26.24 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 117.134 0.467 . . . . 0.0 110.074 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -54.14 128.33 29.42 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.356 1.371 . . . . 0.0 111.984 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.97 -11.87 50.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 111.025 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -92.29 -18.13 23.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.418 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -82.76 -23.19 34.06 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.764 0.792 . . . . 0.0 110.652 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.662 HD12 HG13 ' A' ' 261' ' ' VAL . 2.0 pt -102.48 -173.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.045 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 4.9 t -167.63 125.48 1.22 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.77 113.24 25.6 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.705 0.288 . . . . 0.0 110.812 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -119.17 141.86 48.47 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.426 0.632 . . . . 0.0 111.773 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.34 95.84 2.14 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -69.26 -10.45 57.87 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -178.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 280' ' ' GLY . . . . . 0.484 ' HA2' HG22 ' A' ' 240' ' ' THR . . . 42.09 -113.26 0.53 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.441 ' OE2' ' OD2' ' A' ' 306' ' ' ASP . 51.7 tt0 -143.96 71.87 1.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.7 t -63.84 -37.8 88.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.119 0.485 . . . . 0.0 111.409 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -131.6 83.1 59.27 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.27 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.8 105.79 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.163 1.908 . . . . 0.0 112.364 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 286' ' ' THR . 31.6 m -70.1 -44.44 78.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.181 0.515 . . . . 0.0 110.708 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.618 ' C ' ' H ' ' A' ' 288' ' ' ASN . 10.8 p -60.65 -44.62 96.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.934 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -52.93 1.92 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.618 ' H ' ' C ' ' A' ' 286' ' ' THR . 27.1 m120 -119.84 -59.43 1.8 Allowed 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.7 OUTLIER -65.87 -20.5 66.26 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.804 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.25 26.36 9.51 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.873 0.368 . . . . 0.0 110.28 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 37.3 p-10 -69.93 -6.85 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.043 0.449 . . . . 0.0 110.505 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -100.63 31.51 3.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.288 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.74 129.3 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.207 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -119.41 5.9 11.14 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -97.57 130.28 44.63 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.1 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -52.61 -74.07 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.52 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -43.63 -39.59 3.64 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.214 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.97 95.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.755 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 48.5 mt -68.48 -42.52 78.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.692 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 15.3 mm -54.95 -36.29 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -73.13 -46.83 48.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.35 0.595 . . . . 0.0 109.745 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.7 t -71.04 -2.78 16.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.243 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.568 HD12 ' H ' ' A' ' 242' ' ' ARG . 0.7 OUTLIER -93.29 16.72 12.56 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.431 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -82.4 -44.32 0.97 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 120.838 0.351 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 49.3 Cg_exo -55.1 8.74 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 123.373 2.715 . . . . 0.0 112.835 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 304' ' ' ALA . 88.2 m-20 -110.58 16.4 21.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.497 0.189 . . . . 0.0 110.682 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 8.4 ptm180 -112.46 91.71 3.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.846 0.831 . . . . 0.0 110.302 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -164.58 141.27 6.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.827 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.495 HG12 ' HA2' ' A' ' 238' ' ' GLY . 31.3 m -108.76 145.96 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.406 ' OE2' ' CZ ' ' A' ' 239' ' ' TYR . 32.9 mt-10 -122.05 107.83 12.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.946 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.538 HG23 HG22 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -79.22 118.42 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.344 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.37 125.68 43.61 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.051 0.453 . . . . 0.0 110.546 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.03 116.56 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.632 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -114.68 131.89 56.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 106.82 -23.87 26.74 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.657 ' O ' ' O ' ' A' ' 317' ' ' LYS . 13.6 tt -53.24 171.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.657 ' O ' ' O ' ' A' ' 316' ' ' ILE . 24.8 tttp . . . . . 0 N--CA 1.468 0.432 0 O-C-N 123.68 0.613 . . . . 0.0 111.792 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 120.941 0.401 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 m -81.87 135.94 35.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.366 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -147.26 118.01 7.58 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 120.875 0.369 . . . . 0.0 110.427 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 2.4 m170 -98.9 144.52 27.99 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -105.0 119.38 38.89 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.92 101.19 12.66 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.846 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.82 HD23 HD11 ' A' ' 201' ' ' LEU . 35.3 tp -108.38 143.7 36.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.144 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -94.75 133.45 38.42 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 122.157 0.979 . . . . 0.0 112.34 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 202' ' ' PHE . 1.2 m -62.06 -25.58 67.77 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.2 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.53 ' OD1' ' NE ' ' A' ' 307' ' ' ARG . 85.2 m-20 -60.44 -39.42 87.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.108 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.65 -45.21 85.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.82 HD11 HD23 ' A' ' 196' ' ' LEU . 50.7 mt -78.68 -78.01 0.15 Allowed 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.909 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -128.33 123.43 33.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.824 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -93.61 -74.17 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.568 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -104.05 -11.78 17.16 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -75.58 170.0 17.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.029 0.443 . . . . 0.0 110.179 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -54.81 -82.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.554 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -156.15 3.76 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.188 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.1 p -57.16 144.72 33.87 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.745 HD22 HD22 ' A' ' 201' ' ' LEU . 57.7 mt -89.25 136.1 33.21 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.268 0.556 . . . . 0.0 111.169 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 213' ' ' GLY . 55.6 mttt -98.34 157.51 34.27 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.098 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -33.75 -74.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.549 2.166 . . . . 0.0 111.993 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.596 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 27.3 mp0 -48.16 -27.62 2.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.127 0.489 . . . . 0.0 110.529 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.15 -47.79 35.42 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -64.65 -40.6 95.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.316 0.579 . . . . 0.0 109.888 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.32 -55.71 25.73 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.351 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.91 81.36 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.478 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.586 HD23 HD21 ' A' ' 201' ' ' LEU . 0.7 OUTLIER -61.81 -27.05 68.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.24 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -77.36 -47.45 19.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.462 0.649 . . . . 0.0 110.841 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -62.11 -45.2 94.54 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.614 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.486 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 40.6 tp -63.83 -40.68 97.18 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 225' ' ' SER . 5.0 t80 -51.07 -48.79 61.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.451 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 59.1 p -55.32 -51.52 66.45 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.596 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -51.23 -26.14 6.63 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.424 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.701 ' O ' HD22 ' A' ' 227' ' ' LEU . 17.8 mt -100.69 -19.03 16.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.525 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 221' ' ' TYR . 6.3 t -71.93 -27.51 62.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.997 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 24.9 t-20 -103.32 23.68 12.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.937 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.36 152.97 34.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.687 179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.647 ' N ' ' O ' ' A' ' 315' ' ' GLY . 16.0 t0 -66.04 115.65 25.3 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 232' ' ' GLY . 49.0 Cg_endo -70.14 -17.25 35.94 Favored 'Trans proline' 0 N--CA 1.505 2.164 0 C-N-CA 122.518 2.145 . . . . 0.0 112.941 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 229' ' ' PRO . 22.2 tptm -29.21 -47.68 0.06 Allowed 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 123.525 0.516 . . . . 0.0 110.962 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 232' ' ' GLY . 5.6 p30 -106.32 -14.07 15.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.388 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.25 56.13 0.17 Allowed Glycine 0 N--CA 1.469 0.878 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.7 t -119.72 99.98 6.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.574 0.226 . . . . 0.0 110.589 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 73.5 t -125.02 94.18 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.549 0.69 . . . . 0.0 110.437 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 8.4 t -98.11 121.47 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.53 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.507 HG22 HG23 ' A' ' 311' ' ' ILE . 18.3 t -91.58 122.12 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.572 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.431 HD22 ' SD ' ' A' ' 279' ' ' MET . 39.0 mt -104.55 141.05 37.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.034 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.78 130.27 7.13 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.19 119.96 38.13 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.1 p -113.28 162.97 15.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.838 0.352 . . . . 0.0 110.071 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -83.3 173.03 11.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.386 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.412 ' HG2' ' H ' ' A' ' 244' ' ' GLY . 62.2 ttp180 -101.18 125.24 47.78 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.426 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 8.1 mm -114.59 18.18 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.685 0.755 . . . . 0.0 110.453 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.412 ' H ' ' HG2' ' A' ' 242' ' ' ARG . . . 84.92 13.73 71.33 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.0 m -143.07 96.46 2.93 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.103 0.478 . . . . 0.0 110.284 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 247' ' ' ALA . 27.4 p-10 -49.19 -48.6 45.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.418 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.447 ' N ' ' OD1' ' A' ' 246' ' ' ASP . . . -56.15 -35.83 67.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.859 0.362 . . . . 0.0 110.276 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.518 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 39.0 t80 -70.0 -42.23 73.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.889 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.83 -49.72 75.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.235 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.42 -36.89 83.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.374 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.57 -41.18 98.68 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.605 HD22 HH12 ' A' ' 256' ' ' ARG . 37.9 mt -73.71 -34.16 64.69 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.947 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 85.0 p -64.0 -40.78 97.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.778 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.69 -43.03 69.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -58.64 -46.66 86.63 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.117 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.605 HH12 HD22 ' A' ' 252' ' ' LEU . 64.5 mtt85 -64.55 -60.91 2.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.905 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -48.44 -39.09 21.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 110.008 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -70.04 -43.26 71.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.373 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 44.5 m -59.3 -39.0 81.6 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.36 -51.72 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.157 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.522 HG13 HD12 ' A' ' 274' ' ' ILE . 18.7 t -61.37 -48.89 86.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.687 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -46.99 -41.39 16.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.125 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -81.74 -32.95 31.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.66 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -65.26 -24.28 67.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.254 -179.32 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.532 ' C ' ' H ' ' A' ' 267' ' ' LYS . 87.1 mt -73.51 -51.18 26.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 111.718 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 5.1 m -50.34 -8.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.801 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 265' ' ' ILE . 27.9 mmtp -82.68 -1.94 52.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 95.08 41.62 3.98 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.32 129.43 24.91 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.75 125.81 19.18 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.754 1.636 . . . . 0.0 111.736 176.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.55 -8.5 20.09 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -90.69 -24.08 20.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.719 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.475 ' HE2' HD21 ' A' ' 227' ' ' LEU . 0.7 OUTLIER -78.64 -21.94 47.63 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.315 0.578 . . . . 0.0 111.034 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.522 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -104.48 -174.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.562 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 38.5 t -170.94 131.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.442 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.96 150.2 20.72 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -154.0 138.01 16.38 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.32 0.581 . . . . 0.0 111.293 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -90.17 94.0 1.93 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.431 ' SD ' HD22 ' A' ' 237' ' ' LEU . 2.6 tpt -71.23 -7.04 44.2 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.611 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.53 -98.31 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -142.63 75.61 1.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.757 0.313 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 85.9 p -83.69 -1.64 54.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.977 0.418 . . . . 0.0 110.905 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.568 ' C ' HD22 ' A' ' 283' ' ' ASN . 0.1 OUTLIER -162.89 74.71 2.01 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.94 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -60.06 103.23 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.401 2.068 . . . . 0.0 113.198 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 286' ' ' THR . 13.8 m -69.91 -35.57 65.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.182 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.0 OUTLIER -59.5 -46.44 88.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.401 -179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.05 -5.58 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.619 ' H ' ' C ' ' A' ' 286' ' ' THR . 45.5 t30 -127.22 -57.26 1.31 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.844 0.457 . . . . 0.0 109.781 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 289' ' ' THR . 3.5 m -68.56 -10.71 57.54 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.666 0.27 . . . . 0.0 110.614 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 286' ' ' THR . 72.4 m -132.78 19.06 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 110.396 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -67.35 -5.43 14.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.663 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -108.68 32.24 5.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 7.2 t -131.63 120.48 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.68 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -119.7 10.44 11.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.952 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -101.57 135.8 42.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.145 0.498 . . . . 0.0 110.142 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -52.0 -70.32 0.09 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.845 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.77 -39.23 58.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.94 -39.64 95.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.424 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 303' ' ' LEU . 20.5 mt -65.94 -52.41 50.0 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.43 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 64.5 mt -53.04 -33.03 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.938 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -79.42 -24.23 42.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.979 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -98.03 -12.68 21.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.384 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 299' ' ' LEU . 80.6 mt -91.69 18.77 7.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.883 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.608 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -77.81 -53.25 1.51 Allowed Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.519 177.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 13.0 Cg_endo -53.7 9.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.225 0 C-N-CA 122.852 2.368 . . . . 0.0 112.888 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.608 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.3 t0 -103.1 16.75 25.79 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.53 ' NE ' ' OD1' ' A' ' 199' ' ' ASP . 18.0 ptt-85 -114.35 93.3 4.28 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.78 0.8 . . . . 0.0 110.415 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.502 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 48.1 ptt85 -157.46 131.73 8.35 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.59 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 7.8 m -102.02 140.13 21.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -120.84 105.69 10.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.372 0.606 . . . . 0.0 110.519 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.507 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.17 115.94 22.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.465 -178.466 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -90.68 117.37 29.28 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 123.091 0.245 . . . . 0.0 110.368 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.675 HG21 HD22 ' A' ' 224' ' ' LEU . 22.5 t -115.62 115.81 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.4 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -114.32 126.98 55.63 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.9 43.99 2.96 Favored Glycine 0 C--O 1.219 -0.807 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.692 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.5 tt -119.81 170.51 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.692 ' O ' ' O ' ' A' ' 316' ' ' ILE . 65.0 mttp . . . . . 0 N--CA 1.466 0.37 0 O-C-N 124.125 0.891 . . . . 0.0 111.293 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.8 0.333 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.59 HG22 ' CE1' ' A' ' 193' ' ' HIS . 9.1 m -74.99 130.5 39.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.191 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -147.32 117.54 7.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.167 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.59 ' CE1' HG22 ' A' ' 191' ' ' THR . 0.5 OUTLIER -103.76 151.39 23.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.521 ' CE1' HD21 ' A' ' 224' ' ' LEU . 37.5 m-85 -111.96 122.69 48.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.914 0.388 . . . . 0.0 110.062 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.08 102.44 13.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.541 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.691 ' CD2' HD11 ' A' ' 201' ' ' LEU . 26.8 tp -104.83 131.69 51.99 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.308 0.575 . . . . 0.0 109.728 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.418 ' HG2' ' H ' ' A' ' 199' ' ' ASP . 12.6 ttmm -82.51 129.8 34.99 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.196 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.6 t -62.74 -31.44 72.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.087 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.426 ' OD1' ' OD1' ' A' ' 203' ' ' ASN . 16.2 t70 -59.42 -37.98 79.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.231 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.88 -42.94 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.691 HD11 ' CD2' ' A' ' 196' ' ' LEU . 84.6 mt -80.01 -77.98 0.18 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.437 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.37 125.31 44.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.744 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.426 ' OD1' ' OD1' ' A' ' 199' ' ' ASP . 44.0 m-80 -88.3 -70.09 0.66 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.82 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -113.0 -10.58 13.48 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.749 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -74.63 164.83 26.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.139 0.495 . . . . 0.0 110.035 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -52.51 -77.82 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.292 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.67 56.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.489 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.2 p -107.69 132.97 52.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.179 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.412 HD22 HD22 ' A' ' 201' ' ' LEU . 18.7 mt -80.74 132.29 35.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.809 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -95.62 165.74 16.01 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.672 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -36.14 -76.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.499 2.133 . . . . 0.0 111.973 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -49.96 -20.51 0.94 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.319 0.581 . . . . 0.0 110.277 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.37 -51.45 12.91 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -66.15 -38.25 87.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.023 0.439 . . . . 0.0 109.93 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.4 -53.3 59.85 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.06 -33.76 76.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.575 0.702 . . . . 0.0 110.336 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.2 mt -69.5 -26.2 64.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.394 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -76.23 -49.46 17.08 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.482 0.658 . . . . 0.0 111.113 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -63.91 -41.11 97.76 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.364 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 311' ' ' ILE . 36.8 tp -63.5 -41.81 98.53 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.662 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.8 t80 -51.59 -48.95 62.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.805 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 80.7 p -55.55 -51.37 67.3 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.475 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -53.26 -27.35 22.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.365 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.979 HD22 HG21 ' A' ' 313' ' ' VAL . 47.4 mt -95.61 -19.48 19.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.759 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 221' ' ' TYR . 8.4 t -78.57 -30.38 46.75 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.357 0.41 . . . . 0.0 110.886 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 52.3 t-20 -86.11 20.2 2.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.708 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -77.75 -178.79 5.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.933 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 315' ' ' GLY . 49.4 t0 -100.09 105.19 33.99 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 232' ' ' GLY . 32.5 Cg_exo -55.6 -20.64 28.06 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 123.077 2.518 . . . . 0.0 113.61 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 229' ' ' PRO . 62.6 pttt -27.22 -40.48 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.162 0.506 . . . . 0.0 111.318 -176.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 229' ' ' PRO . 13.3 p30 -115.23 -14.74 11.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.304 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.03 59.82 0.16 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.8 m -118.64 102.09 8.6 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 58.9 t -126.69 92.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.701 0.762 . . . . 0.0 110.273 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.1 t -98.37 121.88 49.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.35 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.49 HG22 HG23 ' A' ' 311' ' ' ILE . 23.6 t -92.23 125.22 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.404 HD22 ' SD ' ' A' ' 279' ' ' MET . 55.0 mt -108.49 141.24 40.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.315 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.87 129.02 7.3 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -113.29 121.6 44.92 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.652 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 6.7 p -115.88 162.63 17.06 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.452 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 45.7 p30 -82.93 172.3 12.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.632 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.602 ' NH1' ' N ' ' A' ' 245' ' ' SER . 0.1 OUTLIER -94.62 126.21 39.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.932 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.4 mm -118.61 14.34 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.416 0.627 . . . . 0.0 110.708 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.425 ' C ' ' NH1' ' A' ' 242' ' ' ARG . . . 77.93 11.0 85.83 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' SER . . . . . 0.602 ' N ' ' NH1' ' A' ' 242' ' ' ARG . 11.2 m -135.97 94.61 3.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.114 0.483 . . . . 0.0 110.049 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.536 ' OD1' ' NH2' ' A' ' 242' ' ' ARG . 47.1 m-20 -46.81 -50.28 18.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.446 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.49 -42.38 74.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.635 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.522 ' CE2' HD11 ' A' ' 252' ' ' LEU . 33.1 t80 -66.0 -38.83 89.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.54 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 27.3 t-20 -61.78 -52.6 63.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.107 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -66.67 -32.78 74.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.545 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.92 -43.79 98.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.522 HD11 ' CE2' ' A' ' 248' ' ' TYR . 33.0 mt -72.69 -35.48 67.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.763 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.8 t -64.76 -44.47 89.97 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.106 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.19 -42.4 75.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.176 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER -60.67 -49.9 75.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.357 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 260' ' ' VAL . 55.0 mtp180 -60.52 -52.38 65.44 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.607 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.11 -31.89 65.77 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -73.71 -45.01 54.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.234 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 77.4 p -61.38 -37.93 85.17 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.43 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.8 t -65.11 -53.1 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.299 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.598 HG13 HD12 ' A' ' 274' ' ' ILE . 9.8 t -60.97 -49.37 85.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.329 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -46.35 -40.77 12.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.93 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -82.65 -31.96 28.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.606 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.37 -9.94 57.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.451 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.554 ' C ' ' H ' ' A' ' 267' ' ' LYS . 62.8 mt -87.14 -53.57 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.775 0.322 . . . . 0.0 111.39 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.2 m -49.79 -6.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.004 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 265' ' ' ILE . 30.0 mmtm -81.39 -3.94 54.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.81 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.42 39.77 3.37 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.69 127.52 25.16 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.748 0.274 . . . . 0.0 110.378 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.48 128.25 27.19 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.917 1.745 . . . . 0.0 111.79 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.79 -7.92 24.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.237 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -91.97 -23.09 19.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.827 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -80.38 -19.71 45.72 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.297 0.57 . . . . 0.0 110.977 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.598 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -104.45 -171.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.525 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 3.1 t -169.45 130.16 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.314 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -101.72 110.7 22.75 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.917 0.389 . . . . 0.0 110.76 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.26 140.52 49.24 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.7 0.762 . . . . 0.0 111.345 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -91.38 93.89 1.89 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.404 ' SD ' HD22 ' A' ' 237' ' ' LEU . 2.2 tpt -69.19 -8.36 44.97 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.419 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.97 -107.94 0.09 OUTLIER Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.27 59.03 1.59 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.75 0.309 . . . . 0.0 110.558 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.0 t -83.04 -8.06 59.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.697 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -157.33 66.27 3.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.471 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.28 110.82 3.14 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.634 2.222 . . . . 0.0 112.042 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.0 m -73.23 -25.32 21.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.525 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.634 ' O ' ' N ' ' A' ' 288' ' ' ASN . 1.5 p -61.44 -46.34 90.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.911 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.81 -5.77 0.01 OUTLIER Glycine 0 CA--C 1.536 1.356 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.634 ' N ' ' O ' ' A' ' 286' ' ' THR . 35.7 m120 -125.49 -55.43 1.54 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.8 m -66.02 -16.32 63.8 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.947 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 302' ' ' CYS . 92.0 m -118.51 24.78 10.71 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.634 0.254 . . . . 0.0 110.424 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 293' ' ' VAL . 57.4 t0 -57.8 -46.57 84.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.75 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -74.48 33.86 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.596 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 291' ' ' ASP . 3.1 t -133.32 104.12 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.387 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -119.41 14.43 12.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.916 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -101.46 142.1 33.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.06 0.457 . . . . 0.0 109.921 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -51.37 -72.07 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.164 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.09 -40.5 67.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.697 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.71 88.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 17.5 mt -66.61 -55.71 14.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.546 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.27 -37.01 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.991 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -72.56 -33.28 66.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.554 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.477 ' O ' ' SG ' ' A' ' 290' ' ' CYS . 1.8 t -92.12 -4.62 54.06 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.68 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.3 mm? -96.58 19.19 12.68 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.682 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.579 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -81.62 -44.42 1.1 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.343 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.2 Cg_exo -58.18 10.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 123.319 2.679 . . . . 0.0 112.376 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.5 t0 -109.91 17.0 21.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 307' ' ' ARG . 18.8 ptt85 -113.06 90.96 3.49 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.652 0.739 . . . . 0.0 110.246 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.53 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 38.3 ptt180 -158.93 130.23 6.29 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.206 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.86 140.53 16.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -120.85 104.3 9.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.451 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -78.46 118.38 25.55 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.784 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -95.99 119.84 35.2 Favored 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 123.171 0.294 . . . . 0.0 110.816 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.979 HG21 HD22 ' A' ' 224' ' ' LEU . 58.3 t -122.64 118.74 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 O-C-N 123.554 0.534 . . . . 0.0 111.088 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -114.8 131.1 56.92 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.05 36.36 4.48 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.669 ' O ' ' O ' ' A' ' 317' ' ' LYS . 11.4 tt -113.3 169.36 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 316' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.223 -0.339 0 O-C-N 124.079 0.862 . . . . 0.0 111.251 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.449 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.114 0.483 . . . . 0.0 110.474 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 35.5 m -70.76 138.41 50.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.447 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 1.3 mmtm -115.17 172.21 7.21 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.425 0.631 . . . . 0.0 110.667 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 59.3 m80 -157.63 126.4 5.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.326 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.66 116.31 29.95 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -84.65 103.31 13.65 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.947 -179.408 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.704 ' CD2' HD11 ' A' ' 201' ' ' LEU . 29.5 tp -106.62 130.01 54.44 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.581 0.705 . . . . 0.0 110.02 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -79.14 127.31 31.86 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 122.572 1.177 . . . . 0.0 112.468 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.522 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 15.4 m -61.73 -35.03 76.89 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.508 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -57.2 -34.6 68.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.95 -44.12 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.704 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.7 mt -79.8 -77.36 0.19 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.574 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.03 124.7 42.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.936 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.544 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 5.0 p-10 -100.51 -76.45 0.56 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.465 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' PHE . . . . . 0.544 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 68.0 m-85 -96.85 -20.53 18.09 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 110.738 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -70.97 165.25 23.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.124 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -51.12 -81.8 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.63 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.0 56.05 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.453 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 28.5 p -109.17 143.5 38.5 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 110.211 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.405 HD12 ' CG ' ' A' ' 263' ' ' TYR . 10.0 mt -81.03 132.17 35.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.839 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 213' ' ' GLY . 30.8 mmtm -93.96 157.48 37.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.982 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 210' ' ' LYS . 75.6 Cg_exo -32.43 -76.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.309 2.006 . . . . 0.0 111.951 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.665 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 1.9 pm0 -48.36 -23.23 0.86 Allowed 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.512 0.672 . . . . 0.0 110.271 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.52 -44.14 27.86 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.198 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -68.03 -40.45 82.9 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.201 0.524 . . . . 0.0 109.742 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.31 -52.89 62.87 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.727 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.53 -35.8 80.58 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.143 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.35 -28.36 69.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.21 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -76.63 -47.49 22.07 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.314 0.578 . . . . 0.0 110.825 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -61.72 -44.39 97.02 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.336 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 39.4 tp -65.17 -40.24 94.02 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.403 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.504 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.3 t80 -51.89 -48.69 63.99 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.35 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.4 m -55.29 -52.31 63.84 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.048 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -49.83 -24.83 2.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.387 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.678 ' O ' HD22 ' A' ' 227' ' ' LEU . 18.7 mt -98.35 -16.94 19.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.77 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 79.9 p -75.62 -21.95 57.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.896 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -104.05 20.07 18.91 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.992 0.425 . . . . 0.0 110.999 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.678 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -77.61 156.03 31.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.158 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 315' ' ' GLY . 23.6 t0 -70.54 119.47 72.77 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.881 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.504 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.3 Cg_endo -69.85 -19.27 35.93 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.758 2.305 . . . . 0.0 113.194 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 229' ' ' PRO . 50.4 tptt -23.98 -50.39 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 124.068 0.855 . . . . 0.0 110.88 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 232' ' ' GLY . 7.7 p30 -113.18 -12.67 13.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.282 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 27.8 59.65 0.12 Allowed Glycine 0 N--CA 1.475 1.258 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 64.1 m -117.83 107.14 13.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 122.736 -0.273 . . . . 0.0 110.726 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 84.0 t -127.3 95.09 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.555 0.693 . . . . 0.0 110.078 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.8 t -97.85 120.93 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.187 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.466 HG22 HG23 ' A' ' 311' ' ' ILE . 17.1 t -92.73 125.3 45.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.719 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 59.5 mt -108.4 142.59 38.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.391 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.479 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -125.62 130.04 7.09 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -116.39 122.48 44.97 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.096 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.9 p -108.46 171.42 7.42 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.051 0.453 . . . . 0.0 109.846 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.501 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 49.6 p-10 -92.68 -178.07 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.907 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.515 ' H ' HD12 ' A' ' 303' ' ' LEU . 73.2 ttt-85 -102.58 121.93 43.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.411 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.8 mm -118.42 13.13 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.503 0.668 . . . . 0.0 110.864 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.32 9.82 83.16 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.6 m -140.28 91.72 2.47 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.239 0.542 . . . . 0.0 110.308 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -48.23 -49.9 31.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.675 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.74 77.51 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.7 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.594 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 50.7 t80 -59.71 -47.78 84.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 110.423 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 19.8 m120 -62.83 -41.38 99.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.458 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -57.08 -46.22 82.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.184 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.01 -34.66 90.52 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.594 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 31.6 mt -71.63 -38.92 70.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.739 0.304 . . . . 0.0 111.121 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 6.5 t -64.97 -43.2 93.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.694 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.98 -46.03 75.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.145 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -55.64 -46.73 77.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.036 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.522 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 50.7 mtp180 -62.53 -61.92 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 110.174 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -50.48 -36.64 34.61 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.286 0.565 . . . . 0.0 109.893 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -73.05 -45.6 56.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.897 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 40.0 t -58.59 -37.97 76.93 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.829 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 256' ' ' ARG . 92.2 t -64.3 -51.08 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.049 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.652 HG13 HD12 ' A' ' 274' ' ' ILE . 12.8 t -61.92 -48.59 87.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.59 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -47.29 -43.08 22.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.878 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.552 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 48.6 t80 -77.42 -34.65 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.449 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -34.36 78.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.961 0.41 . . . . 0.0 110.525 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' A' ' 267' ' ' LYS . 88.3 mt -62.73 -50.33 80.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.253 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.9 t -49.31 -8.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.88 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.552 ' CE ' ' CE2' ' A' ' 263' ' ' TYR . 32.2 mmtp -86.64 12.52 10.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.504 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 79.68 42.66 11.06 Favored Glycine 0 CA--C 1.509 -0.302 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.024 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.12 128.72 25.21 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.226 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.72 127.94 26.47 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.968 1.779 . . . . 0.0 112.274 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.52 -8.71 28.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.841 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -91.94 -23.46 19.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.919 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.03 -22.95 44.68 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.534 0.683 . . . . 0.0 110.61 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.652 HD12 HG13 ' A' ' 261' ' ' VAL . 1.5 pt -102.1 -175.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.822 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 6.7 t -170.48 127.09 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.591 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.46 151.3 19.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -156.73 144.06 18.95 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 111.036 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -97.22 97.21 1.95 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.409 ' HG3' ' CZ ' ' A' ' 239' ' ' TYR . 1.2 mmt -68.6 -7.64 34.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.252 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 45.6 -109.17 0.29 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 281' ' ' GLU . 51.9 mp0 -131.21 57.12 1.77 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.644 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 6.2 t -80.23 -4.59 53.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.627 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -155.87 67.93 4.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.934 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.77 105.8 2.15 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.304 2.003 . . . . 0.0 111.613 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 286' ' ' THR . 15.1 m -69.62 -36.71 71.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.517 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.582 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.9 OUTLIER -63.75 -46.94 83.04 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.194 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -46.79 -6.89 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.582 ' H ' ' C ' ' A' ' 286' ' ' THR . 21.5 t-20 -124.65 -58.44 1.5 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.749 0.309 . . . . 0.0 110.367 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.0 m -63.5 -24.87 68.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.654 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -116.34 27.02 9.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.192 0.307 . . . . 0.0 110.32 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 288' ' ' ASN . 2.4 p30 -69.96 -5.78 28.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.708 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -98.33 32.97 2.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.609 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.429 HG21 ' SG ' ' A' ' 290' ' ' CYS . 16.8 t -131.38 123.9 53.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.894 0.378 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -118.89 8.16 11.66 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.874 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.467 ' O ' HD12 ' A' ' 299' ' ' LEU . 7.5 mt-30 -88.03 169.33 12.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.135 0.493 . . . . 0.0 110.069 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? -85.2 -68.01 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.905 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -60.44 -30.98 69.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.094 0.473 . . . . 0.0 110.831 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.81 83.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.404 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 295' ' ' GLN . 63.0 mt -74.38 -54.67 7.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 72.9 mt -46.91 -36.53 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.062 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.94 -44.36 48.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.143 0.497 . . . . 0.0 110.688 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.2 t -75.57 -3.3 33.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.788 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.515 HD12 ' H ' ' A' ' 242' ' ' ARG . 1.3 mm? -96.19 16.66 17.59 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.383 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.59 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -80.04 -46.03 1.44 Allowed Pre-proline 0 C--O 1.241 0.632 0 CA-C-O 121.336 0.588 . . . . 0.0 110.052 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 24.5 Cg_exo -61.5 8.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.12 2.547 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.2 t0 -103.79 14.82 30.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.679 0.276 . . . . 0.0 110.687 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -114.31 96.88 6.0 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 121.773 0.797 . . . . 0.0 109.788 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.544 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 15.8 ptm180 -156.71 130.13 8.09 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.988 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.9 140.69 16.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -123.25 105.25 9.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.316 0.579 . . . . 0.0 111.044 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.466 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -78.77 118.7 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.32 -178.456 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -95.1 124.33 39.08 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.154 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.535 HG21 HD22 ' A' ' 224' ' ' LEU . 21.9 t -123.66 117.79 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.175 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -116.67 130.59 56.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 95.04 37.93 5.02 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.589 ' O ' ' O ' ' A' ' 317' ' ' LYS . 13.4 tt -117.51 173.42 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.589 ' O ' ' O ' ' A' ' 316' ' ' ILE . 98.1 mttt . . . . . 0 CA--C 1.536 0.42 0 O-C-N 124.154 0.909 . . . . 0.0 110.51 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.402 ' OE1' ' C ' ' A' ' 317' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 121.104 0.478 . . . . 0.0 109.913 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.5 HG22 ' NE2' ' A' ' 193' ' ' HIS . 17.6 m -74.39 130.77 40.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.999 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -147.7 120.31 8.57 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.5 ' NE2' HG22 ' A' ' 191' ' ' THR . 3.4 m170 -108.07 151.45 25.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -112.1 121.47 45.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.317 0.579 . . . . 0.0 110.121 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 195' ' ' THR . 6.4 t -86.2 102.04 13.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.568 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.686 ' CD2' HD11 ' A' ' 201' ' ' LEU . 32.0 tp -104.48 131.95 51.28 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.15 -178.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -81.37 126.37 31.52 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.188 -177.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 202' ' ' PHE . 96.1 p -61.5 -32.63 72.67 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.937 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -59.43 -41.73 90.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.377 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 82.6 t -61.92 -48.75 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.5 mt -72.14 -77.81 0.09 Allowed 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.396 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -120.17 123.16 42.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.33 -179.154 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -86.74 -73.78 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.052 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -107.43 -11.9 15.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.772 0.32 . . . . 0.0 110.51 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -72.44 163.52 27.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.152 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -52.13 -78.25 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.255 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.33 57.01 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.27 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.8 t -108.8 137.79 46.17 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.304 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.482 HD12 ' CG ' ' A' ' 263' ' ' TYR . 10.7 mt -80.95 131.75 35.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.34 0.591 . . . . 0.0 111.394 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 213' ' ' GLY . 9.2 pttp -94.77 154.62 39.86 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.443 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 210' ' ' LYS . 93.5 Cg_exo -31.15 -73.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.269 1.979 . . . . 0.0 112.306 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -50.75 -25.11 3.98 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.954 0.407 . . . . 0.0 110.591 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.86 -46.58 16.83 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -62.42 -41.04 98.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.539 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.39 -52.84 62.22 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.373 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.64 70.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.585 0.707 . . . . 0.0 110.292 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.95 -29.69 66.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.169 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -75.73 -49.07 19.32 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.154 0.502 . . . . 0.0 111.236 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.425 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 15.0 pt20 -61.93 -42.79 99.5 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.497 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 31.5 tp -65.41 -40.1 92.96 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.375 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.3 t80 -52.56 -45.49 66.44 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.907 178.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.3 t -55.5 -51.25 67.63 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.357 -178.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 223' ' ' GLN . 4.6 mp0 -54.14 -25.69 23.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.495 -179.263 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.869 HD22 HG21 ' A' ' 313' ' ' VAL . 18.3 mt -97.86 -21.95 16.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.758 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.2 t -75.26 -32.77 61.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.349 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -97.1 24.16 6.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 -179.139 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.593 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.25 157.7 32.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.502 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 315' ' ' GLY . 8.0 t70 -71.73 120.48 80.23 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 232' ' ' GLY . 56.7 Cg_endo -67.78 -20.08 46.38 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.801 1.667 . . . . 0.0 113.522 -177.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 229' ' ' PRO . 51.3 tptt -28.6 -44.86 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.388 0.43 . . . . 0.0 111.299 -178.091 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 232' ' ' GLY . 72.5 m-20 -109.77 -14.42 14.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.507 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 25.16 51.38 0.04 OUTLIER Glycine 0 N--CA 1.469 0.834 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.1 m -117.84 109.98 17.22 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.738 0.304 . . . . 0.0 111.101 -178.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.48 94.03 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 121.641 0.734 . . . . 0.0 110.116 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.86 121.82 47.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.271 -178.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.437 HG22 HG23 ' A' ' 311' ' ' ILE . 20.9 t -95.3 121.58 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.515 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.45 HD22 ' SD ' ' A' ' 279' ' ' MET . 79.0 mt -105.52 141.01 37.74 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.006 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.7 126.14 6.25 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.66 124.87 53.22 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.2 t -115.96 168.85 9.71 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.832 0.348 . . . . 0.0 110.505 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -92.36 -177.21 4.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.576 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.574 ' NE ' ' OE1' ' A' ' 281' ' ' GLU . 92.2 mtt180 -100.62 128.02 46.81 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.989 0.423 . . . . 0.0 110.482 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.1 mm -118.28 11.67 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.91 3.48 89.22 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.5 t -135.23 102.85 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.286 0.565 . . . . 0.0 110.361 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -55.16 -51.71 65.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.548 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.36 70.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.548 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.687 ' CE2' HD11 ' A' ' 252' ' ' LEU . 47.4 t80 -62.91 -42.12 99.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.307 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.527 HD21 ' H ' ' A' ' 243' ' ' ILE . 98.4 m-20 -61.43 -46.31 90.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.587 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -61.25 -41.63 97.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.451 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.94 -36.07 92.94 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.687 HD11 ' CE2' ' A' ' 248' ' ' TYR . 32.9 mt -70.59 -41.26 72.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.81 178.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 11.7 t -65.33 -42.65 92.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.57 -49.11 72.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.129 0.49 . . . . 0.0 109.816 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -58.46 -44.84 89.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.256 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 51.8 ttm-85 -51.27 -64.25 0.87 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.54 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -56.84 -31.38 64.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.244 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -66.09 -48.19 71.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.542 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.47 ' O ' ' OD2' ' A' ' 262' ' ' ASP . 13.6 t -60.06 -39.13 84.95 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.467 0.651 . . . . 0.0 110.826 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.24 -50.67 79.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.216 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 276' ' ' ALA . 23.1 t -62.2 -48.92 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.794 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 259' ' ' SER . 0.0 OUTLIER -47.53 -41.73 21.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.144 0.497 . . . . 0.0 110.014 -177.835 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.482 ' CG ' HD12 ' A' ' 209' ' ' LEU . 15.6 t80 -79.85 -34.11 39.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.83 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -33.87 76.84 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.33 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.404 ' C ' ' N ' ' A' ' 267' ' ' LYS . 84.6 mt -65.99 -49.36 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 79.0 p -54.07 -11.1 0.41 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.966 -178.096 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.422 ' CB ' ' CD1' ' A' ' 221' ' ' TYR . 70.9 mmtt -78.41 -7.46 57.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.683 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 101.61 43.06 2.2 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.768 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.3 128.74 23.65 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 117.12 0.46 . . . . 0.0 110.029 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.22 129.2 27.85 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.694 1.596 . . . . 0.0 111.817 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.68 -10.53 47.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.954 0.406 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -90.66 -21.36 21.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.385 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -19.9 41.88 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.948 0.88 . . . . 0.0 110.975 -179.234 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.482 HD12 HG13 ' A' ' 261' ' ' VAL . 2.3 pt -104.96 -173.5 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.455 -179.169 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 15.7 t -166.62 135.82 2.98 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.283 178.278 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.495 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -108.06 110.48 22.18 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.957 0.408 . . . . 0.0 110.838 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -115.46 137.24 52.26 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.386 0.612 . . . . 0.0 111.503 -178.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 280' ' ' GLY . . . -86.85 92.09 1.78 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 178.398 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.45 ' SD ' HD22 ' A' ' 237' ' ' LEU . 5.1 tpt -66.19 3.9 0.8 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.502 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 280' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 278' ' ' GLY . . . 35.35 -104.64 0.02 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.12 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.574 ' OE1' ' NE ' ' A' ' 242' ' ' ARG . 30.9 tt0 -142.62 58.21 1.44 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.091 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.3 m -85.33 -4.02 59.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -149.59 65.61 7.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.233 -179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.31 148.31 90.96 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.21 1.94 . . . . 0.0 111.26 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.569 HG23 ' H ' ' A' ' 286' ' ' THR . 19.6 m -110.95 -55.36 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.247 0.546 . . . . 0.0 110.907 178.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.791 HG21 ' O ' ' A' ' 302' ' ' CYS . 18.6 p -58.91 -40.78 85.55 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.075 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.61 -7.73 0.01 OUTLIER Glycine 0 CA--C 1.531 1.078 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.172 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.632 ' N ' ' O ' ' A' ' 286' ' ' THR . 3.2 m-20 -123.45 -54.99 1.76 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.8 m -66.89 -22.03 65.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.324 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.609 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -120.95 24.53 10.14 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.756 0.312 . . . . 0.0 110.481 -179.565 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -66.58 -9.01 30.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.981 0.42 . . . . 0.0 110.358 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -93.77 33.72 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.173 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.609 HG21 ' SG ' ' A' ' 290' ' ' CYS . 14.5 t -135.32 120.59 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.8 0.333 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 13.03 13.14 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.424 ' N ' ' CD ' ' A' ' 295' ' ' GLN . 0.7 OUTLIER -99.59 136.93 38.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.974 0.416 . . . . 0.0 109.953 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -58.14 -46.12 86.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.2 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -67.11 -46.93 72.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.285 -178.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.19 -26.36 68.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.661 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 303' ' ' LEU . 31.8 mt -76.12 -57.04 4.11 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.549 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.36 -36.97 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.0 109.882 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -72.0 -40.34 68.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.099 178.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.791 ' O ' HG21 ' A' ' 286' ' ' THR . 9.1 t -83.68 -8.02 59.37 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.562 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 299' ' ' LEU . 49.4 mt -93.77 21.73 6.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.463 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.25 -43.35 1.4 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 121.055 0.455 . . . . 0.0 110.711 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.3 Cg_exo -60.77 10.27 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.398 2.732 . . . . 0.0 111.681 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 304' ' ' ALA . 2.0 m-20 -103.88 14.26 31.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.743 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -115.87 93.84 4.42 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.239 0.543 . . . . 0.0 110.165 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.505 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 8.4 ptm180 -154.44 128.4 8.85 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.512 0.673 . . . . 0.0 112.575 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.54 135.57 28.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.508 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.448 ' OE2' ' CZ ' ' A' ' 239' ' ' TYR . 28.5 mt-10 -118.66 104.37 10.56 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.26 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.437 HG23 HG22 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -79.48 117.86 25.93 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.543 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -96.0 121.61 37.93 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.141 0.495 . . . . 0.0 110.594 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.869 HG21 HD22 ' A' ' 224' ' ' LEU . 52.4 t -124.34 117.27 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.955 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -112.92 138.67 49.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 87.82 39.14 7.17 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -178.353 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.715 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.3 tt -116.68 169.31 7.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.715 ' O ' ' O ' ' A' ' 316' ' ' ILE . 68.2 mttm . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 121.7 0.762 . . . . 0.0 112.016 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.703 0.287 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 192' ' ' LYS . 43.3 m -76.59 167.03 22.57 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.008 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 191' ' ' THR . 3.8 tptm -152.37 98.5 2.4 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.561 0.696 . . . . 0.0 110.998 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -85.27 125.16 32.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.408 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.606 ' CE2' HD21 ' A' ' 224' ' ' LEU . 54.4 m-85 -112.73 119.27 37.49 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 195' ' ' THR . 7.7 t -86.4 104.93 16.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.427 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.687 ' CD2' HD11 ' A' ' 201' ' ' LEU . 27.7 tp -107.38 129.47 54.92 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.068 0.461 . . . . 0.0 109.773 -179.4 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -78.81 126.78 31.18 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.876 0.845 . . . . 0.0 112.113 -178.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 202' ' ' PHE . 94.6 p -62.74 -30.29 71.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.984 179.298 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -58.86 -40.27 83.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.32 -46.27 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.687 HD11 ' CD2' ' A' ' 196' ' ' LEU . 90.3 mt -75.93 -76.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.359 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -126.48 128.29 46.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.946 -179.787 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -108.45 -76.18 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.27 -34.09 17.83 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.561 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.468 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 48.9 p30 -62.79 165.77 6.27 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.076 0.465 . . . . 0.0 110.223 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -54.93 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.54 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.3 52.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.63 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.468 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 60.9 p -107.14 137.76 44.59 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.279 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.2 mt -74.6 142.74 44.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.18 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 213' ' ' GLY . 34.4 mtpt -101.83 159.68 28.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.137 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 210' ' ' LYS . 82.2 Cg_exo -33.96 -77.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.418 2.079 . . . . 0.0 111.982 179.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 56.2 mp0 -51.47 -17.01 0.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.262 0.553 . . . . 0.0 110.181 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.99 -48.22 10.24 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.343 178.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 214' ' ' GLN . . . . . 0.402 ' NE2' ' CE1' ' A' ' 263' ' ' TYR . 93.1 mt-30 -67.62 -40.11 84.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.139 0.495 . . . . 0.0 109.783 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.49 -50.34 74.11 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 219' ' ' GLN . . . -65.07 -32.65 74.46 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.509 0.671 . . . . 0.0 110.311 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.9 mt -70.33 -26.89 63.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.421 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -74.94 -47.66 28.47 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.36 0.6 . . . . 0.0 111.178 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 216' ' ' ALA . 15.4 pt20 -64.63 -40.72 95.96 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.469 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.2 tp -63.78 -41.47 97.95 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.488 178.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 225' ' ' SER . 6.3 t80 -53.02 -51.02 63.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.998 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 6.1 t -53.19 -51.48 61.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.266 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.416 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 57.2 tt0 -55.12 -25.92 34.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.946 HD22 HG21 ' A' ' 313' ' ' VAL . 86.5 mt -94.89 -20.28 19.56 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.641 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 221' ' ' TYR . 24.6 p -83.36 -11.42 57.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.396 0.435 . . . . 0.0 110.444 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.564 ' O ' ' ND2' ' A' ' 226' ' ' ASN . 0.2 OUTLIER -97.48 22.4 8.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.237 0.541 . . . . 0.0 110.263 -179.494 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.539 ' H ' ' CD2' ' A' ' 227' ' ' LEU . 0.6 OUTLIER -80.03 -177.69 6.14 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.975 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 315' ' ' GLY . 21.5 t0 -100.26 108.02 50.48 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.77 178.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 230' ' ' LYS . 75.6 Cg_exo -46.19 -21.01 1.0 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.667 2.245 . . . . 0.0 112.917 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 229' ' ' PRO . 65.0 tttm -35.91 -52.21 0.73 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.041 0.448 . . . . 0.0 110.546 -177.826 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.47 ' O ' ' C ' ' A' ' 232' ' ' GLY . 57.4 m-20 -98.71 -21.52 16.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.528 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.17 50.32 0.04 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 123.849 0.718 . . . . 0.0 111.646 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.68 111.81 19.0 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 122.574 -0.368 . . . . 0.0 110.69 -179.182 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.02 97.32 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.712 0.767 . . . . 0.0 110.311 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.4 t -99.67 121.17 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.554 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 85.7 t -95.41 126.86 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.428 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.2 mt -111.93 140.53 46.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.051 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.429 ' O ' ' SD ' ' A' ' 279' ' ' MET . . . -116.7 136.48 12.81 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.609 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -120.81 122.04 39.45 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.511 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.402 HG22 ' NH1' ' A' ' 256' ' ' ARG . 3.3 p -113.3 165.8 12.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 0.0 110.218 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.52 ' OD2' HD11 ' A' ' 243' ' ' ILE . 9.4 p-10 -89.98 -177.32 5.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.644 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -98.42 122.06 41.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.281 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.3 mm -118.55 13.6 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.274 0.559 . . . . 0.0 110.702 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 82.73 2.65 90.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.9 m -132.79 98.92 4.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.033 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -54.01 -51.61 63.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.461 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.74 -41.6 74.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.505 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.591 ' CE2' HD11 ' A' ' 252' ' ' LEU . 55.2 t80 -63.36 -43.24 98.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.67 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.06 -42.38 99.13 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.523 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -64.04 -41.57 97.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.785 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.23 -39.07 97.21 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.591 HD11 ' CE2' ' A' ' 248' ' ' TYR . 33.5 mt -69.08 -38.2 78.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.764 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 15.4 m -63.66 -43.74 95.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.959 0.409 . . . . 0.0 111.011 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.11 -40.83 91.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.045 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.457 ' HA ' ' HE ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER -60.09 -47.41 86.01 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.28 -179.718 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.803 HH22 ' HE ' ' A' ' 307' ' ' ARG . 99.6 mtt180 -61.36 -58.78 6.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.115 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -52.74 -32.67 44.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.109 0.48 . . . . 0.0 109.753 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -74.56 -51.28 15.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.352 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.476 ' O ' ' OD2' ' A' ' 262' ' ' ASP . 66.2 m -58.86 -38.79 79.56 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.667 0.746 . . . . 0.0 110.268 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 256' ' ' ARG . 88.0 t -63.4 -50.1 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.365 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.591 HG13 HD12 ' A' ' 274' ' ' ILE . 12.8 t -62.08 -49.16 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.475 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 259' ' ' SER . 0.0 OUTLIER -45.06 -42.43 8.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.16 0.505 . . . . 0.0 110.272 -178.573 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.402 ' CE1' ' NE2' ' A' ' 214' ' ' GLN . 19.9 t80 -80.62 -31.38 36.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.637 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.9 -7.39 45.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.285 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.562 ' C ' ' H ' ' A' ' 267' ' ' LYS . 69.6 mt -88.62 -58.35 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 111.612 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.1 p -49.17 -6.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.075 -178.716 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.0 OUTLIER -78.19 -11.69 59.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.847 0.356 . . . . 0.0 110.527 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 108.67 39.88 1.68 Allowed Glycine 0 C--N 1.329 0.161 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.0 129.98 23.88 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.0 128.85 30.6 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.67 1.58 . . . . 0.0 111.698 176.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.23 -10.17 47.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.849 0.357 . . . . 0.0 111.122 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 33.5 p30 -92.61 -18.21 23.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.479 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 1.4 ttpm? -83.98 -18.26 37.79 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.605 0.717 . . . . 0.0 110.71 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.591 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -105.27 -171.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.717 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 7.6 t -168.53 133.19 1.62 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.202 179.076 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -105.2 112.04 25.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.784 0.326 . . . . 0.0 110.608 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 150.34 45.61 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.539 0.685 . . . . 0.0 110.982 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -115.37 97.63 0.81 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.659 ' CE ' ' H ' ' A' ' 282' ' ' SER . 3.3 ppp? -80.85 6.74 12.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.884 0.374 . . . . 0.0 111.001 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 47.38 -99.17 0.02 OUTLIER Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.983 179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.447 ' CD ' ' N ' ' A' ' 281' ' ' GLU . 1.8 pm0 -139.36 80.14 1.76 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.845 0.355 . . . . 0.0 111.032 -178.612 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.659 ' H ' ' CE ' ' A' ' 279' ' ' MET . 88.0 p -88.92 -2.0 58.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.071 -179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -163.02 75.6 1.93 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.296 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.34 103.7 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.461 2.107 . . . . 0.0 112.805 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 286' ' ' THR . 19.2 m -73.74 -35.88 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.231 0.539 . . . . 0.0 110.095 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.637 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.9 OUTLIER -58.98 -43.51 91.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.507 -179.714 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.38 -0.8 0.02 OUTLIER Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.637 ' H ' ' C ' ' A' ' 286' ' ' THR . 11.0 t30 -122.16 -58.62 1.71 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.08 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.7 m -58.73 -23.0 59.07 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.737 0.303 . . . . 0.0 110.524 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 3.3 m -120.29 28.49 8.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.143 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -70.78 -17.88 62.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.86 0.362 . . . . 0.0 110.952 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -97.57 31.47 2.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.437 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.408 HG12 ' CD1' ' A' ' 299' ' ' LEU . 23.6 t -137.95 129.31 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.194 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -121.23 13.3 11.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -96.44 131.37 43.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.168 0.509 . . . . 0.0 110.249 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -52.76 -67.98 0.21 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.031 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.48 -41.2 60.76 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.891 -178.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.26 80.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.424 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 303' ' ' LEU . 4.9 mp -72.74 -52.03 16.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.714 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 81.6 mt -43.17 -38.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.906 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -76.51 -43.53 39.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.359 178.251 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.7 t -73.93 -5.43 41.14 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.505 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.4 mm? -94.55 13.35 24.37 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.57 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.598 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -73.73 -43.1 6.56 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.734 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.5 Cg_exo -60.81 9.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.438 2.759 . . . . 0.0 112.255 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 304' ' ' ALA . 53.1 t0 -108.81 9.5 26.82 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.662 0.268 . . . . 0.0 110.669 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.803 ' HE ' HH22 ' A' ' 256' ' ' ARG . 68.3 mtp180 -112.38 98.87 7.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.333 0.587 . . . . 0.0 110.148 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.466 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 36.5 ptt180 -167.75 144.54 4.23 Favored 'General case' 0 C--O 1.215 -0.763 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.784 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.414 HG12 ' HA2' ' A' ' 238' ' ' GLY . 22.4 m -107.2 147.67 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.264 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -121.02 110.62 16.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.146 0.498 . . . . 0.0 111.091 -178.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.4 mm -80.49 118.31 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -104.33 98.96 8.67 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.942 -179.304 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.946 HG21 HD22 ' A' ' 224' ' ' LEU . 93.0 t -106.06 123.48 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.444 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -115.53 146.89 41.3 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.999 179.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 91.96 15.84 52.99 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -179.512 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.42 143.71 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.211 0.529 . . . . 0.0 110.825 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 41.4 tptt . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.767 179.385 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 N--CA 1.463 0.197 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.7 m -86.92 146.01 26.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.271 179.194 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 313' ' ' VAL . 20.4 mmtt -112.92 149.78 32.73 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.335 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -128.01 114.16 16.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.191 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.496 ' CE2' HD21 ' A' ' 224' ' ' LEU . 42.9 m-85 -114.03 116.47 29.24 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.678 177.732 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.1 102.18 13.63 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.584 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.732 ' CD2' HD11 ' A' ' 201' ' ' LEU . 29.4 tp -103.27 119.85 39.65 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.737 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -77.59 127.69 32.91 Favored 'General case' 0 C--O 1.255 1.366 0 CA-C-O 123.052 1.406 . . . . 0.0 112.765 -178.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 202' ' ' PHE . 78.4 p -59.48 -20.13 53.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.874 178.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -55.97 -43.63 77.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.15 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 6.7 t -74.6 -28.07 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.732 HD11 ' CD2' ' A' ' 196' ' ' LEU . 51.9 mt -93.52 -81.75 0.36 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.776 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.0 OUTLIER -113.27 130.28 56.29 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.869 -179.161 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.539 ' O ' ' NH1' ' A' ' 307' ' ' ARG . 7.7 m120 -98.7 -72.7 0.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -117.27 -21.13 8.89 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.817 0.341 . . . . 0.0 110.283 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -68.31 172.12 6.34 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.052 0.453 . . . . 0.0 110.321 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -53.37 -92.26 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.657 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -151.29 59.38 0.9 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.506 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 68.1 p -106.9 129.54 54.71 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 37.3 mt -74.7 125.01 27.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.697 -178.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 213' ' ' GLY . 50.4 mttt -86.32 158.52 54.88 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.72 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' N ' ' A' ' 213' ' ' GLY . 73.4 Cg_exo -34.01 -75.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.585 2.19 . . . . 0.0 112.045 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -49.02 -20.06 0.49 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.162 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.79 -51.32 11.4 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 178.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -66.19 -38.95 89.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.355 0.597 . . . . 0.0 110.241 179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.83 -53.75 54.86 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.67 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.37 90.83 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.981 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.88 -29.58 70.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.574 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -71.76 -46.28 58.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.219 0.533 . . . . 0.0 110.239 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -62.16 -44.02 97.53 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.218 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.16 -41.02 97.31 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' A' ' 225' ' ' SER . 3.7 t80 -52.93 -47.69 67.86 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.528 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 72.6 m -53.22 -52.69 58.1 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.424 -178.539 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' A' ' 223' ' ' GLN . 4.6 mp0 -55.78 -27.64 52.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.608 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.91 HD22 HG21 ' A' ' 313' ' ' VAL . 86.6 mt -92.43 -23.12 19.27 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.713 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 221' ' ' TYR . 8.1 t -77.56 -19.78 55.13 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.57 0.544 . . . . 0.0 110.738 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -96.05 22.17 7.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.068 0.461 . . . . 0.0 110.688 -179.242 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.459 ' H ' ' CD2' ' A' ' 227' ' ' LEU . 0.7 OUTLIER -74.03 -177.68 3.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.219 179.903 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 230' ' ' LYS . 3.7 t0 -99.43 127.08 35.38 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.359 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 232' ' ' GLY . 55.4 Cg_endo -69.73 -22.52 32.12 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.959 2.44 . . . . 0.0 113.593 -178.209 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.556 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 34.6 ttmt -23.74 -51.97 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.688 0.617 . . . . 0.0 111.1 -177.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 232' ' ' GLY . 90.2 m-20 -109.54 -10.48 14.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.939 178.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 27.32 58.13 0.1 Allowed Glycine 0 N--CA 1.471 0.992 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.627 ' H ' ' CE ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -124.34 119.0 28.01 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-O 121.249 0.547 . . . . 0.0 110.454 -179.549 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -132.75 99.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.514 0.673 . . . . 0.0 109.805 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.19 127.09 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.152 0.501 . . . . 0.0 111.11 -178.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 89.4 t -102.12 128.39 54.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.399 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 18.2 mt -108.78 140.43 42.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.016 0.436 . . . . 0.0 110.459 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -98.95 138.26 13.75 Favored Glycine 0 N--CA 1.472 1.092 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.201 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 308' ' ' ARG . 9.7 m-85 -125.63 115.82 20.74 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.344 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 4.9 t -117.18 163.94 15.53 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.461 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.584 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 48.9 p-10 -87.74 -174.92 4.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.417 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -99.21 121.79 41.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 110.075 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.8 mm -116.1 12.62 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.371 0.605 . . . . 0.0 110.728 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.05 -3.52 65.21 Favored Glycine 0 C--N 1.315 -0.584 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -125.39 105.26 8.95 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.93 -55.2 37.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.36 69.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.576 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.622 ' CE2' HD11 ' A' ' 252' ' ' LEU . 47.3 t80 -63.03 -44.88 94.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.775 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 18.8 m120 -61.88 -42.16 98.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.398 -179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -64.27 -41.81 96.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.644 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.74 -38.31 96.25 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.622 HD11 ' CE2' ' A' ' 248' ' ' TYR . 35.1 mt -69.2 -38.58 78.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.849 0.357 . . . . 0.0 111.199 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 78.1 p -63.56 -44.01 95.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.43 -45.11 80.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.437 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -56.8 -50.52 72.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.319 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.727 HH22 ' N ' ' A' ' 308' ' ' ARG . 70.3 mtp180 -59.13 -59.01 6.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.473 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.2 -35.68 17.79 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.172 0.511 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.408 ' NE2' ' OD1' ' A' ' 262' ' ' ASP . 68.0 tp60 -69.9 -43.75 71.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.154 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.7 t -60.86 -39.64 89.92 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.314 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.28 -54.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.773 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.571 HG13 HD12 ' A' ' 274' ' ' ILE . 24.4 t -60.21 -50.01 81.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.45 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.408 ' OD1' ' NE2' ' A' ' 258' ' ' GLN . 25.8 m-20 -44.6 -41.75 6.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -83.55 -29.67 27.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.745 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -71.74 -7.0 45.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.474 -179.658 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.0 mt -87.09 -55.74 6.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.832 0.349 . . . . 0.0 111.539 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.3 m -50.93 -5.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.887 -178.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.583 ' H ' ' C ' ' A' ' 265' ' ' ILE . 5.7 mmtm -77.17 -9.87 59.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.94 38.17 2.22 Favored Glycine 0 N--CA 1.458 0.15 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.07 128.35 23.76 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.24 130.24 34.71 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.965 1.777 . . . . 0.0 112.081 177.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.01 -10.71 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.917 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -92.84 -22.71 19.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.898 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -78.34 -23.21 47.09 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.632 0.73 . . . . 0.0 110.472 -179.496 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.571 HD12 HG13 ' A' ' 261' ' ' VAL . 1.4 pt -101.19 -170.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.71 -178.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 8.2 t -169.04 126.3 0.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.012 179.089 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.91 114.55 26.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.795 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -129.28 157.47 41.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.311 0.577 . . . . 0.0 110.18 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.54 155.11 16.25 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.541 ' N ' ' O ' ' A' ' 238' ' ' GLY . 5.5 tpt -118.62 -10.0 10.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.964 0.411 . . . . 0.0 110.293 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 53.58 -110.88 1.57 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -137.33 74.94 1.5 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.804 0.335 . . . . 0.0 110.732 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.9 t -72.86 -48.42 37.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.12 0.486 . . . . 0.0 111.498 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -144.63 76.77 14.06 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.12 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.55 123.26 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.627 2.218 . . . . 0.0 111.744 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.06 -35.87 42.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.115 0.483 . . . . 0.0 110.556 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.722 ' OG1' HD23 ' A' ' 303' ' ' LEU . 71.7 p -67.38 -50.03 61.41 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.643 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -55.12 1.73 0.05 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.7 t-20 -111.64 -61.12 1.75 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.3 t -76.91 -7.35 55.37 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.568 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.45 21.25 7.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.541 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -69.59 -4.2 18.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.575 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -96.6 33.02 1.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.661 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.8 t -125.65 129.96 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.944 0.402 . . . . 0.0 109.917 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.78 4.32 12.25 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -100.25 130.9 46.43 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.19 0.519 . . . . 0.0 110.432 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 299' ' ' LEU . 5.0 ttt180 -53.26 -75.62 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.604 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -42.36 -37.48 1.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.1 0.476 . . . . 0.0 110.747 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.48 84.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.793 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 296' ' ' ARG . 20.8 mt -73.12 -44.32 60.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.168 0.509 . . . . 0.0 110.575 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 300' ' ' ILE . 6.3 mm -60.84 -31.39 49.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.989 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -81.38 -28.97 34.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.611 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.3 t -93.68 -11.23 32.03 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.85 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.722 HD23 ' OG1' ' A' ' 286' ' ' THR . 37.7 mt -93.28 20.36 7.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.62 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -78.44 -46.11 2.03 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.288 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 37.7 Cg_exo -59.76 8.83 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.214 2.609 . . . . 0.0 111.886 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 304' ' ' ALA . 47.2 t0 -109.47 12.11 24.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.793 0.33 . . . . 0.0 110.852 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 203' ' ' ASN . 65.0 mtp180 -109.4 109.74 20.68 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.176 0.512 . . . . 0.0 110.36 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.727 ' N ' HH22 ' A' ' 256' ' ' ARG . 10.4 ptp180 -174.16 -172.38 0.7 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.998 -179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.35 157.11 15.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 177.232 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -121.79 106.65 11.48 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.221 0.534 . . . . 0.0 111.282 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.68 122.48 35.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.305 -178.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -108.06 116.65 32.34 Favored 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 123.775 0.672 . . . . 0.0 110.27 -178.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.91 HG21 HD22 ' A' ' 224' ' ' LEU . 80.2 t -130.77 125.71 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.154 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.652 ' HD3' ' H ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -99.41 179.53 4.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.335 179.043 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' A' ' 314' ' ' LYS . . . 71.52 -49.71 1.03 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 177.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 14.2 tt -47.07 150.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.098 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.058 179.649 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.477 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.442 HG22 ' NE2' ' A' ' 193' ' ' HIS . 17.7 m -69.12 139.03 54.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.291 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -142.33 114.0 7.95 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.9 m-70 -102.95 144.53 31.12 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.41 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 78.1 m-85 -107.22 130.68 54.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 195' ' ' THR . 8.0 t -86.32 104.35 15.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.825 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.597 ' HB3' HG23 ' A' ' 309' ' ' VAL . 3.4 mt -108.83 131.55 54.88 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.426 ' O ' HG22 ' A' ' 200' ' ' VAL . 0.8 OUTLIER -93.38 137.92 32.22 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 122.727 1.251 . . . . 0.0 110.991 -178.643 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 202' ' ' PHE . 0.9 OUTLIER -61.01 -18.21 56.45 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.427 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -57.13 -49.99 74.21 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.863 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 200' ' ' VAL . 4.7 m -68.26 -38.55 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.735 179.021 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.51 HD12 HG21 ' A' ' 309' ' ' VAL . 33.2 mt -82.79 -78.76 0.2 Allowed 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.449 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -138.06 137.86 38.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.841 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -119.49 -75.99 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.552 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -81.69 -37.7 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.933 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -67.26 170.52 7.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.144 0.497 . . . . 0.0 110.494 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -59.32 -82.82 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.775 -179.618 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -153.67 54.23 0.73 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.166 0.507 . . . . 0.0 110.349 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.57 127.93 53.72 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.486 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.6 mt -70.21 140.89 52.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 -179.096 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 213' ' ' GLY . 4.1 mtmp? -103.51 157.36 34.01 Favored Pre-proline 0 N--CA 1.466 0.326 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -32.97 -76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.718 2.279 . . . . 0.0 112.352 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -49.84 -20.32 0.85 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.326 0.584 . . . . 0.0 110.548 -179.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.53 -50.08 12.85 Favored Glycine 0 N--CA 1.461 0.365 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.084 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -65.15 -40.88 95.0 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.232 0.539 . . . . 0.0 109.944 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.0 67.04 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.07 -38.69 91.97 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.607 -179.532 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.31 -28.88 70.05 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.277 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -71.18 -47.24 58.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.374 0.607 . . . . 0.0 110.808 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -62.62 -43.5 98.66 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.974 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 60.9 tp -65.23 -39.36 92.63 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.235 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.431 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.7 t80 -53.42 -47.94 69.18 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.845 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.8 t -59.32 -50.07 75.39 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.537 -178.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.41 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 59.1 tt0 -51.95 -24.99 7.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.942 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.655 HD22 HG21 ' A' ' 313' ' ' VAL . 23.3 mt -96.68 -17.15 20.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.508 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 10.5 t -81.63 -16.12 52.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.795 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -103.32 17.72 23.43 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.581 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.6 OUTLIER -74.38 -179.44 3.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.323 179.701 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -97.96 109.46 51.56 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 230' ' ' LYS . 78.5 Cg_exo -47.6 -19.57 1.33 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.349 2.033 . . . . 0.0 113.438 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 229' ' ' PRO . 1.5 tmtp? -27.13 -51.79 0.06 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.261 0.553 . . . . 0.0 111.11 -177.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 232' ' ' GLY . 67.9 m-20 -110.14 -13.73 14.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.478 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.51 46.61 0.02 OUTLIER Glycine 0 N--CA 1.474 1.228 0 O-C-N 124.101 0.876 . . . . 0.0 111.272 179.546 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 231' ' ' ASP . 74.6 m -114.96 109.93 18.85 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.568 0.223 . . . . 0.0 111.149 -178.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 77.4 t -125.64 95.05 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.37 0.605 . . . . 0.0 109.933 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.7 t -96.69 121.14 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.296 0.569 . . . . 0.0 110.7 -178.144 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.41 HG13 HD13 ' A' ' 311' ' ' ILE . 96.5 t -91.07 122.3 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 45.9 mt -105.79 140.86 38.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.427 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.445 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -125.03 129.72 7.11 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.604 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -113.91 117.01 30.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.824 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.475 HG22 ' HA2' ' A' ' 280' ' ' GLY . 9.7 t -104.88 178.54 4.53 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.133 0.492 . . . . 0.0 110.975 -178.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 307' ' ' ARG . 41.8 m-20 -83.79 -177.08 6.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.394 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -117.02 120.28 37.9 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.768 0.318 . . . . 0.0 110.501 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 243' ' ' ILE . 45.4 mm -120.67 12.66 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.504 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.96 -43.5 3.26 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 6.9 m -71.1 94.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.362 0.601 . . . . 0.0 109.934 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -48.51 -48.34 38.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.203 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.14 84.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.749 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.566 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 44.2 t80 -62.14 -42.22 99.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.148 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.442 ' ND2' HG23 ' A' ' 240' ' ' THR . 15.3 t-20 -60.38 -53.08 61.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -61.67 -37.65 84.86 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.42 -41.83 99.63 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 33.0 mt -71.24 -37.78 71.99 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.073 178.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 4.2 t -63.0 -39.68 95.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.115 0.483 . . . . 0.0 110.879 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -73.19 -39.65 65.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.46 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -58.83 -51.75 68.65 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.517 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 260' ' ' VAL . 18.1 ptp180 -64.39 -44.28 91.81 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.899 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.32 -42.28 98.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.571 0.7 . . . . 0.0 110.421 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -70.72 -42.06 71.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.684 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.8 m -60.61 -39.14 87.09 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.383 0.611 . . . . 0.0 110.355 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 256' ' ' ARG . 88.8 t -63.97 -50.65 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.95 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.557 HG13 HD12 ' A' ' 274' ' ' ILE . 18.8 t -61.32 -48.27 89.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 121.165 0.507 . . . . 0.0 110.315 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -47.93 -40.9 23.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.908 -178.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -79.66 -35.59 39.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.026 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.14 -29.11 70.25 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.99 -179.023 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.483 ' C ' ' H ' ' A' ' 267' ' ' LYS . 89.0 mt -69.06 -49.54 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 120.797 0.332 . . . . 0.0 111.82 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 18.5 m -52.43 -8.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 265' ' ' ILE . 12.3 mmtt -79.75 -6.21 56.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.683 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.06 42.21 2.87 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.19 129.41 24.22 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 117.101 0.451 . . . . 0.0 110.583 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.56 129.34 29.21 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.325 1.35 . . . . 0.0 112.002 178.243 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.4 -11.05 38.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.74 -22.9 21.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -179.33 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.47 -23.54 50.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.295 0.569 . . . . 0.0 110.529 -179.541 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.557 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -104.18 -175.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.751 -179.116 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 25.7 m -169.28 132.53 1.29 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.326 178.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.93 148.99 22.05 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -153.1 138.09 17.22 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.394 0.616 . . . . 0.0 111.172 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.06 94.95 2.05 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.298 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -70.36 -6.88 38.53 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.535 -179.551 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 280' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 240' ' ' THR . . . 42.62 -112.56 0.48 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.88 73.75 1.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.688 0.28 . . . . 0.0 110.317 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 31.9 t -71.27 -37.5 71.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.043 0.449 . . . . 0.0 111.613 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -129.44 79.32 74.15 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.698 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.04 110.35 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.501 2.134 . . . . 0.0 112.112 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 286' ' ' THR . 9.1 m -73.14 -36.07 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.76 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.603 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.1 OUTLIER -62.21 -49.35 76.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.097 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -52.51 0.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 286' ' ' THR . 52.4 t30 -116.21 -59.69 1.95 Allowed 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.822 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -78.18 -3.61 43.44 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.438 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.75 17.9 4.25 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 292' ' ' ASN . 37.9 p-10 -61.53 -36.9 81.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.986 0.422 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 26.4 t-20 -78.73 33.32 0.21 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.947 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.464 ' HB ' HD11 ' A' ' 299' ' ' LEU . 12.1 t -135.93 124.92 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.005 0.431 . . . . 0.0 110.358 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -120.18 16.41 12.35 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.087 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -100.35 133.44 44.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.12 0.486 . . . . 0.0 110.66 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -59.96 -60.46 3.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.607 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.68 -43.26 65.45 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.978 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.93 89.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.268 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 303' ' ' LEU . 4.8 mp -75.62 -61.35 1.95 Allowed 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.324 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' LEU . 72.4 mt -42.32 -34.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.057 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -77.9 -38.72 45.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.316 178.067 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 299' ' ' LEU . 40.7 t -84.7 -6.99 59.38 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.005 0.431 . . . . 0.0 110.858 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 299' ' ' LEU . 92.8 mt -90.5 15.11 11.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.843 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -77.11 -53.28 1.72 Allowed Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.437 177.683 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 11.2 Cg_endo -54.25 8.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.178 1.919 . . . . 0.0 113.186 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 304' ' ' ALA . 59.4 t0 -101.4 12.88 36.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.541 ' NH2' ' OD2' ' A' ' 241' ' ' ASP . 15.1 ptp180 -113.61 95.2 5.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.189 0.995 . . . . 0.0 110.224 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.551 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.4 ptp180 -156.31 128.24 7.38 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.456 -178.869 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 196' ' ' LEU . 0.0 OUTLIER -97.01 135.6 30.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.292 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -118.51 104.91 11.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.333 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.41 HD13 HG13 ' A' ' 236' ' ' VAL . 4.7 mm -77.82 115.31 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.024 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -94.66 123.79 38.31 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 123.13 0.269 . . . . 0.0 110.672 -178.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.655 HG21 HD22 ' A' ' 224' ' ' LEU . 11.5 t -125.57 115.51 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.911 -178.683 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -114.72 134.46 55.08 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.14 17.1 25.9 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.6 tt -103.9 148.9 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.968 0.413 . . . . 0.0 110.38 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.612 -179.774 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.477 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.233 0 CA-C-O 120.916 0.389 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.1 m -67.8 139.12 56.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.146 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.461 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 7.5 mmtt -110.47 161.69 15.43 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.666 0.746 . . . . 0.0 110.611 179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.461 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 4.6 m80 -148.27 119.87 8.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.017 -179.514 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -110.89 120.48 42.53 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.17 103.81 15.15 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.245 -179.957 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.694 ' CD2' HD11 ' A' ' 201' ' ' LEU . 32.2 tp -108.67 128.78 55.15 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -81.81 130.09 34.95 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-O 121.776 0.798 . . . . 0.0 112.291 -178.361 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -64.99 -27.57 68.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.697 179.723 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.782 ' CG ' HD22 ' A' ' 203' ' ' ASN . 11.6 t70 -60.62 -38.48 84.89 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.849 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.25 -42.86 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.694 HD11 ' CD2' ' A' ' 196' ' ' LEU . 88.8 mt -78.12 -79.1 0.13 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.46 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -124.56 129.5 50.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.779 -179.228 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.782 HD22 ' CG ' ' A' ' 199' ' ' ASP . 24.2 m120 -94.44 -74.42 0.54 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.721 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.49 -10.09 14.56 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.7 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -74.3 165.37 25.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.188 0.518 . . . . 0.0 109.919 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.04 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.825 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.09 2.52 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.927 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 63.7 p -53.03 136.27 35.57 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.903 0.383 . . . . 0.0 110.282 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 83.6 mt -82.9 136.36 34.61 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.293 0.568 . . . . 0.0 111.364 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 213' ' ' GLY . 31.2 mtmt -98.6 157.59 34.0 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.956 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -34.44 -75.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.383 2.055 . . . . 0.0 112.419 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 57.0 mp0 -48.9 -24.5 1.5 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.361 0.6 . . . . 0.0 110.225 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -70.92 -51.16 20.29 Favored Glycine 0 CA--C 1.517 0.209 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.603 178.494 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.14 -41.02 99.22 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.318 0.58 . . . . 0.0 109.465 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.444 ' O ' ' CD ' ' A' ' 219' ' ' GLN . . . -54.18 -56.1 21.48 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.973 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.61 72.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.56 0.695 . . . . 0.0 110.612 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.11 -25.97 63.75 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.57 179.51 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -75.59 -49.84 17.35 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.881 0.848 . . . . 0.0 111.054 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.444 ' CD ' ' O ' ' A' ' 215' ' ' ALA . 0.4 OUTLIER -62.46 -44.54 96.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.421 179.58 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 42.3 tp -62.36 -40.73 97.37 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.411 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.4 t80 -51.8 -49.51 62.58 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.896 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.0 m -54.88 -51.02 67.27 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.716 -178.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -51.55 -26.5 8.72 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.424 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.981 HD22 HG21 ' A' ' 313' ' ' VAL . 43.1 mt -100.4 -17.95 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.589 -179.579 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.1 t -73.79 -28.28 61.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.191 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -95.79 23.91 5.85 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.85 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.482 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.61 167.42 21.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.201 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -82.01 129.19 65.4 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.309 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 230' ' ' LYS . 53.8 Cg_endo -70.36 -18.73 34.0 Favored 'Trans proline' 0 N--CA 1.506 2.248 0 C-N-CA 122.979 2.452 . . . . 0.0 112.832 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 229' ' ' PRO . 24.6 mmtm -32.32 -52.27 0.28 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.525 -177.334 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 232' ' ' GLY . 58.4 m-20 -104.45 -17.48 14.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.153 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.75 50.81 0.06 OUTLIER Glycine 0 N--CA 1.471 0.982 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.8 t -118.25 108.47 15.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.819 0.343 . . . . 0.0 110.935 -178.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 313' ' ' VAL . 15.7 t -125.93 95.61 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.285 178.577 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.4 120.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.245 -178.598 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.417 HG21 HG22 ' A' ' 261' ' ' VAL . 73.6 t -91.45 126.66 44.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.223 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 277' ' ' ARG . 23.8 mt -109.97 140.24 44.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.886 -179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -122.54 130.09 7.78 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.21 117.13 29.63 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.028 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.6 p -103.8 171.31 7.43 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 242' ' ' ARG . 43.6 t0 -85.45 -176.28 6.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.726 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.465 ' H ' ' CG ' ' A' ' 241' ' ' ASP . 88.9 mtm180 -109.34 120.65 43.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.957 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.0 mm -120.08 14.47 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.639 0.733 . . . . 0.0 110.645 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.09 -47.81 3.39 Favored Glycine 0 C--N 1.314 -0.653 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.9 p -76.2 91.16 3.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.287 0.565 . . . . 0.0 109.712 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -45.38 -46.5 13.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.372 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.97 80.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.625 ' CE2' HD11 ' A' ' 252' ' ' LEU . 57.2 t80 -59.76 -45.9 90.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.989 0.423 . . . . 0.0 110.347 -179.618 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -62.08 -40.99 97.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.098 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.05 -40.87 95.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.874 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.27 -38.77 96.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.625 HD11 ' CE2' ' A' ' 248' ' ' TYR . 98.3 mt -74.95 -31.2 61.43 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.931 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.5 t -66.49 -45.39 79.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.856 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.39 -39.54 71.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.226 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -61.59 -49.84 75.02 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.508 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.51 ' O ' HG23 ' A' ' 260' ' ' VAL . 99.4 mtt180 -62.28 -51.45 67.66 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.426 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -53.95 -34.34 59.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.162 0.506 . . . . 0.0 109.922 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -71.88 -42.99 66.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.0 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.782 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 16.7 t -62.02 -35.83 79.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.179 0.99 . . . . 0.0 109.92 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 256' ' ' ARG . 71.4 t -67.65 -54.5 22.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.341 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.417 HG22 HG21 ' A' ' 236' ' ' VAL . 55.9 t -63.44 -50.2 79.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 262' ' ' ASP . . . . . 0.782 ' OD1' ' O ' ' A' ' 259' ' ' SER . 40.7 p-10 -49.57 -37.64 28.12 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.577 -177.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.656 ' N ' ' OD1' ' A' ' 262' ' ' ASP . 35.0 t80 -81.34 -33.87 32.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.377 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -64.38 -22.15 66.86 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.893 -179.549 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 267' ' ' LYS . 87.7 mt -78.24 -52.29 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.49 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 62.0 m -49.33 -10.18 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.899 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.0 OUTLIER -77.51 -11.2 59.83 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.302 -179.398 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.8 42.32 1.58 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.402 HD12 ' CE1' ' A' ' 221' ' ' TYR . 0.1 OUTLIER -126.67 137.66 30.91 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 117.188 0.494 . . . . 0.0 110.575 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.81 124.23 15.55 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.698 1.599 . . . . 0.0 111.755 177.403 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.94 -9.83 42.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.874 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -91.22 -23.95 20.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.706 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.448 ' HE3' HD21 ' A' ' 227' ' ' LEU . 2.4 ttpm? -79.81 -19.34 48.72 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.585 0.707 . . . . 0.0 110.994 -179.286 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.5 pt -104.91 -171.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.532 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 47.4 t -170.82 137.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.105 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.43 150.56 22.05 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.456 ' HB3' HD23 ' A' ' 237' ' ' LEU . 62.0 ttm-85 -155.68 139.79 16.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.538 0.685 . . . . 0.0 111.455 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -93.97 96.96 2.13 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.297 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -69.96 -4.49 20.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.875 0.369 . . . . 0.0 110.345 -179.028 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.87 -116.28 1.2 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -138.21 71.0 1.39 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.764 0.316 . . . . 0.0 110.462 -179.658 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.14 5.61 49.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.276 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 283' ' ' ASN . 13.7 p-10 -159.82 74.82 3.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.75 108.32 2.25 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.424 2.083 . . . . 0.0 112.073 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 286' ' ' THR . 6.2 m -70.45 -43.03 78.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.608 ' C ' ' H ' ' A' ' 288' ' ' ASN . 65.7 p -58.83 -43.6 90.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.078 -179.474 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.62 -0.55 0.03 OUTLIER Glycine 0 CA--C 1.533 1.159 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.608 ' H ' ' C ' ' A' ' 286' ' ' THR . 80.5 m-20 -119.86 -59.09 1.83 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.4 OUTLIER -66.71 -18.75 65.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.572 -178.606 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.46 25.79 9.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.291 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 51.5 t0 -69.19 -10.95 60.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 110.393 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -94.89 32.58 1.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.528 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.1 t -129.92 127.26 63.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 110.237 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -117.77 8.13 12.64 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.969 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -95.36 127.81 41.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.044 0.449 . . . . 0.0 109.95 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -55.94 -50.47 70.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.516 -179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.78 96.91 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.982 -179.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.25 -30.09 70.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.62 179.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 39.6 mt -79.18 -57.04 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.398 -179.575 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.7 mt -45.89 -36.52 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.948 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -74.39 -47.21 35.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.509 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 6.7 t -75.8 -4.95 43.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.278 -179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.522 HD23 ' OG1' ' A' ' 286' ' ' THR . 50.5 mt -96.06 13.06 28.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.529 -179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.594 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -75.13 -46.13 4.69 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.828 0.347 . . . . 0.0 110.083 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 32.1 Cg_exo -56.41 10.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.971 2.448 . . . . 0.0 112.258 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.594 ' H ' ' C ' ' A' ' 304' ' ' ALA . 46.9 t0 -101.06 13.49 35.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.741 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.538 ' NH1' ' HB1' ' A' ' 304' ' ' ALA . 28.9 ptt-85 -113.04 101.72 9.73 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.991 0.9 . . . . 0.0 110.86 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.565 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 20.4 ptp180 -162.02 132.31 4.83 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.24 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.6 142.25 14.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -121.58 108.11 13.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.985 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.8 mm -78.97 119.75 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -99.06 120.58 39.72 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.04 -178.412 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.981 HG21 HD22 ' A' ' 224' ' ' LEU . 66.8 t -126.88 119.47 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 123.578 0.549 . . . . 0.0 111.318 -179.352 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -117.34 125.2 50.64 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.443 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 118.15 -18.6 11.23 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.25 144.1 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.377 179.486 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 18.1 tptm . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.458 -179.963 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.809 0.337 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 36.5 m -70.92 142.78 51.09 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.667 179.428 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.435 ' HD3' ' H ' ' A' ' 193' ' ' HIS . 5.3 tmtt? -111.49 162.36 15.18 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.381 0.61 . . . . 0.0 110.715 179.668 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.435 ' H ' ' HD3' ' A' ' 192' ' ' LYS . 53.9 m80 -152.82 121.18 6.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.674 179.699 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.484 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 59.6 m-85 -113.07 123.29 49.93 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.53 103.59 14.53 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.597 -179.588 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 196' ' ' LEU . 3.8 mt -104.69 122.34 45.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.039 0.447 . . . . 0.0 109.983 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.588 ' O ' HG22 ' A' ' 200' ' ' VAL . 8.9 ptpp? -85.73 135.0 33.93 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 122.52 1.153 . . . . 0.0 111.542 -179.562 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 202' ' ' PHE . 4.0 p -59.74 -19.59 51.11 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.679 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -51.86 -50.02 61.75 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.927 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 197' ' ' LYS . 27.2 m -70.92 -33.68 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.675 178.786 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 20.5 mt -86.45 -80.36 0.24 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.356 179.705 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -135.18 145.41 47.7 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.607 -179.146 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -112.58 -67.74 0.98 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.504 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -112.45 -16.57 12.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.574 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -68.28 167.02 15.25 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.01 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.604 ' CG ' ' H ' ' A' ' 207' ' ' ALA . 18.2 pttt -51.29 -70.29 0.09 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.628 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.604 ' H ' ' CG ' ' A' ' 206' ' ' LYS . . . -166.62 -1.18 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.331 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.9 t -52.81 137.16 32.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.897 0.38 . . . . 0.0 110.494 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 96.7 mt -80.17 144.28 33.13 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.566 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 213' ' ' GLY . 38.5 mttm -106.46 156.28 37.29 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.009 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -34.47 -76.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.713 2.275 . . . . 0.0 112.091 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -48.73 -22.16 0.74 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.052 0.453 . . . . 0.0 110.413 -179.146 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.15 -49.64 15.35 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 178.855 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.82 -39.94 91.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.26 0.552 . . . . 0.0 110.118 179.548 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.74 54.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.836 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.95 -37.2 86.53 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.03 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.9 mt -62.72 -30.64 71.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.867 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -71.24 -46.49 60.97 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.087 0.47 . . . . 0.0 110.379 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -63.33 -44.09 95.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.306 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 47.5 tp -63.94 -39.89 95.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.496 ' CE1' ' OG ' ' A' ' 225' ' ' SER . 3.8 t80 -54.02 -49.56 68.63 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.652 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 69.6 m -57.35 -50.56 72.58 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.366 -178.379 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.484 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 58.0 tt0 -52.85 -26.22 13.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.254 -179.56 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.956 HD22 HG21 ' A' ' 313' ' ' VAL . 82.6 mt -97.53 -17.83 19.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.509 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.496 ' OG ' ' CE1' ' A' ' 221' ' ' TYR . 4.8 m -78.81 -12.16 60.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.742 -179.651 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -104.75 22.34 15.29 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 110.325 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.15 177.69 6.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.242 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 315' ' ' GLY . 31.2 t0 -98.97 108.8 51.24 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 230' ' ' LYS . 75.7 Cg_exo -46.9 -19.44 0.79 Allowed 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.605 2.204 . . . . 0.0 113.023 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 229' ' ' PRO . 52.8 tptt -27.11 -52.07 0.06 Allowed 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 123.559 0.537 . . . . 0.0 111.016 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' GLY . 79.1 m-20 -109.4 -15.41 14.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.322 179.019 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.83 50.83 0.06 OUTLIER Glycine 0 C--N 1.338 0.68 0 O-C-N 123.892 0.745 . . . . 0.0 111.666 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 t -117.92 111.08 18.52 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.271 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.83 96.15 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.317 178.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.0 t -99.03 123.12 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.816 -178.701 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 94.8 t -97.88 126.73 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.397 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.603 HD22 ' SD ' ' A' ' 279' ' ' MET . 22.9 mt -110.45 143.88 40.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.513 -179.534 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 279' ' ' MET . . . -119.41 139.55 14.23 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.829 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.3 OUTLIER -120.34 119.66 33.76 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -178.748 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.44 HG23 HD22 ' A' ' 249' ' ' ASN . 0.4 OUTLIER -119.41 167.09 12.26 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.827 0.346 . . . . 0.0 110.414 -179.033 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.499 ' OD2' ' NE ' ' A' ' 307' ' ' ARG . 38.0 m-20 -81.21 -177.03 6.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.458 -179.023 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -105.52 125.71 51.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.33 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.0 mm -116.9 9.17 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.461 0.648 . . . . 0.0 110.829 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.48 10.33 85.72 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.133 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.4 m -129.59 106.38 8.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.128 0.489 . . . . 0.0 109.883 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.446 ' CG ' ' N ' ' A' ' 247' ' ' ALA . 22.1 p-10 -57.43 -53.68 55.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.912 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 247' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' A' ' 246' ' ' ASP . . . -54.63 -44.1 72.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.498 . . . . 0.0 110.458 -179.476 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.677 ' CE2' HD11 ' A' ' 252' ' ' LEU . 40.5 t80 -69.63 -41.3 75.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.994 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.557 ' ND2' ' OE2' ' A' ' 281' ' ' GLU . 0.3 OUTLIER -61.35 -52.49 64.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.713 -179.15 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -63.88 -38.17 90.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.555 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.53 -37.36 93.21 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.677 HD11 ' CE2' ' A' ' 248' ' ' TYR . 32.4 mt -71.6 -39.06 70.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.641 0.258 . . . . 0.0 110.692 178.393 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 52.4 p -61.71 -40.66 95.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.984 0.421 . . . . 0.0 110.599 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -69.52 -43.59 72.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.564 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -57.32 -47.46 81.49 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.414 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.785 ' O ' HG23 ' A' ' 260' ' ' VAL . 79.4 mtt-85 -62.99 -51.32 67.31 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.445 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.5 81.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.254 0.55 . . . . 0.0 109.874 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -72.11 -44.08 63.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.432 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 13.5 t -61.44 -38.36 86.9 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.43 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 256' ' ' ARG . 95.8 t -64.54 -52.59 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.723 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.425 HG13 HD12 ' A' ' 274' ' ' ILE . 41.9 t -60.52 -48.61 87.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.964 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -46.01 -41.86 12.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.077 -179.51 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -82.89 -30.83 28.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -71.08 -9.42 58.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.304 -179.496 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.554 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.6 mt -86.01 -53.89 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.353 179.307 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 84.6 p -51.37 -6.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.689 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 265' ' ' ILE . 10.0 mmpt? -76.18 -12.52 60.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 104.43 42.17 1.92 Allowed Glycine 0 N--CA 1.459 0.21 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.1 tt -127.3 131.46 23.85 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 117.045 0.422 . . . . 0.0 110.852 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.87 125.41 17.02 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.187 1.258 . . . . 0.0 111.923 177.36 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.39 -6.32 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 179.196 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -92.88 -23.67 18.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.944 -179.3 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -80.37 -18.7 48.25 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.443 0.64 . . . . 0.0 110.957 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.425 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -106.58 -174.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.516 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 25.8 t -171.53 134.14 0.83 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.21 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.54 152.85 18.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.565 ' HB3' HD23 ' A' ' 237' ' ' LEU . 46.1 ttt85 -159.62 147.1 16.94 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.547 0.689 . . . . 0.0 111.037 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.1 143.89 16.88 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.16 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.603 ' SD ' HD22 ' A' ' 237' ' ' LEU . 2.1 tpt -114.92 -3.65 12.67 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.616 0.246 . . . . 0.0 110.385 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.07 -100.26 0.02 OUTLIER Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.557 ' OE2' ' ND2' ' A' ' 249' ' ' ASN . 28.4 mp0 -142.11 54.25 1.46 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.705 -0.248 . . . . 0.0 110.573 179.314 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.6 m -65.59 -0.05 1.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 0.0 110.697 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 281' ' ' GLU . 48.1 t-20 -167.19 85.43 0.82 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.32 106.25 2.01 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.212 1.941 . . . . 0.0 112.599 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.6 m -94.65 -17.83 7.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 121.314 0.578 . . . . 0.0 110.645 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 290' ' ' CYS . 19.7 p -58.02 -42.78 86.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.595 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 287' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 290' ' ' CYS . . . -48.09 -93.04 0.01 OUTLIER Glycine 0 C--O 1.225 -0.406 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 287' ' ' GLY . 57.6 t30 -28.53 -56.91 0.12 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.803 0.355 . . . . 0.0 110.432 -178.552 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 m -56.73 -45.28 82.06 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.693 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 287' ' ' GLY . 24.1 m -101.77 32.76 3.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.188 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 287' ' ' GLY . 47.5 t0 -56.21 -47.91 77.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.825 0.345 . . . . 0.0 110.605 -179.074 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 292' ' ' ASN . 58.5 t-20 -76.59 31.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.814 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 291' ' ' ASP . 10.6 t -129.48 107.34 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -119.38 14.02 12.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.738 179.673 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -100.23 134.09 43.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.129 0.49 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -49.81 -69.19 0.12 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.438 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.61 -38.84 60.92 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.448 0.642 . . . . 0.0 110.746 -178.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.04 -34.96 79.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 303' ' ' LEU . 16.6 mt -73.87 -56.98 4.29 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.2 mt -46.16 -29.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.425 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -83.59 -44.04 15.02 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.336 178.3 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 1.9 t -74.51 -16.71 60.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.989 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 299' ' ' LEU . 76.6 mt -82.58 25.15 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.817 0.698 . . . . 0.0 110.448 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.619 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -81.11 -38.0 0.96 Allowed Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 32.3 Cg_exo -58.54 6.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.442 2.761 . . . . 0.0 112.748 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 304' ' ' ALA . 2.8 m-20 -111.6 15.64 21.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.744 0.307 . . . . 0.0 110.513 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.499 ' NE ' ' OD2' ' A' ' 241' ' ' ASP . 96.0 mtt-85 -108.54 94.27 4.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.275 0.56 . . . . 0.0 110.16 179.098 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 8.2 ptm180 -168.56 158.35 9.38 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.001 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.64 150.87 26.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.65 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.457 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 92.4 mt-10 -121.1 106.85 11.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.405 0.622 . . . . 0.0 110.855 -178.842 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.5 mm -79.31 117.93 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.964 -178.179 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -102.87 127.36 50.09 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.956 HG21 HD22 ' A' ' 224' ' ' LEU . 93.6 t -132.2 122.21 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 O-C-N 124.077 0.861 . . . . 0.0 111.753 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -116.8 132.31 56.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.88 37.26 4.74 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 317' ' ' LYS . 7.2 tt -109.03 168.06 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.672 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.619 ' O ' ' O ' ' A' ' 316' ' ' ILE . 21.4 pttm . . . . . 0 CA--C 1.534 0.329 0 O-C-N 124.303 1.002 . . . . 0.0 111.987 -179.322 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.434 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 121.081 0.467 . . . . 0.0 109.925 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.518 HG22 ' CE1' ' A' ' 193' ' ' HIS . 6.9 m -68.47 136.34 53.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.336 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -140.06 105.59 5.1 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.58 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.518 ' CE1' HG22 ' A' ' 191' ' ' THR . 2.7 m80 -94.85 145.3 24.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.582 ' CE1' HD21 ' A' ' 224' ' ' LEU . 33.1 m-85 -111.81 123.9 51.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.43 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 195' ' ' THR . 5.6 t -84.24 103.76 13.7 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.556 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.742 ' CD2' HD11 ' A' ' 201' ' ' LEU . 30.0 tp -108.34 128.98 55.23 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.066 -179.314 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -83.82 129.13 34.94 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 122.297 1.046 . . . . 0.0 112.218 -178.258 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 202' ' ' PHE . 15.3 m -63.91 -30.36 71.45 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.396 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.03 -41.08 74.42 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.14 -42.5 88.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.164 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.742 HD11 ' CD2' ' A' ' 196' ' ' LEU . 61.1 mt -79.18 -79.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.911 179.751 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -120.09 122.46 41.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.747 -179.123 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -87.24 -75.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -113.08 -10.71 13.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.722 HD21 HG22 ' A' ' 208' ' ' THR . 7.5 p-10 -76.25 171.29 14.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.182 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -50.0 -87.49 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.408 -178.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -154.78 5.97 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.278 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.722 HG22 HD21 ' A' ' 205' ' ' ASN . 8.7 t -54.35 141.94 28.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 36.8 mt -83.1 133.98 35.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.244 0.545 . . . . 0.0 111.166 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.457 ' CB ' ' NZ ' ' A' ' 210' ' ' LYS . 6.4 mtpm? -99.14 156.73 35.14 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.064 179.001 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -34.94 -75.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.557 2.171 . . . . 0.0 112.0 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -46.32 -26.66 0.86 Allowed 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.28 0.562 . . . . 0.0 110.307 -179.414 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -69.03 -51.99 25.79 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.887 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -58.65 -39.73 81.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.78 -60.15 3.61 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.419 179.504 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.91 -25.98 68.39 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.695 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -30.4 65.09 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.513 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.93 -47.58 28.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.819 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 13.3 pt20 -63.97 -42.79 97.15 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.91 -179.579 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.506 HD21 HD12 ' A' ' 311' ' ' ILE . 48.1 tp -59.61 -41.51 90.54 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.484 ' C ' ' H ' ' A' ' 223' ' ' GLN . 10.1 t80 -54.94 -60.61 3.13 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.154 177.831 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.4 m -54.44 -8.21 0.2 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.076 0.465 . . . . 0.0 110.642 -179.129 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 221' ' ' TYR . 15.5 tt0 -93.51 -33.82 13.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.339 178.803 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 313' ' ' VAL . 73.5 mt -97.69 -11.42 23.51 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.623 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 25.8 p -79.21 -26.23 42.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.973 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -88.03 18.88 3.92 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.024 0.44 . . . . 0.0 110.496 -179.245 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.512 HD22 ' O ' ' A' ' 224' ' ' LEU . 1.0 OUTLIER -76.12 156.84 33.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.388 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -78.77 116.71 61.81 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.196 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 232' ' ' GLY . 59.6 Cg_exo -48.92 -21.99 4.36 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.893 2.395 . . . . 0.0 113.059 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 229' ' ' PRO . 27.2 tptp -24.76 -52.35 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 123.75 0.656 . . . . 0.0 110.802 -177.746 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 233' ' ' SER . 72.7 m-20 -109.79 -11.49 14.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.8 179.039 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 24.73 42.86 0.01 OUTLIER Glycine 0 N--CA 1.47 0.935 0 O-C-N 123.953 0.783 . . . . 0.0 111.679 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -112.77 114.55 27.17 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 122.516 -0.402 . . . . 0.0 110.449 -178.61 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 75.4 t -129.22 93.88 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.807 0.813 . . . . 0.0 110.325 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.5 t -97.08 123.29 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.001 -179.175 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.516 HG21 ' CG2' ' A' ' 261' ' ' VAL . 20.2 t -95.65 122.46 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.648 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 75.3 mt -105.58 141.95 36.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.032 -179.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.34 127.3 6.39 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -110.25 122.77 48.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.302 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.577 HG22 ' N ' ' A' ' 241' ' ' ASP . 51.0 m -117.3 164.75 14.35 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.322 0.389 . . . . 0.0 110.238 -179.265 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.577 ' N ' HG22 ' A' ' 240' ' ' THR . 42.3 p-10 -80.95 -175.87 5.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.605 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -116.88 122.89 45.64 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 -179.826 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.8 mm -118.11 17.22 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.725 0.774 . . . . 0.0 110.808 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.28 -49.04 2.4 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.501 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 245' ' ' SER . . . . . 0.485 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 5.6 t -76.14 88.72 3.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.918 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -40.4 -43.55 1.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.729 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.4 -38.69 91.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.352 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.555 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 67.1 t80 -59.23 -50.28 74.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.936 -179.057 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 245' ' ' SER . 2.7 p-10 -64.13 -40.74 96.83 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.185 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -61.38 -45.71 93.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.59 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.18 -35.71 92.45 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.555 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 29.6 mt -70.41 -40.37 73.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.006 0.431 . . . . 0.0 111.106 178.704 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.0 t -62.84 -39.24 93.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.515 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -68.69 -45.08 72.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.247 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.18 -44.9 88.23 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.067 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.34 -61.41 2.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.678 178.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.88 -34.04 18.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.105 0.479 . . . . 0.0 110.026 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -72.25 -44.82 62.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.449 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.4 t -58.48 -39.53 80.22 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.301 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.91 -53.44 41.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.392 178.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.605 HG13 HD12 ' A' ' 274' ' ' ILE . 4.7 t -60.96 -50.19 81.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.436 179.659 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -46.28 -41.38 13.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.206 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.51 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 60.8 t80 -80.77 -32.78 35.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.809 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.17 -32.81 74.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.21 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.538 ' C ' ' H ' ' A' ' 267' ' ' LYS . 83.8 mt -63.85 -48.27 87.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.322 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 28.2 m -51.45 -6.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.755 -179.276 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 265' ' ' ILE . 33.1 mmtp -87.19 9.15 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.505 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 84.4 40.83 8.2 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.16 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.74 126.35 25.75 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.9 130.28 36.92 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.98 1.787 . . . . 0.0 112.094 177.271 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.17 -9.45 31.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 65.6 t0 -90.88 -23.42 20.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.529 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -79.24 -21.14 46.62 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.608 0.718 . . . . 0.0 110.526 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.605 HD12 HG13 ' A' ' 261' ' ' VAL . 1.5 pt -105.35 -171.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.332 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 11.9 t -169.55 130.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.176 178.582 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -104.45 110.17 22.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.873 0.368 . . . . 0.0 110.535 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -115.47 140.96 48.67 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.574 0.702 . . . . 0.0 111.097 -179.646 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.578 ' O ' ' NH1' ' A' ' 277' ' ' ARG . . . -90.18 93.35 1.86 Allowed Glycine 0 CA--C 1.519 0.329 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.49 ' N ' ' O ' ' A' ' 238' ' ' GLY . 3.6 tpt -71.62 0.69 8.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.085 -178.793 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 280' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 31.87 -100.07 0.01 OUTLIER Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -144.1 70.18 1.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.714 0.292 . . . . 0.0 110.891 179.122 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.6 p -64.35 -44.24 92.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.192 0.52 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -125.4 80.47 65.43 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.961 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.18 105.76 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.686 2.257 . . . . 0.0 112.669 -179.35 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 285' ' ' VAL . 10.4 m -71.02 -32.83 49.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.193 0.52 . . . . 0.0 110.687 179.307 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.596 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.2 OUTLIER -57.23 -44.55 83.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.357 -179.218 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.84 -5.82 0.02 OUTLIER Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 286' ' ' THR . 74.6 m-20 -125.46 -58.51 1.42 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.579 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.9 m -58.89 -24.64 62.52 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.553 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 84.8 m -116.11 29.6 7.87 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.451 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.93 -4.28 19.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.612 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -109.87 31.48 5.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.661 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.52 121.3 45.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.969 0.414 . . . . 0.0 110.41 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -120.79 7.34 10.46 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.8 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.497 ' O ' HD12 ' A' ' 299' ' ' LEU . 7.6 mt-30 -89.14 172.67 8.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.98 0.419 . . . . 0.0 110.014 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -84.99 -70.47 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.584 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.84 -31.62 68.67 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.89 -178.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.89 -39.93 87.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 295' ' ' GLN . 50.5 mt -69.78 -48.89 57.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.015 0.436 . . . . 0.0 110.644 179.751 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 60.8 mt -49.15 -36.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.899 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.6 -40.27 29.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.117 0.484 . . . . 0.0 110.646 178.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.426 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 1.1 t -74.36 -10.64 59.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.988 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 299' ' ' LEU . 61.4 mt -91.89 22.59 4.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.643 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.622 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -83.21 -41.56 0.83 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.995 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 31.9 Cg_exo -55.8 10.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 123.293 2.662 . . . . 0.0 112.403 -179.07 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.602 ' H ' ' C ' ' A' ' 304' ' ' ALA . 27.5 m-20 -109.55 21.72 16.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.639 0.257 . . . . 0.0 110.849 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 307' ' ' ARG . 15.7 ptp180 -114.04 84.99 2.13 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.14 0.972 . . . . 0.0 110.259 178.839 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.4 ptm180 -156.49 128.06 7.16 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.062 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.77 139.14 19.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.466 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -119.69 104.51 10.32 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.303 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.506 HD12 HD21 ' A' ' 220' ' ' LEU . 0.7 OUTLIER -79.36 116.71 23.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.312 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -96.14 122.14 38.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.819 0.342 . . . . 0.0 111.033 -178.716 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 224' ' ' LEU . 84.0 t -129.5 122.46 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.869 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -118.57 144.86 45.8 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.308 178.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 92.26 22.42 29.72 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -178.208 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.661 ' O ' ' O ' ' A' ' 317' ' ' LYS . 10.8 tt -99.16 170.86 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.661 ' O ' ' O ' ' A' ' 316' ' ' ILE . 29.5 tttp . . . . . 0 CA--C 1.539 0.529 0 O-C-N 123.943 0.777 . . . . 0.0 110.958 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.475 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 1.5 pm0 . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 120.825 0.345 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.645 HG22 ' N ' ' A' ' 192' ' ' LYS . 44.6 m -76.45 170.49 16.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.43 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.645 ' N ' HG22 ' A' ' 191' ' ' THR . 13.0 tptp -141.88 160.64 39.78 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 109.978 178.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -152.02 124.27 8.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.108 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.596 ' CE2' HD21 ' A' ' 224' ' ' LEU . 52.1 m-85 -114.37 119.11 35.81 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.438 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 195' ' ' THR . 5.5 t -86.49 105.23 16.65 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.555 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.694 HD23 HD11 ' A' ' 201' ' ' LEU . 27.0 tp -106.74 123.4 48.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.031 0.443 . . . . 0.0 109.933 -179.223 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -74.53 129.34 37.56 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 122.587 1.184 . . . . 0.0 112.277 -178.346 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 202' ' ' PHE . 41.6 t -62.97 -40.31 97.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.173 178.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -45.75 -34.88 3.91 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.719 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.75 -56.82 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.476 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.694 HD11 HD23 ' A' ' 196' ' ' LEU . 82.2 mt -66.87 -77.8 0.07 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.815 -179.32 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -106.03 135.7 47.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.858 -178.188 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -98.3 -78.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -117.74 -19.04 9.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.963 179.237 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -65.99 171.75 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.127 0.489 . . . . 0.0 110.199 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -53.79 -81.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.844 -179.231 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -157.9 58.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.51 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.0 p -106.95 131.18 54.32 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 110.056 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.414 HD22 HD22 ' A' ' 201' ' ' LEU . 62.4 mt -71.92 145.11 48.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.256 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.9 mtpm? -107.91 158.03 34.54 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.304 179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 213' ' ' GLY . 74.8 Cg_exo -34.91 -77.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.3 2.0 . . . . 0.0 112.01 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -48.41 -19.19 0.29 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 -179.509 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.88 -50.23 19.6 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 178.794 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -65.13 -38.39 90.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.145 0.498 . . . . 0.0 109.77 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.91 -53.87 53.3 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.011 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.91 -33.82 76.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.615 0.721 . . . . 0.0 110.383 -179.564 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.67 -25.9 65.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.603 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 218' ' ' ASP . . . . . 0.537 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 72.2 m-20 -72.79 -47.11 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.569 0.7 . . . . 0.0 109.9 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.35 -40.29 96.86 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.99 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.8 tp -60.37 -40.98 92.76 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.458 ' CG ' ' HB3' ' A' ' 267' ' ' LYS . 69.4 t80 -55.34 -58.95 5.62 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.922 178.259 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 58.8 m -57.14 -7.49 0.53 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.289 0.566 . . . . 0.0 110.216 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.489 ' OE1' ' CE1' ' A' ' 194' ' ' PHE . 17.1 tt0 -95.06 -35.54 11.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.384 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.828 HD22 HG21 ' A' ' 313' ' ' VAL . 80.4 mt -96.51 -11.38 25.56 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.658 -179.291 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 75.8 p -85.89 -7.31 58.78 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.542 0.526 . . . . 0.0 110.579 -179.327 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 223' ' ' GLN . 51.2 p30 -101.35 19.23 18.15 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.311 0.577 . . . . 0.0 110.529 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.7 OUTLIER -78.31 -177.3 5.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.136 -179.973 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -100.69 108.47 53.78 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 230' ' ' LYS . 72.5 Cg_exo -45.62 -21.39 0.84 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.673 2.249 . . . . 0.0 112.897 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 229' ' ' PRO . 88.0 tttt -34.47 -52.07 0.48 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 110.546 -178.15 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 232' ' ' GLY . 25.6 m-20 -98.54 -20.01 17.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.762 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 28.32 52.4 0.11 Allowed Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 59.7 m -118.93 115.17 23.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.557 0.217 . . . . 0.0 111.107 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 72.8 t -133.48 92.26 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.794 0.807 . . . . 0.0 110.195 178.43 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.11 127.62 51.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.279 0.561 . . . . 0.0 110.61 -178.484 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.411 HG13 HD13 ' A' ' 311' ' ' ILE . 91.3 t -100.63 126.42 54.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.399 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.8 mt -111.94 131.64 55.26 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.469 -178.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -86.08 138.37 15.96 Favored Glycine 0 N--CA 1.467 0.766 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.553 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.555 ' O ' ' NH2' ' A' ' 256' ' ' ARG . 11.4 m-85 -131.04 115.89 17.05 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 117.799 0.799 . . . . 0.0 109.431 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.425 ' HA ' HH12 ' A' ' 256' ' ' ARG . 14.8 t -126.71 172.8 10.01 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.465 -179.154 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.565 ' HB2' HD12 ' A' ' 303' ' ' LEU . 54.8 p-10 -86.19 -175.23 5.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.432 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -102.3 124.48 47.95 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.245 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.7 mm -117.64 14.42 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.456 0.646 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 71.8 5.06 60.18 Favored Glycine 0 C--N 1.317 -0.493 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 5.3 t -124.68 105.29 9.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.862 0.363 . . . . 0.0 110.199 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -57.11 -55.22 37.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.195 -179.075 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.77 -46.02 78.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.772 ' CE2' HD11 ' A' ' 252' ' ' LEU . 38.3 t80 -63.38 -42.0 98.8 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.886 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.79 -44.87 96.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.642 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -65.28 -39.64 92.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.19 -42.49 99.8 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.772 HD11 ' CE2' ' A' ' 248' ' ' TYR . 80.2 mt -66.92 -41.81 86.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.006 179.437 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.5 t -66.2 -48.36 70.88 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.118 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.25 -52.21 66.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.589 -179.575 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -55.5 -47.31 76.38 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.273 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.685 HH22 ' N ' ' A' ' 308' ' ' ARG . 66.3 mtp180 -58.29 -59.31 5.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.162 179.158 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -50.59 -32.62 19.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.121 0.486 . . . . 0.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -73.12 -49.7 26.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.986 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 44.6 t -53.42 -41.29 65.88 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.153 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.65 -54.88 23.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.603 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.51 HG13 HD12 ' A' ' 274' ' ' ILE . 10.4 t -57.64 -50.42 77.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.212 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -46.33 -42.84 15.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.914 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -81.55 -31.14 32.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.592 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -71.05 -7.96 50.09 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.274 -179.195 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.2 mt -86.51 -55.69 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 120.84 0.352 . . . . 0.0 111.408 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.7 t -49.78 -6.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.909 -178.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.573 ' H ' ' C ' ' A' ' 265' ' ' ILE . 22.9 mmmt -76.98 -11.38 59.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.08 39.71 1.93 Allowed Glycine 0 CA--C 1.509 -0.291 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.86 133.02 24.66 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.241 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.64 128.88 32.13 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.833 1.689 . . . . 0.0 112.174 176.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.73 -9.31 42.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.986 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.23 -21.32 21.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.774 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -82.54 -20.12 37.27 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.426 0.631 . . . . 0.0 110.893 -179.503 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.51 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -103.76 -172.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.118 -178.78 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 27.9 t -168.81 143.09 3.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.297 178.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -115.72 113.78 23.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.806 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -127.22 150.93 49.31 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.929 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -105.37 100.58 1.74 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 3.4 tpp -70.03 -13.04 62.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.066 0.46 . . . . 0.0 110.155 -179.479 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 63.46 -103.23 0.64 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -141.89 74.12 1.44 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.84 0.353 . . . . 0.0 110.587 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 84.8 p -95.58 2.23 54.13 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.7 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -158.6 70.52 3.73 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.553 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.94 105.6 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.406 2.071 . . . . 0.0 112.291 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 14.7 m -69.58 -31.94 50.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.46 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 288' ' ' ASN . 41.7 p -57.35 -43.96 83.9 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.736 -179.243 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -45.62 -7.93 0.01 OUTLIER Glycine 0 CA--C 1.534 1.222 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.298 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.9 t30 -126.84 -56.57 1.36 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.918 0.389 . . . . 0.0 110.137 178.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.3 m -55.23 -40.4 70.83 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.281 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 72.1 m -98.6 36.44 1.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.421 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -74.56 -2.48 26.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.498 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -107.06 31.67 5.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.497 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.1 t -132.05 123.76 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.526 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -119.39 4.43 11.21 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.208 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -99.64 136.21 39.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.157 0.503 . . . . 0.0 110.095 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -51.43 -76.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.774 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -46.0 -39.17 8.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 -178.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.29 88.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.959 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.69 -43.54 79.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.566 179.153 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.4 mm -58.08 -37.21 60.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.783 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -74.01 -35.65 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.082 179.126 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.1 t -81.77 -3.2 53.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.416 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' ' 241' ' ' ASP . 0.5 OUTLIER -94.18 22.33 6.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.235 -179.485 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.61 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -82.65 -41.82 0.91 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.602 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.8 Cg_exo -60.03 10.09 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.294 2.662 . . . . 0.0 112.099 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 304' ' ' ALA . 57.9 t0 -115.12 18.89 16.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.958 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -109.01 107.18 17.44 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.377 0.608 . . . . 0.0 110.345 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.685 ' N ' HH22 ' A' ' 256' ' ' ARG . 18.0 ptp180 -171.86 -173.74 1.21 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.984 -179.186 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.35 153.65 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.845 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.496 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 95.7 mt-10 -124.64 102.53 7.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.317 0.579 . . . . 0.0 110.801 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.411 HD13 HG13 ' A' ' 236' ' ' VAL . 3.4 mm -81.58 120.34 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.14 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -104.92 119.87 40.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.798 0.332 . . . . 0.0 110.426 -178.855 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.828 HG21 HD22 ' A' ' 224' ' ' LEU . 86.6 t -130.43 124.76 58.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.59 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -118.83 148.19 43.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.56 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.88 4.4 57.83 Favored Glycine 0 N--CA 1.462 0.43 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 16.0 tt -91.55 141.79 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.206 0.527 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 19.0 tptp . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.794 -179.396 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 316' ' ' ILE . 14.0 mm100 . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.919 0.39 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.44 HG22 ' NE2' ' A' ' 193' ' ' HIS . 24.3 m -78.11 127.12 31.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.2 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -146.71 116.45 7.19 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.467 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.5 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 2.2 m-70 -101.18 147.72 25.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -109.77 128.53 55.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.911 0.386 . . . . 0.0 110.302 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.94 103.24 15.13 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.98 -179.765 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.729 ' CD2' HD11 ' A' ' 201' ' ' LEU . 24.8 tp -107.96 129.04 55.14 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 109.955 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.473 ' HB3' HG23 ' A' ' 200' ' ' VAL . 71.8 tttt -80.9 126.57 31.52 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 121.905 0.86 . . . . 0.0 112.033 -178.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.5 t -65.27 -28.08 69.09 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.066 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -62.92 -37.94 88.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.034 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 197' ' ' LYS . 88.6 t -65.96 -44.36 92.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.56 179.295 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.729 HD11 ' CD2' ' A' ' 196' ' ' LEU . 76.6 mt -75.75 -78.75 0.11 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.289 179.472 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.28 118.67 30.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.031 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -94.62 -78.3 0.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.702 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -88.47 -26.94 21.81 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.765 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.407 ' OD1' HG23 ' A' ' 208' ' ' THR . 24.0 t-20 -69.79 158.43 35.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.153 0.501 . . . . 0.0 110.381 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -51.42 -71.47 0.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.221 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -159.77 56.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.428 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.407 HG23 ' OD1' ' A' ' 205' ' ' ASN . 38.5 p -108.08 133.04 52.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.821 0.343 . . . . 0.0 110.172 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.06 138.61 39.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 -179.133 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.8 mtpm? -101.49 157.47 33.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.302 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 210' ' ' LYS . 76.0 Cg_exo -33.22 -75.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.598 2.199 . . . . 0.0 111.969 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -49.61 -23.4 1.67 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.18 0.514 . . . . 0.0 110.328 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.94 -48.73 19.6 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.811 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -66.61 -38.74 87.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.14 0.495 . . . . 0.0 110.012 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.84 -53.06 62.46 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.444 -179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.75 88.53 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.635 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.0 mt -62.53 -27.6 69.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.487 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 218' ' ' ASP . . . . . 0.458 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 51.3 m-20 -73.81 -46.45 45.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.219 0.533 . . . . 0.0 110.535 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.62 -42.89 99.85 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.174 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.459 HD21 HD12 ' A' ' 311' ' ' ILE . 42.9 tp -66.37 -38.96 88.74 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.728 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.436 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.2 t80 -53.78 -50.72 65.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.123 179.379 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 225' ' ' SER . 75.9 p -60.15 -49.75 76.41 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.378 -178.917 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.579 ' OE1' HD11 ' A' ' 316' ' ' ILE . 1.1 tm0? -49.57 -25.89 3.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.184 -179.737 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.743 ' O ' HD22 ' A' ' 227' ' ' LEU . 64.7 mt -97.19 -13.45 22.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.364 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' SER . 36.9 t -72.86 -21.57 60.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.698 179.511 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -99.91 16.79 22.68 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.743 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.74 150.69 36.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.138 179.862 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 315' ' ' GLY . 6.7 t0 -67.12 124.13 88.1 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.468 178.84 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 230' ' ' LYS . 44.5 Cg_endo -69.15 -19.67 38.75 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.79 2.327 . . . . 0.0 112.846 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 229' ' ' PRO . 63.4 tttp -30.09 -52.42 0.15 Allowed 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.682 0.614 . . . . 0.0 110.457 -178.386 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 232' ' ' GLY . 20.6 m-20 -103.28 -18.25 14.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.485 178.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.478 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.75 47.33 0.03 OUTLIER Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 231' ' ' ASP . 0.4 OUTLIER -112.59 111.25 21.93 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.146 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.56 94.42 2.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.311 0.577 . . . . 0.0 109.895 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.2 t -96.47 122.65 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.237 -178.707 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.441 HG22 HG23 ' A' ' 311' ' ' ILE . 12.1 t -95.68 119.7 44.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.642 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 47.4 mt -103.76 147.38 27.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.049 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.85 133.13 8.15 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.636 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.4 OUTLIER -116.54 119.84 36.84 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.504 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.441 ' O ' ' OD1' ' A' ' 306' ' ' ASP . 3.3 p -106.92 168.15 9.39 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 120.772 0.32 . . . . 0.0 110.344 -179.445 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -81.85 179.93 7.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.525 -179.666 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -99.6 119.44 38.08 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.862 0.363 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.4 mm -121.4 6.18 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.404 0.621 . . . . 0.0 111.058 179.358 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.41 -47.65 3.66 Favored Glycine 0 C--N 1.314 -0.666 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.2 p -73.7 90.08 1.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 109.887 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 91.7 m-20 -43.0 -46.55 5.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.676 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.6 83.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.555 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 49.2 t80 -61.08 -49.31 77.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 246' ' ' ASP . 0.2 OUTLIER -63.22 -42.75 99.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.584 -179.741 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -63.71 -46.13 86.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.723 -179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.39 -35.03 90.39 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.555 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 29.9 mt -73.5 -37.53 65.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.887 0.375 . . . . 0.0 111.129 178.795 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.8 m -64.12 -40.95 97.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.747 -179.258 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 258' ' ' GLN . 96.9 mt-10 -71.7 -41.39 68.66 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.189 179.595 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -59.52 -48.3 82.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.524 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 260' ' ' VAL . 89.4 mtt-85 -63.26 -60.38 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.961 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -52.1 -36.62 51.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 254' ' ' GLU . 0.5 OUTLIER -70.84 -42.72 69.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.218 179.665 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.3 t -63.02 -36.77 84.67 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.357 0.599 . . . . 0.0 110.272 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 256' ' ' ARG . 87.2 t -64.27 -50.19 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.552 179.335 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.541 HG13 HD12 ' A' ' 274' ' ' ILE . 10.6 t -60.88 -49.43 84.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.29 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -45.7 -39.81 8.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.9 -179.457 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -83.2 -32.31 26.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.1 -11.11 60.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.488 -179.287 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' A' ' 267' ' ' LYS . 64.6 mt -86.11 -53.14 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-O 120.723 0.297 . . . . 0.0 110.925 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.4 m -50.34 -6.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.186 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 265' ' ' ILE . 22.9 mmmt -80.58 -12.06 59.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.862 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.75 40.41 1.87 Allowed Glycine 0 CA--C 1.51 -0.221 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.25 129.16 24.27 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.854 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.86 128.17 27.62 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.958 1.772 . . . . 0.0 112.04 176.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.02 -8.97 18.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.799 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.32 -23.23 21.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.772 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -80.31 -20.08 45.12 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.38 0.609 . . . . 0.0 110.487 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.541 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -105.62 -173.36 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.795 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 27.3 t -172.4 129.76 0.57 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 179.603 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.39 153.72 17.66 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.019 -0.425 . . . . 0.0 109.859 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -162.31 151.56 15.62 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 178.812 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -127.56 97.65 0.47 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.437 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.636 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 10.5 ptm -85.99 26.8 0.96 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.847 0.356 . . . . 0.0 110.984 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.3 -107.37 0.1 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.82 73.44 1.4 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.683 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.1 t -76.28 -33.72 59.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.108 0.48 . . . . 0.0 111.216 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -124.39 66.37 44.06 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 -179.073 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.14 117.71 5.12 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.626 2.218 . . . . 0.0 111.506 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 286' ' ' THR . 15.0 m -70.8 -38.5 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.701 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 288' ' ' ASN . 2.8 p -61.43 -47.15 87.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.559 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.07 -3.4 0.05 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 286' ' ' THR . 89.3 m-20 -114.29 -60.97 1.81 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.018 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.8 t -77.69 -3.07 39.23 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.558 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.558 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -126.97 18.51 7.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.607 -179.911 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 36.7 p-10 -68.55 -2.98 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.503 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.418 ' O ' ' OD1' ' A' ' 292' ' ' ASN . 19.7 p30 -101.06 32.6 3.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.514 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.558 HG21 ' SG ' ' A' ' 290' ' ' CYS . 17.2 t -130.77 124.33 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.764 0.316 . . . . 0.0 110.437 179.638 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -120.21 9.62 11.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.879 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.39 131.24 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.134 0.492 . . . . 0.0 110.064 -179.498 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -50.55 -68.61 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.076 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.97 -38.7 57.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.53 -36.55 82.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.445 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 303' ' ' LEU . 28.0 mt -72.54 -55.01 7.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.474 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 68.5 mt -50.96 -35.4 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.005 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.11 -31.98 58.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.593 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.49 -5.06 56.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.4 mm? -94.23 19.66 9.1 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.289 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -80.43 -45.78 1.34 Allowed Pre-proline 0 CA--C 1.536 0.424 0 CA-C-O 121.051 0.453 . . . . 0.0 110.184 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 25.7 Cg_exo -60.97 9.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.134 2.556 . . . . 0.0 111.969 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 304' ' ' ALA . 8.1 t70 -106.0 14.12 28.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.874 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 307' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 307' ' ' ARG . 15.6 ptt180 -110.28 99.01 8.12 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.921 0.867 . . . . 0.0 110.346 179.214 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.537 ' NH1' ' OE2' ' A' ' 310' ' ' GLU . 43.7 ptt85 -166.03 139.09 4.13 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.398 -179.219 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.02 145.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.537 ' OE2' ' NH1' ' A' ' 308' ' ' ARG . 78.6 mt-10 -118.71 104.03 10.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.31 0.576 . . . . 0.0 110.865 178.667 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.459 HD12 HD21 ' A' ' 220' ' ' LEU . 0.4 OUTLIER -80.12 113.4 19.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.11 -178.953 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -92.11 123.27 35.34 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 123.525 0.516 . . . . 0.0 110.738 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.71 HG21 HD22 ' A' ' 224' ' ' LEU . 40.1 t -121.14 115.32 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 O-C-N 123.528 0.518 . . . . 0.0 110.875 -179.576 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -114.7 126.58 55.02 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.849 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.52 39.61 3.39 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.719 ' O ' ' O ' ' A' ' 317' ' ' LYS . 6.3 tt -110.97 164.74 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.719 ' O ' ' O ' ' A' ' 316' ' ' ILE . 20.5 pttp . . . . . 0 C--O 1.219 -0.501 0 O-C-N 124.273 0.983 . . . . 0.0 111.319 -178.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.52 HG22 ' NE2' ' A' ' 193' ' ' HIS . 24.3 m -79.06 125.6 29.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.829 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -144.45 112.73 6.47 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.71 0.291 . . . . 0.0 110.555 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 193' ' ' HIS . . . . . 0.52 ' NE2' HG22 ' A' ' 191' ' ' THR . 5.0 m-70 -99.4 144.41 28.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -106.89 129.79 54.66 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.87 0.367 . . . . 0.0 110.204 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.14 105.38 17.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.931 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.721 ' CD2' HD11 ' A' ' 201' ' ' LEU . 34.3 tp -110.16 129.63 55.68 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.426 ' HB3' HG23 ' A' ' 200' ' ' VAL . 16.2 tptm -80.74 127.92 33.05 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 122.036 0.922 . . . . 0.0 112.437 -178.265 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 202' ' ' PHE . 68.6 p -63.31 -31.79 73.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.091 179.489 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.456 ' OD1' ' ND2' ' A' ' 203' ' ' ASN . 22.0 t70 -59.75 -37.46 79.06 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.181 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 197' ' ' LYS . 79.2 t -66.23 -44.41 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.721 HD11 ' CD2' ' A' ' 196' ' ' LEU . 84.3 mt -77.6 -77.53 0.15 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.461 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -118.51 125.42 49.83 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.637 -179.754 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.456 ' ND2' ' OD1' ' A' ' 199' ' ' ASP . 7.2 m120 -94.37 -80.25 0.4 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.767 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -103.31 -17.71 15.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.695 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -70.54 169.66 13.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.998 0.427 . . . . 0.0 110.086 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -53.15 -78.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.267 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.36 59.11 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.552 179.409 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.7 p -108.79 135.3 50.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.048 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.1 135.57 39.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.874 -178.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 213' ' ' GLY . 4.4 mtmp? -96.57 159.97 30.56 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.815 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -34.05 -76.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.417 2.078 . . . . 0.0 111.78 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 31.6 mp0 -50.02 -20.18 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.242 0.544 . . . . 0.0 110.214 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.59 -47.87 14.65 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.368 178.669 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -67.86 -40.04 83.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.255 0.55 . . . . 0.0 110.066 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.54 65.24 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.696 -179.83 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.03 -35.68 81.05 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.62 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.0 -32.99 73.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.548 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 218' ' ' ASP . . . . . 0.535 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 4.4 m-20 -70.97 -44.83 65.19 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.501 0.667 . . . . 0.0 110.405 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.443 ' O ' ' OG ' ' A' ' 222' ' ' SER . 12.6 mt-30 -61.19 -44.0 97.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.085 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 41.4 tp -64.43 -40.37 95.63 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.379 178.693 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.423 ' CG ' ' HB3' ' A' ' 267' ' ' LYS . 4.9 t80 -51.79 -48.83 63.65 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.31 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 219' ' ' GLN . 59.5 p -55.04 -51.67 65.59 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.58 -178.239 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -51.99 -26.76 11.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.423 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.799 HD22 HG21 ' A' ' 313' ' ' VAL . 15.6 mt -97.11 -20.31 18.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.717 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.7 p -74.5 -22.59 58.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.759 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -102.72 19.72 18.66 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.893 -179.538 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -75.9 143.15 41.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.929 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 315' ' ' GLY . 47.2 t0 -52.4 108.19 1.02 Allowed Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 123.37 0.419 . . . . 0.0 110.434 178.056 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.3 Cg_exo -51.8 -24.5 18.53 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.737 2.291 . . . . 0.0 113.043 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 230' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 229' ' ' PRO . 7.5 ttpm? -30.25 -53.16 0.16 Allowed 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 123.568 0.543 . . . . 0.0 110.951 -177.828 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 232' ' ' GLY . 38.9 m-20 -102.43 -17.65 15.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.751 179.009 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.17 46.35 0.02 OUTLIER Glycine 0 N--CA 1.475 1.259 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 231' ' ' ASP . 38.1 m -112.72 110.39 20.48 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.672 0.272 . . . . 0.0 110.928 -178.455 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 76.6 t -127.56 94.09 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.481 0.658 . . . . 0.0 109.959 178.869 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.0 t -96.4 123.07 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.107 -178.117 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.561 HG13 HD13 ' A' ' 311' ' ' ILE . 87.4 t -92.54 120.21 41.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.442 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 57.1 mt -104.35 144.35 31.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.961 -179.485 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.417 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -125.16 130.27 7.28 Favored Glycine 0 N--CA 1.482 1.723 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.871 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.4 OUTLIER -114.91 125.43 53.63 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.83 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 253' ' ' SER . 43.0 p -120.92 166.93 13.12 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 109.933 -179.374 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -80.84 -175.12 5.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.417 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -113.72 122.88 48.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.198 0.523 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.736 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.6 mm -120.06 14.73 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.719 0.771 . . . . 0.0 110.633 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.29 -47.46 3.31 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 20.7 m -73.19 89.66 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.114 0.483 . . . . 0.0 110.006 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 246' ' ' ASP . . . . . 0.547 ' O ' ' NE2' ' A' ' 250' ' ' GLN . 98.9 m-20 -44.36 -46.17 9.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.365 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.81 86.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.629 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.599 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 51.2 t80 -60.33 -44.59 95.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.54 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -62.46 -43.47 98.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.562 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 246' ' ' ASP . 0.9 OUTLIER -65.69 -41.95 91.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.513 -179.991 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.86 95.91 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.599 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 39.1 mt -70.25 -39.41 75.01 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.065 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 253' ' ' SER . . . . . 0.448 ' N ' HG21 ' A' ' 240' ' ' THR . 3.7 t -63.21 -42.78 99.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 0.0 110.605 -178.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -69.33 -35.43 75.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.36 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.4 tpp85 -60.66 -54.3 47.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.672 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.874 ' O ' HG23 ' A' ' 260' ' ' VAL . 16.4 ptp180 -64.42 -44.6 90.68 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 120.95 0.405 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.462 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.7 -39.2 90.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.46 0.647 . . . . 0.0 110.303 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -74.99 -43.87 51.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.266 179.72 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 6.9 t -61.98 -38.43 88.57 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.29 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 256' ' ' ARG . 94.4 t -64.75 -50.98 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.622 178.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.616 HG13 HD12 ' A' ' 274' ' ' ILE . 14.4 t -61.29 -49.1 85.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.298 179.139 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -46.48 -40.8 13.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.079 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 263' ' ' TYR . . . . . 0.622 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 67.0 t80 -81.71 -33.9 30.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -65.08 -28.95 69.81 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.208 -179.521 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.544 ' C ' ' H ' ' A' ' 267' ' ' LYS . 81.6 mt -67.18 -52.22 45.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.273 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.4 p -49.65 -7.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 -179.108 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.622 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 66.3 mmtt -79.97 -5.63 56.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.711 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 97.09 42.3 3.3 Favored Glycine 0 CA--C 1.508 -0.373 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 130.83 23.89 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.321 179.075 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.35 128.34 28.83 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.781 1.654 . . . . 0.0 112.104 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -63.12 -11.0 16.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -88.68 -26.3 21.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.679 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -24.59 58.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.386 0.612 . . . . 0.0 110.457 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 274' ' ' ILE . . . . . 0.616 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -101.83 -176.79 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.857 -179.331 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 16.3 m -169.21 126.67 0.95 Allowed 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.653 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -94.93 151.11 19.48 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -155.89 142.17 18.41 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.377 0.608 . . . . 0.0 111.179 179.139 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -93.08 93.16 1.72 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.349 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 239' ' ' TYR . 5.0 tpt -70.49 -3.89 20.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.674 0.273 . . . . 0.0 110.65 -179.247 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.06 -116.32 0.85 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -135.87 70.47 1.42 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.604 -0.351 . . . . 0.0 110.526 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.7 m -77.58 -40.08 43.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.306 0.574 . . . . 0.0 111.477 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -124.58 62.37 32.7 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.659 -178.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.59 112.75 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.801 2.334 . . . . 0.0 111.364 179.409 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 286' ' ' THR . 32.1 m -71.37 -39.51 71.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.891 179.664 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 288' ' ' ASN . 51.4 p -63.61 -48.27 78.02 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.779 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.77 -2.01 0.05 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 288' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.1 t30 -113.55 -60.41 1.89 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.704 0.288 . . . . 0.0 110.308 179.005 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -80.43 -2.76 47.09 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.73 -179.606 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 290' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -126.88 17.53 7.33 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.889 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 291' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 32.8 p-10 -69.82 -3.28 14.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.977 0.418 . . . . 0.0 110.506 -179.594 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -99.75 32.06 3.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.429 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.456 HG21 ' SG ' ' A' ' 290' ' ' CYS . 5.2 t -133.87 127.36 52.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.954 0.407 . . . . 0.0 110.357 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -118.75 13.42 13.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.063 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 295' ' ' GLN . . . . . 0.631 HE22 ' CZ ' ' A' ' 296' ' ' ARG . 8.8 mm-40 -105.92 137.64 43.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.587 0.708 . . . . 0.0 110.248 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 296' ' ' ARG . . . . . 0.631 ' CZ ' HE22 ' A' ' 295' ' ' GLN . 0.0 OUTLIER -61.15 -54.59 42.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.468 179.954 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.62 85.83 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.016 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.18 -33.31 75.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.557 179.196 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 303' ' ' LEU . 33.4 mt -82.48 -61.67 1.83 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.496 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 296' ' ' ARG . 45.0 mt -42.83 -34.47 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.63 -44.26 19.15 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.124 0.488 . . . . 0.0 110.318 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 302' ' ' CYS . . . . . 0.459 ' O ' HG21 ' A' ' 286' ' ' THR . 44.2 t -74.88 -8.18 55.71 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.978 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 299' ' ' LEU . 73.9 mt -92.98 17.86 10.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.732 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -79.24 -45.56 1.68 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.336 179.711 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 305' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 34.5 Cg_exo -59.63 8.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.085 2.523 . . . . 0.0 111.821 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 304' ' ' ALA . 49.6 m-20 -103.87 12.04 34.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -114.45 94.63 4.88 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.606 0.717 . . . . 0.0 110.176 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 308' ' ' ARG . . . . . 0.417 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 39.4 ptt180 -154.38 131.46 11.0 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.694 0.759 . . . . 0.0 112.295 -179.018 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 309' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 196' ' ' LEU . 0.0 OUTLIER -95.49 134.49 32.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.046 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -116.74 104.63 11.54 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.305 0.574 . . . . 0.0 110.295 -179.263 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.561 HD13 HG13 ' A' ' 236' ' ' VAL . 3.5 mm -78.96 114.04 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.106 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -92.17 122.21 34.44 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 123.532 0.52 . . . . 0.0 110.488 -179.199 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.799 HG21 HD22 ' A' ' 224' ' ' LEU . 25.2 t -122.23 114.83 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.549 -179.309 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -113.9 127.07 55.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.421 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.0 39.88 3.44 Favored Glycine 0 N--CA 1.461 0.347 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.696 ' O ' ' O ' ' A' ' 317' ' ' LYS . 11.1 tt -117.09 172.67 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 317' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 316' ' ' ILE . 8.9 mtmp? . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 122.121 0.962 . . . . 0.0 111.376 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.24 152.44 66.84 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.547 2.165 . . . . 0.0 112.107 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.476 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -171.14 51.38 0.16 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.488 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 41.0 Cg_endo -66.6 -58.2 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.767 2.311 . . . . 0.0 111.967 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 178.97 74.62 0.15 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.337 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -54.04 120.94 8.75 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.372 2.048 . . . . 0.0 112.185 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.552 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . -96.55 -47.25 0.24 Allowed Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.266 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 72.4 Cg_endo -80.46 153.93 21.0 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.209 1.939 . . . . 0.0 112.361 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 190' ' ' GLN . 96.8 mt-10 -69.71 131.38 44.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.321 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 t -67.1 146.68 13.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.334 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 188' ' ' GLU . 15.6 mp0 -102.03 82.66 2.26 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.819 0.342 . . . . 0.0 110.688 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.4 m -80.23 129.11 34.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.638 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -129.06 99.55 5.31 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.739 0.781 . . . . 0.0 111.741 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -83.71 127.7 33.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.054 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.495 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 55.4 m-85 -112.26 124.15 51.83 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.09 104.03 15.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.842 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.692 ' CD2' HD11 ' A' ' 201' ' ' LEU . 31.1 tp -105.7 123.59 48.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.04 130.47 35.55 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-O 122.1 0.952 . . . . 0.0 112.327 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.57 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 39.4 m -61.25 -31.44 71.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.2 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -57.96 -40.44 80.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.85 -43.55 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 196' ' ' LEU . 84.6 mt -79.77 -77.93 0.17 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.526 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER -137.38 131.63 32.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.413 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -107.43 -64.93 1.15 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.28 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.69 -20.51 16.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.545 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.35 159.71 33.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.988 0.423 . . . . 0.0 110.209 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -53.65 -66.74 0.34 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.571 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.07 -2.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.087 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.409 ' H ' ' H ' ' A' ' 207' ' ' ALA . 40.8 p -53.17 135.99 36.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.034 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 54.2 mt -82.02 137.73 35.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.854 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.8 mtpm? -97.79 157.75 34.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.811 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 213' ' ' GLY . 84.6 Cg_exo -34.1 -76.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.597 2.198 . . . . 0.0 112.486 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.72 -19.17 0.58 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.043 0.449 . . . . 0.0 110.3 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.1 -51.73 9.83 Favored Glycine 0 N--CA 1.459 0.229 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -65.39 -40.57 93.61 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.204 0.526 . . . . 0.0 109.846 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.99 -54.75 41.06 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.018 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.25 86.68 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.615 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.34 -30.09 70.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.217 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.13 -46.56 56.07 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.848 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -62.33 -44.15 97.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.237 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.78 -38.07 89.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.476 ' O ' ' OG ' ' A' ' 225' ' ' SER . 3.2 t80 -54.2 -50.84 66.16 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.066 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.8 t -55.78 -51.0 68.92 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.393 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.495 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 56.7 tt0 -52.64 -25.01 9.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.874 HD22 HG21 ' A' ' 313' ' ' VAL . 85.2 mt -99.0 -18.78 17.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.656 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 221' ' ' TYR . 1.3 m -77.42 -30.77 53.62 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.575 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -87.18 25.0 1.44 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 110.298 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.04 -179.14 6.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.811 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 1.6 t70 -100.93 133.47 21.04 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.75 -19.31 47.43 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.259 1.973 . . . . 0.0 112.744 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -37.15 -52.96 1.03 Allowed 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 110.511 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' GLY . 52.9 m-20 -98.3 -21.16 16.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 24.94 45.98 0.02 OUTLIER Glycine 0 C--N 1.343 0.96 0 O-C-N 123.744 0.653 . . . . 0.0 111.725 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 231' ' ' ASP . 5.2 m -119.44 114.29 22.09 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.032 0.444 . . . . 0.0 110.879 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.477 HG22 HG13 ' A' ' 313' ' ' VAL . 43.0 t -130.19 95.76 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.529 0.68 . . . . 0.0 109.977 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.4 HG11 HH12 ' A' ' 277' ' ' ARG . 10.6 t -97.76 122.77 49.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.345 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.459 HG21 HG22 ' A' ' 261' ' ' VAL . 83.0 t -95.63 125.41 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 41.7 mt -109.7 141.89 41.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.126 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -122.12 129.6 7.67 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.57 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -113.33 119.49 37.86 Favored 'General case' 0 C--N 1.349 0.574 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 31.1 p -109.97 168.96 9.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.84 0.352 . . . . 0.0 110.758 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.458 ' OD2' ' NH2' ' A' ' 307' ' ' ARG . 44.5 p-10 -90.69 -178.39 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -100.94 124.57 46.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.333 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.1 mm -117.7 12.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.414 0.626 . . . . 0.0 110.745 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.15 6.1 88.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -136.48 96.71 3.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.517 . . . . 0.0 109.729 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -52.22 -50.04 62.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.432 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.69 77.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.619 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.62 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 58.6 t80 -64.21 -43.84 93.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.475 HD22 ' H ' ' A' ' 243' ' ' ILE . 89.4 m-20 -61.19 -42.83 99.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.467 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.21 -40.11 95.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.377 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.35 -38.94 96.54 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.62 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 81.9 mt -73.56 -34.54 65.21 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.88 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 85.6 p -64.29 -40.25 95.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.129 0.49 . . . . 0.0 110.741 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.43 -39.84 62.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.314 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -61.25 -51.71 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.251 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.57 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 8.5 ptm180 -64.05 -46.06 86.03 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.306 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.479 ' N ' ' CG ' ' A' ' 256' ' ' ARG . . . -56.74 -36.49 69.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.399 0.619 . . . . 0.0 109.703 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -72.75 -44.29 61.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.805 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.9 m -59.1 -39.81 83.38 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.254 0.55 . . . . 0.0 110.134 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 256' ' ' ARG . 97.6 t -64.46 -51.73 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.922 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.559 HG13 HD12 ' A' ' 274' ' ' ILE . 21.3 t -62.4 -48.69 87.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.456 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -48.14 -41.46 26.78 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.95 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -78.74 -35.53 44.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.577 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -31.01 72.04 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.897 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.51 ' C ' ' H ' ' A' ' 267' ' ' LYS . 80.8 mt -65.49 -51.62 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 88.5 p -51.82 -8.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.789 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 265' ' ' ILE . 67.8 mmtt -79.49 -4.45 51.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.541 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.34 41.75 2.92 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.86 127.64 23.92 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 117.031 0.416 . . . . 0.0 110.208 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.31 128.36 25.22 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.609 1.539 . . . . 0.0 111.84 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.07 -8.71 17.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -93.58 -22.9 18.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.191 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -79.86 -17.11 54.03 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.72 0.772 . . . . 0.0 111.032 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.559 HD12 HG13 ' A' ' 261' ' ' VAL . 2.0 pt -107.93 -170.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.463 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 3.2 m -166.86 131.76 2.09 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.224 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -103.1 111.67 24.14 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.768 0.318 . . . . 0.0 110.546 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.4 HH12 HG11 ' A' ' 235' ' ' VAL . 30.8 ttm105 -119.79 141.24 49.67 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.71 0.767 . . . . 0.0 111.566 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -92.46 95.27 2.0 Allowed Glycine 0 CA--C 1.519 0.342 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 238' ' ' GLY . 2.7 tpt -68.11 -10.64 55.55 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.223 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 40.58 -98.73 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -141.59 75.37 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 0.0 110.81 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 70.8 m -83.63 -5.62 59.23 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -167.61 79.2 0.91 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.313 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.71 104.29 0.26 Allowed 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.568 2.179 . . . . 0.0 112.959 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 289' ' ' THR . 27.2 m -75.31 -32.79 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.337 0.589 . . . . 0.0 110.344 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.628 ' C ' ' H ' ' A' ' 288' ' ' ASN . 44.4 p -56.94 -42.59 80.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.793 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.6 -0.3 0.02 OUTLIER Glycine 0 CA--C 1.532 1.124 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.628 ' H ' ' C ' ' A' ' 286' ' ' THR . 17.2 t-20 -122.74 -58.87 1.65 Allowed 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.5 OUTLIER -66.9 -17.59 64.97 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.542 -178.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 302' ' ' CYS . 72.1 m -116.78 25.6 10.43 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.384 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 293' ' ' VAL . 34.5 t70 -57.88 -49.92 75.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.0 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -76.19 32.41 0.12 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.316 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' A' ' 291' ' ' ASP . 2.8 t -131.24 104.57 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.655 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -118.97 13.77 13.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.401 ' OE1' ' CA ' ' A' ' 295' ' ' GLN . 0.0 OUTLIER -100.23 139.98 35.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.92 0.39 . . . . 0.0 110.101 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -50.48 -70.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.184 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.92 -39.05 68.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.545 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.36 80.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.261 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 303' ' ' LEU . 26.0 mt -72.65 -53.38 11.95 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.891 0.377 . . . . 0.0 110.815 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 69.4 mt -53.16 -35.14 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 0.0 109.905 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -76.18 -40.38 52.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.192 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.513 ' O ' ' SG ' ' A' ' 290' ' ' CYS . 5.5 t -82.48 -8.78 59.61 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.957 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 299' ' ' LEU . 34.8 mt -91.06 21.4 4.28 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.836 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.622 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.44 -40.3 1.22 Allowed Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.397 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 36.6 Cg_exo -59.14 7.96 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 123.707 2.938 . . . . 0.0 112.719 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 304' ' ' ALA . 5.3 m-20 -111.12 14.46 21.84 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.458 ' NH2' ' OD2' ' A' ' 241' ' ' ASP . 98.5 mtt180 -111.32 90.5 3.35 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.214 0.53 . . . . 0.0 109.75 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.0 ptp180 -162.81 132.63 4.4 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.47 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.464 HG12 HH22 ' A' ' 256' ' ' ARG . 0.2 OUTLIER -96.15 142.3 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -118.83 106.71 12.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.208 0.527 . . . . 0.0 110.234 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.409 HD13 HG13 ' A' ' 236' ' ' VAL . 3.6 mm -80.05 118.2 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -102.74 102.28 12.43 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.62 0.248 . . . . 0.0 110.874 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.874 HG21 HD22 ' A' ' 224' ' ' LEU . 59.8 t -114.85 122.81 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.958 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -120.03 153.31 36.22 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.196 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 89.97 12.4 62.08 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 7.8 tt -95.17 135.64 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.155 0.502 . . . . 0.0 110.712 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -107.81 153.69 22.63 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.298 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -153.37 166.54 32.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.354 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.575 HG22 ' N ' ' A' ' 320' ' ' VAL . 13.2 p -73.35 164.64 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.364 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.575 ' N ' HG22 ' A' ' 319' ' ' VAL . 25.0 t -62.77 129.53 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.946 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 5.3 p -84.89 138.0 32.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.962 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -91.16 131.08 37.83 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.862 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 324' ' ' GLN . 50.4 Cg_exo -49.01 136.18 29.34 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.608 1.539 . . . . 0.0 112.328 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 323' ' ' PRO . 60.0 tt0 43.48 99.25 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.729 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.49 179.945 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.449 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 36.2 Cg_endo -63.92 -31.3 67.24 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.73 2.287 . . . . 0.0 112.02 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 181' ' ' PRO . . . 176.32 55.84 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.503 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.19 -65.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.792 2.328 . . . . 0.0 112.11 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.638 ' HB3' ' CD ' ' A' ' 185' ' ' PRO . . . -79.4 -62.05 0.45 Allowed Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.451 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.638 ' CD ' ' HB3' ' A' ' 184' ' ' ALA . 28.9 Cg_endo -60.25 144.64 99.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.158 1.905 . . . . 0.0 111.514 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 188' ' ' GLU . . . -121.37 95.9 48.16 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.002 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -47.78 76.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 122.605 2.204 . . . . 0.0 112.383 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.594 ' N ' ' O ' ' A' ' 186' ' ' ALA . 90.0 mt-10 -153.1 120.78 6.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.3 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 98.3 t -130.19 131.95 65.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.234 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -124.58 112.15 16.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.262 0.553 . . . . 0.0 110.385 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.1 m -69.15 137.2 53.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.487 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 5.5 tptp -112.27 166.37 11.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.322 0.582 . . . . 0.0 110.605 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.412 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 96.6 m-70 -154.74 121.4 5.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.114 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.447 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 68.7 m-85 -108.48 121.05 44.16 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.9 104.08 15.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.497 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.685 ' CD2' HD11 ' A' ' 201' ' ' LEU . 33.8 tp -107.92 127.88 54.13 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.451 ' HG2' ' H ' ' A' ' 199' ' ' ASP . 36.3 ttmt -80.95 127.89 33.07 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.61 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.505 ' OG ' ' NH1' ' A' ' 256' ' ' ARG . 1.2 t -63.44 -31.79 73.05 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.024 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.86 ' CG ' HD22 ' A' ' 203' ' ' ASN . 9.7 t70 -57.16 -41.06 78.49 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.941 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.52 -43.73 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.685 HD11 ' CD2' ' A' ' 196' ' ' LEU . 95.8 mt -74.69 -79.15 0.09 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.44 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -123.65 140.01 53.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.05 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.86 HD22 ' CG ' ' A' ' 199' ' ' ASP . 17.6 m120 -109.38 -76.65 0.61 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.383 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.445 ' CE1' ' OD1' ' A' ' 205' ' ' ASN . 53.3 p90 -96.54 -12.68 23.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.622 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.445 ' OD1' ' CE1' ' A' ' 204' ' ' PHE . 81.9 m-20 -75.96 160.7 29.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 110.204 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -55.46 -62.02 1.95 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.51 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.517 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.61 1.15 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.128 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.42 134.24 45.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.18 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.33 144.28 34.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.135 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 213' ' ' GLY . 21.9 mtmt -104.87 157.54 33.98 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.816 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -34.32 -76.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.5 2.133 . . . . 0.0 112.311 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 51.6 mp0 -49.75 -20.8 0.91 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.052 0.453 . . . . 0.0 110.316 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.6 -51.01 17.69 Favored Glycine 0 CA--C 1.518 0.232 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -65.34 -40.92 94.26 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.073 0.463 . . . . 0.0 109.763 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.1 -53.94 49.54 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.037 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.23 -38.45 91.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.798 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.76 -27.66 68.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.234 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -73.3 -46.27 50.57 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.381 0.61 . . . . 0.0 110.801 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -62.17 -42.15 98.99 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.096 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.9 -37.41 84.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.031 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.41 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.3 t80 -54.45 -49.49 69.92 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.822 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 225' ' ' SER . 45.9 t -59.84 -49.27 78.37 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.782 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 1.1 tm0? -50.08 -24.09 2.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.421 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.601 ' O ' HD22 ' A' ' 227' ' ' LEU . 62.7 mt -97.34 -14.13 21.47 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 222' ' ' SER . 94.2 p -78.26 -22.32 48.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.766 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -94.62 18.08 12.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.996 0.427 . . . . 0.0 110.446 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -78.72 168.76 19.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.137 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.75 132.99 40.65 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 230' ' ' LYS . 56.4 Cg_endo -71.18 -17.56 31.23 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.777 2.318 . . . . 0.0 112.561 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 229' ' ' PRO . 79.9 tttt -32.59 -51.09 0.27 Allowed 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.797 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 232' ' ' GLY . 47.0 m-20 -108.41 -18.08 13.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.263 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.6 51.33 0.06 OUTLIER Glycine 0 N--CA 1.471 1.006 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.0 m -118.02 108.62 15.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 111.159 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.68 96.51 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.31 120.07 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.657 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.562 HG13 HD13 ' A' ' 311' ' ' ILE . 92.8 t -92.34 124.81 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.435 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 277' ' ' ARG . 28.1 mt -109.11 143.64 38.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.016 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.33 130.47 7.54 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.622 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -115.32 116.8 28.89 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 241' ' ' ASP . 69.8 m -104.08 160.58 14.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.643 0.259 . . . . 0.0 110.449 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.461 ' N ' HG22 ' A' ' 240' ' ' THR . 39.7 p-10 -89.61 177.81 6.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.69 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.629 ' NE ' ' H ' ' A' ' 244' ' ' GLY . 1.0 OUTLIER -88.74 127.67 35.6 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.0 mm -118.34 9.71 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.248 0.547 . . . . 0.0 110.895 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.629 ' H ' ' NE ' ' A' ' 242' ' ' ARG . . . 102.43 -26.0 25.71 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -118.7 115.27 24.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.173 0.511 . . . . 0.0 110.26 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 246' ' ' ASP . 24.0 p-10 -60.15 -53.1 61.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.861 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.72 -38.93 70.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.299 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.585 ' CE2' HD11 ' A' ' 252' ' ' LEU . 47.8 t80 -63.0 -44.1 96.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.292 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -62.36 -40.23 95.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.348 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.79 -44.07 97.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.06 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.18 -36.33 93.29 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.585 HD11 ' CE2' ' A' ' 248' ' ' TYR . 36.5 mt -71.71 -37.14 70.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.336 . . . . 0.0 111.027 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 35.1 t -64.4 -41.29 96.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.942 0.401 . . . . 0.0 110.652 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.42 -47.76 72.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -59.07 -43.44 91.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.759 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.505 ' NH1' ' OG ' ' A' ' 198' ' ' SER . 0.0 OUTLIER -52.94 -64.17 0.91 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.378 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -56.6 -37.08 70.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.459 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.21 -46.83 87.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.655 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 75.7 m -60.66 -38.26 84.28 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.255 0.55 . . . . 0.0 110.439 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 256' ' ' ARG . 96.0 t -63.98 -51.91 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.999 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.702 HG21 ' HB2' ' A' ' 276' ' ' ALA . 62.6 t -62.11 -49.03 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -45.39 -42.14 9.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.177 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.508 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 54.8 t80 -82.04 -29.94 31.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.72 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.4 ' O ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -72.72 -8.59 56.11 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.726 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.566 ' C ' ' H ' ' A' ' 267' ' ' LYS . 69.2 mt -87.23 -55.87 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.812 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 93.7 p -50.05 -5.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.07 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 265' ' ' ILE . 71.2 mmtt -77.23 -10.99 59.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.546 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.95 -7.93 23.51 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -80.94 129.84 65.96 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.338 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.44 131.17 39.34 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.75 1.634 . . . . 0.0 111.549 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.91 -8.21 34.83 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 111.251 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 25.9 p30 -94.89 -19.66 20.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.618 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 0.9 OUTLIER -80.87 -21.22 40.87 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.496 0.665 . . . . 0.0 110.636 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.47 HD12 HG13 ' A' ' 261' ' ' VAL . 1.3 pt -104.82 -170.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.589 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 14.9 t -170.94 132.96 0.88 Allowed 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.368 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.702 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -96.87 150.93 20.18 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.845 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.477 ' HB3' HD23 ' A' ' 237' ' ' LEU . 63.5 ttt-85 -160.99 150.25 16.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.202 0.525 . . . . 0.0 110.968 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.44 145.65 16.06 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.475 ' SD ' HD22 ' A' ' 237' ' ' LEU . 85.6 mmm -120.64 2.71 10.67 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 121.967 0.107 . . . . 0.0 110.831 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 38.33 -97.89 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 279' ' ' MET . 6.9 pt-20 -142.03 68.89 1.32 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.656 0.265 . . . . 0.0 110.462 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 98.5 p -89.3 -2.67 58.54 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -154.14 65.52 5.1 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.515 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.7 107.61 2.51 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.56 2.173 . . . . 0.0 112.363 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 31.5 m -73.09 -29.08 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.521 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.634 HG21 ' HA ' ' A' ' 303' ' ' LEU . 40.3 p -58.92 -46.15 88.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.569 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -49.6 -2.93 0.02 OUTLIER Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 286' ' ' THR . 97.9 m-20 -119.98 -58.66 1.86 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.77 -3.61 51.57 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.683 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -130.7 15.52 5.36 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.851 0.357 . . . . 0.0 110.155 179.395 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -65.9 -2.47 3.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.98 0.419 . . . . 0.0 110.304 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -109.9 31.71 5.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.86 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.683 HG21 ' SG ' ' A' ' 290' ' ' CYS . 20.8 t -130.25 121.33 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 110.33 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -119.32 12.19 12.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.702 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.96 130.59 45.33 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.088 0.47 . . . . 0.0 109.815 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -51.99 -64.85 0.68 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.937 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.21 -37.55 64.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.638 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.39 84.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.646 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 303' ' ' LEU . 17.4 mt -72.81 -47.86 42.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.004 0.43 . . . . 0.0 110.78 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.5 mt -60.47 -32.83 52.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.433 . . . . 0.0 110.262 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -82.92 -27.25 30.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.712 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 40.5 t -90.8 -20.37 22.42 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.761 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.634 ' HA ' HG21 ' A' ' 286' ' ' THR . 60.8 mt -85.71 24.96 1.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.528 0.517 . . . . 0.0 111.145 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.58 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -76.48 -44.09 3.32 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 22.4 Cg_exo -62.76 9.35 0.1 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.276 2.651 . . . . 0.0 112.084 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 304' ' ' ALA . 8.2 t70 -104.46 10.73 35.1 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.877 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.489 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 7.9 ptm180 -111.9 97.82 6.95 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.539 0.685 . . . . 0.0 109.965 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.543 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.6 ptm180 -159.0 132.3 7.24 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.333 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.63 141.11 16.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -121.35 106.2 11.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.072 0.463 . . . . 0.0 110.53 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.562 HD13 HG13 ' A' ' 236' ' ' VAL . 3.7 mm -78.55 117.48 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -97.49 132.0 43.59 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.434 HG21 HD22 ' A' ' 224' ' ' LEU . 2.2 t -133.23 118.43 32.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.255 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -115.89 134.55 54.87 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.83 -5.12 56.45 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 18.7 tt -79.91 147.17 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.953 0.406 . . . . 0.0 110.524 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -110.78 150.14 29.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.235 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -111.3 120.54 42.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.707 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.74 136.83 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.296 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.55 129.08 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.198 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 57.1 p -144.85 160.01 41.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.276 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -120.98 83.21 37.27 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.154 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.7 149.82 18.55 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.655 2.237 . . . . 0.0 112.15 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -83.37 -13.62 54.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.318 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.564 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 53.9 Cg_exo -51.17 -37.66 59.2 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.526 2.151 . . . . 0.0 112.054 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 62.83 71.09 0.7 Allowed Pre-proline 0 C--O 1.232 0.153 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.82 152.25 46.86 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.312 2.008 . . . . 0.0 112.146 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.12 70.13 2.6 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.924 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.54 -16.92 30.44 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.345 2.03 . . . . 0.0 111.965 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -133.45 152.04 78.5 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.864 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -47.43 -48.97 14.04 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.239 1.959 . . . . 0.0 112.487 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -171.89 -114.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.963 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.555 HG11 ' HZ1' ' A' ' 314' ' ' LYS . 69.8 t -126.29 135.45 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.25 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.45 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.2 OUTLIER -118.73 121.2 39.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.627 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.3 m -75.11 137.88 41.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.696 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.494 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 13.5 tptt -111.26 166.86 10.74 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.487 0.661 . . . . 0.0 110.558 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.494 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 5.4 m80 -150.55 120.38 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.775 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -110.45 119.53 39.48 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 104.9 16.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.45 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.673 ' CD2' HD11 ' A' ' 201' ' ' LEU . 24.6 tp -107.96 122.82 47.6 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -78.62 130.4 35.86 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.909 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 202' ' ' PHE . 90.3 p -61.45 -29.36 69.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.105 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -60.27 -38.21 82.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.921 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.7 t -67.82 -42.97 86.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.673 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.0 mt -79.94 -78.15 0.17 Allowed 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.453 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER -135.39 127.03 28.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.501 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -102.33 -68.4 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.039 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -91.12 -22.69 20.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.552 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -69.22 161.22 29.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.912 0.387 . . . . 0.0 109.967 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -63.02 -57.28 11.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.44 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -165.92 -7.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.947 0.403 . . . . 0.0 110.206 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 69.4 p -52.46 131.22 33.39 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.262 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.8 mt -77.51 144.5 37.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.483 0.659 . . . . 0.0 111.211 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.9 mtpt -105.2 157.29 34.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.141 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 213' ' ' GLY . 89.3 Cg_exo -34.52 -76.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.762 2.308 . . . . 0.0 112.413 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -48.2 -20.37 0.37 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.099 0.476 . . . . 0.0 110.328 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.16 -48.51 19.42 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.389 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -65.62 -40.76 92.92 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.2 -52.34 65.73 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.076 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.88 85.45 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 121.56 0.695 . . . . 0.0 110.397 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 mt -65.62 -28.84 69.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.009 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -72.01 -47.85 48.94 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.371 0.605 . . . . 0.0 110.981 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -62.51 -42.03 99.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.868 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.2 tp -64.91 -40.35 94.93 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.403 ' CG ' ' HB3' ' A' ' 267' ' ' LYS . 5.9 t80 -52.3 -47.27 66.02 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 75.0 p -55.94 -51.27 68.25 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.796 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -52.28 -25.64 9.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.56 ' O ' HD22 ' A' ' 227' ' ' LEU . 42.8 mt -99.15 -20.88 16.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.677 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 6.8 t -72.75 -24.34 60.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -102.79 23.73 11.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.56 HD22 ' O ' ' A' ' 224' ' ' LEU . 1.0 OUTLIER -75.66 147.62 39.34 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 315' ' ' GLY . 25.8 t0 -62.95 112.07 6.08 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 230' ' ' LYS . 50.7 Cg_exo -53.67 -20.89 17.92 Favored 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.517 2.145 . . . . 0.0 113.181 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 229' ' ' PRO . 11.2 mmmt -29.79 -52.54 0.14 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.952 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' GLY . 34.0 m-20 -105.98 -17.18 14.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.388 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 27.86 49.33 0.07 OUTLIER Glycine 0 N--CA 1.465 0.58 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.347 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.96 108.08 15.35 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.9 96.61 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.712 0.768 . . . . 0.0 110.018 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.8 t -96.19 117.78 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.291 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 261' ' ' VAL . 88.2 t -95.26 121.4 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.033 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 277' ' ' ARG . 24.6 mt -108.76 141.8 40.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.986 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -124.48 126.84 6.2 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.34 122.05 46.84 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 241' ' ' ASP . 55.2 m -109.49 166.11 11.14 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.414 0.446 . . . . 0.0 110.613 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.593 ' N ' HG22 ' A' ' 240' ' ' THR . 40.1 p-10 -90.44 173.3 8.17 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.118 0.485 . . . . 0.0 111.17 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.41 ' NH2' ' OE2' ' A' ' 281' ' ' GLU . 64.0 ttm-85 -92.61 126.53 37.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.166 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.1 mm -118.32 15.15 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.231 0.538 . . . . 0.0 110.442 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 86.07 -1.86 87.69 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 11.8 t -131.44 105.92 7.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.156 0.503 . . . . 0.0 110.179 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 247' ' ' ALA . 22.0 p-10 -55.54 -51.5 66.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.613 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 246' ' ' ASP . . . -55.54 -39.61 70.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.551 ' CE2' HD11 ' A' ' 252' ' ' LEU . 29.1 t80 -65.02 -43.46 92.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.204 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 17.6 t-20 -61.87 -43.15 99.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -65.74 -41.77 91.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.81 -39.52 98.09 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' A' ' 248' ' ' TYR . 27.4 mt -72.8 -35.93 67.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.501 -0.349 . . . . 0.0 110.594 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 39.5 t -62.96 -42.69 99.9 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.89 -46.88 79.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.895 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -55.92 -45.25 78.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 260' ' ' VAL . 28.8 ttm105 -55.29 -65.87 0.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.826 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.09 64.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -68.47 -48.4 64.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.612 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 77.6 p -57.7 -39.39 77.08 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.117 0.484 . . . . 0.0 110.404 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 256' ' ' ARG . 58.8 t -65.32 -54.01 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.432 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.483 HG13 HD12 ' A' ' 274' ' ' ILE . 17.6 t -60.11 -49.12 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.954 -0.299 . . . . 0.0 110.492 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.09 -44.17 31.45 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.656 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.585 ' CE1' ' NZ ' ' A' ' 267' ' ' LYS . 90.3 t80 -78.39 -34.9 47.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.831 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -62.41 -25.97 68.23 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.094 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 267' ' ' LYS . 86.6 mt -71.33 -52.46 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.777 0.322 . . . . 0.0 111.708 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 6.2 t -50.04 -10.92 0.06 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.48 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.585 ' NZ ' ' CE1' ' A' ' 263' ' ' TYR . 0.1 OUTLIER -77.81 -10.81 59.74 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.204 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 105.99 41.87 1.75 Allowed Glycine 0 CA--C 1.533 1.172 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.79 131.49 24.02 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-N 117.193 0.496 . . . . 0.0 110.79 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.46 125.26 17.18 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.553 1.502 . . . . 0.0 111.48 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.01 -8.39 29.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.135 0.493 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -91.2 -22.93 20.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.334 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -81.37 -20.22 41.01 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.465 0.65 . . . . 0.0 111.167 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.483 HD12 HG13 ' A' ' 261' ' ' VAL . 1.9 pt -103.71 -173.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.435 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 17.4 p -168.62 129.26 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.511 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.09 111.49 23.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.948 0.404 . . . . 0.0 110.583 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.486 ' HB3' HD23 ' A' ' 237' ' ' LEU . 64.9 ttt180 -120.72 146.46 46.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.464 0.65 . . . . 0.0 111.062 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.51 142.46 16.16 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 1.6 mmt -118.92 -5.87 10.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.92 -104.28 0.05 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.41 ' OE2' ' NH2' ' A' ' 242' ' ' ARG . 9.4 pt-20 -142.26 68.7 1.32 Allowed 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.859 -0.201 . . . . 0.0 110.789 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 74.3 m -67.09 -42.06 85.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.614 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.419 ' ND2' HH21 ' A' ' 308' ' ' ARG . 6.9 p-10 -125.66 80.54 66.3 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.105 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.87 106.67 0.66 Allowed 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.714 2.276 . . . . 0.0 112.543 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 289' ' ' THR . 12.5 m -75.81 -30.76 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.132 0.491 . . . . 0.0 110.414 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.63 ' C ' ' H ' ' A' ' 288' ' ' ASN . 60.4 p -56.69 -43.16 80.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.664 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.13 0.52 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.63 ' H ' ' C ' ' A' ' 286' ' ' THR . 24.1 t-20 -123.2 -58.53 1.63 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER -68.22 -14.33 62.91 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.503 -178.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 57.2 m -128.53 22.28 5.98 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.301 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -69.77 -2.49 12.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.697 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -110.24 32.09 5.41 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.535 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 23.3 t -130.93 124.02 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.99 0.424 . . . . 0.0 110.299 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -118.95 7.9 11.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.385 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.437 ' O ' HD12 ' A' ' 299' ' ' LEU . 4.6 mt-30 -90.27 169.44 11.11 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -82.9 -71.18 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.683 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -57.88 -28.13 63.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.951 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.74 94.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.357 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 303' ' ' LEU . 47.6 mt -70.86 -49.11 49.61 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 110.534 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.4 mt -54.89 -31.67 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -80.25 -32.68 38.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.476 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -12.18 46.82 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.721 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.574 ' HA ' HG21 ' A' ' 286' ' ' THR . 48.5 mt -90.47 21.92 3.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.761 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.586 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -78.48 -43.26 2.01 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.98 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.5 Cg_exo -61.78 8.55 0.1 Allowed 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 123.409 2.739 . . . . 0.0 112.044 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 304' ' ' ALA . 50.6 t0 -102.49 12.2 36.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.457 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -113.98 98.48 7.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.445 0.64 . . . . 0.0 109.838 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.552 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 33.5 ptt180 -157.73 130.9 7.62 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.306 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.5 140.06 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -120.84 105.83 11.08 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.362 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.414 HD13 HG13 ' A' ' 236' ' ' VAL . 4.0 mm -79.33 117.64 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.68 127.75 41.98 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.428 HG21 ' CD2' ' A' ' 224' ' ' LEU . 2.4 t -126.77 115.56 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.196 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.555 ' HZ1' HG11 ' A' ' 189' ' ' VAL . 52.8 tttp -114.83 125.8 54.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 91.15 43.74 4.6 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.605 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.5 tt -114.83 168.61 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.605 ' O ' ' O ' ' A' ' 316' ' ' ILE . 0.1 OUTLIER -48.52 -147.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 O-C-N 124.07 0.857 . . . . 0.0 110.868 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.412 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 6.9 m-20 -154.55 101.3 2.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.219 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 62.9 t -116.23 131.46 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 92.7 t -80.09 130.1 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.13 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.68 161.09 18.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.285 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -142.21 84.26 11.67 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.176 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.73 -33.74 71.41 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.668 2.245 . . . . 0.0 112.06 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -49.57 -21.22 0.93 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.71 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.514 179.693 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.562 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 23.0 Cg_endo -59.03 -41.3 62.75 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.959 2.439 . . . . 0.0 112.127 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 178.45 61.68 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.333 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.86 90.09 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.619 2.213 . . . . 0.0 111.868 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 185' ' ' PRO . . . -172.59 75.35 0.44 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 184' ' ' ALA . 50.0 Cg_exo -51.17 -171.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.65 2.234 . . . . 0.0 111.773 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -133.03 72.56 76.47 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.275 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 188' ' ' GLU . 61.6 Cg_endo -77.13 174.65 12.47 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.717 2.278 . . . . 0.0 111.846 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 187' ' ' PRO . 79.7 mm-40 56.03 160.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.348 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 60.5 t -128.45 135.29 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.439 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.48 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.4 OUTLIER -122.4 128.36 50.84 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.384 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.543 HG22 ' CE1' ' A' ' 193' ' ' HIS . 13.3 m -85.17 142.07 29.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.193 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -143.45 111.42 6.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.562 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.4 OUTLIER -97.96 148.28 23.63 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -112.07 130.36 55.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.913 0.387 . . . . 0.0 110.303 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -88.23 103.7 16.02 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.045 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.717 ' CD2' HD11 ' A' ' 201' ' ' LEU . 28.7 tp -108.47 128.37 54.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.178 0.513 . . . . 0.0 109.648 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.437 ' HB3' HG23 ' A' ' 200' ' ' VAL . 34.0 ttmt -81.7 125.14 30.24 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.994 0.902 . . . . 0.0 112.16 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.481 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 18.5 m -61.05 -32.14 71.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.196 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.419 ' H ' ' HG2' ' A' ' 197' ' ' LYS . 9.9 t0 -59.66 -36.72 76.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 197' ' ' LYS . 87.3 t -67.34 -42.96 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.717 HD11 ' CD2' ' A' ' 196' ' ' LEU . 76.3 mt -78.9 -78.33 0.15 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.322 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.68 128.1 41.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.966 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.418 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 62.0 t-20 -111.93 -71.48 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.438 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -84.34 -32.32 24.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -73.73 165.89 24.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.196 0.522 . . . . 0.0 110.245 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.675 ' C ' HH22 ' A' ' 255' ' ' ARG . 32.6 mmtp -58.94 -82.41 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.457 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.57 ' HB2' ' NH1' ' A' ' 255' ' ' ARG . . . -148.65 56.55 1.03 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 73.4 p -107.54 130.2 54.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.131 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 40.6 mt -78.04 134.97 37.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.732 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.4 mtmt -97.06 159.21 31.92 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.917 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 210' ' ' LYS . 88.8 Cg_exo -34.63 -76.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.235 1.957 . . . . 0.0 111.875 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.22 -22.13 0.96 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.101 0.477 . . . . 0.0 110.244 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.53 -52.0 14.35 Favored Glycine 0 N--CA 1.46 0.276 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -64.99 -39.56 93.66 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.323 0.583 . . . . 0.0 109.908 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.75 -54.66 43.76 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.153 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.6 -36.0 82.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.984 0.421 . . . . 0.0 110.678 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.3 mt -61.56 -31.66 71.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.152 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.67 -45.51 58.51 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.279 0.562 . . . . 0.0 110.616 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -61.52 -44.98 96.09 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.808 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.478 HD21 HD12 ' A' ' 311' ' ' ILE . 38.3 tp -63.65 -40.6 97.27 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.262 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.433 ' CE1' ' OG ' ' A' ' 225' ' ' SER . 6.5 t80 -51.54 -48.35 63.06 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.985 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.7 t -54.25 -52.11 62.38 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.55 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -51.56 -26.66 9.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.4 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.797 HD22 HG21 ' A' ' 313' ' ' VAL . 21.7 mt -98.35 -19.0 18.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.433 ' OG ' ' CE1' ' A' ' 221' ' ' TYR . 4.7 m -71.68 -32.91 68.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -96.96 21.68 9.37 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.677 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -75.07 151.49 38.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.794 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 315' ' ' GLY . 15.6 t0 -65.39 124.6 87.54 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.128 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 232' ' ' GLY . 48.0 Cg_endo -69.16 -19.73 38.59 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 122.894 2.396 . . . . 0.0 113.313 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 229' ' ' PRO . 39.0 ttmt -24.12 -50.06 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.576 0 O-C-N 123.62 0.575 . . . . 0.0 111.037 -177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.472 ' O ' ' C ' ' A' ' 232' ' ' GLY . 32.5 t70 -115.44 -12.9 11.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.212 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 25.66 49.93 0.04 OUTLIER Glycine 0 N--CA 1.472 1.095 0 O-C-N 123.861 0.725 . . . . 0.0 111.456 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.5 t -112.03 114.13 26.83 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 122.574 -0.368 . . . . 0.0 110.352 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.6 t -129.05 95.91 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.266 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 275' ' ' SER . 2.8 t -96.74 123.98 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.097 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.484 HG22 HG23 ' A' ' 311' ' ' ILE . 21.2 t -96.75 120.94 46.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.823 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 40.8 mt -103.74 145.38 30.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.167 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.68 129.04 7.34 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 308' ' ' ARG . 1.0 OUTLIER -110.53 125.77 53.69 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.544 ' OG1' ' ND2' ' A' ' 249' ' ' ASN . 3.1 p -116.78 162.82 17.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.535 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 7.0 p30 -84.75 172.09 11.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -88.74 122.53 32.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.425 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.7 mm -118.06 7.94 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.293 0.568 . . . . 0.0 110.617 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 82.33 13.98 77.53 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -142.08 92.15 2.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.107 0.479 . . . . 0.0 109.943 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -49.25 -49.69 42.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.508 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.24 78.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.797 ' CE2' HD11 ' A' ' 252' ' ' LEU . 40.3 t80 -65.18 -43.2 92.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.062 0.458 . . . . 0.0 110.637 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.544 ' ND2' ' OG1' ' A' ' 240' ' ' THR . 27.4 t-20 -61.49 -43.4 98.94 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.634 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.52 -45.05 92.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.638 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.11 92.1 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 1.108 HD23 ' HE ' ' A' ' 255' ' ' ARG . 18.0 mt -64.69 -43.66 92.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.998 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 33.3 m -66.83 -43.69 83.09 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.885 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.58 -57.21 13.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.475 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 1.108 ' HE ' HD23 ' A' ' 252' ' ' LEU . 36.5 ptt85 -59.11 -45.16 91.58 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.156 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.481 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 19.2 mtp-105 -58.16 -50.58 73.03 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.535 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.38 69.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.84 -40.39 72.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.137 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 76.4 p -63.43 -37.86 88.93 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.192 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.48 -51.1 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.491 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' A' ' 276' ' ' ALA . 23.4 t -61.23 -49.56 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.2 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -45.94 -38.8 8.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.93 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.497 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 63.6 t80 -84.9 -31.68 23.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.49 -13.5 62.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.446 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.561 ' C ' ' H ' ' A' ' 267' ' ' LYS . 66.5 mt -83.89 -52.15 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 111.148 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 9.0 t -50.49 -6.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.561 ' H ' ' C ' ' A' ' 265' ' ' ILE . 73.7 mmtt -79.63 -10.67 59.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.616 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 104.55 40.72 2.15 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.68 127.86 24.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.87 128.03 25.2 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.822 1.681 . . . . 0.0 111.811 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.07 -11.65 15.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.008 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.36 -26.07 21.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.774 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.436 ' CE ' HD21 ' A' ' 227' ' ' LEU . 7.0 tttm -74.51 -22.81 58.87 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.909 0.861 . . . . 0.0 110.659 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -104.14 -172.8 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.547 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 235' ' ' VAL . 13.3 t -170.24 124.8 0.74 Allowed 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.396 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.678 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -99.72 156.97 16.81 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.801 -0.562 . . . . 0.0 109.795 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -174.1 166.84 4.23 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 122.009 0.909 . . . . 0.0 110.855 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.22 146.03 16.02 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.341 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 4.3 tpt -116.0 -10.97 11.51 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.914 0.388 . . . . 0.0 110.291 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 53.7 -111.23 1.77 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -141.76 72.26 1.38 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.879 0.371 . . . . 0.0 110.403 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.1 t -62.23 -42.06 98.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.113 0.482 . . . . 0.0 111.369 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -129.07 79.16 75.03 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.43 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -54.66 107.97 0.26 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.452 2.101 . . . . 0.0 112.113 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 286' ' ' THR . 27.3 m -65.75 -44.99 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.632 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.637 ' O ' ' N ' ' A' ' 288' ' ' ASN . 67.5 p -60.6 -43.68 97.15 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.813 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.37 -6.88 0.01 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.637 ' N ' ' O ' ' A' ' 286' ' ' THR . 29.7 m-80 -130.47 -56.02 1.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.116 0.566 . . . . 0.0 109.675 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 m -64.47 -30.46 71.49 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.918 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.59 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -121.3 22.37 10.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.957 0.408 . . . . 0.0 110.453 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 45.7 t0 -63.46 -10.97 19.98 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.612 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -98.87 32.17 2.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.743 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.59 HG21 ' SG ' ' A' ' 290' ' ' CYS . 40.0 t -128.04 124.98 63.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.1 0.476 . . . . 0.0 110.196 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -119.13 11.01 12.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -100.07 130.26 46.21 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.411 0.624 . . . . 0.0 110.201 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 299' ' ' LEU . 7.9 ttm180 -52.61 -76.24 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.55 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -41.91 -38.35 1.54 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.11 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.85 94.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.104 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 296' ' ' ARG . 35.5 mt -72.2 -41.48 66.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.575 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.4 mm -57.65 -31.48 39.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.11 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -86.84 -43.9 12.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.51 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.75 -19.93 65.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.985 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.46 25.43 1.68 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.459 0.474 . . . . 0.0 111.255 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.57 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -77.2 -43.6 2.69 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.924 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 18.8 Cg_exo -64.73 7.96 0.23 Allowed 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.472 2.781 . . . . 0.0 111.511 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 304' ' ' ALA . 10.0 m-20 -103.29 7.74 38.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.02 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.418 ' NH1' ' OD1' ' A' ' 203' ' ' ASN . 64.7 mtm180 -112.61 94.75 5.06 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.236 0.541 . . . . 0.0 110.2 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 39.5 ptt180 -164.46 136.73 4.7 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.535 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.44 143.9 11.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.61 -0.681 . . . . 0.0 109.562 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -117.69 103.78 10.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.484 HG23 HG22 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -80.98 113.37 20.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.211 -178.371 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -92.84 119.32 32.05 Favored 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 123.374 0.421 . . . . 0.0 110.73 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.797 HG21 HD22 ' A' ' 224' ' ' LEU . 60.9 t -119.25 117.32 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.807 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -113.98 128.63 56.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 98.15 40.83 3.4 Favored Glycine 0 C--O 1.226 -0.366 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.664 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.1 tt -116.94 170.03 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.664 ' O ' ' O ' ' A' ' 316' ' ' ILE . 51.8 mtpt -43.44 -156.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.074 0.859 . . . . 0.0 111.357 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -75.65 173.26 11.29 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.554 -0.716 . . . . 0.0 110.713 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.49 133.38 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.089 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.58 134.91 27.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.428 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.4 m -52.8 139.89 25.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.951 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -134.39 132.4 20.94 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -48.92 139.51 25.3 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.123 1.882 . . . . 0.0 112.352 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.442 ' CD ' ' N ' ' A' ' 324' ' ' GLN . 22.6 mp0 -83.73 -16.73 43.76 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.507 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.555 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.502 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 36.5 Cg_endo -63.81 -28.89 67.96 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.923 2.415 . . . . 0.0 111.955 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.25 72.25 0.45 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.477 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -53.57 93.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.753 2.302 . . . . 0.0 111.964 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.438 ' N ' ' CD ' ' A' ' 185' ' ' PRO . . . -170.5 53.93 0.22 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.348 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 184' ' ' ALA . 56.8 Cg_endo -69.73 155.78 65.14 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.662 2.242 . . . . 0.0 111.487 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -135.5 126.43 17.15 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.359 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -47.02 -47.31 16.96 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.137 1.891 . . . . 0.0 112.532 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 39.83 59.56 1.87 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 94.4 t -88.03 105.7 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.469 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.408 ' H ' ' HG2' ' A' ' 190' ' ' GLN . 3.0 pt20 -108.54 126.69 53.21 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.9 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 36.0 m -69.19 135.19 50.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.425 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 0.1 OUTLIER -115.38 169.44 9.15 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.411 0.624 . . . . 0.0 110.72 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 94.8 m-70 -155.68 125.44 6.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.081 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -112.54 117.64 32.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.409 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.88 104.82 15.89 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.989 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.684 ' CD2' HD11 ' A' ' 201' ' ' LEU . 29.6 tp -108.47 130.82 55.25 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.423 ' HG3' ' H ' ' A' ' 199' ' ' ASP . 20.8 tptp -79.39 128.44 33.34 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.948 0.88 . . . . 0.0 111.877 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 202' ' ' PHE . 18.0 t -64.06 -31.93 73.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.088 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.423 ' H ' ' HG3' ' A' ' 197' ' ' LYS . 46.7 t0 -58.92 -37.28 76.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.979 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 197' ' ' LYS . 91.6 t -66.81 -43.87 89.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.684 HD11 ' CD2' ' A' ' 196' ' ' LEU . 90.7 mt -78.31 -77.73 0.16 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.947 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -126.0 129.55 49.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.716 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -101.35 -74.44 0.62 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.34 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.453 ' CE2' ' OD1' ' A' ' 205' ' ' ASN . 54.7 p90 -99.09 -21.67 16.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.932 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.453 ' OD1' ' CE2' ' A' ' 204' ' ' PHE . 62.2 m-80 -72.77 164.67 26.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.272 0.558 . . . . 0.0 110.057 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.3 pttm -49.56 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.198 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -156.43 58.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.255 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.04 131.62 53.89 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.5 mt -75.21 139.35 42.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.747 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.2 mtpm? -98.44 158.72 32.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.708 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 213' ' ' GLY . 81.8 Cg_exo -34.01 -76.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.558 2.172 . . . . 0.0 112.013 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -50.9 -18.44 0.76 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.126 0.488 . . . . 0.0 110.162 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.72 -47.89 11.22 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -66.98 -40.27 87.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.34 70.19 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.24 83.41 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.411 0.624 . . . . 0.0 110.485 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.82 -30.92 71.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.063 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.49 -47.34 56.08 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.134 0.493 . . . . 0.0 110.867 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -63.9 -42.63 97.38 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.283 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.505 HD21 HD12 ' A' ' 311' ' ' ILE . 40.4 tp -64.87 -40.68 95.51 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.1 t80 -53.44 -49.11 68.05 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.968 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.5 m -55.76 -50.57 70.05 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.348 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -53.17 -24.18 10.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.42 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.739 HD22 HG21 ' A' ' 313' ' ' VAL . 74.3 mt -95.96 -20.02 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.583 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.2 t -73.06 -21.57 60.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.92 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -99.75 20.42 14.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.714 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -76.27 161.4 28.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.18 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 315' ' ' GLY . 9.5 t0 -78.75 126.94 81.66 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' LYS . 45.9 Cg_endo -68.82 -17.27 41.99 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.718 2.279 . . . . 0.0 113.051 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 229' ' ' PRO . 14.4 mmtp -27.62 -46.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.74 0.65 . . . . 0.0 110.964 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.476 ' O ' ' C ' ' A' ' 232' ' ' GLY . 9.6 m-20 -117.89 -14.92 10.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.36 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.21 51.64 0.06 OUTLIER Glycine 0 N--CA 1.474 1.182 0 O-C-N 123.985 0.803 . . . . 0.0 111.346 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 73.6 m -116.63 111.97 20.61 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 122.788 -0.242 . . . . 0.0 110.791 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.3 t -126.71 96.47 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.019 0.438 . . . . 0.0 110.075 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.15 121.18 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.446 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 311' ' ' ILE . 24.2 t -95.54 125.85 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.982 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.641 HD23 ' HB3' ' A' ' 277' ' ' ARG . 23.4 mt -109.08 143.96 37.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.933 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.695 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -120.13 138.95 13.42 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.622 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.2 OUTLIER -121.7 117.32 26.37 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.23 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.413 ' OG1' ' OD1' ' A' ' 249' ' ' ASN . 7.7 p -112.74 164.81 12.92 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.223 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.439 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 47.6 p-10 -85.22 177.53 7.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.32 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -104.0 127.2 51.55 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.103 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.1 mm -118.84 19.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.444 0.64 . . . . 0.0 110.706 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.44 7.51 86.31 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.8 t -136.3 99.06 4.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.996 0.427 . . . . 0.0 110.212 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -51.5 -50.04 60.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.577 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.94 -39.54 71.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.575 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.628 ' CE2' HD11 ' A' ' 252' ' ' LEU . 48.1 t80 -62.14 -47.16 85.78 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.97 0.414 . . . . 0.0 110.502 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 11.1 t-20 -62.2 -41.37 98.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.636 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -64.55 -44.27 91.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 110.751 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.09 -36.03 92.34 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.628 HD11 ' CE2' ' A' ' 248' ' ' TYR . 78.5 mt -74.36 -34.76 63.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.687 0.279 . . . . 0.0 111.365 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.473 ' OG ' ' CA ' ' A' ' 278' ' ' GLY . 12.0 t -65.01 -43.76 91.42 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.016 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -71.09 -40.13 71.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.417 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -60.11 -50.02 75.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.592 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.524 ' O ' HG23 ' A' ' 260' ' ' VAL . 86.2 mtt-85 -61.19 -53.99 49.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.747 0.308 . . . . 0.0 110.351 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -54.58 -35.49 63.39 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.164 0.507 . . . . 0.0 109.919 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -71.3 -44.33 65.37 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.258 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 17.1 m -62.02 -37.49 85.12 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.528 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 256' ' ' ARG . 96.7 t -65.12 -51.41 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.543 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.559 HG13 HD12 ' A' ' 274' ' ' ILE . 25.3 t -61.92 -48.64 87.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.054 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -45.48 -41.08 9.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.942 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.532 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 57.4 t80 -81.42 -30.69 33.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.653 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -73.5 -8.53 56.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.633 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.5 mt -87.33 -55.77 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.807 0.337 . . . . 0.0 111.264 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.9 m -50.72 -4.79 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.573 ' H ' ' C ' ' A' ' 265' ' ' ILE . 30.1 mmtp -79.39 -11.0 59.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.774 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.27 39.92 2.03 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 128.57 24.09 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.5 128.46 25.96 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.595 1.53 . . . . 0.0 112.037 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.8 -6.93 13.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.787 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 6.4 p30 -94.54 -21.75 18.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.905 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 1.2 ttpm? -80.4 -21.2 42.5 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.505 0.669 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.559 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -103.89 -171.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.626 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 22.0 m -171.17 129.56 0.73 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.145 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.86 152.25 18.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.641 ' HB3' HD23 ' A' ' 237' ' ' LEU . 69.2 ttt-85 -161.38 148.79 14.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.361 0.601 . . . . 0.0 110.6 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.473 ' CA ' ' OG ' ' A' ' 253' ' ' SER . . . -126.12 100.46 0.58 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.622 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 8.1 ptp -88.0 24.03 1.92 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.649 0.261 . . . . 0.0 110.931 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.12 -93.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 279' ' ' MET . 4.5 pt-20 -140.68 74.91 1.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.826 0.346 . . . . 0.0 110.447 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.4 m -90.38 -0.73 57.77 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.466 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -153.86 56.28 1.54 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.354 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.61 109.49 1.86 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.558 2.172 . . . . 0.0 112.28 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 22.5 m -78.87 -23.94 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.436 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.648 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.6 OUTLIER -59.71 -45.06 93.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.702 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -49.95 -0.1 0.01 OUTLIER Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.648 ' H ' ' C ' ' A' ' 286' ' ' THR . 25.7 t-20 -124.72 -57.19 1.55 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.6 m -54.82 -42.52 72.0 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 8.2 m -94.22 34.78 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.287 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 41.4 t0 -74.77 -7.99 55.05 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.821 0.343 . . . . 0.0 110.792 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -106.47 30.04 6.35 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.435 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.41 126.56 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.236 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -119.88 13.73 12.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.524 ' O ' HD13 ' A' ' 299' ' ' LEU . 2.1 mp0 -87.6 171.54 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.073 0.463 . . . . 0.0 110.144 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -86.26 -71.1 0.56 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.605 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.57 -32.39 68.88 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.334 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.11 87.23 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.514 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 295' ' ' GLN . 7.5 mp -72.29 -48.34 43.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.917 0.389 . . . . 0.0 110.843 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 81.3 mt -45.49 -38.52 2.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -79.55 -40.78 28.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.406 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 3.5 t -72.7 -8.92 57.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.528 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.7 mm? -92.03 20.95 5.35 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.496 0.498 . . . . 0.0 110.305 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.648 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.02 -38.06 1.14 Allowed Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.029 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.5 Cg_exo -59.13 9.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 123.35 2.7 . . . . 0.0 112.593 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 304' ' ' ALA . 33.6 p30 -114.77 15.44 17.49 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.69 0.281 . . . . 0.0 110.764 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -106.83 97.33 7.13 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.756 0.789 . . . . 0.0 110.285 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 16.6 ptm180 -171.12 157.84 5.3 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.881 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.695 HG12 ' HA2' ' A' ' 238' ' ' GLY . 34.5 m -117.91 148.0 21.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 87.9 mt-10 -121.06 105.91 11.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 110.753 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.506 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -78.44 117.28 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.201 -178.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -97.69 122.74 41.13 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.038 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.739 HG21 HD22 ' A' ' 224' ' ' LEU . 28.6 t -124.65 117.07 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.1 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -115.39 121.63 43.36 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 103.91 40.17 2.36 Favored Glycine 0 N--CA 1.462 0.398 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.506 ' CG1' ' N ' ' A' ' 317' ' ' LYS . 12.4 tt -115.95 168.07 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 109.983 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.506 ' N ' ' CG1' ' A' ' 316' ' ' ILE . 5.0 tmtp? -126.43 138.18 53.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.495 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -158.01 170.48 22.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.511 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 319' ' ' VAL . 9.3 p -79.27 124.68 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.552 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 8.1 p -156.86 150.24 9.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.749 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.4 p -66.91 137.0 56.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -83.79 141.72 41.54 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.884 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.03 158.48 49.5 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.448 2.098 . . . . 0.0 112.081 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -84.13 96.43 8.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.304 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.434 -179.842 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.644 ' HB1' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.644 ' CD ' ' HB1' ' A' ' 180' ' ' ALA . 25.0 Cg_exo -61.59 145.68 97.51 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.332 2.021 . . . . 0.0 111.709 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.63 147.81 11.01 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.382 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -71.1 146.37 51.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.17 1.913 . . . . 0.0 111.597 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -98.61 149.4 35.7 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.295 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 186' ' ' ALA . 80.8 Cg_exo -41.44 116.42 0.49 Allowed 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.75 1.633 . . . . 0.0 111.889 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.548 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . 174.82 -44.82 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 34.9 Cg_exo -60.21 145.46 98.47 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.48 2.12 . . . . 0.0 111.88 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -58.55 137.25 57.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.164 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 9.7 t -84.59 158.37 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.3 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.471 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.3 OUTLIER -126.11 109.6 12.56 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m -87.59 145.21 26.3 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -118.59 170.26 9.11 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.22 0.533 . . . . 0.0 110.002 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -153.55 124.66 7.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.947 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -112.07 122.31 47.4 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.485 ' OG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -87.87 105.9 17.74 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.451 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.694 ' CD2' HD11 ' A' ' 201' ' ' LEU . 37.5 tp -108.21 123.58 48.97 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.425 ' NZ ' ' OD2' ' A' ' 199' ' ' ASP . 5.3 ttpp -81.13 128.25 33.54 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 122.615 1.198 . . . . 0.0 113.2 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 202' ' ' PHE . 20.4 t -59.31 -19.6 47.63 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.159 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.425 ' OD2' ' NZ ' ' A' ' 197' ' ' LYS . 21.0 m-20 -59.69 -47.85 84.0 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.407 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 200' ' ' VAL . 2.5 m -71.64 -25.98 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.326 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.694 HD11 ' CD2' ' A' ' 196' ' ' LEU . 65.6 mt -90.56 -81.28 0.31 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.954 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.503 ' O ' ' OG ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -128.13 99.27 5.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.9 -178.066 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.53 HD21 ' HZ3' ' A' ' 210' ' ' LYS . 3.3 p30 -71.99 -71.78 0.26 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.406 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -105.73 -27.16 11.46 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.554 0.216 . . . . 0.0 110.9 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -61.98 167.83 3.59 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.992 0.425 . . . . 0.0 110.271 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -53.21 -81.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.515 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.47 ' HB1' ' OG ' ' A' ' 259' ' ' SER . . . -161.86 54.2 0.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 60.0 p -107.28 136.97 46.2 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.406 HD22 HD22 ' A' ' 201' ' ' LEU . 18.9 mt -79.8 123.44 27.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.827 0.346 . . . . 0.0 111.633 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.53 ' HZ3' HD21 ' A' ' 203' ' ' ASN . 22.1 mtmt -84.14 158.51 61.17 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.26 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 213' ' ' GLY . 96.1 Cg_exo -32.75 -75.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.702 2.268 . . . . 0.0 112.824 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -49.12 -19.27 0.42 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.386 0.612 . . . . 0.0 110.191 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.33 -50.42 8.35 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.92 -40.62 95.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.224 0.535 . . . . 0.0 109.568 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -51.51 68.99 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.144 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.21 85.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.246 0.546 . . . . 0.0 110.036 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.3 mt -61.64 -37.8 85.35 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.183 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASP . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 32.1 m-20 -63.66 -45.57 89.54 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.112 0.482 . . . . 0.0 111.009 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -62.2 -44.22 97.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.299 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 37.6 tp -63.24 -39.94 96.02 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 225' ' ' SER . 16.1 t80 -53.9 -45.39 71.1 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 87.7 p -51.25 -53.53 34.53 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.038 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -53.83 -29.09 39.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.825 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.579 ' O ' HD22 ' A' ' 227' ' ' LEU . 17.5 mt -93.64 -22.97 18.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.519 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 221' ' ' TYR . 7.2 p -77.86 -30.04 50.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -96.17 22.78 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.167 0.508 . . . . 0.0 110.437 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.579 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.6 OUTLIER -79.71 168.61 19.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.83 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.37 127.85 64.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 230' ' ' LYS . 68.6 Cg_endo -72.22 -16.53 28.24 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.072 1.848 . . . . 0.0 113.071 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.475 ' CG ' ' N ' ' A' ' 231' ' ' ASP . 19.5 ptmt -31.67 -45.77 0.1 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 123.583 0.552 . . . . 0.0 111.232 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' A' ' 230' ' ' LYS . 84.5 m-20 -111.92 -19.39 12.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.998 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 28.31 54.75 0.13 Allowed Glycine 0 N--CA 1.473 1.151 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.754 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.8 p -119.06 109.89 16.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.409 0.147 . . . . 0.0 111.151 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.4 t -125.47 94.74 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.699 0.761 . . . . 0.0 110.205 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.57 120.31 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.549 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.44 HG13 HD13 ' A' ' 311' ' ' ILE . 69.3 t -96.93 123.96 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.297 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.8 mt -107.2 137.83 44.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.185 0.517 . . . . 0.0 110.592 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -90.91 139.54 14.87 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.493 ' CZ ' ' CD ' ' A' ' 310' ' ' GLU . 11.6 m-85 -131.56 118.95 20.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.051 0.925 . . . . 0.0 108.794 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.0 t -129.49 171.05 12.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.843 0.354 . . . . 0.0 111.124 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -76.96 -176.12 3.82 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.321 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -105.82 121.83 44.85 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.781 0.324 . . . . 0.0 110.239 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 243' ' ' ILE . 8.5 mm -118.82 11.15 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.552 0.691 . . . . 0.0 110.453 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.8 -47.36 3.06 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.5 m -68.3 101.04 1.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.314 0.578 . . . . 0.0 109.636 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -54.41 -52.3 62.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.548 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.41 -44.99 80.86 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.194 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.599 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 56.1 t80 -62.17 -45.02 95.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.91 0.385 . . . . 0.0 110.733 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.418 HD22 ' H ' ' A' ' 243' ' ' ILE . 72.9 m-20 -62.3 -41.67 98.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -64.79 -41.8 95.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.673 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.27 96.2 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.599 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 27.7 mt -67.79 -40.76 83.88 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.679 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.5 t -62.2 -43.86 97.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.554 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -65.68 -41.4 92.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.004 0.431 . . . . 0.0 110.687 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.12 -48.84 77.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.684 ' NH2' HH21 ' A' ' 307' ' ' ARG . 66.7 mtt85 -61.36 -53.62 54.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.694 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.87 -30.22 65.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.463 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 5.5 tp-100 -75.45 -46.39 32.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.704 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.641 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 20.4 m -56.77 -37.19 70.75 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.996 0.903 . . . . 0.0 109.872 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 256' ' ' ARG . 44.8 t -71.07 -63.02 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.771 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 276' ' ' ALA . 17.0 t -46.36 -63.84 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.731 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.641 ' OD1' ' O ' ' A' ' 259' ' ' SER . 28.6 p-10 -45.22 -38.72 5.64 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.079 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.524 ' N ' ' OD1' ' A' ' 262' ' ' ASP . 84.1 t80 -80.74 -31.94 35.84 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.981 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 260' ' ' VAL . 0.5 OUTLIER -70.27 -9.15 55.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.561 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.487 ' C ' ' H ' ' A' ' 267' ' ' LYS . 68.9 mt -86.83 -54.79 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.816 0.341 . . . . 0.0 111.744 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 39.0 m -51.59 -7.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.19 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 218' ' ' ASP . 0.0 OUTLIER -78.82 -11.34 59.99 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 109.52 39.49 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.98 130.19 23.84 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 117.173 0.487 . . . . 0.0 109.751 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.94 132.55 50.37 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.253 1.302 . . . . 0.0 112.4 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.33 -13.27 60.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.682 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -90.46 -17.45 27.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.484 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.51 -25.62 35.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.728 0.775 . . . . 0.0 110.413 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.3 pt -100.3 -178.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.548 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 7.7 t -162.17 126.48 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.613 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -97.58 113.97 25.79 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.887 0.375 . . . . 0.0 110.803 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -129.14 156.33 44.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.797 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.48 152.09 16.98 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 238' ' ' GLY . 6.5 tpt -118.11 -10.36 10.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.961 0.41 . . . . 0.0 110.242 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 60.28 -107.79 1.5 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.485 ' CD ' ' N ' ' A' ' 281' ' ' GLU . 1.0 OUTLIER -141.02 71.31 1.36 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.897 0.379 . . . . 0.0 110.235 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 72.8 m -93.44 7.42 44.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -160.98 70.72 2.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.94 105.74 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.35 2.033 . . . . 0.0 112.645 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 286' ' ' THR . 15.1 m -64.28 -42.06 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.572 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.589 ' O ' ' N ' ' A' ' 288' ' ' ASN . 40.8 p -58.27 -45.67 87.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.102 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -43.95 -10.37 0.01 OUTLIER Glycine 0 CA--C 1.533 1.179 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 286' ' ' THR . 87.7 m-20 -129.77 -54.23 1.14 Allowed 'General case' 0 C--O 1.231 0.098 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 m -58.33 -44.22 88.57 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -107.13 33.09 4.16 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 109.903 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 293' ' ' VAL . 28.9 t0 -56.94 -42.65 80.46 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.447 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -75.08 33.18 0.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.502 HG21 ' SG ' ' A' ' 290' ' ' CYS . 15.5 t -131.91 113.51 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.943 0.401 . . . . 0.0 110.343 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -118.51 14.65 13.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.926 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -99.62 130.82 45.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.011 0.434 . . . . 0.0 110.166 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -50.47 -67.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.273 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.89 -38.31 61.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.72 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.96 89.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.332 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 60.3 mt -75.19 -50.25 16.85 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.878 0.37 . . . . 0.0 110.652 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 78.1 mt -52.72 -32.74 17.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.227 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -78.07 -46.22 21.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.924 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 11.9 t -70.64 -13.1 61.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.637 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 35.9 mt -92.58 24.47 3.5 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.398 0.437 . . . . 0.0 111.453 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 305' ' ' PRO . . . -78.45 -45.45 2.05 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.397 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 35.7 Cg_endo -69.28 8.7 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.203 1.935 . . . . 0.0 111.586 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 306' ' ' ASP . 9.4 t70 -104.76 9.76 34.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.228 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.684 HH21 ' NH2' ' A' ' 256' ' ' ARG . 38.6 mtp180 -107.76 116.39 31.86 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.212 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.485 ' NH2' ' OG1' ' A' ' 195' ' ' THR . 15.7 ptm180 -175.67 -171.31 0.46 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.5 m -144.77 154.16 14.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.493 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 95.2 mt-10 -121.7 105.25 10.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.044 0.45 . . . . 0.0 110.925 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.44 HD13 HG13 ' A' ' 236' ' ' VAL . 3.9 mm -80.54 116.71 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.488 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -99.63 119.6 38.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.774 0.321 . . . . 0.0 110.369 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 224' ' ' LEU . 2.5 t -118.94 120.53 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.653 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -118.93 141.13 48.93 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.22 -22.55 40.17 Favored Glycine 0 N--CA 1.469 0.88 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.551 ' CG1' ' H ' ' A' ' 317' ' ' LYS . 14.6 tt -56.47 176.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.551 ' H ' ' CG1' ' A' ' 316' ' ' ILE . 49.5 tttt -54.81 -147.65 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.522 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 44.1 t0 -162.15 151.73 16.11 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 4.0 p -138.81 139.45 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 56.5 t -122.03 129.75 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 322' ' ' GLN . 53.0 m -99.64 162.64 12.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.903 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLN . . . . . 0.53 ' N ' HG22 ' A' ' 321' ' ' THR . 18.2 tt0 -118.39 85.36 25.49 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.013 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.98 -39.19 79.95 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.32 2.013 . . . . 0.0 112.261 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.421 ' O ' ' OXT' ' A' ' 325' ' ' ALA . 59.6 tt0 -156.54 -64.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.62 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' A' ' 324' ' ' GLN . . . . . . . . 0 C--O 1.218 -0.553 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.567 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.448 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 44.9 Cg_endo -67.01 153.7 77.02 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.733 2.288 . . . . 0.0 111.963 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -173.85 61.41 0.25 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.613 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.89 43.22 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.722 2.281 . . . . 0.0 111.868 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 60.44 72.87 0.68 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.471 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.52 145.71 98.27 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.813 2.342 . . . . 0.0 111.955 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.463 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -162.29 52.64 0.38 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.614 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 41.9 Cg_endo -67.17 -19.76 50.45 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.752 2.302 . . . . 0.0 111.927 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -60.42 159.38 10.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.47 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 85.7 t -107.22 134.22 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.913 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -118.26 100.21 7.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.165 0.507 . . . . 0.0 110.463 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.564 HG22 ' CE1' ' A' ' 193' ' ' HIS . 12.2 m -77.16 140.01 40.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.53 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -147.36 117.83 7.45 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.029 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.2 OUTLIER -103.29 150.52 23.67 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.552 ' CE1' HD21 ' A' ' 224' ' ' LEU . 41.1 m-85 -111.76 121.92 46.39 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.798 0.332 . . . . 0.0 110.184 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.59 101.72 12.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.709 ' CD2' HD11 ' A' ' 201' ' ' LEU . 34.4 tp -104.28 132.52 50.44 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.996 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.408 ' HB3' HG23 ' A' ' 200' ' ' VAL . 2.1 ttmp? -78.2 127.04 31.67 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.897 0.856 . . . . 0.0 111.893 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 202' ' ' PHE . 39.2 t -63.75 -33.22 75.17 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.035 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.56 -38.75 81.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.259 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 197' ' ' LYS . 62.0 t -63.21 -46.17 96.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.709 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.3 mt -75.56 -76.34 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.659 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.484 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -130.7 143.5 50.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.363 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.468 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 46.5 t30 -129.77 -72.87 0.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.272 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.34 -37.94 56.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -71.92 165.12 24.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.445 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -57.67 -68.03 0.28 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.589 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.12 57.18 0.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.457 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 18.8 p -106.43 130.06 54.3 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.84 139.22 44.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.78 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 213' ' ' GLY . 30.7 mtmt -101.17 159.66 28.85 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 210' ' ' LYS . 86.3 Cg_exo -34.25 -77.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.387 2.058 . . . . 0.0 112.104 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.72 -20.29 1.2 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.173 0.511 . . . . 0.0 110.424 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.83 -49.69 16.61 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -67.9 -39.19 83.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.19 0.519 . . . . 0.0 109.807 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.29 -53.17 60.44 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.537 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.51 91.34 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.43 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 mt -62.45 -26.34 68.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.502 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -73.01 -46.08 54.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -63.65 -40.25 96.38 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.462 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 311' ' ' ILE . 55.7 tp -61.08 -40.09 92.39 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.512 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 49.4 t80 -54.87 -58.33 8.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.535 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 15.4 m -58.94 -6.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.361 0.601 . . . . 0.0 110.788 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.461 ' OE1' ' CE2' ' A' ' 194' ' ' PHE . 19.0 tt0 -94.38 -34.23 12.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.684 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 1.085 HD22 HG21 ' A' ' 313' ' ' VAL . 42.7 mt -96.92 -13.03 22.7 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.809 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.3 t -83.24 -14.93 52.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.724 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -96.71 17.55 16.29 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.446 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -78.18 178.92 7.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.653 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 315' ' ' GLY . 9.4 t70 -94.2 132.03 30.14 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.734 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 230' ' ' LYS . 42.3 Cg_endo -67.92 -20.47 45.07 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.817 2.344 . . . . 0.0 112.837 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 229' ' ' PRO . 40.6 mmtt -33.43 -53.07 0.4 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.055 0.455 . . . . 0.0 110.582 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 99.3 m-20 -102.76 -19.01 14.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.471 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.03 45.23 0.01 OUTLIER Glycine 0 N--CA 1.469 0.879 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 231' ' ' ASP . 28.0 m -112.22 111.38 22.23 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 71.6 t -126.31 94.06 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.761 0.791 . . . . 0.0 110.285 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.4 t -97.22 121.03 47.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.09 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 311' ' ' ILE . 22.0 t -93.13 124.58 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.58 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 277' ' ' ARG . 19.7 mt -109.49 141.34 42.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.974 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -125.16 126.08 5.85 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.31 120.39 42.08 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 241' ' ' ASP . 2.4 m -108.98 168.53 9.29 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 240' ' ' THR . 52.8 p-10 -95.14 -179.55 4.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.628 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 244' ' ' GLY . 38.6 ttm180 -98.65 127.36 44.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.318 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.711 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.9 mm -118.31 14.2 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.313 0.578 . . . . 0.0 110.667 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.408 ' H ' ' HG2' ' A' ' 242' ' ' ARG . . . 91.87 -3.05 77.19 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 4.2 m -134.01 104.36 6.21 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.998 0.428 . . . . 0.0 110.072 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -55.35 -50.81 68.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.476 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.72 -40.75 76.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.545 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.565 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 48.7 t80 -63.07 -44.56 95.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.293 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -62.67 -40.4 96.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.279 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -63.93 -43.1 96.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.497 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.468 ' C ' ' NH2' ' A' ' 255' ' ' ARG . . . -62.33 -35.86 92.24 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.789 HD22 HH12 ' A' ' 256' ' ' ARG . 14.4 mt -74.66 -35.91 62.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.499 -0.35 . . . . 0.0 111.084 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.4 p -64.64 -41.06 96.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.979 0.418 . . . . 0.0 110.512 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -70.36 -44.48 68.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.178 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.468 ' NH2' ' C ' ' A' ' 251' ' ' GLY . 63.5 mtm-85 -56.55 -46.78 80.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.803 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.789 HH12 HD22 ' A' ' 252' ' ' LEU . 67.2 mtt85 -60.46 -62.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.611 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.72 -34.78 19.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.104 0.478 . . . . 0.0 109.881 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -72.86 -46.07 54.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.406 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 61.5 m -60.11 -38.07 81.9 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.073 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.1 t -64.06 -50.8 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.331 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.58 HG13 HD12 ' A' ' 274' ' ' ILE . 9.5 t -62.31 -48.36 88.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.434 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.44 -41.86 21.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.061 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.637 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 85.5 t80 -79.39 -34.62 41.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.628 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -64.76 -29.48 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.966 -179.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 267' ' ' LYS . 82.4 mt -68.73 -50.16 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 111.88 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 44.6 m -50.76 -8.51 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.906 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.637 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 11.4 mmtp -84.6 2.28 42.18 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.006 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.08 40.81 4.48 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.41 129.0 25.05 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.332 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.06 127.31 25.18 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.862 1.708 . . . . 0.0 111.725 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.22 -8.78 34.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.896 0.379 . . . . 0.0 111.341 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 64.7 t0 -91.86 -22.73 19.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.782 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -80.83 -19.16 45.21 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.486 0.66 . . . . 0.0 110.78 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.58 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -105.34 -171.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.745 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 1.6 t -168.5 136.27 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.206 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -106.91 110.72 22.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.819 0.342 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.486 ' HB3' HD23 ' A' ' 237' ' ' LEU . 58.9 ttm-85 -117.1 142.73 46.63 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.447 0.642 . . . . 0.0 110.532 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.84 99.62 2.33 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.626 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.6 OUTLIER -79.29 9.94 4.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.823 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.548 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 10.26 -95.89 0.01 OUTLIER Glycine 0 N--CA 1.476 1.314 0 O-C-N 123.534 0.521 . . . . 0.0 112.068 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 281' ' ' GLU . 56.1 mp0 -135.68 75.05 1.54 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.835 0.35 . . . . 0.0 110.591 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.429 ' OG ' ' SD ' ' A' ' 279' ' ' MET . 53.8 m -83.65 -3.63 57.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 283' ' ' ASN . 11.4 p-10 -176.42 80.21 0.27 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.593 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.14 107.64 0.27 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.65 2.233 . . . . 0.0 112.214 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 286' ' ' THR . 9.6 m -88.77 -36.63 9.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.524 0.678 . . . . 0.0 110.757 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 286' ' ' THR . 0.2 OUTLIER -60.92 -43.67 98.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.954 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 290' ' ' CYS . . . -45.57 -88.96 0.01 OUTLIER Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 287' ' ' GLY . 86.6 m-20 -27.61 -53.92 0.09 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.655 0.264 . . . . 0.0 110.35 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.4 m -56.06 -47.04 78.7 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.478 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.621 ' N ' ' O ' ' A' ' 287' ' ' GLY . 0.3 OUTLIER -98.37 34.19 2.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 109.928 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 293' ' ' VAL . 51.5 t0 -57.98 -42.61 85.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.447 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -75.43 32.32 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.569 HG21 ' SG ' ' A' ' 290' ' ' CYS . 21.2 t -131.18 113.14 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.92 0.391 . . . . 0.0 110.665 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -118.97 14.22 13.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.605 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.446 ' O ' HD12 ' A' ' 299' ' ' LEU . 1.6 mt-30 -86.65 166.9 14.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.111 0.481 . . . . 0.0 110.308 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -78.78 -67.36 0.75 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.532 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 301' ' ' ASP . . . -61.77 -27.33 68.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.223 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.588 ' O ' ' OD1' ' A' ' 301' ' ' ASP . . . -71.99 -24.26 61.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.156 0.503 . . . . 0.0 110.933 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 295' ' ' GLN . 71.2 mt -86.69 -48.11 8.57 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.66 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.74 -31.8 48.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.054 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.588 ' OD1' ' O ' ' A' ' 298' ' ' ALA . 43.3 p-10 -82.95 -43.77 16.08 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.602 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.574 ' N ' ' OD1' ' A' ' 301' ' ' ASP . 13.1 t -74.86 -13.77 60.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.156 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 35.4 mt -87.39 21.07 2.58 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.514 0.509 . . . . 0.0 110.466 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.626 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -72.73 -41.01 6.91 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.0 Cg_exo -58.94 7.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.464 2.776 . . . . 0.0 112.47 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 304' ' ' ALA . 45.8 t0 -108.18 7.51 27.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.871 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.468 ' NH1' ' OD1' ' A' ' 203' ' ' ASN . 62.4 mtm180 -112.66 86.4 2.36 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.454 0.645 . . . . 0.0 109.376 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.546 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 11.0 ptp180 -156.7 130.48 8.3 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.174 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.64 139.69 18.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -122.5 103.41 8.69 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.317 0.58 . . . . 0.0 110.42 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.505 HG23 HG22 ' A' ' 236' ' ' VAL . 0.8 OUTLIER -79.46 117.89 25.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.509 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -94.9 121.51 36.57 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.642 0.258 . . . . 0.0 110.891 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 1.085 HG21 HD22 ' A' ' 224' ' ' LEU . 54.6 t -122.95 117.89 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -114.27 133.87 55.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 102.25 18.84 15.79 Favored Glycine 0 C--O 1.22 -0.759 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 20.2 tt -105.29 146.81 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 110.644 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -123.23 163.29 20.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.848 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -162.95 175.01 11.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.973 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 320' ' ' VAL . 5.4 p -77.48 160.7 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.51 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.531 ' N ' HG22 ' A' ' 319' ' ' VAL . 34.6 m -63.82 137.03 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.271 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.618 HG22 ' N ' ' A' ' 322' ' ' GLN . 99.0 m -124.1 164.65 19.0 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.463 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLN . . . . . 0.618 ' N ' HG22 ' A' ' 321' ' ' THR . 23.3 mp0 -65.47 148.17 98.22 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 325' ' ' ALA . 55.8 Cg_endo -70.09 -11.82 31.11 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.564 2.176 . . . . 0.0 112.035 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -67.66 61.93 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.692 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 323' ' ' PRO . . . . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.547 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.682 ' HB3' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.682 ' CD ' ' HB3' ' A' ' 180' ' ' ALA . 25.6 Cg_endo -60.36 -29.47 88.9 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.525 2.15 . . . . 0.0 111.855 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.689 ' HB1' ' HD2' ' A' ' 183' ' ' PRO . . . -52.28 175.1 0.1 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.689 ' HD2' ' HB1' ' A' ' 182' ' ' ALA . 46.1 Cg_exo -55.56 138.12 79.78 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.417 2.078 . . . . 0.0 112.014 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -72.97 151.49 90.65 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.512 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 186' ' ' ALA . 51.9 Cg_endo -69.05 152.02 73.06 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.876 2.384 . . . . 0.0 111.92 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . 176.28 -46.4 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.272 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 47.9 Cg_exo -54.7 -38.81 91.28 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.567 2.178 . . . . 0.0 112.183 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 188' ' ' GLU . 56.0 mp0 -84.12 147.66 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.316 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.07 137.99 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.179 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -122.93 127.01 48.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.8 m -77.91 142.03 38.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.131 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 193' ' ' HIS . 21.5 tptt -114.42 166.83 11.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.123 0.487 . . . . 0.0 110.553 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 192' ' ' LYS . 53.2 m80 -155.74 124.21 5.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.836 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.479 ' CE2' HD21 ' A' ' 224' ' ' LEU . 60.2 m-85 -113.66 120.13 39.82 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.15 103.66 14.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.08 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.708 ' CD2' HD11 ' A' ' 201' ' ' LEU . 28.8 tp -105.11 124.24 49.2 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -78.67 129.33 34.6 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 121.897 0.856 . . . . 0.0 112.206 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.0 t -62.3 -32.99 73.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.026 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -54.88 -35.94 64.6 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.085 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 71.0 t -71.48 -38.77 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.878 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.708 HD11 ' CD2' ' A' ' 196' ' ' LEU . 91.8 mt -84.41 -80.59 0.2 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.808 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -124.55 133.16 53.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.076 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.447 ' N ' ' OD1' ' A' ' 203' ' ' ASN . 1.6 m-20 -104.27 -71.11 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.567 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -107.49 -16.48 14.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.808 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -71.9 170.13 14.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.062 0.458 . . . . 0.0 110.241 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -52.49 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.491 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.475 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -162.19 4.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.503 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 76.8 p -55.02 144.89 21.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.014 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 28.0 mt -88.96 133.2 34.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 213' ' ' GLY . 1.5 mptm? -90.74 157.77 43.35 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.975 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -34.1 -74.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.636 2.224 . . . . 0.0 111.828 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -50.41 -21.63 1.53 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.076 0.465 . . . . 0.0 110.048 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.95 -50.27 13.83 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -66.36 -39.2 89.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.305 0.574 . . . . 0.0 110.151 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.3 -54.31 48.24 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.555 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.29 -38.42 91.07 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.703 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.9 mt -61.59 -27.36 68.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.503 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -74.21 -46.67 40.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.202 0.525 . . . . 0.0 110.443 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -61.77 -43.12 99.48 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.209 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 48.2 tp -66.8 -39.11 87.64 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.442 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.435 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.7 t80 -53.57 -49.37 67.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.849 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.7 t -58.11 -51.04 71.38 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.45 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.467 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 58.5 tt0 -52.18 -26.02 10.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.258 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.982 HD22 HG21 ' A' ' 313' ' ' VAL . 72.0 mt -96.13 -17.96 20.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.507 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.1 t -78.47 -17.6 56.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.758 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -97.36 20.67 11.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.785 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.522 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -80.16 178.12 8.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.861 179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -96.04 133.79 24.72 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.495 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.0 Cg_endo -69.75 -18.6 36.95 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.813 2.342 . . . . 0.0 112.356 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 229' ' ' PRO . 56.4 tttp -36.22 -53.66 0.81 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.457 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 232' ' ' GLY . 36.2 m-20 -100.79 -21.59 15.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.65 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.95 50.45 0.05 OUTLIER Glycine 0 N--CA 1.471 1.003 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.5 m -117.65 111.28 18.95 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 122.671 -0.311 . . . . 0.0 110.398 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 99.0 t -129.0 93.9 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.214 0.531 . . . . 0.0 110.145 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.6 t -98.27 123.4 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.621 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 311' ' ' ILE . 95.3 t -95.36 127.85 47.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.641 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 39.1 mt -111.58 142.44 43.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.662 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -118.94 139.42 14.36 Favored Glycine 0 N--CA 1.48 1.587 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.4 OUTLIER -121.14 121.58 38.15 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.453 HG22 ' NH2' ' A' ' 256' ' ' ARG . 2.6 p -112.09 165.3 12.25 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.987 0.422 . . . . 0.0 110.236 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 241' ' ' ASP . 11.3 p30 -87.82 -177.79 5.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.443 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -105.18 120.23 41.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.052 0.453 . . . . 0.0 110.288 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.3 mm -119.09 15.02 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.399 0.619 . . . . 0.0 110.83 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.5 9.03 87.32 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.7 p -134.45 97.19 3.75 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.894 0.378 . . . . 0.0 110.334 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -52.57 -52.48 54.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.647 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.9 72.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.58 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 56.3 t80 -60.19 -46.75 88.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.524 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 12.5 m120 -61.9 -42.63 99.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.569 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -63.36 -42.54 98.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.553 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.68 -36.08 92.15 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.58 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 32.5 mt -74.28 -32.98 63.12 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.704 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 12.0 m -65.36 -43.69 90.03 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.177 0.513 . . . . 0.0 110.598 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -70.42 -35.23 73.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.928 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -59.86 -50.04 75.34 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.549 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.858 ' O ' HG23 ' A' ' 260' ' ' VAL . 16.4 ptp180 -67.16 -47.52 70.77 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.406 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.83 -39.74 92.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.194 0.521 . . . . 0.0 110.189 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -74.6 -45.51 44.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.16 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 46.5 t -60.65 -38.54 85.2 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.084 0.469 . . . . 0.0 110.238 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.6 t -64.92 -52.06 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.557 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.6 HG13 HD12 ' A' ' 274' ' ' ILE . 18.2 t -61.37 -49.11 85.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.326 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -44.96 -41.83 7.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.961 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -82.53 -30.31 29.83 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -72.34 -7.56 50.23 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.371 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 267' ' ' LYS . 61.2 mt -88.05 -54.7 7.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 72.8 m -51.22 -5.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.6 OUTLIER -79.7 -11.4 59.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.894 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.46 39.11 1.97 Allowed Glycine 0 C--N 1.323 -0.174 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.99 127.89 24.29 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.43 128.01 24.29 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.145 1.897 . . . . 0.0 112.273 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.09 -7.9 20.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.716 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -93.03 -24.41 18.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -78.53 -21.76 48.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.563 0.697 . . . . 0.0 110.587 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.6 HD12 HG13 ' A' ' 261' ' ' VAL . 1.4 pt -102.23 -173.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.865 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 26.3 t -171.61 132.49 0.75 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.484 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.89 153.08 19.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -158.49 144.72 17.1 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.091 0.472 . . . . 0.0 110.804 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.98 97.35 2.06 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.462 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.5 tpt -68.46 -10.68 56.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.907 0.384 . . . . 0.0 110.462 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 45.07 -104.62 0.07 OUTLIER Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.07 70.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.389 . . . . 0.0 110.548 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 14.1 m -88.82 -0.16 57.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.585 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.441 HD22 ' HE2' ' A' ' 239' ' ' TYR . 5.9 p30 -169.5 76.66 0.69 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.675 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.76 111.32 3.26 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.536 2.158 . . . . 0.0 111.798 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 286' ' ' THR . 15.5 m -71.52 -39.46 70.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.86 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.625 ' C ' ' H ' ' A' ' 288' ' ' ASN . 21.1 p -63.68 -48.2 78.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.479 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.71 -0.53 0.03 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.625 ' H ' ' C ' ' A' ' 286' ' ' THR . 65.8 t30 -114.0 -60.17 1.92 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.8 t -79.04 -3.86 47.25 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.569 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.4 OUTLIER -127.32 18.22 7.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.531 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 30.1 p-10 -67.57 -3.08 7.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.378 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -99.89 33.41 2.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.451 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.488 HG21 ' SG ' ' A' ' 290' ' ' CYS . 26.6 t -127.95 122.87 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.889 0.376 . . . . 0.0 110.231 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -119.59 6.5 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.824 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.9 168.39 12.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.057 0.456 . . . . 0.0 110.168 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -80.02 -74.89 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.758 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 300' ' ' ILE . . . -55.92 -26.46 47.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.818 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.89 -34.69 78.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.146 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.2 mt -75.46 -64.71 1.01 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 297' ' ' ALA . 10.9 pt -48.41 -30.24 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.396 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -76.62 -42.66 41.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.567 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 15.3 t -80.45 -10.54 59.74 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.73 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.52 HD23 ' OG1' ' A' ' 286' ' ' THR . 54.2 mt -91.95 21.81 4.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.69 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -76.61 -45.12 3.25 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 121.156 0.503 . . . . 0.0 110.375 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 25.2 Cg_exo -61.81 9.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.233 2.622 . . . . 0.0 111.654 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 304' ' ' ALA . 51.0 t0 -106.49 11.08 31.1 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.623 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -111.25 103.26 11.65 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.349 0.595 . . . . 0.0 110.402 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -172.17 153.48 3.09 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.222 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.662 HG12 ' HA2' ' A' ' 238' ' ' GLY . 34.7 m -116.16 149.69 18.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -120.22 107.77 13.39 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.089 0.471 . . . . 0.0 110.839 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 236' ' ' VAL . 3.5 mm -78.37 117.95 24.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -100.74 111.59 23.84 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.301 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.982 HG21 HD22 ' A' ' 224' ' ' LEU . 86.6 t -119.63 123.65 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 O-C-N 123.66 0.6 . . . . 0.0 110.644 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -119.63 140.54 50.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.777 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 101.39 -0.35 53.63 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.8 tt -85.46 144.29 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.064 0.459 . . . . 0.0 110.485 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -85.6 130.33 34.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.435 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -92.12 109.49 20.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.601 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 321' ' ' THR . 4.3 m -107.02 174.58 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.058 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 2.5 m -95.27 90.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.059 0.457 . . . . 0.0 110.378 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 321' ' ' THR . 6.8 t -152.36 112.82 4.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.137 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -93.33 117.38 67.4 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.789 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.57 -17.05 23.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.492 2.128 . . . . 0.0 112.219 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -97.61 124.58 41.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.408 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.596 179.929 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.23 113.8 3.65 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.502 2.135 . . . . 0.0 112.21 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.565 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . . . -86.41 -45.96 0.56 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.171 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 182' ' ' ALA . 73.6 Cg_endo -81.98 12.5 2.78 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.636 2.224 . . . . 0.0 112.333 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.638 ' HB3' ' CD ' ' A' ' 185' ' ' PRO . . . -39.11 -61.34 0.97 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.367 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.638 ' CD ' ' HB3' ' A' ' 184' ' ' ALA . 27.2 Cg_endo -60.33 145.41 98.68 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.374 2.049 . . . . 0.0 111.862 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -173.55 89.68 0.37 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.335 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.0 139.1 61.79 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.411 2.074 . . . . 0.0 112.06 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -93.7 159.82 15.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.545 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 12.3 t -75.08 141.79 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.239 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -114.72 89.53 3.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.34 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.589 HG22 ' N ' ' A' ' 192' ' ' LYS . 23.6 m -69.52 169.35 12.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.46 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.589 ' N ' HG22 ' A' ' 191' ' ' THR . 3.4 tptm -148.83 166.23 29.13 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.083 0.468 . . . . 0.0 110.083 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.502 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 12.8 m80 -153.5 123.93 7.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.756 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -112.09 115.6 29.15 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.434 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.07 103.14 14.46 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.775 -179.239 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.695 ' CD2' HD11 ' A' ' 201' ' ' LEU . 30.2 tp -108.72 132.93 53.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.413 ' HB3' HG23 ' A' ' 200' ' ' VAL . 0.0 OUTLIER -83.76 126.58 33.05 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.244 -178.232 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.4 m -62.02 -32.35 72.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.332 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.491 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 11.8 m-20 -59.31 -36.52 75.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.81 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 197' ' ' LYS . 94.9 t -68.19 -42.91 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.695 HD11 ' CD2' ' A' ' 196' ' ' LEU . 92.7 mt -78.35 -79.48 0.12 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.244 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.427 ' CD1' ' NH1' ' A' ' 256' ' ' ARG . 0.1 OUTLIER -118.04 122.84 44.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.764 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 8.9 p-10 -91.32 -78.09 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.628 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.503 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 82.5 m-85 -98.0 -14.94 20.29 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.809 0.337 . . . . 0.0 110.659 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -72.61 154.54 40.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.235 0.54 . . . . 0.0 109.718 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.56 ' CG ' ' H ' ' A' ' 207' ' ' ALA . 42.2 pttt -49.8 -59.98 3.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.987 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.56 ' H ' ' CG ' ' A' ' 206' ' ' LYS . . . -168.71 57.18 0.05 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.603 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 64.4 p -107.23 129.92 54.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.7 mt -74.48 146.22 42.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.719 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 213' ' ' GLY . 22.7 mttp -105.87 158.5 32.28 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.946 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -33.85 -76.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.495 2.13 . . . . 0.0 112.231 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -52.62 -18.98 2.03 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.251 0.548 . . . . 0.0 110.16 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.38 -49.37 9.39 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -67.27 -40.8 86.23 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.186 0.517 . . . . 0.0 109.77 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.68 -50.89 71.7 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.589 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.26 86.58 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.635 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.1 mt -62.25 -31.37 71.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -70.17 -45.3 67.0 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.291 0.567 . . . . 0.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -63.06 -42.78 99.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.927 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.432 HD21 HD12 ' A' ' 311' ' ' ILE . 38.8 tp -63.87 -40.28 96.17 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.521 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.508 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.3 t80 -52.65 -47.3 67.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.534 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.7 m -52.27 -51.94 55.64 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.67 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -55.43 -26.4 41.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.469 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.559 ' O ' HD22 ' A' ' 227' ' ' LEU . 67.4 mt -94.01 -23.85 17.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.675 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.1 t -75.79 -32.36 59.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.279 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -91.94 21.37 4.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.7 OUTLIER -77.34 173.46 11.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.199 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -88.35 133.7 36.1 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.457 ' O ' ' C ' ' A' ' 230' ' ' LYS . 55.0 Cg_endo -70.56 -18.22 33.38 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.569 2.179 . . . . 0.0 112.709 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 229' ' ' PRO . 11.1 mmtp -28.03 -49.22 0.06 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.594 0.559 . . . . 0.0 110.498 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 67.5 m-20 -118.51 -14.66 9.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.377 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.79 51.27 0.06 OUTLIER Glycine 0 N--CA 1.47 0.929 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.4 m -114.68 110.7 20.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.668 0.271 . . . . 0.0 110.99 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.32 95.67 3.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.811 0.815 . . . . 0.0 109.692 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.11 117.75 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.642 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.495 HG21 ' CG2' ' A' ' 261' ' ' VAL . 24.5 t -93.14 124.17 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.635 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.7 mt -108.6 137.79 45.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.065 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.613 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -120.52 132.42 9.26 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -116.64 126.52 53.35 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.614 HG23 ' ND2' ' A' ' 249' ' ' ASN . 8.0 t -125.14 162.25 25.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.501 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 55.7 p-10 -77.35 -175.82 3.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.224 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.1 ptm85 -120.01 133.74 55.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.369 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.7 mm -118.42 24.14 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.582 0.706 . . . . 0.0 110.626 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 80.93 14.49 79.42 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.0 m -137.37 98.94 3.83 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.083 0.468 . . . . 0.0 110.005 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -52.23 -50.41 62.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.295 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.38 -45.65 80.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.939 0.4 . . . . 0.0 110.709 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.629 ' CE2' HD11 ' A' ' 252' ' ' LEU . 52.1 t80 -60.23 -41.67 93.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.349 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.614 ' ND2' HG23 ' A' ' 240' ' ' THR . 15.1 t-20 -60.12 -50.73 72.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.623 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -57.0 -41.5 78.59 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.46 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.41 -41.32 98.49 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.629 HD11 ' CE2' ' A' ' 248' ' ' TYR . 35.6 mt -67.31 -41.03 86.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.913 0.387 . . . . 0.0 111.274 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.5 t -61.42 -40.23 93.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.999 0.428 . . . . 0.0 110.889 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.52 -42.18 78.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.232 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -58.6 -46.54 86.79 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.472 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.427 ' NH1' ' CD1' ' A' ' 202' ' ' PHE . 86.6 mtt-85 -63.92 -62.44 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.772 0.32 . . . . 0.0 110.774 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.39 -35.71 19.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 110.168 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -72.32 -45.49 59.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.585 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 13.3 t -59.62 -39.06 83.03 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.243 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.28 -52.83 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.414 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.592 HG13 HD12 ' A' ' 274' ' ' ILE . 5.1 t -61.54 -49.27 85.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.215 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -44.7 -42.78 7.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.14 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.638 ' CZ ' ' NZ ' ' A' ' 267' ' ' LYS . 62.2 t80 -80.41 -28.92 37.73 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.766 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -75.0 -4.53 38.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.102 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.576 ' HA ' HG22 ' A' ' 269' ' ' ILE . 55.3 mt -86.23 -52.94 11.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.7 p -54.47 -1.83 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.576 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.638 ' NZ ' ' CZ ' ' A' ' 263' ' ' TYR . 9.7 mptt -87.53 2.56 50.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.704 0.288 . . . . 0.0 110.703 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 89.81 38.31 6.56 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 265' ' ' ILE . 1.2 tp -119.16 120.29 31.23 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -49.09 128.03 18.65 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.173 1.249 . . . . 0.0 112.116 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.04 -16.23 50.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.114 0.483 . . . . 0.0 111.034 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 4.4 m-20 -85.25 -22.62 28.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.077 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -23.5 38.99 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.209 0.528 . . . . 0.0 110.545 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.592 HD12 HG13 ' A' ' 261' ' ' VAL . 1.5 pt -101.98 -174.84 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.985 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 34.8 m -168.96 127.33 1.02 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.224 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.17 110.52 23.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 110.413 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.546 ' NH1' ' SD ' ' A' ' 279' ' ' MET . 73.8 ttt-85 -115.29 139.74 49.71 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.433 0.635 . . . . 0.0 110.985 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.96 95.18 2.06 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.546 ' SD ' ' NH1' ' A' ' 277' ' ' ARG . 3.8 tpt -69.81 -10.63 59.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.665 0.269 . . . . 0.0 110.598 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.408 ' HA2' HG22 ' A' ' 240' ' ' THR . . . 41.75 -102.36 0.03 OUTLIER Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -141.65 75.58 1.5 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.784 0.326 . . . . 0.0 110.813 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 18.0 m -87.04 0.16 55.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.741 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -168.16 75.88 0.87 Allowed Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.47 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -60.82 104.14 0.26 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.554 2.17 . . . . 0.0 112.529 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 286' ' ' THR . 28.4 m -69.1 -44.44 81.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.306 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 302' ' ' CYS . 7.6 p -62.49 -46.21 89.48 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.09 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.93 -1.83 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 286' ' ' THR . 28.3 m120 -115.57 -59.36 2.01 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.1 t -80.88 -3.41 51.19 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.71 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.59 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.6 OUTLIER -127.61 16.89 6.97 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.343 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 31.6 p-10 -68.0 -3.06 8.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.986 0.422 . . . . 0.0 110.592 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -100.23 32.45 2.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.706 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.59 HG21 ' SG ' ' A' ' 290' ' ' CYS . 15.6 t -130.78 125.65 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.027 0.442 . . . . 0.0 110.304 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.92 10.64 12.31 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.12 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -104.06 136.28 43.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.099 0.475 . . . . 0.0 110.242 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 297' ' ' ALA . 0.1 OUTLIER -61.53 -46.37 90.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.941 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 296' ' ' ARG . . . -62.68 -46.06 89.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.107 0.48 . . . . 0.0 111.183 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.98 -29.83 70.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.789 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 39.5 mt -78.17 -53.42 7.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.961 0.41 . . . . 0.0 110.535 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 40.0 mt -51.08 -34.81 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.922 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.9 -43.1 22.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.07 0.462 . . . . 0.0 110.315 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.608 ' O ' HG21 ' A' ' 286' ' ' THR . 38.9 t -73.93 -13.56 60.91 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.775 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 299' ' ' LEU . 53.5 mt -90.45 23.16 3.08 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.291 0.369 . . . . 0.0 111.07 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -77.39 -44.35 2.62 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.457 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.8 Cg_exo -62.47 9.35 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.416 2.744 . . . . 0.0 111.807 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 304' ' ' ALA . 0.4 OUTLIER -104.28 10.32 35.61 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.71 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.491 ' NH1' ' OD1' ' A' ' 199' ' ' ASP . 39.2 mtm105 -113.96 94.81 5.0 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.494 0.664 . . . . 0.0 110.195 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.452 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.3 ptm180 -164.08 139.15 5.95 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.136 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.613 HG12 ' HA2' ' A' ' 238' ' ' GLY . 22.6 m -104.69 144.57 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 121.831 -0.543 . . . . 0.0 109.666 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -121.45 106.26 11.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.342 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.452 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.38 118.21 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.796 -177.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 312' ' ' GLU . 0.1 OUTLIER -96.43 135.62 38.05 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.403 HG21 ' CD2' ' A' ' 224' ' ' LEU . 2.2 t -133.38 120.22 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.236 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -117.29 132.34 56.63 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.6 -13.85 50.44 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 20.1 tt -75.38 154.12 6.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.827 0.346 . . . . 0.0 110.487 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -128.02 167.91 16.05 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.474 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 192' ' ' LYS . 33.0 m-20 -160.61 172.83 16.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.502 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.94 151.21 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.301 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 14.2 p -109.83 135.23 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.17 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 43.6 p -129.65 164.54 23.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.306 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLN . . . . . 0.448 ' CD ' ' N ' ' A' ' 322' ' ' GLN . 6.0 mp0 -80.84 149.2 66.79 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.827 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.93 150.51 73.26 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.421 2.081 . . . . 0.0 112.106 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -156.32 116.51 3.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.398 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.491 179.866 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 40.6 Cg_endo -66.98 -22.77 47.64 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.927 2.418 . . . . 0.0 111.883 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 184' ' ' ALA . . . -155.82 75.18 5.03 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.544 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.8 85.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.554 2.169 . . . . 0.0 112.163 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.605 ' N ' ' CD ' ' A' ' 185' ' ' PRO . . . -95.75 -43.35 0.27 Allowed Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.138 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 184' ' ' ALA . 38.2 Cg_exo -59.31 142.44 99.11 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.524 2.149 . . . . 0.0 112.06 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.3 116.05 65.95 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.333 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.23 -77.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.079 1.852 . . . . 0.0 112.194 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -168.95 154.12 6.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.099 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 66.1 t -121.06 140.63 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.032 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.41 ' OE1' ' N ' ' A' ' 318' ' ' ASP . 2.0 pt20 -122.87 117.22 25.09 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.477 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.424 HG22 ' NE2' ' A' ' 193' ' ' HIS . 12.1 m -73.18 141.24 47.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.274 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -143.46 111.21 5.98 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.4 m-70 -101.39 150.45 23.0 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.434 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 59.6 m-85 -111.28 118.67 36.52 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 195' ' ' THR . 6.9 t -85.26 102.46 13.37 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.837 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.769 HD23 HD11 ' A' ' 201' ' ' LEU . 31.0 tp -105.34 137.26 43.42 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.437 0.637 . . . . 0.0 109.955 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.444 ' H ' ' HG2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -90.06 130.38 36.24 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-O 122.564 1.174 . . . . 0.0 112.021 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 202' ' ' PHE . 7.3 t -60.24 -24.74 65.11 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.255 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -58.31 -43.71 88.28 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.955 0.407 . . . . 0.0 110.423 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.85 -42.7 92.67 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.637 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.769 HD11 HD23 ' A' ' 196' ' ' LEU . 84.9 mt -80.78 -78.36 0.18 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.391 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.47 ' O ' ' OG ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -128.43 102.73 6.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.98 -178.618 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.494 ' OD1' ' CD2' ' A' ' 204' ' ' PHE . 14.3 t-20 -67.4 -70.38 0.26 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.205 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.494 ' CD2' ' OD1' ' A' ' 203' ' ' ASN . 59.7 m-85 -108.51 -10.96 15.2 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.733 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -69.84 161.56 29.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.038 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -55.9 -75.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.415 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.59 49.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 41.6 p -107.33 128.02 54.08 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.819 0.342 . . . . 0.0 110.193 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.47 HD22 HD22 ' A' ' 201' ' ' LEU . 30.5 mt -73.32 129.57 38.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.147 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 213' ' ' GLY . 58.5 mttt -91.6 159.92 37.65 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.696 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 210' ' ' LYS . 71.0 Cg_exo -33.12 -76.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.463 2.109 . . . . 0.0 111.549 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -49.57 -21.97 1.14 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.185 0.517 . . . . 0.0 110.31 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.27 -48.88 22.99 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.23 -38.91 91.89 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.91 63.23 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.225 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.33 -30.42 71.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.533 0.682 . . . . 0.0 110.237 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.24 -28.37 65.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.301 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -76.4 -48.54 19.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.32 0.581 . . . . 0.0 111.319 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.432 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 17.6 pt20 -64.02 -42.43 97.12 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.498 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.484 HD21 HD12 ' A' ' 311' ' ' ILE . 45.0 tp -63.96 -42.16 97.36 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.452 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.4 t80 -51.4 -50.57 59.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.46 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.6 p -56.96 -50.31 73.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.456 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.434 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 59.3 tt0 -50.65 -25.82 4.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.506 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.686 HD22 HG21 ' A' ' 313' ' ' VAL . 39.0 mt -97.42 -15.27 20.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 53.4 p -79.76 -10.31 59.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.49 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -107.82 18.77 20.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.499 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.23 173.14 12.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.15 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 6.5 t70 -88.66 132.1 39.71 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 230' ' ' LYS . 57.1 Cg_endo -72.05 -18.8 27.18 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.718 2.279 . . . . 0.0 112.643 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 229' ' ' PRO . 61.9 tttm -32.63 -52.07 0.3 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.635 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 232' ' ' GLY . 85.8 m-20 -104.69 -17.94 14.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.579 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 27.41 50.19 0.07 OUTLIER Glycine 0 N--CA 1.474 1.215 0 O-C-N 123.917 0.761 . . . . 0.0 111.333 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 16.7 m -115.97 108.07 15.78 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 122.586 -0.361 . . . . 0.0 110.927 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 74.2 t -124.82 93.61 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.939 0.876 . . . . 0.0 109.926 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.405 HG11 ' NH2' ' A' ' 277' ' ' ARG . 66.5 t -97.7 120.89 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.456 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.572 HG22 HG23 ' A' ' 311' ' ' ILE . 48.6 t -93.36 124.48 45.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.522 HD21 ' NE ' ' A' ' 277' ' ' ARG . 28.8 mt -108.05 139.72 42.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.861 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -121.57 130.01 7.94 Favored Glycine 0 N--CA 1.477 1.38 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.12 119.47 36.51 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.637 HG22 ' N ' ' A' ' 241' ' ' ASP . 98.4 m -109.6 170.45 8.06 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.37 0.419 . . . . 0.0 110.462 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.637 ' N ' HG22 ' A' ' 240' ' ' THR . 26.1 p-10 -83.07 -176.08 6.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.448 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 281' ' ' GLU . 62.4 ttm-85 -105.23 121.96 44.94 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.813 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 243' ' ' ILE . 46.3 mm -119.43 7.44 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.565 0.698 . . . . 0.0 110.813 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 85.62 -47.21 3.77 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.66 91.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 0.0 109.685 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -45.91 -48.23 16.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.41 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.4 82.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.878 0.37 . . . . 0.0 110.61 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.615 ' CE2' HD11 ' A' ' 252' ' ' LEU . 51.7 t80 -62.06 -45.24 94.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.525 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 241' ' ' ASP . 33.2 t30 -61.49 -43.87 98.09 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.652 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -64.76 -41.25 96.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.634 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.49 -36.78 93.65 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.615 HD11 ' CE2' ' A' ' 248' ' ' TYR . 30.5 mt -70.06 -41.17 74.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.915 0.388 . . . . 0.0 111.013 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 78.1 p -65.13 -39.61 93.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.818 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.3 -47.1 71.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.92 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -59.43 -43.84 93.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.799 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 239' ' ' TYR . 39.1 ttm180 -54.1 -61.41 2.32 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.329 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -58.7 -27.57 64.98 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.638 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -69.78 -47.31 63.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.374 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 38.5 m -62.17 -37.93 87.12 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.069 0.461 . . . . 0.0 110.393 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 256' ' ' ARG . 77.4 t -63.65 -53.21 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.723 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.533 HG13 HD12 ' A' ' 274' ' ' ILE . 18.0 t -62.02 -48.77 86.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.669 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -45.16 -41.71 8.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.228 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.638 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 57.7 t80 -82.86 -28.9 29.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.764 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.01 -8.05 54.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.437 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.9 mt -88.44 -55.75 6.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.789 0.328 . . . . 0.0 111.619 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 41.6 m -50.61 -4.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.974 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.638 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 33.4 mmtm -77.48 -10.55 59.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.743 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.74 -7.44 22.09 Favored Glycine 0 C--O 1.227 -0.283 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.06 141.72 47.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.404 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.48 132.28 30.68 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.268 1.979 . . . . 0.0 111.826 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.04 -4.1 19.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.517 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -94.15 -26.24 16.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.451 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -79.55 -17.38 54.13 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.237 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.533 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -104.24 -171.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.695 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 39.4 m -168.68 130.51 1.29 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.311 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.88 111.16 23.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.882 0.372 . . . . 0.0 110.627 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.522 ' NE ' HD21 ' A' ' 237' ' ' LEU . 41.4 ttp180 -123.13 148.74 45.38 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.152 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.63 148.83 16.49 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.545 ' N ' ' O ' ' A' ' 238' ' ' GLY . 83.9 mmm -121.99 15.98 10.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 119.335 -0.365 . . . . 0.0 111.554 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 23.32 -88.46 0.01 OUTLIER Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 279' ' ' MET . 0.6 OUTLIER -142.72 74.25 1.44 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.096 0.474 . . . . 0.0 110.738 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.4 t -72.22 -54.05 10.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.836 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -137.77 74.06 45.92 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.779 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.02 120.39 8.22 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.652 2.235 . . . . 0.0 112.26 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.4 m -75.91 -23.91 16.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.279 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.615 ' C ' ' H ' ' A' ' 288' ' ' ASN . 31.2 p -58.41 -44.9 89.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.612 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.21 -4.29 0.02 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.615 ' H ' ' C ' ' A' ' 286' ' ' THR . 82.1 m-20 -126.13 -58.25 1.37 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.0 m -60.52 -22.86 64.06 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.55 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 63.5 m -121.07 27.79 8.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.47 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 29.4 p-10 -68.42 -2.85 9.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.664 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -111.49 31.98 5.73 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.494 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.405 ' O ' HD21 ' A' ' 299' ' ' LEU . 15.5 t -137.86 117.67 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.865 0.364 . . . . 0.0 110.755 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -120.72 14.0 11.66 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.698 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.442 ' O ' HD12 ' A' ' 299' ' ' LEU . 1.5 mp0 -89.6 174.52 7.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.122 0.487 . . . . 0.0 109.849 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -81.01 -75.7 0.27 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -59.1 -27.52 65.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.984 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.87 95.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.481 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 303' ' ' LEU . 60.1 mt -69.36 -50.41 46.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.05 0.452 . . . . 0.0 110.646 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 62.7 mt -53.53 -34.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.006 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -78.34 -35.19 47.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.443 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 0.8 OUTLIER -85.57 -10.59 55.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.539 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.571 ' HA ' HG21 ' A' ' 286' ' ' THR . 47.8 mt -91.55 23.77 3.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.515 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.583 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -85.12 -44.64 0.66 Allowed Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.5 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 33.1 Cg_exo -59.12 7.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.56 2.84 . . . . 0.0 112.232 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 304' ' ' ALA . 35.9 p30 -107.04 18.15 22.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.708 0.289 . . . . 0.0 110.796 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -113.21 98.58 7.22 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.514 0.673 . . . . 0.0 109.881 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 38.0 ptt180 -159.85 133.58 7.2 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.147 -0.621 . . . . 0.0 112.016 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.14 141.37 15.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -122.81 104.28 9.18 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.257 0.551 . . . . 0.0 110.313 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.572 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.87 117.47 25.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -93.35 123.05 36.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 123.12 0.263 . . . . 0.0 110.624 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.686 HG21 HD22 ' A' ' 224' ' ' LEU . 14.6 t -123.12 115.79 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.318 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -115.53 129.11 56.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 105.9 12.04 26.88 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 15.4 tt -93.71 137.34 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.226 0.536 . . . . 0.0 110.672 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -85.18 129.61 34.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.709 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.41 ' N ' ' OE1' ' A' ' 190' ' ' GLN . 4.3 p-10 -157.3 169.11 25.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.618 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 321' ' ' THR . 21.9 t -96.67 131.08 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.488 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 41.7 t -52.27 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.389 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 319' ' ' VAL . 57.1 p -82.37 132.78 35.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.126 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -117.2 149.28 44.15 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.655 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.93 -82.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.447 2.098 . . . . 0.0 112.013 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 43.91 91.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.662 -179.904 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.24 142.52 73.71 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.583 2.189 . . . . 0.0 111.752 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.633 ' H ' ' CD ' ' A' ' 183' ' ' PRO . . . -103.85 -42.55 0.18 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.275 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.633 ' CD ' ' H ' ' A' ' 182' ' ' ALA . 48.0 Cg_exo -55.16 -36.4 93.02 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.615 2.21 . . . . 0.0 111.968 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -155.49 149.8 19.76 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.688 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.08 -31.86 44.89 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.552 2.168 . . . . 0.0 112.036 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 41.22 63.65 5.86 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.765 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.57 149.16 38.47 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.711 2.274 . . . . 0.0 112.011 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -105.72 9.76 32.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.626 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.418 HG13 ' OD2' ' A' ' 231' ' ' ASP . 58.6 t -121.26 127.48 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.512 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -100.22 83.68 2.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.349 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.456 HG22 ' NE2' ' A' ' 193' ' ' HIS . 24.1 m -67.38 125.24 25.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.411 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 313' ' ' VAL . 41.6 tptt -117.1 162.14 18.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.205 0.526 . . . . 0.0 111.04 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.456 ' NE2' HG22 ' A' ' 191' ' ' THR . 87.2 m-70 -149.27 123.16 9.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.112 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.487 ' CE2' HD21 ' A' ' 224' ' ' LEU . 65.2 m-85 -114.82 118.92 34.89 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.469 ' OG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -86.36 108.03 18.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.639 -179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.713 ' CD2' HD11 ' A' ' 201' ' ' LEU . 27.0 tp -109.4 125.35 52.3 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -83.17 129.9 35.06 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 122.192 0.996 . . . . 0.0 112.602 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 202' ' ' PHE . 93.6 p -60.35 -27.87 67.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.834 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 203' ' ' ASN . 14.1 t70 -54.28 -40.56 67.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.03 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.5 t -72.74 -33.44 44.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.713 HD11 ' CD2' ' A' ' 196' ' ' LEU . 79.2 mt -89.43 -79.54 0.33 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.51 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -127.86 116.27 19.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.745 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.43 ' OD1' ' OD1' ' A' ' 199' ' ' ASP . 3.1 m-80 -82.26 -64.59 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.772 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -116.73 -17.52 10.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.77 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -66.16 164.92 14.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.058 0.456 . . . . 0.0 110.194 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -50.85 -80.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.507 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.49 53.0 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.214 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 42.5 p -107.24 134.38 50.41 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.168 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.403 HD22 HD22 ' A' ' 201' ' ' LEU . 18.1 mt -78.17 127.3 32.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.284 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' GLY . 8.0 ptmt -85.01 161.87 51.31 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.717 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -36.89 -75.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.075 1.85 . . . . 0.0 111.553 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -50.54 -19.89 1.02 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.017 0.437 . . . . 0.0 109.963 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.84 -52.08 13.09 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.6 -38.89 90.75 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.158 0.504 . . . . 0.0 109.903 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.53 57.13 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.85 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.81 88.76 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.763 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.2 mt -62.27 -29.08 70.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.519 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -72.34 -45.94 57.69 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.379 0.609 . . . . 0.0 110.486 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -62.14 -42.95 99.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.081 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.45 -39.63 92.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.586 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 225' ' ' SER . 7.1 t80 -52.87 -46.73 68.03 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.46 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.4 m -55.1 -51.32 66.79 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.684 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 223' ' ' GLN . 4.2 mp0 -55.86 -27.02 49.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.582 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.995 HD22 HG21 ' A' ' 313' ' ' VAL . 78.0 mt -95.95 -21.18 18.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.769 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 221' ' ' TYR . 9.2 p -84.7 -13.43 51.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.476 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -106.4 23.6 13.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.157 0.503 . . . . 0.0 110.654 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.58 -179.31 5.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.687 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -101.41 109.11 58.05 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 232' ' ' GLY . 73.9 Cg_exo -44.45 -19.22 0.23 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.829 2.353 . . . . 0.0 112.964 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 229' ' ' PRO . 3.4 ttmp? -24.51 -47.57 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.691 0.619 . . . . 0.0 110.775 -178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 97.6 m-20 -116.49 -11.95 11.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.648 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 24.9 47.76 0.02 OUTLIER Glycine 0 N--CA 1.47 0.963 0 O-C-N 123.587 0.554 . . . . 0.0 111.841 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 231' ' ' ASP . 2.3 m -118.36 117.48 29.19 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 122.588 -0.36 . . . . 0.0 110.171 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.618 HG22 HG22 ' A' ' 313' ' ' VAL . 59.6 t -132.21 95.71 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.57 0.7 . . . . 0.0 110.675 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.3 125.18 51.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.283 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.86 129.83 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.428 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.0 mt -114.02 140.0 48.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.684 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -115.42 141.04 16.72 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.5 OUTLIER -121.55 123.93 43.16 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 249' ' ' ASN . 2.1 p -118.5 161.77 19.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.106 0.479 . . . . 0.0 110.076 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.526 ' OD2' ' NE ' ' A' ' 307' ' ' ARG . 8.5 p30 -84.05 174.91 9.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.337 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -97.31 122.28 40.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.226 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.0 mm -117.15 14.97 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.363 0.601 . . . . 0.0 110.65 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.2 4.51 88.95 Favored Glycine 0 C--N 1.314 -0.688 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 24.8 m -130.07 102.19 6.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 110.235 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -52.31 -51.96 55.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.679 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.9 -42.52 76.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.726 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.569 ' CE2' HD11 ' A' ' 252' ' ' LEU . 33.9 t80 -60.4 -46.08 91.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.552 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.439 ' O ' ' OG ' ' A' ' 253' ' ' SER . 14.5 t-20 -62.92 -46.09 89.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.829 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -63.01 -42.48 99.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.719 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.54 -38.16 95.91 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.569 HD11 ' CE2' ' A' ' 248' ' ' TYR . 28.1 mt -73.71 -34.37 64.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.676 0.274 . . . . 0.0 111.084 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 249' ' ' ASN . 4.4 m -65.26 -44.37 88.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.025 0.44 . . . . 0.0 110.629 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -68.26 -43.67 77.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.084 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -58.59 -47.14 85.3 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.914 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.611 ' O ' HG23 ' A' ' 260' ' ' VAL . 99.5 mtt180 -62.68 -55.0 30.88 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.392 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.49 -33.76 68.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.193 0.521 . . . . 0.0 109.942 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -74.71 -45.89 41.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.283 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 43.0 t -60.06 -39.85 87.45 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 256' ' ' ARG . 86.2 t -64.23 -52.5 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.461 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.619 HG13 HD12 ' A' ' 274' ' ' ILE . 10.6 t -61.15 -49.48 84.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.172 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -44.9 -41.45 7.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.895 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.25 -29.7 31.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.568 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.405 ' O ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -72.8 -7.73 52.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.268 -179.447 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.559 ' C ' ' H ' ' A' ' 267' ' ' LYS . 59.7 mt -87.81 -57.15 4.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.845 0.355 . . . . 0.0 111.472 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 p -49.95 -6.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.974 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 265' ' ' ILE . 4.8 mmtm -78.84 -10.6 59.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.092 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 108.8 37.42 2.04 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.04 128.21 24.21 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.75 130.43 37.12 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.892 1.728 . . . . 0.0 112.062 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.85 -9.27 35.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.001 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 52.0 t0 -92.79 -22.93 19.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.779 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.404 ' HZ2' ' HB3' ' A' ' 273' ' ' LYS . 1.0 OUTLIER -79.49 -21.17 45.7 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.714 0.769 . . . . 0.0 110.548 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.619 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -103.18 -171.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.051 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 1.3 m -166.8 130.23 1.9 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.153 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -105.02 112.79 26.05 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.633 0.254 . . . . 0.0 110.642 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -122.54 147.21 46.65 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.509 0.671 . . . . 0.0 110.517 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.77 99.09 2.25 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.4 tpt -67.99 -11.44 58.88 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.445 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.54 -95.53 0.01 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 279' ' ' MET . 97.8 mt-10 -141.41 75.68 1.51 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 110.8 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.1 p -87.76 -4.9 58.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -172.96 78.93 0.42 Allowed Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.756 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.29 104.62 0.43 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.539 2.159 . . . . 0.0 112.305 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 286' ' ' THR . 17.5 m -70.59 -40.39 77.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.268 0.556 . . . . 0.0 110.193 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.603 ' C ' ' H ' ' A' ' 288' ' ' ASN . 17.7 p -64.81 -47.44 78.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.099 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.65 -1.68 0.04 OUTLIER Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.5 t-20 -112.31 -59.83 1.95 Allowed 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.91 -4.18 55.97 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.382 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.636 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.7 OUTLIER -126.59 16.64 7.56 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.38 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.62 -3.1 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.382 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -101.95 32.37 3.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.636 HG21 ' SG ' ' A' ' 290' ' ' CYS . 21.8 t -129.36 121.43 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.02 0.438 . . . . 0.0 110.143 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -118.88 8.51 11.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.67 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.431 ' O ' HD12 ' A' ' 299' ' ' LEU . 3.2 mp0 -90.71 169.45 10.96 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 110.04 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -82.65 -78.24 0.21 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.636 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -50.7 -29.97 12.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.97 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.99 99.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.244 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.7 mt -68.93 -42.46 76.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.542 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.4 mm -59.48 -34.13 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.015 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.18 -25.41 31.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.412 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.556 ' O ' HG21 ' A' ' 286' ' ' THR . 11.3 t -94.34 -15.19 24.62 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.962 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 299' ' ' LEU . 54.1 mt -91.88 22.72 4.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.717 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.567 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -75.81 -44.86 4.04 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.316 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 22.2 Cg_exo -64.15 8.7 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.434 2.756 . . . . 0.0 111.817 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 304' ' ' ALA . 7.4 t70 -108.41 7.31 26.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.696 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.526 ' NE ' ' OD2' ' A' ' 241' ' ' ASP . 93.1 mtt180 -109.62 100.54 9.56 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.151 0.5 . . . . 0.0 110.086 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.469 ' NH2' ' OG1' ' A' ' 195' ' ' THR . 16.9 ptm180 -173.43 166.62 4.72 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.888 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.684 HG12 ' HA2' ' A' ' 238' ' ' GLY . 34.2 m -126.8 151.06 33.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -120.92 108.37 13.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.178 0.513 . . . . 0.0 110.251 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.4 mm -80.02 119.49 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.767 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -104.33 114.88 29.42 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.02 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.995 HG21 HD22 ' A' ' 224' ' ' LEU . 70.4 t -127.81 123.18 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.658 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -118.98 148.14 43.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.009 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.43 25.03 31.85 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.645 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.2 tt -103.17 177.3 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.645 ' O ' ' O ' ' A' ' 316' ' ' ILE . 14.2 mptt -44.01 -160.74 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 O-C-N 124.124 0.89 . . . . 0.0 110.763 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 319' ' ' VAL . 49.5 t0 -67.81 154.31 41.82 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.762 -0.586 . . . . 0.0 110.905 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.434 ' N ' ' OD1' ' A' ' 318' ' ' ASP . 6.2 p -126.22 131.56 71.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.074 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.05 119.05 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.128 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 321' ' ' THR . 3.1 t -151.76 116.26 5.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.231 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -96.2 146.96 32.21 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.652 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.77 -47.54 9.7 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.226 1.951 . . . . 0.0 112.626 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -142.36 121.87 13.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.516 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.466 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.509 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.509 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 57.7 Cg_endo -71.12 43.43 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.763 2.309 . . . . 0.0 111.865 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -152.38 59.09 2.81 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.718 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.16 160.87 46.19 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.682 2.254 . . . . 0.0 111.921 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.632 ' HB3' ' CD ' ' A' ' 185' ' ' PRO . . . -167.98 -61.79 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.279 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.632 ' CD ' ' HB3' ' A' ' 184' ' ' ALA . 30.7 Cg_endo -61.19 150.01 86.57 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.412 2.075 . . . . 0.0 111.902 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 188' ' ' GLU . . . -140.0 71.72 34.64 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.239 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -75.7 25.48 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.62 2.213 . . . . 0.0 112.055 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 186' ' ' ALA . 96.0 mt-10 57.43 -140.78 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.075 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.409 ' CG1' ' H ' ' A' ' 315' ' ' GLY . 21.3 t -97.67 133.23 40.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.537 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.409 ' H ' ' HA2' ' A' ' 315' ' ' GLY . 67.1 tp60 -95.91 99.52 11.3 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.949 0.404 . . . . 0.0 110.776 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m -70.64 145.99 50.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.209 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.435 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 10.6 tptp -146.33 165.03 30.52 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.225 0.536 . . . . 0.0 110.326 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.435 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 89.2 m-70 -152.83 126.47 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.216 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.461 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 70.1 m-85 -114.84 124.67 52.33 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.538 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -87.52 108.97 19.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.859 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.708 ' CD2' HD11 ' A' ' 201' ' ' LEU . 27.5 tp -110.96 126.99 55.34 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -78.59 129.5 34.85 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.735 0.778 . . . . 0.0 111.932 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.486 ' H ' ' HA ' ' A' ' 308' ' ' ARG . 58.2 m -69.11 -30.86 69.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.404 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.461 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 2.4 p-10 -62.39 -33.81 75.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.657 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.48 -34.97 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.708 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.6 mt -85.62 -81.82 0.2 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.804 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -112.54 132.44 55.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.047 -179.292 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 199' ' ' ASP . 66.5 m-80 -111.65 -81.06 0.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.805 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -83.6 -37.61 22.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -64.43 162.29 15.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.056 0.455 . . . . 0.0 110.504 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -52.24 -66.94 0.3 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.583 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.49 61.14 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.471 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 75.3 p -107.44 134.12 50.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.138 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.66 145.08 45.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 213' ' ' GLY . 13.4 mmmt -104.1 153.11 39.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.017 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 210' ' ' LYS . 86.4 Cg_exo -32.34 -77.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.545 2.163 . . . . 0.0 112.265 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -51.22 -18.81 1.0 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.353 0.597 . . . . 0.0 110.376 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.9 -49.83 8.39 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.052 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -65.98 -41.93 90.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.079 0.466 . . . . 0.0 110.142 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.6 -49.6 75.88 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.399 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.81 92.55 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.486 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.01 -31.31 71.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.311 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.47 -46.32 66.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 0.0 110.852 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -62.71 -41.73 99.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.065 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 50.9 tp -66.02 -39.43 90.22 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.475 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.5 t80 -54.82 -47.99 73.38 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.168 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.1 t -57.6 -51.18 70.54 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.41 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.461 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 58.5 tt0 -53.45 -25.0 14.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.689 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.902 HD22 HG21 ' A' ' 313' ' ' VAL . 68.2 mt -100.29 -22.1 15.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 221' ' ' TYR . 7.5 t -67.87 -17.65 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 58.1 t-20 -111.83 29.46 7.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 227' ' ' LEU . 1.1 pt? -78.94 141.69 37.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 109.987 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 315' ' ' GLY . 38.6 t0 -50.66 107.38 0.8 Allowed Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 232' ' ' GLY . 47.9 Cg_exo -54.3 -19.22 16.28 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.219 1.946 . . . . 0.0 113.018 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.494 ' C ' ' O ' ' A' ' 229' ' ' PRO . 38.1 ttmt -21.42 -50.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.539 0.525 . . . . 0.0 111.376 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 232' ' ' GLY . 2.6 m-20 -115.87 -8.09 11.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.96 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.09 54.77 0.16 Allowed Glycine 0 N--CA 1.473 1.119 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.648 ' H ' ' HD2' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -123.24 116.7 23.81 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 121.294 0.569 . . . . 0.0 110.847 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 79.1 t -131.28 101.33 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.652 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.41 123.04 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.018 0.437 . . . . 0.0 110.59 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.541 HG13 HD13 ' A' ' 311' ' ' ILE . 87.2 t -94.73 127.67 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.244 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 28.3 mt -110.23 145.95 36.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.014 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -111.14 136.47 13.62 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.488 ' CZ ' ' CD ' ' A' ' 310' ' ' GLU . 6.7 m-85 -122.12 115.95 23.36 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 17.5 p -112.72 165.8 11.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.933 0.397 . . . . 0.0 110.692 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -88.43 -177.36 5.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.323 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -97.44 122.18 40.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.33 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.9 mm -118.6 13.42 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.187 0.518 . . . . 0.0 110.689 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.14 1.56 80.52 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.3 p -129.05 104.45 7.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.173 0.511 . . . . 0.0 109.964 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -55.23 -53.13 59.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.358 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.96 -46.29 78.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.59 ' CE2' HD11 ' A' ' 252' ' ' LEU . 62.8 t80 -60.23 -44.98 94.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.62 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.682 HD21 ' H ' ' A' ' 243' ' ' ILE . 77.2 m-20 -61.43 -45.3 94.87 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.35 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -66.29 -37.69 86.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.551 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.11 -40.45 98.55 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.59 HD11 ' CE2' ' A' ' 248' ' ' TYR . 85.4 mt -73.95 -29.92 62.26 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.695 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 14.9 m -66.81 -47.53 71.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.937 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.84 -41.39 78.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.325 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.16 -49.44 77.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.026 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -60.85 -58.6 7.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.495 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.98 -35.69 25.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.068 0.461 . . . . 0.0 109.902 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -71.57 -45.06 63.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.325 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 57.3 m -60.53 -39.47 87.96 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.446 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.69 -51.04 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.406 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.595 HG13 HD12 ' A' ' 274' ' ' ILE . 28.8 t -60.28 -49.7 83.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.152 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -44.63 -41.99 7.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.18 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.558 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 76.8 t80 -81.3 -29.16 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.037 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.93 -5.84 48.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.654 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 267' ' ' LYS . 53.0 mt -88.73 -60.3 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.917 0.389 . . . . 0.0 111.953 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 29.5 t -49.81 -4.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.391 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' A' ' 265' ' ' ILE . 70.7 mmtt -75.76 -10.79 59.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.442 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 116.76 -8.47 16.9 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -83.35 129.34 60.87 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.425 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.28 134.36 56.51 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.641 1.56 . . . . 0.0 111.896 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.61 55.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -92.61 -21.15 20.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.055 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -77.86 -22.97 49.06 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.611 0.719 . . . . 0.0 110.593 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.595 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -101.51 -170.94 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.771 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 15.2 t -170.08 130.18 0.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.102 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.41 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -96.29 153.3 17.89 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.942 -0.473 . . . . 0.0 109.756 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -161.48 149.4 15.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.023 0.44 . . . . 0.0 110.72 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.51 96.78 1.1 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 15.6 tpp -69.86 -13.15 62.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.509 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 57.79 -101.42 0.18 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.66 71.04 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.822 0.344 . . . . 0.0 110.779 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 25.2 t -90.78 -1.55 57.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.662 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -157.73 68.66 4.0 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.317 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.27 105.41 2.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.188 1.925 . . . . 0.0 112.301 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 30.2 m -75.54 -25.7 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.597 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.617 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.0 OUTLIER -58.64 -44.47 90.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.912 -179.31 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.5 -3.08 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.617 ' H ' ' C ' ' A' ' 286' ' ' THR . 94.8 m-20 -122.62 -57.82 1.71 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 m -63.89 -21.31 66.4 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.698 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 55.9 m -122.18 26.0 8.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.281 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 47.5 t0 -70.71 -6.04 34.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.594 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -110.11 30.55 6.63 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.572 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 15.1 t -133.39 120.04 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.462 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -120.27 8.93 10.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.473 ' O ' HD12 ' A' ' 299' ' ' LEU . 3.0 mt-30 -86.17 171.96 10.91 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -80.91 -73.85 0.35 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.755 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -59.25 -26.86 65.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.21 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.55 84.65 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.8 mt -72.21 -47.68 48.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.744 0.307 . . . . 0.0 110.744 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.21 -31.27 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.081 0.467 . . . . 0.0 109.876 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -80.58 -29.65 36.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.68 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.6 t -93.31 -10.72 34.44 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 299' ' ' LEU . 49.8 mt -92.23 19.95 6.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.727 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.608 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -74.07 -41.85 5.46 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.4 Cg_exo -62.71 9.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.408 2.739 . . . . 0.0 112.314 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 304' ' ' ALA . 38.8 t0 -112.54 7.37 18.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.884 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 64.6 mtp180 -104.43 100.43 10.13 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.021 0.439 . . . . 0.0 110.05 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.486 ' HA ' ' H ' ' A' ' 198' ' ' SER . 39.2 ptt180 -171.32 -171.14 0.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.287 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.47 155.85 14.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.488 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 96.2 mt-10 -122.8 102.74 8.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.25 0.547 . . . . 0.0 110.395 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.541 HD13 HG13 ' A' ' 236' ' ' VAL . 3.6 mm -79.18 120.81 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.711 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -101.93 121.31 41.89 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.568 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.902 HG21 HD22 ' A' ' 224' ' ' LEU . 70.4 t -130.04 123.4 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.928 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.648 ' HD2' ' H ' ' A' ' 233' ' ' SER . 0.0 OUTLIER -95.25 -174.21 3.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.935 178.365 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.565 ' CA ' ' HZ3' ' A' ' 314' ' ' LYS . . . 16.69 69.21 0.01 OUTLIER Glycine 0 N--CA 1.472 1.047 0 O-C-N 123.677 0.611 . . . . 0.0 112.386 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.644 ' O ' ' N ' ' A' ' 318' ' ' ASP . 4.1 tt -115.18 160.06 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.46 ' H ' HG13 ' A' ' 316' ' ' ILE . 0.1 OUTLIER -46.36 79.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 122.239 1.018 . . . . 0.0 111.226 -178.226 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.644 ' N ' ' O ' ' A' ' 316' ' ' ILE . 3.1 p30 -56.81 175.81 0.11 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.44 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.47 122.84 49.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 14.5 m -51.93 173.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.425 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.1 p -55.91 128.05 33.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.953 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.34 148.77 50.64 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.754 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -48.37 136.28 25.57 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.85 1.7 . . . . 0.0 112.36 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -83.86 -13.64 53.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.586 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.401 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.66 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.502 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.573 ' O ' ' HB2' ' A' ' 182' ' ' ALA . 29.6 Cg_endo -62.04 -47.23 10.89 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.931 2.421 . . . . 0.0 111.86 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 181' ' ' PRO . . . 169.83 152.14 0.16 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.472 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.57 ' O ' ' HB2' ' A' ' 184' ' ' ALA . 47.2 Cg_endo -68.34 142.71 55.68 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.515 2.144 . . . . 0.0 111.726 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 183' ' ' PRO . . . 170.86 131.93 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.617 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.76 -18.44 24.99 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.508 2.139 . . . . 0.0 112.226 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -162.15 72.3 2.3 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.474 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.45 155.33 55.4 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.499 2.133 . . . . 0.0 111.832 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -132.51 179.75 5.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.165 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.434 HG21 ' OD2' ' A' ' 231' ' ' ASP . 55.8 t -121.3 140.88 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.126 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.2 132.25 53.98 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.562 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.41 ' CG2' ' CE1' ' A' ' 193' ' ' HIS . 29.0 m -87.79 141.17 28.81 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.045 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -133.86 97.4 3.89 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.392 0.615 . . . . 0.0 111.725 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.41 ' CE1' ' CG2' ' A' ' 191' ' ' THR . 8.7 m80 -84.71 135.75 34.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.106 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.472 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 62.0 m-85 -111.04 124.32 51.94 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.876 0.37 . . . . 0.0 110.103 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.6 102.44 14.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.166 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.692 ' CD2' HD11 ' A' ' 201' ' ' LEU . 32.0 tp -104.54 125.66 50.9 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.301 0.572 . . . . 0.0 109.727 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.406 ' HG3' ' H ' ' A' ' 199' ' ' ASP . 39.8 tptt -79.15 128.66 33.57 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-O 122.349 1.071 . . . . 0.0 112.177 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 202' ' ' PHE . 94.5 p -61.25 -30.6 70.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.289 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.406 ' H ' ' HG3' ' A' ' 197' ' ' LYS . 95.8 m-20 -58.56 -37.79 76.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.05 -43.79 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 196' ' ' LEU . 90.4 mt -78.63 -78.25 0.15 Allowed 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.921 -0.711 . . . . 0.0 110.583 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -128.48 130.38 47.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.147 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -96.3 -70.92 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.472 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.493 ' CE1' ' ND2' ' A' ' 205' ' ' ASN . 24.4 p90 -106.31 -13.86 15.27 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.932 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.493 ' ND2' ' CE1' ' A' ' 204' ' ' PHE . 8.8 m120 -71.59 168.09 18.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.059 0.457 . . . . 0.0 110.199 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.631 ' NZ ' ' NH1' ' A' ' 255' ' ' ARG . 19.7 tptm -57.64 -69.94 0.15 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.483 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -163.12 -0.11 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.411 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 14.4 t -52.92 134.83 37.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.995 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.9 139.59 34.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.072 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 213' ' ' GLY . 28.4 mttp -98.34 158.32 32.86 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.822 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -34.47 -75.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.43 2.087 . . . . 0.0 111.831 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -51.21 -21.05 1.82 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.177 0.513 . . . . 0.0 110.243 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.59 -51.41 12.11 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.305 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -67.1 -39.1 86.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.322 0.582 . . . . 0.0 110.072 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.61 -53.79 53.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.757 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.52 87.64 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.699 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 mt -61.36 -28.21 69.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.311 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -74.83 -45.45 43.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.456 0.646 . . . . 0.0 110.53 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -61.51 -42.68 99.17 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.849 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 57.3 tp -65.58 -39.15 91.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.523 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.9 t80 -52.6 -50.1 63.74 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.228 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.4 t -53.87 -51.68 62.88 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.414 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.472 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 55.2 tt0 -52.76 -25.93 12.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.149 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.982 HD22 HG21 ' A' ' 313' ' ' VAL . 22.5 mt -99.13 -18.95 17.44 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.419 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 221' ' ' TYR . 1.7 m -73.36 -31.67 64.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.065 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -91.54 23.15 3.61 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.949 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.566 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -79.24 158.55 27.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.28 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 315' ' ' GLY . 10.0 t0 -76.43 128.93 81.24 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.304 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 230' ' ' LYS . 42.8 Cg_endo -68.36 -18.66 44.21 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.919 2.412 . . . . 0.0 112.813 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 229' ' ' PRO . 65.3 tttm -32.63 -47.31 0.16 Allowed 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 123.508 0.505 . . . . 0.0 110.468 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 232' ' ' GLY . 21.8 m-20 -108.55 -18.84 13.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.886 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.15 47.99 0.03 OUTLIER Glycine 0 N--CA 1.474 1.23 0 O-C-N 123.902 0.751 . . . . 0.0 111.234 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 231' ' ' ASP . 18.0 m -115.36 110.84 19.95 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.7 t -127.03 94.25 2.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.664 0.745 . . . . 0.0 110.074 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 16.0 t -98.72 122.74 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.642 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.505 HG13 HD13 ' A' ' 311' ' ' ILE . 89.2 t -96.87 123.24 49.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.667 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.5 mt -106.35 143.62 34.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.027 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -118.33 135.94 11.92 Favored Glycine 0 N--CA 1.478 1.441 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.334 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.629 ' CE2' ' SD ' ' A' ' 279' ' ' MET . 0.1 OUTLIER -121.2 116.84 25.68 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.2 t -108.09 167.95 9.64 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -90.85 -179.27 5.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.271 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -95.88 123.15 39.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.375 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.9 mm -118.12 9.18 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.418 0.628 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 81.86 4.39 90.32 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.7 t -134.04 98.75 4.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.078 0.466 . . . . 0.0 110.327 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -52.69 -51.66 59.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.488 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.2 69.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.909 0.385 . . . . 0.0 110.413 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.601 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 46.4 t80 -61.27 -41.2 96.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.377 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -60.9 -46.47 90.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.424 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -61.62 -38.71 88.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.388 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.84 -38.33 96.34 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 34.2 mt -71.93 -39.19 69.64 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.378 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.5 t -64.55 -41.19 96.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.227 0.537 . . . . 0.0 110.951 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.01 -38.39 66.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.631 ' NH1' ' NZ ' ' A' ' 206' ' ' LYS . 17.3 mmt85 -60.12 -51.25 70.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.965 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.7 ' O ' HG23 ' A' ' 260' ' ' VAL . 20.1 ptp180 -64.18 -44.66 91.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -60.1 -37.1 78.95 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.305 0.574 . . . . 0.0 110.158 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -73.35 -44.2 59.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.41 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 49.9 m -59.4 -38.37 80.39 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.094 0.474 . . . . 0.0 110.306 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 256' ' ' ARG . 96.4 t -65.71 -52.72 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.376 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.613 HG13 HD12 ' A' ' 274' ' ' ILE . 9.3 t -61.83 -49.21 85.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.441 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -46.53 -41.34 14.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.856 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.573 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 58.3 t80 -81.28 -32.78 33.06 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.56 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -67.7 -9.01 39.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.624 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 267' ' ' LYS . 61.8 mt -86.4 -50.1 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 111.556 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 88.8 p -49.82 -5.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.199 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.586 ' CD ' ' N ' ' A' ' 267' ' ' LYS . 2.0 mptp? -86.89 7.67 26.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 110.35 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 87.24 41.4 6.59 Favored Glycine 0 CA--C 1.507 -0.456 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.79 128.11 25.5 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.37 126.38 21.51 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.755 1.636 . . . . 0.0 111.982 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.49 -8.78 21.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.971 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -91.53 -22.97 20.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -80.46 -18.66 48.06 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.463 0.649 . . . . 0.0 110.713 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.613 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -106.18 -171.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.777 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 28.7 t -171.05 127.63 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.327 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.14 110.56 23.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.472 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -120.18 148.09 44.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.46 0.647 . . . . 0.0 110.86 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.42 97.84 0.5 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.629 ' SD ' ' CE2' ' A' ' 239' ' ' TYR . 2.8 ptp -81.59 31.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.461 0.172 . . . . 0.0 110.816 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 38.19 -97.43 0.01 OUTLIER Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -141.84 70.57 1.34 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.704 0.288 . . . . 0.0 110.415 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.8 m -91.16 0.59 57.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.518 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -155.95 60.67 2.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.51 110.93 3.17 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.505 2.137 . . . . 0.0 112.03 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 286' ' ' THR . 11.5 m -71.37 -36.4 61.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.42 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 288' ' ' ASN . 70.6 p -62.18 -45.75 92.0 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.083 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.31 -3.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.619 ' H ' ' C ' ' A' ' 286' ' ' THR . 55.8 t-20 -123.83 -57.78 1.61 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 m -58.94 -25.61 63.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.615 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 68.3 m -105.12 32.07 4.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 0.0 110.59 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.48 -2.81 18.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.456 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -109.98 30.98 6.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 10.5 t -132.17 121.65 46.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 120.919 0.39 . . . . 0.0 110.42 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -121.23 6.18 10.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.513 ' O ' HD12 ' A' ' 299' ' ' LEU . 5.1 mt-30 -88.5 172.12 9.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.039 0.447 . . . . 0.0 110.402 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -82.01 -72.62 0.43 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.91 -28.99 66.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.47 . . . . 0.0 110.867 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.27 82.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.381 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 303' ' ' LEU . 42.5 mt -71.81 -52.16 18.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 63.6 mt -51.42 -34.73 15.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.51 -35.22 58.45 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.352 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.97 -8.22 57.41 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.814 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 299' ' ' LEU . 65.8 mt -96.23 15.53 20.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.723 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -76.78 -45.93 3.05 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.141 0.496 . . . . 0.0 110.008 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 28.0 Cg_exo -59.47 10.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 123.042 2.495 . . . . 0.0 111.818 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 304' ' ' ALA . 54.6 t0 -104.56 13.52 31.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.873 0.368 . . . . 0.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.429 ' NH1' HH22 ' A' ' 256' ' ' ARG . 78.8 mtp85 -112.58 102.23 10.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.299 0.571 . . . . 0.0 110.557 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.6 ptp180 -165.8 142.51 5.34 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.22 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 15.2 m -107.4 145.54 14.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -118.04 108.63 15.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.118 0.485 . . . . 0.0 110.74 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.505 HD13 HG13 ' A' ' 236' ' ' VAL . 3.4 mm -79.5 114.28 20.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -96.72 111.15 23.43 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.769 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.982 HG21 HD22 ' A' ' 224' ' ' LEU . 59.0 t -113.0 118.4 57.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 O-C-N 123.556 0.535 . . . . 0.0 110.919 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -116.25 131.07 57.05 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.69 33.88 5.96 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.705 ' O ' ' O ' ' A' ' 317' ' ' LYS . 10.5 tt -108.46 168.53 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.705 ' O ' ' O ' ' A' ' 316' ' ' ILE . 42.1 tttt -43.04 -150.98 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 O-C-N 124.205 0.941 . . . . 0.0 111.556 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.43 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 88.2 m-20 -73.93 171.09 14.07 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 121.441 -0.787 . . . . 0.0 110.45 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 319' ' ' VAL . 9.2 p -114.26 122.97 69.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.247 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.424 ' HB ' HE22 ' A' ' 322' ' ' GLN . 3.8 m -142.88 126.05 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.399 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 64.0 m -151.49 96.74 2.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.245 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLN . . . . . 0.424 HE22 ' HB ' ' A' ' 320' ' ' VAL . 28.0 mp0 -87.76 115.5 63.19 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.832 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.92 -12.25 21.67 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.389 2.059 . . . . 0.0 112.164 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -68.56 -137.1 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.628 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.487 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.586 ' HB3' ' HD3' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 180' ' ' ALA . 68.5 Cg_endo -83.67 125.58 3.82 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.294 1.996 . . . . 0.0 112.085 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.526 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -161.23 47.35 0.22 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.784 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 58.1 Cg_endo -69.52 160.98 47.68 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.77 2.313 . . . . 0.0 111.78 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 183' ' ' PRO . . . 70.89 74.59 0.25 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.651 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.34 163.4 37.93 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.47 2.114 . . . . 0.0 112.0 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.588 ' H ' ' HD2' ' A' ' 187' ' ' PRO . . . -178.48 -44.06 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.469 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.588 ' HD2' ' H ' ' A' ' 186' ' ' ALA . 44.8 Cg_exo -55.85 -29.57 73.03 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.578 2.185 . . . . 0.0 112.084 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -45.21 144.33 1.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.643 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.496 HG13 ' OD2' ' A' ' 231' ' ' ASP . 88.3 t -123.24 128.95 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.524 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -103.08 85.7 2.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 48.9 m -64.97 125.79 25.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.402 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 313' ' ' VAL . 39.2 tptt -117.97 163.33 16.74 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.278 0.561 . . . . 0.0 111.086 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -153.17 125.44 8.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.366 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -114.26 116.98 29.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.56 103.45 15.08 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.333 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.671 ' CD2' HD11 ' A' ' 201' ' ' LEU . 31.2 tp -106.64 130.36 54.4 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.911 0.386 . . . . 0.0 110.218 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -84.65 129.04 34.89 Favored 'General case' 0 C--O 1.255 1.355 0 CA-C-O 122.565 1.174 . . . . 0.0 111.819 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 202' ' ' PHE . 37.4 m -61.54 -18.15 57.95 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.53 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.58 -41.31 94.39 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.194 0.521 . . . . 0.0 110.201 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.9 t -72.45 -34.14 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.344 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.671 HD11 ' CD2' ' A' ' 196' ' ' LEU . 62.4 mt -88.12 -80.0 0.28 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.126 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -127.84 114.36 17.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.244 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.438 ' OD1' ' CE2' ' A' ' 204' ' ' PHE . 2.7 t-20 -90.84 -72.09 0.59 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.473 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.438 ' CE2' ' OD1' ' A' ' 203' ' ' ASN . 88.3 m-85 -102.76 -25.89 13.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.795 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -63.56 170.71 3.0 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.982 0.42 . . . . 0.0 110.154 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -53.54 -83.33 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.652 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.04 53.69 0.15 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.443 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.7 t -107.33 145.44 32.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.848 0.356 . . . . 0.0 110.303 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.23 127.61 33.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 213' ' ' GLY . 12.7 mtpp -89.55 158.85 45.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.813 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 210' ' ' LYS . 76.8 Cg_exo -33.34 -76.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.499 2.133 . . . . 0.0 112.01 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -48.47 -22.54 0.74 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.146 0.498 . . . . 0.0 110.321 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.36 -48.45 18.78 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -63.19 -39.63 95.2 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.83 -53.88 52.77 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.568 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.83 -28.65 69.7 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.596 0.712 . . . . 0.0 110.537 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -31.63 68.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.364 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.21 -48.18 30.63 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.173 0.511 . . . . 0.0 111.263 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 12.1 pt20 -64.03 -44.46 92.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.981 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 311' ' ' ILE . 36.0 tp -62.7 -41.71 99.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.336 -0.545 . . . . 0.0 109.892 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 4.2 t80 -52.26 -48.1 65.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.374 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.5 m -52.81 -52.34 57.31 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.485 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -54.3 -27.3 34.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.186 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.718 HD22 HG21 ' A' ' 313' ' ' VAL . 85.0 mt -95.3 -20.28 19.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.668 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 221' ' ' TYR . 23.5 p -79.64 -21.2 45.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.831 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -99.1 21.46 11.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.558 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.34 -179.68 5.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.61 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.434 ' OD2' ' CG ' ' A' ' 230' ' ' LYS . 2.8 t70 -99.09 132.64 23.15 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.41 -17.02 34.89 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.501 2.134 . . . . 0.0 112.94 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.434 ' CG ' ' OD2' ' A' ' 228' ' ' ASP . 40.4 mmtt -37.02 -45.27 0.57 Allowed 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.55 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.496 ' OD2' HG13 ' A' ' 189' ' ' VAL . 95.1 m-20 -107.73 -19.89 13.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.442 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.7 49.04 0.05 OUTLIER Glycine 0 N--CA 1.469 0.847 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.24 112.4 19.44 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 122.591 -0.358 . . . . 0.0 110.791 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 313' ' ' VAL . 52.2 t -130.93 93.38 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.426 0.632 . . . . 0.0 110.497 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.14 123.93 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.334 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 311' ' ' ILE . 22.0 t -100.4 127.1 53.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.598 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.549 HD23 ' HB3' ' A' ' 277' ' ' ARG . 25.5 mt -110.17 145.36 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.068 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.653 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -115.81 142.2 17.4 Favored Glycine 0 N--CA 1.478 1.479 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.559 ' CE2' ' SD ' ' A' ' 279' ' ' MET . 0.7 OUTLIER -122.39 120.64 34.58 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.484 HG22 ' NH2' ' A' ' 256' ' ' ARG . 3.1 p -112.74 164.59 13.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.833 0.349 . . . . 0.0 110.239 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 241' ' ' ASP . 14.5 p-10 -88.47 -176.77 5.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.373 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -100.6 121.72 42.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.277 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.5 mm -118.63 11.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.311 0.577 . . . . 0.0 110.664 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.23 3.72 88.63 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.7 t -133.62 99.81 4.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.068 0.461 . . . . 0.0 110.013 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 56.1 t0 -52.57 -50.78 62.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.466 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.4 67.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.822 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.543 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 45.8 t80 -62.25 -47.99 81.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.454 ' C ' ' ND2' ' A' ' 249' ' ' ASN . 0.1 OUTLIER -62.29 -40.78 97.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.575 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.401 ' N ' ' ND2' ' A' ' 249' ' ' ASN . 27.2 mm100 -60.42 -48.02 83.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.899 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.14 -36.4 92.9 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.543 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 25.9 mt -72.95 -35.98 67.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.097 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.1 m -63.73 -41.71 98.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.87 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -73.21 -35.42 66.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.353 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -60.21 -53.5 56.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.434 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.868 ' O ' HG23 ' A' ' 260' ' ' VAL . 17.4 ptp180 -62.91 -43.96 97.39 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.277 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.451 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.92 -38.87 90.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.319 0.581 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -71.84 -42.18 67.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.277 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 10.6 t -63.24 -38.76 92.41 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.371 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 256' ' ' ARG . 84.5 t -63.36 -51.21 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.277 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.602 HG13 HD12 ' A' ' 274' ' ' ILE . 18.7 t -62.19 -48.75 86.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.234 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -45.08 -41.23 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.08 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.527 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 49.6 t80 -81.79 -29.51 32.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.518 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.94 -7.72 53.42 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.48 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' A' ' 267' ' ' LYS . 59.6 mt -86.95 -54.67 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 111.483 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 33.9 t -50.83 -5.2 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 265' ' ' ILE . 32.2 mmtp -80.18 0.46 32.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.523 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 93.11 40.75 4.78 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.44 139.33 34.36 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.209 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -63.4 129.06 24.16 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.187 1.925 . . . . 0.0 112.097 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.74 -7.28 14.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.999 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -91.1 -28.07 18.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.89 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -77.49 -20.52 54.2 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.954 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.602 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -103.12 -178.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.877 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 13.2 m -171.2 129.63 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.51 155.63 16.69 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.149 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.549 ' HB3' HD23 ' A' ' 237' ' ' LEU . 55.1 ttt85 -161.56 149.43 15.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.105 0.479 . . . . 0.0 110.63 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -118.13 98.46 0.76 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.687 ' HE3' ' H ' ' A' ' 282' ' ' SER . 0.7 OUTLIER -80.08 18.19 0.88 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.718 -0.241 . . . . 0.0 110.838 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 43.77 -102.1 0.03 OUTLIER Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.443 ' OE1' ' OD1' ' A' ' 306' ' ' ASP . 5.4 mm-40 -136.21 74.61 1.51 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.852 0.384 . . . . 0.0 110.57 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.687 ' H ' ' HE3' ' A' ' 279' ' ' MET . 0.6 OUTLIER -88.71 2.18 53.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.337 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -166.81 77.36 1.06 Allowed Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.859 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.62 106.82 2.33 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.015 1.81 . . . . 0.0 111.698 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 286' ' ' THR . 5.2 m -68.29 -43.83 84.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.75 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.1 p -58.85 -44.15 90.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.134 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.58 -3.55 0.02 OUTLIER Glycine 0 CA--C 1.531 1.049 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 286' ' ' THR . 90.9 m-20 -119.33 -57.72 1.98 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.8 OUTLIER -70.35 -13.42 62.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.732 -178.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.91 23.04 6.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.305 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.79 -11.18 54.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.345 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -96.72 33.25 1.89 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.566 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 19.2 t -128.94 124.64 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.447 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -118.68 7.54 11.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -94.93 126.67 40.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 110.2 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -49.59 -57.43 7.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.73 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.12 85.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.997 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.29 -31.2 72.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.546 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 32.6 mt -76.65 -54.15 7.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.4 mt -52.54 -35.79 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.041 0.448 . . . . 0.0 109.954 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -71.25 -42.05 69.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 8.7 t -81.73 -0.73 44.24 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 110.91 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.418 HD12 ' CB ' ' A' ' 241' ' ' ASP . 0.4 OUTLIER -95.55 18.11 13.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.359 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.581 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -79.46 -44.23 1.63 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.297 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.5 Cg_exo -63.17 8.85 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 123.257 2.638 . . . . 0.0 111.991 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 304' ' ' ALA . 6.5 t0 -107.45 12.21 28.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -109.55 106.13 15.72 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.204 0.525 . . . . 0.0 110.118 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -173.09 167.76 4.88 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.769 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.653 HG12 ' HA2' ' A' ' 238' ' ' GLY . 26.8 m -128.25 151.18 34.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.435 ' CD ' ' HH ' ' A' ' 239' ' ' TYR . 90.3 mt-10 -122.3 106.85 11.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.057 0.455 . . . . 0.0 110.198 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.49 117.81 25.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -102.15 120.16 39.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.069 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.718 HG21 HD22 ' A' ' 224' ' ' LEU . 62.0 t -133.41 123.65 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.421 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -118.66 141.7 48.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.583 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.88 -9.19 47.06 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.829 ' O ' ' O ' ' A' ' 317' ' ' LYS . 17.1 tt -81.1 152.92 4.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.829 ' O ' ' O ' ' A' ' 316' ' ' ILE . 40.4 tttm -33.24 -141.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.234 1.016 . . . . 0.0 112.069 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.443 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 35.7 t70 -165.31 111.21 0.92 Allowed 'General case' 0 C--N 1.317 -0.841 0 O-C-N 120.771 -1.206 . . . . 0.0 110.245 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.6 m -108.2 156.47 8.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.146 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 19.4 m -91.79 154.42 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.663 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 20.5 m -65.47 144.05 57.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.364 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -128.3 84.8 62.17 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.283 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.11 147.17 84.69 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.699 2.266 . . . . 0.0 111.977 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.7 125.26 23.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.353 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.484 -179.878 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.581 ' HB3' ' HD3' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 180' ' ' ALA . 72.4 Cg_endo -84.25 77.38 3.21 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.255 1.97 . . . . 0.0 112.254 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.659 ' HB3' ' CD ' ' A' ' 183' ' ' PRO . . . -76.46 -64.38 0.5 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.986 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.659 ' CD ' ' HB3' ' A' ' 182' ' ' ALA . 28.2 Cg_endo -59.49 -38.88 80.5 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.283 1.988 . . . . 0.0 112.035 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 183' ' ' PRO . . . 58.54 145.2 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.62 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.556 ' O ' ' HB2' ' A' ' 186' ' ' ALA . 71.7 Cg_endo -73.21 160.15 45.81 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.498 2.132 . . . . 0.0 112.061 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.618 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . 169.87 -62.4 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.136 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 37.4 Cg_endo -63.22 -166.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.266 1.977 . . . . 0.0 111.95 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 65.86 44.81 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.117 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.93 130.87 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.199 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.527 ' CD ' ' H ' ' A' ' 190' ' ' GLN . 0.0 OUTLIER -112.52 96.39 5.97 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.001 0.429 . . . . 0.0 110.646 -179.279 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.535 HG22 ' NE2' ' A' ' 193' ' ' HIS . 16.2 m -75.41 132.26 40.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.138 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -146.07 118.72 8.58 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.535 ' NE2' HG22 ' A' ' 191' ' ' THR . 1.4 m-70 -106.69 148.51 28.29 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -107.45 124.01 49.23 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.044 0.449 . . . . 0.0 110.097 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.76 101.67 12.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.567 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.767 ' CD2' HD11 ' A' ' 201' ' ' LEU . 38.6 tp -108.56 145.45 34.81 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.665 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.552 ' HD2' ' H ' ' A' ' 199' ' ' ASP . 1.6 tmtm? -88.98 125.8 35.14 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.721 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.0 t -67.92 -33.83 75.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.24 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.552 ' H ' ' HD2' ' A' ' 197' ' ' LYS . 17.3 t0 -63.69 -39.6 94.71 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 197' ' ' LYS . 51.0 t -61.04 -47.93 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.767 HD11 ' CD2' ' A' ' 196' ' ' LEU . 47.0 mt -67.29 -78.37 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.057 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.2 117.93 35.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.67 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 199' ' ' ASP . 69.1 m-80 -90.55 -82.56 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.193 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -93.23 -16.57 24.64 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.716 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -75.49 156.82 34.8 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.264 0.554 . . . . 0.0 109.801 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.491 ' H ' ' CD ' ' A' ' 206' ' ' LYS . 12.9 mptt -50.0 -68.19 0.2 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.77 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.17 60.12 0.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.167 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.3 p -110.31 141.92 42.66 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.472 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.738 HD22 HD22 ' A' ' 201' ' ' LEU . 35.7 mt -85.17 135.21 34.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.435 0.636 . . . . 0.0 111.339 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 213' ' ' GLY . 40.2 mmtm -100.55 153.86 37.51 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.444 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LYS . 91.7 Cg_exo -30.86 -73.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 C-N-CA 122.47 2.113 . . . . 0.0 112.618 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -49.14 -28.23 4.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.041 0.448 . . . . 0.0 110.767 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.61 -47.7 32.77 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -62.53 -39.69 94.39 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.71 -54.34 47.3 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.255 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.76 -29.49 70.7 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.442 0.639 . . . . 0.0 110.156 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.539 HD23 HD21 ' A' ' 201' ' ' LEU . 0.6 OUTLIER -72.05 -27.83 62.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.074 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ASP . . . . . 0.514 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 34.3 m-20 -75.18 -49.76 18.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.491 0.662 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 18.3 pt20 -63.16 -42.55 99.45 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.361 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 31.7 tp -63.19 -41.79 99.24 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.409 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -51.56 -47.07 63.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.511 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.9 m -56.87 -50.82 71.31 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 118.786 -1.165 . . . . 0.0 110.689 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -52.27 -26.97 13.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.96 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.635 HD22 HG21 ' A' ' 313' ' ' VAL . 17.5 mt -96.31 -20.27 18.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.658 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.0 t -77.97 -21.22 51.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.054 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -100.22 19.39 16.59 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.813 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.563 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -75.69 160.74 29.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.754 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 4.7 t0 -77.71 113.16 29.83 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 230' ' ' LYS . 48.6 Cg_exo -50.19 -23.08 9.11 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 122.329 2.019 . . . . 0.0 113.082 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 229' ' ' PRO . 21.2 tptm -29.37 -53.16 0.13 Allowed 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 123.532 0.52 . . . . 0.0 111.085 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 233' ' ' SER . 91.5 m-20 -106.09 -16.03 14.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.021 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 24.94 44.84 0.01 OUTLIER Glycine 0 N--CA 1.469 0.836 0 O-C-N 123.954 0.783 . . . . 0.0 111.701 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 231' ' ' ASP . 41.6 m -114.07 110.58 20.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.828 0.346 . . . . 0.0 110.855 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 84.3 t -126.04 95.83 3.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.354 0.597 . . . . 0.0 109.852 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 t -97.25 121.48 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.239 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.442 HG21 ' CG2' ' A' ' 261' ' ' VAL . 10.8 t -92.87 118.98 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.253 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.45 144.04 31.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.788 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.438 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -125.51 126.05 5.78 Favored Glycine 0 N--CA 1.476 1.345 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.694 ' N ' HH22 ' A' ' 256' ' ' ARG . 0.2 OUTLIER -111.08 126.21 54.58 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.555 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.9 t -117.53 168.09 10.71 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.825 0.345 . . . . 0.0 110.243 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -91.53 176.42 6.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.648 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -92.69 126.47 37.79 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.6 mm -117.98 10.21 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.157 0.503 . . . . 0.0 110.661 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.42 7.25 76.41 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -140.63 104.11 4.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.245 0.545 . . . . 0.0 110.163 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 99.2 m-20 -57.1 -51.15 70.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.71 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.26 -46.18 76.1 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.044 0.449 . . . . 0.0 110.791 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.588 ' CE2' HD11 ' A' ' 252' ' ' LEU . 48.0 t80 -61.29 -40.81 95.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 246' ' ' ASP . 0.1 OUTLIER -58.12 -47.93 81.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.149 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.95 -40.5 93.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.712 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.15 -39.15 96.74 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.588 HD11 ' CE2' ' A' ' 248' ' ' TYR . 32.9 mt -70.38 -39.44 74.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 5.8 t -62.83 -42.28 99.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 110.809 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.52 -44.14 75.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.935 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -59.59 -47.93 83.65 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.45 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.694 HH22 ' N ' ' A' ' 239' ' ' TYR . 42.7 mtm105 -63.39 -49.63 73.03 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.333 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.76 81.08 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -70.59 -43.43 69.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.207 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.0 t -60.35 -39.29 86.62 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.278 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.3 t -62.83 -51.61 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.521 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.56 HG13 HD12 ' A' ' 274' ' ' ILE . 12.9 t -61.22 -48.34 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.625 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -47.87 -42.86 27.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.948 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.421 ' CG ' HD12 ' A' ' 209' ' ' LEU . 66.5 t80 -78.24 -35.26 48.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.994 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.36 -32.26 73.63 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.369 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 267' ' ' LYS . 89.8 mt -66.59 -46.23 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 85.2 p -56.04 -10.44 0.82 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.29 0.566 . . . . 0.0 110.485 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.514 ' NZ ' ' OD1' ' A' ' 218' ' ' ASP . 20.5 mmmt -79.46 -3.54 47.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.684 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.06 43.73 3.74 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.349 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.29 129.37 24.2 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.57 129.66 30.43 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.406 1.404 . . . . 0.0 111.479 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -64.84 -9.69 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.036 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -91.46 -23.8 19.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.016 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.62 -23.81 56.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.437 0.637 . . . . 0.0 110.708 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.56 HD12 HG13 ' A' ' 261' ' ' VAL . 2.3 pt -103.35 -178.52 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.871 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 8.5 t -168.03 129.26 1.4 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.161 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.08 151.93 19.0 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -154.64 136.95 14.89 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.397 0.618 . . . . 0.0 111.649 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -87.29 91.37 1.73 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 4.3 tpt -69.05 -10.4 57.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.741 0.305 . . . . 0.0 110.503 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.09 -101.5 0.02 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -141.63 74.96 1.48 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.79 0.329 . . . . 0.0 110.574 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 25.4 t -82.36 -3.53 55.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.341 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -167.49 79.25 0.92 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.574 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.32 105.26 0.47 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.484 2.123 . . . . 0.0 112.201 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.468 HG23 ' N ' ' A' ' 286' ' ' THR . 6.4 m -71.41 -39.87 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.705 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.588 ' C ' ' H ' ' A' ' 288' ' ' ASN . 63.3 p -58.8 -42.68 89.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.506 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.64 -2.66 0.01 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.588 ' H ' ' C ' ' A' ' 286' ' ' THR . 71.3 m-80 -127.98 -57.52 1.24 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.9 m -59.53 -44.19 93.25 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.566 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -111.8 28.8 8.42 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.627 0.251 . . . . 0.0 110.788 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 48.2 t0 -66.36 -7.18 17.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.518 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.64 31.76 2.79 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.566 HG21 ' SG ' ' A' ' 290' ' ' CYS . 22.3 t -131.91 124.17 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.552 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -118.82 11.82 12.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.842 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -99.2 130.79 45.53 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.081 0.467 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -50.44 -66.08 0.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.375 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -55.08 -38.08 67.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.429 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.18 -37.44 87.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.427 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 303' ' ' LEU . 34.3 mt -72.19 -57.15 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.461 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 67.0 mt -50.71 -33.7 12.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.028 0.442 . . . . 0.0 109.895 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.18 -37.74 53.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.679 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.12 -11.91 55.86 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.538 HD23 HG21 ' A' ' 286' ' ' THR . 70.8 mt -89.03 23.86 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.781 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.572 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -74.37 -41.42 4.88 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.243 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 16.3 Cg_exo -67.65 9.17 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.483 2.122 . . . . 0.0 111.065 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 304' ' ' ALA . 30.0 t0 -102.31 1.19 35.34 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.491 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 304' ' ' ALA . 5.4 ptp180 -114.77 93.35 4.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.5 0.667 . . . . 0.0 109.509 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.513 ' NH1' ' OE2' ' A' ' 310' ' ' GLU . 36.6 ptt85 -154.37 131.8 11.25 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 122.012 0.91 . . . . 0.0 112.456 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.09 134.03 33.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.342 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.513 ' OE2' ' NH1' ' A' ' 308' ' ' ARG . 64.5 mt-10 -117.86 103.66 10.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.133 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.465 HD12 HD21 ' A' ' 220' ' ' LEU . 0.9 OUTLIER -79.63 115.96 22.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -178.153 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 312' ' ' GLU . 6.8 tm-20 -90.93 126.73 36.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 123.201 0.313 . . . . 0.0 110.385 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.635 HG21 HD22 ' A' ' 224' ' ' LEU . 2.8 t -125.67 114.98 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.936 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -115.04 134.09 55.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 98.44 10.3 51.13 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.7 tt -93.95 137.98 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.876 0.37 . . . . 0.0 110.502 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -83.96 127.12 33.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.355 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -83.57 105.62 14.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.752 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 4.6 p -68.57 156.52 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.316 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 320' ' ' VAL . 6.2 p -41.87 126.05 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.697 0.284 . . . . 0.0 110.793 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 8.4 t -75.77 138.15 41.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.586 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -65.64 149.78 96.91 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.381 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.86 135.9 10.01 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.782 1.654 . . . . 0.0 112.158 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -130.68 121.14 24.97 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.412 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.391 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 182' ' ' ALA . 73.1 Cg_exo -41.3 -61.75 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.249 1.966 . . . . 0.0 112.943 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 181' ' ' PRO . . . 176.8 58.23 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.039 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.88 -22.2 56.43 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.756 2.304 . . . . 0.0 111.69 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -164.06 132.89 2.83 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.865 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.22 -15.46 25.48 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.002 1.801 . . . . 0.0 112.303 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -148.58 78.68 9.08 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.677 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.7 -37.45 64.48 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.645 2.23 . . . . 0.0 111.814 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 60.29 -109.39 0.41 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.291 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 47.3 t -148.84 140.07 17.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.616 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -102.84 82.86 2.16 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.945 0.402 . . . . 0.0 110.579 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.424 ' CG2' ' NE2' ' A' ' 193' ' ' HIS . 59.0 m -79.42 126.96 31.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.302 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -143.17 108.72 5.08 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.325 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.424 ' NE2' ' CG2' ' A' ' 191' ' ' THR . 30.9 m170 -95.25 142.5 27.6 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 63.3 m-85 -107.38 123.67 48.7 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 195' ' ' THR . 7.9 t -86.83 102.61 14.46 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.766 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.686 ' CD2' HD11 ' A' ' 201' ' ' LEU . 30.3 tp -107.75 129.34 55.05 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.497 0.665 . . . . 0.0 109.296 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 197' ' ' LYS . 14.5 ptpt -85.99 131.85 34.19 Favored 'General case' 0 C--O 1.252 1.237 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.972 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.538 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 14.6 m -62.11 -26.56 68.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.577 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 200' ' ' VAL . 15.0 p-10 -59.07 -36.05 74.42 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.145 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.614 ' N ' ' OD1' ' A' ' 199' ' ' ASP . 31.9 t -71.3 -45.6 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' A' ' 196' ' ' LEU . 85.8 mt -79.49 -77.61 0.18 Allowed 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.963 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.486 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -133.45 139.43 46.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.469 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.496 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 9.9 p-10 -119.65 -72.75 0.67 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.781 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.496 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 94.2 m-85 -87.01 -31.08 20.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.067 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -69.81 167.57 16.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.168 0.508 . . . . 0.0 110.296 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -58.37 -75.16 0.05 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.479 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -161.18 55.8 0.29 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.37 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.0 p -106.88 132.94 52.27 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.3 mt -75.51 140.24 42.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.684 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 213' ' ' GLY . 20.5 mtmt -101.03 157.94 32.73 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 210' ' ' LYS . 75.9 Cg_exo -34.02 -76.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.529 2.152 . . . . 0.0 112.338 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -49.7 -20.09 0.75 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.313 0.578 . . . . 0.0 110.306 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.96 -51.33 14.99 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.391 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -64.07 -40.26 95.87 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.85 -53.87 51.49 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.45 87.46 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.724 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.3 mt -61.07 -30.77 70.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.872 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.07 -45.87 62.97 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.158 0.504 . . . . 0.0 111.095 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -61.75 -44.82 96.14 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.102 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 52.7 tp -65.25 -38.93 91.85 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.368 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.466 ' CG ' ' HD3' ' A' ' 267' ' ' LYS . 7.6 t80 -55.45 -45.49 76.86 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.982 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.3 p -55.82 -53.34 57.89 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.153 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 12.9 pt20 -60.43 -19.95 58.05 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.646 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.696 HD22 HG21 ' A' ' 313' ' ' VAL . 70.2 mt -89.69 -27.48 20.08 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.025 0.441 . . . . 0.0 110.351 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 3.9 t -72.64 -22.92 60.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.6 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -98.92 18.61 16.76 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.722 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.652 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.41 160.47 29.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.94 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -70.74 125.02 91.93 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 230' ' ' LYS . 50.9 Cg_endo -69.86 -17.14 37.3 Favored 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.505 2.137 . . . . 0.0 113.126 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 229' ' ' PRO . 88.2 tttt -31.47 -48.21 0.13 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.749 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 95.7 m-20 -110.74 -17.58 13.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.217 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.22 48.72 0.03 OUTLIER Glycine 0 N--CA 1.474 1.167 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.6 m -115.36 112.36 22.24 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.766 0.317 . . . . 0.0 110.872 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.95 97.54 4.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.604 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.6 t -97.92 122.4 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.407 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 311' ' ' ILE . 16.9 t -96.05 118.66 42.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.41 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 277' ' ' ARG . 26.1 mt -108.96 106.23 16.1 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.602 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.413 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -87.17 127.83 8.65 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.8 OUTLIER -107.17 123.93 48.98 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 117.683 0.742 . . . . 0.0 109.453 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.596 HG22 ' N ' ' A' ' 241' ' ' ASP . 52.9 m -114.67 166.24 11.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.969 0.414 . . . . 0.0 110.296 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.596 ' N ' HG22 ' A' ' 240' ' ' THR . 53.6 p30 -86.02 -176.0 5.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.965 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 244' ' ' GLY . 59.2 ttp180 -116.58 124.84 50.81 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.376 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.4 mm -114.8 23.26 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.557 0.694 . . . . 0.0 110.605 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.4 ' H ' ' HG2' ' A' ' 242' ' ' ARG . . . 84.4 13.59 73.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.8 t -144.11 94.07 2.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.357 0.598 . . . . 0.0 110.006 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -46.58 -47.33 19.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.66 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.38 -37.58 78.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.193 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.492 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 52.6 t80 -61.51 -47.63 84.74 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.445 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 250' ' ' GLN . 0.1 OUTLIER -62.84 -41.6 99.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.5 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.492 ' N ' ' ND2' ' A' ' 249' ' ' ASN . 94.2 mt-30 -60.7 -45.99 92.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.919 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.15 96.13 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.492 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 26.2 mt -72.81 -37.87 67.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.245 -0.478 . . . . 0.0 111.074 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 29.9 t -63.47 -40.87 98.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.967 0.413 . . . . 0.0 110.239 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.94 -45.81 76.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.045 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -54.33 -45.64 72.7 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.573 HH22 ' N ' ' A' ' 308' ' ' ARG . 42.7 mtp180 -61.38 -64.09 1.06 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.477 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -51.56 -34.28 36.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.129 0.49 . . . . 0.0 109.884 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -73.32 -44.74 58.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.087 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 46.2 m -64.37 -37.75 88.6 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.449 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.7 t -64.52 -51.27 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.6 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.536 HG13 HD12 ' A' ' 274' ' ' ILE . 18.2 t -62.36 -48.65 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.039 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -45.06 -39.42 5.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -84.12 -30.34 26.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.687 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.43 -11.22 60.59 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.489 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.533 ' C ' ' H ' ' A' ' 267' ' ' LYS . 72.5 mt -86.91 -53.65 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 122.107 -0.37 . . . . 0.0 111.729 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.3 p -50.41 -4.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.23 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 265' ' ' ILE . 68.9 mttm -83.96 -0.19 50.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.925 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 105.26 -2.78 40.28 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.09 126.02 78.19 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.871 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.78 130.32 39.84 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.344 1.363 . . . . 0.0 111.256 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.29 -10.0 38.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.968 0.413 . . . . 0.0 111.407 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -90.78 -22.93 20.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.133 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -19.5 52.5 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.819 0.819 . . . . 0.0 110.664 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.536 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -107.03 -171.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.542 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.69 129.78 1.55 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.827 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.72 151.3 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.59 ' HB3' HD23 ' A' ' 237' ' ' LEU . 60.8 ttt180 -158.88 148.75 19.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 110.5 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -123.76 96.89 0.55 Allowed Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 21.3 ptm -94.66 21.45 7.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.921 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 37.74 -97.17 0.01 OUTLIER Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -143.33 75.92 1.5 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 37.3 t -63.82 -32.99 74.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.114 0.483 . . . . 0.0 111.166 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -131.17 77.66 74.2 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.954 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -54.23 108.04 0.26 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.749 2.299 . . . . 0.0 112.848 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 286' ' ' THR . 5.1 m -71.59 -40.3 70.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.489 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.631 ' C ' ' H ' ' A' ' 288' ' ' ASN . 2.2 p -58.97 -42.47 90.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.514 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.5 0.89 0.02 OUTLIER Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.631 ' H ' ' C ' ' A' ' 286' ' ' THR . 28.2 t-20 -125.07 -58.37 1.46 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.3 m -56.2 -42.84 77.82 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 22.8 m -95.74 34.42 1.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.502 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 292' ' ' ASN . 28.4 p30 -59.04 -33.04 70.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.818 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 23.3 m120 -88.78 33.92 0.77 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.434 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.57 109.43 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.849 0.356 . . . . 0.0 110.522 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -118.59 13.89 13.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.611 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -98.0 135.33 39.86 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.108 0.48 . . . . 0.0 109.851 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 299' ' ' LEU . 5.9 ttt-85 -51.09 -76.36 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.568 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -45.74 -41.03 10.18 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.139 0.495 . . . . 0.0 111.071 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.34 81.36 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.043 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 296' ' ' ARG . 16.9 mt -71.01 -43.95 66.87 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.771 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 12.2 mm -52.75 -36.84 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.34 -42.78 35.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.221 0.534 . . . . 0.0 110.315 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -5.6 35.71 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.857 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.34 20.24 8.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.573 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.548 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -79.84 -45.09 1.53 Allowed Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.18 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 24.7 Cg_exo -61.75 8.29 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 123.184 2.589 . . . . 0.0 111.941 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 304' ' ' ALA . 39.4 t0 -102.52 10.91 38.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.609 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.442 ' NH1' ' O ' ' A' ' 203' ' ' ASN . 88.2 mtm180 -112.94 91.65 3.73 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.298 0.571 . . . . 0.0 110.142 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.573 ' N ' HH22 ' A' ' 256' ' ' ARG . 16.4 ptm180 -157.67 129.22 6.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.628 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.99 138.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.431 0.634 . . . . 0.0 109.709 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -118.64 102.17 8.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.713 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.536 HG23 HG22 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -81.0 113.14 19.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.67 118.44 31.05 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.401 0.438 . . . . 0.0 110.154 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.696 HG21 HD22 ' A' ' 224' ' ' LEU . 47.8 t -116.5 114.66 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 O-C-N 123.567 0.542 . . . . 0.0 110.183 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -113.39 132.09 55.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 93.15 41.85 4.47 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.693 ' O ' ' O ' ' A' ' 317' ' ' LYS . 9.8 tt -114.65 169.63 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.693 ' O ' ' O ' ' A' ' 316' ' ' ILE . 27.5 tttp -42.65 -150.78 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.586 0 O-C-N 123.963 0.79 . . . . 0.0 111.614 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -79.26 156.68 27.99 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.612 -0.68 . . . . 0.0 110.556 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 78.1 t -132.95 135.32 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.268 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 66.1 t -72.19 133.21 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.59 132.59 54.76 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.31 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLN . . . . . 0.574 ' NE2' ' O ' ' A' ' 324' ' ' GLN . 2.2 pt20 -88.81 152.07 48.32 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.579 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.25 -41.09 13.34 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.561 2.174 . . . . 0.0 111.971 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.574 ' O ' ' NE2' ' A' ' 322' ' ' GLN . 0.4 OUTLIER -93.68 105.88 17.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.047 0.451 . . . . 0.0 110.702 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.452 179.859 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.33 143.15 94.6 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.598 2.199 . . . . 0.0 111.825 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.99 69.65 1.19 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.573 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.93 105.75 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.083 1.855 . . . . 0.0 111.683 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -169.56 89.41 0.57 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.201 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.28 -36.67 57.81 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.178 1.919 . . . . 0.0 112.031 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 187' ' ' PRO . . . 51.33 85.44 0.18 Allowed Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.366 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 186' ' ' ALA . 51.2 Cg_exo -53.01 -139.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.917 2.411 . . . . 0.0 112.578 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -43.83 125.73 4.35 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.182 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 190' ' ' GLN . 3.1 t -70.09 173.05 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.303 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.614 ' H ' HG12 ' A' ' 189' ' ' VAL . 3.7 mp0 -102.68 83.34 2.25 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.907 0.384 . . . . 0.0 111.16 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 39.2 m -72.0 126.21 29.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.639 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.423 ' NZ ' HG13 ' A' ' 320' ' ' VAL . 7.3 tptp -116.45 167.85 10.68 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.457 0.646 . . . . 0.0 111.032 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -155.93 123.39 5.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.595 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.452 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 60.9 m-85 -110.57 113.35 25.9 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.06 103.86 15.13 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.897 -179.442 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.68 HD23 HD11 ' A' ' 201' ' ' LEU . 30.5 tp -108.94 135.34 50.3 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.287 0.565 . . . . 0.0 110.196 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.517 ' H ' ' CD ' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -88.73 132.14 34.73 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.968 0.89 . . . . 0.0 112.315 -178.006 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 202' ' ' PHE . 1.3 p -61.84 -24.07 66.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.665 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.14 -43.67 92.04 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.275 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.11 -42.41 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.68 HD11 HD23 ' A' ' 196' ' ' LEU . 78.9 mt -80.08 -79.36 0.15 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.86 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.3 OUTLIER -133.27 131.88 40.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.002 -178.067 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.54 ' O ' ' NH2' ' A' ' 307' ' ' ARG . 59.9 t30 -111.04 -71.24 0.77 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.674 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -91.28 -23.57 20.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.844 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -73.14 164.16 27.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 110.423 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -53.78 -74.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.144 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -160.09 3.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.338 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.7 p -54.98 141.35 34.21 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 85.9 mt -86.14 132.62 33.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.875 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.6 mttp -93.27 157.27 39.12 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.582 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -33.11 -74.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.767 2.311 . . . . 0.0 112.428 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.77 -24.24 1.34 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.136 0.493 . . . . 0.0 110.947 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.68 -48.16 18.32 Favored Glycine 0 C--O 1.227 -0.312 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -62.66 -40.83 98.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.346 0.593 . . . . 0.0 109.57 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.42 -55.27 33.58 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.38 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.35 85.0 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.212 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.1 -31.09 70.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.169 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -71.91 -46.73 56.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.935 0.398 . . . . 0.0 110.948 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -64.21 -44.57 91.52 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.564 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.9 tp -65.02 -38.12 89.86 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.539 ' HE1' HD13 ' A' ' 269' ' ' ILE . 2.4 t80 -54.83 -50.3 68.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.146 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 225' ' ' SER . 11.8 t -59.58 -50.67 73.01 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.571 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.452 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 58.7 tt0 -49.01 -24.25 1.45 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.667 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.507 ' O ' HD22 ' A' ' 227' ' ' LEU . 51.3 mt -100.38 -13.73 18.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.606 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 222' ' ' SER . 33.2 t -73.29 -19.82 60.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -103.61 20.84 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.475 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -74.05 161.54 29.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.81 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -84.3 126.18 70.18 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 230' ' ' LYS . 59.9 Cg_endo -69.86 -16.26 37.06 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.982 1.788 . . . . 0.0 113.073 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 229' ' ' PRO . 3.1 tmtm? -30.49 -52.43 0.16 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.604 0.565 . . . . 0.0 111.066 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 232' ' ' GLY . 10.5 m-20 -104.67 -15.33 15.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.133 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.99 51.52 0.07 OUTLIER Glycine 0 N--CA 1.468 0.788 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.638 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.0 m -118.53 109.07 15.76 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 122.88 -0.188 . . . . 0.0 111.041 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 92.4 t -125.3 93.81 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.62 0.724 . . . . 0.0 109.989 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.6 t -98.33 119.49 46.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.159 0.504 . . . . 0.0 110.754 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.538 HG22 HG23 ' A' ' 311' ' ' ILE . 22.1 t -93.62 127.68 45.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.398 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.0 mt -110.35 139.62 45.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.381 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -120.56 131.55 8.83 Favored Glycine 0 N--CA 1.479 1.544 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -117.7 121.94 42.19 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.002 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.532 HG23 ' ND2' ' A' ' 249' ' ' ASN . 9.0 t -115.45 174.26 6.1 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -84.4 -178.2 6.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.165 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.568 ' H ' HD12 ' A' ' 303' ' ' LEU . 59.2 ttp180 -115.84 125.41 52.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.953 0.406 . . . . 0.0 109.971 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.9 mm -117.81 18.57 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.75 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 77.92 15.97 80.51 Favored Glycine 0 C--N 1.315 -0.604 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.3 p -136.58 100.78 4.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.341 0.591 . . . . 0.0 109.947 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -54.21 -50.9 66.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.809 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.96 83.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.714 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.538 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 55.6 t80 -63.95 -41.77 97.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.334 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.532 ' ND2' HG23 ' A' ' 240' ' ' THR . 12.7 t-20 -59.01 -52.09 67.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -57.85 -39.86 78.74 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.681 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.88 99.14 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 31.7 mt -69.99 -38.99 76.18 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.747 -0.267 . . . . 0.0 110.707 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.3 t -62.32 -41.57 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.194 0.521 . . . . 0.0 110.622 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -70.47 -38.88 74.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.344 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -58.69 -51.25 70.75 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.303 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.854 ' O ' HG23 ' A' ' 260' ' ' VAL . 17.2 ptp180 -65.63 -45.74 81.88 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.754 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.55 98.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.401 0.619 . . . . 0.0 109.951 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -71.2 -43.61 67.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.334 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.9 m -60.05 -38.14 81.93 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.693 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 256' ' ' ARG . 89.4 t -65.13 -52.66 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.15 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.662 HG13 HD12 ' A' ' 274' ' ' ILE . 9.1 t -62.12 -48.91 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.621 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -47.18 -43.13 21.04 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.182 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.586 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 53.7 t80 -77.07 -33.47 57.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.981 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.54 -34.93 79.42 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.48 ' C ' ' H ' ' A' ' 267' ' ' LYS . 96.9 mt -63.15 -44.85 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 120.831 0.348 . . . . 0.0 111.527 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 39.3 t -55.07 -8.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.404 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.586 ' CE ' ' CE2' ' A' ' 263' ' ' TYR . 68.8 mmtt -90.98 14.24 14.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.462 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.45 42.59 10.16 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.312 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.539 HD13 ' HE1' ' A' ' 221' ' ' TYR . 0.8 OUTLIER -120.29 127.61 26.24 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 117.134 0.467 . . . . 0.0 110.074 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -54.14 128.33 29.42 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.356 1.371 . . . . 0.0 111.984 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.97 -11.87 50.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 111.025 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -92.29 -18.13 23.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.418 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -82.76 -23.19 34.06 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.764 0.792 . . . . 0.0 110.652 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.662 HD12 HG13 ' A' ' 261' ' ' VAL . 2.0 pt -102.48 -173.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.045 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 4.9 t -167.63 125.48 1.22 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.77 113.24 25.6 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.705 0.288 . . . . 0.0 110.812 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -119.17 141.86 48.47 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.426 0.632 . . . . 0.0 111.773 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.34 95.84 2.14 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -69.26 -10.45 57.87 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -178.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.484 ' HA2' HG22 ' A' ' 240' ' ' THR . . . 42.09 -113.26 0.53 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.441 ' OE2' ' OD2' ' A' ' 306' ' ' ASP . 51.7 tt0 -143.96 71.87 1.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.7 t -63.84 -37.8 88.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.119 0.485 . . . . 0.0 111.409 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -131.6 83.1 59.27 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.27 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.8 105.79 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.163 1.908 . . . . 0.0 112.364 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 286' ' ' THR . 31.6 m -70.1 -44.44 78.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.181 0.515 . . . . 0.0 110.708 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.618 ' C ' ' H ' ' A' ' 288' ' ' ASN . 10.8 p -60.65 -44.62 96.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.934 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -52.93 1.92 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.618 ' H ' ' C ' ' A' ' 286' ' ' THR . 27.1 m120 -119.84 -59.43 1.8 Allowed 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.7 OUTLIER -65.87 -20.5 66.26 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.804 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.25 26.36 9.51 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.873 0.368 . . . . 0.0 110.28 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 37.3 p-10 -69.93 -6.85 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.043 0.449 . . . . 0.0 110.505 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -100.63 31.51 3.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.288 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.74 129.3 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.207 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -119.41 5.9 11.14 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -97.57 130.28 44.63 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.1 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -52.61 -74.07 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.52 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -43.63 -39.59 3.64 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.214 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.97 95.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.755 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 48.5 mt -68.48 -42.52 78.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.692 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 15.3 mm -54.95 -36.29 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -73.13 -46.83 48.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.35 0.595 . . . . 0.0 109.745 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.7 t -71.04 -2.78 16.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.243 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.568 HD12 ' H ' ' A' ' 242' ' ' ARG . 0.7 OUTLIER -93.29 16.72 12.56 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.431 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -82.4 -44.32 0.97 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 120.838 0.351 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 49.3 Cg_exo -55.1 8.74 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 123.373 2.715 . . . . 0.0 112.835 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 304' ' ' ALA . 88.2 m-20 -110.58 16.4 21.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.497 0.189 . . . . 0.0 110.682 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 8.4 ptm180 -112.46 91.71 3.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.846 0.831 . . . . 0.0 110.302 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -164.58 141.27 6.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.827 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.495 HG12 ' HA2' ' A' ' 238' ' ' GLY . 31.3 m -108.76 145.96 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.406 ' OE2' ' CZ ' ' A' ' 239' ' ' TYR . 32.9 mt-10 -122.05 107.83 12.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.946 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.538 HG23 HG22 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -79.22 118.42 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.344 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.37 125.68 43.61 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.051 0.453 . . . . 0.0 110.546 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.03 116.56 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.632 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.41 ' HG3' HG11 ' A' ' 189' ' ' VAL . 20.1 tttt -114.68 131.89 56.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 106.82 -23.87 26.74 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.657 ' O ' ' O ' ' A' ' 317' ' ' LYS . 13.6 tt -53.24 171.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.657 ' O ' ' O ' ' A' ' 316' ' ' ILE . 24.8 tttp -45.34 -149.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.68 0.613 . . . . 0.0 111.792 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.415 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 54.6 p-10 -63.78 169.51 4.04 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.599 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.94 147.64 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.008 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.423 HG13 ' NZ ' ' A' ' 192' ' ' LYS . 19.2 m -68.05 133.68 31.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.47 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 23.3 m -81.49 130.55 35.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.242 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -126.3 85.11 60.57 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.4 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.07 146.56 93.88 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.648 2.232 . . . . 0.0 112.083 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -73.3 47.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.356 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.518 -179.969 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.646 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.646 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 27.6 Cg_exo -61.61 149.83 88.1 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.048 2.499 . . . . 0.0 111.736 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.645 ' HB3' ' CD ' ' A' ' 183' ' ' PRO . . . -171.6 -62.62 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.786 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.645 ' CD ' ' HB3' ' A' ' 182' ' ' ALA . 30.7 Cg_endo -60.36 142.92 99.27 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.433 2.089 . . . . 0.0 112.017 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 183' ' ' PRO . . . 172.07 74.73 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.109 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.66 ' O ' ' HB2' ' A' ' 186' ' ' ALA . 46.7 Cg_exo -55.09 135.34 68.37 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.512 2.141 . . . . 0.0 111.686 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 185' ' ' PRO . . . 163.76 155.17 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.363 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 188' ' ' GLU . 36.8 Cg_endo -65.71 -81.61 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.634 2.223 . . . . 0.0 111.676 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 187' ' ' PRO . 18.7 tp10 55.34 162.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.952 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.537 HG11 ' NZ ' ' A' ' 314' ' ' LYS . 60.5 t -106.87 136.91 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -113.95 105.36 13.15 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.545 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 m -81.87 135.94 35.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.366 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -147.26 118.01 7.58 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 120.875 0.369 . . . . 0.0 110.427 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 2.4 m170 -98.9 144.52 27.99 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -105.0 119.38 38.89 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.92 101.19 12.66 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.846 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.82 HD23 HD11 ' A' ' 201' ' ' LEU . 35.3 tp -108.38 143.7 36.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.144 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -94.75 133.45 38.42 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 122.157 0.979 . . . . 0.0 112.34 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 202' ' ' PHE . 1.2 m -62.06 -25.58 67.77 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.2 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.53 ' OD1' ' NE ' ' A' ' 307' ' ' ARG . 85.2 m-20 -60.44 -39.42 87.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.108 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.65 -45.21 85.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.82 HD11 HD23 ' A' ' 196' ' ' LEU . 50.7 mt -78.68 -78.01 0.15 Allowed 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.909 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -128.33 123.43 33.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.824 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -93.61 -74.17 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.568 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -104.05 -11.78 17.16 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -75.58 170.0 17.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.029 0.443 . . . . 0.0 110.179 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -54.81 -82.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.554 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -156.15 3.76 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.188 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.1 p -57.16 144.72 33.87 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.745 HD22 HD22 ' A' ' 201' ' ' LEU . 57.7 mt -89.25 136.1 33.21 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.268 0.556 . . . . 0.0 111.169 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 213' ' ' GLY . 55.6 mttt -98.34 157.51 34.27 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.098 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -33.75 -74.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.549 2.166 . . . . 0.0 111.993 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.596 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 27.3 mp0 -48.16 -27.62 2.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.127 0.489 . . . . 0.0 110.529 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.15 -47.79 35.42 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -64.65 -40.6 95.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.316 0.579 . . . . 0.0 109.888 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.32 -55.71 25.73 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.351 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.91 81.36 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.478 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.586 HD23 HD21 ' A' ' 201' ' ' LEU . 0.7 OUTLIER -61.81 -27.05 68.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.24 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -77.36 -47.45 19.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.462 0.649 . . . . 0.0 110.841 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -62.11 -45.2 94.54 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.614 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.486 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 40.6 tp -63.83 -40.68 97.18 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 225' ' ' SER . 5.0 t80 -51.07 -48.79 61.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.451 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 59.1 p -55.32 -51.52 66.45 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.596 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -51.23 -26.14 6.63 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.424 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.701 ' O ' HD22 ' A' ' 227' ' ' LEU . 17.8 mt -100.69 -19.03 16.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.525 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 221' ' ' TYR . 6.3 t -71.93 -27.51 62.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.997 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 24.9 t-20 -103.32 23.68 12.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.937 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.36 152.97 34.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.687 179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.647 ' N ' ' O ' ' A' ' 315' ' ' GLY . 16.0 t0 -66.04 115.65 25.3 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 232' ' ' GLY . 49.0 Cg_endo -70.14 -17.25 35.94 Favored 'Trans proline' 0 N--CA 1.505 2.164 0 C-N-CA 122.518 2.145 . . . . 0.0 112.941 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 229' ' ' PRO . 22.2 tptm -29.21 -47.68 0.06 Allowed 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 123.525 0.516 . . . . 0.0 110.962 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 232' ' ' GLY . 5.6 p30 -106.32 -14.07 15.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.388 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.25 56.13 0.17 Allowed Glycine 0 N--CA 1.469 0.878 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.7 t -119.72 99.98 6.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.574 0.226 . . . . 0.0 110.589 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 73.5 t -125.02 94.18 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.549 0.69 . . . . 0.0 110.437 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 8.4 t -98.11 121.47 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.53 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.507 HG22 HG23 ' A' ' 311' ' ' ILE . 18.3 t -91.58 122.12 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.572 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.431 HD22 ' SD ' ' A' ' 279' ' ' MET . 39.0 mt -104.55 141.05 37.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.034 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.78 130.27 7.13 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.19 119.96 38.13 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.1 p -113.28 162.97 15.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.838 0.352 . . . . 0.0 110.071 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -83.3 173.03 11.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.386 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.412 ' HG2' ' H ' ' A' ' 244' ' ' GLY . 62.2 ttp180 -101.18 125.24 47.78 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.426 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 8.1 mm -114.59 18.18 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.685 0.755 . . . . 0.0 110.453 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.412 ' H ' ' HG2' ' A' ' 242' ' ' ARG . . . 84.92 13.73 71.33 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.0 m -143.07 96.46 2.93 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.103 0.478 . . . . 0.0 110.284 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 247' ' ' ALA . 27.4 p-10 -49.19 -48.6 45.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.418 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.447 ' N ' ' OD1' ' A' ' 246' ' ' ASP . . . -56.15 -35.83 67.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.859 0.362 . . . . 0.0 110.276 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.518 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 39.0 t80 -70.0 -42.23 73.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.889 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.83 -49.72 75.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.235 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.42 -36.89 83.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.374 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.57 -41.18 98.68 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.605 HD22 HH12 ' A' ' 256' ' ' ARG . 37.9 mt -73.71 -34.16 64.69 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.947 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 85.0 p -64.0 -40.78 97.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.778 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.69 -43.03 69.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -58.64 -46.66 86.63 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.117 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.605 HH12 HD22 ' A' ' 252' ' ' LEU . 64.5 mtt85 -64.55 -60.91 2.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.905 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -48.44 -39.09 21.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 110.008 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -70.04 -43.26 71.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.373 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 44.5 m -59.3 -39.0 81.6 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.36 -51.72 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.157 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.522 HG13 HD12 ' A' ' 274' ' ' ILE . 18.7 t -61.37 -48.89 86.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.687 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -46.99 -41.39 16.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.125 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -81.74 -32.95 31.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.66 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -65.26 -24.28 67.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.254 -179.32 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.532 ' C ' ' H ' ' A' ' 267' ' ' LYS . 87.1 mt -73.51 -51.18 26.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 111.718 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 5.1 m -50.34 -8.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.801 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 265' ' ' ILE . 27.9 mmtp -82.68 -1.94 52.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 95.08 41.62 3.98 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.32 129.43 24.91 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.75 125.81 19.18 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.754 1.636 . . . . 0.0 111.736 176.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.55 -8.5 20.09 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -90.69 -24.08 20.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.719 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.475 ' HE2' HD21 ' A' ' 227' ' ' LEU . 0.7 OUTLIER -78.64 -21.94 47.63 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.315 0.578 . . . . 0.0 111.034 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.522 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -104.48 -174.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.562 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 38.5 t -170.94 131.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.442 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.96 150.2 20.72 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -154.0 138.01 16.38 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.32 0.581 . . . . 0.0 111.293 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -90.17 94.0 1.93 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.431 ' SD ' HD22 ' A' ' 237' ' ' LEU . 2.6 tpt -71.23 -7.04 44.2 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.611 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.53 -98.31 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -142.63 75.61 1.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.757 0.313 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 85.9 p -83.69 -1.64 54.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.977 0.418 . . . . 0.0 110.905 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.568 ' C ' HD22 ' A' ' 283' ' ' ASN . 0.1 OUTLIER -162.89 74.71 2.01 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.94 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -60.06 103.23 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.401 2.068 . . . . 0.0 113.198 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 286' ' ' THR . 13.8 m -69.91 -35.57 65.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.182 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.0 OUTLIER -59.5 -46.44 88.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.401 -179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.05 -5.58 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.619 ' H ' ' C ' ' A' ' 286' ' ' THR . 45.5 t30 -127.22 -57.26 1.31 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.844 0.457 . . . . 0.0 109.781 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 289' ' ' THR . 3.5 m -68.56 -10.71 57.54 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.666 0.27 . . . . 0.0 110.614 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 286' ' ' THR . 72.4 m -132.78 19.06 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 110.396 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -67.35 -5.43 14.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.663 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -108.68 32.24 5.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 7.2 t -131.63 120.48 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.68 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -119.7 10.44 11.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.952 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -101.57 135.8 42.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.145 0.498 . . . . 0.0 110.142 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -52.0 -70.32 0.09 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.845 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.77 -39.23 58.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.94 -39.64 95.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.424 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 303' ' ' LEU . 20.5 mt -65.94 -52.41 50.0 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.43 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 64.5 mt -53.04 -33.03 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.938 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -79.42 -24.23 42.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.979 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -98.03 -12.68 21.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.384 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 299' ' ' LEU . 80.6 mt -91.69 18.77 7.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.883 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.608 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -77.81 -53.25 1.51 Allowed Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.519 177.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 13.0 Cg_endo -53.7 9.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.225 0 C-N-CA 122.852 2.368 . . . . 0.0 112.888 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.608 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.3 t0 -103.1 16.75 25.79 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.53 ' NE ' ' OD1' ' A' ' 199' ' ' ASP . 18.0 ptt-85 -114.35 93.3 4.28 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.78 0.8 . . . . 0.0 110.415 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.502 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 48.1 ptt85 -157.46 131.73 8.35 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.59 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 7.8 m -102.02 140.13 21.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -120.84 105.69 10.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.372 0.606 . . . . 0.0 110.519 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.507 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.17 115.94 22.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.465 -178.466 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -90.68 117.37 29.28 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 123.091 0.245 . . . . 0.0 110.368 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.675 HG21 HD22 ' A' ' 224' ' ' LEU . 22.5 t -115.62 115.81 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.4 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.537 ' NZ ' HG11 ' A' ' 189' ' ' VAL . 47.3 tttp -114.32 126.98 55.63 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.9 43.99 2.96 Favored Glycine 0 C--O 1.219 -0.807 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.692 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.5 tt -119.81 170.51 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.692 ' O ' ' O ' ' A' ' 316' ' ' ILE . 65.0 mttp -40.68 -160.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.125 0.891 . . . . 0.0 111.293 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 319' ' ' VAL . 35.3 t0 -84.72 175.31 9.27 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.481 -0.762 . . . . 0.0 110.909 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.41 ' H ' ' CG ' ' A' ' 318' ' ' ASP . 80.0 t -127.26 128.65 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.256 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.65 118.06 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.101 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.6 p -151.08 125.31 9.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.305 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -59.27 148.46 72.25 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.778 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.52 152.44 74.92 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.409 2.073 . . . . 0.0 111.985 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 62.27 53.69 2.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.62 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.636 179.848 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 182' ' ' ALA . . . . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.429 ' O ' ' HB3' ' A' ' 182' ' ' ALA . 44.6 Cg_endo -68.65 22.67 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.708 2.272 . . . . 0.0 112.038 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 180' ' ' ALA . . . 66.45 76.86 0.28 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.31 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.0 -35.97 63.06 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.765 2.31 . . . . 0.0 111.94 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 60.22 78.39 0.33 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.215 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.66 144.19 86.84 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.559 2.173 . . . . 0.0 111.897 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -138.71 67.26 43.08 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.319 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.444 ' O ' ' NZ ' ' A' ' 230' ' ' LYS . 46.7 Cg_endo -68.77 148.85 72.27 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.487 2.125 . . . . 0.0 112.05 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.52 174.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.278 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.1 t -78.03 107.22 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.256 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -107.01 103.25 12.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.332 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.59 HG22 ' CE1' ' A' ' 193' ' ' HIS . 9.1 m -74.99 130.5 39.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.191 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -147.32 117.54 7.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.167 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.59 ' CE1' HG22 ' A' ' 191' ' ' THR . 0.5 OUTLIER -103.76 151.39 23.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.521 ' CE1' HD21 ' A' ' 224' ' ' LEU . 37.5 m-85 -111.96 122.69 48.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.914 0.388 . . . . 0.0 110.062 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.08 102.44 13.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.541 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.691 ' CD2' HD11 ' A' ' 201' ' ' LEU . 26.8 tp -104.83 131.69 51.99 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.308 0.575 . . . . 0.0 109.728 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.418 ' HG2' ' H ' ' A' ' 199' ' ' ASP . 12.6 ttmm -82.51 129.8 34.99 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.196 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.6 t -62.74 -31.44 72.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.087 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.426 ' OD1' ' OD1' ' A' ' 203' ' ' ASN . 16.2 t70 -59.42 -37.98 79.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.231 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.88 -42.94 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.691 HD11 ' CD2' ' A' ' 196' ' ' LEU . 84.6 mt -80.01 -77.98 0.18 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.437 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.37 125.31 44.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.744 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.426 ' OD1' ' OD1' ' A' ' 199' ' ' ASP . 44.0 m-80 -88.3 -70.09 0.66 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.82 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -113.0 -10.58 13.48 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.749 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -74.63 164.83 26.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.139 0.495 . . . . 0.0 110.035 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -52.51 -77.82 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.292 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.67 56.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.489 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.2 p -107.69 132.97 52.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.179 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.412 HD22 HD22 ' A' ' 201' ' ' LEU . 18.7 mt -80.74 132.29 35.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.809 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -95.62 165.74 16.01 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.672 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -36.14 -76.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.499 2.133 . . . . 0.0 111.973 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -49.96 -20.51 0.94 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.319 0.581 . . . . 0.0 110.277 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.37 -51.45 12.91 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -66.15 -38.25 87.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.023 0.439 . . . . 0.0 109.93 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.4 -53.3 59.85 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.06 -33.76 76.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.575 0.702 . . . . 0.0 110.336 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.2 mt -69.5 -26.2 64.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.394 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -76.23 -49.46 17.08 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.482 0.658 . . . . 0.0 111.113 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -63.91 -41.11 97.76 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.364 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 311' ' ' ILE . 36.8 tp -63.5 -41.81 98.53 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.662 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.8 t80 -51.59 -48.95 62.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.805 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 80.7 p -55.55 -51.37 67.3 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.475 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -53.26 -27.35 22.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.365 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.979 HD22 HG21 ' A' ' 313' ' ' VAL . 47.4 mt -95.61 -19.48 19.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.759 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 221' ' ' TYR . 8.4 t -78.57 -30.38 46.75 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.357 0.41 . . . . 0.0 110.886 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 52.3 t-20 -86.11 20.2 2.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.708 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -77.75 -178.79 5.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.933 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 315' ' ' GLY . 49.4 t0 -100.09 105.19 33.99 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 232' ' ' GLY . 32.5 Cg_exo -55.6 -20.64 28.06 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 123.077 2.518 . . . . 0.0 113.61 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 229' ' ' PRO . 62.6 pttt -27.22 -40.48 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.162 0.506 . . . . 0.0 111.318 -176.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 229' ' ' PRO . 13.3 p30 -115.23 -14.74 11.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.304 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.03 59.82 0.16 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.8 m -118.64 102.09 8.6 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 58.9 t -126.69 92.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.701 0.762 . . . . 0.0 110.273 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.1 t -98.37 121.88 49.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.35 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.49 HG22 HG23 ' A' ' 311' ' ' ILE . 23.6 t -92.23 125.22 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.404 HD22 ' SD ' ' A' ' 279' ' ' MET . 55.0 mt -108.49 141.24 40.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.315 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.87 129.02 7.3 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -113.29 121.6 44.92 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.652 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 6.7 p -115.88 162.63 17.06 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.452 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 45.7 p30 -82.93 172.3 12.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.632 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.602 ' NH1' ' N ' ' A' ' 245' ' ' SER . 0.1 OUTLIER -94.62 126.21 39.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.932 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.4 mm -118.61 14.34 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.416 0.627 . . . . 0.0 110.708 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.425 ' C ' ' NH1' ' A' ' 242' ' ' ARG . . . 77.93 11.0 85.83 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.602 ' N ' ' NH1' ' A' ' 242' ' ' ARG . 11.2 m -135.97 94.61 3.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.114 0.483 . . . . 0.0 110.049 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.536 ' OD1' ' NH2' ' A' ' 242' ' ' ARG . 47.1 m-20 -46.81 -50.28 18.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.446 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.49 -42.38 74.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.635 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.522 ' CE2' HD11 ' A' ' 252' ' ' LEU . 33.1 t80 -66.0 -38.83 89.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.54 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 27.3 t-20 -61.78 -52.6 63.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.107 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -66.67 -32.78 74.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.545 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.92 -43.79 98.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.522 HD11 ' CE2' ' A' ' 248' ' ' TYR . 33.0 mt -72.69 -35.48 67.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.763 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.8 t -64.76 -44.47 89.97 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.106 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.19 -42.4 75.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.176 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER -60.67 -49.9 75.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.357 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 260' ' ' VAL . 55.0 mtp180 -60.52 -52.38 65.44 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.607 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.11 -31.89 65.77 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -73.71 -45.01 54.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.234 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 77.4 p -61.38 -37.93 85.17 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.43 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.8 t -65.11 -53.1 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.299 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.598 HG13 HD12 ' A' ' 274' ' ' ILE . 9.8 t -60.97 -49.37 85.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.329 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -46.35 -40.77 12.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.93 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -82.65 -31.96 28.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.606 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.37 -9.94 57.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.451 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.554 ' C ' ' H ' ' A' ' 267' ' ' LYS . 62.8 mt -87.14 -53.57 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.775 0.322 . . . . 0.0 111.39 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.2 m -49.79 -6.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.004 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 265' ' ' ILE . 30.0 mmtm -81.39 -3.94 54.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.81 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.42 39.77 3.37 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.69 127.52 25.16 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.748 0.274 . . . . 0.0 110.378 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.48 128.25 27.19 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.917 1.745 . . . . 0.0 111.79 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.79 -7.92 24.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.237 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -91.97 -23.09 19.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.827 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -80.38 -19.71 45.72 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.297 0.57 . . . . 0.0 110.977 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.598 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -104.45 -171.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.525 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 3.1 t -169.45 130.16 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.314 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -101.72 110.7 22.75 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.917 0.389 . . . . 0.0 110.76 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.26 140.52 49.24 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.7 0.762 . . . . 0.0 111.345 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -91.38 93.89 1.89 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.404 ' SD ' HD22 ' A' ' 237' ' ' LEU . 2.2 tpt -69.19 -8.36 44.97 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.419 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.97 -107.94 0.09 OUTLIER Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.27 59.03 1.59 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.75 0.309 . . . . 0.0 110.558 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.0 t -83.04 -8.06 59.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.697 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -157.33 66.27 3.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.471 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.28 110.82 3.14 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.634 2.222 . . . . 0.0 112.042 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.0 m -73.23 -25.32 21.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.525 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.634 ' O ' ' N ' ' A' ' 288' ' ' ASN . 1.5 p -61.44 -46.34 90.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.911 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.81 -5.77 0.01 OUTLIER Glycine 0 CA--C 1.536 1.356 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.634 ' N ' ' O ' ' A' ' 286' ' ' THR . 35.7 m120 -125.49 -55.43 1.54 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.8 m -66.02 -16.32 63.8 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.947 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 302' ' ' CYS . 92.0 m -118.51 24.78 10.71 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.634 0.254 . . . . 0.0 110.424 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 293' ' ' VAL . 57.4 t0 -57.8 -46.57 84.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.75 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -74.48 33.86 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.596 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 291' ' ' ASP . 3.1 t -133.32 104.12 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.387 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -119.41 14.43 12.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.916 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -101.46 142.1 33.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.06 0.457 . . . . 0.0 109.921 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -51.37 -72.07 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.164 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.09 -40.5 67.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.697 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.71 88.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 17.5 mt -66.61 -55.71 14.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.546 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.27 -37.01 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.991 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -72.56 -33.28 66.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.554 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.477 ' O ' ' SG ' ' A' ' 290' ' ' CYS . 1.8 t -92.12 -4.62 54.06 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.68 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.3 mm? -96.58 19.19 12.68 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.682 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.579 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -81.62 -44.42 1.1 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.343 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.2 Cg_exo -58.18 10.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 123.319 2.679 . . . . 0.0 112.376 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.5 t0 -109.91 17.0 21.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 307' ' ' ARG . 18.8 ptt85 -113.06 90.96 3.49 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.652 0.739 . . . . 0.0 110.246 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.53 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 38.3 ptt180 -158.93 130.23 6.29 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.206 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.86 140.53 16.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -120.85 104.3 9.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.451 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -78.46 118.38 25.55 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -95.99 119.84 35.2 Favored 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 123.171 0.294 . . . . 0.0 110.816 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.979 HG21 HD22 ' A' ' 224' ' ' LEU . 58.3 t -122.64 118.74 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 O-C-N 123.554 0.534 . . . . 0.0 111.088 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -114.8 131.1 56.92 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.05 36.36 4.48 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.669 ' O ' ' O ' ' A' ' 317' ' ' LYS . 11.4 tt -113.3 169.36 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 316' ' ' ILE . 0.8 OUTLIER -43.18 -156.16 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 O-C-N 124.079 0.862 . . . . 0.0 111.251 -178.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -74.34 172.66 11.47 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.802 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 319' ' ' VAL . 13.8 p -114.83 126.49 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.083 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.3 t -80.37 134.31 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.906 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.2 t -126.86 158.34 36.95 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.045 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -141.36 132.11 13.25 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.783 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 324' ' ' GLN . 51.3 Cg_exo -50.21 144.69 22.39 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.003 1.802 . . . . 0.0 112.212 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 323' ' ' PRO . 56.8 tt0 59.11 149.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.596 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.52 -179.801 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.576 ' HB3' ' HD3' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 180' ' ' ALA . 62.1 Cg_endo -83.56 117.11 2.35 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 122.474 2.116 . . . . 0.0 112.016 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 50.92 61.27 13.53 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.405 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.44 96.34 0.97 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.468 2.112 . . . . 0.0 111.982 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 185' ' ' PRO . . . -169.16 159.6 7.69 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.44 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 184' ' ' ALA . 54.4 Cg_endo -69.53 151.28 70.35 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.597 2.198 . . . . 0.0 111.436 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -133.06 149.91 74.08 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.756 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.12 137.04 37.82 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.283 1.989 . . . . 0.0 112.052 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -103.98 4.67 34.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.625 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.31 132.78 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.408 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.449 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.3 OUTLIER -122.74 114.76 20.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.114 0.483 . . . . 0.0 110.474 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 35.5 m -70.76 138.41 50.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.447 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 1.3 mmtm -115.17 172.21 7.21 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.425 0.631 . . . . 0.0 110.667 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 59.3 m80 -157.63 126.4 5.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.326 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.66 116.31 29.95 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -84.65 103.31 13.65 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.947 -179.408 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.704 ' CD2' HD11 ' A' ' 201' ' ' LEU . 29.5 tp -106.62 130.01 54.44 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.581 0.705 . . . . 0.0 110.02 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -79.14 127.31 31.86 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 122.572 1.177 . . . . 0.0 112.468 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.522 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 15.4 m -61.73 -35.03 76.89 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.508 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -57.2 -34.6 68.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.95 -44.12 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.704 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.7 mt -79.8 -77.36 0.19 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.574 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.03 124.7 42.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.936 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.544 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 5.0 p-10 -100.51 -76.45 0.56 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.465 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' PHE . . . . . 0.544 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 68.0 m-85 -96.85 -20.53 18.09 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 110.738 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -70.97 165.25 23.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.124 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -51.12 -81.8 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.63 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.0 56.05 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.453 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 28.5 p -109.17 143.5 38.5 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 110.211 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.405 HD12 ' CG ' ' A' ' 263' ' ' TYR . 10.0 mt -81.03 132.17 35.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.839 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 213' ' ' GLY . 30.8 mmtm -93.96 157.48 37.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.982 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 210' ' ' LYS . 75.6 Cg_exo -32.43 -76.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.309 2.006 . . . . 0.0 111.951 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.665 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 1.9 pm0 -48.36 -23.23 0.86 Allowed 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.512 0.672 . . . . 0.0 110.271 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.52 -44.14 27.86 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.198 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -68.03 -40.45 82.9 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.201 0.524 . . . . 0.0 109.742 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.31 -52.89 62.87 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.727 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.53 -35.8 80.58 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.143 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.35 -28.36 69.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.21 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -76.63 -47.49 22.07 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.314 0.578 . . . . 0.0 110.825 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -61.72 -44.39 97.02 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.336 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 39.4 tp -65.17 -40.24 94.02 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.403 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.504 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.3 t80 -51.89 -48.69 63.99 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.35 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.4 m -55.29 -52.31 63.84 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.048 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -49.83 -24.83 2.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.387 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.678 ' O ' HD22 ' A' ' 227' ' ' LEU . 18.7 mt -98.35 -16.94 19.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.77 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 79.9 p -75.62 -21.95 57.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.896 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -104.05 20.07 18.91 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.992 0.425 . . . . 0.0 110.999 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.678 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -77.61 156.03 31.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.158 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 315' ' ' GLY . 23.6 t0 -70.54 119.47 72.77 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.881 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.504 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.3 Cg_endo -69.85 -19.27 35.93 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.758 2.305 . . . . 0.0 113.194 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 229' ' ' PRO . 50.4 tptt -23.98 -50.39 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 124.068 0.855 . . . . 0.0 110.88 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 232' ' ' GLY . 7.7 p30 -113.18 -12.67 13.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.282 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 27.8 59.65 0.12 Allowed Glycine 0 N--CA 1.475 1.258 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 64.1 m -117.83 107.14 13.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 122.736 -0.273 . . . . 0.0 110.726 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 84.0 t -127.3 95.09 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.555 0.693 . . . . 0.0 110.078 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.8 t -97.85 120.93 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.187 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.466 HG22 HG23 ' A' ' 311' ' ' ILE . 17.1 t -92.73 125.3 45.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.719 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 59.5 mt -108.4 142.59 38.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.391 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.479 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -125.62 130.04 7.09 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -116.39 122.48 44.97 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.096 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.9 p -108.46 171.42 7.42 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.051 0.453 . . . . 0.0 109.846 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.501 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 49.6 p-10 -92.68 -178.07 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.907 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.515 ' H ' HD12 ' A' ' 303' ' ' LEU . 73.2 ttt-85 -102.58 121.93 43.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.411 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.8 mm -118.42 13.13 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.503 0.668 . . . . 0.0 110.864 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.32 9.82 83.16 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.6 m -140.28 91.72 2.47 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.239 0.542 . . . . 0.0 110.308 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -48.23 -49.9 31.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.675 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.74 77.51 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.7 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.594 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 50.7 t80 -59.71 -47.78 84.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 110.423 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 19.8 m120 -62.83 -41.38 99.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.458 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -57.08 -46.22 82.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.184 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.01 -34.66 90.52 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.594 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 31.6 mt -71.63 -38.92 70.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.739 0.304 . . . . 0.0 111.121 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 6.5 t -64.97 -43.2 93.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.694 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.98 -46.03 75.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.145 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -55.64 -46.73 77.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.036 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.522 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 50.7 mtp180 -62.53 -61.92 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 110.174 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -50.48 -36.64 34.61 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.286 0.565 . . . . 0.0 109.893 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -73.05 -45.6 56.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.897 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 40.0 t -58.59 -37.97 76.93 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.829 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 256' ' ' ARG . 92.2 t -64.3 -51.08 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.049 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.652 HG13 HD12 ' A' ' 274' ' ' ILE . 12.8 t -61.92 -48.59 87.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.59 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -47.29 -43.08 22.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.878 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.552 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 48.6 t80 -77.42 -34.65 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.449 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -34.36 78.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.961 0.41 . . . . 0.0 110.525 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' A' ' 267' ' ' LYS . 88.3 mt -62.73 -50.33 80.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.253 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.9 t -49.31 -8.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.88 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.552 ' CE ' ' CE2' ' A' ' 263' ' ' TYR . 32.2 mmtp -86.64 12.52 10.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.504 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 79.68 42.66 11.06 Favored Glycine 0 CA--C 1.509 -0.302 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.024 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.12 128.72 25.21 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.226 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.72 127.94 26.47 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.968 1.779 . . . . 0.0 112.274 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.52 -8.71 28.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.841 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -91.94 -23.46 19.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.919 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.03 -22.95 44.68 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.534 0.683 . . . . 0.0 110.61 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.652 HD12 HG13 ' A' ' 261' ' ' VAL . 1.5 pt -102.1 -175.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.822 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 6.7 t -170.48 127.09 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.591 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.46 151.3 19.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -156.73 144.06 18.95 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 111.036 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -97.22 97.21 1.95 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.409 ' HG3' ' CZ ' ' A' ' 239' ' ' TYR . 1.2 mmt -68.6 -7.64 34.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.252 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 45.6 -109.17 0.29 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 281' ' ' GLU . 51.9 mp0 -131.21 57.12 1.77 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.644 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 6.2 t -80.23 -4.59 53.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.627 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -155.87 67.93 4.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.934 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.77 105.8 2.15 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.304 2.003 . . . . 0.0 111.613 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 286' ' ' THR . 15.1 m -69.62 -36.71 71.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.517 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.582 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.9 OUTLIER -63.75 -46.94 83.04 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.194 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -46.79 -6.89 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.582 ' H ' ' C ' ' A' ' 286' ' ' THR . 21.5 t-20 -124.65 -58.44 1.5 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.749 0.309 . . . . 0.0 110.367 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.0 m -63.5 -24.87 68.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.654 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -116.34 27.02 9.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.192 0.307 . . . . 0.0 110.32 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 288' ' ' ASN . 2.4 p30 -69.96 -5.78 28.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.708 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -98.33 32.97 2.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.609 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.429 HG21 ' SG ' ' A' ' 290' ' ' CYS . 16.8 t -131.38 123.9 53.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.894 0.378 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -118.89 8.16 11.66 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.874 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.467 ' O ' HD12 ' A' ' 299' ' ' LEU . 7.5 mt-30 -88.03 169.33 12.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.135 0.493 . . . . 0.0 110.069 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? -85.2 -68.01 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.905 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -60.44 -30.98 69.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.094 0.473 . . . . 0.0 110.831 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.81 83.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.404 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 295' ' ' GLN . 63.0 mt -74.38 -54.67 7.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 72.9 mt -46.91 -36.53 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.062 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.94 -44.36 48.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.143 0.497 . . . . 0.0 110.688 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.2 t -75.57 -3.3 33.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.788 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.515 HD12 ' H ' ' A' ' 242' ' ' ARG . 1.3 mm? -96.19 16.66 17.59 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.383 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.59 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -80.04 -46.03 1.44 Allowed Pre-proline 0 C--O 1.241 0.632 0 CA-C-O 121.336 0.588 . . . . 0.0 110.052 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 24.5 Cg_exo -61.5 8.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.12 2.547 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.2 t0 -103.79 14.82 30.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.679 0.276 . . . . 0.0 110.687 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -114.31 96.88 6.0 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 121.773 0.797 . . . . 0.0 109.788 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.544 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 15.8 ptm180 -156.71 130.13 8.09 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.988 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.9 140.69 16.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -123.25 105.25 9.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.316 0.579 . . . . 0.0 111.044 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.466 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -78.77 118.7 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.32 -178.456 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -95.1 124.33 39.08 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.154 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.535 HG21 HD22 ' A' ' 224' ' ' LEU . 21.9 t -123.66 117.79 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.175 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -116.67 130.59 56.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 95.04 37.93 5.02 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.589 ' O ' ' O ' ' A' ' 317' ' ' LYS . 13.4 tt -117.51 173.42 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.589 ' O ' ' O ' ' A' ' 316' ' ' ILE . 98.1 mttt -49.77 -150.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 O-C-N 124.154 0.909 . . . . 0.0 110.51 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 318' ' ' ASP . 40.8 p-10 -156.24 117.54 3.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.454 -0.779 . . . . 0.0 110.424 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.71 132.13 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 47.9 t -131.64 91.94 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.14 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 22.2 p -88.22 165.13 15.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.311 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -117.64 84.27 19.14 Favored Pre-proline 0 N--CA 1.468 0.433 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.444 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.28 -10.72 17.64 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.762 2.308 . . . . 0.0 111.935 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -168.33 -87.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.452 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.505 -179.846 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.6 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 27.7 Cg_exo -60.75 144.58 99.57 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.632 2.221 . . . . 0.0 112.307 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.612 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -82.82 -41.8 0.88 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.537 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 23.8 Cg_exo -62.94 16.06 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.795 2.33 . . . . 0.0 112.024 179.268 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.551 ' H ' ' C ' ' A' ' 182' ' ' ALA . . . -40.67 149.09 0.34 Allowed Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.828 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.93 -176.17 1.98 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.311 2.007 . . . . 0.0 112.165 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.661 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . -165.85 -62.47 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.231 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.661 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 36.5 Cg_endo -63.47 152.26 81.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.342 2.028 . . . . 0.0 111.624 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -52.34 125.83 17.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.725 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.43 130.82 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.108 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.402 ' OE1' ' C ' ' A' ' 317' ' ' LYS . 0.3 OUTLIER -105.41 85.33 2.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.104 0.478 . . . . 0.0 109.913 -179.823 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.5 HG22 ' NE2' ' A' ' 193' ' ' HIS . 17.6 m -74.39 130.77 40.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.999 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -147.7 120.31 8.57 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.5 ' NE2' HG22 ' A' ' 191' ' ' THR . 3.4 m170 -108.07 151.45 25.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -112.1 121.47 45.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.317 0.579 . . . . 0.0 110.121 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 195' ' ' THR . 6.4 t -86.2 102.04 13.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.568 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.686 ' CD2' HD11 ' A' ' 201' ' ' LEU . 32.0 tp -104.48 131.95 51.28 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.15 -178.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -81.37 126.37 31.52 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.188 -177.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 202' ' ' PHE . 96.1 p -61.5 -32.63 72.67 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.937 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -59.43 -41.73 90.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.377 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 82.6 t -61.92 -48.75 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.5 mt -72.14 -77.81 0.09 Allowed 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.396 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -120.17 123.16 42.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.33 -179.154 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -86.74 -73.78 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.052 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -107.43 -11.9 15.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.772 0.32 . . . . 0.0 110.51 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -72.44 163.52 27.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.152 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -52.13 -78.25 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.255 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.33 57.01 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.27 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.8 t -108.8 137.79 46.17 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.304 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.482 HD12 ' CG ' ' A' ' 263' ' ' TYR . 10.7 mt -80.95 131.75 35.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.34 0.591 . . . . 0.0 111.394 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 213' ' ' GLY . 9.2 pttp -94.77 154.62 39.86 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.443 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 210' ' ' LYS . 93.5 Cg_exo -31.15 -73.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.269 1.979 . . . . 0.0 112.306 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -50.75 -25.11 3.98 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.954 0.407 . . . . 0.0 110.591 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.86 -46.58 16.83 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -62.42 -41.04 98.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.539 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.39 -52.84 62.22 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.373 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.64 70.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.585 0.707 . . . . 0.0 110.292 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.95 -29.69 66.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.169 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -75.73 -49.07 19.32 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.154 0.502 . . . . 0.0 111.236 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.425 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 15.0 pt20 -61.93 -42.79 99.5 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.497 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 31.5 tp -65.41 -40.1 92.96 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.375 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.3 t80 -52.56 -45.49 66.44 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.907 178.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.3 t -55.5 -51.25 67.63 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.357 -178.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 223' ' ' GLN . 4.6 mp0 -54.14 -25.69 23.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.495 -179.263 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.869 HD22 HG21 ' A' ' 313' ' ' VAL . 18.3 mt -97.86 -21.95 16.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.758 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.2 t -75.26 -32.77 61.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.349 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -97.1 24.16 6.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 -179.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.593 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.25 157.7 32.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.502 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 315' ' ' GLY . 8.0 t70 -71.73 120.48 80.23 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 232' ' ' GLY . 56.7 Cg_endo -67.78 -20.08 46.38 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.801 1.667 . . . . 0.0 113.522 -177.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 229' ' ' PRO . 51.3 tptt -28.6 -44.86 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.388 0.43 . . . . 0.0 111.299 -178.091 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 232' ' ' GLY . 72.5 m-20 -109.77 -14.42 14.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.507 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 25.16 51.38 0.04 OUTLIER Glycine 0 N--CA 1.469 0.834 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.1 m -117.84 109.98 17.22 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.738 0.304 . . . . 0.0 111.101 -178.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.48 94.03 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 121.641 0.734 . . . . 0.0 110.116 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.86 121.82 47.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.271 -178.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.437 HG22 HG23 ' A' ' 311' ' ' ILE . 20.9 t -95.3 121.58 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.515 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.45 HD22 ' SD ' ' A' ' 279' ' ' MET . 79.0 mt -105.52 141.01 37.74 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.006 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.7 126.14 6.25 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.66 124.87 53.22 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.2 t -115.96 168.85 9.71 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.832 0.348 . . . . 0.0 110.505 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -92.36 -177.21 4.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.576 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.574 ' NE ' ' OE1' ' A' ' 281' ' ' GLU . 92.2 mtt180 -100.62 128.02 46.81 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.989 0.423 . . . . 0.0 110.482 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.1 mm -118.28 11.67 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.91 3.48 89.22 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.5 t -135.23 102.85 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.286 0.565 . . . . 0.0 110.361 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -55.16 -51.71 65.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.548 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.36 70.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.548 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.687 ' CE2' HD11 ' A' ' 252' ' ' LEU . 47.4 t80 -62.91 -42.12 99.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.307 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.527 HD21 ' H ' ' A' ' 243' ' ' ILE . 98.4 m-20 -61.43 -46.31 90.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.587 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -61.25 -41.63 97.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.451 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.94 -36.07 92.94 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.687 HD11 ' CE2' ' A' ' 248' ' ' TYR . 32.9 mt -70.59 -41.26 72.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.81 178.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 11.7 t -65.33 -42.65 92.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.57 -49.11 72.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.129 0.49 . . . . 0.0 109.816 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -58.46 -44.84 89.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.256 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 51.8 ttm-85 -51.27 -64.25 0.87 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.54 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -56.84 -31.38 64.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.244 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -66.09 -48.19 71.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.542 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.47 ' O ' ' OD2' ' A' ' 262' ' ' ASP . 13.6 t -60.06 -39.13 84.95 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.467 0.651 . . . . 0.0 110.826 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.24 -50.67 79.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.216 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 276' ' ' ALA . 23.1 t -62.2 -48.92 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.794 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 259' ' ' SER . 0.0 OUTLIER -47.53 -41.73 21.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.144 0.497 . . . . 0.0 110.014 -177.835 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.482 ' CG ' HD12 ' A' ' 209' ' ' LEU . 15.6 t80 -79.85 -34.11 39.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.83 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -33.87 76.84 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.33 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.404 ' C ' ' N ' ' A' ' 267' ' ' LYS . 84.6 mt -65.99 -49.36 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 79.0 p -54.07 -11.1 0.41 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.966 -178.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.422 ' CB ' ' CD1' ' A' ' 221' ' ' TYR . 70.9 mmtt -78.41 -7.46 57.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.683 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 101.61 43.06 2.2 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.768 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.3 128.74 23.65 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 117.12 0.46 . . . . 0.0 110.029 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.22 129.2 27.85 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.694 1.596 . . . . 0.0 111.817 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.68 -10.53 47.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.954 0.406 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -90.66 -21.36 21.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.385 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -19.9 41.88 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.948 0.88 . . . . 0.0 110.975 -179.234 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.482 HD12 HG13 ' A' ' 261' ' ' VAL . 2.3 pt -104.96 -173.5 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.455 -179.169 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 15.7 t -166.62 135.82 2.98 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.283 178.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.495 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -108.06 110.48 22.18 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.957 0.408 . . . . 0.0 110.838 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -115.46 137.24 52.26 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.386 0.612 . . . . 0.0 111.503 -178.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 280' ' ' GLY . . . -86.85 92.09 1.78 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 178.398 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.45 ' SD ' HD22 ' A' ' 237' ' ' LEU . 5.1 tpt -66.19 3.9 0.8 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.502 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 278' ' ' GLY . . . 35.35 -104.64 0.02 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.12 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.574 ' OE1' ' NE ' ' A' ' 242' ' ' ARG . 30.9 tt0 -142.62 58.21 1.44 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.091 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.3 m -85.33 -4.02 59.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -149.59 65.61 7.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.233 -179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.31 148.31 90.96 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.21 1.94 . . . . 0.0 111.26 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.569 HG23 ' H ' ' A' ' 286' ' ' THR . 19.6 m -110.95 -55.36 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.247 0.546 . . . . 0.0 110.907 178.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.791 HG21 ' O ' ' A' ' 302' ' ' CYS . 18.6 p -58.91 -40.78 85.55 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.075 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.61 -7.73 0.01 OUTLIER Glycine 0 CA--C 1.531 1.078 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.172 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.632 ' N ' ' O ' ' A' ' 286' ' ' THR . 3.2 m-20 -123.45 -54.99 1.76 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.8 m -66.89 -22.03 65.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.324 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.609 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -120.95 24.53 10.14 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.756 0.312 . . . . 0.0 110.481 -179.565 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -66.58 -9.01 30.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.981 0.42 . . . . 0.0 110.358 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -93.77 33.72 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.173 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.609 HG21 ' SG ' ' A' ' 290' ' ' CYS . 14.5 t -135.32 120.59 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.8 0.333 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 13.03 13.14 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.424 ' N ' ' CD ' ' A' ' 295' ' ' GLN . 0.7 OUTLIER -99.59 136.93 38.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.974 0.416 . . . . 0.0 109.953 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -58.14 -46.12 86.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.2 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -67.11 -46.93 72.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.285 -178.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.19 -26.36 68.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.661 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 303' ' ' LEU . 31.8 mt -76.12 -57.04 4.11 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.549 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.36 -36.97 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.0 109.882 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -72.0 -40.34 68.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.099 178.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.791 ' O ' HG21 ' A' ' 286' ' ' THR . 9.1 t -83.68 -8.02 59.37 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.562 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 299' ' ' LEU . 49.4 mt -93.77 21.73 6.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.463 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.25 -43.35 1.4 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 121.055 0.455 . . . . 0.0 110.711 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.3 Cg_exo -60.77 10.27 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.398 2.732 . . . . 0.0 111.681 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 304' ' ' ALA . 2.0 m-20 -103.88 14.26 31.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.743 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -115.87 93.84 4.42 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.239 0.543 . . . . 0.0 110.165 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.505 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 8.4 ptm180 -154.44 128.4 8.85 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.512 0.673 . . . . 0.0 112.575 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.54 135.57 28.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.508 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.448 ' OE2' ' CZ ' ' A' ' 239' ' ' TYR . 28.5 mt-10 -118.66 104.37 10.56 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.26 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.437 HG23 HG22 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -79.48 117.86 25.93 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.543 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -96.0 121.61 37.93 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.141 0.495 . . . . 0.0 110.594 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.869 HG21 HD22 ' A' ' 224' ' ' LEU . 52.4 t -124.34 117.27 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.955 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -112.92 138.67 49.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 87.82 39.14 7.17 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -178.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.715 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.3 tt -116.68 169.31 7.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.715 ' O ' ' O ' ' A' ' 316' ' ' ILE . 68.2 mttm -38.78 -163.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.7 0.762 . . . . 0.0 112.016 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -87.9 172.71 9.4 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.657 -0.652 . . . . 0.0 110.729 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 16.1 t -98.08 97.87 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.804 179.174 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.67 130.29 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.472 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.3 p -117.57 96.77 5.54 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.318 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -116.69 89.32 27.94 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.001 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.89 135.97 59.01 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.102 1.868 . . . . 0.0 111.858 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.431 ' O ' ' OXT' ' A' ' 325' ' ' ALA . 29.4 pt20 -157.08 151.76 25.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.573 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.431 ' OXT' ' O ' ' A' ' 324' ' ' GLN . . . . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.661 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.05 -19.91 44.93 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.768 2.312 . . . . 0.0 112.018 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 59.56 73.51 0.66 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.334 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.79 148.05 93.22 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.895 2.397 . . . . 0.0 111.918 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.44 69.94 46.32 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.37 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.26 -39.77 79.79 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.623 2.215 . . . . 0.0 112.005 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -174.48 78.69 0.34 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.444 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 188' ' ' GLU . 50.5 Cg_exo -51.8 -35.25 58.12 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.67 2.247 . . . . 0.0 112.016 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 187' ' ' PRO . 84.7 tt0 57.04 114.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.476 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.0 t -135.26 131.25 51.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.133 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -112.87 85.85 2.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.711 -179.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 192' ' ' LYS . 43.3 m -76.59 167.03 22.57 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.008 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 191' ' ' THR . 3.8 tptm -152.37 98.5 2.4 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.561 0.696 . . . . 0.0 110.998 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -85.27 125.16 32.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.408 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.606 ' CE2' HD21 ' A' ' 224' ' ' LEU . 54.4 m-85 -112.73 119.27 37.49 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 195' ' ' THR . 7.7 t -86.4 104.93 16.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.427 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.687 ' CD2' HD11 ' A' ' 201' ' ' LEU . 27.7 tp -107.38 129.47 54.92 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.068 0.461 . . . . 0.0 109.773 -179.4 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -78.81 126.78 31.18 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.876 0.845 . . . . 0.0 112.113 -178.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 202' ' ' PHE . 94.6 p -62.74 -30.29 71.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.984 179.298 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -58.86 -40.27 83.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.32 -46.27 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.687 HD11 ' CD2' ' A' ' 196' ' ' LEU . 90.3 mt -75.93 -76.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.359 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -126.48 128.29 46.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.946 -179.787 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -108.45 -76.18 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.27 -34.09 17.83 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.561 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.468 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 48.9 p30 -62.79 165.77 6.27 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.076 0.465 . . . . 0.0 110.223 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -54.93 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.54 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.3 52.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.63 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.468 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 60.9 p -107.14 137.76 44.59 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.279 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.2 mt -74.6 142.74 44.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.18 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 213' ' ' GLY . 34.4 mtpt -101.83 159.68 28.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.137 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 210' ' ' LYS . 82.2 Cg_exo -33.96 -77.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.418 2.079 . . . . 0.0 111.982 179.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 56.2 mp0 -51.47 -17.01 0.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.262 0.553 . . . . 0.0 110.181 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.99 -48.22 10.24 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.343 178.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 214' ' ' GLN . . . . . 0.402 ' NE2' ' CE1' ' A' ' 263' ' ' TYR . 93.1 mt-30 -67.62 -40.11 84.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.139 0.495 . . . . 0.0 109.783 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.49 -50.34 74.11 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 219' ' ' GLN . . . -65.07 -32.65 74.46 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.509 0.671 . . . . 0.0 110.311 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.9 mt -70.33 -26.89 63.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.421 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -74.94 -47.66 28.47 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.36 0.6 . . . . 0.0 111.178 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 216' ' ' ALA . 15.4 pt20 -64.63 -40.72 95.96 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.469 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.2 tp -63.78 -41.47 97.95 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.488 178.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 225' ' ' SER . 6.3 t80 -53.02 -51.02 63.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.998 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 6.1 t -53.19 -51.48 61.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.266 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.416 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 57.2 tt0 -55.12 -25.92 34.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.946 HD22 HG21 ' A' ' 313' ' ' VAL . 86.5 mt -94.89 -20.28 19.56 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.641 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 221' ' ' TYR . 24.6 p -83.36 -11.42 57.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.396 0.435 . . . . 0.0 110.444 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.564 ' O ' ' ND2' ' A' ' 226' ' ' ASN . 0.2 OUTLIER -97.48 22.4 8.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.237 0.541 . . . . 0.0 110.263 -179.494 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.539 ' H ' ' CD2' ' A' ' 227' ' ' LEU . 0.6 OUTLIER -80.03 -177.69 6.14 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.975 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 315' ' ' GLY . 21.5 t0 -100.26 108.02 50.48 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.77 178.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 230' ' ' LYS . 75.6 Cg_exo -46.19 -21.01 1.0 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.667 2.245 . . . . 0.0 112.917 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 229' ' ' PRO . 65.0 tttm -35.91 -52.21 0.73 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.041 0.448 . . . . 0.0 110.546 -177.826 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.47 ' O ' ' C ' ' A' ' 232' ' ' GLY . 57.4 m-20 -98.71 -21.52 16.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.528 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.17 50.32 0.04 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 123.849 0.718 . . . . 0.0 111.646 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.68 111.81 19.0 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 122.574 -0.368 . . . . 0.0 110.69 -179.182 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.02 97.32 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.712 0.767 . . . . 0.0 110.311 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.4 t -99.67 121.17 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.554 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 85.7 t -95.41 126.86 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.428 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.2 mt -111.93 140.53 46.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.051 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.429 ' O ' ' SD ' ' A' ' 279' ' ' MET . . . -116.7 136.48 12.81 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.609 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -120.81 122.04 39.45 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.511 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.402 HG22 ' NH1' ' A' ' 256' ' ' ARG . 3.3 p -113.3 165.8 12.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 0.0 110.218 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.52 ' OD2' HD11 ' A' ' 243' ' ' ILE . 9.4 p-10 -89.98 -177.32 5.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.644 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -98.42 122.06 41.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.281 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.3 mm -118.55 13.6 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.274 0.559 . . . . 0.0 110.702 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 82.73 2.65 90.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.9 m -132.79 98.92 4.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.033 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -54.01 -51.61 63.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.461 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.74 -41.6 74.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.505 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.591 ' CE2' HD11 ' A' ' 252' ' ' LEU . 55.2 t80 -63.36 -43.24 98.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.67 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.06 -42.38 99.13 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.523 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -64.04 -41.57 97.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.785 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.23 -39.07 97.21 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.591 HD11 ' CE2' ' A' ' 248' ' ' TYR . 33.5 mt -69.08 -38.2 78.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.764 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 15.4 m -63.66 -43.74 95.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.959 0.409 . . . . 0.0 111.011 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.11 -40.83 91.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.045 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.457 ' HA ' ' HE ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER -60.09 -47.41 86.01 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.28 -179.718 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.803 HH22 ' HE ' ' A' ' 307' ' ' ARG . 99.6 mtt180 -61.36 -58.78 6.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.115 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -52.74 -32.67 44.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.109 0.48 . . . . 0.0 109.753 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -74.56 -51.28 15.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.352 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.476 ' O ' ' OD2' ' A' ' 262' ' ' ASP . 66.2 m -58.86 -38.79 79.56 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.667 0.746 . . . . 0.0 110.268 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 256' ' ' ARG . 88.0 t -63.4 -50.1 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.365 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.591 HG13 HD12 ' A' ' 274' ' ' ILE . 12.8 t -62.08 -49.16 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.475 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 259' ' ' SER . 0.0 OUTLIER -45.06 -42.43 8.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.16 0.505 . . . . 0.0 110.272 -178.573 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.402 ' CE1' ' NE2' ' A' ' 214' ' ' GLN . 19.9 t80 -80.62 -31.38 36.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.637 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.9 -7.39 45.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.285 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.562 ' C ' ' H ' ' A' ' 267' ' ' LYS . 69.6 mt -88.62 -58.35 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 111.612 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.1 p -49.17 -6.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.075 -178.716 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.0 OUTLIER -78.19 -11.69 59.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.847 0.356 . . . . 0.0 110.527 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 108.67 39.88 1.68 Allowed Glycine 0 C--N 1.329 0.161 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.0 129.98 23.88 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.0 128.85 30.6 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.67 1.58 . . . . 0.0 111.698 176.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.23 -10.17 47.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.849 0.357 . . . . 0.0 111.122 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 33.5 p30 -92.61 -18.21 23.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.479 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 1.4 ttpm? -83.98 -18.26 37.79 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.605 0.717 . . . . 0.0 110.71 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.591 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -105.27 -171.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.717 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 7.6 t -168.53 133.19 1.62 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.202 179.076 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -105.2 112.04 25.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.784 0.326 . . . . 0.0 110.608 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 150.34 45.61 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.539 0.685 . . . . 0.0 110.982 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -115.37 97.63 0.81 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.659 ' CE ' ' H ' ' A' ' 282' ' ' SER . 3.3 ppp? -80.85 6.74 12.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.884 0.374 . . . . 0.0 111.001 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 47.38 -99.17 0.02 OUTLIER Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.983 179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.447 ' CD ' ' N ' ' A' ' 281' ' ' GLU . 1.8 pm0 -139.36 80.14 1.76 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.845 0.355 . . . . 0.0 111.032 -178.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.659 ' H ' ' CE ' ' A' ' 279' ' ' MET . 88.0 p -88.92 -2.0 58.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.071 -179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -163.02 75.6 1.93 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.296 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.34 103.7 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.461 2.107 . . . . 0.0 112.805 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 286' ' ' THR . 19.2 m -73.74 -35.88 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.231 0.539 . . . . 0.0 110.095 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.637 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.9 OUTLIER -58.98 -43.51 91.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.507 -179.714 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.38 -0.8 0.02 OUTLIER Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.637 ' H ' ' C ' ' A' ' 286' ' ' THR . 11.0 t30 -122.16 -58.62 1.71 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.08 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.7 m -58.73 -23.0 59.07 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.737 0.303 . . . . 0.0 110.524 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 3.3 m -120.29 28.49 8.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.143 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -70.78 -17.88 62.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.86 0.362 . . . . 0.0 110.952 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -97.57 31.47 2.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.437 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.408 HG12 ' CD1' ' A' ' 299' ' ' LEU . 23.6 t -137.95 129.31 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.194 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -121.23 13.3 11.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -96.44 131.37 43.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.168 0.509 . . . . 0.0 110.249 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -52.76 -67.98 0.21 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.031 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.48 -41.2 60.76 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.891 -178.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.26 80.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.424 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 303' ' ' LEU . 4.9 mp -72.74 -52.03 16.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.714 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 81.6 mt -43.17 -38.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.906 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -76.51 -43.53 39.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.359 178.251 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.7 t -73.93 -5.43 41.14 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.505 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.4 mm? -94.55 13.35 24.37 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.57 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.598 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -73.73 -43.1 6.56 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.734 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.5 Cg_exo -60.81 9.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.438 2.759 . . . . 0.0 112.255 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 304' ' ' ALA . 53.1 t0 -108.81 9.5 26.82 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.662 0.268 . . . . 0.0 110.669 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.803 ' HE ' HH22 ' A' ' 256' ' ' ARG . 68.3 mtp180 -112.38 98.87 7.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.333 0.587 . . . . 0.0 110.148 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.466 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 36.5 ptt180 -167.75 144.54 4.23 Favored 'General case' 0 C--O 1.215 -0.763 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.784 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.414 HG12 ' HA2' ' A' ' 238' ' ' GLY . 22.4 m -107.2 147.67 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.264 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -121.02 110.62 16.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.146 0.498 . . . . 0.0 111.091 -178.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.4 mm -80.49 118.31 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -104.33 98.96 8.67 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.942 -179.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.946 HG21 HD22 ' A' ' 224' ' ' LEU . 93.0 t -106.06 123.48 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.444 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -115.53 146.89 41.3 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.999 179.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 91.96 15.84 52.99 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -179.512 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.42 143.71 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.211 0.529 . . . . 0.0 110.825 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 319' ' ' VAL . 41.4 tptt -87.28 129.68 34.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.767 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -50.9 94.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.482 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 317' ' ' LYS . 19.2 t -74.61 133.92 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.446 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 12.4 t -88.49 120.83 37.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.414 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 4.8 t -150.92 167.37 27.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.439 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 322' ' ' GLN . . . . . 0.608 ' CD ' ' H ' ' A' ' 322' ' ' GLN . 7.8 mp0 -80.09 146.69 63.66 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.684 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.86 -26.52 51.99 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.388 2.059 . . . . 0.0 112.079 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -87.95 -42.63 12.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.721 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.603 -179.948 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.626 ' HB3' ' HD3' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 180' ' ' ALA . 73.4 Cg_endo -79.62 153.93 23.56 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.499 2.133 . . . . 0.0 112.157 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 59.44 78.73 0.33 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.475 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.03 145.3 98.1 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.861 2.374 . . . . 0.0 112.058 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.646 ' HB3' ' CD ' ' A' ' 185' ' ' PRO . . . -179.47 -61.45 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.127 -179.294 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.646 ' CD ' ' HB3' ' A' ' 184' ' ' ALA . 25.4 Cg_endo -60.14 146.05 97.1 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.568 2.179 . . . . 0.0 111.962 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 187' ' ' PRO . . . -47.64 179.54 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.333 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.684 ' HD2' ' HB1' ' A' ' 186' ' ' ALA . 33.3 Cg_exo -60.83 151.21 78.82 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.809 2.339 . . . . 0.0 112.111 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -44.65 157.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.34 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 190' ' ' GLN . 4.1 p -80.66 172.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.185 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.591 ' H ' HG22 ' A' ' 189' ' ' VAL . 4.3 tt0 -123.35 111.78 16.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.827 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.7 m -86.92 146.01 26.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.271 179.194 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 313' ' ' VAL . 20.4 mmtt -112.92 149.78 32.73 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.335 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -128.01 114.16 16.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.191 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.496 ' CE2' HD21 ' A' ' 224' ' ' LEU . 42.9 m-85 -114.03 116.47 29.24 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.678 177.732 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.1 102.18 13.63 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.584 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.732 ' CD2' HD11 ' A' ' 201' ' ' LEU . 29.4 tp -103.27 119.85 39.65 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.737 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -77.59 127.69 32.91 Favored 'General case' 0 C--O 1.255 1.366 0 CA-C-O 123.052 1.406 . . . . 0.0 112.765 -178.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 202' ' ' PHE . 78.4 p -59.48 -20.13 53.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.874 178.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -55.97 -43.63 77.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.15 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 6.7 t -74.6 -28.07 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.732 HD11 ' CD2' ' A' ' 196' ' ' LEU . 51.9 mt -93.52 -81.75 0.36 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.776 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.0 OUTLIER -113.27 130.28 56.29 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.869 -179.161 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.539 ' O ' ' NH1' ' A' ' 307' ' ' ARG . 7.7 m120 -98.7 -72.7 0.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -117.27 -21.13 8.89 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.817 0.341 . . . . 0.0 110.283 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -68.31 172.12 6.34 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.052 0.453 . . . . 0.0 110.321 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -53.37 -92.26 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.657 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -151.29 59.38 0.9 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.506 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 68.1 p -106.9 129.54 54.71 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 37.3 mt -74.7 125.01 27.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.697 -178.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 213' ' ' GLY . 50.4 mttt -86.32 158.52 54.88 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.72 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' N ' ' A' ' 213' ' ' GLY . 73.4 Cg_exo -34.01 -75.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.585 2.19 . . . . 0.0 112.045 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -49.02 -20.06 0.49 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.162 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.79 -51.32 11.4 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 178.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -66.19 -38.95 89.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.355 0.597 . . . . 0.0 110.241 179.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.83 -53.75 54.86 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.67 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.37 90.83 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.981 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.88 -29.58 70.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.574 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -71.76 -46.28 58.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.219 0.533 . . . . 0.0 110.239 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -62.16 -44.02 97.53 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.218 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.16 -41.02 97.31 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' A' ' 225' ' ' SER . 3.7 t80 -52.93 -47.69 67.86 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.528 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 72.6 m -53.22 -52.69 58.1 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.424 -178.539 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' A' ' 223' ' ' GLN . 4.6 mp0 -55.78 -27.64 52.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.608 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.91 HD22 HG21 ' A' ' 313' ' ' VAL . 86.6 mt -92.43 -23.12 19.27 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.713 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 221' ' ' TYR . 8.1 t -77.56 -19.78 55.13 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.57 0.544 . . . . 0.0 110.738 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -96.05 22.17 7.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.068 0.461 . . . . 0.0 110.688 -179.242 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.459 ' H ' ' CD2' ' A' ' 227' ' ' LEU . 0.7 OUTLIER -74.03 -177.68 3.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.219 179.903 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 230' ' ' LYS . 3.7 t0 -99.43 127.08 35.38 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.359 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 232' ' ' GLY . 55.4 Cg_endo -69.73 -22.52 32.12 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.959 2.44 . . . . 0.0 113.593 -178.209 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.556 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 34.6 ttmt -23.74 -51.97 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.688 0.617 . . . . 0.0 111.1 -177.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 232' ' ' GLY . 90.2 m-20 -109.54 -10.48 14.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.939 178.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 27.32 58.13 0.1 Allowed Glycine 0 N--CA 1.471 0.992 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.627 ' H ' ' CE ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -124.34 119.0 28.01 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-O 121.249 0.547 . . . . 0.0 110.454 -179.549 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -132.75 99.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.514 0.673 . . . . 0.0 109.805 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.19 127.09 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.152 0.501 . . . . 0.0 111.11 -178.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 89.4 t -102.12 128.39 54.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.399 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 18.2 mt -108.78 140.43 42.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.016 0.436 . . . . 0.0 110.459 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -98.95 138.26 13.75 Favored Glycine 0 N--CA 1.472 1.092 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.201 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 308' ' ' ARG . 9.7 m-85 -125.63 115.82 20.74 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.344 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 4.9 t -117.18 163.94 15.53 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.461 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.584 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 48.9 p-10 -87.74 -174.92 4.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.417 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -99.21 121.79 41.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 110.075 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.8 mm -116.1 12.62 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.371 0.605 . . . . 0.0 110.728 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.05 -3.52 65.21 Favored Glycine 0 C--N 1.315 -0.584 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -125.39 105.26 8.95 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.93 -55.2 37.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.36 69.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.576 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.622 ' CE2' HD11 ' A' ' 252' ' ' LEU . 47.3 t80 -63.03 -44.88 94.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.775 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.584 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 18.8 m120 -61.88 -42.16 98.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.398 -179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -64.27 -41.81 96.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.644 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.74 -38.31 96.25 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.622 HD11 ' CE2' ' A' ' 248' ' ' TYR . 35.1 mt -69.2 -38.58 78.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.849 0.357 . . . . 0.0 111.199 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 78.1 p -63.56 -44.01 95.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.43 -45.11 80.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.437 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -56.8 -50.52 72.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.319 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.727 HH22 ' N ' ' A' ' 308' ' ' ARG . 70.3 mtp180 -59.13 -59.01 6.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.473 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.2 -35.68 17.79 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.172 0.511 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.408 ' NE2' ' OD1' ' A' ' 262' ' ' ASP . 68.0 tp60 -69.9 -43.75 71.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.154 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.7 t -60.86 -39.64 89.92 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.314 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.28 -54.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.773 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.571 HG13 HD12 ' A' ' 274' ' ' ILE . 24.4 t -60.21 -50.01 81.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.45 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.408 ' OD1' ' NE2' ' A' ' 258' ' ' GLN . 25.8 m-20 -44.6 -41.75 6.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -83.55 -29.67 27.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.745 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -71.74 -7.0 45.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.474 -179.658 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.0 mt -87.09 -55.74 6.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.832 0.349 . . . . 0.0 111.539 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.3 m -50.93 -5.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.887 -178.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.583 ' H ' ' C ' ' A' ' 265' ' ' ILE . 5.7 mmtm -77.17 -9.87 59.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.94 38.17 2.22 Favored Glycine 0 N--CA 1.458 0.15 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.07 128.35 23.76 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.24 130.24 34.71 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.965 1.777 . . . . 0.0 112.081 177.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.01 -10.71 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.917 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -92.84 -22.71 19.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.898 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -78.34 -23.21 47.09 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.632 0.73 . . . . 0.0 110.472 -179.496 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.571 HD12 HG13 ' A' ' 261' ' ' VAL . 1.4 pt -101.19 -170.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.71 -178.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 8.2 t -169.04 126.3 0.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.012 179.089 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.91 114.55 26.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.795 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -129.28 157.47 41.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.311 0.577 . . . . 0.0 110.18 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.54 155.11 16.25 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.541 ' N ' ' O ' ' A' ' 238' ' ' GLY . 5.5 tpt -118.62 -10.0 10.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.964 0.411 . . . . 0.0 110.293 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 53.58 -110.88 1.57 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -137.33 74.94 1.5 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.804 0.335 . . . . 0.0 110.732 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.9 t -72.86 -48.42 37.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.12 0.486 . . . . 0.0 111.498 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -144.63 76.77 14.06 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.12 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.55 123.26 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.627 2.218 . . . . 0.0 111.744 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.06 -35.87 42.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.115 0.483 . . . . 0.0 110.556 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.722 ' OG1' HD23 ' A' ' 303' ' ' LEU . 71.7 p -67.38 -50.03 61.41 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.643 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -55.12 1.73 0.05 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.7 t-20 -111.64 -61.12 1.75 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.3 t -76.91 -7.35 55.37 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.568 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.45 21.25 7.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.541 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -69.59 -4.2 18.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.575 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -96.6 33.02 1.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.661 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.8 t -125.65 129.96 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.944 0.402 . . . . 0.0 109.917 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.78 4.32 12.25 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -100.25 130.9 46.43 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.19 0.519 . . . . 0.0 110.432 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 299' ' ' LEU . 5.0 ttt180 -53.26 -75.62 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.604 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -42.36 -37.48 1.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.1 0.476 . . . . 0.0 110.747 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.48 84.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.793 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 296' ' ' ARG . 20.8 mt -73.12 -44.32 60.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.168 0.509 . . . . 0.0 110.575 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 300' ' ' ILE . 6.3 mm -60.84 -31.39 49.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.989 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -81.38 -28.97 34.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.611 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.3 t -93.68 -11.23 32.03 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.85 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.722 HD23 ' OG1' ' A' ' 286' ' ' THR . 37.7 mt -93.28 20.36 7.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.62 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -78.44 -46.11 2.03 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.288 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 37.7 Cg_exo -59.76 8.83 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.214 2.609 . . . . 0.0 111.886 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 304' ' ' ALA . 47.2 t0 -109.47 12.11 24.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.793 0.33 . . . . 0.0 110.852 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 203' ' ' ASN . 65.0 mtp180 -109.4 109.74 20.68 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.176 0.512 . . . . 0.0 110.36 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.727 ' N ' HH22 ' A' ' 256' ' ' ARG . 10.4 ptp180 -174.16 -172.38 0.7 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.998 -179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.35 157.11 15.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 177.232 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -121.79 106.65 11.48 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.221 0.534 . . . . 0.0 111.282 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.68 122.48 35.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.305 -178.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -108.06 116.65 32.34 Favored 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 123.775 0.672 . . . . 0.0 110.27 -178.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.91 HG21 HD22 ' A' ' 224' ' ' LEU . 80.2 t -130.77 125.71 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.154 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.652 ' HD3' ' H ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -99.41 179.53 4.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.335 179.043 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.406 ' H ' HG22 ' A' ' 189' ' ' VAL . . . 71.52 -49.71 1.03 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 177.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 14.2 tt -47.07 150.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.098 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -113.12 161.94 16.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.058 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -65.16 92.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.703 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 28.6 m -59.25 176.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.247 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.55 133.13 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.0 m -118.87 135.48 54.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.615 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -48.86 151.89 2.0 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.415 -179.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.64 149.47 87.27 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.658 2.239 . . . . 0.0 112.229 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 54.03 89.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.457 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.605 179.952 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.66 -39.46 76.02 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.486 2.124 . . . . 0.0 112.332 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -82.88 139.67 43.21 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.563 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.24 158.85 48.21 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.299 2.0 . . . . 0.0 111.809 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -157.01 144.89 14.12 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.56 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.49 ' O ' ' HB3' ' A' ' 186' ' ' ALA . 57.1 Cg_endo -69.86 -17.91 36.85 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.228 1.952 . . . . 0.0 112.278 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 185' ' ' PRO . . . 70.86 73.48 0.27 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.15 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 188' ' ' GLU . 35.0 Cg_exo -55.77 178.3 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.718 2.279 . . . . 0.0 112.128 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 188' ' ' GLU . 1.1 tm-20 77.63 40.07 0.17 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.504 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.4 t -135.23 132.72 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.477 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.1 OUTLIER -122.92 101.92 7.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.013 179.493 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.442 HG22 ' NE2' ' A' ' 193' ' ' HIS . 17.7 m -69.12 139.03 54.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.291 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -142.33 114.0 7.95 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.9 m-70 -102.95 144.53 31.12 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.41 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 78.1 m-85 -107.22 130.68 54.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 195' ' ' THR . 8.0 t -86.32 104.35 15.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.825 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.597 ' HB3' HG23 ' A' ' 309' ' ' VAL . 3.4 mt -108.83 131.55 54.88 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.426 ' O ' HG22 ' A' ' 200' ' ' VAL . 0.8 OUTLIER -93.38 137.92 32.22 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 122.727 1.251 . . . . 0.0 110.991 -178.643 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 202' ' ' PHE . 0.9 OUTLIER -61.01 -18.21 56.45 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.427 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -57.13 -49.99 74.21 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.863 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 200' ' ' VAL . 4.7 m -68.26 -38.55 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.735 179.021 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.51 HD12 HG21 ' A' ' 309' ' ' VAL . 33.2 mt -82.79 -78.76 0.2 Allowed 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.449 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -138.06 137.86 38.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.841 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -119.49 -75.99 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.552 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -81.69 -37.7 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.933 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -67.26 170.52 7.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.144 0.497 . . . . 0.0 110.494 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -59.32 -82.82 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.775 -179.618 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -153.67 54.23 0.73 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.166 0.507 . . . . 0.0 110.349 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.57 127.93 53.72 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.486 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.6 mt -70.21 140.89 52.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 -179.096 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 213' ' ' GLY . 4.1 mtmp? -103.51 157.36 34.01 Favored Pre-proline 0 N--CA 1.466 0.326 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -32.97 -76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.718 2.279 . . . . 0.0 112.352 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -49.84 -20.32 0.85 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.326 0.584 . . . . 0.0 110.548 -179.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.53 -50.08 12.85 Favored Glycine 0 N--CA 1.461 0.365 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.084 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -65.15 -40.88 95.0 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.232 0.539 . . . . 0.0 109.944 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.0 67.04 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.07 -38.69 91.97 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.607 -179.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.31 -28.88 70.05 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.277 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -71.18 -47.24 58.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.374 0.607 . . . . 0.0 110.808 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -62.62 -43.5 98.66 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.974 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 60.9 tp -65.23 -39.36 92.63 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.235 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.431 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.7 t80 -53.42 -47.94 69.18 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.845 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.8 t -59.32 -50.07 75.39 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.537 -178.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.41 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 59.1 tt0 -51.95 -24.99 7.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.942 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.655 HD22 HG21 ' A' ' 313' ' ' VAL . 23.3 mt -96.68 -17.15 20.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.508 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 10.5 t -81.63 -16.12 52.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.795 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -103.32 17.72 23.43 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.581 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.6 OUTLIER -74.38 -179.44 3.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.323 179.701 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -97.96 109.46 51.56 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 230' ' ' LYS . 78.5 Cg_exo -47.6 -19.57 1.33 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.349 2.033 . . . . 0.0 113.438 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 229' ' ' PRO . 1.5 tmtp? -27.13 -51.79 0.06 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.261 0.553 . . . . 0.0 111.11 -177.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 232' ' ' GLY . 67.9 m-20 -110.14 -13.73 14.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.478 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.51 46.61 0.02 OUTLIER Glycine 0 N--CA 1.474 1.228 0 O-C-N 124.101 0.876 . . . . 0.0 111.272 179.546 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 231' ' ' ASP . 74.6 m -114.96 109.93 18.85 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.568 0.223 . . . . 0.0 111.149 -178.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 77.4 t -125.64 95.05 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.37 0.605 . . . . 0.0 109.933 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.7 t -96.69 121.14 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.296 0.569 . . . . 0.0 110.7 -178.144 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.41 HG13 HD13 ' A' ' 311' ' ' ILE . 96.5 t -91.07 122.3 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 45.9 mt -105.79 140.86 38.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.427 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.445 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -125.03 129.72 7.11 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.604 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -113.91 117.01 30.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.824 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.475 HG22 ' HA2' ' A' ' 280' ' ' GLY . 9.7 t -104.88 178.54 4.53 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.133 0.492 . . . . 0.0 110.975 -178.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 307' ' ' ARG . 41.8 m-20 -83.79 -177.08 6.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.394 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -117.02 120.28 37.9 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.768 0.318 . . . . 0.0 110.501 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 243' ' ' ILE . 45.4 mm -120.67 12.66 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.504 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.96 -43.5 3.26 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 6.9 m -71.1 94.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.362 0.601 . . . . 0.0 109.934 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -48.51 -48.34 38.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.203 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.14 84.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.749 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.566 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 44.2 t80 -62.14 -42.22 99.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.148 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.442 ' ND2' HG23 ' A' ' 240' ' ' THR . 15.3 t-20 -60.38 -53.08 61.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -61.67 -37.65 84.86 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.42 -41.83 99.63 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 33.0 mt -71.24 -37.78 71.99 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.073 178.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 4.2 t -63.0 -39.68 95.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.115 0.483 . . . . 0.0 110.879 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -73.19 -39.65 65.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.46 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -58.83 -51.75 68.65 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.517 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 260' ' ' VAL . 18.1 ptp180 -64.39 -44.28 91.81 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.899 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.32 -42.28 98.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.571 0.7 . . . . 0.0 110.421 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -70.72 -42.06 71.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.684 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.8 m -60.61 -39.14 87.09 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.383 0.611 . . . . 0.0 110.355 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 256' ' ' ARG . 88.8 t -63.97 -50.65 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.95 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.557 HG13 HD12 ' A' ' 274' ' ' ILE . 18.8 t -61.32 -48.27 89.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 121.165 0.507 . . . . 0.0 110.315 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -47.93 -40.9 23.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.908 -178.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -79.66 -35.59 39.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.026 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.14 -29.11 70.25 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.99 -179.023 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.483 ' C ' ' H ' ' A' ' 267' ' ' LYS . 89.0 mt -69.06 -49.54 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 120.797 0.332 . . . . 0.0 111.82 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 18.5 m -52.43 -8.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 265' ' ' ILE . 12.3 mmtt -79.75 -6.21 56.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.683 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.06 42.21 2.87 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.19 129.41 24.22 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 117.101 0.451 . . . . 0.0 110.583 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.56 129.34 29.21 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.325 1.35 . . . . 0.0 112.002 178.243 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.4 -11.05 38.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.74 -22.9 21.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -179.33 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.47 -23.54 50.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.295 0.569 . . . . 0.0 110.529 -179.541 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.557 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -104.18 -175.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.751 -179.116 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 25.7 m -169.28 132.53 1.29 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.326 178.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.93 148.99 22.05 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -153.1 138.09 17.22 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.394 0.616 . . . . 0.0 111.172 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.06 94.95 2.05 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.298 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -70.36 -6.88 38.53 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.535 -179.551 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.475 ' HA2' HG22 ' A' ' 240' ' ' THR . . . 42.62 -112.56 0.48 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.88 73.75 1.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.688 0.28 . . . . 0.0 110.317 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 31.9 t -71.27 -37.5 71.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.043 0.449 . . . . 0.0 111.613 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -129.44 79.32 74.15 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.698 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.04 110.35 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.501 2.134 . . . . 0.0 112.112 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 286' ' ' THR . 9.1 m -73.14 -36.07 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.76 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.603 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.1 OUTLIER -62.21 -49.35 76.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.097 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -52.51 0.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 286' ' ' THR . 52.4 t30 -116.21 -59.69 1.95 Allowed 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -78.18 -3.61 43.44 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.438 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.75 17.9 4.25 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 292' ' ' ASN . 37.9 p-10 -61.53 -36.9 81.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.986 0.422 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 26.4 t-20 -78.73 33.32 0.21 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.947 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.464 ' HB ' HD11 ' A' ' 299' ' ' LEU . 12.1 t -135.93 124.92 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.005 0.431 . . . . 0.0 110.358 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -120.18 16.41 12.35 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.087 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -100.35 133.44 44.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.12 0.486 . . . . 0.0 110.66 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -59.96 -60.46 3.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.607 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.68 -43.26 65.45 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.978 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.93 89.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.268 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 303' ' ' LEU . 4.8 mp -75.62 -61.35 1.95 Allowed 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.324 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' LEU . 72.4 mt -42.32 -34.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.057 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -77.9 -38.72 45.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.316 178.067 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 299' ' ' LEU . 40.7 t -84.7 -6.99 59.38 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.005 0.431 . . . . 0.0 110.858 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 299' ' ' LEU . 92.8 mt -90.5 15.11 11.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.843 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -77.11 -53.28 1.72 Allowed Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.437 177.683 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 11.2 Cg_endo -54.25 8.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.178 1.919 . . . . 0.0 113.186 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 304' ' ' ALA . 59.4 t0 -101.4 12.88 36.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.541 ' NH2' ' OD2' ' A' ' 241' ' ' ASP . 15.1 ptp180 -113.61 95.2 5.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.189 0.995 . . . . 0.0 110.224 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.551 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.4 ptp180 -156.31 128.24 7.38 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.456 -178.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 196' ' ' LEU . 0.0 OUTLIER -97.01 135.6 30.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.292 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -118.51 104.91 11.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.333 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.41 HD13 HG13 ' A' ' 236' ' ' VAL . 4.7 mm -77.82 115.31 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.024 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -94.66 123.79 38.31 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 123.13 0.269 . . . . 0.0 110.672 -178.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.655 HG21 HD22 ' A' ' 224' ' ' LEU . 11.5 t -125.57 115.51 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.911 -178.683 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -114.72 134.46 55.08 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.14 17.1 25.9 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.6 tt -103.9 148.9 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.968 0.413 . . . . 0.0 110.38 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -137.24 124.54 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.612 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 319' ' ' VAL . 52.8 t0 -169.14 153.14 5.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.403 179.889 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.475 ' N ' ' OD1' ' A' ' 318' ' ' ASP . 14.9 p -67.4 148.05 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.321 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.66 141.31 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.446 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 62.0 p -80.54 163.0 24.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.25 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 322' ' ' GLN . . . . . 0.419 ' CD ' ' N ' ' A' ' 322' ' ' GLN . 22.5 mp0 -112.94 85.61 8.05 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.169 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 325' ' ' ALA . 67.0 Cg_endo -76.67 -178.9 4.86 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.057 1.838 . . . . 0.0 111.983 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 68.27 -66.0 0.24 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.326 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 323' ' ' PRO . . . . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.584 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.41 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 48.2 Cg_endo -67.64 148.89 78.87 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.597 2.198 . . . . 0.0 111.835 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.86 149.52 1.87 Allowed Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.621 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.58 ' O ' ' HB2' ' A' ' 184' ' ' ALA . 39.4 Cg_endo -65.31 -32.47 50.85 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.558 2.172 . . . . 0.0 112.411 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 183' ' ' PRO . . . 168.26 81.13 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.1 -179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.84 68.04 8.09 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.461 2.107 . . . . 0.0 112.333 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . -79.37 -51.01 1.27 Allowed Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.056 178.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 73.4 Cg_endo -75.47 152.82 39.07 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.154 1.903 . . . . 0.0 112.54 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.59 -164.15 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.701 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.503 HG22 ' H ' ' A' ' 190' ' ' GLN . 2.7 p -94.01 170.59 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.304 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.503 ' H ' HG22 ' A' ' 189' ' ' VAL . 0.2 OUTLIER -125.15 103.92 8.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.171 179.545 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.1 m -67.8 139.12 56.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.146 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.461 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 7.5 mmtt -110.47 161.69 15.43 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.666 0.746 . . . . 0.0 110.611 179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.461 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 4.6 m80 -148.27 119.87 8.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.017 -179.514 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -110.89 120.48 42.53 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.17 103.81 15.15 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.245 -179.957 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.694 ' CD2' HD11 ' A' ' 201' ' ' LEU . 32.2 tp -108.67 128.78 55.15 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -81.81 130.09 34.95 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-O 121.776 0.798 . . . . 0.0 112.291 -178.361 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -64.99 -27.57 68.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.697 179.723 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.782 ' CG ' HD22 ' A' ' 203' ' ' ASN . 11.6 t70 -60.62 -38.48 84.89 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.849 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.25 -42.86 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.694 HD11 ' CD2' ' A' ' 196' ' ' LEU . 88.8 mt -78.12 -79.1 0.13 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.46 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -124.56 129.5 50.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.779 -179.228 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.782 HD22 ' CG ' ' A' ' 199' ' ' ASP . 24.2 m120 -94.44 -74.42 0.54 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.721 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.49 -10.09 14.56 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.7 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -74.3 165.37 25.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.188 0.518 . . . . 0.0 109.919 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.04 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.825 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.09 2.52 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.927 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 63.7 p -53.03 136.27 35.57 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.903 0.383 . . . . 0.0 110.282 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 83.6 mt -82.9 136.36 34.61 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.293 0.568 . . . . 0.0 111.364 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 213' ' ' GLY . 31.2 mtmt -98.6 157.59 34.0 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.956 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -34.44 -75.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.383 2.055 . . . . 0.0 112.419 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 57.0 mp0 -48.9 -24.5 1.5 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.361 0.6 . . . . 0.0 110.225 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -70.92 -51.16 20.29 Favored Glycine 0 CA--C 1.517 0.209 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.603 178.494 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.14 -41.02 99.22 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.318 0.58 . . . . 0.0 109.465 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.444 ' O ' ' CD ' ' A' ' 219' ' ' GLN . . . -54.18 -56.1 21.48 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.973 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.61 72.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.56 0.695 . . . . 0.0 110.612 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.11 -25.97 63.75 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.57 179.51 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -75.59 -49.84 17.35 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.881 0.848 . . . . 0.0 111.054 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.444 ' CD ' ' O ' ' A' ' 215' ' ' ALA . 0.4 OUTLIER -62.46 -44.54 96.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.421 179.58 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 42.3 tp -62.36 -40.73 97.37 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.411 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.4 t80 -51.8 -49.51 62.58 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.896 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.0 m -54.88 -51.02 67.27 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.716 -178.025 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -51.55 -26.5 8.72 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.424 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.981 HD22 HG21 ' A' ' 313' ' ' VAL . 43.1 mt -100.4 -17.95 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.589 -179.579 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.1 t -73.79 -28.28 61.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.191 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -95.79 23.91 5.85 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.85 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.482 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.61 167.42 21.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.201 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -82.01 129.19 65.4 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.309 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 230' ' ' LYS . 53.8 Cg_endo -70.36 -18.73 34.0 Favored 'Trans proline' 0 N--CA 1.506 2.248 0 C-N-CA 122.979 2.452 . . . . 0.0 112.832 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 229' ' ' PRO . 24.6 mmtm -32.32 -52.27 0.28 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.525 -177.334 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 232' ' ' GLY . 58.4 m-20 -104.45 -17.48 14.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.153 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.75 50.81 0.06 OUTLIER Glycine 0 N--CA 1.471 0.982 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.8 t -118.25 108.47 15.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.819 0.343 . . . . 0.0 110.935 -178.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 313' ' ' VAL . 15.7 t -125.93 95.61 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.285 178.577 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.4 120.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.245 -178.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.417 HG21 HG22 ' A' ' 261' ' ' VAL . 73.6 t -91.45 126.66 44.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.223 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 277' ' ' ARG . 23.8 mt -109.97 140.24 44.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.886 -179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -122.54 130.09 7.78 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.21 117.13 29.63 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.028 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.6 p -103.8 171.31 7.43 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 242' ' ' ARG . 43.6 t0 -85.45 -176.28 6.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.726 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.465 ' H ' ' CG ' ' A' ' 241' ' ' ASP . 88.9 mtm180 -109.34 120.65 43.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.957 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.0 mm -120.08 14.47 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.639 0.733 . . . . 0.0 110.645 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.09 -47.81 3.39 Favored Glycine 0 C--N 1.314 -0.653 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.9 p -76.2 91.16 3.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.287 0.565 . . . . 0.0 109.712 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -45.38 -46.5 13.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.372 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.97 80.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.625 ' CE2' HD11 ' A' ' 252' ' ' LEU . 57.2 t80 -59.76 -45.9 90.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.989 0.423 . . . . 0.0 110.347 -179.618 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -62.08 -40.99 97.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.098 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.05 -40.87 95.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.874 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.27 -38.77 96.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.625 HD11 ' CE2' ' A' ' 248' ' ' TYR . 98.3 mt -74.95 -31.2 61.43 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.931 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.5 t -66.49 -45.39 79.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.856 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.39 -39.54 71.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.226 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -61.59 -49.84 75.02 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.508 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.51 ' O ' HG23 ' A' ' 260' ' ' VAL . 99.4 mtt180 -62.28 -51.45 67.66 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.426 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -53.95 -34.34 59.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.162 0.506 . . . . 0.0 109.922 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -71.88 -42.99 66.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.0 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.782 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 16.7 t -62.02 -35.83 79.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.179 0.99 . . . . 0.0 109.92 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 256' ' ' ARG . 71.4 t -67.65 -54.5 22.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.341 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.417 HG22 HG21 ' A' ' 236' ' ' VAL . 55.9 t -63.44 -50.2 79.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 262' ' ' ASP . . . . . 0.782 ' OD1' ' O ' ' A' ' 259' ' ' SER . 40.7 p-10 -49.57 -37.64 28.12 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.577 -177.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.656 ' N ' ' OD1' ' A' ' 262' ' ' ASP . 35.0 t80 -81.34 -33.87 32.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.377 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -64.38 -22.15 66.86 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.893 -179.549 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 267' ' ' LYS . 87.7 mt -78.24 -52.29 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.49 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 62.0 m -49.33 -10.18 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.899 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.0 OUTLIER -77.51 -11.2 59.83 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.302 -179.398 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.8 42.32 1.58 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.402 HD12 ' CE1' ' A' ' 221' ' ' TYR . 0.1 OUTLIER -126.67 137.66 30.91 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 117.188 0.494 . . . . 0.0 110.575 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.81 124.23 15.55 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.698 1.599 . . . . 0.0 111.755 177.403 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.94 -9.83 42.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.874 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -91.22 -23.95 20.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.706 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.448 ' HE3' HD21 ' A' ' 227' ' ' LEU . 2.4 ttpm? -79.81 -19.34 48.72 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.585 0.707 . . . . 0.0 110.994 -179.286 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.5 pt -104.91 -171.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.532 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 47.4 t -170.82 137.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.105 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.43 150.56 22.05 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.456 ' HB3' HD23 ' A' ' 237' ' ' LEU . 62.0 ttm-85 -155.68 139.79 16.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.538 0.685 . . . . 0.0 111.455 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -93.97 96.96 2.13 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.297 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -69.96 -4.49 20.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.875 0.369 . . . . 0.0 110.345 -179.028 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.87 -116.28 1.2 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -138.21 71.0 1.39 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.764 0.316 . . . . 0.0 110.462 -179.658 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.14 5.61 49.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.276 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 283' ' ' ASN . 13.7 p-10 -159.82 74.82 3.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.75 108.32 2.25 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.424 2.083 . . . . 0.0 112.073 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 286' ' ' THR . 6.2 m -70.45 -43.03 78.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.608 ' C ' ' H ' ' A' ' 288' ' ' ASN . 65.7 p -58.83 -43.6 90.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.078 -179.474 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.62 -0.55 0.03 OUTLIER Glycine 0 CA--C 1.533 1.159 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.608 ' H ' ' C ' ' A' ' 286' ' ' THR . 80.5 m-20 -119.86 -59.09 1.83 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.504 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.4 OUTLIER -66.71 -18.75 65.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.572 -178.606 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.46 25.79 9.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.291 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 51.5 t0 -69.19 -10.95 60.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 110.393 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -94.89 32.58 1.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.528 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.1 t -129.92 127.26 63.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 110.237 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -117.77 8.13 12.64 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.969 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -95.36 127.81 41.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.044 0.449 . . . . 0.0 109.95 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -55.94 -50.47 70.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.516 -179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.78 96.91 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.982 -179.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.25 -30.09 70.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.62 179.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 39.6 mt -79.18 -57.04 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.398 -179.575 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.7 mt -45.89 -36.52 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.948 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -74.39 -47.21 35.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.509 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 6.7 t -75.8 -4.95 43.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.278 -179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.522 HD23 ' OG1' ' A' ' 286' ' ' THR . 50.5 mt -96.06 13.06 28.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.529 -179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.594 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -75.13 -46.13 4.69 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.828 0.347 . . . . 0.0 110.083 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 32.1 Cg_exo -56.41 10.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.971 2.448 . . . . 0.0 112.258 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.594 ' H ' ' C ' ' A' ' 304' ' ' ALA . 46.9 t0 -101.06 13.49 35.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.741 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.538 ' NH1' ' HB1' ' A' ' 304' ' ' ALA . 28.9 ptt-85 -113.04 101.72 9.73 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.991 0.9 . . . . 0.0 110.86 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.565 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 20.4 ptp180 -162.02 132.31 4.83 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.24 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.6 142.25 14.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -121.58 108.11 13.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.985 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.8 mm -78.97 119.75 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -99.06 120.58 39.72 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.04 -178.412 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.981 HG21 HD22 ' A' ' 224' ' ' LEU . 66.8 t -126.88 119.47 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 123.578 0.549 . . . . 0.0 111.318 -179.352 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -117.34 125.2 50.64 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 118.15 -18.6 11.23 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.25 144.1 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.377 179.486 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -111.47 87.34 2.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.458 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -115.31 109.69 18.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.224 179.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.9 t -84.84 102.03 10.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.188 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 16.4 m -143.22 126.74 13.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.438 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.88 124.66 8.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.365 179.464 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -134.28 84.33 41.77 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.055 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 324' ' ' GLN . 37.6 Cg_exo -59.06 148.63 84.47 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.732 2.288 . . . . 0.0 111.628 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 324' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 323' ' ' PRO . 87.0 mt-30 58.03 142.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.797 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.608 -179.888 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.645 ' HB1' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.645 ' CD ' ' HB1' ' A' ' 180' ' ' ALA . 32.3 Cg_exo -61.14 144.67 99.19 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.484 2.123 . . . . 0.0 112.034 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.425 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . 55.99 54.29 8.67 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.743 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 38.3 Cg_endo -66.19 -21.52 55.13 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 122.789 2.326 . . . . 0.0 111.685 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.661 ' HB1' ' CD ' ' A' ' 185' ' ' PRO . . . 64.21 179.24 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.569 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.661 ' CD ' ' HB1' ' A' ' 184' ' ' ALA . 27.7 Cg_exo -61.95 149.33 90.66 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.631 2.221 . . . . 0.0 111.958 179.556 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -38.04 103.3 0.26 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.793 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -49.99 -40.3 49.7 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.952 1.768 . . . . 0.0 112.461 -179.291 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -51.77 156.15 1.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.244 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.9 t -90.64 156.02 3.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.306 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.66 100.54 6.25 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.245 179.694 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 36.5 m -70.92 142.78 51.09 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.667 179.428 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.435 ' HD3' ' H ' ' A' ' 193' ' ' HIS . 5.3 tmtt? -111.49 162.36 15.18 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.381 0.61 . . . . 0.0 110.715 179.668 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.435 ' H ' ' HD3' ' A' ' 192' ' ' LYS . 53.9 m80 -152.82 121.18 6.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.674 179.699 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.484 ' CZ ' ' OE1' ' A' ' 223' ' ' GLN . 59.6 m-85 -113.07 123.29 49.93 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.53 103.59 14.53 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.597 -179.588 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 196' ' ' LEU . 3.8 mt -104.69 122.34 45.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.039 0.447 . . . . 0.0 109.983 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.588 ' O ' HG22 ' A' ' 200' ' ' VAL . 8.9 ptpp? -85.73 135.0 33.93 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 122.52 1.153 . . . . 0.0 111.542 -179.562 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 202' ' ' PHE . 4.0 p -59.74 -19.59 51.11 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.679 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -51.86 -50.02 61.75 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.927 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 197' ' ' LYS . 27.2 m -70.92 -33.68 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.675 178.786 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 20.5 mt -86.45 -80.36 0.24 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.356 179.705 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -135.18 145.41 47.7 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.607 -179.146 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -112.58 -67.74 0.98 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.504 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -112.45 -16.57 12.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.574 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -68.28 167.02 15.25 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.01 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.604 ' CG ' ' H ' ' A' ' 207' ' ' ALA . 18.2 pttt -51.29 -70.29 0.09 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.628 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.604 ' H ' ' CG ' ' A' ' 206' ' ' LYS . . . -166.62 -1.18 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.331 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.9 t -52.81 137.16 32.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.897 0.38 . . . . 0.0 110.494 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 96.7 mt -80.17 144.28 33.13 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.566 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 213' ' ' GLY . 38.5 mttm -106.46 156.28 37.29 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.009 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -34.47 -76.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.713 2.275 . . . . 0.0 112.091 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -48.73 -22.16 0.74 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.052 0.453 . . . . 0.0 110.413 -179.146 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.15 -49.64 15.35 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 178.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.82 -39.94 91.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.26 0.552 . . . . 0.0 110.118 179.548 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.74 54.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.836 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.95 -37.2 86.53 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.03 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.9 mt -62.72 -30.64 71.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.867 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -71.24 -46.49 60.97 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.087 0.47 . . . . 0.0 110.379 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -63.33 -44.09 95.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.306 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 47.5 tp -63.94 -39.89 95.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.496 ' CE1' ' OG ' ' A' ' 225' ' ' SER . 3.8 t80 -54.02 -49.56 68.63 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.652 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 69.6 m -57.35 -50.56 72.58 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.366 -178.379 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.484 ' OE1' ' CZ ' ' A' ' 194' ' ' PHE . 58.0 tt0 -52.85 -26.22 13.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.254 -179.56 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.956 HD22 HG21 ' A' ' 313' ' ' VAL . 82.6 mt -97.53 -17.83 19.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.509 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.496 ' OG ' ' CE1' ' A' ' 221' ' ' TYR . 4.8 m -78.81 -12.16 60.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.742 -179.651 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -104.75 22.34 15.29 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 110.325 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.15 177.69 6.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.242 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 315' ' ' GLY . 31.2 t0 -98.97 108.8 51.24 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 230' ' ' LYS . 75.7 Cg_exo -46.9 -19.44 0.79 Allowed 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.605 2.204 . . . . 0.0 113.023 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 229' ' ' PRO . 52.8 tptt -27.11 -52.07 0.06 Allowed 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 123.559 0.537 . . . . 0.0 111.016 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' GLY . 79.1 m-20 -109.4 -15.41 14.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.322 179.019 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.83 50.83 0.06 OUTLIER Glycine 0 C--N 1.338 0.68 0 O-C-N 123.892 0.745 . . . . 0.0 111.666 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 t -117.92 111.08 18.52 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.271 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.83 96.15 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.317 178.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.0 t -99.03 123.12 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.816 -178.701 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 94.8 t -97.88 126.73 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.397 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.603 HD22 ' SD ' ' A' ' 279' ' ' MET . 22.9 mt -110.45 143.88 40.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.513 -179.534 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 279' ' ' MET . . . -119.41 139.55 14.23 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.829 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.3 OUTLIER -120.34 119.66 33.76 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -178.748 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.44 HG23 HD22 ' A' ' 249' ' ' ASN . 0.4 OUTLIER -119.41 167.09 12.26 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.827 0.346 . . . . 0.0 110.414 -179.033 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.499 ' OD2' ' NE ' ' A' ' 307' ' ' ARG . 38.0 m-20 -81.21 -177.03 6.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.458 -179.023 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -105.52 125.71 51.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.33 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.0 mm -116.9 9.17 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.461 0.648 . . . . 0.0 110.829 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.48 10.33 85.72 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.133 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.4 m -129.59 106.38 8.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.128 0.489 . . . . 0.0 109.883 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.446 ' CG ' ' N ' ' A' ' 247' ' ' ALA . 22.1 p-10 -57.43 -53.68 55.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.912 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' A' ' 246' ' ' ASP . . . -54.63 -44.1 72.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.498 . . . . 0.0 110.458 -179.476 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.677 ' CE2' HD11 ' A' ' 252' ' ' LEU . 40.5 t80 -69.63 -41.3 75.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.994 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.557 ' ND2' ' OE2' ' A' ' 281' ' ' GLU . 0.3 OUTLIER -61.35 -52.49 64.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.713 -179.15 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -63.88 -38.17 90.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.555 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.53 -37.36 93.21 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.677 HD11 ' CE2' ' A' ' 248' ' ' TYR . 32.4 mt -71.6 -39.06 70.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.641 0.258 . . . . 0.0 110.692 178.393 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 52.4 p -61.71 -40.66 95.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.984 0.421 . . . . 0.0 110.599 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -69.52 -43.59 72.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.564 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -57.32 -47.46 81.49 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.414 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.785 ' O ' HG23 ' A' ' 260' ' ' VAL . 79.4 mtt-85 -62.99 -51.32 67.31 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.445 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.5 81.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.254 0.55 . . . . 0.0 109.874 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -72.11 -44.08 63.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.432 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 13.5 t -61.44 -38.36 86.9 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.43 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 256' ' ' ARG . 95.8 t -64.54 -52.59 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.723 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.425 HG13 HD12 ' A' ' 274' ' ' ILE . 41.9 t -60.52 -48.61 87.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.964 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -46.01 -41.86 12.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.077 -179.51 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -82.89 -30.83 28.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -71.08 -9.42 58.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.304 -179.496 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.554 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.6 mt -86.01 -53.89 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.353 179.307 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 84.6 p -51.37 -6.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.689 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 265' ' ' ILE . 10.0 mmpt? -76.18 -12.52 60.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 104.43 42.17 1.92 Allowed Glycine 0 N--CA 1.459 0.21 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.1 tt -127.3 131.46 23.85 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 117.045 0.422 . . . . 0.0 110.852 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.87 125.41 17.02 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.187 1.258 . . . . 0.0 111.923 177.36 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.39 -6.32 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 179.196 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -92.88 -23.67 18.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.944 -179.3 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -80.37 -18.7 48.25 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.443 0.64 . . . . 0.0 110.957 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.425 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -106.58 -174.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.516 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 25.8 t -171.53 134.14 0.83 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.21 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.54 152.85 18.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.565 ' HB3' HD23 ' A' ' 237' ' ' LEU . 46.1 ttt85 -159.62 147.1 16.94 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.547 0.689 . . . . 0.0 111.037 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.1 143.89 16.88 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.16 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.603 ' SD ' HD22 ' A' ' 237' ' ' LEU . 2.1 tpt -114.92 -3.65 12.67 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.616 0.246 . . . . 0.0 110.385 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.07 -100.26 0.02 OUTLIER Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.557 ' OE2' ' ND2' ' A' ' 249' ' ' ASN . 28.4 mp0 -142.11 54.25 1.46 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.705 -0.248 . . . . 0.0 110.573 179.314 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.6 m -65.59 -0.05 1.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 0.0 110.697 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 281' ' ' GLU . 48.1 t-20 -167.19 85.43 0.82 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.32 106.25 2.01 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.212 1.941 . . . . 0.0 112.599 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.6 m -94.65 -17.83 7.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 121.314 0.578 . . . . 0.0 110.645 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 290' ' ' CYS . 19.7 p -58.02 -42.78 86.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.595 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 287' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 290' ' ' CYS . . . -48.09 -93.04 0.01 OUTLIER Glycine 0 C--O 1.225 -0.406 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 287' ' ' GLY . 57.6 t30 -28.53 -56.91 0.12 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.803 0.355 . . . . 0.0 110.432 -178.552 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 m -56.73 -45.28 82.06 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.693 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 287' ' ' GLY . 24.1 m -101.77 32.76 3.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.188 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 287' ' ' GLY . 47.5 t0 -56.21 -47.91 77.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.825 0.345 . . . . 0.0 110.605 -179.074 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 292' ' ' ASN . 58.5 t-20 -76.59 31.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.814 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 291' ' ' ASP . 10.6 t -129.48 107.34 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -119.38 14.02 12.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.738 179.673 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -100.23 134.09 43.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.129 0.49 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -49.81 -69.19 0.12 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.438 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.61 -38.84 60.92 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.448 0.642 . . . . 0.0 110.746 -178.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.04 -34.96 79.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 303' ' ' LEU . 16.6 mt -73.87 -56.98 4.29 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.2 mt -46.16 -29.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.425 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -83.59 -44.04 15.02 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.336 178.3 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 1.9 t -74.51 -16.71 60.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.989 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 299' ' ' LEU . 76.6 mt -82.58 25.15 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.817 0.698 . . . . 0.0 110.448 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.619 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -81.11 -38.0 0.96 Allowed Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 32.3 Cg_exo -58.54 6.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.442 2.761 . . . . 0.0 112.748 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 304' ' ' ALA . 2.8 m-20 -111.6 15.64 21.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.744 0.307 . . . . 0.0 110.513 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.499 ' NE ' ' OD2' ' A' ' 241' ' ' ASP . 96.0 mtt-85 -108.54 94.27 4.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.275 0.56 . . . . 0.0 110.16 179.098 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 8.2 ptm180 -168.56 158.35 9.38 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.001 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.64 150.87 26.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.65 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.457 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 92.4 mt-10 -121.1 106.85 11.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.405 0.622 . . . . 0.0 110.855 -178.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.5 mm -79.31 117.93 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.964 -178.179 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -102.87 127.36 50.09 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.956 HG21 HD22 ' A' ' 224' ' ' LEU . 93.6 t -132.2 122.21 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 O-C-N 124.077 0.861 . . . . 0.0 111.753 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -116.8 132.31 56.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.88 37.26 4.74 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 317' ' ' LYS . 7.2 tt -109.03 168.06 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.672 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.619 ' O ' ' O ' ' A' ' 316' ' ' ILE . 21.4 pttm -45.97 -147.62 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 O-C-N 124.303 1.002 . . . . 0.0 111.987 -179.322 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -73.28 168.86 18.3 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.549 -0.72 . . . . 0.0 110.818 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 319' ' ' VAL . 13.4 p -99.64 125.1 53.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.104 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 19.9 t -87.1 131.83 34.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.181 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.5 p -116.09 157.67 24.36 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.169 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 322' ' ' GLN . . . . . 0.418 ' HG2' ' H ' ' A' ' 322' ' ' GLN . 1.2 pt20 -74.68 150.91 86.82 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.664 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.56 -64.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.533 2.155 . . . . 0.0 112.072 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -86.84 -98.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.597 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.38 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.474 179.995 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.491 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 40.5 Cg_endo -65.47 143.98 77.84 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.874 2.383 . . . . 0.0 111.72 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.577 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . 177.68 -44.71 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.051 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 22.9 Cg_exo -63.74 160.92 34.44 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.951 2.434 . . . . 0.0 111.685 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -117.64 83.11 16.98 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.913 179.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -49.4 116.94 2.56 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.423 2.082 . . . . 0.0 112.02 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.546 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -173.4 47.0 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.373 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 37.6 Cg_endo -64.0 145.97 90.52 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.83 2.353 . . . . 0.0 112.049 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -76.76 -4.92 45.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.619 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 18.4 t -138.69 133.77 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.519 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.434 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.1 OUTLIER -118.47 92.39 3.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.925 179.694 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.518 HG22 ' CE1' ' A' ' 193' ' ' HIS . 6.9 m -68.47 136.34 53.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.336 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -140.06 105.59 5.1 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.58 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.518 ' CE1' HG22 ' A' ' 191' ' ' THR . 2.7 m80 -94.85 145.3 24.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.582 ' CE1' HD21 ' A' ' 224' ' ' LEU . 33.1 m-85 -111.81 123.9 51.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.43 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 195' ' ' THR . 5.6 t -84.24 103.76 13.7 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.556 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.742 ' CD2' HD11 ' A' ' 201' ' ' LEU . 30.0 tp -108.34 128.98 55.23 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.066 -179.314 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -83.82 129.13 34.94 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 122.297 1.046 . . . . 0.0 112.218 -178.258 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 202' ' ' PHE . 15.3 m -63.91 -30.36 71.45 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.396 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.03 -41.08 74.42 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.14 -42.5 88.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.164 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.742 HD11 ' CD2' ' A' ' 196' ' ' LEU . 61.1 mt -79.18 -79.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.911 179.751 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -120.09 122.46 41.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.747 -179.123 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -87.24 -75.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -113.08 -10.71 13.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.722 HD21 HG22 ' A' ' 208' ' ' THR . 7.5 p-10 -76.25 171.29 14.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.182 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -50.0 -87.49 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.408 -178.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -154.78 5.97 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.278 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.722 HG22 HD21 ' A' ' 205' ' ' ASN . 8.7 t -54.35 141.94 28.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 36.8 mt -83.1 133.98 35.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.244 0.545 . . . . 0.0 111.166 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.457 ' CB ' ' NZ ' ' A' ' 210' ' ' LYS . 6.4 mtpm? -99.14 156.73 35.14 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.064 179.001 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -34.94 -75.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.557 2.171 . . . . 0.0 112.0 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -46.32 -26.66 0.86 Allowed 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.28 0.562 . . . . 0.0 110.307 -179.414 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -69.03 -51.99 25.79 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -58.65 -39.73 81.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.78 -60.15 3.61 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.419 179.504 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.91 -25.98 68.39 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.695 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -30.4 65.09 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.513 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.93 -47.58 28.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.819 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 13.3 pt20 -63.97 -42.79 97.15 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.91 -179.579 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.506 HD21 HD12 ' A' ' 311' ' ' ILE . 48.1 tp -59.61 -41.51 90.54 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.484 ' C ' ' H ' ' A' ' 223' ' ' GLN . 10.1 t80 -54.94 -60.61 3.13 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.154 177.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.4 m -54.44 -8.21 0.2 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.076 0.465 . . . . 0.0 110.642 -179.129 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 221' ' ' TYR . 15.5 tt0 -93.51 -33.82 13.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.339 178.803 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 313' ' ' VAL . 73.5 mt -97.69 -11.42 23.51 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.623 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 25.8 p -79.21 -26.23 42.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.973 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -88.03 18.88 3.92 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.024 0.44 . . . . 0.0 110.496 -179.245 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.512 HD22 ' O ' ' A' ' 224' ' ' LEU . 1.0 OUTLIER -76.12 156.84 33.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.388 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -78.77 116.71 61.81 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.196 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 232' ' ' GLY . 59.6 Cg_exo -48.92 -21.99 4.36 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.893 2.395 . . . . 0.0 113.059 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 229' ' ' PRO . 27.2 tptp -24.76 -52.35 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 123.75 0.656 . . . . 0.0 110.802 -177.746 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 233' ' ' SER . 72.7 m-20 -109.79 -11.49 14.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.8 179.039 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 24.73 42.86 0.01 OUTLIER Glycine 0 N--CA 1.47 0.935 0 O-C-N 123.953 0.783 . . . . 0.0 111.679 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -112.77 114.55 27.17 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 122.516 -0.402 . . . . 0.0 110.449 -178.61 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 75.4 t -129.22 93.88 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.807 0.813 . . . . 0.0 110.325 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.5 t -97.08 123.29 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.001 -179.175 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.516 HG21 ' CG2' ' A' ' 261' ' ' VAL . 20.2 t -95.65 122.46 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.648 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 75.3 mt -105.58 141.95 36.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.032 -179.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.34 127.3 6.39 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -110.25 122.77 48.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.302 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.577 HG22 ' N ' ' A' ' 241' ' ' ASP . 51.0 m -117.3 164.75 14.35 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.322 0.389 . . . . 0.0 110.238 -179.265 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.577 ' N ' HG22 ' A' ' 240' ' ' THR . 42.3 p-10 -80.95 -175.87 5.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.605 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -116.88 122.89 45.64 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 -179.826 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.8 mm -118.11 17.22 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.725 0.774 . . . . 0.0 110.808 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.28 -49.04 2.4 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.501 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.485 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 5.6 t -76.14 88.72 3.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.918 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -40.4 -43.55 1.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.729 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.4 -38.69 91.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.352 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.555 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 67.1 t80 -59.23 -50.28 74.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.936 -179.057 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 245' ' ' SER . 2.7 p-10 -64.13 -40.74 96.83 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.185 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -61.38 -45.71 93.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.59 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.18 -35.71 92.45 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.555 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 29.6 mt -70.41 -40.37 73.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.006 0.431 . . . . 0.0 111.106 178.704 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.0 t -62.84 -39.24 93.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.515 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -68.69 -45.08 72.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.247 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.18 -44.9 88.23 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.067 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.34 -61.41 2.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.678 178.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.88 -34.04 18.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.105 0.479 . . . . 0.0 110.026 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -72.25 -44.82 62.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.449 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.4 t -58.48 -39.53 80.22 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.301 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.91 -53.44 41.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.392 178.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.605 HG13 HD12 ' A' ' 274' ' ' ILE . 4.7 t -60.96 -50.19 81.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.436 179.659 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -46.28 -41.38 13.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.206 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.51 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 60.8 t80 -80.77 -32.78 35.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.809 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.17 -32.81 74.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.21 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.538 ' C ' ' H ' ' A' ' 267' ' ' LYS . 83.8 mt -63.85 -48.27 87.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.322 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 28.2 m -51.45 -6.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.755 -179.276 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 265' ' ' ILE . 33.1 mmtp -87.19 9.15 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.505 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 84.4 40.83 8.2 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.16 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.74 126.35 25.75 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.9 130.28 36.92 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.98 1.787 . . . . 0.0 112.094 177.271 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.17 -9.45 31.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 65.6 t0 -90.88 -23.42 20.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.529 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -79.24 -21.14 46.62 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.608 0.718 . . . . 0.0 110.526 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.605 HD12 HG13 ' A' ' 261' ' ' VAL . 1.5 pt -105.35 -171.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.332 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 11.9 t -169.55 130.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.176 178.582 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -104.45 110.17 22.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.873 0.368 . . . . 0.0 110.535 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -115.47 140.96 48.67 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.574 0.702 . . . . 0.0 111.097 -179.646 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.578 ' O ' ' NH1' ' A' ' 277' ' ' ARG . . . -90.18 93.35 1.86 Allowed Glycine 0 CA--C 1.519 0.329 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.49 ' N ' ' O ' ' A' ' 238' ' ' GLY . 3.6 tpt -71.62 0.69 8.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.085 -178.793 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 31.87 -100.07 0.01 OUTLIER Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -144.1 70.18 1.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.714 0.292 . . . . 0.0 110.891 179.122 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.6 p -64.35 -44.24 92.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.192 0.52 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -125.4 80.47 65.43 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.961 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.18 105.76 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.686 2.257 . . . . 0.0 112.669 -179.35 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 285' ' ' VAL . 10.4 m -71.02 -32.83 49.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.193 0.52 . . . . 0.0 110.687 179.307 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.596 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.2 OUTLIER -57.23 -44.55 83.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.357 -179.218 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.84 -5.82 0.02 OUTLIER Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 286' ' ' THR . 74.6 m-20 -125.46 -58.51 1.42 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.579 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.9 m -58.89 -24.64 62.52 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.553 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 84.8 m -116.11 29.6 7.87 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.451 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.93 -4.28 19.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.612 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -109.87 31.48 5.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.661 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.52 121.3 45.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.969 0.414 . . . . 0.0 110.41 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -120.79 7.34 10.46 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.8 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.497 ' O ' HD12 ' A' ' 299' ' ' LEU . 7.6 mt-30 -89.14 172.67 8.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.98 0.419 . . . . 0.0 110.014 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -84.99 -70.47 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.584 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.84 -31.62 68.67 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.89 -178.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.89 -39.93 87.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 295' ' ' GLN . 50.5 mt -69.78 -48.89 57.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.015 0.436 . . . . 0.0 110.644 179.751 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 60.8 mt -49.15 -36.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.899 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.6 -40.27 29.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.117 0.484 . . . . 0.0 110.646 178.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.426 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 1.1 t -74.36 -10.64 59.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.988 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 299' ' ' LEU . 61.4 mt -91.89 22.59 4.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.643 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.622 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -83.21 -41.56 0.83 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.995 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 31.9 Cg_exo -55.8 10.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 123.293 2.662 . . . . 0.0 112.403 -179.07 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.602 ' H ' ' C ' ' A' ' 304' ' ' ALA . 27.5 m-20 -109.55 21.72 16.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.639 0.257 . . . . 0.0 110.849 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 307' ' ' ARG . 15.7 ptp180 -114.04 84.99 2.13 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.14 0.972 . . . . 0.0 110.259 178.839 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.4 ptm180 -156.49 128.06 7.16 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.062 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.77 139.14 19.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.466 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -119.69 104.51 10.32 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.303 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.506 HD12 HD21 ' A' ' 220' ' ' LEU . 0.7 OUTLIER -79.36 116.71 23.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.312 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -96.14 122.14 38.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.819 0.342 . . . . 0.0 111.033 -178.716 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 224' ' ' LEU . 84.0 t -129.5 122.46 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.869 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -118.57 144.86 45.8 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.308 178.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 92.26 22.42 29.72 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -178.208 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.661 ' O ' ' O ' ' A' ' 317' ' ' LYS . 10.8 tt -99.16 170.86 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.661 ' O ' ' O ' ' A' ' 316' ' ' ILE . 29.5 tttp -44.5 -153.73 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.943 0.777 . . . . 0.0 110.958 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 318' ' ' ASP . . . . . 0.512 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 32.3 t70 -68.79 160.01 31.3 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.543 -0.723 . . . . 0.0 110.891 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 4.0 p -127.3 129.8 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.177 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 11.4 p -153.32 135.55 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.395 179.546 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.6 p -143.56 154.39 43.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.644 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.53 150.56 6.58 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.537 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.57 151.81 79.11 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.573 2.182 . . . . 0.0 112.055 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 49.05 93.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.518 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.524 -179.954 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 180' ' ' ALA . 73.4 Cg_endo -79.25 166.31 22.71 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.55 2.166 . . . . 0.0 112.047 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.569 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -176.27 -45.35 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.963 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 35.7 Cg_exo -59.5 72.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.657 2.238 . . . . 0.0 111.978 -179.264 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 182' ' ' ALA . . . 62.23 146.76 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.472 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -40.33 117.27 0.44 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.333 2.022 . . . . 0.0 112.323 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.589 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . -81.7 -48.32 0.99 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.963 178.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 73.7 Cg_endo -79.55 158.48 25.38 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.589 2.193 . . . . 0.0 112.38 -179.196 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -160.07 2.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.18 0.514 . . . . 0.0 110.292 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 79.8 t -135.4 134.47 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.332 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.475 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.4 OUTLIER -120.1 135.41 54.96 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.238 179.68 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.645 HG22 ' N ' ' A' ' 192' ' ' LYS . 44.6 m -76.45 170.49 16.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.43 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.645 ' N ' HG22 ' A' ' 191' ' ' THR . 13.0 tptp -141.88 160.64 39.78 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 109.978 178.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -152.02 124.27 8.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.108 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.596 ' CE2' HD21 ' A' ' 224' ' ' LEU . 52.1 m-85 -114.37 119.11 35.81 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.438 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 195' ' ' THR . 5.5 t -86.49 105.23 16.65 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.555 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.694 HD23 HD11 ' A' ' 201' ' ' LEU . 27.0 tp -106.74 123.4 48.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.031 0.443 . . . . 0.0 109.933 -179.223 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -74.53 129.34 37.56 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 122.587 1.184 . . . . 0.0 112.277 -178.346 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 202' ' ' PHE . 41.6 t -62.97 -40.31 97.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.173 178.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -45.75 -34.88 3.91 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.719 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.75 -56.82 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.476 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.694 HD11 HD23 ' A' ' 196' ' ' LEU . 82.2 mt -66.87 -77.8 0.07 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.815 -179.32 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -106.03 135.7 47.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.858 -178.188 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -98.3 -78.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -117.74 -19.04 9.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.963 179.237 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -65.99 171.75 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.127 0.489 . . . . 0.0 110.199 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -53.79 -81.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.844 -179.231 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -157.9 58.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.51 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.0 p -106.95 131.18 54.32 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 110.056 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.414 HD22 HD22 ' A' ' 201' ' ' LEU . 62.4 mt -71.92 145.11 48.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.256 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.9 mtpm? -107.91 158.03 34.54 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.304 179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 213' ' ' GLY . 74.8 Cg_exo -34.91 -77.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.3 2.0 . . . . 0.0 112.01 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -48.41 -19.19 0.29 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 -179.509 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.88 -50.23 19.6 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 178.794 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -65.13 -38.39 90.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.145 0.498 . . . . 0.0 109.77 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.91 -53.87 53.3 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.011 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.91 -33.82 76.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.615 0.721 . . . . 0.0 110.383 -179.564 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.67 -25.9 65.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.603 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 218' ' ' ASP . . . . . 0.537 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 72.2 m-20 -72.79 -47.11 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.569 0.7 . . . . 0.0 109.9 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.35 -40.29 96.86 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.99 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.8 tp -60.37 -40.98 92.76 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.458 ' CG ' ' HB3' ' A' ' 267' ' ' LYS . 69.4 t80 -55.34 -58.95 5.62 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.922 178.259 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 58.8 m -57.14 -7.49 0.53 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.289 0.566 . . . . 0.0 110.216 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.489 ' OE1' ' CE1' ' A' ' 194' ' ' PHE . 17.1 tt0 -95.06 -35.54 11.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.384 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.828 HD22 HG21 ' A' ' 313' ' ' VAL . 80.4 mt -96.51 -11.38 25.56 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.658 -179.291 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 75.8 p -85.89 -7.31 58.78 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.542 0.526 . . . . 0.0 110.579 -179.327 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 223' ' ' GLN . 51.2 p30 -101.35 19.23 18.15 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.311 0.577 . . . . 0.0 110.529 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.7 OUTLIER -78.31 -177.3 5.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.136 -179.973 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -100.69 108.47 53.78 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 230' ' ' LYS . 72.5 Cg_exo -45.62 -21.39 0.84 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.673 2.249 . . . . 0.0 112.897 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 229' ' ' PRO . 88.0 tttt -34.47 -52.07 0.48 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 110.546 -178.15 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 232' ' ' GLY . 25.6 m-20 -98.54 -20.01 17.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.762 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 28.32 52.4 0.11 Allowed Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 59.7 m -118.93 115.17 23.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.557 0.217 . . . . 0.0 111.107 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 72.8 t -133.48 92.26 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.794 0.807 . . . . 0.0 110.195 178.43 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.11 127.62 51.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.279 0.561 . . . . 0.0 110.61 -178.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.411 HG13 HD13 ' A' ' 311' ' ' ILE . 91.3 t -100.63 126.42 54.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.399 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.8 mt -111.94 131.64 55.26 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.469 -178.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -86.08 138.37 15.96 Favored Glycine 0 N--CA 1.467 0.766 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.553 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.555 ' O ' ' NH2' ' A' ' 256' ' ' ARG . 11.4 m-85 -131.04 115.89 17.05 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 117.799 0.799 . . . . 0.0 109.431 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.425 ' HA ' HH12 ' A' ' 256' ' ' ARG . 14.8 t -126.71 172.8 10.01 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.465 -179.154 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.565 ' HB2' HD12 ' A' ' 303' ' ' LEU . 54.8 p-10 -86.19 -175.23 5.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.432 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -102.3 124.48 47.95 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.245 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.7 mm -117.64 14.42 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.456 0.646 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 71.8 5.06 60.18 Favored Glycine 0 C--N 1.317 -0.493 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 5.3 t -124.68 105.29 9.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.862 0.363 . . . . 0.0 110.199 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -57.11 -55.22 37.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.195 -179.075 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.77 -46.02 78.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.772 ' CE2' HD11 ' A' ' 252' ' ' LEU . 38.3 t80 -63.38 -42.0 98.8 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.886 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.79 -44.87 96.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.642 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -65.28 -39.64 92.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.19 -42.49 99.8 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.772 HD11 ' CE2' ' A' ' 248' ' ' TYR . 80.2 mt -66.92 -41.81 86.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.006 179.437 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.5 t -66.2 -48.36 70.88 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.118 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.25 -52.21 66.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.589 -179.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -55.5 -47.31 76.38 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.273 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.685 HH22 ' N ' ' A' ' 308' ' ' ARG . 66.3 mtp180 -58.29 -59.31 5.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.162 179.158 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -50.59 -32.62 19.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.121 0.486 . . . . 0.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -73.12 -49.7 26.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.986 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 44.6 t -53.42 -41.29 65.88 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.153 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.65 -54.88 23.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.603 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.51 HG13 HD12 ' A' ' 274' ' ' ILE . 10.4 t -57.64 -50.42 77.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.212 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -46.33 -42.84 15.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.914 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -81.55 -31.14 32.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.592 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -71.05 -7.96 50.09 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.274 -179.195 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.2 mt -86.51 -55.69 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 120.84 0.352 . . . . 0.0 111.408 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.7 t -49.78 -6.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.909 -178.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.573 ' H ' ' C ' ' A' ' 265' ' ' ILE . 22.9 mmmt -76.98 -11.38 59.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.08 39.71 1.93 Allowed Glycine 0 CA--C 1.509 -0.291 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.86 133.02 24.66 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.241 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.64 128.88 32.13 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.833 1.689 . . . . 0.0 112.174 176.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.73 -9.31 42.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.986 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.23 -21.32 21.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.774 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -82.54 -20.12 37.27 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.426 0.631 . . . . 0.0 110.893 -179.503 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.51 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -103.76 -172.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.118 -178.78 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 27.9 t -168.81 143.09 3.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.297 178.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -115.72 113.78 23.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.806 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -127.22 150.93 49.31 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.929 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -105.37 100.58 1.74 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 3.4 tpp -70.03 -13.04 62.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.066 0.46 . . . . 0.0 110.155 -179.479 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 63.46 -103.23 0.64 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -141.89 74.12 1.44 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.84 0.353 . . . . 0.0 110.587 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 84.8 p -95.58 2.23 54.13 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.7 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -158.6 70.52 3.73 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.553 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.94 105.6 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.406 2.071 . . . . 0.0 112.291 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 14.7 m -69.58 -31.94 50.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.46 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 288' ' ' ASN . 41.7 p -57.35 -43.96 83.9 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.736 -179.243 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -45.62 -7.93 0.01 OUTLIER Glycine 0 CA--C 1.534 1.222 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.298 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.9 t30 -126.84 -56.57 1.36 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.918 0.389 . . . . 0.0 110.137 178.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.3 m -55.23 -40.4 70.83 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.281 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 72.1 m -98.6 36.44 1.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.421 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -74.56 -2.48 26.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.498 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -107.06 31.67 5.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.497 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.1 t -132.05 123.76 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.526 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -119.39 4.43 11.21 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.208 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -99.64 136.21 39.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.157 0.503 . . . . 0.0 110.095 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -51.43 -76.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.774 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -46.0 -39.17 8.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 -178.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.29 88.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.959 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.69 -43.54 79.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.566 179.153 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.4 mm -58.08 -37.21 60.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.783 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -74.01 -35.65 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.082 179.126 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.1 t -81.77 -3.2 53.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.416 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' ' 241' ' ' ASP . 0.5 OUTLIER -94.18 22.33 6.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.235 -179.485 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.61 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -82.65 -41.82 0.91 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.602 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.8 Cg_exo -60.03 10.09 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.294 2.662 . . . . 0.0 112.099 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 304' ' ' ALA . 57.9 t0 -115.12 18.89 16.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.958 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -109.01 107.18 17.44 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.377 0.608 . . . . 0.0 110.345 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.685 ' N ' HH22 ' A' ' 256' ' ' ARG . 18.0 ptp180 -171.86 -173.74 1.21 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.984 -179.186 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.35 153.65 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.496 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 95.7 mt-10 -124.64 102.53 7.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.317 0.579 . . . . 0.0 110.801 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.411 HD13 HG13 ' A' ' 236' ' ' VAL . 3.4 mm -81.58 120.34 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.14 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -104.92 119.87 40.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.798 0.332 . . . . 0.0 110.426 -178.855 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.828 HG21 HD22 ' A' ' 224' ' ' LEU . 86.6 t -130.43 124.76 58.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.59 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -118.83 148.19 43.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.56 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.88 4.4 57.83 Favored Glycine 0 N--CA 1.462 0.43 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 16.0 tt -91.55 141.79 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.206 0.527 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -75.93 120.37 21.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.794 -179.396 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -159.73 169.95 22.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.772 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.77 133.86 30.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.277 179.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.17 136.18 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.174 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.5 t -146.76 170.19 17.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.699 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 322' ' ' GLN . . . . . 0.518 ' OE1' ' N ' ' A' ' 322' ' ' GLN . 1.5 mp0 -81.63 118.29 71.62 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.673 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -49.15 -38.27 40.44 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.181 1.921 . . . . 0.0 112.403 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 47.17 72.68 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 110.389 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.33 -179.908 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.624 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 26.1 Cg_exo -61.55 147.19 96.02 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.833 2.355 . . . . 0.0 111.948 -179.429 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -157.89 153.3 22.14 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.361 179.479 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.08 -21.76 48.56 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.713 2.275 . . . . 0.0 111.759 179.529 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.481 ' HB1' ' HD2' ' A' ' 185' ' ' PRO . . . -58.81 159.96 11.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.473 -179.296 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.481 ' HD2' ' HB1' ' A' ' 184' ' ' ALA . 57.0 Cg_endo -70.66 154.4 64.21 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.786 2.324 . . . . 0.0 112.058 179.125 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.9 151.06 16.69 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.326 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.11 -56.01 0.42 Allowed 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.8 2.334 . . . . 0.0 112.227 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 46.79 -130.94 1.33 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.366 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 11.9 t -79.21 106.51 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.232 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 316' ' ' ILE . 14.0 mm100 -106.34 105.42 15.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.446 -179.553 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.44 HG22 ' NE2' ' A' ' 193' ' ' HIS . 24.3 m -78.11 127.12 31.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.2 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -146.71 116.45 7.19 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.467 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.5 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 2.2 m-70 -101.18 147.72 25.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -109.77 128.53 55.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.911 0.386 . . . . 0.0 110.302 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.94 103.24 15.13 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.98 -179.765 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.729 ' CD2' HD11 ' A' ' 201' ' ' LEU . 24.8 tp -107.96 129.04 55.14 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 109.955 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.473 ' HB3' HG23 ' A' ' 200' ' ' VAL . 71.8 tttt -80.9 126.57 31.52 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 121.905 0.86 . . . . 0.0 112.033 -178.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.5 t -65.27 -28.08 69.09 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.066 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -62.92 -37.94 88.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.034 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 197' ' ' LYS . 88.6 t -65.96 -44.36 92.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.56 179.295 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.729 HD11 ' CD2' ' A' ' 196' ' ' LEU . 76.6 mt -75.75 -78.75 0.11 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.289 179.472 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.28 118.67 30.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.031 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -94.62 -78.3 0.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.702 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -88.47 -26.94 21.81 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.765 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.407 ' OD1' HG23 ' A' ' 208' ' ' THR . 24.0 t-20 -69.79 158.43 35.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.153 0.501 . . . . 0.0 110.381 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -51.42 -71.47 0.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.221 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -159.77 56.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.428 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.407 HG23 ' OD1' ' A' ' 205' ' ' ASN . 38.5 p -108.08 133.04 52.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.821 0.343 . . . . 0.0 110.172 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.06 138.61 39.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 -179.133 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.8 mtpm? -101.49 157.47 33.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.302 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 210' ' ' LYS . 76.0 Cg_exo -33.22 -75.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.598 2.199 . . . . 0.0 111.969 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -49.61 -23.4 1.67 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.18 0.514 . . . . 0.0 110.328 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.94 -48.73 19.6 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.811 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -66.61 -38.74 87.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.14 0.495 . . . . 0.0 110.012 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.84 -53.06 62.46 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.444 -179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.75 88.53 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.635 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.0 mt -62.53 -27.6 69.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.487 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 218' ' ' ASP . . . . . 0.458 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 51.3 m-20 -73.81 -46.45 45.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.219 0.533 . . . . 0.0 110.535 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.62 -42.89 99.85 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.174 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.459 HD21 HD12 ' A' ' 311' ' ' ILE . 42.9 tp -66.37 -38.96 88.74 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.728 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.436 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.2 t80 -53.78 -50.72 65.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.123 179.379 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 225' ' ' SER . 75.9 p -60.15 -49.75 76.41 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.378 -178.917 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.579 ' OE1' HD11 ' A' ' 316' ' ' ILE . 1.1 tm0? -49.57 -25.89 3.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.184 -179.737 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.743 ' O ' HD22 ' A' ' 227' ' ' LEU . 64.7 mt -97.19 -13.45 22.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.364 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' SER . 36.9 t -72.86 -21.57 60.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.698 179.511 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -99.91 16.79 22.68 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.743 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.74 150.69 36.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.138 179.862 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 315' ' ' GLY . 6.7 t0 -67.12 124.13 88.1 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.468 178.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 230' ' ' LYS . 44.5 Cg_endo -69.15 -19.67 38.75 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.79 2.327 . . . . 0.0 112.846 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 229' ' ' PRO . 63.4 tttp -30.09 -52.42 0.15 Allowed 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.682 0.614 . . . . 0.0 110.457 -178.386 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 232' ' ' GLY . 20.6 m-20 -103.28 -18.25 14.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.485 178.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.478 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.75 47.33 0.03 OUTLIER Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 231' ' ' ASP . 0.4 OUTLIER -112.59 111.25 21.93 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.146 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.56 94.42 2.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.311 0.577 . . . . 0.0 109.895 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.2 t -96.47 122.65 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.237 -178.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.441 HG22 HG23 ' A' ' 311' ' ' ILE . 12.1 t -95.68 119.7 44.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.642 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 47.4 mt -103.76 147.38 27.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.049 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.85 133.13 8.15 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.636 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.4 OUTLIER -116.54 119.84 36.84 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.504 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.441 ' O ' ' OD1' ' A' ' 306' ' ' ASP . 3.3 p -106.92 168.15 9.39 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 120.772 0.32 . . . . 0.0 110.344 -179.445 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -81.85 179.93 7.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.525 -179.666 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -99.6 119.44 38.08 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.862 0.363 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.4 mm -121.4 6.18 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.404 0.621 . . . . 0.0 111.058 179.358 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.41 -47.65 3.66 Favored Glycine 0 C--N 1.314 -0.666 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.2 p -73.7 90.08 1.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 109.887 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 91.7 m-20 -43.0 -46.55 5.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.676 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.6 83.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.555 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 49.2 t80 -61.08 -49.31 77.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 246' ' ' ASP . 0.2 OUTLIER -63.22 -42.75 99.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.584 -179.741 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -63.71 -46.13 86.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.723 -179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.39 -35.03 90.39 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.555 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 29.9 mt -73.5 -37.53 65.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.887 0.375 . . . . 0.0 111.129 178.795 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.8 m -64.12 -40.95 97.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.747 -179.258 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 258' ' ' GLN . 96.9 mt-10 -71.7 -41.39 68.66 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.189 179.595 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -59.52 -48.3 82.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.524 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 260' ' ' VAL . 89.4 mtt-85 -63.26 -60.38 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.961 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -52.1 -36.62 51.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 254' ' ' GLU . 0.5 OUTLIER -70.84 -42.72 69.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.218 179.665 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.3 t -63.02 -36.77 84.67 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.357 0.599 . . . . 0.0 110.272 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 256' ' ' ARG . 87.2 t -64.27 -50.19 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.552 179.335 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.541 HG13 HD12 ' A' ' 274' ' ' ILE . 10.6 t -60.88 -49.43 84.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.29 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -45.7 -39.81 8.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.9 -179.457 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -83.2 -32.31 26.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.1 -11.11 60.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.488 -179.287 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' A' ' 267' ' ' LYS . 64.6 mt -86.11 -53.14 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-O 120.723 0.297 . . . . 0.0 110.925 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.4 m -50.34 -6.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.186 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 265' ' ' ILE . 22.9 mmmt -80.58 -12.06 59.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.862 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.75 40.41 1.87 Allowed Glycine 0 CA--C 1.51 -0.221 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.25 129.16 24.27 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.854 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.86 128.17 27.62 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.958 1.772 . . . . 0.0 112.04 176.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.02 -8.97 18.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.799 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.32 -23.23 21.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.772 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -80.31 -20.08 45.12 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.38 0.609 . . . . 0.0 110.487 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.541 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -105.62 -173.36 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.795 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 27.3 t -172.4 129.76 0.57 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 179.603 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.39 153.72 17.66 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.019 -0.425 . . . . 0.0 109.859 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -162.31 151.56 15.62 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 178.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -127.56 97.65 0.47 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.437 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.636 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 10.5 ptm -85.99 26.8 0.96 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.847 0.356 . . . . 0.0 110.984 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.3 -107.37 0.1 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.82 73.44 1.4 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.683 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.1 t -76.28 -33.72 59.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.108 0.48 . . . . 0.0 111.216 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -124.39 66.37 44.06 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 -179.073 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.14 117.71 5.12 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.626 2.218 . . . . 0.0 111.506 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 286' ' ' THR . 15.0 m -70.8 -38.5 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.701 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 288' ' ' ASN . 2.8 p -61.43 -47.15 87.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.559 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.07 -3.4 0.05 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 286' ' ' THR . 89.3 m-20 -114.29 -60.97 1.81 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.018 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.8 t -77.69 -3.07 39.23 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.558 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.558 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -126.97 18.51 7.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.607 -179.911 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 36.7 p-10 -68.55 -2.98 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.503 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.418 ' O ' ' OD1' ' A' ' 292' ' ' ASN . 19.7 p30 -101.06 32.6 3.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.514 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.558 HG21 ' SG ' ' A' ' 290' ' ' CYS . 17.2 t -130.77 124.33 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.764 0.316 . . . . 0.0 110.437 179.638 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -120.21 9.62 11.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.879 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.39 131.24 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.134 0.492 . . . . 0.0 110.064 -179.498 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -50.55 -68.61 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.076 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.97 -38.7 57.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.53 -36.55 82.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.445 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 303' ' ' LEU . 28.0 mt -72.54 -55.01 7.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.474 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 68.5 mt -50.96 -35.4 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.005 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.11 -31.98 58.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.593 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.49 -5.06 56.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.4 mm? -94.23 19.66 9.1 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.289 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -80.43 -45.78 1.34 Allowed Pre-proline 0 CA--C 1.536 0.424 0 CA-C-O 121.051 0.453 . . . . 0.0 110.184 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 25.7 Cg_exo -60.97 9.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.134 2.556 . . . . 0.0 111.969 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 304' ' ' ALA . 8.1 t70 -106.0 14.12 28.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.874 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 307' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 307' ' ' ARG . 15.6 ptt180 -110.28 99.01 8.12 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.921 0.867 . . . . 0.0 110.346 179.214 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.537 ' NH1' ' OE2' ' A' ' 310' ' ' GLU . 43.7 ptt85 -166.03 139.09 4.13 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.398 -179.219 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.02 145.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.537 ' OE2' ' NH1' ' A' ' 308' ' ' ARG . 78.6 mt-10 -118.71 104.03 10.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.31 0.576 . . . . 0.0 110.865 178.667 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.459 HD12 HD21 ' A' ' 220' ' ' LEU . 0.4 OUTLIER -80.12 113.4 19.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.11 -178.953 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -92.11 123.27 35.34 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 123.525 0.516 . . . . 0.0 110.738 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.71 HG21 HD22 ' A' ' 224' ' ' LEU . 40.1 t -121.14 115.32 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 O-C-N 123.528 0.518 . . . . 0.0 110.875 -179.576 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -114.7 126.58 55.02 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.849 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.52 39.61 3.39 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.719 ' O ' ' O ' ' A' ' 317' ' ' LYS . 6.3 tt -110.97 164.74 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.719 ' O ' ' O ' ' A' ' 316' ' ' ILE . 20.5 pttp -42.45 -149.01 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.501 0 O-C-N 124.273 0.983 . . . . 0.0 111.319 -178.935 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -84.83 175.84 8.88 Favored 'General case' 0 C--N 1.318 -0.773 0 O-C-N 121.372 -0.83 . . . . 0.0 111.103 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.0 p -140.92 138.47 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.546 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 62.1 t -71.35 129.1 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.018 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 74.8 p -113.91 134.48 54.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.997 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -140.99 113.51 6.94 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.118 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -48.06 -38.35 31.88 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.307 2.004 . . . . 0.0 112.267 179.5 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -75.95 139.32 41.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.34 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.587 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.507 -179.972 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.435 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.435 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 69.0 Cg_exo -46.96 131.31 16.81 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.271 1.981 . . . . 0.0 111.711 178.823 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.618 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -102.81 -42.35 0.2 Allowed Pre-proline 0 N--CA 1.466 0.351 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.248 179.65 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 36.9 Cg_exo -59.45 143.29 99.74 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.565 2.177 . . . . 0.0 111.847 -178.889 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -95.76 120.68 62.88 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.224 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.53 137.08 26.18 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.967 1.778 . . . . 0.0 112.395 179.492 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.588 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . -69.41 -47.86 26.15 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.094 178.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 71.0 Cg_endo -78.29 150.54 25.71 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.665 2.243 . . . . 0.0 112.115 -178.861 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -171.02 -147.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.433 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 10.6 t -88.77 100.84 11.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.202 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.524 HE21 HG12 ' A' ' 319' ' ' VAL . 20.8 mm100 -106.3 107.7 18.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.338 -179.446 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.52 HG22 ' NE2' ' A' ' 193' ' ' HIS . 24.3 m -79.06 125.6 29.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.829 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -144.45 112.73 6.47 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.71 0.291 . . . . 0.0 110.555 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 193' ' ' HIS . . . . . 0.52 ' NE2' HG22 ' A' ' 191' ' ' THR . 5.0 m-70 -99.4 144.41 28.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -106.89 129.79 54.66 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.87 0.367 . . . . 0.0 110.204 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.14 105.38 17.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.931 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.721 ' CD2' HD11 ' A' ' 201' ' ' LEU . 34.3 tp -110.16 129.63 55.68 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.426 ' HB3' HG23 ' A' ' 200' ' ' VAL . 16.2 tptm -80.74 127.92 33.05 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 122.036 0.922 . . . . 0.0 112.437 -178.265 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 202' ' ' PHE . 68.6 p -63.31 -31.79 73.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.091 179.489 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.456 ' OD1' ' ND2' ' A' ' 203' ' ' ASN . 22.0 t70 -59.75 -37.46 79.06 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.181 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 197' ' ' LYS . 79.2 t -66.23 -44.41 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.721 HD11 ' CD2' ' A' ' 196' ' ' LEU . 84.3 mt -77.6 -77.53 0.15 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.461 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -118.51 125.42 49.83 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.637 -179.754 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.456 ' ND2' ' OD1' ' A' ' 199' ' ' ASP . 7.2 m120 -94.37 -80.25 0.4 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.767 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -103.31 -17.71 15.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.695 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -70.54 169.66 13.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.998 0.427 . . . . 0.0 110.086 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -53.15 -78.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.267 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.36 59.11 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.552 179.409 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.7 p -108.79 135.3 50.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.048 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.1 135.57 39.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.874 -178.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 213' ' ' GLY . 4.4 mtmp? -96.57 159.97 30.56 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.815 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -34.05 -76.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.417 2.078 . . . . 0.0 111.78 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 31.6 mp0 -50.02 -20.18 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.242 0.544 . . . . 0.0 110.214 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.59 -47.87 14.65 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.368 178.669 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -67.86 -40.04 83.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.255 0.55 . . . . 0.0 110.066 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.54 65.24 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.696 -179.83 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.03 -35.68 81.05 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.62 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.0 -32.99 73.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.548 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 218' ' ' ASP . . . . . 0.535 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 4.4 m-20 -70.97 -44.83 65.19 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.501 0.667 . . . . 0.0 110.405 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.443 ' O ' ' OG ' ' A' ' 222' ' ' SER . 12.6 mt-30 -61.19 -44.0 97.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.085 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 41.4 tp -64.43 -40.37 95.63 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.379 178.693 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.423 ' CG ' ' HB3' ' A' ' 267' ' ' LYS . 4.9 t80 -51.79 -48.83 63.65 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.31 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 219' ' ' GLN . 59.5 p -55.04 -51.67 65.59 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.58 -178.239 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -51.99 -26.76 11.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.423 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.799 HD22 HG21 ' A' ' 313' ' ' VAL . 15.6 mt -97.11 -20.31 18.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.717 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.7 p -74.5 -22.59 58.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.759 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -102.72 19.72 18.66 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.893 -179.538 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -75.9 143.15 41.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.929 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 315' ' ' GLY . 47.2 t0 -52.4 108.19 1.02 Allowed Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 123.37 0.419 . . . . 0.0 110.434 178.056 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.3 Cg_exo -51.8 -24.5 18.53 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.737 2.291 . . . . 0.0 113.043 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 229' ' ' PRO . 7.5 ttpm? -30.25 -53.16 0.16 Allowed 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 123.568 0.543 . . . . 0.0 110.951 -177.828 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 232' ' ' GLY . 38.9 m-20 -102.43 -17.65 15.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.751 179.009 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.17 46.35 0.02 OUTLIER Glycine 0 N--CA 1.475 1.259 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 231' ' ' ASP . 38.1 m -112.72 110.39 20.48 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.672 0.272 . . . . 0.0 110.928 -178.455 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 76.6 t -127.56 94.09 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.481 0.658 . . . . 0.0 109.959 178.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.0 t -96.4 123.07 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.107 -178.117 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.561 HG13 HD13 ' A' ' 311' ' ' ILE . 87.4 t -92.54 120.21 41.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.442 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 57.1 mt -104.35 144.35 31.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.961 -179.485 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.417 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -125.16 130.27 7.28 Favored Glycine 0 N--CA 1.482 1.723 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.871 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.4 OUTLIER -114.91 125.43 53.63 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.83 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 253' ' ' SER . 43.0 p -120.92 166.93 13.12 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 109.933 -179.374 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -80.84 -175.12 5.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.417 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -113.72 122.88 48.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.198 0.523 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.736 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.6 mm -120.06 14.73 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.719 0.771 . . . . 0.0 110.633 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.29 -47.46 3.31 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 20.7 m -73.19 89.66 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.114 0.483 . . . . 0.0 110.006 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.547 ' O ' ' NE2' ' A' ' 250' ' ' GLN . 98.9 m-20 -44.36 -46.17 9.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.365 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.81 86.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.629 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.599 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 51.2 t80 -60.33 -44.59 95.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.54 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -62.46 -43.47 98.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.562 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 246' ' ' ASP . 0.9 OUTLIER -65.69 -41.95 91.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.513 -179.991 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.86 95.91 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.599 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 39.1 mt -70.25 -39.41 75.01 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.065 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.448 ' N ' HG21 ' A' ' 240' ' ' THR . 3.7 t -63.21 -42.78 99.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 0.0 110.605 -178.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -69.33 -35.43 75.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.36 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.4 tpp85 -60.66 -54.3 47.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.672 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.874 ' O ' HG23 ' A' ' 260' ' ' VAL . 16.4 ptp180 -64.42 -44.6 90.68 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 120.95 0.405 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.462 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.7 -39.2 90.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.46 0.647 . . . . 0.0 110.303 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -74.99 -43.87 51.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.266 179.72 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 6.9 t -61.98 -38.43 88.57 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.29 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 256' ' ' ARG . 94.4 t -64.75 -50.98 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.622 178.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.616 HG13 HD12 ' A' ' 274' ' ' ILE . 14.4 t -61.29 -49.1 85.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.298 179.139 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -46.48 -40.8 13.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.079 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 263' ' ' TYR . . . . . 0.622 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 67.0 t80 -81.71 -33.9 30.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -65.08 -28.95 69.81 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.208 -179.521 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.544 ' C ' ' H ' ' A' ' 267' ' ' LYS . 81.6 mt -67.18 -52.22 45.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.273 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.4 p -49.65 -7.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 -179.108 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.622 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 66.3 mmtt -79.97 -5.63 56.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.711 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 97.09 42.3 3.3 Favored Glycine 0 CA--C 1.508 -0.373 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 130.83 23.89 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.321 179.075 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.35 128.34 28.83 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.781 1.654 . . . . 0.0 112.104 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -63.12 -11.0 16.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -88.68 -26.3 21.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.679 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -24.59 58.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.386 0.612 . . . . 0.0 110.457 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 274' ' ' ILE . . . . . 0.616 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -101.83 -176.79 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.857 -179.331 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 16.3 m -169.21 126.67 0.95 Allowed 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.653 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -94.93 151.11 19.48 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -155.89 142.17 18.41 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.377 0.608 . . . . 0.0 111.179 179.139 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -93.08 93.16 1.72 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.349 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 239' ' ' TYR . 5.0 tpt -70.49 -3.89 20.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.674 0.273 . . . . 0.0 110.65 -179.247 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.06 -116.32 0.85 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -135.87 70.47 1.42 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.604 -0.351 . . . . 0.0 110.526 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.7 m -77.58 -40.08 43.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.306 0.574 . . . . 0.0 111.477 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -124.58 62.37 32.7 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.659 -178.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.59 112.75 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.801 2.334 . . . . 0.0 111.364 179.409 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 286' ' ' THR . 32.1 m -71.37 -39.51 71.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.891 179.664 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 288' ' ' ASN . 51.4 p -63.61 -48.27 78.02 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.779 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.77 -2.01 0.05 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 288' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.1 t30 -113.55 -60.41 1.89 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.704 0.288 . . . . 0.0 110.308 179.005 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -80.43 -2.76 47.09 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.73 -179.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 290' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -126.88 17.53 7.33 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.889 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 291' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 32.8 p-10 -69.82 -3.28 14.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.977 0.418 . . . . 0.0 110.506 -179.594 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -99.75 32.06 3.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.429 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.456 HG21 ' SG ' ' A' ' 290' ' ' CYS . 5.2 t -133.87 127.36 52.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.954 0.407 . . . . 0.0 110.357 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -118.75 13.42 13.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.063 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 295' ' ' GLN . . . . . 0.631 HE22 ' CZ ' ' A' ' 296' ' ' ARG . 8.8 mm-40 -105.92 137.64 43.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.587 0.708 . . . . 0.0 110.248 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 296' ' ' ARG . . . . . 0.631 ' CZ ' HE22 ' A' ' 295' ' ' GLN . 0.0 OUTLIER -61.15 -54.59 42.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.468 179.954 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.62 85.83 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.016 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.18 -33.31 75.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.557 179.196 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 303' ' ' LEU . 33.4 mt -82.48 -61.67 1.83 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.496 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 296' ' ' ARG . 45.0 mt -42.83 -34.47 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.63 -44.26 19.15 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.124 0.488 . . . . 0.0 110.318 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 302' ' ' CYS . . . . . 0.459 ' O ' HG21 ' A' ' 286' ' ' THR . 44.2 t -74.88 -8.18 55.71 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.978 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 299' ' ' LEU . 73.9 mt -92.98 17.86 10.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.732 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -79.24 -45.56 1.68 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.336 179.711 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 305' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 34.5 Cg_exo -59.63 8.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.085 2.523 . . . . 0.0 111.821 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 304' ' ' ALA . 49.6 m-20 -103.87 12.04 34.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -114.45 94.63 4.88 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.606 0.717 . . . . 0.0 110.176 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 308' ' ' ARG . . . . . 0.417 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 39.4 ptt180 -154.38 131.46 11.0 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.694 0.759 . . . . 0.0 112.295 -179.018 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 309' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 196' ' ' LEU . 0.0 OUTLIER -95.49 134.49 32.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.046 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -116.74 104.63 11.54 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.305 0.574 . . . . 0.0 110.295 -179.263 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.561 HD13 HG13 ' A' ' 236' ' ' VAL . 3.5 mm -78.96 114.04 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.106 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -92.17 122.21 34.44 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 123.532 0.52 . . . . 0.0 110.488 -179.199 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.799 HG21 HD22 ' A' ' 224' ' ' LEU . 25.2 t -122.23 114.83 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.549 -179.309 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -113.9 127.07 55.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.421 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.0 39.88 3.44 Favored Glycine 0 N--CA 1.461 0.347 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.696 ' O ' ' O ' ' A' ' 317' ' ' LYS . 11.1 tt -117.09 172.67 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 317' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 316' ' ' ILE . 8.9 mtmp? -39.87 -162.8 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.121 0.962 . . . . 0.0 111.376 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -85.14 175.23 9.11 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 120.968 -1.083 . . . . 0.0 111.368 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 319' ' ' VAL . . . . . 0.524 HG12 HE21 ' A' ' 190' ' ' GLN . 7.2 p -142.19 156.23 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.152 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 320' ' ' VAL . 12.0 p -110.95 126.77 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.127 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 72.3 p -97.64 133.51 42.09 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.091 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -143.53 153.23 58.4 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.731 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -48.48 143.36 15.86 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.296 1.997 . . . . 0.0 112.24 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -75.2 121.8 22.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.437 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.576 179.839 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 15.6 mp0 . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.819 0.342 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.4 m -80.23 129.11 34.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.638 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -129.06 99.55 5.31 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.739 0.781 . . . . 0.0 111.741 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -83.71 127.7 33.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.054 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.645 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 55.4 m-85 -112.26 124.15 51.83 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.09 104.03 15.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.842 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.692 ' CD2' HD11 ' A' ' 201' ' ' LEU . 31.1 tp -105.7 123.59 48.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.04 130.47 35.55 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-O 122.1 0.952 . . . . 0.0 112.327 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.57 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 39.4 m -61.25 -31.44 71.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.2 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -57.96 -40.44 80.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.85 -43.55 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 196' ' ' LEU . 84.6 mt -79.77 -77.93 0.17 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.526 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER -137.38 131.63 32.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.413 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -107.43 -64.93 1.15 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.28 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.69 -20.51 16.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.545 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.35 159.71 33.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.988 0.423 . . . . 0.0 110.209 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -53.65 -66.74 0.34 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.571 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.07 -2.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.087 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.409 ' H ' ' H ' ' A' ' 207' ' ' ALA . 40.8 p -53.17 135.99 36.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.034 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 54.2 mt -82.02 137.73 35.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.854 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.8 mtpm? -97.79 157.75 34.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.811 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 213' ' ' GLY . 84.6 Cg_exo -34.1 -76.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.597 2.198 . . . . 0.0 112.486 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.72 -19.17 0.58 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.043 0.449 . . . . 0.0 110.3 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.1 -51.73 9.83 Favored Glycine 0 N--CA 1.459 0.229 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -65.39 -40.57 93.61 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.204 0.526 . . . . 0.0 109.846 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.99 -54.75 41.06 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.018 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.25 86.68 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.615 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.34 -30.09 70.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.217 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.13 -46.56 56.07 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.848 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -62.33 -44.15 97.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.237 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.78 -38.07 89.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.476 ' O ' ' OG ' ' A' ' 225' ' ' SER . 3.2 t80 -54.2 -50.84 66.16 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.066 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.8 t -55.78 -51.0 68.92 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.393 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.645 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 12.4 tt0 -52.64 -25.01 9.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.874 HD22 HG21 ' A' ' 313' ' ' VAL . 85.2 mt -99.0 -18.78 17.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.656 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 221' ' ' TYR . 1.3 m -77.42 -30.77 53.62 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.575 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -87.18 25.0 1.44 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 110.298 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.04 -179.14 6.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.811 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 1.6 t70 -100.93 133.47 21.04 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.75 -19.31 47.43 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.259 1.973 . . . . 0.0 112.744 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -37.15 -52.96 1.03 Allowed 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 110.511 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' GLY . 52.9 m-20 -98.3 -21.16 16.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 24.94 45.98 0.02 OUTLIER Glycine 0 C--N 1.343 0.96 0 O-C-N 123.744 0.653 . . . . 0.0 111.725 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 231' ' ' ASP . 5.2 m -119.44 114.29 22.09 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.032 0.444 . . . . 0.0 110.879 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.477 HG22 HG13 ' A' ' 313' ' ' VAL . 43.0 t -130.19 95.76 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.529 0.68 . . . . 0.0 109.977 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.4 HG11 HH12 ' A' ' 277' ' ' ARG . 10.6 t -97.76 122.77 49.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.345 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.459 HG21 HG22 ' A' ' 261' ' ' VAL . 83.0 t -95.63 125.41 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 41.7 mt -109.7 141.89 41.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.126 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -122.12 129.6 7.67 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.57 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -113.33 119.49 37.86 Favored 'General case' 0 C--N 1.349 0.574 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 31.1 p -109.97 168.96 9.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.84 0.352 . . . . 0.0 110.758 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.458 ' OD2' ' NH2' ' A' ' 307' ' ' ARG . 44.5 p-10 -90.69 -178.39 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -100.94 124.57 46.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.333 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.1 mm -117.7 12.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.414 0.626 . . . . 0.0 110.745 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.15 6.1 88.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -136.48 96.71 3.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.517 . . . . 0.0 109.729 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -52.22 -50.04 62.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.432 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.69 77.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.619 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.62 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 58.6 t80 -64.21 -43.84 93.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -61.19 -42.83 99.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.467 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.21 -40.11 95.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.377 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.35 -38.94 96.54 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.62 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 81.9 mt -73.56 -34.54 65.21 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.88 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 85.6 p -64.29 -40.25 95.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.129 0.49 . . . . 0.0 110.741 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.43 -39.84 62.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.314 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -61.25 -51.71 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.251 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.57 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 8.5 ptm180 -64.05 -46.06 86.03 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.306 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.479 ' N ' ' CG ' ' A' ' 256' ' ' ARG . . . -56.74 -36.49 69.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.399 0.619 . . . . 0.0 109.703 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.75 -44.29 61.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.805 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.9 m -59.1 -39.81 83.38 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.254 0.55 . . . . 0.0 110.134 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 256' ' ' ARG . 97.6 t -64.46 -51.73 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.922 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.559 HG13 HD12 ' A' ' 274' ' ' ILE . 21.3 t -62.4 -48.69 87.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.456 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -48.14 -41.46 26.78 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.95 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -78.74 -35.53 44.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.577 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -31.01 72.04 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.897 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.51 ' C ' ' H ' ' A' ' 267' ' ' LYS . 80.8 mt -65.49 -51.62 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 88.5 p -51.82 -8.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.789 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 265' ' ' ILE . 67.8 mmtt -79.49 -4.45 51.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.541 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.34 41.75 2.92 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.86 127.64 23.92 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 117.031 0.416 . . . . 0.0 110.208 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.31 128.36 25.22 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.609 1.539 . . . . 0.0 111.84 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.07 -8.71 17.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -93.58 -22.9 18.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.191 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -79.86 -17.11 54.03 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.72 0.772 . . . . 0.0 111.032 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.559 HD12 HG13 ' A' ' 261' ' ' VAL . 2.0 pt -107.93 -170.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.463 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 3.2 m -166.86 131.76 2.09 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.224 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -103.1 111.67 24.14 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.768 0.318 . . . . 0.0 110.546 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.4 HH12 HG11 ' A' ' 235' ' ' VAL . 30.8 ttm105 -119.79 141.24 49.67 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.71 0.767 . . . . 0.0 111.566 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -92.46 95.27 2.0 Allowed Glycine 0 CA--C 1.519 0.342 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 238' ' ' GLY . 2.7 tpt -68.11 -10.64 55.55 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.223 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 40.58 -98.73 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -141.59 75.37 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 0.0 110.81 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 70.8 m -83.63 -5.62 59.23 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.61 79.2 0.91 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.313 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.71 104.29 0.26 Allowed 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.568 2.179 . . . . 0.0 112.959 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 289' ' ' THR . 27.2 m -75.31 -32.79 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.337 0.589 . . . . 0.0 110.344 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.628 ' C ' ' H ' ' A' ' 288' ' ' ASN . 44.4 p -56.94 -42.59 80.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.793 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.6 -0.3 0.02 OUTLIER Glycine 0 CA--C 1.532 1.124 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.628 ' H ' ' C ' ' A' ' 286' ' ' THR . 17.2 t-20 -122.74 -58.87 1.65 Allowed 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.5 OUTLIER -66.9 -17.59 64.97 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.542 -178.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 302' ' ' CYS . 72.1 m -116.78 25.6 10.43 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.384 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 293' ' ' VAL . 34.5 t70 -57.88 -49.92 75.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.0 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -76.19 32.41 0.12 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.316 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' A' ' 291' ' ' ASP . 2.8 t -131.24 104.57 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.655 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -118.97 13.77 13.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.401 ' OE1' ' CA ' ' A' ' 295' ' ' GLN . 0.0 OUTLIER -100.23 139.98 35.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.92 0.39 . . . . 0.0 110.101 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -50.48 -70.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.184 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.92 -39.05 68.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.545 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.36 80.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.261 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 303' ' ' LEU . 26.0 mt -72.65 -53.38 11.95 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.891 0.377 . . . . 0.0 110.815 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 69.4 mt -53.16 -35.14 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 0.0 109.905 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -76.18 -40.38 52.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.192 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.513 ' O ' ' SG ' ' A' ' 290' ' ' CYS . 5.5 t -82.48 -8.78 59.61 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.957 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 299' ' ' LEU . 34.8 mt -91.06 21.4 4.28 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.836 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.622 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.44 -40.3 1.22 Allowed Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.397 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 36.6 Cg_exo -59.14 7.96 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 123.707 2.938 . . . . 0.0 112.719 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 304' ' ' ALA . 5.3 m-20 -111.12 14.46 21.84 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.458 ' NH2' ' OD2' ' A' ' 241' ' ' ASP . 98.5 mtt180 -111.32 90.5 3.35 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.214 0.53 . . . . 0.0 109.75 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.0 ptp180 -162.81 132.63 4.4 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.47 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.464 HG12 HH22 ' A' ' 256' ' ' ARG . 0.2 OUTLIER -96.15 142.3 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -118.83 106.71 12.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.208 0.527 . . . . 0.0 110.234 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.409 HD13 HG13 ' A' ' 236' ' ' VAL . 3.6 mm -80.05 118.2 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -102.74 102.28 12.43 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.62 0.248 . . . . 0.0 110.874 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.874 HG21 HD22 ' A' ' 224' ' ' LEU . 59.8 t -114.85 122.81 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.958 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -120.03 153.31 36.22 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.196 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 89.97 12.4 62.08 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 7.8 tt -95.17 135.64 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.155 0.502 . . . . 0.0 110.712 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp . . . . . 0 N--CA 1.463 0.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.298 -179.758 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 121.262 0.553 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.1 m -69.15 137.2 53.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.487 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 5.5 tptp -112.27 166.37 11.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.322 0.582 . . . . 0.0 110.605 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.412 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 96.6 m-70 -154.74 121.4 5.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.114 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.447 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 68.7 m-85 -108.48 121.05 44.16 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.9 104.08 15.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.497 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.685 ' CD2' HD11 ' A' ' 201' ' ' LEU . 33.8 tp -107.92 127.88 54.13 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.451 ' HG2' ' H ' ' A' ' 199' ' ' ASP . 36.3 ttmt -80.95 127.89 33.07 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.61 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.505 ' OG ' ' NH1' ' A' ' 256' ' ' ARG . 1.2 t -63.44 -31.79 73.05 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.024 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.456 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 9.7 t70 -57.16 -41.06 78.49 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.941 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.52 -43.73 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.685 HD11 ' CD2' ' A' ' 196' ' ' LEU . 95.8 mt -74.69 -79.15 0.09 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.44 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -123.65 140.01 53.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.05 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.588 HD22 ' NZ ' ' A' ' 210' ' ' LYS . 52.8 m-80 -109.38 -76.65 0.61 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.383 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.596 ' CE1' ' ND2' ' A' ' 205' ' ' ASN . 53.3 p90 -96.54 -12.68 23.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.622 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 204' ' ' PHE . 30.1 m120 -75.96 160.7 29.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 110.204 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -55.46 -62.02 1.95 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.51 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.517 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.61 1.15 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.128 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.42 134.24 45.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.18 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.33 144.28 34.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.135 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.588 ' NZ ' HD22 ' A' ' 203' ' ' ASN . 21.9 mtmt -104.87 157.54 33.98 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.816 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -34.32 -76.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.5 2.133 . . . . 0.0 112.311 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 51.6 mp0 -49.75 -20.8 0.91 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.052 0.453 . . . . 0.0 110.316 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.6 -51.01 17.69 Favored Glycine 0 CA--C 1.518 0.232 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -65.34 -40.92 94.26 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.073 0.463 . . . . 0.0 109.763 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.1 -53.94 49.54 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.037 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.23 -38.45 91.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.798 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.76 -27.66 68.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.234 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -73.3 -46.27 50.57 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.381 0.61 . . . . 0.0 110.801 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -62.17 -42.15 98.99 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.096 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.9 -37.41 84.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.031 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.41 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.3 t80 -54.45 -49.49 69.92 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.822 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 225' ' ' SER . 45.9 t -59.84 -49.27 78.37 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.782 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 1.1 tm0? -50.08 -24.09 2.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.421 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.601 ' O ' HD22 ' A' ' 227' ' ' LEU . 62.7 mt -97.34 -14.13 21.47 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 222' ' ' SER . 94.2 p -78.26 -22.32 48.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.766 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -94.62 18.08 12.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.996 0.427 . . . . 0.0 110.446 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -78.72 168.76 19.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.137 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.75 132.99 40.65 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 230' ' ' LYS . 56.4 Cg_endo -71.18 -17.56 31.23 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.777 2.318 . . . . 0.0 112.561 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 229' ' ' PRO . 79.9 tttt -32.59 -51.09 0.27 Allowed 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.797 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 232' ' ' GLY . 47.0 m-20 -108.41 -18.08 13.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.263 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.6 51.33 0.06 OUTLIER Glycine 0 N--CA 1.471 1.006 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.0 m -118.02 108.62 15.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 111.159 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.68 96.51 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.31 120.07 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.657 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.562 HG13 HD13 ' A' ' 311' ' ' ILE . 92.8 t -92.34 124.81 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.435 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 277' ' ' ARG . 28.1 mt -109.11 143.64 38.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.016 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.33 130.47 7.54 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.622 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -115.32 116.8 28.89 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 241' ' ' ASP . 69.8 m -104.08 160.58 14.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.643 0.259 . . . . 0.0 110.449 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.461 ' N ' HG22 ' A' ' 240' ' ' THR . 39.7 p-10 -89.61 177.81 6.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.69 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.629 ' NE ' ' H ' ' A' ' 244' ' ' GLY . 1.0 OUTLIER -88.74 127.67 35.6 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.0 mm -118.34 9.71 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.248 0.547 . . . . 0.0 110.895 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.629 ' H ' ' NE ' ' A' ' 242' ' ' ARG . . . 102.43 -26.0 25.71 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -118.7 115.27 24.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.173 0.511 . . . . 0.0 110.26 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 246' ' ' ASP . 24.0 p-10 -60.15 -53.1 61.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.861 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.72 -38.93 70.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.299 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.585 ' CE2' HD11 ' A' ' 252' ' ' LEU . 47.8 t80 -63.0 -44.1 96.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.292 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -62.36 -40.23 95.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.348 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.79 -44.07 97.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.06 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.18 -36.33 93.29 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.585 HD11 ' CE2' ' A' ' 248' ' ' TYR . 36.5 mt -71.71 -37.14 70.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.336 . . . . 0.0 111.027 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 35.1 t -64.4 -41.29 96.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.942 0.401 . . . . 0.0 110.652 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.42 -47.76 72.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -59.07 -43.44 91.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.759 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.505 ' NH1' ' OG ' ' A' ' 198' ' ' SER . 0.0 OUTLIER -52.94 -64.17 0.91 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -56.6 -37.08 70.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.459 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.21 -46.83 87.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.655 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 75.7 m -60.66 -38.26 84.28 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.255 0.55 . . . . 0.0 110.439 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 256' ' ' ARG . 96.0 t -63.98 -51.91 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.999 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.702 HG21 ' HB2' ' A' ' 276' ' ' ALA . 62.6 t -62.11 -49.03 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -45.39 -42.14 9.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.177 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.508 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 54.8 t80 -82.04 -29.94 31.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.72 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.4 ' O ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -72.72 -8.59 56.11 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.726 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.566 ' C ' ' H ' ' A' ' 267' ' ' LYS . 69.2 mt -87.23 -55.87 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.812 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 93.7 p -50.05 -5.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.07 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 265' ' ' ILE . 71.2 mmtt -77.23 -10.99 59.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.546 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.95 -7.93 23.51 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -80.94 129.84 65.96 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.338 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.44 131.17 39.34 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.75 1.634 . . . . 0.0 111.549 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.91 -8.21 34.83 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 111.251 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 25.9 p30 -94.89 -19.66 20.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.618 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 0.9 OUTLIER -80.87 -21.22 40.87 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.496 0.665 . . . . 0.0 110.636 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.47 HD12 HG13 ' A' ' 261' ' ' VAL . 1.3 pt -104.82 -170.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.589 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 14.9 t -170.94 132.96 0.88 Allowed 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.368 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.702 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -96.87 150.93 20.18 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.845 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.477 ' HB3' HD23 ' A' ' 237' ' ' LEU . 63.5 ttt-85 -160.99 150.25 16.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.202 0.525 . . . . 0.0 110.968 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.44 145.65 16.06 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.475 ' SD ' HD22 ' A' ' 237' ' ' LEU . 85.6 mmm -120.64 2.71 10.67 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 121.967 0.107 . . . . 0.0 110.831 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 38.33 -97.89 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 279' ' ' MET . 6.9 pt-20 -142.03 68.89 1.32 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.656 0.265 . . . . 0.0 110.462 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 98.5 p -89.3 -2.67 58.54 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -154.14 65.52 5.1 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.515 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.7 107.61 2.51 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.56 2.173 . . . . 0.0 112.363 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 31.5 m -73.09 -29.08 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.521 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.634 HG21 ' HA ' ' A' ' 303' ' ' LEU . 40.3 p -58.92 -46.15 88.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.569 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -49.6 -2.93 0.02 OUTLIER Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 286' ' ' THR . 97.9 m-20 -119.98 -58.66 1.86 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.77 -3.61 51.57 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.683 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -130.7 15.52 5.36 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.851 0.357 . . . . 0.0 110.155 179.395 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -65.9 -2.47 3.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.98 0.419 . . . . 0.0 110.304 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -109.9 31.71 5.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.86 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.683 HG21 ' SG ' ' A' ' 290' ' ' CYS . 20.8 t -130.25 121.33 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 110.33 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -119.32 12.19 12.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.702 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.96 130.59 45.33 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.088 0.47 . . . . 0.0 109.815 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -51.99 -64.85 0.68 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.937 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.21 -37.55 64.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.638 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.39 84.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.646 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 303' ' ' LEU . 17.4 mt -72.81 -47.86 42.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.004 0.43 . . . . 0.0 110.78 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.5 mt -60.47 -32.83 52.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.433 . . . . 0.0 110.262 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -82.92 -27.25 30.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.712 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 40.5 t -90.8 -20.37 22.42 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.761 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.634 ' HA ' HG21 ' A' ' 286' ' ' THR . 60.8 mt -85.71 24.96 1.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.528 0.517 . . . . 0.0 111.145 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.58 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -76.48 -44.09 3.32 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 22.4 Cg_exo -62.76 9.35 0.1 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.276 2.651 . . . . 0.0 112.084 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 304' ' ' ALA . 8.2 t70 -104.46 10.73 35.1 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.877 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.489 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 7.9 ptm180 -111.9 97.82 6.95 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.539 0.685 . . . . 0.0 109.965 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.543 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.6 ptm180 -159.0 132.3 7.24 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.333 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.63 141.11 16.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -121.35 106.2 11.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.072 0.463 . . . . 0.0 110.53 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.562 HD13 HG13 ' A' ' 236' ' ' VAL . 3.7 mm -78.55 117.48 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -97.49 132.0 43.59 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.434 HG21 HD22 ' A' ' 224' ' ' LEU . 2.2 t -133.23 118.43 32.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.255 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -115.89 134.55 54.87 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.83 -5.12 56.45 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 18.7 tt -79.91 147.17 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.953 0.406 . . . . 0.0 110.524 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.235 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.45 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 1.2 pm0 . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 120.606 0.241 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.3 m -75.11 137.88 41.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.696 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.494 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 13.5 tptt -111.26 166.86 10.74 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.487 0.661 . . . . 0.0 110.558 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.494 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 5.4 m80 -150.55 120.38 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.775 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -110.45 119.53 39.48 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 104.9 16.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.45 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.673 ' CD2' HD11 ' A' ' 201' ' ' LEU . 24.6 tp -107.96 122.82 47.6 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -78.62 130.4 35.86 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.909 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 202' ' ' PHE . 90.3 p -61.45 -29.36 69.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.105 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -60.27 -38.21 82.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.921 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.7 t -67.82 -42.97 86.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.673 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.0 mt -79.94 -78.15 0.17 Allowed 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.453 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER -135.39 127.03 28.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.501 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -102.33 -68.4 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.039 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -91.12 -22.69 20.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.552 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -69.22 161.22 29.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.912 0.387 . . . . 0.0 109.967 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -63.02 -57.28 11.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.44 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -165.92 -7.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.947 0.403 . . . . 0.0 110.206 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 69.4 p -52.46 131.22 33.39 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.262 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.8 mt -77.51 144.5 37.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.483 0.659 . . . . 0.0 111.211 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.9 mtpt -105.2 157.29 34.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.141 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 213' ' ' GLY . 89.3 Cg_exo -34.52 -76.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.762 2.308 . . . . 0.0 112.413 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -48.2 -20.37 0.37 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.099 0.476 . . . . 0.0 110.328 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.16 -48.51 19.42 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.389 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -65.62 -40.76 92.92 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.2 -52.34 65.73 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.076 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.88 85.45 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 121.56 0.695 . . . . 0.0 110.397 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 mt -65.62 -28.84 69.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.009 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -72.01 -47.85 48.94 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.371 0.605 . . . . 0.0 110.981 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -62.51 -42.03 99.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.868 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.465 HD12 HE21 ' A' ' 223' ' ' GLN . 49.2 tp -64.91 -40.35 94.93 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.403 ' CG ' ' HB3' ' A' ' 267' ' ' LYS . 5.9 t80 -52.3 -47.27 66.02 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 75.0 p -55.94 -51.27 68.25 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.796 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.465 HE21 HD12 ' A' ' 220' ' ' LEU . 17.6 mt-30 -52.28 -25.64 9.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.56 ' O ' HD22 ' A' ' 227' ' ' LEU . 42.8 mt -99.15 -20.88 16.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.677 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 6.8 t -72.75 -24.34 60.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -102.79 23.73 11.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.56 HD22 ' O ' ' A' ' 224' ' ' LEU . 1.0 OUTLIER -75.66 147.62 39.34 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 315' ' ' GLY . 25.8 t0 -62.95 112.07 6.08 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 230' ' ' LYS . 50.7 Cg_exo -53.67 -20.89 17.92 Favored 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.517 2.145 . . . . 0.0 113.181 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 229' ' ' PRO . 11.2 mmmt -29.79 -52.54 0.14 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.952 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' GLY . 34.0 m-20 -105.98 -17.18 14.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.388 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 27.86 49.33 0.07 OUTLIER Glycine 0 N--CA 1.465 0.58 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.347 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.96 108.08 15.35 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.9 96.61 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.712 0.768 . . . . 0.0 110.018 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.8 t -96.19 117.78 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.291 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 261' ' ' VAL . 88.2 t -95.26 121.4 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.033 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 277' ' ' ARG . 24.6 mt -108.76 141.8 40.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.986 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -124.48 126.84 6.2 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.34 122.05 46.84 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 241' ' ' ASP . 55.2 m -109.49 166.11 11.14 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.414 0.446 . . . . 0.0 110.613 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.593 ' N ' HG22 ' A' ' 240' ' ' THR . 40.1 p-10 -90.44 173.3 8.17 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.118 0.485 . . . . 0.0 111.17 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.41 ' NH2' ' OE2' ' A' ' 281' ' ' GLU . 64.0 ttm-85 -92.61 126.53 37.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.166 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.1 mm -118.32 15.15 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.231 0.538 . . . . 0.0 110.442 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 86.07 -1.86 87.69 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 11.8 t -131.44 105.92 7.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.156 0.503 . . . . 0.0 110.179 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 247' ' ' ALA . 22.0 p-10 -55.54 -51.5 66.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.613 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 246' ' ' ASP . . . -55.54 -39.61 70.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.551 ' CE2' HD11 ' A' ' 252' ' ' LEU . 29.1 t80 -65.02 -43.46 92.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.204 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 17.6 t-20 -61.87 -43.15 99.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -65.74 -41.77 91.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.81 -39.52 98.09 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' A' ' 248' ' ' TYR . 27.4 mt -72.8 -35.93 67.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.501 -0.349 . . . . 0.0 110.594 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 39.5 t -62.96 -42.69 99.9 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.89 -46.88 79.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.895 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -55.92 -45.25 78.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 260' ' ' VAL . 28.8 ttm105 -55.29 -65.87 0.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.826 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.09 64.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.47 -48.4 64.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.612 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 77.6 p -57.7 -39.39 77.08 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.117 0.484 . . . . 0.0 110.404 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 256' ' ' ARG . 58.8 t -65.32 -54.01 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.432 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.483 HG13 HD12 ' A' ' 274' ' ' ILE . 17.6 t -60.11 -49.12 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.954 -0.299 . . . . 0.0 110.492 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.09 -44.17 31.45 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.656 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.585 ' CE1' ' NZ ' ' A' ' 267' ' ' LYS . 90.3 t80 -78.39 -34.9 47.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.831 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -62.41 -25.97 68.23 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.094 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 267' ' ' LYS . 86.6 mt -71.33 -52.46 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.777 0.322 . . . . 0.0 111.708 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 6.2 t -50.04 -10.92 0.06 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.48 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.585 ' NZ ' ' CE1' ' A' ' 263' ' ' TYR . 0.1 OUTLIER -77.81 -10.81 59.74 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.204 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 105.99 41.87 1.75 Allowed Glycine 0 CA--C 1.533 1.172 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.79 131.49 24.02 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-N 117.193 0.496 . . . . 0.0 110.79 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.46 125.26 17.18 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.553 1.502 . . . . 0.0 111.48 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.01 -8.39 29.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.135 0.493 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -91.2 -22.93 20.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.334 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -81.37 -20.22 41.01 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.465 0.65 . . . . 0.0 111.167 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.483 HD12 HG13 ' A' ' 261' ' ' VAL . 1.9 pt -103.71 -173.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.435 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 17.4 p -168.62 129.26 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.511 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.09 111.49 23.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.948 0.404 . . . . 0.0 110.583 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.486 ' HB3' HD23 ' A' ' 237' ' ' LEU . 64.9 ttt180 -120.72 146.46 46.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.464 0.65 . . . . 0.0 111.062 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.51 142.46 16.16 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 1.6 mmt -118.92 -5.87 10.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.92 -104.28 0.05 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.41 ' OE2' ' NH2' ' A' ' 242' ' ' ARG . 9.4 pt-20 -142.26 68.7 1.32 Allowed 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.859 -0.201 . . . . 0.0 110.789 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 74.3 m -67.09 -42.06 85.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.614 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.419 ' ND2' HH21 ' A' ' 308' ' ' ARG . 6.9 p-10 -125.66 80.54 66.3 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.105 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.87 106.67 0.66 Allowed 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.714 2.276 . . . . 0.0 112.543 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 289' ' ' THR . 12.5 m -75.81 -30.76 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.132 0.491 . . . . 0.0 110.414 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.63 ' C ' ' H ' ' A' ' 288' ' ' ASN . 60.4 p -56.69 -43.16 80.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.664 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.13 0.52 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.63 ' H ' ' C ' ' A' ' 286' ' ' THR . 24.1 t-20 -123.2 -58.53 1.63 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER -68.22 -14.33 62.91 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.503 -178.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 57.2 m -128.53 22.28 5.98 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.301 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -69.77 -2.49 12.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.697 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -110.24 32.09 5.41 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.535 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 23.3 t -130.93 124.02 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.99 0.424 . . . . 0.0 110.299 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -118.95 7.9 11.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.385 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.437 ' O ' HD12 ' A' ' 299' ' ' LEU . 4.6 mt-30 -90.27 169.44 11.11 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -82.9 -71.18 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.683 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -57.88 -28.13 63.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.951 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.74 94.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.357 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 303' ' ' LEU . 47.6 mt -70.86 -49.11 49.61 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 110.534 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.4 mt -54.89 -31.67 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -80.25 -32.68 38.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.476 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -12.18 46.82 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.721 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.574 ' HA ' HG21 ' A' ' 286' ' ' THR . 48.5 mt -90.47 21.92 3.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.761 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.586 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -78.48 -43.26 2.01 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.98 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.5 Cg_exo -61.78 8.55 0.1 Allowed 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 123.409 2.739 . . . . 0.0 112.044 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 304' ' ' ALA . 50.6 t0 -102.49 12.2 36.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.457 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -113.98 98.48 7.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.445 0.64 . . . . 0.0 109.838 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.552 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 33.5 ptt180 -157.73 130.9 7.62 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.306 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.5 140.06 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -120.84 105.83 11.08 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.362 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.414 HD13 HG13 ' A' ' 236' ' ' VAL . 4.0 mm -79.33 117.64 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.68 127.75 41.98 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.428 HG21 ' CD2' ' A' ' 224' ' ' LEU . 2.4 t -126.77 115.56 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.196 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -114.83 125.8 54.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 91.15 43.74 4.6 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.605 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.5 tt -114.83 168.61 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.605 ' O ' ' O ' ' A' ' 316' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 O-C-N 124.07 0.857 . . . . 0.0 110.868 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.48 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 1.6 pm0 . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.543 HG22 ' CE1' ' A' ' 193' ' ' HIS . 13.3 m -85.17 142.07 29.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.193 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -143.45 111.42 6.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.562 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.4 OUTLIER -97.96 148.28 23.63 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -112.07 130.36 55.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.913 0.387 . . . . 0.0 110.303 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -88.23 103.7 16.02 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.045 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.717 ' CD2' HD11 ' A' ' 201' ' ' LEU . 28.7 tp -108.47 128.37 54.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.178 0.513 . . . . 0.0 109.648 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.437 ' HB3' HG23 ' A' ' 200' ' ' VAL . 34.0 ttmt -81.7 125.14 30.24 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.994 0.902 . . . . 0.0 112.16 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.481 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 18.5 m -61.05 -32.14 71.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.196 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.419 ' H ' ' HG2' ' A' ' 197' ' ' LYS . 9.9 t0 -59.66 -36.72 76.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 197' ' ' LYS . 87.3 t -67.34 -42.96 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.717 HD11 ' CD2' ' A' ' 196' ' ' LEU . 76.3 mt -78.9 -78.33 0.15 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.322 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.68 128.1 41.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.966 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.418 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 62.0 t-20 -111.93 -71.48 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.438 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -84.34 -32.32 24.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -73.73 165.89 24.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.196 0.522 . . . . 0.0 110.245 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.675 ' C ' HH22 ' A' ' 255' ' ' ARG . 32.6 mmtp -58.94 -82.41 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.457 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.57 ' HB2' ' NH1' ' A' ' 255' ' ' ARG . . . -148.65 56.55 1.03 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 73.4 p -107.54 130.2 54.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.131 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 40.6 mt -78.04 134.97 37.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.732 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.4 mtmt -97.06 159.21 31.92 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.917 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 210' ' ' LYS . 88.8 Cg_exo -34.63 -76.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.235 1.957 . . . . 0.0 111.875 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.22 -22.13 0.96 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.101 0.477 . . . . 0.0 110.244 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.53 -52.0 14.35 Favored Glycine 0 N--CA 1.46 0.276 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -64.99 -39.56 93.66 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.323 0.583 . . . . 0.0 109.908 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.75 -54.66 43.76 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.153 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.6 -36.0 82.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.984 0.421 . . . . 0.0 110.678 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.3 mt -61.56 -31.66 71.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.152 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.67 -45.51 58.51 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.279 0.562 . . . . 0.0 110.616 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -61.52 -44.98 96.09 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.808 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.486 HD12 HE21 ' A' ' 223' ' ' GLN . 38.3 tp -63.65 -40.6 97.27 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.262 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.433 ' CE1' ' OG ' ' A' ' 225' ' ' SER . 6.5 t80 -51.54 -48.35 63.06 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.985 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.7 t -54.25 -52.11 62.38 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.55 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.486 HE21 HD12 ' A' ' 220' ' ' LEU . 16.0 mt-30 -51.56 -26.66 9.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.4 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.797 HD22 HG21 ' A' ' 313' ' ' VAL . 21.7 mt -98.35 -19.0 18.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.433 ' OG ' ' CE1' ' A' ' 221' ' ' TYR . 4.7 m -71.68 -32.91 68.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -96.96 21.68 9.37 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.677 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -75.07 151.49 38.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.794 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 315' ' ' GLY . 15.6 t0 -65.39 124.6 87.54 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.128 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 232' ' ' GLY . 48.0 Cg_endo -69.16 -19.73 38.59 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 122.894 2.396 . . . . 0.0 113.313 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 229' ' ' PRO . 39.0 ttmt -24.12 -50.06 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.576 0 O-C-N 123.62 0.575 . . . . 0.0 111.037 -177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.472 ' O ' ' C ' ' A' ' 232' ' ' GLY . 32.5 t70 -115.44 -12.9 11.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.212 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 25.66 49.93 0.04 OUTLIER Glycine 0 N--CA 1.472 1.095 0 O-C-N 123.861 0.725 . . . . 0.0 111.456 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.5 t -112.03 114.13 26.83 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 122.574 -0.368 . . . . 0.0 110.352 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.6 t -129.05 95.91 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.266 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 275' ' ' SER . 2.8 t -96.74 123.98 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.097 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.484 HG22 HG23 ' A' ' 311' ' ' ILE . 21.2 t -96.75 120.94 46.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.823 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 40.8 mt -103.74 145.38 30.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.167 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.68 129.04 7.34 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 308' ' ' ARG . 1.0 OUTLIER -110.53 125.77 53.69 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.544 ' OG1' ' ND2' ' A' ' 249' ' ' ASN . 3.1 p -116.78 162.82 17.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.535 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 7.0 p30 -84.75 172.09 11.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -88.74 122.53 32.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.425 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.7 mm -118.06 7.94 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.293 0.568 . . . . 0.0 110.617 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 82.33 13.98 77.53 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -142.08 92.15 2.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.107 0.479 . . . . 0.0 109.943 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -49.25 -49.69 42.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.508 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.24 78.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.797 ' CE2' HD11 ' A' ' 252' ' ' LEU . 40.3 t80 -65.18 -43.2 92.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.062 0.458 . . . . 0.0 110.637 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.544 ' ND2' ' OG1' ' A' ' 240' ' ' THR . 27.4 t-20 -61.49 -43.4 98.94 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.634 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.52 -45.05 92.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.638 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.11 92.1 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 1.108 HD23 ' HE ' ' A' ' 255' ' ' ARG . 18.0 mt -64.69 -43.66 92.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.998 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 33.3 m -66.83 -43.69 83.09 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.885 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.58 -57.21 13.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.475 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 1.108 ' HE ' HD23 ' A' ' 252' ' ' LEU . 36.5 ptt85 -59.11 -45.16 91.58 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.156 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.481 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 19.2 mtp-105 -58.16 -50.58 73.03 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.535 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.38 69.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.84 -40.39 72.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.137 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 76.4 p -63.43 -37.86 88.93 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.192 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.48 -51.1 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.491 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' A' ' 276' ' ' ALA . 23.4 t -61.23 -49.56 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.2 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -45.94 -38.8 8.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.93 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.497 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 63.6 t80 -84.9 -31.68 23.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.49 -13.5 62.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.446 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.561 ' C ' ' H ' ' A' ' 267' ' ' LYS . 66.5 mt -83.89 -52.15 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 111.148 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 9.0 t -50.49 -6.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.561 ' H ' ' C ' ' A' ' 265' ' ' ILE . 73.7 mmtt -79.63 -10.67 59.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.616 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 104.55 40.72 2.15 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.68 127.86 24.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.87 128.03 25.2 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.822 1.681 . . . . 0.0 111.811 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.07 -11.65 15.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.008 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.36 -26.07 21.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.774 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.436 ' CE ' HD21 ' A' ' 227' ' ' LEU . 7.0 tttm -74.51 -22.81 58.87 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.909 0.861 . . . . 0.0 110.659 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -104.14 -172.8 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.547 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 235' ' ' VAL . 13.3 t -170.24 124.8 0.74 Allowed 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.396 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.678 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -99.72 156.97 16.81 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.801 -0.562 . . . . 0.0 109.795 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -174.1 166.84 4.23 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 122.009 0.909 . . . . 0.0 110.855 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.22 146.03 16.02 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.341 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 4.3 tpt -116.0 -10.97 11.51 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.914 0.388 . . . . 0.0 110.291 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 53.7 -111.23 1.77 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -141.76 72.26 1.38 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.879 0.371 . . . . 0.0 110.403 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.1 t -62.23 -42.06 98.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.113 0.482 . . . . 0.0 111.369 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -129.07 79.16 75.03 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.43 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -54.66 107.97 0.26 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.452 2.101 . . . . 0.0 112.113 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 286' ' ' THR . 27.3 m -65.75 -44.99 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.632 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.637 ' O ' ' N ' ' A' ' 288' ' ' ASN . 67.5 p -60.6 -43.68 97.15 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.813 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.37 -6.88 0.01 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.637 ' N ' ' O ' ' A' ' 286' ' ' THR . 29.7 m-80 -130.47 -56.02 1.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.116 0.566 . . . . 0.0 109.675 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 m -64.47 -30.46 71.49 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.918 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.59 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -121.3 22.37 10.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.957 0.408 . . . . 0.0 110.453 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 45.7 t0 -63.46 -10.97 19.98 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.612 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -98.87 32.17 2.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.743 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.59 HG21 ' SG ' ' A' ' 290' ' ' CYS . 40.0 t -128.04 124.98 63.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.1 0.476 . . . . 0.0 110.196 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -119.13 11.01 12.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -100.07 130.26 46.21 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.411 0.624 . . . . 0.0 110.201 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 299' ' ' LEU . 7.9 ttm180 -52.61 -76.24 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.55 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -41.91 -38.35 1.54 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.11 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.85 94.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.104 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 296' ' ' ARG . 35.5 mt -72.2 -41.48 66.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.575 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.4 mm -57.65 -31.48 39.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.11 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -86.84 -43.9 12.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.51 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.75 -19.93 65.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.985 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.46 25.43 1.68 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.459 0.474 . . . . 0.0 111.255 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.57 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -77.2 -43.6 2.69 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.924 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 18.8 Cg_exo -64.73 7.96 0.23 Allowed 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.472 2.781 . . . . 0.0 111.511 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 304' ' ' ALA . 10.0 m-20 -103.29 7.74 38.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.02 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.418 ' NH1' ' OD1' ' A' ' 203' ' ' ASN . 64.7 mtm180 -112.61 94.75 5.06 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.236 0.541 . . . . 0.0 110.2 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 39.5 ptt180 -164.46 136.73 4.7 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.535 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.44 143.9 11.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.61 -0.681 . . . . 0.0 109.562 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -117.69 103.78 10.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.484 HG23 HG22 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -80.98 113.37 20.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.211 -178.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -92.84 119.32 32.05 Favored 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 123.374 0.421 . . . . 0.0 110.73 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.797 HG21 HD22 ' A' ' 224' ' ' LEU . 60.9 t -119.25 117.32 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.807 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -113.98 128.63 56.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 98.15 40.83 3.4 Favored Glycine 0 C--O 1.226 -0.366 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.664 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.1 tt -116.94 170.03 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.664 ' O ' ' O ' ' A' ' 316' ' ' ILE . 51.8 mtpt . . . . . 0 N--CA 1.464 0.254 0 O-C-N 124.074 0.859 . . . . 0.0 111.357 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.958 0.409 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 36.0 m -69.19 135.19 50.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.425 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 0.1 OUTLIER -115.38 169.44 9.15 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.411 0.624 . . . . 0.0 110.72 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 94.8 m-70 -155.68 125.44 6.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.081 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.534 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 66.3 m-85 -112.54 117.64 32.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.409 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.88 104.82 15.89 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.989 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.684 ' CD2' HD11 ' A' ' 201' ' ' LEU . 29.6 tp -108.47 130.82 55.25 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.423 ' HG3' ' H ' ' A' ' 199' ' ' ASP . 20.8 tptp -79.39 128.44 33.34 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.948 0.88 . . . . 0.0 111.877 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 202' ' ' PHE . 18.0 t -64.06 -31.93 73.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.088 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.423 ' H ' ' HG3' ' A' ' 197' ' ' LYS . 46.7 t0 -58.92 -37.28 76.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.979 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 197' ' ' LYS . 91.6 t -66.81 -43.87 89.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.684 HD11 ' CD2' ' A' ' 196' ' ' LEU . 90.7 mt -78.31 -77.73 0.16 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.947 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -126.0 129.55 49.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.716 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -101.35 -74.44 0.62 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.34 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.609 ' CE2' ' ND2' ' A' ' 205' ' ' ASN . 54.7 p90 -99.09 -21.67 16.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.932 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.609 ' ND2' ' CE2' ' A' ' 204' ' ' PHE . 32.9 m120 -72.77 164.67 26.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.272 0.558 . . . . 0.0 110.057 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.3 pttm -49.56 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.198 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -156.43 58.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.255 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.04 131.62 53.89 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.5 mt -75.21 139.35 42.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.747 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.2 mtpm? -98.44 158.72 32.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.708 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 213' ' ' GLY . 81.8 Cg_exo -34.01 -76.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.558 2.172 . . . . 0.0 112.013 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -50.9 -18.44 0.76 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.126 0.488 . . . . 0.0 110.162 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.72 -47.89 11.22 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -66.98 -40.27 87.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.34 70.19 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.24 83.41 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.411 0.624 . . . . 0.0 110.485 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.82 -30.92 71.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.063 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.49 -47.34 56.08 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.134 0.493 . . . . 0.0 110.867 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -63.9 -42.63 97.38 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.283 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.505 HD21 HD12 ' A' ' 311' ' ' ILE . 40.4 tp -64.87 -40.68 95.51 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.1 t80 -53.44 -49.11 68.05 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.968 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.5 m -55.76 -50.57 70.05 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.348 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.534 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 10.9 tt0 -53.17 -24.18 10.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.42 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.739 HD22 HG21 ' A' ' 313' ' ' VAL . 74.3 mt -95.96 -20.02 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.583 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.2 t -73.06 -21.57 60.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.92 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -99.75 20.42 14.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.714 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -76.27 161.4 28.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.18 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 315' ' ' GLY . 9.5 t0 -78.75 126.94 81.66 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' LYS . 45.9 Cg_endo -68.82 -17.27 41.99 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.718 2.279 . . . . 0.0 113.051 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 229' ' ' PRO . 14.4 mmtp -27.62 -46.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.74 0.65 . . . . 0.0 110.964 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.476 ' O ' ' C ' ' A' ' 232' ' ' GLY . 9.6 m-20 -117.89 -14.92 10.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.36 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.21 51.64 0.06 OUTLIER Glycine 0 N--CA 1.474 1.182 0 O-C-N 123.985 0.803 . . . . 0.0 111.346 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 73.6 m -116.63 111.97 20.61 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 122.788 -0.242 . . . . 0.0 110.791 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.3 t -126.71 96.47 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.019 0.438 . . . . 0.0 110.075 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.15 121.18 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.446 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 311' ' ' ILE . 24.2 t -95.54 125.85 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.982 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.641 HD23 ' HB3' ' A' ' 277' ' ' ARG . 23.4 mt -109.08 143.96 37.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.933 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.695 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -120.13 138.95 13.42 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.622 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.2 OUTLIER -121.7 117.32 26.37 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.413 ' OG1' ' OD1' ' A' ' 249' ' ' ASN . 7.7 p -112.74 164.81 12.92 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.223 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.439 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 47.6 p-10 -85.22 177.53 7.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.32 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -104.0 127.2 51.55 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.103 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.1 mm -118.84 19.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.444 0.64 . . . . 0.0 110.706 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.44 7.51 86.31 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.8 t -136.3 99.06 4.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.996 0.427 . . . . 0.0 110.212 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -51.5 -50.04 60.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.577 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.94 -39.54 71.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.575 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.628 ' CE2' HD11 ' A' ' 252' ' ' LEU . 48.1 t80 -62.14 -47.16 85.78 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.97 0.414 . . . . 0.0 110.502 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 11.1 t-20 -62.2 -41.37 98.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.636 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -64.55 -44.27 91.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 110.751 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.09 -36.03 92.34 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.628 HD11 ' CE2' ' A' ' 248' ' ' TYR . 78.5 mt -74.36 -34.76 63.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.687 0.279 . . . . 0.0 111.365 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.473 ' OG ' ' CA ' ' A' ' 278' ' ' GLY . 12.0 t -65.01 -43.76 91.42 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.016 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -71.09 -40.13 71.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.417 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -60.11 -50.02 75.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.592 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.524 ' O ' HG23 ' A' ' 260' ' ' VAL . 86.2 mtt-85 -61.19 -53.99 49.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.747 0.308 . . . . 0.0 110.351 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -54.58 -35.49 63.39 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.164 0.507 . . . . 0.0 109.919 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -71.3 -44.33 65.37 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.258 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 17.1 m -62.02 -37.49 85.12 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.528 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 256' ' ' ARG . 96.7 t -65.12 -51.41 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.543 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.559 HG13 HD12 ' A' ' 274' ' ' ILE . 25.3 t -61.92 -48.64 87.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.054 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -45.48 -41.08 9.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.942 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.532 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 57.4 t80 -81.42 -30.69 33.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.653 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -73.5 -8.53 56.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.633 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.5 mt -87.33 -55.77 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.807 0.337 . . . . 0.0 111.264 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.9 m -50.72 -4.79 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.573 ' H ' ' C ' ' A' ' 265' ' ' ILE . 30.1 mmtp -79.39 -11.0 59.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.774 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.27 39.92 2.03 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 128.57 24.09 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.5 128.46 25.96 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.595 1.53 . . . . 0.0 112.037 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.8 -6.93 13.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.787 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 6.4 p30 -94.54 -21.75 18.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.905 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 1.2 ttpm? -80.4 -21.2 42.5 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.505 0.669 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.559 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -103.89 -171.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.626 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 22.0 m -171.17 129.56 0.73 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.145 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.86 152.25 18.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.641 ' HB3' HD23 ' A' ' 237' ' ' LEU . 69.2 ttt-85 -161.38 148.79 14.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.361 0.601 . . . . 0.0 110.6 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.473 ' CA ' ' OG ' ' A' ' 253' ' ' SER . . . -126.12 100.46 0.58 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.622 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 8.1 ptp -88.0 24.03 1.92 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.649 0.261 . . . . 0.0 110.931 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.12 -93.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 279' ' ' MET . 4.5 pt-20 -140.68 74.91 1.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.826 0.346 . . . . 0.0 110.447 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.4 m -90.38 -0.73 57.77 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.466 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -153.86 56.28 1.54 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.354 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.61 109.49 1.86 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.558 2.172 . . . . 0.0 112.28 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 22.5 m -78.87 -23.94 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.436 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.648 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.6 OUTLIER -59.71 -45.06 93.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.702 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -49.95 -0.1 0.01 OUTLIER Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.648 ' H ' ' C ' ' A' ' 286' ' ' THR . 25.7 t-20 -124.72 -57.19 1.55 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.6 m -54.82 -42.52 72.0 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 8.2 m -94.22 34.78 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.287 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 41.4 t0 -74.77 -7.99 55.05 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.821 0.343 . . . . 0.0 110.792 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -106.47 30.04 6.35 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.435 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.41 126.56 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.236 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -119.88 13.73 12.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.524 ' O ' HD13 ' A' ' 299' ' ' LEU . 2.1 mp0 -87.6 171.54 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.073 0.463 . . . . 0.0 110.144 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -86.26 -71.1 0.56 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.605 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.57 -32.39 68.88 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.334 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.11 87.23 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.514 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 295' ' ' GLN . 7.5 mp -72.29 -48.34 43.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.917 0.389 . . . . 0.0 110.843 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 81.3 mt -45.49 -38.52 2.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -79.55 -40.78 28.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.406 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 3.5 t -72.7 -8.92 57.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.528 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.7 mm? -92.03 20.95 5.35 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.496 0.498 . . . . 0.0 110.305 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.648 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.02 -38.06 1.14 Allowed Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.029 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.5 Cg_exo -59.13 9.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 123.35 2.7 . . . . 0.0 112.593 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 304' ' ' ALA . 33.6 p30 -114.77 15.44 17.49 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.69 0.281 . . . . 0.0 110.764 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -106.83 97.33 7.13 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.756 0.789 . . . . 0.0 110.285 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 16.6 ptm180 -171.12 157.84 5.3 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.881 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.695 HG12 ' HA2' ' A' ' 238' ' ' GLY . 34.5 m -117.91 148.0 21.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 87.9 mt-10 -121.06 105.91 11.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 110.753 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.506 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -78.44 117.28 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.201 -178.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -97.69 122.74 41.13 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.038 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.739 HG21 HD22 ' A' ' 224' ' ' LEU . 28.6 t -124.65 117.07 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.1 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -115.39 121.63 43.36 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 103.91 40.17 2.36 Favored Glycine 0 N--CA 1.462 0.398 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.506 ' CG1' ' N ' ' A' ' 317' ' ' LYS . 12.4 tt -115.95 168.07 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 109.983 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.506 ' N ' ' CG1' ' A' ' 316' ' ' ILE . 5.0 tmtp? . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.495 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.471 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 1.1 pm0 . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m -87.59 145.21 26.3 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -118.59 170.26 9.11 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.22 0.533 . . . . 0.0 110.002 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -153.55 124.66 7.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.947 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -112.07 122.31 47.4 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.485 ' OG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -87.87 105.9 17.74 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.451 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.694 ' CD2' HD11 ' A' ' 201' ' ' LEU . 37.5 tp -108.21 123.58 48.97 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.425 ' NZ ' ' OD2' ' A' ' 199' ' ' ASP . 5.3 ttpp -81.13 128.25 33.54 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 122.615 1.198 . . . . 0.0 113.2 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 202' ' ' PHE . 20.4 t -59.31 -19.6 47.63 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.159 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.425 ' OD2' ' NZ ' ' A' ' 197' ' ' LYS . 21.0 m-20 -59.69 -47.85 84.0 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.407 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 200' ' ' VAL . 2.5 m -71.64 -25.98 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.326 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.694 HD11 ' CD2' ' A' ' 196' ' ' LEU . 65.6 mt -90.56 -81.28 0.31 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.954 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.503 ' O ' ' OG ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -128.13 99.27 5.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.9 -178.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.53 HD21 ' HZ3' ' A' ' 210' ' ' LYS . 3.3 p30 -71.99 -71.78 0.26 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.406 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -105.73 -27.16 11.46 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.554 0.216 . . . . 0.0 110.9 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -61.98 167.83 3.59 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.992 0.425 . . . . 0.0 110.271 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -53.21 -81.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.515 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.47 ' HB1' ' OG ' ' A' ' 259' ' ' SER . . . -161.86 54.2 0.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 60.0 p -107.28 136.97 46.2 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.406 HD22 HD22 ' A' ' 201' ' ' LEU . 18.9 mt -79.8 123.44 27.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.827 0.346 . . . . 0.0 111.633 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.53 ' HZ3' HD21 ' A' ' 203' ' ' ASN . 22.1 mtmt -84.14 158.51 61.17 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.26 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 213' ' ' GLY . 96.1 Cg_exo -32.75 -75.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.702 2.268 . . . . 0.0 112.824 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -49.12 -19.27 0.42 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.386 0.612 . . . . 0.0 110.191 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.33 -50.42 8.35 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.92 -40.62 95.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.224 0.535 . . . . 0.0 109.568 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -51.51 68.99 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.144 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.21 85.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.246 0.546 . . . . 0.0 110.036 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.3 mt -61.64 -37.8 85.35 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.183 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 32.1 m-20 -63.66 -45.57 89.54 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.112 0.482 . . . . 0.0 111.009 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -62.2 -44.22 97.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.299 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.449 HD12 HE21 ' A' ' 223' ' ' GLN . 37.6 tp -63.24 -39.94 96.02 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 225' ' ' SER . 16.1 t80 -53.9 -45.39 71.1 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 87.7 p -51.25 -53.53 34.53 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.038 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.449 HE21 HD12 ' A' ' 220' ' ' LEU . 20.5 mt-30 -53.83 -29.09 39.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.825 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.579 ' O ' HD22 ' A' ' 227' ' ' LEU . 17.5 mt -93.64 -22.97 18.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.519 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 221' ' ' TYR . 7.2 p -77.86 -30.04 50.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -96.17 22.78 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.167 0.508 . . . . 0.0 110.437 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.579 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.6 OUTLIER -79.71 168.61 19.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.83 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.37 127.85 64.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 230' ' ' LYS . 68.6 Cg_endo -72.22 -16.53 28.24 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.072 1.848 . . . . 0.0 113.071 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.475 ' CG ' ' N ' ' A' ' 231' ' ' ASP . 19.5 ptmt -31.67 -45.77 0.1 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 123.583 0.552 . . . . 0.0 111.232 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' A' ' 230' ' ' LYS . 84.5 m-20 -111.92 -19.39 12.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.998 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 28.31 54.75 0.13 Allowed Glycine 0 N--CA 1.473 1.151 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.754 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.8 p -119.06 109.89 16.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.409 0.147 . . . . 0.0 111.151 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.4 t -125.47 94.74 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.699 0.761 . . . . 0.0 110.205 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.57 120.31 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.549 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.44 HG13 HD13 ' A' ' 311' ' ' ILE . 69.3 t -96.93 123.96 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.297 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.8 mt -107.2 137.83 44.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.185 0.517 . . . . 0.0 110.592 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -90.91 139.54 14.87 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.493 ' CZ ' ' CD ' ' A' ' 310' ' ' GLU . 11.6 m-85 -131.56 118.95 20.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.051 0.925 . . . . 0.0 108.794 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.0 t -129.49 171.05 12.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.843 0.354 . . . . 0.0 111.124 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -76.96 -176.12 3.82 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.321 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -105.82 121.83 44.85 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.781 0.324 . . . . 0.0 110.239 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 243' ' ' ILE . 8.5 mm -118.82 11.15 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.552 0.691 . . . . 0.0 110.453 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.8 -47.36 3.06 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.5 m -68.3 101.04 1.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.314 0.578 . . . . 0.0 109.636 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -54.41 -52.3 62.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.548 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.41 -44.99 80.86 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.194 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.599 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 56.1 t80 -62.17 -45.02 95.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.91 0.385 . . . . 0.0 110.733 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.461 HD21 ' N ' ' A' ' 243' ' ' ILE . 28.0 m120 -62.3 -41.67 98.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -64.79 -41.8 95.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.673 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.27 96.2 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.599 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 27.7 mt -67.79 -40.76 83.88 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.679 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.5 t -62.2 -43.86 97.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.554 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -65.68 -41.4 92.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.004 0.431 . . . . 0.0 110.687 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.12 -48.84 77.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.684 ' NH2' HH21 ' A' ' 307' ' ' ARG . 66.7 mtt85 -61.36 -53.62 54.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.694 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.87 -30.22 65.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.463 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 5.5 tp-100 -75.45 -46.39 32.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.704 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.641 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 20.4 m -56.77 -37.19 70.75 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.996 0.903 . . . . 0.0 109.872 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 256' ' ' ARG . 44.8 t -71.07 -63.02 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.771 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 276' ' ' ALA . 17.0 t -46.36 -63.84 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.731 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.641 ' OD1' ' O ' ' A' ' 259' ' ' SER . 28.6 p-10 -45.22 -38.72 5.64 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.079 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.524 ' N ' ' OD1' ' A' ' 262' ' ' ASP . 84.1 t80 -80.74 -31.94 35.84 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.981 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 260' ' ' VAL . 0.5 OUTLIER -70.27 -9.15 55.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.561 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.487 ' C ' ' H ' ' A' ' 267' ' ' LYS . 68.9 mt -86.83 -54.79 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.816 0.341 . . . . 0.0 111.744 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 39.0 m -51.59 -7.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.19 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 218' ' ' ASP . 0.0 OUTLIER -78.82 -11.34 59.99 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 109.52 39.49 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.98 130.19 23.84 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 117.173 0.487 . . . . 0.0 109.751 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.94 132.55 50.37 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.253 1.302 . . . . 0.0 112.4 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.33 -13.27 60.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.682 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -90.46 -17.45 27.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.484 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.51 -25.62 35.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.728 0.775 . . . . 0.0 110.413 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.3 pt -100.3 -178.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.548 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 7.7 t -162.17 126.48 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.613 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -97.58 113.97 25.79 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.887 0.375 . . . . 0.0 110.803 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -129.14 156.33 44.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.797 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.48 152.09 16.98 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 238' ' ' GLY . 6.5 tpt -118.11 -10.36 10.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.961 0.41 . . . . 0.0 110.242 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 60.28 -107.79 1.5 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.485 ' CD ' ' N ' ' A' ' 281' ' ' GLU . 1.0 OUTLIER -141.02 71.31 1.36 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.897 0.379 . . . . 0.0 110.235 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 72.8 m -93.44 7.42 44.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -160.98 70.72 2.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.94 105.74 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.35 2.033 . . . . 0.0 112.645 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 286' ' ' THR . 15.1 m -64.28 -42.06 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.572 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.589 ' O ' ' N ' ' A' ' 288' ' ' ASN . 40.8 p -58.27 -45.67 87.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.102 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -43.95 -10.37 0.01 OUTLIER Glycine 0 CA--C 1.533 1.179 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 286' ' ' THR . 87.7 m-20 -129.77 -54.23 1.14 Allowed 'General case' 0 C--O 1.231 0.098 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 m -58.33 -44.22 88.57 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -107.13 33.09 4.16 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 109.903 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 293' ' ' VAL . 28.9 t0 -56.94 -42.65 80.46 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.447 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -75.08 33.18 0.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.502 HG21 ' SG ' ' A' ' 290' ' ' CYS . 15.5 t -131.91 113.51 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.943 0.401 . . . . 0.0 110.343 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -118.51 14.65 13.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.926 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -99.62 130.82 45.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.011 0.434 . . . . 0.0 110.166 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -50.47 -67.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.273 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.89 -38.31 61.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.72 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.96 89.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.332 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 60.3 mt -75.19 -50.25 16.85 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.878 0.37 . . . . 0.0 110.652 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 78.1 mt -52.72 -32.74 17.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.227 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -78.07 -46.22 21.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.924 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 11.9 t -70.64 -13.1 61.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.637 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 35.9 mt -92.58 24.47 3.5 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.398 0.437 . . . . 0.0 111.453 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 305' ' ' PRO . . . -78.45 -45.45 2.05 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.397 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 35.7 Cg_endo -69.28 8.7 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.203 1.935 . . . . 0.0 111.586 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 306' ' ' ASP . 9.4 t70 -104.76 9.76 34.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.228 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.684 HH21 ' NH2' ' A' ' 256' ' ' ARG . 38.6 mtp180 -107.76 116.39 31.86 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.212 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.485 ' NH2' ' OG1' ' A' ' 195' ' ' THR . 15.7 ptm180 -175.67 -171.31 0.46 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.5 m -144.77 154.16 14.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.493 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 95.2 mt-10 -121.7 105.25 10.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.044 0.45 . . . . 0.0 110.925 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.44 HD13 HG13 ' A' ' 236' ' ' VAL . 3.9 mm -80.54 116.71 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.488 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -99.63 119.6 38.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.774 0.321 . . . . 0.0 110.369 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 224' ' ' LEU . 2.5 t -118.94 120.53 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.653 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -118.93 141.13 48.93 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.22 -22.55 40.17 Favored Glycine 0 N--CA 1.469 0.88 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.551 ' CG1' ' H ' ' A' ' 317' ' ' LYS . 14.6 tt -56.47 176.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.551 ' H ' ' CG1' ' A' ' 316' ' ' ILE . 49.5 tttt . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.522 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 121.165 0.507 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.564 HG22 ' CE1' ' A' ' 193' ' ' HIS . 12.2 m -77.16 140.01 40.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.53 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -147.36 117.83 7.45 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.029 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.2 OUTLIER -103.29 150.52 23.67 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.611 ' CE2' ' NE2' ' A' ' 223' ' ' GLN . 41.1 m-85 -111.76 121.92 46.39 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.798 0.332 . . . . 0.0 110.184 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.59 101.72 12.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.709 ' CD2' HD11 ' A' ' 201' ' ' LEU . 34.4 tp -104.28 132.52 50.44 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.996 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.408 ' HB3' HG23 ' A' ' 200' ' ' VAL . 2.1 ttmp? -78.2 127.04 31.67 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.897 0.856 . . . . 0.0 111.893 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 202' ' ' PHE . 39.2 t -63.75 -33.22 75.17 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.035 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.56 -38.75 81.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.259 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 197' ' ' LYS . 62.0 t -63.21 -46.17 96.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.709 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.3 mt -75.56 -76.34 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.659 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.484 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -130.7 143.5 50.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.363 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.468 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 46.5 t30 -129.77 -72.87 0.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.272 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.34 -37.94 56.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -71.92 165.12 24.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.445 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -57.67 -68.03 0.28 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.589 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.12 57.18 0.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.457 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 18.8 p -106.43 130.06 54.3 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.84 139.22 44.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.78 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 213' ' ' GLY . 30.7 mtmt -101.17 159.66 28.85 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 210' ' ' LYS . 86.3 Cg_exo -34.25 -77.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.387 2.058 . . . . 0.0 112.104 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.72 -20.29 1.2 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.173 0.511 . . . . 0.0 110.424 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.83 -49.69 16.61 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -67.9 -39.19 83.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.19 0.519 . . . . 0.0 109.807 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.29 -53.17 60.44 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.537 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.51 91.34 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.43 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 mt -62.45 -26.34 68.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.502 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -73.01 -46.08 54.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -63.65 -40.25 96.38 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.462 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.639 HD12 HE21 ' A' ' 223' ' ' GLN . 55.7 tp -61.08 -40.09 92.39 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.512 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 49.4 t80 -54.87 -58.33 8.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.535 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 15.4 m -58.94 -6.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.361 0.601 . . . . 0.0 110.788 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.639 HE21 HD12 ' A' ' 220' ' ' LEU . 4.0 tt0 -94.38 -34.23 12.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.684 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 1.085 HD22 HG21 ' A' ' 313' ' ' VAL . 42.7 mt -96.92 -13.03 22.7 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.809 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.3 t -83.24 -14.93 52.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.724 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -96.71 17.55 16.29 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.446 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -78.18 178.92 7.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.653 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 315' ' ' GLY . 9.4 t70 -94.2 132.03 30.14 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.734 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 230' ' ' LYS . 42.3 Cg_endo -67.92 -20.47 45.07 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.817 2.344 . . . . 0.0 112.837 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 229' ' ' PRO . 40.6 mmtt -33.43 -53.07 0.4 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.055 0.455 . . . . 0.0 110.582 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 99.3 m-20 -102.76 -19.01 14.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.471 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.03 45.23 0.01 OUTLIER Glycine 0 N--CA 1.469 0.879 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 231' ' ' ASP . 28.0 m -112.22 111.38 22.23 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 71.6 t -126.31 94.06 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.761 0.791 . . . . 0.0 110.285 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.4 t -97.22 121.03 47.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.09 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 311' ' ' ILE . 22.0 t -93.13 124.58 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.58 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 277' ' ' ARG . 19.7 mt -109.49 141.34 42.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.974 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -125.16 126.08 5.85 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.31 120.39 42.08 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 241' ' ' ASP . 2.4 m -108.98 168.53 9.29 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 240' ' ' THR . 52.8 p-10 -95.14 -179.55 4.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.628 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 244' ' ' GLY . 38.6 ttm180 -98.65 127.36 44.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.318 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.711 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.9 mm -118.31 14.2 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.313 0.578 . . . . 0.0 110.667 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.408 ' H ' ' HG2' ' A' ' 242' ' ' ARG . . . 91.87 -3.05 77.19 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 4.2 m -134.01 104.36 6.21 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.998 0.428 . . . . 0.0 110.072 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -55.35 -50.81 68.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.476 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.72 -40.75 76.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.545 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.565 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 48.7 t80 -63.07 -44.56 95.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.293 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.456 HD21 ' H ' ' A' ' 243' ' ' ILE . 27.1 m120 -62.67 -40.4 96.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.279 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -63.93 -43.1 96.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.497 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.468 ' C ' ' NH2' ' A' ' 255' ' ' ARG . . . -62.33 -35.86 92.24 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.789 HD22 HH12 ' A' ' 256' ' ' ARG . 14.4 mt -74.66 -35.91 62.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.499 -0.35 . . . . 0.0 111.084 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.4 p -64.64 -41.06 96.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.979 0.418 . . . . 0.0 110.512 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -70.36 -44.48 68.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.178 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.468 ' NH2' ' C ' ' A' ' 251' ' ' GLY . 63.5 mtm-85 -56.55 -46.78 80.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.803 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.789 HH12 HD22 ' A' ' 252' ' ' LEU . 67.2 mtt85 -60.46 -62.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.611 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.72 -34.78 19.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.104 0.478 . . . . 0.0 109.881 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -72.86 -46.07 54.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.406 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 61.5 m -60.11 -38.07 81.9 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.073 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.1 t -64.06 -50.8 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.331 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.58 HG13 HD12 ' A' ' 274' ' ' ILE . 9.5 t -62.31 -48.36 88.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.434 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.44 -41.86 21.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.061 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.637 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 85.5 t80 -79.39 -34.62 41.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.628 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -64.76 -29.48 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.966 -179.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 267' ' ' LYS . 82.4 mt -68.73 -50.16 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 111.88 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 44.6 m -50.76 -8.51 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.906 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.637 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 11.4 mmtp -84.6 2.28 42.18 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.006 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.08 40.81 4.48 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.41 129.0 25.05 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.332 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.06 127.31 25.18 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.862 1.708 . . . . 0.0 111.725 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.22 -8.78 34.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.896 0.379 . . . . 0.0 111.341 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 64.7 t0 -91.86 -22.73 19.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.782 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -80.83 -19.16 45.21 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.486 0.66 . . . . 0.0 110.78 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.58 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -105.34 -171.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.745 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 1.6 t -168.5 136.27 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.206 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -106.91 110.72 22.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.819 0.342 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.486 ' HB3' HD23 ' A' ' 237' ' ' LEU . 58.9 ttm-85 -117.1 142.73 46.63 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.447 0.642 . . . . 0.0 110.532 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.84 99.62 2.33 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.626 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.6 OUTLIER -79.29 9.94 4.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.823 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . 0.548 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 10.26 -95.89 0.01 OUTLIER Glycine 0 N--CA 1.476 1.314 0 O-C-N 123.534 0.521 . . . . 0.0 112.068 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 281' ' ' GLU . 56.1 mp0 -135.68 75.05 1.54 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.835 0.35 . . . . 0.0 110.591 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.429 ' OG ' ' SD ' ' A' ' 279' ' ' MET . 53.8 m -83.65 -3.63 57.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 283' ' ' ASN . 11.4 p-10 -176.42 80.21 0.27 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.593 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.14 107.64 0.27 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.65 2.233 . . . . 0.0 112.214 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 286' ' ' THR . 9.6 m -88.77 -36.63 9.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.524 0.678 . . . . 0.0 110.757 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 286' ' ' THR . 0.2 OUTLIER -60.92 -43.67 98.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.954 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 290' ' ' CYS . . . -45.57 -88.96 0.01 OUTLIER Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 287' ' ' GLY . 86.6 m-20 -27.61 -53.92 0.09 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.655 0.264 . . . . 0.0 110.35 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.4 m -56.06 -47.04 78.7 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.478 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.621 ' N ' ' O ' ' A' ' 287' ' ' GLY . 0.3 OUTLIER -98.37 34.19 2.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 109.928 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 293' ' ' VAL . 51.5 t0 -57.98 -42.61 85.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.447 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -75.43 32.32 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.569 HG21 ' SG ' ' A' ' 290' ' ' CYS . 21.2 t -131.18 113.14 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.92 0.391 . . . . 0.0 110.665 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -118.97 14.22 13.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.605 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.446 ' O ' HD12 ' A' ' 299' ' ' LEU . 1.6 mt-30 -86.65 166.9 14.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.111 0.481 . . . . 0.0 110.308 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -78.78 -67.36 0.75 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.532 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 301' ' ' ASP . . . -61.77 -27.33 68.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.223 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.588 ' O ' ' OD1' ' A' ' 301' ' ' ASP . . . -71.99 -24.26 61.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.156 0.503 . . . . 0.0 110.933 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 295' ' ' GLN . 71.2 mt -86.69 -48.11 8.57 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.66 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.74 -31.8 48.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.054 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.588 ' OD1' ' O ' ' A' ' 298' ' ' ALA . 43.3 p-10 -82.95 -43.77 16.08 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.602 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.574 ' N ' ' OD1' ' A' ' 301' ' ' ASP . 13.1 t -74.86 -13.77 60.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.156 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 35.4 mt -87.39 21.07 2.58 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.514 0.509 . . . . 0.0 110.466 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.626 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -72.73 -41.01 6.91 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.0 Cg_exo -58.94 7.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.464 2.776 . . . . 0.0 112.47 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 304' ' ' ALA . 45.8 t0 -108.18 7.51 27.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.871 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.468 ' NH1' ' OD1' ' A' ' 203' ' ' ASN . 62.4 mtm180 -112.66 86.4 2.36 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.454 0.645 . . . . 0.0 109.376 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.546 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 11.0 ptp180 -156.7 130.48 8.3 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.174 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.64 139.69 18.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -122.5 103.41 8.69 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.317 0.58 . . . . 0.0 110.42 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.505 HG23 HG22 ' A' ' 236' ' ' VAL . 0.8 OUTLIER -79.46 117.89 25.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -94.9 121.51 36.57 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.642 0.258 . . . . 0.0 110.891 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 1.085 HG21 HD22 ' A' ' 224' ' ' LEU . 54.6 t -122.95 117.89 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -114.27 133.87 55.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 102.25 18.84 15.79 Favored Glycine 0 C--O 1.22 -0.759 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 20.2 tt -105.29 146.81 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 110.644 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 64.9 pttt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.848 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.933 0.397 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.8 m -77.91 142.03 38.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.131 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 193' ' ' HIS . 21.5 tptt -114.42 166.83 11.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.123 0.487 . . . . 0.0 110.553 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 192' ' ' LYS . 53.2 m80 -155.74 124.21 5.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.836 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.617 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 60.2 m-85 -113.66 120.13 39.82 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.15 103.66 14.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.08 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.708 ' CD2' HD11 ' A' ' 201' ' ' LEU . 28.8 tp -105.11 124.24 49.2 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -78.67 129.33 34.6 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 121.897 0.856 . . . . 0.0 112.206 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.0 t -62.3 -32.99 73.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.026 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -54.88 -35.94 64.6 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.085 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 71.0 t -71.48 -38.77 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.878 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.708 HD11 ' CD2' ' A' ' 196' ' ' LEU . 91.8 mt -84.41 -80.59 0.2 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.808 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -124.55 133.16 53.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.076 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.447 ' N ' ' OD1' ' A' ' 203' ' ' ASN . 1.6 m-20 -104.27 -71.11 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.567 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -107.49 -16.48 14.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.808 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 26.6 t30 -71.9 170.13 14.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.062 0.458 . . . . 0.0 110.241 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -52.49 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.491 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.475 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -162.19 4.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.503 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.528 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 76.8 p -55.02 144.89 21.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.014 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 28.0 mt -88.96 133.2 34.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 213' ' ' GLY . 1.5 mptm? -90.74 157.77 43.35 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.975 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -34.1 -74.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.636 2.224 . . . . 0.0 111.828 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -50.41 -21.63 1.53 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.076 0.465 . . . . 0.0 110.048 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.95 -50.27 13.83 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -66.36 -39.2 89.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.305 0.574 . . . . 0.0 110.151 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.3 -54.31 48.24 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.555 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.29 -38.42 91.07 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.703 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.9 mt -61.59 -27.36 68.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.503 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -74.21 -46.67 40.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.202 0.525 . . . . 0.0 110.443 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -61.77 -43.12 99.48 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.209 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 48.2 tp -66.8 -39.11 87.64 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.442 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.435 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.7 t80 -53.57 -49.37 67.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.849 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.7 t -58.11 -51.04 71.38 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.45 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.617 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 9.2 tt0 -52.18 -26.02 10.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.258 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.982 HD22 HG21 ' A' ' 313' ' ' VAL . 72.0 mt -96.13 -17.96 20.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.507 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.1 t -78.47 -17.6 56.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.758 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -97.36 20.67 11.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.785 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.522 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -80.16 178.12 8.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.861 179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -96.04 133.79 24.72 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.495 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.0 Cg_endo -69.75 -18.6 36.95 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.813 2.342 . . . . 0.0 112.356 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 229' ' ' PRO . 56.4 tttp -36.22 -53.66 0.81 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.457 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 232' ' ' GLY . 36.2 m-20 -100.79 -21.59 15.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.65 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.95 50.45 0.05 OUTLIER Glycine 0 N--CA 1.471 1.003 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.5 m -117.65 111.28 18.95 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 122.671 -0.311 . . . . 0.0 110.398 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 99.0 t -129.0 93.9 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.214 0.531 . . . . 0.0 110.145 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.6 t -98.27 123.4 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.621 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 311' ' ' ILE . 95.3 t -95.36 127.85 47.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.641 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 39.1 mt -111.58 142.44 43.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.662 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -118.94 139.42 14.36 Favored Glycine 0 N--CA 1.48 1.587 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.4 OUTLIER -121.14 121.58 38.15 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.453 HG22 ' NH2' ' A' ' 256' ' ' ARG . 2.6 p -112.09 165.3 12.25 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.987 0.422 . . . . 0.0 110.236 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 241' ' ' ASP . 11.3 p30 -87.82 -177.79 5.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.443 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -105.18 120.23 41.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.052 0.453 . . . . 0.0 110.288 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.3 mm -119.09 15.02 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.399 0.619 . . . . 0.0 110.83 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.5 9.03 87.32 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.7 p -134.45 97.19 3.75 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.894 0.378 . . . . 0.0 110.334 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -52.57 -52.48 54.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.647 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.9 72.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.58 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 56.3 t80 -60.19 -46.75 88.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.524 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.437 HD21 ' H ' ' A' ' 243' ' ' ILE . 91.0 m-20 -61.9 -42.63 99.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.569 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -63.36 -42.54 98.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.553 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.68 -36.08 92.15 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.58 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 32.5 mt -74.28 -32.98 63.12 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.704 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 12.0 m -65.36 -43.69 90.03 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.177 0.513 . . . . 0.0 110.598 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -70.42 -35.23 73.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.928 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -59.86 -50.04 75.34 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.549 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.858 ' O ' HG23 ' A' ' 260' ' ' VAL . 16.4 ptp180 -67.16 -47.52 70.77 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.406 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.83 -39.74 92.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.194 0.521 . . . . 0.0 110.189 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -74.6 -45.51 44.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.16 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 46.5 t -60.65 -38.54 85.2 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.084 0.469 . . . . 0.0 110.238 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.6 t -64.92 -52.06 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.557 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.6 HG13 HD12 ' A' ' 274' ' ' ILE . 18.2 t -61.37 -49.11 85.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.326 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -44.96 -41.83 7.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.961 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -82.53 -30.31 29.83 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -72.34 -7.56 50.23 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.371 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 267' ' ' LYS . 61.2 mt -88.05 -54.7 7.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 72.8 m -51.22 -5.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.6 OUTLIER -79.7 -11.4 59.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.894 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.46 39.11 1.97 Allowed Glycine 0 C--N 1.323 -0.174 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.99 127.89 24.29 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.43 128.01 24.29 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.145 1.897 . . . . 0.0 112.273 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.09 -7.9 20.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.716 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -93.03 -24.41 18.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -78.53 -21.76 48.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.563 0.697 . . . . 0.0 110.587 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.6 HD12 HG13 ' A' ' 261' ' ' VAL . 1.4 pt -102.23 -173.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.865 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 26.3 t -171.61 132.49 0.75 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.484 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.89 153.08 19.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -158.49 144.72 17.1 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.091 0.472 . . . . 0.0 110.804 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.98 97.35 2.06 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.462 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.5 tpt -68.46 -10.68 56.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.907 0.384 . . . . 0.0 110.462 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 45.07 -104.62 0.07 OUTLIER Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.07 70.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.389 . . . . 0.0 110.548 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 14.1 m -88.82 -0.16 57.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.585 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 283' ' ' ASN . 0.1 OUTLIER -169.5 76.66 0.69 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.675 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.76 111.32 3.26 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.536 2.158 . . . . 0.0 111.798 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 286' ' ' THR . 15.5 m -71.52 -39.46 70.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.86 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.625 ' C ' ' H ' ' A' ' 288' ' ' ASN . 21.1 p -63.68 -48.2 78.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.479 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.71 -0.53 0.03 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.625 ' H ' ' C ' ' A' ' 286' ' ' THR . 65.8 t30 -114.0 -60.17 1.92 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.8 t -79.04 -3.86 47.25 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.569 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.4 OUTLIER -127.32 18.22 7.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.531 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 30.1 p-10 -67.57 -3.08 7.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.378 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -99.89 33.41 2.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.451 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.488 HG21 ' SG ' ' A' ' 290' ' ' CYS . 26.6 t -127.95 122.87 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.889 0.376 . . . . 0.0 110.231 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -119.59 6.5 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.824 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.9 168.39 12.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.057 0.456 . . . . 0.0 110.168 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -80.02 -74.89 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.758 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 300' ' ' ILE . . . -55.92 -26.46 47.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.818 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.89 -34.69 78.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.146 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.2 mt -75.46 -64.71 1.01 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 297' ' ' ALA . 10.9 pt -48.41 -30.24 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.396 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -76.62 -42.66 41.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.567 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 15.3 t -80.45 -10.54 59.74 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.73 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.52 HD23 ' OG1' ' A' ' 286' ' ' THR . 54.2 mt -91.95 21.81 4.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.69 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -76.61 -45.12 3.25 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 121.156 0.503 . . . . 0.0 110.375 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 25.2 Cg_exo -61.81 9.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.233 2.622 . . . . 0.0 111.654 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 304' ' ' ALA . 51.0 t0 -106.49 11.08 31.1 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.623 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -111.25 103.26 11.65 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.349 0.595 . . . . 0.0 110.402 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -172.17 153.48 3.09 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.222 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.662 HG12 ' HA2' ' A' ' 238' ' ' GLY . 34.7 m -116.16 149.69 18.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -120.22 107.77 13.39 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.089 0.471 . . . . 0.0 110.839 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 236' ' ' VAL . 3.5 mm -78.37 117.95 24.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -100.74 111.59 23.84 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.301 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.982 HG21 HD22 ' A' ' 224' ' ' LEU . 86.6 t -119.63 123.65 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 O-C-N 123.66 0.6 . . . . 0.0 110.644 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -119.63 140.54 50.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.777 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 101.39 -0.35 53.63 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.8 tt -85.46 144.29 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.064 0.459 . . . . 0.0 110.485 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 52.0 tptt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.435 179.681 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.712 0.291 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.589 HG22 ' N ' ' A' ' 192' ' ' LYS . 23.6 m -69.52 169.35 12.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.46 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.589 ' N ' HG22 ' A' ' 191' ' ' THR . 3.4 tptm -148.83 166.23 29.13 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.083 0.468 . . . . 0.0 110.083 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.502 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 12.8 m80 -153.5 123.93 7.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.756 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -112.09 115.6 29.15 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.434 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.07 103.14 14.46 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.775 -179.239 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.695 ' CD2' HD11 ' A' ' 201' ' ' LEU . 30.2 tp -108.72 132.93 53.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.413 ' HB3' HG23 ' A' ' 200' ' ' VAL . 0.0 OUTLIER -83.76 126.58 33.05 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.244 -178.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.4 m -62.02 -32.35 72.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.332 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.491 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 11.8 m-20 -59.31 -36.52 75.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.81 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 197' ' ' LYS . 94.9 t -68.19 -42.91 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.695 HD11 ' CD2' ' A' ' 196' ' ' LEU . 92.7 mt -78.35 -79.48 0.12 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.244 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.427 ' CD1' ' NH1' ' A' ' 256' ' ' ARG . 0.1 OUTLIER -118.04 122.84 44.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.764 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 8.9 p-10 -91.32 -78.09 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.628 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.503 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 82.5 m-85 -98.0 -14.94 20.29 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.809 0.337 . . . . 0.0 110.659 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -72.61 154.54 40.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.235 0.54 . . . . 0.0 109.718 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.56 ' CG ' ' H ' ' A' ' 207' ' ' ALA . 42.2 pttt -49.8 -59.98 3.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.987 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.56 ' H ' ' CG ' ' A' ' 206' ' ' LYS . . . -168.71 57.18 0.05 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.603 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 64.4 p -107.23 129.92 54.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.7 mt -74.48 146.22 42.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.719 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 213' ' ' GLY . 22.7 mttp -105.87 158.5 32.28 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.946 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -33.85 -76.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.495 2.13 . . . . 0.0 112.231 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -52.62 -18.98 2.03 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.251 0.548 . . . . 0.0 110.16 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.38 -49.37 9.39 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -67.27 -40.8 86.23 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.186 0.517 . . . . 0.0 109.77 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.68 -50.89 71.7 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.589 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.26 86.58 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.635 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.1 mt -62.25 -31.37 71.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -70.17 -45.3 67.0 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.291 0.567 . . . . 0.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -63.06 -42.78 99.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.927 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.495 HD12 HE21 ' A' ' 223' ' ' GLN . 38.8 tp -63.87 -40.28 96.17 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.521 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.508 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.3 t80 -52.65 -47.3 67.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.534 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.7 m -52.27 -51.94 55.64 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.67 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.495 HE21 HD12 ' A' ' 220' ' ' LEU . 15.6 mt-30 -55.43 -26.4 41.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.469 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.559 ' O ' HD22 ' A' ' 227' ' ' LEU . 67.4 mt -94.01 -23.85 17.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.675 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.1 t -75.79 -32.36 59.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.279 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -91.94 21.37 4.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.7 OUTLIER -77.34 173.46 11.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.199 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -88.35 133.7 36.1 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.457 ' O ' ' C ' ' A' ' 230' ' ' LYS . 55.0 Cg_endo -70.56 -18.22 33.38 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.569 2.179 . . . . 0.0 112.709 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 229' ' ' PRO . 11.1 mmtp -28.03 -49.22 0.06 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.594 0.559 . . . . 0.0 110.498 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 67.5 m-20 -118.51 -14.66 9.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.377 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.79 51.27 0.06 OUTLIER Glycine 0 N--CA 1.47 0.929 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.4 m -114.68 110.7 20.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.668 0.271 . . . . 0.0 110.99 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.32 95.67 3.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.811 0.815 . . . . 0.0 109.692 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.11 117.75 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.642 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.495 HG21 ' CG2' ' A' ' 261' ' ' VAL . 24.5 t -93.14 124.17 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.635 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.7 mt -108.6 137.79 45.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.065 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.613 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -120.52 132.42 9.26 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -116.64 126.52 53.35 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.473 HG23 ' OD1' ' A' ' 249' ' ' ASN . 8.0 t -125.14 162.25 25.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -77.35 -175.82 3.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.224 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.1 ptm85 -120.01 133.74 55.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.369 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.7 mm -118.42 24.14 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.582 0.706 . . . . 0.0 110.626 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 80.93 14.49 79.42 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.0 m -137.37 98.94 3.83 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.083 0.468 . . . . 0.0 110.005 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -52.23 -50.41 62.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.295 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.38 -45.65 80.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.939 0.4 . . . . 0.0 110.709 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.629 ' CE2' HD11 ' A' ' 252' ' ' LEU . 52.1 t80 -60.23 -41.67 93.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.349 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.531 HD21 ' CA ' ' A' ' 280' ' ' GLY . 0.6 OUTLIER -60.12 -50.73 72.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.623 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -57.0 -41.5 78.59 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.46 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.41 -41.32 98.49 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.629 HD11 ' CE2' ' A' ' 248' ' ' TYR . 35.6 mt -67.31 -41.03 86.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.913 0.387 . . . . 0.0 111.274 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.5 t -61.42 -40.23 93.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.999 0.428 . . . . 0.0 110.889 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.52 -42.18 78.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.232 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -58.6 -46.54 86.79 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.472 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.427 ' NH1' ' CD1' ' A' ' 202' ' ' PHE . 86.6 mtt-85 -63.92 -62.44 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.772 0.32 . . . . 0.0 110.774 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.39 -35.71 19.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 110.168 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.32 -45.49 59.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.585 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 13.3 t -59.62 -39.06 83.03 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.243 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.28 -52.83 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.414 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.592 HG13 HD12 ' A' ' 274' ' ' ILE . 5.1 t -61.54 -49.27 85.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.215 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -44.7 -42.78 7.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.14 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.638 ' CZ ' ' NZ ' ' A' ' 267' ' ' LYS . 62.2 t80 -80.41 -28.92 37.73 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.766 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -75.0 -4.53 38.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.102 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.576 ' HA ' HG22 ' A' ' 269' ' ' ILE . 55.3 mt -86.23 -52.94 11.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.7 p -54.47 -1.83 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.576 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.638 ' NZ ' ' CZ ' ' A' ' 263' ' ' TYR . 9.7 mptt -87.53 2.56 50.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.704 0.288 . . . . 0.0 110.703 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 89.81 38.31 6.56 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 265' ' ' ILE . 1.2 tp -119.16 120.29 31.23 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -49.09 128.03 18.65 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.173 1.249 . . . . 0.0 112.116 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.04 -16.23 50.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.114 0.483 . . . . 0.0 111.034 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 4.4 m-20 -85.25 -22.62 28.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.077 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -23.5 38.99 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.209 0.528 . . . . 0.0 110.545 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.592 HD12 HG13 ' A' ' 261' ' ' VAL . 1.5 pt -101.98 -174.84 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.985 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 34.8 m -168.96 127.33 1.02 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.224 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.17 110.52 23.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 110.413 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.546 ' NH1' ' SD ' ' A' ' 279' ' ' MET . 73.8 ttt-85 -115.29 139.74 49.71 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.433 0.635 . . . . 0.0 110.985 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.96 95.18 2.06 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.546 ' SD ' ' NH1' ' A' ' 277' ' ' ARG . 3.8 tpt -69.81 -10.63 59.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.665 0.269 . . . . 0.0 110.598 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . 0.531 ' CA ' HD21 ' A' ' 249' ' ' ASN . . . 41.75 -102.36 0.03 OUTLIER Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -141.65 75.58 1.5 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.784 0.326 . . . . 0.0 110.813 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 18.0 m -87.04 0.16 55.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.741 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.491 ' C ' HD22 ' A' ' 283' ' ' ASN . 0.4 OUTLIER -168.16 75.88 0.87 Allowed Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.47 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -60.82 104.14 0.26 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.554 2.17 . . . . 0.0 112.529 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 286' ' ' THR . 28.4 m -69.1 -44.44 81.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.306 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 302' ' ' CYS . 7.6 p -62.49 -46.21 89.48 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.09 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.93 -1.83 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 286' ' ' THR . 28.3 m120 -115.57 -59.36 2.01 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.1 t -80.88 -3.41 51.19 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.71 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.59 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.6 OUTLIER -127.61 16.89 6.97 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.343 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 31.6 p-10 -68.0 -3.06 8.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.986 0.422 . . . . 0.0 110.592 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -100.23 32.45 2.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.706 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.59 HG21 ' SG ' ' A' ' 290' ' ' CYS . 15.6 t -130.78 125.65 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.027 0.442 . . . . 0.0 110.304 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.92 10.64 12.31 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.12 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -104.06 136.28 43.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.099 0.475 . . . . 0.0 110.242 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 297' ' ' ALA . 0.1 OUTLIER -61.53 -46.37 90.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.941 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 296' ' ' ARG . . . -62.68 -46.06 89.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.107 0.48 . . . . 0.0 111.183 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.98 -29.83 70.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.789 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 39.5 mt -78.17 -53.42 7.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.961 0.41 . . . . 0.0 110.535 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 40.0 mt -51.08 -34.81 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.922 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.9 -43.1 22.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.07 0.462 . . . . 0.0 110.315 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.608 ' O ' HG21 ' A' ' 286' ' ' THR . 38.9 t -73.93 -13.56 60.91 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.775 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 299' ' ' LEU . 53.5 mt -90.45 23.16 3.08 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.291 0.369 . . . . 0.0 111.07 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -77.39 -44.35 2.62 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.457 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.8 Cg_exo -62.47 9.35 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.416 2.744 . . . . 0.0 111.807 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 304' ' ' ALA . 0.4 OUTLIER -104.28 10.32 35.61 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.71 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.491 ' NH1' ' OD1' ' A' ' 199' ' ' ASP . 39.2 mtm105 -113.96 94.81 5.0 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.494 0.664 . . . . 0.0 110.195 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.452 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.3 ptm180 -164.08 139.15 5.95 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.136 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.613 HG12 ' HA2' ' A' ' 238' ' ' GLY . 22.6 m -104.69 144.57 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 121.831 -0.543 . . . . 0.0 109.666 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -121.45 106.26 11.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.342 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.452 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.38 118.21 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.796 -177.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 312' ' ' GLU . 0.1 OUTLIER -96.43 135.62 38.05 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.403 HG21 ' CD2' ' A' ' 224' ' ' LEU . 2.2 t -133.38 120.22 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.236 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -117.29 132.34 56.63 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.6 -13.85 50.44 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 20.1 tt -75.38 154.12 6.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.827 0.346 . . . . 0.0 110.487 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.2 pttt . . . . . 0 N--CA 1.464 0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.474 179.715 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.131 0.491 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.424 HG22 ' NE2' ' A' ' 193' ' ' HIS . 12.1 m -73.18 141.24 47.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.274 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -143.46 111.21 5.98 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.4 m-70 -101.39 150.45 23.0 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.577 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 59.6 m-85 -111.28 118.67 36.52 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 195' ' ' THR . 6.9 t -85.26 102.46 13.37 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.837 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.769 HD23 HD11 ' A' ' 201' ' ' LEU . 31.0 tp -105.34 137.26 43.42 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.437 0.637 . . . . 0.0 109.955 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.444 ' H ' ' HG2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -90.06 130.38 36.24 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-O 122.564 1.174 . . . . 0.0 112.021 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 202' ' ' PHE . 7.3 t -60.24 -24.74 65.11 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.255 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -58.31 -43.71 88.28 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.955 0.407 . . . . 0.0 110.423 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.85 -42.7 92.67 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.637 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.769 HD11 HD23 ' A' ' 196' ' ' LEU . 84.9 mt -80.78 -78.36 0.18 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.391 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.47 ' O ' ' OG ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -128.43 102.73 6.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.98 -178.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.494 ' OD1' ' CD2' ' A' ' 204' ' ' PHE . 14.3 t-20 -67.4 -70.38 0.26 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.205 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.494 ' CD2' ' OD1' ' A' ' 203' ' ' ASN . 59.7 m-85 -108.51 -10.96 15.2 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.733 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -69.84 161.56 29.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.038 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -55.9 -75.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.415 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.59 49.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 41.6 p -107.33 128.02 54.08 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.819 0.342 . . . . 0.0 110.193 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.47 HD22 HD22 ' A' ' 201' ' ' LEU . 30.5 mt -73.32 129.57 38.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.147 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 213' ' ' GLY . 58.5 mttt -91.6 159.92 37.65 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.696 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 210' ' ' LYS . 71.0 Cg_exo -33.12 -76.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.463 2.109 . . . . 0.0 111.549 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -49.57 -21.97 1.14 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.185 0.517 . . . . 0.0 110.31 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.27 -48.88 22.99 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.23 -38.91 91.89 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.91 63.23 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.225 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.33 -30.42 71.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.533 0.682 . . . . 0.0 110.237 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.24 -28.37 65.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.301 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -76.4 -48.54 19.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.32 0.581 . . . . 0.0 111.319 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.432 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 4.9 pt20 -64.02 -42.43 97.12 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.498 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.484 HD21 HD12 ' A' ' 311' ' ' ILE . 45.0 tp -63.96 -42.16 97.36 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.452 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.4 t80 -51.4 -50.57 59.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.46 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.6 p -56.96 -50.31 73.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.456 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.577 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 10.5 tt0 -50.65 -25.82 4.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.506 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.686 HD22 HG21 ' A' ' 313' ' ' VAL . 39.0 mt -97.42 -15.27 20.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 53.4 p -79.76 -10.31 59.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.49 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -107.82 18.77 20.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.499 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.23 173.14 12.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.15 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 6.5 t70 -88.66 132.1 39.71 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 230' ' ' LYS . 57.1 Cg_endo -72.05 -18.8 27.18 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.718 2.279 . . . . 0.0 112.643 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 229' ' ' PRO . 61.9 tttm -32.63 -52.07 0.3 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.635 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 232' ' ' GLY . 85.8 m-20 -104.69 -17.94 14.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.579 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 27.41 50.19 0.07 OUTLIER Glycine 0 N--CA 1.474 1.215 0 O-C-N 123.917 0.761 . . . . 0.0 111.333 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 16.7 m -115.97 108.07 15.78 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 122.586 -0.361 . . . . 0.0 110.927 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 74.2 t -124.82 93.61 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.939 0.876 . . . . 0.0 109.926 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.405 HG11 ' NH2' ' A' ' 277' ' ' ARG . 66.5 t -97.7 120.89 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.456 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.572 HG22 HG23 ' A' ' 311' ' ' ILE . 48.6 t -93.36 124.48 45.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.522 HD21 ' NE ' ' A' ' 277' ' ' ARG . 28.8 mt -108.05 139.72 42.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.861 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -121.57 130.01 7.94 Favored Glycine 0 N--CA 1.477 1.38 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.12 119.47 36.51 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.637 HG22 ' N ' ' A' ' 241' ' ' ASP . 98.4 m -109.6 170.45 8.06 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.37 0.419 . . . . 0.0 110.462 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.637 ' N ' HG22 ' A' ' 240' ' ' THR . 26.1 p-10 -83.07 -176.08 6.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.448 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 281' ' ' GLU . 62.4 ttm-85 -105.23 121.96 44.94 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.813 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 243' ' ' ILE . 46.3 mm -119.43 7.44 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.565 0.698 . . . . 0.0 110.813 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 85.62 -47.21 3.77 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.66 91.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 0.0 109.685 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -45.91 -48.23 16.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.41 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.4 82.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.878 0.37 . . . . 0.0 110.61 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.615 ' CE2' HD11 ' A' ' 252' ' ' LEU . 51.7 t80 -62.06 -45.24 94.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.525 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 241' ' ' ASP . 33.2 t30 -61.49 -43.87 98.09 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.652 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -64.76 -41.25 96.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.634 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.49 -36.78 93.65 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.615 HD11 ' CE2' ' A' ' 248' ' ' TYR . 30.5 mt -70.06 -41.17 74.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.915 0.388 . . . . 0.0 111.013 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 78.1 p -65.13 -39.61 93.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.818 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.3 -47.1 71.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.92 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -59.43 -43.84 93.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.799 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 239' ' ' TYR . 39.1 ttm180 -54.1 -61.41 2.32 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.329 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -58.7 -27.57 64.98 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.638 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -69.78 -47.31 63.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.374 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 38.5 m -62.17 -37.93 87.12 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.069 0.461 . . . . 0.0 110.393 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 256' ' ' ARG . 77.4 t -63.65 -53.21 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.723 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.533 HG13 HD12 ' A' ' 274' ' ' ILE . 18.0 t -62.02 -48.77 86.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.669 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -45.16 -41.71 8.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.228 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.638 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 57.7 t80 -82.86 -28.9 29.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.764 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.01 -8.05 54.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.437 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.9 mt -88.44 -55.75 6.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.789 0.328 . . . . 0.0 111.619 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 41.6 m -50.61 -4.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.974 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.638 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 33.4 mmtm -77.48 -10.55 59.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.743 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.74 -7.44 22.09 Favored Glycine 0 C--O 1.227 -0.283 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.06 141.72 47.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.404 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.48 132.28 30.68 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.268 1.979 . . . . 0.0 111.826 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.04 -4.1 19.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.517 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -94.15 -26.24 16.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.451 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -79.55 -17.38 54.13 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.237 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.533 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -104.24 -171.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.695 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 39.4 m -168.68 130.51 1.29 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.311 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.88 111.16 23.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.882 0.372 . . . . 0.0 110.627 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.522 ' NE ' HD21 ' A' ' 237' ' ' LEU . 41.4 ttp180 -123.13 148.74 45.38 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.152 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.63 148.83 16.49 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.545 ' N ' ' O ' ' A' ' 238' ' ' GLY . 83.9 mmm -121.99 15.98 10.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 119.335 -0.365 . . . . 0.0 111.554 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 23.32 -88.46 0.01 OUTLIER Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 279' ' ' MET . 0.6 OUTLIER -142.72 74.25 1.44 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.096 0.474 . . . . 0.0 110.738 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.4 t -72.22 -54.05 10.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.836 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -137.77 74.06 45.92 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.779 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.02 120.39 8.22 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.652 2.235 . . . . 0.0 112.26 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.4 m -75.91 -23.91 16.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.279 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.615 ' C ' ' H ' ' A' ' 288' ' ' ASN . 31.2 p -58.41 -44.9 89.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.612 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.21 -4.29 0.02 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.615 ' H ' ' C ' ' A' ' 286' ' ' THR . 22.0 m120 -126.13 -58.25 1.37 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.0 m -60.52 -22.86 64.06 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.55 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 63.5 m -121.07 27.79 8.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.47 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 29.4 p-10 -68.42 -2.85 9.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.664 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -111.49 31.98 5.73 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.494 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.405 ' O ' HD21 ' A' ' 299' ' ' LEU . 15.5 t -137.86 117.67 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.865 0.364 . . . . 0.0 110.755 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -120.72 14.0 11.66 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.698 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.442 ' O ' HD12 ' A' ' 299' ' ' LEU . 1.5 mp0 -89.6 174.52 7.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.122 0.487 . . . . 0.0 109.849 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -81.01 -75.7 0.27 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -59.1 -27.52 65.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.984 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.87 95.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.481 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 303' ' ' LEU . 60.1 mt -69.36 -50.41 46.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.05 0.452 . . . . 0.0 110.646 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 62.7 mt -53.53 -34.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.006 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -78.34 -35.19 47.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.443 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 0.8 OUTLIER -85.57 -10.59 55.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.539 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.571 ' HA ' HG21 ' A' ' 286' ' ' THR . 47.8 mt -91.55 23.77 3.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.515 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.583 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -85.12 -44.64 0.66 Allowed Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.5 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 33.1 Cg_exo -59.12 7.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.56 2.84 . . . . 0.0 112.232 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 304' ' ' ALA . 35.9 p30 -107.04 18.15 22.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.708 0.289 . . . . 0.0 110.796 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -113.21 98.58 7.22 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.514 0.673 . . . . 0.0 109.881 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 38.0 ptt180 -159.85 133.58 7.2 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.147 -0.621 . . . . 0.0 112.016 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.14 141.37 15.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -122.81 104.28 9.18 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.257 0.551 . . . . 0.0 110.313 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.572 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.87 117.47 25.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -93.35 123.05 36.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 123.12 0.263 . . . . 0.0 110.624 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.686 HG21 HD22 ' A' ' 224' ' ' LEU . 14.6 t -123.12 115.79 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.318 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -115.53 129.11 56.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 105.9 12.04 26.88 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 15.4 tt -93.71 137.34 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.226 0.536 . . . . 0.0 110.672 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.709 179.939 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.99 0.424 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.456 HG22 ' NE2' ' A' ' 193' ' ' HIS . 24.1 m -67.38 125.24 25.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.411 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 313' ' ' VAL . 41.6 tptt -117.1 162.14 18.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.205 0.526 . . . . 0.0 111.04 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.456 ' NE2' HG22 ' A' ' 191' ' ' THR . 87.2 m-70 -149.27 123.16 9.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.112 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.487 ' CE2' HD21 ' A' ' 224' ' ' LEU . 65.2 m-85 -114.82 118.92 34.89 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.469 ' OG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -86.36 108.03 18.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.639 -179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.713 ' CD2' HD11 ' A' ' 201' ' ' LEU . 27.0 tp -109.4 125.35 52.3 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -83.17 129.9 35.06 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 122.192 0.996 . . . . 0.0 112.602 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 202' ' ' PHE . 93.6 p -60.35 -27.87 67.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.834 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 203' ' ' ASN . 14.1 t70 -54.28 -40.56 67.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.03 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.5 t -72.74 -33.44 44.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.713 HD11 ' CD2' ' A' ' 196' ' ' LEU . 79.2 mt -89.43 -79.54 0.33 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.51 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -127.86 116.27 19.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.745 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.43 ' OD1' ' OD1' ' A' ' 199' ' ' ASP . 3.1 m-80 -82.26 -64.59 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.772 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -116.73 -17.52 10.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.77 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.531 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 54.4 t30 -66.16 164.92 14.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.058 0.456 . . . . 0.0 110.194 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -50.85 -80.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.507 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.49 53.0 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.214 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.531 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 42.5 p -107.24 134.38 50.41 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.168 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.403 HD22 HD22 ' A' ' 201' ' ' LEU . 18.1 mt -78.17 127.3 32.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.284 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' GLY . 8.0 ptmt -85.01 161.87 51.31 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.717 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -36.89 -75.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.075 1.85 . . . . 0.0 111.553 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -50.54 -19.89 1.02 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.017 0.437 . . . . 0.0 109.963 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.84 -52.08 13.09 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.6 -38.89 90.75 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.158 0.504 . . . . 0.0 109.903 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.53 57.13 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.85 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.81 88.76 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.763 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.2 mt -62.27 -29.08 70.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.519 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -72.34 -45.94 57.69 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.379 0.609 . . . . 0.0 110.486 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.528 ' O ' ' NE2' ' A' ' 223' ' ' GLN . 6.7 mt-30 -62.14 -42.95 99.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.081 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.45 -39.63 92.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.586 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 225' ' ' SER . 7.1 t80 -52.87 -46.73 68.03 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.46 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.4 m -55.1 -51.32 66.79 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.684 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.913 HE21 ' H ' ' A' ' 223' ' ' GLN . 0.0 OUTLIER -55.86 -27.02 49.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.582 -179.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.995 HD22 HG21 ' A' ' 313' ' ' VAL . 78.0 mt -95.95 -21.18 18.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.769 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 221' ' ' TYR . 9.2 p -84.7 -13.43 51.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.476 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -106.4 23.6 13.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.157 0.503 . . . . 0.0 110.654 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.58 -179.31 5.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.687 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -101.41 109.11 58.05 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 232' ' ' GLY . 73.9 Cg_exo -44.45 -19.22 0.23 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.829 2.353 . . . . 0.0 112.964 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 229' ' ' PRO . 3.4 ttmp? -24.51 -47.57 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.691 0.619 . . . . 0.0 110.775 -178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 97.6 m-20 -116.49 -11.95 11.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.648 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 24.9 47.76 0.02 OUTLIER Glycine 0 N--CA 1.47 0.963 0 O-C-N 123.587 0.554 . . . . 0.0 111.841 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 231' ' ' ASP . 2.3 m -118.36 117.48 29.19 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 122.588 -0.36 . . . . 0.0 110.171 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.618 HG22 HG22 ' A' ' 313' ' ' VAL . 59.6 t -132.21 95.71 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.57 0.7 . . . . 0.0 110.675 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.3 125.18 51.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.283 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.86 129.83 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.428 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.0 mt -114.02 140.0 48.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.684 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -115.42 141.04 16.72 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.5 OUTLIER -121.55 123.93 43.16 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 249' ' ' ASN . 2.1 p -118.5 161.77 19.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.106 0.479 . . . . 0.0 110.076 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.526 ' OD2' ' NE ' ' A' ' 307' ' ' ARG . 8.5 p30 -84.05 174.91 9.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.337 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -97.31 122.28 40.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.226 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.0 mm -117.15 14.97 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.363 0.601 . . . . 0.0 110.65 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.2 4.51 88.95 Favored Glycine 0 C--N 1.314 -0.688 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 24.8 m -130.07 102.19 6.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 110.235 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -52.31 -51.96 55.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.679 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.9 -42.52 76.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.726 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.569 ' CE2' HD11 ' A' ' 252' ' ' LEU . 33.9 t80 -60.4 -46.08 91.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.552 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.439 ' O ' ' OG ' ' A' ' 253' ' ' SER . 14.5 t-20 -62.92 -46.09 89.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.829 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -63.01 -42.48 99.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.719 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.54 -38.16 95.91 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.569 HD11 ' CE2' ' A' ' 248' ' ' TYR . 28.1 mt -73.71 -34.37 64.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.676 0.274 . . . . 0.0 111.084 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 249' ' ' ASN . 4.4 m -65.26 -44.37 88.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.025 0.44 . . . . 0.0 110.629 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -68.26 -43.67 77.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.084 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -58.59 -47.14 85.3 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.914 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.611 ' O ' HG23 ' A' ' 260' ' ' VAL . 99.5 mtt180 -62.68 -55.0 30.88 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.392 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.49 -33.76 68.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.193 0.521 . . . . 0.0 109.942 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -45.89 41.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.283 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 43.0 t -60.06 -39.85 87.45 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 256' ' ' ARG . 86.2 t -64.23 -52.5 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.461 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.619 HG13 HD12 ' A' ' 274' ' ' ILE . 10.6 t -61.15 -49.48 84.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.172 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -44.9 -41.45 7.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.895 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.25 -29.7 31.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.568 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.405 ' O ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -72.8 -7.73 52.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.268 -179.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.559 ' C ' ' H ' ' A' ' 267' ' ' LYS . 59.7 mt -87.81 -57.15 4.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.845 0.355 . . . . 0.0 111.472 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 p -49.95 -6.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.974 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 265' ' ' ILE . 4.8 mmtm -78.84 -10.6 59.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.092 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 108.8 37.42 2.04 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.04 128.21 24.21 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.75 130.43 37.12 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.892 1.728 . . . . 0.0 112.062 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.85 -9.27 35.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.001 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 52.0 t0 -92.79 -22.93 19.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.779 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.404 ' HZ2' ' HB3' ' A' ' 273' ' ' LYS . 1.0 OUTLIER -79.49 -21.17 45.7 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.714 0.769 . . . . 0.0 110.548 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.619 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -103.18 -171.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.051 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 1.3 m -166.8 130.23 1.9 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.153 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -105.02 112.79 26.05 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.633 0.254 . . . . 0.0 110.642 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -122.54 147.21 46.65 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.509 0.671 . . . . 0.0 110.517 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.77 99.09 2.25 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.4 tpt -67.99 -11.44 58.88 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.445 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.54 -95.53 0.01 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 279' ' ' MET . 97.8 mt-10 -141.41 75.68 1.51 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 110.8 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.1 p -87.76 -4.9 58.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -172.96 78.93 0.42 Allowed Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.756 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.29 104.62 0.43 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.539 2.159 . . . . 0.0 112.305 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 286' ' ' THR . 17.5 m -70.59 -40.39 77.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.268 0.556 . . . . 0.0 110.193 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.603 ' C ' ' H ' ' A' ' 288' ' ' ASN . 17.7 p -64.81 -47.44 78.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.099 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.65 -1.68 0.04 OUTLIER Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.5 t-20 -112.31 -59.83 1.95 Allowed 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.91 -4.18 55.97 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.382 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.636 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.7 OUTLIER -126.59 16.64 7.56 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.38 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.62 -3.1 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.382 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -101.95 32.37 3.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.636 HG21 ' SG ' ' A' ' 290' ' ' CYS . 21.8 t -129.36 121.43 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.02 0.438 . . . . 0.0 110.143 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -118.88 8.51 11.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.67 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.431 ' O ' HD12 ' A' ' 299' ' ' LEU . 3.2 mp0 -90.71 169.45 10.96 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 110.04 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -82.65 -78.24 0.21 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.636 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -50.7 -29.97 12.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.97 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.99 99.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.244 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.7 mt -68.93 -42.46 76.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.542 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.4 mm -59.48 -34.13 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.015 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.18 -25.41 31.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.412 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.556 ' O ' HG21 ' A' ' 286' ' ' THR . 11.3 t -94.34 -15.19 24.62 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.962 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 299' ' ' LEU . 54.1 mt -91.88 22.72 4.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.717 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.567 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -75.81 -44.86 4.04 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.316 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 22.2 Cg_exo -64.15 8.7 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.434 2.756 . . . . 0.0 111.817 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 304' ' ' ALA . 7.4 t70 -108.41 7.31 26.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.696 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.526 ' NE ' ' OD2' ' A' ' 241' ' ' ASP . 93.1 mtt180 -109.62 100.54 9.56 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.151 0.5 . . . . 0.0 110.086 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.469 ' NH2' ' OG1' ' A' ' 195' ' ' THR . 16.9 ptm180 -173.43 166.62 4.72 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.888 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.684 HG12 ' HA2' ' A' ' 238' ' ' GLY . 34.2 m -126.8 151.06 33.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -120.92 108.37 13.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.178 0.513 . . . . 0.0 110.251 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.4 mm -80.02 119.49 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.767 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -104.33 114.88 29.42 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.02 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.995 HG21 HD22 ' A' ' 224' ' ' LEU . 70.4 t -127.81 123.18 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.658 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -118.98 148.14 43.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.009 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.43 25.03 31.85 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.645 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.2 tt -103.17 177.3 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.645 ' O ' ' O ' ' A' ' 316' ' ' ILE . 14.2 mptt . . . . . 0 CA--C 1.533 0.322 0 O-C-N 124.124 0.89 . . . . 0.0 110.763 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 120.949 0.404 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m -70.64 145.99 50.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.209 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.435 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 10.6 tptp -146.33 165.03 30.52 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.225 0.536 . . . . 0.0 110.326 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.435 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 89.2 m-70 -152.83 126.47 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.216 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 70.1 m-85 -114.84 124.67 52.33 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.538 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -87.52 108.97 19.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.859 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.708 ' CD2' HD11 ' A' ' 201' ' ' LEU . 27.5 tp -110.96 126.99 55.34 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -78.59 129.5 34.85 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.735 0.778 . . . . 0.0 111.932 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.486 ' H ' ' HA ' ' A' ' 308' ' ' ARG . 58.2 m -69.11 -30.86 69.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.404 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.461 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 2.4 p-10 -62.39 -33.81 75.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.657 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.48 -34.97 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.708 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.6 mt -85.62 -81.82 0.2 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.804 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -112.54 132.44 55.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.047 -179.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 199' ' ' ASP . 66.5 m-80 -111.65 -81.06 0.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.805 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -83.6 -37.61 22.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -64.43 162.29 15.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.056 0.455 . . . . 0.0 110.504 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -52.24 -66.94 0.3 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.583 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.49 61.14 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.471 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 75.3 p -107.44 134.12 50.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.138 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.66 145.08 45.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 213' ' ' GLY . 13.4 mmmt -104.1 153.11 39.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.017 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 210' ' ' LYS . 86.4 Cg_exo -32.34 -77.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.545 2.163 . . . . 0.0 112.265 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -51.22 -18.81 1.0 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.353 0.597 . . . . 0.0 110.376 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.9 -49.83 8.39 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.052 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -65.98 -41.93 90.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.079 0.466 . . . . 0.0 110.142 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.6 -49.6 75.88 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.399 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.81 92.55 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.486 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.01 -31.31 71.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.311 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.47 -46.32 66.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 0.0 110.852 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -62.71 -41.73 99.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.065 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 50.9 tp -66.02 -39.43 90.22 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.475 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.5 t80 -54.82 -47.99 73.38 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.168 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.1 t -57.6 -51.18 70.54 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.41 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 11.4 tt0 -53.45 -25.0 14.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.689 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.902 HD22 HG21 ' A' ' 313' ' ' VAL . 68.2 mt -100.29 -22.1 15.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 221' ' ' TYR . 7.5 t -67.87 -17.65 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 58.1 t-20 -111.83 29.46 7.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 227' ' ' LEU . 1.1 pt? -78.94 141.69 37.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 109.987 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 315' ' ' GLY . 38.6 t0 -50.66 107.38 0.8 Allowed Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 232' ' ' GLY . 47.9 Cg_exo -54.3 -19.22 16.28 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.219 1.946 . . . . 0.0 113.018 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.494 ' C ' ' O ' ' A' ' 229' ' ' PRO . 38.1 ttmt -21.42 -50.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.539 0.525 . . . . 0.0 111.376 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 232' ' ' GLY . 2.6 m-20 -115.87 -8.09 11.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.96 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.09 54.77 0.16 Allowed Glycine 0 N--CA 1.473 1.119 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.648 ' H ' ' HD2' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -123.24 116.7 23.81 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 121.294 0.569 . . . . 0.0 110.847 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 79.1 t -131.28 101.33 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.652 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.41 123.04 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.018 0.437 . . . . 0.0 110.59 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.541 HG13 HD13 ' A' ' 311' ' ' ILE . 87.2 t -94.73 127.67 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.244 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 28.3 mt -110.23 145.95 36.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.014 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -111.14 136.47 13.62 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.488 ' CZ ' ' CD ' ' A' ' 310' ' ' GLU . 6.7 m-85 -122.12 115.95 23.36 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 17.5 p -112.72 165.8 11.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.933 0.397 . . . . 0.0 110.692 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -88.43 -177.36 5.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.323 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -97.44 122.18 40.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.33 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.9 mm -118.6 13.42 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.187 0.518 . . . . 0.0 110.689 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.14 1.56 80.52 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.3 p -129.05 104.45 7.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.173 0.511 . . . . 0.0 109.964 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -55.23 -53.13 59.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.358 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.96 -46.29 78.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.59 ' CE2' HD11 ' A' ' 252' ' ' LEU . 62.8 t80 -60.23 -44.98 94.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.62 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.682 HD21 ' H ' ' A' ' 243' ' ' ILE . 77.2 m-20 -61.43 -45.3 94.87 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.35 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -66.29 -37.69 86.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.551 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.11 -40.45 98.55 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.59 HD11 ' CE2' ' A' ' 248' ' ' TYR . 85.4 mt -73.95 -29.92 62.26 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.695 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 14.9 m -66.81 -47.53 71.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.937 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.84 -41.39 78.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.325 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.16 -49.44 77.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.026 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -60.85 -58.6 7.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.495 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.98 -35.69 25.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.068 0.461 . . . . 0.0 109.902 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -71.57 -45.06 63.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.325 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 57.3 m -60.53 -39.47 87.96 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.446 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.69 -51.04 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.406 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.595 HG13 HD12 ' A' ' 274' ' ' ILE . 28.8 t -60.28 -49.7 83.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.152 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -44.63 -41.99 7.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.18 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.558 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 76.8 t80 -81.3 -29.16 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.037 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.93 -5.84 48.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.654 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 267' ' ' LYS . 53.0 mt -88.73 -60.3 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.917 0.389 . . . . 0.0 111.953 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 29.5 t -49.81 -4.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.391 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' A' ' 265' ' ' ILE . 70.7 mmtt -75.76 -10.79 59.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.442 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 116.76 -8.47 16.9 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -83.35 129.34 60.87 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.425 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.28 134.36 56.51 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.641 1.56 . . . . 0.0 111.896 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.61 55.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -92.61 -21.15 20.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.055 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -77.86 -22.97 49.06 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.611 0.719 . . . . 0.0 110.593 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.595 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -101.51 -170.94 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.771 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 15.2 t -170.08 130.18 0.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.102 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.41 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -96.29 153.3 17.89 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.942 -0.473 . . . . 0.0 109.756 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -161.48 149.4 15.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.023 0.44 . . . . 0.0 110.72 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.51 96.78 1.1 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 15.6 tpp -69.86 -13.15 62.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.509 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 57.79 -101.42 0.18 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.66 71.04 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.822 0.344 . . . . 0.0 110.779 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 25.2 t -90.78 -1.55 57.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.662 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -157.73 68.66 4.0 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.317 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.27 105.41 2.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.188 1.925 . . . . 0.0 112.301 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 30.2 m -75.54 -25.7 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.597 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.617 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.0 OUTLIER -58.64 -44.47 90.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.912 -179.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.5 -3.08 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.617 ' H ' ' C ' ' A' ' 286' ' ' THR . 94.8 m-20 -122.62 -57.82 1.71 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 m -63.89 -21.31 66.4 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.698 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 55.9 m -122.18 26.0 8.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.281 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 47.5 t0 -70.71 -6.04 34.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.594 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -110.11 30.55 6.63 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.572 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 15.1 t -133.39 120.04 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.462 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -120.27 8.93 10.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.473 ' O ' HD12 ' A' ' 299' ' ' LEU . 3.0 mt-30 -86.17 171.96 10.91 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -80.91 -73.85 0.35 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.755 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -59.25 -26.86 65.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.21 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.55 84.65 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.8 mt -72.21 -47.68 48.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.744 0.307 . . . . 0.0 110.744 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.21 -31.27 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.081 0.467 . . . . 0.0 109.876 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -80.58 -29.65 36.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.68 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.6 t -93.31 -10.72 34.44 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 299' ' ' LEU . 49.8 mt -92.23 19.95 6.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.727 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.608 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -74.07 -41.85 5.46 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.4 Cg_exo -62.71 9.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.408 2.739 . . . . 0.0 112.314 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 304' ' ' ALA . 38.8 t0 -112.54 7.37 18.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.884 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 64.6 mtp180 -104.43 100.43 10.13 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.021 0.439 . . . . 0.0 110.05 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.486 ' HA ' ' H ' ' A' ' 198' ' ' SER . 39.2 ptt180 -171.32 -171.14 0.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.287 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.47 155.85 14.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.488 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 96.2 mt-10 -122.8 102.74 8.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.25 0.547 . . . . 0.0 110.395 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.541 HD13 HG13 ' A' ' 236' ' ' VAL . 3.6 mm -79.18 120.81 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.711 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -101.93 121.31 41.89 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.568 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.902 HG21 HD22 ' A' ' 224' ' ' LEU . 70.4 t -130.04 123.4 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.928 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.648 ' HD2' ' H ' ' A' ' 233' ' ' SER . 0.0 OUTLIER -95.25 -174.21 3.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.935 178.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.565 ' CA ' ' HZ3' ' A' ' 314' ' ' LYS . . . 16.69 69.21 0.01 OUTLIER Glycine 0 N--CA 1.472 1.047 0 O-C-N 123.677 0.611 . . . . 0.0 112.386 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 317' ' ' LYS . 4.1 tt -115.18 160.06 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.46 ' H ' HG13 ' A' ' 316' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 122.239 1.018 . . . . 0.0 111.226 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.405 ' N ' ' NE2' ' A' ' 190' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.07 0.462 . . . . 0.0 110.562 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.41 ' CG2' ' CE1' ' A' ' 193' ' ' HIS . 29.0 m -87.79 141.17 28.81 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.045 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -133.86 97.4 3.89 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.392 0.615 . . . . 0.0 111.725 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.41 ' CE1' ' CG2' ' A' ' 191' ' ' THR . 8.7 m80 -84.71 135.75 34.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.106 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.615 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 62.0 m-85 -111.04 124.32 51.94 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.876 0.37 . . . . 0.0 110.103 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.6 102.44 14.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.166 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.692 ' CD2' HD11 ' A' ' 201' ' ' LEU . 32.0 tp -104.54 125.66 50.9 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.301 0.572 . . . . 0.0 109.727 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.406 ' HG3' ' H ' ' A' ' 199' ' ' ASP . 39.8 tptt -79.15 128.66 33.57 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-O 122.349 1.071 . . . . 0.0 112.177 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 202' ' ' PHE . 94.5 p -61.25 -30.6 70.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.289 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.406 ' H ' ' HG3' ' A' ' 197' ' ' LYS . 95.8 m-20 -58.56 -37.79 76.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.05 -43.79 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 196' ' ' LEU . 90.4 mt -78.63 -78.25 0.15 Allowed 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.921 -0.711 . . . . 0.0 110.583 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -128.48 130.38 47.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.147 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -96.3 -70.92 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.472 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -106.31 -13.86 15.27 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.932 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.59 168.09 18.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.059 0.457 . . . . 0.0 110.199 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.631 ' NZ ' ' NH1' ' A' ' 255' ' ' ARG . 19.7 tptm -57.64 -69.94 0.15 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.483 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -163.12 -0.11 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.411 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 14.4 t -52.92 134.83 37.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.995 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.9 139.59 34.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.072 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 213' ' ' GLY . 28.4 mttp -98.34 158.32 32.86 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.822 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -34.47 -75.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.43 2.087 . . . . 0.0 111.831 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -51.21 -21.05 1.82 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.177 0.513 . . . . 0.0 110.243 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.59 -51.41 12.11 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.305 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -67.1 -39.1 86.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.322 0.582 . . . . 0.0 110.072 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.61 -53.79 53.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.757 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.52 87.64 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.699 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 mt -61.36 -28.21 69.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.311 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -74.83 -45.45 43.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.456 0.646 . . . . 0.0 110.53 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -61.51 -42.68 99.17 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.849 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 57.3 tp -65.58 -39.15 91.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.523 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.9 t80 -52.6 -50.1 63.74 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.228 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.4 t -53.87 -51.68 62.88 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.414 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.615 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 8.7 tt0 -52.76 -25.93 12.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.149 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.982 HD22 HG21 ' A' ' 313' ' ' VAL . 22.5 mt -99.13 -18.95 17.44 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.419 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 221' ' ' TYR . 1.7 m -73.36 -31.67 64.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.065 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -91.54 23.15 3.61 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.949 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.566 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -79.24 158.55 27.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.28 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 315' ' ' GLY . 10.0 t0 -76.43 128.93 81.24 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.304 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 230' ' ' LYS . 42.8 Cg_endo -68.36 -18.66 44.21 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.919 2.412 . . . . 0.0 112.813 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 229' ' ' PRO . 65.3 tttm -32.63 -47.31 0.16 Allowed 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 123.508 0.505 . . . . 0.0 110.468 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 232' ' ' GLY . 21.8 m-20 -108.55 -18.84 13.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.886 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.15 47.99 0.03 OUTLIER Glycine 0 N--CA 1.474 1.23 0 O-C-N 123.902 0.751 . . . . 0.0 111.234 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 231' ' ' ASP . 18.0 m -115.36 110.84 19.95 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.7 t -127.03 94.25 2.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.664 0.745 . . . . 0.0 110.074 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 16.0 t -98.72 122.74 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.642 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.505 HG13 HD13 ' A' ' 311' ' ' ILE . 89.2 t -96.87 123.24 49.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.667 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.5 mt -106.35 143.62 34.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.027 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -118.33 135.94 11.92 Favored Glycine 0 N--CA 1.478 1.441 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.334 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.629 ' CE2' ' SD ' ' A' ' 279' ' ' MET . 0.1 OUTLIER -121.2 116.84 25.68 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.2 t -108.09 167.95 9.64 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -90.85 -179.27 5.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.271 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -95.88 123.15 39.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.375 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.9 mm -118.12 9.18 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.418 0.628 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 81.86 4.39 90.32 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.7 t -134.04 98.75 4.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.078 0.466 . . . . 0.0 110.327 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -52.69 -51.66 59.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.488 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.2 69.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.909 0.385 . . . . 0.0 110.413 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.601 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 46.4 t80 -61.27 -41.2 96.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.377 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -60.9 -46.47 90.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.424 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -61.62 -38.71 88.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.388 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.84 -38.33 96.34 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 34.2 mt -71.93 -39.19 69.64 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.378 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.5 t -64.55 -41.19 96.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.227 0.537 . . . . 0.0 110.951 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.01 -38.39 66.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.631 ' NH1' ' NZ ' ' A' ' 206' ' ' LYS . 17.3 mmt85 -60.12 -51.25 70.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.965 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.7 ' O ' HG23 ' A' ' 260' ' ' VAL . 20.1 ptp180 -64.18 -44.66 91.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -60.1 -37.1 78.95 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.305 0.574 . . . . 0.0 110.158 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -44.2 59.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.41 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 49.9 m -59.4 -38.37 80.39 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.094 0.474 . . . . 0.0 110.306 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 256' ' ' ARG . 96.4 t -65.71 -52.72 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.376 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.613 HG13 HD12 ' A' ' 274' ' ' ILE . 9.3 t -61.83 -49.21 85.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.441 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -46.53 -41.34 14.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.856 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.573 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 58.3 t80 -81.28 -32.78 33.06 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.56 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -67.7 -9.01 39.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.624 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 267' ' ' LYS . 61.8 mt -86.4 -50.1 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 111.556 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 88.8 p -49.82 -5.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.199 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.586 ' CD ' ' N ' ' A' ' 267' ' ' LYS . 2.0 mptp? -86.89 7.67 26.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 110.35 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 87.24 41.4 6.59 Favored Glycine 0 CA--C 1.507 -0.456 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.79 128.11 25.5 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.37 126.38 21.51 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.755 1.636 . . . . 0.0 111.982 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.49 -8.78 21.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.971 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -91.53 -22.97 20.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -80.46 -18.66 48.06 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.463 0.649 . . . . 0.0 110.713 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.613 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -106.18 -171.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.777 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 28.7 t -171.05 127.63 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.327 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.14 110.56 23.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.472 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -120.18 148.09 44.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.46 0.647 . . . . 0.0 110.86 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.42 97.84 0.5 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.629 ' SD ' ' CE2' ' A' ' 239' ' ' TYR . 2.8 ptp -81.59 31.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.461 0.172 . . . . 0.0 110.816 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 38.19 -97.43 0.01 OUTLIER Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -141.84 70.57 1.34 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.704 0.288 . . . . 0.0 110.415 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.8 m -91.16 0.59 57.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.518 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -155.95 60.67 2.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.51 110.93 3.17 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.505 2.137 . . . . 0.0 112.03 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 286' ' ' THR . 11.5 m -71.37 -36.4 61.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.42 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 288' ' ' ASN . 70.6 p -62.18 -45.75 92.0 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.083 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.31 -3.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.619 ' H ' ' C ' ' A' ' 286' ' ' THR . 55.8 t-20 -123.83 -57.78 1.61 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 m -58.94 -25.61 63.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.615 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 68.3 m -105.12 32.07 4.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 0.0 110.59 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.48 -2.81 18.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.456 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -109.98 30.98 6.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 10.5 t -132.17 121.65 46.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 120.919 0.39 . . . . 0.0 110.42 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -121.23 6.18 10.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.513 ' O ' HD12 ' A' ' 299' ' ' LEU . 5.1 mt-30 -88.5 172.12 9.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.039 0.447 . . . . 0.0 110.402 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -82.01 -72.62 0.43 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.91 -28.99 66.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.47 . . . . 0.0 110.867 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.27 82.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.381 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 303' ' ' LEU . 42.5 mt -71.81 -52.16 18.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 63.6 mt -51.42 -34.73 15.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.51 -35.22 58.45 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.352 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.97 -8.22 57.41 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.814 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 299' ' ' LEU . 65.8 mt -96.23 15.53 20.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.723 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -76.78 -45.93 3.05 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.141 0.496 . . . . 0.0 110.008 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 28.0 Cg_exo -59.47 10.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 123.042 2.495 . . . . 0.0 111.818 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 304' ' ' ALA . 54.6 t0 -104.56 13.52 31.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.873 0.368 . . . . 0.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.429 ' NH1' HH22 ' A' ' 256' ' ' ARG . 78.8 mtp85 -112.58 102.23 10.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.299 0.571 . . . . 0.0 110.557 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.6 ptp180 -165.8 142.51 5.34 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.22 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 15.2 m -107.4 145.54 14.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -118.04 108.63 15.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.118 0.485 . . . . 0.0 110.74 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.505 HD13 HG13 ' A' ' 236' ' ' VAL . 3.4 mm -79.5 114.28 20.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -96.72 111.15 23.43 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.769 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.982 HG21 HD22 ' A' ' 224' ' ' LEU . 59.0 t -113.0 118.4 57.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 O-C-N 123.556 0.535 . . . . 0.0 110.919 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -116.25 131.07 57.05 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.69 33.88 5.96 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.705 ' O ' ' O ' ' A' ' 317' ' ' LYS . 10.5 tt -108.46 168.53 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.705 ' O ' ' O ' ' A' ' 316' ' ' ILE . 42.1 tttt . . . . . 0 CA--C 1.537 0.468 0 O-C-N 124.205 0.941 . . . . 0.0 111.556 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 121.124 0.488 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 48.9 m -64.97 125.79 25.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.402 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 313' ' ' VAL . 39.2 tptt -117.97 163.33 16.74 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.278 0.561 . . . . 0.0 111.086 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -153.17 125.44 8.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.366 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -114.26 116.98 29.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.56 103.45 15.08 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.333 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.671 ' CD2' HD11 ' A' ' 201' ' ' LEU . 31.2 tp -106.64 130.36 54.4 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.911 0.386 . . . . 0.0 110.218 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -84.65 129.04 34.89 Favored 'General case' 0 C--O 1.255 1.355 0 CA-C-O 122.565 1.174 . . . . 0.0 111.819 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 202' ' ' PHE . 37.4 m -61.54 -18.15 57.95 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.53 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.58 -41.31 94.39 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.194 0.521 . . . . 0.0 110.201 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.9 t -72.45 -34.14 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.344 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.671 HD11 ' CD2' ' A' ' 196' ' ' LEU . 62.4 mt -88.12 -80.0 0.28 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.126 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -127.84 114.36 17.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.244 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.588 ' ND2' ' CE2' ' A' ' 204' ' ' PHE . 62.6 t30 -90.84 -72.09 0.59 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.473 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.588 ' CE2' ' ND2' ' A' ' 203' ' ' ASN . 88.3 m-85 -102.76 -25.89 13.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.795 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -63.56 170.71 3.0 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.982 0.42 . . . . 0.0 110.154 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -53.54 -83.33 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.652 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.04 53.69 0.15 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.443 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.7 t -107.33 145.44 32.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.848 0.356 . . . . 0.0 110.303 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.23 127.61 33.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 213' ' ' GLY . 12.7 mtpp -89.55 158.85 45.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.813 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 210' ' ' LYS . 76.8 Cg_exo -33.34 -76.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.499 2.133 . . . . 0.0 112.01 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -48.47 -22.54 0.74 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.146 0.498 . . . . 0.0 110.321 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.36 -48.45 18.78 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -63.19 -39.63 95.2 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.83 -53.88 52.77 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.568 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.83 -28.65 69.7 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.596 0.712 . . . . 0.0 110.537 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -31.63 68.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.364 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.21 -48.18 30.63 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.173 0.511 . . . . 0.0 111.263 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 12.1 pt20 -64.03 -44.46 92.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.981 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 311' ' ' ILE . 36.0 tp -62.7 -41.71 99.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.336 -0.545 . . . . 0.0 109.892 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 4.2 t80 -52.26 -48.1 65.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.374 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.5 m -52.81 -52.34 57.31 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.485 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -54.3 -27.3 34.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.186 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.718 HD22 HG21 ' A' ' 313' ' ' VAL . 85.0 mt -95.3 -20.28 19.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.668 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 221' ' ' TYR . 23.5 p -79.64 -21.2 45.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.831 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -99.1 21.46 11.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.558 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.34 -179.68 5.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.61 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.434 ' OD2' ' CG ' ' A' ' 230' ' ' LYS . 2.8 t70 -99.09 132.64 23.15 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.41 -17.02 34.89 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.501 2.134 . . . . 0.0 112.94 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.434 ' CG ' ' OD2' ' A' ' 228' ' ' ASP . 40.4 mmtt -37.02 -45.27 0.57 Allowed 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.55 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' GLY . 95.1 m-20 -107.73 -19.89 13.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.442 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.7 49.04 0.05 OUTLIER Glycine 0 N--CA 1.469 0.847 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.24 112.4 19.44 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 122.591 -0.358 . . . . 0.0 110.791 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 313' ' ' VAL . 52.2 t -130.93 93.38 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.426 0.632 . . . . 0.0 110.497 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.14 123.93 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.334 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 311' ' ' ILE . 22.0 t -100.4 127.1 53.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.598 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.549 HD23 ' HB3' ' A' ' 277' ' ' ARG . 25.5 mt -110.17 145.36 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.068 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.653 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -115.81 142.2 17.4 Favored Glycine 0 N--CA 1.478 1.479 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.559 ' CE2' ' SD ' ' A' ' 279' ' ' MET . 0.7 OUTLIER -122.39 120.64 34.58 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.484 HG22 ' NH2' ' A' ' 256' ' ' ARG . 3.1 p -112.74 164.59 13.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.833 0.349 . . . . 0.0 110.239 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 241' ' ' ASP . 14.5 p-10 -88.47 -176.77 5.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.373 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -100.6 121.72 42.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.277 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.5 mm -118.63 11.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.311 0.577 . . . . 0.0 110.664 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.23 3.72 88.63 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.7 t -133.62 99.81 4.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.068 0.461 . . . . 0.0 110.013 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 56.1 t0 -52.57 -50.78 62.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.466 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.4 67.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.822 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.543 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 45.8 t80 -62.25 -47.99 81.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.562 HD21 HE21 ' A' ' 250' ' ' GLN . 0.1 OUTLIER -62.29 -40.78 97.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.575 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.562 HE21 HD21 ' A' ' 249' ' ' ASN . 97.6 mm-40 -60.42 -48.02 83.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.899 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.14 -36.4 92.9 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.543 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 25.9 mt -72.95 -35.98 67.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.097 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.1 m -63.73 -41.71 98.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.87 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -73.21 -35.42 66.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.353 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -60.21 -53.5 56.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.434 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.868 ' O ' HG23 ' A' ' 260' ' ' VAL . 17.4 ptp180 -62.91 -43.96 97.39 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.277 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.451 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.92 -38.87 90.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.319 0.581 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -71.84 -42.18 67.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.277 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 10.6 t -63.24 -38.76 92.41 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.371 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 256' ' ' ARG . 84.5 t -63.36 -51.21 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.277 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.602 HG13 HD12 ' A' ' 274' ' ' ILE . 18.7 t -62.19 -48.75 86.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.234 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -45.08 -41.23 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.08 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.527 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 49.6 t80 -81.79 -29.51 32.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.518 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.94 -7.72 53.42 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.48 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' A' ' 267' ' ' LYS . 59.6 mt -86.95 -54.67 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 111.483 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 33.9 t -50.83 -5.2 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 265' ' ' ILE . 32.2 mmtp -80.18 0.46 32.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.523 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 93.11 40.75 4.78 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.44 139.33 34.36 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.209 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -63.4 129.06 24.16 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.187 1.925 . . . . 0.0 112.097 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.74 -7.28 14.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.999 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -91.1 -28.07 18.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.89 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -77.49 -20.52 54.2 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.954 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.602 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -103.12 -178.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.877 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 13.2 m -171.2 129.63 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.51 155.63 16.69 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.149 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.549 ' HB3' HD23 ' A' ' 237' ' ' LEU . 55.1 ttt85 -161.56 149.43 15.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.105 0.479 . . . . 0.0 110.63 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -118.13 98.46 0.76 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.687 ' HE3' ' H ' ' A' ' 282' ' ' SER . 0.7 OUTLIER -80.08 18.19 0.88 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.718 -0.241 . . . . 0.0 110.838 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 43.77 -102.1 0.03 OUTLIER Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.443 ' OE1' ' OD1' ' A' ' 306' ' ' ASP . 5.4 mm-40 -136.21 74.61 1.51 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.852 0.384 . . . . 0.0 110.57 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.687 ' H ' ' HE3' ' A' ' 279' ' ' MET . 0.6 OUTLIER -88.71 2.18 53.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.337 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.41 ' C ' HD22 ' A' ' 283' ' ' ASN . 0.3 OUTLIER -166.81 77.36 1.06 Allowed Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.859 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.62 106.82 2.33 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.015 1.81 . . . . 0.0 111.698 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 286' ' ' THR . 5.2 m -68.29 -43.83 84.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.75 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.1 p -58.85 -44.15 90.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.134 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.58 -3.55 0.02 OUTLIER Glycine 0 CA--C 1.531 1.049 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 286' ' ' THR . 90.9 m-20 -119.33 -57.72 1.98 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.8 OUTLIER -70.35 -13.42 62.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.732 -178.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.91 23.04 6.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.305 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.79 -11.18 54.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.345 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -96.72 33.25 1.89 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.566 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 19.2 t -128.94 124.64 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.447 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -118.68 7.54 11.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -94.93 126.67 40.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 110.2 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -49.59 -57.43 7.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.73 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.12 85.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.997 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.29 -31.2 72.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.546 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 32.6 mt -76.65 -54.15 7.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.4 mt -52.54 -35.79 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.041 0.448 . . . . 0.0 109.954 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -71.25 -42.05 69.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 8.7 t -81.73 -0.73 44.24 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 110.91 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.418 HD12 ' CB ' ' A' ' 241' ' ' ASP . 0.4 OUTLIER -95.55 18.11 13.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.359 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.581 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -79.46 -44.23 1.63 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.297 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.5 Cg_exo -63.17 8.85 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 123.257 2.638 . . . . 0.0 111.991 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 304' ' ' ALA . 6.5 t0 -107.45 12.21 28.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -109.55 106.13 15.72 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.204 0.525 . . . . 0.0 110.118 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -173.09 167.76 4.88 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.769 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.653 HG12 ' HA2' ' A' ' 238' ' ' GLY . 26.8 m -128.25 151.18 34.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.435 ' CD ' ' HH ' ' A' ' 239' ' ' TYR . 90.3 mt-10 -122.3 106.85 11.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.057 0.455 . . . . 0.0 110.198 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.49 117.81 25.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -102.15 120.16 39.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.069 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.718 HG21 HD22 ' A' ' 224' ' ' LEU . 62.0 t -133.41 123.65 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.421 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -118.66 141.7 48.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.583 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.88 -9.19 47.06 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.829 ' O ' ' O ' ' A' ' 317' ' ' LYS . 17.1 tt -81.1 152.92 4.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.829 ' O ' ' O ' ' A' ' 316' ' ' ILE . 40.4 tttm . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 122.234 1.016 . . . . 0.0 112.069 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 316' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 121.001 0.429 . . . . 0.0 110.646 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.535 HG22 ' NE2' ' A' ' 193' ' ' HIS . 16.2 m -75.41 132.26 40.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.138 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -146.07 118.72 8.58 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.535 ' NE2' HG22 ' A' ' 191' ' ' THR . 1.4 m-70 -106.69 148.51 28.29 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -107.45 124.01 49.23 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.044 0.449 . . . . 0.0 110.097 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.76 101.67 12.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.567 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.767 ' CD2' HD11 ' A' ' 201' ' ' LEU . 38.6 tp -108.56 145.45 34.81 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.665 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.552 ' HD2' ' H ' ' A' ' 199' ' ' ASP . 1.6 tmtm? -88.98 125.8 35.14 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.721 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.0 t -67.92 -33.83 75.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.24 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.552 ' H ' ' HD2' ' A' ' 197' ' ' LYS . 17.3 t0 -63.69 -39.6 94.71 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 197' ' ' LYS . 51.0 t -61.04 -47.93 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.767 HD11 ' CD2' ' A' ' 196' ' ' LEU . 47.0 mt -67.29 -78.37 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.057 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.2 117.93 35.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.67 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 199' ' ' ASP . 69.1 m-80 -90.55 -82.56 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.193 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -93.23 -16.57 24.64 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.716 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.713 HD22 ' NZ ' ' A' ' 210' ' ' LYS . 67.7 m-20 -75.49 156.82 34.8 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.264 0.554 . . . . 0.0 109.801 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.491 ' H ' ' CD ' ' A' ' 206' ' ' LYS . 12.9 mptt -50.0 -68.19 0.2 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.77 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.17 60.12 0.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.167 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.3 p -110.31 141.92 42.66 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.472 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.738 HD22 HD22 ' A' ' 201' ' ' LEU . 35.7 mt -85.17 135.21 34.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.435 0.636 . . . . 0.0 111.339 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.713 ' NZ ' HD22 ' A' ' 205' ' ' ASN . 40.2 mmtm -100.55 153.86 37.51 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.444 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LYS . 91.7 Cg_exo -30.86 -73.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 C-N-CA 122.47 2.113 . . . . 0.0 112.618 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -49.14 -28.23 4.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.041 0.448 . . . . 0.0 110.767 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.61 -47.7 32.77 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -62.53 -39.69 94.39 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.71 -54.34 47.3 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.255 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.76 -29.49 70.7 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.442 0.639 . . . . 0.0 110.156 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.539 HD23 HD21 ' A' ' 201' ' ' LEU . 0.6 OUTLIER -72.05 -27.83 62.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.074 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . 0.514 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 34.3 m-20 -75.18 -49.76 18.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.491 0.662 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 5.3 pt20 -63.16 -42.55 99.45 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.361 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 31.7 tp -63.19 -41.79 99.24 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.409 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -51.56 -47.07 63.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.511 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.9 m -56.87 -50.82 71.31 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 118.786 -1.165 . . . . 0.0 110.689 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.452 HE21 HD12 ' A' ' 220' ' ' LEU . 17.8 mt-30 -52.27 -26.97 13.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.96 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.635 HD22 HG21 ' A' ' 313' ' ' VAL . 17.5 mt -96.31 -20.27 18.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.658 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.0 t -77.97 -21.22 51.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.054 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -100.22 19.39 16.59 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.813 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.563 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -75.69 160.74 29.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.754 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 4.7 t0 -77.71 113.16 29.83 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 230' ' ' LYS . 48.6 Cg_exo -50.19 -23.08 9.11 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 122.329 2.019 . . . . 0.0 113.082 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 229' ' ' PRO . 21.2 tptm -29.37 -53.16 0.13 Allowed 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 123.532 0.52 . . . . 0.0 111.085 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 233' ' ' SER . 91.5 m-20 -106.09 -16.03 14.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.021 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 24.94 44.84 0.01 OUTLIER Glycine 0 N--CA 1.469 0.836 0 O-C-N 123.954 0.783 . . . . 0.0 111.701 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 231' ' ' ASP . 41.6 m -114.07 110.58 20.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.828 0.346 . . . . 0.0 110.855 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 84.3 t -126.04 95.83 3.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.354 0.597 . . . . 0.0 109.852 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 t -97.25 121.48 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.239 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.442 HG21 ' CG2' ' A' ' 261' ' ' VAL . 10.8 t -92.87 118.98 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.253 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.45 144.04 31.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.788 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.438 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -125.51 126.05 5.78 Favored Glycine 0 N--CA 1.476 1.345 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.694 ' N ' HH22 ' A' ' 256' ' ' ARG . 0.2 OUTLIER -111.08 126.21 54.58 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.555 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.9 t -117.53 168.09 10.71 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.825 0.345 . . . . 0.0 110.243 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -91.53 176.42 6.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.648 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -92.69 126.47 37.79 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.6 mm -117.98 10.21 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.157 0.503 . . . . 0.0 110.661 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.42 7.25 76.41 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -140.63 104.11 4.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.245 0.545 . . . . 0.0 110.163 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 99.2 m-20 -57.1 -51.15 70.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.71 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.26 -46.18 76.1 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.044 0.449 . . . . 0.0 110.791 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.588 ' CE2' HD11 ' A' ' 252' ' ' LEU . 48.0 t80 -61.29 -40.81 95.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 246' ' ' ASP . 0.1 OUTLIER -58.12 -47.93 81.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.149 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.95 -40.5 93.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.712 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.15 -39.15 96.74 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.588 HD11 ' CE2' ' A' ' 248' ' ' TYR . 32.9 mt -70.38 -39.44 74.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 5.8 t -62.83 -42.28 99.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 110.809 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.52 -44.14 75.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.935 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -59.59 -47.93 83.65 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.45 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.694 HH22 ' N ' ' A' ' 239' ' ' TYR . 42.7 mtm105 -63.39 -49.63 73.03 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.333 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.76 81.08 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -70.59 -43.43 69.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.207 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.0 t -60.35 -39.29 86.62 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.278 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.3 t -62.83 -51.61 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.521 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.56 HG13 HD12 ' A' ' 274' ' ' ILE . 12.9 t -61.22 -48.34 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.625 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -47.87 -42.86 27.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.948 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.421 ' CG ' HD12 ' A' ' 209' ' ' LEU . 66.5 t80 -78.24 -35.26 48.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.994 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.36 -32.26 73.63 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.369 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 267' ' ' LYS . 89.8 mt -66.59 -46.23 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 85.2 p -56.04 -10.44 0.82 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.29 0.566 . . . . 0.0 110.485 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.514 ' NZ ' ' OD1' ' A' ' 218' ' ' ASP . 20.5 mmmt -79.46 -3.54 47.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.684 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.06 43.73 3.74 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.349 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.29 129.37 24.2 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.57 129.66 30.43 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.406 1.404 . . . . 0.0 111.479 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -64.84 -9.69 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.036 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -91.46 -23.8 19.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.016 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.62 -23.81 56.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.437 0.637 . . . . 0.0 110.708 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.56 HD12 HG13 ' A' ' 261' ' ' VAL . 2.3 pt -103.35 -178.52 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.871 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 8.5 t -168.03 129.26 1.4 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.161 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.08 151.93 19.0 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -154.64 136.95 14.89 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.397 0.618 . . . . 0.0 111.649 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -87.29 91.37 1.73 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 4.3 tpt -69.05 -10.4 57.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.741 0.305 . . . . 0.0 110.503 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.09 -101.5 0.02 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -141.63 74.96 1.48 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.79 0.329 . . . . 0.0 110.574 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 25.4 t -82.36 -3.53 55.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.341 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -167.49 79.25 0.92 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.574 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.32 105.26 0.47 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.484 2.123 . . . . 0.0 112.201 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.468 HG23 ' N ' ' A' ' 286' ' ' THR . 6.4 m -71.41 -39.87 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.705 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.588 ' C ' ' H ' ' A' ' 288' ' ' ASN . 63.3 p -58.8 -42.68 89.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.506 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.64 -2.66 0.01 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.588 ' H ' ' C ' ' A' ' 286' ' ' THR . 71.3 m-80 -127.98 -57.52 1.24 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.9 m -59.53 -44.19 93.25 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.566 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -111.8 28.8 8.42 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.627 0.251 . . . . 0.0 110.788 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 48.2 t0 -66.36 -7.18 17.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.518 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -98.64 31.76 2.79 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.566 HG21 ' SG ' ' A' ' 290' ' ' CYS . 22.3 t -131.91 124.17 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.552 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -118.82 11.82 12.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.842 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -99.2 130.79 45.53 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.081 0.467 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -50.44 -66.08 0.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.375 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -55.08 -38.08 67.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.429 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.18 -37.44 87.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.427 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 303' ' ' LEU . 34.3 mt -72.19 -57.15 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.461 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 67.0 mt -50.71 -33.7 12.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.028 0.442 . . . . 0.0 109.895 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.18 -37.74 53.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.679 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.12 -11.91 55.86 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.538 HD23 HG21 ' A' ' 286' ' ' THR . 70.8 mt -89.03 23.86 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.781 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.572 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -74.37 -41.42 4.88 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.243 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 16.3 Cg_exo -67.65 9.17 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.483 2.122 . . . . 0.0 111.065 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 304' ' ' ALA . 30.0 t0 -102.31 1.19 35.34 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.491 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 304' ' ' ALA . 5.4 ptp180 -114.77 93.35 4.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.5 0.667 . . . . 0.0 109.509 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.513 ' NH1' ' OE2' ' A' ' 310' ' ' GLU . 36.6 ptt85 -154.37 131.8 11.25 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 122.012 0.91 . . . . 0.0 112.456 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.09 134.03 33.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.342 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.513 ' OE2' ' NH1' ' A' ' 308' ' ' ARG . 64.5 mt-10 -117.86 103.66 10.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.133 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.465 HD12 HD21 ' A' ' 220' ' ' LEU . 0.9 OUTLIER -79.63 115.96 22.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -178.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 312' ' ' GLU . 6.8 tm-20 -90.93 126.73 36.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 123.201 0.313 . . . . 0.0 110.385 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.635 HG21 HD22 ' A' ' 224' ' ' LEU . 2.8 t -125.67 114.98 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.936 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -115.04 134.09 55.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 98.44 10.3 51.13 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.538 ' O ' ' NE2' ' A' ' 190' ' ' GLN . 19.7 tt -93.95 137.98 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.876 0.37 . . . . 0.0 110.502 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.355 179.842 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.945 0.402 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.424 ' CG2' ' NE2' ' A' ' 193' ' ' HIS . 59.0 m -79.42 126.96 31.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.302 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -143.17 108.72 5.08 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.325 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.424 ' NE2' ' CG2' ' A' ' 191' ' ' THR . 30.9 m170 -95.25 142.5 27.6 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 63.3 m-85 -107.38 123.67 48.7 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 195' ' ' THR . 7.9 t -86.83 102.61 14.46 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.766 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.686 ' CD2' HD11 ' A' ' 201' ' ' LEU . 30.3 tp -107.75 129.34 55.05 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.497 0.665 . . . . 0.0 109.296 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 197' ' ' LYS . 14.5 ptpt -85.99 131.85 34.19 Favored 'General case' 0 C--O 1.252 1.237 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.972 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.538 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 14.6 m -62.11 -26.56 68.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.577 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 200' ' ' VAL . 15.0 p-10 -59.07 -36.05 74.42 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.145 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.614 ' N ' ' OD1' ' A' ' 199' ' ' ASP . 31.9 t -71.3 -45.6 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' A' ' 196' ' ' LEU . 85.8 mt -79.49 -77.61 0.18 Allowed 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.963 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.486 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -133.45 139.43 46.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.469 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.496 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 9.9 p-10 -119.65 -72.75 0.67 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.781 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.496 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 94.2 m-85 -87.01 -31.08 20.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.067 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -69.81 167.57 16.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.168 0.508 . . . . 0.0 110.296 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -58.37 -75.16 0.05 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.479 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -161.18 55.8 0.29 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.37 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.0 p -106.88 132.94 52.27 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.3 mt -75.51 140.24 42.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.684 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 213' ' ' GLY . 20.5 mtmt -101.03 157.94 32.73 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 210' ' ' LYS . 75.9 Cg_exo -34.02 -76.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.529 2.152 . . . . 0.0 112.338 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -49.7 -20.09 0.75 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.313 0.578 . . . . 0.0 110.306 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.96 -51.33 14.99 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.391 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -64.07 -40.26 95.87 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.85 -53.87 51.49 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.45 87.46 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.724 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.3 mt -61.07 -30.77 70.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.872 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.07 -45.87 62.97 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.158 0.504 . . . . 0.0 111.095 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -61.75 -44.82 96.14 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.102 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 52.7 tp -65.25 -38.93 91.85 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.368 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.466 ' CG ' ' HD3' ' A' ' 267' ' ' LYS . 7.6 t80 -55.45 -45.49 76.86 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.982 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.3 p -55.82 -53.34 57.89 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.153 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 12.9 pt20 -60.43 -19.95 58.05 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.646 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.696 HD22 HG21 ' A' ' 313' ' ' VAL . 70.2 mt -89.69 -27.48 20.08 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.025 0.441 . . . . 0.0 110.351 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 3.9 t -72.64 -22.92 60.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.6 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -98.92 18.61 16.76 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.722 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.652 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.41 160.47 29.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.94 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -70.74 125.02 91.93 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 230' ' ' LYS . 50.9 Cg_endo -69.86 -17.14 37.3 Favored 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.505 2.137 . . . . 0.0 113.126 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 229' ' ' PRO . 88.2 tttt -31.47 -48.21 0.13 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.749 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 95.7 m-20 -110.74 -17.58 13.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.217 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.22 48.72 0.03 OUTLIER Glycine 0 N--CA 1.474 1.167 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.6 m -115.36 112.36 22.24 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.766 0.317 . . . . 0.0 110.872 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.95 97.54 4.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.604 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.6 t -97.92 122.4 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.407 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 311' ' ' ILE . 16.9 t -96.05 118.66 42.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.41 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 277' ' ' ARG . 26.1 mt -108.96 106.23 16.1 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.602 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.413 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -87.17 127.83 8.65 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.8 OUTLIER -107.17 123.93 48.98 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 117.683 0.742 . . . . 0.0 109.453 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.596 HG22 ' N ' ' A' ' 241' ' ' ASP . 52.9 m -114.67 166.24 11.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.969 0.414 . . . . 0.0 110.296 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.596 ' N ' HG22 ' A' ' 240' ' ' THR . 53.6 p30 -86.02 -176.0 5.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.965 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 244' ' ' GLY . 59.2 ttp180 -116.58 124.84 50.81 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.376 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.4 mm -114.8 23.26 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.557 0.694 . . . . 0.0 110.605 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.4 ' H ' ' HG2' ' A' ' 242' ' ' ARG . . . 84.4 13.59 73.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.8 t -144.11 94.07 2.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.357 0.598 . . . . 0.0 110.006 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -46.58 -47.33 19.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.66 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.38 -37.58 78.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.193 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.492 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 52.6 t80 -61.51 -47.63 84.74 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.445 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 250' ' ' GLN . 0.1 OUTLIER -62.84 -41.6 99.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.5 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.492 ' N ' ' ND2' ' A' ' 249' ' ' ASN . 94.2 mt-30 -60.7 -45.99 92.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.919 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.15 96.13 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.492 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 26.2 mt -72.81 -37.87 67.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.245 -0.478 . . . . 0.0 111.074 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 29.9 t -63.47 -40.87 98.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.967 0.413 . . . . 0.0 110.239 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.94 -45.81 76.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.045 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -54.33 -45.64 72.7 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.573 HH22 ' N ' ' A' ' 308' ' ' ARG . 42.7 mtp180 -61.38 -64.09 1.06 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.477 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -51.56 -34.28 36.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.129 0.49 . . . . 0.0 109.884 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -73.32 -44.74 58.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.087 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 46.2 m -64.37 -37.75 88.6 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.449 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.7 t -64.52 -51.27 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.6 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.536 HG13 HD12 ' A' ' 274' ' ' ILE . 18.2 t -62.36 -48.65 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.039 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -45.06 -39.42 5.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -84.12 -30.34 26.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.687 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.43 -11.22 60.59 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.489 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.533 ' C ' ' H ' ' A' ' 267' ' ' LYS . 72.5 mt -86.91 -53.65 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 122.107 -0.37 . . . . 0.0 111.729 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.3 p -50.41 -4.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.23 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 265' ' ' ILE . 68.9 mttm -83.96 -0.19 50.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.925 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 105.26 -2.78 40.28 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.09 126.02 78.19 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.871 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.78 130.32 39.84 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.344 1.363 . . . . 0.0 111.256 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.29 -10.0 38.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.968 0.413 . . . . 0.0 111.407 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -90.78 -22.93 20.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.133 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -19.5 52.5 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.819 0.819 . . . . 0.0 110.664 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.536 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -107.03 -171.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.542 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.69 129.78 1.55 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.827 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.72 151.3 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.59 ' HB3' HD23 ' A' ' 237' ' ' LEU . 60.8 ttt180 -158.88 148.75 19.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 110.5 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -123.76 96.89 0.55 Allowed Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 21.3 ptm -94.66 21.45 7.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.921 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 37.74 -97.17 0.01 OUTLIER Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -143.33 75.92 1.5 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 37.3 t -63.82 -32.99 74.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.114 0.483 . . . . 0.0 111.166 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.438 ' C ' HD22 ' A' ' 283' ' ' ASN . 0.4 OUTLIER -131.17 77.66 74.2 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.954 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -54.23 108.04 0.26 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.749 2.299 . . . . 0.0 112.848 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 286' ' ' THR . 5.1 m -71.59 -40.3 70.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.489 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.631 ' C ' ' H ' ' A' ' 288' ' ' ASN . 2.2 p -58.97 -42.47 90.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.514 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.5 0.89 0.02 OUTLIER Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.631 ' H ' ' C ' ' A' ' 286' ' ' THR . 28.2 t-20 -125.07 -58.37 1.46 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.3 m -56.2 -42.84 77.82 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 22.8 m -95.74 34.42 1.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.502 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 292' ' ' ASN . 28.4 p30 -59.04 -33.04 70.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.818 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 23.3 m120 -88.78 33.92 0.77 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.434 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.57 109.43 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.849 0.356 . . . . 0.0 110.522 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -118.59 13.89 13.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.611 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -98.0 135.33 39.86 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.108 0.48 . . . . 0.0 109.851 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 299' ' ' LEU . 5.9 ttt-85 -51.09 -76.36 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.568 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -45.74 -41.03 10.18 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.139 0.495 . . . . 0.0 111.071 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.34 81.36 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.043 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 296' ' ' ARG . 16.9 mt -71.01 -43.95 66.87 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.771 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 12.2 mm -52.75 -36.84 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.34 -42.78 35.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.221 0.534 . . . . 0.0 110.315 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -5.6 35.71 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.857 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.34 20.24 8.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.573 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.548 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -79.84 -45.09 1.53 Allowed Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.18 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 24.7 Cg_exo -61.75 8.29 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 123.184 2.589 . . . . 0.0 111.941 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 304' ' ' ALA . 39.4 t0 -102.52 10.91 38.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.609 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.442 ' NH1' ' O ' ' A' ' 203' ' ' ASN . 88.2 mtm180 -112.94 91.65 3.73 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.298 0.571 . . . . 0.0 110.142 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.573 ' N ' HH22 ' A' ' 256' ' ' ARG . 16.4 ptm180 -157.67 129.22 6.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.628 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.99 138.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.431 0.634 . . . . 0.0 109.709 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -118.64 102.17 8.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.713 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.536 HG23 HG22 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -81.0 113.14 19.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.67 118.44 31.05 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.401 0.438 . . . . 0.0 110.154 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.696 HG21 HD22 ' A' ' 224' ' ' LEU . 47.8 t -116.5 114.66 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 O-C-N 123.567 0.542 . . . . 0.0 110.183 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -113.39 132.09 55.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 93.15 41.85 4.47 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.693 ' O ' ' O ' ' A' ' 317' ' ' LYS . 9.8 tt -114.65 169.63 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.693 ' O ' ' O ' ' A' ' 316' ' ' ILE . 27.5 tttp . . . . . 0 C--O 1.218 -0.586 0 O-C-N 123.963 0.79 . . . . 0.0 111.614 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.501 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 17.6 mp0 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.907 0.384 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 39.2 m -72.0 126.21 29.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.639 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -116.45 167.85 10.68 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.457 0.646 . . . . 0.0 111.032 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -155.93 123.39 5.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.595 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.591 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 60.9 m-85 -110.57 113.35 25.9 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.06 103.86 15.13 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.897 -179.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.68 HD23 HD11 ' A' ' 201' ' ' LEU . 30.5 tp -108.94 135.34 50.3 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.287 0.565 . . . . 0.0 110.196 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.517 ' H ' ' CD ' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -88.73 132.14 34.73 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.968 0.89 . . . . 0.0 112.315 -178.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 202' ' ' PHE . 1.3 p -61.84 -24.07 66.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.665 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.14 -43.67 92.04 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.275 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.11 -42.41 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.68 HD11 HD23 ' A' ' 196' ' ' LEU . 78.9 mt -80.08 -79.36 0.15 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.86 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.3 OUTLIER -133.27 131.88 40.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.002 -178.067 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.54 ' O ' ' NH2' ' A' ' 307' ' ' ARG . 59.9 t30 -111.04 -71.24 0.77 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.674 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -91.28 -23.57 20.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.844 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -73.14 164.16 27.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 110.423 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -53.78 -74.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.144 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -160.09 3.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.338 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.7 p -54.98 141.35 34.21 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 85.9 mt -86.14 132.62 33.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.875 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.6 mttp -93.27 157.27 39.12 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.582 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -33.11 -74.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.767 2.311 . . . . 0.0 112.428 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.77 -24.24 1.34 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.136 0.493 . . . . 0.0 110.947 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.68 -48.16 18.32 Favored Glycine 0 C--O 1.227 -0.312 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -62.66 -40.83 98.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.346 0.593 . . . . 0.0 109.57 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.42 -55.27 33.58 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.38 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.35 85.0 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.212 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.1 -31.09 70.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.169 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -71.91 -46.73 56.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.935 0.398 . . . . 0.0 110.948 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -64.21 -44.57 91.52 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.564 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.452 HD12 HE21 ' A' ' 223' ' ' GLN . 49.9 tp -65.02 -38.12 89.86 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.539 ' HE1' HD13 ' A' ' 269' ' ' ILE . 2.4 t80 -54.83 -50.3 68.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.146 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 225' ' ' SER . 11.8 t -59.58 -50.67 73.01 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.571 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.591 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 9.2 tt0 -49.01 -24.25 1.45 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.667 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.507 ' O ' HD22 ' A' ' 227' ' ' LEU . 51.3 mt -100.38 -13.73 18.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.606 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 222' ' ' SER . 33.2 t -73.29 -19.82 60.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -103.61 20.84 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.475 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -74.05 161.54 29.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -84.3 126.18 70.18 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 230' ' ' LYS . 59.9 Cg_endo -69.86 -16.26 37.06 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.982 1.788 . . . . 0.0 113.073 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 229' ' ' PRO . 3.1 tmtm? -30.49 -52.43 0.16 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.604 0.565 . . . . 0.0 111.066 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 232' ' ' GLY . 10.5 m-20 -104.67 -15.33 15.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.133 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.99 51.52 0.07 OUTLIER Glycine 0 N--CA 1.468 0.788 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.638 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.0 m -118.53 109.07 15.76 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 122.88 -0.188 . . . . 0.0 111.041 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 92.4 t -125.3 93.81 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.62 0.724 . . . . 0.0 109.989 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.6 t -98.33 119.49 46.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.159 0.504 . . . . 0.0 110.754 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.538 HG22 HG23 ' A' ' 311' ' ' ILE . 22.1 t -93.62 127.68 45.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.398 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.0 mt -110.35 139.62 45.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.381 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -120.56 131.55 8.83 Favored Glycine 0 N--CA 1.479 1.544 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -117.7 121.94 42.19 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.002 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.532 HG23 ' ND2' ' A' ' 249' ' ' ASN . 9.0 t -115.45 174.26 6.1 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -84.4 -178.2 6.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.165 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.568 ' H ' HD12 ' A' ' 303' ' ' LEU . 59.2 ttp180 -115.84 125.41 52.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.953 0.406 . . . . 0.0 109.971 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.9 mm -117.81 18.57 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.75 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 77.92 15.97 80.51 Favored Glycine 0 C--N 1.315 -0.604 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.3 p -136.58 100.78 4.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.341 0.591 . . . . 0.0 109.947 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -54.21 -50.9 66.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.809 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.96 83.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.714 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.538 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 55.6 t80 -63.95 -41.77 97.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.334 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.532 ' ND2' HG23 ' A' ' 240' ' ' THR . 12.7 t-20 -59.01 -52.09 67.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -57.85 -39.86 78.74 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.681 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.88 99.14 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 31.7 mt -69.99 -38.99 76.18 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.747 -0.267 . . . . 0.0 110.707 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.3 t -62.32 -41.57 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.194 0.521 . . . . 0.0 110.622 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -70.47 -38.88 74.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.344 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -58.69 -51.25 70.75 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.303 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.854 ' O ' HG23 ' A' ' 260' ' ' VAL . 17.2 ptp180 -65.63 -45.74 81.88 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.754 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.55 98.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.401 0.619 . . . . 0.0 109.951 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -71.2 -43.61 67.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.334 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.9 m -60.05 -38.14 81.93 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.693 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 256' ' ' ARG . 89.4 t -65.13 -52.66 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.15 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.662 HG13 HD12 ' A' ' 274' ' ' ILE . 9.1 t -62.12 -48.91 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.621 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -47.18 -43.13 21.04 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.182 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.586 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 53.7 t80 -77.07 -33.47 57.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.981 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.54 -34.93 79.42 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.48 ' C ' ' H ' ' A' ' 267' ' ' LYS . 96.9 mt -63.15 -44.85 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 120.831 0.348 . . . . 0.0 111.527 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 39.3 t -55.07 -8.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.404 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.586 ' CE ' ' CE2' ' A' ' 263' ' ' TYR . 68.8 mmtt -90.98 14.24 14.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.462 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.45 42.59 10.16 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.312 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.539 HD13 ' HE1' ' A' ' 221' ' ' TYR . 0.8 OUTLIER -120.29 127.61 26.24 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 117.134 0.467 . . . . 0.0 110.074 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -54.14 128.33 29.42 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.356 1.371 . . . . 0.0 111.984 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.97 -11.87 50.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 111.025 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -92.29 -18.13 23.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.418 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -82.76 -23.19 34.06 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.764 0.792 . . . . 0.0 110.652 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.662 HD12 HG13 ' A' ' 261' ' ' VAL . 2.0 pt -102.48 -173.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.045 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 4.9 t -167.63 125.48 1.22 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.77 113.24 25.6 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.705 0.288 . . . . 0.0 110.812 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -119.17 141.86 48.47 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.426 0.632 . . . . 0.0 111.773 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.34 95.84 2.14 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -69.26 -10.45 57.87 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -178.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . 0.484 ' HA2' HG22 ' A' ' 240' ' ' THR . . . 42.09 -113.26 0.53 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.441 ' OE2' ' OD2' ' A' ' 306' ' ' ASP . 51.7 tt0 -143.96 71.87 1.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.7 t -63.84 -37.8 88.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.119 0.485 . . . . 0.0 111.409 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -131.6 83.1 59.27 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.27 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.8 105.79 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.163 1.908 . . . . 0.0 112.364 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 286' ' ' THR . 31.6 m -70.1 -44.44 78.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.181 0.515 . . . . 0.0 110.708 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.618 ' C ' ' H ' ' A' ' 288' ' ' ASN . 10.8 p -60.65 -44.62 96.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.934 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -52.93 1.92 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.618 ' H ' ' C ' ' A' ' 286' ' ' THR . 75.6 m-20 -119.84 -59.43 1.8 Allowed 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.7 OUTLIER -65.87 -20.5 66.26 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.804 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.25 26.36 9.51 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.873 0.368 . . . . 0.0 110.28 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 37.3 p-10 -69.93 -6.85 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.043 0.449 . . . . 0.0 110.505 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -100.63 31.51 3.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.288 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.74 129.3 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.207 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -119.41 5.9 11.14 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -97.57 130.28 44.63 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.1 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -52.61 -74.07 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.52 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -43.63 -39.59 3.64 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.214 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.97 95.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.755 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 48.5 mt -68.48 -42.52 78.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.692 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 15.3 mm -54.95 -36.29 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -73.13 -46.83 48.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.35 0.595 . . . . 0.0 109.745 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.7 t -71.04 -2.78 16.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.243 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.568 HD12 ' H ' ' A' ' 242' ' ' ARG . 0.7 OUTLIER -93.29 16.72 12.56 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.431 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -82.4 -44.32 0.97 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 120.838 0.351 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 49.3 Cg_exo -55.1 8.74 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 123.373 2.715 . . . . 0.0 112.835 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 304' ' ' ALA . 88.2 m-20 -110.58 16.4 21.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.497 0.189 . . . . 0.0 110.682 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 8.4 ptm180 -112.46 91.71 3.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.846 0.831 . . . . 0.0 110.302 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -164.58 141.27 6.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.827 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.495 HG12 ' HA2' ' A' ' 238' ' ' GLY . 31.3 m -108.76 145.96 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.406 ' OE2' ' CZ ' ' A' ' 239' ' ' TYR . 32.9 mt-10 -122.05 107.83 12.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.946 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.538 HG23 HG22 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -79.22 118.42 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.37 125.68 43.61 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.051 0.453 . . . . 0.0 110.546 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.03 116.56 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.632 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -114.68 131.89 56.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 106.82 -23.87 26.74 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.657 ' O ' ' O ' ' A' ' 317' ' ' LYS . 13.6 tt -53.24 171.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.657 ' O ' ' O ' ' A' ' 316' ' ' ILE . 24.8 tttp . . . . . 0 N--CA 1.468 0.432 0 O-C-N 123.68 0.613 . . . . 0.0 111.792 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 120.941 0.401 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 m -81.87 135.94 35.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.366 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -147.26 118.01 7.58 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 120.875 0.369 . . . . 0.0 110.427 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 2.4 m170 -98.9 144.52 27.99 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -105.0 119.38 38.89 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.92 101.19 12.66 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.846 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.82 HD23 HD11 ' A' ' 201' ' ' LEU . 35.3 tp -108.38 143.7 36.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.144 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -94.75 133.45 38.42 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 122.157 0.979 . . . . 0.0 112.34 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 202' ' ' PHE . 1.2 m -62.06 -25.58 67.77 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.2 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.53 ' OD1' ' NE ' ' A' ' 307' ' ' ARG . 85.2 m-20 -60.44 -39.42 87.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.108 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.65 -45.21 85.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.82 HD11 HD23 ' A' ' 196' ' ' LEU . 50.7 mt -78.68 -78.01 0.15 Allowed 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.909 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -128.33 123.43 33.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.824 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -93.61 -74.17 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.568 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -104.05 -11.78 17.16 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -75.58 170.0 17.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.029 0.443 . . . . 0.0 110.179 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -54.81 -82.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.554 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -156.15 3.76 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.188 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.1 p -57.16 144.72 33.87 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.745 HD22 HD22 ' A' ' 201' ' ' LEU . 57.7 mt -89.25 136.1 33.21 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.268 0.556 . . . . 0.0 111.169 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 213' ' ' GLY . 55.6 mttt -98.34 157.51 34.27 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.098 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -33.75 -74.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.549 2.166 . . . . 0.0 111.993 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.596 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 27.3 mp0 -48.16 -27.62 2.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.127 0.489 . . . . 0.0 110.529 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.15 -47.79 35.42 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -64.65 -40.6 95.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.316 0.579 . . . . 0.0 109.888 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.32 -55.71 25.73 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.351 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.91 81.36 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.478 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.586 HD23 HD21 ' A' ' 201' ' ' LEU . 0.7 OUTLIER -61.81 -27.05 68.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.24 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -77.36 -47.45 19.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.462 0.649 . . . . 0.0 110.841 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -62.11 -45.2 94.54 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.614 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.52 HD12 HE21 ' A' ' 223' ' ' GLN . 40.6 tp -63.83 -40.68 97.18 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 225' ' ' SER . 5.0 t80 -51.07 -48.79 61.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.451 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 59.1 p -55.32 -51.52 66.45 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.596 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.52 HE21 HD12 ' A' ' 220' ' ' LEU . 16.2 mt-30 -51.23 -26.14 6.63 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.424 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.701 ' O ' HD22 ' A' ' 227' ' ' LEU . 17.8 mt -100.69 -19.03 16.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.525 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 221' ' ' TYR . 6.3 t -71.93 -27.51 62.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.997 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 24.9 t-20 -103.32 23.68 12.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.937 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.36 152.97 34.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.687 179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.647 ' N ' ' O ' ' A' ' 315' ' ' GLY . 16.0 t0 -66.04 115.65 25.3 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 232' ' ' GLY . 49.0 Cg_endo -70.14 -17.25 35.94 Favored 'Trans proline' 0 N--CA 1.505 2.164 0 C-N-CA 122.518 2.145 . . . . 0.0 112.941 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 229' ' ' PRO . 22.2 tptm -29.21 -47.68 0.06 Allowed 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 123.525 0.516 . . . . 0.0 110.962 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 232' ' ' GLY . 5.6 p30 -106.32 -14.07 15.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.388 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.25 56.13 0.17 Allowed Glycine 0 N--CA 1.469 0.878 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.7 t -119.72 99.98 6.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.574 0.226 . . . . 0.0 110.589 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 73.5 t -125.02 94.18 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.549 0.69 . . . . 0.0 110.437 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 8.4 t -98.11 121.47 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.53 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.507 HG22 HG23 ' A' ' 311' ' ' ILE . 18.3 t -91.58 122.12 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.572 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.431 HD22 ' SD ' ' A' ' 279' ' ' MET . 39.0 mt -104.55 141.05 37.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.034 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.78 130.27 7.13 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.19 119.96 38.13 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.1 p -113.28 162.97 15.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.838 0.352 . . . . 0.0 110.071 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -83.3 173.03 11.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.386 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.412 ' HG2' ' H ' ' A' ' 244' ' ' GLY . 62.2 ttp180 -101.18 125.24 47.78 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.426 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 8.1 mm -114.59 18.18 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.685 0.755 . . . . 0.0 110.453 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.412 ' H ' ' HG2' ' A' ' 242' ' ' ARG . . . 84.92 13.73 71.33 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.0 m -143.07 96.46 2.93 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.103 0.478 . . . . 0.0 110.284 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 247' ' ' ALA . 27.4 p-10 -49.19 -48.6 45.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.418 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.447 ' N ' ' OD1' ' A' ' 246' ' ' ASP . . . -56.15 -35.83 67.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.859 0.362 . . . . 0.0 110.276 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.518 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 39.0 t80 -70.0 -42.23 73.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.889 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.83 -49.72 75.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.235 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.42 -36.89 83.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.374 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.57 -41.18 98.68 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.605 HD22 HH12 ' A' ' 256' ' ' ARG . 37.9 mt -73.71 -34.16 64.69 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.947 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 85.0 p -64.0 -40.78 97.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.778 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.69 -43.03 69.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -58.64 -46.66 86.63 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.117 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.605 HH12 HD22 ' A' ' 252' ' ' LEU . 64.5 mtt85 -64.55 -60.91 2.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.905 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -48.44 -39.09 21.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 110.008 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -70.04 -43.26 71.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.373 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 44.5 m -59.3 -39.0 81.6 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.36 -51.72 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.157 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.522 HG13 HD12 ' A' ' 274' ' ' ILE . 18.7 t -61.37 -48.89 86.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.687 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -46.99 -41.39 16.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.125 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -81.74 -32.95 31.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.66 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -65.26 -24.28 67.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.254 -179.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.532 ' C ' ' H ' ' A' ' 267' ' ' LYS . 87.1 mt -73.51 -51.18 26.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 111.718 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 5.1 m -50.34 -8.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.801 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 265' ' ' ILE . 27.9 mmtp -82.68 -1.94 52.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 95.08 41.62 3.98 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.32 129.43 24.91 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.75 125.81 19.18 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.754 1.636 . . . . 0.0 111.736 176.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.55 -8.5 20.09 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -90.69 -24.08 20.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.719 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.475 ' HE2' HD21 ' A' ' 227' ' ' LEU . 0.7 OUTLIER -78.64 -21.94 47.63 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.315 0.578 . . . . 0.0 111.034 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.522 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -104.48 -174.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.562 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 38.5 t -170.94 131.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.442 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.96 150.2 20.72 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -154.0 138.01 16.38 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.32 0.581 . . . . 0.0 111.293 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -90.17 94.0 1.93 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.431 ' SD ' HD22 ' A' ' 237' ' ' LEU . 2.6 tpt -71.23 -7.04 44.2 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.611 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.53 -98.31 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -142.63 75.61 1.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.757 0.313 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 85.9 p -83.69 -1.64 54.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.977 0.418 . . . . 0.0 110.905 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.568 ' C ' HD22 ' A' ' 283' ' ' ASN . 0.1 OUTLIER -162.89 74.71 2.01 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.94 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -60.06 103.23 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.401 2.068 . . . . 0.0 113.198 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 286' ' ' THR . 13.8 m -69.91 -35.57 65.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.182 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.0 OUTLIER -59.5 -46.44 88.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.401 -179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.05 -5.58 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.619 ' H ' ' C ' ' A' ' 286' ' ' THR . 45.5 t30 -127.22 -57.26 1.31 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.844 0.457 . . . . 0.0 109.781 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 289' ' ' THR . 3.5 m -68.56 -10.71 57.54 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.666 0.27 . . . . 0.0 110.614 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 286' ' ' THR . 72.4 m -132.78 19.06 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 110.396 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -67.35 -5.43 14.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.663 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -108.68 32.24 5.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 7.2 t -131.63 120.48 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.68 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -119.7 10.44 11.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.952 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -101.57 135.8 42.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.145 0.498 . . . . 0.0 110.142 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -52.0 -70.32 0.09 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.845 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.77 -39.23 58.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.94 -39.64 95.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.424 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 303' ' ' LEU . 20.5 mt -65.94 -52.41 50.0 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.43 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 64.5 mt -53.04 -33.03 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.938 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -79.42 -24.23 42.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.979 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -98.03 -12.68 21.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.384 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 299' ' ' LEU . 80.6 mt -91.69 18.77 7.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.883 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.608 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -77.81 -53.25 1.51 Allowed Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.519 177.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 13.0 Cg_endo -53.7 9.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.225 0 C-N-CA 122.852 2.368 . . . . 0.0 112.888 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.608 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.3 t0 -103.1 16.75 25.79 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.53 ' NE ' ' OD1' ' A' ' 199' ' ' ASP . 18.0 ptt-85 -114.35 93.3 4.28 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.78 0.8 . . . . 0.0 110.415 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.502 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 48.1 ptt85 -157.46 131.73 8.35 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.59 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 7.8 m -102.02 140.13 21.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -120.84 105.69 10.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.372 0.606 . . . . 0.0 110.519 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.507 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.17 115.94 22.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.465 -178.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -90.68 117.37 29.28 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 123.091 0.245 . . . . 0.0 110.368 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.675 HG21 HD22 ' A' ' 224' ' ' LEU . 22.5 t -115.62 115.81 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.4 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -114.32 126.98 55.63 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.9 43.99 2.96 Favored Glycine 0 C--O 1.219 -0.807 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.692 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.5 tt -119.81 170.51 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.692 ' O ' ' O ' ' A' ' 316' ' ' ILE . 65.0 mttp . . . . . 0 N--CA 1.466 0.37 0 O-C-N 124.125 0.891 . . . . 0.0 111.293 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.8 0.333 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.59 HG22 ' CE1' ' A' ' 193' ' ' HIS . 9.1 m -74.99 130.5 39.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.191 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -147.32 117.54 7.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.167 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.59 ' CE1' HG22 ' A' ' 191' ' ' THR . 0.5 OUTLIER -103.76 151.39 23.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.521 ' CE1' HD21 ' A' ' 224' ' ' LEU . 37.5 m-85 -111.96 122.69 48.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.914 0.388 . . . . 0.0 110.062 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.08 102.44 13.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.541 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.691 ' CD2' HD11 ' A' ' 201' ' ' LEU . 26.8 tp -104.83 131.69 51.99 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.308 0.575 . . . . 0.0 109.728 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.418 ' HG2' ' H ' ' A' ' 199' ' ' ASP . 12.6 ttmm -82.51 129.8 34.99 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.196 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.6 t -62.74 -31.44 72.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.087 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.426 ' OD1' ' OD1' ' A' ' 203' ' ' ASN . 16.2 t70 -59.42 -37.98 79.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.231 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.88 -42.94 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.691 HD11 ' CD2' ' A' ' 196' ' ' LEU . 84.6 mt -80.01 -77.98 0.18 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.437 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.37 125.31 44.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.744 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.426 ' OD1' ' OD1' ' A' ' 199' ' ' ASP . 44.0 m-80 -88.3 -70.09 0.66 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.82 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -113.0 -10.58 13.48 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.749 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -74.63 164.83 26.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.139 0.495 . . . . 0.0 110.035 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -52.51 -77.82 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.292 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.67 56.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.489 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.2 p -107.69 132.97 52.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.179 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.412 HD22 HD22 ' A' ' 201' ' ' LEU . 18.7 mt -80.74 132.29 35.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.809 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -95.62 165.74 16.01 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.672 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -36.14 -76.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.499 2.133 . . . . 0.0 111.973 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -49.96 -20.51 0.94 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.319 0.581 . . . . 0.0 110.277 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.37 -51.45 12.91 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -66.15 -38.25 87.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.023 0.439 . . . . 0.0 109.93 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.4 -53.3 59.85 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.06 -33.76 76.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.575 0.702 . . . . 0.0 110.336 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.2 mt -69.5 -26.2 64.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.394 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -76.23 -49.46 17.08 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.482 0.658 . . . . 0.0 111.113 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -63.91 -41.11 97.76 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.364 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 311' ' ' ILE . 36.8 tp -63.5 -41.81 98.53 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.662 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.8 t80 -51.59 -48.95 62.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.805 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 80.7 p -55.55 -51.37 67.3 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.475 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.435 HE21 HD12 ' A' ' 220' ' ' LEU . 17.0 mt-30 -53.26 -27.35 22.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.365 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.979 HD22 HG21 ' A' ' 313' ' ' VAL . 47.4 mt -95.61 -19.48 19.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.759 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 221' ' ' TYR . 8.4 t -78.57 -30.38 46.75 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.357 0.41 . . . . 0.0 110.886 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 52.3 t-20 -86.11 20.2 2.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.708 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -77.75 -178.79 5.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.933 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 315' ' ' GLY . 49.4 t0 -100.09 105.19 33.99 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 232' ' ' GLY . 32.5 Cg_exo -55.6 -20.64 28.06 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 123.077 2.518 . . . . 0.0 113.61 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 229' ' ' PRO . 62.6 pttt -27.22 -40.48 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.162 0.506 . . . . 0.0 111.318 -176.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 229' ' ' PRO . 13.3 p30 -115.23 -14.74 11.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.304 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.03 59.82 0.16 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.8 m -118.64 102.09 8.6 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 58.9 t -126.69 92.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.701 0.762 . . . . 0.0 110.273 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.1 t -98.37 121.88 49.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.35 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.49 HG22 HG23 ' A' ' 311' ' ' ILE . 23.6 t -92.23 125.22 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.404 HD22 ' SD ' ' A' ' 279' ' ' MET . 55.0 mt -108.49 141.24 40.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.315 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.87 129.02 7.3 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -113.29 121.6 44.92 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.652 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 6.7 p -115.88 162.63 17.06 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.452 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 45.7 p30 -82.93 172.3 12.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.632 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.602 ' NH1' ' N ' ' A' ' 245' ' ' SER . 0.1 OUTLIER -94.62 126.21 39.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.932 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.4 mm -118.61 14.34 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.416 0.627 . . . . 0.0 110.708 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.425 ' C ' ' NH1' ' A' ' 242' ' ' ARG . . . 77.93 11.0 85.83 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . 0.602 ' N ' ' NH1' ' A' ' 242' ' ' ARG . 11.2 m -135.97 94.61 3.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.114 0.483 . . . . 0.0 110.049 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.536 ' OD1' ' NH2' ' A' ' 242' ' ' ARG . 47.1 m-20 -46.81 -50.28 18.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.446 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.49 -42.38 74.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.635 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.522 ' CE2' HD11 ' A' ' 252' ' ' LEU . 33.1 t80 -66.0 -38.83 89.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.54 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 27.3 t-20 -61.78 -52.6 63.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.107 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.67 -32.78 74.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.545 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.92 -43.79 98.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.522 HD11 ' CE2' ' A' ' 248' ' ' TYR . 33.0 mt -72.69 -35.48 67.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.763 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.8 t -64.76 -44.47 89.97 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.106 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.19 -42.4 75.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.176 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER -60.67 -49.9 75.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.357 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 260' ' ' VAL . 55.0 mtp180 -60.52 -52.38 65.44 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.607 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.11 -31.89 65.77 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -73.71 -45.01 54.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.234 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 77.4 p -61.38 -37.93 85.17 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.43 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.8 t -65.11 -53.1 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.299 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.598 HG13 HD12 ' A' ' 274' ' ' ILE . 9.8 t -60.97 -49.37 85.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.329 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -46.35 -40.77 12.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.93 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -82.65 -31.96 28.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.606 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.37 -9.94 57.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.451 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.554 ' C ' ' H ' ' A' ' 267' ' ' LYS . 62.8 mt -87.14 -53.57 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.775 0.322 . . . . 0.0 111.39 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.2 m -49.79 -6.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.004 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 265' ' ' ILE . 30.0 mmtm -81.39 -3.94 54.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.81 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.42 39.77 3.37 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.69 127.52 25.16 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.748 0.274 . . . . 0.0 110.378 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.48 128.25 27.19 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.917 1.745 . . . . 0.0 111.79 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.79 -7.92 24.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.237 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -91.97 -23.09 19.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.827 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -80.38 -19.71 45.72 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.297 0.57 . . . . 0.0 110.977 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.598 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -104.45 -171.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.525 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 3.1 t -169.45 130.16 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.314 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -101.72 110.7 22.75 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.917 0.389 . . . . 0.0 110.76 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.26 140.52 49.24 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.7 0.762 . . . . 0.0 111.345 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -91.38 93.89 1.89 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.404 ' SD ' HD22 ' A' ' 237' ' ' LEU . 2.2 tpt -69.19 -8.36 44.97 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.419 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.97 -107.94 0.09 OUTLIER Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.27 59.03 1.59 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.75 0.309 . . . . 0.0 110.558 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.0 t -83.04 -8.06 59.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.697 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -157.33 66.27 3.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.471 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.28 110.82 3.14 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.634 2.222 . . . . 0.0 112.042 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.0 m -73.23 -25.32 21.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.525 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.634 ' O ' ' N ' ' A' ' 288' ' ' ASN . 1.5 p -61.44 -46.34 90.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.911 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.81 -5.77 0.01 OUTLIER Glycine 0 CA--C 1.536 1.356 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.634 ' N ' ' O ' ' A' ' 286' ' ' THR . 35.7 m120 -125.49 -55.43 1.54 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.8 m -66.02 -16.32 63.8 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.947 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 302' ' ' CYS . 92.0 m -118.51 24.78 10.71 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.634 0.254 . . . . 0.0 110.424 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 293' ' ' VAL . 57.4 t0 -57.8 -46.57 84.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.75 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -74.48 33.86 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.596 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 291' ' ' ASP . 3.1 t -133.32 104.12 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.387 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -119.41 14.43 12.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.916 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.46 142.1 33.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.06 0.457 . . . . 0.0 109.921 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -51.37 -72.07 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.164 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.09 -40.5 67.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.697 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.71 88.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 17.5 mt -66.61 -55.71 14.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.546 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.27 -37.01 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.991 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -72.56 -33.28 66.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.554 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.477 ' O ' ' SG ' ' A' ' 290' ' ' CYS . 1.8 t -92.12 -4.62 54.06 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.68 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.3 mm? -96.58 19.19 12.68 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.682 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.579 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -81.62 -44.42 1.1 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.343 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.2 Cg_exo -58.18 10.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 123.319 2.679 . . . . 0.0 112.376 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.5 t0 -109.91 17.0 21.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 307' ' ' ARG . 18.8 ptt85 -113.06 90.96 3.49 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.652 0.739 . . . . 0.0 110.246 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.53 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 38.3 ptt180 -158.93 130.23 6.29 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.206 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.86 140.53 16.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -120.85 104.3 9.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.451 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -78.46 118.38 25.55 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -95.99 119.84 35.2 Favored 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 123.171 0.294 . . . . 0.0 110.816 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.979 HG21 HD22 ' A' ' 224' ' ' LEU . 58.3 t -122.64 118.74 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 O-C-N 123.554 0.534 . . . . 0.0 111.088 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -114.8 131.1 56.92 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.05 36.36 4.48 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.669 ' O ' ' O ' ' A' ' 317' ' ' LYS . 11.4 tt -113.3 169.36 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 316' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.223 -0.339 0 O-C-N 124.079 0.862 . . . . 0.0 111.251 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.449 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.114 0.483 . . . . 0.0 110.474 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 35.5 m -70.76 138.41 50.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.447 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 1.3 mmtm -115.17 172.21 7.21 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.425 0.631 . . . . 0.0 110.667 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 59.3 m80 -157.63 126.4 5.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.326 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.66 116.31 29.95 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -84.65 103.31 13.65 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.947 -179.408 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.704 ' CD2' HD11 ' A' ' 201' ' ' LEU . 29.5 tp -106.62 130.01 54.44 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.581 0.705 . . . . 0.0 110.02 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -79.14 127.31 31.86 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 122.572 1.177 . . . . 0.0 112.468 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.522 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 15.4 m -61.73 -35.03 76.89 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.508 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -57.2 -34.6 68.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.95 -44.12 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.704 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.7 mt -79.8 -77.36 0.19 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.574 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.03 124.7 42.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.936 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.544 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 5.0 p-10 -100.51 -76.45 0.56 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.465 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . 0.544 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 68.0 m-85 -96.85 -20.53 18.09 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 110.738 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -70.97 165.25 23.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.124 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -51.12 -81.8 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.63 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.0 56.05 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.453 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 28.5 p -109.17 143.5 38.5 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 110.211 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.405 HD12 ' CG ' ' A' ' 263' ' ' TYR . 10.0 mt -81.03 132.17 35.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.839 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 213' ' ' GLY . 30.8 mmtm -93.96 157.48 37.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.982 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 210' ' ' LYS . 75.6 Cg_exo -32.43 -76.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.309 2.006 . . . . 0.0 111.951 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.665 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 1.9 pm0 -48.36 -23.23 0.86 Allowed 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.512 0.672 . . . . 0.0 110.271 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.52 -44.14 27.86 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.198 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -68.03 -40.45 82.9 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.201 0.524 . . . . 0.0 109.742 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.31 -52.89 62.87 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.727 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.53 -35.8 80.58 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.143 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.35 -28.36 69.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.21 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -76.63 -47.49 22.07 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.314 0.578 . . . . 0.0 110.825 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -61.72 -44.39 97.02 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.336 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.473 HD12 HE21 ' A' ' 223' ' ' GLN . 39.4 tp -65.17 -40.24 94.02 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.403 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.504 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.3 t80 -51.89 -48.69 63.99 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.35 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.4 m -55.29 -52.31 63.84 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.048 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.473 HE21 HD12 ' A' ' 220' ' ' LEU . 17.2 mt-30 -49.83 -24.83 2.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.387 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.678 ' O ' HD22 ' A' ' 227' ' ' LEU . 18.7 mt -98.35 -16.94 19.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.77 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 79.9 p -75.62 -21.95 57.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.896 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -104.05 20.07 18.91 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.992 0.425 . . . . 0.0 110.999 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.678 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -77.61 156.03 31.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.158 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 315' ' ' GLY . 23.6 t0 -70.54 119.47 72.77 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.881 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.504 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.3 Cg_endo -69.85 -19.27 35.93 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.758 2.305 . . . . 0.0 113.194 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 229' ' ' PRO . 50.4 tptt -23.98 -50.39 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 124.068 0.855 . . . . 0.0 110.88 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 232' ' ' GLY . 7.7 p30 -113.18 -12.67 13.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.282 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 27.8 59.65 0.12 Allowed Glycine 0 N--CA 1.475 1.258 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 64.1 m -117.83 107.14 13.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 122.736 -0.273 . . . . 0.0 110.726 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 84.0 t -127.3 95.09 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.555 0.693 . . . . 0.0 110.078 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.8 t -97.85 120.93 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.187 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.466 HG22 HG23 ' A' ' 311' ' ' ILE . 17.1 t -92.73 125.3 45.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.719 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 59.5 mt -108.4 142.59 38.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.391 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.479 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -125.62 130.04 7.09 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -116.39 122.48 44.97 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.9 p -108.46 171.42 7.42 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.051 0.453 . . . . 0.0 109.846 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -92.68 -178.07 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.515 ' H ' HD12 ' A' ' 303' ' ' LEU . 73.2 ttt-85 -102.58 121.93 43.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.411 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.8 mm -118.42 13.13 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.503 0.668 . . . . 0.0 110.864 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.32 9.82 83.16 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.6 m -140.28 91.72 2.47 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.239 0.542 . . . . 0.0 110.308 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -48.23 -49.9 31.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.675 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.74 77.51 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.7 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.594 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 50.7 t80 -59.71 -47.78 84.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 110.423 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.543 HD21 ' H ' ' A' ' 243' ' ' ILE . 87.2 m-20 -62.83 -41.38 99.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.458 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -57.08 -46.22 82.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.184 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.01 -34.66 90.52 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.594 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 31.6 mt -71.63 -38.92 70.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.739 0.304 . . . . 0.0 111.121 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 6.5 t -64.97 -43.2 93.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.694 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.98 -46.03 75.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.145 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -55.64 -46.73 77.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.036 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.522 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 50.7 mtp180 -62.53 -61.92 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 110.174 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -50.48 -36.64 34.61 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.286 0.565 . . . . 0.0 109.893 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -73.05 -45.6 56.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.897 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 40.0 t -58.59 -37.97 76.93 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.829 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 256' ' ' ARG . 92.2 t -64.3 -51.08 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.049 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.652 HG13 HD12 ' A' ' 274' ' ' ILE . 12.8 t -61.92 -48.59 87.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.59 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -47.29 -43.08 22.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.878 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.552 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 48.6 t80 -77.42 -34.65 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.449 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -34.36 78.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.961 0.41 . . . . 0.0 110.525 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' A' ' 267' ' ' LYS . 88.3 mt -62.73 -50.33 80.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.253 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.9 t -49.31 -8.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.88 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.552 ' CE ' ' CE2' ' A' ' 263' ' ' TYR . 32.2 mmtp -86.64 12.52 10.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.504 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 79.68 42.66 11.06 Favored Glycine 0 CA--C 1.509 -0.302 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.024 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.12 128.72 25.21 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.226 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.72 127.94 26.47 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.968 1.779 . . . . 0.0 112.274 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.52 -8.71 28.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.841 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -91.94 -23.46 19.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.919 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.03 -22.95 44.68 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.534 0.683 . . . . 0.0 110.61 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.652 HD12 HG13 ' A' ' 261' ' ' VAL . 1.5 pt -102.1 -175.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.822 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 6.7 t -170.48 127.09 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.591 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.46 151.3 19.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -156.73 144.06 18.95 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 111.036 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -97.22 97.21 1.95 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.409 ' HG3' ' CZ ' ' A' ' 239' ' ' TYR . 1.2 mmt -68.6 -7.64 34.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.252 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 45.6 -109.17 0.29 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 281' ' ' GLU . 51.9 mp0 -131.21 57.12 1.77 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.644 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 6.2 t -80.23 -4.59 53.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.627 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -155.87 67.93 4.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.934 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.77 105.8 2.15 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.304 2.003 . . . . 0.0 111.613 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 286' ' ' THR . 15.1 m -69.62 -36.71 71.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.517 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.582 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.9 OUTLIER -63.75 -46.94 83.04 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.194 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -46.79 -6.89 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.582 ' H ' ' C ' ' A' ' 286' ' ' THR . 21.5 t-20 -124.65 -58.44 1.5 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.749 0.309 . . . . 0.0 110.367 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.0 m -63.5 -24.87 68.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.654 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -116.34 27.02 9.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.192 0.307 . . . . 0.0 110.32 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 288' ' ' ASN . 2.4 p30 -69.96 -5.78 28.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.708 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -98.33 32.97 2.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.609 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.429 HG21 ' SG ' ' A' ' 290' ' ' CYS . 16.8 t -131.38 123.9 53.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.894 0.378 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -118.89 8.16 11.66 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.874 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.467 ' O ' HD12 ' A' ' 299' ' ' LEU . 7.5 mt-30 -88.03 169.33 12.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.135 0.493 . . . . 0.0 110.069 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? -85.2 -68.01 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.905 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -60.44 -30.98 69.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.094 0.473 . . . . 0.0 110.831 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.81 83.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.404 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 295' ' ' GLN . 63.0 mt -74.38 -54.67 7.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 72.9 mt -46.91 -36.53 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.062 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.94 -44.36 48.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.143 0.497 . . . . 0.0 110.688 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.2 t -75.57 -3.3 33.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.788 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.515 HD12 ' H ' ' A' ' 242' ' ' ARG . 1.3 mm? -96.19 16.66 17.59 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.383 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.59 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -80.04 -46.03 1.44 Allowed Pre-proline 0 C--O 1.241 0.632 0 CA-C-O 121.336 0.588 . . . . 0.0 110.052 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 24.5 Cg_exo -61.5 8.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.12 2.547 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.2 t0 -103.79 14.82 30.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.679 0.276 . . . . 0.0 110.687 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -114.31 96.88 6.0 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 121.773 0.797 . . . . 0.0 109.788 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.544 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 15.8 ptm180 -156.71 130.13 8.09 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.988 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.9 140.69 16.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -123.25 105.25 9.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.316 0.579 . . . . 0.0 111.044 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.466 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -78.77 118.7 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.32 -178.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -95.1 124.33 39.08 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.154 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.535 HG21 HD22 ' A' ' 224' ' ' LEU . 21.9 t -123.66 117.79 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.175 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -116.67 130.59 56.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 95.04 37.93 5.02 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.589 ' O ' ' O ' ' A' ' 317' ' ' LYS . 13.4 tt -117.51 173.42 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.589 ' O ' ' O ' ' A' ' 316' ' ' ILE . 98.1 mttt . . . . . 0 CA--C 1.536 0.42 0 O-C-N 124.154 0.909 . . . . 0.0 110.51 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.402 ' OE1' ' C ' ' A' ' 317' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 121.104 0.478 . . . . 0.0 109.913 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.5 HG22 ' NE2' ' A' ' 193' ' ' HIS . 17.6 m -74.39 130.77 40.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.999 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -147.7 120.31 8.57 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.5 ' NE2' HG22 ' A' ' 191' ' ' THR . 3.4 m170 -108.07 151.45 25.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -112.1 121.47 45.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.317 0.579 . . . . 0.0 110.121 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 195' ' ' THR . 6.4 t -86.2 102.04 13.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.568 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.686 ' CD2' HD11 ' A' ' 201' ' ' LEU . 32.0 tp -104.48 131.95 51.28 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.15 -178.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -81.37 126.37 31.52 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.188 -177.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 202' ' ' PHE . 96.1 p -61.5 -32.63 72.67 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.937 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -59.43 -41.73 90.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.377 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 82.6 t -61.92 -48.75 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.5 mt -72.14 -77.81 0.09 Allowed 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.396 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -120.17 123.16 42.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.33 -179.154 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -86.74 -73.78 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.052 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -107.43 -11.9 15.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.772 0.32 . . . . 0.0 110.51 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -72.44 163.52 27.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.152 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -52.13 -78.25 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.255 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.33 57.01 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.27 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.8 t -108.8 137.79 46.17 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.304 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.482 HD12 ' CG ' ' A' ' 263' ' ' TYR . 10.7 mt -80.95 131.75 35.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.34 0.591 . . . . 0.0 111.394 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 213' ' ' GLY . 9.2 pttp -94.77 154.62 39.86 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.443 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 210' ' ' LYS . 93.5 Cg_exo -31.15 -73.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.269 1.979 . . . . 0.0 112.306 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -50.75 -25.11 3.98 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.954 0.407 . . . . 0.0 110.591 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.86 -46.58 16.83 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -62.42 -41.04 98.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.39 -52.84 62.22 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.373 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.64 70.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.585 0.707 . . . . 0.0 110.292 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.95 -29.69 66.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.169 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -75.73 -49.07 19.32 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.154 0.502 . . . . 0.0 111.236 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.538 ' O ' ' NE2' ' A' ' 223' ' ' GLN . 2.6 pt20 -61.93 -42.79 99.5 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.497 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 31.5 tp -65.41 -40.1 92.96 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.3 t80 -52.56 -45.49 66.44 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.907 178.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.3 t -55.5 -51.25 67.63 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.357 -178.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.858 HE21 ' H ' ' A' ' 223' ' ' GLN . 0.0 OUTLIER -54.14 -25.69 23.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.495 -179.263 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.869 HD22 HG21 ' A' ' 313' ' ' VAL . 18.3 mt -97.86 -21.95 16.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.758 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.2 t -75.26 -32.77 61.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.349 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -97.1 24.16 6.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 -179.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.593 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.25 157.7 32.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.502 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 315' ' ' GLY . 8.0 t70 -71.73 120.48 80.23 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 232' ' ' GLY . 56.7 Cg_endo -67.78 -20.08 46.38 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.801 1.667 . . . . 0.0 113.522 -177.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 229' ' ' PRO . 51.3 tptt -28.6 -44.86 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.388 0.43 . . . . 0.0 111.299 -178.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 232' ' ' GLY . 72.5 m-20 -109.77 -14.42 14.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.507 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 25.16 51.38 0.04 OUTLIER Glycine 0 N--CA 1.469 0.834 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.1 m -117.84 109.98 17.22 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.738 0.304 . . . . 0.0 111.101 -178.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.48 94.03 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 121.641 0.734 . . . . 0.0 110.116 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.86 121.82 47.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.271 -178.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.437 HG22 HG23 ' A' ' 311' ' ' ILE . 20.9 t -95.3 121.58 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.515 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.45 HD22 ' SD ' ' A' ' 279' ' ' MET . 79.0 mt -105.52 141.01 37.74 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.006 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.7 126.14 6.25 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.66 124.87 53.22 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.2 t -115.96 168.85 9.71 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.832 0.348 . . . . 0.0 110.505 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -92.36 -177.21 4.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.576 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.574 ' NE ' ' OE1' ' A' ' 281' ' ' GLU . 92.2 mtt180 -100.62 128.02 46.81 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.989 0.423 . . . . 0.0 110.482 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.1 mm -118.28 11.67 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.91 3.48 89.22 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.5 t -135.23 102.85 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.286 0.565 . . . . 0.0 110.361 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -55.16 -51.71 65.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.548 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.36 70.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.548 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.687 ' CE2' HD11 ' A' ' 252' ' ' LEU . 47.4 t80 -62.91 -42.12 99.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.307 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.527 HD21 ' H ' ' A' ' 243' ' ' ILE . 98.4 m-20 -61.43 -46.31 90.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.587 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.4 HE22 ' HA3' ' A' ' 280' ' ' GLY . 95.8 mm-40 -61.25 -41.63 97.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.451 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.94 -36.07 92.94 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.687 HD11 ' CE2' ' A' ' 248' ' ' TYR . 32.9 mt -70.59 -41.26 72.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.81 178.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 11.7 t -65.33 -42.65 92.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.57 -49.11 72.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.129 0.49 . . . . 0.0 109.816 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -58.46 -44.84 89.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.256 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 51.8 ttm-85 -51.27 -64.25 0.87 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.54 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -56.84 -31.38 64.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.244 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -66.09 -48.19 71.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.542 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.47 ' O ' ' OD2' ' A' ' 262' ' ' ASP . 13.6 t -60.06 -39.13 84.95 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.467 0.651 . . . . 0.0 110.826 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.24 -50.67 79.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.216 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 276' ' ' ALA . 23.1 t -62.2 -48.92 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.794 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 259' ' ' SER . 0.0 OUTLIER -47.53 -41.73 21.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.144 0.497 . . . . 0.0 110.014 -177.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.482 ' CG ' HD12 ' A' ' 209' ' ' LEU . 15.6 t80 -79.85 -34.11 39.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.83 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -33.87 76.84 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.33 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.404 ' C ' ' N ' ' A' ' 267' ' ' LYS . 84.6 mt -65.99 -49.36 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 79.0 p -54.07 -11.1 0.41 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.966 -178.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.422 ' CB ' ' CD1' ' A' ' 221' ' ' TYR . 70.9 mmtt -78.41 -7.46 57.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.683 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 101.61 43.06 2.2 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.768 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.3 128.74 23.65 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 117.12 0.46 . . . . 0.0 110.029 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.22 129.2 27.85 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.694 1.596 . . . . 0.0 111.817 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.68 -10.53 47.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.954 0.406 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -90.66 -21.36 21.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.385 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -19.9 41.88 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.948 0.88 . . . . 0.0 110.975 -179.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.482 HD12 HG13 ' A' ' 261' ' ' VAL . 2.3 pt -104.96 -173.5 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.455 -179.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 15.7 t -166.62 135.82 2.98 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.283 178.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.495 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -108.06 110.48 22.18 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.957 0.408 . . . . 0.0 110.838 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -115.46 137.24 52.26 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.386 0.612 . . . . 0.0 111.503 -178.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 280' ' ' GLY . . . -86.85 92.09 1.78 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 178.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.45 ' SD ' HD22 ' A' ' 237' ' ' LEU . 5.1 tpt -66.19 3.9 0.8 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.502 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 278' ' ' GLY . . . 35.35 -104.64 0.02 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.12 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.574 ' OE1' ' NE ' ' A' ' 242' ' ' ARG . 30.9 tt0 -142.62 58.21 1.44 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.3 m -85.33 -4.02 59.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -149.59 65.61 7.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.233 -179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.31 148.31 90.96 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.21 1.94 . . . . 0.0 111.26 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.569 HG23 ' H ' ' A' ' 286' ' ' THR . 19.6 m -110.95 -55.36 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.247 0.546 . . . . 0.0 110.907 178.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.791 HG21 ' O ' ' A' ' 302' ' ' CYS . 18.6 p -58.91 -40.78 85.55 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.075 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.61 -7.73 0.01 OUTLIER Glycine 0 CA--C 1.531 1.078 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.632 ' N ' ' O ' ' A' ' 286' ' ' THR . 3.2 m-20 -123.45 -54.99 1.76 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.8 m -66.89 -22.03 65.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.324 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.609 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -120.95 24.53 10.14 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.756 0.312 . . . . 0.0 110.481 -179.565 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -66.58 -9.01 30.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.981 0.42 . . . . 0.0 110.358 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -93.77 33.72 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.173 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.609 HG21 ' SG ' ' A' ' 290' ' ' CYS . 14.5 t -135.32 120.59 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.8 0.333 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 13.03 13.14 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.424 ' N ' ' CD ' ' A' ' 295' ' ' GLN . 0.1 OUTLIER -99.59 136.93 38.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.974 0.416 . . . . 0.0 109.953 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -58.14 -46.12 86.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.2 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -67.11 -46.93 72.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.285 -178.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.19 -26.36 68.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.661 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 303' ' ' LEU . 31.8 mt -76.12 -57.04 4.11 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.549 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.36 -36.97 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.0 109.882 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -72.0 -40.34 68.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.099 178.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.791 ' O ' HG21 ' A' ' 286' ' ' THR . 9.1 t -83.68 -8.02 59.37 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.562 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 299' ' ' LEU . 49.4 mt -93.77 21.73 6.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.463 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.25 -43.35 1.4 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 121.055 0.455 . . . . 0.0 110.711 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.3 Cg_exo -60.77 10.27 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.398 2.732 . . . . 0.0 111.681 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 304' ' ' ALA . 2.0 m-20 -103.88 14.26 31.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.743 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -115.87 93.84 4.42 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.239 0.543 . . . . 0.0 110.165 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.505 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 8.4 ptm180 -154.44 128.4 8.85 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.512 0.673 . . . . 0.0 112.575 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.54 135.57 28.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.508 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.448 ' OE2' ' CZ ' ' A' ' 239' ' ' TYR . 28.5 mt-10 -118.66 104.37 10.56 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.26 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.437 HG23 HG22 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -79.48 117.86 25.93 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.543 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -96.0 121.61 37.93 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.141 0.495 . . . . 0.0 110.594 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.869 HG21 HD22 ' A' ' 224' ' ' LEU . 52.4 t -124.34 117.27 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.955 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -112.92 138.67 49.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 87.82 39.14 7.17 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -178.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.715 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.3 tt -116.68 169.31 7.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.715 ' O ' ' O ' ' A' ' 316' ' ' ILE . 68.2 mttm . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 121.7 0.762 . . . . 0.0 112.016 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.703 0.287 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 192' ' ' LYS . 43.3 m -76.59 167.03 22.57 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.008 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 191' ' ' THR . 3.8 tptm -152.37 98.5 2.4 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.561 0.696 . . . . 0.0 110.998 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -85.27 125.16 32.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.408 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.606 ' CE2' HD21 ' A' ' 224' ' ' LEU . 54.4 m-85 -112.73 119.27 37.49 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 195' ' ' THR . 7.7 t -86.4 104.93 16.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.427 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.687 ' CD2' HD11 ' A' ' 201' ' ' LEU . 27.7 tp -107.38 129.47 54.92 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.068 0.461 . . . . 0.0 109.773 -179.4 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -78.81 126.78 31.18 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.876 0.845 . . . . 0.0 112.113 -178.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 202' ' ' PHE . 94.6 p -62.74 -30.29 71.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.984 179.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -58.86 -40.27 83.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.32 -46.27 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.687 HD11 ' CD2' ' A' ' 196' ' ' LEU . 90.3 mt -75.93 -76.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.359 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -126.48 128.29 46.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.946 -179.787 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -108.45 -76.18 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.27 -34.09 17.83 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.561 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.468 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 48.9 p30 -62.79 165.77 6.27 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.076 0.465 . . . . 0.0 110.223 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -54.93 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.54 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.3 52.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.63 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.468 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 60.9 p -107.14 137.76 44.59 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.279 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.2 mt -74.6 142.74 44.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.18 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 213' ' ' GLY . 34.4 mtpt -101.83 159.68 28.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.137 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 210' ' ' LYS . 82.2 Cg_exo -33.96 -77.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.418 2.079 . . . . 0.0 111.982 179.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 56.2 mp0 -51.47 -17.01 0.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.262 0.553 . . . . 0.0 110.181 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.99 -48.22 10.24 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.343 178.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . 0.402 ' NE2' ' CE1' ' A' ' 263' ' ' TYR . 93.1 mt-30 -67.62 -40.11 84.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.139 0.495 . . . . 0.0 109.783 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.49 -50.34 74.11 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 219' ' ' GLN . . . -65.07 -32.65 74.46 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.509 0.671 . . . . 0.0 110.311 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.9 mt -70.33 -26.89 63.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.421 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -74.94 -47.66 28.47 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.36 0.6 . . . . 0.0 111.178 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 216' ' ' ALA . 15.4 pt20 -64.63 -40.72 95.96 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.469 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.2 tp -63.78 -41.47 97.95 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.488 178.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 225' ' ' SER . 6.3 t80 -53.02 -51.02 63.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.998 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 6.1 t -53.19 -51.48 61.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.266 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.562 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 11.1 tt0 -55.12 -25.92 34.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.946 HD22 HG21 ' A' ' 313' ' ' VAL . 86.5 mt -94.89 -20.28 19.56 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.641 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 221' ' ' TYR . 24.6 p -83.36 -11.42 57.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.396 0.435 . . . . 0.0 110.444 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 13.7 t-20 -97.48 22.4 8.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.237 0.541 . . . . 0.0 110.263 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.539 ' H ' ' CD2' ' A' ' 227' ' ' LEU . 0.6 OUTLIER -80.03 -177.69 6.14 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.975 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 315' ' ' GLY . 21.5 t0 -100.26 108.02 50.48 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.77 178.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 230' ' ' LYS . 75.6 Cg_exo -46.19 -21.01 1.0 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.667 2.245 . . . . 0.0 112.917 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 229' ' ' PRO . 65.0 tttm -35.91 -52.21 0.73 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.041 0.448 . . . . 0.0 110.546 -177.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.47 ' O ' ' C ' ' A' ' 232' ' ' GLY . 57.4 m-20 -98.71 -21.52 16.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.528 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.17 50.32 0.04 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 123.849 0.718 . . . . 0.0 111.646 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.68 111.81 19.0 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 122.574 -0.368 . . . . 0.0 110.69 -179.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.02 97.32 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.712 0.767 . . . . 0.0 110.311 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.4 t -99.67 121.17 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.554 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 85.7 t -95.41 126.86 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.428 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.2 mt -111.93 140.53 46.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.051 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.429 ' O ' ' SD ' ' A' ' 279' ' ' MET . . . -116.7 136.48 12.81 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.609 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -120.81 122.04 39.45 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.511 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.402 HG22 ' NH1' ' A' ' 256' ' ' ARG . 3.3 p -113.3 165.8 12.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 0.0 110.218 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.52 ' OD2' HD11 ' A' ' 243' ' ' ILE . 9.4 p-10 -89.98 -177.32 5.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.644 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -98.42 122.06 41.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.281 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.3 mm -118.55 13.6 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.274 0.559 . . . . 0.0 110.702 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 82.73 2.65 90.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.9 m -132.79 98.92 4.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.033 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -54.01 -51.61 63.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.461 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.74 -41.6 74.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.505 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.591 ' CE2' HD11 ' A' ' 252' ' ' LEU . 55.2 t80 -63.36 -43.24 98.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.67 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.06 -42.38 99.13 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.523 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -64.04 -41.57 97.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.785 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.23 -39.07 97.21 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.591 HD11 ' CE2' ' A' ' 248' ' ' TYR . 33.5 mt -69.08 -38.2 78.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.764 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 15.4 m -63.66 -43.74 95.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.959 0.409 . . . . 0.0 111.011 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.11 -40.83 91.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.045 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.457 ' HA ' ' HE ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER -60.09 -47.41 86.01 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.28 -179.718 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.803 HH22 ' HE ' ' A' ' 307' ' ' ARG . 99.6 mtt180 -61.36 -58.78 6.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.115 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -52.74 -32.67 44.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.109 0.48 . . . . 0.0 109.753 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.56 -51.28 15.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.352 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.476 ' O ' ' OD2' ' A' ' 262' ' ' ASP . 66.2 m -58.86 -38.79 79.56 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.667 0.746 . . . . 0.0 110.268 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 256' ' ' ARG . 88.0 t -63.4 -50.1 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.365 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.591 HG13 HD12 ' A' ' 274' ' ' ILE . 12.8 t -62.08 -49.16 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.475 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 259' ' ' SER . 0.0 OUTLIER -45.06 -42.43 8.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.16 0.505 . . . . 0.0 110.272 -178.573 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.402 ' CE1' ' NE2' ' A' ' 214' ' ' GLN . 19.9 t80 -80.62 -31.38 36.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.637 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.9 -7.39 45.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.285 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.562 ' C ' ' H ' ' A' ' 267' ' ' LYS . 69.6 mt -88.62 -58.35 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 111.612 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.1 p -49.17 -6.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.075 -178.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.0 OUTLIER -78.19 -11.69 59.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.847 0.356 . . . . 0.0 110.527 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 108.67 39.88 1.68 Allowed Glycine 0 C--N 1.329 0.161 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.0 129.98 23.88 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.0 128.85 30.6 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.67 1.58 . . . . 0.0 111.698 176.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.23 -10.17 47.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.849 0.357 . . . . 0.0 111.122 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 33.5 p30 -92.61 -18.21 23.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.479 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 1.4 ttpm? -83.98 -18.26 37.79 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.605 0.717 . . . . 0.0 110.71 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.591 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -105.27 -171.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.717 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 7.6 t -168.53 133.19 1.62 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.202 179.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -105.2 112.04 25.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.784 0.326 . . . . 0.0 110.608 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 150.34 45.61 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.539 0.685 . . . . 0.0 110.982 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -115.37 97.63 0.81 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.659 ' CE ' ' H ' ' A' ' 282' ' ' SER . 3.3 ppp? -80.85 6.74 12.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.884 0.374 . . . . 0.0 111.001 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 47.38 -99.17 0.02 OUTLIER Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.983 179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.447 ' CD ' ' N ' ' A' ' 281' ' ' GLU . 1.8 pm0 -139.36 80.14 1.76 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.845 0.355 . . . . 0.0 111.032 -178.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.659 ' H ' ' CE ' ' A' ' 279' ' ' MET . 88.0 p -88.92 -2.0 58.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.071 -179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -163.02 75.6 1.93 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.296 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.34 103.7 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.461 2.107 . . . . 0.0 112.805 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 286' ' ' THR . 19.2 m -73.74 -35.88 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.231 0.539 . . . . 0.0 110.095 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.637 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.9 OUTLIER -58.98 -43.51 91.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.507 -179.714 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.38 -0.8 0.02 OUTLIER Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.637 ' H ' ' C ' ' A' ' 286' ' ' THR . 11.0 t30 -122.16 -58.62 1.71 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.7 m -58.73 -23.0 59.07 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.737 0.303 . . . . 0.0 110.524 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 3.3 m -120.29 28.49 8.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.143 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -70.78 -17.88 62.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.86 0.362 . . . . 0.0 110.952 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -97.57 31.47 2.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.437 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.408 HG12 ' CD1' ' A' ' 299' ' ' LEU . 23.6 t -137.95 129.31 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.194 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -121.23 13.3 11.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -96.44 131.37 43.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.168 0.509 . . . . 0.0 110.249 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -52.76 -67.98 0.21 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.031 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.48 -41.2 60.76 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.891 -178.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.26 80.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.424 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 303' ' ' LEU . 4.9 mp -72.74 -52.03 16.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.714 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 81.6 mt -43.17 -38.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.906 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -76.51 -43.53 39.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.359 178.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.7 t -73.93 -5.43 41.14 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.505 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.4 mm? -94.55 13.35 24.37 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.57 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.598 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -73.73 -43.1 6.56 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.734 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.5 Cg_exo -60.81 9.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.438 2.759 . . . . 0.0 112.255 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 304' ' ' ALA . 53.1 t0 -108.81 9.5 26.82 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.662 0.268 . . . . 0.0 110.669 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.803 ' HE ' HH22 ' A' ' 256' ' ' ARG . 68.3 mtp180 -112.38 98.87 7.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.333 0.587 . . . . 0.0 110.148 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.466 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 36.5 ptt180 -167.75 144.54 4.23 Favored 'General case' 0 C--O 1.215 -0.763 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.784 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.414 HG12 ' HA2' ' A' ' 238' ' ' GLY . 22.4 m -107.2 147.67 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -121.02 110.62 16.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.146 0.498 . . . . 0.0 111.091 -178.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.4 mm -80.49 118.31 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -104.33 98.96 8.67 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.942 -179.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.946 HG21 HD22 ' A' ' 224' ' ' LEU . 93.0 t -106.06 123.48 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.444 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -115.53 146.89 41.3 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.999 179.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 91.96 15.84 52.99 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -179.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.42 143.71 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.211 0.529 . . . . 0.0 110.825 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 41.4 tptt . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.767 179.385 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 N--CA 1.463 0.197 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.7 m -86.92 146.01 26.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.271 179.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 313' ' ' VAL . 20.4 mmtt -112.92 149.78 32.73 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.335 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -128.01 114.16 16.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.191 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.496 ' CE2' HD21 ' A' ' 224' ' ' LEU . 42.9 m-85 -114.03 116.47 29.24 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.678 177.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.1 102.18 13.63 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.584 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.732 ' CD2' HD11 ' A' ' 201' ' ' LEU . 29.4 tp -103.27 119.85 39.65 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.737 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -77.59 127.69 32.91 Favored 'General case' 0 C--O 1.255 1.366 0 CA-C-O 123.052 1.406 . . . . 0.0 112.765 -178.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 202' ' ' PHE . 78.4 p -59.48 -20.13 53.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.874 178.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -55.97 -43.63 77.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.15 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 6.7 t -74.6 -28.07 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.732 HD11 ' CD2' ' A' ' 196' ' ' LEU . 51.9 mt -93.52 -81.75 0.36 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.776 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.0 OUTLIER -113.27 130.28 56.29 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.869 -179.161 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.539 ' O ' ' NH1' ' A' ' 307' ' ' ARG . 7.7 m120 -98.7 -72.7 0.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -117.27 -21.13 8.89 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.817 0.341 . . . . 0.0 110.283 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.31 172.12 6.34 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.052 0.453 . . . . 0.0 110.321 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -53.37 -92.26 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.657 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -151.29 59.38 0.9 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.506 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 68.1 p -106.9 129.54 54.71 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 37.3 mt -74.7 125.01 27.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.697 -178.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 213' ' ' GLY . 50.4 mttt -86.32 158.52 54.88 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.72 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' N ' ' A' ' 213' ' ' GLY . 73.4 Cg_exo -34.01 -75.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.585 2.19 . . . . 0.0 112.045 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -49.02 -20.06 0.49 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.162 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.79 -51.32 11.4 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 178.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -66.19 -38.95 89.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.355 0.597 . . . . 0.0 110.241 179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.83 -53.75 54.86 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.67 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.37 90.83 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.981 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.88 -29.58 70.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.574 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -71.76 -46.28 58.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.219 0.533 . . . . 0.0 110.239 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.543 ' O ' ' NE2' ' A' ' 223' ' ' GLN . 7.1 mt-30 -62.16 -44.02 97.53 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.218 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.16 -41.02 97.31 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' A' ' 225' ' ' SER . 3.7 t80 -52.93 -47.69 67.86 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.528 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 72.6 m -53.22 -52.69 58.1 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.424 -178.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.879 HE21 ' H ' ' A' ' 223' ' ' GLN . 0.0 OUTLIER -55.78 -27.64 52.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.608 -179.203 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.91 HD22 HG21 ' A' ' 313' ' ' VAL . 86.6 mt -92.43 -23.12 19.27 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.713 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 221' ' ' TYR . 8.1 t -77.56 -19.78 55.13 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.57 0.544 . . . . 0.0 110.738 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -96.05 22.17 7.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.068 0.461 . . . . 0.0 110.688 -179.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.459 ' H ' ' CD2' ' A' ' 227' ' ' LEU . 0.7 OUTLIER -74.03 -177.68 3.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.219 179.903 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 230' ' ' LYS . 3.7 t0 -99.43 127.08 35.38 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 232' ' ' GLY . 55.4 Cg_endo -69.73 -22.52 32.12 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.959 2.44 . . . . 0.0 113.593 -178.209 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.556 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 34.6 ttmt -23.74 -51.97 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.688 0.617 . . . . 0.0 111.1 -177.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 232' ' ' GLY . 90.2 m-20 -109.54 -10.48 14.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.939 178.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 27.32 58.13 0.1 Allowed Glycine 0 N--CA 1.471 0.992 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.627 ' H ' ' CE ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -124.34 119.0 28.01 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-O 121.249 0.547 . . . . 0.0 110.454 -179.549 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -132.75 99.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.514 0.673 . . . . 0.0 109.805 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.19 127.09 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.152 0.501 . . . . 0.0 111.11 -178.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 89.4 t -102.12 128.39 54.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.399 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 18.2 mt -108.78 140.43 42.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.016 0.436 . . . . 0.0 110.459 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -98.95 138.26 13.75 Favored Glycine 0 N--CA 1.472 1.092 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.201 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 308' ' ' ARG . 9.7 m-85 -125.63 115.82 20.74 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.344 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 4.9 t -117.18 163.94 15.53 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.461 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 48.9 p-10 -87.74 -174.92 4.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.417 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -99.21 121.79 41.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 110.075 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.752 ' H ' HD21 ' A' ' 249' ' ' ASN . 47.8 mm -116.1 12.62 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.371 0.605 . . . . 0.0 110.728 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.05 -3.52 65.21 Favored Glycine 0 C--N 1.315 -0.584 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -125.39 105.26 8.95 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.93 -55.2 37.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.36 69.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.576 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.622 ' CE2' HD11 ' A' ' 252' ' ' LEU . 47.3 t80 -63.03 -44.88 94.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.775 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.752 HD21 ' H ' ' A' ' 243' ' ' ILE . 57.8 m-80 -61.88 -42.16 98.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.398 -179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -64.27 -41.81 96.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.644 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.74 -38.31 96.25 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.622 HD11 ' CE2' ' A' ' 248' ' ' TYR . 35.1 mt -69.2 -38.58 78.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.849 0.357 . . . . 0.0 111.199 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 78.1 p -63.56 -44.01 95.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.43 -45.11 80.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.437 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -56.8 -50.52 72.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.319 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.727 HH22 ' N ' ' A' ' 308' ' ' ARG . 70.3 mtp180 -59.13 -59.01 6.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.473 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.2 -35.68 17.79 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.172 0.511 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.408 ' NE2' ' OD1' ' A' ' 262' ' ' ASP . 68.0 tp60 -69.9 -43.75 71.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.154 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.7 t -60.86 -39.64 89.92 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.314 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.28 -54.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.773 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.571 HG13 HD12 ' A' ' 274' ' ' ILE . 24.4 t -60.21 -50.01 81.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.45 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.408 ' OD1' ' NE2' ' A' ' 258' ' ' GLN . 25.8 m-20 -44.6 -41.75 6.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -83.55 -29.67 27.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.745 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -71.74 -7.0 45.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.474 -179.658 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.0 mt -87.09 -55.74 6.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.832 0.349 . . . . 0.0 111.539 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.3 m -50.93 -5.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.887 -178.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.583 ' H ' ' C ' ' A' ' 265' ' ' ILE . 5.7 mmtm -77.17 -9.87 59.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.94 38.17 2.22 Favored Glycine 0 N--CA 1.458 0.15 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.07 128.35 23.76 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.24 130.24 34.71 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.965 1.777 . . . . 0.0 112.081 177.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.01 -10.71 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.917 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -92.84 -22.71 19.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.898 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -78.34 -23.21 47.09 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.632 0.73 . . . . 0.0 110.472 -179.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.571 HD12 HG13 ' A' ' 261' ' ' VAL . 1.4 pt -101.19 -170.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.71 -178.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 8.2 t -169.04 126.3 0.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.012 179.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.91 114.55 26.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.795 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -129.28 157.47 41.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.311 0.577 . . . . 0.0 110.18 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.54 155.11 16.25 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.541 ' N ' ' O ' ' A' ' 238' ' ' GLY . 5.5 tpt -118.62 -10.0 10.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.964 0.411 . . . . 0.0 110.293 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 53.58 -110.88 1.57 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -137.33 74.94 1.5 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.804 0.335 . . . . 0.0 110.732 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.408 ' C ' ' ND2' ' A' ' 283' ' ' ASN . 47.9 t -72.86 -48.42 37.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.12 0.486 . . . . 0.0 111.498 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 282' ' ' SER . 3.8 m-80 -144.63 76.77 14.06 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.12 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.55 123.26 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.627 2.218 . . . . 0.0 111.744 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.06 -35.87 42.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.115 0.483 . . . . 0.0 110.556 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.722 ' OG1' HD23 ' A' ' 303' ' ' LEU . 71.7 p -67.38 -50.03 61.41 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.643 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -55.12 1.73 0.05 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.7 t-20 -111.64 -61.12 1.75 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.3 t -76.91 -7.35 55.37 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.568 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.45 21.25 7.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.541 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -69.59 -4.2 18.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.575 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -96.6 33.02 1.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.661 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.8 t -125.65 129.96 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.944 0.402 . . . . 0.0 109.917 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.78 4.32 12.25 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -100.25 130.9 46.43 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.19 0.519 . . . . 0.0 110.432 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 299' ' ' LEU . 5.0 ttt180 -53.26 -75.62 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.604 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -42.36 -37.48 1.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.1 0.476 . . . . 0.0 110.747 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.48 84.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.793 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 296' ' ' ARG . 20.8 mt -73.12 -44.32 60.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.168 0.509 . . . . 0.0 110.575 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 300' ' ' ILE . 6.3 mm -60.84 -31.39 49.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.989 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -81.38 -28.97 34.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.611 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.3 t -93.68 -11.23 32.03 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.85 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.722 HD23 ' OG1' ' A' ' 286' ' ' THR . 37.7 mt -93.28 20.36 7.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.62 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -78.44 -46.11 2.03 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.288 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 37.7 Cg_exo -59.76 8.83 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.214 2.609 . . . . 0.0 111.886 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 304' ' ' ALA . 47.2 t0 -109.47 12.11 24.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.793 0.33 . . . . 0.0 110.852 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 203' ' ' ASN . 65.0 mtp180 -109.4 109.74 20.68 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.176 0.512 . . . . 0.0 110.36 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.727 ' N ' HH22 ' A' ' 256' ' ' ARG . 10.4 ptp180 -174.16 -172.38 0.7 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.998 -179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.35 157.11 15.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 177.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -121.79 106.65 11.48 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.221 0.534 . . . . 0.0 111.282 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.68 122.48 35.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.305 -178.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -108.06 116.65 32.34 Favored 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 123.775 0.672 . . . . 0.0 110.27 -178.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.91 HG21 HD22 ' A' ' 224' ' ' LEU . 80.2 t -130.77 125.71 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.154 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.652 ' HD3' ' H ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -99.41 179.53 4.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.335 179.043 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' A' ' 314' ' ' LYS . . . 71.52 -49.71 1.03 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 177.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 14.2 tt -47.07 150.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.098 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.058 179.649 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.477 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.442 HG22 ' NE2' ' A' ' 193' ' ' HIS . 17.7 m -69.12 139.03 54.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.291 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -142.33 114.0 7.95 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.9 m-70 -102.95 144.53 31.12 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.546 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 78.1 m-85 -107.22 130.68 54.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 195' ' ' THR . 8.0 t -86.32 104.35 15.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.825 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.597 ' HB3' HG23 ' A' ' 309' ' ' VAL . 3.4 mt -108.83 131.55 54.88 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.426 ' O ' HG22 ' A' ' 200' ' ' VAL . 0.8 OUTLIER -93.38 137.92 32.22 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 122.727 1.251 . . . . 0.0 110.991 -178.643 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 202' ' ' PHE . 0.9 OUTLIER -61.01 -18.21 56.45 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.427 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -57.13 -49.99 74.21 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.863 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 200' ' ' VAL . 4.7 m -68.26 -38.55 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.735 179.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.51 HD12 HG21 ' A' ' 309' ' ' VAL . 33.2 mt -82.79 -78.76 0.2 Allowed 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.449 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -138.06 137.86 38.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.841 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.753 HD22 HH11 ' A' ' 307' ' ' ARG . 0.8 OUTLIER -119.49 -75.99 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.552 179.808 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -81.69 -37.7 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.933 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -67.26 170.52 7.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.144 0.497 . . . . 0.0 110.494 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -59.32 -82.82 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.775 -179.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -153.67 54.23 0.73 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.166 0.507 . . . . 0.0 110.349 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.57 127.93 53.72 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.486 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.6 mt -70.21 140.89 52.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 -179.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 213' ' ' GLY . 4.1 mtmp? -103.51 157.36 34.01 Favored Pre-proline 0 N--CA 1.466 0.326 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -32.97 -76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.718 2.279 . . . . 0.0 112.352 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -49.84 -20.32 0.85 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.326 0.584 . . . . 0.0 110.548 -179.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.53 -50.08 12.85 Favored Glycine 0 N--CA 1.461 0.365 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.084 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -65.15 -40.88 95.0 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.232 0.539 . . . . 0.0 109.944 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.0 67.04 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.07 -38.69 91.97 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.607 -179.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.31 -28.88 70.05 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.277 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -71.18 -47.24 58.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.374 0.607 . . . . 0.0 110.808 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -62.62 -43.5 98.66 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.974 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 60.9 tp -65.23 -39.36 92.63 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.235 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.431 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.7 t80 -53.42 -47.94 69.18 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.845 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.8 t -59.32 -50.07 75.39 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.537 -178.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 9.0 tt0 -51.95 -24.99 7.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.942 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.655 HD22 HG21 ' A' ' 313' ' ' VAL . 23.3 mt -96.68 -17.15 20.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.508 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 10.5 t -81.63 -16.12 52.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.795 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -103.32 17.72 23.43 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.581 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.6 OUTLIER -74.38 -179.44 3.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.323 179.701 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -97.96 109.46 51.56 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 230' ' ' LYS . 78.5 Cg_exo -47.6 -19.57 1.33 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.349 2.033 . . . . 0.0 113.438 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 229' ' ' PRO . 1.5 tmtp? -27.13 -51.79 0.06 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.261 0.553 . . . . 0.0 111.11 -177.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 232' ' ' GLY . 67.9 m-20 -110.14 -13.73 14.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.478 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.51 46.61 0.02 OUTLIER Glycine 0 N--CA 1.474 1.228 0 O-C-N 124.101 0.876 . . . . 0.0 111.272 179.546 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 231' ' ' ASP . 74.6 m -114.96 109.93 18.85 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.568 0.223 . . . . 0.0 111.149 -178.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 77.4 t -125.64 95.05 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.37 0.605 . . . . 0.0 109.933 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.7 t -96.69 121.14 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.296 0.569 . . . . 0.0 110.7 -178.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.41 HG13 HD13 ' A' ' 311' ' ' ILE . 96.5 t -91.07 122.3 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 45.9 mt -105.79 140.86 38.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.427 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.445 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -125.03 129.72 7.11 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.604 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -113.91 117.01 30.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.824 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.475 HG22 ' HA2' ' A' ' 280' ' ' GLY . 9.7 t -104.88 178.54 4.53 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.133 0.492 . . . . 0.0 110.975 -178.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 307' ' ' ARG . 41.8 m-20 -83.79 -177.08 6.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.394 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -117.02 120.28 37.9 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.768 0.318 . . . . 0.0 110.501 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 243' ' ' ILE . 45.4 mm -120.67 12.66 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.504 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.96 -43.5 3.26 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 6.9 m -71.1 94.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.362 0.601 . . . . 0.0 109.934 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -48.51 -48.34 38.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.203 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.14 84.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.749 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.566 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 44.2 t80 -62.14 -42.22 99.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.148 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.57 HD21 ' CA ' ' A' ' 280' ' ' GLY . 0.5 OUTLIER -60.38 -53.08 61.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 -179.775 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -61.67 -37.65 84.86 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.42 -41.83 99.63 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 33.0 mt -71.24 -37.78 71.99 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.073 178.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 4.2 t -63.0 -39.68 95.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.115 0.483 . . . . 0.0 110.879 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -73.19 -39.65 65.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.46 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -58.83 -51.75 68.65 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.517 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 260' ' ' VAL . 18.1 ptp180 -64.39 -44.28 91.81 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.899 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.32 -42.28 98.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.571 0.7 . . . . 0.0 110.421 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -70.72 -42.06 71.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.684 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.8 m -60.61 -39.14 87.09 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.383 0.611 . . . . 0.0 110.355 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 256' ' ' ARG . 88.8 t -63.97 -50.65 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.95 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.557 HG13 HD12 ' A' ' 274' ' ' ILE . 18.8 t -61.32 -48.27 89.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 121.165 0.507 . . . . 0.0 110.315 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -47.93 -40.9 23.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.908 -178.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -79.66 -35.59 39.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.026 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.14 -29.11 70.25 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.99 -179.023 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.483 ' C ' ' H ' ' A' ' 267' ' ' LYS . 89.0 mt -69.06 -49.54 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 120.797 0.332 . . . . 0.0 111.82 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 18.5 m -52.43 -8.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 265' ' ' ILE . 12.3 mmtt -79.75 -6.21 56.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.683 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.06 42.21 2.87 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.19 129.41 24.22 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 117.101 0.451 . . . . 0.0 110.583 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.56 129.34 29.21 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.325 1.35 . . . . 0.0 112.002 178.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.4 -11.05 38.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.74 -22.9 21.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -179.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.47 -23.54 50.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.295 0.569 . . . . 0.0 110.529 -179.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.557 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -104.18 -175.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.751 -179.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 25.7 m -169.28 132.53 1.29 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.326 178.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.93 148.99 22.05 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -153.1 138.09 17.22 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.394 0.616 . . . . 0.0 111.172 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.06 94.95 2.05 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -70.36 -6.88 38.53 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.535 -179.551 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . 0.57 ' CA ' HD21 ' A' ' 249' ' ' ASN . . . 42.62 -112.56 0.48 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.88 73.75 1.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.688 0.28 . . . . 0.0 110.317 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 31.9 t -71.27 -37.5 71.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.043 0.449 . . . . 0.0 111.613 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -129.44 79.32 74.15 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.698 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.04 110.35 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.501 2.134 . . . . 0.0 112.112 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 286' ' ' THR . 9.1 m -73.14 -36.07 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.76 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.603 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.1 OUTLIER -62.21 -49.35 76.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.097 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -52.51 0.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 286' ' ' THR . 2.5 t-20 -116.21 -59.69 1.95 Allowed 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -78.18 -3.61 43.44 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.438 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.75 17.9 4.25 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 292' ' ' ASN . 37.9 p-10 -61.53 -36.9 81.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.986 0.422 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 26.4 t-20 -78.73 33.32 0.21 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.947 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.464 ' HB ' HD11 ' A' ' 299' ' ' LEU . 12.1 t -135.93 124.92 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.005 0.431 . . . . 0.0 110.358 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -120.18 16.41 12.35 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.087 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -100.35 133.44 44.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.12 0.486 . . . . 0.0 110.66 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -59.96 -60.46 3.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.607 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.68 -43.26 65.45 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.978 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.93 89.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.268 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 303' ' ' LEU . 4.8 mp -75.62 -61.35 1.95 Allowed 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.324 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' LEU . 72.4 mt -42.32 -34.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.057 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -77.9 -38.72 45.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.316 178.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 299' ' ' LEU . 40.7 t -84.7 -6.99 59.38 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.005 0.431 . . . . 0.0 110.858 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 299' ' ' LEU . 92.8 mt -90.5 15.11 11.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.843 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -77.11 -53.28 1.72 Allowed Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.437 177.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 11.2 Cg_endo -54.25 8.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.178 1.919 . . . . 0.0 113.186 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 304' ' ' ALA . 59.4 t0 -101.4 12.88 36.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.753 HH11 HD22 ' A' ' 203' ' ' ASN . 15.1 ptp180 -113.61 95.2 5.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.189 0.995 . . . . 0.0 110.224 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.551 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.4 ptp180 -156.31 128.24 7.38 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.456 -178.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 196' ' ' LEU . 0.0 OUTLIER -97.01 135.6 30.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.292 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -118.51 104.91 11.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.333 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.41 HD13 HG13 ' A' ' 236' ' ' VAL . 4.7 mm -77.82 115.31 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.024 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -94.66 123.79 38.31 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 123.13 0.269 . . . . 0.0 110.672 -178.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.655 HG21 HD22 ' A' ' 224' ' ' LEU . 11.5 t -125.57 115.51 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.911 -178.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -114.72 134.46 55.08 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.14 17.1 25.9 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.6 tt -103.9 148.9 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.968 0.413 . . . . 0.0 110.38 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.612 -179.774 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.477 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.233 0 CA-C-O 120.916 0.389 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.1 m -67.8 139.12 56.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.146 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.461 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 7.5 mmtt -110.47 161.69 15.43 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.666 0.746 . . . . 0.0 110.611 179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.461 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 7.0 m-70 -148.27 119.87 8.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.017 -179.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -110.89 120.48 42.53 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.17 103.81 15.15 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.245 -179.957 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.694 ' CD2' HD11 ' A' ' 201' ' ' LEU . 32.2 tp -108.67 128.78 55.15 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -81.81 130.09 34.95 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-O 121.776 0.798 . . . . 0.0 112.291 -178.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -64.99 -27.57 68.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.697 179.723 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.62 -38.48 84.89 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.849 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.25 -42.86 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.694 HD11 ' CD2' ' A' ' 196' ' ' LEU . 88.8 mt -78.12 -79.1 0.13 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.46 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -124.56 129.5 50.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.779 -179.228 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.592 HD22 ' NZ ' ' A' ' 210' ' ' LYS . 66.0 m-80 -94.44 -74.42 0.54 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.721 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.49 -10.09 14.56 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.7 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -74.3 165.37 25.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.188 0.518 . . . . 0.0 109.919 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.04 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.825 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.09 2.52 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.927 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 63.7 p -53.03 136.27 35.57 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.903 0.383 . . . . 0.0 110.282 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 83.6 mt -82.9 136.36 34.61 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.293 0.568 . . . . 0.0 111.364 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.592 ' NZ ' HD22 ' A' ' 203' ' ' ASN . 31.2 mtmt -98.6 157.59 34.0 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.956 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -34.44 -75.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.383 2.055 . . . . 0.0 112.419 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 57.0 mp0 -48.9 -24.5 1.5 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.361 0.6 . . . . 0.0 110.225 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -70.92 -51.16 20.29 Favored Glycine 0 CA--C 1.517 0.209 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.603 178.494 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.14 -41.02 99.22 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.318 0.58 . . . . 0.0 109.465 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.465 ' O ' ' NE2' ' A' ' 219' ' ' GLN . . . -54.18 -56.1 21.48 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.973 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.61 72.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.56 0.695 . . . . 0.0 110.612 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.11 -25.97 63.75 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.57 179.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -75.59 -49.84 17.35 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.881 0.848 . . . . 0.0 111.054 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 215' ' ' ALA . 0.0 OUTLIER -62.46 -44.54 96.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.421 179.58 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.503 HD12 HE21 ' A' ' 223' ' ' GLN . 42.3 tp -62.36 -40.73 97.37 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.411 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.4 t80 -51.8 -49.51 62.58 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.896 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.0 m -54.88 -51.02 67.27 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.716 -178.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.503 HE21 HD12 ' A' ' 220' ' ' LEU . 18.7 mt-30 -51.55 -26.5 8.72 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.424 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.981 HD22 HG21 ' A' ' 313' ' ' VAL . 43.1 mt -100.4 -17.95 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.589 -179.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.1 t -73.79 -28.28 61.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.191 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -95.79 23.91 5.85 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.85 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.482 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.61 167.42 21.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.201 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -82.01 129.19 65.4 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 230' ' ' LYS . 53.8 Cg_endo -70.36 -18.73 34.0 Favored 'Trans proline' 0 N--CA 1.506 2.248 0 C-N-CA 122.979 2.452 . . . . 0.0 112.832 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 229' ' ' PRO . 24.6 mmtm -32.32 -52.27 0.28 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.525 -177.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 232' ' ' GLY . 58.4 m-20 -104.45 -17.48 14.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.153 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.75 50.81 0.06 OUTLIER Glycine 0 N--CA 1.471 0.982 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.8 t -118.25 108.47 15.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.819 0.343 . . . . 0.0 110.935 -178.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 313' ' ' VAL . 15.7 t -125.93 95.61 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.285 178.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.4 120.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.245 -178.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.417 HG21 HG22 ' A' ' 261' ' ' VAL . 73.6 t -91.45 126.66 44.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.223 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 277' ' ' ARG . 23.8 mt -109.97 140.24 44.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.886 -179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -122.54 130.09 7.78 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.21 117.13 29.63 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.028 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.6 p -103.8 171.31 7.43 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 242' ' ' ARG . 43.6 t0 -85.45 -176.28 6.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.726 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.465 ' H ' ' CG ' ' A' ' 241' ' ' ASP . 88.9 mtm180 -109.34 120.65 43.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.957 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.0 mm -120.08 14.47 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.639 0.733 . . . . 0.0 110.645 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.09 -47.81 3.39 Favored Glycine 0 C--N 1.314 -0.653 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.9 p -76.2 91.16 3.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.287 0.565 . . . . 0.0 109.712 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -45.38 -46.5 13.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.372 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.97 80.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.625 ' CE2' HD11 ' A' ' 252' ' ' LEU . 57.2 t80 -59.76 -45.9 90.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.989 0.423 . . . . 0.0 110.347 -179.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -62.08 -40.99 97.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.098 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.05 -40.87 95.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.874 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.27 -38.77 96.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.625 HD11 ' CE2' ' A' ' 248' ' ' TYR . 98.3 mt -74.95 -31.2 61.43 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.931 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.5 t -66.49 -45.39 79.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.856 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.39 -39.54 71.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.226 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -61.59 -49.84 75.02 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.508 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.51 ' O ' HG23 ' A' ' 260' ' ' VAL . 99.4 mtt180 -62.28 -51.45 67.66 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.426 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -53.95 -34.34 59.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.162 0.506 . . . . 0.0 109.922 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -71.88 -42.99 66.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.0 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.782 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 16.7 t -62.02 -35.83 79.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.179 0.99 . . . . 0.0 109.92 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 256' ' ' ARG . 71.4 t -67.65 -54.5 22.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.341 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.417 HG22 HG21 ' A' ' 236' ' ' VAL . 55.9 t -63.44 -50.2 79.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.782 ' OD1' ' O ' ' A' ' 259' ' ' SER . 40.7 p-10 -49.57 -37.64 28.12 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.577 -177.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.656 ' N ' ' OD1' ' A' ' 262' ' ' ASP . 35.0 t80 -81.34 -33.87 32.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.377 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -64.38 -22.15 66.86 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.893 -179.549 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 267' ' ' LYS . 87.7 mt -78.24 -52.29 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.49 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 62.0 m -49.33 -10.18 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.899 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.0 OUTLIER -77.51 -11.2 59.83 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.302 -179.398 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.8 42.32 1.58 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.402 HD12 ' CE1' ' A' ' 221' ' ' TYR . 0.1 OUTLIER -126.67 137.66 30.91 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 117.188 0.494 . . . . 0.0 110.575 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.81 124.23 15.55 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.698 1.599 . . . . 0.0 111.755 177.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.94 -9.83 42.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.874 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -91.22 -23.95 20.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.706 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.448 ' HE3' HD21 ' A' ' 227' ' ' LEU . 2.4 ttpm? -79.81 -19.34 48.72 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.585 0.707 . . . . 0.0 110.994 -179.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.5 pt -104.91 -171.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.532 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 47.4 t -170.82 137.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.105 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.43 150.56 22.05 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.456 ' HB3' HD23 ' A' ' 237' ' ' LEU . 62.0 ttm-85 -155.68 139.79 16.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.538 0.685 . . . . 0.0 111.455 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -93.97 96.96 2.13 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -69.96 -4.49 20.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.875 0.369 . . . . 0.0 110.345 -179.028 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.87 -116.28 1.2 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -138.21 71.0 1.39 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.764 0.316 . . . . 0.0 110.462 -179.658 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.14 5.61 49.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.276 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 283' ' ' ASN . 13.7 p-10 -159.82 74.82 3.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.75 108.32 2.25 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.424 2.083 . . . . 0.0 112.073 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 286' ' ' THR . 6.2 m -70.45 -43.03 78.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.608 ' C ' ' H ' ' A' ' 288' ' ' ASN . 65.7 p -58.83 -43.6 90.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.078 -179.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.62 -0.55 0.03 OUTLIER Glycine 0 CA--C 1.533 1.159 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.608 ' H ' ' C ' ' A' ' 286' ' ' THR . 18.9 m120 -119.86 -59.09 1.83 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.4 OUTLIER -66.71 -18.75 65.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.572 -178.606 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.46 25.79 9.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.291 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 51.5 t0 -69.19 -10.95 60.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 110.393 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -94.89 32.58 1.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.528 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.1 t -129.92 127.26 63.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 110.237 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -117.77 8.13 12.64 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.969 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -95.36 127.81 41.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.044 0.449 . . . . 0.0 109.95 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -55.94 -50.47 70.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.516 -179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.78 96.91 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.982 -179.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.25 -30.09 70.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.62 179.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 39.6 mt -79.18 -57.04 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.398 -179.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.7 mt -45.89 -36.52 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.948 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -74.39 -47.21 35.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.509 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 6.7 t -75.8 -4.95 43.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.278 -179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.522 HD23 ' OG1' ' A' ' 286' ' ' THR . 50.5 mt -96.06 13.06 28.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.529 -179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.594 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -75.13 -46.13 4.69 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.828 0.347 . . . . 0.0 110.083 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 32.1 Cg_exo -56.41 10.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.971 2.448 . . . . 0.0 112.258 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.594 ' H ' ' C ' ' A' ' 304' ' ' ALA . 46.9 t0 -101.06 13.49 35.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.741 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.538 ' NH1' ' HB1' ' A' ' 304' ' ' ALA . 28.9 ptt-85 -113.04 101.72 9.73 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.991 0.9 . . . . 0.0 110.86 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.565 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 20.4 ptp180 -162.02 132.31 4.83 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.24 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.6 142.25 14.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -121.58 108.11 13.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.985 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.8 mm -78.97 119.75 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . 0.442 ' OE2' ' CE1' ' A' ' 193' ' ' HIS . 28.2 tp10 -99.06 120.58 39.72 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.04 -178.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.981 HG21 HD22 ' A' ' 224' ' ' LEU . 66.8 t -126.88 119.47 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 123.578 0.549 . . . . 0.0 111.318 -179.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -117.34 125.2 50.64 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 118.15 -18.6 11.23 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.25 144.1 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.377 179.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 18.1 tptm . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.458 -179.963 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.809 0.337 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 36.5 m -70.92 142.78 51.09 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.667 179.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.435 ' HD3' ' H ' ' A' ' 193' ' ' HIS . 5.3 tmtt? -111.49 162.36 15.18 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.381 0.61 . . . . 0.0 110.715 179.668 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.435 ' H ' ' HD3' ' A' ' 192' ' ' LYS . 53.9 m80 -152.82 121.18 6.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.674 179.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.634 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 59.6 m-85 -113.07 123.29 49.93 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.53 103.59 14.53 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.597 -179.588 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 196' ' ' LEU . 3.8 mt -104.69 122.34 45.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.039 0.447 . . . . 0.0 109.983 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.588 ' O ' HG22 ' A' ' 200' ' ' VAL . 8.9 ptpp? -85.73 135.0 33.93 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 122.52 1.153 . . . . 0.0 111.542 -179.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 202' ' ' PHE . 4.0 p -59.74 -19.59 51.11 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.679 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -51.86 -50.02 61.75 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.927 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 197' ' ' LYS . 27.2 m -70.92 -33.68 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.675 178.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 20.5 mt -86.45 -80.36 0.24 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.356 179.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -135.18 145.41 47.7 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.607 -179.146 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -112.58 -67.74 0.98 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.504 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -112.45 -16.57 12.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.574 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -68.28 167.02 15.25 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.01 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.604 ' CG ' ' H ' ' A' ' 207' ' ' ALA . 18.2 pttt -51.29 -70.29 0.09 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.628 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.604 ' H ' ' CG ' ' A' ' 206' ' ' LYS . . . -166.62 -1.18 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.331 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.9 t -52.81 137.16 32.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.897 0.38 . . . . 0.0 110.494 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 96.7 mt -80.17 144.28 33.13 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.566 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 213' ' ' GLY . 38.5 mttm -106.46 156.28 37.29 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.009 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -34.47 -76.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.713 2.275 . . . . 0.0 112.091 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -48.73 -22.16 0.74 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.052 0.453 . . . . 0.0 110.413 -179.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.15 -49.64 15.35 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 178.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.82 -39.94 91.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.26 0.552 . . . . 0.0 110.118 179.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.74 54.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.836 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.95 -37.2 86.53 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.03 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.9 mt -62.72 -30.64 71.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.867 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -71.24 -46.49 60.97 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.087 0.47 . . . . 0.0 110.379 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -63.33 -44.09 95.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.306 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 47.5 tp -63.94 -39.89 95.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.496 ' CE1' ' OG ' ' A' ' 225' ' ' SER . 3.8 t80 -54.02 -49.56 68.63 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.652 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 69.6 m -57.35 -50.56 72.58 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.366 -178.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.634 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 11.3 tt0 -52.85 -26.22 13.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.254 -179.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.956 HD22 HG21 ' A' ' 313' ' ' VAL . 82.6 mt -97.53 -17.83 19.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.509 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.496 ' OG ' ' CE1' ' A' ' 221' ' ' TYR . 4.8 m -78.81 -12.16 60.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.742 -179.651 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -104.75 22.34 15.29 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 110.325 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.15 177.69 6.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.242 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 315' ' ' GLY . 31.2 t0 -98.97 108.8 51.24 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 230' ' ' LYS . 75.7 Cg_exo -46.9 -19.44 0.79 Allowed 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.605 2.204 . . . . 0.0 113.023 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 229' ' ' PRO . 52.8 tptt -27.11 -52.07 0.06 Allowed 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 123.559 0.537 . . . . 0.0 111.016 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' GLY . 79.1 m-20 -109.4 -15.41 14.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.322 179.019 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.83 50.83 0.06 OUTLIER Glycine 0 C--N 1.338 0.68 0 O-C-N 123.892 0.745 . . . . 0.0 111.666 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 t -117.92 111.08 18.52 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.271 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.83 96.15 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.317 178.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.0 t -99.03 123.12 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.816 -178.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 94.8 t -97.88 126.73 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.397 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.603 HD22 ' SD ' ' A' ' 279' ' ' MET . 22.9 mt -110.45 143.88 40.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.513 -179.534 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 279' ' ' MET . . . -119.41 139.55 14.23 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.3 OUTLIER -120.34 119.66 33.76 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -178.748 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.41 167.09 12.26 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.827 0.346 . . . . 0.0 110.414 -179.033 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.499 ' OD2' ' NE ' ' A' ' 307' ' ' ARG . 38.0 m-20 -81.21 -177.03 6.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.458 -179.023 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -105.52 125.71 51.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.33 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.0 mm -116.9 9.17 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.461 0.648 . . . . 0.0 110.829 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.48 10.33 85.72 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.4 m -129.59 106.38 8.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.128 0.489 . . . . 0.0 109.883 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.446 ' CG ' ' N ' ' A' ' 247' ' ' ALA . 22.1 p-10 -57.43 -53.68 55.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.912 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' A' ' 246' ' ' ASP . . . -54.63 -44.1 72.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.498 . . . . 0.0 110.458 -179.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.677 ' CE2' HD11 ' A' ' 252' ' ' LEU . 40.5 t80 -69.63 -41.3 75.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.994 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.529 ' ND2' ' OE2' ' A' ' 281' ' ' GLU . 18.0 t-20 -61.35 -52.49 64.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.713 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -63.88 -38.17 90.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.555 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.53 -37.36 93.21 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.677 HD11 ' CE2' ' A' ' 248' ' ' TYR . 32.4 mt -71.6 -39.06 70.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.641 0.258 . . . . 0.0 110.692 178.393 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 52.4 p -61.71 -40.66 95.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.984 0.421 . . . . 0.0 110.599 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -69.52 -43.59 72.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.564 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -57.32 -47.46 81.49 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.414 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.785 ' O ' HG23 ' A' ' 260' ' ' VAL . 79.4 mtt-85 -62.99 -51.32 67.31 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.445 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.5 81.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.254 0.55 . . . . 0.0 109.874 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -72.11 -44.08 63.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.432 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 13.5 t -61.44 -38.36 86.9 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.43 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 256' ' ' ARG . 95.8 t -64.54 -52.59 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.723 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.425 HG13 HD12 ' A' ' 274' ' ' ILE . 41.9 t -60.52 -48.61 87.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.964 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -46.01 -41.86 12.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.077 -179.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -82.89 -30.83 28.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -71.08 -9.42 58.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.304 -179.496 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.554 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.6 mt -86.01 -53.89 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.353 179.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 84.6 p -51.37 -6.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.689 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 265' ' ' ILE . 10.0 mmpt? -76.18 -12.52 60.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 104.43 42.17 1.92 Allowed Glycine 0 N--CA 1.459 0.21 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.1 tt -127.3 131.46 23.85 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 117.045 0.422 . . . . 0.0 110.852 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.87 125.41 17.02 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.187 1.258 . . . . 0.0 111.923 177.36 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.39 -6.32 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 179.196 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -92.88 -23.67 18.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.944 -179.3 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -80.37 -18.7 48.25 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.443 0.64 . . . . 0.0 110.957 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.425 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -106.58 -174.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.516 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 25.8 t -171.53 134.14 0.83 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.54 152.85 18.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.565 ' HB3' HD23 ' A' ' 237' ' ' LEU . 46.1 ttt85 -159.62 147.1 16.94 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.547 0.689 . . . . 0.0 111.037 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.1 143.89 16.88 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.603 ' SD ' HD22 ' A' ' 237' ' ' LEU . 2.1 tpt -114.92 -3.65 12.67 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.616 0.246 . . . . 0.0 110.385 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.07 -100.26 0.02 OUTLIER Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.529 ' OE2' ' ND2' ' A' ' 249' ' ' ASN . 28.4 mp0 -142.11 54.25 1.46 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.705 -0.248 . . . . 0.0 110.573 179.314 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.6 m -65.59 -0.05 1.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 0.0 110.697 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 281' ' ' GLU . 48.1 t-20 -167.19 85.43 0.82 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.32 106.25 2.01 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.212 1.941 . . . . 0.0 112.599 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.6 m -94.65 -17.83 7.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 121.314 0.578 . . . . 0.0 110.645 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 290' ' ' CYS . 19.7 p -58.02 -42.78 86.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.595 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 290' ' ' CYS . . . -48.09 -93.04 0.01 OUTLIER Glycine 0 C--O 1.225 -0.406 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 287' ' ' GLY . 57.6 t30 -28.53 -56.91 0.12 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.803 0.355 . . . . 0.0 110.432 -178.552 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 m -56.73 -45.28 82.06 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.693 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 287' ' ' GLY . 24.1 m -101.77 32.76 3.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.188 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 287' ' ' GLY . 47.5 t0 -56.21 -47.91 77.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.825 0.345 . . . . 0.0 110.605 -179.074 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 292' ' ' ASN . 58.5 t-20 -76.59 31.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.814 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 291' ' ' ASP . 10.6 t -129.48 107.34 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -119.38 14.02 12.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.738 179.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -100.23 134.09 43.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.129 0.49 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -49.81 -69.19 0.12 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.438 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.61 -38.84 60.92 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.448 0.642 . . . . 0.0 110.746 -178.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.04 -34.96 79.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 303' ' ' LEU . 16.6 mt -73.87 -56.98 4.29 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.2 mt -46.16 -29.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.425 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -83.59 -44.04 15.02 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.336 178.3 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 1.9 t -74.51 -16.71 60.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.989 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 299' ' ' LEU . 76.6 mt -82.58 25.15 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.817 0.698 . . . . 0.0 110.448 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.619 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -81.11 -38.0 0.96 Allowed Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 32.3 Cg_exo -58.54 6.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.442 2.761 . . . . 0.0 112.748 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 304' ' ' ALA . 2.8 m-20 -111.6 15.64 21.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.744 0.307 . . . . 0.0 110.513 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.499 ' NE ' ' OD2' ' A' ' 241' ' ' ASP . 96.0 mtt-85 -108.54 94.27 4.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.275 0.56 . . . . 0.0 110.16 179.098 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 8.2 ptm180 -168.56 158.35 9.38 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.001 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.64 150.87 26.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.457 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 92.4 mt-10 -121.1 106.85 11.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.405 0.622 . . . . 0.0 110.855 -178.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.5 mm -79.31 117.93 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.964 -178.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -102.87 127.36 50.09 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.956 HG21 HD22 ' A' ' 224' ' ' LEU . 93.6 t -132.2 122.21 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 O-C-N 124.077 0.861 . . . . 0.0 111.753 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -116.8 132.31 56.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.88 37.26 4.74 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 317' ' ' LYS . 7.2 tt -109.03 168.06 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.619 ' O ' ' O ' ' A' ' 316' ' ' ILE . 21.4 pttm . . . . . 0 CA--C 1.534 0.329 0 O-C-N 124.303 1.002 . . . . 0.0 111.987 -179.322 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.434 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 121.081 0.467 . . . . 0.0 109.925 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.518 HG22 ' CE1' ' A' ' 193' ' ' HIS . 6.9 m -68.47 136.34 53.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.336 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -140.06 105.59 5.1 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.58 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.518 ' CE1' HG22 ' A' ' 191' ' ' THR . 2.7 m80 -94.85 145.3 24.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.625 ' CE2' ' NE2' ' A' ' 223' ' ' GLN . 33.1 m-85 -111.81 123.9 51.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.43 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 195' ' ' THR . 5.6 t -84.24 103.76 13.7 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.556 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.742 ' CD2' HD11 ' A' ' 201' ' ' LEU . 30.0 tp -108.34 128.98 55.23 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.066 -179.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -83.82 129.13 34.94 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 122.297 1.046 . . . . 0.0 112.218 -178.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 202' ' ' PHE . 15.3 m -63.91 -30.36 71.45 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.396 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.03 -41.08 74.42 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.14 -42.5 88.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.164 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.742 HD11 ' CD2' ' A' ' 196' ' ' LEU . 61.1 mt -79.18 -79.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.911 179.751 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -120.09 122.46 41.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.747 -179.123 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.532 ' H ' HD21 ' A' ' 205' ' ' ASN . 22.5 t-20 -87.24 -75.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -113.08 -10.71 13.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.801 ' H ' HD22 ' A' ' 205' ' ' ASN . 0.1 OUTLIER -76.25 171.29 14.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.182 179.955 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -50.0 -87.49 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.408 -178.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -154.78 5.97 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.278 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 8.7 t -54.35 141.94 28.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.254 -179.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 36.8 mt -83.1 133.98 35.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.244 0.545 . . . . 0.0 111.166 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.457 ' CB ' ' NZ ' ' A' ' 210' ' ' LYS . 6.4 mtpm? -99.14 156.73 35.14 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.064 179.001 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -34.94 -75.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.557 2.171 . . . . 0.0 112.0 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -46.32 -26.66 0.86 Allowed 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.28 0.562 . . . . 0.0 110.307 -179.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -69.03 -51.99 25.79 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -58.65 -39.73 81.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.78 -60.15 3.61 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.419 179.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.91 -25.98 68.39 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.695 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -30.4 65.09 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.513 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.93 -47.58 28.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.819 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 13.3 pt20 -63.97 -42.79 97.15 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.91 -179.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.591 HD12 HE21 ' A' ' 223' ' ' GLN . 48.1 tp -59.61 -41.51 90.54 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.484 ' C ' ' H ' ' A' ' 223' ' ' GLN . 10.1 t80 -54.94 -60.61 3.13 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.154 177.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.4 m -54.44 -8.21 0.2 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.076 0.465 . . . . 0.0 110.642 -179.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.625 ' NE2' ' CE2' ' A' ' 194' ' ' PHE . 3.3 tt0 -93.51 -33.82 13.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.339 178.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 313' ' ' VAL . 73.5 mt -97.69 -11.42 23.51 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.623 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 25.8 p -79.21 -26.23 42.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.973 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -88.03 18.88 3.92 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.024 0.44 . . . . 0.0 110.496 -179.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.512 HD22 ' O ' ' A' ' 224' ' ' LEU . 1.0 OUTLIER -76.12 156.84 33.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.388 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -78.77 116.71 61.81 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 232' ' ' GLY . 59.6 Cg_exo -48.92 -21.99 4.36 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.893 2.395 . . . . 0.0 113.059 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 229' ' ' PRO . 27.2 tptp -24.76 -52.35 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 123.75 0.656 . . . . 0.0 110.802 -177.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 233' ' ' SER . 72.7 m-20 -109.79 -11.49 14.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.8 179.039 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 24.73 42.86 0.01 OUTLIER Glycine 0 N--CA 1.47 0.935 0 O-C-N 123.953 0.783 . . . . 0.0 111.679 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -112.77 114.55 27.17 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 122.516 -0.402 . . . . 0.0 110.449 -178.61 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 75.4 t -129.22 93.88 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.807 0.813 . . . . 0.0 110.325 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.5 t -97.08 123.29 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.001 -179.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.516 HG21 ' CG2' ' A' ' 261' ' ' VAL . 20.2 t -95.65 122.46 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.648 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 75.3 mt -105.58 141.95 36.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.032 -179.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.34 127.3 6.39 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -110.25 122.77 48.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.302 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.577 HG22 ' N ' ' A' ' 241' ' ' ASP . 51.0 m -117.3 164.75 14.35 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.322 0.389 . . . . 0.0 110.238 -179.265 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.577 ' N ' HG22 ' A' ' 240' ' ' THR . 42.3 p-10 -80.95 -175.87 5.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.605 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -116.88 122.89 45.64 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 -179.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.8 mm -118.11 17.22 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.725 0.774 . . . . 0.0 110.808 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.28 -49.04 2.4 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . 0.485 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 5.6 t -76.14 88.72 3.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.918 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -40.4 -43.55 1.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.729 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.4 -38.69 91.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.352 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.555 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 67.1 t80 -59.23 -50.28 74.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.936 -179.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 245' ' ' SER . 2.7 p-10 -64.13 -40.74 96.83 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.185 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -61.38 -45.71 93.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.59 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.18 -35.71 92.45 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.555 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 29.6 mt -70.41 -40.37 73.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.006 0.431 . . . . 0.0 111.106 178.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.0 t -62.84 -39.24 93.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.515 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -68.69 -45.08 72.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.247 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.18 -44.9 88.23 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.067 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.34 -61.41 2.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.678 178.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.88 -34.04 18.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.105 0.479 . . . . 0.0 110.026 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -72.25 -44.82 62.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.449 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.4 t -58.48 -39.53 80.22 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.301 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.91 -53.44 41.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.392 178.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.605 HG13 HD12 ' A' ' 274' ' ' ILE . 4.7 t -60.96 -50.19 81.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.436 179.659 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -46.28 -41.38 13.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.206 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.51 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 60.8 t80 -80.77 -32.78 35.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.809 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.17 -32.81 74.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.21 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.538 ' C ' ' H ' ' A' ' 267' ' ' LYS . 83.8 mt -63.85 -48.27 87.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.322 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 28.2 m -51.45 -6.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.755 -179.276 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 265' ' ' ILE . 33.1 mmtp -87.19 9.15 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.505 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 84.4 40.83 8.2 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.74 126.35 25.75 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.9 130.28 36.92 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.98 1.787 . . . . 0.0 112.094 177.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.17 -9.45 31.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 65.6 t0 -90.88 -23.42 20.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.529 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -79.24 -21.14 46.62 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.608 0.718 . . . . 0.0 110.526 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.605 HD12 HG13 ' A' ' 261' ' ' VAL . 1.5 pt -105.35 -171.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.332 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 11.9 t -169.55 130.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.176 178.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -104.45 110.17 22.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.873 0.368 . . . . 0.0 110.535 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -115.47 140.96 48.67 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.574 0.702 . . . . 0.0 111.097 -179.646 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.578 ' O ' ' NH1' ' A' ' 277' ' ' ARG . . . -90.18 93.35 1.86 Allowed Glycine 0 CA--C 1.519 0.329 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.49 ' N ' ' O ' ' A' ' 238' ' ' GLY . 3.6 tpt -71.62 0.69 8.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.085 -178.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 31.87 -100.07 0.01 OUTLIER Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -144.1 70.18 1.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.714 0.292 . . . . 0.0 110.891 179.122 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.6 p -64.35 -44.24 92.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.192 0.52 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -125.4 80.47 65.43 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.961 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.18 105.76 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.686 2.257 . . . . 0.0 112.669 -179.35 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 285' ' ' VAL . 10.4 m -71.02 -32.83 49.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.193 0.52 . . . . 0.0 110.687 179.307 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.596 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.2 OUTLIER -57.23 -44.55 83.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.357 -179.218 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.84 -5.82 0.02 OUTLIER Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 286' ' ' THR . 13.2 m120 -125.46 -58.51 1.42 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.9 m -58.89 -24.64 62.52 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.553 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 84.8 m -116.11 29.6 7.87 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.451 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.93 -4.28 19.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.612 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -109.87 31.48 5.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.661 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.52 121.3 45.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.969 0.414 . . . . 0.0 110.41 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -120.79 7.34 10.46 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.8 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.497 ' O ' HD12 ' A' ' 299' ' ' LEU . 7.6 mt-30 -89.14 172.67 8.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.98 0.419 . . . . 0.0 110.014 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -84.99 -70.47 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.584 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.84 -31.62 68.67 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.89 -178.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.89 -39.93 87.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 295' ' ' GLN . 50.5 mt -69.78 -48.89 57.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.015 0.436 . . . . 0.0 110.644 179.751 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 60.8 mt -49.15 -36.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.899 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.6 -40.27 29.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.117 0.484 . . . . 0.0 110.646 178.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.426 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 1.1 t -74.36 -10.64 59.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.988 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 299' ' ' LEU . 61.4 mt -91.89 22.59 4.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.643 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.622 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -83.21 -41.56 0.83 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.995 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 31.9 Cg_exo -55.8 10.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 123.293 2.662 . . . . 0.0 112.403 -179.07 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.602 ' H ' ' C ' ' A' ' 304' ' ' ALA . 27.5 m-20 -109.55 21.72 16.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.639 0.257 . . . . 0.0 110.849 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 307' ' ' ARG . 15.7 ptp180 -114.04 84.99 2.13 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.14 0.972 . . . . 0.0 110.259 178.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.4 ptm180 -156.49 128.06 7.16 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.062 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.77 139.14 19.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.466 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -119.69 104.51 10.32 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.303 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.506 HD12 HD21 ' A' ' 220' ' ' LEU . 0.7 OUTLIER -79.36 116.71 23.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.312 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -96.14 122.14 38.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.819 0.342 . . . . 0.0 111.033 -178.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 224' ' ' LEU . 84.0 t -129.5 122.46 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.869 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -118.57 144.86 45.8 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.308 178.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 92.26 22.42 29.72 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -178.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.661 ' O ' ' O ' ' A' ' 317' ' ' LYS . 10.8 tt -99.16 170.86 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.661 ' O ' ' O ' ' A' ' 316' ' ' ILE . 29.5 tttp . . . . . 0 CA--C 1.539 0.529 0 O-C-N 123.943 0.777 . . . . 0.0 110.958 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.475 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 1.5 pm0 . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 120.825 0.345 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.645 HG22 ' N ' ' A' ' 192' ' ' LYS . 44.6 m -76.45 170.49 16.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.43 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.645 ' N ' HG22 ' A' ' 191' ' ' THR . 13.0 tptp -141.88 160.64 39.78 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 109.978 178.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -152.02 124.27 8.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.108 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 223' ' ' GLN . 52.1 m-85 -114.37 119.11 35.81 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.438 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 195' ' ' THR . 5.5 t -86.49 105.23 16.65 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.555 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.694 HD23 HD11 ' A' ' 201' ' ' LEU . 27.0 tp -106.74 123.4 48.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.031 0.443 . . . . 0.0 109.933 -179.223 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -74.53 129.34 37.56 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 122.587 1.184 . . . . 0.0 112.277 -178.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 202' ' ' PHE . 41.6 t -62.97 -40.31 97.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.173 178.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -45.75 -34.88 3.91 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.719 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.75 -56.82 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.694 HD11 HD23 ' A' ' 196' ' ' LEU . 82.2 mt -66.87 -77.8 0.07 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.815 -179.32 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -106.03 135.7 47.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.858 -178.188 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -98.3 -78.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -117.74 -19.04 9.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.963 179.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -65.99 171.75 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.127 0.489 . . . . 0.0 110.199 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -53.79 -81.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.844 -179.231 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -157.9 58.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.51 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.0 p -106.95 131.18 54.32 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 110.056 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.414 HD22 HD22 ' A' ' 201' ' ' LEU . 62.4 mt -71.92 145.11 48.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.256 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.9 mtpm? -107.91 158.03 34.54 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.304 179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 213' ' ' GLY . 74.8 Cg_exo -34.91 -77.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.3 2.0 . . . . 0.0 112.01 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -48.41 -19.19 0.29 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 -179.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.88 -50.23 19.6 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 178.794 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -65.13 -38.39 90.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.145 0.498 . . . . 0.0 109.77 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.91 -53.87 53.3 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.011 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.91 -33.82 76.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.615 0.721 . . . . 0.0 110.383 -179.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.67 -25.9 65.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.603 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . 0.537 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 72.2 m-20 -72.79 -47.11 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.569 0.7 . . . . 0.0 109.9 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.35 -40.29 96.86 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.99 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.518 HD12 HE21 ' A' ' 223' ' ' GLN . 61.8 tp -60.37 -40.98 92.76 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.458 ' CG ' ' HB3' ' A' ' 267' ' ' LYS . 69.4 t80 -55.34 -58.95 5.62 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.922 178.259 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 58.8 m -57.14 -7.49 0.53 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.289 0.566 . . . . 0.0 110.216 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.639 ' NE2' ' CE1' ' A' ' 194' ' ' PHE . 5.4 tt0 -95.06 -35.54 11.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.384 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.828 HD22 HG21 ' A' ' 313' ' ' VAL . 80.4 mt -96.51 -11.38 25.56 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.658 -179.291 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 75.8 p -85.89 -7.31 58.78 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.542 0.526 . . . . 0.0 110.579 -179.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 223' ' ' GLN . 51.2 p30 -101.35 19.23 18.15 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.311 0.577 . . . . 0.0 110.529 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.7 OUTLIER -78.31 -177.3 5.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.136 -179.973 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -100.69 108.47 53.78 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 230' ' ' LYS . 72.5 Cg_exo -45.62 -21.39 0.84 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.673 2.249 . . . . 0.0 112.897 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 229' ' ' PRO . 88.0 tttt -34.47 -52.07 0.48 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 110.546 -178.15 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 232' ' ' GLY . 25.6 m-20 -98.54 -20.01 17.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.762 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 28.32 52.4 0.11 Allowed Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 59.7 m -118.93 115.17 23.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.557 0.217 . . . . 0.0 111.107 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 72.8 t -133.48 92.26 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.794 0.807 . . . . 0.0 110.195 178.43 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.11 127.62 51.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.279 0.561 . . . . 0.0 110.61 -178.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.411 HG13 HD13 ' A' ' 311' ' ' ILE . 91.3 t -100.63 126.42 54.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.399 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.8 mt -111.94 131.64 55.26 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.469 -178.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -86.08 138.37 15.96 Favored Glycine 0 N--CA 1.467 0.766 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.555 ' O ' ' NH2' ' A' ' 256' ' ' ARG . 11.4 m-85 -131.04 115.89 17.05 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 117.799 0.799 . . . . 0.0 109.431 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.425 ' HA ' HH12 ' A' ' 256' ' ' ARG . 14.8 t -126.71 172.8 10.01 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.465 -179.154 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.565 ' HB2' HD12 ' A' ' 303' ' ' LEU . 54.8 p-10 -86.19 -175.23 5.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.432 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -102.3 124.48 47.95 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.245 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.7 mm -117.64 14.42 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.456 0.646 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 71.8 5.06 60.18 Favored Glycine 0 C--N 1.317 -0.493 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 5.3 t -124.68 105.29 9.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.862 0.363 . . . . 0.0 110.199 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -57.11 -55.22 37.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.195 -179.075 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.77 -46.02 78.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.772 ' CE2' HD11 ' A' ' 252' ' ' LEU . 38.3 t80 -63.38 -42.0 98.8 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.886 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.79 -44.87 96.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.642 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -65.28 -39.64 92.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.19 -42.49 99.8 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.772 HD11 ' CE2' ' A' ' 248' ' ' TYR . 80.2 mt -66.92 -41.81 86.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.006 179.437 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.5 t -66.2 -48.36 70.88 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.118 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.25 -52.21 66.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.589 -179.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -55.5 -47.31 76.38 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.273 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.685 HH22 ' N ' ' A' ' 308' ' ' ARG . 66.3 mtp180 -58.29 -59.31 5.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.162 179.158 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -50.59 -32.62 19.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.121 0.486 . . . . 0.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -73.12 -49.7 26.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.986 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 44.6 t -53.42 -41.29 65.88 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.153 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.65 -54.88 23.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.603 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.51 HG13 HD12 ' A' ' 274' ' ' ILE . 10.4 t -57.64 -50.42 77.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.212 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -46.33 -42.84 15.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.914 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -81.55 -31.14 32.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.592 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -71.05 -7.96 50.09 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.274 -179.195 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.2 mt -86.51 -55.69 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 120.84 0.352 . . . . 0.0 111.408 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.7 t -49.78 -6.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.909 -178.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.573 ' H ' ' C ' ' A' ' 265' ' ' ILE . 22.9 mmmt -76.98 -11.38 59.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.08 39.71 1.93 Allowed Glycine 0 CA--C 1.509 -0.291 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.86 133.02 24.66 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.241 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.64 128.88 32.13 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.833 1.689 . . . . 0.0 112.174 176.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.73 -9.31 42.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.986 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.23 -21.32 21.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.774 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -82.54 -20.12 37.27 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.426 0.631 . . . . 0.0 110.893 -179.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.51 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -103.76 -172.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.118 -178.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 27.9 t -168.81 143.09 3.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.297 178.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -115.72 113.78 23.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.806 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -127.22 150.93 49.31 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.929 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -105.37 100.58 1.74 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 3.4 tpp -70.03 -13.04 62.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.066 0.46 . . . . 0.0 110.155 -179.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 63.46 -103.23 0.64 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -141.89 74.12 1.44 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.84 0.353 . . . . 0.0 110.587 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 84.8 p -95.58 2.23 54.13 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.7 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.6 70.52 3.73 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.553 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.94 105.6 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.406 2.071 . . . . 0.0 112.291 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 14.7 m -69.58 -31.94 50.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.46 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 288' ' ' ASN . 41.7 p -57.35 -43.96 83.9 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.736 -179.243 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -45.62 -7.93 0.01 OUTLIER Glycine 0 CA--C 1.534 1.222 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.298 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.9 t30 -126.84 -56.57 1.36 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.918 0.389 . . . . 0.0 110.137 178.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.3 m -55.23 -40.4 70.83 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.281 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 72.1 m -98.6 36.44 1.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.421 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -74.56 -2.48 26.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.498 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.06 31.67 5.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.497 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.1 t -132.05 123.76 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.526 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -119.39 4.43 11.21 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.208 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -99.64 136.21 39.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.157 0.503 . . . . 0.0 110.095 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -51.43 -76.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.774 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -46.0 -39.17 8.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 -178.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.29 88.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.959 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.69 -43.54 79.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.566 179.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.4 mm -58.08 -37.21 60.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.783 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -74.01 -35.65 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.082 179.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.1 t -81.77 -3.2 53.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.416 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' ' 241' ' ' ASP . 0.5 OUTLIER -94.18 22.33 6.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.235 -179.485 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.61 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -82.65 -41.82 0.91 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.602 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.8 Cg_exo -60.03 10.09 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.294 2.662 . . . . 0.0 112.099 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 304' ' ' ALA . 57.9 t0 -115.12 18.89 16.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.958 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -109.01 107.18 17.44 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.377 0.608 . . . . 0.0 110.345 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.685 ' N ' HH22 ' A' ' 256' ' ' ARG . 18.0 ptp180 -171.86 -173.74 1.21 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.984 -179.186 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.35 153.65 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.496 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 95.7 mt-10 -124.64 102.53 7.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.317 0.579 . . . . 0.0 110.801 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.411 HD13 HG13 ' A' ' 236' ' ' VAL . 3.4 mm -81.58 120.34 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.14 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -104.92 119.87 40.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.798 0.332 . . . . 0.0 110.426 -178.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.828 HG21 HD22 ' A' ' 224' ' ' LEU . 86.6 t -130.43 124.76 58.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.59 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -118.83 148.19 43.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.56 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.88 4.4 57.83 Favored Glycine 0 N--CA 1.462 0.43 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 16.0 tt -91.55 141.79 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.206 0.527 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 19.0 tptp . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.794 -179.396 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 316' ' ' ILE . 14.0 mm100 . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.919 0.39 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.44 HG22 ' NE2' ' A' ' 193' ' ' HIS . 24.3 m -78.11 127.12 31.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.2 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -146.71 116.45 7.19 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.467 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.5 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 2.2 m-70 -101.18 147.72 25.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -109.77 128.53 55.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.911 0.386 . . . . 0.0 110.302 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.94 103.24 15.13 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.98 -179.765 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.729 ' CD2' HD11 ' A' ' 201' ' ' LEU . 24.8 tp -107.96 129.04 55.14 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 109.955 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.473 ' HB3' HG23 ' A' ' 200' ' ' VAL . 71.8 tttt -80.9 126.57 31.52 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 121.905 0.86 . . . . 0.0 112.033 -178.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.5 t -65.27 -28.08 69.09 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.066 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -62.92 -37.94 88.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.034 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 197' ' ' LYS . 88.6 t -65.96 -44.36 92.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.56 179.295 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.729 HD11 ' CD2' ' A' ' 196' ' ' LEU . 76.6 mt -75.75 -78.75 0.11 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.289 179.472 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.28 118.67 30.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.031 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -94.62 -78.3 0.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.702 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -88.47 -26.94 21.81 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.765 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.407 ' OD1' HG23 ' A' ' 208' ' ' THR . 24.0 t-20 -69.79 158.43 35.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.153 0.501 . . . . 0.0 110.381 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -51.42 -71.47 0.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.221 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -159.77 56.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.428 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.407 HG23 ' OD1' ' A' ' 205' ' ' ASN . 38.5 p -108.08 133.04 52.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.821 0.343 . . . . 0.0 110.172 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.06 138.61 39.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 -179.133 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.8 mtpm? -101.49 157.47 33.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 210' ' ' LYS . 76.0 Cg_exo -33.22 -75.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.598 2.199 . . . . 0.0 111.969 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -49.61 -23.4 1.67 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.18 0.514 . . . . 0.0 110.328 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.94 -48.73 19.6 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -66.61 -38.74 87.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.14 0.495 . . . . 0.0 110.012 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.84 -53.06 62.46 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.444 -179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.75 88.53 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.635 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.0 mt -62.53 -27.6 69.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.487 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . 0.458 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 51.3 m-20 -73.81 -46.45 45.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.219 0.533 . . . . 0.0 110.535 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.62 -42.89 99.85 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.174 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.459 HD21 HD12 ' A' ' 311' ' ' ILE . 42.9 tp -66.37 -38.96 88.74 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.436 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.2 t80 -53.78 -50.72 65.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.123 179.379 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 225' ' ' SER . 75.9 p -60.15 -49.75 76.41 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.378 -178.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.579 ' OE1' HD11 ' A' ' 316' ' ' ILE . 1.1 tm0? -49.57 -25.89 3.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.184 -179.737 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.743 ' O ' HD22 ' A' ' 227' ' ' LEU . 64.7 mt -97.19 -13.45 22.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.364 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' SER . 36.9 t -72.86 -21.57 60.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.698 179.511 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -99.91 16.79 22.68 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.743 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.74 150.69 36.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.138 179.862 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 315' ' ' GLY . 6.7 t0 -67.12 124.13 88.1 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.468 178.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 230' ' ' LYS . 44.5 Cg_endo -69.15 -19.67 38.75 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.79 2.327 . . . . 0.0 112.846 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 229' ' ' PRO . 63.4 tttp -30.09 -52.42 0.15 Allowed 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.682 0.614 . . . . 0.0 110.457 -178.386 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 232' ' ' GLY . 20.6 m-20 -103.28 -18.25 14.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.485 178.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.478 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.75 47.33 0.03 OUTLIER Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 231' ' ' ASP . 0.4 OUTLIER -112.59 111.25 21.93 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.146 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.56 94.42 2.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.311 0.577 . . . . 0.0 109.895 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.2 t -96.47 122.65 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.237 -178.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.441 HG22 HG23 ' A' ' 311' ' ' ILE . 12.1 t -95.68 119.7 44.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.642 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 47.4 mt -103.76 147.38 27.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.049 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.85 133.13 8.15 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.636 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.4 OUTLIER -116.54 119.84 36.84 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.504 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.441 ' O ' ' OD1' ' A' ' 306' ' ' ASP . 3.3 p -106.92 168.15 9.39 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 120.772 0.32 . . . . 0.0 110.344 -179.445 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -81.85 179.93 7.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.525 -179.666 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -99.6 119.44 38.08 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.862 0.363 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.4 mm -121.4 6.18 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.404 0.621 . . . . 0.0 111.058 179.358 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.41 -47.65 3.66 Favored Glycine 0 C--N 1.314 -0.666 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.2 p -73.7 90.08 1.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 109.887 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 91.7 m-20 -43.0 -46.55 5.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.676 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.6 83.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.555 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 49.2 t80 -61.08 -49.31 77.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 246' ' ' ASP . 0.2 OUTLIER -63.22 -42.75 99.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.584 -179.741 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -63.71 -46.13 86.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.723 -179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.39 -35.03 90.39 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.555 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 29.9 mt -73.5 -37.53 65.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.887 0.375 . . . . 0.0 111.129 178.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.8 m -64.12 -40.95 97.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.747 -179.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 258' ' ' GLN . 96.9 mt-10 -71.7 -41.39 68.66 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.189 179.595 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -59.52 -48.3 82.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.524 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 260' ' ' VAL . 89.4 mtt-85 -63.26 -60.38 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.961 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -52.1 -36.62 51.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.565 HE21 ' C ' ' A' ' 258' ' ' GLN . 0.6 OUTLIER -70.84 -42.72 69.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.218 179.665 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.3 t -63.02 -36.77 84.67 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.357 0.599 . . . . 0.0 110.272 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 256' ' ' ARG . 87.2 t -64.27 -50.19 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.552 179.335 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.541 HG13 HD12 ' A' ' 274' ' ' ILE . 10.6 t -60.88 -49.43 84.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.29 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . 0.549 ' OD2' ' NE2' ' A' ' 258' ' ' GLN . 7.9 m-20 -45.7 -39.81 8.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.9 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -83.2 -32.31 26.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.1 -11.11 60.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.488 -179.287 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' A' ' 267' ' ' LYS . 64.6 mt -86.11 -53.14 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-O 120.723 0.297 . . . . 0.0 110.925 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.4 m -50.34 -6.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 265' ' ' ILE . 22.9 mmmt -80.58 -12.06 59.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.862 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.75 40.41 1.87 Allowed Glycine 0 CA--C 1.51 -0.221 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.25 129.16 24.27 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.86 128.17 27.62 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.958 1.772 . . . . 0.0 112.04 176.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.02 -8.97 18.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.799 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.32 -23.23 21.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.772 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -80.31 -20.08 45.12 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.38 0.609 . . . . 0.0 110.487 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.541 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -105.62 -173.36 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.795 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 27.3 t -172.4 129.76 0.57 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 179.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.39 153.72 17.66 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.019 -0.425 . . . . 0.0 109.859 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -162.31 151.56 15.62 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 178.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -127.56 97.65 0.47 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.636 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 10.5 ptm -85.99 26.8 0.96 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.847 0.356 . . . . 0.0 110.984 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.3 -107.37 0.1 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.82 73.44 1.4 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.683 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.1 t -76.28 -33.72 59.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.108 0.48 . . . . 0.0 111.216 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -124.39 66.37 44.06 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 -179.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.14 117.71 5.12 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.626 2.218 . . . . 0.0 111.506 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 286' ' ' THR . 15.0 m -70.8 -38.5 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.701 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 288' ' ' ASN . 2.8 p -61.43 -47.15 87.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.559 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.07 -3.4 0.05 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 286' ' ' THR . 89.3 m-20 -114.29 -60.97 1.81 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.018 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.8 t -77.69 -3.07 39.23 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.558 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.558 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -126.97 18.51 7.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.607 -179.911 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 36.7 p-10 -68.55 -2.98 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.503 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.418 ' O ' ' OD1' ' A' ' 292' ' ' ASN . 19.7 p30 -101.06 32.6 3.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.514 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.558 HG21 ' SG ' ' A' ' 290' ' ' CYS . 17.2 t -130.77 124.33 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.764 0.316 . . . . 0.0 110.437 179.638 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -120.21 9.62 11.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.879 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.39 131.24 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.134 0.492 . . . . 0.0 110.064 -179.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -50.55 -68.61 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.076 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.97 -38.7 57.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.53 -36.55 82.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.445 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 303' ' ' LEU . 28.0 mt -72.54 -55.01 7.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.474 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 68.5 mt -50.96 -35.4 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.005 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.11 -31.98 58.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.593 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.49 -5.06 56.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.4 mm? -94.23 19.66 9.1 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.289 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -80.43 -45.78 1.34 Allowed Pre-proline 0 CA--C 1.536 0.424 0 CA-C-O 121.051 0.453 . . . . 0.0 110.184 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 25.7 Cg_exo -60.97 9.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.134 2.556 . . . . 0.0 111.969 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 304' ' ' ALA . 8.1 t70 -106.0 14.12 28.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.874 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 307' ' ' ARG . 15.6 ptt180 -110.28 99.01 8.12 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.921 0.867 . . . . 0.0 110.346 179.214 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.537 ' NH1' ' OE2' ' A' ' 310' ' ' GLU . 43.7 ptt85 -166.03 139.09 4.13 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.398 -179.219 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.02 145.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.537 ' OE2' ' NH1' ' A' ' 308' ' ' ARG . 78.6 mt-10 -118.71 104.03 10.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.31 0.576 . . . . 0.0 110.865 178.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.459 HD12 HD21 ' A' ' 220' ' ' LEU . 0.4 OUTLIER -80.12 113.4 19.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.11 -178.953 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -92.11 123.27 35.34 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 123.525 0.516 . . . . 0.0 110.738 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.71 HG21 HD22 ' A' ' 224' ' ' LEU . 40.1 t -121.14 115.32 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 O-C-N 123.528 0.518 . . . . 0.0 110.875 -179.576 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -114.7 126.58 55.02 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.52 39.61 3.39 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.719 ' O ' ' O ' ' A' ' 317' ' ' LYS . 6.3 tt -110.97 164.74 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.719 ' O ' ' O ' ' A' ' 316' ' ' ILE . 20.5 pttp . . . . . 0 C--O 1.219 -0.501 0 O-C-N 124.273 0.983 . . . . 0.0 111.319 -178.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.52 HG22 ' NE2' ' A' ' 193' ' ' HIS . 24.3 m -79.06 125.6 29.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.829 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -144.45 112.73 6.47 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.71 0.291 . . . . 0.0 110.555 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 193' ' ' HIS . . . . . 0.52 ' NE2' HG22 ' A' ' 191' ' ' THR . 5.0 m-70 -99.4 144.41 28.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -106.89 129.79 54.66 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.87 0.367 . . . . 0.0 110.204 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.14 105.38 17.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.931 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.721 ' CD2' HD11 ' A' ' 201' ' ' LEU . 34.3 tp -110.16 129.63 55.68 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.426 ' HB3' HG23 ' A' ' 200' ' ' VAL . 16.2 tptm -80.74 127.92 33.05 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 122.036 0.922 . . . . 0.0 112.437 -178.265 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 202' ' ' PHE . 68.6 p -63.31 -31.79 73.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.091 179.489 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.456 ' OD1' ' ND2' ' A' ' 203' ' ' ASN . 22.0 t70 -59.75 -37.46 79.06 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.181 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 197' ' ' LYS . 79.2 t -66.23 -44.41 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.721 HD11 ' CD2' ' A' ' 196' ' ' LEU . 84.3 mt -77.6 -77.53 0.15 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.461 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -118.51 125.42 49.83 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.637 -179.754 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.456 ' ND2' ' OD1' ' A' ' 199' ' ' ASP . 7.2 m120 -94.37 -80.25 0.4 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.767 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -103.31 -17.71 15.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.695 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -70.54 169.66 13.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.998 0.427 . . . . 0.0 110.086 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -53.15 -78.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.267 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.36 59.11 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.552 179.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.7 p -108.79 135.3 50.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.048 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.1 135.57 39.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.874 -178.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 213' ' ' GLY . 4.4 mtmp? -96.57 159.97 30.56 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.815 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -34.05 -76.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.417 2.078 . . . . 0.0 111.78 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 31.6 mp0 -50.02 -20.18 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.242 0.544 . . . . 0.0 110.214 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.59 -47.87 14.65 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.368 178.669 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -67.86 -40.04 83.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.255 0.55 . . . . 0.0 110.066 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.54 65.24 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.696 -179.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.03 -35.68 81.05 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.62 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.0 -32.99 73.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.548 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . 0.535 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 4.4 m-20 -70.97 -44.83 65.19 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.501 0.667 . . . . 0.0 110.405 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.443 ' O ' ' OG ' ' A' ' 222' ' ' SER . 12.6 mt-30 -61.19 -44.0 97.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.085 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 41.4 tp -64.43 -40.37 95.63 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.379 178.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.423 ' CG ' ' HB3' ' A' ' 267' ' ' LYS . 4.9 t80 -51.79 -48.83 63.65 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.31 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 219' ' ' GLN . 59.5 p -55.04 -51.67 65.59 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.58 -178.239 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.441 HE21 HD12 ' A' ' 220' ' ' LEU . 16.7 mt-30 -51.99 -26.76 11.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.423 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.799 HD22 HG21 ' A' ' 313' ' ' VAL . 15.6 mt -97.11 -20.31 18.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.717 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.7 p -74.5 -22.59 58.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.759 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -102.72 19.72 18.66 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.893 -179.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -75.9 143.15 41.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.929 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 315' ' ' GLY . 47.2 t0 -52.4 108.19 1.02 Allowed Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 123.37 0.419 . . . . 0.0 110.434 178.056 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.3 Cg_exo -51.8 -24.5 18.53 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.737 2.291 . . . . 0.0 113.043 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 230' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 229' ' ' PRO . 7.5 ttpm? -30.25 -53.16 0.16 Allowed 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 123.568 0.543 . . . . 0.0 110.951 -177.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 232' ' ' GLY . 38.9 m-20 -102.43 -17.65 15.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.751 179.009 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.17 46.35 0.02 OUTLIER Glycine 0 N--CA 1.475 1.259 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 231' ' ' ASP . 38.1 m -112.72 110.39 20.48 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.672 0.272 . . . . 0.0 110.928 -178.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 76.6 t -127.56 94.09 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.481 0.658 . . . . 0.0 109.959 178.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.0 t -96.4 123.07 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.107 -178.117 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.561 HG13 HD13 ' A' ' 311' ' ' ILE . 87.4 t -92.54 120.21 41.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.442 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 57.1 mt -104.35 144.35 31.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.961 -179.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.417 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -125.16 130.27 7.28 Favored Glycine 0 N--CA 1.482 1.723 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.871 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.4 OUTLIER -114.91 125.43 53.63 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.83 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 253' ' ' SER . 43.0 p -120.92 166.93 13.12 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 109.933 -179.374 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -80.84 -175.12 5.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.417 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -113.72 122.88 48.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.198 0.523 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.736 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.6 mm -120.06 14.73 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.719 0.771 . . . . 0.0 110.633 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.29 -47.46 3.31 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 20.7 m -73.19 89.66 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.114 0.483 . . . . 0.0 110.006 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 246' ' ' ASP . . . . . 0.547 ' O ' ' NE2' ' A' ' 250' ' ' GLN . 98.9 m-20 -44.36 -46.17 9.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.365 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.81 86.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.629 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.599 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 51.2 t80 -60.33 -44.59 95.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.54 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -62.46 -43.47 98.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.562 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 246' ' ' ASP . 0.9 OUTLIER -65.69 -41.95 91.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.513 -179.991 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.86 95.91 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.599 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 39.1 mt -70.25 -39.41 75.01 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.065 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 253' ' ' SER . . . . . 0.448 ' N ' HG21 ' A' ' 240' ' ' THR . 3.7 t -63.21 -42.78 99.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 0.0 110.605 -178.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -69.33 -35.43 75.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.36 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.4 tpp85 -60.66 -54.3 47.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.672 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.874 ' O ' HG23 ' A' ' 260' ' ' VAL . 16.4 ptp180 -64.42 -44.6 90.68 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 120.95 0.405 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.462 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.7 -39.2 90.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.46 0.647 . . . . 0.0 110.303 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -74.99 -43.87 51.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.266 179.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 6.9 t -61.98 -38.43 88.57 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.29 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 256' ' ' ARG . 94.4 t -64.75 -50.98 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.622 178.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.616 HG13 HD12 ' A' ' 274' ' ' ILE . 14.4 t -61.29 -49.1 85.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.298 179.139 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -46.48 -40.8 13.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.079 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 263' ' ' TYR . . . . . 0.622 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 67.0 t80 -81.71 -33.9 30.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -65.08 -28.95 69.81 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.208 -179.521 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.544 ' C ' ' H ' ' A' ' 267' ' ' LYS . 81.6 mt -67.18 -52.22 45.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.273 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.4 p -49.65 -7.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 -179.108 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.622 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 66.3 mmtt -79.97 -5.63 56.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.711 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 97.09 42.3 3.3 Favored Glycine 0 CA--C 1.508 -0.373 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 130.83 23.89 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.321 179.075 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.35 128.34 28.83 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.781 1.654 . . . . 0.0 112.104 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -63.12 -11.0 16.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -88.68 -26.3 21.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.679 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -24.59 58.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.386 0.612 . . . . 0.0 110.457 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 274' ' ' ILE . . . . . 0.616 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -101.83 -176.79 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.857 -179.331 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 16.3 m -169.21 126.67 0.95 Allowed 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.653 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -94.93 151.11 19.48 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -155.89 142.17 18.41 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.377 0.608 . . . . 0.0 111.179 179.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -93.08 93.16 1.72 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.349 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 239' ' ' TYR . 5.0 tpt -70.49 -3.89 20.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.674 0.273 . . . . 0.0 110.65 -179.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.06 -116.32 0.85 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -135.87 70.47 1.42 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.604 -0.351 . . . . 0.0 110.526 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.7 m -77.58 -40.08 43.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.306 0.574 . . . . 0.0 111.477 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -124.58 62.37 32.7 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.659 -178.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.59 112.75 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.801 2.334 . . . . 0.0 111.364 179.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 286' ' ' THR . 32.1 m -71.37 -39.51 71.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.891 179.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 288' ' ' ASN . 51.4 p -63.61 -48.27 78.02 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.779 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.77 -2.01 0.05 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 288' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.1 t30 -113.55 -60.41 1.89 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.704 0.288 . . . . 0.0 110.308 179.005 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -80.43 -2.76 47.09 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.73 -179.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 290' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -126.88 17.53 7.33 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.889 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 32.8 p-10 -69.82 -3.28 14.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.977 0.418 . . . . 0.0 110.506 -179.594 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -99.75 32.06 3.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.429 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.456 HG21 ' SG ' ' A' ' 290' ' ' CYS . 5.2 t -133.87 127.36 52.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.954 0.407 . . . . 0.0 110.357 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -118.75 13.42 13.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.063 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 295' ' ' GLN . . . . . 0.631 HE22 ' CZ ' ' A' ' 296' ' ' ARG . 8.8 mm-40 -105.92 137.64 43.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.587 0.708 . . . . 0.0 110.248 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 296' ' ' ARG . . . . . 0.631 ' CZ ' HE22 ' A' ' 295' ' ' GLN . 0.0 OUTLIER -61.15 -54.59 42.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.468 179.954 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.62 85.83 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.016 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.18 -33.31 75.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.557 179.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 303' ' ' LEU . 33.4 mt -82.48 -61.67 1.83 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.496 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 296' ' ' ARG . 45.0 mt -42.83 -34.47 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.63 -44.26 19.15 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.124 0.488 . . . . 0.0 110.318 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 302' ' ' CYS . . . . . 0.459 ' O ' HG21 ' A' ' 286' ' ' THR . 44.2 t -74.88 -8.18 55.71 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.978 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 299' ' ' LEU . 73.9 mt -92.98 17.86 10.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.732 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -79.24 -45.56 1.68 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.336 179.711 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 305' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 34.5 Cg_exo -59.63 8.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.085 2.523 . . . . 0.0 111.821 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 304' ' ' ALA . 49.6 m-20 -103.87 12.04 34.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -114.45 94.63 4.88 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.606 0.717 . . . . 0.0 110.176 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . 0.417 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 39.4 ptt180 -154.38 131.46 11.0 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.694 0.759 . . . . 0.0 112.295 -179.018 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 309' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 196' ' ' LEU . 0.0 OUTLIER -95.49 134.49 32.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.046 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -116.74 104.63 11.54 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.305 0.574 . . . . 0.0 110.295 -179.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.561 HD13 HG13 ' A' ' 236' ' ' VAL . 3.5 mm -78.96 114.04 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.106 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -92.17 122.21 34.44 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 123.532 0.52 . . . . 0.0 110.488 -179.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.799 HG21 HD22 ' A' ' 224' ' ' LEU . 25.2 t -122.23 114.83 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.549 -179.309 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -113.9 127.07 55.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.0 39.88 3.44 Favored Glycine 0 N--CA 1.461 0.347 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.696 ' O ' ' O ' ' A' ' 317' ' ' LYS . 11.1 tt -117.09 172.67 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 317' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 316' ' ' ILE . 8.9 mtmp? . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 122.121 0.962 . . . . 0.0 111.376 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.24 152.44 66.84 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.547 2.165 . . . . 0.0 112.107 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.476 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -171.14 51.38 0.16 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.488 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 41.0 Cg_endo -66.6 -58.2 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.767 2.311 . . . . 0.0 111.967 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 178.97 74.62 0.15 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.337 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -54.04 120.94 8.75 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.372 2.048 . . . . 0.0 112.185 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.552 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . -96.55 -47.25 0.24 Allowed Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.266 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 72.4 Cg_endo -80.46 153.93 21.0 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.209 1.939 . . . . 0.0 112.361 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 190' ' ' GLN . 96.8 mt-10 -69.71 131.38 44.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.321 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 t -67.1 146.68 13.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.334 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 188' ' ' GLU . 15.6 mp0 -102.03 82.66 2.26 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.819 0.342 . . . . 0.0 110.688 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.4 m -80.23 129.11 34.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.638 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -129.06 99.55 5.31 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.739 0.781 . . . . 0.0 111.741 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -83.71 127.7 33.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.054 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.645 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 55.4 m-85 -112.26 124.15 51.83 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.09 104.03 15.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.842 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.692 ' CD2' HD11 ' A' ' 201' ' ' LEU . 31.1 tp -105.7 123.59 48.19 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.04 130.47 35.55 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-O 122.1 0.952 . . . . 0.0 112.327 -177.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.57 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 39.4 m -61.25 -31.44 71.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.2 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -57.96 -40.44 80.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 85.6 t -65.85 -43.55 93.12 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 196' ' ' LEU . 84.6 mt -79.77 -77.93 0.17 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.526 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER -137.38 131.63 32.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.413 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -107.43 -64.93 1.15 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.28 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -98.69 -20.51 16.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.545 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.35 159.71 33.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.988 0.423 . . . . 0.0 110.209 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -53.65 -66.74 0.34 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.571 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.07 -2.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.087 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.409 ' H ' ' H ' ' A' ' 207' ' ' ALA . 40.8 p -53.17 135.99 36.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.906 0.384 . . . . 0.0 110.034 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 54.2 mt -82.02 137.73 35.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.854 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.8 mtpm? -97.79 157.75 34.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.811 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.402 ' C ' ' N ' ' A' ' 213' ' ' GLY . 84.6 Cg_exo -34.1 -76.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.597 2.198 . . . . 0.0 112.486 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.72 -19.17 0.58 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.043 0.449 . . . . 0.0 110.3 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.1 -51.73 9.83 Favored Glycine 0 N--CA 1.459 0.229 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -65.39 -40.57 93.61 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.204 0.526 . . . . 0.0 109.846 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.99 -54.75 41.06 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.018 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.25 86.68 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.615 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.5 mt -61.34 -30.09 70.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.217 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.13 -46.56 56.07 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.848 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -62.33 -44.15 97.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.237 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.78 -38.07 89.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.476 ' O ' ' OG ' ' A' ' 225' ' ' SER . 3.2 t80 -54.2 -50.84 66.16 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.066 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.8 t -55.78 -51.0 68.92 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.393 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.645 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 12.4 tt0 -52.64 -25.01 9.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.874 HD22 HG21 ' A' ' 313' ' ' VAL . 85.2 mt -99.0 -18.78 17.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.656 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 221' ' ' TYR . 1.3 m -77.42 -30.77 53.62 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.575 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -87.18 25.0 1.44 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 110.298 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.04 -179.14 6.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.811 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 1.6 t70 -100.93 133.47 21.04 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.75 -19.31 47.43 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.259 1.973 . . . . 0.0 112.744 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -37.15 -52.96 1.03 Allowed 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 110.511 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' GLY . 52.9 m-20 -98.3 -21.16 16.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.472 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 24.94 45.98 0.02 OUTLIER Glycine 0 C--N 1.343 0.96 0 O-C-N 123.744 0.653 . . . . 0.0 111.725 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 231' ' ' ASP . 5.2 m -119.44 114.29 22.09 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.032 0.444 . . . . 0.0 110.879 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.477 HG22 HG13 ' A' ' 313' ' ' VAL . 43.0 t -130.19 95.76 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.529 0.68 . . . . 0.0 109.977 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.4 HG11 HH12 ' A' ' 277' ' ' ARG . 10.6 t -97.76 122.77 49.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.345 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.459 HG21 HG22 ' A' ' 261' ' ' VAL . 83.0 t -95.63 125.41 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 41.7 mt -109.7 141.89 41.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.126 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -122.12 129.6 7.67 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.57 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -113.33 119.49 37.86 Favored 'General case' 0 C--N 1.349 0.574 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 31.1 p -109.97 168.96 9.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.84 0.352 . . . . 0.0 110.758 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.458 ' OD2' ' NH2' ' A' ' 307' ' ' ARG . 44.5 p-10 -90.69 -178.39 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -100.94 124.57 46.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.333 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.1 mm -117.7 12.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.414 0.626 . . . . 0.0 110.745 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.15 6.1 88.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -136.48 96.71 3.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.517 . . . . 0.0 109.729 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -52.22 -50.04 62.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.432 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.61 -41.69 77.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.619 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.62 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 58.6 t80 -64.21 -43.84 93.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -61.19 -42.83 99.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.467 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.21 -40.11 95.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.377 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.35 -38.94 96.54 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.62 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 81.9 mt -73.56 -34.54 65.21 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.88 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 85.6 p -64.29 -40.25 95.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.129 0.49 . . . . 0.0 110.741 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -74.43 -39.84 62.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.314 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -61.25 -51.71 67.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.251 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.57 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 8.5 ptm180 -64.05 -46.06 86.03 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.306 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.479 ' N ' ' CG ' ' A' ' 256' ' ' ARG . . . -56.74 -36.49 69.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.399 0.619 . . . . 0.0 109.703 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.75 -44.29 61.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.805 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.9 m -59.1 -39.81 83.38 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.254 0.55 . . . . 0.0 110.134 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 256' ' ' ARG . 97.6 t -64.46 -51.73 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.922 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.559 HG13 HD12 ' A' ' 274' ' ' ILE . 21.3 t -62.4 -48.69 87.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.456 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -48.14 -41.46 26.78 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.95 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -78.74 -35.53 44.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.577 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.0 -31.01 72.04 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.897 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.51 ' C ' ' H ' ' A' ' 267' ' ' LYS . 80.8 mt -65.49 -51.62 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 88.5 p -51.82 -8.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.043 0.449 . . . . 0.0 110.789 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 265' ' ' ILE . 67.8 mmtt -79.49 -4.45 51.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.541 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.34 41.75 2.92 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.86 127.64 23.92 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 117.031 0.416 . . . . 0.0 110.208 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.31 128.36 25.22 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.609 1.539 . . . . 0.0 111.84 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.07 -8.71 17.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -93.58 -22.9 18.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.191 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -79.86 -17.11 54.03 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.72 0.772 . . . . 0.0 111.032 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.559 HD12 HG13 ' A' ' 261' ' ' VAL . 2.0 pt -107.93 -170.35 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.463 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 3.2 m -166.86 131.76 2.09 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.224 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -103.1 111.67 24.14 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.768 0.318 . . . . 0.0 110.546 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.4 HH12 HG11 ' A' ' 235' ' ' VAL . 30.8 ttm105 -119.79 141.24 49.67 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.71 0.767 . . . . 0.0 111.566 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -92.46 95.27 2.0 Allowed Glycine 0 CA--C 1.519 0.342 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.467 ' N ' ' O ' ' A' ' 238' ' ' GLY . 2.7 tpt -68.11 -10.64 55.55 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.223 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 40.58 -98.73 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -141.59 75.37 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.788 0.328 . . . . 0.0 110.81 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 70.8 m -83.63 -5.62 59.23 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.61 79.2 0.91 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.313 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.71 104.29 0.26 Allowed 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.568 2.179 . . . . 0.0 112.959 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 289' ' ' THR . 27.2 m -75.31 -32.79 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.337 0.589 . . . . 0.0 110.344 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.628 ' C ' ' H ' ' A' ' 288' ' ' ASN . 44.4 p -56.94 -42.59 80.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.793 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.6 -0.3 0.02 OUTLIER Glycine 0 CA--C 1.532 1.124 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.628 ' H ' ' C ' ' A' ' 286' ' ' THR . 17.2 t-20 -122.74 -58.87 1.65 Allowed 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.5 OUTLIER -66.9 -17.59 64.97 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.542 -178.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 302' ' ' CYS . 72.1 m -116.78 25.6 10.43 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.384 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 293' ' ' VAL . 34.5 t70 -57.88 -49.92 75.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.0 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -76.19 32.41 0.12 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.316 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' A' ' 291' ' ' ASP . 2.8 t -131.24 104.57 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.655 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -118.97 13.77 13.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.401 ' OE1' ' CA ' ' A' ' 295' ' ' GLN . 0.0 OUTLIER -100.23 139.98 35.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.92 0.39 . . . . 0.0 110.101 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -50.48 -70.11 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.184 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.92 -39.05 68.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.545 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.36 80.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.261 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 303' ' ' LEU . 26.0 mt -72.65 -53.38 11.95 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.891 0.377 . . . . 0.0 110.815 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 69.4 mt -53.16 -35.14 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 0.0 109.905 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -76.18 -40.38 52.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.192 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.513 ' O ' ' SG ' ' A' ' 290' ' ' CYS . 5.5 t -82.48 -8.78 59.61 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.957 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 299' ' ' LEU . 34.8 mt -91.06 21.4 4.28 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.836 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.622 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.44 -40.3 1.22 Allowed Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.397 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 36.6 Cg_exo -59.14 7.96 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 123.707 2.938 . . . . 0.0 112.719 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 304' ' ' ALA . 5.3 m-20 -111.12 14.46 21.84 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.458 ' NH2' ' OD2' ' A' ' 241' ' ' ASP . 98.5 mtt180 -111.32 90.5 3.35 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.214 0.53 . . . . 0.0 109.75 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.522 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.0 ptp180 -162.81 132.63 4.4 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.47 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.464 HG12 HH22 ' A' ' 256' ' ' ARG . 0.2 OUTLIER -96.15 142.3 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -118.83 106.71 12.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.208 0.527 . . . . 0.0 110.234 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.409 HD13 HG13 ' A' ' 236' ' ' VAL . 3.6 mm -80.05 118.2 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -102.74 102.28 12.43 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.62 0.248 . . . . 0.0 110.874 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.874 HG21 HD22 ' A' ' 224' ' ' LEU . 59.8 t -114.85 122.81 69.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.958 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -120.03 153.31 36.22 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.196 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 89.97 12.4 62.08 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 7.8 tt -95.17 135.64 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 121.155 0.502 . . . . 0.0 110.712 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -107.81 153.69 22.63 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.298 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -153.37 166.54 32.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.354 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.575 HG22 ' N ' ' A' ' 320' ' ' VAL . 13.2 p -73.35 164.64 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.364 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.575 ' N ' HG22 ' A' ' 319' ' ' VAL . 25.0 t -62.77 129.53 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.946 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 5.3 p -84.89 138.0 32.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.962 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -91.16 131.08 37.83 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.862 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 324' ' ' GLN . 50.4 Cg_exo -49.01 136.18 29.34 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.608 1.539 . . . . 0.0 112.328 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 323' ' ' PRO . 7.3 tt0 43.48 99.25 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.729 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.49 179.945 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.449 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 36.2 Cg_endo -63.92 -31.3 67.24 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.73 2.287 . . . . 0.0 112.02 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 181' ' ' PRO . . . 176.32 55.84 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.503 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.19 -65.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.792 2.328 . . . . 0.0 112.11 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.638 ' HB3' ' CD ' ' A' ' 185' ' ' PRO . . . -79.4 -62.05 0.45 Allowed Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.451 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.638 ' CD ' ' HB3' ' A' ' 184' ' ' ALA . 28.9 Cg_endo -60.25 144.64 99.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.158 1.905 . . . . 0.0 111.514 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 188' ' ' GLU . . . -121.37 95.9 48.16 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.002 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -47.78 76.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 122.605 2.204 . . . . 0.0 112.383 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.594 ' N ' ' O ' ' A' ' 186' ' ' ALA . 90.0 mt-10 -153.1 120.78 6.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.3 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 98.3 t -130.19 131.95 65.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.234 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.58 112.15 16.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.262 0.553 . . . . 0.0 110.385 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.1 m -69.15 137.2 53.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.487 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 5.5 tptp -112.27 166.37 11.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.322 0.582 . . . . 0.0 110.605 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.412 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 96.6 m-70 -154.74 121.4 5.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.114 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.447 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 68.7 m-85 -108.48 121.05 44.16 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.9 104.08 15.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.497 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.685 ' CD2' HD11 ' A' ' 201' ' ' LEU . 33.8 tp -107.92 127.88 54.13 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.451 ' HG2' ' H ' ' A' ' 199' ' ' ASP . 36.3 ttmt -80.95 127.89 33.07 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.61 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.505 ' OG ' ' NH1' ' A' ' 256' ' ' ARG . 1.2 t -63.44 -31.79 73.05 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.024 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.456 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 9.7 t70 -57.16 -41.06 78.49 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.941 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.52 -43.73 96.86 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.685 HD11 ' CD2' ' A' ' 196' ' ' LEU . 95.8 mt -74.69 -79.15 0.09 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.44 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -123.65 140.01 53.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.05 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.588 HD22 ' NZ ' ' A' ' 210' ' ' LYS . 52.8 m-80 -109.38 -76.65 0.61 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.383 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.596 ' CE1' ' ND2' ' A' ' 205' ' ' ASN . 53.3 p90 -96.54 -12.68 23.72 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.622 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 204' ' ' PHE . 30.1 m120 -75.96 160.7 29.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 110.204 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -55.46 -62.02 1.95 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.51 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.517 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.61 1.15 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.128 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.42 134.24 45.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.18 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.33 144.28 34.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.135 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.588 ' NZ ' HD22 ' A' ' 203' ' ' ASN . 21.9 mtmt -104.87 157.54 33.98 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.816 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -34.32 -76.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.5 2.133 . . . . 0.0 112.311 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 51.6 mp0 -49.75 -20.8 0.91 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.052 0.453 . . . . 0.0 110.316 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.6 -51.01 17.69 Favored Glycine 0 CA--C 1.518 0.232 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -65.34 -40.92 94.26 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.073 0.463 . . . . 0.0 109.763 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.1 -53.94 49.54 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.037 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.23 -38.45 91.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.798 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.76 -27.66 68.89 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.234 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -73.3 -46.27 50.57 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.381 0.61 . . . . 0.0 110.801 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -62.17 -42.15 98.99 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.096 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.9 -37.41 84.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.031 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.41 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.3 t80 -54.45 -49.49 69.92 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.822 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 225' ' ' SER . 45.9 t -59.84 -49.27 78.37 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.782 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 1.1 tm0? -50.08 -24.09 2.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.421 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.601 ' O ' HD22 ' A' ' 227' ' ' LEU . 62.7 mt -97.34 -14.13 21.47 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.469 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 222' ' ' SER . 94.2 p -78.26 -22.32 48.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.766 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -94.62 18.08 12.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.996 0.427 . . . . 0.0 110.446 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -78.72 168.76 19.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.137 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.75 132.99 40.65 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 230' ' ' LYS . 56.4 Cg_endo -71.18 -17.56 31.23 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.777 2.318 . . . . 0.0 112.561 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 229' ' ' PRO . 79.9 tttt -32.59 -51.09 0.27 Allowed 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.797 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 232' ' ' GLY . 47.0 m-20 -108.41 -18.08 13.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.263 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.6 51.33 0.06 OUTLIER Glycine 0 N--CA 1.471 1.006 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.0 m -118.02 108.62 15.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 111.159 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.68 96.51 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.31 120.07 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.19 0.519 . . . . 0.0 110.657 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.562 HG13 HD13 ' A' ' 311' ' ' ILE . 92.8 t -92.34 124.81 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.435 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 277' ' ' ARG . 28.1 mt -109.11 143.64 38.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.016 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.33 130.47 7.54 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.622 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -115.32 116.8 28.89 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 241' ' ' ASP . 69.8 m -104.08 160.58 14.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.643 0.259 . . . . 0.0 110.449 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.461 ' N ' HG22 ' A' ' 240' ' ' THR . 39.7 p-10 -89.61 177.81 6.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.69 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.629 ' NE ' ' H ' ' A' ' 244' ' ' GLY . 1.0 OUTLIER -88.74 127.67 35.6 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.0 mm -118.34 9.71 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.248 0.547 . . . . 0.0 110.895 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.629 ' H ' ' NE ' ' A' ' 242' ' ' ARG . . . 102.43 -26.0 25.71 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.449 -0.661 . . . . 0.0 111.449 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -118.7 115.27 24.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.173 0.511 . . . . 0.0 110.26 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 246' ' ' ASP . 24.0 p-10 -60.15 -53.1 61.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.861 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.72 -38.93 70.4 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.299 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.585 ' CE2' HD11 ' A' ' 252' ' ' LEU . 47.8 t80 -63.0 -44.1 96.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.292 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -62.36 -40.23 95.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.348 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.79 -44.07 97.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.06 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.18 -36.33 93.29 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.585 HD11 ' CE2' ' A' ' 248' ' ' TYR . 36.5 mt -71.71 -37.14 70.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.336 . . . . 0.0 111.027 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 35.1 t -64.4 -41.29 96.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.942 0.401 . . . . 0.0 110.652 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.42 -47.76 72.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -59.07 -43.44 91.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.759 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.505 ' NH1' ' OG ' ' A' ' 198' ' ' SER . 0.0 OUTLIER -52.94 -64.17 0.91 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -56.6 -37.08 70.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.459 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.21 -46.83 87.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.655 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 75.7 m -60.66 -38.26 84.28 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.255 0.55 . . . . 0.0 110.439 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 256' ' ' ARG . 96.0 t -63.98 -51.91 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.999 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.702 HG21 ' HB2' ' A' ' 276' ' ' ALA . 62.6 t -62.11 -49.03 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -45.39 -42.14 9.85 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.177 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.508 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 54.8 t80 -82.04 -29.94 31.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.72 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.4 ' O ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -72.72 -8.59 56.11 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.726 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.566 ' C ' ' H ' ' A' ' 267' ' ' LYS . 69.2 mt -87.23 -55.87 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.812 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 93.7 p -50.05 -5.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.07 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 265' ' ' ILE . 71.2 mmtt -77.23 -10.99 59.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.546 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 113.95 -7.93 23.51 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -80.94 129.84 65.96 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.338 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.44 131.17 39.34 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.75 1.634 . . . . 0.0 111.549 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.91 -8.21 34.83 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 111.251 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 25.9 p30 -94.89 -19.66 20.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.618 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 0.9 OUTLIER -80.87 -21.22 40.87 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.496 0.665 . . . . 0.0 110.636 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.47 HD12 HG13 ' A' ' 261' ' ' VAL . 1.3 pt -104.82 -170.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.589 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 14.9 t -170.94 132.96 0.88 Allowed 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.368 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.702 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -96.87 150.93 20.18 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.845 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.477 ' HB3' HD23 ' A' ' 237' ' ' LEU . 63.5 ttt-85 -160.99 150.25 16.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.202 0.525 . . . . 0.0 110.968 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.44 145.65 16.06 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.475 ' SD ' HD22 ' A' ' 237' ' ' LEU . 85.6 mmm -120.64 2.71 10.67 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 121.967 0.107 . . . . 0.0 110.831 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 38.33 -97.89 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 279' ' ' MET . 6.9 pt-20 -142.03 68.89 1.32 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.656 0.265 . . . . 0.0 110.462 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 98.5 p -89.3 -2.67 58.54 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 110.756 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -154.14 65.52 5.1 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.515 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.7 107.61 2.51 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.56 2.173 . . . . 0.0 112.363 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 31.5 m -73.09 -29.08 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.521 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.634 HG21 ' HA ' ' A' ' 303' ' ' LEU . 40.3 p -58.92 -46.15 88.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.569 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -49.6 -2.93 0.02 OUTLIER Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 286' ' ' THR . 97.9 m-20 -119.98 -58.66 1.86 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.77 -3.61 51.57 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.597 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.683 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -130.7 15.52 5.36 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.851 0.357 . . . . 0.0 110.155 179.395 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -65.9 -2.47 3.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.98 0.419 . . . . 0.0 110.304 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -109.9 31.71 5.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.86 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.683 HG21 ' SG ' ' A' ' 290' ' ' CYS . 20.8 t -130.25 121.33 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 110.33 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -119.32 12.19 12.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.702 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.96 130.59 45.33 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.088 0.47 . . . . 0.0 109.815 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -51.99 -64.85 0.68 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.937 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.21 -37.55 64.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.638 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.39 84.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.646 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 303' ' ' LEU . 17.4 mt -72.81 -47.86 42.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.004 0.43 . . . . 0.0 110.78 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.5 mt -60.47 -32.83 52.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.433 . . . . 0.0 110.262 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -82.92 -27.25 30.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.712 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 40.5 t -90.8 -20.37 22.42 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.761 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.634 ' HA ' HG21 ' A' ' 286' ' ' THR . 60.8 mt -85.71 24.96 1.14 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.528 0.517 . . . . 0.0 111.145 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.58 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -76.48 -44.09 3.32 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 22.4 Cg_exo -62.76 9.35 0.1 Allowed 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 123.276 2.651 . . . . 0.0 112.084 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 304' ' ' ALA . 8.2 t70 -104.46 10.73 35.1 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.877 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.489 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 7.9 ptm180 -111.9 97.82 6.95 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.539 0.685 . . . . 0.0 109.965 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.543 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.6 ptm180 -159.0 132.3 7.24 Favored 'General case' 0 C--O 1.212 -0.878 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.333 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.63 141.11 16.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -121.35 106.2 11.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.072 0.463 . . . . 0.0 110.53 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.562 HD13 HG13 ' A' ' 236' ' ' VAL . 3.7 mm -78.55 117.48 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -97.49 132.0 43.59 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.434 HG21 HD22 ' A' ' 224' ' ' LEU . 2.2 t -133.23 118.43 32.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.255 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -115.89 134.55 54.87 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.83 -5.12 56.45 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 18.7 tt -79.91 147.17 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.953 0.406 . . . . 0.0 110.524 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -110.78 150.14 29.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.235 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -111.3 120.54 42.57 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.707 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.74 136.83 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.296 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.55 129.08 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.198 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 57.1 p -144.85 160.01 41.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.276 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -120.98 83.21 37.27 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.154 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.7 149.82 18.55 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.655 2.237 . . . . 0.0 112.15 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -83.37 -13.62 54.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.318 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.379 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.564 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 53.9 Cg_exo -51.17 -37.66 59.2 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.526 2.151 . . . . 0.0 112.054 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 62.83 71.09 0.7 Allowed Pre-proline 0 C--O 1.232 0.153 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.82 152.25 46.86 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.312 2.008 . . . . 0.0 112.146 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.12 70.13 2.6 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.924 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.54 -16.92 30.44 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.345 2.03 . . . . 0.0 111.965 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -133.45 152.04 78.5 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.864 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -47.43 -48.97 14.04 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.239 1.959 . . . . 0.0 112.487 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -171.89 -114.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.963 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.555 HG11 ' HZ1' ' A' ' 314' ' ' LYS . 69.8 t -126.29 135.45 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.25 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.45 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 1.2 pm0 -118.73 121.2 39.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.627 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.3 m -75.11 137.88 41.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.696 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.494 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 13.5 tptt -111.26 166.86 10.74 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.487 0.661 . . . . 0.0 110.558 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.494 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 5.4 m80 -150.55 120.38 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.775 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -110.45 119.53 39.48 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 104.9 16.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.45 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.673 ' CD2' HD11 ' A' ' 201' ' ' LEU . 24.6 tp -107.96 122.82 47.6 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -78.62 130.4 35.86 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.909 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 202' ' ' PHE . 90.3 p -61.45 -29.36 69.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.105 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -60.27 -38.21 82.84 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.921 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.7 t -67.82 -42.97 86.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.673 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.0 mt -79.94 -78.15 0.17 Allowed 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.453 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.57 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.2 OUTLIER -135.39 127.03 28.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.501 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -102.33 -68.4 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.039 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -91.12 -22.69 20.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.552 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -69.22 161.22 29.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.912 0.387 . . . . 0.0 109.967 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -63.02 -57.28 11.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.44 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.57 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -165.92 -7.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.947 0.403 . . . . 0.0 110.206 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 69.4 p -52.46 131.22 33.39 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.262 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.8 mt -77.51 144.5 37.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.483 0.659 . . . . 0.0 111.211 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.9 mtpt -105.2 157.29 34.66 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.141 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 213' ' ' GLY . 89.3 Cg_exo -34.52 -76.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.762 2.308 . . . . 0.0 112.413 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -48.2 -20.37 0.37 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.099 0.476 . . . . 0.0 110.328 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.16 -48.51 19.42 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.389 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -65.62 -40.76 92.92 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.2 -52.34 65.73 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.076 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.88 85.45 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 121.56 0.695 . . . . 0.0 110.397 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 mt -65.62 -28.84 69.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.009 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -72.01 -47.85 48.94 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.371 0.605 . . . . 0.0 110.981 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -62.51 -42.03 99.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.868 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.465 HD12 HE21 ' A' ' 223' ' ' GLN . 49.2 tp -64.91 -40.35 94.93 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.403 ' CG ' ' HB3' ' A' ' 267' ' ' LYS . 5.9 t80 -52.3 -47.27 66.02 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.813 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 75.0 p -55.94 -51.27 68.25 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.796 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.465 HE21 HD12 ' A' ' 220' ' ' LEU . 17.6 mt-30 -52.28 -25.64 9.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.56 ' O ' HD22 ' A' ' 227' ' ' LEU . 42.8 mt -99.15 -20.88 16.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.677 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 6.8 t -72.75 -24.34 60.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -102.79 23.73 11.68 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.56 HD22 ' O ' ' A' ' 224' ' ' LEU . 1.0 OUTLIER -75.66 147.62 39.34 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 315' ' ' GLY . 25.8 t0 -62.95 112.07 6.08 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 230' ' ' LYS . 50.7 Cg_exo -53.67 -20.89 17.92 Favored 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.517 2.145 . . . . 0.0 113.181 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 229' ' ' PRO . 11.2 mmmt -29.79 -52.54 0.14 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.952 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' GLY . 34.0 m-20 -105.98 -17.18 14.43 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.388 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 27.86 49.33 0.07 OUTLIER Glycine 0 N--CA 1.465 0.58 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.347 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.96 108.08 15.35 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.9 96.61 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.712 0.768 . . . . 0.0 110.018 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.8 t -96.19 117.78 41.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.291 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 261' ' ' VAL . 88.2 t -95.26 121.4 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.033 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 277' ' ' ARG . 24.6 mt -108.76 141.8 40.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.986 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -124.48 126.84 6.2 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.34 122.05 46.84 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 241' ' ' ASP . 55.2 m -109.49 166.11 11.14 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.414 0.446 . . . . 0.0 110.613 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.593 ' N ' HG22 ' A' ' 240' ' ' THR . 40.1 p-10 -90.44 173.3 8.17 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.118 0.485 . . . . 0.0 111.17 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.41 ' NH2' ' OE2' ' A' ' 281' ' ' GLU . 64.0 ttm-85 -92.61 126.53 37.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.166 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.1 mm -118.32 15.15 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.231 0.538 . . . . 0.0 110.442 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 86.07 -1.86 87.69 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 11.8 t -131.44 105.92 7.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.156 0.503 . . . . 0.0 110.179 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.423 ' CG ' ' N ' ' A' ' 247' ' ' ALA . 22.0 p-10 -55.54 -51.5 66.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.613 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 246' ' ' ASP . . . -55.54 -39.61 70.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.551 ' CE2' HD11 ' A' ' 252' ' ' LEU . 29.1 t80 -65.02 -43.46 92.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.204 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 17.6 t-20 -61.87 -43.15 99.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.879 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -65.74 -41.77 91.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.81 -39.52 98.09 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' A' ' 248' ' ' TYR . 27.4 mt -72.8 -35.93 67.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.501 -0.349 . . . . 0.0 110.594 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 39.5 t -62.96 -42.69 99.9 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.89 -46.88 79.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.895 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -55.92 -45.25 78.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 260' ' ' VAL . 28.8 ttm105 -55.29 -65.87 0.51 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.826 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -55.13 -35.09 64.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.47 -48.4 64.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.612 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 77.6 p -57.7 -39.39 77.08 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.117 0.484 . . . . 0.0 110.404 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 256' ' ' ARG . 58.8 t -65.32 -54.01 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.432 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.483 HG13 HD12 ' A' ' 274' ' ' ILE . 17.6 t -60.11 -49.12 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 120.954 -0.299 . . . . 0.0 110.492 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.09 -44.17 31.45 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.656 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.585 ' CE1' ' NZ ' ' A' ' 267' ' ' LYS . 90.3 t80 -78.39 -34.9 47.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.831 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -62.41 -25.97 68.23 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.094 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 267' ' ' LYS . 86.6 mt -71.33 -52.46 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.777 0.322 . . . . 0.0 111.708 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 6.2 t -50.04 -10.92 0.06 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.48 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.585 ' NZ ' ' CE1' ' A' ' 263' ' ' TYR . 0.1 OUTLIER -77.81 -10.81 59.74 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.204 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 105.99 41.87 1.75 Allowed Glycine 0 CA--C 1.533 1.172 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.79 131.49 24.02 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-N 117.193 0.496 . . . . 0.0 110.79 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.46 125.26 17.18 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.553 1.502 . . . . 0.0 111.48 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.01 -8.39 29.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.135 0.493 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -91.2 -22.93 20.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.334 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -81.37 -20.22 41.01 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.465 0.65 . . . . 0.0 111.167 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.483 HD12 HG13 ' A' ' 261' ' ' VAL . 1.9 pt -103.71 -173.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.435 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 17.4 p -168.62 129.26 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.511 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.09 111.49 23.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.948 0.404 . . . . 0.0 110.583 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.486 ' HB3' HD23 ' A' ' 237' ' ' LEU . 64.9 ttt180 -120.72 146.46 46.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.464 0.65 . . . . 0.0 111.062 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.51 142.46 16.16 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 1.6 mmt -118.92 -5.87 10.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.92 -104.28 0.05 OUTLIER Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.41 ' OE2' ' NH2' ' A' ' 242' ' ' ARG . 9.4 pt-20 -142.26 68.7 1.32 Allowed 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.859 -0.201 . . . . 0.0 110.789 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 74.3 m -67.09 -42.06 85.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.614 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.419 ' ND2' HH21 ' A' ' 308' ' ' ARG . 6.9 p-10 -125.66 80.54 66.3 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.105 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.87 106.67 0.66 Allowed 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.714 2.276 . . . . 0.0 112.543 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 289' ' ' THR . 12.5 m -75.81 -30.76 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.132 0.491 . . . . 0.0 110.414 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.63 ' C ' ' H ' ' A' ' 288' ' ' ASN . 60.4 p -56.69 -43.16 80.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.664 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.13 0.52 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.63 ' H ' ' C ' ' A' ' 286' ' ' THR . 24.1 t-20 -123.2 -58.53 1.63 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.1 OUTLIER -68.22 -14.33 62.91 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.503 -178.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 57.2 m -128.53 22.28 5.98 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.301 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -69.77 -2.49 12.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.697 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -110.24 32.09 5.41 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.535 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 23.3 t -130.93 124.02 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.99 0.424 . . . . 0.0 110.299 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -118.95 7.9 11.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.385 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.437 ' O ' HD12 ' A' ' 299' ' ' LEU . 4.6 mt-30 -90.27 169.44 11.11 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -82.9 -71.18 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.683 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -57.88 -28.13 63.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.951 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.04 -39.74 94.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.357 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 303' ' ' LEU . 47.6 mt -70.86 -49.11 49.61 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 110.534 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.4 mt -54.89 -31.67 25.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -80.25 -32.68 38.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.476 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -87.46 -12.18 46.82 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.721 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.574 ' HA ' HG21 ' A' ' 286' ' ' THR . 48.5 mt -90.47 21.92 3.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.761 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.586 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -78.48 -43.26 2.01 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.98 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.5 Cg_exo -61.78 8.55 0.1 Allowed 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 123.409 2.739 . . . . 0.0 112.044 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 304' ' ' ALA . 50.6 t0 -102.49 12.2 36.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.457 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -113.98 98.48 7.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.445 0.64 . . . . 0.0 109.838 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.552 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 33.5 ptt180 -157.73 130.9 7.62 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.306 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.5 140.06 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -120.84 105.83 11.08 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.362 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.414 HD13 HG13 ' A' ' 236' ' ' VAL . 4.0 mm -79.33 117.64 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.68 127.75 41.98 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.428 HG21 ' CD2' ' A' ' 224' ' ' LEU . 2.4 t -126.77 115.56 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.196 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.555 ' HZ1' HG11 ' A' ' 189' ' ' VAL . 52.8 tttp -114.83 125.8 54.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 91.15 43.74 4.6 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.605 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.5 tt -114.83 168.61 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.605 ' O ' ' O ' ' A' ' 316' ' ' ILE . 0.1 OUTLIER -48.52 -147.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 O-C-N 124.07 0.857 . . . . 0.0 110.868 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.412 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 6.9 m-20 -154.55 101.3 2.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.219 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 62.9 t -116.23 131.46 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 92.7 t -80.09 130.1 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.13 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.68 161.09 18.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.285 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -142.21 84.26 11.67 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.176 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.73 -33.74 71.41 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.668 2.245 . . . . 0.0 112.06 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -49.57 -21.22 0.93 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.71 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.514 179.693 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.562 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 23.0 Cg_endo -59.03 -41.3 62.75 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.959 2.439 . . . . 0.0 112.127 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 178.45 61.68 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.333 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.86 90.09 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.619 2.213 . . . . 0.0 111.868 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 185' ' ' PRO . . . -172.59 75.35 0.44 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.397 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 184' ' ' ALA . 50.0 Cg_exo -51.17 -171.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.65 2.234 . . . . 0.0 111.773 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -133.03 72.56 76.47 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.275 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 188' ' ' GLU . 61.6 Cg_endo -77.13 174.65 12.47 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.717 2.278 . . . . 0.0 111.846 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 187' ' ' PRO . 79.7 mm-40 56.03 160.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.348 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 60.5 t -128.45 135.29 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.439 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.48 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 1.6 pm0 -122.4 128.36 50.84 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.384 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.543 HG22 ' CE1' ' A' ' 193' ' ' HIS . 13.3 m -85.17 142.07 29.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.193 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -143.45 111.42 6.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.562 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.4 OUTLIER -97.96 148.28 23.63 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -112.07 130.36 55.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.913 0.387 . . . . 0.0 110.303 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -88.23 103.7 16.02 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.045 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.717 ' CD2' HD11 ' A' ' 201' ' ' LEU . 28.7 tp -108.47 128.37 54.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.178 0.513 . . . . 0.0 109.648 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.437 ' HB3' HG23 ' A' ' 200' ' ' VAL . 34.0 ttmt -81.7 125.14 30.24 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.994 0.902 . . . . 0.0 112.16 -178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.481 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 18.5 m -61.05 -32.14 71.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.196 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.419 ' H ' ' HG2' ' A' ' 197' ' ' LYS . 9.9 t0 -59.66 -36.72 76.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.178 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 197' ' ' LYS . 87.3 t -67.34 -42.96 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.717 HD11 ' CD2' ' A' ' 196' ' ' LEU . 76.3 mt -78.9 -78.33 0.15 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.322 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.68 128.1 41.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.966 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.418 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 62.0 t-20 -111.93 -71.48 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.438 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -84.34 -32.32 24.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -73.73 165.89 24.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.196 0.522 . . . . 0.0 110.245 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.675 ' C ' HH22 ' A' ' 255' ' ' ARG . 32.6 mmtp -58.94 -82.41 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.457 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.57 ' HB2' ' NH1' ' A' ' 255' ' ' ARG . . . -148.65 56.55 1.03 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 73.4 p -107.54 130.2 54.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.131 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 40.6 mt -78.04 134.97 37.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.732 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.4 mtmt -97.06 159.21 31.92 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.917 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 210' ' ' LYS . 88.8 Cg_exo -34.63 -76.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.235 1.957 . . . . 0.0 111.875 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -49.22 -22.13 0.96 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.101 0.477 . . . . 0.0 110.244 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.53 -52.0 14.35 Favored Glycine 0 N--CA 1.46 0.276 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -64.99 -39.56 93.66 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.323 0.583 . . . . 0.0 109.908 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.75 -54.66 43.76 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.153 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.6 -36.0 82.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.984 0.421 . . . . 0.0 110.678 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.3 mt -61.56 -31.66 71.71 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.152 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -72.67 -45.51 58.51 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.279 0.562 . . . . 0.0 110.616 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -61.52 -44.98 96.09 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.808 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.486 HD12 HE21 ' A' ' 223' ' ' GLN . 38.3 tp -63.65 -40.6 97.27 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.262 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.433 ' CE1' ' OG ' ' A' ' 225' ' ' SER . 6.5 t80 -51.54 -48.35 63.06 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.985 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.7 t -54.25 -52.11 62.38 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.55 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.486 HE21 HD12 ' A' ' 220' ' ' LEU . 16.0 mt-30 -51.56 -26.66 9.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.4 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.797 HD22 HG21 ' A' ' 313' ' ' VAL . 21.7 mt -98.35 -19.0 18.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.433 ' OG ' ' CE1' ' A' ' 221' ' ' TYR . 4.7 m -71.68 -32.91 68.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -96.96 21.68 9.37 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.677 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -75.07 151.49 38.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.794 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.572 ' N ' ' O ' ' A' ' 315' ' ' GLY . 15.6 t0 -65.39 124.6 87.54 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.128 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 232' ' ' GLY . 48.0 Cg_endo -69.16 -19.73 38.59 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 122.894 2.396 . . . . 0.0 113.313 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 229' ' ' PRO . 39.0 ttmt -24.12 -50.06 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.576 0 O-C-N 123.62 0.575 . . . . 0.0 111.037 -177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.472 ' O ' ' C ' ' A' ' 232' ' ' GLY . 32.5 t70 -115.44 -12.9 11.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.212 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 25.66 49.93 0.04 OUTLIER Glycine 0 N--CA 1.472 1.095 0 O-C-N 123.861 0.725 . . . . 0.0 111.456 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.5 t -112.03 114.13 26.83 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 122.574 -0.368 . . . . 0.0 110.352 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.6 t -129.05 95.91 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.266 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 275' ' ' SER . 2.8 t -96.74 123.98 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.097 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.484 HG22 HG23 ' A' ' 311' ' ' ILE . 21.2 t -96.75 120.94 46.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.823 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 40.8 mt -103.74 145.38 30.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.167 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.68 129.04 7.34 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 308' ' ' ARG . 1.0 OUTLIER -110.53 125.77 53.69 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.544 ' OG1' ' ND2' ' A' ' 249' ' ' ASN . 3.1 p -116.78 162.82 17.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.535 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 7.0 p30 -84.75 172.09 11.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -88.74 122.53 32.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.425 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.7 mm -118.06 7.94 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.293 0.568 . . . . 0.0 110.617 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 82.33 13.98 77.53 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -142.08 92.15 2.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.107 0.479 . . . . 0.0 109.943 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -49.25 -49.69 42.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.508 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.24 78.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.797 ' CE2' HD11 ' A' ' 252' ' ' LEU . 40.3 t80 -65.18 -43.2 92.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.062 0.458 . . . . 0.0 110.637 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.544 ' ND2' ' OG1' ' A' ' 240' ' ' THR . 27.4 t-20 -61.49 -43.4 98.94 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.634 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -63.52 -45.05 92.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.638 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.11 92.1 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 1.108 HD23 ' HE ' ' A' ' 255' ' ' ARG . 18.0 mt -64.69 -43.66 92.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.998 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 33.3 m -66.83 -43.69 83.09 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.885 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.58 -57.21 13.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.475 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 1.108 ' HE ' HD23 ' A' ' 252' ' ' LEU . 36.5 ptt85 -59.11 -45.16 91.58 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.156 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.481 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 19.2 mtp-105 -58.16 -50.58 73.03 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.535 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.38 69.89 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.84 -40.39 72.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.137 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 76.4 p -63.43 -37.86 88.93 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.192 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.48 -51.1 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.491 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' A' ' 276' ' ' ALA . 23.4 t -61.23 -49.56 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.2 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -45.94 -38.8 8.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.93 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.497 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 63.6 t80 -84.9 -31.68 23.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.49 -13.5 62.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.446 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.561 ' C ' ' H ' ' A' ' 267' ' ' LYS . 66.5 mt -83.89 -52.15 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.789 0.328 . . . . 0.0 111.148 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 9.0 t -50.49 -6.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.561 ' H ' ' C ' ' A' ' 265' ' ' ILE . 73.7 mmtt -79.63 -10.67 59.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.616 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 104.55 40.72 2.15 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.68 127.86 24.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.87 128.03 25.2 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.822 1.681 . . . . 0.0 111.811 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.07 -11.65 15.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.008 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.36 -26.07 21.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.774 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.436 ' CE ' HD21 ' A' ' 227' ' ' LEU . 7.0 tttm -74.51 -22.81 58.87 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 121.909 0.861 . . . . 0.0 110.659 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -104.14 -172.8 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.547 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 235' ' ' VAL . 13.3 t -170.24 124.8 0.74 Allowed 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.396 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.678 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -99.72 156.97 16.81 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.801 -0.562 . . . . 0.0 109.795 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -174.1 166.84 4.23 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-O 122.009 0.909 . . . . 0.0 110.855 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.22 146.03 16.02 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.341 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 4.3 tpt -116.0 -10.97 11.51 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.914 0.388 . . . . 0.0 110.291 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 53.7 -111.23 1.77 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -141.76 72.26 1.38 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.879 0.371 . . . . 0.0 110.403 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.1 t -62.23 -42.06 98.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.113 0.482 . . . . 0.0 111.369 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -129.07 79.16 75.03 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.43 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -54.66 107.97 0.26 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.452 2.101 . . . . 0.0 112.113 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 286' ' ' THR . 27.3 m -65.75 -44.99 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.632 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.637 ' O ' ' N ' ' A' ' 288' ' ' ASN . 67.5 p -60.6 -43.68 97.15 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.813 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.37 -6.88 0.01 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.637 ' N ' ' O ' ' A' ' 286' ' ' THR . 29.7 m-80 -130.47 -56.02 1.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.116 0.566 . . . . 0.0 109.675 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 m -64.47 -30.46 71.49 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.918 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.59 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -121.3 22.37 10.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.957 0.408 . . . . 0.0 110.453 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 45.7 t0 -63.46 -10.97 19.98 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.612 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -98.87 32.17 2.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.743 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.59 HG21 ' SG ' ' A' ' 290' ' ' CYS . 40.0 t -128.04 124.98 63.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.1 0.476 . . . . 0.0 110.196 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -119.13 11.01 12.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -100.07 130.26 46.21 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.411 0.624 . . . . 0.0 110.201 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 299' ' ' LEU . 7.9 ttm180 -52.61 -76.24 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.55 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -41.91 -38.35 1.54 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.11 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.85 94.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.104 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 296' ' ' ARG . 35.5 mt -72.2 -41.48 66.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.575 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.4 mm -57.65 -31.48 39.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.11 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -86.84 -43.9 12.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.51 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.75 -19.93 65.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.985 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.46 25.43 1.68 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.459 0.474 . . . . 0.0 111.255 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.57 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -77.2 -43.6 2.69 Favored Pre-proline 0 CA--C 1.545 0.759 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.924 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 18.8 Cg_exo -64.73 7.96 0.23 Allowed 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.472 2.781 . . . . 0.0 111.511 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 304' ' ' ALA . 10.0 m-20 -103.29 7.74 38.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.02 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.418 ' NH1' ' OD1' ' A' ' 203' ' ' ASN . 64.7 mtm180 -112.61 94.75 5.06 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.236 0.541 . . . . 0.0 110.2 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 39.5 ptt180 -164.46 136.73 4.7 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.535 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.44 143.9 11.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.61 -0.681 . . . . 0.0 109.562 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -117.69 103.78 10.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.484 HG23 HG22 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -80.98 113.37 20.31 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.211 -178.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -92.84 119.32 32.05 Favored 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 123.374 0.421 . . . . 0.0 110.73 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.797 HG21 HD22 ' A' ' 224' ' ' LEU . 60.9 t -119.25 117.32 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.807 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -113.98 128.63 56.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 98.15 40.83 3.4 Favored Glycine 0 C--O 1.226 -0.366 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.664 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.1 tt -116.94 170.03 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.664 ' O ' ' O ' ' A' ' 316' ' ' ILE . 51.8 mtpt -43.44 -156.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 124.074 0.859 . . . . 0.0 111.357 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -75.65 173.26 11.29 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.554 -0.716 . . . . 0.0 110.713 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.49 133.38 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.089 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.58 134.91 27.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.428 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 13.4 m -52.8 139.89 25.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.951 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -134.39 132.4 20.94 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -48.92 139.51 25.3 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.123 1.882 . . . . 0.0 112.352 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.442 ' CD ' ' N ' ' A' ' 324' ' ' GLN . 22.6 mp0 -83.73 -16.73 43.76 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.507 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.555 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.502 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 36.5 Cg_endo -63.81 -28.89 67.96 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.923 2.415 . . . . 0.0 111.955 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.25 72.25 0.45 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.477 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -53.57 93.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.753 2.302 . . . . 0.0 111.964 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.438 ' N ' ' CD ' ' A' ' 185' ' ' PRO . . . -170.5 53.93 0.22 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.348 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 184' ' ' ALA . 56.8 Cg_endo -69.73 155.78 65.14 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.662 2.242 . . . . 0.0 111.487 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -135.5 126.43 17.15 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.359 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -47.02 -47.31 16.96 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.137 1.891 . . . . 0.0 112.532 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 39.83 59.56 1.87 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 94.4 t -88.03 105.7 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.469 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.408 ' H ' ' HG2' ' A' ' 190' ' ' GLN . 3.0 pt20 -108.54 126.69 53.21 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.9 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 36.0 m -69.19 135.19 50.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.425 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 0.1 OUTLIER -115.38 169.44 9.15 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.411 0.624 . . . . 0.0 110.72 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 94.8 m-70 -155.68 125.44 6.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.081 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.534 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 66.3 m-85 -112.54 117.64 32.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.409 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.88 104.82 15.89 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.989 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.684 ' CD2' HD11 ' A' ' 201' ' ' LEU . 29.6 tp -108.47 130.82 55.25 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.423 ' HG3' ' H ' ' A' ' 199' ' ' ASP . 20.8 tptp -79.39 128.44 33.34 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.948 0.88 . . . . 0.0 111.877 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 202' ' ' PHE . 18.0 t -64.06 -31.93 73.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.088 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.423 ' H ' ' HG3' ' A' ' 197' ' ' LYS . 46.7 t0 -58.92 -37.28 76.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.979 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 197' ' ' LYS . 91.6 t -66.81 -43.87 89.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.684 HD11 ' CD2' ' A' ' 196' ' ' LEU . 90.7 mt -78.31 -77.73 0.16 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.947 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -126.0 129.55 49.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.716 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -101.35 -74.44 0.62 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.34 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.609 ' CE2' ' ND2' ' A' ' 205' ' ' ASN . 54.7 p90 -99.09 -21.67 16.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.932 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.609 ' ND2' ' CE2' ' A' ' 204' ' ' PHE . 32.9 m120 -72.77 164.67 26.2 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.272 0.558 . . . . 0.0 110.057 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.3 pttm -49.56 -83.13 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.198 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -156.43 58.96 0.56 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.255 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.04 131.62 53.89 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.5 mt -75.21 139.35 42.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.747 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.2 mtpm? -98.44 158.72 32.12 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.708 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 213' ' ' GLY . 81.8 Cg_exo -34.01 -76.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.558 2.172 . . . . 0.0 112.013 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -50.9 -18.44 0.76 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.126 0.488 . . . . 0.0 110.162 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.72 -47.89 11.22 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -66.98 -40.27 87.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.3 -51.34 70.19 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.24 83.41 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.411 0.624 . . . . 0.0 110.485 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.82 -30.92 71.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.063 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.49 -47.34 56.08 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.134 0.493 . . . . 0.0 110.867 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -63.9 -42.63 97.38 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.283 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.505 HD21 HD12 ' A' ' 311' ' ' ILE . 40.4 tp -64.87 -40.68 95.51 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.1 t80 -53.44 -49.11 68.05 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.968 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.5 m -55.76 -50.57 70.05 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.348 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.534 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 10.9 tt0 -53.17 -24.18 10.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.42 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.739 HD22 HG21 ' A' ' 313' ' ' VAL . 74.3 mt -95.96 -20.02 19.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.583 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.2 t -73.06 -21.57 60.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.92 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -99.75 20.42 14.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.714 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -76.27 161.4 28.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.18 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 315' ' ' GLY . 9.5 t0 -78.75 126.94 81.66 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 230' ' ' LYS . 45.9 Cg_endo -68.82 -17.27 41.99 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.718 2.279 . . . . 0.0 113.051 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 229' ' ' PRO . 14.4 mmtp -27.62 -46.46 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.74 0.65 . . . . 0.0 110.964 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.476 ' O ' ' C ' ' A' ' 232' ' ' GLY . 9.6 m-20 -117.89 -14.92 10.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.36 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.21 51.64 0.06 OUTLIER Glycine 0 N--CA 1.474 1.182 0 O-C-N 123.985 0.803 . . . . 0.0 111.346 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 73.6 m -116.63 111.97 20.61 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 122.788 -0.242 . . . . 0.0 110.791 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 34.3 t -126.71 96.47 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.019 0.438 . . . . 0.0 110.075 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.15 121.18 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.446 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 311' ' ' ILE . 24.2 t -95.54 125.85 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.982 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.641 HD23 ' HB3' ' A' ' 277' ' ' ARG . 23.4 mt -109.08 143.96 37.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.933 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.695 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -120.13 138.95 13.42 Favored Glycine 0 N--CA 1.48 1.619 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.622 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.2 OUTLIER -121.7 117.32 26.37 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.413 ' OG1' ' OD1' ' A' ' 249' ' ' ASN . 7.7 p -112.74 164.81 12.92 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.848 0.356 . . . . 0.0 110.223 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.439 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 47.6 p-10 -85.22 177.53 7.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.32 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -104.0 127.2 51.55 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.103 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.1 mm -118.84 19.58 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-O 121.444 0.64 . . . . 0.0 110.706 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.44 7.51 86.31 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.8 t -136.3 99.06 4.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.996 0.427 . . . . 0.0 110.212 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -51.5 -50.04 60.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.577 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.94 -39.54 71.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.575 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.628 ' CE2' HD11 ' A' ' 252' ' ' LEU . 48.1 t80 -62.14 -47.16 85.78 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.97 0.414 . . . . 0.0 110.502 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 11.1 t-20 -62.2 -41.37 98.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.636 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -64.55 -44.27 91.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 110.751 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.09 -36.03 92.34 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.628 HD11 ' CE2' ' A' ' 248' ' ' TYR . 78.5 mt -74.36 -34.76 63.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.687 0.279 . . . . 0.0 111.365 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.473 ' OG ' ' CA ' ' A' ' 278' ' ' GLY . 12.0 t -65.01 -43.76 91.42 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.016 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -71.09 -40.13 71.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.417 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -60.11 -50.02 75.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.592 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.524 ' O ' HG23 ' A' ' 260' ' ' VAL . 86.2 mtt-85 -61.19 -53.99 49.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.747 0.308 . . . . 0.0 110.351 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -54.58 -35.49 63.39 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.164 0.507 . . . . 0.0 109.919 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -71.3 -44.33 65.37 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.258 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 17.1 m -62.02 -37.49 85.12 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.528 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 256' ' ' ARG . 96.7 t -65.12 -51.41 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.543 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.559 HG13 HD12 ' A' ' 274' ' ' ILE . 25.3 t -61.92 -48.64 87.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.054 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -45.48 -41.08 9.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.942 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.532 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 57.4 t80 -81.42 -30.69 33.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.653 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -73.5 -8.53 56.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.633 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.5 mt -87.33 -55.77 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.807 0.337 . . . . 0.0 111.264 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.9 m -50.72 -4.79 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.573 ' H ' ' C ' ' A' ' 265' ' ' ILE . 30.1 mmtp -79.39 -11.0 59.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.774 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.27 39.92 2.03 Favored Glycine 0 CA--C 1.517 0.211 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 128.57 24.09 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.5 128.46 25.96 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.595 1.53 . . . . 0.0 112.037 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.8 -6.93 13.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.787 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 6.4 p30 -94.54 -21.75 18.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.905 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 1.2 ttpm? -80.4 -21.2 42.5 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.505 0.669 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.559 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -103.89 -171.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.626 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 22.0 m -171.17 129.56 0.73 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.145 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.86 152.25 18.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.641 ' HB3' HD23 ' A' ' 237' ' ' LEU . 69.2 ttt-85 -161.38 148.79 14.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.361 0.601 . . . . 0.0 110.6 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.473 ' CA ' ' OG ' ' A' ' 253' ' ' SER . . . -126.12 100.46 0.58 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.622 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 8.1 ptp -88.0 24.03 1.92 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.649 0.261 . . . . 0.0 110.931 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.12 -93.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 279' ' ' MET . 4.5 pt-20 -140.68 74.91 1.48 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.826 0.346 . . . . 0.0 110.447 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.4 m -90.38 -0.73 57.77 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.466 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -153.86 56.28 1.54 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.354 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.61 109.49 1.86 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.558 2.172 . . . . 0.0 112.28 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 22.5 m -78.87 -23.94 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.436 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.648 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.6 OUTLIER -59.71 -45.06 93.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.702 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -49.95 -0.1 0.01 OUTLIER Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.648 ' H ' ' C ' ' A' ' 286' ' ' THR . 25.7 t-20 -124.72 -57.19 1.55 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.6 m -54.82 -42.52 72.0 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 8.2 m -94.22 34.78 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.287 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 41.4 t0 -74.77 -7.99 55.05 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.821 0.343 . . . . 0.0 110.792 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -106.47 30.04 6.35 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.435 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.41 126.56 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.236 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -119.88 13.73 12.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.524 ' O ' HD13 ' A' ' 299' ' ' LEU . 2.1 mp0 -87.6 171.54 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.073 0.463 . . . . 0.0 110.144 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -86.26 -71.1 0.56 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.605 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.57 -32.39 68.88 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.334 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.08 -41.11 87.23 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.514 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 295' ' ' GLN . 7.5 mp -72.29 -48.34 43.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.917 0.389 . . . . 0.0 110.843 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 81.3 mt -45.49 -38.52 2.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -79.55 -40.78 28.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.406 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 3.5 t -72.7 -8.92 57.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.528 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.7 mm? -92.03 20.95 5.35 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.496 0.498 . . . . 0.0 110.305 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.648 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.02 -38.06 1.14 Allowed Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.029 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.5 Cg_exo -59.13 9.55 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 123.35 2.7 . . . . 0.0 112.593 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 304' ' ' ALA . 33.6 p30 -114.77 15.44 17.49 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.69 0.281 . . . . 0.0 110.764 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -106.83 97.33 7.13 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.756 0.789 . . . . 0.0 110.285 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 16.6 ptm180 -171.12 157.84 5.3 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.881 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.695 HG12 ' HA2' ' A' ' 238' ' ' GLY . 34.5 m -117.91 148.0 21.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 87.9 mt-10 -121.06 105.91 11.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 110.753 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.506 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -78.44 117.28 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.201 -178.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -97.69 122.74 41.13 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.038 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.739 HG21 HD22 ' A' ' 224' ' ' LEU . 28.6 t -124.65 117.07 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.1 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -115.39 121.63 43.36 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 103.91 40.17 2.36 Favored Glycine 0 N--CA 1.462 0.398 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.506 ' CG1' ' N ' ' A' ' 317' ' ' LYS . 12.4 tt -115.95 168.07 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.913 0.387 . . . . 0.0 109.983 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.506 ' N ' ' CG1' ' A' ' 316' ' ' ILE . 5.0 tmtp? -126.43 138.18 53.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.495 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -158.01 170.48 22.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.511 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 319' ' ' VAL . 9.3 p -79.27 124.68 37.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.552 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 8.1 p -156.86 150.24 9.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.749 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.4 p -66.91 137.0 56.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -83.79 141.72 41.54 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.884 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.03 158.48 49.5 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.448 2.098 . . . . 0.0 112.081 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -84.13 96.43 8.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.304 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.434 -179.842 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.644 ' HB1' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.644 ' CD ' ' HB1' ' A' ' 180' ' ' ALA . 25.0 Cg_exo -61.59 145.68 97.51 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.332 2.021 . . . . 0.0 111.709 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.63 147.81 11.01 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.382 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -71.1 146.37 51.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.17 1.913 . . . . 0.0 111.597 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -98.61 149.4 35.7 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.295 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 186' ' ' ALA . 80.8 Cg_exo -41.44 116.42 0.49 Allowed 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.75 1.633 . . . . 0.0 111.889 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.548 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . 174.82 -44.82 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.405 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 34.9 Cg_exo -60.21 145.46 98.47 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.48 2.12 . . . . 0.0 111.88 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -58.55 137.25 57.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.164 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 9.7 t -84.59 158.37 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.3 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.471 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 1.1 pm0 -126.11 109.6 12.56 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 84.8 m -87.59 145.21 26.3 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -118.59 170.26 9.11 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.22 0.533 . . . . 0.0 110.002 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -153.55 124.66 7.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.947 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -112.07 122.31 47.4 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.485 ' OG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -87.87 105.9 17.74 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.451 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.694 ' CD2' HD11 ' A' ' 201' ' ' LEU . 37.5 tp -108.21 123.58 48.97 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.425 ' NZ ' ' OD2' ' A' ' 199' ' ' ASP . 5.3 ttpp -81.13 128.25 33.54 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 122.615 1.198 . . . . 0.0 113.2 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 202' ' ' PHE . 20.4 t -59.31 -19.6 47.63 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.159 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.425 ' OD2' ' NZ ' ' A' ' 197' ' ' LYS . 21.0 m-20 -59.69 -47.85 84.0 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.407 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 200' ' ' VAL . 2.5 m -71.64 -25.98 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.326 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.694 HD11 ' CD2' ' A' ' 196' ' ' LEU . 65.6 mt -90.56 -81.28 0.31 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 118.732 -1.187 . . . . 0.0 109.954 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.503 ' O ' ' OG ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -128.13 99.27 5.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.9 -178.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.53 HD21 ' HZ3' ' A' ' 210' ' ' LYS . 3.3 p30 -71.99 -71.78 0.26 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.406 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -105.73 -27.16 11.46 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.554 0.216 . . . . 0.0 110.9 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -61.98 167.83 3.59 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.992 0.425 . . . . 0.0 110.271 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -53.21 -81.7 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.515 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.47 ' HB1' ' OG ' ' A' ' 259' ' ' SER . . . -161.86 54.2 0.25 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 60.0 p -107.28 136.97 46.2 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.406 HD22 HD22 ' A' ' 201' ' ' LEU . 18.9 mt -79.8 123.44 27.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.827 0.346 . . . . 0.0 111.633 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.53 ' HZ3' HD21 ' A' ' 203' ' ' ASN . 22.1 mtmt -84.14 158.51 61.17 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.26 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 213' ' ' GLY . 96.1 Cg_exo -32.75 -75.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.702 2.268 . . . . 0.0 112.824 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -49.12 -19.27 0.42 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.386 0.612 . . . . 0.0 110.191 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.33 -50.42 8.35 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -64.92 -40.62 95.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.224 0.535 . . . . 0.0 109.568 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -51.51 68.99 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.144 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.21 85.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.246 0.546 . . . . 0.0 110.036 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.3 mt -61.64 -37.8 85.35 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.183 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 32.1 m-20 -63.66 -45.57 89.54 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.112 0.482 . . . . 0.0 111.009 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -62.2 -44.22 97.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.299 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.449 HD12 HE21 ' A' ' 223' ' ' GLN . 37.6 tp -63.24 -39.94 96.02 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 225' ' ' SER . 16.1 t80 -53.9 -45.39 71.1 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 87.7 p -51.25 -53.53 34.53 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.038 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.449 HE21 HD12 ' A' ' 220' ' ' LEU . 20.5 mt-30 -53.83 -29.09 39.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.825 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.579 ' O ' HD22 ' A' ' 227' ' ' LEU . 17.5 mt -93.64 -22.97 18.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.519 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 221' ' ' TYR . 7.2 p -77.86 -30.04 50.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.206 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -96.17 22.78 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.167 0.508 . . . . 0.0 110.437 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.579 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.6 OUTLIER -79.71 168.61 19.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.83 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.37 127.85 64.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 230' ' ' LYS . 68.6 Cg_endo -72.22 -16.53 28.24 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.072 1.848 . . . . 0.0 113.071 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.475 ' CG ' ' N ' ' A' ' 231' ' ' ASP . 19.5 ptmt -31.67 -45.77 0.1 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 123.583 0.552 . . . . 0.0 111.232 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.475 ' N ' ' CG ' ' A' ' 230' ' ' LYS . 84.5 m-20 -111.92 -19.39 12.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.998 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 28.31 54.75 0.13 Allowed Glycine 0 N--CA 1.473 1.151 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.754 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.8 p -119.06 109.89 16.45 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.409 0.147 . . . . 0.0 111.151 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.4 t -125.47 94.74 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.699 0.761 . . . . 0.0 110.205 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.57 120.31 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.549 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.44 HG13 HD13 ' A' ' 311' ' ' ILE . 69.3 t -96.93 123.96 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.297 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.8 mt -107.2 137.83 44.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.185 0.517 . . . . 0.0 110.592 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -90.91 139.54 14.87 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.493 ' CZ ' ' CD ' ' A' ' 310' ' ' GLU . 11.6 m-85 -131.56 118.95 20.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.051 0.925 . . . . 0.0 108.794 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.0 t -129.49 171.05 12.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.843 0.354 . . . . 0.0 111.124 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -76.96 -176.12 3.82 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.321 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -105.82 121.83 44.85 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.781 0.324 . . . . 0.0 110.239 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.691 HG22 ' O ' ' A' ' 243' ' ' ILE . 8.5 mm -118.82 11.15 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 121.552 0.691 . . . . 0.0 110.453 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.8 -47.36 3.06 Favored Glycine 0 C--N 1.315 -0.585 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.5 m -68.3 101.04 1.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.314 0.578 . . . . 0.0 109.636 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -54.41 -52.3 62.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.548 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.41 -44.99 80.86 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.194 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.599 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 56.1 t80 -62.17 -45.02 95.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.91 0.385 . . . . 0.0 110.733 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.461 HD21 ' N ' ' A' ' 243' ' ' ILE . 28.0 m120 -62.3 -41.67 98.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -64.79 -41.8 95.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.673 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.27 96.2 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.599 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 27.7 mt -67.79 -40.76 83.88 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.679 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.5 t -62.2 -43.86 97.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.554 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -65.68 -41.4 92.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.004 0.431 . . . . 0.0 110.687 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.12 -48.84 77.67 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.684 ' NH2' HH21 ' A' ' 307' ' ' ARG . 66.7 mtt85 -61.36 -53.62 54.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.694 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.87 -30.22 65.65 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.463 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 5.5 tp-100 -75.45 -46.39 32.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.704 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.641 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 20.4 m -56.77 -37.19 70.75 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.996 0.903 . . . . 0.0 109.872 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 256' ' ' ARG . 44.8 t -71.07 -63.02 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.771 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 276' ' ' ALA . 17.0 t -46.36 -63.84 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.731 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.641 ' OD1' ' O ' ' A' ' 259' ' ' SER . 28.6 p-10 -45.22 -38.72 5.64 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.079 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.524 ' N ' ' OD1' ' A' ' 262' ' ' ASP . 84.1 t80 -80.74 -31.94 35.84 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.981 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 260' ' ' VAL . 0.5 OUTLIER -70.27 -9.15 55.14 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.561 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.487 ' C ' ' H ' ' A' ' 267' ' ' LYS . 68.9 mt -86.83 -54.79 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.816 0.341 . . . . 0.0 111.744 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 39.0 m -51.59 -7.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.19 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 218' ' ' ASP . 0.0 OUTLIER -78.82 -11.34 59.99 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 109.52 39.49 1.61 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.98 130.19 23.84 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 117.173 0.487 . . . . 0.0 109.751 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.94 132.55 50.37 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 121.253 1.302 . . . . 0.0 112.4 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.33 -13.27 60.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.682 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -90.46 -17.45 27.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.484 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.51 -25.62 35.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.728 0.775 . . . . 0.0 110.413 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 2.3 pt -100.3 -178.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.548 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 7.7 t -162.17 126.48 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.613 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -97.58 113.97 25.79 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.887 0.375 . . . . 0.0 110.803 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -129.14 156.33 44.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.797 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.48 152.09 16.98 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.432 ' N ' ' O ' ' A' ' 238' ' ' GLY . 6.5 tpt -118.11 -10.36 10.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.961 0.41 . . . . 0.0 110.242 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 60.28 -107.79 1.5 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.485 ' CD ' ' N ' ' A' ' 281' ' ' GLU . 1.0 OUTLIER -141.02 71.31 1.36 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.897 0.379 . . . . 0.0 110.235 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 72.8 m -93.44 7.42 44.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -160.98 70.72 2.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.94 105.74 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.35 2.033 . . . . 0.0 112.645 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 286' ' ' THR . 15.1 m -64.28 -42.06 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.572 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.589 ' O ' ' N ' ' A' ' 288' ' ' ASN . 40.8 p -58.27 -45.67 87.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.102 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -43.95 -10.37 0.01 OUTLIER Glycine 0 CA--C 1.533 1.179 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 286' ' ' THR . 87.7 m-20 -129.77 -54.23 1.14 Allowed 'General case' 0 C--O 1.231 0.098 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 m -58.33 -44.22 88.57 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.103 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -107.13 33.09 4.16 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.004 0.43 . . . . 0.0 109.903 -179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 293' ' ' VAL . 28.9 t0 -56.94 -42.65 80.46 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.447 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -75.08 33.18 0.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.502 HG21 ' SG ' ' A' ' 290' ' ' CYS . 15.5 t -131.91 113.51 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.943 0.401 . . . . 0.0 110.343 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -118.51 14.65 13.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.926 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -99.62 130.82 45.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.011 0.434 . . . . 0.0 110.166 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -50.47 -67.32 0.27 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.273 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.89 -38.31 61.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.72 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.96 89.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.332 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 60.3 mt -75.19 -50.25 16.85 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.878 0.37 . . . . 0.0 110.652 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 78.1 mt -52.72 -32.74 17.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.227 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -78.07 -46.22 21.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.924 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 11.9 t -70.64 -13.1 61.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.637 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 35.9 mt -92.58 24.47 3.5 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.398 0.437 . . . . 0.0 111.453 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 305' ' ' PRO . . . -78.45 -45.45 2.05 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.397 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 35.7 Cg_endo -69.28 8.7 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.203 1.935 . . . . 0.0 111.586 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 306' ' ' ASP . 9.4 t70 -104.76 9.76 34.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.228 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.684 HH21 ' NH2' ' A' ' 256' ' ' ARG . 38.6 mtp180 -107.76 116.39 31.86 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.212 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.485 ' NH2' ' OG1' ' A' ' 195' ' ' THR . 15.7 ptm180 -175.67 -171.31 0.46 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 34.5 m -144.77 154.16 14.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.493 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 95.2 mt-10 -121.7 105.25 10.24 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.044 0.45 . . . . 0.0 110.925 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.44 HD13 HG13 ' A' ' 236' ' ' VAL . 3.9 mm -80.54 116.71 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.488 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -99.63 119.6 38.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.774 0.321 . . . . 0.0 110.369 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 224' ' ' LEU . 2.5 t -118.94 120.53 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.653 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 8.3 tttm -118.93 141.13 48.93 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.22 -22.55 40.17 Favored Glycine 0 N--CA 1.469 0.88 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.551 ' CG1' ' H ' ' A' ' 317' ' ' LYS . 14.6 tt -56.47 176.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.551 ' H ' ' CG1' ' A' ' 316' ' ' ILE . 49.5 tttt -54.81 -147.65 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.522 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 44.1 t0 -162.15 151.73 16.11 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 4.0 p -138.81 139.45 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 56.5 t -122.03 129.75 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 322' ' ' GLN . 53.0 m -99.64 162.64 12.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.903 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.53 ' N ' HG22 ' A' ' 321' ' ' THR . 18.2 tt0 -118.39 85.36 25.49 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.013 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.98 -39.19 79.95 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.32 2.013 . . . . 0.0 112.261 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.421 ' O ' ' OXT' ' A' ' 325' ' ' ALA . 59.6 tt0 -156.54 -64.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.62 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' A' ' 324' ' ' GLN . . . . . . . . 0 C--O 1.218 -0.553 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.567 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.448 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 44.9 Cg_endo -67.01 153.7 77.02 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.733 2.288 . . . . 0.0 111.963 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -173.85 61.41 0.25 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.613 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.89 43.22 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.722 2.281 . . . . 0.0 111.868 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 60.44 72.87 0.68 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.471 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.52 145.71 98.27 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.813 2.342 . . . . 0.0 111.955 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.463 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -162.29 52.64 0.38 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.614 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 41.9 Cg_endo -67.17 -19.76 50.45 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.752 2.302 . . . . 0.0 111.927 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -60.42 159.38 10.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.47 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 85.7 t -107.22 134.22 49.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.913 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -118.26 100.21 7.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.165 0.507 . . . . 0.0 110.463 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.564 HG22 ' CE1' ' A' ' 193' ' ' HIS . 12.2 m -77.16 140.01 40.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.53 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -147.36 117.83 7.45 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.029 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 193' ' ' HIS . 0.2 OUTLIER -103.29 150.52 23.67 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.611 ' CE2' ' NE2' ' A' ' 223' ' ' GLN . 41.1 m-85 -111.76 121.92 46.39 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.798 0.332 . . . . 0.0 110.184 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.59 101.72 12.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.709 ' CD2' HD11 ' A' ' 201' ' ' LEU . 34.4 tp -104.28 132.52 50.44 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.996 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.408 ' HB3' HG23 ' A' ' 200' ' ' VAL . 2.1 ttmp? -78.2 127.04 31.67 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 121.897 0.856 . . . . 0.0 111.893 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 202' ' ' PHE . 39.2 t -63.75 -33.22 75.17 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.035 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -59.56 -38.75 81.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.259 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 197' ' ' LYS . 62.0 t -63.21 -46.17 96.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.709 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.3 mt -75.56 -76.34 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.659 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.484 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -130.7 143.5 50.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.363 -179.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.468 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 46.5 t30 -129.77 -72.87 0.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.272 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -76.34 -37.94 56.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -71.92 165.12 24.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.445 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -57.67 -68.03 0.28 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.589 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.12 57.18 0.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.457 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 18.8 p -106.43 130.06 54.3 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.84 139.22 44.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.78 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 213' ' ' GLY . 30.7 mtmt -101.17 159.66 28.85 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 210' ' ' LYS . 86.3 Cg_exo -34.25 -77.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.387 2.058 . . . . 0.0 112.104 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.72 -20.29 1.2 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.173 0.511 . . . . 0.0 110.424 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.83 -49.69 16.61 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -67.9 -39.19 83.65 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.19 0.519 . . . . 0.0 109.807 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.29 -53.17 60.44 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.537 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.51 91.34 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.43 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.9 mt -62.45 -26.34 68.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.502 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -73.01 -46.08 54.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.612 0.72 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -63.65 -40.25 96.38 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.462 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.639 HD12 HE21 ' A' ' 223' ' ' GLN . 55.7 tp -61.08 -40.09 92.39 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.512 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 49.4 t80 -54.87 -58.33 8.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.535 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 15.4 m -58.94 -6.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.361 0.601 . . . . 0.0 110.788 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.639 HE21 HD12 ' A' ' 220' ' ' LEU . 4.0 tt0 -94.38 -34.23 12.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.684 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 1.085 HD22 HG21 ' A' ' 313' ' ' VAL . 42.7 mt -96.92 -13.03 22.7 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.809 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.3 t -83.24 -14.93 52.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.724 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -96.71 17.55 16.29 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.446 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -78.18 178.92 7.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.653 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 315' ' ' GLY . 9.4 t70 -94.2 132.03 30.14 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.734 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 230' ' ' LYS . 42.3 Cg_endo -67.92 -20.47 45.07 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.817 2.344 . . . . 0.0 112.837 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 229' ' ' PRO . 40.6 mmtt -33.43 -53.07 0.4 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.055 0.455 . . . . 0.0 110.582 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 99.3 m-20 -102.76 -19.01 14.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.471 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.03 45.23 0.01 OUTLIER Glycine 0 N--CA 1.469 0.879 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 231' ' ' ASP . 28.0 m -112.22 111.38 22.23 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 71.6 t -126.31 94.06 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.761 0.791 . . . . 0.0 110.285 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.4 t -97.22 121.03 47.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.09 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 311' ' ' ILE . 22.0 t -93.13 124.58 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.58 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 277' ' ' ARG . 19.7 mt -109.49 141.34 42.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.974 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -125.16 126.08 5.85 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.31 120.39 42.08 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -178.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 241' ' ' ASP . 2.4 m -108.98 168.53 9.29 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 240' ' ' THR . 52.8 p-10 -95.14 -179.55 4.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.628 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 244' ' ' GLY . 38.6 ttm180 -98.65 127.36 44.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.318 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.711 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.9 mm -118.31 14.2 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.313 0.578 . . . . 0.0 110.667 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.408 ' H ' ' HG2' ' A' ' 242' ' ' ARG . . . 91.87 -3.05 77.19 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 4.2 m -134.01 104.36 6.21 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.998 0.428 . . . . 0.0 110.072 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -55.35 -50.81 68.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.476 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.72 -40.75 76.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.545 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.565 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 48.7 t80 -63.07 -44.56 95.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.293 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.456 HD21 ' H ' ' A' ' 243' ' ' ILE . 27.1 m120 -62.67 -40.4 96.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.279 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -63.93 -43.1 96.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.497 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.468 ' C ' ' NH2' ' A' ' 255' ' ' ARG . . . -62.33 -35.86 92.24 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.789 HD22 HH12 ' A' ' 256' ' ' ARG . 14.4 mt -74.66 -35.91 62.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.499 -0.35 . . . . 0.0 111.084 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.4 p -64.64 -41.06 96.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.979 0.418 . . . . 0.0 110.512 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -70.36 -44.48 68.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.178 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.468 ' NH2' ' C ' ' A' ' 251' ' ' GLY . 63.5 mtm-85 -56.55 -46.78 80.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.803 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.789 HH12 HD22 ' A' ' 252' ' ' LEU . 67.2 mtt85 -60.46 -62.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.611 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.72 -34.78 19.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.104 0.478 . . . . 0.0 109.881 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -72.86 -46.07 54.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.406 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 61.5 m -60.11 -38.07 81.9 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.073 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.1 t -64.06 -50.8 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.331 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.58 HG13 HD12 ' A' ' 274' ' ' ILE . 9.5 t -62.31 -48.36 88.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.434 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.44 -41.86 21.22 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.061 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.637 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 85.5 t80 -79.39 -34.62 41.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.628 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -64.76 -29.48 70.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.966 -179.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 267' ' ' LYS . 82.4 mt -68.73 -50.16 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 111.88 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 44.6 m -50.76 -8.51 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.906 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.637 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 11.4 mmtp -84.6 2.28 42.18 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.006 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.08 40.81 4.48 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.41 129.0 25.05 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.332 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.06 127.31 25.18 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.862 1.708 . . . . 0.0 111.725 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.22 -8.78 34.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.896 0.379 . . . . 0.0 111.341 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 64.7 t0 -91.86 -22.73 19.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.782 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -80.83 -19.16 45.21 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.486 0.66 . . . . 0.0 110.78 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.58 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -105.34 -171.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.745 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 1.6 t -168.5 136.27 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.206 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -106.91 110.72 22.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.819 0.342 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.486 ' HB3' HD23 ' A' ' 237' ' ' LEU . 58.9 ttm-85 -117.1 142.73 46.63 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.447 0.642 . . . . 0.0 110.532 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.84 99.62 2.33 Favored Glycine 0 CA--C 1.518 0.231 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.626 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.6 OUTLIER -79.29 9.94 4.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.823 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.548 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 10.26 -95.89 0.01 OUTLIER Glycine 0 N--CA 1.476 1.314 0 O-C-N 123.534 0.521 . . . . 0.0 112.068 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 281' ' ' GLU . 56.1 mp0 -135.68 75.05 1.54 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.835 0.35 . . . . 0.0 110.591 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.429 ' OG ' ' SD ' ' A' ' 279' ' ' MET . 53.8 m -83.65 -3.63 57.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 283' ' ' ASN . 11.4 p-10 -176.42 80.21 0.27 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.593 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.14 107.64 0.27 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.65 2.233 . . . . 0.0 112.214 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 286' ' ' THR . 9.6 m -88.77 -36.63 9.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.524 0.678 . . . . 0.0 110.757 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 286' ' ' THR . 0.2 OUTLIER -60.92 -43.67 98.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.954 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 290' ' ' CYS . . . -45.57 -88.96 0.01 OUTLIER Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.507 ' C ' ' O ' ' A' ' 287' ' ' GLY . 86.6 m-20 -27.61 -53.92 0.09 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.655 0.264 . . . . 0.0 110.35 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.4 m -56.06 -47.04 78.7 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.478 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.621 ' N ' ' O ' ' A' ' 287' ' ' GLY . 0.3 OUTLIER -98.37 34.19 2.05 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 109.928 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 293' ' ' VAL . 51.5 t0 -57.98 -42.61 85.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.447 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -75.43 32.32 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.569 HG21 ' SG ' ' A' ' 290' ' ' CYS . 21.2 t -131.18 113.14 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.92 0.391 . . . . 0.0 110.665 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -118.97 14.22 13.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.605 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.446 ' O ' HD12 ' A' ' 299' ' ' LEU . 1.6 mt-30 -86.65 166.9 14.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.111 0.481 . . . . 0.0 110.308 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -78.78 -67.36 0.75 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.532 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . 0.421 ' O ' ' CG ' ' A' ' 301' ' ' ASP . . . -61.77 -27.33 68.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.223 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.588 ' O ' ' OD1' ' A' ' 301' ' ' ASP . . . -71.99 -24.26 61.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.156 0.503 . . . . 0.0 110.933 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 295' ' ' GLN . 71.2 mt -86.69 -48.11 8.57 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.66 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 93.4 mt -59.74 -31.8 48.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.054 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.588 ' OD1' ' O ' ' A' ' 298' ' ' ALA . 43.3 p-10 -82.95 -43.77 16.08 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.602 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.574 ' N ' ' OD1' ' A' ' 301' ' ' ASP . 13.1 t -74.86 -13.77 60.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.156 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 35.4 mt -87.39 21.07 2.58 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.514 0.509 . . . . 0.0 110.466 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.626 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -72.73 -41.01 6.91 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.0 Cg_exo -58.94 7.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.464 2.776 . . . . 0.0 112.47 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 304' ' ' ALA . 45.8 t0 -108.18 7.51 27.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.871 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.468 ' NH1' ' OD1' ' A' ' 203' ' ' ASN . 62.4 mtm180 -112.66 86.4 2.36 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.454 0.645 . . . . 0.0 109.376 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.546 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 11.0 ptp180 -156.7 130.48 8.3 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.174 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.64 139.69 18.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -122.5 103.41 8.69 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.317 0.58 . . . . 0.0 110.42 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.505 HG23 HG22 ' A' ' 236' ' ' VAL . 0.8 OUTLIER -79.46 117.89 25.97 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -94.9 121.51 36.57 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.642 0.258 . . . . 0.0 110.891 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 1.085 HG21 HD22 ' A' ' 224' ' ' LEU . 54.6 t -122.95 117.89 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -114.27 133.87 55.34 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 102.25 18.84 15.79 Favored Glycine 0 C--O 1.22 -0.759 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 20.2 tt -105.29 146.81 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 110.644 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -123.23 163.29 20.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.848 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -162.95 175.01 11.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.973 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 320' ' ' VAL . 5.4 p -77.48 160.7 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.51 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.531 ' N ' HG22 ' A' ' 319' ' ' VAL . 34.6 m -63.82 137.03 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.271 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.618 HG22 ' N ' ' A' ' 322' ' ' GLN . 99.0 m -124.1 164.65 19.0 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.463 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.618 ' N ' HG22 ' A' ' 321' ' ' THR . 23.3 mp0 -65.47 148.17 98.22 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 325' ' ' ALA . 55.8 Cg_endo -70.09 -11.82 31.11 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.564 2.176 . . . . 0.0 112.035 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -67.66 61.93 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.692 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 323' ' ' PRO . . . . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.547 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.682 ' HB3' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.682 ' CD ' ' HB3' ' A' ' 180' ' ' ALA . 25.6 Cg_endo -60.36 -29.47 88.9 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.525 2.15 . . . . 0.0 111.855 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.689 ' HB1' ' HD2' ' A' ' 183' ' ' PRO . . . -52.28 175.1 0.1 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.689 ' HD2' ' HB1' ' A' ' 182' ' ' ALA . 46.1 Cg_exo -55.56 138.12 79.78 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.417 2.078 . . . . 0.0 112.014 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -72.97 151.49 90.65 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.512 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 186' ' ' ALA . 51.9 Cg_endo -69.05 152.02 73.06 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.876 2.384 . . . . 0.0 111.92 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . 176.28 -46.4 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.272 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 47.9 Cg_exo -54.7 -38.81 91.28 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.567 2.178 . . . . 0.0 112.183 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 188' ' ' GLU . 56.0 mp0 -84.12 147.66 27.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.316 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.07 137.99 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.179 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -122.93 127.01 48.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.8 m -77.91 142.03 38.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.131 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.5 ' O ' ' CD2' ' A' ' 193' ' ' HIS . 21.5 tptt -114.42 166.83 11.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.123 0.487 . . . . 0.0 110.553 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 192' ' ' LYS . 53.2 m80 -155.74 124.21 5.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.836 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.617 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 60.2 m-85 -113.66 120.13 39.82 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.15 103.66 14.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.08 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.708 ' CD2' HD11 ' A' ' 201' ' ' LEU . 28.8 tp -105.11 124.24 49.2 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -78.67 129.33 34.6 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 121.897 0.856 . . . . 0.0 112.206 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.0 t -62.3 -32.99 73.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.026 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -54.88 -35.94 64.6 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.085 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 71.0 t -71.48 -38.77 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.878 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.708 HD11 ' CD2' ' A' ' 196' ' ' LEU . 91.8 mt -84.41 -80.59 0.2 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.808 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -124.55 133.16 53.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.076 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.447 ' N ' ' OD1' ' A' ' 203' ' ' ASN . 1.6 m-20 -104.27 -71.11 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.567 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -107.49 -16.48 14.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.808 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.528 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 26.6 t30 -71.9 170.13 14.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.062 0.458 . . . . 0.0 110.241 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -52.49 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.491 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.475 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -162.19 4.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.503 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.528 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 76.8 p -55.02 144.89 21.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.014 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 28.0 mt -88.96 133.2 34.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 213' ' ' GLY . 1.5 mptm? -90.74 157.77 43.35 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.975 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -34.1 -74.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.636 2.224 . . . . 0.0 111.828 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -50.41 -21.63 1.53 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.076 0.465 . . . . 0.0 110.048 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.95 -50.27 13.83 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -66.36 -39.2 89.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.305 0.574 . . . . 0.0 110.151 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.3 -54.31 48.24 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.555 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.29 -38.42 91.07 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.703 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.9 mt -61.59 -27.36 68.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.503 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -74.21 -46.67 40.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.202 0.525 . . . . 0.0 110.443 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -61.77 -43.12 99.48 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.209 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 48.2 tp -66.8 -39.11 87.64 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.442 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.435 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.7 t80 -53.57 -49.37 67.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.849 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.7 t -58.11 -51.04 71.38 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.45 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.617 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 9.2 tt0 -52.18 -26.02 10.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.258 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.982 HD22 HG21 ' A' ' 313' ' ' VAL . 72.0 mt -96.13 -17.96 20.48 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.507 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.1 t -78.47 -17.6 56.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.758 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -97.36 20.67 11.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.785 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.522 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -80.16 178.12 8.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.861 179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -96.04 133.79 24.72 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.495 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.0 Cg_endo -69.75 -18.6 36.95 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.813 2.342 . . . . 0.0 112.356 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 229' ' ' PRO . 56.4 tttp -36.22 -53.66 0.81 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.457 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 232' ' ' GLY . 36.2 m-20 -100.79 -21.59 15.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.65 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.95 50.45 0.05 OUTLIER Glycine 0 N--CA 1.471 1.003 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.5 m -117.65 111.28 18.95 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 122.671 -0.311 . . . . 0.0 110.398 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 99.0 t -129.0 93.9 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.214 0.531 . . . . 0.0 110.145 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.6 t -98.27 123.4 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.621 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 311' ' ' ILE . 95.3 t -95.36 127.85 47.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.641 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 39.1 mt -111.58 142.44 43.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.662 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -118.94 139.42 14.36 Favored Glycine 0 N--CA 1.48 1.587 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.4 OUTLIER -121.14 121.58 38.15 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.453 HG22 ' NH2' ' A' ' 256' ' ' ARG . 2.6 p -112.09 165.3 12.25 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.987 0.422 . . . . 0.0 110.236 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 241' ' ' ASP . 11.3 p30 -87.82 -177.79 5.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.443 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -105.18 120.23 41.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.052 0.453 . . . . 0.0 110.288 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.3 mm -119.09 15.02 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.399 0.619 . . . . 0.0 110.83 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.5 9.03 87.32 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.7 p -134.45 97.19 3.75 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.894 0.378 . . . . 0.0 110.334 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -52.57 -52.48 54.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.647 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.9 72.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.685 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.58 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 56.3 t80 -60.19 -46.75 88.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.524 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.437 HD21 ' H ' ' A' ' 243' ' ' ILE . 91.0 m-20 -61.9 -42.63 99.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.569 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -63.36 -42.54 98.89 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.553 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.68 -36.08 92.15 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.58 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 32.5 mt -74.28 -32.98 63.12 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.704 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 12.0 m -65.36 -43.69 90.03 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.177 0.513 . . . . 0.0 110.598 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -70.42 -35.23 73.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.928 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -59.86 -50.04 75.34 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.549 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.858 ' O ' HG23 ' A' ' 260' ' ' VAL . 16.4 ptp180 -67.16 -47.52 70.77 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.406 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.83 -39.74 92.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.194 0.521 . . . . 0.0 110.189 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -74.6 -45.51 44.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.16 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 46.5 t -60.65 -38.54 85.2 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.084 0.469 . . . . 0.0 110.238 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.6 t -64.92 -52.06 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.557 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.6 HG13 HD12 ' A' ' 274' ' ' ILE . 18.2 t -61.37 -49.11 85.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.326 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -44.96 -41.83 7.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.961 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -82.53 -30.31 29.83 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -72.34 -7.56 50.23 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.371 -179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 267' ' ' LYS . 61.2 mt -88.05 -54.7 7.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 72.8 m -51.22 -5.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.6 OUTLIER -79.7 -11.4 59.85 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.894 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.46 39.11 1.97 Allowed Glycine 0 C--N 1.323 -0.174 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.99 127.89 24.29 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.43 128.01 24.29 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.145 1.897 . . . . 0.0 112.273 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.09 -7.9 20.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.716 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -93.03 -24.41 18.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.88 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -78.53 -21.76 48.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.563 0.697 . . . . 0.0 110.587 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.6 HD12 HG13 ' A' ' 261' ' ' VAL . 1.4 pt -102.23 -173.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.865 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 26.3 t -171.61 132.49 0.75 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.484 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.89 153.08 19.45 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -158.49 144.72 17.1 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.091 0.472 . . . . 0.0 110.804 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.98 97.35 2.06 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.462 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.5 tpt -68.46 -10.68 56.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.907 0.384 . . . . 0.0 110.462 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 45.07 -104.62 0.07 OUTLIER Glycine 0 CA--C 1.521 0.413 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.07 70.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.916 0.389 . . . . 0.0 110.548 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 14.1 m -88.82 -0.16 57.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.585 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 283' ' ' ASN . 0.1 OUTLIER -169.5 76.66 0.69 Allowed Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.675 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.76 111.32 3.26 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.536 2.158 . . . . 0.0 111.798 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.476 HG23 ' N ' ' A' ' 286' ' ' THR . 15.5 m -71.52 -39.46 70.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.86 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.625 ' C ' ' H ' ' A' ' 288' ' ' ASN . 21.1 p -63.68 -48.2 78.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.479 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.71 -0.53 0.03 OUTLIER Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.625 ' H ' ' C ' ' A' ' 286' ' ' THR . 65.8 t30 -114.0 -60.17 1.92 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.8 t -79.04 -3.86 47.25 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.569 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.4 OUTLIER -127.32 18.22 7.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.531 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 30.1 p-10 -67.57 -3.08 7.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.378 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -99.89 33.41 2.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.451 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.488 HG21 ' SG ' ' A' ' 290' ' ' CYS . 26.6 t -127.95 122.87 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.889 0.376 . . . . 0.0 110.231 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -119.59 6.5 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.824 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.9 168.39 12.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.057 0.456 . . . . 0.0 110.168 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -80.02 -74.89 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.758 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' A' ' 300' ' ' ILE . . . -55.92 -26.46 47.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.818 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.89 -34.69 78.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.146 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.2 mt -75.46 -64.71 1.01 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 297' ' ' ALA . 10.9 pt -48.41 -30.24 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.396 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -76.62 -42.66 41.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.567 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 15.3 t -80.45 -10.54 59.74 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.73 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.52 HD23 ' OG1' ' A' ' 286' ' ' THR . 54.2 mt -91.95 21.81 4.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.69 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -76.61 -45.12 3.25 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 121.156 0.503 . . . . 0.0 110.375 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 25.2 Cg_exo -61.81 9.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.233 2.622 . . . . 0.0 111.654 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 304' ' ' ALA . 51.0 t0 -106.49 11.08 31.1 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.623 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -111.25 103.26 11.65 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.349 0.595 . . . . 0.0 110.402 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -172.17 153.48 3.09 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.222 -179.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.662 HG12 ' HA2' ' A' ' 238' ' ' GLY . 34.7 m -116.16 149.69 18.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -120.22 107.77 13.39 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.089 0.471 . . . . 0.0 110.839 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 236' ' ' VAL . 3.5 mm -78.37 117.95 24.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -100.74 111.59 23.84 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.301 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.982 HG21 HD22 ' A' ' 224' ' ' LEU . 86.6 t -119.63 123.65 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 O-C-N 123.66 0.6 . . . . 0.0 110.644 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -119.63 140.54 50.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.777 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 101.39 -0.35 53.63 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.8 tt -85.46 144.29 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.064 0.459 . . . . 0.0 110.485 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -85.6 130.33 34.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.435 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -92.12 109.49 20.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.601 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 321' ' ' THR . 4.3 m -107.02 174.58 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.058 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 2.5 m -95.27 90.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.059 0.457 . . . . 0.0 110.378 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 321' ' ' THR . 6.8 t -152.36 112.82 4.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.137 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -93.33 117.38 67.4 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.789 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.57 -17.05 23.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.492 2.128 . . . . 0.0 112.219 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -97.61 124.58 41.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.408 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.596 179.929 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.23 113.8 3.65 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.502 2.135 . . . . 0.0 112.21 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.565 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . . . -86.41 -45.96 0.56 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.171 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 182' ' ' ALA . 73.6 Cg_endo -81.98 12.5 2.78 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.636 2.224 . . . . 0.0 112.333 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.638 ' HB3' ' CD ' ' A' ' 185' ' ' PRO . . . -39.11 -61.34 0.97 Allowed Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.367 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.638 ' CD ' ' HB3' ' A' ' 184' ' ' ALA . 27.2 Cg_endo -60.33 145.41 98.68 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.374 2.049 . . . . 0.0 111.862 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -173.55 89.68 0.37 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.335 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.0 139.1 61.79 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.411 2.074 . . . . 0.0 112.06 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -93.7 159.82 15.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.545 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 12.3 t -75.08 141.79 15.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.239 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -114.72 89.53 3.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.34 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.589 HG22 ' N ' ' A' ' 192' ' ' LYS . 23.6 m -69.52 169.35 12.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.46 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.589 ' N ' HG22 ' A' ' 191' ' ' THR . 3.4 tptm -148.83 166.23 29.13 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.083 0.468 . . . . 0.0 110.083 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.502 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 12.8 m80 -153.5 123.93 7.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.756 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -112.09 115.6 29.15 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.434 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.07 103.14 14.46 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.775 -179.239 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.695 ' CD2' HD11 ' A' ' 201' ' ' LEU . 30.2 tp -108.72 132.93 53.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.413 ' HB3' HG23 ' A' ' 200' ' ' VAL . 0.0 OUTLIER -83.76 126.58 33.05 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.244 -178.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.4 m -62.02 -32.35 72.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.332 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.491 ' OD1' ' NH1' ' A' ' 307' ' ' ARG . 11.8 m-20 -59.31 -36.52 75.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.81 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 197' ' ' LYS . 94.9 t -68.19 -42.91 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.695 HD11 ' CD2' ' A' ' 196' ' ' LEU . 92.7 mt -78.35 -79.48 0.12 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.244 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.427 ' CD1' ' NH1' ' A' ' 256' ' ' ARG . 0.1 OUTLIER -118.04 122.84 44.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.764 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 8.9 p-10 -91.32 -78.09 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.628 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.503 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 82.5 m-85 -98.0 -14.94 20.29 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.809 0.337 . . . . 0.0 110.659 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -72.61 154.54 40.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.235 0.54 . . . . 0.0 109.718 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.56 ' CG ' ' H ' ' A' ' 207' ' ' ALA . 42.2 pttt -49.8 -59.98 3.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.987 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.56 ' H ' ' CG ' ' A' ' 206' ' ' LYS . . . -168.71 57.18 0.05 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.603 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 64.4 p -107.23 129.92 54.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.7 mt -74.48 146.22 42.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.719 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 213' ' ' GLY . 22.7 mttp -105.87 158.5 32.28 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.946 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -33.85 -76.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.495 2.13 . . . . 0.0 112.231 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -52.62 -18.98 2.03 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.251 0.548 . . . . 0.0 110.16 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.38 -49.37 9.39 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -67.27 -40.8 86.23 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.186 0.517 . . . . 0.0 109.77 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.68 -50.89 71.7 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.589 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.26 86.58 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.635 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.1 mt -62.25 -31.37 71.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.58 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -70.17 -45.3 67.0 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.291 0.567 . . . . 0.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -63.06 -42.78 99.76 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.927 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.495 HD12 HE21 ' A' ' 223' ' ' GLN . 38.8 tp -63.87 -40.28 96.17 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.521 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.508 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.3 t80 -52.65 -47.3 67.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.534 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.7 m -52.27 -51.94 55.64 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.67 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.495 HE21 HD12 ' A' ' 220' ' ' LEU . 15.6 mt-30 -55.43 -26.4 41.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.469 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.559 ' O ' HD22 ' A' ' 227' ' ' LEU . 67.4 mt -94.01 -23.85 17.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.675 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.1 t -75.79 -32.36 59.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.279 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -91.94 21.37 4.98 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.7 OUTLIER -77.34 173.46 11.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.199 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -88.35 133.7 36.1 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.457 ' O ' ' C ' ' A' ' 230' ' ' LYS . 55.0 Cg_endo -70.56 -18.22 33.38 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.569 2.179 . . . . 0.0 112.709 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 229' ' ' PRO . 11.1 mmtp -28.03 -49.22 0.06 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.594 0.559 . . . . 0.0 110.498 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 67.5 m-20 -118.51 -14.66 9.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.377 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.79 51.27 0.06 OUTLIER Glycine 0 N--CA 1.47 0.929 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.4 m -114.68 110.7 20.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.668 0.271 . . . . 0.0 110.99 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.32 95.67 3.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.811 0.815 . . . . 0.0 109.692 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.11 117.75 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.642 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.495 HG21 ' CG2' ' A' ' 261' ' ' VAL . 24.5 t -93.14 124.17 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.635 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.7 mt -108.6 137.79 45.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.065 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.613 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -120.52 132.42 9.26 Favored Glycine 0 N--CA 1.479 1.508 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -116.64 126.52 53.35 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.473 HG23 ' OD1' ' A' ' 249' ' ' ASN . 8.0 t -125.14 162.25 25.05 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -77.35 -175.82 3.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.224 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 10.1 ptm85 -120.01 133.74 55.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.369 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.7 mm -118.42 24.14 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.582 0.706 . . . . 0.0 110.626 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 80.93 14.49 79.42 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.0 m -137.37 98.94 3.83 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.083 0.468 . . . . 0.0 110.005 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -52.23 -50.41 62.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.295 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.38 -45.65 80.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.939 0.4 . . . . 0.0 110.709 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.629 ' CE2' HD11 ' A' ' 252' ' ' LEU . 52.1 t80 -60.23 -41.67 93.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.349 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.531 HD21 ' CA ' ' A' ' 280' ' ' GLY . 0.6 OUTLIER -60.12 -50.73 72.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.623 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -57.0 -41.5 78.59 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.46 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.41 -41.32 98.49 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.629 HD11 ' CE2' ' A' ' 248' ' ' TYR . 35.6 mt -67.31 -41.03 86.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.913 0.387 . . . . 0.0 111.274 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.5 t -61.42 -40.23 93.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.999 0.428 . . . . 0.0 110.889 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.52 -42.18 78.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.232 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -58.6 -46.54 86.79 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.472 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.427 ' NH1' ' CD1' ' A' ' 202' ' ' PHE . 86.6 mtt-85 -63.92 -62.44 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.772 0.32 . . . . 0.0 110.774 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.39 -35.71 19.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.042 0.449 . . . . 0.0 110.168 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.32 -45.49 59.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.585 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 13.3 t -59.62 -39.06 83.03 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.243 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.28 -52.83 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.414 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.592 HG13 HD12 ' A' ' 274' ' ' ILE . 5.1 t -61.54 -49.27 85.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.215 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -44.7 -42.78 7.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.14 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.638 ' CZ ' ' NZ ' ' A' ' 267' ' ' LYS . 62.2 t80 -80.41 -28.92 37.73 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.766 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -75.0 -4.53 38.84 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.102 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.576 ' HA ' HG22 ' A' ' 269' ' ' ILE . 55.3 mt -86.23 -52.94 11.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.7 p -54.47 -1.83 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.576 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.638 ' NZ ' ' CZ ' ' A' ' 263' ' ' TYR . 9.7 mptt -87.53 2.56 50.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.704 0.288 . . . . 0.0 110.703 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 89.81 38.31 6.56 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 265' ' ' ILE . 1.2 tp -119.16 120.29 31.23 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -49.09 128.03 18.65 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.173 1.249 . . . . 0.0 112.116 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.04 -16.23 50.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.114 0.483 . . . . 0.0 111.034 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 4.4 m-20 -85.25 -22.62 28.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.077 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -23.5 38.99 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.209 0.528 . . . . 0.0 110.545 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.592 HD12 HG13 ' A' ' 261' ' ' VAL . 1.5 pt -101.98 -174.84 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.985 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 34.8 m -168.96 127.33 1.02 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.224 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.17 110.52 23.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 110.413 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.546 ' NH1' ' SD ' ' A' ' 279' ' ' MET . 73.8 ttt-85 -115.29 139.74 49.71 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.433 0.635 . . . . 0.0 110.985 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.96 95.18 2.06 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.546 ' SD ' ' NH1' ' A' ' 277' ' ' ARG . 3.8 tpt -69.81 -10.63 59.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.665 0.269 . . . . 0.0 110.598 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.531 ' CA ' HD21 ' A' ' 249' ' ' ASN . . . 41.75 -102.36 0.03 OUTLIER Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -141.65 75.58 1.5 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.784 0.326 . . . . 0.0 110.813 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 18.0 m -87.04 0.16 55.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.741 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.491 ' C ' HD22 ' A' ' 283' ' ' ASN . 0.4 OUTLIER -168.16 75.88 0.87 Allowed Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.47 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -60.82 104.14 0.26 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.554 2.17 . . . . 0.0 112.529 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 286' ' ' THR . 28.4 m -69.1 -44.44 81.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.306 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 302' ' ' CYS . 7.6 p -62.49 -46.21 89.48 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.09 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.93 -1.83 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 286' ' ' THR . 28.3 m120 -115.57 -59.36 2.01 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.1 t -80.88 -3.41 51.19 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.71 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.59 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.6 OUTLIER -127.61 16.89 6.97 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.343 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 31.6 p-10 -68.0 -3.06 8.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.986 0.422 . . . . 0.0 110.592 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -100.23 32.45 2.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.706 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.59 HG21 ' SG ' ' A' ' 290' ' ' CYS . 15.6 t -130.78 125.65 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.027 0.442 . . . . 0.0 110.304 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.92 10.64 12.31 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.12 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -104.06 136.28 43.99 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.099 0.475 . . . . 0.0 110.242 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 297' ' ' ALA . 0.1 OUTLIER -61.53 -46.37 90.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.941 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . 0.415 ' H ' ' HG3' ' A' ' 296' ' ' ARG . . . -62.68 -46.06 89.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.107 0.48 . . . . 0.0 111.183 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.98 -29.83 70.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.789 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 39.5 mt -78.17 -53.42 7.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.961 0.41 . . . . 0.0 110.535 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 40.0 mt -51.08 -34.81 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.922 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.9 -43.1 22.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.07 0.462 . . . . 0.0 110.315 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.608 ' O ' HG21 ' A' ' 286' ' ' THR . 38.9 t -73.93 -13.56 60.91 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.775 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 299' ' ' LEU . 53.5 mt -90.45 23.16 3.08 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.291 0.369 . . . . 0.0 111.07 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -77.39 -44.35 2.62 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.457 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.8 Cg_exo -62.47 9.35 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.416 2.744 . . . . 0.0 111.807 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 304' ' ' ALA . 0.4 OUTLIER -104.28 10.32 35.61 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.71 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.491 ' NH1' ' OD1' ' A' ' 199' ' ' ASP . 39.2 mtm105 -113.96 94.81 5.0 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.494 0.664 . . . . 0.0 110.195 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.452 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.3 ptm180 -164.08 139.15 5.95 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.136 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.613 HG12 ' HA2' ' A' ' 238' ' ' GLY . 22.6 m -104.69 144.57 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 121.831 -0.543 . . . . 0.0 109.666 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -121.45 106.26 11.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.131 0.491 . . . . 0.0 110.342 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.452 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.38 118.21 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.796 -177.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 312' ' ' GLU . 0.1 OUTLIER -96.43 135.62 38.05 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.403 HG21 ' CD2' ' A' ' 224' ' ' LEU . 2.2 t -133.38 120.22 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.236 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -117.29 132.34 56.63 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.6 -13.85 50.44 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 20.1 tt -75.38 154.12 6.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.827 0.346 . . . . 0.0 110.487 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -128.02 167.91 16.05 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.474 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 192' ' ' LYS . 33.0 m-20 -160.61 172.83 16.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.502 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.94 151.21 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.301 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 14.2 p -109.83 135.23 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.17 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 43.6 p -129.65 164.54 23.68 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.306 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.448 ' CD ' ' N ' ' A' ' 322' ' ' GLN . 6.0 mp0 -80.84 149.2 66.79 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.827 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.93 150.51 73.26 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.421 2.081 . . . . 0.0 112.106 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -156.32 116.51 3.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.398 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.491 179.866 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 40.6 Cg_endo -66.98 -22.77 47.64 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.927 2.418 . . . . 0.0 111.883 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 184' ' ' ALA . . . -155.82 75.18 5.03 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.544 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.8 85.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.554 2.169 . . . . 0.0 112.163 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.605 ' N ' ' CD ' ' A' ' 185' ' ' PRO . . . -95.75 -43.35 0.27 Allowed Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.138 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 184' ' ' ALA . 38.2 Cg_exo -59.31 142.44 99.11 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.524 2.149 . . . . 0.0 112.06 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.3 116.05 65.95 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.333 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.23 -77.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.079 1.852 . . . . 0.0 112.194 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -168.95 154.12 6.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.099 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 66.1 t -121.06 140.63 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.032 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.41 ' OE1' ' N ' ' A' ' 318' ' ' ASP . 2.0 pt20 -122.87 117.22 25.09 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.477 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.424 HG22 ' NE2' ' A' ' 193' ' ' HIS . 12.1 m -73.18 141.24 47.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.274 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 25.5 tttp -143.46 111.21 5.98 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.4 m-70 -101.39 150.45 23.0 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.577 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 59.6 m-85 -111.28 118.67 36.52 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 195' ' ' THR . 6.9 t -85.26 102.46 13.37 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.837 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.769 HD23 HD11 ' A' ' 201' ' ' LEU . 31.0 tp -105.34 137.26 43.42 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.437 0.637 . . . . 0.0 109.955 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.444 ' H ' ' HG2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -90.06 130.38 36.24 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-O 122.564 1.174 . . . . 0.0 112.021 -178.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 202' ' ' PHE . 7.3 t -60.24 -24.74 65.11 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.255 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -58.31 -43.71 88.28 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.955 0.407 . . . . 0.0 110.423 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.85 -42.7 92.67 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.637 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.769 HD11 HD23 ' A' ' 196' ' ' LEU . 84.9 mt -80.78 -78.36 0.18 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.391 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.47 ' O ' ' OG ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -128.43 102.73 6.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.98 -178.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.494 ' OD1' ' CD2' ' A' ' 204' ' ' PHE . 14.3 t-20 -67.4 -70.38 0.26 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.205 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.494 ' CD2' ' OD1' ' A' ' 203' ' ' ASN . 59.7 m-85 -108.51 -10.96 15.2 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.733 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -69.84 161.56 29.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.038 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -55.9 -75.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.415 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.59 49.74 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.428 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 41.6 p -107.33 128.02 54.08 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.819 0.342 . . . . 0.0 110.193 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.47 HD22 HD22 ' A' ' 201' ' ' LEU . 30.5 mt -73.32 129.57 38.3 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.147 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 213' ' ' GLY . 58.5 mttt -91.6 159.92 37.65 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.696 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 210' ' ' LYS . 71.0 Cg_exo -33.12 -76.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.463 2.109 . . . . 0.0 111.549 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -49.57 -21.97 1.14 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.185 0.517 . . . . 0.0 110.31 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.27 -48.88 22.99 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -65.23 -38.91 91.89 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.91 63.23 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.225 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.33 -30.42 71.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.533 0.682 . . . . 0.0 110.237 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.24 -28.37 65.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.301 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -76.4 -48.54 19.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.32 0.581 . . . . 0.0 111.319 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.432 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 4.9 pt20 -64.02 -42.43 97.12 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.498 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.484 HD21 HD12 ' A' ' 311' ' ' ILE . 45.0 tp -63.96 -42.16 97.36 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.452 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CD1' ' CB ' ' A' ' 267' ' ' LYS . 4.4 t80 -51.4 -50.57 59.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.46 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.6 p -56.96 -50.31 73.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.456 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.577 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 10.5 tt0 -50.65 -25.82 4.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.506 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.686 HD22 HG21 ' A' ' 313' ' ' VAL . 39.0 mt -97.42 -15.27 20.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.479 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 53.4 p -79.76 -10.31 59.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.49 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -107.82 18.77 20.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.499 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.23 173.14 12.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.15 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 6.5 t70 -88.66 132.1 39.71 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 230' ' ' LYS . 57.1 Cg_endo -72.05 -18.8 27.18 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.718 2.279 . . . . 0.0 112.643 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 229' ' ' PRO . 61.9 tttm -32.63 -52.07 0.3 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.635 -177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 232' ' ' GLY . 85.8 m-20 -104.69 -17.94 14.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.579 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 27.41 50.19 0.07 OUTLIER Glycine 0 N--CA 1.474 1.215 0 O-C-N 123.917 0.761 . . . . 0.0 111.333 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 16.7 m -115.97 108.07 15.78 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 122.586 -0.361 . . . . 0.0 110.927 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 74.2 t -124.82 93.61 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.939 0.876 . . . . 0.0 109.926 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.405 HG11 ' NH2' ' A' ' 277' ' ' ARG . 66.5 t -97.7 120.89 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.456 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.572 HG22 HG23 ' A' ' 311' ' ' ILE . 48.6 t -93.36 124.48 45.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.522 HD21 ' NE ' ' A' ' 277' ' ' ARG . 28.8 mt -108.05 139.72 42.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.861 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -121.57 130.01 7.94 Favored Glycine 0 N--CA 1.477 1.38 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.12 119.47 36.51 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.637 HG22 ' N ' ' A' ' 241' ' ' ASP . 98.4 m -109.6 170.45 8.06 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.37 0.419 . . . . 0.0 110.462 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.637 ' N ' HG22 ' A' ' 240' ' ' THR . 26.1 p-10 -83.07 -176.08 6.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.448 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 281' ' ' GLU . 62.4 ttm-85 -105.23 121.96 44.94 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.813 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 243' ' ' ILE . 46.3 mm -119.43 7.44 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.565 0.698 . . . . 0.0 110.813 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 85.62 -47.21 3.77 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.66 91.65 1.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 0.0 109.685 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -45.91 -48.23 16.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.41 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.93 -47.4 82.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.878 0.37 . . . . 0.0 110.61 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.615 ' CE2' HD11 ' A' ' 252' ' ' LEU . 51.7 t80 -62.06 -45.24 94.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.525 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 241' ' ' ASP . 33.2 t30 -61.49 -43.87 98.09 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.652 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -64.76 -41.25 96.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.634 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.49 -36.78 93.65 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.615 HD11 ' CE2' ' A' ' 248' ' ' TYR . 30.5 mt -70.06 -41.17 74.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.915 0.388 . . . . 0.0 111.013 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 78.1 p -65.13 -39.61 93.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.818 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.3 -47.1 71.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.92 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -59.43 -43.84 93.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.799 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 239' ' ' TYR . 39.1 ttm180 -54.1 -61.41 2.32 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.329 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -58.7 -27.57 64.98 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.638 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -69.78 -47.31 63.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.374 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 38.5 m -62.17 -37.93 87.12 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.069 0.461 . . . . 0.0 110.393 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 256' ' ' ARG . 77.4 t -63.65 -53.21 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.723 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.533 HG13 HD12 ' A' ' 274' ' ' ILE . 18.0 t -62.02 -48.77 86.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.669 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -45.16 -41.71 8.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.228 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.638 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 57.7 t80 -82.86 -28.9 29.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.764 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.01 -8.05 54.7 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.437 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.9 mt -88.44 -55.75 6.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 120.789 0.328 . . . . 0.0 111.619 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 41.6 m -50.61 -4.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.974 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.638 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 33.4 mmtm -77.48 -10.55 59.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.743 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 114.74 -7.44 22.09 Favored Glycine 0 C--O 1.227 -0.283 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.06 141.72 47.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.404 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.48 132.28 30.68 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.268 1.979 . . . . 0.0 111.826 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.04 -4.1 19.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.517 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -94.15 -26.24 16.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.451 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -79.55 -17.38 54.13 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.237 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.533 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -104.24 -171.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.695 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 39.4 m -168.68 130.51 1.29 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.311 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.88 111.16 23.57 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.882 0.372 . . . . 0.0 110.627 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.522 ' NE ' HD21 ' A' ' 237' ' ' LEU . 41.4 ttp180 -123.13 148.74 45.38 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.152 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.63 148.83 16.49 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.545 ' N ' ' O ' ' A' ' 238' ' ' GLY . 83.9 mmm -121.99 15.98 10.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 119.335 -0.365 . . . . 0.0 111.554 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 23.32 -88.46 0.01 OUTLIER Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 279' ' ' MET . 0.6 OUTLIER -142.72 74.25 1.44 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.096 0.474 . . . . 0.0 110.738 179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.4 t -72.22 -54.05 10.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.836 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -137.77 74.06 45.92 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.779 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.02 120.39 8.22 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.652 2.235 . . . . 0.0 112.26 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.4 m -75.91 -23.91 16.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.279 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.615 ' C ' ' H ' ' A' ' 288' ' ' ASN . 31.2 p -58.41 -44.9 89.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.612 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.21 -4.29 0.02 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.615 ' H ' ' C ' ' A' ' 286' ' ' THR . 22.0 m120 -126.13 -58.25 1.37 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.0 m -60.52 -22.86 64.06 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.55 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 63.5 m -121.07 27.79 8.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.47 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 29.4 p-10 -68.42 -2.85 9.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.664 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -111.49 31.98 5.73 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.494 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.405 ' O ' HD21 ' A' ' 299' ' ' LEU . 15.5 t -137.86 117.67 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.865 0.364 . . . . 0.0 110.755 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -120.72 14.0 11.66 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.698 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.442 ' O ' HD12 ' A' ' 299' ' ' LEU . 1.5 mp0 -89.6 174.52 7.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.122 0.487 . . . . 0.0 109.849 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -81.01 -75.7 0.27 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -59.1 -27.52 65.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.984 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.87 95.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.481 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 303' ' ' LEU . 60.1 mt -69.36 -50.41 46.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.05 0.452 . . . . 0.0 110.646 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 62.7 mt -53.53 -34.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.006 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -78.34 -35.19 47.89 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.443 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.409 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 0.8 OUTLIER -85.57 -10.59 55.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.539 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.571 ' HA ' HG21 ' A' ' 286' ' ' THR . 47.8 mt -91.55 23.77 3.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.515 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.583 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -85.12 -44.64 0.66 Allowed Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.5 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 33.1 Cg_exo -59.12 7.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.56 2.84 . . . . 0.0 112.232 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 304' ' ' ALA . 35.9 p30 -107.04 18.15 22.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.708 0.289 . . . . 0.0 110.796 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -113.21 98.58 7.22 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.514 0.673 . . . . 0.0 109.881 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 38.0 ptt180 -159.85 133.58 7.2 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 120.147 -0.621 . . . . 0.0 112.016 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.14 141.37 15.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -122.81 104.28 9.18 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.257 0.551 . . . . 0.0 110.313 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.572 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.87 117.47 25.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -93.35 123.05 36.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 123.12 0.263 . . . . 0.0 110.624 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.686 HG21 HD22 ' A' ' 224' ' ' LEU . 14.6 t -123.12 115.79 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.318 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -115.53 129.11 56.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 105.9 12.04 26.88 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 15.4 tt -93.71 137.34 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.226 0.536 . . . . 0.0 110.672 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -85.18 129.61 34.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.709 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.41 ' N ' ' OE1' ' A' ' 190' ' ' GLN . 4.3 p-10 -157.3 169.11 25.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.618 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 321' ' ' THR . 21.9 t -96.67 131.08 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.488 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 41.7 t -52.27 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.389 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 319' ' ' VAL . 57.1 p -82.37 132.78 35.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.126 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -117.2 149.28 44.15 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.655 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.93 -82.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.447 2.098 . . . . 0.0 112.013 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 43.91 91.07 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.662 -179.904 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.24 142.52 73.71 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.583 2.189 . . . . 0.0 111.752 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.633 ' H ' ' CD ' ' A' ' 183' ' ' PRO . . . -103.85 -42.55 0.18 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.275 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.633 ' CD ' ' H ' ' A' ' 182' ' ' ALA . 48.0 Cg_exo -55.16 -36.4 93.02 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.615 2.21 . . . . 0.0 111.968 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -155.49 149.8 19.76 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.688 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.08 -31.86 44.89 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.552 2.168 . . . . 0.0 112.036 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 41.22 63.65 5.86 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.765 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.57 149.16 38.47 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.711 2.274 . . . . 0.0 112.011 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -105.72 9.76 32.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.626 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.418 HG13 ' OD2' ' A' ' 231' ' ' ASP . 58.6 t -121.26 127.48 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.512 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -100.22 83.68 2.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.349 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.456 HG22 ' NE2' ' A' ' 193' ' ' HIS . 24.1 m -67.38 125.24 25.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.411 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 313' ' ' VAL . 41.6 tptt -117.1 162.14 18.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.205 0.526 . . . . 0.0 111.04 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.456 ' NE2' HG22 ' A' ' 191' ' ' THR . 87.2 m-70 -149.27 123.16 9.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.112 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.487 ' CE2' HD21 ' A' ' 224' ' ' LEU . 65.2 m-85 -114.82 118.92 34.89 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.469 ' OG1' ' NH2' ' A' ' 308' ' ' ARG . 0.0 OUTLIER -86.36 108.03 18.27 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.639 -179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.713 ' CD2' HD11 ' A' ' 201' ' ' LEU . 27.0 tp -109.4 125.35 52.3 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -83.17 129.9 35.06 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 122.192 0.996 . . . . 0.0 112.602 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 202' ' ' PHE . 93.6 p -60.35 -27.87 67.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.834 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 203' ' ' ASN . 14.1 t70 -54.28 -40.56 67.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.03 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.5 t -72.74 -33.44 44.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.713 HD11 ' CD2' ' A' ' 196' ' ' LEU . 79.2 mt -89.43 -79.54 0.33 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.51 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -127.86 116.27 19.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.745 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.43 ' OD1' ' OD1' ' A' ' 199' ' ' ASP . 3.1 m-80 -82.26 -64.59 1.15 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.772 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -116.73 -17.52 10.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.77 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.531 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 54.4 t30 -66.16 164.92 14.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.058 0.456 . . . . 0.0 110.194 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -50.85 -80.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.507 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.49 53.0 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.214 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.531 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 42.5 p -107.24 134.38 50.41 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.168 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.403 HD22 HD22 ' A' ' 201' ' ' LEU . 18.1 mt -78.17 127.3 32.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.284 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 213' ' ' GLY . 8.0 ptmt -85.01 161.87 51.31 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.717 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -36.89 -75.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.075 1.85 . . . . 0.0 111.553 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -50.54 -19.89 1.02 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.017 0.437 . . . . 0.0 109.963 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.84 -52.08 13.09 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -65.6 -38.89 90.75 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.158 0.504 . . . . 0.0 109.903 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.53 57.13 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.85 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.81 88.76 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.763 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.2 mt -62.27 -29.08 70.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.519 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -72.34 -45.94 57.69 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.379 0.609 . . . . 0.0 110.486 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.528 ' O ' ' NE2' ' A' ' 223' ' ' GLN . 6.7 mt-30 -62.14 -42.95 99.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.081 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.7 tp -65.45 -39.63 92.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.586 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 225' ' ' SER . 7.1 t80 -52.87 -46.73 68.03 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.46 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 21.4 m -55.1 -51.32 66.79 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.684 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.913 HE21 ' H ' ' A' ' 223' ' ' GLN . 0.0 OUTLIER -55.86 -27.02 49.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.582 -179.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.995 HD22 HG21 ' A' ' 313' ' ' VAL . 78.0 mt -95.95 -21.18 18.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.769 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 221' ' ' TYR . 9.2 p -84.7 -13.43 51.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.476 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -106.4 23.6 13.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.157 0.503 . . . . 0.0 110.654 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.58 -179.31 5.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.687 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -101.41 109.11 58.05 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 232' ' ' GLY . 73.9 Cg_exo -44.45 -19.22 0.23 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.829 2.353 . . . . 0.0 112.964 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 229' ' ' PRO . 3.4 ttmp? -24.51 -47.57 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.691 0.619 . . . . 0.0 110.775 -178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 97.6 m-20 -116.49 -11.95 11.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.648 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 24.9 47.76 0.02 OUTLIER Glycine 0 N--CA 1.47 0.963 0 O-C-N 123.587 0.554 . . . . 0.0 111.841 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 231' ' ' ASP . 2.3 m -118.36 117.48 29.19 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 122.588 -0.36 . . . . 0.0 110.171 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.618 HG22 HG22 ' A' ' 313' ' ' VAL . 59.6 t -132.21 95.71 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.57 0.7 . . . . 0.0 110.675 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.3 125.18 51.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.283 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 93.0 t -99.86 129.83 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.428 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.0 mt -114.02 140.0 48.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.684 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -115.42 141.04 16.72 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.5 OUTLIER -121.55 123.93 43.16 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -178.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 249' ' ' ASN . 2.1 p -118.5 161.77 19.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.106 0.479 . . . . 0.0 110.076 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.526 ' OD2' ' NE ' ' A' ' 307' ' ' ARG . 8.5 p30 -84.05 174.91 9.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.337 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -97.31 122.28 40.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.226 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.0 mm -117.15 14.97 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.363 0.601 . . . . 0.0 110.65 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.2 4.51 88.95 Favored Glycine 0 C--N 1.314 -0.688 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 24.8 m -130.07 102.19 6.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.148 0.499 . . . . 0.0 110.235 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -52.31 -51.96 55.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.679 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.9 -42.52 76.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.726 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.569 ' CE2' HD11 ' A' ' 252' ' ' LEU . 33.9 t80 -60.4 -46.08 91.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.552 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.439 ' O ' ' OG ' ' A' ' 253' ' ' SER . 14.5 t-20 -62.92 -46.09 89.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.829 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -63.01 -42.48 99.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.719 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.54 -38.16 95.91 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.569 HD11 ' CE2' ' A' ' 248' ' ' TYR . 28.1 mt -73.71 -34.37 64.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.676 0.274 . . . . 0.0 111.084 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 249' ' ' ASN . 4.4 m -65.26 -44.37 88.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.025 0.44 . . . . 0.0 110.629 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -68.26 -43.67 77.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.084 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -58.59 -47.14 85.3 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.914 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.611 ' O ' HG23 ' A' ' 260' ' ' VAL . 99.5 mtt180 -62.68 -55.0 30.88 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.392 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.49 -33.76 68.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.193 0.521 . . . . 0.0 109.942 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -45.89 41.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.283 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 43.0 t -60.06 -39.85 87.45 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 256' ' ' ARG . 86.2 t -64.23 -52.5 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.461 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.619 HG13 HD12 ' A' ' 274' ' ' ILE . 10.6 t -61.15 -49.48 84.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.172 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -44.9 -41.45 7.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.895 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.25 -29.7 31.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.568 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.405 ' O ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -72.8 -7.73 52.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.268 -179.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.559 ' C ' ' H ' ' A' ' 267' ' ' LYS . 59.7 mt -87.81 -57.15 4.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.845 0.355 . . . . 0.0 111.472 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 68.1 p -49.95 -6.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.974 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.559 ' H ' ' C ' ' A' ' 265' ' ' ILE . 4.8 mmtm -78.84 -10.6 59.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.092 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 108.8 37.42 2.04 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.04 128.21 24.21 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.75 130.43 37.12 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.892 1.728 . . . . 0.0 112.062 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.85 -9.27 35.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.001 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 52.0 t0 -92.79 -22.93 19.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.779 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.404 ' HZ2' ' HB3' ' A' ' 273' ' ' LYS . 1.0 OUTLIER -79.49 -21.17 45.7 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.714 0.769 . . . . 0.0 110.548 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.619 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -103.18 -171.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.051 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 1.3 m -166.8 130.23 1.9 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.153 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -105.02 112.79 26.05 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.633 0.254 . . . . 0.0 110.642 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -122.54 147.21 46.65 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.509 0.671 . . . . 0.0 110.517 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.77 99.09 2.25 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' A' ' 238' ' ' GLY . 2.4 tpt -67.99 -11.44 58.88 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.445 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.54 -95.53 0.01 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 279' ' ' MET . 97.8 mt-10 -141.41 75.68 1.51 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.809 0.338 . . . . 0.0 110.8 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 79.1 p -87.76 -4.9 58.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -172.96 78.93 0.42 Allowed Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.756 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.29 104.62 0.43 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.539 2.159 . . . . 0.0 112.305 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.456 HG23 ' N ' ' A' ' 286' ' ' THR . 17.5 m -70.59 -40.39 77.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.268 0.556 . . . . 0.0 110.193 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.603 ' C ' ' H ' ' A' ' 288' ' ' ASN . 17.7 p -64.81 -47.44 78.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.099 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.65 -1.68 0.04 OUTLIER Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.5 t-20 -112.31 -59.83 1.95 Allowed 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.91 -4.18 55.97 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.382 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.636 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.7 OUTLIER -126.59 16.64 7.56 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.38 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -66.62 -3.1 5.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.382 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -101.95 32.37 3.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.636 HG21 ' SG ' ' A' ' 290' ' ' CYS . 21.8 t -129.36 121.43 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.02 0.438 . . . . 0.0 110.143 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -118.88 8.51 11.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.67 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.431 ' O ' HD12 ' A' ' 299' ' ' LEU . 3.2 mp0 -90.71 169.45 10.96 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.953 0.406 . . . . 0.0 110.04 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -82.65 -78.24 0.21 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.636 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -50.7 -29.97 12.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.97 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.99 99.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.244 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.7 mt -68.93 -42.46 76.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.542 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.4 mm -59.48 -34.13 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.015 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -83.18 -25.41 31.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.412 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.556 ' O ' HG21 ' A' ' 286' ' ' THR . 11.3 t -94.34 -15.19 24.62 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.962 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 299' ' ' LEU . 54.1 mt -91.88 22.72 4.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.717 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.567 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -75.81 -44.86 4.04 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.316 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 22.2 Cg_exo -64.15 8.7 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.434 2.756 . . . . 0.0 111.817 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 304' ' ' ALA . 7.4 t70 -108.41 7.31 26.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.696 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.526 ' NE ' ' OD2' ' A' ' 241' ' ' ASP . 93.1 mtt180 -109.62 100.54 9.56 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.151 0.5 . . . . 0.0 110.086 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.469 ' NH2' ' OG1' ' A' ' 195' ' ' THR . 16.9 ptm180 -173.43 166.62 4.72 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.888 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.684 HG12 ' HA2' ' A' ' 238' ' ' GLY . 34.2 m -126.8 151.06 33.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -120.92 108.37 13.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.178 0.513 . . . . 0.0 110.251 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.4 mm -80.02 119.49 29.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.767 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -104.33 114.88 29.42 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.02 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.995 HG21 HD22 ' A' ' 224' ' ' LEU . 70.4 t -127.81 123.18 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.658 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -118.98 148.14 43.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.009 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 88.43 25.03 31.85 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.645 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.2 tt -103.17 177.3 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.645 ' O ' ' O ' ' A' ' 316' ' ' ILE . 14.2 mptt -44.01 -160.74 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 O-C-N 124.124 0.89 . . . . 0.0 110.763 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 319' ' ' VAL . 49.5 t0 -67.81 154.31 41.82 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.762 -0.586 . . . . 0.0 110.905 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.434 ' N ' ' OD1' ' A' ' 318' ' ' ASP . 6.2 p -126.22 131.56 71.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.074 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.05 119.05 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.128 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 321' ' ' THR . 3.1 t -151.76 116.26 5.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.231 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -96.2 146.96 32.21 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.652 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.77 -47.54 9.7 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.226 1.951 . . . . 0.0 112.626 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -142.36 121.87 13.27 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.516 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.466 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.509 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.509 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 57.7 Cg_endo -71.12 43.43 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.763 2.309 . . . . 0.0 111.865 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -152.38 59.09 2.81 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.718 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.16 160.87 46.19 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.682 2.254 . . . . 0.0 111.921 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.632 ' HB3' ' CD ' ' A' ' 185' ' ' PRO . . . -167.98 -61.79 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.279 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.632 ' CD ' ' HB3' ' A' ' 184' ' ' ALA . 30.7 Cg_endo -61.19 150.01 86.57 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.412 2.075 . . . . 0.0 111.902 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 188' ' ' GLU . . . -140.0 71.72 34.64 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.239 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -75.7 25.48 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.62 2.213 . . . . 0.0 112.055 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 186' ' ' ALA . 96.0 mt-10 57.43 -140.78 0.8 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.075 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.409 ' CG1' ' H ' ' A' ' 315' ' ' GLY . 21.3 t -97.67 133.23 40.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.537 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.409 ' H ' ' HA2' ' A' ' 315' ' ' GLY . 67.1 tp60 -95.91 99.52 11.3 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.949 0.404 . . . . 0.0 110.776 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.6 m -70.64 145.99 50.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.209 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.435 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 10.6 tptp -146.33 165.03 30.52 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.225 0.536 . . . . 0.0 110.326 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.435 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 89.2 m-70 -152.83 126.47 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.216 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 70.1 m-85 -114.84 124.67 52.33 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.538 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -87.52 108.97 19.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.859 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.708 ' CD2' HD11 ' A' ' 201' ' ' LEU . 27.5 tp -110.96 126.99 55.34 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -78.59 129.5 34.85 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.735 0.778 . . . . 0.0 111.932 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.486 ' H ' ' HA ' ' A' ' 308' ' ' ARG . 58.2 m -69.11 -30.86 69.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.404 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.461 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 2.4 p-10 -62.39 -33.81 75.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.657 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.48 -34.97 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.708 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.6 mt -85.62 -81.82 0.2 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.804 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.429 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -112.54 132.44 55.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.047 -179.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 199' ' ' ASP . 66.5 m-80 -111.65 -81.06 0.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.805 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -83.6 -37.61 22.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -64.43 162.29 15.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.056 0.455 . . . . 0.0 110.504 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -52.24 -66.94 0.3 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.583 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.49 61.14 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.471 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 75.3 p -107.44 134.12 50.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.138 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.66 145.08 45.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 213' ' ' GLY . 13.4 mmmt -104.1 153.11 39.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.017 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 210' ' ' LYS . 86.4 Cg_exo -32.34 -77.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.545 2.163 . . . . 0.0 112.265 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -51.22 -18.81 1.0 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.353 0.597 . . . . 0.0 110.376 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.9 -49.83 8.39 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.052 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -65.98 -41.93 90.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.079 0.466 . . . . 0.0 110.142 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.6 -49.6 75.88 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.399 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.81 92.55 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.486 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.01 -31.31 71.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.311 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.47 -46.32 66.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.12 0.486 . . . . 0.0 110.852 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -62.71 -41.73 99.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.065 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 50.9 tp -66.02 -39.43 90.22 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.475 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.5 t80 -54.82 -47.99 73.38 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.168 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 10.1 t -57.6 -51.18 70.54 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.41 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 11.4 tt0 -53.45 -25.0 14.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.689 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.902 HD22 HG21 ' A' ' 313' ' ' VAL . 68.2 mt -100.29 -22.1 15.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 221' ' ' TYR . 7.5 t -67.87 -17.65 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 58.1 t-20 -111.83 29.46 7.84 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 227' ' ' LEU . 1.1 pt? -78.94 141.69 37.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 109.987 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 315' ' ' GLY . 38.6 t0 -50.66 107.38 0.8 Allowed Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.567 ' O ' ' N ' ' A' ' 232' ' ' GLY . 47.9 Cg_exo -54.3 -19.22 16.28 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.219 1.946 . . . . 0.0 113.018 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.494 ' C ' ' O ' ' A' ' 229' ' ' PRO . 38.1 ttmt -21.42 -50.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.539 0.525 . . . . 0.0 111.376 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 232' ' ' GLY . 2.6 m-20 -115.87 -8.09 11.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.96 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.09 54.77 0.16 Allowed Glycine 0 N--CA 1.473 1.119 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.648 ' H ' ' HD2' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -123.24 116.7 23.81 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 121.294 0.569 . . . . 0.0 110.847 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 79.1 t -131.28 101.33 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.652 178.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.41 123.04 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.018 0.437 . . . . 0.0 110.59 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.541 HG13 HD13 ' A' ' 311' ' ' ILE . 87.2 t -94.73 127.67 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.244 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 28.3 mt -110.23 145.95 36.45 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.014 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -111.14 136.47 13.62 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.488 ' CZ ' ' CD ' ' A' ' 310' ' ' GLU . 6.7 m-85 -122.12 115.95 23.36 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 17.5 p -112.72 165.8 11.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.933 0.397 . . . . 0.0 110.692 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -88.43 -177.36 5.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.323 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -97.44 122.18 40.19 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.33 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.9 mm -118.6 13.42 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.187 0.518 . . . . 0.0 110.689 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 78.14 1.56 80.52 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.3 p -129.05 104.45 7.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.173 0.511 . . . . 0.0 109.964 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -55.23 -53.13 59.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.358 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.96 -46.29 78.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.59 ' CE2' HD11 ' A' ' 252' ' ' LEU . 62.8 t80 -60.23 -44.98 94.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.62 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.682 HD21 ' H ' ' A' ' 243' ' ' ILE . 77.2 m-20 -61.43 -45.3 94.87 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.35 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -66.29 -37.69 86.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.551 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.11 -40.45 98.55 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.59 HD11 ' CE2' ' A' ' 248' ' ' TYR . 85.4 mt -73.95 -29.92 62.26 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.695 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 14.9 m -66.81 -47.53 71.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.937 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.84 -41.39 78.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.325 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.16 -49.44 77.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.026 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -60.85 -58.6 7.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.495 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.98 -35.69 25.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.068 0.461 . . . . 0.0 109.902 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -71.57 -45.06 63.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.325 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 57.3 m -60.53 -39.47 87.96 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.446 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.69 -51.04 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.406 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.595 HG13 HD12 ' A' ' 274' ' ' ILE . 28.8 t -60.28 -49.7 83.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.152 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -44.63 -41.99 7.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.18 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.558 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 76.8 t80 -81.3 -29.16 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.037 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.93 -5.84 48.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.654 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 267' ' ' LYS . 53.0 mt -88.73 -60.3 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.917 0.389 . . . . 0.0 111.953 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 29.5 t -49.81 -4.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.391 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' A' ' 265' ' ' ILE . 70.7 mmtt -75.76 -10.79 59.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.442 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 116.76 -8.47 16.9 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -83.35 129.34 60.87 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.425 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.28 134.36 56.51 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.641 1.56 . . . . 0.0 111.896 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.74 -11.61 55.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.176 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -92.61 -21.15 20.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.055 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -77.86 -22.97 49.06 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.611 0.719 . . . . 0.0 110.593 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.595 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -101.51 -170.94 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.771 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 15.2 t -170.08 130.18 0.95 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.102 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.41 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -96.29 153.3 17.89 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.942 -0.473 . . . . 0.0 109.756 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -161.48 149.4 15.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.023 0.44 . . . . 0.0 110.72 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.51 96.78 1.1 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 15.6 tpp -69.86 -13.15 62.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.066 0.46 . . . . 0.0 110.509 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 57.79 -101.42 0.18 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.66 71.04 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.822 0.344 . . . . 0.0 110.779 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 25.2 t -90.78 -1.55 57.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.662 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -157.73 68.66 4.0 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.317 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.27 105.41 2.07 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.188 1.925 . . . . 0.0 112.301 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 30.2 m -75.54 -25.7 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.597 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.617 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.0 OUTLIER -58.64 -44.47 90.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.912 -179.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.5 -3.08 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.617 ' H ' ' C ' ' A' ' 286' ' ' THR . 94.8 m-20 -122.62 -57.82 1.71 Allowed 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 m -63.89 -21.31 66.4 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.698 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 55.9 m -122.18 26.0 8.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.281 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 47.5 t0 -70.71 -6.04 34.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.594 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -110.11 30.55 6.63 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.572 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 15.1 t -133.39 120.04 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.462 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -120.27 8.93 10.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.473 ' O ' HD12 ' A' ' 299' ' ' LEU . 3.0 mt-30 -86.17 171.96 10.91 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -80.91 -73.85 0.35 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.755 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -59.25 -26.86 65.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.21 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.55 84.65 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 303' ' ' LEU . 50.8 mt -72.21 -47.68 48.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.744 0.307 . . . . 0.0 110.744 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.21 -31.27 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.081 0.467 . . . . 0.0 109.876 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -80.58 -29.65 36.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.68 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 3.6 t -93.31 -10.72 34.44 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 299' ' ' LEU . 49.8 mt -92.23 19.95 6.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.727 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.608 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -74.07 -41.85 5.46 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.4 Cg_exo -62.71 9.84 0.1 OUTLIER 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 123.408 2.739 . . . . 0.0 112.314 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 304' ' ' ALA . 38.8 t0 -112.54 7.37 18.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.884 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 64.6 mtp180 -104.43 100.43 10.13 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.021 0.439 . . . . 0.0 110.05 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.486 ' HA ' ' H ' ' A' ' 198' ' ' SER . 39.2 ptt180 -171.32 -171.14 0.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.287 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.47 155.85 14.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.488 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 96.2 mt-10 -122.8 102.74 8.21 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.25 0.547 . . . . 0.0 110.395 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.541 HD13 HG13 ' A' ' 236' ' ' VAL . 3.6 mm -79.18 120.81 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.711 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -101.93 121.31 41.89 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.568 -179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.902 HG21 HD22 ' A' ' 224' ' ' LEU . 70.4 t -130.04 123.4 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.928 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.648 ' HD2' ' H ' ' A' ' 233' ' ' SER . 0.0 OUTLIER -95.25 -174.21 3.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.935 178.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.565 ' CA ' ' HZ3' ' A' ' 314' ' ' LYS . . . 16.69 69.21 0.01 OUTLIER Glycine 0 N--CA 1.472 1.047 0 O-C-N 123.677 0.611 . . . . 0.0 112.386 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.644 ' O ' ' N ' ' A' ' 318' ' ' ASP . 4.1 tt -115.18 160.06 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.46 ' H ' HG13 ' A' ' 316' ' ' ILE . 0.1 OUTLIER -46.36 79.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 122.239 1.018 . . . . 0.0 111.226 -178.226 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.644 ' N ' ' O ' ' A' ' 316' ' ' ILE . 3.1 p30 -56.81 175.81 0.11 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.44 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.47 122.84 49.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 14.5 m -51.93 173.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.425 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.1 p -55.91 128.05 33.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.953 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 323' ' ' PRO . 1.6 pp0? -85.34 148.77 50.64 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.754 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.515 ' O ' ' NE2' ' A' ' 322' ' ' GLN . 51.7 Cg_exo -48.37 136.28 25.57 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.85 1.7 . . . . 0.0 112.36 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -83.86 -13.64 53.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.586 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.401 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.66 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.502 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.573 ' O ' ' HB2' ' A' ' 182' ' ' ALA . 29.6 Cg_endo -62.04 -47.23 10.89 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.931 2.421 . . . . 0.0 111.86 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 181' ' ' PRO . . . 169.83 152.14 0.16 Allowed Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.472 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.57 ' O ' ' HB2' ' A' ' 184' ' ' ALA . 47.2 Cg_endo -68.34 142.71 55.68 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.515 2.144 . . . . 0.0 111.726 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 183' ' ' PRO . . . 170.86 131.93 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.617 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.76 -18.44 24.99 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.508 2.139 . . . . 0.0 112.226 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -162.15 72.3 2.3 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.474 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.45 155.33 55.4 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.499 2.133 . . . . 0.0 111.832 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -132.51 179.75 5.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.165 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.434 HG21 ' OD2' ' A' ' 231' ' ' ASP . 55.8 t -121.3 140.88 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.126 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.492 ' NE2' ' H ' ' A' ' 190' ' ' GLN . 1.0 OUTLIER -123.2 132.25 53.98 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.562 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.41 ' CG2' ' CE1' ' A' ' 193' ' ' HIS . 29.0 m -87.79 141.17 28.81 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.045 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -133.86 97.4 3.89 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.392 0.615 . . . . 0.0 111.725 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.41 ' CE1' ' CG2' ' A' ' 191' ' ' THR . 8.7 m80 -84.71 135.75 34.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.106 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.615 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 62.0 m-85 -111.04 124.32 51.94 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.876 0.37 . . . . 0.0 110.103 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.6 102.44 14.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.166 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.692 ' CD2' HD11 ' A' ' 201' ' ' LEU . 32.0 tp -104.54 125.66 50.9 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.301 0.572 . . . . 0.0 109.727 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.406 ' HG3' ' H ' ' A' ' 199' ' ' ASP . 39.8 tptt -79.15 128.66 33.57 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-O 122.349 1.071 . . . . 0.0 112.177 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 202' ' ' PHE . 94.5 p -61.25 -30.6 70.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.289 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.406 ' H ' ' HG3' ' A' ' 197' ' ' LYS . 95.8 m-20 -58.56 -37.79 76.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.05 -43.79 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 196' ' ' LEU . 90.4 mt -78.63 -78.25 0.15 Allowed 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.921 -0.711 . . . . 0.0 110.583 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -128.48 130.38 47.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.147 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -96.3 -70.92 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.472 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -106.31 -13.86 15.27 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.932 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -71.59 168.09 18.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.059 0.457 . . . . 0.0 110.199 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.631 ' NZ ' ' NH1' ' A' ' 255' ' ' ARG . 19.7 tptm -57.64 -69.94 0.15 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.483 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -163.12 -0.11 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.411 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 14.4 t -52.92 134.83 37.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.995 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.9 139.59 34.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.072 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 213' ' ' GLY . 28.4 mttp -98.34 158.32 32.86 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.822 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -34.47 -75.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.43 2.087 . . . . 0.0 111.831 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -51.21 -21.05 1.82 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.177 0.513 . . . . 0.0 110.243 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.59 -51.41 12.11 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.305 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -67.1 -39.1 86.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.322 0.582 . . . . 0.0 110.072 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.61 -53.79 53.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.757 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.52 87.64 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.699 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.5 mt -61.36 -28.21 69.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.311 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -74.83 -45.45 43.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.456 0.646 . . . . 0.0 110.53 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -61.51 -42.68 99.17 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.849 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 57.3 tp -65.58 -39.15 91.31 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.523 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.9 t80 -52.6 -50.1 63.74 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.228 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.4 t -53.87 -51.68 62.88 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.414 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.615 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 8.7 tt0 -52.76 -25.93 12.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.149 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.982 HD22 HG21 ' A' ' 313' ' ' VAL . 22.5 mt -99.13 -18.95 17.44 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.419 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 221' ' ' TYR . 1.7 m -73.36 -31.67 64.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.065 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -91.54 23.15 3.61 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.949 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.566 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -79.24 158.55 27.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.28 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 315' ' ' GLY . 10.0 t0 -76.43 128.93 81.24 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.304 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 230' ' ' LYS . 42.8 Cg_endo -68.36 -18.66 44.21 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.919 2.412 . . . . 0.0 112.813 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 229' ' ' PRO . 65.3 tttm -32.63 -47.31 0.16 Allowed 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 123.508 0.505 . . . . 0.0 110.468 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 232' ' ' GLY . 21.8 m-20 -108.55 -18.84 13.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.886 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.15 47.99 0.03 OUTLIER Glycine 0 N--CA 1.474 1.23 0 O-C-N 123.902 0.751 . . . . 0.0 111.234 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 231' ' ' ASP . 18.0 m -115.36 110.84 19.95 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.7 t -127.03 94.25 2.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.664 0.745 . . . . 0.0 110.074 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 16.0 t -98.72 122.74 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.642 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.505 HG13 HD13 ' A' ' 311' ' ' ILE . 89.2 t -96.87 123.24 49.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.667 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.5 mt -106.35 143.62 34.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.027 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -118.33 135.94 11.92 Favored Glycine 0 N--CA 1.478 1.441 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.334 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.629 ' CE2' ' SD ' ' A' ' 279' ' ' MET . 0.1 OUTLIER -121.2 116.84 25.68 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.2 t -108.09 167.95 9.64 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -90.85 -179.27 5.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.271 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -95.88 123.15 39.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.375 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.9 mm -118.12 9.18 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.418 0.628 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 81.86 4.39 90.32 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.7 t -134.04 98.75 4.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.078 0.466 . . . . 0.0 110.327 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -52.69 -51.66 59.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.488 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.96 -49.2 69.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.909 0.385 . . . . 0.0 110.413 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.601 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 46.4 t80 -61.27 -41.2 96.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.377 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -60.9 -46.47 90.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.424 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -61.62 -38.71 88.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.388 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.84 -38.33 96.34 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 34.2 mt -71.93 -39.19 69.64 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.378 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 38.5 t -64.55 -41.19 96.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.227 0.537 . . . . 0.0 110.951 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.01 -38.39 66.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.631 ' NH1' ' NZ ' ' A' ' 206' ' ' LYS . 17.3 mmt85 -60.12 -51.25 70.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.965 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.7 ' O ' HG23 ' A' ' 260' ' ' VAL . 20.1 ptp180 -64.18 -44.66 91.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.135 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -60.1 -37.1 78.95 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.305 0.574 . . . . 0.0 110.158 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -44.2 59.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.41 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 49.9 m -59.4 -38.37 80.39 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.094 0.474 . . . . 0.0 110.306 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 256' ' ' ARG . 96.4 t -65.71 -52.72 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.376 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.613 HG13 HD12 ' A' ' 274' ' ' ILE . 9.3 t -61.83 -49.21 85.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.441 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -46.53 -41.34 14.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.856 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.573 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 58.3 t80 -81.28 -32.78 33.06 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.56 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -67.7 -9.01 39.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.624 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 267' ' ' LYS . 61.8 mt -86.4 -50.1 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 111.556 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 88.8 p -49.82 -5.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.199 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.586 ' CD ' ' N ' ' A' ' 267' ' ' LYS . 2.0 mptp? -86.89 7.67 26.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.909 0.385 . . . . 0.0 110.35 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 87.24 41.4 6.59 Favored Glycine 0 CA--C 1.507 -0.456 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.79 128.11 25.5 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.37 126.38 21.51 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.755 1.636 . . . . 0.0 111.982 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.49 -8.78 21.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.971 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -91.53 -22.97 20.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -80.46 -18.66 48.06 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.463 0.649 . . . . 0.0 110.713 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.613 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -106.18 -171.65 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.777 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 28.7 t -171.05 127.63 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.327 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -97.14 110.56 23.08 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.472 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -120.18 148.09 44.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.46 0.647 . . . . 0.0 110.86 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.42 97.84 0.5 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.629 ' SD ' ' CE2' ' A' ' 239' ' ' TYR . 2.8 ptp -81.59 31.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.461 0.172 . . . . 0.0 110.816 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 38.19 -97.43 0.01 OUTLIER Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -141.84 70.57 1.34 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.704 0.288 . . . . 0.0 110.415 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.8 m -91.16 0.59 57.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.518 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -155.95 60.67 2.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.51 110.93 3.17 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.505 2.137 . . . . 0.0 112.03 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 286' ' ' THR . 11.5 m -71.37 -36.4 61.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.42 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 288' ' ' ASN . 70.6 p -62.18 -45.75 92.0 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.083 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.31 -3.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.619 ' H ' ' C ' ' A' ' 286' ' ' THR . 55.8 t-20 -123.83 -57.78 1.61 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.6 m -58.94 -25.61 63.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.615 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 68.3 m -105.12 32.07 4.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 0.0 110.59 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -71.48 -2.81 18.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.456 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -109.98 30.98 6.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 10.5 t -132.17 121.65 46.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 120.919 0.39 . . . . 0.0 110.42 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -121.23 6.18 10.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.513 ' O ' HD12 ' A' ' 299' ' ' LEU . 5.1 mt-30 -88.5 172.12 9.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.039 0.447 . . . . 0.0 110.402 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -82.01 -72.62 0.43 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.868 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.91 -28.99 66.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.47 . . . . 0.0 110.867 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.52 -36.27 82.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.381 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 303' ' ' LEU . 42.5 mt -71.81 -52.16 18.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 63.6 mt -51.42 -34.73 15.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.51 -35.22 58.45 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.352 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.97 -8.22 57.41 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.814 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 299' ' ' LEU . 65.8 mt -96.23 15.53 20.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.723 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -76.78 -45.93 3.05 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.141 0.496 . . . . 0.0 110.008 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 28.0 Cg_exo -59.47 10.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 123.042 2.495 . . . . 0.0 111.818 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.577 ' H ' ' C ' ' A' ' 304' ' ' ALA . 54.6 t0 -104.56 13.52 31.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.873 0.368 . . . . 0.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.429 ' NH1' HH22 ' A' ' 256' ' ' ARG . 78.8 mtp85 -112.58 102.23 10.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.299 0.571 . . . . 0.0 110.557 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.6 ptp180 -165.8 142.51 5.34 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.22 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 15.2 m -107.4 145.54 14.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -118.04 108.63 15.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.118 0.485 . . . . 0.0 110.74 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.505 HD13 HG13 ' A' ' 236' ' ' VAL . 3.4 mm -79.5 114.28 20.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -96.72 111.15 23.43 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.769 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.982 HG21 HD22 ' A' ' 224' ' ' LEU . 59.0 t -113.0 118.4 57.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 O-C-N 123.556 0.535 . . . . 0.0 110.919 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -116.25 131.07 57.05 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.69 33.88 5.96 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.705 ' O ' ' O ' ' A' ' 317' ' ' LYS . 10.5 tt -108.46 168.53 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.705 ' O ' ' O ' ' A' ' 316' ' ' ILE . 42.1 tttt -43.04 -150.98 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 O-C-N 124.205 0.941 . . . . 0.0 111.556 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.43 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 88.2 m-20 -73.93 171.09 14.07 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 121.441 -0.787 . . . . 0.0 110.45 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 319' ' ' VAL . 9.2 p -114.26 122.97 69.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.247 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.424 ' HB ' HE22 ' A' ' 322' ' ' GLN . 3.8 m -142.88 126.05 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.399 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 64.0 m -151.49 96.74 2.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.245 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.424 HE22 ' HB ' ' A' ' 320' ' ' VAL . 28.0 mp0 -87.76 115.5 63.19 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.832 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.92 -12.25 21.67 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.389 2.059 . . . . 0.0 112.164 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -68.56 -137.1 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.628 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.487 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.586 ' HB3' ' HD3' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 180' ' ' ALA . 68.5 Cg_endo -83.67 125.58 3.82 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.294 1.996 . . . . 0.0 112.085 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.526 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -161.23 47.35 0.22 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.784 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 58.1 Cg_endo -69.52 160.98 47.68 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.77 2.313 . . . . 0.0 111.78 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 183' ' ' PRO . . . 70.89 74.59 0.25 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.651 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.34 163.4 37.93 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.47 2.114 . . . . 0.0 112.0 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.588 ' H ' ' HD2' ' A' ' 187' ' ' PRO . . . -178.48 -44.06 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.469 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.588 ' HD2' ' H ' ' A' ' 186' ' ' ALA . 44.8 Cg_exo -55.85 -29.57 73.03 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.578 2.185 . . . . 0.0 112.084 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -45.21 144.33 1.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.643 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.496 HG13 ' OD2' ' A' ' 231' ' ' ASP . 88.3 t -123.24 128.95 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.524 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -103.08 85.7 2.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 48.9 m -64.97 125.79 25.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.402 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 313' ' ' VAL . 39.2 tptt -117.97 163.33 16.74 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.278 0.561 . . . . 0.0 111.086 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -153.17 125.44 8.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.366 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -114.26 116.98 29.88 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.56 103.45 15.08 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.333 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.671 ' CD2' HD11 ' A' ' 201' ' ' LEU . 31.2 tp -106.64 130.36 54.4 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.911 0.386 . . . . 0.0 110.218 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -84.65 129.04 34.89 Favored 'General case' 0 C--O 1.255 1.355 0 CA-C-O 122.565 1.174 . . . . 0.0 111.819 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 202' ' ' PHE . 37.4 m -61.54 -18.15 57.95 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.53 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.58 -41.31 94.39 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.194 0.521 . . . . 0.0 110.201 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.9 t -72.45 -34.14 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.344 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.671 HD11 ' CD2' ' A' ' 196' ' ' LEU . 62.4 mt -88.12 -80.0 0.28 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.126 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -127.84 114.36 17.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.244 -178.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.588 ' ND2' ' CE2' ' A' ' 204' ' ' PHE . 62.6 t30 -90.84 -72.09 0.59 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.473 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.588 ' CE2' ' ND2' ' A' ' 203' ' ' ASN . 88.3 m-85 -102.76 -25.89 13.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.795 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -63.56 170.71 3.0 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.982 0.42 . . . . 0.0 110.154 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -53.54 -83.33 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.652 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.04 53.69 0.15 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.443 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.7 t -107.33 145.44 32.83 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.848 0.356 . . . . 0.0 110.303 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.23 127.61 33.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 213' ' ' GLY . 12.7 mtpp -89.55 158.85 45.08 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.813 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 210' ' ' LYS . 76.8 Cg_exo -33.34 -76.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.499 2.133 . . . . 0.0 112.01 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -48.47 -22.54 0.74 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.146 0.498 . . . . 0.0 110.321 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.36 -48.45 18.78 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -63.19 -39.63 95.2 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.83 -53.88 52.77 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.568 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.83 -28.65 69.7 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.596 0.712 . . . . 0.0 110.537 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -31.63 68.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.364 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -74.21 -48.18 30.63 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.173 0.511 . . . . 0.0 111.263 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 12.1 pt20 -64.03 -44.46 92.45 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.981 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.464 HD21 HD12 ' A' ' 311' ' ' ILE . 36.0 tp -62.7 -41.71 99.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.336 -0.545 . . . . 0.0 109.892 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 4.2 t80 -52.26 -48.1 65.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.374 178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.5 m -52.81 -52.34 57.31 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.485 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -54.3 -27.3 34.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.186 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.718 HD22 HG21 ' A' ' 313' ' ' VAL . 85.0 mt -95.3 -20.28 19.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.668 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 221' ' ' TYR . 23.5 p -79.64 -21.2 45.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.831 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -99.1 21.46 11.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.558 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.34 -179.68 5.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.61 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.434 ' OD2' ' CG ' ' A' ' 230' ' ' LYS . 2.8 t70 -99.09 132.64 23.15 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.41 -17.02 34.89 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.501 2.134 . . . . 0.0 112.94 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.434 ' CG ' ' OD2' ' A' ' 228' ' ' ASP . 40.4 mmtt -37.02 -45.27 0.57 Allowed 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.55 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.496 ' OD2' HG13 ' A' ' 189' ' ' VAL . 95.1 m-20 -107.73 -19.89 13.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.442 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.7 49.04 0.05 OUTLIER Glycine 0 N--CA 1.469 0.847 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.24 112.4 19.44 Favored 'General case' 0 C--O 1.243 0.732 0 O-C-N 122.591 -0.358 . . . . 0.0 110.791 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 313' ' ' VAL . 52.2 t -130.93 93.38 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.426 0.632 . . . . 0.0 110.497 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.14 123.93 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.334 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 311' ' ' ILE . 22.0 t -100.4 127.1 53.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.598 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.549 HD23 ' HB3' ' A' ' 277' ' ' ARG . 25.5 mt -110.17 145.36 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.068 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.653 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -115.81 142.2 17.4 Favored Glycine 0 N--CA 1.478 1.479 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.559 ' CE2' ' SD ' ' A' ' 279' ' ' MET . 0.7 OUTLIER -122.39 120.64 34.58 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.484 HG22 ' NH2' ' A' ' 256' ' ' ARG . 3.1 p -112.74 164.59 13.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.833 0.349 . . . . 0.0 110.239 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 241' ' ' ASP . 14.5 p-10 -88.47 -176.77 5.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.373 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -100.6 121.72 42.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.277 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.5 mm -118.63 11.12 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.311 0.577 . . . . 0.0 110.664 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.23 3.72 88.63 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.7 t -133.62 99.81 4.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.068 0.461 . . . . 0.0 110.013 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 56.1 t0 -52.57 -50.78 62.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.466 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.4 67.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.822 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.543 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 45.8 t80 -62.25 -47.99 81.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.735 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.562 HD21 HE21 ' A' ' 250' ' ' GLN . 0.1 OUTLIER -62.29 -40.78 97.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.575 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.562 HE21 HD21 ' A' ' 249' ' ' ASN . 97.6 mm-40 -60.42 -48.02 83.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.899 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.14 -36.4 92.9 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.543 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 25.9 mt -72.95 -35.98 67.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.097 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.1 m -63.73 -41.71 98.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 110.87 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -73.21 -35.42 66.32 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.353 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -60.21 -53.5 56.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.434 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.868 ' O ' HG23 ' A' ' 260' ' ' VAL . 17.4 ptp180 -62.91 -43.96 97.39 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.277 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.451 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.92 -38.87 90.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.319 0.581 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -71.84 -42.18 67.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.277 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 10.6 t -63.24 -38.76 92.41 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.371 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 256' ' ' ARG . 84.5 t -63.36 -51.21 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.277 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.602 HG13 HD12 ' A' ' 274' ' ' ILE . 18.7 t -62.19 -48.75 86.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.234 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -45.08 -41.23 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.08 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.527 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 49.6 t80 -81.79 -29.51 32.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.518 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.94 -7.72 53.42 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.48 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' A' ' 267' ' ' LYS . 59.6 mt -86.95 -54.67 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.748 0.309 . . . . 0.0 111.483 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 33.9 t -50.83 -5.2 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.066 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 265' ' ' ILE . 32.2 mmtp -80.18 0.46 32.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.523 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 93.11 40.75 4.78 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.44 139.33 34.36 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.209 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -63.4 129.06 24.16 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.187 1.925 . . . . 0.0 112.097 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.74 -7.28 14.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.999 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -91.1 -28.07 18.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.89 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -77.49 -20.52 54.2 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.954 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.602 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -103.12 -178.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.877 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 13.2 m -171.2 129.63 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.51 155.63 16.69 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.149 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.549 ' HB3' HD23 ' A' ' 237' ' ' LEU . 55.1 ttt85 -161.56 149.43 15.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.105 0.479 . . . . 0.0 110.63 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -118.13 98.46 0.76 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.687 ' HE3' ' H ' ' A' ' 282' ' ' SER . 0.7 OUTLIER -80.08 18.19 0.88 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.718 -0.241 . . . . 0.0 110.838 -179.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 43.77 -102.1 0.03 OUTLIER Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.443 ' OE1' ' OD1' ' A' ' 306' ' ' ASP . 5.4 mm-40 -136.21 74.61 1.51 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.852 0.384 . . . . 0.0 110.57 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.687 ' H ' ' HE3' ' A' ' 279' ' ' MET . 0.6 OUTLIER -88.71 2.18 53.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.337 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.41 ' C ' HD22 ' A' ' 283' ' ' ASN . 0.3 OUTLIER -166.81 77.36 1.06 Allowed Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.859 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.62 106.82 2.33 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.015 1.81 . . . . 0.0 111.698 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 286' ' ' THR . 5.2 m -68.29 -43.83 84.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.75 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 288' ' ' ASN . 1.1 p -58.85 -44.15 90.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.134 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.58 -3.55 0.02 OUTLIER Glycine 0 CA--C 1.531 1.049 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 286' ' ' THR . 90.9 m-20 -119.33 -57.72 1.98 Allowed 'General case' 0 C--O 1.231 0.109 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.8 OUTLIER -70.35 -13.42 62.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.732 -178.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.91 23.04 6.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.305 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.79 -11.18 54.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.345 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -96.72 33.25 1.89 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.566 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 19.2 t -128.94 124.64 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.447 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -118.68 7.54 11.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -94.93 126.67 40.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.012 0.434 . . . . 0.0 110.2 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -49.59 -57.43 7.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.73 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -61.25 -38.12 85.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.997 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.29 -31.2 72.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.546 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 32.6 mt -76.65 -54.15 7.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.4 mt -52.54 -35.79 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.041 0.448 . . . . 0.0 109.954 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -71.25 -42.05 69.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 8.7 t -81.73 -0.73 44.24 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 110.91 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.418 HD12 ' CB ' ' A' ' 241' ' ' ASP . 0.4 OUTLIER -95.55 18.11 13.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.359 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.581 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -79.46 -44.23 1.63 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.297 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 23.5 Cg_exo -63.17 8.85 0.12 Allowed 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 123.257 2.638 . . . . 0.0 111.991 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 304' ' ' ALA . 6.5 t0 -107.45 12.21 28.12 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -109.55 106.13 15.72 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.204 0.525 . . . . 0.0 110.118 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -173.09 167.76 4.88 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.769 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.653 HG12 ' HA2' ' A' ' 238' ' ' GLY . 26.8 m -128.25 151.18 34.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.435 ' CD ' ' HH ' ' A' ' 239' ' ' TYR . 90.3 mt-10 -122.3 106.85 11.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.057 0.455 . . . . 0.0 110.198 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.49 117.81 25.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -102.15 120.16 39.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.069 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.718 HG21 HD22 ' A' ' 224' ' ' LEU . 62.0 t -133.41 123.65 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.421 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -118.66 141.7 48.35 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.583 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.88 -9.19 47.06 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.829 ' O ' ' O ' ' A' ' 317' ' ' LYS . 17.1 tt -81.1 152.92 4.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.863 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.829 ' O ' ' O ' ' A' ' 316' ' ' ILE . 40.4 tttm -33.24 -141.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.234 1.016 . . . . 0.0 112.069 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.443 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 35.7 t70 -165.31 111.21 0.92 Allowed 'General case' 0 C--N 1.317 -0.841 0 O-C-N 120.771 -1.206 . . . . 0.0 110.245 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.6 m -108.2 156.47 8.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.146 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 19.4 m -91.79 154.42 3.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.663 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 20.5 m -65.47 144.05 57.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.364 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -128.3 84.8 62.17 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.283 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.11 147.17 84.69 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.699 2.266 . . . . 0.0 111.977 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.7 125.26 23.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.353 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.484 -179.878 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.581 ' HB3' ' HD3' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 180' ' ' ALA . 72.4 Cg_endo -84.25 77.38 3.21 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.255 1.97 . . . . 0.0 112.254 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.659 ' HB3' ' CD ' ' A' ' 183' ' ' PRO . . . -76.46 -64.38 0.5 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.986 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.659 ' CD ' ' HB3' ' A' ' 182' ' ' ALA . 28.2 Cg_endo -59.49 -38.88 80.5 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.283 1.988 . . . . 0.0 112.035 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 183' ' ' PRO . . . 58.54 145.2 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.62 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.556 ' O ' ' HB2' ' A' ' 186' ' ' ALA . 71.7 Cg_endo -73.21 160.15 45.81 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.498 2.132 . . . . 0.0 112.061 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.618 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . 169.87 -62.4 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.136 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 37.4 Cg_endo -63.22 -166.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.266 1.977 . . . . 0.0 111.95 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 65.86 44.81 2.7 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.117 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.93 130.87 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.199 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.776 ' NE2' ' H ' ' A' ' 190' ' ' GLN . 0.0 OUTLIER -112.52 96.39 5.97 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.001 0.429 . . . . 0.0 110.646 -179.279 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.535 HG22 ' NE2' ' A' ' 193' ' ' HIS . 16.2 m -75.41 132.26 40.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.138 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -146.07 118.72 8.58 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.535 ' NE2' HG22 ' A' ' 191' ' ' THR . 1.4 m-70 -106.69 148.51 28.29 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -107.45 124.01 49.23 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.044 0.449 . . . . 0.0 110.097 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.76 101.67 12.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.567 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.767 ' CD2' HD11 ' A' ' 201' ' ' LEU . 38.6 tp -108.56 145.45 34.81 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.665 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.552 ' HD2' ' H ' ' A' ' 199' ' ' ASP . 1.6 tmtm? -88.98 125.8 35.14 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.721 -178.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.0 t -67.92 -33.83 75.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.24 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.552 ' H ' ' HD2' ' A' ' 197' ' ' LYS . 17.3 t0 -63.69 -39.6 94.71 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 197' ' ' LYS . 51.0 t -61.04 -47.93 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.767 HD11 ' CD2' ' A' ' 196' ' ' LEU . 47.0 mt -67.29 -78.37 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.057 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.2 117.93 35.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.67 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 199' ' ' ASP . 69.1 m-80 -90.55 -82.56 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.193 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -93.23 -16.57 24.64 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.716 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.713 HD22 ' NZ ' ' A' ' 210' ' ' LYS . 67.7 m-20 -75.49 156.82 34.8 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.264 0.554 . . . . 0.0 109.801 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.491 ' H ' ' CD ' ' A' ' 206' ' ' LYS . 12.9 mptt -50.0 -68.19 0.2 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.77 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.17 60.12 0.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.167 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.3 p -110.31 141.92 42.66 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.472 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.738 HD22 HD22 ' A' ' 201' ' ' LEU . 35.7 mt -85.17 135.21 34.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.435 0.636 . . . . 0.0 111.339 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.713 ' NZ ' HD22 ' A' ' 205' ' ' ASN . 40.2 mmtm -100.55 153.86 37.51 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.444 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LYS . 91.7 Cg_exo -30.86 -73.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 C-N-CA 122.47 2.113 . . . . 0.0 112.618 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -49.14 -28.23 4.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.041 0.448 . . . . 0.0 110.767 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.61 -47.7 32.77 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -62.53 -39.69 94.39 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.71 -54.34 47.3 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.255 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.76 -29.49 70.7 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.442 0.639 . . . . 0.0 110.156 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.539 HD23 HD21 ' A' ' 201' ' ' LEU . 0.6 OUTLIER -72.05 -27.83 62.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.074 179.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . 0.514 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 34.3 m-20 -75.18 -49.76 18.44 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.491 0.662 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 5.3 pt20 -63.16 -42.55 99.45 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.361 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 31.7 tp -63.19 -41.79 99.24 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.409 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -51.56 -47.07 63.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.511 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.9 m -56.87 -50.82 71.31 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 118.786 -1.165 . . . . 0.0 110.689 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.452 HE21 HD12 ' A' ' 220' ' ' LEU . 17.8 mt-30 -52.27 -26.97 13.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.96 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.635 HD22 HG21 ' A' ' 313' ' ' VAL . 17.5 mt -96.31 -20.27 18.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.658 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.0 t -77.97 -21.22 51.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.054 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -100.22 19.39 16.59 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.813 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.563 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -75.69 160.74 29.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.754 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 315' ' ' GLY . 4.7 t0 -77.71 113.16 29.83 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.43 ' O ' ' C ' ' A' ' 230' ' ' LYS . 48.6 Cg_exo -50.19 -23.08 9.11 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 122.329 2.019 . . . . 0.0 113.082 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 229' ' ' PRO . 21.2 tptm -29.37 -53.16 0.13 Allowed 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 123.532 0.52 . . . . 0.0 111.085 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 233' ' ' SER . 91.5 m-20 -106.09 -16.03 14.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.021 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 24.94 44.84 0.01 OUTLIER Glycine 0 N--CA 1.469 0.836 0 O-C-N 123.954 0.783 . . . . 0.0 111.701 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 231' ' ' ASP . 41.6 m -114.07 110.58 20.25 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.828 0.346 . . . . 0.0 110.855 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 84.3 t -126.04 95.83 3.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.354 0.597 . . . . 0.0 109.852 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 t -97.25 121.48 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.239 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.442 HG21 ' CG2' ' A' ' 261' ' ' VAL . 10.8 t -92.87 118.98 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.253 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 64.2 mt -102.45 144.04 31.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.788 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.438 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -125.51 126.05 5.78 Favored Glycine 0 N--CA 1.476 1.345 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.694 ' N ' HH22 ' A' ' 256' ' ' ARG . 0.2 OUTLIER -111.08 126.21 54.58 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.555 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.9 t -117.53 168.09 10.71 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.825 0.345 . . . . 0.0 110.243 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -91.53 176.42 6.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.648 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -92.69 126.47 37.79 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.6 mm -117.98 10.21 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.157 0.503 . . . . 0.0 110.661 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.42 7.25 76.41 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -140.63 104.11 4.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.245 0.545 . . . . 0.0 110.163 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.53 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 99.2 m-20 -57.1 -51.15 70.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.71 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.26 -46.18 76.1 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.044 0.449 . . . . 0.0 110.791 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.588 ' CE2' HD11 ' A' ' 252' ' ' LEU . 48.0 t80 -61.29 -40.81 95.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 246' ' ' ASP . 0.1 OUTLIER -58.12 -47.93 81.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.149 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.95 -40.5 93.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.712 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.15 -39.15 96.74 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.588 HD11 ' CE2' ' A' ' 248' ' ' TYR . 32.9 mt -70.38 -39.44 74.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.772 0.32 . . . . 0.0 110.77 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 5.8 t -62.83 -42.28 99.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.432 . . . . 0.0 110.809 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.52 -44.14 75.25 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.935 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -59.59 -47.93 83.65 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.45 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.694 HH22 ' N ' ' A' ' 239' ' ' TYR . 42.7 mtm105 -63.39 -49.63 73.03 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.333 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.76 81.08 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -70.59 -43.43 69.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.207 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.0 t -60.35 -39.29 86.62 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.278 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.3 t -62.83 -51.61 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.521 179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.56 HG13 HD12 ' A' ' 274' ' ' ILE . 12.9 t -61.22 -48.34 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.625 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -47.87 -42.86 27.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.948 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.421 ' CG ' HD12 ' A' ' 209' ' ' LEU . 66.5 t80 -78.24 -35.26 48.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.994 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.36 -32.26 73.63 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.369 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 267' ' ' LYS . 89.8 mt -66.59 -46.23 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 85.2 p -56.04 -10.44 0.82 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.29 0.566 . . . . 0.0 110.485 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.514 ' NZ ' ' OD1' ' A' ' 218' ' ' ASP . 20.5 mmmt -79.46 -3.54 47.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.684 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 94.06 43.73 3.74 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.349 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.29 129.37 24.2 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.57 129.66 30.43 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.406 1.404 . . . . 0.0 111.479 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -64.84 -9.69 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.036 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -91.46 -23.8 19.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.016 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.62 -23.81 56.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.437 0.637 . . . . 0.0 110.708 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.56 HD12 HG13 ' A' ' 261' ' ' VAL . 2.3 pt -103.35 -178.52 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.871 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 8.5 t -168.03 129.26 1.4 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.161 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.08 151.93 19.0 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -154.64 136.95 14.89 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.397 0.618 . . . . 0.0 111.649 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -87.29 91.37 1.73 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 4.3 tpt -69.05 -10.4 57.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.741 0.305 . . . . 0.0 110.503 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.09 -101.5 0.02 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -141.63 74.96 1.48 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.79 0.329 . . . . 0.0 110.574 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 25.4 t -82.36 -3.53 55.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.341 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -167.49 79.25 0.92 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.574 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -63.32 105.26 0.47 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.484 2.123 . . . . 0.0 112.201 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.468 HG23 ' N ' ' A' ' 286' ' ' THR . 6.4 m -71.41 -39.87 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.705 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.588 ' C ' ' H ' ' A' ' 288' ' ' ASN . 63.3 p -58.8 -42.68 89.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.506 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -48.64 -2.66 0.01 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.588 ' H ' ' C ' ' A' ' 286' ' ' THR . 71.3 m-80 -127.98 -57.52 1.24 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.9 m -59.53 -44.19 93.25 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.566 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -111.8 28.8 8.42 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.627 0.251 . . . . 0.0 110.788 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 48.2 t0 -66.36 -7.18 17.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.518 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -98.64 31.76 2.79 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.566 HG21 ' SG ' ' A' ' 290' ' ' CYS . 22.3 t -131.91 124.17 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.552 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -118.82 11.82 12.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.842 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -99.2 130.79 45.53 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.081 0.467 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -50.44 -66.08 0.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.375 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -55.08 -38.08 67.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.429 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.18 -37.44 87.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.427 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 303' ' ' LEU . 34.3 mt -72.19 -57.15 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.461 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 67.0 mt -50.71 -33.7 12.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.028 0.442 . . . . 0.0 109.895 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.18 -37.74 53.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.679 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.12 -11.91 55.86 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.538 HD23 HG21 ' A' ' 286' ' ' THR . 70.8 mt -89.03 23.86 2.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.781 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.572 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -74.37 -41.42 4.88 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.243 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 16.3 Cg_exo -67.65 9.17 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.483 2.122 . . . . 0.0 111.065 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 304' ' ' ALA . 30.0 t0 -102.31 1.19 35.34 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.491 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 304' ' ' ALA . 5.4 ptp180 -114.77 93.35 4.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.5 0.667 . . . . 0.0 109.509 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.513 ' NH1' ' OE2' ' A' ' 310' ' ' GLU . 36.6 ptt85 -154.37 131.8 11.25 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 122.012 0.91 . . . . 0.0 112.456 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.09 134.03 33.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.342 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.513 ' OE2' ' NH1' ' A' ' 308' ' ' ARG . 64.5 mt-10 -117.86 103.66 10.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.133 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.465 HD12 HD21 ' A' ' 220' ' ' LEU . 0.9 OUTLIER -79.63 115.96 22.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -178.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 312' ' ' GLU . 6.8 tm-20 -90.93 126.73 36.15 Favored 'General case' 0 CA--C 1.512 -0.508 0 O-C-N 123.201 0.313 . . . . 0.0 110.385 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.635 HG21 HD22 ' A' ' 224' ' ' LEU . 2.8 t -125.67 114.98 41.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.936 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -115.04 134.09 55.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 228' ' ' ASP . . . 98.44 10.3 51.13 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.538 ' O ' ' NE2' ' A' ' 190' ' ' GLN . 19.7 tt -93.95 137.98 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.876 0.37 . . . . 0.0 110.502 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -83.96 127.12 33.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.355 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -83.57 105.62 14.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.752 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 4.6 p -68.57 156.52 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.316 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 320' ' ' VAL . 6.2 p -41.87 126.05 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.697 0.284 . . . . 0.0 110.793 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 8.4 t -75.77 138.15 41.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.586 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -65.64 149.78 96.91 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.381 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.86 135.9 10.01 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.782 1.654 . . . . 0.0 112.158 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -130.68 121.14 24.97 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.412 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.391 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 182' ' ' ALA . 73.1 Cg_exo -41.3 -61.75 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.249 1.966 . . . . 0.0 112.943 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 181' ' ' PRO . . . 176.8 58.23 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.039 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.88 -22.2 56.43 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.756 2.304 . . . . 0.0 111.69 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -164.06 132.89 2.83 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.865 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.22 -15.46 25.48 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.002 1.801 . . . . 0.0 112.303 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -148.58 78.68 9.08 Favored Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.677 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.7 -37.45 64.48 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.645 2.23 . . . . 0.0 111.814 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 60.29 -109.39 0.41 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.291 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 47.3 t -148.84 140.07 17.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.616 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -102.84 82.86 2.16 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.945 0.402 . . . . 0.0 110.579 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.424 ' CG2' ' NE2' ' A' ' 193' ' ' HIS . 59.0 m -79.42 126.96 31.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.302 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -143.17 108.72 5.08 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.325 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.424 ' NE2' ' CG2' ' A' ' 191' ' ' THR . 30.9 m170 -95.25 142.5 27.6 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.613 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 63.3 m-85 -107.38 123.67 48.7 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 195' ' ' THR . 7.9 t -86.83 102.61 14.46 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.766 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.686 ' CD2' HD11 ' A' ' 201' ' ' LEU . 30.3 tp -107.75 129.34 55.05 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.497 0.665 . . . . 0.0 109.296 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 197' ' ' LYS . 14.5 ptpt -85.99 131.85 34.19 Favored 'General case' 0 C--O 1.252 1.237 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.972 -177.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.538 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 14.6 m -62.11 -26.56 68.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.577 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 200' ' ' VAL . 15.0 p-10 -59.07 -36.05 74.42 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.145 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.614 ' N ' ' OD1' ' A' ' 199' ' ' ASP . 31.9 t -71.3 -45.6 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' A' ' 196' ' ' LEU . 85.8 mt -79.49 -77.61 0.18 Allowed 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.963 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.486 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -133.45 139.43 46.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.469 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.496 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 9.9 p-10 -119.65 -72.75 0.67 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.781 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.496 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 94.2 m-85 -87.01 -31.08 20.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.067 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -69.81 167.57 16.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.168 0.508 . . . . 0.0 110.296 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -58.37 -75.16 0.05 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.479 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -161.18 55.8 0.29 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.37 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.0 p -106.88 132.94 52.27 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.3 mt -75.51 140.24 42.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.684 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 213' ' ' GLY . 20.5 mtmt -101.03 157.94 32.73 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 210' ' ' LYS . 75.9 Cg_exo -34.02 -76.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.529 2.152 . . . . 0.0 112.338 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -49.7 -20.09 0.75 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.313 0.578 . . . . 0.0 110.306 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.96 -51.33 14.99 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.391 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -64.07 -40.26 95.87 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.85 -53.87 51.49 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.45 87.46 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.724 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.3 mt -61.07 -30.77 70.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.872 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.07 -45.87 62.97 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.158 0.504 . . . . 0.0 111.095 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -61.75 -44.82 96.14 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.102 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 52.7 tp -65.25 -38.93 91.85 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.368 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.466 ' CG ' ' HD3' ' A' ' 267' ' ' LYS . 7.6 t80 -55.45 -45.49 76.86 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.982 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.3 p -55.82 -53.34 57.89 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.153 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.613 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 12.9 pt20 -60.43 -19.95 58.05 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.646 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.696 HD22 HG21 ' A' ' 313' ' ' VAL . 70.2 mt -89.69 -27.48 20.08 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.025 0.441 . . . . 0.0 110.351 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 3.9 t -72.64 -22.92 60.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.6 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -98.92 18.61 16.76 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.722 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.652 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.41 160.47 29.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.94 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -70.74 125.02 91.93 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 230' ' ' LYS . 50.9 Cg_endo -69.86 -17.14 37.3 Favored 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 122.505 2.137 . . . . 0.0 113.126 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 229' ' ' PRO . 88.2 tttt -31.47 -48.21 0.13 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.749 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' C ' ' A' ' 232' ' ' GLY . 95.7 m-20 -110.74 -17.58 13.33 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.217 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.22 48.72 0.03 OUTLIER Glycine 0 N--CA 1.474 1.167 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.6 m -115.36 112.36 22.24 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.766 0.317 . . . . 0.0 110.872 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.95 97.54 4.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.604 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.6 t -97.92 122.4 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.407 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.536 HG22 HG23 ' A' ' 311' ' ' ILE . 16.9 t -96.05 118.66 42.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.41 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 277' ' ' ARG . 26.1 mt -108.96 106.23 16.1 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.602 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.413 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -87.17 127.83 8.65 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.8 OUTLIER -107.17 123.93 48.98 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 117.683 0.742 . . . . 0.0 109.453 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.596 HG22 ' N ' ' A' ' 241' ' ' ASP . 52.9 m -114.67 166.24 11.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.969 0.414 . . . . 0.0 110.296 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.596 ' N ' HG22 ' A' ' 240' ' ' THR . 53.6 p30 -86.02 -176.0 5.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.965 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 244' ' ' GLY . 59.2 ttp180 -116.58 124.84 50.81 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.376 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.4 mm -114.8 23.26 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.557 0.694 . . . . 0.0 110.605 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.4 ' H ' ' HG2' ' A' ' 242' ' ' ARG . . . 84.4 13.59 73.15 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.8 t -144.11 94.07 2.53 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.357 0.598 . . . . 0.0 110.006 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -46.58 -47.33 19.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.66 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.38 -37.58 78.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.193 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.492 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 52.6 t80 -61.51 -47.63 84.74 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.445 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 250' ' ' GLN . 0.1 OUTLIER -62.84 -41.6 99.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.5 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.492 ' N ' ' ND2' ' A' ' 249' ' ' ASN . 94.2 mt-30 -60.7 -45.99 92.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.919 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.15 96.13 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.492 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 26.2 mt -72.81 -37.87 67.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.245 -0.478 . . . . 0.0 111.074 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 29.9 t -63.47 -40.87 98.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.967 0.413 . . . . 0.0 110.239 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.94 -45.81 76.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.045 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -54.33 -45.64 72.7 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.573 HH22 ' N ' ' A' ' 308' ' ' ARG . 42.7 mtp180 -61.38 -64.09 1.06 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.477 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -51.56 -34.28 36.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.129 0.49 . . . . 0.0 109.884 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -73.32 -44.74 58.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.087 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 46.2 m -64.37 -37.75 88.6 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.449 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.7 t -64.52 -51.27 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.6 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.536 HG13 HD12 ' A' ' 274' ' ' ILE . 18.2 t -62.36 -48.65 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.039 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -45.06 -39.42 5.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -84.12 -30.34 26.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.687 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.43 -11.22 60.59 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.489 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.533 ' C ' ' H ' ' A' ' 267' ' ' LYS . 72.5 mt -86.91 -53.65 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 122.107 -0.37 . . . . 0.0 111.729 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.3 p -50.41 -4.91 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.23 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 265' ' ' ILE . 68.9 mttm -83.96 -0.19 50.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.925 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 105.26 -2.78 40.28 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -81.09 126.02 78.19 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.871 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.78 130.32 39.84 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.344 1.363 . . . . 0.0 111.256 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.29 -10.0 38.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.968 0.413 . . . . 0.0 111.407 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -90.78 -22.93 20.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.133 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -19.5 52.5 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.819 0.819 . . . . 0.0 110.664 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.536 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -107.03 -171.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.542 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.69 129.78 1.55 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.827 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.72 151.3 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.59 ' HB3' HD23 ' A' ' 237' ' ' LEU . 60.8 ttt180 -158.88 148.75 19.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.914 0.388 . . . . 0.0 110.5 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -123.76 96.89 0.55 Allowed Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 21.3 ptm -94.66 21.45 7.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.921 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 37.74 -97.17 0.01 OUTLIER Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.4 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -143.33 75.92 1.5 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 37.3 t -63.82 -32.99 74.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.114 0.483 . . . . 0.0 111.166 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.438 ' C ' HD22 ' A' ' 283' ' ' ASN . 0.4 OUTLIER -131.17 77.66 74.2 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.954 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -54.23 108.04 0.26 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.749 2.299 . . . . 0.0 112.848 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 286' ' ' THR . 5.1 m -71.59 -40.3 70.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.489 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.631 ' C ' ' H ' ' A' ' 288' ' ' ASN . 2.2 p -58.97 -42.47 90.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.514 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.5 0.89 0.02 OUTLIER Glycine 0 CA--C 1.532 1.129 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.631 ' H ' ' C ' ' A' ' 286' ' ' THR . 28.2 t-20 -125.07 -58.37 1.46 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.3 m -56.2 -42.84 77.82 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 22.8 m -95.74 34.42 1.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.502 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 292' ' ' ASN . 28.4 p30 -59.04 -33.04 70.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.818 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 23.3 m120 -88.78 33.92 0.77 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.434 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.57 109.43 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.849 0.356 . . . . 0.0 110.522 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -118.59 13.89 13.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.611 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -98.0 135.33 39.86 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.108 0.48 . . . . 0.0 109.851 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 299' ' ' LEU . 5.9 ttt-85 -51.09 -76.36 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.568 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -45.74 -41.03 10.18 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.139 0.495 . . . . 0.0 111.071 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.34 81.36 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.043 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 296' ' ' ARG . 16.9 mt -71.01 -43.95 66.87 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.771 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 12.2 mm -52.75 -36.84 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -77.34 -42.78 35.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.221 0.534 . . . . 0.0 110.315 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.88 -5.6 35.71 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.857 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.34 20.24 8.49 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.573 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.548 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -79.84 -45.09 1.53 Allowed Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.18 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 24.7 Cg_exo -61.75 8.29 0.11 Allowed 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 123.184 2.589 . . . . 0.0 111.941 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 304' ' ' ALA . 39.4 t0 -102.52 10.91 38.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.609 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.442 ' NH1' ' O ' ' A' ' 203' ' ' ASN . 88.2 mtm180 -112.94 91.65 3.73 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.298 0.571 . . . . 0.0 110.142 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.573 ' N ' HH22 ' A' ' 256' ' ' ARG . 16.4 ptm180 -157.67 129.22 6.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.628 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.99 138.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.431 0.634 . . . . 0.0 109.709 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -118.64 102.17 8.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.713 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.536 HG23 HG22 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -81.0 113.14 19.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.67 118.44 31.05 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.401 0.438 . . . . 0.0 110.154 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.696 HG21 HD22 ' A' ' 224' ' ' LEU . 47.8 t -116.5 114.66 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 O-C-N 123.567 0.542 . . . . 0.0 110.183 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -113.39 132.09 55.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 93.15 41.85 4.47 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.693 ' O ' ' O ' ' A' ' 317' ' ' LYS . 9.8 tt -114.65 169.63 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.693 ' O ' ' O ' ' A' ' 316' ' ' ILE . 27.5 tttp -42.65 -150.78 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.586 0 O-C-N 123.963 0.79 . . . . 0.0 111.614 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -79.26 156.68 27.99 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.612 -0.68 . . . . 0.0 110.556 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 78.1 t -132.95 135.32 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.268 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 66.1 t -72.19 133.21 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.59 132.59 54.76 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.31 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 324' ' ' GLN . 4.1 pt20 -88.81 152.07 48.32 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.579 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.25 -41.09 13.34 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.561 2.174 . . . . 0.0 111.971 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.426 ' O ' ' OE1' ' A' ' 322' ' ' GLN . 0.4 OUTLIER -93.68 105.88 17.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.047 0.451 . . . . 0.0 110.702 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.452 179.859 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.33 143.15 94.6 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.598 2.199 . . . . 0.0 111.825 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.99 69.65 1.19 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.573 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.93 105.75 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.083 1.855 . . . . 0.0 111.683 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -169.56 89.41 0.57 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.201 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.28 -36.67 57.81 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.178 1.919 . . . . 0.0 112.031 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 187' ' ' PRO . . . 51.33 85.44 0.18 Allowed Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.366 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 186' ' ' ALA . 51.2 Cg_exo -53.01 -139.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.917 2.411 . . . . 0.0 112.578 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -43.83 125.73 4.35 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.182 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 190' ' ' GLN . 3.1 t -70.09 173.05 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.303 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.614 ' H ' HG12 ' A' ' 189' ' ' VAL . 17.6 mp0 -102.68 83.34 2.25 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.907 0.384 . . . . 0.0 111.16 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 39.2 m -72.0 126.21 29.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.639 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.423 ' NZ ' HG13 ' A' ' 320' ' ' VAL . 7.3 tptp -116.45 167.85 10.68 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.457 0.646 . . . . 0.0 111.032 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -155.93 123.39 5.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.595 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.591 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 60.9 m-85 -110.57 113.35 25.9 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.06 103.86 15.13 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.897 -179.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.68 HD23 HD11 ' A' ' 201' ' ' LEU . 30.5 tp -108.94 135.34 50.3 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.287 0.565 . . . . 0.0 110.196 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.517 ' H ' ' CD ' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -88.73 132.14 34.73 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.968 0.89 . . . . 0.0 112.315 -178.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 202' ' ' PHE . 1.3 p -61.84 -24.07 66.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.665 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -59.14 -43.67 92.04 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.275 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.11 -42.41 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.68 HD11 HD23 ' A' ' 196' ' ' LEU . 78.9 mt -80.08 -79.36 0.15 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.86 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.3 OUTLIER -133.27 131.88 40.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.002 -178.067 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.54 ' O ' ' NH2' ' A' ' 307' ' ' ARG . 59.9 t30 -111.04 -71.24 0.77 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.674 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -91.28 -23.57 20.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.844 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -73.14 164.16 27.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.159 0.504 . . . . 0.0 110.423 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -53.78 -74.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.144 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -160.09 3.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.338 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.7 p -54.98 141.35 34.21 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 85.9 mt -86.14 132.62 33.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.875 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 213' ' ' GLY . 29.6 mttp -93.27 157.27 39.12 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.582 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -33.11 -74.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.767 2.311 . . . . 0.0 112.428 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.77 -24.24 1.34 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.136 0.493 . . . . 0.0 110.947 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.68 -48.16 18.32 Favored Glycine 0 C--O 1.227 -0.312 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -62.66 -40.83 98.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.346 0.593 . . . . 0.0 109.57 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.42 -55.27 33.58 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.38 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.21 -37.35 85.0 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.212 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.1 -31.09 70.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.169 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -71.91 -46.73 56.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.935 0.398 . . . . 0.0 110.948 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -64.21 -44.57 91.52 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.564 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.452 HD12 HE21 ' A' ' 223' ' ' GLN . 49.9 tp -65.02 -38.12 89.86 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.539 ' HE1' HD13 ' A' ' 269' ' ' ILE . 2.4 t80 -54.83 -50.3 68.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.146 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 225' ' ' SER . 11.8 t -59.58 -50.67 73.01 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.571 -178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.591 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 9.2 tt0 -49.01 -24.25 1.45 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.667 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.507 ' O ' HD22 ' A' ' 227' ' ' LEU . 51.3 mt -100.38 -13.73 18.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.606 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 222' ' ' SER . 33.2 t -73.29 -19.82 60.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.942 0.401 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -103.61 20.84 17.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.475 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -74.05 161.54 29.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -84.3 126.18 70.18 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 230' ' ' LYS . 59.9 Cg_endo -69.86 -16.26 37.06 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.982 1.788 . . . . 0.0 113.073 -178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 229' ' ' PRO . 3.1 tmtm? -30.49 -52.43 0.16 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.604 0.565 . . . . 0.0 111.066 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 232' ' ' GLY . 10.5 m-20 -104.67 -15.33 15.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.133 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.99 51.52 0.07 OUTLIER Glycine 0 N--CA 1.468 0.788 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.638 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.0 m -118.53 109.07 15.76 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 122.88 -0.188 . . . . 0.0 111.041 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 92.4 t -125.3 93.81 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.62 0.724 . . . . 0.0 109.989 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.6 t -98.33 119.49 46.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.159 0.504 . . . . 0.0 110.754 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.538 HG22 HG23 ' A' ' 311' ' ' ILE . 22.1 t -93.62 127.68 45.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.398 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.0 mt -110.35 139.62 45.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.381 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -120.56 131.55 8.83 Favored Glycine 0 N--CA 1.479 1.544 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -117.7 121.94 42.19 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.002 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.532 HG23 ' ND2' ' A' ' 249' ' ' ASN . 9.0 t -115.45 174.26 6.1 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.84 0.353 . . . . 0.0 111.054 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -84.4 -178.2 6.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.165 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.568 ' H ' HD12 ' A' ' 303' ' ' LEU . 59.2 ttp180 -115.84 125.41 52.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.953 0.406 . . . . 0.0 109.971 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 243' ' ' ILE . 48.9 mm -117.81 18.57 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.75 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 77.92 15.97 80.51 Favored Glycine 0 C--N 1.315 -0.604 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.3 p -136.58 100.78 4.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.341 0.591 . . . . 0.0 109.947 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -54.21 -50.9 66.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.809 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.96 83.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.714 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.538 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 55.6 t80 -63.95 -41.77 97.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.334 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.532 ' ND2' HG23 ' A' ' 240' ' ' THR . 12.7 t-20 -59.01 -52.09 67.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.513 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -57.85 -39.86 78.74 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.681 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.43 -42.88 99.14 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.538 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 31.7 mt -69.99 -38.99 76.18 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.747 -0.267 . . . . 0.0 110.707 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.3 t -62.32 -41.57 98.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.194 0.521 . . . . 0.0 110.622 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -70.47 -38.88 74.51 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.344 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.2 ttm-85 -58.69 -51.25 70.75 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.303 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.854 ' O ' HG23 ' A' ' 260' ' ' VAL . 17.2 ptp180 -65.63 -45.74 81.88 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.754 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.55 98.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.401 0.619 . . . . 0.0 109.951 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -71.2 -43.61 67.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.334 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.9 m -60.05 -38.14 81.93 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.693 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 256' ' ' ARG . 89.4 t -65.13 -52.66 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.15 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.662 HG13 HD12 ' A' ' 274' ' ' ILE . 9.1 t -62.12 -48.91 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.621 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -47.18 -43.13 21.04 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.182 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.586 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 53.7 t80 -77.07 -33.47 57.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.981 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.54 -34.93 79.42 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.48 ' C ' ' H ' ' A' ' 267' ' ' LYS . 96.9 mt -63.15 -44.85 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 120.831 0.348 . . . . 0.0 111.527 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 39.3 t -55.07 -8.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.404 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.586 ' CE ' ' CE2' ' A' ' 263' ' ' TYR . 68.8 mmtt -90.98 14.24 14.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.462 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 80.45 42.59 10.16 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.312 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.539 HD13 ' HE1' ' A' ' 221' ' ' TYR . 0.8 OUTLIER -120.29 127.61 26.24 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 117.134 0.467 . . . . 0.0 110.074 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -54.14 128.33 29.42 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.356 1.371 . . . . 0.0 111.984 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.97 -11.87 50.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.001 0.429 . . . . 0.0 111.025 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -92.29 -18.13 23.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.418 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -82.76 -23.19 34.06 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.764 0.792 . . . . 0.0 110.652 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.662 HD12 HG13 ' A' ' 261' ' ' VAL . 2.0 pt -102.48 -173.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.045 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 4.9 t -167.63 125.48 1.22 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.77 113.24 25.6 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.705 0.288 . . . . 0.0 110.812 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -119.17 141.86 48.47 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.426 0.632 . . . . 0.0 111.773 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.34 95.84 2.14 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -69.26 -10.45 57.87 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -178.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.484 ' HA2' HG22 ' A' ' 240' ' ' THR . . . 42.09 -113.26 0.53 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.441 ' OE2' ' OD2' ' A' ' 306' ' ' ASP . 51.7 tt0 -143.96 71.87 1.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.7 t -63.84 -37.8 88.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.119 0.485 . . . . 0.0 111.409 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -131.6 83.1 59.27 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.27 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.8 105.79 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.163 1.908 . . . . 0.0 112.364 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 286' ' ' THR . 31.6 m -70.1 -44.44 78.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 121.181 0.515 . . . . 0.0 110.708 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.618 ' C ' ' H ' ' A' ' 288' ' ' ASN . 10.8 p -60.65 -44.62 96.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.934 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -52.93 1.92 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.618 ' H ' ' C ' ' A' ' 286' ' ' THR . 75.6 m-20 -119.84 -59.43 1.8 Allowed 'General case' 0 C--O 1.231 0.127 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.7 OUTLIER -65.87 -20.5 66.26 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.804 -179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.25 26.36 9.51 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.873 0.368 . . . . 0.0 110.28 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 37.3 p-10 -69.93 -6.85 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.043 0.449 . . . . 0.0 110.505 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -100.63 31.51 3.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.288 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.74 129.3 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.207 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -119.41 5.9 11.14 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -97.57 130.28 44.63 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.906 0.384 . . . . 0.0 110.1 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -52.61 -74.07 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.52 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -43.63 -39.59 3.64 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.214 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.97 95.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.755 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 48.5 mt -68.48 -42.52 78.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.692 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 15.3 mm -54.95 -36.29 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -73.13 -46.83 48.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.35 0.595 . . . . 0.0 109.745 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 4.7 t -71.04 -2.78 16.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.243 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.568 HD12 ' H ' ' A' ' 242' ' ' ARG . 0.7 OUTLIER -93.29 16.72 12.56 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.431 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -82.4 -44.32 0.97 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 120.838 0.351 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 49.3 Cg_exo -55.1 8.74 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 123.373 2.715 . . . . 0.0 112.835 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.571 ' H ' ' C ' ' A' ' 304' ' ' ALA . 88.2 m-20 -110.58 16.4 21.51 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.497 0.189 . . . . 0.0 110.682 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 203' ' ' ASN . 8.4 ptm180 -112.46 91.71 3.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.846 0.831 . . . . 0.0 110.302 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -164.58 141.27 6.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.827 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.495 HG12 ' HA2' ' A' ' 238' ' ' GLY . 31.3 m -108.76 145.96 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.406 ' OE2' ' CZ ' ' A' ' 239' ' ' TYR . 32.9 mt-10 -122.05 107.83 12.66 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.946 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.538 HG23 HG22 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -79.22 118.42 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.37 125.68 43.61 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.051 0.453 . . . . 0.0 110.546 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.03 116.56 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.632 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.41 ' HG3' HG11 ' A' ' 189' ' ' VAL . 20.1 tttt -114.68 131.89 56.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 106.82 -23.87 26.74 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.657 ' O ' ' O ' ' A' ' 317' ' ' LYS . 13.6 tt -53.24 171.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.657 ' O ' ' O ' ' A' ' 316' ' ' ILE . 24.8 tttp -45.34 -149.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.68 0.613 . . . . 0.0 111.792 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.415 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 54.6 p-10 -63.78 169.51 4.04 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.599 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.94 147.64 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.008 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.423 HG13 ' NZ ' ' A' ' 192' ' ' LYS . 19.2 m -68.05 133.68 31.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.47 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 23.3 m -81.49 130.55 35.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.242 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -126.3 85.11 60.57 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.4 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.07 146.56 93.88 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.648 2.232 . . . . 0.0 112.083 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -73.3 47.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.356 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.518 -179.969 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.646 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.646 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 27.6 Cg_exo -61.61 149.83 88.1 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.048 2.499 . . . . 0.0 111.736 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.645 ' HB3' ' CD ' ' A' ' 183' ' ' PRO . . . -171.6 -62.62 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.786 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.645 ' CD ' ' HB3' ' A' ' 182' ' ' ALA . 30.7 Cg_endo -60.36 142.92 99.27 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.433 2.089 . . . . 0.0 112.017 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 183' ' ' PRO . . . 172.07 74.73 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.109 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.66 ' O ' ' HB2' ' A' ' 186' ' ' ALA . 46.7 Cg_exo -55.09 135.34 68.37 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.512 2.141 . . . . 0.0 111.686 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 185' ' ' PRO . . . 163.76 155.17 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.363 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 188' ' ' GLU . 36.8 Cg_endo -65.71 -81.61 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.634 2.223 . . . . 0.0 111.676 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 187' ' ' PRO . 18.7 tp10 55.34 162.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.952 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.537 HG11 ' NZ ' ' A' ' 314' ' ' LYS . 60.5 t -106.87 136.91 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -113.95 105.36 13.15 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.545 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 15.4 m -81.87 135.94 35.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.366 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -147.26 118.01 7.58 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 120.875 0.369 . . . . 0.0 110.427 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.514 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 2.4 m170 -98.9 144.52 27.99 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -105.0 119.38 38.89 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.92 101.19 12.66 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.846 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.82 HD23 HD11 ' A' ' 201' ' ' LEU . 35.3 tp -108.38 143.7 36.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.144 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -94.75 133.45 38.42 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 122.157 0.979 . . . . 0.0 112.34 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 202' ' ' PHE . 1.2 m -62.06 -25.58 67.77 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.2 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.53 ' OD1' ' NE ' ' A' ' 307' ' ' ARG . 85.2 m-20 -60.44 -39.42 87.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.108 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.65 -45.21 85.3 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.82 HD11 HD23 ' A' ' 196' ' ' LEU . 50.7 mt -78.68 -78.01 0.15 Allowed 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.909 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.2 OUTLIER -128.33 123.43 33.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.824 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -93.61 -74.17 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.568 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -104.05 -11.78 17.16 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -75.58 170.0 17.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.029 0.443 . . . . 0.0 110.179 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -54.81 -82.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.554 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -156.15 3.76 0.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.188 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 80.1 p -57.16 144.72 33.87 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.745 HD22 HD22 ' A' ' 201' ' ' LEU . 57.7 mt -89.25 136.1 33.21 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.268 0.556 . . . . 0.0 111.169 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 213' ' ' GLY . 55.6 mttt -98.34 157.51 34.27 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.098 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -33.75 -74.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.549 2.166 . . . . 0.0 111.993 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.596 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 27.3 mp0 -48.16 -27.62 2.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.127 0.489 . . . . 0.0 110.529 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.15 -47.79 35.42 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -64.65 -40.6 95.72 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.316 0.579 . . . . 0.0 109.888 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.32 -55.71 25.73 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.351 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.91 81.36 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.478 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.586 HD23 HD21 ' A' ' 201' ' ' LEU . 0.7 OUTLIER -61.81 -27.05 68.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.24 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -77.36 -47.45 19.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.462 0.649 . . . . 0.0 110.841 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -62.11 -45.2 94.54 Favored 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.614 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.52 HD12 HE21 ' A' ' 223' ' ' GLN . 40.6 tp -63.83 -40.68 97.18 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 225' ' ' SER . 5.0 t80 -51.07 -48.79 61.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.451 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 59.1 p -55.32 -51.52 66.45 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.596 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.52 HE21 HD12 ' A' ' 220' ' ' LEU . 16.2 mt-30 -51.23 -26.14 6.63 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.424 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.701 ' O ' HD22 ' A' ' 227' ' ' LEU . 17.8 mt -100.69 -19.03 16.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.525 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 221' ' ' TYR . 6.3 t -71.93 -27.51 62.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.997 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 24.9 t-20 -103.32 23.68 12.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.937 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.36 152.97 34.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.687 179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.647 ' N ' ' O ' ' A' ' 315' ' ' GLY . 16.0 t0 -66.04 115.65 25.3 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 232' ' ' GLY . 49.0 Cg_endo -70.14 -17.25 35.94 Favored 'Trans proline' 0 N--CA 1.505 2.164 0 C-N-CA 122.518 2.145 . . . . 0.0 112.941 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 229' ' ' PRO . 22.2 tptm -29.21 -47.68 0.06 Allowed 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 123.525 0.516 . . . . 0.0 110.962 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 232' ' ' GLY . 5.6 p30 -106.32 -14.07 15.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.388 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.25 56.13 0.17 Allowed Glycine 0 N--CA 1.469 0.878 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.7 t -119.72 99.98 6.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.574 0.226 . . . . 0.0 110.589 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 73.5 t -125.02 94.18 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.549 0.69 . . . . 0.0 110.437 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 8.4 t -98.11 121.47 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.53 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.507 HG22 HG23 ' A' ' 311' ' ' ILE . 18.3 t -91.58 122.12 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.572 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.431 HD22 ' SD ' ' A' ' 279' ' ' MET . 39.0 mt -104.55 141.05 37.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.034 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.78 130.27 7.13 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.19 119.96 38.13 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.1 p -113.28 162.97 15.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.838 0.352 . . . . 0.0 110.071 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -83.3 173.03 11.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.386 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.412 ' HG2' ' H ' ' A' ' 244' ' ' GLY . 62.2 ttp180 -101.18 125.24 47.78 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.426 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 8.1 mm -114.59 18.18 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.685 0.755 . . . . 0.0 110.453 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.412 ' H ' ' HG2' ' A' ' 242' ' ' ARG . . . 84.92 13.73 71.33 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 22.0 m -143.07 96.46 2.93 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.103 0.478 . . . . 0.0 110.284 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 247' ' ' ALA . 27.4 p-10 -49.19 -48.6 45.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.418 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.447 ' N ' ' OD1' ' A' ' 246' ' ' ASP . . . -56.15 -35.83 67.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.859 0.362 . . . . 0.0 110.276 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.518 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 39.0 t80 -70.0 -42.23 73.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.889 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.83 -49.72 75.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.235 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -66.42 -36.89 83.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.374 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.57 -41.18 98.68 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.605 HD22 HH12 ' A' ' 256' ' ' ARG . 37.9 mt -73.71 -34.16 64.69 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.947 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 85.0 p -64.0 -40.78 97.13 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.778 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.69 -43.03 69.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -58.64 -46.66 86.63 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.117 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.605 HH12 HD22 ' A' ' 252' ' ' LEU . 64.5 mtt85 -64.55 -60.91 2.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.905 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -48.44 -39.09 21.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 0.0 110.008 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -70.04 -43.26 71.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.373 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 44.5 m -59.3 -39.0 81.6 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.36 -51.72 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.157 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.522 HG13 HD12 ' A' ' 274' ' ' ILE . 18.7 t -61.37 -48.89 86.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.687 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -46.99 -41.39 16.24 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.125 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -81.74 -32.95 31.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.66 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -65.26 -24.28 67.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.254 -179.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.532 ' C ' ' H ' ' A' ' 267' ' ' LYS . 87.1 mt -73.51 -51.18 26.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 111.718 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 5.1 m -50.34 -8.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.801 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 265' ' ' ILE . 27.9 mmtp -82.68 -1.94 52.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 95.08 41.62 3.98 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.32 129.43 24.91 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.75 125.81 19.18 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.754 1.636 . . . . 0.0 111.736 176.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.55 -8.5 20.09 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -90.69 -24.08 20.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.719 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.475 ' HE2' HD21 ' A' ' 227' ' ' LEU . 0.7 OUTLIER -78.64 -21.94 47.63 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.315 0.578 . . . . 0.0 111.034 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.522 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -104.48 -174.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.562 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 38.5 t -170.94 131.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.442 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.96 150.2 20.72 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -154.0 138.01 16.38 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.32 0.581 . . . . 0.0 111.293 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -90.17 94.0 1.93 Allowed Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.431 ' SD ' HD22 ' A' ' 237' ' ' LEU . 2.6 tpt -71.23 -7.04 44.2 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.611 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.53 -98.31 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -142.63 75.61 1.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.757 0.313 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 85.9 p -83.69 -1.64 54.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.977 0.418 . . . . 0.0 110.905 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.568 ' C ' HD22 ' A' ' 283' ' ' ASN . 0.1 OUTLIER -162.89 74.71 2.01 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.94 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -60.06 103.23 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.401 2.068 . . . . 0.0 113.198 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 286' ' ' THR . 13.8 m -69.91 -35.57 65.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.182 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.0 OUTLIER -59.5 -46.44 88.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.401 -179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.05 -5.58 0.01 OUTLIER Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.619 ' H ' ' C ' ' A' ' 286' ' ' THR . 45.5 t30 -127.22 -57.26 1.31 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.844 0.457 . . . . 0.0 109.781 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 289' ' ' THR . 3.5 m -68.56 -10.71 57.54 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.666 0.27 . . . . 0.0 110.614 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 286' ' ' THR . 72.4 m -132.78 19.06 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 110.396 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 42.2 p30 -67.35 -5.43 14.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.663 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -108.68 32.24 5.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 7.2 t -131.63 120.48 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.68 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -119.7 10.44 11.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.952 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -101.57 135.8 42.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.145 0.498 . . . . 0.0 110.142 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -52.0 -70.32 0.09 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.845 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.77 -39.23 58.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.94 -39.64 95.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.424 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 303' ' ' LEU . 20.5 mt -65.94 -52.41 50.0 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.43 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 64.5 mt -53.04 -33.03 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.938 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -79.42 -24.23 42.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.979 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -98.03 -12.68 21.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.384 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 299' ' ' LEU . 80.6 mt -91.69 18.77 7.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.883 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.608 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -77.81 -53.25 1.51 Allowed Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.519 177.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 13.0 Cg_endo -53.7 9.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.225 0 C-N-CA 122.852 2.368 . . . . 0.0 112.888 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.608 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.3 t0 -103.1 16.75 25.79 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.53 ' NE ' ' OD1' ' A' ' 199' ' ' ASP . 18.0 ptt-85 -114.35 93.3 4.28 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.78 0.8 . . . . 0.0 110.415 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.502 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 48.1 ptt85 -157.46 131.73 8.35 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.59 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 7.8 m -102.02 140.13 21.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -120.84 105.69 10.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.372 0.606 . . . . 0.0 110.519 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.507 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -79.17 115.94 22.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.465 -178.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -90.68 117.37 29.28 Favored 'General case' 0 C--N 1.344 0.349 0 O-C-N 123.091 0.245 . . . . 0.0 110.368 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.675 HG21 HD22 ' A' ' 224' ' ' LEU . 22.5 t -115.62 115.81 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.4 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.537 ' NZ ' HG11 ' A' ' 189' ' ' VAL . 47.3 tttp -114.32 126.98 55.63 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.9 43.99 2.96 Favored Glycine 0 C--O 1.219 -0.807 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.692 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.5 tt -119.81 170.51 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.692 ' O ' ' O ' ' A' ' 316' ' ' ILE . 65.0 mttp -40.68 -160.22 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.125 0.891 . . . . 0.0 111.293 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 319' ' ' VAL . 35.3 t0 -84.72 175.31 9.27 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.481 -0.762 . . . . 0.0 110.909 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.41 ' H ' ' CG ' ' A' ' 318' ' ' ASP . 80.0 t -127.26 128.65 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.256 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.65 118.06 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.101 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.6 p -151.08 125.31 9.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.305 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -59.27 148.46 72.25 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.778 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.52 152.44 74.92 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.409 2.073 . . . . 0.0 111.985 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 62.27 53.69 2.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.62 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.636 179.848 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 182' ' ' ALA . . . . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.429 ' O ' ' HB3' ' A' ' 182' ' ' ALA . 44.6 Cg_endo -68.65 22.67 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.708 2.272 . . . . 0.0 112.038 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 180' ' ' ALA . . . 66.45 76.86 0.28 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.31 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.0 -35.97 63.06 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.765 2.31 . . . . 0.0 111.94 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 60.22 78.39 0.33 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.215 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.66 144.19 86.84 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.559 2.173 . . . . 0.0 111.897 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -138.71 67.26 43.08 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.319 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.444 ' O ' ' NZ ' ' A' ' 230' ' ' LYS . 46.7 Cg_endo -68.77 148.85 72.27 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.487 2.125 . . . . 0.0 112.05 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.52 174.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.278 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.1 t -78.03 107.22 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.256 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -107.01 103.25 12.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.332 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.59 HG22 ' CE1' ' A' ' 193' ' ' HIS . 9.1 m -74.99 130.5 39.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.191 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -147.32 117.54 7.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.167 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.59 ' CE1' HG22 ' A' ' 191' ' ' THR . 0.5 OUTLIER -103.76 151.39 23.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.521 ' CE1' HD21 ' A' ' 224' ' ' LEU . 37.5 m-85 -111.96 122.69 48.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.914 0.388 . . . . 0.0 110.062 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.08 102.44 13.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.541 179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.691 ' CD2' HD11 ' A' ' 201' ' ' LEU . 26.8 tp -104.83 131.69 51.99 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.308 0.575 . . . . 0.0 109.728 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.418 ' HG2' ' H ' ' A' ' 199' ' ' ASP . 12.6 ttmm -82.51 129.8 34.99 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.196 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.6 t -62.74 -31.44 72.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.087 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.426 ' OD1' ' OD1' ' A' ' 203' ' ' ASN . 16.2 t70 -59.42 -37.98 79.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.231 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.88 -42.94 89.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.691 HD11 ' CD2' ' A' ' 196' ' ' LEU . 84.6 mt -80.01 -77.98 0.18 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.437 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.37 125.31 44.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.744 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.426 ' OD1' ' OD1' ' A' ' 199' ' ' ASP . 44.0 m-80 -88.3 -70.09 0.66 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.82 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -113.0 -10.58 13.48 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.749 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -74.63 164.83 26.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.139 0.495 . . . . 0.0 110.035 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -52.51 -77.82 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.292 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.67 56.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.489 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.2 p -107.69 132.97 52.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.179 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.412 HD22 HD22 ' A' ' 201' ' ' LEU . 18.7 mt -80.74 132.29 35.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.809 -178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 201' ' ' LEU . 0.0 OUTLIER -95.62 165.74 16.01 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.672 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -36.14 -76.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.499 2.133 . . . . 0.0 111.973 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -49.96 -20.51 0.94 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.319 0.581 . . . . 0.0 110.277 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.37 -51.45 12.91 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -66.15 -38.25 87.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.023 0.439 . . . . 0.0 109.93 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.4 -53.3 59.85 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.06 -33.76 76.8 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.575 0.702 . . . . 0.0 110.336 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.2 mt -69.5 -26.2 64.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.394 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -76.23 -49.46 17.08 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.482 0.658 . . . . 0.0 111.113 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -63.91 -41.11 97.76 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.364 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 311' ' ' ILE . 36.8 tp -63.5 -41.81 98.53 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.662 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.8 t80 -51.59 -48.95 62.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.805 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 80.7 p -55.55 -51.37 67.3 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.475 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.435 HE21 HD12 ' A' ' 220' ' ' LEU . 17.0 mt-30 -53.26 -27.35 22.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.365 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.979 HD22 HG21 ' A' ' 313' ' ' VAL . 47.4 mt -95.61 -19.48 19.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.759 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 221' ' ' TYR . 8.4 t -78.57 -30.38 46.75 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.357 0.41 . . . . 0.0 110.886 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 52.3 t-20 -86.11 20.2 2.39 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.708 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -77.75 -178.79 5.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.933 179.443 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 315' ' ' GLY . 49.4 t0 -100.09 105.19 33.99 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 232' ' ' GLY . 32.5 Cg_exo -55.6 -20.64 28.06 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 123.077 2.518 . . . . 0.0 113.61 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 229' ' ' PRO . 62.6 pttt -27.22 -40.48 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.162 0.506 . . . . 0.0 111.318 -176.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 229' ' ' PRO . 13.3 p30 -115.23 -14.74 11.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.304 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 29.03 59.82 0.16 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.8 m -118.64 102.09 8.6 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 58.9 t -126.69 92.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.701 0.762 . . . . 0.0 110.273 179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.1 t -98.37 121.88 49.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.35 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.49 HG22 HG23 ' A' ' 311' ' ' ILE . 23.6 t -92.23 125.22 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.404 HD22 ' SD ' ' A' ' 279' ' ' MET . 55.0 mt -108.49 141.24 40.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.315 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.87 129.02 7.3 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -113.29 121.6 44.92 Favored 'General case' 0 C--N 1.346 0.416 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.652 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 6.7 p -115.88 162.63 17.06 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.452 ' O ' ' ND2' ' A' ' 249' ' ' ASN . 45.7 p30 -82.93 172.3 12.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.632 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.602 ' NH1' ' N ' ' A' ' 245' ' ' SER . 0.1 OUTLIER -94.62 126.21 39.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.327 -0.397 . . . . 0.0 109.932 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.4 mm -118.61 14.34 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.416 0.627 . . . . 0.0 110.708 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.425 ' C ' ' NH1' ' A' ' 242' ' ' ARG . . . 77.93 11.0 85.83 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.602 ' N ' ' NH1' ' A' ' 242' ' ' ARG . 11.2 m -135.97 94.61 3.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.114 0.483 . . . . 0.0 110.049 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.536 ' OD1' ' NH2' ' A' ' 242' ' ' ARG . 47.1 m-20 -46.81 -50.28 18.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.446 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.49 -42.38 74.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.635 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.522 ' CE2' HD11 ' A' ' 252' ' ' LEU . 33.1 t80 -66.0 -38.83 89.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.54 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 241' ' ' ASP . 27.3 t-20 -61.78 -52.6 63.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.107 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.67 -32.78 74.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.545 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.92 -43.79 98.72 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.522 HD11 ' CE2' ' A' ' 248' ' ' TYR . 33.0 mt -72.69 -35.48 67.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.763 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.8 t -64.76 -44.47 89.97 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.106 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.19 -42.4 75.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.176 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER -60.67 -49.9 75.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.357 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 260' ' ' VAL . 55.0 mtp180 -60.52 -52.38 65.44 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.607 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -57.11 -31.89 65.77 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -73.71 -45.01 54.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.234 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 77.4 p -61.38 -37.93 85.17 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.43 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 256' ' ' ARG . 91.8 t -65.11 -53.1 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.299 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.598 HG13 HD12 ' A' ' 274' ' ' ILE . 9.8 t -60.97 -49.37 85.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.329 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -46.35 -40.77 12.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.93 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -82.65 -31.96 28.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.606 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.37 -9.94 57.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.451 -179.301 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.554 ' C ' ' H ' ' A' ' 267' ' ' LYS . 62.8 mt -87.14 -53.57 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.775 0.322 . . . . 0.0 111.39 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 47.2 m -49.79 -6.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.004 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 265' ' ' ILE . 30.0 mmtm -81.39 -3.94 54.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.81 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.42 39.77 3.37 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.69 127.52 25.16 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.748 0.274 . . . . 0.0 110.378 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.48 128.25 27.19 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.917 1.745 . . . . 0.0 111.79 177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.79 -7.92 24.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.237 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -91.97 -23.09 19.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.827 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -80.38 -19.71 45.72 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.297 0.57 . . . . 0.0 110.977 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.598 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -104.45 -171.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.525 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 3.1 t -169.45 130.16 1.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.314 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -101.72 110.7 22.75 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.917 0.389 . . . . 0.0 110.76 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.26 140.52 49.24 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.7 0.762 . . . . 0.0 111.345 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -91.38 93.89 1.89 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.404 ' SD ' HD22 ' A' ' 237' ' ' LEU . 2.2 tpt -69.19 -8.36 44.97 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.419 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 39.97 -107.94 0.09 OUTLIER Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.27 59.03 1.59 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.75 0.309 . . . . 0.0 110.558 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.0 t -83.04 -8.06 59.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.697 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -157.33 66.27 3.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.471 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.28 110.82 3.14 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.634 2.222 . . . . 0.0 112.042 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 11.0 m -73.23 -25.32 21.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.525 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.634 ' O ' ' N ' ' A' ' 288' ' ' ASN . 1.5 p -61.44 -46.34 90.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.911 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.81 -5.77 0.01 OUTLIER Glycine 0 CA--C 1.536 1.356 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.634 ' N ' ' O ' ' A' ' 286' ' ' THR . 35.7 m120 -125.49 -55.43 1.54 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.8 m -66.02 -16.32 63.8 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.947 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 302' ' ' CYS . 92.0 m -118.51 24.78 10.71 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.634 0.254 . . . . 0.0 110.424 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 293' ' ' VAL . 57.4 t0 -57.8 -46.57 84.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.75 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -74.48 33.86 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.596 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 291' ' ' ASP . 3.1 t -133.32 104.12 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.387 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -119.41 14.43 12.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.916 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.46 142.1 33.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.06 0.457 . . . . 0.0 109.921 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -51.37 -72.07 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.164 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -54.09 -40.5 67.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.697 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.71 88.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.491 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 17.5 mt -66.61 -55.71 14.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.546 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.27 -37.01 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.991 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -72.56 -33.28 66.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.554 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.477 ' O ' ' SG ' ' A' ' 290' ' ' CYS . 1.8 t -92.12 -4.62 54.06 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.68 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.3 mm? -96.58 19.19 12.68 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.682 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.579 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -81.62 -44.42 1.1 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.343 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 37.2 Cg_exo -58.18 10.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 123.319 2.679 . . . . 0.0 112.376 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.5 t0 -109.91 17.0 21.59 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 307' ' ' ARG . 18.8 ptt85 -113.06 90.96 3.49 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.652 0.739 . . . . 0.0 110.246 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.53 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 38.3 ptt180 -158.93 130.23 6.29 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.206 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.86 140.53 16.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -120.85 104.3 9.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.451 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 236' ' ' VAL . 0.5 OUTLIER -78.46 118.38 25.55 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -95.99 119.84 35.2 Favored 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 123.171 0.294 . . . . 0.0 110.816 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.979 HG21 HD22 ' A' ' 224' ' ' LEU . 58.3 t -122.64 118.74 56.06 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 O-C-N 123.554 0.534 . . . . 0.0 111.088 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -114.8 131.1 56.92 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.05 36.36 4.48 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.669 ' O ' ' O ' ' A' ' 317' ' ' LYS . 11.4 tt -113.3 169.36 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.669 ' O ' ' O ' ' A' ' 316' ' ' ILE . 0.8 OUTLIER -43.18 -156.16 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 O-C-N 124.079 0.862 . . . . 0.0 111.251 -178.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -74.34 172.66 11.47 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.096 -0.641 . . . . 0.0 110.802 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 319' ' ' VAL . 13.8 p -114.83 126.49 72.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.083 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.3 t -80.37 134.31 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.906 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.2 t -126.86 158.34 36.95 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.045 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -141.36 132.11 13.25 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.783 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 324' ' ' GLN . 51.3 Cg_exo -50.21 144.69 22.39 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.003 1.802 . . . . 0.0 112.212 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 323' ' ' PRO . 56.8 tt0 59.11 149.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.596 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.52 -179.801 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.576 ' HB3' ' HD3' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 180' ' ' ALA . 62.1 Cg_endo -83.56 117.11 2.35 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 122.474 2.116 . . . . 0.0 112.016 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 50.92 61.27 13.53 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.405 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.44 96.34 0.97 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.468 2.112 . . . . 0.0 111.982 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 185' ' ' PRO . . . -169.16 159.6 7.69 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.44 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 184' ' ' ALA . 54.4 Cg_endo -69.53 151.28 70.35 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.597 2.198 . . . . 0.0 111.436 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -133.06 149.91 74.08 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.756 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.12 137.04 37.82 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.283 1.989 . . . . 0.0 112.052 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -103.98 4.67 34.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.625 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.31 132.78 64.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.408 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.449 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.3 OUTLIER -122.74 114.76 20.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.114 0.483 . . . . 0.0 110.474 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 35.5 m -70.76 138.41 50.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.447 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 193' ' ' HIS . 1.3 mmtm -115.17 172.21 7.21 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.425 0.631 . . . . 0.0 110.667 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' A' ' 192' ' ' LYS . 59.3 m80 -157.63 126.4 5.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.326 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.66 116.31 29.95 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -84.65 103.31 13.65 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.947 -179.408 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.704 ' CD2' HD11 ' A' ' 201' ' ' LEU . 29.5 tp -106.62 130.01 54.44 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.581 0.705 . . . . 0.0 110.02 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -79.14 127.31 31.86 Favored 'General case' 0 C--O 1.252 1.186 0 CA-C-O 122.572 1.177 . . . . 0.0 112.468 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.522 ' OG ' ' NH2' ' A' ' 256' ' ' ARG . 15.4 m -61.73 -35.03 76.89 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.508 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -57.2 -34.6 68.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.95 -44.12 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.704 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.7 mt -79.8 -77.36 0.19 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.574 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.03 124.7 42.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.936 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.544 ' CG ' ' H ' ' A' ' 204' ' ' PHE . 5.0 p-10 -100.51 -76.45 0.56 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.465 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . 0.544 ' H ' ' CG ' ' A' ' 203' ' ' ASN . 68.0 m-85 -96.85 -20.53 18.09 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.783 0.325 . . . . 0.0 110.738 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -70.97 165.25 23.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.124 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -51.12 -81.8 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.63 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -162.0 56.05 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.453 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 28.5 p -109.17 143.5 38.5 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 110.211 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.405 HD12 ' CG ' ' A' ' 263' ' ' TYR . 10.0 mt -81.03 132.17 35.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.839 -178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 213' ' ' GLY . 30.8 mmtm -93.96 157.48 37.85 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.982 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 210' ' ' LYS . 75.6 Cg_exo -32.43 -76.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.309 2.006 . . . . 0.0 111.951 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.665 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 1.9 pm0 -48.36 -23.23 0.86 Allowed 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.512 0.672 . . . . 0.0 110.271 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.52 -44.14 27.86 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.198 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -68.03 -40.45 82.9 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.201 0.524 . . . . 0.0 109.742 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.31 -52.89 62.87 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.727 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.53 -35.8 80.58 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.143 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.35 -28.36 69.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.21 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -76.63 -47.49 22.07 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.314 0.578 . . . . 0.0 110.825 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -61.72 -44.39 97.02 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.336 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.473 HD12 HE21 ' A' ' 223' ' ' GLN . 39.4 tp -65.17 -40.24 94.02 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.403 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.504 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.3 t80 -51.89 -48.69 63.99 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.35 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.4 m -55.29 -52.31 63.84 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.048 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.473 HE21 HD12 ' A' ' 220' ' ' LEU . 17.2 mt-30 -49.83 -24.83 2.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.387 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.678 ' O ' HD22 ' A' ' 227' ' ' LEU . 18.7 mt -98.35 -16.94 19.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.77 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 79.9 p -75.62 -21.95 57.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.896 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -104.05 20.07 18.91 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.992 0.425 . . . . 0.0 110.999 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.678 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -77.61 156.03 31.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.158 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 315' ' ' GLY . 23.6 t0 -70.54 119.47 72.77 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.881 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.504 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.3 Cg_endo -69.85 -19.27 35.93 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.758 2.305 . . . . 0.0 113.194 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.504 ' C ' ' O ' ' A' ' 229' ' ' PRO . 50.4 tptt -23.98 -50.39 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 124.068 0.855 . . . . 0.0 110.88 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 232' ' ' GLY . 7.7 p30 -113.18 -12.67 13.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.282 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 27.8 59.65 0.12 Allowed Glycine 0 N--CA 1.475 1.258 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 64.1 m -117.83 107.14 13.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 122.736 -0.273 . . . . 0.0 110.726 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 84.0 t -127.3 95.09 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.555 0.693 . . . . 0.0 110.078 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.8 t -97.85 120.93 47.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.187 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.466 HG22 HG23 ' A' ' 311' ' ' ILE . 17.1 t -92.73 125.3 45.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.719 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 59.5 mt -108.4 142.59 38.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.391 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.479 ' O ' ' OG ' ' A' ' 253' ' ' SER . . . -125.62 130.04 7.09 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -116.39 122.48 44.97 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.9 p -108.46 171.42 7.42 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.051 0.453 . . . . 0.0 109.846 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -92.68 -178.07 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.515 ' H ' HD12 ' A' ' 303' ' ' LEU . 73.2 ttt-85 -102.58 121.93 43.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.411 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.8 mm -118.42 13.13 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.503 0.668 . . . . 0.0 110.864 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.32 9.82 83.16 Favored Glycine 0 C--N 1.315 -0.625 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.6 m -140.28 91.72 2.47 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.239 0.542 . . . . 0.0 110.308 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -48.23 -49.9 31.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.675 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.74 77.51 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.7 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.594 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 50.7 t80 -59.71 -47.78 84.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 110.423 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.543 HD21 ' H ' ' A' ' 243' ' ' ILE . 87.2 m-20 -62.83 -41.38 99.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.458 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -57.08 -46.22 82.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.184 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.01 -34.66 90.52 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.594 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 31.6 mt -71.63 -38.92 70.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.739 0.304 . . . . 0.0 111.121 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 238' ' ' GLY . 6.5 t -64.97 -43.2 93.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.694 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.98 -46.03 75.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.145 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -55.64 -46.73 77.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.036 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.522 ' NH2' ' OG ' ' A' ' 198' ' ' SER . 50.7 mtp180 -62.53 -61.92 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 110.174 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -50.48 -36.64 34.61 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.286 0.565 . . . . 0.0 109.893 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -73.05 -45.6 56.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.897 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 40.0 t -58.59 -37.97 76.93 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.829 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 256' ' ' ARG . 92.2 t -64.3 -51.08 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.049 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.652 HG13 HD12 ' A' ' 274' ' ' ILE . 12.8 t -61.92 -48.59 87.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.59 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -47.29 -43.08 22.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.878 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.552 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 48.6 t80 -77.42 -34.65 54.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.449 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -34.36 78.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.961 0.41 . . . . 0.0 110.525 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' A' ' 267' ' ' LYS . 88.3 mt -62.73 -50.33 80.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.253 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.9 t -49.31 -8.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.88 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.552 ' CE ' ' CE2' ' A' ' 263' ' ' TYR . 32.2 mmtp -86.64 12.52 10.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.504 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 79.68 42.66 11.06 Favored Glycine 0 CA--C 1.509 -0.302 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.024 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.12 128.72 25.21 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.226 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.72 127.94 26.47 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.968 1.779 . . . . 0.0 112.274 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.52 -8.71 28.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.841 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -91.94 -23.46 19.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.919 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.03 -22.95 44.68 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.534 0.683 . . . . 0.0 110.61 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.652 HD12 HG13 ' A' ' 261' ' ' VAL . 1.5 pt -102.1 -175.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.822 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 6.7 t -170.48 127.09 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.591 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.46 151.3 19.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -156.73 144.06 18.95 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.078 0.466 . . . . 0.0 111.036 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -97.22 97.21 1.95 Allowed Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.409 ' HG3' ' CZ ' ' A' ' 239' ' ' TYR . 1.2 mmt -68.6 -7.64 34.63 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.252 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 45.6 -109.17 0.29 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 281' ' ' GLU . 51.9 mp0 -131.21 57.12 1.77 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.644 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 6.2 t -80.23 -4.59 53.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.627 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -155.87 67.93 4.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.934 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.77 105.8 2.15 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.304 2.003 . . . . 0.0 111.613 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 286' ' ' THR . 15.1 m -69.62 -36.71 71.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.517 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.582 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.9 OUTLIER -63.75 -46.94 83.04 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.194 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -46.79 -6.89 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.582 ' H ' ' C ' ' A' ' 286' ' ' THR . 21.5 t-20 -124.65 -58.44 1.5 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.749 0.309 . . . . 0.0 110.367 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.0 m -63.5 -24.87 68.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.654 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.429 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.1 OUTLIER -116.34 27.02 9.49 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.192 0.307 . . . . 0.0 110.32 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 288' ' ' ASN . 2.4 p30 -69.96 -5.78 28.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.708 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -98.33 32.97 2.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.609 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.429 HG21 ' SG ' ' A' ' 290' ' ' CYS . 16.8 t -131.38 123.9 53.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.894 0.378 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -118.89 8.16 11.66 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.874 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.467 ' O ' HD12 ' A' ' 299' ' ' LEU . 7.5 mt-30 -88.03 169.33 12.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.135 0.493 . . . . 0.0 110.069 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.7 tmm_? -85.2 -68.01 0.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.905 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -60.44 -30.98 69.99 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.094 0.473 . . . . 0.0 110.831 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.81 83.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.404 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 295' ' ' GLN . 63.0 mt -74.38 -54.67 7.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 72.9 mt -46.91 -36.53 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.062 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.94 -44.36 48.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.143 0.497 . . . . 0.0 110.688 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.2 t -75.57 -3.3 33.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.788 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.515 HD12 ' H ' ' A' ' 242' ' ' ARG . 1.3 mm? -96.19 16.66 17.59 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.383 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.59 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -80.04 -46.03 1.44 Allowed Pre-proline 0 C--O 1.241 0.632 0 CA-C-O 121.336 0.588 . . . . 0.0 110.052 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 24.5 Cg_exo -61.5 8.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.12 2.547 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 304' ' ' ALA . 56.2 t0 -103.79 14.82 30.13 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.679 0.276 . . . . 0.0 110.687 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -114.31 96.88 6.0 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 121.773 0.797 . . . . 0.0 109.788 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.544 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 15.8 ptm180 -156.71 130.13 8.09 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.988 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.9 140.69 16.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -123.25 105.25 9.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.316 0.579 . . . . 0.0 111.044 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.466 HG23 HG22 ' A' ' 236' ' ' VAL . 0.2 OUTLIER -78.77 118.7 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.32 -178.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -95.1 124.33 39.08 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.154 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.535 HG21 HD22 ' A' ' 224' ' ' LEU . 21.9 t -123.66 117.79 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.175 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -116.67 130.59 56.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 95.04 37.93 5.02 Favored Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.589 ' O ' ' O ' ' A' ' 317' ' ' LYS . 13.4 tt -117.51 173.42 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.589 ' O ' ' O ' ' A' ' 316' ' ' ILE . 98.1 mttt -49.77 -150.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 O-C-N 124.154 0.909 . . . . 0.0 110.51 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 318' ' ' ASP . 40.8 p-10 -156.24 117.54 3.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.454 -0.779 . . . . 0.0 110.424 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.71 132.13 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 47.9 t -131.64 91.94 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.14 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 22.2 p -88.22 165.13 15.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.311 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -117.64 84.27 19.14 Favored Pre-proline 0 N--CA 1.468 0.433 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.444 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.28 -10.72 17.64 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.762 2.308 . . . . 0.0 111.935 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -168.33 -87.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.452 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.505 -179.846 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.6 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 27.7 Cg_exo -60.75 144.58 99.57 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.632 2.221 . . . . 0.0 112.307 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.612 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -82.82 -41.8 0.88 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.537 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 23.8 Cg_exo -62.94 16.06 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.795 2.33 . . . . 0.0 112.024 179.268 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.551 ' H ' ' C ' ' A' ' 182' ' ' ALA . . . -40.67 149.09 0.34 Allowed Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.828 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.93 -176.17 1.98 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.311 2.007 . . . . 0.0 112.165 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.661 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . -165.85 -62.47 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.231 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.661 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 36.5 Cg_endo -63.47 152.26 81.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.342 2.028 . . . . 0.0 111.624 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -52.34 125.83 17.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.725 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.43 130.82 43.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.108 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.402 ' OE1' ' C ' ' A' ' 317' ' ' LYS . 0.3 OUTLIER -105.41 85.33 2.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.104 0.478 . . . . 0.0 109.913 -179.823 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.5 HG22 ' NE2' ' A' ' 193' ' ' HIS . 17.6 m -74.39 130.77 40.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.999 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -147.7 120.31 8.57 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.5 ' NE2' HG22 ' A' ' 191' ' ' THR . 3.4 m170 -108.07 151.45 25.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -112.1 121.47 45.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.317 0.579 . . . . 0.0 110.121 178.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 195' ' ' THR . 6.4 t -86.2 102.04 13.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.568 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.686 ' CD2' HD11 ' A' ' 201' ' ' LEU . 32.0 tp -104.48 131.95 51.28 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.15 -178.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -81.37 126.37 31.52 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.188 -177.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 202' ' ' PHE . 96.1 p -61.5 -32.63 72.67 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.937 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -59.43 -41.73 90.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.377 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 82.6 t -61.92 -48.75 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.686 HD11 ' CD2' ' A' ' 196' ' ' LEU . 89.5 mt -72.14 -77.81 0.09 Allowed 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.396 179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -120.17 123.16 42.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.33 -179.154 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -86.74 -73.78 0.45 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.052 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -107.43 -11.9 15.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.772 0.32 . . . . 0.0 110.51 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -72.44 163.52 27.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.152 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -52.13 -78.25 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.255 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.33 57.01 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.27 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.8 t -108.8 137.79 46.17 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.304 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.482 HD12 ' CG ' ' A' ' 263' ' ' TYR . 10.7 mt -80.95 131.75 35.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.34 0.591 . . . . 0.0 111.394 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 213' ' ' GLY . 9.2 pttp -94.77 154.62 39.86 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.443 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.439 ' C ' ' O ' ' A' ' 210' ' ' LYS . 93.5 Cg_exo -31.15 -73.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.269 1.979 . . . . 0.0 112.306 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -50.75 -25.11 3.98 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.954 0.407 . . . . 0.0 110.591 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.86 -46.58 16.83 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -62.42 -41.04 98.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.39 -52.84 62.22 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.373 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.64 70.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.585 0.707 . . . . 0.0 110.292 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.95 -29.69 66.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.169 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -75.73 -49.07 19.32 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.154 0.502 . . . . 0.0 111.236 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.538 ' O ' ' NE2' ' A' ' 223' ' ' GLN . 2.6 pt20 -61.93 -42.79 99.5 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.497 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 31.5 tp -65.41 -40.1 92.96 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.3 t80 -52.56 -45.49 66.44 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.907 178.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 48.3 t -55.5 -51.25 67.63 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.357 -178.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.858 HE21 ' H ' ' A' ' 223' ' ' GLN . 0.0 OUTLIER -54.14 -25.69 23.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.495 -179.263 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.869 HD22 HG21 ' A' ' 313' ' ' VAL . 18.3 mt -97.86 -21.95 16.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.758 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.2 t -75.26 -32.77 61.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.349 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -97.1 24.16 6.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 -179.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.593 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.25 157.7 32.33 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.502 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 315' ' ' GLY . 8.0 t70 -71.73 120.48 80.23 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 232' ' ' GLY . 56.7 Cg_endo -67.78 -20.08 46.38 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 121.801 1.667 . . . . 0.0 113.522 -177.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 229' ' ' PRO . 51.3 tptt -28.6 -44.86 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.388 0.43 . . . . 0.0 111.299 -178.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.481 ' O ' ' C ' ' A' ' 232' ' ' GLY . 72.5 m-20 -109.77 -14.42 14.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.507 179.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 25.16 51.38 0.04 OUTLIER Glycine 0 N--CA 1.469 0.834 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.1 m -117.84 109.98 17.22 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.738 0.304 . . . . 0.0 111.101 -178.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.48 94.03 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 121.641 0.734 . . . . 0.0 110.116 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.86 121.82 47.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.271 -178.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.437 HG22 HG23 ' A' ' 311' ' ' ILE . 20.9 t -95.3 121.58 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.515 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.45 HD22 ' SD ' ' A' ' 279' ' ' MET . 79.0 mt -105.52 141.01 37.74 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.006 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.7 126.14 6.25 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -111.66 124.87 53.22 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.2 t -115.96 168.85 9.71 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.832 0.348 . . . . 0.0 110.505 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -92.36 -177.21 4.56 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.576 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.574 ' NE ' ' OE1' ' A' ' 281' ' ' GLU . 92.2 mtt180 -100.62 128.02 46.81 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.989 0.423 . . . . 0.0 110.482 179.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.1 mm -118.28 11.67 7.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.773 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 83.91 3.48 89.22 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.5 t -135.23 102.85 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.286 0.565 . . . . 0.0 110.361 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -55.16 -51.71 65.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.548 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.97 -48.36 70.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.548 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.687 ' CE2' HD11 ' A' ' 252' ' ' LEU . 47.4 t80 -62.91 -42.12 99.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.307 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.527 HD21 ' H ' ' A' ' 243' ' ' ILE . 98.4 m-20 -61.43 -46.31 90.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.587 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.4 HE22 ' HA3' ' A' ' 280' ' ' GLY . 95.8 mm-40 -61.25 -41.63 97.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.451 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.94 -36.07 92.94 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.687 HD11 ' CE2' ' A' ' 248' ' ' TYR . 32.9 mt -70.59 -41.26 72.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.81 178.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 11.7 t -65.33 -42.65 92.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.57 -49.11 72.46 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.129 0.49 . . . . 0.0 109.816 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -58.46 -44.84 89.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.256 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 51.8 ttm-85 -51.27 -64.25 0.87 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.54 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -56.84 -31.38 64.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.244 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -66.09 -48.19 71.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.542 179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.47 ' O ' ' OD2' ' A' ' 262' ' ' ASP . 13.6 t -60.06 -39.13 84.95 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.467 0.651 . . . . 0.0 110.826 -178.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 87.5 t -62.24 -50.67 79.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.216 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 276' ' ' ALA . 23.1 t -62.2 -48.92 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.794 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' ' 259' ' ' SER . 0.0 OUTLIER -47.53 -41.73 21.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.144 0.497 . . . . 0.0 110.014 -177.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.482 ' CG ' HD12 ' A' ' 209' ' ' LEU . 15.6 t80 -79.85 -34.11 39.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.83 -178.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -33.87 76.84 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.33 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.404 ' C ' ' N ' ' A' ' 267' ' ' LYS . 84.6 mt -65.99 -49.36 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 79.0 p -54.07 -11.1 0.41 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.966 -178.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.422 ' CB ' ' CD1' ' A' ' 221' ' ' TYR . 70.9 mmtt -78.41 -7.46 57.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.683 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 101.61 43.06 2.2 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.768 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.3 128.74 23.65 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 117.12 0.46 . . . . 0.0 110.029 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.22 129.2 27.85 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.694 1.596 . . . . 0.0 111.817 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.68 -10.53 47.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.954 0.406 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -90.66 -21.36 21.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.385 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -19.9 41.88 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.948 0.88 . . . . 0.0 110.975 -179.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.482 HD12 HG13 ' A' ' 261' ' ' VAL . 2.3 pt -104.96 -173.5 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.455 -179.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 15.7 t -166.62 135.82 2.98 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.283 178.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.495 ' HB2' HG21 ' A' ' 261' ' ' VAL . . . -108.06 110.48 22.18 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.957 0.408 . . . . 0.0 110.838 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -115.46 137.24 52.26 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.386 0.612 . . . . 0.0 111.503 -178.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 280' ' ' GLY . . . -86.85 92.09 1.78 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 178.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.45 ' SD ' HD22 ' A' ' 237' ' ' LEU . 5.1 tpt -66.19 3.9 0.8 Allowed 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.502 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 278' ' ' GLY . . . 35.35 -104.64 0.02 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.12 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.574 ' OE1' ' NE ' ' A' ' 242' ' ' ARG . 30.9 tt0 -142.62 58.21 1.44 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.3 m -85.33 -4.02 59.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -149.59 65.61 7.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.233 -179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.31 148.31 90.96 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.21 1.94 . . . . 0.0 111.26 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.569 HG23 ' H ' ' A' ' 286' ' ' THR . 19.6 m -110.95 -55.36 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.247 0.546 . . . . 0.0 110.907 178.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.791 HG21 ' O ' ' A' ' 302' ' ' CYS . 18.6 p -58.91 -40.78 85.55 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.075 -179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -44.61 -7.73 0.01 OUTLIER Glycine 0 CA--C 1.531 1.078 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.632 ' N ' ' O ' ' A' ' 286' ' ' THR . 3.2 m-20 -123.45 -54.99 1.76 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 177.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.8 m -66.89 -22.03 65.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.324 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.609 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -120.95 24.53 10.14 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.756 0.312 . . . . 0.0 110.481 -179.565 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -66.58 -9.01 30.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.981 0.42 . . . . 0.0 110.358 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -93.77 33.72 1.27 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.173 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.609 HG21 ' SG ' ' A' ' 290' ' ' CYS . 14.5 t -135.32 120.59 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.8 0.333 . . . . 0.0 110.733 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 13.03 13.14 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.424 ' N ' ' CD ' ' A' ' 295' ' ' GLN . 0.1 OUTLIER -99.59 136.93 38.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.974 0.416 . . . . 0.0 109.953 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -58.14 -46.12 86.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.2 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -67.11 -46.93 72.69 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.285 -178.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.19 -26.36 68.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.661 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 303' ' ' LEU . 31.8 mt -76.12 -57.04 4.11 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.549 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 82.2 mt -53.36 -36.97 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.244 0.545 . . . . 0.0 109.882 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -72.0 -40.34 68.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.099 178.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.791 ' O ' HG21 ' A' ' 286' ' ' THR . 9.1 t -83.68 -8.02 59.37 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.562 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 299' ' ' LEU . 49.4 mt -93.77 21.73 6.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.463 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -80.25 -43.35 1.4 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 121.055 0.455 . . . . 0.0 110.711 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.3 Cg_exo -60.77 10.27 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.398 2.732 . . . . 0.0 111.681 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 304' ' ' ALA . 2.0 m-20 -103.88 14.26 31.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.743 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 85.9 mtm-85 -115.87 93.84 4.42 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.239 0.543 . . . . 0.0 110.165 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.505 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 8.4 ptm180 -154.44 128.4 8.85 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.512 0.673 . . . . 0.0 112.575 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.54 135.57 28.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.508 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.448 ' OE2' ' CZ ' ' A' ' 239' ' ' TYR . 28.5 mt-10 -118.66 104.37 10.56 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.26 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.437 HG23 HG22 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -79.48 117.86 25.93 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.543 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -96.0 121.61 37.93 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.141 0.495 . . . . 0.0 110.594 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.869 HG21 HD22 ' A' ' 224' ' ' LEU . 52.4 t -124.34 117.27 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.955 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -112.92 138.67 49.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 87.82 39.14 7.17 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -178.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.715 ' O ' ' O ' ' A' ' 317' ' ' LYS . 12.3 tt -116.68 169.31 7.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.715 ' O ' ' O ' ' A' ' 316' ' ' ILE . 68.2 mttm -38.78 -163.94 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.7 0.762 . . . . 0.0 112.016 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -87.9 172.71 9.4 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.657 -0.652 . . . . 0.0 110.729 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 16.1 t -98.08 97.87 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.804 179.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.67 130.29 36.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.472 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.3 p -117.57 96.77 5.54 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.318 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -116.69 89.32 27.94 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.001 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.89 135.97 59.01 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.102 1.868 . . . . 0.0 111.858 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.431 ' O ' ' OXT' ' A' ' 325' ' ' ALA . 29.4 pt20 -157.08 151.76 25.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.573 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.431 ' OXT' ' O ' ' A' ' 324' ' ' GLN . . . . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.661 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.05 -19.91 44.93 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.768 2.312 . . . . 0.0 112.018 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 59.56 73.51 0.66 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.334 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.79 148.05 93.22 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.895 2.397 . . . . 0.0 111.918 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.44 69.94 46.32 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.37 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.26 -39.77 79.79 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.623 2.215 . . . . 0.0 112.005 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -174.48 78.69 0.34 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.444 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 188' ' ' GLU . 50.5 Cg_exo -51.8 -35.25 58.12 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.67 2.247 . . . . 0.0 112.016 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 187' ' ' PRO . 84.7 tt0 57.04 114.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.476 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.0 t -135.26 131.25 51.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.133 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -112.87 85.85 2.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.711 -179.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 192' ' ' LYS . 43.3 m -76.59 167.03 22.57 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.008 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 191' ' ' THR . 3.8 tptm -152.37 98.5 2.4 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.561 0.696 . . . . 0.0 110.998 178.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -85.27 125.16 32.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.408 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.606 ' CE2' HD21 ' A' ' 224' ' ' LEU . 54.4 m-85 -112.73 119.27 37.49 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 195' ' ' THR . 7.7 t -86.4 104.93 16.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.427 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.687 ' CD2' HD11 ' A' ' 201' ' ' LEU . 27.7 tp -107.38 129.47 54.92 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.068 0.461 . . . . 0.0 109.773 -179.4 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -78.81 126.78 31.18 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.876 0.845 . . . . 0.0 112.113 -178.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 202' ' ' PHE . 94.6 p -62.74 -30.29 71.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.984 179.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -58.86 -40.27 83.8 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.32 -46.27 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.687 HD11 ' CD2' ' A' ' 196' ' ' LEU . 90.3 mt -75.93 -76.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.359 179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -126.48 128.29 46.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.946 -179.787 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -108.45 -76.18 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.27 -34.09 17.83 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.561 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.468 ' ND2' ' OG1' ' A' ' 208' ' ' THR . 48.9 p30 -62.79 165.77 6.27 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.076 0.465 . . . . 0.0 110.223 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -54.93 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.54 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -163.3 52.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.63 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.468 ' OG1' ' ND2' ' A' ' 205' ' ' ASN . 60.9 p -107.14 137.76 44.59 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.279 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.2 mt -74.6 142.74 44.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.18 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 213' ' ' GLY . 34.4 mtpt -101.83 159.68 28.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.137 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 210' ' ' LYS . 82.2 Cg_exo -33.96 -77.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.418 2.079 . . . . 0.0 111.982 179.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 56.2 mp0 -51.47 -17.01 0.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.262 0.553 . . . . 0.0 110.181 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -75.99 -48.22 10.24 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.343 178.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . 0.402 ' NE2' ' CE1' ' A' ' 263' ' ' TYR . 93.1 mt-30 -67.62 -40.11 84.69 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.139 0.495 . . . . 0.0 109.783 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.49 -50.34 74.11 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.661 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 219' ' ' GLN . . . -65.07 -32.65 74.46 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.509 0.671 . . . . 0.0 110.311 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.9 mt -70.33 -26.89 63.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.421 179.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -74.94 -47.66 28.47 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.36 0.6 . . . . 0.0 111.178 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 216' ' ' ALA . 15.4 pt20 -64.63 -40.72 95.96 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.469 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 49.2 tp -63.78 -41.47 97.95 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.488 178.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 225' ' ' SER . 6.3 t80 -53.02 -51.02 63.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.998 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 6.1 t -53.19 -51.48 61.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.266 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.562 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 11.1 tt0 -55.12 -25.92 34.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.946 HD22 HG21 ' A' ' 313' ' ' VAL . 86.5 mt -94.89 -20.28 19.56 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.641 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 221' ' ' TYR . 24.6 p -83.36 -11.42 57.65 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.396 0.435 . . . . 0.0 110.444 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.443 ' O ' ' OD1' ' A' ' 226' ' ' ASN . 13.7 t-20 -97.48 22.4 8.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.237 0.541 . . . . 0.0 110.263 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.539 ' H ' ' CD2' ' A' ' 227' ' ' LEU . 0.6 OUTLIER -80.03 -177.69 6.14 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.975 -179.833 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 315' ' ' GLY . 21.5 t0 -100.26 108.02 50.48 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.77 178.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 230' ' ' LYS . 75.6 Cg_exo -46.19 -21.01 1.0 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.667 2.245 . . . . 0.0 112.917 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 229' ' ' PRO . 65.0 tttm -35.91 -52.21 0.73 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.041 0.448 . . . . 0.0 110.546 -177.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.47 ' O ' ' C ' ' A' ' 232' ' ' GLY . 57.4 m-20 -98.71 -21.52 16.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.528 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.17 50.32 0.04 OUTLIER Glycine 0 N--CA 1.471 1.007 0 O-C-N 123.849 0.718 . . . . 0.0 111.646 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.68 111.81 19.0 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 122.574 -0.368 . . . . 0.0 110.69 -179.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.02 97.32 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.712 0.767 . . . . 0.0 110.311 179.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.4 t -99.67 121.17 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.554 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 85.7 t -95.41 126.86 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.428 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 55.2 mt -111.93 140.53 46.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.051 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.429 ' O ' ' SD ' ' A' ' 279' ' ' MET . . . -116.7 136.48 12.81 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.609 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -120.81 122.04 39.45 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.511 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.402 HG22 ' NH1' ' A' ' 256' ' ' ARG . 3.3 p -113.3 165.8 12.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.011 0.434 . . . . 0.0 110.218 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.52 ' OD2' HD11 ' A' ' 243' ' ' ILE . 9.4 p-10 -89.98 -177.32 5.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.644 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -98.42 122.06 41.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.281 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.3 mm -118.55 13.6 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.274 0.559 . . . . 0.0 110.702 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 82.73 2.65 90.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.9 m -132.79 98.92 4.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.033 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -54.01 -51.61 63.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.461 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.74 -41.6 74.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.505 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.591 ' CE2' HD11 ' A' ' 252' ' ' LEU . 55.2 t80 -63.36 -43.24 98.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.67 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.06 -42.38 99.13 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.523 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -64.04 -41.57 97.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.785 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.23 -39.07 97.21 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.591 HD11 ' CE2' ' A' ' 248' ' ' TYR . 33.5 mt -69.08 -38.2 78.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.764 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 15.4 m -63.66 -43.74 95.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.959 0.409 . . . . 0.0 111.011 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.11 -40.83 91.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.045 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.457 ' HA ' ' HE ' ' A' ' 255' ' ' ARG . 0.0 OUTLIER -60.09 -47.41 86.01 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.28 -179.718 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.803 HH22 ' HE ' ' A' ' 307' ' ' ARG . 99.6 mtt180 -61.36 -58.78 6.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.115 179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -52.74 -32.67 44.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.109 0.48 . . . . 0.0 109.753 179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.56 -51.28 15.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.352 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.476 ' O ' ' OD2' ' A' ' 262' ' ' ASP . 66.2 m -58.86 -38.79 79.56 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.667 0.746 . . . . 0.0 110.268 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 256' ' ' ARG . 88.0 t -63.4 -50.1 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.365 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.591 HG13 HD12 ' A' ' 274' ' ' ILE . 12.8 t -62.08 -49.16 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.475 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 259' ' ' SER . 0.0 OUTLIER -45.06 -42.43 8.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.16 0.505 . . . . 0.0 110.272 -178.573 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.402 ' CE1' ' NE2' ' A' ' 214' ' ' GLN . 19.9 t80 -80.62 -31.38 36.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.637 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.9 -7.39 45.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.285 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.562 ' C ' ' H ' ' A' ' 267' ' ' LYS . 69.6 mt -88.62 -58.35 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 111.612 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 58.1 p -49.17 -6.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.075 -178.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.0 OUTLIER -78.19 -11.69 59.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.847 0.356 . . . . 0.0 110.527 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 108.67 39.88 1.68 Allowed Glycine 0 C--N 1.329 0.161 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.0 129.98 23.88 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.0 128.85 30.6 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.67 1.58 . . . . 0.0 111.698 176.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.23 -10.17 47.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.849 0.357 . . . . 0.0 111.122 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 273' ' ' LYS . 33.5 p30 -92.61 -18.21 23.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.479 ' N ' ' OD1' ' A' ' 272' ' ' ASP . 1.4 ttpm? -83.98 -18.26 37.79 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.605 0.717 . . . . 0.0 110.71 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.591 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -105.27 -171.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.717 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 7.6 t -168.53 133.19 1.62 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.202 179.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -105.2 112.04 25.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.784 0.326 . . . . 0.0 110.608 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.35 150.34 45.61 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.539 0.685 . . . . 0.0 110.982 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -115.37 97.63 0.81 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.659 ' CE ' ' H ' ' A' ' 282' ' ' SER . 3.3 ppp? -80.85 6.74 12.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.884 0.374 . . . . 0.0 111.001 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 47.38 -99.17 0.02 OUTLIER Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.983 179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.447 ' CD ' ' N ' ' A' ' 281' ' ' GLU . 1.8 pm0 -139.36 80.14 1.76 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.845 0.355 . . . . 0.0 111.032 -178.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.659 ' H ' ' CE ' ' A' ' 279' ' ' MET . 88.0 p -88.92 -2.0 58.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.071 -179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -163.02 75.6 1.93 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.296 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.34 103.7 0.68 Allowed 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.461 2.107 . . . . 0.0 112.805 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 286' ' ' THR . 19.2 m -73.74 -35.88 44.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.231 0.539 . . . . 0.0 110.095 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.637 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.9 OUTLIER -58.98 -43.51 91.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.507 -179.714 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -50.38 -0.8 0.02 OUTLIER Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.637 ' H ' ' C ' ' A' ' 286' ' ' THR . 11.0 t30 -122.16 -58.62 1.71 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.7 m -58.73 -23.0 59.07 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.737 0.303 . . . . 0.0 110.524 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 3.3 m -120.29 28.49 8.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.143 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -70.78 -17.88 62.77 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.86 0.362 . . . . 0.0 110.952 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -97.57 31.47 2.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.437 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.408 HG12 ' CD1' ' A' ' 299' ' ' LEU . 23.6 t -137.95 129.31 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.194 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -121.23 13.3 11.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -96.44 131.37 43.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.168 0.509 . . . . 0.0 110.249 -179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -52.76 -67.98 0.21 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.031 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.48 -41.2 60.76 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.891 -178.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.26 80.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.424 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 303' ' ' LEU . 4.9 mp -72.74 -52.03 16.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.714 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 81.6 mt -43.17 -38.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.906 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -76.51 -43.53 39.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.359 178.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.7 t -73.93 -5.43 41.14 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.505 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.4 mm? -94.55 13.35 24.37 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.57 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.598 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -73.73 -43.1 6.56 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.734 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 26.5 Cg_exo -60.81 9.51 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.438 2.759 . . . . 0.0 112.255 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 304' ' ' ALA . 53.1 t0 -108.81 9.5 26.82 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.662 0.268 . . . . 0.0 110.669 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.803 ' HE ' HH22 ' A' ' 256' ' ' ARG . 68.3 mtp180 -112.38 98.87 7.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.333 0.587 . . . . 0.0 110.148 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.466 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 36.5 ptt180 -167.75 144.54 4.23 Favored 'General case' 0 C--O 1.215 -0.763 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.784 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.414 HG12 ' HA2' ' A' ' 238' ' ' GLY . 22.4 m -107.2 147.67 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -121.02 110.62 16.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.146 0.498 . . . . 0.0 111.091 -178.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.4 mm -80.49 118.31 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -104.33 98.96 8.67 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.942 -179.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.946 HG21 HD22 ' A' ' 224' ' ' LEU . 93.0 t -106.06 123.48 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.444 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -115.53 146.89 41.3 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.999 179.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 91.96 15.84 52.99 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -179.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.42 143.71 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.211 0.529 . . . . 0.0 110.825 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 319' ' ' VAL . 41.4 tptt -87.28 129.68 34.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.767 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -50.9 94.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.482 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 317' ' ' LYS . 19.2 t -74.61 133.92 30.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.446 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 12.4 t -88.49 120.83 37.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.414 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 4.8 t -150.92 167.37 27.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.439 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.608 ' CD ' ' H ' ' A' ' 322' ' ' GLN . 7.8 mp0 -80.09 146.69 63.66 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.684 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.86 -26.52 51.99 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.388 2.059 . . . . 0.0 112.079 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -87.95 -42.63 12.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.721 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.603 -179.948 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.626 ' HB3' ' HD3' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 180' ' ' ALA . 73.4 Cg_endo -79.62 153.93 23.56 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.499 2.133 . . . . 0.0 112.157 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . 59.44 78.73 0.33 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.475 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.03 145.3 98.1 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.861 2.374 . . . . 0.0 112.058 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.646 ' HB3' ' CD ' ' A' ' 185' ' ' PRO . . . -179.47 -61.45 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.127 -179.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.646 ' CD ' ' HB3' ' A' ' 184' ' ' ALA . 25.4 Cg_endo -60.14 146.05 97.1 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.568 2.179 . . . . 0.0 111.962 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 187' ' ' PRO . . . -47.64 179.54 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.333 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.684 ' HD2' ' HB1' ' A' ' 186' ' ' ALA . 33.3 Cg_exo -60.83 151.21 78.82 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.809 2.339 . . . . 0.0 112.111 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -44.65 157.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.34 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 190' ' ' GLN . 4.1 p -80.66 172.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.185 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.591 ' H ' HG22 ' A' ' 189' ' ' VAL . 4.3 tt0 -123.35 111.78 16.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.827 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 92.7 m -86.92 146.01 26.33 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.271 179.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 313' ' ' VAL . 20.4 mmtt -112.92 149.78 32.73 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.335 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -128.01 114.16 16.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.191 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.496 ' CE2' HD21 ' A' ' 224' ' ' LEU . 42.9 m-85 -114.03 116.47 29.24 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.678 177.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.1 102.18 13.63 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.584 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.732 ' CD2' HD11 ' A' ' 201' ' ' LEU . 29.4 tp -103.27 119.85 39.65 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.737 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -77.59 127.69 32.91 Favored 'General case' 0 C--O 1.255 1.366 0 CA-C-O 123.052 1.406 . . . . 0.0 112.765 -178.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 202' ' ' PHE . 78.4 p -59.48 -20.13 53.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.874 178.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -55.97 -43.63 77.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.15 -179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 6.7 t -74.6 -28.07 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.732 HD11 ' CD2' ' A' ' 196' ' ' LEU . 51.9 mt -93.52 -81.75 0.36 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.776 179.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.0 OUTLIER -113.27 130.28 56.29 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.869 -179.161 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.539 ' O ' ' NH1' ' A' ' 307' ' ' ARG . 7.7 m120 -98.7 -72.7 0.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -117.27 -21.13 8.89 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.817 0.341 . . . . 0.0 110.283 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.31 172.12 6.34 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.052 0.453 . . . . 0.0 110.321 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -53.37 -92.26 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.657 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -151.29 59.38 0.9 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.506 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 68.1 p -106.9 129.54 54.71 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 37.3 mt -74.7 125.01 27.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.697 -178.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 213' ' ' GLY . 50.4 mttt -86.32 158.52 54.88 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.72 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.413 ' C ' ' N ' ' A' ' 213' ' ' GLY . 73.4 Cg_exo -34.01 -75.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.585 2.19 . . . . 0.0 112.045 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -49.02 -20.06 0.49 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.162 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.79 -51.32 11.4 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 178.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -66.19 -38.95 89.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.355 0.597 . . . . 0.0 110.241 179.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.83 -53.75 54.86 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.67 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.37 90.83 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.981 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 3.1 mt -61.88 -29.58 70.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.574 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -71.76 -46.28 58.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.219 0.533 . . . . 0.0 110.239 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.543 ' O ' ' NE2' ' A' ' 223' ' ' GLN . 7.1 mt-30 -62.16 -44.02 97.53 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.218 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.16 -41.02 97.31 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.477 ' O ' ' N ' ' A' ' 225' ' ' SER . 3.7 t80 -52.93 -47.69 67.86 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.528 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 72.6 m -53.22 -52.69 58.1 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.424 -178.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.879 HE21 ' H ' ' A' ' 223' ' ' GLN . 0.0 OUTLIER -55.78 -27.64 52.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.608 -179.203 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.91 HD22 HG21 ' A' ' 313' ' ' VAL . 86.6 mt -92.43 -23.12 19.27 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.713 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 221' ' ' TYR . 8.1 t -77.56 -19.78 55.13 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.57 0.544 . . . . 0.0 110.738 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -96.05 22.17 7.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.068 0.461 . . . . 0.0 110.688 -179.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.459 ' H ' ' CD2' ' A' ' 227' ' ' LEU . 0.7 OUTLIER -74.03 -177.68 3.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.219 179.903 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 230' ' ' LYS . 3.7 t0 -99.43 127.08 35.38 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 232' ' ' GLY . 55.4 Cg_endo -69.73 -22.52 32.12 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.959 2.44 . . . . 0.0 113.593 -178.209 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.556 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 34.6 ttmt -23.74 -51.97 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.688 0.617 . . . . 0.0 111.1 -177.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 232' ' ' GLY . 90.2 m-20 -109.54 -10.48 14.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.939 178.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 27.32 58.13 0.1 Allowed Glycine 0 N--CA 1.471 0.992 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.627 ' H ' ' CE ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -124.34 119.0 28.01 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-O 121.249 0.547 . . . . 0.0 110.454 -179.549 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 45.4 t -132.75 99.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.514 0.673 . . . . 0.0 109.805 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.19 127.09 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.152 0.501 . . . . 0.0 111.11 -178.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 89.4 t -102.12 128.39 54.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.399 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 18.2 mt -108.78 140.43 42.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.016 0.436 . . . . 0.0 110.459 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -98.95 138.26 13.75 Favored Glycine 0 N--CA 1.472 1.092 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.201 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 308' ' ' ARG . 9.7 m-85 -125.63 115.82 20.74 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.344 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 4.9 t -117.18 163.94 15.53 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.461 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 48.9 p-10 -87.74 -174.92 4.97 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.417 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -99.21 121.79 41.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 110.075 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.752 ' H ' HD21 ' A' ' 249' ' ' ASN . 47.8 mm -116.1 12.62 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.371 0.605 . . . . 0.0 110.728 179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 79.05 -3.52 65.21 Favored Glycine 0 C--N 1.315 -0.584 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 m -125.39 105.26 8.95 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.125 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.93 -55.2 37.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.36 69.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.576 -179.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.622 ' CE2' HD11 ' A' ' 252' ' ' LEU . 47.3 t80 -63.03 -44.88 94.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.775 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.752 HD21 ' H ' ' A' ' 243' ' ' ILE . 57.8 m-80 -61.88 -42.16 98.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.398 -179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -64.27 -41.81 96.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.644 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.74 -38.31 96.25 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.622 HD11 ' CE2' ' A' ' 248' ' ' TYR . 35.1 mt -69.2 -38.58 78.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.849 0.357 . . . . 0.0 111.199 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 78.1 p -63.56 -44.01 95.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.43 -45.11 80.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.437 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -56.8 -50.52 72.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.319 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.727 HH22 ' N ' ' A' ' 308' ' ' ARG . 70.3 mtp180 -59.13 -59.01 6.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.473 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.2 -35.68 17.79 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.172 0.511 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.408 ' NE2' ' OD1' ' A' ' 262' ' ' ASP . 68.0 tp60 -69.9 -43.75 71.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.154 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 11.7 t -60.86 -39.64 89.92 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.314 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.28 -54.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.773 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.571 HG13 HD12 ' A' ' 274' ' ' ILE . 24.4 t -60.21 -50.01 81.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.45 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.408 ' OD1' ' NE2' ' A' ' 258' ' ' GLN . 25.8 m-20 -44.6 -41.75 6.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.994 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -83.55 -29.67 27.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.745 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -71.74 -7.0 45.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.474 -179.658 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.583 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.0 mt -87.09 -55.74 6.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.832 0.349 . . . . 0.0 111.539 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 8.3 m -50.93 -5.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.887 -178.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.583 ' H ' ' C ' ' A' ' 265' ' ' ILE . 5.7 mmtm -77.17 -9.87 59.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.94 38.17 2.22 Favored Glycine 0 N--CA 1.458 0.15 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.07 128.35 23.76 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.24 130.24 34.71 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.965 1.777 . . . . 0.0 112.081 177.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.01 -10.71 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.917 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -92.84 -22.71 19.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.898 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -78.34 -23.21 47.09 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.632 0.73 . . . . 0.0 110.472 -179.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.571 HD12 HG13 ' A' ' 261' ' ' VAL . 1.4 pt -101.19 -170.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.71 -178.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 8.2 t -169.04 126.3 0.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.012 179.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.91 114.55 26.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.795 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -129.28 157.47 41.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.311 0.577 . . . . 0.0 110.18 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -109.54 155.11 16.25 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.541 ' N ' ' O ' ' A' ' 238' ' ' GLY . 5.5 tpt -118.62 -10.0 10.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.964 0.411 . . . . 0.0 110.293 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 53.58 -110.88 1.57 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -137.33 74.94 1.5 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.804 0.335 . . . . 0.0 110.732 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.408 ' C ' ' ND2' ' A' ' 283' ' ' ASN . 47.9 t -72.86 -48.42 37.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.12 0.486 . . . . 0.0 111.498 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 282' ' ' SER . 3.8 m-80 -144.63 76.77 14.06 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.12 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.55 123.26 13.34 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.627 2.218 . . . . 0.0 111.744 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.06 -35.87 42.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.115 0.483 . . . . 0.0 110.556 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.722 ' OG1' HD23 ' A' ' 303' ' ' LEU . 71.7 p -67.38 -50.03 61.41 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.643 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -55.12 1.73 0.05 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.604 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.7 t-20 -111.64 -61.12 1.75 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.3 t -76.91 -7.35 55.37 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.568 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.45 21.25 7.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.541 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -69.59 -4.2 18.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.575 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -96.6 33.02 1.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.661 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.8 t -125.65 129.96 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.944 0.402 . . . . 0.0 109.917 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.78 4.32 12.25 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -100.25 130.9 46.43 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.19 0.519 . . . . 0.0 110.432 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 299' ' ' LEU . 5.0 ttt180 -53.26 -75.62 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.604 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -42.36 -37.48 1.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.1 0.476 . . . . 0.0 110.747 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.48 84.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.793 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 296' ' ' ARG . 20.8 mt -73.12 -44.32 60.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.168 0.509 . . . . 0.0 110.575 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 300' ' ' ILE . 6.3 mm -60.84 -31.39 49.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.989 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -81.38 -28.97 34.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.611 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 5.3 t -93.68 -11.23 32.03 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.85 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.722 HD23 ' OG1' ' A' ' 286' ' ' THR . 37.7 mt -93.28 20.36 7.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.576 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.62 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -78.44 -46.11 2.03 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 120.993 0.425 . . . . 0.0 110.288 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 37.7 Cg_exo -59.76 8.83 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.214 2.609 . . . . 0.0 111.886 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 304' ' ' ALA . 47.2 t0 -109.47 12.11 24.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.793 0.33 . . . . 0.0 110.852 -179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 203' ' ' ASN . 65.0 mtp180 -109.4 109.74 20.68 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.176 0.512 . . . . 0.0 110.36 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.727 ' N ' HH22 ' A' ' 256' ' ' ARG . 10.4 ptp180 -174.16 -172.38 0.7 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.998 -179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.35 157.11 15.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 177.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -121.79 106.65 11.48 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.221 0.534 . . . . 0.0 111.282 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.68 122.48 35.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.305 -178.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -108.06 116.65 32.34 Favored 'General case' 0 CA--C 1.514 -0.424 0 O-C-N 123.775 0.672 . . . . 0.0 110.27 -178.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.91 HG21 HD22 ' A' ' 224' ' ' LEU . 80.2 t -130.77 125.71 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.154 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.652 ' HD3' ' H ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -99.41 179.53 4.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.335 179.043 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.406 ' H ' HG22 ' A' ' 189' ' ' VAL . . . 71.52 -49.71 1.03 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 177.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 14.2 tt -47.07 150.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.098 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -113.12 161.94 16.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.058 179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -65.16 92.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.703 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 28.6 m -59.25 176.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.247 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.55 133.13 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.0 m -118.87 135.48 54.54 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.615 -179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -48.86 151.89 2.0 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.415 -179.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.64 149.47 87.27 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.658 2.239 . . . . 0.0 112.229 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 54.03 89.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.457 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.605 179.952 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.66 -39.46 76.02 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.486 2.124 . . . . 0.0 112.332 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -82.88 139.67 43.21 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.563 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.24 158.85 48.21 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.299 2.0 . . . . 0.0 111.809 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -157.01 144.89 14.12 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.56 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.49 ' O ' ' HB3' ' A' ' 186' ' ' ALA . 57.1 Cg_endo -69.86 -17.91 36.85 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.228 1.952 . . . . 0.0 112.278 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 185' ' ' PRO . . . 70.86 73.48 0.27 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.15 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 188' ' ' GLU . 35.0 Cg_exo -55.77 178.3 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.718 2.279 . . . . 0.0 112.128 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 188' ' ' GLU . 1.1 tm-20 77.63 40.07 0.17 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.504 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.4 t -135.23 132.72 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.477 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.1 OUTLIER -122.92 101.92 7.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.013 179.493 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.442 HG22 ' NE2' ' A' ' 193' ' ' HIS . 17.7 m -69.12 139.03 54.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.291 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -142.33 114.0 7.95 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 1.9 m-70 -102.95 144.53 31.12 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.546 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 78.1 m-85 -107.22 130.68 54.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 195' ' ' THR . 8.0 t -86.32 104.35 15.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.825 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.597 ' HB3' HG23 ' A' ' 309' ' ' VAL . 3.4 mt -108.83 131.55 54.88 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.426 ' O ' HG22 ' A' ' 200' ' ' VAL . 0.8 OUTLIER -93.38 137.92 32.22 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 122.727 1.251 . . . . 0.0 110.991 -178.643 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 202' ' ' PHE . 0.9 OUTLIER -61.01 -18.21 56.45 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.427 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -57.13 -49.99 74.21 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.863 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 200' ' ' VAL . 4.7 m -68.26 -38.55 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.735 179.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.51 HD12 HG21 ' A' ' 309' ' ' VAL . 33.2 mt -82.79 -78.76 0.2 Allowed 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.449 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -138.06 137.86 38.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.841 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.753 HD22 HH11 ' A' ' 307' ' ' ARG . 0.8 OUTLIER -119.49 -75.99 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.552 179.808 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -81.69 -37.7 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.933 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -67.26 170.52 7.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.144 0.497 . . . . 0.0 110.494 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -59.32 -82.82 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.775 -179.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -153.67 54.23 0.73 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.166 0.507 . . . . 0.0 110.349 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.57 127.93 53.72 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.486 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 9.6 mt -70.21 140.89 52.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 -179.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 213' ' ' GLY . 4.1 mtmp? -103.51 157.36 34.01 Favored Pre-proline 0 N--CA 1.466 0.326 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -32.97 -76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.718 2.279 . . . . 0.0 112.352 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -49.84 -20.32 0.85 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.326 0.584 . . . . 0.0 110.548 -179.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.53 -50.08 12.85 Favored Glycine 0 N--CA 1.461 0.365 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.084 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -65.15 -40.88 95.0 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.232 0.539 . . . . 0.0 109.944 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.0 67.04 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.07 -38.69 91.97 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.607 -179.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.31 -28.88 70.05 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.277 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -71.18 -47.24 58.74 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.374 0.607 . . . . 0.0 110.808 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -62.62 -43.5 98.66 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.974 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 60.9 tp -65.23 -39.36 92.63 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.235 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.431 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 5.7 t80 -53.42 -47.94 69.18 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.845 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.8 t -59.32 -50.07 75.39 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.537 -178.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 9.0 tt0 -51.95 -24.99 7.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.942 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.655 HD22 HG21 ' A' ' 313' ' ' VAL . 23.3 mt -96.68 -17.15 20.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.508 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 10.5 t -81.63 -16.12 52.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.795 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -103.32 17.72 23.43 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.581 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.6 OUTLIER -74.38 -179.44 3.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.323 179.701 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -97.96 109.46 51.56 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 230' ' ' LYS . 78.5 Cg_exo -47.6 -19.57 1.33 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.349 2.033 . . . . 0.0 113.438 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 229' ' ' PRO . 1.5 tmtp? -27.13 -51.79 0.06 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.261 0.553 . . . . 0.0 111.11 -177.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 232' ' ' GLY . 67.9 m-20 -110.14 -13.73 14.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.478 178.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.51 46.61 0.02 OUTLIER Glycine 0 N--CA 1.474 1.228 0 O-C-N 124.101 0.876 . . . . 0.0 111.272 179.546 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 231' ' ' ASP . 74.6 m -114.96 109.93 18.85 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.568 0.223 . . . . 0.0 111.149 -178.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 77.4 t -125.64 95.05 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.37 0.605 . . . . 0.0 109.933 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.7 t -96.69 121.14 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.296 0.569 . . . . 0.0 110.7 -178.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.41 HG13 HD13 ' A' ' 311' ' ' ILE . 96.5 t -91.07 122.3 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 45.9 mt -105.79 140.86 38.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.427 -179.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.445 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -125.03 129.72 7.11 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.604 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -113.91 117.01 30.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.824 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.475 HG22 ' HA2' ' A' ' 280' ' ' GLY . 9.7 t -104.88 178.54 4.53 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.133 0.492 . . . . 0.0 110.975 -178.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 307' ' ' ARG . 41.8 m-20 -83.79 -177.08 6.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.394 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -117.02 120.28 37.9 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.768 0.318 . . . . 0.0 110.501 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 243' ' ' ILE . 45.4 mm -120.67 12.66 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.576 0.703 . . . . 0.0 110.504 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.96 -43.5 3.26 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 6.9 m -71.1 94.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.362 0.601 . . . . 0.0 109.934 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -48.51 -48.34 38.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.203 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.14 84.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.749 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.566 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 44.2 t80 -62.14 -42.22 99.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.148 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.57 HD21 ' CA ' ' A' ' 280' ' ' GLY . 0.5 OUTLIER -60.38 -53.08 61.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.769 -179.775 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -61.67 -37.65 84.86 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.42 -41.83 99.63 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 33.0 mt -71.24 -37.78 71.99 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.073 178.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 4.2 t -63.0 -39.68 95.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.115 0.483 . . . . 0.0 110.879 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -73.19 -39.65 65.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.46 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -58.83 -51.75 68.65 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.517 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.879 ' O ' HG23 ' A' ' 260' ' ' VAL . 18.1 ptp180 -64.39 -44.28 91.81 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.899 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.32 -42.28 98.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.571 0.7 . . . . 0.0 110.421 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -70.72 -42.06 71.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.684 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.8 m -60.61 -39.14 87.09 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.383 0.611 . . . . 0.0 110.355 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 256' ' ' ARG . 88.8 t -63.97 -50.65 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.95 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.557 HG13 HD12 ' A' ' 274' ' ' ILE . 18.8 t -61.32 -48.27 89.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 121.165 0.507 . . . . 0.0 110.315 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -47.93 -40.9 23.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.908 -178.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -79.66 -35.59 39.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.026 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.14 -29.11 70.25 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.99 -179.023 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.483 ' C ' ' H ' ' A' ' 267' ' ' LYS . 89.0 mt -69.06 -49.54 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 120.797 0.332 . . . . 0.0 111.82 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 18.5 m -52.43 -8.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 265' ' ' ILE . 12.3 mmtt -79.75 -6.21 56.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.683 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 99.06 42.21 2.87 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.19 129.41 24.22 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 117.101 0.451 . . . . 0.0 110.583 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.56 129.34 29.21 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.325 1.35 . . . . 0.0 112.002 178.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.4 -11.05 38.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -89.74 -22.9 21.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -179.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.47 -23.54 50.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.295 0.569 . . . . 0.0 110.529 -179.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.557 HD12 HG13 ' A' ' 261' ' ' VAL . 1.8 pt -104.18 -175.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.751 -179.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 25.7 m -169.28 132.53 1.29 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.326 178.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -95.93 148.99 22.05 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -153.1 138.09 17.22 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.394 0.616 . . . . 0.0 111.172 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -89.06 94.95 2.05 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.409 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -70.36 -6.88 38.53 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.535 -179.551 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.57 ' CA ' HD21 ' A' ' 249' ' ' ASN . . . 42.62 -112.56 0.48 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.88 73.75 1.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.688 0.28 . . . . 0.0 110.317 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 31.9 t -71.27 -37.5 71.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.043 0.449 . . . . 0.0 111.613 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -129.44 79.32 74.15 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.698 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.04 110.35 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.501 2.134 . . . . 0.0 112.112 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 286' ' ' THR . 9.1 m -73.14 -36.07 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.76 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.603 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.1 OUTLIER -62.21 -49.35 76.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.097 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -52.51 0.2 0.03 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.603 ' H ' ' C ' ' A' ' 286' ' ' THR . 2.5 t-20 -116.21 -59.69 1.95 Allowed 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -78.18 -3.61 43.44 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.438 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.75 17.9 4.25 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 292' ' ' ASN . 37.9 p-10 -61.53 -36.9 81.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.986 0.422 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 26.4 t-20 -78.73 33.32 0.21 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.947 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.464 ' HB ' HD11 ' A' ' 299' ' ' LEU . 12.1 t -135.93 124.92 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.005 0.431 . . . . 0.0 110.358 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -120.18 16.41 12.35 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.087 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -100.35 133.44 44.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.12 0.486 . . . . 0.0 110.66 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -59.96 -60.46 3.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.607 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.68 -43.26 65.45 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.978 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.93 89.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.268 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 303' ' ' LEU . 4.8 mp -75.62 -61.35 1.95 Allowed 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.324 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' LEU . 72.4 mt -42.32 -34.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.057 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -77.9 -38.72 45.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.316 178.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 299' ' ' LEU . 40.7 t -84.7 -6.99 59.38 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.005 0.431 . . . . 0.0 110.858 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 299' ' ' LEU . 92.8 mt -90.5 15.11 11.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.843 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -77.11 -53.28 1.72 Allowed Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.437 177.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 304' ' ' ALA . 11.2 Cg_endo -54.25 8.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.178 1.919 . . . . 0.0 113.186 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 304' ' ' ALA . 59.4 t0 -101.4 12.88 36.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.753 HH11 HD22 ' A' ' 203' ' ' ASN . 15.1 ptp180 -113.61 95.2 5.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.189 0.995 . . . . 0.0 110.224 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.551 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 18.4 ptp180 -156.31 128.24 7.38 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.456 -178.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 196' ' ' LEU . 0.0 OUTLIER -97.01 135.6 30.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.292 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -118.51 104.91 11.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.333 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.41 HD13 HG13 ' A' ' 236' ' ' VAL . 4.7 mm -77.82 115.31 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.024 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -94.66 123.79 38.31 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 123.13 0.269 . . . . 0.0 110.672 -178.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.655 HG21 HD22 ' A' ' 224' ' ' LEU . 11.5 t -125.57 115.51 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.911 -178.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -114.72 134.46 55.08 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 100.14 17.1 25.9 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.6 tt -103.9 148.9 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.968 0.413 . . . . 0.0 110.38 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -137.24 124.54 21.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.612 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 319' ' ' VAL . 52.8 t0 -169.14 153.14 5.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.403 179.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.475 ' N ' ' OD1' ' A' ' 318' ' ' ASP . 14.9 p -67.4 148.05 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.321 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.66 141.31 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.446 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 62.0 p -80.54 163.0 24.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.25 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.419 ' CD ' ' N ' ' A' ' 322' ' ' GLN . 22.5 mp0 -112.94 85.61 8.05 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.169 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 325' ' ' ALA . 67.0 Cg_endo -76.67 -178.9 4.86 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.057 1.838 . . . . 0.0 111.983 -179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 68.27 -66.0 0.24 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.326 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 323' ' ' PRO . . . . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.584 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.41 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 48.2 Cg_endo -67.64 148.89 78.87 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.597 2.198 . . . . 0.0 111.835 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.86 149.52 1.87 Allowed Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.621 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.58 ' O ' ' HB2' ' A' ' 184' ' ' ALA . 39.4 Cg_endo -65.31 -32.47 50.85 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.558 2.172 . . . . 0.0 112.411 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 183' ' ' PRO . . . 168.26 81.13 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.1 -179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.84 68.04 8.09 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.461 2.107 . . . . 0.0 112.333 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . -79.37 -51.01 1.27 Allowed Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.056 178.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 73.4 Cg_endo -75.47 152.82 39.07 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.154 1.903 . . . . 0.0 112.54 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.59 -164.15 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.701 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.503 HG22 ' H ' ' A' ' 190' ' ' GLN . 2.7 p -94.01 170.59 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.304 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.503 ' H ' HG22 ' A' ' 189' ' ' VAL . 0.8 OUTLIER -125.15 103.92 8.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.171 179.545 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 59.1 m -67.8 139.12 56.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.146 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.461 ' C ' ' CG ' ' A' ' 193' ' ' HIS . 7.5 mmtt -110.47 161.69 15.43 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.666 0.746 . . . . 0.0 110.611 179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.461 ' CG ' ' C ' ' A' ' 192' ' ' LYS . 7.0 m-70 -148.27 119.87 8.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.017 -179.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -110.89 120.48 42.53 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.17 103.81 15.15 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.245 -179.957 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.694 ' CD2' HD11 ' A' ' 201' ' ' LEU . 32.2 tp -108.67 128.78 55.15 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -81.81 130.09 34.95 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-O 121.776 0.798 . . . . 0.0 112.291 -178.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 202' ' ' PHE . 0.4 OUTLIER -64.99 -27.57 68.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.697 179.723 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -60.62 -38.48 84.89 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.849 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.25 -42.86 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.694 HD11 ' CD2' ' A' ' 196' ' ' LEU . 88.8 mt -78.12 -79.1 0.13 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.768 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.46 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -124.56 129.5 50.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.779 -179.228 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.592 HD22 ' NZ ' ' A' ' 210' ' ' LYS . 66.0 m-80 -94.44 -74.42 0.54 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.721 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -110.49 -10.09 14.56 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.7 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -74.3 165.37 25.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.188 0.518 . . . . 0.0 109.919 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.04 -73.21 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.825 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -164.09 2.52 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.927 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 63.7 p -53.03 136.27 35.57 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.903 0.383 . . . . 0.0 110.282 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 83.6 mt -82.9 136.36 34.61 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.293 0.568 . . . . 0.0 111.364 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.592 ' NZ ' HD22 ' A' ' 203' ' ' ASN . 31.2 mtmt -98.6 157.59 34.0 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.956 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -34.44 -75.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.383 2.055 . . . . 0.0 112.419 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 57.0 mp0 -48.9 -24.5 1.5 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.361 0.6 . . . . 0.0 110.225 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -70.92 -51.16 20.29 Favored Glycine 0 CA--C 1.517 0.209 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.603 178.494 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.14 -41.02 99.22 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.318 0.58 . . . . 0.0 109.465 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.465 ' O ' ' NE2' ' A' ' 219' ' ' GLN . . . -54.18 -56.1 21.48 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.973 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.61 72.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.56 0.695 . . . . 0.0 110.612 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.11 -25.97 63.75 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.57 179.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -75.59 -49.84 17.35 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.881 0.848 . . . . 0.0 111.054 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 215' ' ' ALA . 0.0 OUTLIER -62.46 -44.54 96.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.421 179.58 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.503 HD12 HE21 ' A' ' 223' ' ' GLN . 42.3 tp -62.36 -40.73 97.37 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.411 ' O ' ' N ' ' A' ' 225' ' ' SER . 4.4 t80 -51.8 -49.51 62.58 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.896 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.0 m -54.88 -51.02 67.27 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.716 -178.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.503 HE21 HD12 ' A' ' 220' ' ' LEU . 18.7 mt-30 -51.55 -26.5 8.72 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.424 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.981 HD22 HG21 ' A' ' 313' ' ' VAL . 43.1 mt -100.4 -17.95 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.589 -179.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 221' ' ' TYR . 5.1 t -73.79 -28.28 61.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.191 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -95.79 23.91 5.85 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.85 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.482 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -77.61 167.42 21.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.201 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -82.01 129.19 65.4 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 230' ' ' LYS . 53.8 Cg_endo -70.36 -18.73 34.0 Favored 'Trans proline' 0 N--CA 1.506 2.248 0 C-N-CA 122.979 2.452 . . . . 0.0 112.832 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 229' ' ' PRO . 24.6 mmtm -32.32 -52.27 0.28 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.525 -177.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 232' ' ' GLY . 58.4 m-20 -104.45 -17.48 14.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.153 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.75 50.81 0.06 OUTLIER Glycine 0 N--CA 1.471 0.982 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.8 t -118.25 108.47 15.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.819 0.343 . . . . 0.0 110.935 -178.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 313' ' ' VAL . 15.7 t -125.93 95.61 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.285 178.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.4 120.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.245 -178.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.417 HG21 HG22 ' A' ' 261' ' ' VAL . 73.6 t -91.45 126.66 44.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.223 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 277' ' ' ARG . 23.8 mt -109.97 140.24 44.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.886 -179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -122.54 130.09 7.78 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -115.21 117.13 29.63 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.028 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.6 p -103.8 171.31 7.43 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.908 0.385 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 242' ' ' ARG . 43.6 t0 -85.45 -176.28 6.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.726 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.465 ' H ' ' CG ' ' A' ' 241' ' ' ASP . 88.9 mtm180 -109.34 120.65 43.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.957 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.0 mm -120.08 14.47 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.639 0.733 . . . . 0.0 110.645 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.09 -47.81 3.39 Favored Glycine 0 C--N 1.314 -0.653 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.9 p -76.2 91.16 3.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.287 0.565 . . . . 0.0 109.712 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -45.38 -46.5 13.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.372 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.97 80.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.625 ' CE2' HD11 ' A' ' 252' ' ' LEU . 57.2 t80 -59.76 -45.9 90.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.989 0.423 . . . . 0.0 110.347 -179.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -62.08 -40.99 97.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.098 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.05 -40.87 95.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.874 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.27 -38.77 96.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.625 HD11 ' CE2' ' A' ' 248' ' ' TYR . 98.3 mt -74.95 -31.2 61.43 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.931 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 5.5 t -66.49 -45.39 79.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.856 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.39 -39.54 71.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.226 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -61.59 -49.84 75.02 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.508 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.51 ' O ' HG23 ' A' ' 260' ' ' VAL . 99.4 mtt180 -62.28 -51.45 67.66 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.426 179.309 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -53.95 -34.34 59.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.162 0.506 . . . . 0.0 109.922 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -71.88 -42.99 66.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.0 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.782 ' O ' ' OD1' ' A' ' 262' ' ' ASP . 16.7 t -62.02 -35.83 79.74 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 122.179 0.99 . . . . 0.0 109.92 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 256' ' ' ARG . 71.4 t -67.65 -54.5 22.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.341 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.417 HG22 HG21 ' A' ' 236' ' ' VAL . 55.9 t -63.44 -50.2 79.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.782 ' OD1' ' O ' ' A' ' 259' ' ' SER . 40.7 p-10 -49.57 -37.64 28.12 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.577 -177.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.656 ' N ' ' OD1' ' A' ' 262' ' ' ASP . 35.0 t80 -81.34 -33.87 32.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.377 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -64.38 -22.15 66.86 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.893 -179.549 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 267' ' ' LYS . 87.7 mt -78.24 -52.29 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.49 179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 62.0 m -49.33 -10.18 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.899 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 265' ' ' ILE . 0.0 OUTLIER -77.51 -11.2 59.83 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.302 -179.398 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.8 42.32 1.58 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.402 HD12 ' CE1' ' A' ' 221' ' ' TYR . 0.1 OUTLIER -126.67 137.66 30.91 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 117.188 0.494 . . . . 0.0 110.575 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.81 124.23 15.55 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.698 1.599 . . . . 0.0 111.755 177.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.94 -9.83 42.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.874 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -91.22 -23.95 20.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.706 -179.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.448 ' HE3' HD21 ' A' ' 227' ' ' LEU . 2.4 ttpm? -79.81 -19.34 48.72 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.585 0.707 . . . . 0.0 110.994 -179.286 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . . . . . . . . . 1.5 pt -104.91 -171.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.532 -179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 47.4 t -170.82 137.27 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.105 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -99.43 150.56 22.05 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.456 ' HB3' HD23 ' A' ' 237' ' ' LEU . 62.0 ttm-85 -155.68 139.79 16.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.538 0.685 . . . . 0.0 111.455 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -93.97 96.96 2.13 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 238' ' ' GLY . 0.0 OUTLIER -69.96 -4.49 20.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.875 0.369 . . . . 0.0 110.345 -179.028 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.87 -116.28 1.2 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -138.21 71.0 1.39 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.764 0.316 . . . . 0.0 110.462 -179.658 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.14 5.61 49.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.276 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 283' ' ' ASN . 13.7 p-10 -159.82 74.82 3.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.837 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.75 108.32 2.25 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.424 2.083 . . . . 0.0 112.073 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 286' ' ' THR . 6.2 m -70.45 -43.03 78.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.649 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.608 ' C ' ' H ' ' A' ' 288' ' ' ASN . 65.7 p -58.83 -43.6 90.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.078 -179.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.62 -0.55 0.03 OUTLIER Glycine 0 CA--C 1.533 1.159 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.608 ' H ' ' C ' ' A' ' 286' ' ' THR . 18.9 m120 -119.86 -59.09 1.83 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 285' ' ' VAL . 0.4 OUTLIER -66.71 -18.75 65.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.572 -178.606 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.46 25.79 9.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.291 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 291' ' ' ASP . 51.5 t0 -69.19 -10.95 60.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 110.393 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -94.89 32.58 1.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.528 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.1 t -129.92 127.26 63.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 110.237 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -117.77 8.13 12.64 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.969 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -95.36 127.81 41.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.044 0.449 . . . . 0.0 109.95 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -55.94 -50.47 70.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.516 -179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.2 -41.78 96.91 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.982 -179.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.25 -30.09 70.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.62 179.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 303' ' ' LEU . 39.6 mt -79.18 -57.04 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.398 -179.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.7 mt -45.89 -36.52 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.948 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -74.39 -47.21 35.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.509 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 6.7 t -75.8 -4.95 43.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.278 -179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.522 HD23 ' OG1' ' A' ' 286' ' ' THR . 50.5 mt -96.06 13.06 28.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.529 -179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.594 ' C ' ' H ' ' A' ' 306' ' ' ASP . . . -75.13 -46.13 4.69 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.828 0.347 . . . . 0.0 110.083 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 32.1 Cg_exo -56.41 10.09 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.971 2.448 . . . . 0.0 112.258 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.594 ' H ' ' C ' ' A' ' 304' ' ' ALA . 46.9 t0 -101.06 13.49 35.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.741 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.538 ' NH1' ' HB1' ' A' ' 304' ' ' ALA . 28.9 ptt-85 -113.04 101.72 9.73 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.991 0.9 . . . . 0.0 110.86 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.565 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 20.4 ptp180 -162.02 132.31 4.83 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.24 -179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.6 142.25 14.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -121.58 108.11 13.2 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.985 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.8 mm -78.97 119.75 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -178.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.442 ' OE2' ' CE1' ' A' ' 193' ' ' HIS . 28.2 tp10 -99.06 120.58 39.72 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.04 -178.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.981 HG21 HD22 ' A' ' 224' ' ' LEU . 66.8 t -126.88 119.47 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 123.578 0.549 . . . . 0.0 111.318 -179.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 28.1 tttt -117.34 125.2 50.64 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 118.15 -18.6 11.23 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 18.9 tt -65.25 144.1 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.377 179.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -111.47 87.34 2.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.458 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -115.31 109.69 18.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.224 179.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.9 t -84.84 102.03 10.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.188 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 16.4 m -143.22 126.74 13.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.438 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.88 124.66 8.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.365 179.464 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -134.28 84.33 41.77 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.055 179.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 324' ' ' GLN . 37.6 Cg_exo -59.06 148.63 84.47 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.732 2.288 . . . . 0.0 111.628 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 323' ' ' PRO . 87.0 mt-30 58.03 142.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.797 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.608 -179.888 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.645 ' HB1' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.645 ' CD ' ' HB1' ' A' ' 180' ' ' ALA . 32.3 Cg_exo -61.14 144.67 99.19 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.484 2.123 . . . . 0.0 112.034 179.528 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.425 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . 55.99 54.29 8.67 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.743 179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 38.3 Cg_endo -66.19 -21.52 55.13 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 122.789 2.326 . . . . 0.0 111.685 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.661 ' HB1' ' CD ' ' A' ' 185' ' ' PRO . . . 64.21 179.24 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.569 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.661 ' CD ' ' HB1' ' A' ' 184' ' ' ALA . 27.7 Cg_exo -61.95 149.33 90.66 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.631 2.221 . . . . 0.0 111.958 179.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -38.04 103.3 0.26 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.793 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -49.99 -40.3 49.7 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.952 1.768 . . . . 0.0 112.461 -179.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -51.77 156.15 1.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.244 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.9 t -90.64 156.02 3.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.306 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.455 ' H ' HE21 ' A' ' 190' ' ' GLN . 0.0 OUTLIER -126.66 100.54 6.25 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.245 179.694 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 36.5 m -70.92 142.78 51.09 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.667 179.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.435 ' HD3' ' H ' ' A' ' 193' ' ' HIS . 5.3 tmtt? -111.49 162.36 15.18 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.381 0.61 . . . . 0.0 110.715 179.668 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.435 ' H ' ' HD3' ' A' ' 192' ' ' LYS . 53.9 m80 -152.82 121.18 6.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.674 179.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.634 ' CZ ' ' NE2' ' A' ' 223' ' ' GLN . 59.6 m-85 -113.07 123.29 49.93 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -85.53 103.59 14.53 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.597 -179.588 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 196' ' ' LEU . 3.8 mt -104.69 122.34 45.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.039 0.447 . . . . 0.0 109.983 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.588 ' O ' HG22 ' A' ' 200' ' ' VAL . 8.9 ptpp? -85.73 135.0 33.93 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 122.52 1.153 . . . . 0.0 111.542 -179.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 202' ' ' PHE . 4.0 p -59.74 -19.59 51.11 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.679 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -51.86 -50.02 61.75 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.927 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 197' ' ' LYS . 27.2 m -70.92 -33.68 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.417 -0.513 . . . . 0.0 109.675 178.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 20.5 mt -86.45 -80.36 0.24 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.356 179.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -135.18 145.41 47.7 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.607 -179.146 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -112.58 -67.74 0.98 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.504 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -112.45 -16.57 12.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.574 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -68.28 167.02 15.25 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.01 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.604 ' CG ' ' H ' ' A' ' 207' ' ' ALA . 18.2 pttt -51.29 -70.29 0.09 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.628 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.604 ' H ' ' CG ' ' A' ' 206' ' ' LYS . . . -166.62 -1.18 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.331 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.9 t -52.81 137.16 32.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.897 0.38 . . . . 0.0 110.494 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 96.7 mt -80.17 144.28 33.13 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.566 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 213' ' ' GLY . 38.5 mttm -106.46 156.28 37.29 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.009 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -34.47 -76.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.713 2.275 . . . . 0.0 112.091 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -48.73 -22.16 0.74 Allowed 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.052 0.453 . . . . 0.0 110.413 -179.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -73.15 -49.64 15.35 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 178.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.82 -39.94 91.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.26 0.552 . . . . 0.0 110.118 179.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.74 54.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.836 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.95 -37.2 86.53 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.03 -179.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.9 mt -62.72 -30.64 71.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.867 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -71.24 -46.49 60.97 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.087 0.47 . . . . 0.0 110.379 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -63.33 -44.09 95.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.306 -179.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 47.5 tp -63.94 -39.89 95.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.496 ' CE1' ' OG ' ' A' ' 225' ' ' SER . 3.8 t80 -54.02 -49.56 68.63 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.652 179.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 69.6 m -57.35 -50.56 72.58 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.366 -178.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.634 ' NE2' ' CZ ' ' A' ' 194' ' ' PHE . 11.3 tt0 -52.85 -26.22 13.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.254 -179.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.956 HD22 HG21 ' A' ' 313' ' ' VAL . 82.6 mt -97.53 -17.83 19.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.509 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.496 ' OG ' ' CE1' ' A' ' 221' ' ' TYR . 4.8 m -78.81 -12.16 60.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.742 -179.651 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -104.75 22.34 15.29 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 110.325 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.15 177.69 6.97 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.242 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 315' ' ' GLY . 31.2 t0 -98.97 108.8 51.24 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 230' ' ' LYS . 75.7 Cg_exo -46.9 -19.44 0.79 Allowed 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.605 2.204 . . . . 0.0 113.023 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.464 ' C ' ' O ' ' A' ' 229' ' ' PRO . 52.8 tptt -27.11 -52.07 0.06 Allowed 'General case' 0 CA--C 1.514 -0.44 0 O-C-N 123.559 0.537 . . . . 0.0 111.016 -178.043 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' GLY . 79.1 m-20 -109.4 -15.41 14.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.322 179.019 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 26.83 50.83 0.06 OUTLIER Glycine 0 C--N 1.338 0.68 0 O-C-N 123.892 0.745 . . . . 0.0 111.666 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 t -117.92 111.08 18.52 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.271 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.83 96.15 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.317 178.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.0 t -99.03 123.12 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.816 -178.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 94.8 t -97.88 126.73 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.397 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.603 HD22 ' SD ' ' A' ' 279' ' ' MET . 22.9 mt -110.45 143.88 40.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.513 -179.534 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 279' ' ' MET . . . -119.41 139.55 14.23 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.3 OUTLIER -120.34 119.66 33.76 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -178.748 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.41 167.09 12.26 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.827 0.346 . . . . 0.0 110.414 -179.033 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.499 ' OD2' ' NE ' ' A' ' 307' ' ' ARG . 38.0 m-20 -81.21 -177.03 6.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.458 -179.023 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -105.52 125.71 51.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.33 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 243' ' ' ILE . 50.0 mm -116.9 9.17 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.461 0.648 . . . . 0.0 110.829 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.48 10.33 85.72 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.4 m -129.59 106.38 8.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.128 0.489 . . . . 0.0 109.883 179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.446 ' CG ' ' N ' ' A' ' 247' ' ' ALA . 22.1 p-10 -57.43 -53.68 55.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.912 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' A' ' 246' ' ' ASP . . . -54.63 -44.1 72.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.147 0.498 . . . . 0.0 110.458 -179.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.677 ' CE2' HD11 ' A' ' 252' ' ' LEU . 40.5 t80 -69.63 -41.3 75.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.994 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.529 ' ND2' ' OE2' ' A' ' 281' ' ' GLU . 18.0 t-20 -61.35 -52.49 64.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.713 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -63.88 -38.17 90.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.555 179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.53 -37.36 93.21 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.677 HD11 ' CE2' ' A' ' 248' ' ' TYR . 32.4 mt -71.6 -39.06 70.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.641 0.258 . . . . 0.0 110.692 178.393 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 52.4 p -61.71 -40.66 95.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.984 0.421 . . . . 0.0 110.599 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -69.52 -43.59 72.74 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.564 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -57.32 -47.46 81.49 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.414 -179.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.785 ' O ' HG23 ' A' ' 260' ' ' VAL . 79.4 mtt-85 -62.99 -51.32 67.31 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.445 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.5 81.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.254 0.55 . . . . 0.0 109.874 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -72.11 -44.08 63.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.432 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 13.5 t -61.44 -38.36 86.9 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.43 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 256' ' ' ARG . 95.8 t -64.54 -52.59 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.723 179.324 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.425 HG13 HD12 ' A' ' 274' ' ' ILE . 41.9 t -60.52 -48.61 87.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.964 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -46.01 -41.86 12.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.077 -179.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -82.89 -30.83 28.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -71.08 -9.42 58.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.304 -179.496 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.554 ' C ' ' H ' ' A' ' 267' ' ' LYS . 57.6 mt -86.01 -53.89 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.353 179.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 84.6 p -51.37 -6.34 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.689 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 265' ' ' ILE . 10.0 mmpt? -76.18 -12.52 60.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 104.43 42.17 1.92 Allowed Glycine 0 N--CA 1.459 0.21 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.1 tt -127.3 131.46 23.85 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 117.045 0.422 . . . . 0.0 110.852 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.87 125.41 17.02 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.187 1.258 . . . . 0.0 111.923 177.36 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.39 -6.32 9.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.055 179.196 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -92.88 -23.67 18.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.944 -179.3 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -80.37 -18.7 48.25 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.443 0.64 . . . . 0.0 110.957 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.425 HD12 HG13 ' A' ' 261' ' ' VAL . 1.7 pt -106.58 -174.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.516 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 25.8 t -171.53 134.14 0.83 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.54 152.85 18.24 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.565 ' HB3' HD23 ' A' ' 237' ' ' LEU . 46.1 ttt85 -159.62 147.1 16.94 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.547 0.689 . . . . 0.0 111.037 178.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -95.1 143.89 16.88 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.603 ' SD ' HD22 ' A' ' 237' ' ' LEU . 2.1 tpt -114.92 -3.65 12.67 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.616 0.246 . . . . 0.0 110.385 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.07 -100.26 0.02 OUTLIER Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.529 ' OE2' ' ND2' ' A' ' 249' ' ' ASN . 28.4 mp0 -142.11 54.25 1.46 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.705 -0.248 . . . . 0.0 110.573 179.314 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.6 m -65.59 -0.05 1.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 0.0 110.697 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 281' ' ' GLU . 48.1 t-20 -167.19 85.43 0.82 Allowed Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.32 106.25 2.01 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.212 1.941 . . . . 0.0 112.599 -179.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 27.6 m -94.65 -17.83 7.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 121.314 0.578 . . . . 0.0 110.645 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 290' ' ' CYS . 19.7 p -58.02 -42.78 86.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.595 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 290' ' ' CYS . . . -48.09 -93.04 0.01 OUTLIER Glycine 0 C--O 1.225 -0.406 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 287' ' ' GLY . 57.6 t30 -28.53 -56.91 0.12 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.803 0.355 . . . . 0.0 110.432 -178.552 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 m -56.73 -45.28 82.06 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.693 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.587 ' N ' ' O ' ' A' ' 287' ' ' GLY . 24.1 m -101.77 32.76 3.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.188 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 287' ' ' GLY . 47.5 t0 -56.21 -47.91 77.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.825 0.345 . . . . 0.0 110.605 -179.074 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 292' ' ' ASN . 58.5 t-20 -76.59 31.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.814 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 291' ' ' ASP . 10.6 t -129.48 107.34 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 110.211 179.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -119.38 14.02 12.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.738 179.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -100.23 134.09 43.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.129 0.49 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -49.81 -69.19 0.12 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.438 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -52.61 -38.84 60.92 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.448 0.642 . . . . 0.0 110.746 -178.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.04 -34.96 79.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 303' ' ' LEU . 16.6 mt -73.87 -56.98 4.29 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 73.2 mt -46.16 -29.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.425 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -83.59 -44.04 15.02 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.336 178.3 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 1.9 t -74.51 -16.71 60.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.989 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 299' ' ' LEU . 76.6 mt -82.58 25.15 0.66 Allowed 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.817 0.698 . . . . 0.0 110.448 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.619 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -81.11 -38.0 0.96 Allowed Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 32.3 Cg_exo -58.54 6.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.442 2.761 . . . . 0.0 112.748 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 304' ' ' ALA . 2.8 m-20 -111.6 15.64 21.0 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.744 0.307 . . . . 0.0 110.513 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.499 ' NE ' ' OD2' ' A' ' 241' ' ' ASP . 96.0 mtt-85 -108.54 94.27 4.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.275 0.56 . . . . 0.0 110.16 179.098 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 239' ' ' TYR . 8.2 ptm180 -168.56 158.35 9.38 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.001 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 6.2 m -122.64 150.87 26.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.457 ' OE1' ' OH ' ' A' ' 239' ' ' TYR . 92.4 mt-10 -121.1 106.85 11.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.405 0.622 . . . . 0.0 110.855 -178.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 4.5 mm -79.31 117.93 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.964 -178.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -102.87 127.36 50.09 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -178.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.956 HG21 HD22 ' A' ' 224' ' ' LEU . 93.6 t -132.2 122.21 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 O-C-N 124.077 0.861 . . . . 0.0 111.753 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -116.8 132.31 56.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 96.88 37.26 4.74 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.619 ' O ' ' O ' ' A' ' 317' ' ' LYS . 7.2 tt -109.03 168.06 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.619 ' O ' ' O ' ' A' ' 316' ' ' ILE . 21.4 pttm -45.97 -147.62 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 O-C-N 124.303 1.002 . . . . 0.0 111.987 -179.322 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 45.9 p30 -73.28 168.86 18.3 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.549 -0.72 . . . . 0.0 110.818 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 319' ' ' VAL . 13.4 p -99.64 125.1 53.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.104 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 19.9 t -87.1 131.83 34.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.181 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.5 p -116.09 157.67 24.36 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.169 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.418 ' HG2' ' H ' ' A' ' 322' ' ' GLN . 1.2 pt20 -74.68 150.91 86.82 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.664 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.56 -64.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.533 2.155 . . . . 0.0 112.072 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -86.84 -98.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.597 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.38 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.474 179.995 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.491 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 40.5 Cg_endo -65.47 143.98 77.84 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.874 2.383 . . . . 0.0 111.72 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.577 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . 177.68 -44.71 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.051 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 22.9 Cg_exo -63.74 160.92 34.44 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.951 2.434 . . . . 0.0 111.685 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -117.64 83.11 16.98 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.913 179.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -49.4 116.94 2.56 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.423 2.082 . . . . 0.0 112.02 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.546 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -173.4 47.0 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.373 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 186' ' ' ALA . 37.6 Cg_endo -64.0 145.97 90.52 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.83 2.353 . . . . 0.0 112.049 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -76.76 -4.92 45.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.619 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 18.4 t -138.69 133.77 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.519 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.434 ' CD ' ' N ' ' A' ' 190' ' ' GLN . 0.1 OUTLIER -118.47 92.39 3.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.925 179.694 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.518 HG22 ' CE1' ' A' ' 193' ' ' HIS . 6.9 m -68.47 136.34 53.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.336 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -140.06 105.59 5.1 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.58 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.518 ' CE1' HG22 ' A' ' 191' ' ' THR . 2.7 m80 -94.85 145.3 24.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.625 ' CE2' ' NE2' ' A' ' 223' ' ' GLN . 33.1 m-85 -111.81 123.9 51.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.43 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 195' ' ' THR . 5.6 t -84.24 103.76 13.7 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.556 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.742 ' CD2' HD11 ' A' ' 201' ' ' LEU . 30.0 tp -108.34 128.98 55.23 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.066 -179.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -83.82 129.13 34.94 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-O 122.297 1.046 . . . . 0.0 112.218 -178.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 202' ' ' PHE . 15.3 m -63.91 -30.36 71.45 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.396 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -56.03 -41.08 74.42 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 61.1 t -67.14 -42.5 88.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.164 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.742 HD11 ' CD2' ' A' ' 196' ' ' LEU . 61.1 mt -79.18 -79.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.911 179.751 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 207' ' ' ALA . 0.1 OUTLIER -120.09 122.46 41.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.747 -179.123 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.532 ' H ' HD21 ' A' ' 205' ' ' ASN . 22.5 t-20 -87.24 -75.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.452 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -113.08 -10.71 13.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.801 ' H ' HD22 ' A' ' 205' ' ' ASN . 0.1 OUTLIER -76.25 171.29 14.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.182 179.955 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -50.0 -87.49 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.408 -178.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.429 ' O ' ' CD2' ' A' ' 202' ' ' PHE . . . -154.78 5.97 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.278 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 8.7 t -54.35 141.94 28.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.254 -179.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 36.8 mt -83.1 133.98 35.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.244 0.545 . . . . 0.0 111.166 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.457 ' CB ' ' NZ ' ' A' ' 210' ' ' LYS . 6.4 mtpm? -99.14 156.73 35.14 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.064 179.001 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -34.94 -75.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.557 2.171 . . . . 0.0 112.0 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -46.32 -26.66 0.86 Allowed 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.28 0.562 . . . . 0.0 110.307 -179.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -69.03 -51.99 25.79 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -58.65 -39.73 81.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.78 -60.15 3.61 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.419 179.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.91 -25.98 68.39 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.695 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -30.4 65.09 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.513 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.93 -47.58 28.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.819 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 220' ' ' LEU . 13.3 pt20 -63.97 -42.79 97.15 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.91 -179.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.591 HD12 HE21 ' A' ' 223' ' ' GLN . 48.1 tp -59.61 -41.51 90.54 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.484 ' C ' ' H ' ' A' ' 223' ' ' GLN . 10.1 t80 -54.94 -60.61 3.13 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.154 177.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.4 m -54.44 -8.21 0.2 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.076 0.465 . . . . 0.0 110.642 -179.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.625 ' NE2' ' CE2' ' A' ' 194' ' ' PHE . 3.3 tt0 -93.51 -33.82 13.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.339 178.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 313' ' ' VAL . 73.5 mt -97.69 -11.42 23.51 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.623 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 25.8 p -79.21 -26.23 42.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.973 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -88.03 18.88 3.92 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.024 0.44 . . . . 0.0 110.496 -179.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.512 HD22 ' O ' ' A' ' 224' ' ' LEU . 1.0 OUTLIER -76.12 156.84 33.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.388 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -78.77 116.71 61.81 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 232' ' ' GLY . 59.6 Cg_exo -48.92 -21.99 4.36 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.893 2.395 . . . . 0.0 113.059 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 229' ' ' PRO . 27.2 tptp -24.76 -52.35 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 123.75 0.656 . . . . 0.0 110.802 -177.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 233' ' ' SER . 72.7 m-20 -109.79 -11.49 14.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.8 179.039 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 229' ' ' PRO . . . 24.73 42.86 0.01 OUTLIER Glycine 0 N--CA 1.47 0.935 0 O-C-N 123.953 0.783 . . . . 0.0 111.679 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -112.77 114.55 27.17 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 122.516 -0.402 . . . . 0.0 110.449 -178.61 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 75.4 t -129.22 93.88 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.807 0.813 . . . . 0.0 110.325 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.5 t -97.08 123.29 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.001 -179.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.516 HG21 ' CG2' ' A' ' 261' ' ' VAL . 20.2 t -95.65 122.46 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.648 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 75.3 mt -105.58 141.95 36.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.032 -179.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 279' ' ' MET . . . -124.34 127.3 6.39 Favored Glycine 0 N--CA 1.476 1.323 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -110.25 122.77 48.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.302 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.577 HG22 ' N ' ' A' ' 241' ' ' ASP . 51.0 m -117.3 164.75 14.35 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.322 0.389 . . . . 0.0 110.238 -179.265 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.577 ' N ' HG22 ' A' ' 240' ' ' THR . 42.3 p-10 -80.95 -175.87 5.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.605 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -116.88 122.89 45.64 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.655 -179.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 243' ' ' ILE . 51.8 mm -118.11 17.22 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.725 0.774 . . . . 0.0 110.808 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.28 -49.04 2.4 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.485 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 5.6 t -76.14 88.72 3.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.918 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -40.4 -43.55 1.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.729 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.4 -38.69 91.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.352 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.555 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 67.1 t80 -59.23 -50.28 74.63 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.936 -179.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 245' ' ' SER . 2.7 p-10 -64.13 -40.74 96.83 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.185 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -61.38 -45.71 93.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.59 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.18 -35.71 92.45 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.555 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 29.6 mt -70.41 -40.37 73.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.006 0.431 . . . . 0.0 111.106 178.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.0 t -62.84 -39.24 93.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.515 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -68.69 -45.08 72.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.247 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.18 -44.9 88.23 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.067 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.34 -61.41 2.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.678 178.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -49.88 -34.04 18.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.105 0.479 . . . . 0.0 110.026 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -72.25 -44.82 62.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.449 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.4 t -58.48 -39.53 80.22 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.301 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.91 -53.44 41.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.392 178.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.605 HG13 HD12 ' A' ' 274' ' ' ILE . 4.7 t -60.96 -50.19 81.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.436 179.659 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -46.28 -41.38 13.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.206 -179.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.51 ' CE2' ' CE ' ' A' ' 267' ' ' LYS . 60.8 t80 -80.77 -32.78 35.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.809 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.17 -32.81 74.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.21 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.538 ' C ' ' H ' ' A' ' 267' ' ' LYS . 83.8 mt -63.85 -48.27 87.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.322 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 28.2 m -51.45 -6.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.755 -179.276 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 265' ' ' ILE . 33.1 mmtp -87.19 9.15 21.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.505 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 84.4 40.83 8.2 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.74 126.35 25.75 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.9 130.28 36.92 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.98 1.787 . . . . 0.0 112.094 177.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.17 -9.45 31.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 272' ' ' ASP . 65.6 t0 -90.88 -23.42 20.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.529 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -79.24 -21.14 46.62 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.608 0.718 . . . . 0.0 110.526 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.605 HD12 HG13 ' A' ' 261' ' ' VAL . 1.5 pt -105.35 -171.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.332 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 11.9 t -169.55 130.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.176 178.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -104.45 110.17 22.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.873 0.368 . . . . 0.0 110.535 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 278' ' ' GLY . 0.0 OUTLIER -115.47 140.96 48.67 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.574 0.702 . . . . 0.0 111.097 -179.646 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.578 ' O ' ' NH1' ' A' ' 277' ' ' ARG . . . -90.18 93.35 1.86 Allowed Glycine 0 CA--C 1.519 0.329 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.49 ' N ' ' O ' ' A' ' 238' ' ' GLY . 3.6 tpt -71.62 0.69 8.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.085 -178.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 279' ' ' MET . . . 31.87 -100.07 0.01 OUTLIER Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -144.1 70.18 1.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.714 0.292 . . . . 0.0 110.891 179.122 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 77.6 p -64.35 -44.24 92.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.192 0.52 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -125.4 80.47 65.43 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.961 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.18 105.76 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.686 2.257 . . . . 0.0 112.669 -179.35 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 285' ' ' VAL . 10.4 m -71.02 -32.83 49.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.193 0.52 . . . . 0.0 110.687 179.307 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.596 ' C ' ' H ' ' A' ' 288' ' ' ASN . 0.2 OUTLIER -57.23 -44.55 83.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.357 -179.218 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -47.84 -5.82 0.02 OUTLIER Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 286' ' ' THR . 13.2 m120 -125.46 -58.51 1.42 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.9 m -58.89 -24.64 62.52 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.553 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 84.8 m -116.11 29.6 7.87 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.451 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.93 -4.28 19.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.612 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -109.87 31.48 5.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.661 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.52 121.3 45.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.969 0.414 . . . . 0.0 110.41 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -120.79 7.34 10.46 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.8 179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.497 ' O ' HD12 ' A' ' 299' ' ' LEU . 7.6 mt-30 -89.14 172.67 8.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.98 0.419 . . . . 0.0 110.014 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -84.99 -70.47 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.584 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -58.84 -31.62 68.67 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.89 -178.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.89 -39.93 87.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.376 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 295' ' ' GLN . 50.5 mt -69.78 -48.89 57.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.015 0.436 . . . . 0.0 110.644 179.751 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 60.8 mt -49.15 -36.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.899 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.6 -40.27 29.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.117 0.484 . . . . 0.0 110.646 178.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.426 ' O ' ' HD2' ' A' ' 305' ' ' PRO . 1.1 t -74.36 -10.64 59.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.988 -179.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 299' ' ' LEU . 61.4 mt -91.89 22.59 4.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.643 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.622 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -83.21 -41.56 0.83 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.995 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 31.9 Cg_exo -55.8 10.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 123.293 2.662 . . . . 0.0 112.403 -179.07 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.602 ' H ' ' C ' ' A' ' 304' ' ' ALA . 27.5 m-20 -109.55 21.72 16.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.639 0.257 . . . . 0.0 110.849 179.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 307' ' ' ARG . 15.7 ptp180 -114.04 84.99 2.13 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.14 0.972 . . . . 0.0 110.259 178.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.527 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 16.4 ptm180 -156.49 128.06 7.16 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.062 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.77 139.14 19.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.466 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -119.69 104.51 10.32 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.303 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.506 HD12 HD21 ' A' ' 220' ' ' LEU . 0.7 OUTLIER -79.36 116.71 23.78 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -178.312 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -96.14 122.14 38.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.819 0.342 . . . . 0.0 111.033 -178.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 224' ' ' LEU . 84.0 t -129.5 122.46 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.869 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -118.57 144.86 45.8 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.308 178.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 92.26 22.42 29.72 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -178.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.661 ' O ' ' O ' ' A' ' 317' ' ' LYS . 10.8 tt -99.16 170.86 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.661 ' O ' ' O ' ' A' ' 316' ' ' ILE . 29.5 tttp -44.5 -153.73 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.943 0.777 . . . . 0.0 110.958 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . 0.512 ' H ' ' HG2' ' A' ' 317' ' ' LYS . 32.3 t70 -68.79 160.01 31.3 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 121.543 -0.723 . . . . 0.0 110.891 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 4.0 p -127.3 129.8 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.177 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 11.4 p -153.32 135.55 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.395 179.546 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.6 p -143.56 154.39 43.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.644 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -51.53 150.56 6.58 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.537 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.57 151.81 79.11 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 122.573 2.182 . . . . 0.0 112.055 179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 49.05 93.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.518 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.524 -179.954 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 180' ' ' ALA . 73.4 Cg_endo -79.25 166.31 22.71 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.55 2.166 . . . . 0.0 112.047 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.569 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -176.27 -45.35 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.963 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 35.7 Cg_exo -59.5 72.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.657 2.238 . . . . 0.0 111.978 -179.264 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 182' ' ' ALA . . . 62.23 146.76 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.472 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -40.33 117.27 0.44 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.333 2.022 . . . . 0.0 112.323 179.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.589 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . -81.7 -48.32 0.99 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.963 178.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 73.7 Cg_endo -79.55 158.48 25.38 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.589 2.193 . . . . 0.0 112.38 -179.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -160.07 2.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.18 0.514 . . . . 0.0 110.292 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 79.8 t -135.4 134.47 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.332 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.527 ' NE2' ' H ' ' A' ' 190' ' ' GLN . 1.5 pm0 -120.1 135.41 54.96 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.238 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.645 HG22 ' N ' ' A' ' 192' ' ' LYS . 44.6 m -76.45 170.49 16.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.43 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.645 ' N ' HG22 ' A' ' 191' ' ' THR . 13.0 tptp -141.88 160.64 39.78 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.953 0.406 . . . . 0.0 109.978 178.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -152.02 124.27 8.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.108 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.639 ' CE1' ' NE2' ' A' ' 223' ' ' GLN . 52.1 m-85 -114.37 119.11 35.81 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.438 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 195' ' ' THR . 5.5 t -86.49 105.23 16.65 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.555 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.694 HD23 HD11 ' A' ' 201' ' ' LEU . 27.0 tp -106.74 123.4 48.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.031 0.443 . . . . 0.0 109.933 -179.223 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -74.53 129.34 37.56 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 122.587 1.184 . . . . 0.0 112.277 -178.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 202' ' ' PHE . 41.6 t -62.97 -40.31 97.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.173 178.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -45.75 -34.88 3.91 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.719 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.75 -56.82 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.694 HD11 HD23 ' A' ' 196' ' ' LEU . 82.2 mt -66.87 -77.8 0.07 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.815 -179.32 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -106.03 135.7 47.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.858 -178.188 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -98.3 -78.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -117.74 -19.04 9.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.963 179.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -65.99 171.75 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.127 0.489 . . . . 0.0 110.199 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -53.79 -81.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.844 -179.231 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -157.9 58.2 0.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.51 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 49.0 p -106.95 131.18 54.32 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 110.056 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.414 HD22 HD22 ' A' ' 201' ' ' LEU . 62.4 mt -71.92 145.11 48.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.256 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.9 mtpm? -107.91 158.03 34.54 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.304 179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 213' ' ' GLY . 74.8 Cg_exo -34.91 -77.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.3 2.0 . . . . 0.0 112.01 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -48.41 -19.19 0.29 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.196 0.522 . . . . 0.0 110.037 -179.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -71.88 -50.23 19.6 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 178.794 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -65.13 -38.39 90.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.145 0.498 . . . . 0.0 109.77 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.91 -53.87 53.3 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.011 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.91 -33.82 76.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.615 0.721 . . . . 0.0 110.383 -179.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.67 -25.9 65.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.603 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . 0.537 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 72.2 m-20 -72.79 -47.11 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.569 0.7 . . . . 0.0 109.9 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.35 -40.29 96.86 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.99 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.518 HD12 HE21 ' A' ' 223' ' ' GLN . 61.8 tp -60.37 -40.98 92.76 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.458 ' CG ' ' HB3' ' A' ' 267' ' ' LYS . 69.4 t80 -55.34 -58.95 5.62 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.922 178.259 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 58.8 m -57.14 -7.49 0.53 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.289 0.566 . . . . 0.0 110.216 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.639 ' NE2' ' CE1' ' A' ' 194' ' ' PHE . 5.4 tt0 -95.06 -35.54 11.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.384 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.828 HD22 HG21 ' A' ' 313' ' ' VAL . 80.4 mt -96.51 -11.38 25.56 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.658 -179.291 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 75.8 p -85.89 -7.31 58.78 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.542 0.526 . . . . 0.0 110.579 -179.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 223' ' ' GLN . 51.2 p30 -101.35 19.23 18.15 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.311 0.577 . . . . 0.0 110.529 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.7 OUTLIER -78.31 -177.3 5.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.136 -179.973 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -100.69 108.47 53.78 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 230' ' ' LYS . 72.5 Cg_exo -45.62 -21.39 0.84 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.673 2.249 . . . . 0.0 112.897 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 229' ' ' PRO . 88.0 tttt -34.47 -52.07 0.48 Allowed 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.14 0.495 . . . . 0.0 110.546 -178.15 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 232' ' ' GLY . 25.6 m-20 -98.54 -20.01 17.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.762 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 28.32 52.4 0.11 Allowed Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 59.7 m -118.93 115.17 23.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.557 0.217 . . . . 0.0 111.107 -178.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 274' ' ' ILE . 72.8 t -133.48 92.26 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.794 0.807 . . . . 0.0 110.195 178.43 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.11 127.62 51.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.279 0.561 . . . . 0.0 110.61 -178.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.411 HG13 HD13 ' A' ' 311' ' ' ILE . 91.3 t -100.63 126.42 54.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.399 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 52.8 mt -111.94 131.64 55.26 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.469 -178.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -86.08 138.37 15.96 Favored Glycine 0 N--CA 1.467 0.766 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.555 ' O ' ' NH2' ' A' ' 256' ' ' ARG . 11.4 m-85 -131.04 115.89 17.05 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 117.799 0.799 . . . . 0.0 109.431 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.425 ' HA ' HH12 ' A' ' 256' ' ' ARG . 14.8 t -126.71 172.8 10.01 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.465 -179.154 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.565 ' HB2' HD12 ' A' ' 303' ' ' LEU . 54.8 p-10 -86.19 -175.23 5.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.432 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -102.3 124.48 47.95 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.245 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.7 mm -117.64 14.42 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.456 0.646 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 71.8 5.06 60.18 Favored Glycine 0 C--N 1.317 -0.493 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 5.3 t -124.68 105.29 9.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.862 0.363 . . . . 0.0 110.199 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -57.11 -55.22 37.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.195 -179.075 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.77 -46.02 78.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.772 ' CE2' HD11 ' A' ' 252' ' ' LEU . 38.3 t80 -63.38 -42.0 98.8 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.886 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.79 -44.87 96.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.642 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -65.28 -39.64 92.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.19 -42.49 99.8 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.772 HD11 ' CE2' ' A' ' 248' ' ' TYR . 80.2 mt -66.92 -41.81 86.42 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.006 179.437 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 6.5 t -66.2 -48.36 70.88 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.118 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.25 -52.21 66.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.589 -179.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -55.5 -47.31 76.38 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.273 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.685 HH22 ' N ' ' A' ' 308' ' ' ARG . 66.3 mtp180 -58.29 -59.31 5.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.162 179.158 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -50.59 -32.62 19.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.121 0.486 . . . . 0.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -73.12 -49.7 26.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.986 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 44.6 t -53.42 -41.29 65.88 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.153 -179.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.65 -54.88 23.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.603 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.51 HG13 HD12 ' A' ' 274' ' ' ILE . 10.4 t -57.64 -50.42 77.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.212 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -46.33 -42.84 15.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.914 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -81.55 -31.14 32.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.592 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -71.05 -7.96 50.09 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.274 -179.195 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 267' ' ' LYS . 55.2 mt -86.51 -55.69 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 120.84 0.352 . . . . 0.0 111.408 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 22.7 t -49.78 -6.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.909 -178.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.573 ' H ' ' C ' ' A' ' 265' ' ' ILE . 22.9 mmmt -76.98 -11.38 59.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 107.08 39.71 1.93 Allowed Glycine 0 CA--C 1.509 -0.291 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.86 133.02 24.66 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.241 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.64 128.88 32.13 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.833 1.689 . . . . 0.0 112.174 176.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -67.73 -9.31 42.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.986 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.23 -21.32 21.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.774 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -82.54 -20.12 37.27 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.426 0.631 . . . . 0.0 110.893 -179.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.51 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -103.76 -172.28 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.118 -178.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 27.9 t -168.81 143.09 3.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.297 178.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -115.72 113.78 23.94 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.927 0.394 . . . . 0.0 110.806 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -127.22 150.93 49.31 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.929 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -105.37 100.58 1.74 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . . . . . . . . . 3.4 tpp -70.03 -13.04 62.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.066 0.46 . . . . 0.0 110.155 -179.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 63.46 -103.23 0.64 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -141.89 74.12 1.44 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.84 0.353 . . . . 0.0 110.587 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 84.8 p -95.58 2.23 54.13 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.7 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.6 70.52 3.73 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.553 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.94 105.6 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.406 2.071 . . . . 0.0 112.291 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 14.7 m -69.58 -31.94 50.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.46 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 288' ' ' ASN . 41.7 p -57.35 -43.96 83.9 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.736 -179.243 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -45.62 -7.93 0.01 OUTLIER Glycine 0 CA--C 1.534 1.222 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.298 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.9 t30 -126.84 -56.57 1.36 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.918 0.389 . . . . 0.0 110.137 178.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.3 m -55.23 -40.4 70.83 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.281 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . . . . . . . . . 72.1 m -98.6 36.44 1.64 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.421 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -74.56 -2.48 26.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.498 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.06 31.67 5.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.497 -179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.1 t -132.05 123.76 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.526 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -119.39 4.43 11.21 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.208 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -99.64 136.21 39.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.157 0.503 . . . . 0.0 110.095 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -51.43 -76.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.774 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -46.0 -39.17 8.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 -178.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.29 88.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.959 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.1 mt -67.69 -43.54 79.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.566 179.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 9.4 mm -58.08 -37.21 60.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.783 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -74.01 -35.65 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.082 179.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 1.1 t -81.77 -3.2 53.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.416 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' ' 241' ' ' ASP . 0.5 OUTLIER -94.18 22.33 6.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.235 -179.485 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.61 ' N ' ' CD ' ' A' ' 305' ' ' PRO . . . -82.65 -41.82 0.91 Allowed Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.602 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 304' ' ' ALA . 34.8 Cg_exo -60.03 10.09 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.294 2.662 . . . . 0.0 112.099 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 304' ' ' ALA . 57.9 t0 -115.12 18.89 16.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.884 0.373 . . . . 0.0 110.958 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -109.01 107.18 17.44 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.377 0.608 . . . . 0.0 110.345 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.685 ' N ' HH22 ' A' ' 256' ' ' ARG . 18.0 ptp180 -171.86 -173.74 1.21 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.984 -179.186 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.35 153.65 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.496 ' CD ' ' CZ ' ' A' ' 239' ' ' TYR . 95.7 mt-10 -124.64 102.53 7.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.317 0.579 . . . . 0.0 110.801 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.411 HD13 HG13 ' A' ' 236' ' ' VAL . 3.4 mm -81.58 120.34 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.14 -179.162 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -104.92 119.87 40.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.798 0.332 . . . . 0.0 110.426 -178.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.828 HG21 HD22 ' A' ' 224' ' ' LEU . 86.6 t -130.43 124.76 58.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.59 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -118.83 148.19 43.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.56 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 97.88 4.4 57.83 Favored Glycine 0 N--CA 1.462 0.43 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 16.0 tt -91.55 141.79 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.206 0.527 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -75.93 120.37 21.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.794 -179.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -159.73 169.95 22.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.772 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.77 133.86 30.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.277 179.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.17 136.18 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.174 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.5 t -146.76 170.19 17.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.699 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . 0.518 ' OE1' ' N ' ' A' ' 322' ' ' GLN . 1.5 mp0 -81.63 118.29 71.62 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.673 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -49.15 -38.27 40.44 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.181 1.921 . . . . 0.0 112.403 179.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 47.17 72.68 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 110.389 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.33 -179.908 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.624 ' N ' ' CD ' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 180' ' ' ALA . 26.1 Cg_exo -61.55 147.19 96.02 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.833 2.355 . . . . 0.0 111.948 -179.429 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -157.89 153.3 22.14 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.361 179.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.08 -21.76 48.56 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.713 2.275 . . . . 0.0 111.759 179.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.481 ' HB1' ' HD2' ' A' ' 185' ' ' PRO . . . -58.81 159.96 11.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.473 -179.296 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.481 ' HD2' ' HB1' ' A' ' 184' ' ' ALA . 57.0 Cg_endo -70.66 154.4 64.21 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.786 2.324 . . . . 0.0 112.058 179.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.9 151.06 16.69 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.326 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.11 -56.01 0.42 Allowed 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.8 2.334 . . . . 0.0 112.227 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 46.79 -130.94 1.33 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.366 -179.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 11.9 t -79.21 106.51 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.232 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 316' ' ' ILE . 14.0 mm100 -106.34 105.42 15.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.446 -179.553 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.44 HG22 ' NE2' ' A' ' 193' ' ' HIS . 24.3 m -78.11 127.12 31.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.2 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -146.71 116.45 7.19 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.467 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.5 ' CD2' ' N ' ' A' ' 193' ' ' HIS . 2.2 m-70 -101.18 147.72 25.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -109.77 128.53 55.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.911 0.386 . . . . 0.0 110.302 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 195' ' ' THR . 0.0 OUTLIER -86.94 103.24 15.13 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.98 -179.765 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.729 ' CD2' HD11 ' A' ' 201' ' ' LEU . 24.8 tp -107.96 129.04 55.14 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 109.955 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.473 ' HB3' HG23 ' A' ' 200' ' ' VAL . 71.8 tttt -80.9 126.57 31.52 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 121.905 0.86 . . . . 0.0 112.033 -178.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 2.5 t -65.27 -28.08 69.09 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.066 179.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -62.92 -37.94 88.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.034 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 197' ' ' LYS . 88.6 t -65.96 -44.36 92.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.56 179.295 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.729 HD11 ' CD2' ' A' ' 196' ' ' LEU . 76.6 mt -75.75 -78.75 0.11 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.289 179.472 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.28 118.67 30.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.031 -179.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -94.62 -78.3 0.45 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.702 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -88.47 -26.94 21.81 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.765 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.407 ' OD1' HG23 ' A' ' 208' ' ' THR . 24.0 t-20 -69.79 158.43 35.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.153 0.501 . . . . 0.0 110.381 -179.589 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -51.42 -71.47 0.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.221 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -159.77 56.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.428 179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.407 HG23 ' OD1' ' A' ' 205' ' ' ASN . 38.5 p -108.08 133.04 52.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.821 0.343 . . . . 0.0 110.172 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.06 138.61 39.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 -179.133 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 213' ' ' GLY . 7.8 mtpm? -101.49 157.47 33.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 210' ' ' LYS . 76.0 Cg_exo -33.22 -75.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.598 2.199 . . . . 0.0 111.969 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -49.61 -23.4 1.67 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.18 0.514 . . . . 0.0 110.328 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -72.94 -48.73 19.6 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -66.61 -38.74 87.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.14 0.495 . . . . 0.0 110.012 179.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.84 -53.06 62.46 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.444 -179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.75 88.53 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.635 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.0 mt -62.53 -27.6 69.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.487 179.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . 0.458 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 51.3 m-20 -73.81 -46.45 45.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.219 0.533 . . . . 0.0 110.535 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -62.62 -42.89 99.85 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.174 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.459 HD21 HD12 ' A' ' 311' ' ' ILE . 42.9 tp -66.37 -38.96 88.74 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.436 ' CZ ' ' O ' ' A' ' 267' ' ' LYS . 3.2 t80 -53.78 -50.72 65.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.123 179.379 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 225' ' ' SER . 75.9 p -60.15 -49.75 76.41 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.378 -178.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.579 ' OE1' HD11 ' A' ' 316' ' ' ILE . 1.1 tm0? -49.57 -25.89 3.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.184 -179.737 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.743 ' O ' HD22 ' A' ' 227' ' ' LEU . 64.7 mt -97.19 -13.45 22.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.364 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 222' ' ' SER . 36.9 t -72.86 -21.57 60.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.698 179.511 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -99.91 16.79 22.68 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.743 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.8 OUTLIER -76.74 150.69 36.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.138 179.862 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 315' ' ' GLY . 6.7 t0 -67.12 124.13 88.1 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.468 178.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 230' ' ' LYS . 44.5 Cg_endo -69.15 -19.67 38.75 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.79 2.327 . . . . 0.0 112.846 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 229' ' ' PRO . 63.4 tttp -30.09 -52.42 0.15 Allowed 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.682 0.614 . . . . 0.0 110.457 -178.386 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 232' ' ' GLY . 20.6 m-20 -103.28 -18.25 14.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.485 178.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.478 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.75 47.33 0.03 OUTLIER Glycine 0 N--CA 1.473 1.134 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 231' ' ' ASP . 0.4 OUTLIER -112.59 111.25 21.93 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.146 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.56 94.42 2.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.311 0.577 . . . . 0.0 109.895 178.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.2 t -96.47 122.65 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.237 -178.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.441 HG22 HG23 ' A' ' 311' ' ' ILE . 12.1 t -95.68 119.7 44.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.642 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 47.4 mt -103.76 147.38 27.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.049 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -125.85 133.13 8.15 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.636 ' CZ ' ' SD ' ' A' ' 279' ' ' MET . 0.4 OUTLIER -116.54 119.84 36.84 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.504 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.441 ' O ' ' OD1' ' A' ' 306' ' ' ASP . 3.3 p -106.92 168.15 9.39 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 120.772 0.32 . . . . 0.0 110.344 -179.445 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -81.85 179.93 7.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.525 -179.666 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -99.6 119.44 38.08 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.862 0.363 . . . . 0.0 110.237 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 243' ' ' ILE . 49.4 mm -121.4 6.18 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.404 0.621 . . . . 0.0 111.058 179.358 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.41 -47.65 3.66 Favored Glycine 0 C--N 1.314 -0.666 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.2 p -73.7 90.08 1.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 109.887 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 249' ' ' ASN . 91.7 m-20 -43.0 -46.55 5.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.676 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.6 83.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.555 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 49.2 t80 -61.08 -49.31 77.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 246' ' ' ASP . 0.2 OUTLIER -63.22 -42.75 99.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.584 -179.741 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -63.71 -46.13 86.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.723 -179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.39 -35.03 90.39 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.555 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 29.9 mt -73.5 -37.53 65.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.887 0.375 . . . . 0.0 111.129 178.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 20.8 m -64.12 -40.95 97.29 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.747 -179.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 258' ' ' GLN . 96.9 mt-10 -71.7 -41.39 68.66 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.189 179.595 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -59.52 -48.3 82.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.524 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 260' ' ' VAL . 89.4 mtt-85 -63.26 -60.38 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.961 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -52.1 -36.62 51.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.565 HE21 ' C ' ' A' ' 258' ' ' GLN . 0.6 OUTLIER -70.84 -42.72 69.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.218 179.665 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.3 t -63.02 -36.77 84.67 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.357 0.599 . . . . 0.0 110.272 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 256' ' ' ARG . 87.2 t -64.27 -50.19 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.552 179.335 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.541 HG13 HD12 ' A' ' 274' ' ' ILE . 10.6 t -60.88 -49.43 84.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.29 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . 0.549 ' OD2' ' NE2' ' A' ' 258' ' ' GLN . 7.9 m-20 -45.7 -39.81 8.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.9 -179.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -83.2 -32.31 26.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.728 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.6 OUTLIER -70.1 -11.11 60.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.488 -179.287 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' A' ' 267' ' ' LYS . 64.6 mt -86.11 -53.14 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-O 120.723 0.297 . . . . 0.0 110.925 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 73.4 m -50.34 -6.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 265' ' ' ILE . 22.9 mmmt -80.58 -12.06 59.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.862 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 106.75 40.41 1.87 Allowed Glycine 0 CA--C 1.51 -0.221 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.25 129.16 24.27 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.86 128.17 27.62 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.958 1.772 . . . . 0.0 112.04 176.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.02 -8.97 18.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.799 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.32 -23.23 21.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.772 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -80.31 -20.08 45.12 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.38 0.609 . . . . 0.0 110.487 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.541 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -105.62 -173.36 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.795 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 27.3 t -172.4 129.76 0.57 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 179.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -96.39 153.72 17.66 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.019 -0.425 . . . . 0.0 109.859 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -162.31 151.56 15.62 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 178.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -127.56 97.65 0.47 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.636 ' SD ' ' CZ ' ' A' ' 239' ' ' TYR . 10.5 ptm -85.99 26.8 0.96 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.847 0.356 . . . . 0.0 110.984 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 42.3 -107.37 0.1 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.82 73.44 1.4 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.683 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.1 t -76.28 -33.72 59.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.108 0.48 . . . . 0.0 111.216 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -124.39 66.37 44.06 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 -179.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.14 117.71 5.12 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.626 2.218 . . . . 0.0 111.506 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 286' ' ' THR . 15.0 m -70.8 -38.5 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.701 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 288' ' ' ASN . 2.8 p -61.43 -47.15 87.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.559 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.07 -3.4 0.05 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 286' ' ' THR . 89.3 m-20 -114.29 -60.97 1.81 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.018 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.8 t -77.69 -3.07 39.23 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.558 -179.55 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.558 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -126.97 18.51 7.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.607 -179.911 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 36.7 p-10 -68.55 -2.98 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.503 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.418 ' O ' ' OD1' ' A' ' 292' ' ' ASN . 19.7 p30 -101.06 32.6 3.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.514 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.558 HG21 ' SG ' ' A' ' 290' ' ' CYS . 17.2 t -130.77 124.33 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.764 0.316 . . . . 0.0 110.437 179.638 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -120.21 9.62 11.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.879 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.39 131.24 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.134 0.492 . . . . 0.0 110.064 -179.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -50.55 -68.61 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.076 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -51.97 -38.7 57.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.53 -36.55 82.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.445 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 303' ' ' LEU . 28.0 mt -72.54 -55.01 7.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.474 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 68.5 mt -50.96 -35.4 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.005 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.11 -31.98 58.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.593 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.49 -5.06 56.49 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 179.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 299' ' ' LEU . 1.4 mm? -94.23 19.66 9.1 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.289 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -80.43 -45.78 1.34 Allowed Pre-proline 0 CA--C 1.536 0.424 0 CA-C-O 121.051 0.453 . . . . 0.0 110.184 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 25.7 Cg_exo -60.97 9.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.134 2.556 . . . . 0.0 111.969 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 304' ' ' ALA . 8.1 t70 -106.0 14.12 28.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.874 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 307' ' ' ARG . 15.6 ptt180 -110.28 99.01 8.12 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.921 0.867 . . . . 0.0 110.346 179.214 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.537 ' NH1' ' OE2' ' A' ' 310' ' ' GLU . 43.7 ptt85 -166.03 139.09 4.13 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.398 -179.219 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.02 145.67 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.537 ' OE2' ' NH1' ' A' ' 308' ' ' ARG . 78.6 mt-10 -118.71 104.03 10.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.31 0.576 . . . . 0.0 110.865 178.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.459 HD12 HD21 ' A' ' 220' ' ' LEU . 0.4 OUTLIER -80.12 113.4 19.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.11 -178.953 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -92.11 123.27 35.34 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 123.525 0.516 . . . . 0.0 110.738 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.71 HG21 HD22 ' A' ' 224' ' ' LEU . 40.1 t -121.14 115.32 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 O-C-N 123.528 0.518 . . . . 0.0 110.875 -179.576 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -114.7 126.58 55.02 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.52 39.61 3.39 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.583 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.719 ' O ' ' O ' ' A' ' 317' ' ' LYS . 6.3 tt -110.97 164.74 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.719 ' O ' ' O ' ' A' ' 316' ' ' ILE . 20.5 pttp -42.45 -149.01 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.501 0 O-C-N 124.273 0.983 . . . . 0.0 111.319 -178.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -84.83 175.84 8.88 Favored 'General case' 0 C--N 1.318 -0.773 0 O-C-N 121.372 -0.83 . . . . 0.0 111.103 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.0 p -140.92 138.47 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.546 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 62.1 t -71.35 129.1 35.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.018 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 74.8 p -113.91 134.48 54.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.997 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -140.99 113.51 6.94 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.118 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -48.06 -38.35 31.88 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.307 2.004 . . . . 0.0 112.267 179.5 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -75.95 139.32 41.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.34 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.587 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.507 -179.972 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.435 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.435 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 69.0 Cg_exo -46.96 131.31 16.81 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.271 1.981 . . . . 0.0 111.711 178.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.618 ' N ' ' CD ' ' A' ' 183' ' ' PRO . . . -102.81 -42.35 0.2 Allowed Pre-proline 0 N--CA 1.466 0.351 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.248 179.65 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 182' ' ' ALA . 36.9 Cg_exo -59.45 143.29 99.74 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.565 2.177 . . . . 0.0 111.847 -178.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -95.76 120.68 62.88 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.224 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.53 137.08 26.18 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.967 1.778 . . . . 0.0 112.395 179.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.588 ' HB3' ' HD3' ' A' ' 187' ' ' PRO . . . -69.41 -47.86 26.15 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.094 178.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 186' ' ' ALA . 71.0 Cg_endo -78.29 150.54 25.71 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.665 2.243 . . . . 0.0 112.115 -178.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.599 ' CG ' HE21 ' A' ' 190' ' ' GLN . 16.9 pt-20 -171.02 -147.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.433 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 10.6 t -88.77 100.84 11.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.202 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.599 HE21 ' CG ' ' A' ' 188' ' ' GLU . 81.8 mm-40 -106.3 107.7 18.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.338 -179.446 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.52 HG22 ' NE2' ' A' ' 193' ' ' HIS . 24.3 m -79.06 125.6 29.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.829 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -144.45 112.73 6.47 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.71 0.291 . . . . 0.0 110.555 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' HIS . . . . . 0.52 ' NE2' HG22 ' A' ' 191' ' ' THR . 5.0 m-70 -99.4 144.41 28.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -106.89 129.79 54.66 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.87 0.367 . . . . 0.0 110.204 179.133 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.14 105.38 17.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.931 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.721 ' CD2' HD11 ' A' ' 201' ' ' LEU . 34.3 tp -110.16 129.63 55.68 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.426 ' HB3' HG23 ' A' ' 200' ' ' VAL . 16.2 tptm -80.74 127.92 33.05 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 122.036 0.922 . . . . 0.0 112.437 -178.265 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 202' ' ' PHE . 68.6 p -63.31 -31.79 73.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.091 179.489 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.456 ' OD1' ' ND2' ' A' ' 203' ' ' ASN . 22.0 t70 -59.75 -37.46 79.06 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.181 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 197' ' ' LYS . 79.2 t -66.23 -44.41 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.721 HD11 ' CD2' ' A' ' 196' ' ' LEU . 84.3 mt -77.6 -77.53 0.15 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.461 179.304 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 198' ' ' SER . 0.1 OUTLIER -118.51 125.42 49.83 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.637 -179.754 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.456 ' ND2' ' OD1' ' A' ' 199' ' ' ASP . 7.2 m120 -94.37 -80.25 0.4 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.767 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -103.31 -17.71 15.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.695 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -70.54 169.66 13.73 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.998 0.427 . . . . 0.0 110.086 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -53.15 -78.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.267 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -164.36 59.11 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.552 179.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.7 p -108.79 135.3 50.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.048 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.1 135.57 39.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.874 -178.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 213' ' ' GLY . 4.4 mtmp? -96.57 159.97 30.56 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.815 179.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -34.05 -76.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.417 2.078 . . . . 0.0 111.78 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 31.6 mp0 -50.02 -20.18 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.242 0.544 . . . . 0.0 110.214 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -74.59 -47.87 14.65 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.368 178.669 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -67.86 -40.04 83.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.255 0.55 . . . . 0.0 110.066 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.54 65.24 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.696 -179.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.03 -35.68 81.05 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.62 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.0 -32.99 73.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.548 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . 0.535 ' OD1' ' NZ ' ' A' ' 267' ' ' LYS . 4.4 m-20 -70.97 -44.83 65.19 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.501 0.667 . . . . 0.0 110.405 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.443 ' O ' ' OG ' ' A' ' 222' ' ' SER . 12.6 mt-30 -61.19 -44.0 97.99 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.085 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 224' ' ' LEU . 41.4 tp -64.43 -40.37 95.63 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.379 178.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.423 ' CG ' ' HB3' ' A' ' 267' ' ' LYS . 4.9 t80 -51.79 -48.83 63.65 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.31 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 219' ' ' GLN . 59.5 p -55.04 -51.67 65.59 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.58 -178.239 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.441 HE21 HD12 ' A' ' 220' ' ' LEU . 16.7 mt-30 -51.99 -26.76 11.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.423 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.799 HD22 HG21 ' A' ' 313' ' ' VAL . 15.6 mt -97.11 -20.31 18.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.717 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.7 p -74.5 -22.59 58.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.759 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -102.72 19.72 18.66 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.893 -179.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 224' ' ' LEU . 0.9 OUTLIER -75.9 143.15 41.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.929 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 315' ' ' GLY . 47.2 t0 -52.4 108.19 1.02 Allowed Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 123.37 0.419 . . . . 0.0 110.434 178.056 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 230' ' ' LYS . 51.3 Cg_exo -51.8 -24.5 18.53 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.737 2.291 . . . . 0.0 113.043 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 229' ' ' PRO . 7.5 ttpm? -30.25 -53.16 0.16 Allowed 'General case' 0 CA--C 1.505 -0.787 0 O-C-N 123.568 0.543 . . . . 0.0 110.951 -177.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.467 ' O ' ' C ' ' A' ' 232' ' ' GLY . 38.9 m-20 -102.43 -17.65 15.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.751 179.009 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 231' ' ' ASP . . . 25.17 46.35 0.02 OUTLIER Glycine 0 N--CA 1.475 1.259 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 231' ' ' ASP . 38.1 m -112.72 110.39 20.48 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.672 0.272 . . . . 0.0 110.928 -178.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 76.6 t -127.56 94.09 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.481 0.658 . . . . 0.0 109.959 178.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.0 t -96.4 123.07 48.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.107 -178.117 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.561 HG13 HD13 ' A' ' 311' ' ' ILE . 87.4 t -92.54 120.21 41.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.442 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 57.1 mt -104.35 144.35 31.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.961 -179.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.417 ' HA2' HG12 ' A' ' 309' ' ' VAL . . . -125.16 130.27 7.28 Favored Glycine 0 N--CA 1.482 1.723 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.871 179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 239' ' ' TYR . 0.4 OUTLIER -114.91 125.43 53.63 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.83 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 253' ' ' SER . 43.0 p -120.92 166.93 13.12 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 109.933 -179.374 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -80.84 -175.12 5.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.417 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -113.72 122.88 48.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.198 0.523 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.736 HG22 ' O ' ' A' ' 243' ' ' ILE . 47.6 mm -120.06 14.73 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.719 0.771 . . . . 0.0 110.633 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.29 -47.46 3.31 Favored Glycine 0 C--N 1.316 -0.55 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 20.7 m -73.19 89.66 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.114 0.483 . . . . 0.0 110.006 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.547 ' O ' ' NE2' ' A' ' 250' ' ' GLN . 98.9 m-20 -44.36 -46.17 9.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.365 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.81 86.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.629 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.599 ' CZ ' HD11 ' A' ' 252' ' ' LEU . 51.2 t80 -60.33 -44.59 95.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.54 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -62.46 -43.47 98.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.562 -179.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 246' ' ' ASP . 0.9 OUTLIER -65.69 -41.95 91.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.513 -179.991 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.86 95.91 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.599 HD11 ' CZ ' ' A' ' 248' ' ' TYR . 39.1 mt -70.25 -39.41 75.01 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.065 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.448 ' N ' HG21 ' A' ' 240' ' ' THR . 3.7 t -63.21 -42.78 99.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 0.0 110.605 -178.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -69.33 -35.43 75.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.36 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.4 tpp85 -60.66 -54.3 47.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.672 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.874 ' O ' HG23 ' A' ' 260' ' ' VAL . 16.4 ptp180 -64.42 -44.6 90.68 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 120.95 0.405 . . . . 0.0 110.565 179.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.462 ' N ' ' HG3' ' A' ' 256' ' ' ARG . . . -61.7 -39.2 90.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.46 0.647 . . . . 0.0 110.303 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -74.99 -43.87 51.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.266 179.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 6.9 t -61.98 -38.43 88.57 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.29 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 256' ' ' ARG . 94.4 t -64.75 -50.98 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.622 178.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.616 HG13 HD12 ' A' ' 274' ' ' ILE . 14.4 t -61.29 -49.1 85.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.298 179.139 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -46.48 -40.8 13.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.079 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 263' ' ' TYR . . . . . 0.622 ' CE2' ' NZ ' ' A' ' 267' ' ' LYS . 67.0 t80 -81.71 -33.9 30.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 264' ' ' LEU . 0.7 OUTLIER -65.08 -28.95 69.81 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.208 -179.521 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.544 ' C ' ' H ' ' A' ' 267' ' ' LYS . 81.6 mt -67.18 -52.22 45.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.273 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.4 p -49.65 -7.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 -179.108 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.622 ' NZ ' ' CE2' ' A' ' 263' ' ' TYR . 66.3 mmtt -79.97 -5.63 56.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.711 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 97.09 42.3 3.3 Favored Glycine 0 CA--C 1.508 -0.373 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.96 130.83 23.89 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.321 179.075 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.35 128.34 28.83 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.781 1.654 . . . . 0.0 112.104 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -63.12 -11.0 16.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -88.68 -26.3 21.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.679 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.83 -24.59 58.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.386 0.612 . . . . 0.0 110.457 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 274' ' ' ILE . . . . . 0.616 HD12 HG13 ' A' ' 261' ' ' VAL . 1.6 pt -101.83 -176.79 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.857 -179.331 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . . . . . . . . . 16.3 m -169.21 126.67 0.95 Allowed 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.653 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -94.93 151.11 19.48 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -155.89 142.17 18.41 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.377 0.608 . . . . 0.0 111.179 179.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -93.08 93.16 1.72 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.349 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 239' ' ' TYR . 5.0 tpt -70.49 -3.89 20.09 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.674 0.273 . . . . 0.0 110.65 -179.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 41.06 -116.32 0.85 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -135.87 70.47 1.42 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 122.604 -0.351 . . . . 0.0 110.526 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.7 m -77.58 -40.08 43.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.306 0.574 . . . . 0.0 111.477 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -124.58 62.37 32.7 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.659 -178.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.59 112.75 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.801 2.334 . . . . 0.0 111.364 179.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 286' ' ' THR . 32.1 m -71.37 -39.51 71.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.891 179.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 288' ' ' ASN . 51.4 p -63.61 -48.27 78.02 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.779 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -51.77 -2.01 0.05 OUTLIER Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 288' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 286' ' ' THR . 60.1 t30 -113.55 -60.41 1.89 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.704 0.288 . . . . 0.0 110.308 179.005 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -80.43 -2.76 47.09 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.73 -179.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 290' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -126.88 17.53 7.33 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.504 179.889 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 291' ' ' ASP . 32.8 p-10 -69.82 -3.28 14.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.977 0.418 . . . . 0.0 110.506 -179.594 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -99.75 32.06 3.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.429 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.456 HG21 ' SG ' ' A' ' 290' ' ' CYS . 5.2 t -133.87 127.36 52.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.954 0.407 . . . . 0.0 110.357 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -118.75 13.42 13.24 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.063 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 295' ' ' GLN . . . . . 0.631 HE22 ' CZ ' ' A' ' 296' ' ' ARG . 8.8 mm-40 -105.92 137.64 43.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.587 0.708 . . . . 0.0 110.248 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 296' ' ' ARG . . . . . 0.631 ' CZ ' HE22 ' A' ' 295' ' ' GLN . 0.0 OUTLIER -61.15 -54.59 42.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.468 179.954 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.62 85.83 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.016 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.18 -33.31 75.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.557 179.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.554 ' O ' ' N ' ' A' ' 303' ' ' LEU . 33.4 mt -82.48 -61.67 1.83 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.496 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 296' ' ' ARG . 45.0 mt -42.83 -34.47 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -80.63 -44.26 19.15 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.124 0.488 . . . . 0.0 110.318 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 302' ' ' CYS . . . . . 0.459 ' O ' HG21 ' A' ' 286' ' ' THR . 44.2 t -74.88 -8.18 55.71 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.978 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 299' ' ' LEU . 73.9 mt -92.98 17.86 10.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.732 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' A' ' 305' ' ' PRO . . . -79.24 -45.56 1.68 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.336 179.711 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 305' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 304' ' ' ALA . 34.5 Cg_exo -59.63 8.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 123.085 2.523 . . . . 0.0 111.821 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 304' ' ' ALA . 49.6 m-20 -103.87 12.04 34.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 307' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -114.45 94.63 4.88 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.606 0.717 . . . . 0.0 110.176 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . 0.417 ' O ' ' CD1' ' A' ' 239' ' ' TYR . 39.4 ptt180 -154.38 131.46 11.0 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.694 0.759 . . . . 0.0 112.295 -179.018 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 309' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 196' ' ' LEU . 0.0 OUTLIER -95.49 134.49 32.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.046 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -116.74 104.63 11.54 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.305 0.574 . . . . 0.0 110.295 -179.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.561 HD13 HG13 ' A' ' 236' ' ' VAL . 3.5 mm -78.96 114.04 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.106 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -92.17 122.21 34.44 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 123.532 0.52 . . . . 0.0 110.488 -179.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.799 HG21 HD22 ' A' ' 224' ' ' LEU . 25.2 t -122.23 114.83 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.549 -179.309 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -113.9 127.07 55.82 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 228' ' ' ASP . . . 99.0 39.88 3.44 Favored Glycine 0 N--CA 1.461 0.347 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.696 ' O ' ' O ' ' A' ' 317' ' ' LYS . 11.1 tt -117.09 172.67 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 317' ' ' LYS . . . . . 0.696 ' O ' ' O ' ' A' ' 316' ' ' ILE . 8.9 mtmp? -39.87 -162.8 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.121 0.962 . . . . 0.0 111.376 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 318' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -85.14 175.23 9.11 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 120.968 -1.083 . . . . 0.0 111.368 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 320' ' ' VAL . 7.2 p -142.19 156.23 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.152 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 320' ' ' VAL . 12.0 p -110.95 126.77 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.127 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 72.3 p -97.64 133.51 42.09 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.091 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 322' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -143.53 153.23 58.4 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.731 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -48.48 143.36 15.86 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.296 1.997 . . . . 0.0 112.24 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -75.2 121.8 22.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.437 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.576 179.839 . . . . . . . . 0 0 . 1 stop_ save_